PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Gronovist, J; Haggman-Henrikson, B; Eriksson, PO				Gronovist, Johan; Haggman-Henrikson, Birgitta; Eriksson, Per-Olof			Impaired jaw function and eating difficulties in Whiplash-associated disorders	SWEDISH DENTAL JOURNAL			English	Article						Chewing; eating behaviour; jaw; neck; whiplash injuries	HEAD-NECK MOVEMENTS; CERVICAL-SPINE DISORDERS; TEMPOROMANDIBULAR DISORDERS; STOMATOGNATHIC SYSTEM; SYMPTOMS; DYSFUNCTION; PAIN; PREVALENCE; MODULATION; INJURY	Eating requires mouth opening, biting, chewing and swallowing and should be performed without dysfunction or pain. Previous studies have shown that jaw opening-closing movements are the result of coordinated activation of both jaw and neck muscles,with simultaneous movements in the temporomandibular, atlanto-occipital and cervical spine joints. Consequently, it can be assumed that pain or dysfunction in any of the three joint systems involved could impair jaw activities. In fact, recent findings support this hypothesis by showing an association between neck injury and reduced amplitudes, speed and coordination of integrated jaw-neck movements. This study investigated the possible association between neck injury and disturbed eating behaviour. Fifty Whiplash-associated disorders (WAD) patients with pain and dysfunction in the jaw-face region and 50 healthy age-and sex-matched controls without any history of neck injury participated in the study. All participants were assessed by a questionnaire, which contained 26 items about eating behaviour jaw pain and dysfunction. For the WAD group there were significant differences in jaw pain and dysfunction and eating behaviour before and after the accident, but no significant differences between WAD before and healthy. The healthy and the WAD group before the accident reported no or few symptoms. The WAD patients after the accident reported pain and dysfunction during mouth opening, biting, chewing, swallowing and yawning and felt fatigue, stiffness and numbness in the jaw-face region. In addition, a majority also reported avoiding tough food and big pieces of food, and taking breaks during meals. Altogether, these observations suggest an association between neck injury and disturbed jaw function and therefore impaired eating behaviour. A clinical implication is that examination of jaw function should be recommended as part of the assessment and rehabilitation of WAD patients.	[Gronovist, Johan; Haggman-Henrikson, Birgitta; Eriksson, Per-Olof] Umea Univ, Clin Oral Physiol Fac Med, Muscle & Motor Control & MotoRehab Lab, SE-90187 Umea, Sweden		Eriksson, PO (corresponding author), Umea Univ, Clin Oral Physiol Fac Med, Muscle & Motor Control & MotoRehab Lab, SE-90187 Umea, Sweden.	per-olof.eriksson@odont.umu.se	Haggman-Henrikson, Birgitta/C-6998-2008	Haggman-Henrikson, Birgitta/0000-0001-6088-3739	Department of Odontology; Faculty of Medicine, Umea University; Public Dental Health Service, Vasterbotten, Sweden; RTP (The Swedish Association of Survivors of Traffic Accidents and Polio)	Supported by the Department of Odontology and the Faculty of Medicine, Umea University, the Public Dental Health Service, Vasterbotten, Sweden, and RTP (The Swedish Association of Survivors of Traffic Accidents and Polio).	Capra NF, 2000, PAIN, V86, P151, DOI 10.1016/S0304-3959(00)00231-1; Ciancaglini R, 1999, SCAND J REHABIL MED, V31, P17; CLARK GT, 1987, J AM DENT ASSOC, V115, P251, DOI 10.14219/jada.archive.1987.0231; De Laat A, 1998, Clin Oral Investig, V2, P54, DOI 10.1007/s007840050045; DeWijer A, 1996, J ORAL REHABIL, V23, P742, DOI 10.1046/j.1365-2842.1996.d01-187.x; DeWijer A, 1996, J ORAL REHABIL, V23, P733, DOI 10.1046/j.1365-2842.1996.00427.x; Egermark I, 2001, ACTA ODONTOL SCAND, V59, P40, DOI 10.1080/000163501300035788; Elfving L, 2002, SWED DENT J, V26, P9; Eriksson PO, 2007, ARCH ORAL BIOL, V52, P404, DOI 10.1016/j.archoralbio.2006.12.016; Eriksson PO, 2000, J DENT RES, V79, P1378, DOI 10.1177/00220345000790060501; Eriksson PO, 2004, EUR J ORAL SCI, V112, P25, DOI 10.1111/j.0909-8836.2004.00098.x; Eriksson PO, 1998, J ORAL REHABIL, V25, P859, DOI 10.1046/j.1365-2842.1998.00333.x; ERIKSSON PO, 2005, CONNS CURRENT THERAP, P1128; Feine JS, 2006, J ORAL REHABIL, V33, P301, DOI 10.1111/j.1365-2842.2006.01614.x; Ferrari R, 2005, ANN RHEUM DIS, V64, P1337, DOI 10.1136/ard.2004.034447; Freeman MD, 1999, SPINE, V24, P86, DOI 10.1097/00007632-199901010-00022; Haggman-Henrikson B, 2006, J DENT RES, V85, P1001, DOI 10.1177/154405910608501105; Haggman-Henrikson B, 2004, J DENT RES, V83, P864, DOI 10.1177/154405910408301108; Haggman-Henrikson B, 2002, J DENT RES, V81, P747, DOI 10.1177/154405910208101105; Haggman-Henrikson B, 2004, J DENT RES, V83, P946, DOI 10.1177/154405910408301211; HEISE AP, 1992, J ORAL MAXIL SURG, V50, P825, DOI 10.1016/0278-2391(92)90273-3; Hellstrom F, 2000, J DENT RES, V79, P1815, DOI 10.1177/00220345000790101401; HU JW, 1993, PAIN, V55, P243, DOI 10.1016/0304-3959(93)90153-G; Igarashi N, 2000, BRAIN RES, V871, P151, DOI 10.1016/S0006-8993(00)02433-1; Johansson H, 1999, AM J IND MED, P104; Kasch H, 2002, J OROFAC PAIN, V16, P118; KIRVESKARI P, 1988, ACTA ODONTOL SCAND, V46, P281, DOI 10.3109/00016358809004778; Klobas L, 2004, SWED DENT J, V28, P29; Magnusson T, 2000, J OROFAC PAIN, V14, P310; Ro JY, 2001, PAIN, V92, P117, DOI 10.1016/S0304-3959(00)00477-2; Sale H, 2007, J AM DENT ASSOC, V138, P1084, DOI 10.14219/jada.archive.2007.0320; SPITZER WO, 1995, SPINE, V20, pS1; Visscher CM, 2001, EUR J ORAL SCI, V109, P76, DOI 10.1034/j.1600-0722.2001.00996.x; Zafar H, 2006, SWED DENT J, V30, P9; Zafar H, 2000, ARCH ORAL BIOL, V45, P675, DOI 10.1016/S0003-9969(00)00032-7; Zeredo JL, 2003, J DENT RES, V82, P402, DOI 10.1177/154405910308200515; Zeredo JL, 2002, J DENT RES, V81, P39, DOI 10.1177/154405910208100109	37	23	23	0	2	SWEDISH DENTAL JOURNAL	STOCKHOLM	BOX 1217, SE-111 82 STOCKHOLM, SWEDEN	0347-9994			SWED DENT J	Swed. Dent. J.		2008	32	4					171	178					8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	389HC	WOS:000262082500003	19172918				2022-02-06	
J	Kitagawa, Y; Yasuki, T; Hasegawa, J				Kitagawa, Yuichi; Yasuki, Tsuyoshi; Hasegawa, Junji			Research Study on Neck Injury Lessening with Active Head Restraint Using Human Body FE Model	TRAFFIC INJURY PREVENTION			English	Article						Rear Impacts; Neck Injury; Seats; Active Head Restraint		Objectives: The objective of this study is to examine the effectiveness of the active head restraint system in reducing neck injury risk of car occupants in low-speed rear impacts. Methods: A human body FE model "THUMS" was used to simulate head and neck kinematics of the occupant and to evaluate loading to the neck. Joint capsule strain was calculated to predict neck injury risk as well as NIC. The validity of the model was confirmed comparing its mechanical responses to those in human subjects in the literatures. Seat FE models were also prepared representing one with a fixed head restraint and the other one with an active head restraint system. The active head restraint system was designed to move the head restraint forward and upward when the lower unit was lower unit was loaded by the pelvis. Rear impact simulations were performed assuming a triangular acceleration pulse at a delta-V of 25 km/h. Results: The model reproduced similar head and neck motions to those measured in the human volunteer test, except for active muscular responses. The calculated joint capsule strain also showed a good match with those of PMHS tests in the literature. A rear-impact simulation was conducted using the model with the fixed head restraint. The result revealed that NIC was strongly correlated with the relative acceleration between the head and the torso and that its maximum peak appeared when the head contacted the head restraint. It was also found that joint capsule strain grew in later timing synchronizing with the relative displacement. Another simulation with the active head restraint system showed that both NIC and joint capsule strain were lowered owing to the forward and upward motion of the head restraint. A close investigation of the vertebral motion indicated that the active head restraint reduced the magnitude of shear deformation in the facet joint, which contributed to the strain growth in the fixed head restraint case. Conclusions: Rear-impact simulations were conducted using a human body FE model, THUMS, representing an average-size male occupant. The cervical system including the facet joint capsules was incorporated to the model. The validity of the model was examined comparing its mechanical responses to those in the literature such as the whole body motion of the volunteer subject and the vertebral motion in the PMHS tests. Rear-impact simulations were conducted using the validated THUMS model and two prototype seat models; one had a fixed head restraint and the other one was equipped with an active head restraint system. The active head restraint system works moving the head restraint forward and upward when the lower unit is loaded by the pelvis. The head and neck kinematics and responses were analyzed from the simulation results. The force and acceleration rose at the pelvis first, followed by T1 and the head. The early timing of force rise and its magnitude indicated that the pelvis force was a good trigger for the active head restraint system. The results showed that the head was supported earlier in a case with the active head restraint system, and both NIC and joint capsule strain were lowered. The study also analyzed the mechanism of strain growth in the joint capsules. Relatively greater strain was observed in the direction of the facet joint surface, which was around 45 degrees inclined to the spinal column. The forward and upward motion of the active head restraint were aligned with the direction of the joint deformation and contributed to lower strain in the joint capsules. The results indicated that the active head restraint could help reduce the neck injury risk not only by supporting the head at an early timing but also through its trajectory stopping the joint deformation.	[Kitagawa, Yuichi; Yasuki, Tsuyoshi] Toyota Motor Co Ltd, Toyota 4718572, Japan; [Hasegawa, Junji] Toyota Motor Co Ltd, Susono, Japan		Kitagawa, Y (corresponding author), Toyota Motor Co Ltd, 1 Toyota Cho, Toyota 4718572, Japan.	yuichi@kitagawa.tec.toyota.co.jp					Deng B, 2000, Stapp Car Crash J, V44, P171; Haland Y., 1996, P IRCOBI C, P123; HASEGAWA J, 2004, P INT C BIOM IMP, P321; IWAMOTO M, 2002, P IRCOBI C, P31; JAKOBSSON L, 2004, THESIS CHALMERS U TE; *JAP NAT POL AG, 2004, TRAFF GREEN PAP 2003; KITAGAWA Y, 2007, P 20 ESV C; KITAGAWA Y, 2008, P WORLD C NECK PAIN; Kitagawa Yuichi, 2006, Stapp Car Crash J, V50, P545; KRAFT R, P INT C BIOM IMP, P221; Kullgren A., 2007, P 20 ESV C; Lee Kathryn E, 2004, Stapp Car Crash J, V48, P373; Lu Ying, 2005, Stapp Car Crash J, V49, P49; *MIN LAND INFR TRA, 2002, P 3 CAR SAF S; Ono K., 1997, P IRCOBI C, P223; SAWADA M, 2005, P 19 ESV C; SEKIZUKA M, 1998, P 16 ESV C; Siegmund G P, 2000, Stapp Car Crash J, V44, P159; SVENSSON Y, 1993, P INT C BIOM IMP, P189; WINKELSTEIN BA, 1999, P 43 STAPP CAR CRASH, P243; Yamada H., 1970, STRENGTH BIOL MAT; YOGANANDAN N, 1998, P 42 STAPP CAR CRASH	22	23	25	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2008	9	6					574	582		10.1080/15389580802381954			9	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	387DN	WOS:000261932000011	19058105				2022-02-06	
J	Ord, JS; Greve, KW; Bianchini, KJ				Ord, Jonathan S.; Greve, Kevin W.; Bianchini, Kevin J.			Using the Wechsler Memory Scale-III to detect malingering in mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Wechsler scales; memory; malingering; response bias; neuropsychological assessment; traumatic brain injury	VERBAL-LEARNING TEST; RARELY MISSED INDEX; WMS-III; NEUROCOGNITIVE DYSFUNCTION; HEAD-INJURY; PERFORMANCE; VALIDATION; INDICATORS; SPECIFICITY; SENSITIVITY	This study examined the classification accuracy of the WMS-III primary indices in the detection of Malingered Neurocognitive Dysfunction (MND) in Traumatic Brain Injury (TBI) using a known-groups design. Sensitivity, specificity, and positive predictive power are presented for a range of index scores comparing mild TBI non-malingering (n = 34) and mild TBI malingering (n = 31) groups. A moderate/severe TBI non-malingering (n = 28) and general clinical group (n = 93) are presented to examine specificity in these samples. In mild TBI, sensitivities for the primary indices ranged from 26% to 68% at 97% specificity. Three systems used to combine all eight index scores were also examined and all achieved at least 58% sensitivity at 97% specificity in mild TBI. Specificity was generally lower in the moderate/severe TBI and clinical comparison groups. This study indicates that the WMS-III primary indices can accurately identify malingered neurocognitive dysfunction in mild TBI when used as part of a comprehensive classification system.	[Ord, Jonathan S.; Greve, Kevin W.; Bianchini, Kevin J.] Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; BUTCHER JN, 1989, MMPI, V2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Glassmire DM, 2003, J CLIN EXP NEUROPSYC, V25, P465, DOI 10.1076/jcen.25.4.465.13875; Gouvier WD, 1998, CRIT ISS NE, P55; Greve KW, 2007, CLIN NEUROPSYCHOL, V21, P318, DOI 10.1080/13854040500488552; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; HEATON RK, 2003, CLIN INTERPRETATION, V3, P181; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Killgore WDS, 2000, PSYCHOL REP, V86, P851, DOI 10.2466/PR0.86.3.851-857; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Lange RT, 2006, J CLIN EXP NEUROPSYC, V28, P294, DOI 10.1080/13803390490918156; Langeluddecke PM, 2005, J CLIN EXP NEUROPSYC, V27, P576, DOI 10.1080/13803390490918372; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; LARRABEE GJ, 2007, EVALUATION MALINGERI, P334; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; [No title captured]	38	23	23	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2008	22	4					689	704		10.1080/13854040701425437			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	321WH	WOS:000257336700008	17853130				2022-02-06	
J	Pearce, JMS				Pearce, J. M. S.			Observations on concussion	EUROPEAN NEUROLOGY			English	Article						concussion, definitions of; commotio cerebri; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; WHITE MATTER; HEAD-INJURY; LESIONS; MEMORY	The word 'concussion' has several meanings and applications that are controversial. This paper attempts to trace the historical origins and evolution of the descriptive classifications of concussive head injuries. It is suggested that head injuries should be described on the available evidence of the severity and duration of altered consciousness, traumatic amnesia and, when present, the variably associated neurological, physiological and imaging signs. The word concussion reflects an overenthusiastic trend in medical labelling. Since our understanding of types of brain injury and their symptoms and sequelae has advanced, the term should be abandoned. Copyright (C) 2007 S. Karger AG, Basel.	[Pearce, J. M. S.] Hull Royal Infirm, Dept Neurol, Kingston Upon Hull HU3 2JZ, N Humberside, England		Pearce, JMS (corresponding author), 304 Beverley Rd, Anlaby HU10 7BG, E Yorks, England.						ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BENSON DF, 1967, J NEUROL NEUROSUR PS, V30, P539, DOI 10.1136/jnnp.30.6.539; Berner O, 1930, VIRCHOWS ARCH A, V277, P386, DOI 10.1007/BF02275335; BLONSTEIN JL, 1957, LANCET, V1, P362; BOIREL A, 1674, TRAITE PLAIES TETE; Breasted J., 1930, E SMITH SURG PAPYRUS; Bright R., 1827, REPORTS MED CASES SE; BRYANT R, 1878, PRACTICE SURG; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; DECAPRI JB, 1518, TRACTATUS FRACTURA C; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DURET H, 1920, TRAUMATISMS CRANIOCE; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; FANO S, 1853, MEM SOC CHIR PARIS, V3, P162; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; FLAMM E S, 1972, Medical History, V16, P194; GERSDORPF H, 1517, FELDBUCH WUNDARTZNEI; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KOCH W, 1874, ARCH KLIN CHIR, V17, P190; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LITTRE M, 1705, HIST ACAD ROYALE SCI, P54; *LOEB CLASS LIBR, 1923, HIPP WOUNDS HEAD HIP; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; MCLATCHIE G, 1994, BRIT MED J, V308, P1620, DOI 10.1136/bmj.308.6944.1620; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PARE A, 1634, OEUVRES COMPLETES; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; SYMONDS C, 1962, LANCET, V1, P1; Trotter W, 1924, LANCET, V1, P935; Vance BM, 1927, ARCH SURG-CHICAGO, V14, P1023, DOI 10.1001/archsurg.1927.01130170071005; VONBERGMANN E, 1880, LEHRE KOPFVERLETZUNG, V30; *WORLD FED NEUR, NEWSL; YARNELL PR, 1970, LANCET, V1, P863; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; AM HERITAGE SCI DICT	52	23	23	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.		2008	59	3-4					113	119		10.1159/000111872			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	265PA	WOS:000253371700001	18057896	Bronze			2022-02-06	
J	Shuttleworth-Edwards, AB; Smith, I; Radloff, SE				Shuttleworth-Edwards, Ann B.; Smith, Ian; Radloff, Sarah E.			Neurocognitive vulnerability amongst university rugby players versus noncontact sport controls	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Sports concussion; Rugby Union	TRAUMATIC BRAIN-INJURY; FOOTBALL SOCCER PLAY; NEUROPSYCHOLOGICAL IMPAIRMENT; COGNITIVE IMPAIRMENT; HEAD TRAUMA; CONCUSSION; RECOVERY; IMPACT; PERFORMANCE; SCHOOL	University rugby players were compared with IQ-equivalent noncontact sports controls on memory and attentional tasks at the pre- and postseason intervals. Results revealed significant lowering for rugby players relative to controls at the postseason interval for attentional tasks with a speeded visuomotor component (ImPACT Visual Motor Speed; Trail Making Test, TMT, A and B). There was a practice effect for controls only between the pre- and postseason intervals for attentional tasks that commonly reveal improvements after a long retest interval (TMT A and B; Digits Backwards). Medium to large effect sizes implicate clinically relevant cognitive vulnerability for university-level rugby players in association with years of exposure to repetitive concussive injury.	[Shuttleworth-Edwards, Ann B.] Rhodes Univ, Psychol Clin, Dept Psychol, ZA-6139 Grahamstown, South Africa; [Radloff, Sarah E.] Rhodes Univ, Dept Stat, ZA-6139 Grahamstown, South Africa		Shuttleworth-Edwards, AB (corresponding author), Rhodes Univ, Psychol Clin, Dept Psychol, ZA-6139 Grahamstown, South Africa.	a.edwards@ru.ac.za			South African National Research Foundation (NRF)National Research Foundation - South Africa; Rhodes University Council	This research was funded by the South African National Research Foundation (NRF) and a Rhodes University Council Grant. Thanks are due to: coresearchers Stephanie Case and Melissa Boulind who assisted in the data collection; Andre Kock for scoring assistance and editing; and Professor Mark Lovell, Director of the University of Pittsburgh Medical School Sports Concussion Center for donation of the ImPACT software for the purposes of the research. The first author is commercially involved in concussion management in South Africa, using the ImPACT program.	Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Barth JT, 1989, MILD HEAD INJURY, P257; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bieliauskas LA, 2007, J INT NEUROPSYCH SOC, V13, P687, DOI 10.1017/S1355617707070877; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Briscoe J H, 1985, Br J Sports Med, V19, P67; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/0013164401614002; Cumming G, 2001, EXPLORATORY SOFTWARE; Cysique LA, 2007, J INT NEUROPSYCH SOC, V13, P1, DOI 10.1017/S1355617707070026; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; DELANEY JS, 2007, BRIT J SPORTS MED; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Farace E, 2003, J INT NEUROPSYCH SOC, V9, P207; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; HILLIS WS, 1994, BRIT MED J, V309, P657, DOI 10.1136/bmj.309.6955.657; Iverson G. L., 2002, IMMEDIATE POSTCONCUS; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770; Kelly JP, 1997, NEUROLOGY, V48, P581; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; KNIGHT RG, 1992, NEUROPSYCHOLOGY DEGE; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LINGARD DA, 1976, NEW ZEAL MED J, V83, P69; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon Joseph C, 2002, Clin Neurosurg, V49, P319; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; NATHAN M, 1983, S AFR MED J, V64, P132; Pettersen JA, 2000, PSYCHOBIOLOGY, V28, P81; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reitan R., 1979, MANUAL ADM NEUROPSYC; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Shuttleworth-Edwards A, 2004, STUD NEUROPSYCHOL DE, P149; Shuttleworth-Jordan AB, 1993, P 5 NAT NEUR C S AFR, P38; SHUTTLEWORTHEDW.AB, 2008, CLIN J SPORT M UNPUB; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	69	23	23	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	8					870	884		10.1080/13803390701846914			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	362OJ	WOS:000260206700002	18608657				2022-02-06	
J	Van Baalen, B; Odding, E; Stam, HJ				Van Baalen, B.; Odding, E.; Stam, H. J.			Cognitive status at discharge from the hospital determines discharge destination in traumatic brain injury patients	BRAIN INJURY			English	Article						cognitive status; discharge destination; hospital; traumatic brain injury	HEAD-INJURY; RATING-SCALE; REHABILITATION; COMA	Purpose: To determine which basic and functional status characteristics of patients with a moderate or severe traumatic brain injury (TBI) are associated with discharge destination. Method: Cross-sectional study among TBI patients. The study included 111 patients aged 16-67 years with a moderate-to-severe TBI (Glasgow Coma Scale (GCS) score 3-14). Functional outcome was assessed with Barthel Index (BI), Functional Independence Measurement (FIM), Level of Cognitive Functioning Scale (LCFS), Functional Assessment Measurement (FAM), Supervision Rating Scale (SRS) and Neurobehavioural Rating Scale (NRS). Patients were interviewed at the time of being discharged from hospital. Outcome variable was discharge destination; (1) home vs. institution and (2) rehabilitation centre vs. nursing home. Results: Gender, age and length of stay were not associated with discharge destination. TBI severity, physical status, level of arousal and cognitive status were univariately associated. Multivariate analyses, however, showed that the risk of being admitted to an institution was significantly higher for those with severe TBI (adjusted OR = 14) and/or lowered cognitive status at the time of discharge from hospital (adjusted OR = 12). Conclusions: Discharge destination is associated with TBI-severity at admittance to the hospital and cognitive status at discharge from the hospital.	[Van Baalen, B.; Odding, E.; Stam, H. J.] Erasmus MC, Dept Rehabil Med, NL-3000 CA Rotterdam, Netherlands		Van Baalen, B (corresponding author), Erasmus MC, Dept Rehabil Med, NL-3000 CA Rotterdam, Netherlands.	j.t.m.vanbaalen@erasmusmc.nl					Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Collin C, 1988, Int Disabil Stud, V10, P61; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Hall KM, 1997, ARCH PHYS MED REHAB, V78, pS5, DOI 10.1016/S0003-9993(97)90149-0; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; TEASDALE G, 1974, LANCET, V2, P81; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Unsworth CA, 1993, CLIN REHABIL, V7, P181; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	21	23	23	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	1					25	32		10.1080/02699050701810662			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400004	18183506				2022-02-06	
J	Cohen, O; De La Zerda, DJ; Beygui, R; Hekmat, D; Laks, H				Cohen, O.; De La Zerda, D. J.; Beygui, R.; Hekmat, D.; Laks, H.			Donor brain death mechanisms and outcomes after heart transplantation	TRANSPLANTATION PROCEEDINGS			English	Article							INTRACRANIAL-PRESSURE; GRADUAL INCREASE; ACTIVATION; EXPERIENCE; INJURY; IMPACT	We sought to explore whether the cause of donor brain death influenced recipient outcomes after cardiac transplantation. In retrospect, 358 consecutive donors provided cardiac allografts to adult patients undergoing orthotopic heart transplantation at a single urban US medical center from January 2000 through December 2005. Alternate recipients were excluded. Mechanism and cause of donor brain injury and death were divided into five categories: anoxia (nontraumatic) (n = 36), blunt head trauma (n = 220), penetrating head trauma (n = 83), brain tumor/infection (n = 7), and cerebrovascular event (n = 12). The five subgroups were categorized as traumatic or nontraumatic. The end points of the study were causes of early and late mortality, survival, and rejection rate. There were 59 deaths in the 6-year period. Total and short-term recipient mortality were found to be statistically higher among heart transplant recipients when the donors suffered from traumatic brain death compared to those whose brain death etiology was nontraumatic (P =.045, P =.033, respectively). Rejection rate was similar in all groups (P =.497). In conclusion, donor traumatic brain death was found to be a valid risk factor for recipient mortality after heart transplantation. Caution should be used when evaluating such donors, particularly in the presence of other risk factors.	[Cohen, O.; De La Zerda, D. J.; Beygui, R.; Hekmat, D.; Laks, H.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiac Surg, Los Angeles, CA 90095 USA		Cohen, O (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiac Surg, Box 951741,62-182 CHS, Los Angeles, CA 90095 USA.	oved.cohen@gmail.com	cohen, oved/AAI-7068-2020				Anyanwu AC, 2003, J HEART LUNG TRANSPL, V22, P281, DOI 10.1016/S1053-2498(02)00490-4; Baroldi G, 1997, J HEART LUNG TRANSPL, V16, P994; Billingham M, 2005, J HEART LUNG TRANSPL, V24, P1709, DOI 10.1016/j.healun.2005.03.018; Billingham M E, 1990, J Heart Transplant, V9, P587; Birks EJ, 2000, TRANSPLANTATION, V70, P1498, DOI 10.1097/00007890-200011270-00018; BUSSON M, 1995, TRANSPLANT P, V27, P1662; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; Goel Radha, 2005, Congest Heart Fail, V11, P99; Marelli D, 2002, ANN THORAC SURG, V74, P1558, DOI 10.1016/S0003-4975(02)03933-4; MARELLI D, 2000, CLIN TRANSPL, V10, P297; McCarthy JF, 1998, ANN THORAC SURG, V65, P1574, DOI 10.1016/S0003-4975(98)00138-6; Mehra MR, 2004, J AM COLL CARDIOL, V43, P806, DOI 10.1016/j.jacc.2003.08.059; NOVITZKY D, 1988, TRANSPLANTATION, V45, P964, DOI 10.1097/00007890-198805000-00025; Plenz G, 2002, J AM COLL CARDIOL, V39, P1508, DOI 10.1016/S0735-1097(02)01791-6; POWNER DJ, 1992, J HEART LUNG TRANSPL, V11, P1046; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Takada M, 1998, TRANSPLANTATION, V65, P1533, DOI 10.1097/00007890-199806270-00001; Taylor DO, 2003, J HEART LUNG TRANSPL, V22, P616, DOI 10.1016/S1053-2498(03)00186-4; Tsai FC, 2002, J HEART LUNG TRANSPL, V21, P623, DOI 10.1016/S1053-2498(01)00425-9; VANLOON J, 1993, J NEUROSURG, V79, P705, DOI 10.3171/jns.1993.79.5.0705; WAHLERS T, 1991, J HEART LUNG TRANSPL, V10, P22; Wilhelm MJ, 2000, J HEART LUNG TRANSPL, V19, P414, DOI 10.1016/S1053-2498(00)00073-5; Wilhelm MJ, 2000, CIRCULATION, V102, P2426, DOI 10.1161/01.CIR.102.19.2426	24	23	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	DEC	2007	39	10					2964	2969		10.1016/j.transproceed.2007.08.102			6	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	246WG	WOS:000252037900004	18089301				2022-02-06	
J	Rite, I; Arguelles, S; Venero, JL; Garcia-Rodriguez, S; Ayala, A; Cano, J; Machado, A				Rite, I.; Argueelles, S.; Venero, J. L.; Garcia-Rodriguez, S.; Ayala, A.; Cano, J.; Machado, A.			Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						haptoglobin; transthyretin; Apo E; rat cerebrospinal fluid; nigrostriatal dopaminergic system; axotomy; Parkinson's disease; substantia nigra; proteome	TRAUMATIC BRAIN-INJURY; AMYLOID-BETA-PROTEIN; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; GENE-EXPRESSION; TRANSTHYRETIN; SYSTEM; DEMENTIA; CSF	We have performed proteomic analysis in the cerebrospinal fluid in an animal model of Parkinson's disease induced by axotomy of the medial forebrain bundle. In this model, the degeneration of dopaminergic neurons was completed in 14 days, with a loss of about 50% dopaminergic neurons in the substantia nigra and a loss of more than 80% dopamine terminals in the striatum, with a similar diminution of dopamine levels in both structures. Proteins were separated by 2D electrophoresis and identified by matrix-assisted laser desorption-ionization time-of-flight (MALDI-TOF). We found significant increases of haptoglobin and transthyretin along with a decrease of Apo E concentrations in the cerebrospinal fluid of axotomized animals. Changes for haptoglobin and transthyretin were further confirmed in cerebrospinal fluid and plasma by Western blotting. These results suggest that monitoring plasma levels of these signals appears to be a promising biological marker of neuronal degeneration of the nigrostriatal dopaminergic system. (C) 2007 Wiley-Liss, Inc.	[Rite, I.; Argueelles, S.; Venero, J. L.; Garcia-Rodriguez, S.; Ayala, A.; Cano, J.; Machado, A.] Univ Seville, Fac Farm, Dept Bioquim Bromatol & Toxicol, E-41012 Seville, Spain		Machado, A (corresponding author), Univ Seville, Fac Farm, Dept Bioquim, C Prof Garcia Gonzalez 2, E-41012 Seville, Spain.	machado@us.es	IBIS, ENVEJECIMIENTO/O-9381-2015; Arguelles, Sandro/Y-6343-2019; Ayala, Antonio/N-7591-2019; Venero, Jose/E-9979-2015	Arguelles, Sandro/0000-0001-8450-3227; Ayala, Antonio/0000-0001-9711-3711; Venero, Jose/0000-0003-1137-8706			BLENNOW K, 1994, NEUROREPORT, V5, P2534, DOI 10.1097/00001756-199412000-00032; CARLSSON J, 1991, CLIN CHIM ACTA, V196, P167, DOI 10.1016/0009-8981(91)90070-S; Choe LH, 2002, ELECTROPHORESIS, V23, P2242, DOI 10.1002/1522-2683(200207)23:14<2242::AID-ELPS2242>3.0.CO;2-F; Consiglio AR, 2000, BRAIN RES PROTOC, V5, P109, DOI 10.1016/S1385-299X(99)00062-8; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Danik M, 1999, CRIT REV NEUROBIOL, V13, P357, DOI 10.1615/CritRevNeurobiol.v13.i4.20; Davidsson P, 2002, MOL BRAIN RES, V109, P128, DOI 10.1016/S0169-328X(02)00549-1; DIEDRICH JF, 1991, J VIROL, V65, P4759, DOI 10.1128/JVI.65.9.4759-4768.1991; DIVINO CM, 1990, J BIOL CHEM, V265, P1425; do Nascimento CO, 2004, BIOCHEM BIOPH RES CO, V313, P702, DOI 10.1016/j.bbrc.2003.12.008; Farrer M, 2005, NEUROLOGY, V65, P738, DOI 10.1212/01.WNL.0000169023.51764.b0; FRYER HJL, 1986, ANAL BIOCHEM, V153, P262, DOI 10.1016/0003-2697(86)90090-4; Fujita K, 1998, BRAIN RES, V785, P31, DOI 10.1016/S0006-8993(97)00612-4; Fukuyama R, 2000, EUR NEUROL, V43, P161, DOI 10.1159/000008157; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Herrera AJ, 2000, NEUROBIOL DIS, V7, P429, DOI 10.1006/nbdi.2000.0289; Hund E, 2001, NEUROLOGY, V56, P431, DOI 10.1212/WNL.56.4.431; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Jiang L, 2003, AMINO ACIDS, V25, P49, DOI 10.1007/s00726-003-0356-6; Johnson Ginger, 1992, Applied and Theoretical Electrophoresis, V3, P47; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kay AD, 2003, J NEUROTRAUM, V20, P243, DOI 10.1089/089771503321532824; Landen M, 1996, DEMENTIA, V7, P273, DOI 10.1159/000106892; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Lesage S, 2005, AM J HUM GENET, V77, P330, DOI 10.1086/432422; Li MD, 2000, J NEUROSCI, V20, P1318; Lim KL, 2003, IUBMB LIFE, V55, P315, DOI 10.1080/1521654031000153030; Liverman CS, 2004, MOL BRAIN RES, V126, P57, DOI 10.1016/j.molbrainres.2004.02.028; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAZURKOLECKA B, 1995, BRAIN RES, V698, P217, DOI 10.1016/0006-8993(95)00873-O; Merched A, 1998, FEBS LETT, V425, P225, DOI 10.1016/S0014-5793(98)00234-8; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Piccini P, 2004, LANCET NEUROL, V3, P284, DOI 10.1016/S1474-4422(04)00736-7; PIRTTILA T, 1994, J NEUROL SCI, V127, P90, DOI 10.1016/0022-510X(94)90140-6; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Revuelta M, 1997, GLIA, V21, P204, DOI 10.1002/(SICI)1098-1136(199710)21:2<204::AID-GLIA4>3.3.CO;2-U; RIISOEN H, 1988, ACTA NEUROL SCAND, V78, P455, DOI 10.1111/j.1600-0404.1988.tb03687.x; ROHIFF C, 2000, ELECTROPHORESIS, V21, P1227; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Serot J M, 1997, Ann N Y Acad Sci, V826, P507, DOI 10.1111/j.1749-6632.1997.tb48514.x; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SNIPS GJ, 1986, P NATL ACAD SCI USA, V83, P1130, DOI 10.1073/pnas.83.4.1130; STCLAIR D, 1994, NEUROSCI LETT, V176, P45, DOI 10.1016/0304-3940(94)90867-2; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAN EK, 2007, IN PRESS HUM MUTAT; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; Venero JL, 1997, J NEUROCHEM, V68, P2458; Venero JL, 2003, FREE RADICAL BIO MED, V34, P111, DOI 10.1016/S0891-5849(02)01191-7; Westman-Brinkmalm A, 2002, ANAL BIOCHEM, V301, P161, DOI 10.1006/abio.2001.5487	55	23	25	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC	2007	85	16					3607	3618		10.1002/jnr.21452			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	243EP	WOS:000251778200012	17705290				2022-02-06	
J	Smits, M; Hunink, MGM; Nederkoorn, PJ; Dekker, HM; Vos, PE; Kool, DR; Hofman, PAM; Twijnstra, A; de Haan, GG; Tanghe, HLJ; Dippel, DWJ				Smits, M.; Hunink, M. G. M.; Nederkoorn, P. J.; Dekker, H. M.; Vos, P. E.; Kool, D. R.; Hofman, P. A. M.; Twijnstra, A.; de Haan, G. G.; Tanghe, H. L. J.; Dippel, D. W. J.			A history of loss of consciousness or post-traumatic amnesia in minor head injury: "conditio sine qua non" or one of the risk factors?	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC INTRACRANIAL HEMATOMA; COMPUTED-TOMOGRAPHY; BRAIN INJURY; MILD; MANAGEMENT; METAANALYSIS; ADULTS; RULE; GUIDELINES; DIAGNOSIS	Objective: A history of loss of consciousness (LOC) or post-traumatic amnesia (PTA) is commonly considered a prerequisite for minor head injury (MHI), although neurocranial complications also occur when LOC/PTA are absent, particularly in the presence of other risk factors. The purpose of this study was to evaluate whether known risk factors for complications after MHI in the absence of LOC/PTA have the same predictive value as when LOC/PTA are present. Methods: A prospective multicentre study was performed in four university hospitals between February 2002 and August 2004 of consecutive blunt head injury patients (>= 16 years) presenting with a normal level of consciousness and a risk factor. Outcome measures were any neurocranial traumatic CT finding and neurosurgical intervention. Common odds ratios (OR) were estimated for each of the risk factors and tested for homogeneity. Results: 2462 patients were included: 1708 with and 754 without LOC/PTA. Neurocranial traumatic findings on CT were present in 7.5% and were more common when LOC/PTA was present (8.7%). Neurosurgical intervention was required in 0.4%, irrespective of the presence of LOC/PTA. ORs were comparable across the two subgroups (p>0.05), except for clinical evidence of a skull fracture, with high ORs both when LOC/PTA was present (OR = 37, 95% CI 17 to 80) or absent (OR = 6.9, 95% CI 1.8 to 27). LOC and PTA had significant ORs of 1.9 (95% CI 1.0 to 2.7) and 1.7 (95% CI 1.3 to 2.3), respectively. Conclusion: Known risk factors have comparable ORs in MHI patients with or without LOC or PTA. MHI patients without LOC or PTA need to be explicitly considered in clinical guidelines.	[Smits, M.; Tanghe, H. L. J.] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Hunink, M. G. M.] Erasmus Univ, Med Ctr, Dept Radiol, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [de Haan, G. G.] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Dippel, D. W. J.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Dekker, H. M.] Univ Med Ctr Nijmegen St Radboud, Dept Radiol, Nijmegen, Netherlands; [Vos, P. E.] Univ Med Ctr Nijmegen St Radboud, Dept Neurol, Nijmegen, Netherlands; [Kool, D. R.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Nederkoorn, P. J.] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Hofman, P. A. M.] Univ Hosp Maastricht, Dept Radiol, Maastricht, Netherlands; [Twijnstra, A.] Univ Hosp Maastricht, Dept Neurol, Maastricht, Netherlands		Hunink, MGM (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Dept Radiol, Rotterdam, Netherlands.	m.hunink@erasmusmc.nl	Smits, Marion/AAB-3985-2019; Smits, Marion/E-4795-2011; Dippel, Diederik/AAJ-2192-2020; Dekker, H.M./L-4262-2015; Vos, Pieter/A-6043-2012	Smits, Marion/0000-0001-5563-2871; Dippel, Diederik/0000-0002-9234-3515; 			ALTMAN DG, 1999, PRACTICAL STAT MED R, P268; Batchelor J, 2002, EMERG MED J, V19, P515, DOI 10.1136/emj.19.6.515; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Kruijk JR, 2001, BRAIN INJURY, V15, P117, DOI 10.1080/026990501458353; Dunham CM, 1996, J TRAUMA, V41, P679, DOI 10.1097/00005373-199610000-00014; Dunning J, 2004, J NEUROTRAUM, V21, P877, DOI 10.1089/0897715041526122; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; HOSMER DW, 1989, APPL LOGISTIC REGRES, P74; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Hunink MGM, 2005, RADIOLOGY, V235, P375, DOI 10.1148/radiol.2352040727; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLINE R, 1998, METHODOLOGY SOCIAL S, P74; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; NICE, HEAD INJ TRIAG ASS I; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; *SIGN, EARL MAN PAT HEAD IN; SMITS M, 2007, RADIOLOGY; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Sonis J, 1998, Fam Med, V30, P584; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; TWIJNSTRA A, GUIDELINES DIAGNOSIS; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	36	23	25	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	DEC	2007	78	12					1359	1364		10.1136/jnnp.2007.117143			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	240CD	WOS:000251563700016	17470468	Green Submitted, Green Published			2022-02-06	
J	Dean, NP; Boslaugh, S; Adelson, D; Pineda, JA; Leonard, JR				Dean, Nathan P.; Boslaugh, Susan; Adelson, David; Pineda, Jose A.; Leonard, Jeffrey R.			Physician agreement with evidence-based recommendations for the treatment of severe traumatic brain injury in children	JOURNAL OF NEUROSURGERY			English	Article						guideline; intracranial hypertension; pediatric neurosurgery; survey; traumatic brain injury	INTRACRANIAL-PRESSURE; CARE	Object. The aim of this study was to evaluate physician agreement with published recommendations and guidelines for the management of severe traumatic brain injury (TBI) in children and to identify markers associated with physician responses matching published guidelines. Methods. An Internet survey was created based on recommendations and guidelines published in 2003 and was sent to US physicians and neurosurgeons caring for pediatric patients with severe TBI. Agreement with each recommendation was tabulated. Characteristics of the surveyed physicians and their institutions were compared to identify markers of conformity with first-tier recommendations (intracranial pressure [ICP] treatment threshold, monitoring cerebral perfusion pressure, use of sedation/neuromuscular blockade, and use of hyperosmolar therapy). Results. One hundred ninety-four US physicians responded: 36 neurosurgeons and 158 nonsurgeons. Overall, physician responses matched most recommendations more than 60% of the time. The serum osmolality threshold of hypertonic saline., use of prophylactic hyperventilation, and differences in ICP thresholds based on a child's age comprised the recommendations with the least agreement. No physician variable was linked to increased agreement with first-tier recommendations. Conclusions. Overall, physician responses coincided with the published guidelines and recommendations. Examples of variable conformance most likely reflect the paucity of available data and lack of randomized controlled trials in the field of severe TBI.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA		Dean, NP (corresponding author), Childrens Natl Med Ctr, Div Pediat Crit Care, 111 Michigan Ave NW, Washington, DC 20010 USA.	ndean@cnmc.org	Pineda, Jose/W-2806-2019				Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Dominguez TE, 2004, CRIT CARE MED, V32, P1438, DOI 10.1097/01.CCM.0000124860.91886.C2; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kornecki A, 2002, CHILD NERV SYST, V18, P375, DOI 10.1007/s00381-002-0613-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717	14	23	23	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	2007	107	5		S			387	391		10.3171/PED-07/11/387			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	233GT	WOS:000251079200005	18459901				2022-02-06	
J	Bellinger, DC				Bellinger, David C.			Lead neurotoxicity in children: Decomposing the variability in dose-effect relationships	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article; Proceedings Paper	Workshop on Neurotoxic Metals - Lead, Mercury and Manganese	JUN 17-18, 2006	Brescia, ITALY	ICOH, Sci Comm Toxicol Metals, ICOH, Sci Comm Neurotoxicol & Psychophysiol		lead; children; neurotoxicity	AMINOLEVULINIC-ACID DEHYDRATASE; ENVIRONMENTAL-HEALTH DISPARITIES; PHYSIOLOGICALLY-BASED MODELS; TRAUMATIC BRAIN-INJURY; BONE-SEEKING ELEMENTS; BLOOD-LEAD; ENRICHED ENVIRONMENT; INFANT DEVELOPMENT; MOUSE MODEL; GENETIC SUSCEPTIBILITY	Background Enormous progress has been made in recent decades in our understanding of lead neurotoxicology in children, but an important obstacle to additional progress is the striking variability that is evident in any plot of a lead biomarker versus a health endpoint. Methods In this article, three potential sources of variability are identified: (1) errors or imprecision in characterizing dose (and/or outcome); (2) incomplete characterization of endpoint variance attributable to factors other than lead; and (3) inter-individual differences in susceptibility to lead neurotoxicity. Results Strategies are suggested for reducing the variability contributed by these sources, including the development of validated PBPK models and biomarkers of early biological effects; the development of more comprehensive models of outcome variance and, specifically, the application of multi-level models that incorporate supra-individual and supra-family risk factors; and the use of study designs that permit assessments of the effect modifying influence of contextual factors on the form and severity of neurotoxicity. Conclusion Decomposing the variability in the distribution of observed scores around the best-fit lines that describe the dose-effect relationships for lead neurotoxicity in children is a major research need.	Childrens Hosp, Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA		Bellinger, DC (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	david.bellinger@childrens.harvard.edu					Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; BELLINGER D, 1990, ENVIRON HEALTH PERSP, V89, P5, DOI 10.2307/3430890; BELLINGER D, 1985, ENVIRON RES, V38, P119, DOI 10.1016/0013-9351(85)90077-5; BELLINGER D, 1988, NEUROTOXICOL TERATOL, V10, P497, DOI 10.1016/0892-0362(88)90084-0; Bellinger DC, 2000, NEUROTOXICOL TERATOL, V22, P133, DOI 10.1016/S0892-0362(99)00053-7; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Bergdahl IA, 1999, ENVIRON RES, V80, P25, DOI 10.1006/enrs.1998.3880; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Chia SE, 2004, NEUROTOXICOLOGY, V25, P1041, DOI 10.1016/j.neuro.2004.01.010; CHIA SE, IN PRESS NEUROTOXICO; Chuang HY, 2001, ENVIRON HEALTH PERSP, V109, P527, DOI 10.2307/3454713; Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9; Cory-Slechta DA, 2005, NEUROTOXICOLOGY, V26, P491, DOI 10.1016/j.neuro.2004.12.007; COSTA DA, IN PRESS NEUROBIOL A; Cremin JD, 1999, TOXICOL APPL PHARM, V161, P283, DOI 10.1006/taap.1999.8807; ERNHART CB, 1995, NEUROTOXICOL TERATOL, V17, P227, DOI 10.1016/0892-0362(94)00087-T; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Frank DA, 2005, NEUROTOXICOL TERATOL, V27, P15, DOI 10.1016/j.ntt.2004.09.003; FROEHLICH TE, 2006, EFFECTS DRD4 LEAD SE; GALLO LC, 2003, PSYCHOL BULL, V10, P129; GOCHFELD M, IN PRESS ENC RES; GRANDJEAN P, 2005, TOXICOL APPL PHARM S, V1, P652; Grandjean Philippe, 2004, Int J Occup Med Environ Health, V17, P131; GREENE T, 1991, J DEV BEHAV PEDIATR, V12, P378; Guilarte TR, 2003, ANN NEUROL, V53, P50, DOI 10.1002/ana.10399; HARVEY PG, 1984, SCI TOTAL ENVIRON, V40, P45, DOI 10.1016/0048-9697(84)90341-3; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Kamel F, 2005, NEURODEGENER DIS, V2, P195, DOI 10.1159/000089625; Kamel F, 2003, ENVIRON HEALTH PERSP, V111, P1335, DOI 10.1289/ehp.6109; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; LANSDOWN R, 1986, INT ARCH OCC ENV HEA, V57, P225, DOI 10.1007/BF00405790; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; LEGGETT RW, 1993, ENVIRON HEALTH PERSP, V101, P598, DOI 10.2307/3431645; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Li LZ, 2005, BIOCHEM BIOPH RES CO, V334, P293, DOI 10.1016/j.bbrc.2005.05.162; Louis ED, 2005, MOVEMENT DISORD, V20, P1170, DOI 10.1002/mds.20565; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; Meng XM, 2005, NEUROLOGY, V64, P1644, DOI 10.1212/01.WNL.0000160391.58004.D4; MONTENEGRO MF, 2005, ARCH TOXICOL, V9, P1; Morello-Frosch R, 2002, ENVIRON HEALTH PERSP, V110, P149, DOI 10.1289/ehp.02110s2149; Neugebauer NM, 2004, DEV BRAIN RES, V153, P213, DOI 10.1016/j.devbrainres.2004.09.001; OFLAHERTY EJ, 1993, TOXICOL APPL PHARM, V118, P16, DOI 10.1006/taap.1993.1004; OFLAHERTY EJ, 1995, TOXICOL APPL PHARM, V131, P297, DOI 10.1006/taap.1995.1072; Onalaja AO, 2000, ENVIRON HEALTH PERSP, V108, P23, DOI 10.2307/3454630; Payne-Sturges D, 2006, ENVIRON RES, V102, P146, DOI 10.1016/j.envres.2005.11.001; Rauh VA, 2003, J COMMUNITY PSYCHOL, V31, P255, DOI 10.1002/jcop.10049; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rothman K.J., 1998, MODERN EPIDEMIOLOGY, P7; Schneider T, 2006, NEUROPSYCHOPHARMACOL, V31, P36, DOI 10.1038/sj.npp.1300767; Smith D, 2002, ENVIRON HEALTH PERSP, V110, P263, DOI 10.1289/ehp.02110263; Soobader M, 2006, ENVIRON RES, V102, P172, DOI 10.1016/j.envres.2006.05.001; Spires TL, 2005, FEBS J, V272, P2347, DOI 10.1111/j.1742-4658.2005.04677.x; Stangle DE, 2004, ENVIRON HEALTH PERSP, V112, P302, DOI 10.1289/ehp.6517; Stewart WF, 2002, ENVIRON HEALTH PERSP, V110, P501, DOI 10.1289/ehp.02110501; Tong SL, 2001, ANN EPIDEMIOL, V11, P38, DOI 10.1016/S1047-2797(00)00176-9; Trope I, 2001, PEDIATRICS, V107, P1437, DOI 10.1542/peds.107.6.1437; *US EPA, 2005, ALL AG LEAD MOD; Virgolini MB, 2006, NEUROTOXICOLOGY, V27, P11, DOI 10.1016/j.neuro.2005.05.012; Virgolini MB, 2005, TOXICOL SCI, V87, P469, DOI 10.1093/toxsci/kfi269; Wallace CS, 2003, ENVIRON HEALTH PERSP, V111, P1294, DOI 10.1289/ehp.6088; Weiss B, 2006, ENVIRON HEALTH PERSP, V114, P1479, DOI 10.1289/ehp.9101; Weisskopf MG, 2004, ENVIRON HEALTH PERSP, V112, P620, DOI 10.1289/ehp.6687; Weuve J, 2006, OCCUP ENVIRON MED, V63, P746, DOI 10.1136/oem.2006.027417; White PD, 1998, ENVIRON HEALTH PERSP, V106, P1513, DOI 10.1289/ehp.98106s61513; Wilson MA, 2000, P NATL ACAD SCI USA, V97, P5540, DOI 10.1073/pnas.97.10.5540; WILSON MA, 2006, 23 INT NEUR C LITTL; WINNEKE G, 1984, NEUROPSYCHOBIOLOGY, V11, P195, DOI 10.1159/000118077; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE; Yuan WH, 2006, PEDIATRICS, V118, P971, DOI 10.1542/peds.2006-0467	72	23	23	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	OCT	2007	50	10					720	728		10.1002/ajim.20438			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health	214SM	WOS:000249758400004	17290364				2022-02-06	
J	Kerner, A; Schlenk, F; Sakowitz, O; Haux, D; Sarrafzadeh, A				Kerner, Antje; Schlenk, Florian; Sakowitz, Oliver; Haux, Daniel; Sarrafzadeh, Asita			Impact of hyperglycemia on neurological deficits and extracellular glucose levels in aneurysmal subarachnoid hemorrhage patients	NEUROLOGICAL RESEARCH			English	Article						glucose; hyperglycemia; cerebral metabolism; microdialysis; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; POOR-GRADE PATIENTS; INTRACEREBRAL MICRODIALYSIS; CEREBRAL MICRODIALYSIS; BEDSIDE MICRODIALYSIS; METABOLISM; VASOSPASM; ISCHEMIA; VALUES; SCALE	Objective: Hyperglycemia after aneurysmal subarachnoid hemorrhage (SAH) is associated with serious complications. Blood glucose may indicate a target for therapy to prevent delayed ischemic neurological deficits (DIND) and improve outcome. The objective of this study was to investigate energy metabolism in the extracellular/cerebrospinal fluid and blood in relation to outcome. Methods: Prospective non-randomized study was carried out in the intensive care unit (ICU) of university hospital (n = 170 aneurysmal SAH patients, age: 51.0 +/- 12.6 years old). Following approval by the ethics committee, a microdialysis catheter was inserted into the vascular territory of the aneurysm after clipping. Patients were studied for 165 +/- 84 hours and classified according to the presence of neurological symptoms as asymptomatic (n = 66) and symptomatic (n = 104): acute focal neurological deficits (AFND, n = 61) and delayed ischemic neurological deficits (DIND, n = 43). The microdialysates were analysed hourly for energy metabolites. Daily morning blood glucose and cerebrospinal fluid (CSF) levels (glucose and lactate) were determined. Six-month Glasgow outcome scale (GOS) was assessed. Results: Hyperglycemia on admission and high blood glucose levels on the following days were significantly related to the presence of symptoms, most pronounced in patients with poor outcome (p<0.05). In symptomatic patients (high blood glucose), the lowest extracellular fluid (ECF) glucose concentrations were found, most pronounced in the AFND group (1.0 +/- 1.2 mmol/l). The anaerobic metabolites lactate, lactate/pyruvate ratio (LPR) and lactate/glucose ratio (LGR) were higher in symptomatic patients (p<0.001) indicating cerebral metabolic distress. CSF concentrations of glucose and lactate were of no specific value. Conclusion: This study confirms the relevance of hyperglycemia to neurological outcome in SAH patients. Cerebral glucose was significantly lower in AFND patients despite hyperglycemic blood levels. More detailed works are necessary to select risk patients for optimized targeted therapy to avoid insulin-induced cerebral metabolic crisis.	Univmed Berlin, Virchow Med Ctr, Dept Neurosurg, Berlin, Germany; Univ Heidelberg, Dept Neurosurg, Heidelberg, Germany		Sarrafzadeh, A (corresponding author), Humboldt Univ, Charite Virchow Med Ctr, Clin Neurosurg, Augustenburger Platz 1, D-13353 Berlin, Germany.	asita.sarrafzadeh@charite.de		Sakowitz, Oliver/0000-0003-3248-6335			Alberti O, 2000, CLIN NEUROL NEUROSUR, V102, P78, DOI 10.1016/S0303-8467(00)00067-6; Badjatia N, 2005, CRIT CARE MED, V33, P1603, DOI 10.1097/01.CCM.0000168054.60538.2B; Bell DA, 2005, BRIT J NEUROSURG, V19, P21, DOI 10.1080/02688690500089423; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; DRAKE CG, 1988, J NEUROSURG, V68, P985; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; Germanson TP, 1998, SURG NEUROL, V49, P155, DOI 10.1016/S0090-3019(97)00337-6; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; JENNETT B, 1975, LANCET, V1, P480; Juvela S, 2005, J NEUROSURG, V102, P998, DOI 10.3171/jns.2005.102.6.0998; LANZINO G, 1993, J NEUROSURG, V79, P885, DOI 10.3171/jns.1993.79.6.0885; Mees SMD, 2003, NEUROLOGY, V61, P1132, DOI 10.1212/01.WNL.0000090466.68866.02; Mocco J, 2006, NEUROSURGERY, V59, P529, DOI 10.1227/01.NEU.0000228680.22550.A2; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Sato M, 2006, ACTA NEUROCHIR, V148, P623, DOI 10.1007/s00701-005-0717-x; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF	29	23	25	0	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	OCT	2007	29	7					647	653		10.1179/016164107X248983			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234MJ	WOS:000251167900003	18173901				2022-02-06	
J	Blizzard, CA; Haas, MA; Vickers, JC; Dickson, TC				Blizzard, C. A.; Haas, M. A.; Vickers, J. C.; Dickson, T. C.			Cellular dynamics underlying regeneration of damaged axons differs from initial axon development	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						brain injury; cytoskeleton; growth cone; growth factor; live-cell imaging	GROWTH CONE MOTILITY; SPINAL-CORD-INJURY; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; IN-VITRO; NEUROTROPHIC FACTOR; TRAUMATIC BRAIN; CEREBRAL-CORTEX; GUIDANCE; CYTOSKELETAL	While long-distance regeneration may be limited in mammalian species, it is becoming apparent that damaged mature neurons retain some capacity for attempted regeneration and that the adult CNS is not entirely inhibitory to axon growth. Our investigations show that there are critical intrinsic features of postinjury axonal regeneration that differ from initial axon development, and that these distinct differences may account for the limited and inappropriate regenerative response that currently characterizes the mature CNS. We compared the neurochemical and dynamic characteristics of developing axons to relatively mature regenerating axons, utilizing an in vitro model of axonal transection to long-term cultured rat cortical neurons. Immunolabelling studies revealed that regenerating and developing axons have a similar localization of cytoskeletal proteins, but the tips of regenerating axons, although morphologically similar, were smaller with reduced fillopodial extension, relative to developmental growth cones. Live imaging demonstrated that regenerating axons exhibited significantly less outgrowth than developmental neurites. Furthermore, growth cones of regenerating axons had a significant reduction in pausing, considered vital for interstitial branching and pathfinding, than did developmental growth cones. In addition, unlike developing axons, the regenerating axons were unresponsive to the growth factors BDNF and GDNF. Thus, although similar in their cytoskeletal composition, the growth cones of regenerative sprouts differed from their developmental counterparts in their size, their dynamic behaviour and their ability to respond to critical growth factors. These intrinsic differences may account for the inability of post-traumatic locally sprouting axons to make accurate pathway decisions and successfully respond to trauma.	Univ Tasmania, Menzies Res Inst, Neuro Repair Grp, Hobart, Tas 7001, Australia		Dickson, TC (corresponding author), Univ Tasmania, Menzies Res Inst, Neuro Repair Grp, Private Bag 29, Hobart, Tas 7001, Australia.	Tracey.Dickson@utas.edu.au	Vickers, James C/J-7464-2014	Vickers, James C/0000-0001-5671-4879; Haas, Matilda/0000-0002-5149-0471; Dickson, Tracey/0000-0002-9196-1661; Blizzard, Catherine/0000-0002-8683-2937			Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Blackmore M, 2006, J NEUROBIOL, V66, P348, DOI 10.1002/neu.20224; Brandt R, 1998, CELL TISSUE RES, V292, P181, DOI 10.1007/s004410051049; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Chuckowree JA, 2004, NEUROSCIENTIST, V10, P280, DOI 10.1177/1073858404263511; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Dent EW, 2003, NEUROSCIENTIST, V9, P343, DOI 10.1177/1073858403252683; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson TC, 1999, EXP NEUROL, V156, P100, DOI 10.1006/exnr.1998.7010; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Dickson TC, 2005, NEUROBIOL DIS, V18, P286, DOI 10.1016/j.nbd.2004.10.001; Dickson TC, 2007, NEUROREPORT, V18, P283, DOI 10.1097/WNR.0b013e3280143cdb; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Haas MA, 2004, EUR J NEUROSCI, V20, P1436, DOI 10.1111/j.1460-9568.2004.03620.x; Hafidi A, 2004, J COMP NEUROL, V470, P80, DOI 10.1002/cne.20003; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hortsch M, 1996, NEURON, V17, P587, DOI 10.1016/S0896-6273(00)80192-0; Jones SL, 2006, J NEUROBIOL, V66, P1630, DOI 10.1002/neu.20309; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kalil K, 1996, PROG BRAIN RES, V108, P31, DOI 10.1016/S0079-6123(08)62530-3; King CE, 1997, NEUROREPORT, V8, P1663; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; LURIE DI, 1994, J COMP NEUROL, V344, P559, DOI 10.1002/cne.903440406; Mason CA, 1997, J NEUROSCI, V17, P1086; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Niwa H, 2002, NEUROCHEM RES, V27, P485, DOI 10.1023/A:1019896502774; Salin P, 1995, J NEUROSCI, V15, P8234; Skaliora I, 2000, J NEUROSCI, V20, P3650, DOI 10.1523/JNEUROSCI.20-10-03650.2000; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Swanwick CC, 2004, J COMP NEUROL, V478, P405, DOI 10.1002/cne.20295; Szebenyi G, 1998, J NEUROSCI, V18, P7930; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vickers JC, 2000, PROG NEUROBIOL, V60, P139, DOI 10.1016/S0301-0082(99)00023-4; Woodhouse A, 2005, NEUROTOX RES, V7, P5, DOI 10.1007/BF03033772; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang GX, 2005, NEUROREHAB NEURAL RE, V19, P46, DOI 10.1177/1545968305274577; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou LJ, 2003, J NEUROSCI RES, V74, P221, DOI 10.1002/jnr.10718	49	23	23	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	SEP	2007	26	5					1100	1108		10.1111/j.1460-9568.2007.05750.x			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205QT	WOS:000249130400003	17767489				2022-02-06	
J	Gross, J; Machulik, A; Amarjargal, N; Moller, R; Ungethum, U; Kuban, RJ; Fuchs, FU; Andreeva, N; Fuchs, J; Henke, W; Pohl, EE; Szczepek, AJ; Haupt, H; Mazurek, B				Gross, Johann; Machulik, Astrid; Amarjargal, Nyamaa; Moller, Renate; Ungethuem, Ute; Kuban, Ralf-Juergen; Fuchs, Frank-Uwe; Andreeva, Nadezhda; Fuchs, Julia; Henke, Wolfgang; Pohl, Elena E.; Szczepek, Agnieszka J.; Haupt, Heidemarie; Mazurek, Birgit			Expression of apoptosis-related genes in the organ of Corti, modiolus and stria vascularis of newborn rats	BRAIN RESEARCH			English	Article						apoptosis; cochlea; culture; gene expression; microarray; rat	TRAUMATIC BRAIN-INJURY; EXTRACELLULAR-SUPEROXIDE DISMUTASE; CELL-DEATH; BCL-2 FAMILY; OXIDATIVE STRESS; MESSENGER-RNA; HEARING-LOSS; AUDITORY NEURONS; CASPASE ACTIVITY; SPIRAL GANGLION	Cell death in the inner ear tissues is an important mechanism leading to hearing impairment. Here, using microarrays and real-time RT-PCR we analyzed expression of selected apoptosis -related genes in rat's inner ear. We determined the gene expression in tissues freshly isolated from neonatal rats (3-5 days old) and compared it to that of explants cultured for 24 h under normoxic or hypoxic conditions. For the analyses, we used pooled samples of the organ of Corti (OC), modiolus (MOD) and stria. vascularis (SV), respectively. We observed region-specific changes in gene expression between the fresh tissues and the normoxic culture. In the OC, expression of the proapoptotic genes caspase-2, caspase-3, caspase-6 and calpain-1 was downregulated. In the MOD, the antioxidative defense SOD-2 and SOD-3 were upregulated. In the SV, caspase-2, caspase-6, calpain-1 and SOD-3 were downregulated and SOD-2 upregulated. We speculate that these changes could reflect survival shift in transcriptome of inner ear explants tissues under in vitro conditions. With the exception of SOD-2, hypoxic culture conditions induced the same changes in gene expression as the normoxic conditions indicating that culture preparation is likely the dominating factor, which modifies the gene expression pattern. We conclude that various culture conditions induce different expression pattern of apoptosis -related genes in the organotypic cochlear cultures, as compared to fresh tissues. This transcriptional pattern may reflect the survival ability of specific tissues and could become a tempting target for a pharmacological intervention in inner ear diseases. (c) 2007 Elsevier B.V. All rights reserved.	Univ Med Berlin, Mol Biol Res Lab, Dept Othorhinolaryngol, Charite, D-10117 Berlin, Germany; Acad Med Sci, Brain Res Inst, Moscow, Russia; Inst Cell & Neurobiol, Berlin, Germany		Gross, J (corresponding author), Univ Med Berlin, Mol Biol Res Lab, Dept Othorhinolaryngol, Charite, CharitePl 1, D-10117 Berlin, Germany.	johann.gross@charite.de	Szczepek, Agnieszka J./C-1434-2019; Pohl, Elena E./A-4025-2009; Szczepek, Agnieszka/AAK-8514-2021	Pohl, Elena E./0000-0002-0604-5950; Szczepek, Agnieszka/0000-0002-9292-6606; Amarjargal, Nyamaa/0000-0002-8541-8662			Andreeva N, 2006, NEUROSCI LETT, V396, P86, DOI 10.1016/j.neulet.2005.11.013; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Brockhaus F, 1999, BIOCHEM J, V338, P295, DOI 10.1042/0264-6021:3380295; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Chen MHJ, 2006, NEUROSCI LETT, V397, P69, DOI 10.1016/j.neulet.2005.12.011; Cheng AG, 1999, BRAIN RES, V850, P234, DOI 10.1016/S0006-8993(99)01983-6; Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; CIANCIO G, 1988, J HISTOCHEM CYTOCHEM, V36, P1147, DOI 10.1177/36.9.2457047; Dhar-Mascareno M, 2005, FREE RADICAL BIO MED, V38, P1311, DOI 10.1016/j.freeradbiomed.2005.01.017; Endo T, 2005, LARYNGOSCOPE, V115, P2016, DOI 10.1097/01.mlg.0000183020.32435.59; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Feghali J G, 1998, Ear Nose Throat J, V77, P282; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gao J, 1999, J NEURAL TRANSM, V106, P111, DOI 10.1007/s007020050143; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Ginham R, 2001, NEUROSCI LETT, V302, P113, DOI 10.1016/S0304-3940(01)01687-1; Gramsbergen JB, 2002, BRAIN RES, V935, P47, DOI 10.1016/S0006-8993(02)02451-4; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Gross J, 2005, HEARING RES, V204, P183, DOI 10.1016/j.heares.2005.02.001; Harrison DC, 2001, MOL BRAIN RES, V89, P133, DOI 10.1016/S0169-328X(01)00058-4; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hernandez-Saavedra D, 2005, BIOMED PHARMACOTHER, V59, P204, DOI 10.1016/j.biopha.2005.03.001; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Ito A, 2000, FEBS LETT, V470, P360, DOI 10.1016/S0014-5793(00)01351-X; Jin KL, 2002, J NEUROCHEM, V81, P25, DOI 10.1046/j.1471-4159.2002.00781.x; Jin KL, 2001, J NEUROCHEM, V77, P1508, DOI 10.1046/j.1471-4159.2001.00361.x; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; Kim HN, 1996, ACTA OTO-LARYNGOL, V116, P805, DOI 10.3109/00016489609137930; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kirby J, 2002, HUM MOL GENET, V11, P2061, DOI 10.1093/hmg/11.17.2061; Kirkegaard M, 2006, NEUROSCIENCE, V142, P425, DOI 10.1016/j.neuroscience.2006.06.037; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee JE, 2004, ORL-J OTO-RHIN-LARYN, V66, P111, DOI 10.1159/000079329; Lee SJ, 2007, CELL DEATH DIFFER, V14, P1106, DOI 10.1038/sj.cdd.4402111; LEFEBVRE PP, 1991, BRAIN RES, V567, P306, DOI 10.1016/0006-8993(91)90809-A; Lefebvre PP, 2002, AUDIOL NEURO-OTOL, V7, P165, DOI 10.1159/000058304; Lindsten T, 2005, NEUROSCIENTIST, V11, P10, DOI 10.1177/1073858404269267; Lowenheim H, 1999, HEARING RES, V128, P16, DOI 10.1016/S0378-5955(98)00181-6; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004; Mazurek B, 2003, HEARING RES, V182, P2, DOI 10.1016/S0378-5955(03)00134-5; Mou K, 1997, J COMP NEUROL, V386, P529; Mou K, 1997, HEARING RES, V103, P47, DOI 10.1016/S0378-5955(96)00163-3; Nicotera TM, 2004, AUDIOL NEURO-OTOL, V9, P353, DOI 10.1159/000081284; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Nozik-Grayck E, 2005, INT J BIOCHEM CELL B, V37, P2466, DOI 10.1016/j.biocel.2005.06.012; Ohlemiller KK, 2006, BRAIN RES, V1091, P89, DOI 10.1016/j.brainres.2006.03.017; Ohlemiller KK, 2004, J COMP NEUROL, V479, P103, DOI 10.1002/cne.20326; Orita Y, 2002, OTOL NEUROTOL, V23, P34, DOI 10.1097/00129492-200201000-00009; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister Bryan, 2004, Mech Chem Biosyst, V1, P233; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Ripoll C, 1997, J NEUROSCI METH, V73, P123, DOI 10.1016/S0165-0270(96)02217-0; Riva C, 2007, EXP GERONTOL, V42, P327, DOI 10.1016/j.exger.2006.10.014; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; Shroff EH, 2007, CELL CYCLE, V6, P807, DOI 10.4161/cc.6.7.4044; Singh AB, 2002, KIDNEY INT, V62, P106, DOI 10.1046/j.1523-1755.2002.00427.x; Soane L, 2005, J BIOENERG BIOMEMBR, V37, P179, DOI 10.1007/s10863-005-6590-8; SOBKOWICZ HM, 1993, ACTA OTO-LARYNGOL, P3; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Tamada Y, 2005, BRAIN RES, V1050, P148, DOI 10.1016/j.brainres.2005.05.048; Van De Water TR, 2004, OTOL NEUROTOL, V25, P627, DOI 10.1097/00129492-200407000-00035; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Whitlon DS, 2006, NEUROSCIENCE, V138, P653, DOI 10.1016/j.neuroscience.2005.11.030; Yao XF, 1996, HEARING RES, V96, P199, DOI 10.1016/0378-5955(96)00050-0; Yokota M, 2003, BRAIN RES, V984, P122, DOI 10.1016/S0006-8993(03)03121-4; Zelko IN, 2005, ENDOCRINOLOGY, V146, P332, DOI 10.1210/en.2004-1007; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	77	23	26	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 8	2007	1162						56	68		10.1016/j.brainres.2007.05.061			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202BS	WOS:000248877100007	17612509				2022-02-06	
J	Lengenfelder, J; Chiaravalloti, ND; DeLuca, J				Lengenfelder, Jean; Chiaravalloti, Nancy D.; DeLuca, John			The efficacy of the generation effect in improving new learning in persons with traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article; Proceedings Paper	30th Annual Meeting of the International-Neuropsychological-Society	FEB 13-16, 2002	TORONTO, CANADA	Int Neuropsychol Soc		generation effect; traumatic brain injury; learning and memory; cognitive rehabilitation	ALZHEIMER-TYPE DEMENTIA; SEMANTIC-MEMORY; MULTIPLE-SCLEROSIS; SELF-GENERATION; HEAD-INJURY; WORDS; DEFICITS; REHABILITATION; CONSEQUENCES; RETRIEVAL	Objective: To evaluate the usefulness of the generation effect in improving learning and memory abilities in neurologically impaired individuals. The generation effect is the observation that items self-generated by participants are better remembered than items provided by the examiner. Although this effect has shown to be relatively robust in healthy adults, few studies have examined the usefulness of the generation effect in neurological populations. Participants: 18 individuals with moderate-severe traumatic brain injury (TBI) and 18 healthy adults. Main Outcome Measure: The measure was the generation effect protocol. Results: Results indicated recall and recognition of generated information was significantly higher than that of provided information across testing conditions. However, healthy adults showed greater benefit from the generation effect than did individuals with TBI. As expected, recall and recognition performance diminished over time (i.e., immediate recall, 30 min, 1 week) however, rates of forgetting did not differ between groups. Conclusion: Self-generation significantly improved verbal learning and memory in individuals with TBI. The results of self-generation in improving learning suggest that applying that technique may be beneficial in the cognitive rehabilitation of persons with TBI.	Kessler Med Rehabil Res & Educ Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA		DeLuca, J (corresponding author), Kessler Med Rehabil Res & Educ Ctr, Neuropsychol & Neurosci Lab, 300 Execut Dr,Suite 010, W Orange, NJ 07052 USA.	jdeluca@kmrrec.org		Chiaravalloti, Nancy/0000-0003-2943-7567			Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; BEGG I, 1989, J EXP PSYCHOL LEARN, V15, P977, DOI 10.1037/0278-7393.15.5.977; BOWER GH, 1979, J RES PERS, V13, P420, DOI 10.1016/0092-6566(79)90005-9; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; DICK MB, 1989, BRAIN COGNITION, V9, P71, DOI 10.1016/0278-2626(89)90045-6; DICK MB, 1989, BRAIN COGNITION, V9, P88, DOI 10.1016/0278-2626(89)90046-8; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; GARDINER JM, 1984, MEM COGNITION, V12, P443, DOI 10.3758/BF03198305; GARDINER JM, 1985, J EXP PSYCHOL LEARN, V11, P732, DOI 10.1037/0278-7393.11.1-4.732; GOVEROVER Y, 2004, ARCH PHYS MED REHAB, V85, pE5; Higginson CI, 2000, ARCH CLIN NEUROPSYCH, V15, P185, DOI 10.1016/S0887-6177(99)00004-9; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; Jennett B, 1981, MANAGEMENT HEAD INJU; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; MCELROY LA, 1982, J VERB LEARN VERB BE, V21, P249, DOI 10.1016/S0022-5371(82)90593-X; MCFARLAND CE, 1983, J EXP CHILD PSYCHOL, V36, P413, DOI 10.1016/0022-0965(83)90043-7; MCFARLAND CE, 1985, J GERONTOL, V40, P205, DOI 10.1093/geronj/40.2.205; MITCHELL DB, 1986, J GERONTOL, V41, P79, DOI 10.1093/geronj/41.1.79; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; NAIRNE JS, 1985, MEM COGNITION, V13, P183, DOI 10.3758/BF03197011; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; SLAMECKA NJ, 1983, J VERB LEARN VERB BE, V22, P153, DOI 10.1016/S0022-5371(83)90112-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Souliez L, 1996, CORTEX, V32, P347, DOI 10.1016/S0010-9452(96)80056-6; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530; Westmacott R, 2003, MEM COGNITION, V31, P761, DOI 10.3758/BF03196114; Wilkinson G. S, 1993, WRAT 3 WIDE RANGE AC; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	37	23	24	0	10	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2007	52	3					290	296		10.1037/0090-5550.52.3.290			7	Psychology, Clinical; Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology; Rehabilitation	202LV	WOS:000248904100006					2022-02-06	
J	Hart, T; Hanks, R; Bogner, JA; Millis, S; Esselman, P				Hart, Tessa; Hanks, Robin; Bogner, Jennifer A.; Millis, Scott; Esselman, Peter			Blame attribution in intentional and unintentional traumatic brain injury: Longitudinal changes and impact on subjective well-being	REHABILITATION PSYCHOLOGY			English	Article						brain injuries; violence; psychological outcome; intentional TBI; blame attribution	SPINAL-CORD-INJURY; GLASGOW OUTCOME SCALE; LIFE SATISFACTION; REHABILITATION OUTCOMES; STRESS-DISORDER; RISK-FACTORS; SET-POINT; VIOLENCE; RESPONSIBILITY; DISABILITY	Objective: Examine longitudinal changes in attribution of blame to self and others, and concern over cause of injury, in both intentional (violence-related) and unintentional (accidental) traumatic brain injury (TBI); investigate the relation of these factors to subjective well-being outcomes at I year post-TBI. Study Design: Prospective, multicenter, observational study with longitudinal component. Participants: 99 men with unintentional TBI and 25 men with intentional TBI who sustained moderate to severe injuries, received inpatient rehabilitation, and provided data in both acute rehabilitation and 1-year follow-up. Measures: Blame Attribution Questionnaire, General Health Questionnaire-30, Neurobehavioral Functioning Inventory-Revised Depression Scale, Satisfaction With Life Scale, community participation measures. Results: At both time points, participants with intentional TBI blamed others more while those with unintentional TBI blamed themselves more (trend). Other-blame at I year predicted depression but not life satisfaction. Self-blame was not a significant predictor of depression or life satisfaction. Increasing concern over cause/blame for injury from acute rehabilitation to follow-up was associated with high levels of emotional distress. Conclusion: Blame attribution issues may be markers of TBI-related emotional distress regardless of injury etiology, particularly when others are blamed for the injury and/or concerns over cause of injury do not resolve over time.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Rehabil Inst Michigan, Detroit, MI 48202 USA; Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.	thart@einstein.edu	Bogner, Jennifer/E-2773-2011				Alicke MD, 2000, PSYCHOL BULL, V126, P556, DOI 10.1037//0033-2909.126.4.556; ATHELSTAN GT, 1979, REHABIL COUNS BULL, V22, P311; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BULMAN RJ, 1977, J PERS SOC PSYCHOL, V35, P351, DOI 10.1037/0022-3514.35.5.351; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; *CDCP, 1998, BEHAV RISK FACT SURV; Celano Marianne, 2002, Child Maltreat, V7, P65, DOI 10.1177/1077559502007001006; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; CORRIGAN J, 2000, INTRO SATISFACTION L; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2003, PROBLEMATIC SUBSTANC; Delahanty DL, 1997, J CONSULT CLIN PSYCH, V65, P560, DOI 10.1037/0022-006X.65.4.560; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Esselman PC, 2004, ARCH PHYS MED REHAB, V85, P1445, DOI 10.1016/j.apmr.2003.10.018; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Goldberg D., 1978, MANUAL GEN HLTH QUES; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hart T, 2003, REHABIL PSYCHOL, V48, P86, DOI 10.1037/0090-5550.48.2.86; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; HEINEMANN AW, 1988, REHABIL PSYCHOL, V33, P195, DOI 10.1037//0090-5550.33.4.195; Hickling EJ, 1999, J TRAUMA STRESS, V12, P345, DOI 10.1023/A:1024784711484; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Lambert JF, 2004, J NERV MENT DIS, V192, P304, DOI 10.1097/01.nmd.0000120890.16617.af; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lucas RE, 2003, J PERS SOC PSYCHOL, V84, P527, DOI 10.1037/0022-3514.84.3.527; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; Lyubomirsky S, 2001, AM PSYCHOL, V56, P239, DOI 10.1037/0003-066X.56.3.239; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; MCDOWELL I, 1996, MEASURING HLTH; Myers DG, 2000, AM PSYCHOL, V55, P56, DOI 10.1037/0003-066X.55.1.56; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REIDY K, 1994, ARCH PHYS MED REHAB, V75, P837, DOI 10.1016/0003-9993(94)90106-6; Richards JS, 1997, REHABIL PSYCHOL, V42, P115, DOI 10.1037/0090-5550.42.2.115; SCHULZ R, 1985, J PERS SOC PSYCHOL, V48, P1162, DOI 10.1037/0022-3514.48.5.1162; SHOLOMSKAS DE, 1990, J APPL SOC PSYCHOL, V20, P548, DOI 10.1111/j.1559-1816.1990.tb00427.x; *US DEP HLTH HUM S, 1998, NAT HOUSE SURV DRUG; VANDENBOUT J, 1988, J CLIN PSYCHOL, V44, P17, DOI 10.1002/1097-4679(198801)44:1<17::AID-JCLP2270440104>3.0.CO;2-J; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	52	23	23	0	10	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2007	52	2					152	161		10.1037/0090-5550.52.2.152			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	167EL	WOS:000246433900004					2022-02-06	
J	Laskey, AL; Sheridan, MJ; Hymel, KP				Laskey, Antoinette L.; Sheridan, Michael J.; Hymel, Kent P.			Physicians' initial forensic impressions of hypothetical cases of pediatric traumatic brain injury	CHILD ABUSE & NEGLECT			English	Article						traumatic brain injury; case definition; inflicted trauma; accidental trauma; survey	NONACCIDENTAL HEAD-INJURY; SHAKEN BABY SYNDROME; YOUNG-CHILDREN; RETINAL HEMORRHAGES; INFANTS; ABUSE; MECHANISMS	Objective: To describe physicians' initial forensic impressions of hypothetical cases of pediatric traumatic brain injury (TBI) and to compare the responses of pathologists and pediatricians. Method: A survey was administered to physicians who attended workshops on pediatric TBI; were members of two national internet list serves; and were members of the Section on Child Abuse and Neglect of the American Academy of Pediatrics (N= 522) and the National Association of Medical Examiners (N= 815). The survey included 16 hypothetical case scenarios depicting a pediatric TBI. Participants were asked to categorize their initial forensic impressions of each scenario on a seven-point scale from definitive unintentional to definitive inflicted injury. Results: A total of 570 surveys were completed, including 465 of 1337 surveys (35%) distributed through the regular mail. In 8 of 16 hypothetical cases, a majority of respondents (range, 60-98%) and a majority of the more experienced respondents (range, 59-97%) categorized the hypothetical TBI as either unintentional or inflicted. Pathologists were less likely than the pediatric participants to view these scenarios as inflicted TBI. Conclusion: Certain features of TBI cases result in a majority of clinicians categorizing them as inflicted or intentional. In the absence of a confession of inflicted injury, witnessed or verifiable events, severe injuries without explanation or injuries that can be linked clearly to a perinatal period, clinicians were unable to agree on the etiology of the injury. Our results will be helpful to other researchers so that consistent, validated research definitions are used to classify pediatric TBI for research purposes. (c) 2007 Elsevier Ltd. All rights reserved.	Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; Inova Fairfax Hosp, Dept Med, Falls Church, VA USA; Inova Fairfax Hosp Children, Dept Pediat, Falls Church, VA USA; Inova Fairfax Hosp, Dept Psychiat, Falls Church, VA USA		Laskey, AL (corresponding author), Indiana Univ, Sch Med, Dept Pediat, 410 W 10th St,Suite 1020, Indianapolis, IN 46202 USA.			Hymel, Kent/0000-0002-1422-182X			Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; HAHN YS, 1983, CHILD BRAIN, V10, P229; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V282, P29; McMahon SR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e299; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Shugerman RP, 1996, PEDIATRICS, V97, P664; STARLING SP, 1995, PEDIATRICS, V95, P259; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3	19	23	24	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	APR	2007	31	4					329	342		10.1016/j.chiabu.2006.02.017			14	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	173LT	WOS:000246875300002	17408739				2022-02-06	
J	Davis, KL; Joshi, AV; Tortella, BJ; Candrilli, SD				Davis, Keith L.; Joshi, Ashish V.; Tortella, Bartholomew J.; Candrilli, Sean D.			The direct economic burden of blunt and penetrating trauma in a managed care population	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	65th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 28-30, 2006	New Orleans, LA	Amer Assoc Surg Trauma		economic burden; blunt and penetrating trauma; retrospective claims analysis	BRAIN INJURY; DIAGNOSES	Background: Although the prevalence of trauma in the United States is high, data on the economic burden of this public health problem to third-party payors is limited. Methods: Retrospective claims from a large health plan were analyzed for 12,615 adults (age >= 18 years) hospitalized for blunt or penetrating trauma between January 1, 2003 and February 1, 2005. Per patient charges were estimated for resources utilized during a 6-month period before and after initial injury. Continuous health plan enrollment during these periods was required. Three cohorts were examined: isolated traumatic brain injury (TBI); other trauma with TBI (trauma w/TBI); and other trauma without TBI (trauma w/o TBI). Patients were also stratified by Injury Severity Score (ISS) and trauma designation of the admitting hospital. Results: Initial hospitalization charges ranged from $32,627 for isolated TBI to $103,667 for trauma w/TBI. Charges for initial hospitalization were highest ($199,443) among patients with the most severe injuries. Overall, initial hospitalization charges were highest among those admitted to Level I trauma centers ($68,626); for trauma w/TBI, however, initial hospitalization charges were highest among those admitted to nontrauma centers ($130,997). Charges incurred during postdischarge medical encounters ranged from $16,361 for isolated TBI to $23,761 for trauma w/TBI. Increased charges for postdischarge encounters compared with the 6-month preinjury period ranged from $6,756 for isolated TBI to $19,771 for trauma w/TBI. Conclusions: The economic burden of blunt and penetrating trauma to thirdparty payors is high. Efforts to reduce the incidence of trauma may result in substantial economic savings to managed care systems.	RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; Drexel Univ, Novo Nordisk, Philadelphia, PA 19104 USA; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA		Davis, KL (corresponding author), RTI Hlth Solut, 200 Pk Pff Dr 218, Res Triangle Pk, NC 27709 USA.	kldavis@rti.org		Candrilli, Sean/0000-0002-2062-1192; Davis, Keith/0000-0002-0044-7107			Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Finkelstein E., 2006, INCIDENCE EC BURDEN; Friedman Bernard, 2002, J Health Care Finance, V29, P1; FRIEDMAN Z, 1999, AM J FOREN MED PATH, V20, P102; *J HOPK U TRI AN I, 1998, ICDMAP 90 COMP SOFTW; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Losina E, 2003, J CLIN EPIDEMIOL, V56, P515, DOI 10.1016/S0895-4356(03)00056-8; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; *NAT TRAUM DAT BAN, 2005, NTDB ANN REP 2005 VE; Newcomer R, 1999, J AM GERIATR SOC, V47, P215, DOI 10.1111/j.1532-5415.1999.tb04580.x; Thurman DJ., 1995, GUIDELINES SURVEILLA; WYATT JP, 1996, AM J FOREN MED PATH, V17, P233	14	23	24	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2007	62	3					622	629		10.1097/TA.0b013e318031afe3			8	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	145PP	WOS:000244877300015	17414338				2022-02-06	
J	Goettler, CE; Tucci, KA				Goettler, Claudia E.; Tucci, Keith A.			Decreasing the morbidity of decompressive craniectomy: The Tucci flap	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; MANAGEMENT		E Carolina Univ, Brody Sch Med, Dept Surg, Dept Trauma & Surg Crit Care, Greenville, NC USA; Eastern Neurosurg & Spine Associates, Greenville, NC USA		Goettler, CE (corresponding author), ED 2 Trauma,600 Moye Blvd, Greenville, NC 27585 USA.	cgoettle@pcmh.com					BENZEL EC, 1991, PLAST RECONSTR SURG, V87, P153, DOI 10.1097/00006534-199101000-00026; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Wick J, 1999, AORN J, V69, P517, DOI 10.1016/S0001-2092(06)62463-0; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	9	23	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2007	62	3					777	778		10.1097/TA.0b013e31802ee55e			2	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	145PP	WOS:000244877300050	17414367				2022-02-06	
J	Baskin, JH; Edersheim, JG; Price, BH				Baskin, Joseph H.; Edersheim, Judith G.; Price, Bruce H.			Is a picture worth a thousand words? Neuroimaging in the courtroom	AMERICAN JOURNAL OF LAW & MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; EMISSION-TOMOGRAPHY; EPILEPSY; BEHAVIOR; DEFICITS; VIOLENCE; PSYCHOPATHY; MURDERERS; MATTER; DEATH		Univ Massachusetts, Sch Med, Dept Psychiat, Amherst, MA 01003 USA; Massachusetts Gen Hosp, Dept Psychiat, Law & Psychiat Serv, Boston, MA 02114 USA		Baskin, JH (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Amherst, MA 01003 USA.						[Anonymous], 2006, NATURE, V441, P907, DOI 10.1038/441907a; Appelbaum PS, 2002, PSYCHIATR SERV, V53, P389, DOI 10.1176/appi.ps.53.4.389; Bassarath L, 2001, CAN J PSYCHIAT, V46, P728, DOI 10.1177/070674370104600805; BEAR D, 1991, NEUROLOGICAL PERSPEC, pS3; Benning TB, 2003, BRIT J PSYCHIAT, V183, P563, DOI 10.1192/bjp.183.6.563; Benuzzi F, 2004, BRAIN RES BULL, V63, P269, DOI 10.1016/j.brainresbull.2004.03.005; Blair RJR, 2003, BRIT J PSYCHIAT, V182, P5, DOI 10.1192/bjp.182.1.5; Blakemore C, 2005, LANCET, V366, P2035, DOI 10.1016/S0140-6736(05)67816-6; BOBAN M, BRAIN, V129, pE42; Bonilha L, 2003, J NEUROL NEUROSUR PS, V74, P1627, DOI 10.1136/jnnp.74.12.1627; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Brower MC, 2000, EPILEPSY BEHAV, V1, P145, DOI 10.1006/ebeh.2000.0069; BRUFKIN JL, 2001, TRAUMA VIOLENCE ABUS, V6, P181; BUCKSBAUM MS, 2004, AM J PSYCHIAT, V161, P2178; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Chio A, 2003, NEUROLOGY, V61, P1412, DOI 10.1212/01.WNL.0000094383.65150.07; Chronister RB, 1997, FUNDAMENTAL NEUROSCI, P443; Cohen-Gadol AA, 2005, J NEUROSURG, V102, P902, DOI 10.3171/jns.2005.102.5.0902; CUMMINGS JL, 2003, NEUROPSYCHIATRY BEHA, P7; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; FENSTER JM, 2003, MAVERICKS MIRACLES M, P190; Filley C. M., 2000, NEUROPSY NEUROPSY BE, V14, P1; FIX JD, 1995, HIGH YIELD NEUROANAT; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; FREEMAN LZ, 1965, AM J PSYCHIAT, V120, P708; Gatzke-Kopp LM, 2001, J NEUROPSYCH CLIN N, V13, P486, DOI 10.1176/appi.neuropsych.13.4.486; GEORGE W, LIE BEHIND LIE DETEC, pCH4; GIBSON M, 2002, BORN CRIME CESARE LO, P19; GOLDSTEIN MA, 2004, MAGNETIC RESONANCE I, P21; GOULD SJ, 1977, EVER SINCE DARWIN RE, P224; GOULD SJ, 1981, MISMEASURE MAN, P124; HEINSEN H, BRAIN, V129, pE43; HELEN S, 1996, J NUCL MED, V37, P18; ICHISE M, 1994, J NUCL MED, V35, P217; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; KAUFMAN DM, 2001, CLIN NEUROLOGY PSYCH, P123; KICHL KA, 2001, BIOL PSYCHIAT, V50, P677; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Kulynych J, 1997, STANFORD LAW REV, V49, P1249, DOI 10.2307/1229252; Laakso MP, 2001, BEHAV BRAIN RES, V118, P187, DOI 10.1016/S0166-4328(00)00324-7; Lee Bruce, 2005, NeuroRx, V2, P372; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; LEVINE B, 2006, J NEUROTRAUM, V23, P1411; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; LEWIS DO, 1988, AM J PSYCHIAT, V145, P584; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; LEWIS DO, 2006, J AM ACAD PSYCHIAT L, V32, P408; Marsh L, 2000, EPILEPSY BEHAV, V1, P160, DOI 10.1006/ebeh.2000.0061; Masdeu JC, 2005, J NEUROL SCI, V236, P55, DOI 10.1016/j.jns.2005.05.001; MASS P, 1997, UNDERBROSS, P185; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; Mendez ME, 2005, J NEUROPSYCH CLIN N, V17, P413, DOI 10.1176/appi.neuropsych.17.3.413; Mendez MF, 2006, J NEUROL NEUROSUR PS, V77, P4, DOI 10.1136/jnnp.2005.072496; Miller BL, 1997, BRIT J PSYCHIAT, V170, P150, DOI 10.1192/bjp.170.2.150; Miller BL, 2007, NEUROLOGY, V68, P68, DOI 10.1212/01.wnl.0000251313.89403.b3; MORSE SJ, 1996, SEMINAR CLIN NEUROPS, P222; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Nakaji P, 2003, PEDIATRICS, V112, pE430, DOI 10.1542/peds.112.5.e430; NOVELLINE RA, 2004, SQUIRES FUNDAMENTALS, P602; Pearson H, 2006, NATURE, V441, P918, DOI 10.1038/441918a; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; Pridmore S, 2005, AUST NZ J PSYCHIAT, V39, P856, DOI 10.1111/j.1440-1614.2005.01679.x; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 1996, ARCH GEN PSYCHIAT, V53, P544; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Reid William H, 2003, J Psychiatr Pract, V9, P388, DOI 10.1097/00131746-200309000-00008; Relkin, 1996, Semin Clin Neuropsychiatry, V1, P172; RESTAK RM, 1992, SCIENCES, V32, P16, DOI 10.1002/j.2326-1951.1992.tb02400.x; SHEPHERD GM, 1999, INFORM PROCESSING DE, V393; STEFAN SJ, 2006, BRAIN, V128, P2626; Stein DJ, 2005, CNS SPECTRUMS, V10, P88, DOI 10.1017/S1092852900019404; Tiihonen J, 1997, EUR J NUCL MED, V24, P1253, DOI 10.1007/s002590050149; TONKONOGY JM, 1991, NEUROPSYCHIATRY, V3, P189; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; van Elst LT, 2000, BRAIN, V123, P234, DOI 10.1093/brain/123.2.234; VATZ RE, 2004, US TODAY MAGAZIN MAR, P26; VOLKOW ND, 1987, BRIT J PSYCHIAT, V151, P668, DOI 10.1192/bjp.151.5.668; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; WEIGER WA, 1988, J PSYCHIAT RES, V22, P85, DOI 10.1016/0022-3956(88)90073-8; Wild J, 2005, NATURE, V437, P457, DOI 10.1038/437457a; Wilson J, 1996, J NUCL MED, V37, P1256; Yang YL, 2005, BRIT J PSYCHIAT, V187, P320, DOI 10.1192/bjp.187.4.320; 2007, HARV U GAZETTE  FEB, P1	85	23	23	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0098-8588	2375-835X		AM J LAW MED	Am. J. Law Med.		2007	33	2-3					239	269		10.1177/009885880703300205			31	Law	Social Science Citation Index (SSCI)	Government & Law	205WO	WOS:000249145500005	17910159				2022-02-06	
J	Durham, SR; Duhaime, AC				Durham, Susan R.; Duhaime, Ann-Christine			Maturation-dependent response of the immature brain to experimental subdural hematoma	JOURNAL OF NEUROTRAUMA			English	Article						age; animal studies; models of injury; pediatric brain injury; traumatic brain injury	INFLICTED HEAD-INJURY; AXONAL INJURY; NEUROPATHOLOGY; CHILDREN; TRAUMA; DAMAGE; INFANTS; MODEL	In children less than 2 years of age, the radiographic finding of a subdural hematoma (SDH) in the absence of trauma is highly suggestive of inflicted head injury. Little is understood about the unique pathophysiologic response of the immature brain to a SDH. The goal of the current study was to develop an experimental SDH model to determine whether there is a maturation-dependent response of the immature brain to SDH. Fifteen domestic Yorkshire piglets of three different age groups (five each of 5-days, 1-month, and 4-months old) were selected for study. A volume of blood equal to 10% of the intracranial volume (4.5 cc in the 5-day old, 5.4 cc in the 1-month old, and 9.4 cc in the 4-month old) was injected through a right frontal burr hole. Histologic analysis, including hematoxylin and eosin staining and TUNEL staining, was performed at 7 days survival. A significant difference in percentage of injured hemisphere was noted between the 5-day old group and the 1- and 4-month old animals (p = 0.0382). The number of TUNEL-positive cells/HPF increased significantly with increasing animal age (p = 0.0450). The current study demonstrates a significant maturation-dependent response of the immature brain to SDH, with the youngest animals being quite resistant to a SDH alone. This model will allow further study of additional cerebral insults, such as the addition of apnea or seizures, which may act synergistically along with a SDH to overwhelm the innate neuroprotective capacity of the immature brain to traumatic injury.	Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA		Durham, SR (corresponding author), Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA.	srd@hitchcock.org					Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Duhaime A.C., 1993, J NEUROTRAUM, V10, pS59; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Duhaime AC, 1996, J NEUROTRAUM, V13, P79, DOI 10.1089/neu.1996.13.79; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Lo T Y M, 2003, Pediatr Rehabil, V6, P47, DOI 10.1080/1363849031000109516; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; Parizel PM, 2003, PEDIATR RADIOL, V33, P868, DOI 10.1007/s00247-003-1025-3; Ransom GH, 2003, CHILD ABUSE NEGLECT, V27, P381, DOI 10.1016/S0145-2134(03)00025-5; Sasaki M, 2001, J NEUROTRAUM, V18, P1241, DOI 10.1089/089771501317095278; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; Sawauchi S, 2002, ACT NEUR S, V81, P243; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; THOMAS JM, 1971, GROWTH, V35, P259; Tomita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P213	34	23	23	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2007	24	1					5	14		10.1089/neu.2006.0054			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	131GX	WOS:000243858100002	17263666				2022-02-06	
J	Park, JH; Strittmatter, SM				Park, James H.; Strittmatter, Stephen M.			Nogo receptor interacts with brain APP and A beta to reduce pathologic changes in Alzheimer's transgenic mice	CURRENT ALZHEIMER RESEARCH			English	Article; Proceedings Paper	7th International Conference on Alzheimers Disease Drug Discovery	OCT 12-13, 2006	New York, NY	Alzheimers Drug Discovery Fdn, Accera Inc, Acumen Pharmaceut Inc, Eisai Inc, Elan Pharmaceut Inc, Forest Lab Inc, Marteck Biosci Corp, Neurochem Inc, Ortho-McNeil Neurol Inc, Pfizer Inc, Sanofi-Aventis US Inc, Wyeth Res, Targacept Inc			NICOTINIC ACETYLCHOLINE-RECEPTOR; AXONAL REGENERATION; IN-VIVO; DISEASE; PROTEIN; INHIBITION; BINDS; BETA-AMYLOID(1-42); IDENTIFICATION; PLASTICITY	Pathophysiologic hypotheses for Alzheimer's disease (AD) are centered on the role of the amyloid plaque A beta peptide and the mechanism of its derivation from the amyloid precursor protein (APP). As part of the disease process, an aberrant axonal sprouting response is known to occur near A beta deposits. A Nogo to Nogo-66 receptor (NgR) pathway contributes to determining the ability of adult CNS axons to extend after traumatic injuries. Here, we consider the potential role of NgR mechanisms in AD. Both Nogo and NgR are mislocalized in AD brain samples. APP physically associates with the NgR. Overexpression of NgR decreases A beta production in neuroblastoma culture, and targeted disruption of NgR expression increases transgenic mouse brain A beta levels, plaque deposition, and dystrophic neurites. Infusion of a soluble NgR fragment reduces A beta levels, amyloid plaque deposits, and dystrophic neurites in a mouse transgenic AD model. Changes in NgR level produce parallel changes in secreted APP and AB, implicating NgR as a blocker of secretase processing of APP. The NgR provides a novel site for modifying the course of AD and highlights the role of axonal dysfunction in the disease.	[Park, James H.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA		Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, POB 208018, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu	; Strittmatter, Stephen/F-5739-2011	Park, James/0000-0002-1377-1707; Strittmatter, Stephen/0000-0001-8188-3092	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039962, R37NS033020, R01NS056485, R01NS042304] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37 NS033020, R01 NS056485, R01 NS042304-08, R01 NS042304, R01 NS056485-04, R37 NS033020-17, R37 NS033020-16, R01 NS039962-10, R01 NS039962] Funding Source: Medline		Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gil V, 2006, J NEUROPATH EXP NEUR, V65, P433, DOI 10.1097/01.jnen.0000222894.59293.98; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Guevara J, 2004, HISTOL HISTOPATHOL, V19, P1075, DOI 10.14670/HH-19.1075; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; YANG X, 1996, P NATL ACAD SCI USA, V9, P475	26	23	23	0	3	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050			CURR ALZHEIMER RES	Curr. Alzheimer Res.		2007	4	5					568	570		10.2174/156720507783018235			3	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	268PP	WOS:000253592000015	18220524	Green Accepted			2022-02-06	
J	Rees, RJ; Bellon, ML				Rees, Roger J.; Bellon, Michelle L.			Post concussion syndrome ebb and flow: Longitudinal effects and management	NEUROREHABILITATION			English	Article						concussion; post concussion syndrome; minimal brain damage; psychological difficulties; neurological impairment	TRAUMATIC BRAIN-INJURY; CHRONIC-FATIGUE-SYNDROME; MILD HEAD-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SELF-AWARENESS; POSTCONCUSSION SYNDROME; MEMORY IMPAIRMENT; SYMPTOMS; REHABILITATION; DEFINITION	This research identified persistent post concussion symptoms (PCS) in a group of 20 adult subjects. PCS generally lasted for two years with a mean of 3.35 years. Typical symptoms included physical and cognitive fatigue, depressive behaviors, sensitivity to noise, social withdrawal, irritability, concentration and problem solving difficulties, loss of libido and much difficulty making decisions at even the simplest strategic level. They represented a hard core group for whom the original symptoms persisted well beyond the 6 month period. Participants identified their PCS according to sensory, somatic affective and cognitive items immediately following their trauma (01) and two years later (02). Counseling and psychotherapy intervention took place between 01 and 02. Items on the PCS schedules and the Beck Depression Inventory (II) demonstrated significant decline in the presence of overall symptoms most noticeably in reduction of agitation, irritability and suicidal wishes. However, subjects throughout generally experienced the feeling that they were being punished which equated with behaviors comparable with learned helplessness. The PCS group considered themselves to be different people after trauma. They had different goals, changing lifestyle, relationships and employment and were more often in a dependent state. Comparability with other conditions such as PTSD and chronic fatigue syndrome (CFS) was demonstrated by individuals who experienced persistent and invasive post concussion symptoms.	Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia		Rees, RJ (corresponding author), Flinders Univ S Australia, Sch Med, Sturt Rd,Bedford Pk,GPO BOX 2100, Adelaide, SA 5001, Australia.	rees1@iinet.net.au		Bellon, Michelle/0000-0003-2551-1846			ABBEY SE, 1991, AM J PSYCHIAT, V148, P1638; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; Atkinson P., 1994, HDB QUALITATIVE RES, P248; Beck AT, 1987, BECK DEPRESSION INVE; BECKER M, 1995, PHARMACOECONOMICS, V7, P229, DOI 10.2165/00019053-199507030-00006; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1996, BEHAV RES THER, V34, P775, DOI 10.1016/0005-7967(96)00038-1; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BRISON S, 2002, AFERMATH VIOLENCE RE; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CICERONE KD, 2000, TRAUMATIC BRAIN INJU, P95; COREY G, 1992, THEORY PRACTICE COUN, P140; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DELUCA J, 1995, J NEUROL NEUROSUR PS, V58, P38, DOI 10.1136/jnnp.58.1.38; DeLuca J, 2004, REHABIL PSYCHOL, V49, P62, DOI 10.1037/0090-5550.49.1.62; DEVINSKY O, 1992, BEHAV NEUROLOGY 100; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fontana A., 1994, HDB QUALITATIVE RES, P361; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Gray T., 1989, NEUROPEPTIDES STRESS, P92; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; HAGEN C, 1979, REHABILTATION HEAD I; HILTON J, 1877, LECT REST PAIN; Hirt ER, 1996, J PERS SOC PSYCHOL, V71, P245, DOI 10.1037/0022-3514.71.2.245; ISEN AM, 1983, SOC COGNITION, V2, P18, DOI 10.1521/soco.1983.2.1.18; ISEN AM, 2000, HDB EMOTIONS, P00417; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kraus J, 1996, NEUROTRAUMA, P13; Larrabee GJ, 2000, CLIN GUIDE NEUROPSYC, P301; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; Levin H. S., 1987, NEUROBEHAVIORAL RECO, P262; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P97; LIDVALL F, 1974, ACTA NEUROL SCAND, V20, P56; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MARION DW, 1995, MED REHABILITATION T, P29; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; MIDDELBOE T, 1991, ACTA NEUROL SCAND, V85, P687; MILLER L, 1993, PSYCHOTHERAPY BRAIN, P173; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; PALLANT J, 2001, SPSS SURVIVAL MANUAL, P180; Patton J.H., 1991, CLIN NEUROPSYCHOL, V5, P33, DOI [10.1080/13854049108401840, DOI 10.1080/13854049108401840]; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; RASKIN NJ, 1995, CURRENT PSYCHOTHERAP, P128; RESS RJ, 2005, INTERUPTED LIVES REH; RESS RJ, 1997, PLATEAUS SUMMITS TRA; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Ruff RM, 1999, BRAIN INJURY, V13, P943; SCHLUEDERBERG A, 1992, ANN INTERN MED, V117, P325, DOI 10.7326/0003-4819-117-4-325; SCHMALING KB, 1994, PSYCHOSOM MED, V56, P383, DOI 10.1097/00006842-199409000-00001; SOHLBERG MM, 2001, COGNITIVE REHABILITA, P453; STONER HB, 1994, BRAIN CONTROL RESPON, P3; SYMONDS C, 1962, LANCET, V1, P1; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tiersky LA, 1997, J CLIN EXP NEUROPSYC, V19, P560, DOI 10.1080/01688639708403744; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wrightson P, 1999, MILD HEAD INJURY GUI; [No title captured]; [No title captured]	76	23	23	0	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2007	22	3					229	242					14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	216NM	WOS:000249884800009	17917173				2022-02-06	
J	Scremin, OU; Li, MGG; Roch, M; Booth, R; Jenden, DJ				Scremin, Oscar U.; Li, Mingen Grace; Roch, Margareth; Booth, Ruth; Jenden, Donald J.			Acetylcholine and choline dynamics provide early and late markers of traumatic brain injury	BRAIN RESEARCH			English	Article						brain injury; acetylcholine; choline	MAGNETIC-RESONANCE SPECTROSCOPY; TIME-DEPENDENT CHANGES; CEREBRAL-CORTEX; BLOOD-FLOW; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; MEMORY DEFICITS; WORKING MEMORY; RAT-BRAIN; ISCHEMIA	We assessed acetylcholine (ACh) and choline (Ch) dynamics 2.5 h, 1, 4 and 14 days after cerebral cortex impact injury or craniotomy only in adult male Sprague-Dawley rats. Cortical endogenous ACh (D0ACh), endogenous free Ch (D0Ch), deuterium-labeled Ch (D4Ch), and ACh synthesized from D4Ch (D4ACh) were measured by gas-chromatography mass-spectrometry after intravenous injection of D4Ch followed in 1 min by microwave fixation of the brain. D0Ch increased in and around the impact up to 700% of control within 1 day after trauma. Smaller D0Ch increases were found in the cortex contralateral to the impact and in both hemispheres after craniotomy only. D4Ch contents increased to 200% in the impact and surrounding regions 4-14 days post-trauma, with lower increases 2.5 h post-trauma. DOACh decreased at all times post-trauma in the impact center, and initially in the periphery and adjacent regions with a recovery at 14 days. Similar DOACh decreases, although of lesser extent and magnitude were present in the craniotomy only group. D4ACh showed a peak at one day post-trauma in all regions studied in the impact and craniotomy groups. In conclusion, D0Ch tissue level was an early marker of trauma, while 14 days after trauma Ch uptake from blood was enhanced in and around the traumatized cortex. Craniotomy by itself induced a generalized increase in ACh turnover 1 day after this minimal trauma. Choline acetyltransferase activity was reduced in the impact center region but not affected in the adjacent and contralateral regions or by cramotomy. (c) 2006 Elsevier B.V. All rights reserved.	Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Scremin, OU (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Bldg 115,Room 319, Los Angeles, CA 90073 USA.	oscremin@ucla.edu					Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Berger PA, 1979, NUTR BRAIN, P425; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; CHROBAK JJ, 1988, BRAIN RES, V463, P107, DOI 10.1016/0006-8993(88)90532-X; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; DAWSON GR, 1991, PHARMACOL BIOCHEM BE, V39, P865, DOI 10.1016/0091-3057(91)90045-4; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Gold PE, 2003, NEUROBIOL LEARN MEM, V80, P194, DOI 10.1016/j.nlm.2003.07.003; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Harada H, 2000, NEUROSCI LETT, V284, P163, DOI 10.1016/S0304-3940(00)01013-2; HARRELL LE, 1987, BEHAV NEUROSCI, V101, P644, DOI 10.1037/0735-7044.101.5.644; HUDSON DM, 1985, BRAIN RES, V338, P267, DOI 10.1016/0006-8993(85)90156-8; JENDEN DJ, 1974, LIFE SCI, V14, P55, DOI 10.1016/0024-3205(74)90245-8; JENDEN DJ, 1973, ANAL BIOCHEM, V55, P438, DOI 10.1016/0003-2697(73)90134-6; Jenden DJ, 1991, B CLIN NEUROSCI, V55, P99; KUMAGAE Y, 1991, J NEUROCHEM, V56, P1169, DOI 10.1111/j.1471-4159.1991.tb11407.x; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LUINE V, 1990, BRAIN RES, V523, P321, DOI 10.1016/0006-8993(90)91507-D; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Phillis John W., 2003, Critical Reviews in Neurobiology, V15, P61, DOI 10.1615/CritRevNeurobiol.v15.i1.30; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.3.CO;2-L; Power AE, 2003, NEUROBIOL LEARN MEM, V80, P178, DOI 10.1016/S1074-7427(03)00086-8; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sasaki M, 1987, No To Shinkei, V39, P983; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Scremin OU, 1973, STROKE, V4, P232, DOI 10.1161/01.STR.4.2.232; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; SCREMIN OU, 1991, ANNU REV PHARMACOL, V31, P229; SCREMIN OU, 1989, STROKE, V20, P1524, DOI 10.1161/01.STR.20.11.1524; SCREMIN OU, 1989, STROKE, V20, P92, DOI 10.1161/01.STR.20.1.92; Scremin OU, 1996, LIFE SCI, V58, P2011, DOI 10.1016/0024-3205(96)00192-0; Scremin OU, 1997, J NEUROTRAUM, V14, P573, DOI 10.1089/neu.1997.14.573; SCREMIN OU, 1993, PROG BRAIN RES, V98, P191; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; SZERB JC, 1967, J PHYSIOL-LONDON, V192, P329, DOI 10.1113/jphysiol.1967.sp008303; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Waite JJ, 1999, BRAIN RES, V818, P1, DOI 10.1016/S0006-8993(98)01174-3; Wyss MT, 2004, EUR J NUCL MED MOL I, V31, P312, DOI 10.1007/s00259-003-1337-4	53	23	24	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 8	2006	1124						155	166		10.1016/j.brainres.2006.09.062			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	119MQ	WOS:000243016800018	17084821				2022-02-06	
J	De Monte, VE; Geffen, GM; Massavelli, BM				De Monte, Veronica Eileen; Geffen, Gina Malke; Massavelli, Bronwyn May			The effects of post-traumatic amnesia on information processing following mild traumatic brain injury	BRAIN INJURY			English	Article						post-traumatic amnesia; mild-traumatic brain injury; severity; information processing; verbal recall	HEAD-INJURY; RAPID SCREEN; CONCUSSION; SYMPTOMS	Primary objective: The aim of this study was to determine whether a single measurement of level of PTA could distinguish patients more severely injured from those less so, by investigating the effect of PTA on psychometric test performance. Methods and procedures: Ninety patients with mTBI completed a word recall test, a spoken version of the Speed of Comprehension test and the Digit Symbol Substitution Test (Digit Symbol), within 24 hours of injury. These patients were divided into two groups, based on the presence (n = 42) or absence (n = 48) of PTA at the time of testing. PTA was measured with an eight-item orientation scale. Main outcomes and results: An independent groups design showed that patients with mTBI in PTA recalled fewer words after two presentations and after a delay and completed fewer symbols in 90 seconds on Digit Symbol than patients with mTBI not in PTA. Discriminant function analysis was applied to explore whether classifying severity of injury in terms of number of orientation questions answered would be useful. Conclusions: These results indicate that for individuals with mTBI in PTA, speed of information processing and verbal memory are impaired. A single brief administration of orientation questions may be sufficient to provide an index of severity of mTBI within the first 24 hours.	Univ Queensland, Cognit Psychophysiol Lab, Med Sch, Herston, Qld 4006, Australia		Geffen, GM (corresponding author), Univ Queensland, Cognit Psychophysiol Lab, Med Sch, Edith Cavell Bldg,Herston Rd, Herston, Qld 4006, Australia.	geffen@psy.uq.edu.au					Baddeley A., 1992, SPEED CAPACITY LANGU; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; De Monte VE, 2004, J CLIN EXP NEUROPSYC, V26, P628, DOI 10.1080/13803390490504443; De Monte VE., 2005, BRAIN IMPAIR, V6, P109, DOI [10.1375/brim.2005.6.2.109, DOI 10.1375/BRIM.2005.6.2.109]; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KWAPIL KJ, 2003, BRAIN IMPAIR, V4, P155; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Shores E A, 1995, Appl Neuropsychol, V2, P167; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Tabachnick B.G., 2001, USING MULTIVARIATE S; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Wechsler, 1997, WECHSLER ADULT INTEL; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; [No title captured]; [No title captured]	29	23	23	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2006	20	13-14					1345	1354		10.1080/02699050601082073			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	130GF	WOS:000243787100004	17378226				2022-02-06	
J	Chen, Q; Wang, S; Thompson, SN; Hall, ED; Guttmann, RP				Chen, Qinghua; Wang, Susan; Thompson, Stephanie N.; Hall, Edward D.; Guttmann, Rodney P.			Identification and characterization of PEBP as a calpain substrate	JOURNAL OF NEUROCHEMISTRY			English	Article						Alzheimer's disease; calpain; phosphatidylethanolamine-binding protein; proteasome	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; PEPTIDE (HCNP)-RELATED COMPONENTS; ALZHEIMERS-DISEASE; IN-SITU; CORTICAL-NEURONS; PROSTATE-CANCER; ALPHA-SYNUCLEIN; CELL-MIGRATION; RAT-BRAIN	Calpains are calcium- and thiol-dependent proteases whose dysregulation has been implicated in a number of diseases and conditions such as cardiovascular dysfunction, ischemic stroke, and Alzheimer's disease (AD). While the effects of calpain activity are evident, the precise mechanism(s) by which dysregulated calpain activity results in cellular degeneration are less clear. In order to determine the impact of calpain activity, there is a need to identify the range of specific calpain substrates. Using an in vitro proteomics approach we confirmed that phosphatidylethanolamine-binding protein (PEBP) as a novel in vitro and in situ calpain substrate. We also observed PEBP proteolysis in a model of brain injury in which calpain is clearly activated. In addition, with evidence of calpain dysregulation in AD, we quantitated protein levels of PEBP in postmortem brain samples from the hippocampus of AD and age-matched controls and found that PEBP levels were approximately 20% greater in AD. Finally, with previous evidence that PEBP may act as a serine protease inhibitor, we tested PEBP as an inhibitor of the proteasome and found that PEBP inhibited the chymostrypsin-like activity of the proteasome by similar to 30%. Together these data identify PEBP as a potential in vivo calpain substrate and indicate that increased PEBP levels may contribute to impaired proteasome function.	Univ Kentucky, Dept Gerontol, Lexington, KY 40536 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Guttmann, RP (corresponding author), Univ Kentucky, Dept Gerontol & Physiol, 800 S Limestone,Room 305 SB, Lexington, KY 40536 USA.	rodneyg@uky.edu	Thompson, Stephanie/AAB-8272-2020; Hall, Edward D/F-8930-2013; guttmann, rodney/AAN-8880-2021	Thompson, Stephanie/0000-0002-9128-7515; guttmann, rodney/0000-0001-5553-3099	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS047635] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS047635] Funding Source: NIH RePORTER		Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; BARTUS RT, 1995, NEUROL RES, V17, P249, DOI 10.1080/01616412.1995.11740322; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bi RF, 2000, J BIOL CHEM, V275, P26477, DOI 10.1074/jbc.M003763200; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; BLOMGREN K, 1995, BRAIN RES, V684, P143, DOI 10.1016/0006-8993(95)00399-B; CRESSMAN CM, 1995, FEBS LETT, V367, P223, DOI 10.1016/0014-5793(95)00543-I; Dong YZ, 2006, FASEB J, V20, P331, DOI 10.1096/fj.05-4524fje; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; GEDDES JW, 1995, NEUROBIOL AGING, V16, P651, DOI 10.1016/0197-4580(95)00062-J; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guttmann RP, 1998, J BIOL CHEM, V273, P13331, DOI 10.1074/jbc.273.21.13331; Guttmann RP, 1997, J BIOL CHEM, V272, P2005, DOI 10.1074/jbc.272.3.2005; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hengst U, 2001, J BIOL CHEM, V276, P535, DOI 10.1074/jbc.M002524200; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; HONG SC, 1994, BRAIN RES, V661, P43, DOI 10.1016/0006-8993(94)91178-9; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; JOHNSON GVW, 1989, BIOCHEM BIOPH RES CO, V163, P1505, DOI 10.1016/0006-291X(89)91150-9; Johnson GVW, 1997, BIOESSAYS, V19, P1011, DOI 10.1002/bies.950191111; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; LODISH HF, 1990, J BIOL CHEM, V265, P10893; Mamoune A, 2003, CANCER RES, V63, P4632; Marcum JL, 2005, BIOCHEM BIOPH RES CO, V334, P342, DOI 10.1016/j.bbrc.2005.06.089; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; McCollum AT, 2004, J NEUROSCI RES, V76, P104, DOI 10.1002/jnr.20059; MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; MITAKE S, 1995, NEUROPATH APPL NEURO, V21, P35, DOI 10.1111/j.1365-2990.1995.tb01026.x; Mitake S, 1996, NEUROPATH APPL NEURO, V22, P440, DOI 10.1111/j.1365-2990.1996.tb00918.x; Mitake Shigehisa, 1997, Kaohsiung Journal of Medical Sciences, V13, P10; MURACHI T, 1981, ADV ENZYME REGUL, V19, P407; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Otsuka Y, 1996, NEUROCHEM RES, V21, P369, DOI 10.1007/BF02531654; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; Robinson A, 1996, CAN MED ASSOC J, V154, P193; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P24876, DOI 10.1074/jbc.272.40.24876; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; SIMAN R, 1983, J NEUROCHEM, V41, P950, DOI 10.1111/j.1471-4159.1983.tb09039.x; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sun AY, 1999, CLIN NEUROPHARMACOL, V22, P164; Tsugu Y, 1998, EUR J NEUROL, V5, P561, DOI 10.1046/j.1468-1331.1998.560561.x; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Yamazaki T, 1997, BIOCHEMISTRY-US, V36, P8377, DOI 10.1021/bi970209y; Zalewska T, 1996, FOLIA NEUROPATHOL, V34, P121; Zhang JW, 1998, J NEUROCHEM, V71, P240; ZHANG L, 1999, J BIOL CHEM, V274, P8699; Zhang SX, 2003, J NEUROTRAUM, V20, P59, DOI 10.1089/08977150360517182	71	23	25	1	6	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0022-3042			J NEUROCHEM	J. Neurochem.	NOV	2006	99	4					1133	1141		10.1111/j.1471-4159.2006.04160.x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	098ZS	WOS:000241562900009	17018026	Bronze			2022-02-06	
J	Pascale, CL; Szmydynger-Chodobska, J; Sarri, JE; Chodobski, A				Pascale, C. L.; Szmydynger-Chodobska, J.; Sarri, J. E.; Chodobski, A.			TRAUMATIC BRAIN INJURY RESULTS IN A CONCOMITANT INCREASE IN NEOCORTICAL EXPRESSION OF VASOPRESSIN AND ITS V-1A RECEPTOR	JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						vasopressin; V-1a receptor; traumatic brain injury; cerebral cortex; rat	ARGININE-VASOPRESSIN; ENDOTHELIAL-CELLS; CHOROID-PLEXUS; MESSENGER-RNA; EDEMA; WATER; PERMEABILITY; PLASMA; VOLUME	Arginine vasopressin (AVP) has been shown to promote the disruption of the blood-brain barrier (BBB) and the formation of edema in various animal models of brain injury. However, the source(s) of this AVP have not been identified. Since the cerebral cortex was considerably affected in some of these brain injury models, we sought to determine if AVP was produced in the cerebral cortex, and, if so, whether or not this cortical AVP expression was up regulated after injury. In the present study, a controlled cortical impact model of traumatic brain injury (TBI) in rats was used, and the temporal changes in expression of AVP and its V-1a receptor were analyzed by real-time reverse-transcriptase polymerase chain reaction. The expression of AVP and its V-1a receptor in the ipsilateral cortex adjacent to the lesion area was significantly up regulated between 4 h and 1day post-TBI. The maximum increase in mRNA for AVP (4.3-fold) and its receptor (2.6-fold) in the ipsilateral vs. contralateral cortex was observed at 6 h post-TBI. Compared to sham-injured rats, no statistically significant changes in expression of AVP or its receptor were found in the contralateral cortex. These results suggest that the cerebral cortex is an important source of AVP in the injured brain, and the parallel increase in the expression of AVP and its cognate receptor may act to augment the actions of AVP related to promoting the disruption of the BBB and the formation of post-traumatic edema.	[Pascale, C. L.; Szmydynger-Chodobska, J.; Sarri, J. E.; Chodobski, A.] Brown Univ, Sch Med, Dept Clin Neurosci, Providence, RI 02903 USA		Chodobski, A (corresponding author), Brown Univ, Sch Med, Dept Clin Neurosci, Aldrich Bldg,Room 405,593 Eddy St, Providence, RI 02903 USA.	adam_chodobski@brown.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS49479]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049479] Funding Source: NIH RePORTER	We thank Grzegorz Michalowski (Michalowski Inc., Zossen, Germany) for providing the controlled cortical impact device. This work was supported by grant NS49479 from the NIH.	Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; BUIJS RM, 1978, CELL TISSUE RES, V186, P423, DOI 10.1007/BF00224932; Buijs RM, 1987, VASOPRESSIN PRINCIPL, P91; Chodobski A, 1997, MOL BRAIN RES, V48, P67, DOI 10.1016/S0169-328X(97)00079-X; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059, DOI 10.1152/ajprenal.1989.256.6.F1059; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; Hallbeck M, 1999, J COMP NEUROL, V411, P181; Hertz L, 2000, J NEUROSCI RES, V62, P480, DOI 10.1002/1097-4547(20001115)62:4<480::AID-JNR2>3.0.CO;2-K; Huang Wei-dong, 2003, Chin J Traumatol, V6, P139; Hupf H, 1999, CIRC RES, V84, P365, DOI 10.1161/01.RES.84.3.365; JOYNT RJ, 1981, ANN NEUROL, V9, P182, DOI 10.1002/ana.410090212; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; Liu XZ, 2000, HEALTH POLICY PLANN, V15, P157, DOI 10.1093/heapol/15.2.157; LOESCH A, 1991, ANAT EMBRYOL, V183, P129; LOESCH A, 1993, BRAIN RES, V611, P333, DOI 10.1016/0006-8993(93)90522-O; LOESCH A, 1991, PEPTIDES, V12, P1095, DOI 10.1016/0196-9781(91)90065-W; MATHER HM, 1981, J NEUROL NEUROSUR PS, V44, P216, DOI 10.1136/jnnp.44.3.216; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Rosenberg G A, 1990, Adv Neurol, V52, P149; ROSENBERG GA, 1986, AM J PHYSIOL, V251, pF485, DOI 10.1152/ajprenal.1986.251.3.F485; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097	28	23	26	0	0	POLISH PHYSIOLOGICAL SOC	GRZEGORZECKA	JAGIELLONIAN UNIV SCHOOL MED, INST PHYSIOLOGY, 31-531 KRAKOW, 16 GRZEGORZECKA, POLAND	0867-5910			J PHYSIOL PHARMACOL	J. Physiol. Pharmacol.	NOV	2006	57			11			161	167					7	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	V19RD	WOS:000208088600013	17244947				2022-02-06	
J	Rangel-Castillo, L; Robertson, CS				Rangel-Castillo, Leonardo; Robertson, Claudia S.			Management of intracranial hypertension	CRITICAL CARE CLINICS			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL BLOOD-FLOW; INTRA-CRANICAL PRESSURE; DECOMPRESSIVE CRANIECTOMY; CONTROLLED-TRIAL; PERFUSION-PRESSURE; CLINICAL-TRIAL; SUBARACHNOID HEMORRHAGE; 20-PERCENT MANNITOL	Effective treatment of intracranial hypertension involves meticulous avoidance of factors that precipitate or aggravate increased intracranial pressure. When intracranial pressure becomes elevated, it is important to rule out new mass lesions that should be surgically evacuated. Medical management of increased intracranial pressure should include sedation and paralysis, drainage of cerebrospinal fluid, and osmotherapy with either mannitol or hypertonic saline. For intracranial hypertension refractory to initial medical management, barbiturate coma, hypothermia, or decompressive craniectomy should be considered. Steroids are not indicated and may be harmful in the treatment of intracranial hypertension resulting from traumatic brain injury.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER		Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Biousse V, 2003, AM J OPHTHALMOL, V135, P437, DOI 10.1016/S0002-9394(02)02062-7; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Cherian L, 2004, J NEUROTRAUM, V21, P1196; Cheung A, 2005, NEUROCRIT CARE, V3, P216, DOI 10.1385/NCC:3:3:216; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2001, NEUROSURGERY, V49, P864; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Digre K, 2005, NEUROLOGY, V64, P1827; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; DOCZI T, 1993, ACTA NEUROCHIR, V121, P1, DOI 10.1007/BF01405174; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; ENGBERG M, 1989, ACTA ANAESTH SCAND, V33, P642, DOI 10.1111/j.1399-6576.1989.tb02983.x; Feigin VL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004583.pub2; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Friedman DI, 2005, AM J CLIN DERMATOL, V6, P29, DOI 10.2165/00128071-200506010-00004; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; GUDEMAN SK, 1979, J NEUROSURG, V51, P301, DOI 10.3171/jns.1979.51.3.0301; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jacob S, 2005, HEADACHE, V45, P75, DOI 10.1111/j.1526-4610.2005.05013.x; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Kaal ECA, 2004, CURR OPIN ONCOL, V16, P593, DOI 10.1097/01.cco.0000142076.52721.b3; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Marchuk G, 2005, CAN J NEUROL SCI, V32, pS22; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Miller J D, 1979, Int Anesthesiol Clin, V17, P19, DOI 10.1097/00004311-197917020-00005; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; Nates JL, 1997, ANAESTH INTENS CARE, V25, P502, DOI 10.1177/0310057X9702500509; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; NORTH JB, 1974, ARCH NEUROL-CHICAGO, V31, P338, DOI 10.1001/archneur.1974.00490410086010; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; PRIELIPP RC, 1995, ANESTH ANALG, V81, P3, DOI 10.1097/00000539-199507000-00002; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SATO M, 1991, ACTA NEUROCHIR, V110, P174, DOI 10.1007/BF01400687; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; SCHALEN W, 1992, ACTA NEUROCHIR, V117, P153, DOI 10.1007/BF01400613; Schramm WM, 1998, ANESTH ANALG, V86, P123, DOI 10.1097/00000539-199801000-00025; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SELHORST JB, 1985, NEUROSURGERY, V16, P357, DOI 10.1227/00006123-198503000-00013; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEMPKIN NR, 1990, NEW ENGL J MED, V323, P497; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725	82	23	24	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	OCT	2006	22	4					713	+		10.1016/j.ccc.2006.06.003			21	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AJ	WOS:000244334500009	17239751				2022-02-06	
J	Ryb, GE; Soderstrom, CA; Kufera, JA; Dischinger, P				Ryb, Gabriel E.; Soderstrom, Carl A.; Kufera, Joseph A.; Dischinger, Patricia			Longitudinal study of suicide after traumatic injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	7th World Conference on Injury Prevention and Safety Promotion	JUN 06-09, 2004	Vienna, AUSTRIA			alcoholism; suicide; trauma	POSTTRAUMATIC-STRESS-DISORDER; SPINAL-CORD INJURY; BRAIN-INJURY; RISK-FACTORS; PSYCHIATRIC-DISORDERS; ALCOHOL; DEPRESSION; LIFE; PSYCHOPATHOLOGY; METAANALYSIS	Background. Suicide risk after discharge among trauma patients could be influenced by multiple factors. The aim of this study is to establish whether patients discharged from a trauma center experience an increased suicide rate and whether this can be explained by defined demographic, injury, or alcohol abuse risk factors. Methods: Patients admitted between July 1, 1983, and June 30, 1995, and discharged alive from a Level I trauma center (n = 27,399) were followed for 1.5 to 14.5 years to determine whether they had died. Death determination was made by an epidemiologic support service, which had created a repository of death certificates. Variables used in the analyses included age, gender, race, Injury Severity Score, discharge disposition, mechanism of injury, and alcohol toxicology. General and trauma populations were compared using standard mortality rates. Risk factors for suicide within the trauma population were explored using Pearson's chi(2), Mantel-Haenszel chi(2), Cox proportional hazards, and Mantel-Cox log-rank methodology. Results: Suicide was more common in the trauma than in the general population (standard mortality rate = 1.71). This difference may be attributed primarily to alcohol use problems. Suicide risk in the trauma population increased with age from 25 to 44 years, male gender, Caucasian race, and positive alcohol toxicology. Disability (as measured by discharge disposition), but not injury severity, also seemed to have an influence on suicide rates. Conclusion: Interventions that address modifiable risk factors for suicide (substance abuse, psychiatric disorders, hopelessness, and social isolation) could benefit trauma patients known to be at higher risk for suicide, particularly those abusing alcohol.	Univ Maryland, Natl Study Ctr Trauma & Emergency Med Syst, Sch Med, Baltimore, MD 21201 USA		Ryb, GE (corresponding author), Univ Maryland, Natl Study Ctr Trauma & Emergency Med Syst, Sch Med, 701 W Pratt St,5th Floor, Baltimore, MD 21201 USA.	gabyryb@pol.net					[Anonymous], WEB BAS INJ STAT QUE; Beautrais AL, 1999, SUICIDE LIFE-THREAT, V29, P37; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Blow FC, 2004, ALCOHOL CLIN EXP RES, V28, p48S, DOI 10.1097/01.ALC.0000127414.15000.83; BLUMENTHAL SJ, 1988, MED CLIN N AM, V72, P937, DOI 10.1016/S0025-7125(16)30754-4; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; CHARLIFUE SW, 1991, ARCH PHYS MED REHAB, V72, P488; Conner KR, 2004, ALCOHOL CLIN EXP RES, V28, p6S, DOI 10.1097/01.ALC.0000127410.84505.2A; DEVIVO MJ, 1991, PARAPLEGIA, V29, P620, DOI 10.1038/sc.1991.91; Dischinger PC, 2001, J TRAUMA, V51, P877, DOI 10.1097/00005373-200111000-00009; Dunham C M, 1989, Md Med J, V38, P227; Fu Q, 2002, PSYCHOL MED, V32, P11, DOI 10.1017/S0033291701004846; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; GUNNELL DJ, 1995, BRIT MED J, V311, P226, DOI 10.1136/bmj.311.6999.226; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hartkopp A, 1998, ARCH PHYS MED REHAB, V79, P1356, DOI 10.1016/S0003-9993(98)90227-1; Harwitz D, 2000, EMERG MED CLIN N AM, V18, P263, DOI 10.1016/S0733-8627(05)70123-1; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hirschfeld RMA, 1997, NEW ENGL J MED, V337, P910, DOI 10.1056/NEJM199709253371307; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Koller G, 2002, EUR ARCH PSY CLIN N, V252, P155, DOI 10.1007/s00406-002-0362-9; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Maio RF, 1997, ACAD EMERG MED, V4, P256, DOI 10.1111/j.1553-2712.1997.tb03545.x; Malone KM, 2000, AM J PSYCHIAT, V157, P1084, DOI 10.1176/appi.ajp.157.7.1084; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Mazza JJ, 2000, SUICIDE LIFE-THREAT, V30, P91; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Neeleman J, 2001, INT J EPIDEMIOL, V30, P154, DOI 10.1093/ije/30.1.154; Pellmar T.C., 2002, REDUCING SUICIDE NAT; PETRONIS KR, 1990, SOC PSYCH PSYCH EPID, V25, P193; Poole GV, 1997, J TRAUMA, V42, P711, DOI 10.1097/00005373-199704000-00022; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; Ryb GE, 1999, J TRAUMA, V47, P874, DOI 10.1097/00005373-199911000-00010; Satcher D., 1999, SURG GEN CALL ACTION; Shea MT, 2000, COMPR PSYCHIAT, V41, P315, DOI 10.1053/comp.2000.9007; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Soderstrom CA, 1997, J TRAUMA, V42, P67, DOI 10.1097/00005373-199701000-00012; WARSHAW MG, 1993, AM J PSYCHIAT, V150, P1512; Welch SS, 2001, PSYCHIAT SERV, V52, P368, DOI 10.1176/appi.ps.52.3.368; WHETSELL LA, 1989, J TRAUMA, V29, P1158, DOI 10.1097/00005373-198908000-00015; ZATRICK D, 2004, J TRAUMA, V57, P360	46	23	23	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2006	61	4					799	804		10.1097/01.ta.0000196763.14289.4e			6	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	096YU	WOS:000241413700008	17033543				2022-02-06	
J	Figaji, AA; Fieggen, AG; Argent, A; Peter, JC				Figaji, A. A.; Fieggen, A. G.; Argent, A.; Peter, J. C.			Surgical treatment for 'brain compartment syndrome' in children with severe head injury	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							BIFRONTAL DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL HYPERTENSION; CEREBRAL EDEMA; PRESSURE; CRANIOTOMY; MANAGEMENT; MANNITOL; FAILURE	Objectives. Traumatic brain injury accounts for a high percentage of deaths in children. Raised intracrainal pressure (ICP) due to brain swelling within the closed compartment of the skull leads to death or severe neurological disability if not effectively treated. We report our experience with 12 children who presented with cerebral herniation due to traumatic brain swelling in whom decompressive craniectomy was used as an emergency. Design. Prospective, observational. Setting. Red Cross Children's Hospital. Subjects. Children with severe traumatic brain injury and cerebral swelling. Outcome measures. Computed tomography (CT) scanning, ICP control, clinical outcome. Results. Despite the very poor clinical condition of these children preoperatively, aggressive management of the raised pressure resulted in unexpectedly good outcomes. Conclusion. Aggressive surgical measures to decrease ICP in the emergency situation can be of considerable benefit; the key concepts are selection of appropriate patients and early intervention.	Univ Cape Town, Sch Child & Adolescent Hlth, Div Paediat Neurosurg, ZA-7700 Rondebosch, South Africa; Univ Cape Town, Sch Child & Adolescent Hlth, Div Paediat Crit Care, ZA-7700 Rondebosch, South Africa; Red Cross War Mem Childrens Hosp, Rondebosch, South Africa		Figaji, AA (corresponding author), Univ Cape Town, Sch Child & Adolescent Hlth, Div Paediat Neurosurg, ZA-7700 Rondebosch, South Africa.	afigaji@ich.uct.ac.za	Fieggen, Anthony Graham/AAT-6510-2021; Argent, Andrew/J-1605-2019	Fieggen, Anthony Graham/0000-0001-6541-8377; Argent, Andrew/0000-0001-9333-2036; Figaji, Anthony/0000-0002-3357-6490			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; BRADSHAW D, 2003, 3 MRC; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Gondim FDA, 2005, J NEUROSURG, V103, P444; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HATASHITA S, 1985, STROKE, V16, P661, DOI 10.1161/01.STR.16.4.661; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KERR FWL, 1968, MAYO CLIN PROC, V43, P852; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Marshall LF, 2006, NEUROSURGERY, V59, P289; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; RINALDI A, 1990, ACT NEUR S, V51, P394; ROBERTS I, 2000, COCHRANE DB SYST REV, V2; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHAPIRO K, 1985, J NEUROSURG, V63, P76, DOI 10.3171/jns.1985.63.1.0076; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	33	23	24	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	SEP	2006	96	9	2				969	975					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092OX	WOS:000241108300025	17077927				2022-02-06	
J	Johnston, NJ; King, AT; Protheroe, R; Childs, C				Johnston, Nicola J.; King, Andrew T.; Protheroe, Richard; Childs, Charmaine			Body temperature management after severe traumatic brain injury: Methods and protocols used in the United Kingdom and Ireland	RESUSCITATION			English	Article						brain injury; temperature; intensive care	INTENSIVE-CARE-UNIT; SEVERE HEAD-INJURY; LENGTH-OF-STAY; THERAPEUTIC HYPOTHERMIA; RECTAL TEMPERATURES; CLINICAL-TRIAL; FEVER CONTROL; ACUTE STROKE; HYPERTHERMIA; WORSENS	Objective: To establish whether there is consensus in the management of body temperature in patients with severe traumatic brain injury (TBI) admitted to hospitals in the United Kingdom and Ireland for neurosurgical intensive care. Methods: Permission was granted from the Society of British Neurosurgeons (SBNS) and the Local Research Ethics Committee to undertake the survey. A senior member of nursing staff from all adult neurosurgical units, excluding our own, was contacted by telephone. Results: All 33 adult neurosurgical centres participated. Six units had a formal written protocol for the management of body temperature. For the remainder (27 units), interest was expressed in a protocol for temperature management particularly for those patients with intractable hyperthermia/fever. Administration of the antipyretic paracetamol was the most common 'first-line' treatment (13 units). Other 'first-line' methods were: circulating air-cooling blankets (9 units), water-filled cooling blankets (6 units), tepid sponging or wet soaks (2 units), convection fans (2 units) and administration of cold fluids via the gut or circulation (1 unit). When 'first-line' methods failed to bring about a fall in temperature, different combinations of these methods were used. Conclusions: From this survey, it is evident that there is no consensus in the approach to temperature management in neurosurgical intensive care patients with severe TBI. Review and rationalisation of systems of care may be required in an effort to develop evidence-based nationwide guidelines. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Univ Manchester, Hope Hosp, Dept Neurosurg, Div Med & Neurosci, Salford M6 8HD, Lancs, England; Hope Hosp, Dept Neurosurg, Salford M6 8HD, Lancs, England; Hope Hosp, Dept Intens Care Med, Salford M6 8HD, Lancs, England		Childs, C (corresponding author), Univ Manchester, Hope Hosp, Dept Neurosurg, Div Med & Neurosci, Eccles Old Rd, Salford M6 8HD, Lancs, England.	cchilds@manchester.ac.uk	Childs, Charmaine/G-9928-2012; Protheroe, Richard/AAT-9329-2021; King, Andrew/AAR-1656-2020	King, Andrew/0000-0002-6546-7248			ALDERSON P, THERAPEUTIC HYPOTHER; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2004, ANAESTHESIA, V59, P192, DOI 10.1111/j.1365-2044.2003.03638.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Fulbrook Paul, 2003, Nurs Crit Care, V8, P249; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Mayer SA, 2001, NEUROLOGY, V56, P292, DOI 10.1212/WNL.56.3.292; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; O'Grady NP, 1998, CRIT CARE MED, V26, P392, DOI 10.1097/00003246-199802000-00046; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; TAKAGI K, 1994, AM J PHYSIOL-HEART C, V267, pH1770, DOI 10.1152/ajpheart.1994.267.5.H1770; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X	29	23	24	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	AUG	2006	70	2					254	262		10.1016/j.resuscitation.2006.02.010			9	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	083WL	WOS:000240488800014	16828961				2022-02-06	
J	Taupin, P				Taupin, Philippe			Adult neurogenesis in mammals	CURRENT OPINION IN MOLECULAR THERAPEUTICS			English	Article						adult brain; central nervous system; CNS; homeostasis; neural stem cells; neuroadaptation; neurogenesis; plasticity; regeneration	GRANULE CELL NEUROGENESIS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; RAT DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; SUBSTANTIA-NIGRA; OLFACTORY-BULB; ENRICHED ENVIRONMENT; SUBVENTRICULAR ZONE	With the recent confirmation that neurogenesis occurs in the adult brain, and that neural stem cells reside in the adult central nervous system (CNS), the function of newly generated neuronal cells in the adult brain is the source of intense research and debate. Neurogenesis is modulated by a wide variety of physiopathological conditions and environmental stimuli, offering the possibility that newly generated neuronal cells might be functionally associated with the response to these processes. Newly generated neuronal cells in the hippocampus have also been implicated in mechanisms of learning, memory and depression. However, a number of studies have challenged some of these findings, and the roles of newly generated neuronal cells in the functioning of the CNS remain to be fully understood. Neurogenesis has been shown to increase bilaterally in the adult brain and new neuronal cells are generated at sites of degeneration in the brain during disease and after injuries. Taken together, these findings suggest that new neuronal cells may be involved in processes such as homeostasis of brain tissue, regeneration, plasticity, and neuroadaptation.	Natl Univ Singapore, Natl Inst Neurosci, Singapore 308433, Singapore		Taupin, P (corresponding author), Natl Univ Singapore, Natl Inst Neurosci, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	obgpjt@nus.edu.sg					ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CAVINESS VS, 1973, J COMP NEUROL, V151, P113, DOI 10.1002/cne.901510203; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cramer SC, 2000, NEUROPHARMACOLOGY, V39, P842, DOI 10.1016/S0028-3908(99)00258-0; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Danilov AI, 2006, EUR J NEUROSCI, V23, P394, DOI 10.1111/j.1460-9568.2005.04563.x; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Frielingsdorf H, 2004, P NATL ACAD SCI USA, V101, P10177, DOI 10.1073/pnas.0401229101; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Jackson-Guilford J, 2000, NEUROSCI LETT, V293, P91, DOI 10.1016/S0304-3940(00)01502-0; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Koketsu D, 2006, EXP NEUROL, V199, P92, DOI 10.1016/j.expneurol.2006.03.012; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Lie DC, 2002, J NEUROSCI, V22, P6639; Liu JL, 1998, J NEUROSCI, V18, P7768; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; Mohapel P, 2005, NEUROSCIENCE, V132, P767, DOI 10.1016/j.neuroscience.2004.11.056; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Parent JM, 1999, J NEUROSCI, V19, P4508; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Parent JM, 1998, NEUROSCI LETT, V247, P9, DOI 10.1016/S0304-3940(98)00269-9; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Perna RB, 2003, J HEAD TRAUMA REHAB, V18, P201; Rhodes JS, 2004, BEHAV NEUROSCI, V118, P305, DOI 10.1037/0735-7044.118.2.305; Ribotta MG, 2004, ACTA NEUROCHIR SUPPL, V89, P87; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sawabini KA, 2004, PARKINSONISM RELAT D, V10, pS37, DOI 10.1016/j.parkreldis.2004.02.002; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; SHIBUI S, 1989, J HISTOCHEM CYTOCHEM, V37, P1007, DOI 10.1177/37.7.2659659; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V414, P938, DOI 10.1038/414938a; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Taupin P, 2005, MED SCI MONITOR, V11, pRA247; Taupin P, 2006, CURR OPIN MOL THER, V8, P225; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Witte OW, 1998, CURR OPIN NEUROL, V11, P655, DOI 10.1097/00019052-199812000-00008; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	75	23	23	1	4	THOMSON REUTERS (SCIENTIFIC) LTD	LONDON	77 HATTON GARDEN, LONDON, EC1N 8JS, ENGLAND	1464-8431	2040-3445		CURR OPIN MOL THER	Curr. Opin. Mol. Ther.	AUG	2006	8	4					345	351					7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	069DG	WOS:000239425200010	16955698				2022-02-06	
J	Troen, AM; Shukitt-Hale, B; Chao, WH; Albuquerque, B; Smith, DE; Selhub, J; Rosenberg, IH				Troen, Aron M.; Shukitt-Hale, Barbara; Chao, Wei-Hsun; Albuquerque, Bina; Smith, Donald E.; Selhub, Jacob; Rosenberg, Irwin H.			The cognitive impact of nutritional homocysteinemia in Apolipoprotein-E deficient mice	JOURNAL OF ALZHEIMERS DISEASE			English	Article						ApoE; folate; homocysteine; methionine; nutrition; behavior; cognition; model; dementia; neurodegeneration	E KNOCKOUT MICE; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; CLOSED-HEAD INJURY; MORRIS WATER MAZE; FOLATE-DEFICIENCY; MEMORY DEFICITS; INDUCED HYPERHOMOCYSTEINEMIA; CHOLINERGIC IMPAIRMENTS; PLASMA HOMOCYSTEINE	Homocysteinemia is associated with cognitive dysfunction in the elderly ranging from subtle cognitive decline to dementia. Homocysteine is generated from methionine as a product of biological methylation reactions and is disposed of through reactions that require folate and vitamins B12 and B6. While different disruptions in these reactions can result in homocysteinemia, it is unclear if they will also result in homocysteine-mediated cognitive dysfunction. Young ApoE-deficient mice were fed one of four diets with differing methionine and B-vitamin content for eight weeks, before undergoing psychomotor tests, the Morris Water Maze test of spatial memory and learning, and measurement of home-cage activity. B-vitamin deficiency induced homocysteinemia and selectively impaired Morris Water Maze performance without affecting other behavioral measures. The cognitive deficits occurred in the absence of overt histologic neurodegeneration but in association with moderate impairments of brain methylation potential. Diets that yielded cognitive deficits were different from those that exacerbated aortic pathology. These findings are inconsistent with a single mechanism linking homocysteinemia to neurological dysfunctions mediated by homocysteine vasotoxicity. Instead, they indicate that different "types" of homocysteinemia, or in other words different impairments of nutritional metabolism affecting homocysteine levels, may lead to different end organ dysfunctions and/or diseases.	Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA		Troen, AM (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	aron.troen@tufts.edu		Chao, Wei-Hsun/0000-0003-3789-1276; Shukitt-Hale, Barbara/0000-0002-3810-1910			AKESSON B, 1982, BRIT J NUTR, V47, P505, DOI 10.1079/BJN19820063; Anderson R, 1998, NEUROSCIENCE, V85, P93, DOI 10.1016/S0306-4522(97)00598-8; Anderson R, 1997, PSYCHOPHARMACOLOGY, V132, P135, DOI 10.1007/s002130050329; Bottiglieri T, 1996, NUTR REV, V54, P382, DOI 10.1111/j.1753-4887.1996.tb03851.x; Buttini M, 1999, J NEUROSCI, V19, P4867; Casadesus G, 2001, MECH AGEING DEV, V122, P1887, DOI 10.1016/S0047-6374(01)00324-4; Champagne D, 2002, NEUROSCIENCE, V114, P641, DOI 10.1016/S0306-4522(02)00313-5; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Christie LA, 2005, NEUROSCI LETT, V373, P119, DOI 10.1016/j.neulet.2004.09.072; Crawley JN, 2003, COMPARATIVE MED, V53, P140; Dayal S, 2005, CIRCULATION, V112, P737, DOI 10.1161/CIRCULATIONAHA.104.529248; Duan W, 2002, J NEUROCHEM, V80, P101, DOI 10.1046/j.0022-3042.2001.00676.x; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; Duthie SJ, 2002, AM J CLIN NUTR, V75, P908, DOI 10.1093/ajcn/75.5.908; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Fisher A, 1998, J NEUROCHEM, V70, P1991; GALLAGHER M, 1993, BEHAV BRAIN RES, V57, P155, DOI 10.1016/0166-4328(93)90131-9; Garcia A, 2004, J GERONTOL A-BIOL, V59, P1323, DOI 10.1093/gerona/59.12.1323; GENIS I, 1995, NEUROSCI LETT, V199, P5, DOI 10.1016/0304-3940(95)12007-Q; Genis I, 1999, ALZHEIMER'S DISEASE AND RELATED DISORDERS, P733; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; Gordon I, 1996, MOL CHEM NEUROPATHOL, V28, P97, DOI 10.1007/BF02815210; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; GOSPE SM, 1995, PHYSL BEHAV, V58; GROOME N, 1988, J NEUROIMMUNOL, V19, P305, DOI 10.1016/0165-5728(88)90011-2; Halliday GM, 1996, NEUROSCI LETT, V209, P29, DOI 10.1016/0304-3940(96)12592-1; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Higuchi Y, 2002, J RADIAT RES, V43, pS219; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Ingram D., 1994, PATHOBIOLOGY AGING R, P149; JOSEPH JA, 1983, NEUROBIOL AGING, V4, P313, DOI 10.1016/0197-4580(83)90008-8; Kim JM, 2002, J NUTR, V132, P3418, DOI 10.1093/jn/132.11.3418; KIM YI, 1994, J NUTR, V124, P2197, DOI 10.1093/jn/124.11.2197; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Krzywkowski P, 1999, NEUROSCIENCE, V92, P1273, DOI 10.1016/S0306-4522(99)00061-5; Lee HY, 2004, BRAIN RES, V996, P139, DOI 10.1016/j.brainres.2003.10.027; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Lomnitski L, 1999, J NEUROSCI RES, V58, P586; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; McCaddon A, 2001, DEMENT GERIATR COGN, V12, P309, DOI 10.1159/000051275; Mihalick SM, 2003, NEUROMOL MED, V4, P197, DOI 10.1385/NMM:4:3:197; MILLER JW, 1992, AM J CLIN NUTR, V55, P1154, DOI 10.1093/ajcn/55.6.1154; Montine TJ, 1999, EXP NEUROL, V158, P234, DOI 10.1006/exnr.1999.7067; Nagy Z, 1999, ACTA NEUROPATHOL, V97, P346, DOI 10.1007/s004010050997; Ogura T, 2005, NEUROSCI RES, V51, P299, DOI 10.1016/j.neures.2004.12.006; Oitzl MS, 1997, BRAIN RES, V752, P189, DOI 10.1016/S0006-8993(96)01448-5; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Puolivali J, 2000, NEUROSCIENCE, V96, P291, DOI 10.1016/S0306-4522(99)00545-X; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; REYNOLDS EH, 1976, CLIN HAEMATOL, V5, P661; Riggs KM, 1996, AM J CLIN NUTR, V63, P306, DOI 10.1093/ajcn/63.3.306; Robertson TA, 1998, NEUROSCIENCE, V82, P171; ROSENBERG IH, 1992, AM J CLIN NUTR, V55, P1237; Sachdev PS, 2003, DEMENT GERIATR COGN, V15, P155, DOI 10.1159/000068481; SAUBERLICH HE, 1991, MICRONUTRIENTS HLTH, P187; Schneede J, 2000, SEMIN THROMB HEMOST, V26, P263, DOI 10.1055/s-2000-8471; Scott TM, 2004, AM J GERIAT PSYCHIAT, V12, P631, DOI 10.1176/appi.ajgp.12.6.631; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Selhub J, 2000, AM J CLIN NUTR, V71, p614S; Shea TB, 2004, J ALZHEIMERS DIS, V6, P269; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Shukitt-Hale B, 1998, EXP GERONTOL, V33, P615, DOI 10.1016/S0531-5565(98)00024-2; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Stabler SP, 2004, CLIN CHEM, V50, P365, DOI 10.1373/clinchem.2003.026252; Streck EL, 2004, BEHAV BRAIN RES, V153, P377, DOI 10.1016/j.bbr.2003.12.013; Streck EL, 2003, BBA-MOL BASIS DIS, V1637, P187, DOI 10.1016/S0925-4439(03)00019-X; TAANMAN JW, 1993, BIOCHIM BIOPHYS ACTA, V1225, P95, DOI 10.1016/0925-4439(93)90128-N; Teunissen C E, 2003, J Nutr Health Aging, V7, P153; Troen AM, 2005, PROG NEURO-PSYCHOPH, V29, P1140, DOI 10.1016/j.pnpbp.2005.06.025; Troen AM, 2003, P NATL ACAD SCI USA, V100, P15089, DOI 10.1073/pnas.2436385100; Troen Aron, 2005, Semin Vasc Med, V5, P209, DOI 10.1055/s-2005-872406; Veinbergs I, 1999, NEUROSCIENCE, V91, P401, DOI 10.1016/S0306-4522(98)00602-2; Weir DG, 1999, BRIT MED BULL, V55, P669, DOI 10.1258/0007142991902547; WEIR DG, 1995, BAILLIERE CLIN HAEM, V8, P479, DOI 10.1016/S0950-3536(05)80217-3; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhou J, 2003, ATHEROSCLEROSIS, V168, P255, DOI 10.1016/S0021-9150(03)00138-2; Zhou J, 2001, ARTERIOSCL THROM VAS, V21, P1470, DOI 10.1161/hq0901.096582; ZITTOUN J, 1995, BAILLIERE CLIN HAEM, V8, P603, DOI 10.1016/S0950-3536(05)80222-7	80	23	23	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.	AUG	2006	9	4					381	392					12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097JZ	WOS:000241444800003	16917146				2022-02-06	
J	Soustiel, JF; Vlodausky, E; Zaaroor, M				Soustiel, Jean F.; Vlodausky, Eugene; Zaaroor, Menashe			Relative effects of mannitol and hypertonic saline on calpain activity, apoptosis and polymorphonuclear infiltration in traumatic focal brain injury	BRAIN RESEARCH			English	Article						traumatic brain injury; hypertonic saline; apoptosis; neuroinflammation	CEREBRAL-BLOOD-FLOW; POSTTRAUMATIC INTRACRANIAL HYPERTENSION; SEVERE HEAD-INJURY; HYPERBARIC-OXYGEN THERAPY; PROTEIN-KINASE P38; CEREBROSPINAL-FLUID; 20-PERCENT MANNITOL; CONTROLLED-TRIAL; SODIUM-CHLORIDE; SPINAL-FLUID	The purpose of this study was to compare the relative effects of mannitol and hypertonic saline (HTS) on calpain activity, apoptosis and neuroinflammatory response induced by experimental cortical contusion. Four groups of 5 Sprague-Dawley male rats were submitted to focal brain injury produced by exposing the parietal cortex to dynamic cortical deformation. Groups were defined by rescucitation fluids administered 30 min post-injury as follows: group 1-0.9% normal saline 2 ml/kg; group 2-mannitol 20% 0.5 g/kg; group 3-HTS 2 ml/kg; group 4-HTS 4 mVkg. At 72 h, animals were sacrificed. Paraffin-mounted sections of were stained for p-Calpain, TUNEL, active caspase 3 and myeloperoxidase. There was no difference in the lesion size between the different groups. In contrast, there was a significant reduction in calpain and apoptosis activity and in the neuroinflammatory response in animals receiving HTS. Although mannitol proved to significantly decrease the neuroinflammatory response and calpain activity, it did not affect apoptosis, and its effect was significantly less than that of HTS. Importantly, the effect of HTS was mostly independent from the infused volume. our results show that HTS promotes cell survival and reduces secondary brain damage following TBI. This protective effect was evidenced at rather small infused volumes, proved to encompass several cellular and molecular mechanisms involved in secondary cell death and could not be related to relief of intracranial pressure. These findings suggest that the high osmolality of HTS may have protective effects besides its impact on brain edema.	Technion Israel Inst Technol, Acute Brain Injury Res Lab, Haifa, Israel; Technion Israel Inst Technol, AB Rappaport Fac Med, Haifa, Israel; Rambam Med Ctr, Dept Pathol, Haifa, Israel		Soustiel, JF (corresponding author), Rambam Med Ctr, Dept Neurosurg, Bat Galim,POB 9602, IL-31096 Haifa, Israel.	j_soustiel@rambam.health.gov.il; e_viodavsky@rambam.health.gov.il					ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BUCKELL M, 1964, LANCET, V2, P1151; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Ciesla DJ, 2001, J TRAUMA, V50, P206, DOI 10.1097/00005373-200102000-00004; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Junger H, 2003, J MOL NEUROSCI, V21, P111, DOI 10.1385/JMN:21:2:111; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Krep H, 2004, RESUSCITATION, V63, P73, DOI 10.1016/j.resuscitation.2004.03.023; LANGFITT TW, 1961, NEUROLOGY, V11, P196, DOI 10.1212/WNL.11.3.196; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; LUNDBERG N, 1959, Acta Psychiatr Scand Suppl, V34, P1; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Murao Y, 2003, SHOCK, V20, P23, DOI 10.1097/01.shk.0000078832.57685.6c; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; O'Dell DM, 2000, J NEUROSCI, V20, P4821; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; RINK A, 1995, AM J PATHOL, V147, P1575; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schatzmann C, 1998, ACT NEUR S, V71, P31; Shires GT, 2005, AM J SURG, V189, P85, DOI 10.1016/j.amjsurg.2004.06.040; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; Valadka AB, 2000, CRIT CARE MED, V28, P1245, DOI 10.1097/00003246-200004000-00069; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; WISE BL, 1968, J NEUROSURG, V28, P124, DOI 10.3171/jns.1968.28.2.0124; WISE BL, 1962, J NEUROSURG, V19, P1038, DOI 10.3171/jns.1962.19.12.1038	71	23	27	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 26	2006	1101						136	144		10.1016/j.brainres.2006.05.045			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070RK	WOS:000239541000017	16787640				2022-02-06	
J	Taitsman, LA; Nork, SE; Coles, CP; Barei, DP; Agel, J				Taitsman, Lisa A.; Nork, Sean E.; Coles, Chad P.; Barei, David P.; Agel, Julie			Open clavicle fractures and associated injuries	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						clavicle fracture; open fracture; pneumothorax; polytrauma	PLATE FIXATION; MIDCLAVICULAR FRACTURES; NONOPERATIVE TREATMENT; INTERNAL-FIXATION; LONG BONES; MIDSHAFT; PNEUMOTHORAX; NONUNION; COMPLICATIONS; MANAGEMENT	Objectives: To describe the associated injuries, demographic distribution, and management of patients sustaining open clavicle fractures. Design: Retrospective case series. Setting: A single level-1 trauma center. Patients: Twenty patients with open clavicle fractures were identified from a prospectively collected orthopaedic trauma registry. Intervention: All patients were managed with surgical irrigation and debridement with or without internal fixation. Results: Thirteen patients (65%) had a closed head injury. Fifteen patients (75%) had a significant associated pulmonary injury. In that group, there were 10 patients who had a pneumothorax (7 bilateral). Additionally, 12 patients had rib fractures and I I had documented pulmonary contusions or effusions. Seven patients (35%) had a cervical or thoracic spine fracture or dislocation. Eight patients (40%) had concomitant scapula fractures. Six patients (30%) had additional ipsilateral upper extremity injuries remote from the shoulder girdle. One patient had a scapulothoracie dissociation. Eleven patients (55%) sustained significant facial trauma including fractures (5 patients), lacerations, and hematomas. Fourteen patients (70%) were treated with open reduction internal fixation. Fifteen patients (75%) were followed to healing (mean: 111 wk, median: 56 wk, range: 13 to 333 wk). There were no other complications related to the operative fixations. There were no known infections or nonunions. Conclusions: Open clavicle fractures are a rare injury. Patients often have associated pulmonary and cranial injuries. lpsilateral upper extremity and shoulder girdle injuries are common, whereas concomitant neurologic and vascular injuries are infrequent. The majority of patients have rapid and uneventful healing of their fractures after surgical treatment.	Dept Orthopaed, Seattle, WA 98104 USA; Dalhousie Univ, Halifax, NS B3H 3A7, Canada		Taitsman, LA (corresponding author), Dept Orthopaed, Box 359798,325 9th Ave, Seattle, WA 98104 USA.	ltaitsman@u.washington.edu		Coles, Chad/0000-0003-0454-3507			ALLMAN FL, 1967, J BONE JOINT SURG AM, VA 49, P774, DOI 10.2106/00004623-196749040-00024; Bostman O, 1997, J TRAUMA, V43, P778, DOI 10.1097/00005373-199711000-00008; Chu CM, 2002, ACTA ORTHOP SCAND, V73, P134, DOI 10.1080/000164702753671696; Coupe BD, 2005, INJURY, V36, P1166, DOI 10.1016/j.injury.2005.03.007; Dath R, 2004, EMERG MED J, V21, P395, DOI 10.1136/emj.2002.002733; DUGDALE TW, 1987, CLIN ORTHOP RELAT R, P212; Ebraheim NA, 1997, J TRAUMA, V42, P701, DOI 10.1097/00005373-199704000-00020; Grassi FA, 2001, J TRAUMA, V50, P1096, DOI 10.1097/00005373-200106000-00019; Graves ML, 2005, ORTHOPEDICS, V28, P761; GUSTILO RB, 1987, ORTHOPEDICS, V10, P1781; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; HERSCOVICI D, 1995, CLIN ORTHOP RELAT R, V318, P54; Jones G L, 2000, J South Orthop Assoc, V9, P43; Kabak S, 2004, J SHOULDER ELB SURG, V13, P396, DOI 10.1016/j.jse.2004.01.033; Kitsis CK, 2003, INJURY, V34, P69, DOI 10.1016/S0020-1383(02)00169-9; Kloen P, 2002, J ORTHOP TRAUMA, V16, P425, DOI 10.1097/00005131-200207000-00011; Laursen MB, 1999, J SHOULDER ELB SURG, V8, P410, DOI 10.1016/S1058-2746(99)90068-X; LIM M, 2003, P 20 ANN M ORTH TRAU; MALCOLM BW, 1979, CAN J SURG, V22, P84; McKee MD, 2003, J BONE JOINT SURG AM, V85A, P790, DOI 10.2106/00004623-200305000-00003; McKee Michael D, 2004, J Bone Joint Surg Am, V86-A Suppl 1, P37; MEEKS RJ, 1991, AM J EMERG MED, V9, P555, DOI 10.1016/0735-6757(91)90112-W; Ngarmukos C, 1998, J BONE JOINT SURG BR, V80B, P106, DOI 10.1302/0301-620X.80B1.7880; NORDQVIST A, 1994, CLIN ORTHOP RELAT R, P127; Nowak J, 2004, J SHOULDER ELB SURG, V13, P479, DOI 10.1016/j.jse.2004.01.026; O'Connor D, 2004, INJURY, V35, P575, DOI 10.1016/S0020-1383(03)00239-0; *ORTH TRAUM ASS CO, 1996, J ORTHOP TRAUMA, V10; POST M, 1989, CLIN ORTHOP RELAT R, P89; Postacchini F, 2002, J SHOULDER ELB SURG, V11, P452, DOI 10.1067/mse.2002.126613; Ring D, 1998, SKELETAL TRAUMA, P1670; Robinson M, 2004, J BONE JOINT SURG AM, V86A, P1359, DOI 10.2106/00004623-200407000-00002; ROWE CR, 1968, CLIN ORTHOP RELAT R, P29; SCHUIND F, 1988, J BONE JOINT SURG AM, V70A, P692, DOI 10.2106/00004623-198870050-00008; Shen WJ, 1999, INJURY, V30, P497, DOI 10.1016/S0020-1383(99)00140-0; Simon R G, 1999, Am J Orthop (Belle Mead NJ), V28, P301; Tavitian JD, 2002, INJURY, V33, P135, DOI 10.1016/S0020-1383(01)00069-9; Verborgt Olivier, 2005, Acta Orthop Belg, V71, P17; WILLIAMS RJ, 1995, J ACCID EMERG MED, V12, P218; YOKOYAMA K, 1994, J TRAUMA, V37, P230, DOI 10.1097/00005373-199408000-00014; Zlowodzki M, 2005, J ORTHOP TRAUMA, V19, P504, DOI 10.1097/01.bot.0000172287.44278.ef	40	23	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	JUL	2006	20	6					396	399		10.1097/00005131-200607000-00005			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	064TD	WOS:000239111100005	16825964				2022-02-06	
J	Truog, RD; Christ, G; Browning, DM; Meyer, EC				Truog, Robert D.; Christ, Grace; Browning, David M.; Meyer, Elaine C.			Sudden traumatic death in children - "We did everything, but your child didn't survive"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; ORGAN DONATION; PARENTAL PERSPECTIVES; FAMILY PERSPECTIVES; HOSPITAL STAFF; BRAIN-DEATH; END; QUALITY; BEREAVEMENT; ETHICS	When caring for children who become suddenly and catastrophically ill, clinicians must simultaneously attend to a complex and rapidly evolving medical situation, as well as to the equally challenging demands of establishing compassionate relationships with family members and communicating well with colleagues. An 18-month-old toddler was brought to the hospital with severe head injury after being struck by a car. Over a period of hours, her condition evolved from prognostic uncertainty to the diagnosis of brain death and considerations of organ donation. Against this medical backdrop, the clinicians successfully established a trusting relationship with family members by careful attention to their emotional, informational, and care needs as they absorbed the devastating prognosis, took in the results of the brain death examination, and considered the option of organ donation. This case illustrates the importance of interdisciplinary communication, the vital role of social workers and other psychosocial providers with expertise in working with families, and the critical significance of mutual care and support for the clinicians who accompany families through these tragic life events.	Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Childrens Hosp Boston, Div Crit Care Med, Boston, MA USA; Educ Dev Ctr Inc, Initiat Pediat Palliat Care, Boston, MA USA; Columbia Univ, Sch Social Work, New York, NY USA		Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Social Med, 641 Huntington Ave, Boston, MA 02115 USA.	robert.truog@childrens.harvard.edu					Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; [Anonymous], 1998, Fed Regist, V63, P33856; Back AL, 2003, J CLIN ONCOL, V21, P2433, DOI 10.1200/JCO.2003.09.073; Back Anthony L, 2003, Ann Intern Med, V138, P439; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; BROWNING D, 2003, DIFFICULT CONVERSATI; Browning David, 2002, Bioethics Forum, V18, P23; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; CHAMBLISS DF, 1996, CARING HOSP NURSES S; CHRIST G, IN PRESS INNOVATIVE; Contro N, 2002, ARCH PEDIAT ADOL MED, V156, P14, DOI 10.1001/archpedi.156.1.14; Contro NA, 2004, PEDIATRICS, V114, P1248, DOI 10.1542/peds.2003-0857-L; Cook P, 2002, ARCH DIS CHILD, V87, P36, DOI 10.1136/adc.87.1.36; Curtis JR, 2002, J CRIT CARE, V17, P147, DOI 10.1053/jcrc.2002.35929; Davies B, 2002, J NURS ADMIN, V32, P5, DOI 10.1097/00005110-200201000-00001; Davis CG, 2000, DEATH STUD, V24, P497; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; FALLOWFIELD L, 1993, LANCET, V341, P476, DOI 10.1016/0140-6736(93)90219-7; FIELD MJ, 2003, I MED CHILDREN DIE I; FINLAY I, 1991, BRIT MED J, V302, P1524, DOI 10.1136/bmj.302.6791.1524; FLEISCHMAN AR, 1994, PEDIATRICS, V94, P433; Frank AW, 2004, INTERN MED J, V34, P355, DOI 10.1111/j.1445-5994.2004.00622.x; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Harbaugh Bonnie Lee, 2004, Issues Compr Pediatr Nurs, V27, P163, DOI 10.1080/01460860490497985; Hurwitz CA, 2004, JAMA-J AM MED ASSOC, V292, P2141, DOI 10.1001/jama.292.17.2141; *I MED, 2003, CHILDR DIE IMPR PALL; Janzen L, 2003, OMEGA-J DEATH DYING, V48, P149; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kirschbaum MS, 1996, ADV NURS SCI, V19, P51, DOI 10.1097/00012272-199609000-00007; LEHMAN DR, 1987, J PERS SOC PSYCHOL, V52, P218, DOI 10.1037/0022-3514.52.1.218; Lipton H, 2000, Int J Emerg Ment Health, V2, P19; Lipton H, 2000, Int J Emerg Ment Health, V2, P181; Lock, 2002, TWICE DEAD ORGAN TRA; Macdonald ME, 2005, PEDIATRICS, V116, P884, DOI 10.1542/peds.2004-1980; Mack JW, 2005, J CLIN ONCOL, V23, P9155, DOI 10.1200/JCO.2005.04.010; Martinez R, 2002, THEOR MED BIOETH, V23, P185, DOI 10.1023/A:1020816824759; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Meert K L, 2001, Pediatr Crit Care Med, V2, P324, DOI 10.1097/00130478-200110000-00007; Meert K L, 2000, Pediatr Crit Care Med, V1, P179, DOI 10.1097/00130478-200010000-00017; Meyer EC, 2006, PEDIATRICS, V117, P649, DOI 10.1542/peds.2005-0144; Meyer EC, 2002, CRIT CARE MED, V30, P226, DOI 10.1097/00003246-200201000-00032; Murphy SA, 2003, J TRAUMA STRESS, V16, P17, DOI 10.1023/A:1022003126168; NOLENHOEKSEMA S, 1999, COPING LOSS; OLIVER RC, 1995, J TRAUMA, V39, P303, DOI 10.1097/00005373-199508000-00019; Plum F, 1999, DEFINITION OF DEATH, P34; Rabow MW, 1999, WESTERN J MED, V171, P260; Rachmani R, 1999, TRANSPLANT P, V31, P1912, DOI 10.1016/S0041-1345(99)00152-9; Roter DL, 2000, ARCH INTERN MED, V160, P3477, DOI 10.1001/archinte.160.22.3477; Seecharan GA, 2004, ARCH PEDIAT ADOL MED, V158, P515, DOI 10.1001/archpedi.158.6.515; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Siminoff LA, 2001, CLIN TRANSPLANT, V15, P39, DOI 10.1034/j.1399-0012.2001.150107.x; Solomon MZ, 2005, PEDIATRICS, V116, P872, DOI 10.1542/peds.2004-0905; *SPEC TASK FORC, 1987, PEDIATRICS, V80, P298; Stack CG, 2003, PAEDIATR ANAESTH, V13, P651, DOI 10.1046/j.1460-9592.2003.01112.x; Truog R, 2003, J CLIN ETHIC, V14, P63; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Truog RD, 2003, CRIT CARE MED, V31, P2391, DOI 10.1097/01.CCM.0000090869.19410.3C; WALKER JA, 1990, CAN MED ASSOC J, V142, P1383; Wellesley A, 1997, J ACCID EMERG MED, V14, P24; Wheeler I, 2001, DEATH STUD, V25, P51, DOI 10.1080/074811801750058627; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; WIJNGAARDSDEMEI.J, 2005, J CONSULT CLIN PSYCH, V73, P617; YOUNGNER SJ, 1989, JAMA-J AM MED ASSOC, V261, P2205, DOI 10.1001/jama.261.15.2205; 2003, J TRAUMA, V54, pS235	64	23	23	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2646	2654		10.1001/jama.295.22.2646			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HI	WOS:000238224000027	16772628				2022-02-06	
J	Wood, RL; Liossi, C				Wood, Rodger L.; Liossi, Christina			Neuropsychological and neurobehavioral correlates of aggression following traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							LONG-TERM SURVIVORS; BLUNT HEAD-INJURY; IMPULSIVE AGGRESSION; RELATIVES; SEQUELAE; BEHAVIOR; DEFICITS; IMPACT	This study aimed to establish the neuropsychological and neurobehavioral pro. le of individuals who develop aggression following traumatic brain injury. In a prospective cohort study, 134 brain-injured individuals who exhibited aggression were compared to 153 individuals who had sustained comparable injuries but were not aggressive. In the aggressive group, specific deficits were identified in verbal memory and visuo-perceptual skills. Compared to normative data, this group had impaired executive-attention function. It is tentatively suggested that significant impairment in verbal memory and visuospatial abilities against a background of diminished executive-attention functioning is associated with the development of aggression after brain injury, especially when other risk factors such as low premorbid IQ, low socioeconomic status, and male gender are present.	Univ Southampton, Sch Psychol, Southampton S017 1BJ, Hants, England; Swansea Univ, Swansea, W Glam, Wales		Liossi, C (corresponding author), Univ Southampton, Sch Psychol, Southampton S017 1BJ, Hants, England.	cliossi@soton.ac.uk		Liossi, Christina/0000-0003-0627-6377			Baddeley A., 1992, SPEED CAPACITY LANGU; Barratt ES, 1997, BIOL PSYCHIAT, V41, P1045, DOI 10.1016/S0006-3223(96)00175-8; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; COHEN RA, 1999, VIOLENCE VICT, V4, P397; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; ESLINGER PJ, 1995, NEUROREHABILITATION, V5, P161, DOI 10.3233/NRE-1995-5206; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Greve KW, 2002, PERS INDIV DIFFER, V32, P639, DOI 10.1016/S0191-8869(01)00066-6; Greve KW, 2001, BRAIN INJURY, V15, P255; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Linares-Orama N, 2005, J COMMUN DISORD, V38, P311, DOI 10.1016/j.jcomdis.2005.02.006; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MOFFITT TE, 1990, CRIME JUSTICE, V12, P99, DOI 10.1086/449165; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Nelson HE., 1991, NATL ADULT READING R; Paschall MJ, 2002, AGGRESS VIOLENT BEH, V7, P215, DOI 10.1016/S1359-1789(00)00044-6; PETRIDES M, 1995, ANN NY ACAD SI, V15, P85; Reitan RM, 1985, HALSTEADREITAN NEURO; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; Ruff CC, 2003, NEUROPSYCHOLOGIA, V41, P1241, DOI 10.1016/S0028-3932(03)00016-2; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; *SPSS INC, 2004, SPSS REF GUID; Stanford MS, 1997, PERS INDIV DIFFER, V23, P961, DOI 10.1016/S0191-8869(97)00120-7; Wechsler D., 1997, WECHSLER ADULT MEMOR; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wood R. L., 1987, BRAIN INJURY REHABIL; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 2004, NEUROPSYCHOL REHABIL, V14, P329, DOI 10.1080/09602010343000255; YEUDALL LT, 1997, CANADIAN MENTAL HLTH, V25, P7; [No title captured]	40	23	23	0	7	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2006	18	3					333	341		10.1176/appi.neuropsych.18.3.333			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	081AC	WOS:000240288600004	16963582				2022-02-06	
J	Dandona, R				Dandona, Rakhi			Making road safety a public health concern for policy-makers in India	NATIONAL MEDICAL JOURNAL OF INDIA			English	Article							TRAUMATIC BRAIN-INJURIES; DEVELOPING-COUNTRIES; TRAFFIC INJURIES; EDUCATION; CRASHES; DEATHS	Background. Road traffic injuries contribute substantially to the disease burden in India. This paper describes the road safety issues discussed by members of the Indian Parliament, and highlights the gaps that need to be addressed to make road safety visible as a public health problem to policy-makers in India. Methods. All questions asked to and information provided by the Ministry of Road Transport and Highways, and questions relating to accident asked to the Ministry of Health and Family Welfare of the Government of India were reviewed for the two Houses of the Indian Parliament for the years 2002 to 2004. Results. Of the 1529 questions asked to the Ministry of Road Transport and Highways, only 140 (9.1%) were related to. road safety, whereas 1076 (70.5%), 1.81 (11.8%), 51 (3.3%) and 81 (5.3%) were related to other aspects of the national highways, state roads, vehicles and other issues, respectively. Data on the magnitude of road crashes dealt only with the number of crashes and fatalities and not with the age, sex and type of road users affected by road traffic, injuries. The parliamentarians were informed that human error was the main cause of road crashes in India; however, the robustness of this information is questionable. Strategies to prevent road crashes focused mainly on training of drivers with little attention to other factors that cause road crashes. The discussion on legislations also focused on drivers, ignoring other road users. Ten of the 4741 questions (0.2%) asked to Ministry of Health and Family Welfare were related to accident, the majority of which were about the setting up of trauma care services. Conclusion. An appropriate policy and intervention response by policy-makers is not possible with data that are presented in a manner that do not highlight the true nature of the problem, and are neither comprehensive nor robust. Majority of the proposed road safety interventions by the Ministry of Road Transport and Highways are based on the traditional view of human error as a major cause of road crashes highlighting the lack of a scientific public health approach towards prevention of road crashes. It would be useful to build the technical capacity of the Ministry of Road Transport and Highways in road safety to use the available data more effectively, and to facilitate generation of further relevant data about the magnitude, underlying causes and impact of road traffic injuries, for policy-makers to better understand the critical issues for planning effective road safety policies and interventions to reduce the high burden of mortality and morbidity due to road crashes in India.	Adm Staff Coll India, Hlth Studies Area, Ctr Human Dev, Hyderabad 500082, Andhra Pradesh, India		Dandona, R (corresponding author), Adm Staff Coll India, Hlth Studies Area, Ctr Human Dev, Raj Bhavan Rd, Hyderabad 500082, Andhra Pradesh, India.	rakhi@asci.org.in		Dandona, Rakhi/0000-0003-0926-788X			*COMM EUR COMM, 2001, COST, V327; Dandona L, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-55; Dandona R, 2004, NATL MED J INDIA, V17, P74; Dandona R, 2006, J SAFETY RES, V37, P149, DOI 10.1016/j.jsr.2005.11.002; Dandona Rakhi, 2005, Int J Inj Contr Saf Promot, V12, P167, DOI 10.1080/17457300500088840; Evans Tim, 2003, Inj Control Saf Promot, V10, P11, DOI 10.1076/icsp.10.1.11.14117; Ghaffar A, 2004, PUBLIC HEALTH, V118, P211, DOI 10.1016/j.puhe.2003.05.003; *GOV IND, 2002, TRANSP CHAPT 10 5 YE; *GOV IND, RAIYA SABH QUEST ANS; *GOV IND, ROAD ACC IND 1970 20; *GOV IND, 2006, ROAD SAF; *GOV IND, IND PARL; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; GURURAJ G, 2000, P INJ PREV CONTR P; HEIM L, 1988, VEHICLE OCCUPANT PRO; Ian R, 2001, COCHRANE DB SYST REV, V3; Jacobs G., 2000, ESTIMATING GLOBAL RO; Krug E., 1999, INJURY LEADING CAUSE; Kulanthayan S, 2000, Med J Malaysia, V55, P40; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; MISHRA BK, 1984, ACCIDENT ANAL PREV, V16, P407, DOI 10.1016/0001-4575(84)90053-8; Mock C, 2004, B WORLD HEALTH ORGAN, V82, P241; MOHAN D, 2001, ECO POL WKLY, P4656; MOHAN D, 1983, INDIAN HIGHWAYS, V11, P8; MOHAN D, 2002, INJ SE AS REG PRIOR; MURRAY CJ, 2001, 36 WHO; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P3, DOI 10.1076/icsp.10.1.3.14109; *NAT CRIM REC BUR, 2000, ACC DEATHS SUIC IND; O'Neill B, 2002, BRIT MED J, V324, P1142, DOI 10.1136/bmj.324.7346.1142; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; OJHA AK, 2002, ROAD ACCIDENTS DELHI; ONEILL B, 2000, P WHO M DEV 5 YEAR S; Peden, 2004, GUIDELINES ESSENTIAL; Peden M., 2004, WORLD REPORT ROAD TR; PREUSSER DF, 1984, J SAFETY RES, V15, P47, DOI 10.1016/0022-4375(84)90001-X; Ross H. Laurence, 1982, DETERRING DRINKING D; Rumar K., 1999, TRANSPORT SAFETY VIS; SATHIYASEKARAN BWC, 1991, J ROY SOC HEALTH, V111, P10, DOI 10.1177/146642409111100104; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; UMAR RS, 2002, P 2 WORLD ENG C SAR; *UNDP, 2003, HUM DEV REP 2003; Vernick JS, 1999, AM J PREV MED, V16, P40, DOI 10.1016/S0749-3797(98)00115-9	42	23	23	0	3	ALL INDIA INST MEDICAL SCIENCES	NEW DELHI	ANSARI NAGAR, NEW DELHI 110 029, INDIA	0970-258X			NATL MED J INDIA	Natl. Med. J. India	MAY-JUN	2006	19	3					126	133					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059HO	WOS:000238724100003	16836261				2022-02-06	
J	Huang, PS; Tang, GJ; Chen, CH; Kou, YR				Huang, PS; Tang, GJ; Chen, CH; Kou, YR			Whole-body moderate hypothermia confers protection from wood smoke-induced acute lung injury in rats: The therapeutic window	CRITICAL CARE MEDICINE			English	Article						smoke inhalation injury; acute lung injury; induced hypothermia; pulmonary inflammation; bronchoalveolar lavage fluid; cytokines	RESPIRATORY-DISTRESS-SYNDROME; PROMISING TREATMENT MODALITY; TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; OXIDATIVE STRESS; CARDIOPULMONARY BYPASS; INHALATION INJURY; ENDOTOXEMIC RATS; LIPID-PEROXIDATION; ISCHEMIA	objective: Toxic smoke inhalation causes acute lung injury. We studied the efficacy and therapeutic window of whole-body hypothermia in rats with wood smoke-induced acute lung injury. Design: Randomized, controlled study. Setting. Research laboratory. Subjects: Anesthetized, paralyzed, and artificially ventilated rats (n = 100) were used. Interventions. Air or wood smoke (30 breaths) was delivered into the lung using a respirator. Immediately after challenge, the rat's colonic temperature was kept a) 37 degrees C (normothermia, NT) for I (NT-1-Air and NT-1-Smoke), 2.5 (NT-2.5-Air and NT-2.5-Smoke), or 5 hrs (NT-5-Air and NT-5-Smoke) in six groups; b) 30 degrees C (hypothermia, HT) for 2.5 (HT-2.5-Smoke) or 5 hrs (HT-5-Air and HT-5-Smoke) in three groups; c) 30 degrees C for the first 2.5 hrs followed by 37 degrees C for another 2.5 hrs (HT-NT-5-Smoke) in one group; or d) 37 degrees C for the first 2.5 hrs followed by 30 degrees C for another 2.5 hrs (NT-HT-5-Smoke) in on group. Measurements and Main Results. Various acute lung injury indexes were assessed at 1, 2.5, or 5 hrs after challenge. In the air group, whole-body hypothermia did not affect the level of lung lipid peroxidation and the amount of proteins, total and differential cell counts, and concentrations of tumor necrosis factor-et and interleukin-1 beta in bronchoalveolar lavage fluid. In the smoke groups, these acute lung injury indexes were increased showing that NT-5-Smoke > NT-2.5-Smoke > NT-1-Smoke. Whole-body hypothermia prevented increases in these acute lung injury indexes in the HT-2.5-Smoke and HT-5-Smoke groups. The efficacy of whole-body hypothermia in the HT-NT-5-Smoke group was superior to that in the NT-HT-5-Smoke group and similar to that in the HT-5-Smoke group. Whole-body hypothermia also alleviated smoke-induced poor gas exchange, pulmonary edema, and pathohistologic injurious signs. Conclusions: Whole-body hypothermia confers protection from wood smoke-induced acute lung injury in rats by suppressing oxidant bronchoalveolar damage and pulmonary inflammation. Early and short-period (2 hrs) application of whole-body hypothermia provides favorable therapeutic effects.	Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 11221, Taiwan; Vet Gen Hosp, I Lan Hosp, DOH, Ilan, Taiwan; Mackay Mem Hosp, Dept Surg, Thorac Surg Div, Taipei, Taiwan		Kou, YR (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 11221, Taiwan.	yrkou@ym.edu.tw		Kou, Yu Ru/0000-0002-4681-9009			Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Allen BS, 2003, J THORAC CARDIOV SUR, V125, P625, DOI 10.1067/mtc.2003.96; Attuwaybi BO, 2003, J SURG RES, V115, P48, DOI 10.1016/S0022-4804(03)00313-5; BARROW RE, 1990, J APPL PHYSIOL, V68, P2165, DOI 10.1152/jappl.1990.68.5.2165; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; BLACK PR, 1976, J SURG RES, V20, P49, DOI 10.1016/0022-4804(76)90083-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiang CH, 1999, AM J RESP CRIT CARE, V160, P1319, DOI 10.1164/ajrccm.160.4.9811079; Cullen KE, 1997, J BIOL CHEM, V272, P1742, DOI 10.1074/jbc.272.3.1742; FLETCHER BL, 1973, ANAL BIOCHEM, V52, P1, DOI 10.1016/0003-2697(73)90327-8; Gazmuri RJ, 2003, CRIT CARE MED, V31, P2811, DOI 10.1097/01.CCM.0000099344.57796.F3; GILSTON A, 1983, INTENS CARE MED, V9, P37, DOI 10.1007/BF01693705; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Guven H, 2002, J TRAUMA, V53, P66, DOI 10.1097/00005373-200207000-00014; Hassoun HT, 2002, SURGERY, V132, P369, DOI 10.1067/msy.2002.125722; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Honore PM, 2001, CRIT CARE MED, V29, P1903, DOI 10.1097/00003246-200110000-00009; Horiguchi T, 2003, J NEUROTRAUM, V20, P511, DOI 10.1089/089771503765355577; HURST JM, 1985, CRIT CARE MED, V13, P771, DOI 10.1097/00003246-198509000-00019; JANSSENS SP, 1994, J APPL PHYSIOL, V77, P888, DOI 10.1152/jappl.1994.77.2.888; Javadpour M, 1998, BRIT J SURG, V85, P943; Jeng MJ, 2003, CRIT CARE MED, V31, P1166, DOI 10.1097/01.CCM.0000059312.90697.32; Khandoga A, 2003, FREE RADICAL BIO MED, V35, P901, DOI 10.1016/S0891-5849(03)00430-1; Kimmel EC, 1999, DRUG CHEM TOXICOL, V22, P91, DOI 10.3109/01480549909029726; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Koh Y, 1999, Respirology, V4, P325, DOI 10.1046/j.1440-1843.1999.00200.x; KOU YR, 1994, J APPL PHYSIOL, V76, P2333, DOI 10.1152/jappl.1994.76.6.2333; Laffon M, 1999, AM J RESP CRIT CARE, V160, P1443, DOI 10.1164/ajrccm.160.5.9901097; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; Lim CM, 2004, INTENS CARE MED, V30, P1638, DOI 10.1007/s00134-004-2336-z; Lim CM, 2003, LUNG, V181, P23, DOI 10.1007/s00408-002-0111-x; Lim CM, 2003, INTENS CARE MED, V29, P453, DOI 10.1007/s00134-002-1529-6; Lin YS, 2000, EUR J PHARMACOL, V394, P139, DOI 10.1016/S0014-2999(00)00126-6; Lin YS, 2001, EUR J PHARMACOL, V425, P141, DOI 10.1016/S0014-2999(01)01184-0; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Marion DW, 1996, CRIT CARE MED, V24, pS81; Matsuoka Koji, 2003, Pancreas, V26, pe12, DOI 10.1097/00006676-200301000-00024; Murakami K, 2003, NEWS PHYSIOL SCI, V18, P125, DOI 10.1152/nips.01427.2002; Ning XH, 2002, J APPL PHYSIOL, V92, P2200, DOI 10.1152/japplphysiol.01035.2001; Park MS, 2004, TOXICOLOGY, V195, P97, DOI 10.1016/j.tox.2003.09.005; Patel S, 2000, J AM COLL SURGEONS, V191, P650, DOI 10.1016/S1072-7515(00)00736-5; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Qing M, 2003, CRIT CARE MED, V31, P2769, DOI 10.1097/01.CCM.0000098858.64868.9C; Qing M, 2001, SHOCK, V15, P372, DOI 10.1097/00024382-200115050-00007; Sarcia PJ, 2003, SHOCK, V20, P41, DOI 10.1097/01.shk.0000071080.50028.f2; Satas S, 2003, BIOL NEONATE, V83, P146, DOI 10.1159/000067958; Scumpia PO, 2002, AM J PHYSIOL-LUNG C, V283, pL1231, DOI 10.1152/ajplung.00102.2002; Sievers HH, 2002, ANN THORAC SURG, V74, P1167, DOI 10.1016/S0003-4975(02)03853-5; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Suzuki S, 2004, CRIT CARE MED, V32, P144, DOI 10.1097/01.CCM.0000098857.14923.44; Taniguchi T, 2004, ANESTH ANALG, V98, P1114, DOI 10.1213/01.ANE.0000100740.07331.A2; TOLEDOPEREYRA LH, 1977, ANN THORAC SURG, V23, P487, DOI 10.1016/S0003-4975(10)64176-8; TRABER DL, 1992, AM REV RESPIR DIS, V146, pS15, DOI 10.1164/ajrccm/146.5_Pt_2.S15; TRABER DL, 1986, RESP INJURY SMOKE IN, P61; VILLAR J, 1993, RESUSCITATION, V26, P183, DOI 10.1016/0300-9572(93)90178-S; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; WETTERBERG T, 1992, ACTA ANAESTH SCAND, V36, P490, DOI 10.1111/j.1399-6576.1992.tb03504.x; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; YOUN YK, 1992, FREE RADICAL BIO MED, V12, P409; Zar HA, 1999, ANESTHESIOLOGY, V90, P1103, DOI 10.1097/00000542-199904000-00025	63	23	26	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2006	34	4					1160	1167		10.1097/01.CCM.0000207342.50559.0F			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025YH	WOS:000236303000033	16484924				2022-02-06	
J	Ates, O; Ondul, S; Onal, C; Buyukkiraz, M; Somay, H; Cayli, SR; Gogusgeren, MA; Okrakdogen, M; Kocak, A; Yologlu, S; Berkman, Z; Tevruz, M				Ates, O; Ondul, S; Onal, C; Buyukkiraz, M; Somay, H; Cayli, SR; Gogusgeren, MA; Okrakdogen, M; Kocak, A; Yologlu, S; Berkman, Z; Tevruz, M			Post-traumatic early epilepsy in pediatric age group with emphasis on influential factors	CHILDS NERVOUS SYSTEM			English	Article; Proceedings Paper	18th Congress of the European-Society-for-Pediatric-Neurosurgery	JUN 14-18, 2002	KIRUNA, SWEDEN	European Soc Pediat Neurosurg		pediatric; head injury; posttraumatic epilepsy; early epilepsy; diphenylhydantoin	SEVERE HEAD-INJURY; EARLY SEIZURES; CHILDREN; PREDICTORS; PHENYTOIN; TRAUMA	Objective: Posttraumatic epilepsy in the pediatric age group is mostly seen within the first week. An acute posttraumatic epileptic fit, which may induce secondary insults, should be hindered. The aim of the study is to define the risk factors for posttraumatic early epilepsy (PTEE) and the indications for prophylactic therapy. Methods: In this survey, a total of 1,785 pediatric patients-under the age of 16-are studied. The majority of the patients (1,655) were treated in Haydarpa Numune Hospital within the years 1993-1999. The rest, which consists of 130 patients, were treated in Inonu University Turgut Ozal Medical Center between the years 2001 and 2003. The patients were categorized according to age, gender, neurological manifestations, type of trauma, cranial pathology, number and type of epileptic fits, the interval between trauma and convulsion, electroencephalogram findings, and antiepileptic therapy. All these factors were challenged due to their effect on the evolution of PTEE. Results: Only 149 cases had PTEE (8.4%). There was no correlation between gender and the incidence of PTEE. The data showed that 11.7% of the patients at or under the age of 3 (p=0.00072), 30.8% of the patients with severe head injury (Glasgow Coma Scale=3-8; Children's Coma Scale = 3-8; p=0.00000), 19.3% of the patients with depressed skull fractures (p=0.00038), 13.7% of the patients with intraparenchymal hemorrhage (p=0.0000072), and 21.6% of the patients with cerebral edema (p=0.000008) had PTEE. Only 20% of the patients with PTEE had a Glasgow Outcome Scale (GOS) of 3 or less (p=0.0000075). Conclusion: Those patients at or under the age of 3, with severe head injury, cerebral edema, intraparenchymal hemorrhage, or depressed skull fracture, have a higher incidence of PTEE. Moreover, because the GOS of these patients are prone to be worse, antiepileptic therapy in acute stage may be effective in preventing the secondary brain damage.	Inonu Univ, Turgut Ozal Med Ctr, Sch Med, Dept Neurosurg, TR-44069 Malatya, Turkey; Haydarpasa Numune Hosp, Dept Neurosurg, Istanbul, Turkey; Inonu Univ Sch Med, Dept Biostat, Malatya, Turkey		Ates, O (corresponding author), Inonu Univ, Turgut Ozal Med Ctr, Sch Med, Dept Neurosurg, TR-44069 Malatya, Turkey.	atesozkan@hotmail.com	Yologlu, Saim/ABI-8014-2020	Yologlu, Saim/0000-0002-9619-3462			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P549, DOI DOI 10.1089/NEU.2000.17.549; CAVENESS WF, 1961, EPILEPSIA, V2, P123; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HEEVER CMV, 1989, J NEUROSURG, V71, P186; HENDRICK EB, 1968, J TRAUM, V8, P547; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; JENNETT B, 1965, BRIT MED J, V2, P1215; KAPLAN HA, 1961, EPILEPSIA, V2, P111; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL C, 1961, EPILEPSIA, V2, P138; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; MOSHE SL, 1987, EPILEPSIA S1, V28, P3; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; SADIKOGLU S, 1988, DERGISI, V3, P240; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tuncer R, 1989, TURK NEUROSURG, V1, P23; WALKER AE, 1970, EPILEPSIA, V11, P17, DOI 10.1111/j.1528-1157.1970.tb03861.x; WEISS GH, 1972, J NEUROSURG, V37, P164, DOI 10.3171/jns.1972.37.2.0164; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	32	23	25	0	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2006	22	3					279	284		10.1007/s00381-005-1177-6			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics; Surgery	015IV	WOS:000235546000012	15889309				2022-02-06	
J	Moor, E; Shohami, E; Kanevsky, E; Grigoriadis, N; Symeonidou, C; Kohen, R				Moor, E; Shohami, E; Kanevsky, E; Grigoriadis, N; Symeonidou, C; Kohen, R			Impairment of the ability of the injured aged brain in elevating urate and ascorbate	EXPERIMENTAL GERONTOLOGY			English	Article						aging; ascorbic acid; uric acid; axonal injury; microdialysis; traumatic brain injury; closed head injury; low molecular weight antioxidants	CLOSED-HEAD-INJURY; OXIDATIVE STRESS; EXTRACELLULAR ASCORBATE; IN-VIVO; FOREBRAIN ISCHEMIA; RAT-BRAIN; RELEASE; ANTIOXIDANTS; GLUTAMATE; ACID	Urate and ascorbate play a major role in the defense mechanism of the brain against oxidative damage induced by traumatic brain injury. The severity and extent of brain damage are known to increase with age. This may be due to different basal levels of endogenous antioxidants, and/or to impaired ability of the old brain to recruit and elevate the levels of antioxidants following injury. To investigate this hypothesis, we measured basal ascorbate and urate levels in the hippocampus, using microdialysis in young, adults and old rats, and performed closed head injury (CHI) in young (5-6 weeks) and old rats (19-20 months). Basal ascorbate, but not urate levels in old rats were significantly lower than in the adults. The ability of the old rats to increase ascorbate levels after CHI was significantly lower than that of the young ones, as indicated by lower levels of ascorbate and urate in the dialysate of old rats. This lower level of antioxidant mobilization in the old brain may explain the extended damage found in histology. Evaluation of hippocampal cell loss (p < 0.05) and axonal degeneration in the corpus callosum showed more extensive damage in old as compared to young rats (chi(2)=4.25; p < 0.05). These findings shed more light on the susceptibility of old rat brain to CHI-induced oxidative damage. (c) 2006 Elsevier Inc. All rights reserved.	Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Neurol, GR-54006 Thessaloniki, Greece; Aristotle Univ Thessaloniki, Fac Med, Dept Physiol, GR-54006 Thessaloniki, Greece		Kohen, R (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel.	ronko@cc.huji.ac.il	Kohen, Ron/ABC-2281-2021	Kohen, Ron/0000-0001-7268-9845			AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Berry EM, 1999, MED HYPOTHESES, V53, P397, DOI 10.1054/mehy.1998.0786; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; COHEN G, 1994, ANN NY ACAD SCI, V738, P8; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; Elangovan V, 2000, J NEUROTRAUM, V17, P1013, DOI 10.1089/neu.2000.17.1013; Esposito E, 2002, NEUROBIOL AGING, V23, P719, DOI 10.1016/S0197-4580(02)00078-7; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Glantz L, 2005, EXP NEUROL, V192, P117, DOI 10.1016/j.expneurol.2004.11.012; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HALLIWELL B, 1987, FEBS LETT, V213, P9, DOI 10.1016/0014-5793(87)81455-2; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HILLERED L, 1988, NEUROSCI LETT, V95, P286, DOI 10.1016/0304-3940(88)90672-6; HILLERED L, 1990, NEUROSCI LETT, V113, P328, DOI 10.1016/0304-3940(90)90606-A; JAVOUHEY E, 2005, IN PRESS ACCIDENT AN; Joseph JA, 2000, MECH AGEING DEV, V116, P141, DOI 10.1016/S0047-6374(00)00128-7; Kohen R, 1997, ARCH GERONTOL GERIAT, V24, P103, DOI 10.1016/S0167-4943(96)00744-3; Litchfield S, 2001, ACTA NEUROPATHOL, V101, P17; Lomnitski L, 2000, EXP TOXICOL PATHOL, V52, P177; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Miele M, 2000, BRIT J PHARMACOL, V129, P582, DOI 10.1038/sj.bjp.0703066; MIELE M, 1994, NEUROSCIENCE, V62, P87, DOI 10.1016/0306-4522(94)90316-6; Miele M, 1996, J NEUROSCI METH, V70, P15, DOI 10.1016/S0165-0270(96)00094-5; Moor E, 2001, NEUROSCI LETT, V316, P169, DOI 10.1016/S0304-3940(01)02394-1; MOTCHNIK PA, 1994, METHOD ENZYMOL, V234, P115; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; SEVANIAN A, 1991, AM J CLIN NUTR, V54, pS1129, DOI 10.1093/ajcn/54.6.1129s; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SVENSSON L, 1993, BRAIN RES, V609, P36, DOI 10.1016/0006-8993(93)90851-D; Tayag EC, 1996, BRAIN RES, V733, P287, DOI 10.1016/0006-8993(96)00669-5; van der Loo B, 2003, BIOCHEM BIOPH RES CO, V303, P483, DOI 10.1016/S0006-291X(03)00360-7; Wei YH, 1998, P SOC EXP BIOL MED, V217, P53; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Yusa T, 2000, NEUROSCI LETT, V293, P123, DOI 10.1016/S0304-3940(00)01501-9; Yusa T, 2001, BRAIN RES, V897, P104, DOI 10.1016/S0006-8993(01)02099-6	47	23	25	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	MAR	2006	41	3					303	311		10.1016/j.exger.2005.12.006			9	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	030RY	WOS:000236653300009	16459044				2022-02-06	
J	Caricato, A; Pennisi, M; Mancino, A; Vigna, G; Sandroni, C; Arcangeli, A; Antonelli, M				Caricato, A; Pennisi, M; Mancino, A; Vigna, G; Sandroni, C; Arcangeli, A; Antonelli, M			Levels of vancomycin in the cerebral interstitial fluid after severe head injury	INTENSIVE CARE MEDICINE			English	Article						blood-brain barrier; cerebral interstitial fluid; cerebral posttraumatic hemorrhage; microdialysis; severe head injury; vancomycin	BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; MICRODIALYSIS; PHARMACOKINETICS; SAMPLES; KILL	Objective:To evaluate the concentrations of vancomycin in the cerebral interstitial fluid after intravenous administration by multiple boli. Design:Prospective non randomized study. Setting:University hospital general ICU. Patients:Four patients undergone to craniotomy for evacuation of cerebral posttraumatic hemorrhage, who developed pneumonia 4-7 days from the injury. Methods:Two microdialysis catheters were placed in each patient: one in the edematous brain surrounding the focal lesion and one in the subcutaneous tissue of abdomen. Levels of vancomycin were measured in serum and in the microdialysates samples. Results:Plasmatic concentration of 10-15 mu g/ml in the trough level was obtained after four administrations of vancomycin. Levels of vancomycin in the subcutaneous tissue was above minimum inhibitory concentrations in all patients after the second administration. Mean serum/brain ratio was 8%. Cerebral interstitial concentration of vancomycin was never above minimum inhibitory concentrations; its maximum value was 1.2 mu g/ml. Conclusions:In edematous brain close to a posttraumatic hemorrhage the levels of vancomycin do not differ from that in healthy subjects. At these plasmatic concentrations cerebral interstitial levels of vancomycin were insufficient while subcutaneous interstitial levels were effective for clinical use.	Univ Sacred Heart, Sch Med, Dept Anesthesia & Intens Care, I-00168 Rome, Italy		Caricato, A (corresponding author), Univ Sacred Heart, Sch Med, Dept Anesthesia & Intens Care, Lgo A Gemelli 1, I-00168 Rome, Italy.	anselmo.caricato@fastwebnet.it	Sandroni, Claudio/A-7320-2019; Antonelli, Massimo/K-9915-2016; Antonelli, Massimo/F-9848-2010	Sandroni, Claudio/0000-0002-8878-2611; Antonelli, Massimo/0000-0003-3007-1670; mancino, aldo/0000-0003-4556-8647; PENNISI, Mariano Alberto/0000-0001-8761-5144			Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; ACKERMAN BH, 1992, ANTIMICROB AGENTS CH, V36, P1766, DOI 10.1128/AAC.36.8.1766; Albanese J, 2000, ANTIMICROB AGENTS CH, V44, P1356, DOI 10.1128/AAC.44.5.1356-1358.2000; Begg EJ, 1999, BRIT J CLIN PHARMACO, V47, P23, DOI 10.1046/j.1365-2125.1999.00850.x; Bouw R, 2001, ACTA ANAESTH SCAND, V45, P390, DOI 10.1034/j.1399-6576.2001.045003390.x; *BRIT NAT FORM, 2005, BRIT NAT FORM, V49; Davies MI, 2000, ADV DRUG DELIVER REV, V45, P169, DOI 10.1016/S0169-409X(00)00114-9; de Lange ECM, 2002, CLIN PHARMACOKINET, V41, P691, DOI 10.2165/00003088-200241100-00001; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; Iwamoto T, 2003, BIOL PHARM BULL, V26, P876; Lutsar I, 1998, CLIN INFECT DIS, V27, P1117, DOI 10.1086/515003; Mackie CE, 1997, J PHARMACEUT BIOMED, V15, P917, DOI 10.1016/S0731-7085(96)01924-3; MOELLERING RC, 1981, ANN INTERN MED, V94, P343, DOI 10.7326/0003-4819-94-3-343; PEETERMANS WE, 1990, ANTIMICROB AGENTS CH, V34, P1869, DOI 10.1128/AAC.34.10.1869; Plock N, 2005, BIOMED CHROMATOGR, V19, P237, DOI 10.1002/bmc.446; Povlishock J.T, 1998, INTRO BLOOD BRAIN BA, P441; Rocha LL, 1997, J NEUROCHEM, V68, P616; STRATTON CW, 1987, ANTIMICROB AGENTS CH, V31, P1210, DOI 10.1128/AAC.31.8.1210; STRAUSBAUGH LJ, 1981, J ANTIMICROB CHEMOTH, V6, P363; Tobin CM, 2002, J ANTIMICROB CHEMOTH, V50, P713, DOI 10.1093/jac/dkf212	20	23	27	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	FEB	2006	32	2					325	328		10.1007/s00134-005-0015-3			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011EH	WOS:000235250300024	16432677				2022-02-06	
J	Childs, C; Vail, A; Leach, P; Rainey, T; Protheroe, R; King, A				Childs, Charmaine; Vail, Andy; Leach, Paul; Rainey, Timothy; Protheroe, Richard; King, Andrew			Brain temperature and outcome after severe traumatic brain injury	NEUROCRITICAL CARE			English	Article						brain; temperature; outcome; survival; injury severity	CEREBRAL-BLOOD-FLOW; BODY-TEMPERATURE; INTRACEREBRAL TEMPERATURE; SYSTEMIC TEMPERATURE; RECTAL TEMPERATURES; HYPERTHERMIA; STROKE; FEVER; CARE	Introduction: In human's, raised body temperature is linked to poor outcome after brain injury. Because deviations between brain and body temperature have been reported after severe traumatic brain injury (TBI), the aim of this study was to explore the relationship between initial and, mean brain temperature and survival at 3 months. Methods: Intraparenchymal temperature was measured 3-4 cm within white matter. Logistic regression was used to explore linear and quadratic relationships between initial and average brain temperature and survival at 3 months. Results: In 36 patients, initial brain temperatures ranged from 33.5 to 39.2 degrees C (median 37.4 degrees C). There was no evidence of an association between initial brain temperature and risk of death, either linear (odds ratio [OR] 95% confidence interval [Cl] = 1.3 [0.68 to 2.5], p = 0.42) or quadratic (p = 0.26). Assuming a linear relationship, patients with higher mean brain temperatures were less likely to die: OR (95% Cl) for death per 1 degrees C was 0.31 (0.09 to 1.1), p = 0.06. However, by fitting the quadratic relationship, there was a suggestion that both high and low temperatures were associated with increased risk of death: p = 0.06. Conclusion: Initial brain temperature measured shortly after admission did not predict outcome. There is a suggestion that patients with "middle range" temperatures were less likely to die.	Univ Manchester, Hope Hosp, Dept Neurosurg, Salford M6 8HD, Lancs, England; Univ Manchester, Hope Hosp, Div Med & Neurosci, Salford M6 8HD, Lancs, England; Univ Manchester, Hope Hosp, Biostat Grp, Salford M6 8HD, Lancs, England		Childs, C (corresponding author), Univ Manchester, Hope Hosp, Dept Neurosurg, Eccles Old Rd, Salford M6 8HD, Lancs, England.	cchilds@manchester.ac.uk	Protheroe, Richard/AAT-9329-2021; Childs, Charmaine/G-9928-2012; King, Andrew/AAR-1656-2020	Vail, Andy/0000-0001-8274-2726			AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; Brinnel H., 1987, HEAT STRESS PHYS EXE, P209; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2004, ANAESTHESIA, V59, P192, DOI 10.1111/j.1365-2044.2003.03638.x; Childs C, 1999, ARCH DIS CHILD, V80, P262, DOI 10.1136/adc.80.3.262; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; GUPTA AK, 2000, BRIT J NEUROSURG, V14, P208; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; LITTLE RA, 1981, BRIT J SURG, V68, P221, DOI 10.1002/bjs.1800680402; Manno EM, 2004, CRIT CARE MED, V32, P1611, DOI 10.1097/01.CCM.0000131864.83506.86; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; MELLERGARD P, 1994, ACTA NEUROCHIR, P485; MELLERGARD P, 1995, SURG NEUROL, V43, P91, DOI 10.1016/0090-3019(95)80049-M; Otawara Y, 2003, SURG NEUROL, V60, P159, DOI 10.1016/S0090-3019(03)00083-1; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; STONER HB, 1986, SCI BASIS CARE CRITI, P215; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008	28	23	26	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2006	5	1					10	14		10.1385/NCC:5:1:10			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	073UB	WOS:000239767000003	16960288				2022-02-06	
J	Dunham, CM; Ransom, KJ; McAuley, CE; Gruber, BS; Mangalat, D; Flowers, LL				Dunham, C. Michael; Ransom, Kenneth J.; McAuley, Clyde E.; Gruber, Brian S.; Mangalat, Dev; Flowers, Laurie L.			Severe brain injury ICU outcomes are associated with Cranial-Arterial Pressure Index and noninvasive Bispectral Index and transcranial oxygen saturation: a prospective, preliminary study	CRITICAL CARE			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; EMERGENCY-DEPARTMENT; MONITOR PLACEMENT; OXIMETRY; MANAGEMENT; HYPOXIA	Introduction The purpose of this study was to determine if noninvasive transcranial oxygen saturation (StcO(2)) and Bispectral Index (BIS) correlate with severe traumatic brain injury intensive care unit (ICU) outcomes. Methods This is a prospective observational study. Values of intracranial pressure (ICP), mean arterial pressure ( MAP), BIS, and StcO(2) were recorded hourly for the first six, post-injury days in 18 patients with severe brain injury. Included in the analyses was the Cranial-Arterial Pressure (CAP) Index, which is ICP/ ( MAP - ICP). Results After 1,883 hours of data were analyzed, we found that StcO(2) and BIS are associated with survival, good neurological outcome, ICP <= 20, cerebral perfusion pressure (CPP) >= 60, and CAP index <= 0.30 ( p <= 0.001). Survival and good outcome are independently associated with BIS >= 60, StcO(2) >= 70, and ICP <= 20 ( p < 0.0001). BIS >= 60 or StcO(2) >= 70 is associated with survival, good outcome, CPP >= 60, ICP <= 20, CAP index <= 0.30, and fewer ICP interventions ( p < 0.0001). With BIS >= 60 or StcO2 >= 70, the rate of CPP >= 60 is 97.2% and the rate of ICP <= 25 is 97.1%. An increased CAP index is associated with death, poor neurological outcome, and increased ICP interventions ( p < 0.0001). With CAP index > 0.25, MAP is not related to ICP ( p = 0.16). Conclusion Numerous significant associations with ICU outcomes indicate that BIS and StcO(2) are clinically relevant. The independent associations of BIS, StcO(2), and ICP with outcomes suggest that noninvasive multi-modal monitoring may be beneficial. Future studies of patients with BIS >= 60 or StcO(2) >= 70 will determine if select patients can be managed without ICP monitoring and whether marginal ICP can be observed. An increased CAP index is associated with poor outcome.	St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA		Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA.	michael_dunham@hmis.org		Dunham, C. Michael/0000-0002-7842-9750			Abdul-Khaliq H, 2000, BIOMED TECH, V45, P328, DOI 10.1515/bmte.2000.45.11.328; AHMAD S, 2004, CRITICAL CARE MED S, V32, pA104; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; *BRAIN TRAUM FDN I, 2003, GUID MAN SEV TRAUM B, P1; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; Fabregas N, 2004, ANESTHESIOLOGY, V101, P43, DOI 10.1097/00000542-200407000-00009; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; Haug E, 2004, ACAD EMERG MED, V11, P349, DOI 10.1197/j.aem.2003.12.015; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Isa Ruwaida, 2003, Neurosurg Focus, V15, pE1; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Kim MB, 2000, J CLIN MONIT COMPUT, V16, P191, DOI 10.1023/A:1009940031063; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; Madsen PL, 1999, PROG NEUROBIOL, V58, P541, DOI 10.1016/S0301-0082(98)00093-8; Oertel M, 2002, ACT NEUR S, V81, P67; Pillai S, 2004, NEUROL INDIA, V52, P67; Riker RR, 2003, PHARMACOTHERAPY, V23, P1087, DOI 10.1592/phco.23.10.1087.32766; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosow C, 2001, Anesthesiol Clin North Am, V19, P947; Vivien B, 2002, INTENS CARE MED, V28, P419, DOI 10.1007/s00134-002-1219-4	23	23	32	0	3	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1466-609X			CRIT CARE	Crit. Care		2006	10	6							R159	10.1186/cc5097			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185NU	WOS:000247718500007	17105656	gold, Green Published			2022-02-06	
J	Felde, AB; Westermeyer, J; Thuras, P				Felde, AB; Westermeyer, J; Thuras, P			Co-morbid traumatic brain injury and substance use disorder: Childhood predictors and adult correlates	BRAIN INJURY			English	Article						traumatic brain injury; substance; related disorders; antisocial personality disorder; comorbidity; conduct disorder	EPIDEMIOLOGIC CATCHMENT-AREA; HEAD-INJURY; PSYCHIATRIC-DISORDERS; RATING-SCALE; AXIS-I; ABUSE; POPULATION; ALCOHOLISM; DEPRESSION; PSYCHOPATHOLOGY	Primary objective: To examine demographic factors, childhood experiences and behaviour problems and adult psychopathology associated with a history of adult traumatic brain injury (TBI) with unconsciousness in patients with substance use disorders (SUD). Design and methods: Voluntary patients (n = 550) undergoing treatment for SUD were compared for clinical and demographic variables based on report of TBI. Results: Among the 218 (40%) patients reporting TBI, 61% were men. Childhood conduct problems and loss of a parent were strongly associated with adult TBI. Patients with TBI had more severe SUD and higher rates of depressive and anxiety symptoms, somatic concerns, physical trauma, attempted suicide and Antisocial Personality Disorder. Conclusions: Men have a higher rate of TBI than women, but women with SUD have an increased relative risk of TBI compared to women in the general population. Childhood conduct problems and loss of a parent in childhood may predict adult risk-taking behaviour that leads to TBI in patients with SUD. TBI is associated with higher rates of psychopathology in patients with SUD.	Vet Adm Med Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Minneapolis, MN USA		Felde, AB (corresponding author), Vet Adm Med Ctr, 116A,1 Vet Dr, Minneapolis, MN 55417 USA.	anne.felde@med.va.gov					ALTERMAN AI, 1985, J STUD ALCOHOL, V46, P256, DOI 10.15288/jsa.1985.46.256; *AM PSYCH ASS, 1987, DIGN STAT MAN MENT D; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; BOTSIS AJ, 1995, SUICIDE LIFE-THREAT, V25, P253; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Bussing R, 1996, ARCH PEDIAT ADOL MED, V150, P50, DOI 10.1001/archpedi.1996.02170260054009; Carbonneau R, 1998, J STUD ALCOHOL, V59, P387, DOI 10.15288/jsa.1998.59.387; Cobb BK, 1995, J ADOLESCENT HEALTH, V17, P381, DOI 10.1016/1054-139X(95)00059-2; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DEROGATIS LR, 1977, SYMPTOM CHECKLIST 90; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; GOLDSTEIN HS, 1984, J AM ACAD CHILD PSY, V23, P679, DOI 10.1016/S0002-7138(09)60536-7; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, BRIT J MED PSYCHOL; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HILLBOM M, 1986, J NEUROL NEUROSUR PS, V49, P1348, DOI 10.1136/jnnp.49.12.1348; Knight DK, 1998, AM J DRUG ALCOHOL AB, V24, P361, DOI 10.3109/00952999809016903; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus Jess F., 1994, P3; LINDENBAUM GA, 1989, J TRAUMA, V29, P1654, DOI 10.1097/00005373-198912000-00012; MALLOY P, 1990, ADDICT BEHAV, V15, P431, DOI 10.1016/0306-4603(90)90029-W; MANNUZZA S, 1989, ARCH GEN PSYCHIAT, V46, P1073; MEEHL PE, 1978, J CONSULT CLIN PSYCH, V46, P806, DOI 10.1037/0022-006X.46.4.806; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PARKINSON D, 1985, CAN J SURG, V28, P79; Pulkkinen L, 1995, CHILD DEV, V66, P1660, DOI 10.2307/1131902; Redeker N S, 1995, Am J Crit Care, V4, P370; REDLICH FC, 1953, AM J PSYCHIAT, V109, P729, DOI 10.1176/ajp.109.10.729; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROBINS LN, 1991, PSYCHIATRY, V54, P116; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Westermeyer J, 2005, AM J DRUG ALCOHOL AB, V31, P93, DOI 10.1081/ADA-200047895; WESTERMEYER J, 1988, AM J PSYCHIAT, V145, P1265; Westermeyer J, 1998, AM J ADDICTION, V7, P24; Westermeyer Joe, 1994, Journal of Addictive Diseases, V13, P67; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955	47	23	23	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					41	49		10.1080/02699050500309718			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000005	16403699				2022-02-06	
J	Okonkwo, DO; Reece, TB; Laurent, JJ; Hawkins, AS; Ellman, PI; Linden, J; Kron, IL; Tribble, CG; Stone, JR; Kern, JA				Okonkwo, DO; Reece, TB; Laurent, JJ; Hawkins, AS; Ellman, PI; Linden, J; Kron, IL; Tribble, CG; Stone, JR; Kern, JA			A comparison of adenosine A(2A) agonism and methylprednisolone in attenuating neuronal damage and improving functional outcome after experimental traumatic spinal cord injury in rabbits	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal cord injury; trauma; adenosine; A(2A) receptor; methylprednisolone; rabbit	SODIUM SUCCINATE ESTER; TUMOR-NECROSIS-FACTOR; REPERFUSION INJURY; BLOOD-FLOW; CELL-DEATH; VASCULAR MECHANISMS; RECEPTOR AGONISTS; CONTROLLED-TRIAL; FACTOR-ALPHA; ACTIVATION	Object. Steroid agents remain the lone pharmacological treatment in widespread use For acute spinal cord injury (SCI), although their utility remains ill dispute in the neurotrauma literature. Adenosine A, receptor activation with ATL-146e, a selective A(2A) agonist, has shown potential benefit in treating SCI; however, it has not been compared with the gold standard, methylprednisolone. The authors of this study evaluated ATL-146e and methylprednisolone for their ability to preserve neuronal viability and motor function in experimental SCI. Methods. New Zealand White rabbits Sustained SCI or sham injury via the Allen weight-drop technique. Ten minutes postinjury, animals received ATL-146e (ATL group, 0.06 mu g/kg/min intravenously for 3 hours), methylprednisolone (steroid group, 30 mg/kg intravenously), or saline (trauma control group). Hindlimb motor function was recorded every 12 hours using the Tarlov motor grading scale (0, paralysis-5, normal hop). At 48 hours, fixed spinal cord tissue was evaluated for neuronal viability. Hindlimb motor function in animals treated with ATL-146e was equivalent to that of sham-injured animals and was significantly better than that of trauma control animals at all time points and that of steroid-treated animals at 12 hours (p = 0.05). Motor function in steroid-treated animals was worse than in those given ATL-146e and better than that of 0 trauma control animals at later time points, but was not statistically significant (both p > 0.05). Neuronal viability (measured in neurons/hpf) was significantly higher in both treatment groups compared with the trauma control group (12.1 +/- 1.4 neurons/hpf for the ATL and 13.3 +/- 1.4 neurons/hpf for the steroid group compared with 7.5 +/- 1.5 neurons/hpf for the trauma control group; both p < 0.04). Neuronal viability did not differ among ATL-146e-treated. steroid-treated, and sham-injured groups. Conclusions. The use of ATL-146e is at least as effective as methylprednisolone in preserving function and is equivalent to methylprednisolone in preserving the structure of spinal cord tissue after blunt SCI. Adenosine A(2A) receptor activation may be an effective treatment for acute SCI while avoiding the adverse effects of steroid agents.	Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA		Okonkwo, DO (corresponding author), Univ Virginia Hlth Syst, Dept Neurol Surg, Box 800212, Charlottesville, VA 22908 USA.	doo5a@hscmail.mcc.virginia.edu	Linden, Joel/AAH-5690-2020				BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; BERNE RM, 1983, FED PROC, V42, P3136; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BRAUGHLER JM, 1982, DRUG METAB DISPOS, V10, P551; BRAUGHLER JM, 1983, J NEUROSURG, V58, P538; BRUNSTOCK G, 1998, CARDIOVASCULAR BIOL; Cassada DC, 2002, J VASC SURG, V35, P994, DOI 10.1067/mva.2002.123091; Cassada DC, 2002, J TRAUMA, V53, P225, DOI 10.1097/00005373-200208000-00005; Cassada DC, 2001, SURGERY, V130, P230, DOI 10.1067/msy.2001.115838; Cassada DC, 2002, ANN THORAC SURG, V74, P846, DOI 10.1016/S0003-4975(02)03793-1; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Ferreira JM, 2001, BRAIN RES, V900, P169, DOI 10.1016/S0006-8993(01)02279-X; GEORGE ER, 1995, AM SURGEON, V61, P659; GERHART KA, 1995, PARAPLEGIA, V33, P316, DOI 10.1038/sc.1995.71; Glover DK, 2001, CIRCULATION, V104, P1181, DOI 10.1161/hc3601.093983; HALL ED, 1982, SURG NEUROL, V18, P320, DOI 10.1016/0090-3019(82)90140-9; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Hinschen AK, 2003, J CARDIOVASC PHARM, V41, P73, DOI 10.1097/00005344-200301000-00010; Hugenholtz H, 2002, CAN J NEUROL SCI, V29, P227, DOI 10.1017/S0317167100001992; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; Jacobson KA, 1999, APOPTOSIS, V4, P197, DOI 10.1023/A:1009666707307; Kitagawa H, 2002, NEUROL RES, V24, P317, DOI 10.1179/016164102101199819; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; LAYCOCK J R D, 1984, Neurological Research, V6, P75; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; McDonald JW, 2002, J NEUROSURG, V97, P252, DOI 10.3171/spi.2002.97.2.0252; MEANS ED, 1981, J NEUROSURG, V55, P200, DOI 10.3171/jns.1981.55.2.0200; Nemecek S, 1978, Adv Neurol, V20, P395; Ngai AC, 2001, AM J PHYSIOL-HEART C, V280, pH2329, DOI 10.1152/ajpheart.2001.280.5.H2329; Nicholls J., 2002, Autonomic & Autacoid Pharmacology, V22, P209, DOI 10.1046/j.1474-8673.2002.00259.x; Nieri P, 2001, BRIT J PHARMACOL, V134, P745, DOI 10.1038/sj.bjp.0704301; Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404, DOI 10.1152/ajprenal.1999.277.3.F404; Pan WH, 2003, J NEUROIMMUNOL, V134, P111, DOI 10.1016/S0165-5728(02)00426-5; Reece TB, 2004, J SURG RES, V121, P130, DOI 10.1016/j.jss.2004.04.006; Rieger JM, 2001, J MED CHEM, V44, P531, DOI 10.1021/jm0003642; Ross SC, 1999, J HEART LUNG TRANSPL, V18, P994, DOI 10.1016/S1053-2498(99)00066-2; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SENTER HJ, 1979, J NEUROSURG, V50, P198, DOI 10.3171/jns.1979.50.2.0198; Shin HK, 2000, LIFE SCI, V67, P1435, DOI 10.1016/S0024-3205(00)00737-2; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Sullivan Gail W, 2003, Curr Opin Investig Drugs, V4, P1313; Sullivan GW, 2004, J LEUKOCYTE BIOL, V75, P127, DOI 10.1189/jlb.0603300; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vinten-Johansen J, 2003, ANN THORAC SURG, V75, pS691, DOI 10.1016/S0003-4975(02)04694-5; VonLubitz DKJE, 1995, EUR J PHARMACOL, V287, P295, DOI 10.1016/0014-2999(95)00498-X; Wei MX, 2001, CHEST, V120, P860, DOI 10.1378/chest.120.3.860; Wirkner K, 2000, BRIT J PHARMACOL, V130, P259, DOI 10.1038/sj.bjp.0703234; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Yin XM, 2000, J MOL MED-JMM, V78, P203, DOI 10.1007/s001090000099; YOUNG W, 1982, J NEUROSURG, V57, P667, DOI 10.3171/jns.1982.57.5.0667; Yune TY, 2003, J NEUROTRAUM, V20, P207, DOI 10.1089/08977150360547116; Zhao ZQ, 2001, J MOL CELL CARDIOL, V33, P57, DOI 10.1006/jmcc.2000.1275	59	23	23	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JAN	2006	4	1					64	70		10.3171/spi.2006.4.1.64			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	001OZ	WOS:000234547500010	16506468				2022-02-06	
J	Salmond, CH; Menon, DK; Chatfield, DA; Pickard, JD; Sahakian, BJ				Salmond, C. H.; Menon, D. K.; Chatfield, D. A.; Pickard, J. D.; Sahakian, B. J.			Changes over time in cognitive and structural profiles of head injury survivors	NEUROPSYCHOLOGIA			English	Article						head injury; acetylcholine; MRI; neuropsychology	TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; DEFICITS	Survivors of traumatic head injury often suffer chronic cognitive deficits. Considerable evidence implicates the cholinergic system in these deficits. Recently, we reported cognitive and structural abnormalities in a cohort of head injured survivors consistent with this hypothesis [see Salmond, C. H., Chatfield, D. A., Menon, D. K., Pickard, J. D., & Sahakian, B. J. (2005). Cognitive Sequelae of Head Injury: Involvement of Basal Forebrain and associated structures. Brain, 128(1), 189-200]. The stability of the cognitive and structural MRI profiles was investigated in a longitudinal study. Twenty-one survivors of moderate-severe head injury completed two comprehensive neuropsychological assessments and two structural MRI scans at least six months apart. A cohort of controls also completed these investigations. The results revealed that the cognitive and structural profiles are relatively stable from six months post-injury forward up to 3 years post-injury. Deficits in memory, attention and reaction time were found, with relative preservation of working memory, consistent with abnormalities in the cholinergic system. These findings suggest that cholinergic enhancers may be an effective treatment for cognitive deficits post-head injury in survivors up to three years post-injury. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Anaesthet, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England		Salmond, CH (corresponding author), Inst Psychiat, Addict Sci Bldg,4 Windsor Walk, London SE5 8AF, England.	Claire.Salmond@iop.kcl.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0001354, G9439390, G0600986] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390] Funding Source: UKRI		Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; BECK A, 1970, DEPRESSION CAUSES TE; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nelson H.E., 1982, NATL ADULT READING T; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	19	23	23	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia		2006	44	10					1995	1998		10.1016/j.neuropsychologia.2006.03.013			4	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	068VS	WOS:000239403200037	16620889				2022-02-06	
J	Du, T; Ciuffreda, KJ; Kapoor, N				Du, T; Ciuffreda, KJ; Kapoor, N			Elevated dark adaptation thresholds in traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; dark adaptation; photosensitivity; cortical gain control; vision dysfunction	VISUAL ADAPTATION; HEAD-INJURY; LIGHT; SENSITIVITY; SOUND; CELLS	Primary objective: To expand upon earlier findings of elevated dark adaptation ( scotopic) thresholds in photosensitive individuals with traumatic brain injury (TBI). Methods and procedures: To assess scotopic thresholds in individuals with TBI (n = 17) manifesting varying degrees of photosensitivity ( mild, moderate or marked), but without retinal dysfunction, to those of non-photosensitive, visually-normal individuals (n = 21) using a hand-held dark adaptometer. Main outcomes and results: The group mean scotopic threshold for the TBI group was significantly higher than that of the visually-normal group. Over 50% (nine out of 17) of the TBI group exhibited elevated thresholds. There was no correlation between the threshold value and degree of photosensitivity. Conclusion: The elevated scotopic thresholds suggest an abnormality in cortical gain control. An anomalous adaptive response may develop due to cortical damage, thereby attenuating subjective light sensation.	SUNY Coll Optometry, Dept Vis Sci, New York, NY 10036 USA; SUNY Coll Optometry, Dept Clin Sci, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Dept Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu			NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T32 EY07079-17] Funding Source: Medline		BIGLER ED, 1989, TRAUMATIC BRAIN INJU, P13; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; DOWLING JE, 1967, SCIENCE, V155, P273, DOI 10.1126/science.155.3760.273; DOWLING JE, 1987, RETINA APPROACHABLE, P187; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; FREED S, 1997, J OPTOMETRIC VISION, V30, P58; FUSTER JM, 1990, ANN NY ACAD SCI, V608, P318, DOI 10.1111/j.1749-6632.1990.tb48901.x; Hecht S, 1937, J GEN PHYSIOL, V20, P831, DOI 10.1085/jgp.20.6.831; Jackowski MM, 1996, NEUROREHABILITATION, V6, P193, DOI 10.3233/NRE-1996-6305; JACKOWSKI MM, 2001, VISUAL VESTIBULAR CO, P145; JONSSON CO, 1967, ACTA NEUROL SCAND, V43, P158, DOI 10.1111/j.1600-0404.1967.tb05725.x; Kaplan E., 2004, VISUAL NEUROSCIENCES, V1, P481; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; LIDVALL HF, 1974, ACTA NEUROL SCAND, V56, P50; Raymond MJ, 1996, NEUROREHABILITATION, V6, P229, DOI 10.3233/NRE-1996-6309; Reeves A., 2004, VISUAL NEUROSCIENCES, P851; Rosen S. A., 2001, VISUAL VESTIBULAR CO, P174; RUSHTON WAH, 1965, PROC R SOC SER B-BIO, V162, P20, DOI 10.1098/rspb.1965.0024; SCHNAPF JL, 1987, SCI AM, V256, P40, DOI 10.1038/scientificamerican0487-40; SKANDRIES W, 1988, CLIN VISION SCI, V3, P45; SUCHOFF IB, 2000, LIGHTHOUSE HDB VISIO, P517; VIRSU V, 1977, EXP BRAIN RES, V27, P35; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; WALD G, 1954, SCIENCE, V119, P887, DOI 10.1126/science.119.3104.887; ZIHL J, 1990, CLIN VISION SCI, V5, P185	26	23	23	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	13					1125	1138		10.1080/02699050500149817			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZD	WOS:000233270000007	16286326				2022-02-06	
J	Kochanek, PM; Hendrich, KS; Jackson, EK; Wisniewski, SR; Melick, JA; Shore, PM; Janesko, KL; Zacharia, L; Ho, C				Kochanek, PM; Hendrich, KS; Jackson, EK; Wisniewski, SR; Melick, JA; Shore, PM; Janesko, KL; Zacharia, L; Ho, C			Characterization of the effects of adenosine receptor agonists on cerebral blood flow in uninjured and traumatically injured rat brain using continuous arterial spin-labeled magnetic resonance imaging	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						A(1) receptor; A(2A) receptor; CGS 21680; 2-chloroadenosine; perfusion; traumatic brain injury	CONTROLLED CORTICAL IMPACT; POSITRON EMISSION TOMOGRAPHY; AMYGDALA-KINDLED SEIZURES; AMINO-ACID RELEASE; PROTEIN-KINASE-C; A(2A) RECEPTOR; L-ARGININE; GLUCOSE-UTILIZATION; CGS 21680; PERFUSION	Hypoperfusion after traumatic brain injury may exacerbate damage. Adenosine, a vasodilator, regulates cerebral blood flow (CBF). Treatment with adenosine receptor agonists has shown benefit in experimental CNS trauma; however, their effects on CBF after injury remain undefined. We used magnetic resonance imaging to assess CBF in uninjured rats both early and at 24 h after intrahippocampal administration of either the nonselective adenosine receptor agonist 2-chloroadenosine (2-CA, 12 nmol) or the A(2A)-receptor agonist 2-p-(2-carboxyethyl)-phenethylamino-5'-N-ethylcarbox-amidoadenosine (CGS 21680, 6 nmol). We also assessed the effects of these agents on cerebral metabolic rate for glucose (CMRglu). We then assessed the effect of 2-CA on CBF at 3.5 to 5 h after controlled cortical impact (CCI). Injection of 2-CA into uninjured rat brain produced marked increases in CBF in ipsilateral hippocampus and cortex versus vehicle (P<0.05); CBF increases persisted even at 24 h. Measurement of hippocampal levels of 2-CA showed persistent increases to 24 h. CGS 21680 produced even more marked global increases in CBF than seen with 2-CA (2-6-fold versus vehicle, P<0.05 in 10/12 regions of interest (ROIs)). Neither agonist altered CMRglu versus vehicle. After CCI, 2-CA increased CBF in ipsilateral hippocampal and hemispheric ROIs (P<0.05 versus vehicle), but the response was attenuated at severe injury levels. We report marked increases in CBF after injection of adenosine receptor agonists into uninjured rat brain despite unaltered CMRglu. 2-Chloroadenosine produced enduring increases in CBF in uninjured brain and attenuated posttraumatic hypoperfusion. Future studies of adenosine-related therapies in CNS injury should address the role of CBF.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Sch Publ Hlth, Pittsburgh, PA USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.	Kochanekpm@ccm.upmc.edu	Ho, Chien/O-6112-2016; Kochanek, Patrick M/D-2371-2015	Ho, Chien/0000-0002-4094-9232; Kochanek, Patrick M/0000-0002-2627-913X; Zacharia, Lefteris/0000-0002-0327-2373; Wisniewski, Stephen/0000-0002-3877-9860; Jackson, Edwin/0000-0002-8101-6009	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR010962, P41RR003631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038087, P20NS030318, P01NS030318, P50NS030318] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR 10962, RR 03631] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD 40686] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38087, NS 30318] Funding Source: Medline		AbdulGhani AS, 1997, EUR J PHARMACOL, V326, P7, DOI 10.1016/S0014-2999(97)00139-8; Aden U, 2003, STROKE, V34, P739, DOI 10.1161/01.STR.0000060204.67672.8B; Armstead WM, 2003, BRAIN RES, V971, P153, DOI 10.1016/S0006-8993(03)02287-X; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 1998, J NEUROTRAUM, V15, P721, DOI 10.1089/neu.1998.15.721; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Cassada DC, 2002, J TRAUMA, V53, P225, DOI 10.1097/00005373-200208000-00005; Cassada DC, 2002, ANN THORAC SURG, V74, P846, DOI 10.1016/S0003-4975(02)03793-1; Chen JF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001; Cheng P, 1999, J POROUS MEDIA, V2, P19, DOI 10.1615/JPorMedia.v2.i1.20; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Coney AM, 1998, J PHYSIOL-LONDON, V509, P507, DOI 10.1111/j.1469-7793.1998.507bn.x; Cunha RA, 1996, N-S ARCH PHARMACOL, V353, P261, DOI 10.1007/BF00168627; Cunha RA, 2000, NEUROSCI LETT, V289, P127, DOI 10.1016/S0304-3940(00)01295-7; DESARRO G, 1991, EUR J PHARMACOL, V194, P145, DOI 10.1016/0014-2999(91)90098-B; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dixon AK, 1997, J NEUROCHEM, V69, P315; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DUNWIDDIE TV, 1982, J PHARMACOL EXP THER, V220, P70; EVANS MC, 1987, NEUROSCI LETT, V83, P287, DOI 10.1016/0304-3940(87)90101-7; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Golding EM, 2002, PHYSIOL MEAS, V23, P615, DOI 10.1088/0967-3334/23/4/302; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; Higashi H, 2002, J NEUROSURG, V96, P117, DOI 10.3171/jns.2002.96.1.0117; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HUTCHISON AJ, 1989, J PHARMACOL EXP THER, V251, P47; IBAYASHI S, 1991, J CEREBR BLOOD F MET, V11, P72, DOI 10.1038/jcbfm.1991.8; JACOBSON KA, 1997, PURINERGIC APPROACHE, P103; Joshi S, 2002, ANESTH ANALG, V94, P393, DOI 10.1097/00000539-200202000-00031; KALARIA RN, 1988, J CEREBR BLOOD F MET, V8, P32, DOI 10.1038/jcbfm.1988.5; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2001, MAGNET RESON MED, V45, P924, DOI 10.1002/mrm.1123; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; MCBEAN DE, 1989, J CEREBR BLOOD F MET, V9, P548, DOI 10.1038/jcbfm.1989.78; NEHLIG A, 1994, EUR J PHARMACOL, V258, P57, DOI 10.1016/0014-2999(94)90057-4; Ngai AC, 2001, AM J PHYSIOL-HEART C, V280, pH2329, DOI 10.1152/ajpheart.2001.280.5.H2329; OREGAN MH, 1992, NEUROSCI LETT, V138, P169, DOI 10.1016/0304-3940(92)90498-V; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Pourgholami MH, 1997, BRAIN RES, V775, P37, DOI 10.1016/S0006-8993(97)00769-5; Shin HK, 2000, AM J PHYSIOL-HEART C, V278, pH339, DOI 10.1152/ajpheart.2000.278.2.H339; SIMPSON RE, 1992, J NEUROCHEM, V58, P1683, DOI 10.1111/j.1471-4159.1992.tb10041.x; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOLLEVI A, 1987, J CEREBR BLOOD F MET, V7, P673, DOI 10.1038/jcbfm.1987.121; SORICELLI A, 1995, STROKE, V26, P1572, DOI 10.1161/01.STR.26.9.1572; Stange K, 1997, ACTA PHYSIOL SCAND, V160, P117, DOI 10.1046/j.1365-201X.1997.00113.x; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Strupp JP, 1996, NEUROIMAGE, V3, pS607; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; TSENG CJ, 1988, HYPERTENSION, V11, P191, DOI 10.1161/01.HYP.11.2.191; VANWYLEN DGL, 1989, J CEREBR BLOOD F MET, V9, P556, DOI 10.1038/jcbfm.1989.79; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Warner DS, 1996, ANESTHESIOLOGY, V84, P1475, DOI 10.1097/00000542-199606000-00024; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YU L, 2004, NAT MED, V10, P1; ZHANG WG, 1995, MAGNET RESON MED, V33, P370, DOI 10.1002/mrm.1910330310; ZHANG WG, 1993, MAGNET RESON MED, V29, P416, DOI 10.1002/mrm.1910290323	64	23	24	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2005	25	12					1596	1612		10.1038/sj.jcbfm.9600154			17	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	020UZ	WOS:000235939600004	15931163	Bronze			2022-02-06	
J	Lyons, JM; Pearl, JM; McLean, KM; Akhter, SA; Wagner, CJ; Pandalai, PK; Duffy, JY				Lyons, JM; Pearl, JM; McLean, KM; Akhter, SA; Wagner, CJ; Pandalai, PK; Duffy, JY			Glucocorticoid administration reduces cardiac dysfunction after brain death in pigs	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Article							CARDIOPULMONARY BYPASS; PHYSIOLOGICAL-CHANGES; DONOR; HEARTS; TRANSPLANTATION; HEMODYNAMICS; PRESERVATION; ACTIVATION; CHILDREN; SURGERY	Background: Traumatic brain injury and subsequent brain death (BD) account for nearly half of all organ donors, yet only 33% of available hearts are transplanted. Alterations in multiple physiologic pathways after BD can lead to cardiac dysfunction and exclusion from transplantation. Triple hormone resuscitation with methylprednisolone, thyroid hormone and vasopressin has had inconsistent results in the effort to reduce cardiac dysfunction associated with BD, but individual analysis of these agents is limited. The hypothesis was that glucocorticoid administration alone could reduce BD-associated cardiac dysfunction. Methods: Crossbred pigs (25 to 35 kg) had BD induced by sub-dural balloon inflation. Hemodynamics were measured for 360 minutes after BD. Negative cerebral perfusion pressures and decreased laser Doppler cerebral blood flow confirmed BD. Animals (n = 5/treatment group) received: saline (Group 1); 30 mg/kg methylprednisolone 2 hours before BD (Group 2); or 30 mg/kg methylprednisolone 1 hour after BD (Group 3). Repeated measures analysis of variance and unpaired t-tests were used for appropriate comparisons. Results: Left ventricular (LV) pre-load recruitable stroke work (PRSW) decreased in untreated Group I over time (p < 0.001), whereas PRSW in animals treated with glucocorticoids, Groups 2 and 3, was not different from baseline at 360 minutes after BD. Diastolic function measured as LV -dP/dt (minimum derivative of the change in pressure over time) and tau (time constant of isovolumic relaxation) was also preserved 360 minutes after brain death by glucocorticoids in Groups 2 and 3 (p > 0.05). Oxygen delivery 360 minutes after BD was higher in Group 2 compared with Group 1 (p = 0.02) and Group 3 (p = 0.006). Conclusions: Glucocorticoid therapy before or after BD preserved IV systolic and diastolic function. Glucocorticoids administered after brain death might increase the number of hearts available for transplant by reducing brain death-associated cardiac dysfunction.	Cincinnati Childrens Hosp, Ctr Med, Div Cardiothorac Surg, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA		Duffy, JY (corresponding author), Cincinnati Childrens Hosp, Ctr Med, Div Cardiothorac Surg, 3333 Burnet Ave,ML2004, Cincinnati, OH 45229 USA.	jodie.duff@cchmc.org		Pandalai, Prakash/0000-0002-2729-0058			Akhter SA, 1997, P NATL ACAD SCI USA, V94, P12100, DOI 10.1073/pnas.94.22.12100; Bittner HB, 1996, J HEART LUNG TRANSPL, V15, P764; Duffy Jodie Y, 2004, Pediatr Crit Care Med, V5, P28, DOI 10.1097/01.PCC.0000102382.92024.04; Duval ELIM, 1999, EUR J PEDIATR, V158, P387, DOI 10.1007/s004310051098; Follette DM, 1998, J HEART LUNG TRANSPL, V17, P423; Herijgers P, 1996, TRANSPLANTATION, V62, P330, DOI 10.1097/00007890-199608150-00005; MERTES PM, 1994, TRANSPLANTATION, V58, P414, DOI 10.1097/00007890-199408270-00004; Nishimura H, 1997, HEART VESSELS, V12, P84, DOI 10.1007/BF02820871; NOVITZKY D, 1988, TRANSPLANTATION, V45, P964, DOI 10.1097/00007890-198805000-00025; Pearl JM, 2004, ANN THORAC SURG, V77, P994, DOI 10.1016/j.athoracsur.2003.09.067; Pearl JM, 2002, ANN THORAC SURG, V74, P830, DOI 10.1016/S0003-4975(02)03843-2; Pratschke J, 2001, ANN SURG, V234, P732, DOI 10.1097/00000658-200112000-00004; Rosendale JD, 2003, TRANSPLANTATION, V75, P1336, DOI 10.1097/01.TP.0000062839.58826.6D; Rosengard BR, 2002, AM J TRANSPLANT, V2, P701, DOI 10.1034/j.1600-6143.2002.20804.x; Ryan JB, 2003, J HEART LUNG TRANSPL, V22, P922, DOI 10.1016/S1053-2498(02)00558-2; Smith M, 2004, J HEART LUNG TRANSPL, V23, pS217, DOI 10.1016/j.healun.2004.06.017; Szabo G, 1998, J HEART LUNG TRANSPL, V17, P921; Szabo G, 2004, J HEART LUNG TRANSPL, V23, pS223, DOI 10.1016/j.healun.2004.04.005; Szabo G, 1999, WORLD J SURG, V23, P36, DOI 10.1007/s002689900562; Tarnok A, 1999, PEDIATR CARDIOL, V20, P113, DOI 10.1007/s002469900417; Wilhelm MJ, 2000, CIRCULATION, V102, P2426, DOI 10.1161/01.CIR.102.19.2426; Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75	22	23	23	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	DEC	2005	24	12					2249	2254		10.1016/j.healun.2005.07.010			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	998HH	WOS:000234308700037	16364878				2022-02-06	
J	Canzoniero, LMT; Snider, BJ				Canzoniero, LMT; Snider, BJ			Calcium in Alzheimer's disease pathogenesis: Too much, too little or in the wrong place?	JOURNAL OF ALZHEIMERS DISEASE			English	Article						excitotoxicity; glutamate; cell death; proteasome	AMYLOID PRECURSOR PROTEIN; NERVE GROWTH-FACTOR; UBIQUITIN-PROTEASOME SYSTEM; CEREBELLAR GRANULE NEURONS; D-ASPARTATE ANTAGONISTS; TRAUMATIC BRAIN-INJURY; ROOT GANGLION NEURONS; APOPTOTIC CELL-DEATH; CORTICAL-NEURONS; INTRACELLULAR CALCIUM	Our understanding of the molecular genetics and biochemical pathology of Alzheimer's disease has progressed tremendously in the past decade. The metabolism of amyloid beta-peptide is being unraveled, and specific anti-amyloid therapies are now in clinical trials worldwide. The precise biophysical structure of the amyloid beta-peptide that causes neuronal dysfunction remains under investigation, as does the interaction between amyloid peptides and tau hyperphosphorylation, but these two molecules likely play key roles in neuronal dysfunction in Alzheimer's disease. Despite these advances, the cell biology of neuronal dysfunction and cell death in the Alzheimer's disease brain remains poorly understood. This brief review will explore the role of calcium (Ca2+) in neuronal death occurring during Alzheimer's disease. The evidence for glutamate receptor-mediated Ca2+ overload, or excitotoxicity, and other derangements of Ca2+ homeostasis in cell culture and animal models of Alzheimer's disease is reviewed. Finally, we raise the possibility that some of the neuronal death observed in Alzheimer's disease might be associated with a reduction in rather than an increase in cytosolic Ca2+ levels, an idea with potentially important therapeutic implications.	Univ Sannio, Dept Biol & Environm Sci, I-82100 Benovento, Italy; Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO USA; Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO USA		Canzoniero, LMT (corresponding author), Univ Sannio, Dept Biol & Environm Sci, Via Port Arsa 11, I-82100 Benovento, Italy.	canzoniero@unisannio.it			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044923] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS44923-01] Funding Source: Medline		Akbari Y, 2004, BIOCHEM BIOPH RES CO, V322, P1145, DOI 10.1016/j.bbrc.2004.07.136; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Beal MF, 2004, J BIOENERG BIOMEMBR, V36, P381, DOI 10.1023/B:JOBB.0000041772.74810.92; Begley JG, 1999, J NEUROCHEM, V72, P1030, DOI 10.1046/j.1471-4159.1999.0721030.x; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Borsello T, 2000, NEUROSCIENCE, V95, P163; BRORSON JR, 1995, J NEUROBIOL, V26, P325, DOI 10.1002/neu.480260305; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Canzoniero LMT, 2004, NEUROBIOL DIS, V15, P520, DOI 10.1016/j.nbd.2003.10.013; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1602/neurorx.1.1.36; Cluskey S, 2001, J CLIN PATHOL-MOL PA, V54, P386; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Distasi C, 1998, EUR J NEUROSCI, V10, P2276, DOI 10.1046/j.1460-9568.1998.00239.x; Doody R, 2004, DEMENT GERIATR COGN, V18, P227, DOI 10.1159/000079833; EICHLER ME, 1992, J NEUROCHEM, V58, P263, DOI 10.1111/j.1471-4159.1992.tb09305.x; GALLI C, 1995, J NEUROSCI, V15, P1172; GALLO V, 1987, J NEUROSCI, V7, P2203; German DC, 2004, REV NEUROSCIENCE, V15, P353, DOI 10.1515/REVNEURO.2004.15.5.353; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harkany T, 1999, NEUROBIOL DIS, V6, P109, DOI 10.1006/nbdi.1998.0230; He LM, 2002, BRAIN RES, V939, P65, DOI 10.1016/S0006-8993(02)02549-0; HEIMER L, 1978, J COMP NEUROL, V178, P559, DOI 10.1002/cne.901780310; Herms J, 2003, J BIOL CHEM, V278, P2484, DOI 10.1074/jbc.M206769200; Hoyte L, 2004, CURR MOL MED, V4, P131, DOI 10.2174/1566524043479248; Hwang JY, 1999, EXP NEUROL, V159, P124, DOI 10.1006/exnr.1999.7126; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Irizarry MC, 1997, J NEUROSCI, V17, P7053; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; KOIKE T, 1991, P NATL ACAD SCI USA, V88, P3892, DOI 10.1073/pnas.88.9.3892; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LAMPE PA, 1995, J NEUROBIOL, V26, P205, DOI 10.1002/neu.480260205; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; LEVICK V, 1995, BRAIN RES, V676, P325, DOI 10.1016/0006-8993(95)00115-7; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; Ludolph AC, 2000, J NEUROL, V247, P17; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Maurice T, 1996, BRAIN RES, V731, P249, DOI 10.1016/0006-8993(96)00710-X; McNaught KSP, 2004, INT REV NEUROBIOL, V62, P95, DOI 10.1016/S0074-7742(04)62003-4; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9; Morimoto K, 1998, NEUROSCIENCE, V84, P479, DOI 10.1016/S0306-4522(97)00507-1; O'Mahony S, 1998, BRAIN RES BULL, V45, P405, DOI 10.1016/S0361-9230(97)00405-X; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Pak K, 2003, NEUROMOL MED, V3, P53, DOI 10.1385/NMM:3:1:53; PEARSON H, 1992, EUR J NEUROSCI, V4, P1369, DOI 10.1111/j.1460-9568.1992.tb00162.x; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Pike CJ, 1996, J NEUROCHEM, V67, P1774; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; Sanner C, 1994, Neurobiol Dis, V1, P121, DOI 10.1006/nbdi.1994.0015; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Sheehan JP, 1997, J NEUROCHEM, V68, P1221; Smith IF, 2002, BRAIN RES, V949, P105, DOI 10.1016/S0006-8993(02)02970-0; Snider BJ, 2002, EUR J NEUROSCI, V15, P419, DOI 10.1046/j.0953-816x.2001.01867.x; Soler RM, 1998, J NEUROSCI, V18, P1230; Song SM, 2004, TRENDS MOL MED, V10, P565, DOI 10.1016/j.molmed.2004.09.005; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; WEISS JH, 1994, J NEUROCHEM, V62, P372; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; Wozniak DF, 1998, NEUROBIOL DIS, V5, P305, DOI 10.1006/nbdi.1998.0206; Wozniak DF, 1996, BRAIN RES, V707, P165, DOI 10.1016/0006-8993(95)01230-3; YAN GM, 1994, BRAIN RES, V656, P43, DOI 10.1016/0006-8993(94)91364-1; Yang Y, 2004, NEUROSCIENCE, V124, P501, DOI 10.1016/j.neuroscience.2003.11.029; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	88	23	26	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.	NOV	2005	8	2					147	154					8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	021XE	WOS:000236018400007	16308483				2022-02-06	
J	Frederickson, CJ; Cuajungco, MP; Frederickson, CJ				Frederickson, CJ; Cuajungco, MP; Frederickson, CJ			Is zinc the link between compromises of brain perfusion (excitotoxicity) and Alzheimer's disease?	JOURNAL OF ALZHEIMERS DISEASE			English	Article							AMYLOID PRECURSOR PROTEIN; CEREBRAL CORTICAL-NEURONS; OXIDE SYNTHASE INHIBITORS; CLOSED-HEAD INJURY; NITRIC-OXIDE; TRANSGENIC MICE; APOLIPOPROTEIN-E; EXTRACELLULAR ACCUMULATION; MITOCHONDRIAL DYSFUNCTION; CEREBROSPINAL-FLUID	Prior brain injury is a major risk factor in the development of Alzheimer's disease. This is true for traumatic brain injury, stroke or ischemic brain injury, and (more speculatively) for brain injury resulting from the hypo-perfusion-reperfusion in cardiac arrest or cardiac bypass surgery and even hypo- or hypertension. Here we propose that the release of excess, toxic, "floods" of free zinc into the brain that occurs during and after all excitotoxic brain injury is a key factor that sets the stage for the later development of Alzheimer's disease. Rapid and aggressive administration of zinc buffering compounds to patients suffering brain injury may therefore not only ameliorate the acute injury but might also reduce the risk of subsequent development of Alzheimer's disease.	NeuroBioTex Inc, Galveston, TX 77550 USA; Univ Texas, Sch Med, Galveston, TX 77550 USA; Harvard Univ, Sch Med, Dept Otol & Laryngologist, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA		Frederickson, CJ (corresponding author), NeuroBioTex Inc, Galveston, TX 77550 USA.	cathy@neurobiotex.com	Cuajungco, Math/B-2647-2008	Cuajungco, Math/0000-0003-0749-9564	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS042882, R44NS041682, R43NS040215, R43NS041682] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS41682, NS42882, NS40215] Funding Source: Medline		Adlard PA, 1998, NEUROBIOL DIS, V5, P349, DOI 10.1006/nbdi.1998.0203; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Balaji RV, 2005, NEUROCHEM RES, V30, P171, DOI 10.1007/s11064-004-2438-6; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; BUSH AI, 1994, J BIOL CHEM, V269, P12152; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CHNEIWEISS H, 1991, J NEUROCHEM, V57, P1708, DOI 10.1111/j.1471-4159.1991.tb06371.x; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Colvin RA, 2000, NEUROCHEM INT, V36, P539, DOI 10.1016/S0197-0186(99)00127-8; Colvin RA, 2000, J NUTR, V130, p1484S, DOI 10.1093/jn/130.5.1484S; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Danscher G, 1997, J NEUROSCI METH, V76, P53, DOI 10.1016/S0165-0270(97)00079-4; Daumas S, 2004, EUR J NEUROSCI, V20, P597, DOI 10.1111/j.1460-9568.2004.03484.x; De Deyn PP, 1999, PHARMACOPSYCHIATRY, V32, P17, DOI 10.1055/s-2007-979232; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Di Vaira M, 2004, INORG CHEM, V43, P3795, DOI 10.1021/ic0494051; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Ezra Y, 2003, NEUROSCIENCE, V121, P315, DOI 10.1016/S0306-4522(03)00436-6; FERREIRO JA, 1989, J NEUROL, V236, P267, DOI 10.1007/BF00314454; Frederickson CJ, 2002, NEUROSCIENCE, V115, P471, DOI 10.1016/S0306-4522(02)00399-8; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 2005, NAT REV NEUROSCI; FREDERICKSON CJ, 2004, ZINC EXCITOTOOXIC BR, P18; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Huckle Richard, 2005, Curr Opin Investig Drugs, V6, P99; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jacob C, 1998, P NATL ACAD SCI USA, V95, P3489, DOI 10.1073/pnas.95.7.3489; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Jiang LJ, 2000, P NATL ACAD SCI USA, V97, P2503, DOI 10.1073/pnas.97.6.2503; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Labiner David M, 2002, Curr Opin Investig Drugs, V3, P921; Law A, 2001, BRAIN RES REV, V35, P73, DOI 10.1016/S0165-0173(00)00051-5; Law A, 2001, BRIT J PHARMACOL, V133, P1114, DOI 10.1038/sj.bjp.0704179; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Macfarlane DP, 1999, NEUROREPORT, V10, P3945, DOI 10.1097/00001756-199912160-00040; Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; Maret W, 1999, P NATL ACAD SCI USA, V96, P1936, DOI 10.1073/pnas.96.5.1936; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Molnar P, 2001, BRAIN RES, V910, P205, DOI 10.1016/S0006-8993(01)02720-2; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; O'Mahony S, 1998, BRAIN RES BULL, V45, P405, DOI 10.1016/S0361-9230(97)00405-X; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paris D, 1998, EXP NEUROL, V152, P116, DOI 10.1006/exnr.1998.6828; Pasquier F, 1997, J NEUROL, V244, P135, DOI 10.1007/s004150050064; Pasquier F, 1998, REV NEUROL-FRANCE, V154, P743; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; PLUTA R, 1994, BRAIN RES, V649, P323, DOI 10.1016/0006-8993(94)91081-2; Pluta R, 1997, FOLIA NEUROPATHOL, V35, P94; Pluta R, 2000, ANN NY ACAD SCI, V903, P324, DOI 10.1111/j.1749-6632.2000.tb06383.x; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44; Royter V, 2005, J NEUROL SCI, V229, P65, DOI 10.1016/j.jns.2004.11.003; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 1999, NEUROREPORT, V10, P1723, DOI 10.1097/00001756-199906030-00018; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Smith MA, 1997, J NEUROSCI, V17, P2653; Sparks DL, 2000, NEUROBIOL AGING, V21, P363, DOI 10.1016/S0197-4580(00)00101-9; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 2005, NEUROCHEM INT, V46, P221, DOI 10.1016/j.neuint.2004.10.003; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; Tsai EC, 2005, CURR PHARM DESIGN, V11, P1211, DOI 10.2174/1381612053507404; Tsuchiya D, 2002, J CEREBR BLOOD F MET, V22, P1231, DOI 10.1097/01.wcb.0000037995.34930.F5; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Verghese J, 2003, NEUROLOGY, V61, P1667, DOI 10.1212/01.WNL.0000098934.18300.BE; Wei G, 2004, NEUROSCI LETT, V370, P118, DOI 10.1016/j.neulet.2004.08.027; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Wisniewski HM, 1996, FOLIA NEUROPATHOL, V34, P65; Xie Z, 2002, J NEUROSCI, V22, P3484; YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198; Yeung Pollen K F, 2004, Curr Opin Investig Drugs, V5, P90; Zambenedetti P, 1998, J CHEM NEUROANAT, V15, P21, DOI 10.1016/S0891-0618(98)00024-6	98	23	24	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.	NOV	2005	8	2					155	160					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	021XE	WOS:000236018400008	16308484				2022-02-06	
J	Arbour, R				Arbour, Richard			Clinical Management of the Organ Donor	AACN ADVANCED CRITICAL CARE			English	Article						advance directive; brain death; brain-stem herniation; cardiogenic ventilator triggering; clinical stress; family communication at end-of-life; metabolic resuscitation; physiologic consequences of brain death	INTENSIVE-CARE-UNIT; BRAIN-STEM DEATH; OF-LIFE CARE; PALLIATIVE CARE; SURVIVAL; DONATION; FAMILY; TIME; TRANSPLANTATION; PULMONARY	There is a critical mismatch between available organs for transplant and acutely or critically ill patients with end-stage organ disease. Patients who may benefit from organ transplantation far outnumber available organs. The causes for this imbalance are multiple. One cause is family refusal to donate. A second cause is nonrecognition or delay in determination of brain death. A third cause is donor loss due to profound cardiopulmonary and metabolic instability consequent to brain-stem herniation and brain death. Family refusal may be addressed by education, public awareness, as well as close attention to social, cultural and ethical issues, and optimal communication with donor families. Brain death may be consequent to traumatic brain injury, ischemic versus hemorrhagic stroke, as well as massive cerebral anoxia/ischemic following cardiac arrest. Nonrecognition or delay in brain death determination may be addressed by clinician education and frequent clinical assessment to detect early stages of brain-stem herniation refractory to aggressive measures for control of intracranial pressure. Donor loss due to profound cardiopulmonary and metabolic instability may be addressed by aggressive, mechanism-based treatment for clinical instability based on affected body system, as well as measures to support metabolic activity at the cellular and tissue level in the brain-dead organ donor. This article explores cerebral physiology related to impending brain death and catastrophic intracranial pressure elevations. In addition, physiologic consequences of brain death are correlated with affected body systems and mechanism-based therapies to support organ function pending transplantation. Ethical/legal issues are explored as related to patient autonomy and optimal family outcomes. Effective family communication, astute clinical assessment, and optimal clinical management of the organ donor are illustrated using a case study approach, highlighting the role of the advanced practice nurse in donor management.	[Arbour, Richard] Albert Einstein Healthcare Network, Med Intens Care Unit, 5501 Old York Rd, Philadelphia, PA 19141 USA		Arbour, R (corresponding author), Albert Einstein Healthcare Network, Med Intens Care Unit, 5501 Old York Rd, Philadelphia, PA 19141 USA.	RichNrs@aol.com					Arbour Richard, 2004, Crit Care Nurse, V24, P19; Arbour Richard, 2003, AACN Clin Issues, V14, P185, DOI 10.1097/00044067-200305000-00009; Arriola KRJ, 2005, J NATL MED ASSOC, V97, P339; Avlonitis VS, 2003, TRANSPLANTATION, V75, P1928, DOI 10.1097/01.TP.0000066351.87480.9E; Baggs JG, 2004, CRIT CARE CLIN, V20, P525, DOI 10.1016/j.ccc.2004.03.008; Blatt L, 1999, Clin Nurse Spec, V13, P219, DOI 10.1097/00002800-199909000-00005; Braverman Jane M, 2002, Prog Transplant, V12, P266; Caballero F, 2002, TRANSPLANTATION, V74, P532, DOI 10.1097/00007890-200208270-00017; Cantin B, 2003, TRANSPLANTATION, V76, P1275, DOI 10.1097/01.TP.0000093445.50624.5A; Carney David, 2005, Crit Care Med, V33, pS122, DOI 10.1097/01.CCM.0000155928.95341.BC; Chabalewski Franki L, 2002, Prog Transplant, V12, P243; Ciccarello Gail P, 2003, Dimens Crit Care Nurs, V22, P216, DOI 10.1097/00003465-200309000-00005; Cole RP, 2003, RESUSCITATION, V56, P335, DOI 10.1016/S0300-9572(02)00429-X; Coyle M A, 2000, Intensive Crit Care Nurs, V16, P45, DOI 10.1054/iccn.1999.1469; Curtis J R, 2000, Respir Care, V45, P1385; Curtis JR, 2004, CRIT CARE CLIN, V20, P363, DOI 10.1016/j.ccc.2004.03.001; Day L, 2001, Am J Crit Care, V10, P306; Delgado DH, 2002, CAN J CARDIOL, V18, P1217; Dickerson J, 2002, J NEUROSURG, V97, P811, DOI 10.3171/jns.2002.97.4.0811; Dimopoulou I, 2003, CRIT CARE MED, V31, P1113, DOI 10.1097/01.CCM.0000059644.54819.67; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Dominguez-Roldan JM, 2002, TRANSPLANT P, V34, P13, DOI 10.1016/S0041-1345(01)02648-3; Dominguez-Roldan JM, 2002, TRANSPLANT P, V34, P9, DOI 10.1016/S0041-1345(01)02646-X; Evers K A, 1999, Crit Care Nurse, V19, P57; Farrell M, 1989, Intensive Care Nurs, V5, P39, DOI 10.1016/0266-612X(89)90039-4; Fenstermacher Denise, 2004, Crit Care Nurs Q, V27, P258; Frid I, 2001, Intensive Crit Care Nurs, V17, P263, DOI 10.1054/iccn.2001.1590; Henneman Elizabeth A, 2004, Crit Care Nurse, V24, P50; Heyland DK, 2003, CHEST, V124, P392, DOI 10.1378/chest.124.1.392; Hill LL, 2000, CRIT CARE MED, V28, P579, DOI 10.1097/00003246-200002000-00054; Holt T B, 2001, Respir Care, V46, P1054; Huttemann E, 2000, INTENS CARE MED, V26, P422, DOI 10.1007/s001340051176; Imanaka H, 2000, CRIT CARE MED, V28, P402, DOI 10.1097/00003246-200002000-00019; Karcioglu O, 2003, EUR J EMERG MED, V10, P52, DOI 10.1097/01.mej.0000043848.56375.64; Kirchhoff KT, 2004, CRIT CARE CLIN, V20, P453, DOI 10.1016/j.ccc.2004.03.009; Kopfman JE, 2002, TRANSPL P, V34, P3035, DOI 10.1016/S0041-1345(02)03611-4; Leatherman JW, 2004, CRIT CARE MED, V32, P1542, DOI 10.1097/01.CCM.0000130993.43076.20; Lenart S B, 1998, J Nurses Staff Dev, V14, P293, DOI 10.1097/00124645-199811000-00008; Levetown M, 1998, NEW HORIZ-SCI PRACT, V6, P383; Lopez-Navidad A, 2002, TRANSPLANT P, V34, P20, DOI 10.1016/S0041-1345(01)02826-3; Lovasik D, 2000, Crit Care Nurs Clin North Am, V12, P531; Lutz-Dettinger N, 2001, PEDIATR CLIN N AM, V48, P715, DOI 10.1016/S0031-3955(05)70336-9; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Marshall VC, 2001, TRANSPL P, V33, P845, DOI 10.1016/S0041-1345(00)02342-3; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Morenski John D, 2003, J Intensive Care Med, V18, P211, DOI 10.1177/0885066603254359; Murali B, 2003, Ann Card Anaesth, V6, P31; Nelson-Marten P, 2001, Crit Care Nurs Clin North Am, V13, P577; Ng HP, 2001, ANAESTHESIA, V56, P85, DOI 10.1046/j.1365-2044.2001.01840-7.x; Phongsamran Paula V, 2004, Prog Transplant, V14, P105; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Powner D J, 2000, Prog Transplant, V10, P25; Powner DJ, 2003, CRIT CARE MED, V31, P1241, DOI 10.1097/01.CCM.0000059643.45027.96; Puchalski C, 2004, CRIT CARE CLIN, V20, P487, DOI 10.1016/j.ccc.2004.03.007; Randell TT, 2004, ACTA ANAESTH SCAND, V48, P139, DOI 10.1111/j.0001-5172.2004.00304.x; Razek T, 2000, SURG CLIN N AM, V80, P1021, DOI 10.1016/S0039-6109(05)70111-0; Recicar John, 2002, Prog Transplant, V12, P238; Reeves RR, 2004, SOUTH MED J, V97, P1259, DOI 10.1097/01.SMJ.0000136280.23617.2A; Rodrigo GJ, 2004, CHEST, V125, P1081, DOI 10.1378/chest.125.3.1081; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; Rosendale JD, 2003, TRANSPLANTATION, V75, P1336, DOI 10.1097/01.TP.0000062839.58826.6D; Rosendale JD, 2003, TRANSPLANTATION, V75, P482, DOI 10.1097/01.TP.0000045683.85282.93; Rosendale JD, 2002, AM J TRANSPLANT, V2, P761, DOI 10.1034/j.1600-6143.2002.20810.x; Rozon-Solomon M, 1999, MT SINAI J MED, V66, P273; Sadala MLA, 2000, QUAL HEALTH RES, V10, P788, DOI 10.1177/104973200129118822; Salim A, 2001, ARCH SURG-CHICAGO, V136, P1377, DOI 10.1001/archsurg.136.12.1377; Scanlon C, 2003, AM J NURS, V103, P48, DOI 10.1097/00000446-200301000-00021; Schnuelle P, 2001, TRANSPLANTATION, V72, P455, DOI 10.1097/00007890-200108150-00017; Siminoff Laura A, 2003, Prog Transplant, V13, P218; Smith SL, 2003, ORGAN TRANSPLANT; Stoica SC, 2002, Z HERZ THORAX GEF S1, V16, p1/20; Straznicka M, 2002, J THORAC CARDIOV SUR, V124, P250, DOI 10.1067/mtc.2002.123813; Sullivan J, 1999, Crit Care Nurse, V19, P37; Sztark F, 2000, Ann Transplant, V5, P41; Takasu A, 2001, RESUSCITATION, V49, P273, DOI 10.1016/S0300-9572(00)00360-9; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Tuttle-Newhall JE, 2003, CURR PROB SURG, V40, P257; Twaddle ML, 2001, PRIMARY CARE, V28, P329, DOI 10.1016/S0095-4543(05)70025-7; United Network for Organ Sharing (UNOS), DAT WAIT LIST CAND; Virani R, 2003, AM J NURS, V103, P52, DOI 10.1097/00000446-200305000-00020; Wakefield A, 2000, Int J Palliat Nurs, V6, P245; White DB, 2004, CRIT CARE CLIN, V20, P329, DOI 10.1016/j.ccc.2004.03.003; Willatts SM, 2000, ANAESTHESIA, V55, P676, DOI 10.1046/j.1365-2044.2000.01421.x; Williams MA, 2003, CRIT CARE MED, V31, P1568, DOI 10.1097/01.CCM.0000063090.21056.A6; Yuen CC, 1998, J NATL MED ASSOC, V90, P13; Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75	86	23	27	0	4	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	OCT-DEC	2005	16	4					551	580		10.1097/00044067-200510000-00011			30	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF0BG	WOS:000441621700011	16269899				2022-02-06	
J	Salorio, CF; Slomine, BS; Grados, MA; Vasa, RA; Christensen, JR; Gerring, JP				Salorio, CF; Slomine, BS; Grados, MA; Vasa, RA; Christensen, JR; Gerring, JP			Neuroanatomic correlates of CVLT-C performance following pediatric traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI (traumatic brain injury); memory; children; magnetic resonance imaging; diffuse brain injury; neuropsychological test	CLOSED-HEAD-INJURY; VERBAL-LEARNING TEST; CHILDRENS VERSION; MEMORY FUNCTION; AXONAL DAMAGE; 1ST YEAR; ADOLESCENTS; SEVERITY; MRI; RECOVERY	Traumatic brain injury (TBI) frequently results in memory problems, and the degree of memory impairment is related to injury severity and is commonly associated with lesions in frontal and temporal brain areas. This study examined the relationship among injury severity, brain lesions, and memory in children with moderate to severe TBI using Donders' (1999) 5-factor model of performance on the California Verbal Learning Test-Children's Version (CVLT-C). Seventy-six children underwent magnetic resonance imaging (MRI) scans 3 months post-TBI and testing 1 year post-TBI. Results showed injury severity (Glasgow Coma Scale) was not predictive of performance on 4 of the 5 factors. Volume of frontal and/or temporal brain lesions was significantly predictive of performance on 3 of the 5 factors. Unexpectedly, lesion volume outside these areas (extra-frontotemporal) was predictive of performance on all 5 factors. In contrast, Verbal IQ at 1 year was most strongly associated with preinjury factors (socioeconomic status and special education involvement), although extra-frontotemporal lesions also contributed to the variability in this measure. Results suggest that in children with moderate to severe TBI, extra-frontal/temporal lesions are predictive of memory outcome 1 year postinjury above and beyond initial severity or frontal/temporal contusions. This finding may relate to widespread diffuse axonal injury, which potentially disconnects brain circuits mediating memory following moderate to severe TBI.	Kennedy Krieger Inst, Dept Pediat Rehabil, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD USA		Salorio, CF (corresponding author), Kennedy Krieger Inst, Dept Pediat Rehabil, 707 N Broadway, Baltimore, MD 21205 USA.	salorio@kennedykrieger.org		Grados, Marco/0000-0002-6189-6264	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K20MH000997] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5-T32-HD0741410] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K20 MH-00997] Funding Source: Medline		Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Delis DC., 1994, CALIFORNIA VERBAL LE; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Donders J, 1999, DEV NEUROPSYCHOL, V15, P395, DOI 10.1080/87565649909540757; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; EWINGCOBBS L, 1998, TRAUMATIC BRAIN INJU, P11; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; *ISG TECHN, 1995, ALL SOFTW; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1989, NEUROSURGERY, V24, P223, DOI 10.1227/00006123-198902000-00011; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; Mandzia JL, 2004, HUM BRAIN MAPP, V21, P1, DOI 10.1002/hbm.10140; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; SLIFER KJ, 1993, J APPL BEHAV ANAL, V26, P469, DOI 10.1901/jaba.1993.26-469; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; SQUIRE LR, 1989, J NEUROSCI, V9, P828; STUSS D T, 1981, Journal of Clinical Neuropsychology, V3, P13, DOI 10.1080/01688638108403110; Talairach TM, 1988, COPLANAR STEREOTAXIC; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Verger K, 2001, BRAIN INJURY, V15, P211; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; WELNER Z, 1987, J AM ACAD CHILD PSY, V26, P649, DOI 10.1097/00004583-198709000-00007; WILSON J T L, 1990, Brain Injury, V4, P349; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; [No title captured]	60	23	23	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2005	11	6					686	696		10.1017/S1355617705050885			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	980NQ	WOS:000233025600004	16248904				2022-02-06	
J	Symons, FJ; Danov, SE				Symons, FJ; Danov, SE			A prospective clinical analysis of pain behavior and self-injurious behavior	PAIN			English	Article						pain; self-injurious behavior; traumatic brain injury	BORDERLINE PERSONALITY-DISORDER; SEVERE COGNITIVE IMPAIRMENTS; CONGENITAL INSENSITIVITY; MENTAL-RETARDATION; NALTREXONE TREATMENT; MUTILATION; CHECKLIST; DISREGULATION; INDIVIDUALS; VALIDATION	It is a widely assumed but rarely tested proposition that the experience and expression of pain is altered among individuals with self-injurious behavior and disabilities. As a preliminary test of this proposition, the purpose of this case study was to apply a validated pain measure to examine ratings of pain behavior in relation to ratings of self-injurious behavior (SIB). A prospective correlational design was used with maternal ratings completed three times/day for 9 days using two item independent rating scales specific to pain and SIB. The participant was a 6-year-old boy with severe SIB secondary to midbrain tumor (pilocytic astrocytoma) resection and post-operative sequelae. Measures were taken in the child's home. Pain behavior was measured using the Non-Communicating Children's Pain Checklist Revised (NCCPC-R). Self-injury was measured using the Self-Injury Trauma Scale (SITS). Time intervals associated with elevated ratings of SIB were associated with elevated pain ratings. There was a significant difference (P<0.05) for pain ratings between time intervals with and without self-injury. It is suggested that additional empirical work is needed to clarify the relation between pain and self-injury to improve assessment and treatment outcomes. (c) 2005 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	Univ Minnesota, Dept Educ Psychol, Minneapolis, MN 55455 USA		Symons, FJ (corresponding author), Univ Minnesota, Dept Educ Psychol, 206 Burton Hall,178 Pillsbury Dr, Minneapolis, MN 55455 USA.	symon007@umn.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD35682, HD44763] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD044763] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R29HD035682] Funding Source: NIH RePORTER		[Anonymous], 2009, J CHILD ADOL PS NURS, DOI DOI 10.1089/CAP.1990.1.237; Barrera F, 1994, J DEV PHYS DISABIL, V6, P169; Bodfish JW, 1997, J DEV PHYS DISABIL, V9, P135, DOI 10.1023/A:1024977719165; Breau LM, 2003, ARCH PEDIAT ADOL MED, V157, P1219, DOI 10.1001/archpedi.157.12.1219; Breau LM, 2003, J PEDIATR-US, V142, P498, DOI 10.1067/mpd.2003.163; Breau LM, 2002, PAIN, V99, P349, DOI 10.1016/S0304-3959(02)00179-3; Breau LM, 2002, ANESTHESIOLOGY, V96, P528, DOI 10.1097/00000542-200203000-00004; Breau LM, 2000, DEV MED CHILD NEUROL, V42, P609, DOI 10.1017/S0012162200001146; Cowdry, 1987, J PERSONALITY DISORD, V1, P317, DOI [10.1521/pedi.1987.1.4.317, DOI 10.1521/PEDI.1987.1.4.317]; Critchley M, 1934, BRIT MED J, V1934, P891, DOI 10.1136/bmj.2.3854.891; Defrin R, 2004, PAIN, V108, P58, DOI 10.1016/j.pain.2003.12.003; EVANS C, 1992, BRIT J PSYCHIAT, V161, P643, DOI 10.1192/bjp.161.5.643; FAVAZZA AR, 1989, SUICIDE LIFE-THREAT, V19, P352; FELDMAN MD, 1988, COMPR PSYCHIAT, V29, P252, DOI 10.1016/0010-440X(88)90048-X; GRUNAU RVE, 1987, PAIN, V28, P395, DOI 10.1016/0304-3959(87)90073-X; GRUNAU RVE, 1990, ADV PAIN RES THER, V15, P147; HERPERTZ S, 1995, ACTA PSYCHIAT SCAND, V91, P57, DOI 10.1111/j.1600-0447.1995.tb09743.x; IWATA BA, 1990, J APPL BEHAV ANAL, V23, P99, DOI 10.1901/jaba.1990.23-99; Kemperman I, 1997, PSYCHIAT RES, V70, P175, DOI 10.1016/S0165-1781(97)00034-6; Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042; KIRMAN BH, 1968, DEV MED CHILD NEUROL, V10, P57; LaChapelle DL, 1999, CLIN J PAIN, V15, P13, DOI 10.1097/00002508-199903000-00004; LEVITT M, 1985, BRAIN RES REV, V10, P247, DOI 10.1016/0165-0173(85)90027-X; McGrath PJ, 1998, DEV MED CHILD NEUROL, V40, P340; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; Nolano M, 2000, CLIN NEUROPHYSIOL, V111, P1596, DOI 10.1016/S1388-2457(00)00351-5; Oberlander TF, 1999, CLIN J PAIN, V15, P201, DOI 10.1097/00002508-199909000-00007; PINKSY L, 1966, J PEDIATR-US, V68, P1; ROACH ES, 1985, NEUROPEDIATRICS, V16, P159, DOI 10.1055/s-2008-1059532; ROBERTSON MM, 1989, PSYCHOL MED, V19, P611, DOI 10.1017/S0033291700024211; RUSS MJ, 1992, BIOL PSYCHIAT, V32, P501, DOI 10.1016/0006-3223(92)90218-O; Russ MJ, 1999, PSYCHIAT RES, V89, P201, DOI 10.1016/S0165-1781(99)00113-4; SANDMAN CA, 1988, SYNAPSE, V2, P193, DOI 10.1002/syn.890020304; Sandman CA, 1999, MENT RETARD DEV D R, V5, P314, DOI 10.1002/(SICI)1098-2779(1999)5:4<314::AID-MRDD9>3.0.CO;2-G; SANDMAN CA, 1990, AM J MENT RETARD, V95, P84; Schmahl C, 2004, PAIN, V110, P470, DOI 10.1016/j.pain.2004.04.035; Schroeder SR, 2001, MENT RETARD DEV D R, V7, P3, DOI 10.1002/1098-2779(200102)7:1<3::AID-MRDD1002>3.0.CO;2-#; Swoboda KJ, 1998, MUSCLE NERVE, V21, P104, DOI 10.1002/(SICI)1097-4598(199801)21:1<104::AID-MUS13>3.0.CO;2-3; Symons FJ, 2004, MENT RETARD DEV D R, V10, P193, DOI 10.1002/mrdd.20031; SYMONS FS, 2002, SELF INJURIOUS BEHAV, P223; THOMPSON T, 1995, MENT RETARD DEV DIS, V1; Zafeiriou DI, 2004, J PEDIATR-US, V144, P284, DOI 10.1016/S0022-3476(03)00385-8	42	23	24	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	OCT	2005	117	3					473	477		10.1016/j.pain.2005.07.010			5	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; Neurosciences & Neurology	975PZ	WOS:000232675700025	16154695				2022-02-06	
J	Mackenzie, JA; McMillan, TM				Mackenzie, JA; McMillan, TM			Knowledge of post-concussional syndrome in naive lay-people, general practitioners and people with minor traumatic brain injury	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; RANDOMIZED-TRIAL; BASE RATES; MISCONCEPTIONS; STRESS; PHYSIOGENESIS; PSYCHOGENESIS; ABILITY	Background. Expectations about effects of minor traumatic brain injury (MTBI) may play a role in maintaining symptoms, the ability to simulate post-concussion syndrome (PCS) and the extent to which professionals might associate patient complaints with MTBI. In turn, expectations will be related to knowledge about MTBI. This study investigates knowledge of PCS in people with MTBI compared with general practitioners (GPs) and lay-people, using recall (a vignette) and symptom guessing or recognition (checklists). Methods. Thirty GPs, 30 people with MTBI, and 30 lay-people generated symptoms from a vignette describing a MTB1. They then completed a PCS checklist or a checklist containing PCS and 'bogus' items pertaining to the vignette. Results. Only 1 of 90 participants reported enough PCS symptoms to indicate 'caseness' from the vignette alone. Using checklists, more GPs (60%) than controls (20%) ticked enough symptoms to attain PCS'caseness'. Few people with MTB1 who did not themselves achieve PCS 'caseness' by self-report using checklists achieved Icaseness' using the vignette and checklists. The frequency of non-physical symptom reporting was higher than for physical symptom reporting. The addition of 'bogus' items to checklists did not affect responding. Conclusions. It is unlikely that pre-injury expectations about MTBI maintain PCS symptoms. PCS was difficult to simulate without prompting, even by GPs and PCS,cases'. The use of 'caseness', rather than simple symptom scores, and further development of checklists with 'bogus' items may provide a more valid assessment of MTBI effects. GPs may benefit from further information about PCS and available treatments.	Univ Glasgow, Dept Psychol Med, Glasgow G12 8QQ, Lanark, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	t.m.mcmillan@clinmed.gla.ac.uk					Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; BADDELEY AD, 1992, MANUAL SPEED CAPACIT; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLEEKER JK, 1995, PSYCHOTHER PSYCHOSOM, V63, P151, DOI 10.1159/000288952; Burges C, 2001, BRIT J CLIN PSYCHOL, V40, P209, DOI 10.1348/014466501163544; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEESHALEY PR, 1994, J CLIN PSYCHOL, V50, P252, DOI 10.1002/1097-4679(199403)50:2<252::AID-JCLP2270500217>3.0.CO;2-T; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; McMillan T, 2003, STUD NEUROPSYCHOL DE, P271; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V41, P611; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Oddy M, 2003, HDB NEUROLOGICAL REH, P453; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; *SCOTT INT GUID NE, 2000, SCOTT INT GUID NETW; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	35	23	24	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0144-6657	2044-8260		BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	SEP	2005	44		3				417	424		10.1348/014466505X35696			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	969IF	WOS:000232227100009	16238886				2022-02-06	
J	Xu, GY; Hughes, MG; Zhang, LP; Cain, L; McAdoo, DJ				Xu, GY; Hughes, MG; Zhang, LP; Cain, L; McAdoo, DJ			Administration of glutamate into the spinal cord at extracellular concentrations reached post-injury causes functional impairments	NEUROSCIENCE LETTERS			English	Article						activity box; excitotoxicity; functional impairment; glutamate; microdialysis; oligodendrocyte; spinal cord injury	MODEL COMBINING MICRODIALYSIS; EXCITATORY AMINO-ACIDS; RAT STRIATUM; CHRONIC INFUSION; IMPACT INJURY; TISSUE LOSS; NEUROTOXICITY; ELECTROPHYSIOLOGY; NEUROCHEMISTRY; EXCITOTOXICITY	In vivo experiments addressing the role of released glutamate in damage caused by neurotrauma seldom administer glutamate itself because it usually produces relatively little damage when administered into central nervous system (CNS) tissue in vivo. However, because of recent observations that glutamate administered into the spinal cord at the levels attained following spinal cord injury (SCI) kills neurons and oligodendrocytes, we tested the effects of administering glutamate at those concentrations on locomotor function. The Basso-Beattie-Bresnahan (BBB) test and activity box measures demonstrated that those glutainate concentrations produce lasting functional impairments. Several parameters provided by the activity box provided sensitive measures of the degree of post-SCI impairment, demonstrating their substantial potential for evaluating outcomes of SCI. Results obtained also enhance evidence that glutainate toxicity contributes to secondary damage following SO and suggest that damage to white matter is an important contributor to such damage. (c) 2005 Elsevier Ireland Ltd. All rights reserved.	Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA		McAdoo, DJ (corresponding author), Univ Texas, Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	djmcadoo@utmb.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS11255, NS39161] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS039161, P01NS011255] Funding Source: NIH RePORTER		BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; CAIN LD, IN PRESS J NEUROTRAU; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; Houghton AK, 1997, NEUROREPORT, V8, P3795, DOI 10.1097/00001756-199712010-00028; KOHLER C, 1981, BRAIN RES, V211, P485, DOI 10.1016/0006-8993(81)90978-1; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU DX, 1993, J NEUROTRAUM, V10, P349, DOI 10.1089/neu.1993.10.349; LIU DX, 1994, MOL CHEM NEUROPATHOL, V23, P77, DOI 10.1007/BF02815402; Magnuson DSK, 1999, EXP NEUROL, V156, P191, DOI 10.1006/exnr.1999.7016; MANGANO RM, 1983, BRAIN RES BULL, V10, P47, DOI 10.1016/0361-9230(83)90073-4; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; McAdoo DJ, 2005, BRAIN RES, V1038, P92, DOI 10.1016/j.brainres.2005.01.024; McAdoo DJ, 2000, BRAIN RES, V865, P283, DOI 10.1016/S0006-8993(00)02296-4; MCBEAN GJ, 1985, J NEUROCHEM, V44, P247, DOI 10.1111/j.1471-4159.1985.tb07137.x; MCBEAN GJ, 1984, BRAIN RES, V290, P372, DOI 10.1016/0006-8993(84)90959-4; Mills CD, 2002, EXP NEUROL, V173, P153, DOI 10.1006/exnr.2001.7828; Mills CD, 2001, J NEUROTRAUM, V18, P1091, DOI 10.1089/08977150152693773; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Plunkett JA, 2001, EXP NEUROL, V168, P144, DOI 10.1006/exnr.2000.7604; SORKIN LS, 1988, J NEUROSCI METH, V23, P131, DOI 10.1016/0165-0270(88)90185-9; Teng YD, 1997, J NEUROSCI, V17, P4359; Wada S, 1999, J NEUROSURG, V91, P98, DOI 10.3171/spi.1999.91.1.0098; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; Wrathall JR, 1997, EXP NEUROL, V145, P565, DOI 10.1006/exnr.1997.6506; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; Xu GY, 2004, EXP NEUROL, V187, P329, DOI 10.1016/j.expneurol.2004.01.029; XU GY, 2004, P 34 ANN M SOC NEUR; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445	31	23	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 26	2005	384	3					271	276		10.1016/j.neulet.2005.04.100			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944XF	WOS:000230463700013	15925447				2022-02-06	
J	Lescot, T; Bonnet, MP; Zouaoui, A; Muller, JC; Fetita, C; Coriat, P; Puybasset, L				Lescot, T; Bonnet, MP; Zouaoui, A; Muller, JC; Fetita, C; Coriat, P; Puybasset, L			A quantitative computed tomography assessment of brain weight, volume, and specific gravity in severe head trauma	INTENSIVE CARE MEDICINE			English	Article						head trauma; specific gravity; computed tomography; brain edema; contusion	RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; ACUTE LUNG INJURY; CEREBRAL BLOOD-VOLUME; REGIONAL-DISTRIBUTION; WATER-CONTENT; INTRACRANIAL VOLUME; CT; TISSUE; EDEMA	Background: Computed tomography DICOM images analysis allows a quantitative measurement of organ weight, volume and specific gravity in humans. Methods: The brain weight, volume and specific gravity of 15 traumatic brain-injury patients (3 +/- 2 days after trauma) were computed using a specially designed software (BrainView). Data were compared with those obtained from 15 healthy subjects paired for age and overall intracranial volume. Results: Hemisphere weight were 91 g higher in patients than in controls (1167 +/- 101 vs 1076 +/- 112 g; p < 0.05). Specific gravity of hemispheres (1.0367 +/- 0.0017 vs 1.0335 +/- 0.0012 g/ml; p < 0.001), brainstem (1.0302 +/- 0.0016 vs 1.0277 +/- 0.0015 g/ml; p < 0.001) and cerebellum (1.0396 +/- 0.0020 vs 1.0375 +/- 0.0015 g/ml; p < 0.05) was significantly higher in traumatic brain injury (TBI) patients than in controls (all p < 0.0001 without interaction). This increase in specific gravity was evenly distributed between the hemispheres, the brainstem and the cerebellum, and the grey and white matter. It was more pronounced in the rostral than in the caudal areas of the hemispheres. It was independent of the volume of brain contusion, of the mechanism of head injury, of natremia and of initial Glasgow coma score. Conclusion: Human TBI patients present a diffuse increase in specific gravity. This observation is in sharp opposition with the data derived from the experimental literature.	Hop La Pitie Salpetriere, Dept Anesthesiol, F-75013 Paris, France; Univ Paris 06, F-75013 Paris, France; Inst Natl Telecommun, ARTEMIS Project Unit, F-91011 Evry, France		Puybasset, L (corresponding author), Hop La Pitie Salpetriere, Dept Anesthesiol, 47-83 Bd Hop, F-75013 Paris, France.	louis.puybasset@psl.ap-hop-paris.fr					Abbott AH, 2000, J CRANIOFAC SURG, V11, P211, DOI 10.1097/00001665-200011030-00002; Bigler E D, 1999, Appl Neuropsychol, V6, P217, DOI 10.1207/s15324826an0604_4; BLACQUEBELAIR A, 1965, DICT CONSTANTES BIOL; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Edland SD, 2002, NEUROLOGY, V59, P272, DOI 10.1212/WNL.59.2.272; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; GATTINONI L, 1995, AM J RESP CRIT CARE, V151, P1807, DOI 10.1164/ajrccm.151.6.7767524; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; HO KC, 1980, ARCH PATHOL LAB MED, V104, P635; HO KC, 1980, ARCH PATHOL LAB MED, V104, P640; KITA H, 1994, ACTA NEUROCHIR, P452; KUHL DE, 1980, J NEUROSURG, V52, P309, DOI 10.3171/jns.1980.52.3.0309; Lu Q, 2001, INTENS CARE MED, V27, P1504, DOI 10.1007/s001340101049; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Malbouisson LM, 2001, AM J RESP CRIT CARE, V163, P1444, DOI 10.1164/ajrccm.163.6.2005001; Malbouisson LM, 2001, INTENS CARE MED, V27, P602, DOI 10.1007/s001340100860; Malbouisson LM, 2000, AM J RESP CRIT CARE, V161, P2005, DOI 10.1164/ajrccm.161.6.9907067; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; NATH F, 1986, J NEUROSURG, V65, P41, DOI 10.3171/jns.1986.65.1.0041; Pelosi P, 1996, EUR RESPIR J, V9, P1055, DOI 10.1183/09031936.96.09051055; PELOSI P, 1994, AM J RESP CRIT CARE, V149, P8, DOI 10.1164/ajrccm.149.1.8111603; PELOSI P, 1995, AM J RESP CRIT CARE, V152, P531, DOI 10.1164/ajrccm.152.2.7633703; PHELPS ME, 1975, RADIOLOGY, V117, P585, DOI 10.1148/117.3.585; Puybasset L, 2000, INTENS CARE MED, V26, P1215, DOI 10.1007/s001340051340; Puybasset L, 2000, INTENS CARE MED, V26, P857, DOI 10.1007/s001340051274; RIETH KG, 1980, RADIOLOGY, V135, P343, DOI 10.1148/radiology.135.2.6768102; Rouby JJ, 2000, INTENS CARE MED, V26, P1046, DOI 10.1007/s001340051317; TAKAGI H, 1981, J NEUROSURG, V54, P797, DOI 10.3171/jns.1981.54.6.0797; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017; TORACK RM, 1976, J NEUROPATH EXP NEUR, V35, P385, DOI 10.1097/00005072-197607000-00001; UNGER E, 1988, AM J NEURORADIOL, V9, P687; Verger K, 2001, BRAIN INJURY, V15, P211; Vieira SRR, 1998, AM J RESP CRIT CARE, V158, P1571, DOI 10.1164/ajrccm.158.5.9802101; Vieira SRR, 1999, AM J RESP CRIT CARE, V159, P1612, DOI 10.1164/ajrccm.159.5.9805112	37	23	23	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	AUG	2005	31	8					1042	1050		10.1007/s00134-005-2709-y			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951CD	WOS:000230905600007	15991008				2022-02-06	
J	Sen, J; Belli, A; Petzold, A; Russo, S; Keir, G; Thompson, EJ; Smith, M; Kitchen, N				Sen, J; Belli, A; Petzold, A; Russo, S; Keir, G; Thompson, EJ; Smith, M; Kitchen, N			Extracellular fluid S100B in the injured brain: a future surrogate marker of acute brain injury?	ACTA NEUROCHIRURGICA			English	Article						acute brain injury; microdialysis; S100B; monitoring; marker	CEREBROSPINAL-FLUID; SERUM S100B	The authors describe the measurement of S100B protein in brain extracellular fluid (ECF) of patients with acute brain injury (traumatic brain injury and subarachnoid haemorrhage) using the technique of microdialysis. To our knowledge, this is the first report of S100B measurement in the human brain. Acute Brain Injury (ABI) is a leading cause of death and disability and the need for a practical and sensitive biochemical marker for monitoring these patients is urgent. The calcium binding astrocyte protein, S100B, may be a candidate for this role. Previous serum studies have shown S100B to be a sensitive predictor of mortality and rise in intracranial pressure in ABI, but it has never before been measured directly within the brain. The ECF reflects the local biochemistry of the brain parenchyma, and the use of intracerebral microdialysis opens up the possibility of studying many novel surrogate markers of injury in the laboratory, in addition to the conventional markers it measures at the bedside (lactate, pyruvate, glucose, and glycerol). In this preliminary report of two cases, the authors demonstrate the quantification of S100B in ECF microdialysate, and investigate whether changes in hourly S100B profile can be related to secondary brain injury. It is shown that extracellular concentrations of S100B change markedly in response to secondary brain injury. Further investigation is required to determine whether extracellular S100B measurement in ABI could assist in patient management.	UCL Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Surg Intens Care Unit, London WC1N 3BG, England; Victor Horsley Dept Neurosurg, London, England; Inst Neurol, Dept Neuroimmunol, London WC1N 3BG, England		Sen, J (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Surg Intens Care Unit, Queen Sq, London WC1N 3BG, England.	j.sen@ion.ucl.ac.uk	Belli, Antonio/I-3799-2015; Petzold, Axel/C-1090-2009; Smith, Martin/B-2616-2009	Belli, Antonio/0000-0002-3211-9933; Petzold, Axel/0000-0002-0344-9749; 			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Green AJE, 1997, J IMMUNOL METHODS, V205, P35, DOI 10.1016/S0022-1759(97)00050-1; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; TAKAYASU M, 1985, J NEUROSURG, V63, P417, DOI 10.3171/jns.1985.63.3.0417; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x	7	23	23	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	AUG	2005	147	8					897	900		10.1007/s00701-005-0526-2			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	950FY	WOS:000230844200028	15824882				2022-02-06	
J	Rondina, C; Videtta, W; Petroni, G; Lujan, S; Schoon, P; Mori, LB; Matkovich, J; Carney, N; Chesnut, R				Rondina, C; Videtta, W; Petroni, G; Lujan, S; Schoon, P; Mori, LB; Matkovich, J; Carney, N; Chesnut, R			Mortality and morbidity from moderate to severe traumatic brain injury in Argentina	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Argentina; outcomes; rehabilitation; traumatic brain injury	DISABILITY RATING-SCALE; HEAD; COMA	After adopting the Guidelines for the Management of Severe Head Injury, critical care physicians in Argentina reduced the mortality rate of patients with traumatic brain injury (TBI). However, there is no in-hospital or postdischarge rehabilitation services for persons with TBI in Argentina. Thus, severely disabled survivors were being discharged to home without follow-up or long-term care. Objectives: The objectives of this project were to establish a structure for conducting research about TBI in Argentina, and to conduct a prospective, observational study of outcomes from TBI in hospitals that had adopted the acute care guidelines. The goal was to document outcomes for people treated in a medical system that does not provide TBI rehabilitation. The focus of this report is mortality and morbidity during the acute care and hospital ward treatment of TBI in Argentina. Methods: We established a data-collection system in 5 hospitals in Argentina, using instruments and protocols developed by the NIDRR-funded TBI Model System program. Data-collection intervals were established to be comparable with intervals used in the TBI Model System program. The Argentine team consists of 11 neurocritical care physicians and I project manager/translator. All patient evaluation, data collection and entry, quality control, and local administration were conducted by this group. Results: Over 31 months, 278 patients were entered into the study. Approximately 61% were discharged from acute care directly to home. The in-hospital mortality rate was 31%. Seventy-six percent of expired patients died from secondary complications such as sepsis and pneumonia, and 93% while in the hospital. Discussion: TBI is a major public health concern in Argentina. However, rehabilitation for TBI is not a part of this country's medical system. The greatest proportion of expired patients in the Argentine sample died of secondary complications such as pneumonia or sepsis, which may have been avoided employing basic medical rehabilitation. The next research questions to be addressed in this population should be designed to identify solutions to the immediate need for rehabilitation, including treatment efficacy questions as well as questions about systems for delivering treatments.	Hosp Emergencias Dr Clemente Alvarez, RA-2000 Rosario, Santa Fe, Argentina; Hosp Nacl Professor A Posadas, Buenos Aires, DF, Argentina; Hosp Interzonal Gen Agudos Professor Dr Luis Guem, Buenos Aires, DF, Argentina; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Univ Washington, Harborview Hosp, Seattle, WA 98195 USA		Rondina, C (corresponding author), Hosp Emergencias Dr Clemente Alvarez, Rueda 1100, RA-2000 Rosario, Santa Fe, Argentina.			Chesnut, Randall/0000-0001-6377-3666			Adelson PD, 2003, CRIT CARE MED, V31, pS418, DOI 10.1097/00003246-200306006-00002; ADELSON PD, 2003, TRAUMA, V54, pS235; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bond M R, 1979, Acta Neurochir Suppl (Wien), V28, P126; BULLOCK R, 1996, GUIDELINES MANAGEMEN; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; *COMM TRAUM AM COL, 1999, RES OPT CAR INJ PAT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; NEIRA JA, 2001, MED INTENSIVA, V18, P92; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Verdejo G, 2000, Epidemiol Bull, V21, P7	17	23	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2005	20	4					368	376		10.1097/00001199-200507000-00008			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941MV	WOS:000230219800008	16030443				2022-02-06	
J	Corrigan, JD; Bogner, J; Lamb-Hart, G; Heinemann, AW; Moore, D				Corrigan, JD; Bogner, J; Lamb-Hart, G; Heinemann, AW; Moore, D			Increasing substance abuse treatment compliance for persons with traumatic brain injury	PSYCHOLOGY OF ADDICTIVE BEHAVIORS			English	Article							COGNITIVE STATUS EXAMINATION; TREATMENT RETENTION; CHANGE QUESTIONNAIRE; USE DISORDERS; DRUG-ABUSERS; READINESS; DEPENDENCE; PERFORMANCE; PREDICTORS; MOTIVATION	This study compared 3 methods of increasing participation in substance abuse treatment for clients with traumatic brain injury. Participants (N = 195) were randomly assigned to 4 conditions: (a) motivational interview, (b) reduction of logistical barriers to attendance, (c) financial incentive, and (d) attention control. Four interviewers conducted structured, brief telephone interventions targeting the timeliness of signing an individualized service plan. Participants assigned to the barrier reduction (74%) and financial incentive (83%) groups were more likely to sign within 30 days compared with the motivational interview (45%) and attention control (45%) groups. Similar results were observed for time to signing, perfect attendance at appointments, and premature termination during the following 6 months. Extent of psychiatric symptoms was the only significant covariate.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA; Wright State Univ, Dept Community Hlth, Sch Med, Dayton, OH 45435 USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Corrigan, John D./E-2921-2011; Heinemann, Allen W/K-6283-2012; Bogner, Jennifer/E-2773-2011; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barber JP, 2001, J CONSULT CLIN PSYCH, V69, P119, DOI 10.1037/0022-006X.69.1.119; Bates ME, 2002, EXP CLIN PSYCHOPHARM, V10, P193, DOI 10.1037//1064-1297.10.3.193; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Becker M H, 1980, J Community Health, V6, P113, DOI 10.1007/BF01318980; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BEUTLER LE, 1991, J CONSULT CLIN PSYCH, V59, P1; Bogner JA, 1997, J HEAD TRAUMA REHAB, V12, P57, DOI 10.1097/00001199-199710000-00006; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brown VB, 1999, J PSYCHOACTIVE DRUGS, V31, P31, DOI 10.1080/02791072.1999.10471723; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corrigan J. D., 1999, REHABILITATION ADULT; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; *CTR SUBST AB TREA, 1998, DHHS PUBL; DANSEREAU DF, 1993, J COUNS PSYCHOL, V40, P385, DOI 10.1037/0022-0167.40.4.385; De Weert-Van Oene GH, 2001, J SUBST ABUSE TREAT, V20, P253, DOI 10.1016/S0740-5472(01)00160-X; DeLeon G, 1997, AM J DRUG ALCOHOL AB, V23, P169; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Doninger NA, 2000, J HEAD TRAUMA REHAB, V15, P683, DOI 10.1097/00001199-200002000-00007; ENGELHART C, 1994, CLIN NEUROPSYCHOL, V8, P405, DOI 10.1080/13854049408402043; Fals-Stewart W, 2003, EXP CLIN PSYCHOPHARM, V11, P34, DOI 10.1037/1064-1297.11.1.34; FALSSTEWART W, 1994, PSYCHOL ADDICT BEHAV, V8, P179, DOI 10.1037/0893-164X.8.3.179; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedmann PD, 2001, J SUBST ABUSE TREAT, V21, P97, DOI 10.1016/S0740-5472(01)00185-4; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; Heather N, 1993, READINESS CHANGE QUE; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Higgins ST, 2002, ADDICT BEHAV, V27, P887, DOI 10.1016/S0306-4603(02)00297-6; Hser YI, 1999, J SUBST ABUSE TREAT, V16, P299, DOI 10.1016/S0740-5472(98)00037-3; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kokkevi A, 1998, ADDICT BEHAV, V23, P841, DOI 10.1016/S0306-4603(98)00071-9; LANGLEY M, 1991, WORK WORTH DOING ADV, P251; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luborsky L, 1996, J Psychother Pract Res, V5, P260; McCaul ME, 2001, DRUG ALCOHOL DEPEN, V62, P9, DOI 10.1016/S0376-8716(00)00155-1; MCCLELLAN AT, 1990, ADDICTION SEVERITY I; *NAT ASS ALC DRUGS, 1998, ACC LTD SUBST AB SER; Newman C F, 1997, NIDA Res Monogr, V165, P181; Paraherakis A, 2000, CAN J PSYCHIAT, V45, P927, DOI 10.1177/070674370004501009; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Petry Nancy M, 2003, Sci Pract Perspect, V2, P55; Petry NM, 2000, J CONSULT CLIN PSYCH, V68, P250, DOI 10.1037/0022-006X.68.2.250; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; Simpson DD, 1997, DRUG ALCOHOL DEPEN, V47, P227; SIMPSON DD, 1993, PSYCHOTHER, V30, P357, DOI 10.1037/0033-3204.30.2.357; SOBELL MB, 1992, BEHAV THER, V23, P43, DOI 10.1016/S0005-7894(05)80307-7; War Department, 1944, ARM IND TEST BATT MA	51	23	23	0	11	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0893-164X	1939-1501		PSYCHOL ADDICT BEHAV	Psychol. Addict. Behav.	JUN	2005	19	2					131	139		10.1037/0893-164X.19.2.131			9	Substance Abuse; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Substance Abuse; Psychology	943RD	WOS:000230370900002	16011383				2022-02-06	
J	Kleindienst, A; Tolias, CM; Corwin, FD; Muller, C; Marmarou, A; Fatouros, P; Bullock, MR				Kleindienst, A; Tolias, CM; Corwin, FD; Muller, C; Marmarou, A; Fatouros, P; Bullock, MR			Assessment of cerebral S100B levels by proton magnetic resonance spectroscopy after lateral fluid-percussion injury in the rat	JOURNAL OF NEUROSURGERY			English	Article						proton magnetic resonance spectroscopy; S100B protein; traumatic brain injury; prognosis; rat	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CORTICAL IMPACT INJURY; CEREBROSPINAL-FLUID; NEURITE EXTENSION; PROTEIN S100B; GROWTH-FACTOR; SERUM-LEVELS; HEAD-INJURY; S-100	Object. After traumatic brain injury (TBI), S100B protein is released by astrocytes. Furthermore, cerebrospinal fluid (CSF) and serum S100B levels have been correlated to outcome. Given that no data exist about the temporal profile of cerebral S100B levels following TBI and their correlation to serum levels, the authors examined whether proton magnetic resonance (MR) spectroscopy is capable of measuring S100B. Methods. Results of in vitro proton MR spectroscopy experiments (2.35-tesla magnet, 25 G/cm, point-resolved spatially localized spectroscopy) revealed an S100B-specific peak at 4.5 ppm and confirmed a positive correlation between different S100B concentrations (10 nM-1 mu M) and the area under the curve (AUC) for the S100B peak (r = 0.991, p < 0.001). Thereafter, proton MR spectroscopy was performed in male Sprague-Dawley rats (7 X 5 X 5-mm voxel in each hemisphere, TR 3000 msec, TE 30 msec, 256 acquisitions). Exogenously increased CSF S100B levels (similar to 200 ng/ml) through the intraventricular infusion of S100B increased the AUC of the S100B peak from 0.06 +/- 0.02 to 0.44 +/- 0.06 (p < 0.05), whereas serum S100B levels remained normal. Two hours after lateral fluid-percussion injury, serum S100B levels increased to 0.61 +/- 0.09 ng/ml (p < 0.01) and rapidly returned to normal levels, whereas the AUC of the S100B peak increased to 0.19 +/- 0.04 at 2 hours postinjury and 0.41 +/- 0.07 (p < 0.05) on Day 5 postinjury. Conclusions. Proton MR spectroscopy proves a strong correlation between the AUC of the S100B peak and S100B concentrations. Following experimental TBI, serum S100B levels increased for only a very short period, whereas cerebral S100B levels were increased up to Day 5 postinjury. Given that experimental data indicate that S100B is actively released following TBI, proton MR spectroscopy may represent a new tool to identify increased cerebral S100B levels in patients after injury, thus allowing its biological function to be better understood.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiol, Richmond, VA USA; Humboldt Univ, Inst Lab Med & Pathobiochem, Berlin, Germany		Kleindienst, A (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Med Coll Virginia Campus, Richmond, VA 23284 USA.	akleindienst@vcu.edu	Kleindienst, Andrea/F-1674-2014	Kleindienst, Andrea/0000-0003-4758-0324	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587-26] Funding Source: Medline		Agelink MW, 2001, J NEUROL NEUROSUR PS, V71, P394, DOI 10.1136/jnnp.71.3.394; BARGER SW, 1995, BRAIN RES, V677, P167, DOI 10.1016/0006-8993(95)00160-R; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Ciccarelli R, 1999, GLIA, V27, P275, DOI 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.3.CO;2-S; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; ESOUZA MT, 2000, PHYSIOL BEHAV, V71, P29; Green AJE, 1997, J IMMUNOL METHODS, V205, P35, DOI 10.1016/S0022-1759(97)00050-1; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Hilton G, 1994, Orthop Nurs, V13, P25, DOI 10.1097/00006416-199407000-00006; Hu JR, 1997, J NEUROCHEM, V69, P2294; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; KRAGH J, 1993, BIOL PSYCHIAT, V33, P794, DOI 10.1016/0006-3223(93)90020-E; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Li YK, 1998, J NEUROCHEM, V71, P1421; MATSUTANI T, 1985, NEUROCHEM RES, V10, P1155, DOI 10.1007/BF00965889; ODowd BS, 1997, NEUROBIOL LEARN MEM, V67, P197, DOI 10.1006/nlme.1997.3766; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; RICKMANN M, 1995, BRAIN RES, V688, P8, DOI 10.1016/0006-8993(95)00495-C; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; WHITAKERAZMITIA PM, 1990, BRAIN RES, V528, P155, DOI 10.1016/0006-8993(90)90210-3; Wilder PT, 1998, PROTEIN SCI, V7, P794, DOI 10.1002/pro.5560070330; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; ZIMMER DB, 1986, J BIOL CHEM, V261, P1424	44	23	23	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2005	102	6					1115	1121		10.3171/jns.2005.102.6.1115			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	938NL	WOS:000230010000024	16028772				2022-02-06	
J	Morelli, V; Espinoza, L				Morelli, V; Espinoza, L			Groin injuries and groin pain in athletes: Part 2	PRIMARY CARE			English	Article							ACETABULAR LABRAL TEARS; OSTEITIS PUBIS; FEMORAL-HEAD; AVASCULAR NECROSIS; MAGNETIC-RESONANCE; HIP PAIN; CORE DECOMPRESSION; ILIOPSOAS TENDON; LIGAMENTUM TERES; STRESS-FRACTURES	Sports injuries to the hip and groin region have been noted in 5% to 9% of high school athletes [1,2]. These injuries occur most commonly in athletes participating in sports involving side-to-side cutting, quick accelerations and decelerations, and sudden directional changes. Symptoms may range from intermittent episodes of mild discomfort to severe and chronic career-ending pain. Groin injuries may result from a variety of causes. Although this article deals mainly with athletic etiologies, the physician must keep in mind that many other medical conditions may also affect the groin. Differential diagnosis of nonathletic causes of groin pain is outlined below: Intra-abdominal disorders (eg, aneurysm, appendicitis, diverticulosis, inflammatory bowel disease) Genitourinary abnormalities (eg, urinary tract infection, lymphadenitis, prostatitis, scrotal and testicular abnormalities, gynecologic abnormalities, nephrolithiasis) Referred lumbosacral pain (eg, lumbar disc disease) Hip joint disorders (eg, Legg-Calve-Perthes disease, synovitis, slipped femoral capital epiphysis in younger patients and osteochondritis dissecans of femoral head, osteoarthritis) Because of these overlapping medical conditions and because the anatomy of the region is so complex, a team approach is optimal. In the National Institute for Groin Injuries, primary care sports physicians coordinate input from a team of urologists, neurologists, radiologists, interventional radiologists, orthopedists, general surgeons, gynecologists, physical therapists, and gastroenterologists. The primary care physician, in addition to performing a focused history and physical examination, should have an understanding of the diagnostic imaging available and a working knowledge of the sensitivities and specificities of each test. After generating a complete differential diagnosis, appropriate referral when needed, and formulation of a treatment plan, the coordinating physician must diligently maintain oversight of the athlete's response to initial conservative management. This is paramount not only because of the difficulty of diagnosis, but also because 27% to 90% of patients presenting with groin pain have more than one coexisting injury [3,4]. As the authors will illustrate, these coexisting injuries are thought to arise due to the close proximity of anatomical elements in the region, predisposing one insult to naturally involve adjacent structures. Alternatively, an initial injury may alter the delicate biomechanics of the hip and groin, leading to secondary overuse injuries. Whatever the reason, it is common for one injury to be properly diagnosed and be improving with treatment, while at the same time a concomitant injury may have gone entirely undiagnosed and untreated, leaving both the athlete and physician frustrated if proper monitoring and re-evaluation are not done. In the second of this two-part series, disorders of the os pubis, stress fractures and various hip pathologies are reviewed as causes of groin pain.	Louisiana State Univ, Hlth Sci Ctr, Primary Care Sports Med Fellowship, Kenner, LA 70065 USA; Louisiana State Univ, Hlth Sci Ctr, Orthopaed Residency Program, Kenner, LA 70065 USA		Morelli, V (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Primary Care Sports Med Fellowship, 200 W Esplanade Ave,Suite 412, Kenner, LA 70065 USA.	morellivincent@yahoo.com					Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Baber YF, 1999, J BONE JOINT SURG BR, V81B, P600, DOI 10.1302/0301-620X.81B4.8803; Barile A, 2000, Radiol Med, V100, P216; Bencardino Jenny T, 2003, Top Magn Reson Imaging, V14, P145, DOI 10.1097/00002142-200304000-00004; Byrd JWT, 2004, ARTHROSCOPY, V20, P385, DOI 10.1016/j.arthro.2004.01.025; Byrd JWT, 2001, CLIN SPORT MED, V20, P801; Combs JA, 1998, MED SCI SPORT EXER, V30, P1561, DOI 10.1097/00005768-199811000-00001; COOPER DE, 1991, AM J SPORT MED, V19, P322, DOI 10.1177/036354659101900319; COVENTRY MB, 1961, JAMA-J AM MED ASSOC, V178, P898, DOI 10.1001/jama.1961.03040480028006; DIPAOLA J D, 1991, Arthroscopy, V7, P101, DOI 10.1016/0749-8063(91)90087-E; DORRELL JH, 1986, J BONE JOINT SURG BR, V68, P400, DOI 10.1302/0301-620X.68B3.3733805; EDWARDS DJ, 1995, J BONE JOINT SURG BR, V77B, P374, DOI 10.1302/0301-620X.77B3.7744918; EKBERG O, 1988, SPORTS MED, V6, P56, DOI 10.2165/00007256-198806010-00006; Eskridge C, 1997, J Perinatol, V17, P321; Farjo LA, 1999, ARTHROSCOPY, V15, P132, DOI 10.1053/ar.1999.v15.015013; FRICKER PA, 1991, SPORTS MED, V12, P266, DOI 10.2165/00007256-199112040-00005; Fricker PA, 1997, BRIT J SPORT MED, V31, P97, DOI 10.1136/bjsm.31.2.97; GLUECK CJ, 1995, AM J HEMATOL, V48, P213, DOI 10.1002/ajh.2830480402; GLUECK CJ, 1994, AM J HEMATOL, V45, P156, DOI 10.1002/ajh.2830450212; GRACE JN, 1989, J BONE JOINT SURG AM, V71A, P358, DOI 10.2106/00004623-198971030-00008; HARRIS NH, 1974, BRIT MED J, V4, P211, DOI 10.1136/bmj.4.5938.211; HEDSTROM SA, 1982, AM J SPORT MED, V10, P44, DOI 10.1177/036354658201000111; Hill PF, 1996, J BONE JOINT SURG BR, V78B, P383, DOI 10.1302/0301-620X.78B3.0780383; HOLT MA, 1995, AM J SPORT MED, V23, P601, DOI 10.1177/036354659502300515; IKEDA T, 1988, J BONE JOINT SURG BR, V70, P13, DOI 10.1302/0301-620X.70B1.3339044; Ishizaka M, 1997, CLIN ORTHOP RELAT R, P140, DOI 10.1097/00003086-199704000-00016; JACOBSON T, 1990, AM J SPORT MED, V18, P470, DOI 10.1177/036354659001800504; Janzen DL, 1996, CAN ASSOC RADIOL J, V47, P202; Johnston CAM, 1998, SPORTS MED, V25, P271, DOI 10.2165/00007256-199825040-00005; Karlsson J, 1997, SPORTS MED ARTHROSC, V5, P268; Kelly BT, 2003, AM J SPORT MED, V31, P1020, DOI 10.1177/03635465030310060701; Knight A, 2001, CAN MED ASSOC J, V165, P397; Koch S., 1981, J APPL COMMUN RES, V9, P1; KOO KH, 1995, J BONE JOINT SURG BR, V77B, P870, DOI 10.1302/0301-620X.77B6.7593097; Lage LA, 1996, ARTHROSCOPY, V12, P269, DOI 10.1016/S0749-8063(96)90057-2; LAORR A, 1995, SKELETAL RADIOL, V24, P239; Lavernia C J, 1999, J Am Acad Orthop Surg, V7, P250; LEE JK, 1988, RADIOLOGY, V169, P217, DOI 10.1148/radiology.169.1.3420261; Lynch SA, 1999, SPORTS MED, V28, P137, DOI 10.2165/00007256-199928020-00006; Maksymowych WP, 2001, J RHEUMATOL, V28, P2754; McCarthy J, 2003, CLIN ORTHOP RELAT R, P38, DOI 10.1097/01.blo.0000043042.84315.17; McCarthy JC, 2001, CLIN ORTHOP RELAT R, P25; McCarthy JC, 2001, J ARTHROPLASTY, V16, P81, DOI 10.1054/arth.2001.28370; Mitchell B, 2003, CLIN J SPORT MED, V13, P152, DOI 10.1097/00042752-200305000-00005; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Moore RS, 1998, J BONE JOINT SURG AM, V80A, P1043, DOI 10.2106/00004623-199807000-00013; Narvani AA, 2003, KNEE SURG SPORT TR A, V11, P403, DOI 10.1007/s00167-003-0390-7; NOCCION SL, 2003, DELEE DREZS ORTHOPAE, P1443; Ohashi K, 1997, RADIOL CLIN N AM, V35, P591; Pauli S, 2002, BRIT J SPORT MED, V36, P71, DOI 10.1136/bjsm.36.1.71; PETTINE KA, 1991, AM J SPORT MED, V19, P96, DOI 10.1177/036354659101900118; Rao J, 2001, CLIN SPORT MED, V20, P791, DOI 10.1016/S0278-5919(05)70285-4; Reichert-Penetrat S, 2001, DERMATOLOGY, V203, P356, DOI 10.1159/000051794; Renstrom PAFH, 1997, SPORTS MED ARTHROSC, V5, P247; Rijnen WHC, 2003, CLIN ORTHOP RELAT R, P74, DOI 10.1097/01.blo.0000096823.67494.64; Rolf C, 1997, SPORTS MED ARTHROSC, V5, P301; Roos HP, 1997, SPORTS MED ARTHROSC, V5, P292; Ross JJ, 2003, MEDICINE, V82, P340, DOI 10.1097/01.md.0000091180.93122.1c; Schmid MR, 2003, RADIOLOGY, V226, P382, DOI 10.1148/radiol.2262020019; Shin AY, 1996, AM J SPORT MED, V24, P168, DOI 10.1177/036354659602400209; Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71; STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34, DOI 10.1302/0301-620X.77B1.7822393; STULBERG BN, 1991, CLIN ORTHOP RELAT R, P140; Weaver CJ, 2002, AM J ROENTGENOL, V178, P973, DOI 10.2214/ajr.178.4.1780973; Westlin N, 1997, SPORTS MED ARTHROSC, V5, P280; Williams J G, 1978, Br J Sports Med, V12, P129; Williams PR, 2000, AM J SPORT MED, V28, P350, DOI 10.1177/03635465000280031101	67	23	23	1	19	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0095-4543			PRIMARY CARE	Primary Care	MAR	2005	32	1					185	+		10.1016/j.pop.2004.11.012			17	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925JF	WOS:000229048700010	15831318				2022-02-06	
J	McDermott, S; Moran, R; Platt, T; Issac, T; Wood, H; Dasari, S				McDermott, S; Moran, R; Platt, T; Issac, T; Wood, H; Dasari, S			Depression in adults with disabilities, in primary care	DISABILITY AND REHABILITATION			English	Article							NATIONAL-COMORBIDITY-SURVEY; INTELLECTUAL DISABILITY; SYMPTOMS; EPIDEMIOLOGY; LIFETIME; INJURY; PEOPLE; RISK	Purpose: This research was designed to answer the question: Does the prevalence of depression differ between adults with and without disability, in the same family medicine practice? Method: A retrospective cohort design was used, to study depression among adults, with and without primary disabling conditions, receiving primary care in either a university based urban or rural family practice setting. Results: When we compared individuals with disability to those without disability, and controlled for individual characteristics, the relative risk for depression was significantly lower for individuals with autism (Relative Risk (RR) 0.20: 95% Confidence Interval (CI) 0.05-0.55), cerebral palsy with mental retardation (RR 0.40: 95% CI: 0.24-0.65), and MR (RR 0.56: 95% CI: 0.39-0.77). The risk for depression was significantly higher for those with cerebral vascular accidents/stroke (RR 2.18: 95% CI: 1.72-3.76) and traumatic brain injury (RR 2.55: 95% CI: 1.72-2.77). The earliest onset of depression was among individuals with traumatic disabilities and mild mental retardation. Our estimate of depression prevalence for the non-disabled and disabled primary care patients was 22.8% and 24.9% respectively, when patients with disabilities were grouped together (p=0.008). Conclusion: It is important for physicians to recognize the higher prevalence of depression among patients with adult onset disabilities ( e. g. stroke, traumatic brain injury). In addition, they should be aware of lower prevalence of depression among many individuals with lifelong disabilities, such as mental retardation, cerebral palsy, and autism.	Univ S Carolina, Sch Med, Dept Family & Prevent Med, Columbia, SC USA		McDermott, S (corresponding author), Family Practice Ctr, 3209 Colonial Dr, Columbia, SC 29208 USA.	Suzanne.mcdermott@palmettohealth.org			ODCDC CDC HHS [R04/CCR418776] Funding Source: Medline		CHARLOT LR, 1993, AM J MENT RETARD, V98, P408; Chen LS, 2000, AM J PSYCHIAT, V157, P573, DOI 10.1176/appi.ajp.157.4.573; Davis JP, 1997, AUST NZ J PSYCHIAT, V31, P232, DOI 10.3109/00048679709073826; Dickens C, 2003, PSYCHOSOMATICS, V44, P209, DOI 10.1176/appi.psy.44.3.209; Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horwath Ewald, 1995, P317; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Labbate L A, 2000, Curr Psychiatry Rep, V2, P268, DOI 10.1007/s11920-996-0021-3; Marston GM, 1997, J INTELL DISABIL RES, V41, P476, DOI 10.1111/j.1365-2788.1997.tb00739.x; McBrien JA, 2003, J INTELL DISABIL RES, V47, P1, DOI 10.1046/j.1365-2788.2003.00455.x; MEINS W, 1995, J INTELL DISABIL RES, V39, P41, DOI 10.1111/j.1365-2788.1995.tb00912.x; *SAS I, 1999, SAS STAT US GUID VER; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; STURMEY P, 1993, J INTELL DISABIL RES, V37, P437; *WHO, 1980, INT STAT CLASS DIS; Whyte EM, 2002, BIOL PSYCHIAT, V52, P253, DOI 10.1016/S0006-3223(02)01424-5; Wu Lawrence R, 2002, J Am Board Fam Pract, V15, P183	20	23	23	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1464-5165			DISABIL REHABIL	Disabil. Rehabil.	FEB 4	2005	27	3					117	123		10.1080/09638280400007380			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	903WL	WOS:000227456200006	15823993				2022-02-06	
J	Cristofori, L; Tavazzi, B; Gambin, R; Vagnozzi, R; Signoretti, S; Arnorini, AM; Fazzina, G; Lazzarino, G				Cristofori, L; Tavazzi, B; Gambin, R; Vagnozzi, R; Signoretti, S; Arnorini, AM; Fazzina, G; Lazzarino, G			Biochemical analysis of the cerebrospinal fluid: evidence for catastrophic energy failure and oxidative damage preceding brain death in severe head injury: a case report	CLINICAL BIOCHEMISTRY			English	Article						cerebrospinal fluid; energy metabolism; high-performance liquid chromatography; oxidative stress; traumatic brain injury	LIPID-PEROXIDATION; MITOCHONDRIAL DYSFUNCTION; GLUTAMATE; CHILDREN; INFANTS; ACID; RATS	Objectives: To compare biochemical and clinical parameters in a case of fatal severe traumatic brain injury (TBI) with secondary insult. Design and methods: A TBI patient was catheterized for intracranial pressure (ICP) monitoring and cerebrospinal fluid (CSF) analysis of ascorbate, malondialdehyde, oxypurines, and nucleosides. Results: Oxidative brain damage preceded ATP catabolite increment in the CSF even with ICP below 20 mm Hg. Sustained oxidative stress caused irreversible energy state derangement followed by a refractory ICP rise. Massive oxypurine and nucleoside release was recorded 36 h before brain death. Conclusions: Molecular events, detected by biochemical CSF analysis and preceding modification of clinical parameters in severe TBI with secondary insult, are discussed. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved.	Univ Catania, Dept Chem Sci, Biochem Lab, I-95125 Catania, Italy; Univ Hosp Verona, Dept Neurosurg, Verona, Italy; Catholic Univ Rome, Inst Biochem & Clin Biochem, Rome, Italy; Univ Roma Tor Vergata, Dept Neurosci, Chair Neurosurg, Rome, Italy; San Camillo Hosp, Dept Neurosci, Div Neurosurg, Rome, Italy		Lazzarino, G (corresponding author), Univ Catania, Dept Chem Sci, Biochem Lab, Viale A Doria 6, I-95125 Catania, Italy.	lazzarig@mbox.unict.it	TAVAZZI, BARBARA/AAB-9830-2019; Signoretti, stefano/AAL-5631-2020; lazzarino, giuseppe/K-2277-2015	TAVAZZI, BARBARA/0000-0001-8743-0895; Signoretti, stefano/0000-0002-8086-1622; AMORINI, Angela Maria/0000-0003-3525-9955; lazzarino, giuseppe/0000-0002-5917-7279			Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; DIPIERRO D, 1995, ANAL BIOCHEM, V231, P407, DOI 10.1006/abio.1995.0071; LAZZARINO G, 1991, ANAL BIOCHEM, V197, P191, DOI 10.1016/0003-2697(91)90378-7; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005	10	23	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	JAN	2005	38	1					97	100		10.1016/j.clinbiochem.2004.09.013			4	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	890IZ	WOS:000226506200017	15607325				2022-02-06	
J	Hirshberg, LM; Chiu, SF; Frazier, JA				Hirshberg, LM; Chiu, SF; Frazier, JA			Emerging brain-based interventions for children and adolescents: overview and clinical perspective	CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article							PSYCHOTHERAPY; DISORDER	Electroencephalogram biofeedback (EBF), repetitive transcranial magnetic stimulation (rTMS), and vagal nerve stimulation (VNS) are emerging interventions that attempt to directly impact brain function through neurostimulation and neurofeedback mechanisms. This article provides a brief overview of each of these techniques, summarizes the relevant research findings, and examines the implications of this research for practice standards based on the guidelines for recommending evidence based treatments as developed by the American Academy of Child and Adolescent Psychiatry for attention deficit hyperactivity disorder (ADHD). EBF meets the "Clinical Guidelines" standard for ADHD, seizure disorders, anxiety, depression, and traumatic brain injury. VNS meets this same standard for treatment of refractory epilepsy and meets the lower "Options" standard for several other disorders. rTMS meets the standard for "Clinical Guidelines" for bipolar disorder, unipoloar disorder, and schizophrenia. Several conditions are discussed regarding the use of evidence based thinking related to these emerging interventions and future directions.	Neurodev Ctr, Providence, RI 02903 USA; Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA; Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; Harvard Univ, Cambridge Hosp, Sch Med, Dept Psychiat, Cambridge, MA 02193 USA		Hirshberg, LM (corresponding author), Neurodev Ctr, 260 W Exchange St,Suite 302, Providence, RI 02903 USA.	lhirshberg@cox.net					Akshoomoff N, 2002, DEV PSYCHOPATHOL, V14, P613, DOI 10.1017/S0954579402003115; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BLECKER C, 2004, HUM BRAIN MAPP C BUD; Britton A, 1998, HLTH TECHNOLOGY ASSE, V2, p[i, 1]; Chambless D.L., 1998, CLIN PSYCHOL-UK, V51, P3, DOI [10.1037/e619622010-001, DOI 10.1037/E619622010-001]; Chambless DL, 1998, J CONSULT CLIN PSYCH, V66, P7, DOI 10.1037/0022-006X.66.1.7; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); GRINYATSENKO VA, 2001, HUM PHYSL, V27, P5; Hamilton JD, 2004, J AM ACAD CHILD PSY, V43, P105, DOI 10.1097/00004583-200401000-00020; Iakovenko E A, 2003, Fiziol Cheloveka, V29, P61; Jarusiewicz B., 2002, J NEUROTHERAPY, V6, P39, DOI DOI 10.1300/J184V06N04_05; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kraemer HC, 2003, J AM ACAD CHILD PSY, V42, P1524, DOI 10.1097/00004583-200312000-00022; KROPOTOV JD, INT J PSYCHOPHYSIOL; Lambert MJ, 2001, PSYCHOTHERAPY, V38, P357, DOI 10.1037/0033-3204.38.4.357; LaVaque T.J., 2002, J NEUROTHERAPY, V6, P11; LEVANT R, CLIN PSYCHOL SCI PRA; Lewine JD, 2002, AM J PSYCHIAT, V159, P1689, DOI 10.1176/appi.ajp.159.10.1689; Nock MK, 2004, J AM ACAD CHILD PSY, V43, P777, DOI 10.1097/01.chi.0000120023.14101.58; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Ponomarev V. A., 1999, HUM PHYSL, V25, P143; Rieppi R, 2002, J AM ACAD CHILD PSY, V41, P269, DOI 10.1097/00004583-200203000-00006; Rohan M, 2004, AM J PSYCHIAT, V161, P93, DOI 10.1176/appi.ajp.161.1.93; SCHAMOWSKI F, 2004, HUM BRAIN MAPP C BUD; SELIGMAN MEP, 1995, AM PSYCHOL, V50, P965, DOI 10.1037/0003-066X.50.12.965; Shevelev IA, 1998, PROG NEUROBIOL, V56, P269, DOI 10.1016/S0301-0082(98)00038-0; Swerdlow B., 1991, HEADACHE Q-CURR TREA, V2, P96; Toomim H., 1999, BIOFEEDBACK, V27, P10; Weingarten K, 1998, FAM PROCESS, V37, P3, DOI 10.1111/j.1545-5300.1998.00003.x; Westen D, 2001, J CONSULT CLIN PSYCH, V69, P875, DOI 10.1037//0022-006X.69.6.875; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490	34	23	24	1	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1056-4993	1558-0490		CHILD ADOL PSYCH CL	Child Adolesc. Psychiatr. N. Am.	JAN	2005	14	1					1	+		10.1016/j.chc.2004.07.011			20	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	883CS	WOS:000225988400003	15564050				2022-02-06	
J	Mussack, T; Briegel, J; Schelling, G; Biberthaler, P; Jochum, M				Mussack, T; Briegel, J; Schelling, G; Biberthaler, P; Jochum, M			Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						cerebral ischemia; hydrocortisone; inflammation; septic shock; S-100B	SYSTEMIC INFLAMMATORY RESPONSE; TRAUMATIC BRAIN-INJURY; NEUROLOGICAL COMPLICATIONS; NEUROBIOCHEMICAL MARKERS; ORGAN FAILURE; DOUBLE-BLIND; HEAD TRAUMA; PROTEIN; SERUM; SEPSIS	Stress doses of hydrocortisone a re known to have immunomodulatory effects in patients with hyperdynamic septic shock. The prognosis correlates with the presence and severity of septic encephalopathy. However, neurological evaluation is influenced by the use of analgesia sedation during artificial ventilation. The objective of this study was to demonstrate the effect of stress doses of hydrocortisone during the initial phase of human septic shock on the serum values of the neurospecific protein S-100B in comparison to the inflammation markers interleukin (IL)-8 in serum and polymorphonuclear (PMN) elastase in plasma. A total of 24 consecutive patients, who met the American College of Chest Physicians/Society of Critical Care Medicine criteria for septic shock, were enrolled in this prospective, randomized, double-blind, single-center trial. The severity of illness at recruitment was graded using the Acute Physiology and Chronic Health Evaluation 11 and the Simplified Acute Physiology Score 11 scoring systems. Multi-organ dysfunction syndrome was described by the Sepsis-related Organ Failure Assessment (SOFA) score. All patients were prospectively randomized to receive either stress doses of hydrocortisone or placebo. Hydrocortisone was started in 12 patients with a loading dose of 100 mg and followed by a continuous infusion of 0.18 mg/kg/h for 6 days. Median S-100B serum levels of the hydrocortisone group decreased from 0.32 ng/mL at study entry to 0.07 ng/mL 6 days later without significant differences compared to the placebo group. Initial IL-8 serum levels were significantly higher in the hydrocortisone group up to 12 h after study entry, and significantly decreased from 715 to 17 pg/mL at the end of the observation period. Median PMN elastase plasma levels were not affected by hydrocortisone infusion. Patients with initial S-100B serum levels >0.50 ng/mL revealed significantly higher SOFA scores up to 30 h, IL-8 serum levels up to 12 h, and PMN elastase plasma levels up to 36 h after study entry than those patients with <= 0.50 ng/mL. These effects were independent of the amount of fluid correction for hemodilution. Starting S-100B, IL-8 and PMN elastase values of the hydrocortisone group were within the ranges already known in patients with out-of-hospital cardiac arrest or severe traumatic brain injury. Stress doses of hydrocortisone resulted in a significant reduction in IL-8 serum, but not in S-100B serum and PMN elastase plasma concentrations in patients with hyperdynamic septic shock. For the first time, a similar extent of S-100B increase in serum of septic patients at the time of diagnosis was shown as reported for cardiac arrest or severe traumatic brain injury.	Univ Munich Klinikum, Dept Surg Innenstadt, D-80336 Munich, Germany; Univ Munich Klinikum, Dept Anesthesiol Grosshadern, D-80336 Munich, Germany; Univ Munich Klinikum, Dept Clin Chem & Clin Biochem Innenstadt, D-80336 Munich, Germany		Mussack, T (corresponding author), Univ Munich Klinikum, Dept Surg Innenstadt, Nussbaumstr 20, D-80336 Munich, Germany.	thomas.mussack@med.uni-muenchen.de	Josef, Briegel/ABF-3522-2021; Briegel, Josef/AAG-3774-2019; Schelling, Gustav/U-2603-2018	Schelling, Gustav/0000-0002-6538-0652			Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Astudillo R, 1996, Eur J Cardiothorac Surg, V10, P1107, DOI 10.1016/S1010-7940(96)80358-7; Barie PS, 1998, J TRAUMA, V44, P1108, DOI 10.1097/00005373-199806000-00032; BARIE PS, 1994, J TRAUMA, V37, P660, DOI 10.1097/00005373-199410000-00022; BASTOS PG, 1993, CRIT CARE MED, V21, P1459, DOI 10.1097/00003246-199310000-00012; Bertsch T, 2001, CLIN CHEM LAB MED, V39, P319, DOI 10.1515/CCLM.2001.050; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BOLTON CF, 1993, ANN NEUROL, V33, P94, DOI 10.1002/ana.410330115; Bolton CF, 1996, CRIT CARE MED, V24, P1408, DOI 10.1097/00003246-199608000-00022; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BRIEGEL J, 1994, CLIN INVESTIGATOR, V72, P782; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Briegel J, 2001, J AM SOC NEPHROL, V12, pS70; BRIEGEL J, 1991, LANCET, V338, P507, DOI 10.1016/0140-6736(91)90575-A; Danielson D, 2001, Curr Opin Crit Care, V7, P367, DOI 10.1097/00075198-200110000-00009; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; ENDO S, 1995, J INFLAMM, V45, P136; HAIMOTO H, 1987, LAB INVEST, V57, P489; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Hollenberg SM, 2004, CRIT CARE MED, V32, P1928, DOI 10.1097/01.CCM.0000139761.05492.D6; Hund E, 2001, J NEUROL, V248, P929, DOI 10.1007/s004150170043; Hund E, 1999, CRIT CARE MED, V27, P2544, DOI 10.1097/00003246-199911000-00036; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Lindner A, 1998, INTERNIST, V39, P485, DOI 10.1007/s001080050200; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; METINKO AP, 1992, J CLIN INVEST, V90, P791, DOI 10.1172/JCI115953; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Mussack T, 2000, ACT NEUR S, V76, P393; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Schwarz S, 1997, NERVENARZT, V68, P292, DOI 10.1007/s001150050127; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; USUI A, 1989, CLIN CHEM, V35, P1942; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WAAGE A, 1988, IMMUNOLOGY, V63, P299; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; YOUNG GB, 1990, CLIN INVEST MED, V13, P297	46	23	23	0	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.		2005	43	3					259	268		10.1515/CCLM.2005.044			10	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	912FN	WOS:000228063100001	15843228	Green Submitted			2022-02-06	
J	Muthukumar, N				Muthukumar, N			Uncommon cause of sinus thrombosis following closed mild head injury in a child	CHILDS NERVOUS SYSTEM			English	Article						antiphospholipid antibodies; cerebral venous thrombosis; fracture; magnetic resonance venography; mild head injury; thrombophilia		Object: Sinus thrombosis following a closed mild head injury is rare. A case of dural sinus thrombosis following a mild closed head injury due to an uncommon cause is reported. Methods: A 7-year-old child presented with GCS 15 after a road traffic accident. CT revealed an occipital fracture. Ten days later the child developed signs of increased intracranial pressure. An MR venogram at this time revealed thrombosis of the transverse sinus with hypoplasia of the contralateral transverse and sigmoid sinuses. The patient's anitiphospholipid antibody titres were elevated. The patient was treated with anticoagulants and improved. Conclusions: The role of inherited and acquired procoagulant factors in the aetiology of sinus thrombosis is increasingly being recognized. When a patient presents with sinus thrombosis after a closed mild head injury, it is necessary to investigate for the presence of risk factors for thrombophilia as it has implications for the long-term management of the patient.	Madurai Med Coll, Dept Neurosurg, Madurai 625020, Tamil Nadu, India		Muthukumar, N (corresponding author), Madurai Med Coll, Dept Neurosurg, Muruganagam,138,Anna Nagar, Madurai 625020, Tamil Nadu, India.	prasan86@eth.net					ABRAMSON N, 2001, SOUTH MED J, V94, P997; Brors M, 2001, NEURORADIOLOGY, V43, P144, DOI 10.1007/PL00006045; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; RICH C, 1993, STROKE, V24, P603, DOI 10.1161/01.STR.24.4.603; Satoh H, 2000, NEUROL MED-CHIR, V40, P361, DOI 10.2176/nmc.40.361; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008	11	23	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2005	21	1					86	88		10.1007/s00381-004-0926-2			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	889RN	WOS:000226460200019	15168052				2022-02-06	
J	Geddes, JF; Whitwell, HL				Geddes, JF; Whitwell, HL			Inflicted head injury in infants	FORENSIC SCIENCE INTERNATIONAL			English	Article						infant head injury; non-accidental injury; hypoxia; craniocervical injury; subdural haemorrhage; retinal haemorrhages	DIFFUSE AXONAL INJURY; SHAKEN BABY SYNDROME; BRAIN-INJURY; NEUROPATHOLOGY; HEMORRHAGE; CHILDREN; LESIONS; TRAUMA; HYPEREXTENSION; DIAGNOSIS	There is scant neuropathological information in the child abuse literature; even the best reviews include assumptions based on the findings of a few inadequate early studies. Our recent series of 53 fatal cases (Brain 124 (2001) 1290, 1299 [1,2]) demonstrated age-related patterns of brain injury and showed the substrate of severe encephalopathy in the infants to be hypoxic brain damage, not diffuse traumatic axonal injury ("DAI"), as had previously been thought. About one-third had craniocervical injuries, particularly in the brain stem, suggestive of stretch injury to the neuraxis. Our interpretation was that this finding implied a mechanism of injury-brain stem damage from stretch injury to the neck with resultant apnoea-that could account for the clinical scenario in many cases, and for which violence would not necessarily be required. Since publishing this study we have turned our attention to the subgroup of infants who die without objective signs of injury, such as skull fracture or impact, whose carers are accused of abuse, usually, "violent shaking", on the pathologic findings alone. Given the striking discrepancy that there often is in such cases between the relatively trivial findings in the brain and the accusations of violence, we have been looking at the pathogenesis of the typical intracranial bleeding. A histologic study of dura from 50 paediatric autopsies, none of whom had suffered a head injury, has led us to propose that the subdural and retinal bleeding in such cases may well have a physiological aetiology, rather than being caused directly by trauma. (C) 2003 Elsevier Ireland Ltd. All rights reserved.	Royal London Hosp, Dept Histopathol & Morbid Anat, London E1 1BB, England; Univ London Queen Mary Coll, Dept Histopathol & Morbid Anat, London E1 4NS, England; Univ Sheffield, Dept Forens Pathol, Sheffield, S Yorkshire, England		Geddes, JF (corresponding author), Royal London Hosp, Dept Histopathol & Morbid Anat, London E1 1BB, England.	j.f.geddes@doctors.org.uk					Anteby II, 2001, J AAPOS, V5, P90, DOI 10.1067/mpa.2001.113841; BIAGGIONI I, 1994, HYPERTENSION, V23, P491, DOI 10.1161/01.HYP.23.4.491; BROWN JK, 1993, DEV MED CHILD NEUROL, V35, P849; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chase W. H., 1930, SURG GYNECOL OBSTET, V51, P31; David TJ, 1999, J ROY SOC MED, V92, P556, DOI 10.1177/014107689909201105; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; FERRARIO CM, 1981, HYPERTENSION, V3; Friede R, 1989, DEV NEUROPATHOLOGY, P44; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 2001, CURR TOPICS PATHOL, V95, P101; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; GOVAERT P, 1993, CRANIAL HAEMORRHAGE, P52; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Green MA, 1996, BRIT J OPHTHALMOL, V80, P282, DOI 10.1136/bjo.80.4.282; Green PM, 1999, FETAL DIAGN THER, V14, P275, DOI 10.1159/000020938; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; HARDMAN JM, 1979, COMPLICATIONS NERVOU, P15; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Maxeiner H, 2001, Med Law, V20, P463; Maxeiner H, 2001, J FORENSIC SCI, V46, P85; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; RIGGS JE, 1995, MIL MED, V160, P94, DOI 10.1093/milmed/160.2.94; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Stoodley N, 2002, LANCET, V360, P271, DOI 10.1016/S0140-6736(02)09563-6; Volpe J., 2001, NEUROLOGY NEWBORN; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185	36	23	25	0	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	DEC 16	2004	146	2-3					83	88		10.1016/S0379-0738(03)00283-4			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	879OZ	WOS:000225728400003	15542267				2022-02-06	
J	Jokinen, H; Kalska, H; Ylikoski, R; Hietanen, M; Mantyla, R; Pohjasvaara, T; Kaste, M; Erkinjuntti, T				Jokinen, H; Kalska, H; Ylikoski, R; Hietanen, M; Mantyla, R; Pohjasvaara, T; Kaste, M; Erkinjuntti, T			Medial temporal lobe atrophy and memory deficits in elderly stroke patients	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						aging; cognition; medial temporal lobe atrophy; memory; stroke	PROBABLE ALZHEIMERS-DISEASE; TRAUMATIC BRAIN INJURY; VASCULAR DEMENTIA; COGNITIVE IMPAIRMENT; ENTORHINAL CORTEX; ISCHEMIC-STROKE; LEWY BODIES; MRI; HIPPOCAMPAL; DEPRESSION	Medial temporal lobe atrophy (MTA) and its role in memory deficits have been studied extensively in patients with various dementias and non-degenerative neurologic diseases. In stroke patients MTA is a significant risk factor for dementia. However, its role in memory decline in non-demented stroke patients is not yet known. Our aim was to evaluate the relationship between MTA and cognitive functions in a large cohort of elderly patients, who underwent a comprehensive neuropsychologic examination and magnetic resonance imaging 3 months after an ischemic stroke. The study sample (n = 260) was divided into three groups according to the severity of MTA. After adjusting for age, volume of infarcts and cortical atrophy, we found that patients with moderate to severe MTA performed significantly worse in tests of learning, story recall, visual reproduction, block design and mental speed. In contrast, the groups did not differ in tests of digit span, flexibility, verbal fluency and conceptualization. Our conclusion is that in aged stroke patients, MTA is associated with poor performance in specific cognitive domains. The most vulnerable domains are memory and visuospatial functions, whereas verbal and executive functions seem to be unrelated to MTA.	Univ Helsinki, Cent Hosp, Dept Neurol, Unit Neuropsychol, FIN-00029 Helsinki, Finland; Univ Helsinki, Dept Psychol, SF-00100 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Radiol, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Neurol, Memory Res Unit, Helsinki, Finland; Lohja Dist Hosp, Helsinki, Finland		Jokinen, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurol, Unit Neuropsychol, POB 302, FIN-00029 Helsinki, Finland.	hanna.jokinen@helsinki.fi	Jokinen, Hanna/AAG-5863-2019	Jokinen, Hanna/0000-0001-7889-1120; Kaste, Markku/0000-0001-6557-6412			*AM PSYCH ASS, 1987, AM PSYCH ASS COMM NO; Barba R, 2001, CEREBROVASC DIS, V11, P216, DOI 10.1159/000047642; Barber R, 1999, NEUROLOGY, V52, P1153, DOI 10.1212/WNL.52.6.1153; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; DESMOND PM, 1994, AUST NZ J MED, V24, P547, DOI 10.1111/j.1445-5994.1994.tb01756.x; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Du AT, 2002, NEUROLOGY, V58, P1635, DOI 10.1212/WNL.58.11.1635; Eichenbaum H, 1997, ANNU REV PSYCHOL, V48, P547, DOI 10.1146/annurev.psych.48.1.547; ERKINJUNTTI T, 1993, ARCH NEUROL-CHICAGO, V50, P305, DOI 10.1001/archneur.1993.00540030069017; Fein G, 2000, NEUROLOGY, V55, P1626, DOI 10.1212/WNL.55.11.1626; FULD PA, 1982, FULD OBJECT MEMORY E; Goodglass H, 1983, ASSESSMENT APHASIA R; Hashimoto M, 1998, NEUROLOGY, V51, P357, DOI 10.1212/WNL.51.2.357; Henon H, 1998, J NEUROL NEUROSUR PS, V65, P641, DOI 10.1136/jnnp.65.5.641; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kril JJ, 2002, J NEUROL NEUROSUR PS, V72, P747, DOI 10.1136/jnnp.72.6.747; Laakso MP, 2000, BIOL PSYCHIAT, V47, P1056, DOI 10.1016/S0006-3223(99)00306-6; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; Leskela M, 1999, EUR J NEUROL, V6, P653, DOI 10.1046/j.1468-1331.1999.660653.x; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mantyla R, 2000, STROKE, V31, P695, DOI 10.1161/01.STR.31.3.695; MILLER LA, 1993, ARCH NEUROL-CHICAGO, V50, P391, DOI 10.1001/archneur.1993.00540040051014; Mizuno K, 2000, J NEUROL SCI, V173, P18, DOI 10.1016/S0022-510X(99)00289-0; Mori E, 1997, J NEUROL NEUROSUR PS, V63, P214, DOI 10.1136/jnnp.63.2.214; OBrien JT, 1997, PSYCHOL MED, V27, P1267, DOI 10.1017/S0033291797005606; Pohjasvaara T, 1999, J NEUROL NEUROSUR PS, V67, P742, DOI 10.1136/jnnp.67.6.742; Pohjasvaara T, 2000, ARCH NEUROL-CHICAGO, V57, P1295, DOI 10.1001/archneur.57.9.1295; Pohjasvaara T, 1997, STROKE, V28, P785, DOI 10.1161/01.STR.28.4.785; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SASS KJ, 1990, NEUROLOGY, V40, P1694, DOI 10.1212/WNL.40.11.1694; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Visser PJ, 2002, J NEUROL NEUROSUR PS, V72, P491; Wahlund LO, 2000, J NEUROL NEUROSUR PS, V69, P630, DOI 10.1136/jnnp.69.5.630; Wechsler D, 1987, WECHSLER MEMORY SCAL; Wechsler D., 1981, WAIS R MANUAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223	41	23	23	0	1	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	1351-5101			EUR J NEUROL	Eur. J. Neurol.	DEC	2004	11	12					825	832		10.1111/j.1468-1331.2004.00870.x			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	878AA	WOS:000225616900005	15667413				2022-02-06	
J	Brauer, SG; Broome, A; Stone, C; Clewett, S; Herzig, P				Brauer, SG; Broome, A; Stone, C; Clewett, S; Herzig, P			Simplest tasks have greatest dual task interference with balance in brain injured adults	HUMAN MOVEMENT SCIENCE			English	Article; Proceedings Paper	Conference on Sensorimotor CoordinationConference on Sensorimotor Coordination - Behavioural Modes and Neural Mechanisms	JUL 06-09, 2003JUL 06-09, 2003	Fraser Isl, AUSTRALIAQueensland, AUSTRALIA			attention; posture; equilibrium; brain injury	CLOSED-HEAD-INJURY; POSTURAL CONTROL; ATTENTIONAL DEMANDS; COGNITIVE TASKS; BODY SWAY; DEFICITS; RECOVERY; IDENTIFICATION; STABILITY; AGE	Attention difficulties and poor balance are both common sequel following a brain injury. This study aimed to determine whether brain injured adults had greater difficulty than controls in performing a basic balance task while concurrently completing several different cognitive tasks varying in visuo-spatial attentional load and complexity. Twenty brain injured adults and 20 age-, sex- and education level-matched controls performed a balance-only task (step stance held for 30s), five cognitive-only tasks (simple and complex non-spatial, visuo-spatial, and a control articulation task), and both together (dual tasks). Brain injured adults showed a greater centre of pressure (COP) excursion and velocity in all conditions than controls. Brain injured adults also demonstrated greater interference with balance when concurrently performing two cognitive tasks than control subjects. These were the control articulation and the simple non-spatial task. It is likely that distractibility during these simple tasks contributed to an increase in COP motion and interference with postural stability in stance. Performing visuo-spatial tasks concurrently with the balance task did not result in any change in COP motion. Dual task interference in this group is thus unlikely to be due to structural interference. Similarly, as the more complex tasks did not uniformly result in increased interference, a reduction in attentional capacity in the brain injured population is unlikely to be the primary cause of dual task interference in this group. (C) 2004 Elsevier B.V. All rights reserved.	Univ Queensland, Dept Physiotherapy, Brisbane, Qld 4072, Australia; Princess Alexandra Hosp, Dept Physiotherapy, Brisbane, Qld 4102, Australia; Princess Alexandra Hosp, Dept Psychol, Brisbane, Qld 4102, Australia		Brauer, SG (corresponding author), Univ Queensland, Dept Physiotherapy, Brisbane, Qld 4072, Australia.	s.brauer@shrs.uq.edu.au	Brauer, Sandra G/D-4519-2011	Brauer, Sandra G/0000-0001-9961-4739			Barin K, 1997, Biomed Sci Instrum, V33, P388; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Becker RA., 1988, NEW S LANGUAGE; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; Brauer SG, 2001, J GERONTOL A-BIOL, V56, pM489, DOI 10.1093/gerona/56.8.M489; BYUNG YJ, 1991, ARCH PHYS MED REHAB, V72, P642; Camicioli R, 1997, NEUROLOGY, V48, P955, DOI 10.1212/WNL.48.4.955; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; DAULT M, 1999, GAIT POSTURE, pS41; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; Dault MC, 2001, GAIT POSTURE, V14, P248, DOI 10.1016/S0966-6362(01)00130-8; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Hillier SL, 1997, BRAIN INJURY, V11, P661; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Kahneman D., 1973, ATTENTION EFFORT; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Lajoie Y, 1996, CHANGES SENSORY MOTO, P235, DOI [10.1016/S0166-4115(96)80011-2, DOI 10.1016/S0166-4115(96)80011-2]; Leclercq M, 2002, APPL NEUROPSYCHOLOGY; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; Melzer I, 2001, GERONTOLOGY, V47, P189, DOI 10.1159/000052797; OBLAK B, 1985, VESTIBULAR VISUAL CO, P355; Oxford university press, 1998, COMPENDIUM NEUROPSYC; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Quinn B, 2000, BRAIN INJURY, V14, P1063; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; WHITE KD, 1980, SCIENCE, V208, P621, DOI 10.1126/science.7367888; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; Yardley L, 1999, NEUROREPORT, V10, P215, DOI 10.1097/00001756-199902050-00003; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	40	23	23	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	OCT	2004	23	3-4					489	502		10.1016/j.humov.2004.08.020			14	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Psychology; Sport Sciences	875LW	WOS:000225422800016	15541531				2022-02-06	
J	Marzo, SJ; Leonetti, JP; Raffin, MJ; Letarte, P				Marzo, SJ; Leonetti, JP; Raffin, MJ; Letarte, P			Diagnosis and management of post-traumatic vertigo	LARYNGOSCOPE			English	Article; Proceedings Paper	Meeting of the Middle Section of the Triological-Society	JAN 08-11, 2004	Marco Isl, FL	Triol Socl, Middle Sect		vertigo; dysequilibrium; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY	Objectives/Hypothesis: Patients with post-traumatic vertigo can be difficult to treat secondary to the chronicity of their symptoms. Patients can have peripheral, central, and combined vestibular deficits. Furthermore, no comprehensive guidelines exist for returning these patients to work. The objectives of the study were to discuss diagnosis, management techniques, and guidelines for returning these patients to work. Study Design: Retrospective analysis of a tertiary referral neurotology and balance clinic. Methods. Between July 1997 and July 2003, 2390 patients with chief complaints of vertigo and/or dizziness were analyzed. Of these, 16 patients met the requirements for inclusion in the study, including head trauma and/or concussion and residual vertigo. Their inpatient and outpatient charts, imaging studies, audiograms, vestibular tests, and physical therapy evaluations were reviewed. All patients had at least 6 months of follow-up. Results. There were 5 women and 11 men, with an average age of 42 years. Five patients had symptoms consistent with traumatic perilymphatic fistulas, and two patients had symptoms consistent with post-traumatic Meniere's syndrome. Surgical therapy was not beneficial in relieving dysequilibrium. Balance testing results did not predict return-to-work status. Eleven patients were not allowed to return to work in any capacity, two patients were allowed to return to work with limited duties, and three patients were allowed to return to work with no restrictions. Conclusion: Post-traumatic vertigo can result in chronic symptoms. Balance testing did not predict the ability of patients to return to work. Surgical intervention might not control patient symptoms. Many patients were unable to return to work.	Loyola Univ, Hlth Syst, Dept Otolaryngol Head & Neck Surg, Maywood, IL 60153 USA; Loyola Univ, Hlth Syst, Dept Audiol, Maywood, IL 60153 USA; Loyola Univ, Hlth Syst, Dept Neurol Surg, Maywood, IL 60153 USA		Marzo, SJ (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	smarzo@lumc.edu					Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; *CDCP, 1999, TRAUM BRAIN INJ US; Chi JH, 2003, SEMIN NEUROSURG, V14, P071; Corrigan JD, 2001, CLIN J WOMENS HLTH, V1, P184; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Guyot JP, 2001, ANN OTO RHINOL LARYN, V110, P562, DOI 10.1177/000348940111000611; KELLEY MJ, 1990, J SPORT MED PHYS FIT, V30, P202; MAITLAND CG, 2001, CURR NEUROL NEUROSCI, P1486; Paniak C, 2000, BRAIN INJURY, V14, P219; SATALOFF RT, 1999, J OCCUP HEARING LOSS, V2, P191	15	23	25	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0023-852X			LARYNGOSCOPE	Laryngoscope	OCT	2004	114	10					1720	1723		10.1097/00005537-200410000-00008			4	Medicine, Research & Experimental; Otorhinolaryngology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	862CU	WOS:000224468100008	15454760				2022-02-06	
J	Colantonio, A; Ratcliff, G; Chase, S; Vernich, L				Colantonio, A; Ratcliff, G; Chase, S; Vernich, L			Aging with traumatic brain injury: long-term health conditions	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						long-term outcome; traumatic brain injury	DISORDERS	Although traumatic brain injury (TBI) is a leading cause of death and disability in young adults, older adults over the age of 75 are also at high risk for TBI. As even mild injury can lead to disabling consequences, the long-term consequences of TBI need to be better understood, especially as the survival rate has increased dramatically in the last few decades. This research examined the prevalence of long-term health conditions after TBI. Using a retrospective cohort design, we examined consecutive records of adults with moderate to severe TBI discharged from a large rehabilitation hospital in Pennsylvania from 1974 to 1989. Baseline clinical information was abstracted from medical records. We interviewed consenting participants up to 24 years after injury. Our findings show a higher than expected prevalence of self-reported arthritis in the middle-aged population. There was also a high prevalence of problems with sleep and nerves many years post-injury. Some of the health conditions documented in this study could potentially be addressed early in rehabilitation; this study supports the screening of more physical health conditions in persons aging with TBI.	Univ Toronto, Dept Occupat Therapy, Toronto, ON M5G 1V7, Canada; Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada; HealthS Harmarville Rehabil Hosp, Pittsburgh, PA USA; CCC SLP Working Order, Pittsburgh, PA USA; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Therapy, 500 Univ Ave,Room 950, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F33 AG05856-01A1] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34740-2] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F33AG005856] Funding Source: NIH RePORTER		Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; *CDCP, 1996, NAT HLTH INT SURV 19; Clarke P, 2002, STROKE, V33, P1016, DOI 10.1161/01.STR.0000013066.24300.F9; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; *COUNC CLIN CLASS, 1980, INT CLASS DIS; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Kim JH, 1997, ASIAN AUSTRAL J ANIM, V10, P178, DOI 10.5713/ajas.1997.178; KINGMA J, 1992, 9201 ASS RES INC; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; RAO V, 2002, CURRENT TREATMENT OP, V9, P77; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	14	23	23	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2004	27	3					209	214		10.1097/00004356-200409000-00006			6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	858BA	WOS:000224163900006	15319691				2022-02-06	
J	Reinert, M; Schaller, B; Widmer, HR; Seiler, R; Bullock, R				Reinert, M; Schaller, B; Widmer, HR; Seiler, R; Bullock, R			Influence of oxygen therapy on glucose-lactate metabolism after diffuse brain injury	JOURNAL OF NEUROSURGERY			English	Article						severe head injury; oxygen; glucose; lactate; rat	SEVERE HEAD-INJURY; FREE-RADICAL PRODUCTION; CEREBRAL-BLOOD-FLOW; ADULT-MOUSE BRAIN; INSPIRED OXYGEN; INTRACRANIAL-PRESSURE; PROLONGED ANESTHESIA; HYPERBARIC-OXYGEN; SUBDURAL-HEMATOMA; GLUTAMATE RELEASE	Object. Severe traumatic brain injury (TBI) imposes a huge metabolic load on brain tissue, which can be summarized initially as a state of hypermetabolism and hyperglycolysis. In experiments O-2 consumption has been shown to increase early after trauma, especially in the presence of high lactate levels and forced O-2 availability. In recent clinical studies the effect of increasing O-2 availability on brain metabolism has been analyzed. By their nature, however, clinical trauma models suffer from a heterogeneous injury distribution. The aim of this study was to analyze, in a standardized diffuse brain injury model, the effect of increasing the fraction of inspired O-2 on brain glucose and lactate levels, and to compare this effect with the metabolism of the noninjured sham-operated brain. Methods. A diffuse severe TBI model developed by Foda and Maramarou, et al., in which a 420-g weight is dropped from a height of 2 m was used in this study. Forty-one male Wistar rats each weighing approximately 300 g were included. Anesthesized rats were monitored by placing a femoral arterial line for blood pressure and blood was drawn for a blood gas analysis. Two time periods were defined: Period A was defined as preinjury and Period B as postinjury. During Period B two levels of fraction of inspired oxygen (FiO(2)) were studied: air (FiO(2) 0.21) and oxygen (FiO(2) 1). Four groups were studied including sham-operated animals: air-air-sham (AAS); air-O-2-sham (AOS); air-air-trauma (AAT); and air-O-2-trauma (AOT). In six rats the effect of increasing the FiO(2) on serum glucose and lactate was analyzed. During Period B lactate values in the brain determined using microdialysis were significantly lower (p < 0.05) in the AOT group than in the AAT group and glucose values in the brain determined using microdialysis were significantly higher (p < 0.04). No differences were demonstrated in the other groups. Increasing the FiO(2) had no significant effect on the serum levels of glucose and lactate. Conclusions. Increasing the FiO(2) influences dialysate glucose and lactate levels in injured brain tissue. Using an FiO(2) of 1 influences brain metabolism in such a way that lactate is significantly reduced and glucose significantly increased. No changes in dialysate glucose and lactate values were found in the noninjured brain.	Univ Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; Univ Bern, Dept Neurol Surg, Bern, Switzerland; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA		Reinert, M (corresponding author), Univ Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland.	michael.reinert@neurochirurgie-bern.ch	Reinert, Michael/AAA-3929-2019; Widmer, Hans R./AAC-8948-2022; Widmer, Hans Rudolf/O-5172-2017; Reinert, Michael/E-4964-2011	Reinert, Michael/0000-0002-0971-9543; Widmer, Hans Rudolf/0000-0003-3378-8765; Schaller, Benoit/0000-0002-6861-2340			AGARDH CD, 1991, INT J DEV NEUROSCI, V9, P127, DOI 10.1016/0736-5748(91)90003-5; BARBER RE, 1970, NEW ENGL J MED, V283, P1478, DOI 10.1056/NEJM197012312832702; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; Cater HL, 2001, J PHYSIOL-LONDON, V531, P459, DOI 10.1111/j.1469-7793.2001.0459i.x; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; DAUGHERTY WP, 2001, J NEUROTRAUM, V18, P1185; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FOLZ R, 1997, LUNG SCI FDN, P2713; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HEMPEL FG, 1977, J APPL PHYSIOL, V43, P873, DOI 10.1152/jappl.1977.43.5.873; INGLIS F, 1992, J NEUROTRAUM, V9, P75, DOI 10.1089/neu.1992.9.75; INGLIS FM, 1990, ACT NEUR S, V51, P277; Kuroda Y, 1997, ANESTHESIOLOGY, V87, P527, DOI 10.1097/00000542-199709000-00011; Kuroda Y, 1996, ANESTHESIOLOGY, V84, P555, DOI 10.1097/00000542-199603000-00010; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall L F, 1995, New Horiz, V3, P573; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; Morimoto T, 1996, J CEREBR BLOOD F MET, V16, P92, DOI 10.1097/00004647-199601000-00011; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murakami N, 2001, CRIT CARE MED, V29, P814, DOI 10.1097/00003246-200104000-00027; Oshima T, 2003, EUR J ANAESTH, V20, P543, DOI 10.1097/00003643-200307000-00005; Pellerin L, 2002, DIABETES NUTR METAB, V15, P268; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pellerin L, 2003, J PHYSIOL-LONDON, V546, P325, DOI 10.1113/jphysiol.2002.035105; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2002, J CEREBR BLOOD F MET, V22, P586, DOI 10.1097/00004647-200205000-00010; REASONER DK, 1990, BRIT J ANAESTH, V65, P210, DOI 10.1093/bja/65.2.210; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; SINGER MM, 1970, NEW ENGL J MED, V283, P1473, DOI 10.1056/NEJM197012312832701; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Tseng MT, 2003, NEUROL RES, V25, P83, DOI 10.1179/016164103101200978; van den Brink WA, 1998, ACT NEUR S, V71, P190; VANDEWATER JM, 1970, NEW ENGL J MED, V283, P621, DOI 10.1056/NEJM197009172831203; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	51	23	26	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2004	101	2					323	329		10.3171/jns.2004.101.2.0323			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	842JQ	WOS:000223000600024	15309926				2022-02-06	
J	Ariza, M; Mataro, M; Poca, MA; Junque, C; Garnacho, A; Amoros, S; Sahuquillo, J				Ariza, M; Mataro, M; Poca, MA; Junque, C; Garnacho, A; Amoros, S; Sahuquillo, J			Influence of extraneurological insults on ventricular enlargement and neuropsychological functioning after moderate and severe traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						head injury; hypoxia; neuropsychology; outcome; ventricular enlargement	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; COMA DATA-BANK; INTRACRANIAL HYPERTENSION; COMPUTED-TOMOGRAPHY; COGNITIVE SEQUELAE; PRACTICAL SCALE; PROGNOSIS; RECOVERY; MEMORY	Extraneurological insults secondary to TBI such as hypotension or hypoxia have been associated with mortality and morbidity. The purpose of this study was to investigate the influence of systemic complications on both neuropsychological outcome and cerebral atrophy. Fifty-seven patients selected from 122 consecutive admissions were studied. Data on the type and severity of injury as well as other systemic insults were collected prior to and during the first 3 days of hospitalization. These data included the presence or absence of a hypoxic episode during the pre-hospital period, the presence and degree of hypoxia, hypercapnia, anemia, hypotension and intracranial hypertension, pupillary reactivity, Glasgow Coma Scale score and coma duration. From the last control CT scan image, performed 6 months post-injury, four different indexes of ventricular dilatation were calculated. Neuropsychological assessment at 6 months included tests of verbal and visual memory, visuoconstructive functions, fine motor speed, and frontal lobe functions. Our results showed that hypoxia and hypotension were related to neuropsychological outcome and long-term ventricular enlargement. Hypoxic episodes prior to hospitalization were related to third ventricle dilatation and to adverse neurological and cognitive outcomes, especially to attention, motor speed, mental flexibility, fluency and verbal memory impairments, suggesting fronto-striatal and hippocampal dysfunction. We conclude that the effect of extraneurological insults on brain structure and function may be as important as the severity of the primary injury.	Univ Barcelona, Hosp Gen Valle Hebron, Dept Neurosurg, Barcelona 08035, Spain; Univ Barcelona, Hosp Gen Valle Hebron, Neurotraumatol Res Unit, Barcelona 08035, Spain; Univ Barcelona, Hosp Gen Valle Hebron, Neurotraumatol Intens Care Unit, Barcelona 08035, Spain; Univ Barcelona, Dept Psychiat & Clin Psychobiol, E-08007 Barcelona, Spain		Sahuquillo, J (corresponding author), Univ Barcelona, Hosp Gen Valle Hebron, Dept Neurosurg, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	sahuquillo@homemail.com	Garnacho, Angel/A-9309-2013; Sahuquillo, Juan/B-3577-2008; Junque, Carme/B-4400-2011; Mataro, Maria/B-4524-2011; Ariza, Mar/F-2754-2019; Poca, Maria A./B-8475-2008	Sahuquillo, Juan/0000-0003-0713-5875; Junque, Carme/0000-0002-6381-3063; Mataro, Maria/0000-0002-9946-2656; Poca, Maria A./0000-0002-3831-0536; Ariza, Mar/0000-0003-1020-6945			Benton AL, 1994, MULTILINGUAL APHASIA; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; CORTBUS F, 1994, ACTA NEUROCHIR, V130, P117, DOI 10.1007/BF01405511; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Fujioka M, 2000, CEREBROVASC DIS, V10, P2, DOI 10.1159/000016018; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; JANE JA, 1982, CLIN NEUR, V29, P346; JENNETT B, 1975, LANCET, V1, P480; KlOve H, 1963, MED CLIN N AM; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Maneru C, 2001, NEUROLOGY, V57, P1115, DOI 10.1212/WNL.57.6.1115; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Rey A, 1959, TEST COPIE REPRODUCT; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Smith A., 1991, SYMBOL DIGIT MODALIT; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; Vollmer DG, 1991, J NEUROSURG S, V75, P37; WILSON B, 1991, Brain Injury, V5, P189, DOI 10.3109/02699059109008089; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300	45	23	23	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2004	21	7					864	876		10.1089/0897715041526203			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	842AE	WOS:000222973800004	15307899				2022-02-06	
J	Penkowa, M; Quintana, A; Carrasco, J; Giralt, M; Molinero, A; Hidalgo, J				Penkowa, M; Quintana, A; Carrasco, J; Giralt, M; Molinero, A; Hidalgo, J			Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neuropathology; inflammation; neurodegeneration; cell death	ASTROCYTE-TARGETED EXPRESSION; AMYOTROPHIC-LATERAL-SCLEROSIS; FOCAL BRAIN-INJURY; TRANSGENIC MICE; OXIDATIVE STRESS; INTERLEUKIN-6 EXPRESSION; DEFICIENCY LEADS; REACTIVE OXYGEN; GENE-EXPRESSION; III EXPRESSION	Transgenic expression of interleukin-6 (IL-6) in the CNS under the control of the glial fibrillary acidic protein (GFAP) gene promoter (GFAP-IL6 mice) induces significant inflammation and neurodegeneration but also affords neuroprotection against acute traumatic brain injury. This neuroprotection is likely mediated by the IL-6-induced protective factors metallothioneins-I and -II (MT-I+II). Here we evaluate the neuroprotective roles of IL-6 vs. MT-I+II during 6-aminonicotinamide (6-AN)-induced neurotoxicity, by using GFAP-IL6 mice and transgenic mice overexpressing MT-I (TgMT) as well as GFAP-IL6 mice crossed with TgMT mice (GFAP-IL6 X TgMT). 6-AN caused acute damage of brainstem gray matter areas identified by necrosis of astrocytes, followed by inflammatory responses. After 6-AN-induced toxicity, secondary damage was observed, consisting of oxidative stress, neurodegeneration, and apoptotic cell death. We hereby show that the primary injury caused by 6-AN was comparable in wild-type and GFAP-IL6 mice, but MT-I overexpression could significantly protect the brain tissue. As expected, GFAP-IL6 mice showed increased CNS inflammation with more gliosis, macrophages, and lymphocytes, including increased cytokine expression, relative to the other mice. However, GFAP-IL6 mice showed reduced oxidative stress (judged from nitrotyrosine, malondialdehyde and 8-oxoguanine stainings), neurodegeneration (accumulation of neurofibrillary tangles), and apoptosis (determined from TUNEL and caspase-3). MT-I+II expression was significantly higher in GFAP-IL6 mice than in wild types, which may contribute to the IL-6-induced neuroprotection. In support of this, overexpression of MT-I in GFAP-IL6 x TgMT as well as TgMT mice protected the brainstem tissue significantly from 6-AN-induced toxicity and secondary brain tissue damage. Overall, the results demonstrate that brain MT-I+II proteins are fundamental neuroprotective factors, which in the future may become therapeutic agents. (C) 2004 Wiley-Liss, Inc.	Univ Copenhagen, Panum Inst, Dept Med Anat, Copenhagen, Denmark; Autonomous Univ Barcelona, Inst Neurosci, Barcelona, Spain; Autonomous Univ Barcelona, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain		Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Dept Biol Celular Fisiol & Immunol, Unidad Fisiol Anim, E-08193 Barcelona, Spain.	juan.hidalgo@uab.es	Hidalgo, Juan/C-9082-2011; molinero, amalia/K-2147-2014; Carrasco, Javier/C-9732-2011; Quintana, Albert/N-5544-2015; Giralt, Mercedes/K-1626-2014	Hidalgo, Juan/0000-0003-0921-1122; molinero, amalia/0000-0001-8661-8570; Carrasco, Javier/0000-0001-6436-0863; Quintana, Albert/0000-0003-1674-7160; Giralt, Mercedes/0000-0002-1806-1528			ABEL J, 1989, TOXICOL LETT, V47, P191, DOI 10.1016/0378-4274(89)90075-1; Aschner M, 1998, NEUROTOXICOLOGY, V19, P653; Bishop A, 2003, CURR DRUG METAB, V4, P171, DOI 10.2174/1389200033489514; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Budihardjo II, 2000, MOL PHARMACOL, V57, P529, DOI 10.1124/mol.57.3.529; Cai L, 2003, TOXICOL LETT, V136, P193, DOI 10.1016/S0378-4274(02)00359-4; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; Campbell IL, 1998, ANN NY ACAD SCI, V840, P83, DOI 10.1111/j.1749-6632.1998.tb09552.x; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carrasco J, 1998, EXP NEUROL, V153, P184, DOI 10.1006/exnr.1998.6861; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Chen HN, 2001, DIABETES, V50, P2040, DOI 10.2337/diabetes.50.9.2040; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Chung RS, 2003, J NEUROSCI, V23, P3336; Clark WM, 2000, STROKE, V31, P1715, DOI 10.1161/01.STR.31.7.1715; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Floyd RA, 1999, FREE RADICAL BIO MED, V26, P1346, DOI 10.1016/S0891-5849(98)00293-7; Giralt M, 2001, EXP NEUROL, V168, P334, DOI 10.1006/exnr.2000.7601; Giralt M, 2002, NEUROBIOL DIS, V9, P319, DOI 10.1006/nbdi.2002.0480; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Gong YH, 2000, EXP NEUROL, V162, P27, DOI 10.1006/exnr.2000.7323; GRIFFITHS IR, 1981, LAB INVEST, V44, P547; Haghighat N, 1997, METAB BRAIN DIS, V12, P29, DOI 10.1007/BF02676352; Haidara K, 1999, TOXICOL SCI, V49, P297, DOI 10.1093/toxsci/49.2.297; Hernandez J, 1997, MOL BRAIN RES, V48, P125, DOI 10.1016/S0169-328X(97)00087-9; Hidalgo J, 2002, METHOD ENZYMOL, V348, P238, DOI 10.1016/S0076-6879(02)48642-9; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hothersall JS, 1998, FEBS LETT, V434, P97, DOI 10.1016/S0014-5793(98)00959-4; Jellinger KA, 2003, J NEURAL TRANSM-SUPP, P101; Jin GB, 2003, CLIN EXP IMMUNOL, V131, P275, DOI 10.1046/j.1365-2249.2003.02074.x; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Kohler LB, 2003, BRAIN RES, V992, P128, DOI 10.1016/j.brainres.2003.08.049; Koutsilieri E, 2002, PARKINSONISM RELAT D, V8, P401, DOI 10.1016/S1353-8020(02)00021-4; Krinke GJ, 1998, EXP TOXICOL PATHOL, V50, P277, DOI 10.1016/S0940-2993(98)80007-9; KRUM JM, 1995, MOL CHEM NEUROPATHOL, V26, P79, DOI 10.1007/BF02815007; KRUM JM, 1994, GLIA, V11, P354, DOI 10.1002/glia.440110408; Lee YS, 1999, J AM ASSOC GYN LAP, V6, P59, DOI 10.1016/S1074-3804(99)80042-5; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Molinero A, 2003, J NEUROPATH EXP NEUR, V62, P315, DOI 10.1093/jnen/62.3.315; Moosmann B, 2002, EXPERT OPIN INV DRUG, V11, P1407, DOI 10.1517/13543784.11.10.1407; Nagano S, 2001, EUR J NEUROSCI, V13, P1363, DOI 10.1046/j.0953-816x.2001.01512.x; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; Penkowa M, 2000, EXP NEUROL, V163, P72, DOI 10.1006/exnr.2000.7383; Penkowa M, 2003, J NEUROSCI RES, V73, P481, DOI 10.1002/jnr.10681; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 2002, EXP NEUROL, V176, P308, DOI 10.1006/exnr.2002.7968; Penkowa M, 2002, J COMP NEUROL, V444, P174, DOI 10.1002/cne.10149; Penkowa M, 2003, GLIA, V42, P287, DOI 10.1002/glia.10208; PENKOWA M, 2002, BIOMED REV, V13, P1; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198	60	23	25	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL 1	2004	77	1					35	53		10.1002/jnr.20154			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	834KW	WOS:000222411000005	15197737				2022-02-06	
J	Ringger, NC; Tolentino, PJ; McKinsey, DM; Pike, BR; Wang, KKW; Hayes, RL				Ringger, NC; Tolentino, PJ; McKinsey, DM; Pike, BR; Wang, KKW; Hayes, RL			Effects of injury severity on regional and temporal mRNA expression levels of calpains and caspases after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; injury magnitude; neuronal death; proteases; RT-PCR	CORTICAL IMPACT INJURY; FOCAL CEREBRAL-ISCHEMIA; NEURONAL CELL-DEATH; SEPTOHIPPOCAMPAL CULTURES; MITOCHONDRIAL DYSFUNCTION; DIFFERENTIAL EXPRESSION; DNA FRAGMENTATION; SPATIAL PROFILE; AXONAL INJURY; HEAD-INJURY	Despite a preponderance of studies demonstrating gene expression and/or enzymatic activation of calpain and caspase proteases after traumatic brain injury (TBI), no studies have examined the effects of injury magnitude on expression levels of these cell death effectors after TBI. Determination of the degree to which injury severity affects specific expression profiles is critical to understanding the relevant pathways contributing to post-trauma pathology and for developing targeted therapeutics. This investigation tested the hypothesis that different injury magnitudes (1.0, 1.2, and 1.6 mm) cause alterations in the regional and temporal patterns of mRNA expression of calpain-related (calpain-1 and -2, calpastatin) and caspase-related (caspases -3, -8, -9, BID) gene products after cortical impact in rats. Quantitative RT-PCR was used to compare effects of injury severity on mRNA levels in ipsilateral (injured) cortex and hippocampus, 6 h to 5 days post-injury. TBI caused increases in mRNA expression of all proteins examined, with the highest expression detected in the cortex. Generally, injury magnitude and levels of gene expression were positively correlated. High levels of gene induction were observed with BID, caspase-3, and -8, while caspase-9 mRNA had the lowest level of induction. Interestingly, although calpains are activated within minutes of TBI, calpain mRNA expression was highest 72 h to 5 days post-TBI. This study is the first analysis of the regional and temporal expression of calpains and caspases after TBI. These data provide insight into the inter-relationship of these two protease families and on the distinct but overlapping cascades of cell death after TBI.	Univ Florida, Eyelyn F & William L McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32611 USA; Univ Florida, Eyelyn F & William L McKnight Brain Inst, Dept Neurosurg, Gainesville, FL 32611 USA; Univ Florida, Eyelyn F & William L McKnight Brain Inst, Dept Psychiat, Gainesville, FL 32611 USA; Univ Florida, Eyelyn F & William L McKnight Brain Inst, Ctr Traumat Brain Injuries, Gainesville, FL 32611 USA; NIGMS, NIH, Bethesda, MD USA		Ringger, NC (corresponding author), 100 S Newell Dr,L1-100 POB, Gainesville, FL 32610 USA.	ringger@ufbi.ufl.edu	Pike, Bruce/K-5562-2014	Pike, Bruce/0000-0001-8924-683X; Wang, Kevin/0000-0002-9343-6473			Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Buki A, 2000, J NEUROSCI, V20, P2825; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Conti AC, 1998, J NEUROSCI, V18, P5663; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Faddis BT, 1997, J NEUROSCI, V17, P951; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Harrison DC, 2001, MOL BRAIN RES, V89, P133, DOI 10.1016/S0169-328X(01)00058-4; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Matsushita K, 2000, J NEUROSCI, V20, P6879, DOI 10.1523/JNEUROSCI.20-18-06879.2000; McGinnis KM, 1999, BIOCHEM BIOPH RES CO, V263, P94, DOI 10.1006/bbrc.1999.1315; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; NATHANIEL PD, 2000, 18 ANN NAT NEUR SOC; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Newcomb JK, 1999, J NEUROTRAUM, V16, P1, DOI 10.1089/neu.1999.16.1; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Pike BR, 1998, J NEUROSCI RES, V52, P505, DOI 10.1002/(SICI)1097-4547(19980601)52:5<505::AID-JNR3>3.3.CO;2-Y; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rami A, 2000, BRAIN RES, V866, P299, DOI 10.1016/S0006-8993(00)02301-5; Shi YX, 2000, AM J PHYSIOL-RENAL, V279, pF509, DOI 10.1152/ajprenal.2000.279.3.F509; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Thompson M. B., 2000, Journal of Neurotrauma, V17, P953; Tolentino PJ, 2002, J NEUROCHEM, V80, P579, DOI 10.1046/j.0022-3042.2001.00726.x; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhao X, 1999, NEUROCHEM RES, V24, P371, DOI 10.1023/A:1020933616351	51	23	25	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2004	21	7					829	841		10.1089/0897715041526177			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	842AE	WOS:000222973800001	15307896				2022-02-06	
J	Chieregato, A; Fainardi, E; Servadei, F; Tanfani, A; Pugliese, G; Pascarella, R; Targa, L				Chieregato, A; Fainardi, E; Servadei, F; Tanfani, A; Pugliese, G; Pascarella, R; Targa, L			Centrifugal distribution of regional cerebral blood flow and its time course in traumatic intracerebral hematomas	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; head injury; ischemia; time course; traumatic contusions; traumatic hematomas; xenon-CT	HEAD-INJURED PATIENTS; BRAIN-INJURY; XENON-CT; CONTUSIONS; ISCHEMIA; HEMORRHAGE; EDEMA; PERFUSION; CONSCIOUSNESS; HYPOPERFUSION	Cerebral blood flow (CBF) alterations following post-traumatic contusions have been demonstrated in recent papers. We evaluated regional CBF (rCBF) by means of Xenon-enhanced computerized tomography (Xe-CT) in 29 traumatic intracerebral hematomas, from 22 patients with severe head injury (GCS less than or equal to 8). Fifty traumatic hematoma/Xe-CT CBF measurements were obtained from 39 Xe-CT studies performed during the acute phase (corresponding to the first 20 days post-injury). The rCBF was measured in three different regions of interest: the hemorrhagic core, the perihematoma edematous low-density area, and a I-cm rim of perihematoma normal-appearing brain tissue, surrounding the edematous low-density area. We found a centrifugal improvement of rCBF as well as a decrease in the rates of CBF levels below 18 mL/100 g/min from the core to the periphery (p < 0.0001), which persisted over time. Ischemic rCBF values were detected in the perihematoma low-density area only in 24% of the traumatic hematomas. The time course of rCBF levels showed a reduced flow in the first 24 h, with a recovery of flow from day 2 to day 4, followed by another reduced flow (p < 0.0001) both in the perihematoma edematous low-density area and in the non-lesioned tissue. Our findings suggest that the only area with persistent ischemic values was the hemorrhagic core. Low rCBF levels seen in the perihematoma low-density area may only be ascribed partially to ischemia and can possibly recover over time. These results could encourage a surgical approach based on an early evacuation of the hemorrhagic core associated to a preservation of the surrounding edematous tissue.	Osped Gen Provinciale M Bufalini, Unita Operat Anestesia & Rianimazone, I-47023 Cesena, Italy; Arcispedale St Anna, Ferrara, Italy		Chieregato, A (corresponding author), Osped Gen Provinciale M Bufalini, Unita Operat Anestesia & Rianimazone, Viale Ghirotti 286, I-47023 Cesena, Italy.	achiere@ausl-cesena.emr.it	Pascarella, Rosario/ABA-7178-2021; Pascarella, Rosario/AAL-2639-2021	Pascarella, Rosario/0000-0002-0512-9298; Servadei, Franco/0000-0002-3595-3464			ALEXANDER MJ, 1994, ACTA NEUROCHIR, P479; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock MR, 2002, NEUROSURGERY, V50, P788; BULLOCK R, 1988, SURG NEUROL, V29, P101, DOI 10.1016/0090-3019(88)90065-1; BULLOCK R, 1990, ACT NEUR S, V51, P286; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carhuapoma JR, 2002, AM J NEURORADIOL, V23, P1322; CHESNUT R, 1999, TRAUMATIC BRAIN INJU, P81; Chieregato A, 2003, ACTA NEUROCHIR SUPPL, V86, P333; CRUZ J, 1994, J NEUROSURG, V80, P143, DOI 10.3171/jns.1994.80.1.0143; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; GUR D, 1985, STROKE, V16, P871, DOI 10.1161/01.STR.16.5.871; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hoelper BM, 2000, ACTA NEUROCHIR SUPPL, V76, P21; JENNETT B, 1975, LANCET, V1, P480; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Kawamata T, 2002, ACTA NEUROCHIR SUPPL, V81, P281; KUSHI H, 1994, ACTA NEUROCHIR, P472; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; LOU HC, 1987, ANN NEUROL, V22, P289, DOI 10.1002/ana.410220302; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MADSEN FF, 1990, ACTA NEUROCHIR, V106, P24, DOI 10.1007/BF01809329; Maeda T, 2003, ACT NEUR S, V86, P329; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; MARION DW, 1995, QUANTITATIVE CEREBRAL BLOOD FLOW MEASUREMENTS USING STABLE XENON/CT: CLINICAL APPLICATIONS, P283; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Pindzola RR, 1998, NEUROSURGERY, V43, P1488; Portella G, 2000, ACT NEUR S, V76, P273; RIBAS GC, 1992, J NEUROTRAUM, V9, pS265; Schellinger PD, 2003, STROKE, V34, P1674, DOI 10.1161/01.STR.0000076010.10696.55; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Siddique MS, 2002, J NEUROSURG, V96, P736, DOI 10.3171/jns.2002.96.4.0736; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; SUTTON LN, 1990, ACT NEUR S, V51, P397; TEASDALE G, 1974, LANCET, V2, P81; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; von Oettingen G, 2000, NEURORADIOLOGY, V42, P168, DOI 10.1007/s002340050039; WOLFSON SK, 1990, STROKE, V21, P751, DOI 10.1161/01.STR.21.5.751; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005	56	23	26	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2004	21	6					655	666		10.1089/0897715041269669			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	836EG	WOS:000222537600002	15253794				2022-02-06	
J	Man, DWK; Lee, EWT; Tong, ECH; Yip, SCS; Lui, WF; Lam, CS				Man, DWK; Lee, EWT; Tong, ECH; Yip, SCS; Lui, WF; Lam, CS			Health services needs and quality of life assessment of individuals with brain injuries: a pilot cross-sectional study	BRAIN INJURY			English	Article							CLOSED-HEAD INJURY; COMMUNITY INTEGRATION; NEGATIVE AFFECT; FOLLOW-UP; SATISFACTION; SCALES; REHABILITATION; DISABILITY; ADULTS	Background and purpose: Quality of Life (QoL) studies have received a substantial amount of attention in medical and rehabilitative practices. However, there is still a paucity of studies in the area, especially on persons with brain injuries (BI). This pilot study, on the QoL of individuals with brain injuries in Hong Kong, attempts to fill this void. It is hoped that the finding of this study will guide the development of programmes and services to people with brain injuries. Methods: Through the Self-help Group for People with Brain Damage in Hong Kong, 35 subjects (22 men and 13 women) were successfully recruited to participate in this study by convenience sampling. Demographic data were collected through face-to-face interviews guided by a questionnaire and QoL data were gathered using the Comprehensive Quality of Life Scale-Intellectual/Cognitive Disability-5th edition (ComQol-15). The general emotional condition of the participants over the past 2 months was measured by a validated Chinese version of the Positive and Negative Affect Scale (PANAS). The participants' ratings on the importance of and their satisfaction with 20 health services areas were also collected. Results: Preliminary results show that the overall mean quality of life score, as measured by ComQol-15, was slightly less than two-thirds of the maximum score. Among the seven QoL domains, health and safety received some of the highest scores, while the lowest scores were obtained in the area of material well-being, place in community and productivity. People whose injuries had occurred relatively recently (less than 5 years ago) were found to have higher intimacy QoL scores than their counterparts injured more than 5 years ago. In the domain of safety, persons with a brain injury who were employed scored significantly higher than those who were not. Positive affect scores and the total affect of PANAS scores correlated significantly with the overall QoL scores. Moreover, persons with a brain injury usually felt satisfied with the services they valued as important. The top five most important services were medical services, occupational therapy, physiotherapy, vocational counselling and social work. Discussion and conclusion: The QoL profile of people with brain injuries in Hong Kong was initially obtained and low scores in the ComQoL were identified in the domains of material well-being, community activities and responsibility and productivity. These might be the consequences of their physical and cognitive limitations due to brain injury. This implies that appropriate interventions to improve their daily life conditions and their social integration would be necessary to improve their QoL. On the other hand, the BI sample also rated relatively high scores in other ComQoL areas such as safety and health, reflecting a good living environment and probably good health care services. Those whose brain injuries had occurred less than 5 years ago tended to have a higher ComQoL intimacy score than those whose injuries occurred more than 5 years ago. In other words, their social relationships may deteriorate with the longer period post-injury so that this group may need more supportive services. In the safety domain, it was found that subjects who were employed after their brain injury scored significantly higher than those who were not, which matched studies about the significant contribution of work towards life satisfaction. The satisfaction of their needs in the services they received, which may affect their QoL, was also investigated. It is clear that they valued the medical and rehabilitation services they received and felt satisfied with them.	Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China; IIT, Chicago, IL 60616 USA		Man, DWK (corresponding author), Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China.	rsdavid@polyu.edu.hk					Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BAGOZZI RP, 1993, J PERS SOC PSYCHOL, V65, P836, DOI 10.1037/0022-3514.65.4.836; BECONA E, 1933, JUEGO COMPULSIVE COM; BOYLE GJ, 1991, PERS INDIV DIFFER, V12, P291, DOI 10.1016/0191-8869(91)90115-R; BRWON I, 1996, QUALITY LIFE HLTH PR, P3; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Collins R, 2000, J HEAD TRAUMA REHAB, V15, P1139, DOI 10.1097/00001199-200010000-00007; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cummins RA, 1997, J APPL RES INTELLECT, V10, P199, DOI 10.1111/j.1468-3148.1997.tb00017.x; Cummins RA, 1996, SOC INDIC RES, V38, P303, DOI 10.1007/BF00292050; CUMMINS RA, 1999, URBAN QUALITY LIFE C, P325; CUMMINS RA, 1996, DIRECTORY INSTRUMENT, P1; CUMMINS RA, 1994, EDUC PSYCHOL MEAS, V54, P378; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Dawson DR, 2000, BRAIN COGNITION, V44, P35; DePalma J A, 2001, Crit Care Nurs Q, V23, P42; Donnelly KZ, 2000, BRAIN COGNITION, V44, P21; Glover A, 2003, DISABIL REHABIL, V25, P750, DOI 10.1080/0963828021000058503; Goldstein FC, 1999, J NEUROPSYCH CLIN N, V11, P38, DOI 10.1176/jnp.11.1.38; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Health and Welfare Bureau, 1999, HONG KONG REH PROGR; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; *HLTH WELF BUR, 2000, CONS DOC HLTH CAR RE, P5; *HLTH WELF BUR, 1999, HARV REP IMPR HONG K; Hoofien D, 2001, BRAIN INJURY, V15, P189; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KALPAKJIAN CZ, 2000, DISS ABSTR INT, V61, P6709; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LO SK, 2000, 1 NAT QUAL LIF S GUA; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; Man DWK, 2001, BRAIN INJURY, V15, P961, DOI 10.1080/02699050110065664; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ravens-Sieberer U, 2002, RESTOR NEUROL NEUROS, V20, P151; RENWICK R, 1996, QUALITY LIFE HLTH PR, P26; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TABOLT LR, 2000, BRAIN COGNITION, V44, P39; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; THOMAS DF, 2001, J APPL REHABILITATIO, V32, P17; THOMSEN IV, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P52; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	43	23	24	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2004	18	6					577	591		10.1080/02699050310001646143			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	811DX	WOS:000220753700005	15204338				2022-02-06	
J	Lee, JS; Han, YM; Yoo, DS; Choi, SJ; Choi, BH; Kim, JH; Kim, YH; Huh, PW; Ko, YJ; Rha, HK; Cho, KS; Kim, DS				Lee, JS; Han, YM; Yoo, DS; Choi, SJ; Choi, BH; Kim, JH; Kim, YH; Huh, PW; Ko, YJ; Rha, HK; Cho, KS; Kim, DS			A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion injury; gene expression; magnesium ion; traumatic brain injury	DNA STRAND BREAKS; EXPRESSION; NICKEL(II); APOPTOSIS; EXCISION; REPAIR; BAX; P53	Magnesium ions have been shown to be a promising treatment for brain lesions caused by traumatic brain injury (TBI), as well as for the associated acute neurodegeneration and progressive functional deficits. This study investigated the effects of magnesium on the expression of the cell death/survival related proteins following TBI. Male Sprague-Dawley (SD) rats (n = 66, 280-320 g body weight) were subjected to sham surgery alone (n = 14), or to the surgery followed by a lateral fluid percussion brain injury of moderate severity (n = 52, 2.4-2.7 atm). The injured rats were randomly treated with an intravenous bolus of magnesium chloride (n = 26, 125 mumol) or saline vehicle (n = 26). The coronal brain sections were quantitatively analyzed for cell apoptosis and the expression of p53-related proteins, Bcl-2, cyclin D1 and PCNA at 1, 2, and 4 days post-injury by immunohistochemistry or in situ hybridization. Tissue damage was observed primarily in the ipsilateral cortex of the injured region with the induction of apoptosis and p53 mRNA level at 2 days after TBI. The expression of p53 and responding proteins (p21(WAF1/C1P1), Mdm2 and Bax) showed a temporal pattern similar to the apoptotic events in the time course experiments. They were induced in the early time points of days 1-2, decreasing by day 4 after TBI. In contrast, the expression of the cell survival related proteins-Bcl-2, cyclin D1, and PCNA-was most significant at day 4 post-injury, when the rate of apoptosis decreased. Magnesium treatment resulted in a reduction in apoptosis and expression of p53-related proteins. However, it had only a slight additive effect on the expression of the survival related proteins in the same time-course. These results provide a molecular basis for the efficiency of magnesium in treating TBI-induced tissue damage.	Catholic Univ Korea, Coll Med, Dept Rehabil Med, Seoul 137701, South Korea; Catholic Univ Korea, Coll Med, Catholic Neurosci Ctr, Seoul 137701, South Korea; Catholic Univ Korea, Uijongbu St Marys Hosp, Dept Neurosurg, Uijongbu, South Korea		Ko, YJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Rehabil Med, 505 Banpo Dong, Seoul 137701, South Korea.	yjko@catholic.ac.kr					Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Hartmann M, 1998, CARCINOGENESIS, V19, P617, DOI 10.1093/carcin/19.4.617; HARTWIG A, 1994, CANCER RES, V54, P4045; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Jordan J, 1997, J NEUROSCI, V17, P1397; JUDITH KM, 1999, EXP NEUROL, V159, P584; Kawabata H, 1997, BIOCHEM BIOPH RES CO, V233, P133, DOI 10.1006/bbrc.1997.6362; LAPLACA MC, 1998, J NEUROTRAUM, V15, P878; Li Y, 1997, BRAIN RES, V765, P301, DOI 10.1016/S0006-8993(97)00524-6; LITTEFIELD NA, 1994, CELL BIOL TOXICOL, V10, P127, DOI 10.1007/BF00756493; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MIYASHITA T, 1995, CELL, V80, P293; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; Raghupathi R, 1998, J NEUROTRAUM, V15, P555, DOI 10.1089/neu.1998.15.555; RAGHUPATHI R, 1997, J CEREB BLOOD FLOW M, V17, pS494; Ravishankar S, 2001, BRAIN RES, V901, P23, DOI 10.1016/S0006-8993(01)02109-6; SENSOL SK, 1999, BRAIN RES, V818, P23; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2	35	23	24	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2004	21	5					549	561		10.1089/089771504774129883			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821LK	WOS:000221461900006	15165363				2022-02-06	
J	Brewer, KL; Hardin, JS				Brewer, KL; Hardin, JS			Neuroprotective effects of nicotinamide after experimental spinal cord injury	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the SAEM	MAY, 2003	BOSTON, MASSACHUSETTS	SAEM		neurotrauma; neuroprotection; excitotoxicity; vitamin B3	FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE; WISTAR RATS; POLY(ADP-RIBOSE) POLYMERASE; GENE-EXPRESSION; MESSENGER-RNA; CHRONIC PAIN; METHYLPREDNISOLONE; INFARCTION; BEHAVIOR	Objective: To investigate the ability of nicotinamide to protect against secondary damage in spinal cord tissue after an experimental injury. Trauma to the spinal cord induces a cascade of cellular events that lead to progressive tissue injury over time. Nicotinamide has been shown to affect many elements of this cascade, including excitatory amino acid release, inflammation, apoptosis, and cellular energy balance. Methods: Male Long-Evans (n=12) rats received an excitotoxic spinal cord injury by intraspinal injection of quisqualic acid (QUIS), a glutamate receptor agonist. A second set of rats (n=4) received intraspinal saline as a sham injury. Thirty minutes after injury, animals that had QUIS injections received an intraperitoneal injection of either saline (control, n=4) or nicotinamide (500 mg/kg, n=8). Seven days postinjury, the spinal cords were removed, and serial sections were cut, mounted on slides, and stained. By using light microscopy, the extent of tissue damage was assessed at the epicenter of injury as well as sections up to 450-mum rostral and 450-mum caudal to the epicenter. Results: Only those animals receiving QUIS injections showed damaged tissue. There was no significant difference in the amount of damage at the epicenter of injury between the saline- and nicotinamide-treated animals. However, when comparing the total amounts of damage over the 975-mum length of cord examined, the rostro-caudal extent of injury was significantly reduced in the nicotinamide-treated animals compared with the saline-treated animals. Conclusions: Systemic nicotinamide serves to limit the rostro-caudal extent of cell death after experimental spinal cord injury.	E Carolina Univ, Brody Sch Med, Div Res, Dept Emergency Med, Greenville, NC 27858 USA		Brewer, KL (corresponding author), E Carolina Univ, Brody Sch Med, Div Res, Dept Emergency Med, Phys Quadrangle,Bldg M, Greenville, NC 27858 USA.	brewerk@mail.ecu.edu					Abraham KE, 2001, NEUROSCIENCE, V104, P863, DOI 10.1016/S0306-4522(01)00134-8; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Burke DA, 2001, SPINAL CORD, V39, P274, DOI 10.1038/sj.sc.3101158; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Ding YC, 2001, BRAIN RES, V915, P210, DOI 10.1016/S0006-8993(01)02852-9; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; Fujimura M, 1997, NEUROSCI LETT, V228, P107, DOI 10.1016/S0304-3940(97)00373-X; Hall E D, 2001, J Spinal Cord Med, V24, P142; Hugenholtz H, 2002, CAN J NEUROL SCI, V29, P227, DOI 10.1017/S0317167100001992; Hurlbert RJ, 2002, CAN J NEUROL SCI, V29, P236, DOI 10.1017/S0317167100002006; Klaidman LK, 2001, BBA-GEN SUBJECTS, V1525, P136, DOI 10.1016/S0304-4165(00)00181-1; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; Liu CL, 2002, CHINESE MED J-PEKING, V115, P740; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Liu SL, 1997, BRAIN RES, V756, P160, DOI 10.1016/S0006-8993(97)00137-6; LONGUEMARE MC, 1995, J NEUROSCI RES, V40, P379, DOI 10.1002/jnr.490400312; Maynard KI, 2001, ANN NY ACAD SCI, V939, P416; Molloy S, 2002, INJURY, V33, P575, DOI 10.1016/S0020-1383(02)00142-0; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; Plunkett JA, 2001, EXP NEUROL, V168, P144, DOI 10.1006/exnr.2000.7604; Sakakibara Y, 2000, NEUROSCI LETT, V281, P111, DOI 10.1016/S0304-3940(00)00854-5; Santoscopy C, 2002, NEUROSCI LETT, V330, P94, DOI 10.1016/S0304-3940(02)00716-4; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Turner JA, 2001, ARCH PHYS MED REHAB, V82, P501, DOI 10.1053/apmr.2001.21855; Wallis RA, 1996, BRAIN RES, V710, P169, DOI 10.1016/0006-8993(95)01278-8; Walter JS, 2002, J REHABIL RES DEV, V39, P53; Widerstrom-Noga EG, 2001, ARCH PHYS MED REHAB, V82, P1571, DOI 10.1053/apmr.2001.26068; Xu M, 2000, EXP NEUROL, V161, P472, DOI 10.1006/exnr.1999.7278; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Yezierski R P, 2000, Prog Brain Res, V129, P429; Yezierski RP, 1998, PAIN, V75, P141, DOI 10.1016/S0304-3959(97)00216-9; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445	36	23	25	0	1	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	FEB	2004	11	2					125	130		10.1197/j.aem.2003.09.010			6	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	771GQ	WOS:000188777600001	14759952				2022-02-06	
J	Moorthy, RK; Rajshekhar, V				Moorthy, RK; Rajshekhar, V			Development of glioblastoma multiforme following traumatic cerebral contusion: Case report and review of literature	SURGICAL NEUROLOGY			English	Article						computed tomography; head injury; brain tumor; diagnosis	POSTTRAUMATIC MALIGNANT GLIOMA; BRAIN-TUMORS; HEAD TRAUMA; INJURY; PROLIFERATION; RAT	BACKGROUND Diagnostic criteria for posttraumatic brain tumors were formulated in the pre-CT (computerized tomography) era. We propose that radiologic criteria incorporating imaging data be added to the existing criteria. CASE DESCRIPTION We report a case of a 56-year-old man who presented with history of raised intracranial pressure of 20 days' duration. Imaging showed a large left frontal intra-axial mass lesion. He had history of head injury 5 years prior with CT evidence of bilateral basifrontal contusions. There was no contrast enhancement at the site of the contusions in an intervening CT scan done 18 months after the trauma. He underwent radical excision of the mass, and the histopathology was reported as glioblastoma multiforme. We formulated additional radiologic criteria for tumors that may present following trauma. A review of the literature of posttraumatic gliomas is also presented. CONCLUSION Fulfillment of the additional radiologic criteria proposed by us will help distinguish a tumor that developed following trauma from that which was present before the occurrence of the injury. (C) 2004 Elsevier Inc. All rights reserved.	Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India		Rajshekhar, V (corresponding author), Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India.						ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; BOHNEN NI, 1997, HAND CLINIC, V67, P129; DIEZEL P, 1949, Frankf Z Pathol, V60, P316; DiTrapani G, 1996, ITAL J NEUROL SCI, V17, P283, DOI 10.1007/BF01997787; FINKEMEYER H, 1956, Zentralbl Neurochir, V16, P318; Hallervorden J, 1948, NERVENARZT, V19, P163; Henderson RD, 2000, J CLIN NEUROSCI, V7, P262, DOI 10.1054/jocn.1999.0204; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; HEYCK H, MONATS SCHR PSYCHIAT, V128, P180; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; JANDA J, 1987, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V133, P55; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; Manuelidis EE, 1978, PATHOLOGY NERVOUS SY, V2, P2237; MORANTZ RA, 1978, NEUROSURGERY, V3, P181, DOI 10.1227/00006123-197809000-00009; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; PEREZDIAZ C, 1985, SURG NEUROL, V24, P581, DOI 10.1016/0090-3019(85)90278-2; Sabel M, 1999, J NEUROSURG, V91, P1041, DOI 10.3171/jns.1999.91.6.1041; SCHIFFER D, 1993, INT J DEV NEUROSCI, V11, P269, DOI 10.1016/0736-5748(93)90085-R; TROOST D, 1984, CLIN NEUROPATHOL, V3, P139; Wrensch M, 2000, NEUROEPIDEMIOLOGY, V19, P234, DOI 10.1159/000026261; ZULCH KJ, 1974, HDB CLIN NEUROLOGY, V16, P1	23	23	28	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	FEB	2004	61	2					180	184		10.1016/S0090-3019(03)00423-3			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	767WZ	WOS:000188498000016	14751638				2022-02-06	
J	Adickes, MS; Stuart, MJ				Adickes, MS; Stuart, MJ			Youth football injuries	SPORTS MEDICINE			English	Article							HIGH-SCHOOL FOOTBALL; YOUNG ATHLETE; SPORTS; PITFALLS	A paucity of literature exists on the subject of youth football with the majority of research concentrating on athletes of high-school age or older. Youth football participants include those athletes who compete in organised football prior to high school. Injury rate and severity for youth players is surprisingly low when compared with those competitors who have passed through puberty. As children mature they become bigger, faster and stronger, which is accompanied by an increased injury risk. Quarterbacks and running backs are injured almost five times more often than offensive linemen and linebackers. The knee is the most common site of injury followed by the ankle, wrist and hand. Fortunately, traumatic brain and cervical spine injuries are exceedingly rare. In this article, we review the youth football literature, identify the most common injuries by anatomical location, discuss the differential diagnoses and outline treatment options.	Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA		Stuart, MJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 1st St,SW, Rochester, MN 55905 USA.						Culpepper M I, 1983, Phys Sportsmed, V11, P117, DOI 10.1080/00913847.1983.11708662; DAGIAU RF, 1980, AM J SPORT MED, V8, P257, DOI 10.1177/036354658000800408; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; GARRICK JG, 1978, PEDIATRICS, V61, P465, DOI 10.1542/peds.61.3.465; Godshall R W, 1975, J Sports Med, V3, P139; GOLDBERG B, 1984, PHYSICIAN SPORTSMED, V12, P122; HALPERN B, 1987, AM J SPORT MED, V15, P316, DOI 10.1177/036354658701500404; HANKIN FM, 1990, HAND CLIN, V6, P429; Iobst CA, 2000, CLIN SPORT MED, V19, P621, DOI 10.1016/S0278-5919(05)70229-5; LECLERC S, 2002, ANN EMERG MED, V40, P442; LINDER MM, 1995, CLIN J SPORT MED, V5, P167, DOI 10.1097/00042752-199507000-00006; Metzl JD, 1999, PEDIATR EMERG CARE, V15, P363, DOI 10.1097/00006565-199910000-00018; MORETZ A, 1978, J OKLA ST MED ASSOC, V71, P85; Perron AD, 2001, AM J EMERG MED, V19, P413, DOI 10.1053/ajem.2001.24464; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; ROSER LA, 1970, CLIN ORTHOP RELAT R, P219; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; THOMPSON N, 1987, AM J SPORT MED, V15, P117, DOI 10.1177/036354658701500204; Title CI, 2002, ORTHOP CLIN N AM, V33, P587, DOI 10.1016/S0030-5898(02)00006-8	21	23	23	1	9	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	0112-1642			SPORTS MED	Sports Med.		2004	34	3					201	207		10.2165/00007256-200434030-00005			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	802WN	WOS:000220193700005	14987128				2022-02-06	
J	Bamdad, MJ; Ryan, LM; Warden, DL				Bamdad, MJ; Ryan, LM; Warden, DL			Functional assessment of executive abilities following traumatic brain injury	BRAIN INJURY			English	Article							LESIONS	Primary objective: The Test of Functional Executive Abilities (TOFEA) is a measure of real-world planning/problem-solving abilities. The present study sought to identify the relationship between the TOFEA and traditional executive measures. Design: Correlational and principal components factor analyses were conducted using the TOFEA and traditional neuropsychological executive measures. Methods: Participants were 340 patients with traumatic brain injury. All participants underwent neuropsychological and speech-language assessments. Results: Factor analysis of the TOFEA yielded a two-factor solution, planning/initiation and awareness/ comprehension. Correlational analysis between the TOFEA and traditional measures demonstrated only a weak relationship. Factor analysis indicated a four factor executive solution with the TOFEA loading on the third planning/initiation and reasoning factor. Conclusions: The data support the notion that there is no one single measure of frontal-executive functioning, but rather these tests represent different executive components and, as such, more than one measure should be used in a comprehensive assessment.	George Washington Univ, Dept Speech & Hearing Sci, Washington, DC 20052 USA; Uniformed Serv Univ Hlth Sci, Def & Vet Head Injury Program, Washington, DC USA		Bamdad, MJ (corresponding author), George Washington Univ, Dept Speech & Hearing Sci, 2201 G St NW,Funger Hall,Suite 423, Washington, DC 20052 USA.						Benton A., 1978, MULTILINGUAL APHASIA; Boone KB, 1998, ARCH CLIN NEUROPSYCH, V13, P585, DOI 10.1016/S0887-6177(97)00074-7; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; Bush BA, 1999, ARCH CLIN NEUROPSYCH, V14, P783; DELIS D, 1987, CALIFORNIA VERBAL LE; GOLDEN CJ, 1978, COLOUR WORD TEST MAN; Heaton PDRK., 1993, WISCONSIN CARD SORTI; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Malloy, 1998, Semin Clin Neuropsychiatry, V3, P186; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P605; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Ross J. D., 1976, ROSS TEST HIGHER COG; SHORES A, 1990, AUST NZ J PSYCHIAT, V24, P133, DOI 10.3109/00048679009062895; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Wechsler, 1997, WECHSLER ADULT INTEL; Wolfson, 1993, HALSTEAD REITAN NEUR	20	23	24	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2003	17	12					1011	1020		10.1080/0269905031000110553			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731WR	WOS:000185909900001	14555361				2022-02-06	
J	Fujita, R; Ueda, H				Fujita, R; Ueda, H			Protein kinase C-mediated cell death mode switch induced by high glucose	CELL DEATH AND DIFFERENTIATION			English	Article						necrosis; apoptosis; glucose; protein kinase C; ATP	TRAUMATIC BRAIN-INJURY; SODIUM-POTASSIUM ATPASE; CEREBRAL BLOOD-FLOW; CORTICAL-NEURONS; CYTOCHROME-C; BCL-2 FAMILY; PHOSPHOLIPASE-C; NERVOUS-SYSTEM; APOPTOSIS; NECROSIS	Cortical neurons rapidly die in necrosis due to poor glucose uptake in the low-density (LD) culture under serum-free condition without any supplements. The scanning and transmission electron microscopical analyses characterized the necrosis by membrane disruption, mitochondrial swelling and loss of cytoplasmic electron density. High-glucose treatment delayed the neuronal death by suppressing necrosis, but induced apoptosis through increase in Bax levels, cytochrome c release, caspase-3 activation and DNA ladder formation. Although pyruvate as well as high glucose inhibited necrotic cell death and rapid decrease in cellular ATP levels, possibly related to decreased [(3)H]-2-deoxy glucose uptake under the serum-free condition, it did not induce apoptosis. Protein kinase C inhibitors blocked these changes related to the cell death mode switch. Several neurotrophic factors did not affect the necrosis, but potentiated high-glucose-induced survival activity, while inhibiting cytochrome c release. All these results suggest that high-glucose treatment causes neuronal cell death mode switch by inhibiting necrosis, while inducing apoptosis, which is prevented by neurotrophic factors.	Nagasaki Univ, Grad Sch Biomed Sci, Div Mol Pharmacol & Neurosci, Nagasaki 8528521, Japan		Ueda, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Div Mol Pharmacol & Neurosci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	ueda@net.nagasaki-u.ac.jp		Ueda, Hiroshi/0000-0002-8002-0137			Ansari K, 1999, J BIOL CHEM, V274, P30052, DOI 10.1074/jbc.274.42.30052; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Becker KJ, 1998, CURR OPIN NEUROL, V11, P45, DOI 10.1097/00019052-199802000-00008; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Eguchi Y, 1997, CANCER RES, V57, P1835; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; Fujita R, 2003, CELL DEATH DIFFER, V10, P782, DOI 10.1038/sj.cdd.4401239; Fujita R, 2001, CELL MOL NEUROBIOL, V21, P317, DOI 10.1023/A:1012645920229; FUJITA R, 2002, SFN 32 ANN M, P15; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hamabe W, 2000, CELL MOL NEUROBIOL, V20, P695, DOI 10.1023/A:1007050808754; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOIVISTO UM, 1991, J BIOL CHEM, V266, P2615; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V247, P780, DOI 10.1006/bbrc.1998.8815; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; LEES GJ, 1994, BRAIN RES, V649, P225, DOI 10.1016/0006-8993(94)91068-5; LEES GJ, 1990, NEUROSCI LETT, V120, P159, DOI 10.1016/0304-3940(90)90027-7; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; MacManus JP, 1997, J CEREBR BLOOD F MET, V17, P815, DOI 10.1038/aj.jcbfm.9590266; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; MUIZELAAR JP, 1994, CAN J NEUROL SCI, V21, pS6, DOI 10.1017/S0084255900003685; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nicotera P, 1997, CELL DEATH DIFFER, V4, P435, DOI 10.1038/sj.cdd.4400265; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4; RINK A, 1995, AM J PATHOL, V147, P1575; Senatorov VV, 2000, J PHYSIOL-LONDON, V525, P343, DOI 10.1111/j.1469-7793.2000.00343.x; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tisi R, 2002, FEBS LETT, V520, P133, DOI 10.1016/S0014-5793(02)02806-5; Towne JE, 2001, J BIOL CHEM, V276, P18657, DOI 10.1074/jbc.M100322200; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshida A, 1999, BIOCHEM BIOPH RES CO, V259, P78, DOI 10.1006/bbrc.1999.0627; Yoshida A, 2000, INT J MOL MED, V6, P329; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	50	23	24	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047			CELL DEATH DIFFER	Cell Death Differ.	DEC	2003	10	12					1336	1347		10.1038/sj.cdd.4401300			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	745ZA	WOS:000186720300007	12934062	Bronze			2022-02-06	
J	Fujita, Y; Yamamoto, N; Sobue, K; Inagaki, M; Ito, H; Arima, H; Morishima, T; Takeuchi, A; Tsuda, T; Katsuya, H; Asai, K				Fujita, Y; Yamamoto, N; Sobue, K; Inagaki, M; Ito, H; Arima, H; Morishima, T; Takeuchi, A; Tsuda, T; Katsuya, H; Asai, K			Effect of mild hypothermia on the expression of aquaporin family in cultured rat astrocytes under hypoxic condition	NEUROSCIENCE RESEARCH			English	Article						astrocytes; aquaporins; hypothermia; hypoxia; normothermia; normoxia	TRAUMATIC BRAIN-INJURY; EDEMA; ACTIVATION; RELEASE; STRESS; KINASE	Aquaporins (AQPs) are a family of water-selective transporting proteins with homology to the major intrinsic protein (MIP) of lens, that increase plasma membrane water permeability in secretory and absorptive cells. In this study, we investigated the effect of mild hypothermia on the expression of AQP4, AQP5 and AQP9 in rat astrocytes cultured under hypoxic conditions. At 37degreesC, a marked decrease in the expression of AQP4, AQP5 and AQP9 mRNAs was observed. However, at 32degreesC (mild hypothermia), the expression of AQP5 mRNA was restored to its basal level. Interestingly, under mild hypothermia AQP4 mRNA expression transiently decreased and then increased about two-fold; while AQP9 mRNA expression decreased the same as at 37degreesC. The changes in the expression of AQP4 and AQP9 proteins were confirmed by Western blot analysis. The restoration of the AQP4 and AQP5 expression at 32degreesC from the hypoxia-induced decrease at 37degreesC may play an important role in the reduction of brain edema under hypothermic conditions. (C) 2003 Elsevier Ireland Ltd and The Japan Neuroscience Society. All rights reserved.	Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Mizuho Ku, Nagoya, Aichi 4678901, Japan; Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan		Sobue, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Mizuho Ku, Nagoya, Aichi 4678901, Japan.	kazsobue@med.nagoya-cu.ac.jp	Asai, Kiyofumi/H-2356-2014; Inagaki, Masatoshi/J-3438-2019	Asai, Kiyofumi/0000-0001-7015-2251; Inagaki, Masatoshi/0000-0002-9822-8649			Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; D'Arceuil H, 2000, STROKE, V31, P2692, DOI 10.1161/01.STR.31.11.2692; Echevarria M, 1998, J PHYSIOL BIOCHEM, V54, P107; Hicks SD, 2000, NEUROSCIENCE, V98, P677, DOI 10.1016/S0306-4522(00)00169-X; Kataoka H, 1998, LIFE SCI, V63, P553, DOI 10.1016/S0024-3205(98)00306-3; KATO T, 1979, BIOCHIM BIOPHYS ACTA, V579, P216, DOI 10.1016/0005-2795(79)90100-4; Kawai N, 2001, BRAIN RES, V895, P50, DOI 10.1016/S0006-8993(01)02026-1; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; Plesnila N, 1999, ACTA NEUROCHIR SUPPL, V73, P63; Roberts JR, 2002, CRYOBIOLOGY, V44, P161, DOI 10.1016/S0011-2240(02)00018-4; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Yager JY, 1996, STROKE, V27, P919, DOI 10.1161/01.STR.27.5.919; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X	18	23	36	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	DEC	2003	47	4					437	444		10.1016/j.neures.2003.08.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	750EB	WOS:000186977400009	14630348				2022-02-06	
J	Mino, M; Kamii, H; Fujimura, M; Kondo, T; Takasawa, S; Okamoto, H; Yoshimoto, T				Mino, M; Kamii, H; Fujimura, M; Kondo, T; Takasawa, S; Okamoto, H; Yoshimoto, T			Temporal changes of neurogenesis in the mouse hippocampus after experimental subarachnoid hemorrhage	NEUROLOGICAL RESEARCH			English	Article						subarachnoid hemorrhage; hippocampus; dentate gyrus; neurogenesis; progenitor cells; mice	NEURAL STEM-CELLS; TRAUMATIC BRAIN INJURY; FOCAL CEREBRAL-ISCHEMIA; CUZN-SUPEROXIDE DISMUTASE; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; PROGENITOR CELLS; DENTATE GYRUS; ADULT-RAT; SUBVENTRICULAR ZONE	Recent studies indicate the existence of progenitor cells and their potential for neurogenesis in the subventricular zone (SVZ) and the hippocampus dentate gyrus (DG) of normal adult mammalian brain. Increased neurogenesis has been shown following cerebral ischemia and traumatic brain injury, however, the involvement of neurogenesis in subarachnoid hemorrhage (SAH) has not been examined. Adult male CD-I mice were subjected to SAH by endovascular perforation of the left anterior cerebral artery. Mice received intraperitoneal injections of the cell proliferation-specific marker 5'-bromodeoxyuridine (BrdU) after SAH induction. BrdU incorporation was examined from 1 to 30 days after SAH by immunohistochemistry. The BrdU-positive cells were detected in SVZ and DC of normal control brain, and were significantly decreased in both areas three days after SAH. The number of these cells had recovered to its control level seven days after SAH. Double staining with BrdU and NeuN indicated that the majority of the BrdU-positive cells migrating into the granular cell layer of the DG became NeuN-positive 30 days after SAH. In conclusion, temporal changes of the neurogenesis as shown in the present study suggest that neurogenesis in the hippocampus may affect functional outcome after SAH. The induction of the neurogenesis can provide therapeutic value against SAH.	Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; Tohoku Univ, Grad Sch Med, Dept Biochem, Aoba Ku, Sendai, Miyagi 9808574, Japan		Fujimura, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.						Alonso G, 2000, GLIA, V31, P219, DOI 10.1002/1098-1136(200009)31:3<219::AID-GLIA30>3.0.CO;2-R; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Iwai M, 2002, J CEREBR BLOOD F MET, V22, P411, DOI 10.1097/00004647-200204000-00005; Iwai M, 2001, BRAIN RES, V902, P288, DOI 10.1016/S0006-8993(01)02399-X; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kamii H, 1999, STROKE, V30, P867, DOI 10.1161/01.STR.30.4.867; KAMII H, 1995, CENTRAL NERVOUS SYST, P139; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Liu JL, 1998, J NEUROSCI, V18, P7768; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Matz PG, 2001, STROKE, V32, P506, DOI 10.1161/01.STR.32.2.506; Matz PG, 2000, BRAIN RES, V858, P312, DOI 10.1016/S0006-8993(99)02454-3; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nakamura K, 2000, JPN J APPL ENTOMOL Z, V44, P27, DOI 10.1303/jjaez.2000.27; Nau R, 2002, BRAIN PATHOL, V12, P329; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Saito A, 2001, STROKE, V32, P1652, DOI 10.1161/01.STR.32.7.1652; Sato K, 2001, BRAIN RES, V922, P135, DOI 10.1016/S0006-8993(01)03137-7; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	39	23	26	1	3	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	DEC	2003	25	8					839	845		10.1179/016164103771953934			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756LW	WOS:000187467500010	14669527				2022-02-06	
J	Davis, DP; Patel, PM				Davis, Daniel P.; Patel, Piyush M.			Ischemic preconditioning in the brain	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						cerebral ischemia preconditioning; ischemic preconditioning; volatile anesthetics	FOCAL CEREBRAL-ISCHEMIA; RAT CORTICAL-NEURONS; PROTEIN-KINASE-II; BICUCULLINE EVOKED SEIZURES; LONG-TERM SURVIVAL; NITRIC-OXIDE; 3-NITROPROPIONIC ACID; TRANSIENT EPISODE; IN-VITRO; SUBCELLULAR-DISTRIBUTION	Purpose of review Brain ischemia is responsible for significant morbidity and mortality associated with cardiovascular surgery, and is the end result of multiple disease states, including cardiac arrest, stroke, and traumatic brain injury. Despite significant resources dedicated to developing neuroprotective strategies, little progress has been made in this regard. Neuronal ischemic preconditioning is an endogenous neuroprotective strategy that provides sustained and robust ischemic tolerance. Identification of the mechanisms responsible for mediating the preconditioning response may offer novel therapeutic targets and further our understanding of the natural adaptations to brain injury. Recent findings Recent research efforts have elucidated many intracellular signaling pathways that ultimately lead to ischemic tolerance after a preconditioning stimulus. Most of these are associated with glutamate receptor signal transduction, the intracellular kinases, and several transcription regulators. Microarray analysis has identified several gene families that warrant further investigation to identify novel candidates for neuroprotective therapies. These include genes involved in synaptic architecture and signal propagation, cell cycle and transcription regulators, and mediators of apoptosis such as the heat shock proteins and anti-apoptotic mitochondrial proteins. Summary Neuronal ischemic preconditioning is an endogenous mechanism that leads to robust neuroprotection from ischemia. Identification of the upstream pathways that initiate preconditioning and candidate genes that mediate this phenomenon may offer novel therapeutic targets, with applicability to a variety of disease states and perioperative complications.	[Patel, Piyush M.] VA Med Ctr, Anesthesia Serv 125, San Diego, CA 92161 USA; [Davis, Daniel P.] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Patel, Piyush M.] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA		Patel, PM (corresponding author), VA Med Ctr, Anesthesia Serv 125, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ppatel@ucsd.edu			National Institutes of Health (USA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; SAEM (Society for Academic Emergency Medicine)	This study was supported by a grant from the National Institutes of Health (USA) to P.M.P. and from SAEM (Society for Academic Emergency Medicine) to D.P.D.	Abe H, 2000, NEUROSCI LETT, V295, P54, DOI 10.1016/S0304-3940(00)01577-9; Aizenman E, 2000, J PHARMACOL EXP THER, V295, P572; Bauer B, 1999, BASIC RES CARDIOL, V94, P31, DOI 10.1007/s003950050124; Belayev L, 1996, NEUROREPORT, V8, P55, DOI 10.1097/00001756-199612200-00012; Bhardwaj A, 2001, STROKE, V32, P1920, DOI 10.1161/01.STR.32.8.1920; Blanck TJJ, 2000, ANESTHESIOLOGY, V93, P1285, DOI 10.1097/00000542-200011000-00023; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Bond A, 1999, EUR J PHARMACOL, V380, P91, DOI 10.1016/S0014-2999(99)00523-3; Bossenmeyer-Pourie C, 2000, PEDIATR RES, V47, P385, DOI 10.1203/00006450-200003000-00017; Brambrink AM, 2000, J CEREBR BLOOD F MET, V20, P1425, DOI 10.1097/00004647-200010000-00004; Bruer U, 1997, FEBS LETT, V414, P117, DOI 10.1016/S0014-5793(97)00954-X; Centeno JM, 1999, BRAIN RES, V836, P62, DOI 10.1016/S0006-8993(99)01610-8; Corbett D, 1997, BRAIN RES, V760, P129, DOI 10.1016/S0006-8993(97)00294-1; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Dawson VL, 2000, TRENDS PHARMACOL SCI, V21, P423, DOI 10.1016/S0165-6147(00)01560-1; Deplanque D, 2000, STROKE, V31, P1465; Dowden J, 1999, STROKE, V30, P1240, DOI 10.1161/01.STR.30.6.1240; Emerson MR, 1999, BRAIN RES, V825, P189, DOI 10.1016/S0006-8993(99)01195-6; Furuya K, 2001, J CEREBR BLOOD F MET, V21, P226, DOI 10.1097/00004647-200103000-00006; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; Ginis I, 2002, J CEREBR BLOOD F MET, V22, P142, DOI 10.1097/00004647-200202000-00002; Ginis I, 1999, AM J PHYSIOL-CELL PH, V276, pC1171, DOI 10.1152/ajpcell.1999.276.5.C1171; GLAZIER SS, 1994, J CEREBR BLOOD F MET, V14, P545, DOI 10.1038/jcbfm.1994.68; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; HANYU S, 1993, ACTA NEUROPATHOL, V86, P16, DOI 10.1007/BF00454893; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; Johns L, 2000, BIOCHEM BIOPH RES CO, V276, P134, DOI 10.1006/bbrc.2000.3443; Kapinya KJ, 2002, NEUROREPORT, V13, P1431, DOI 10.1097/00001756-200208070-00017; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; KATO H, 1992, BRAIN RES BULL, V29, P559, DOI 10.1016/0361-9230(92)90123-F; Katsura K, 2001, NEUROL RES, V23, P751, DOI 10.1179/016164101101199126; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Kitagawa K, 1997, NEUROSCIENCE, V81, P989, DOI 10.1016/S0306-4522(97)00229-7; Kurkinen K, 2001, NEUROREPORT, V12, P269, DOI 10.1097/00001756-200102120-00018; Kuroiwa T, 2000, NEUROSCI LETT, V283, P145, DOI 10.1016/S0304-3940(00)00937-X; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Masada T, 2001, J CEREBR BLOOD F MET, V21, P22, DOI 10.1097/00004647-200101000-00004; Matsushima K, 1996, J CEREBR BLOOD F MET, V16, P221, DOI 10.1097/00004647-199603000-00006; Matsuyama K, 1997, ANN THORAC SURG, V63, P1315, DOI 10.1016/S0003-4975(97)00104-5; Mori T, 2000, NEUROPATH APPL NEURO, V26, P31, DOI 10.1046/j.1365-2990.2000.00215.x; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nagata A, 1998, ANESTH ANALG, V87, P1416, DOI 10.1097/00000539-199812000-00040; Nishio S, 2000, J NEUROSURG, V93, P845, DOI 10.3171/jns.2000.93.5.0845; Nishio S, 1999, ANN NY ACAD SCI, V890, P26, DOI 10.1111/j.1749-6632.1999.tb07978.x; Ohno M, 1996, BRAIN RES BULL, V40, P229, DOI 10.1016/0361-9230(96)00050-0; Premkumar A, 2002, J NEUROCHEM, V82, P345, DOI 10.1046/j.1471-4159.2002.00966.x; Puisieux F, 2000, EUR J PHARMACOL, V389, P71, DOI 10.1016/S0014-2999(99)00893-6; Rauca C, 2000, BRAIN RES, V868, P147, DOI 10.1016/S0006-8993(00)02388-X; Ravati A, 2001, J NEUROCHEM, V78, P909, DOI 10.1046/j.1471-4159.2001.00463.x; Rejdak K, 2000, EPILEPSY RES, V41, P213, DOI 10.1016/S0920-1211(00)00143-1; Rejdak K, 2000, J NEURAL TRANSM, V107, P1263, DOI 10.1007/s007020070016; Rejdak K, 2000, J NEURAL TRANSM, V107, P947, DOI 10.1007/s007020070044; Reshef A, 1998, ADV EXP MED BIOL, V431, P365; Rubino A, 2000, TRENDS PHARMACOL SCI, V21, P225, DOI 10.1016/S0165-6147(00)01483-8; Shamloo M, 1999, J CEREBR BLOOD F MET, V19, P173, DOI 10.1097/00004647-199902000-00009; Shamloo M, 2000, NEUROSCIENCE, V96, P665, DOI 10.1016/S0306-4522(99)00586-2; Shamloo M, 1999, NEUROSCIENCE, V93, P81, DOI 10.1016/S0306-4522(99)00137-2; Skaper SD, 2001, ANN NY ACAD SCI, V939, P11; Taga K, 1997, ANESTHESIOLOGY, V87, P918, DOI 10.1097/00000542-199710000-00027; Tan SE, 2002, NEUROPHARMACOLOGY, V42, P540, DOI 10.1016/S0028-3908(02)00004-7; Tauskela JS, 1999, BRAIN RES, V827, P143, DOI 10.1016/S0006-8993(99)01322-0; Toyoda T, 2000, J NEUROSURG, V92, P435, DOI 10.3171/jns.2000.92.3.0435; Tremblay R, 2000, J NEUROSCI, V20, P7183; Vannucci RC, 1998, J NEUROCHEM, V71, P1215; von Arnim CAF, 2001, NEUROSCI LETT, V299, P130, DOI 10.1016/S0304-3940(00)01762-6; Wang XK, 2000, J CEREBR BLOOD F MET, V20, P15, DOI 10.1097/00004647-200001000-00004; Weih M, 1999, NEUROSCI LETT, V272, P207, DOI 10.1016/S0304-3940(99)00594-7; Whitfield PC, 1999, BRAIN RES, V818, P450, DOI 10.1016/S0006-8993(98)01342-0; Xiong LZ, 2003, ANESTH ANALG, V96, P233, DOI 10.1097/00000539-200301000-00047; Zhan RZ, 2002, ANESTHESIOLOGY, V97, P896, DOI 10.1097/00000542-200210000-00022; Zvara DA, 1999, ANN THORAC SURG, V68, P874, DOI 10.1016/S0003-4975(99)00559-7	71	23	28	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2003	16	5					447	452		10.1097/00001503-200310000-00002			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	V24WJ	WOS:000208440200002	17021495				2022-02-06	
J	Gorski, TF; Gorski, YC; McLeod, G; Suh, D; Cordero, R; Essien, F; Berry, D; Dada, F				Gorski, TF; Gorski, YC; McLeod, G; Suh, D; Cordero, R; Essien, F; Berry, D; Dada, F			Patterns of injury and outcomes associated with motocross accidents	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southern California Chapter of the American-College-of-Surgeons	JAN 24-26, 2003	SANTA BARBARA, CALIFORNIA	Amer Coll Surg, SO Calif Chapter			MOTORCYCLE-HELMET-USE; CRASHES	Motocross has become a popular recreation activity in Southern California, particularly in the Inland Empire area. In order to evaluate the patterns of injury and outcomes associated with motocross accidents, the Trauma Registry data and charts of all patients with motocross-related injuries from January 2000 to December 2001 were reviewed. Of the 270 patients studied, 265 were males and 5 were females, with a mean age of 26 years (range, 5-61). The mean Injury Severity Score was 6.8 (range, 1-38). Injuries involved extremity trauma in 52 per cent of patients closed head injuries in 33 per cent, blunt chest trauma in 23 per cent, abdominal trauma in 15 per cent, spinal trauma in 14 per cent, and pelvic trauma in 8 per cent. Surgery was required in 96 patients (36%), most commonly for treatment of orthopedic injuries. After initial evaluation, 179 patients were admitted (66%), 60 were discharged home (22%), 29 were transferred for higher level of care (11%), and two expired (1%). The mean hospital length of stay was 2.3 days (range, 1-9). Motocross accidents are most commonly associated with extremity injuries and closed head trauma. Although the overall mortality is low, the morbidity is high, with a large proportion of patients requiring surgery.	Inland Valley Reg Med Ctr, Dept Surg, Wildomar, CA USA		Gorski, TF (corresponding author), 800 Magnolia Ave 107, Corona, CA 92879 USA.						Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; Brandt MM, 2002, J TRAUMA, V53, P469, DOI 10.1097/00005373-200209000-00012; DRYSDALE WF, 1975, J TRAUMA, V15, P99, DOI 10.1097/00005373-197502000-00003; Kraus JF, 2002, J TRAUMA, V52, P548, DOI 10.1097/00005373-200203000-00022; KRAUS JF, 1994, JAMA-J AM MED ASSOC, V272, P1506, DOI 10.1001/jama.272.19.1506; KUPPFERSCHMID JP, 1989, J TRAUMA, V29, P593; MACKENZIE EJ, 1993, J TRAUMA, V34, P528, DOI 10.1097/00005373-199304000-00009; *NAT HIGHW TRAFF S, 2002, ANN EMERG MED, V39, P195; Robertson A, 2002, J TRAUMA, V53, P5, DOI 10.1097/00005373-200207000-00002; Yates JM, 2002, INJURY, V33, P479, DOI 10.1016/S0020-1383(02)00007-4; ZETTAS JP, 1979, J TRAUMA, V19, P833, DOI 10.1097/00005373-197911000-00007	11	23	23	0	3	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	OCT	2003	69	10					895	898					4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	729KD	WOS:000185771600015	14570370				2022-02-06	
J	Ursino, M; Giulloni, M				Ursino, M; Giulloni, M			Quantitative assessment of cerebral autoregulation from transcranial Doppler pulsatility: a computer simulation study	MEDICAL ENGINEERING & PHYSICS			English	Article						cerebral autoregulation; cerebral perfusion pressure; intracranial pressure; mathematical model; Transcranial Doppler	HUMAN INTRACRANIAL HYDRODYNAMICS; TRAUMATIC BRAIN INJURY; FLUID PULSE PRESSURE; BLOOD-FLOW VELOCITY; SEVERE HEAD-INJURY; MATHEMATICAL-MODEL; AUTO-REGULATION; CO2 REACTIVITY; ULTRASOUND; DYNAMICS	Transcranial Doppler (TCD) ultrasonography is largely used today to achieve non-invasive assessment of cerebral autoregulation and cerebrovascular reactivity in neurosurgical patients. Recent experimental and clinical studies suggest that not only the pattern of mean velocity, but also velocity pulse amplitude alterations during changes in cerebral perfusion pressure (CPP) contain information on autoregulation status. The aim of this work is to investigate the relationship between cerebral autoregulation and TCD pulsatility by means of a comprehensive mathematical model of intracranial dynamics and cerebrovascular regulation. Simulation results, performed using different values of the most important clinical parameters of the model (autoregulation strength, cerebrospinal fluid (CSF) outflow resistance and intracranial elastance coefficient) show that velocity pulse amplitude increases with a reduction in CPP in patients with intact autoregulation, whereas changes in velocity pulsatility are modest in patients with weak autoregulation. Finally, velocity pulse amplitude decreases during a CPP reduction in patients with impaired autoregulation. Moreover, the relationship between the velocity pulse amplitude changes and autoregulation strength is almost linear in a wide range of CPP values, and is scarcely affected by changes in CSF circulation and intracranial elasticity. Starting from these results, we suggest a new quantitative index to assess autoregulation strength, i.e. G(aut)% = (s-b)/a, where G(aut)% is autoregulation strength (100% means intact autoregulation, 0% means impaired autoregulation), a similar or equal to -0.03; bsimilar or equal to1.5 and s is the slope of the relationship percentage changes of velocity pulse amplitude to arterial pressure pulse amplitude vs. CPP changes'. (C) 2003 IPEM. Published by Elsevier Science Ltd. All rights reserved.	Univ Bologna, Dipartimento Elettron Informat & Sistemist, I-40136 Bologna, Italy; Bellaria Hosp, Dept Neurosurg, Bologna, Italy		Ursino, M (corresponding author), Univ Bologna, Dipartimento Elettron Informat & Sistemist, Viale Risorgimento 2, I-40136 Bologna, Italy.			Ursino, Mauro/0000-0002-0911-0308			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; AUER LM, 1987, J NEUROSURG, V67, P263, DOI 10.3171/jns.1987.67.2.0263; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; AVEZAAT CJJ, 1983, INTRACRANIAL PRESSUR, V5, P326; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; CZOSNYKA M, 1994, NEUROSURGERY, V35, P287, DOI 10.1227/00006123-199408000-00015; Enevoldsen E, 1986, Acta Neurochir Suppl (Wien), V36, P133; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; KONTOS HA, 1978, AM J PHYSIOL, V234, P371; KOSTELJANETZ M, 1986, NEUROSURGERY, V18, P17, DOI 10.1227/00006123-198601000-00004; Lodi CA, 1998, AM J PHYSIOL-HEART C, V274, pH1729, DOI 10.1152/ajpheart.1998.274.5.H1729; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARMAROU A, 1991, J NEUROSURG S, V75, P59; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Milnor WR, 1982, HEMODYNAMICS; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; NELSON RJ, 1992, NEUROSURGERY, V31, P705; NORNES H, 1977, ACTA NEUROCHIR, V38, P177, DOI 10.1007/BF01401089; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Ursino M, 1998, AM J PHYSIOL-HEART C, V274, pH1715, DOI 10.1152/ajpheart.1998.274.5.H1715; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; URSINO M, 1995, IEEE T BIO-MED ENG, V42, P529, DOI 10.1109/10.387192; URSINO M, 1988, ANN BIOMED ENG, V16, P379, DOI 10.1007/BF02364625; URSINO M, 1988, ANN BIOMED ENG, V16, P403, DOI 10.1007/BF02364626; Ursino M, 2001, ANN BIOMED ENG, V29, P563, DOI 10.1114/1.1380423	34	23	25	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533			MED ENG PHYS	Med. Eng. Phys.	OCT	2003	25	8					655	666		10.1016/S1350-4533(02)00251-5			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	722MK	WOS:000185379200005	12900181				2022-02-06	
J	Hayman-Abello, SE; Rourke, BP; Fuerst, DR				Hayman-Abello, SE; Rourke, BP; Fuerst, DR			Psychosocial status after pediatric traumatic brain injury: A subtype analysis using the Child Behavior Checklist	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Proceedings Paper	28th Annual Meeting of the International-Neuropsychological-Society	FEB 09-12, 2000	DENVER, COLORADO	Int Neuropsychol Soc		TBI; psychosocial; subtypes; CBCL	CLOSED-HEAD-INJURY; NEUROBEHAVIORAL SYMPTOMS; PSYCHIATRIC-DISORDERS; ADOLESCENTS; MILD; PERFORMANCE; PREVALENCE; OUTCOMES	This study identified subtypes of psychosocial functioning in children who had sustained traumatic brain injury (TBI). Child Behavior Checklist (CBCL) profiles for 92 participants, aged 12 to 18 years, who had sustained a mild, moderate. or severe TBI were subjected to Q-Factor analysis. Sixty-four of the participants (75%) were classified into a four-category psychosocial typology labelled Normal (n = 32), Attention (n = 14), Delinquent (n = 10). and Withdrawn-Somatic (n = 8). This typology was found to overlap in part with previous TBI psychosocial typology (Butler et at., 1997), and with three of the clinical profile types derived by Achenbach (1993) for the CBCL. The majority of participants, including those who sustained severe TBI, were assigned to the Normal subtype and the overall level of psychosocial deviance was relatively mild in the other three subtypes. The results of this study support previous typology efforts and confirm the heterogeneous presentation of social and emotional functioning following TBI.	Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; Yale Univ, New Haven, CT 06520 USA; Wayne State Univ, Sch Med, Detroit, MI USA		Hayman-Abello, SE (corresponding author), Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.						Achenbach T, 1983, MANUAL CHILD BEHAV C; Achenbach T. M., 1993, EMPIRICALLY BASED TA; Achenbach TM, 1991, MANUAL CHILD BEHAV C; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Butler K, 1997, CHILD NEUROPSYCHOL, V3, P98, DOI 10.1080/09297049708401371; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; DROTAR D, 1995, J CLIN CHILD PSYCHOL, V24, P184, DOI 10.1207/s15374424jccp2402_6; EWINGCOBBS L, 1995, SYNDROME NONVERBAL L, P433; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; FLETCHER JM, 1997, ASSESSMENT CHILDHOOD, P453; FUERST DR, 1990, J CONSULT CLIN PSYCH, V58, P657, DOI 10.1037/0022-006X.58.5.657; FUERST DR, 1991, THESIS U WINDSOR ONT; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; PORTER JE, 1985, NEUROPSYCHOLOGY LEAR, P257; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rourke B. P., 1991, LEARNING DISABILITIE; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Shaffer D, 1975, Ciba Found Symp, P191; SHAFFER D, 1995, TRAUMATIC HEAD INJUR, P55; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tsatsanis KD, 1997, J LEARN DISABIL, V30, P490, DOI 10.1177/002221949703000505; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	39	23	23	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2003	9	6					887	898		10.1017/S1355617703960097			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	714YA	WOS:000184941000009	14632248				2022-02-06	
J	Gamble, D; Moore, CL				Gamble, D; Moore, CL			The relation between VR services and employment outcomes of individuals with traumatic brain injury	JOURNAL OF REHABILITATION			English	Article							TERM FOLLOW-UP; REHABILITATION SERVICES; HEAD-INJURY; SUPPORTED EMPLOYMENT; MENTAL-RETARDATION; PLACEMENT OUTCOMES; SOCIAL-ADJUSTMENT; WORK; RETURN; RACE	This study examined the relationship between the provision of six vocational rehabilitation services to persons with traumatic brain injury (TBI) and the employment outcomes of these individuals as measured by closure status and weekly earnings. The sample consisted of 1,073 vocational rehabilitation clients with TBI whose cases were closed in a southeastern state. The researchers employed a binary logistic regression analysis and a factorial ANOVA to evaluate the relationship between these services and employment outcomes. Logistic regression analysis identified a significant relationship between four services and closure status. A six-way between participants ANOVA yielded a significant main effect for one service on weekly earnings and a significant interaction for three services on weekly earnings. These findings are presented and discussed for closure status and weekly earnings.	Compass Sch, Tuscaloosa, AL 35405 USA; Langston Univ, Langston, OK 73050 USA		Gamble, D (corresponding author), Compass Sch, 6001 12th Ave E, Tuscaloosa, AL 35405 USA.						Ashley MJ, 1997, BRAIN INJURY, V11, P677; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; BRANDT GC, 1992, J CAN HIST ASSOC, V3, P3; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bullard J. A., 1991, VOCATIONAL EVALUATIO, V24, P15; BULLIS M, 1995, REHABIL COUNS BULL, V39, P130; CHANDLER SK, 1993, THESIS VIRGINIA COMM; CHANDLER SK, 1993, VOCATIONAL EVALUATIO, V26, P161; CICERONE KD, 2000, TRAUMATIC BRAIN INJU, P95; Cohen J., 1983, MULTIPLE REGRESSION; ELLERD DA, 1992, J APPL REHABILITATIO, V23, P48; FABIANO RL, 1991, THESIS MICHIGAN STAT; FAUST P, 1998, ARCH CLIN NEUROPSYCH, V3, P145; Gamble D., 2002, J APPL REHABILITATIO, V33, P41, DOI DOI 10.1891/0047-2220.33.3.41; GARSKE GG, 1992, REHABIL COUNS BULL, V36, P44; Gilmore DS, 2000, REHABIL COUNS BULL, V44, P30, DOI 10.1177/003435520004400105; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Hillier SL, 1997, BRAIN INJURY, V11, P661; Huck SW, 1996, READING STAT RES; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KOSCIULEK JF, 1991, VOCATIONAL EVALUATIO, V24, P137; KRANKOWSKI T, 1993, VOCATIONAL EVALUATIO, V26, P85; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; Michaels C.A., 1992, J APPL REHABILITATIO, V24, P38; Moore CL, 2002, J REHABIL, V68, P14; Moore CL, 2002, REHABIL COUNS BULL, V45, P162, DOI 10.1177/003435520204500305; Moore CL, 2001, REHABIL COUNS BULL, V44, P144, DOI 10.1177/003435520104400304; MOORE CL, 2001, J APPL REHABIL COUS, V32, P15; MORRIS J, 1982, M AM PSYCH ASS WASH; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PECK E, 1984, ANN M INT NEUR SOC H; PEDHAZUR EJ, 1991, MEASUREMENT DESIGN A; PRESTON B, 1992, REHABIL COUNS BULL, V35, P230; PRICEELLINGSTAD D, 1999, AM REHABILITATION, V25, P2; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Schmidt-Davis H, 1999, AM REHABILITATION, V25, P11; SHANNON DM, 2001, USING SPSS SOLVE STA; *SPSS INC, 1995, SPSS 6 1 COMP PROGR; Target P, 1998, INT J REHABIL RES, V21, P41, DOI 10.1097/00004356-199803000-00004; Taylor TE, 1998, TROP MED INT HEALTH, V3, P3, DOI 10.1046/j.1365-3156.1998.00166.x; Uomoto J.M., 2000, TRAUMATIC BRAIN INJU; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WEHMAN P, 2000, TRAUMATIC BRAIN INJU, P201; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; West MD, 1996, J VOCATIONAL REHABIL, V7, P143; Wheaton JE, 1996, REHABIL COUNS BULL, V40, P116; [No title captured]	53	23	23	0	5	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	JUL-SEP	2003	69	3					31	38					8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	711DW	WOS:000184725200006					2022-02-06	
J	Baker-Price, L; Persinger, MA				Baker-Price, L; Persinger, MA			Intermittent burst-firing weak (1 microTesla) magnetic fields reduce psychometric depression in patients who sustained closed head injuries: A replication and electroencephalographic validation	PERCEPTUAL AND MOTOR SKILLS			English	Article								14 patients who reported chronic depression more than one year after closed head injuries were exposed to weak (1 microTesla), burst-firing magnetic fields either across the temporal lobes or over the left frontal lobe. The treatment was for 30 min. once per week for 6 wk. The reduction in depression scores after 5 wk. of treatments and after 6 wk. of no treatment (follow-up) accommodated 54% of the variance for both groups. The changes in depression scores did not differ significantly between the two groups (temporal vs frontal). Following treatment, the frequency of complex partial epileptic-like experiences decreased significantly only for the 7 who received the bilateral stimulation over the temporal lobes. Quantitative bipolar electroencephalographic measurements over the occipital, prefrontal, and temporal regions showed increased power within the 16-Hz to 18-Hz range 6 wk. after termination of treatment for those 7 patients who received the burst-firing magnetic fields bilaterally over the temporal lobes but not over the left prefrontal region.	Laurentian Univ, Clin Neurosci Lab, Sudbury, ON P3E 2C6, Canada		Persinger, MA (corresponding author), Laurentian Univ, Clin Neurosci Lab, Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada.						BakerPrice LA, 1996, PERCEPT MOTOR SKILL, V83, P491, DOI 10.2466/pms.1996.83.2.491; Beck AT, 1987, BECK DEPRESSION INVE; BUREAU YRJ, 1995, ELECTRO MAGNETOBIOL, V14, P1, DOI 10.3109/15368379509028464; GODDARD GV, 1986, LIMBIC SYSTEM FUNCTI, P95; Pearlson Godfrey D., 1995, P1019; Persinger MA, 2000, PERCEPT MOTOR SKILL, V90, P659, DOI 10.2466/PMS.90.2.659-674; Roberts RJ, 1990, NEUROPSYCHOLOGY, V4, P65; Speer AM, 2000, BIOL PSYCHIAT, V48, P1133, DOI 10.1016/S0006-3223(00)01065-9; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; TSANG EW, 2002, INT J BIOELECTROMAGN, V2, P263; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5; ZHONGQI N, 1998, P 20 ANN INT C IEEE, V20, P3275	13	23	23	0	0	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	2003	96	3	1				965	974		10.2466/PMS.96.3.965-974			10	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	687JA	WOS:000183372000035	12831278				2022-02-06	
J	Hurley, SD; Coleman, PD				Hurley, SD; Coleman, PD			Facial nerve axotomy in aged and young adult rats: analysis of the glial response	NEUROBIOLOGY OF AGING			English	Article						microglia; astrocytes; T cells	FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; MICROGLIAL CELLS; MESSENGER-RNA; ADHESION MOLECULES; OUTCOME PREDICTION; WHITE-MATTER; SPINAL-CORD; EXPRESSION	With increasing age, there is a trend towards greater morbidity and injury extent with brain injury. Because several reports have suggested that microglia and astrocytes have an exacerbated response to brain injury in the aged, we set out to explore glial responses to facial nerve axotomy. This model was chosen because the glial responses are well-characterized in young rats and there is no perturbation of the blood-brain barrier (BBB). Immunohistochemistry was performed for glial fibrillary acidic protein (GFAP), leukocyte common antigen, type 3 complement receptor, and major histocompatability complex classes I and II. Quantitative analysis showed that age does not affect the glial response to axotomy in the lesioned facial nucleus; however, an aging-related contralateral effect with enhanced GFAP-labeling was observed. Interestingly, despite a lack of infiltrating neutrophils, a T cell influx was observed in both young and aged rats. Overall, these results suggest that neutrophil extravasion and BBB breakdown are underappreciated with regards to aging and injury exacerbation. (C) 2002 Elsevier Science Inc. All rights reserved.	Univ Rochester, Alzheimers Dis Ctr, Rochester, NY 14642 USA; Univ Rochester, Ctr Aging & Dev Biol, Rochester, NY 14642 USA		Hurley, SD (corresponding author), Dept Neurobiol & Anat, 601 Elmwood Ave,POB 603, Rochester, NY 14642 USA.				NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000107, P30AG008665] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG08665, AG1096, T32 AG00107] Funding Source: Medline		Bailly Y., 1990, HEMOPOIETIC SYSTEM, P27; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; BRONSON RT, 1993, BRAIN RES, V609, P124, DOI 10.1016/0006-8993(93)90864-J; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gordon MN, 1997, J COMP NEUROL, V388, P106; GOSS JR, 1995, J NEUROCHEM, V64, P1351; GRAEBER MB, 1988, J NEUROCYTOL, V17, P209, DOI 10.1007/BF01674208; GRAEBER MB, 1986, J NEUROCYTOL, V15, P363; GRAEBER MB, 1988, NEUROSCI LETT, V85, P317, DOI 10.1016/0304-3940(88)90585-X; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; HANSEN LA, 1987, NEUROBIOL AGING, V8, P1, DOI 10.1016/0197-4580(87)90051-0; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Major DE, 1997, NEUROBIOL AGING, V18, P523, DOI 10.1016/S0197-4580(97)00102-4; Morgan TE, 1999, NEUROSCIENCE, V89, P687, DOI 10.1016/S0306-4522(98)00334-0; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Nogawa S, 1998, P NATL ACAD SCI USA, V95, P10966, DOI 10.1073/pnas.95.18.10966; OCALLAGHAN JP, 1991, NEUROBIOL AGING, V12, P171, DOI 10.1016/0197-4580(91)90057-Q; OGURA K, 1994, NEUROREPORT, V5, P1224, DOI 10.1097/00001756-199406020-00016; Olschowka JA, 1997, BRAIN BEHAV IMMUN, V11, P273, DOI 10.1006/brbi.1997.0506; OLSSON T, 1992, AUTOIMMUNITY, V13, P117, DOI 10.3109/08916939209001912; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Pohjasvaara T, 1997, STROKE, V28, P729, DOI 10.1161/01.STR.28.4.729; Raivich G, 1998, J NEUROSCI, V18, P5804; RIOHORTEGA P, 1932, CYTOLOGY CELLULAR PA, P481; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; SCHWAB CW, 1992, ARCH SURG-CHICAGO, V127, P701; Searle S. R., 1992, VARIANCE COMPONENTS; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Sheffield LG, 1998, NEUROBIOL AGING, V19, P47, DOI 10.1016/S0197-4580(97)00168-1; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229, DOI 10.1007/s004010050792; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Sloane JA, 1999, NEUROBIOL AGING, V20, P395, DOI 10.1016/S0197-4580(99)00066-4; Streit WJ, 1996, NEUROTOXICOLOGY, V17, P671; STREIT WJ, 1989, EXP NEUROL, V105, P115, DOI 10.1016/0014-4886(89)90111-8; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Streit WJ, 1997, J MOL MED-JMM, V75, P130, DOI 10.1007/s001090050097; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Stuesse SL, 2000, NEUROSCI LETT, V287, P121, DOI 10.1016/S0304-3940(00)01142-3; Sutherland GR, 1996, STROKE, V27, P1663, DOI 10.1161/01.STR.27.9.1663; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; Thorvaldsen P, 1999, STROKE, V30, P2529, DOI 10.1161/01.STR.30.12.2529; Vollmer DG, 1991, J NEUROSURG S, V75, P37; WANG XK, 1995, J NEUROTRAUM, V12, P825, DOI 10.1089/neu.1995.12.825; WOOD GS, 1981, J HISTOCHEM CYTOCHEM, V29, P1196, DOI 10.1177/29.10.7028859; Zhang RL, 1999, STROKE, V30, P624, DOI 10.1161/01.STR.30.3.624	53	23	24	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580			NEUROBIOL AGING	Neurobiol. Aging	MAY-JUN	2003	24	3					511	518	PII S0197-4580(02)00097-0	10.1016/S0197-4580(02)00097-0			8	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	654FT	WOS:000181484100012	12600726				2022-02-06	
J	Hoane, MR; Knotts, AA; Akstulewicz, SL; Aquilano, M; Means, LW				Hoane, MR; Knotts, AA; Akstulewicz, SL; Aquilano, M; Means, LW			The behavioral effects of magnesium therapy on recovery of function following bilateral anterior medial cortex lesions in the rat	BRAIN RESEARCH BULLETIN			English	Article						brain injury; DMTS; cognitive deficits; working memory; reference memory; sensorimotor behavior	TRAUMATIC BRAIN INJURY; SENSORIMOTOR CORTEX; FACILITATE RECOVERY; COGNITIVE DEFICITS; PREFRONTAL CORTEX; NMDA ANTAGONISTS; CORTICAL DAMAGE; WORKING-MEMORY; FRONTAL-CORTEX; DRUGS	Magnesium (Mg++) therapy has been shown to be neuroprotective and to facilitate recovery of motor and sensorimotor function in a variety of animal models of traumatic brain injury. However, few studies have investigated the efficacy of Mg++ therapy on cognitive impairments following injury. The present study evaluated the ability of magnesium chloride (MgCl2) to facilitate recovery of function following bilateral anterior medial cortex lesions (bAMC). Rats received electrolytic bAMC lesions or sham surgery and were then treated with 1 mmol/kg, i.P. MgCl2, 2 mmol/kg, i.p. MgCl2, or 1.0 ml/kg, i.p. 0.9% saline. Drug treatment was administered 15 min following injury with subsequent injections administered at 24 and 12 h. Rats were tested on a battery of behavioral tests that measured both cognitive (reference and working memory in the Morris Water Maze (MWM) and spatial delayed matching-to-sample (DMTS)) and sensorimotor performance (bilateral tactile adhesive removal). The results indicated that bAMC lesions produced significant cognitive impairments in reference memory and working memory in the MWM, DMTS and sensorimotor impairments compared to shams. Mg++ therapy exhibited a dose-dependent effect in facilitating recovery of function. Administration of 2 mmol of MgCl2 significantly improved performance on the bilateral adhesive tactile removal test, DMTS and working memory tests. The 1 mmol dose of MgCl2 reduced the initial deficit on the tactile adhesive removal test and reduced the working memory impairment on the second day of testing. These results suggest Mg++ therapy improves cognitive performance following injury in a dose-dependent manner. (C) 2003 Elsevier Science Inc. All rights reserved.	E Carolina Univ, Dept Psychol, Brain Injury Lab, Greenville, NC 27858 USA; E Carolina Univ, Program Neurosci, Greenville, NC 27858 USA		Hoane, MR (corresponding author), E Carolina Univ, Dept Psychol, Brain Injury Lab, Rawl 218, Greenville, NC 27858 USA.			Hoane, Michael/0000-0001-7779-2657			Aikawa J.K., 1981, MAGNESIUM ITS BIOL S, V1st ed.; Bara M., 1984, MAGNESIUM, V3, P212; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Barth TM, 1998, RESTORATIVE NEUROLOGY, P121; CLOUGHHELFMAN C, 1991, FREE RADICAL RES COM, V15, P177, DOI 10.3109/10715769109049138; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; GARFINKEL L, 1985, Magnesium, V4, P60; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; GUNTHER T, 1984, MAGNESIUM-B, V6, P77; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, MAGNESIUM RES, V12, P269; Hoane MR, 2000, BRAIN RES BULL, V53, P175, DOI 10.1016/S0361-9230(00)00327-0; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; Hoane MR, 1997, RESTOR NEUROL NEUROS, V11, P71, DOI 10.3233/RNN-1997-111208; Hoane MR, 2002, PHYSIOL BEHAV, V76, P271, DOI 10.1016/S0031-9384(02)00714-X; Hoane MR, 2001, MAGNESIUM RES, V14, P51; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; Kesner RP, 1996, CEREB CORTEX, V6, P311, DOI 10.1093/cercor/6.2.311; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Lindner MD, 1999, BEHAV BRAIN RES, V102, P1, DOI 10.1016/S0166-4328(98)00160-0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Means LW, 2001, PHYSIOL BEHAV, V74, P613, DOI 10.1016/S0031-9384(01)00621-7; MEANS LW, 1993, NEUROSCI PROTOCOLS, V93, P1; MEANS LW, 1993, NEUROBEHAVIORAL PLAS, P67; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Ragozzino ME, 2001, NEUROSCI LETT, V308, P145, DOI 10.1016/S0304-3940(01)02020-1; Regan RF, 1998, J NEUROCHEM, V70, P77; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; SCHALLERT T, 1990, STROKE, V21, P143; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; Voorhies AC, 2002, BEHAV BRAIN RES, V133, P237, DOI 10.1016/S0166-4328(02)00029-3	45	23	24	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230			BRAIN RES BULL	Brain Res. Bull.	APR 15	2003	60	1-2					105	114		10.1016/S0361-9230(03)00022-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677MC	WOS:000182811200010	12725898				2022-02-06	
J	Zaltzman, R; Beni, SM; Giladi, E; Pinhasov, A; Steingart, RA; Romano, J; Shohami, E; Gozes, I				Zaltzman, R; Beni, SM; Giladi, E; Pinhasov, A; Steingart, RA; Romano, J; Shohami, E; Gozes, I			Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults	NEUROREPORT			English	Article						inflammation; peptides; traumatic brain injury; water maze	TRAUMATIC BRAIN INJURY; E-DEFICIENT MICE; NEURONAL CULTURES; MEMORY DEFICITS; PC12 CELLS; RAT-BRAIN; PROTEIN; DEATH; VIP; PROTECTION	The prophylactic neuroprotective effects of NAP, a femtomolar-acting neuroprotective peptide were tested in a mouse model of head trauma. NAP was injected for the first 3 weeks of life and head injury was initiated at 4 months. After trauma, mice were tested for their performance by evaluating damaged motor ability, balance and alertness. Comparison of the performance 1 h and 1 week after injury indicated that NAP treatment resulted in faster and enhanced recovery. In a 5-day Morris water maze test with mice suffering moderate to severe injuries, only the NAP-treated group learned to find the hidden platform in the maze. Furthermore, NAP treatment resulted in decreased mRNA expression of the inflammation marker, Mac-I. Thus, a potentially new prophylactic treatment against neurodegeneration is suggested.	Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Pharmacol, Jerusalem, Israel		Gozes, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel.		Pinhasov, Albert/X-5304-2019	Pinhasov, Albert/0000-0001-8116-4565			Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Benimetskaya L, 1997, NAT MED, V3, P414, DOI 10.1038/nm0497-414; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; Gozes I, 1997, J NEUROBIOL, V33, P329, DOI 10.1002/(SICI)1097-4695(199709)33:3<329::AID-NEU10>3.0.CO;2-A; Gozes I, 2001, TRENDS NEUROSCI, V24, P700, DOI 10.1016/S0166-2236(00)01931-7; Gozes I, 2000, J MOL NEUROSCI, V14, P61, DOI 10.1385/JMN:14:1-2:061; GOZES I, 2000, J PHARMACOL EXP THER, V293, P1191; Hailer NP, 2001, NEUROSCI LETT, V298, P33, DOI 10.1016/S0304-3940(00)01711-0; HILL JM, 1991, PEPTIDES, V12, P187, DOI 10.1016/0196-9781(91)90186-S; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Leker RR, 2002, STROKE, V33, P1085, DOI 10.1161/01.STR.0000014207.05597.D7; Offen D, 2000, BRAIN RES, V854, P257, DOI 10.1016/S0006-8993(99)02375-6; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Romano J, 2002, J MOL NEUROSCI, V18, P37, DOI 10.1385/JMN:18:1-2:37; Sigalov E, 2000, J MOL NEUROSCI, V15, P147, DOI 10.1385/JMN:15:3:147; Spong CY, 2001, J PHARMACOL EXP THER, V297, P774; Steingart RA, 2000, J MOL NEUROSCI, V15, P137, DOI 10.1385/JMN:15:3:137; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1	25	23	23	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	MAR 3	2003	14	3					481	484		10.1097/01.wnr.0000058036.29600.ff			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	656ZW	WOS:000181641800037	12634508				2022-02-06	
J	Furukawa, T; Hoshino, S; Kobayashi, S; Asakura, T; Takahashi, M; Atsumi, T; Teramoto, A				Furukawa, T; Hoshino, S; Kobayashi, S; Asakura, T; Takahashi, M; Atsumi, T; Teramoto, A			The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						AMPA receptor antagonist; excitotoxicity; glutamate; neuroprotection; traumatic brain injury	LATERAL FLUID-PERCUSSION; CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; NEURONAL DEATH; POSTTRAUMATIC HYPOTHERMIA; EXTRACELLULAR POTASSIUM; ARTERY OCCLUSION; MESSENGER-RNA; AMINO-ACIDS; ISCHEMIA	A massive increase in extracellular glutamate is thought to contribute to brain damage after traumatic brain injury. We examined the neuroprotective effect of the AMPA receptor antagonist YM872 in a rat head injury model using the fluid-percussion procedure. Male Sprague-Dawley rats were subjected to right lateral (parasagittal) fluid-percussion brain injury or sham injury. At 15 min postinjury, they received either YM872 (20 mg/kg/h, 20 mg/3 mL) or normal saline (vehicle) intravenously for 4 h. The administration of YM872 significantly improved the composite neuroscore at 1 and 2 weeks postinjury (p < 0.05), and markedly reduced the volume of tissue loss in the injured cortex (p < 0.05). It also significantly reduced cerebral edema in the ipsilateral parietal cortex at 48 h postinjury (p < 0.01). These results indicate that the posttraumatic administration of YM872 may be neuroprotective by ameliorating cortical tissue loss and regional cerebral edema, and suggest the importance of AMPA receptors in traumatic brain damage involving secondary injury processes.	Nippon Med Coll, Dept Neurosurg, Tokyo 113, Japan; Nippon Med Coll, Dept Crit Care Med, Tokyo 113, Japan; Chiba Hokusoh Hosp, Nippon Med Sch, Dept Neurosurg, Chiba, Japan; Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Pharmacol Labs, Ibaraki, Japan		Hoshino, S (corresponding author), Heiwadai Hosp, Dept Neurosurg, 834-28 Abiko, Chiba 2701101, Japan.						Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BULLOCK R, 1992, J NEUROTRAUM, V9, pS442; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; CHOI DW, 1987, J NEUROSCI, V7, P357; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Gorter JA, 1997, J NEUROSCI, V17, P6179; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Hoshino S, 1996, BRAIN RES, V711, P73, DOI 10.1016/0006-8993(95)01329-6; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Kamegai J, 2001, ENDOCRINOLOGY, V142, P4154, DOI 10.1210/en.142.9.4154; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawasaki-Yatsugi S, 1998, BRAIN RES, V793, P39, DOI 10.1016/S0006-8993(98)00108-5; KawasakiYatsugi S, 1997, JPN J PHARMACOL, V74, P253, DOI 10.1254/jjp.74.253; Kohara A, 1998, J PHARM PHARMACOL, V50, P795, DOI 10.1111/j.2042-7158.1998.tb07142.x; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MINAMISAWA H, 1990, STROKE, V21, P758, DOI 10.1161/01.STR.21.5.758; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; SANGER DJ, 1991, PSYCHOPHARMACOLOGY, V104, P27, DOI 10.1007/BF02244550; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Shimizu-Sasamata M, 1998, STROKE, V29, P2141, DOI 10.1161/01.STR.29.10.2141; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Takahashi M, 1998, J PHARMACOL EXP THER, V287, P559; Takahashi M, 1998, J PHARMACOL EXP THER, V284, P467; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; XUE D, 1994, J CEREBR BLOOD F MET, V14, P251, DOI 10.1038/jcbfm.1994.32; YOUNG W, 1992, J NEUROTRAUMA S1, V9, P9	53	23	24	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2003	20	3					269	278		10.1089/089771503321532851			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	661GU	WOS:000181883500005	12820681				2022-02-06	
J	Reichard, RR; White, CL; Hladik, CL; Dolinak, D				Reichard, RR; White, CL; Hladik, CL; Dolinak, D			Beta-amyloid precursor protein staining in nonhomicidal pediatric medicolegal autopsies	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article; Proceedings Paper	77th Annual Meeting of the American-Association-of-Neuropathologists	JUN 21-24, 2001	CHICAGO, ILLINOIS	Amer Assoc Neuropathologists		autopsy; beta-amyloid precursor protein; brain; immunohistochemistry; sudden infant death syndrome (SIDS); pediatric	CENTRAL-NERVOUS-SYSTEM; DIFFUSE AXONAL INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; REACTIVE ASTROCYTES; EXPRESSION; BRAIN; RAT; APP; NEUROPATHOLOGY	Immunohistochemical staining for beta-amyloid precursor protein (betaAPP) has been validated as a marker for axonal injury in adults surviving greater than or equal to2 hours after white matter damage. The significance of betaAPP staining in pediatric brains and spinal cords is not as well established. We evaluated the white matter immunoreactivity for betaAPP from a variety of pediatric medicolegal autopsies: natural disease (non-Sudden Infant Death Syndrome [SIDS]), SIDS, motor vehicle accidents, drowning, near-drowning, overlay, carbon monoxide toxicity, miscellaneous trauma, and mechanical asphyxia. The cases of carbon monoxide toxicity, motor vehicle accidents (death at scene), drowning (with resuscitation), and a natural (non-SIDS) death had no significant white matter staining. The traumatic deaths with a significant survival interval, a variety of natural deaths, the near-drowning case, and surprisingly, all SIDS had detectable betaAPP white matter immunostaining. These results demonstrate that features other than traumatic axonal injury, such as metabolic insults and hypoxic-ischemic injury secondary to vascular compromise, must contribute to betaAPP immunostaining. In addition, we describe a variety of betaAPP-immunoreactive structures not previously reported in the pediatric population. This study illustrates that betaAPP immunostaining enhances detection of a variety of white matter changes, and provides a basis for interpretation of these results.	Univ Texas, Hlth Sci Ctr, SW Med Sch, Dept Pathol,Neuropathol Lab, Dallas, TX 75235 USA; Univ Texas, Hlth Sci Ctr, SW Med Sch, Dept Pathol,Immunohistochem Lab, Dallas, TX 75235 USA; SW Inst Forens Sci, Dallas, TX USA		Reichard, RR (corresponding author), 922 Varian Way, Palo Alto, CA 94304 USA.		White, Charles L/AAJ-1858-2021	White, Charles L/0000-0002-3870-2804			ARAI H, 1991, ANN NEUROL, V30, P686, DOI 10.1002/ana.410300509; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; CORIA F, 1992, NEUROPATH APPL NEURO, V18, P27, DOI 10.1111/j.1365-2990.1992.tb00762.x; Dolinak D, 2000, NEUROPATH APPL NEURO, V26, P448, DOI 10.1046/j.1365-2990.2000.00273.x; Dolinak D, 2000, ACTA NEUROPATHOL, V100, P553, DOI 10.1007/s004010000218; GARDELLA JE, 1992, LAB INVEST, V67, P303; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; IKEDA K, 1990, BRAIN RES, V527, P140, DOI 10.1016/0006-8993(90)91072-O; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MITA S, 1989, AM J PATHOL, V134, P1253; NAVES FJ, 1994, NEUROSCI LETT, V181, P73, DOI 10.1016/0304-3940(94)90563-0; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Obonai T, 1998, PEDIATR NEUROL, V19, P23, DOI 10.1016/S0887-8994(98)00008-3; OHTA M, 1993, DEV BRAIN RES, V75, P151, DOI 10.1016/0165-3806(93)90019-7; OKUDA R, 1994, ACTA NEUROPATHOL, V87, P161, DOI 10.1007/BF00296186; Panegyres PK, 1997, NEUROPEPTIDES, V31, P523, DOI 10.1016/S0143-4179(97)90000-7; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHAW CM, 1989, J CHILD NEUROL, V4, P39, DOI 10.1177/088307388900400106; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; TRAPP BD, 1994, J NEUROSCI RES, V37, P538, DOI 10.1002/jnr.490370413; WILLIAMS G, 1999, DISCOVERY, V1, P11	27	23	23	0	1	AMER ASSN NEUROPATHOLOGISTS INC	LAWRENCE	1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	MAR	2003	62	3					237	247		10.1093/jnen/62.3.237			11	Clinical Neurology; Neurosciences; Pathology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	653QM	WOS:000181448400003	12638728	Bronze			2022-02-06	
J	Cherian, L; Chacko, G; Goodman, C; Robertson, CS				Cherian, L; Chacko, G; Goodman, C; Robertson, CS			Neuroprotective effects of L-arginine administration after cortical impact injury in rats: Dose response and time window	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; NITRIC-OXIDE SYNTHASE; METHYL-D-ASPARTATE; SUPEROXIDE; ISCHEMIA; DAMAGE; REDUCTION; VELOCITY; INSULTS	Administration of L-arginine has been shown to increase cerebral blood flow and reduce neurological damage after experimental traumatic brain injury. The purpose of this study was to examine the optimal dose and time window for these neuroprotective effects. In a dose response experiment, doses of L-arginine ranging from 37.5 to 600 mg/kg were administered 5 min after a 5-m/s, 3-mm, controlled cortical impact in rats. The amount of brain injury found at 2 weeks after injury, both at the contusion site and in the ipsilateral hippocampus, were inversely related to the dose of L-arginine administered. Both 300- and 600-mg/kg doses of L-arginine significantly reduced contusion volume. The 300-mg/kg dose significantly increased the neuron density in the CA1 region of the hippocampus. Physiological effects of L-arginine were also dose-related. The greatest reduction in intracranial pressure occurred with the 300-mg/kg dose of L-arginine. Doses up to 300 mg/kg were well tolerated, but the 600-mg/kg dose resulted in transient hypotension. In another experiment, 300 mg/kg L-arginine was administered at times varying from 5 min to 48 h after injury. Contusion volume was significantly reduced when the L-arginine was given at 5 min and 1 h after injury. The protective effect was less when the same dose was given at the later times, but there was no evidence of an adverse effect even when the L-arginine was administered 48 h after injury.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Cherian, L (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660] Funding Source: Medline		BARBUL A, 1990, SURGERY, V108, P331; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CHERIAN L, 2002, IN PRESS J NEUROTRAU; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; FAGNI L, 1995, MOL PHARMACOL, V47, P1239; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Iadecola C, 1997, J NEUROSCI, V17, P9157; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kontos HA, 1998, AM J PHYSIOL-HEART C, V274, pH974; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Micieli G, 1997, J NEUROL SCI, V150, P71, DOI 10.1016/S0022-510X(97)05380-X; MONTAGUE PR, 1994, SCIENCE, V263, P973, DOI 10.1126/science.7508638; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; REIF DW, 1990, ARCH BIOCHEM BIOPHYS, V283, P537, DOI 10.1016/0003-9861(90)90680-W; Reutens DC, 1997, J CEREBR BLOOD F MET, V17, P309, DOI 10.1097/00004647-199703000-00008; REYES AA, 1994, AM J PHYSIOL, V267, pF331, DOI 10.1152/ajprenal.1994.267.3.F331; Sadoshima S, 1997, BRAIN RES, V744, P246, DOI 10.1016/S0006-8993(96)01063-3; SEIFTER E, 1978, SURGERY, V84, P224; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; ZHANG FY, 1994, J CEREBR BLOOD F MET, V14, P574, DOI 10.1038/jcbfm.1994.71; ZHANG FY, 1994, J CEREBR BLOOD F MET, V14, P217, DOI 10.1038/jcbfm.1994.28; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; ZHANG FY, 1993, NEUROREPORT, V4, P559, DOI 10.1097/00001756-199305000-00024	34	23	25	0	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	2003	304	2					617	623		10.1124/JPET.102.043430			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	637RL	WOS:000180526600017	12538814				2022-02-06	
J	Feinstein, A; Hershkop, S; Ouchterlony, D; Jardine, A; McCullagh, S				Feinstein, A; Hershkop, S; Ouchterlony, D; Jardine, A; McCullagh, S			Posttraumatic amnesia and recall of a traumatic event following traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							CLOSED-HEAD INJURY; ACUTE STRESS DISORDER; GENERAL HEALTH; PREDICTORS; ACCIDENTS; IMPACT; MEMORY	The relationship between posttraumatic amnesia (PTA) and symptoms of posttraumatic stress disorder (PTSD) was examined in 282 outpatients at a mean of 53 days after traumatic brain injury (TBI). Patients were assessed for TBI severity, intrusive and avoidant PTSD-type symptoms, and psychological distress, and were stratified into four comparison groups by duration of PTA. Levels of PTSD-type symptoms and psychological distress did not differ significantly between groups. Even patients with PTA >1 week reported intrusive and avoidant PTSD-type symptoms. However, when patients were stratified into those with PTA of <1 hour or >1 hour, the former were more likely to report such symptoms. TBI patients with brief PTA are more likely to experience PTSD-type reactions, but severe TBI with prolonged PTA is not incompatible with such reactions in a subset of patients. Possible mechanisms that could account for this finding are discussed.	Sunnybrook & Womens Coll, Dept Psychiat, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada		Feinstein, A (corresponding author), Sunnybrook & Womens Coll, Dept Psychiat, Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.		Jardine, Alan/L-5770-2019				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; BRYANT RA, 1995, PSYCHOL MED, V25, P869, DOI 10.1017/S0033291700035121; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; FEINSTEIN A, 1991, PSYCHOL MED, V21, P85, DOI 10.1017/S0033291700014689; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GRISBY J, 1993, BRAIN INJURY, V7, P507; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Krikorian R, 1998, J NEUROPSYCH CLIN N, V10, P359, DOI 10.1176/jnp.10.3.359; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; McNeil J E, 1996, Cogn Neuropsychiatry, V1, P239, DOI 10.1080/135468096396532; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; 1961, LANCET, V2, P1445	29	23	24	0	2	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2002	14	1					25	30		10.1176/appi.neuropsych.14.1.25			6	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	517BD	WOS:000173590500005	11884651				2022-02-06	
J	Maekawa, S; Aibiki, M; Si, QS; Nakamura, Y; Shirakawa, Y; Kataoka, K				Maekawa, S; Aibiki, M; Si, QS; Nakamura, Y; Shirakawa, Y; Kataoka, K			Differential effects of lowering culture temperature on mediator release from lipopolysaccharide-stimulated neonatal rat microglia	CRITICAL CARE MEDICINE			English	Article						lipopolysaccharide; mediator; microglia; temperature reduction	TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA THERAPY; NITRIC-OXIDE PRODUCTION; PROTEIN-KINASE-C; POSTISCHEMIC HYPOTHERMIA; MODERATE HYPOTHERMIA; ACTIVATED MICROGLIA; CEREBRAL-ISCHEMIA; ARTERY OCCLUSION; ASTROCYTES	Objective: Therapeutic moderate hypothermia has the potential for neuronal protection against brain injury. Microglia, a type of immune-related cell in the brain, may play a certain role in neuronal damage subsequent to injury. We examined the effects of culture temperature changes from 37degreesC to 33degreesC or 30degreesC on mediator release, including nitric oxide, interleukin-6, and tumor necrosis factor-alpha from lipopolysaccharide-stimulated microglia harvested from neonatal rats. Design: Laboratory study. Setting: University medical school. Subjects: Microglial cells isolated from primary cultures of rat brains. Interventions: The production of nitric oxide was measured by a nitrite accumulation method in a culture medium, whereas cytokines, interleukin-6, and tumor necrosis factor-alpha were measured by enzyme-linked immunosorbent assay. Measurement and Main Results: At 30degreesC and 33degreesC, nitric oxide production stimulated by Iipopolysaccha ride decreased to 10 and 30% of control (37degreesC), respectively, 24 hrs after the stimulation, and the decrease was sustained for 48 hrs. Interleukin-6 production at 30degreesC and 33degreesC was also reduced to 30% of control 6 hrs after the activation. Such responses lasted throughout the study. However, tumor necrosis factor-alpha release at 30degreesC and 33degreesC was depressed for only 6 hrs after stimulation, followed by subsequent elevation to concentrations similar to those at 37degreesC. Microglial morphologic activation, showing changes from, round to bipolar, reached a peak at 6 hrs in the 37degreesC group, returning to round 12 hrs after lipopolysaccharide application. In 30degreesC and 33degreesC, the zenith was detected at 6 hrs, with activation remaining even 12 hrs after the stimulation, suggesting prolongation of the microglial response to lipopolysaccha ride, which was inconsistent with changes in tumor necrosis factor release. Conclusions: Decreasing culture temperature inhibits the production of nitric oxide and interleukin-6 from activated microglia. Differences were found in the degree or time course change between tumor necrosis factor-alpha and the other mediators. Also, the time course of morphologic changes in microglia was dependent on culture temperature. Further studies are required to define the mechanisms for such differences in mediator release from cooled microglia and also to clarify the inconsistency between morphologic change and its function in the cell.	Ehime Univ, Sch Med, Dept Emergency Med, Shigenobu, Ehime 7910295, Japan; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; Kanazawa Univ, Fac Pharmacol, Kanazawa, Ishikawa 920, Japan		Aibiki, M (corresponding author), Ehime Univ, Sch Med, Dept Emergency Med, 454 Shitsukawa, Shigenobu, Ehime 7910295, Japan.						Abraham H, 2000, BRAIN RES, V862, P63, DOI 10.1016/S0006-8993(00)02072-2; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; CHAO CC, 1995, CLIN IMMUNOL IMMUNOP, V77, P358, DOI 10.1006/clin.1995.1163; CHAO CC, 1992, J IMMUNOL, V149, P2736; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Colbourne F, 2000, J CEREBR BLOOD F MET, V20, P1702, DOI 10.1097/00004647-200012000-00009; Ding MZ, 1997, J BIOL CHEM, V272, P11327; Fabrizi C, 2001, J BIOL CHEM, V276, P25692, DOI 10.1074/jbc.M100133200; Goghari V, 2000, NEUROSCI LETT, V281, P83, DOI 10.1016/S0304-3940(00)00824-7; Hemmer K, 2001, NEUROCHEM INT, V38, P557, DOI 10.1016/S0197-0186(00)00119-4; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iadecola C, 1997, ANN NY ACAD SCI, V835, P203, DOI 10.1111/j.1749-6632.1997.tb48631.x; Inamasu J, 2000, J NEUROIMMUNOL, V109, P66, DOI 10.1016/S0165-5728(00)00211-3; Janabi N, 1996, J IMMUNOL, V157, P2129; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KATHLEEN MB, 1992, BRAIN RES, V587, P250; LEE SC, 1993, J IMMUNOL, V150, P2659; LIU MK, 1994, J IMMUNOL, V153, P2642; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Nakamura Y, 2001, NEUROCHEM INT, V38, P1, DOI 10.1016/S0197-0186(00)00067-X; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NISHIZUKA Y, 1984, SCIENCE, V225, P1365, DOI 10.1126/science.6147898; PETERSON PK, 1994, J INFECT DIS, V170, P457, DOI 10.1093/infdis/170.2.457; Phanithi PB, 2000, NEUROPATHOLOGY, V20, P273, DOI 10.1046/j.1440-1789.2000.00346.x; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Si QS, 1997, NEUROSCIENCE, V81, P223, DOI 10.1016/S0306-4522(97)00172-3; Si QS, 1996, EXP NEUROL, V137, P345, DOI 10.1006/exnr.1996.0035; Si QS, 1998, BRAIN RES, V812, P97, DOI 10.1016/S0006-8993(98)00954-8; Zhao ML, 2001, J NEUROIMMUNOL, V115, P182, DOI 10.1016/S0165-5728(00)00463-X	32	23	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2002	30	12					2700	2704		10.1097/00003246-200212000-00014			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633AP	WOS:000180257300014	12483061				2022-02-06	
J	Beal, AL; Scheltema, KE; Beilman, GJ; Deuser, WE				Beal, AL; Scheltema, KE; Beilman, GJ; Deuser, WE			Hypokalemia following trauma	SHOCK			English	Article						wounds and injuries-complications; head injury; resuscitation; electrolytes; Injury Severity Score (ISS); Length of Stay (LOS); Traumatic Brain Injury JBI); Glasgow Coma Score (GCS)	SERUM POTASSIUM; SEVERITY	Frequent hypokalemia was noted immediately after trauma, and it was hypothesized that hypokalemia occurred more frequently in the more severely injured. A retrospective trauma registry and chart review was done on 546 trauma patients looking at admission potassium, a variety of lab tests related to potassium, specific injuries, hospital/ICU lengths of stay, and general patient demographics. Admission hypokalemia (K < 3.6 meq/l) was more frequent in those with closed head injuries (41.1% vs. 27.5%, P < .001) and in those who suffered spinal cord injuries (54.5% vs. 33.6%, P < .05). Hyperglycemia was more frequent with admission hypokalemia (45.2% vs. 29.7%, P < .001). Hypokalemia occurred more frequently in younger patients (28.6 vs. 37.7 y, P < .001). Also, the pediatric group, ages 5-14, had admission hypolkalemia more frequently than those ages 15-59, or those ages > 59. (54.9% vs. 34.5% vs. 16.7%, P < .001). Glasgow Coma Scores (GCS) were significantly lower(12.0 vs. 13.5, P < .001) and Injury Severity Scores (ISS) were higher (17.4 vs. 13.4, P < .001), with admission hypokalemia. Additionally, hypokalemia was a positive predictor of ISS (P = .05). Hypokalemic patients more likely needed a ventilator, (26.6% vs. 16.5%, P < .01) but did not have significantly more ventilator days (P > .05). Subsequently, hypokalemic patients had longer ICU lengths of stay (LOS) (2.6 vs. 1.5 days, P < .005) and longer hospital LOS (8.5 vs. 5.6 days, P < .001). When stratified into categories of "severe": (K < 3.1 meq/l), "moderate": (K = 3.1-3.3 meq/l), and "mild": (K = 3.4-3.5 meq/l) hypokalemia, those with severe hypokalemia had significantly lower GCS (10.0 vs. 13.1, p < .05), higher serum glucose levels (167 vs. 137 mg/dl, P < .05), lower creatinine levels (.77 vs. .95 mg/dl, P < .05), and longer hospital lengths of stay (13.1 days vs. 7.6 days, P < .05 results).	N Mem Hlth Care, Robbinsdale, MN 55441 USA; Univ Minnesota, Minneapolis, MN 55414 USA		Beal, AL (corresponding author), N Mem Hlth Care, 3300 Oakdale Ave, Robbinsdale, MN 55441 USA.			Beilman, Gregory/0000-0001-5036-3027			CLAUSEN T, 1983, ACTA MED SCAND, P111; EPSTEIN FH, 1983, NEW ENGL J MED, V309, P1450, DOI 10.1056/NEJM198312083092308; Gabow PA, 1992, RENAL ELECTROLYTE DI, P231; Grace G T, 1988, Curr Surg, V45, P463; Lazar L, 1997, J PEDIATR SURG, V32, P88, DOI 10.1016/S0022-3468(97)90102-0; MORELL V, 1993, SOUTHERN MED J, V86, P658, DOI 10.1097/00007611-199306000-00014; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741; SHIN B, 1986, ANESTHESIOLOGY, V65, P90, DOI 10.1097/00000542-198607000-00018; SMITH JS, 1978, SURG GYNECOL OBSTET, V147, P18; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; VANEK VW, 1994, SOUTHERN MED J, V87, P41, DOI 10.1097/00007611-199401000-00010; WILLIAMS ME, 1985, NEW ENGL J MED, V312, P823, DOI 10.1056/NEJM198503283121304	12	23	29	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	AUG	2002	18	2					107	110		10.1097/00024382-200208000-00002			4	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	617VR	WOS:000179382000002	12166770				2022-02-06	
J	Mu, XJ; Azbill, RD; Springer, JE				Mu, XJ; Azbill, RD; Springer, JE			NBQX treatment improves mitochondrial function and reduces oxidative events after spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						glutamate receptors; mitochondrial function; MK-801; NBQX; spinal cord injury	METHYL-D-ASPARTATE; CENTRAL-NERVOUS-SYSTEM; EXCITATORY AMINO-ACIDS; AMYLOID BETA-PEPTIDE; ANTIOXIDANT ENZYME-ACTIVITIES; LIPID-PEROXIDATION PRODUCT; NMDA RECEPTOR ANTAGONISTS; TRAUMATIC BRAIN INJURY; OXYGEN-FREE RADICALS; GLUTAMATE UPTAKE	The purpose of this study was to examine the effects of inhibiting ionotropic glutamate receptor subtypes on measures of oxidative stress events at acute times following traumatic spinal cord injury (SCI). Rats received a moderate contusion injury and 15 min later were treated with one of two doses of 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzol[f]quinoxaline-7-sulfonamide disodium (NBQX), MK-801, or the appropriate vehicle. At 4 h following injury, spinal cords were removed and a crude synaptosomal preparation obtained to examine mitochondrial function using the MTT assay, as well as measures of reactive oxygen species (ROS), lipid peroxidation, and glutamate and glucose uptake. We report here that intraspinal treatment with either 15 or 30 nmol of NBQX improves mitochondrial function and reduces the levels of ROS and lipid peroxidation products. In contrast, MK-801, given intravenously at doses of 1.0 or 5.0 mg/kg, was without effect on these same measures. Neither drug treatment had an effect on glutamate or glucose uptake, both of which are reduced at acute times following SCI. Previous studies have documented that drugs acting on non-N-methyl-D-aspartate (NMDA) receptors exhibit greater efficacy compared to NMDA receptor antagonists on recovery of function and tissue sparing following traumatic spinal cord injury. The results of this study provide a potential mechanism by which blockade of the non-NMDA ionotropic receptors exhibit positive effects following traumatic SCI.	Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Ctr Spinal Cord & Brain Injury Res, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Dept Physiol, Ctr Spinal Cord & Brain Injury Res, Lexington, KY 40536 USA		Springer, JE (corresponding author), Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Ctr Spinal Cord & Brain Injury Res, 800 Rose St, Lexington, KY 40536 USA.			Azbill, David/0000-0001-7989-1771	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS040015, NS40015] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040015] Funding Source: NIH RePORTER		Agrawal SK, 1997, J NEUROSCI, V17, P1055; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BARUT S, 1993, NEUROSURG REV, V16, P53, DOI 10.1007/BF00308614; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; BONDY SC, 1993, FREE RADICAL BIO MED, V14, P633, DOI 10.1016/0891-5849(93)90144-J; BONDY SC, 1993, BRAIN RES, V610, P229, DOI 10.1016/0006-8993(93)91405-H; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BRAUGHLER JM, 1992, J NEUROTRAUMA, V9, P1; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P49; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEMEDIUK P, 1989, J NEUROCHEM, V52, P1529, DOI 10.1111/j.1471-4159.1989.tb09204.x; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DYKENS JA, 1994, J NEUROCHEM, V63, P584; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 1988, J NEUROTRAUM, V5, P33, DOI 10.1089/neu.1988.5.33; Farooque M, 1996, J NEUROCHEM, V66, P1125; Farooque M, 1997, EXP BRAIN RES, V113, P1, DOI 10.1007/BF02454136; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Floyd RA, 1992, ANN NEUROL, V32, P22; FRIQUET B, 1994, J BIOL CHEM, V269, P21639; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOMEZPINILLA F, 1989, EXP NEUROL, V104, P118, DOI 10.1016/S0014-4886(89)80004-4; Goodman Y, 1996, J NEUROCHEM, V66, P869, DOI 10.1046/j.1471-4159.1996.66020869.x; GRAHAM SH, 1990, NEUROSCI LETT, V110, P124, DOI 10.1016/0304-3940(90)90799-F; GUNASEKAR PG, 1995, J NEUROCHEM, V65, P2016; Haghighi SS, 1996, NEUROL RES, V18, P509; HALL ED, 1992, J NEUROTRAUM, V9, pS165; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; HALL ED, 1989, CRIT CARE CLIN, V5, P793; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALL ED, 1992, J NEUROTRAUMA, V9, P425; Hall Edward D., 1993, Journal of Emergency Medicine, V11, P31; HENDERSON L, 1993, EUR J BIOCHEM, V217, P273; HEXUM TD, 1979, NEUROCHEM RES, V4, P73, DOI 10.1007/BF00963833; HOLTZ A, 1991, ACTA NEUROL SCAND, V84, P334, DOI 10.1111/j.1600-0404.1991.tb04964.x; IKEDA Y, 1989, Neurological Research, V11, P213; ILDAN F, 1995, NEUROSURG REV, V18, P35, DOI 10.1007/BF00416476; Jamme I, 1995, NEUROREPORT, V7, P333; Kanellopoulos GK, 2000, STROKE, V31, P1945, DOI 10.1161/01.STR.31.8.1945; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; Keller JN, 1997, J NEUROCHEM, V69, P273; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; KOOY NW, 1994, FREE RADICAL BIO MED, V16, P149, DOI 10.1016/0891-5849(94)90138-4; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Li SX, 2000, NEUROL RES, V22, P171, DOI 10.1080/01616412.2000.11758605; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu SL, 1997, BRAIN RES, V756, P160, DOI 10.1016/S0006-8993(97)00137-6; Mark RJ, 1997, J NEUROCHEM, V68, P255; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; McAdoo DJ, 2000, BRAIN RES, V865, P283, DOI 10.1016/S0006-8993(00)02296-4; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Mills CD, 2002, EXP NEUROL, V173, P153, DOI 10.1006/exnr.2001.7828; Mills CD, 2001, EXP NEUROL, V170, P244, DOI 10.1006/exnr.2001.7721; Mills CD, 2001, J NEUROCHEM, V79, P835, DOI 10.1046/j.1471-4159.2001.00630.x; MOYNER H, 1990, NEURON, V5, P121; Mu XJ, 2000, BRAIN RES, V870, P66, DOI 10.1016/S0006-8993(00)02402-1; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; MUSSER DA, 1994, PHOTOCHEM PHOTOBIOL, V59, P621; NAG S, 1990, ACTA NEUROPATHOL, V81, P7, DOI 10.1007/BF00662631; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Rosen CJ, 1999, J CLIN DENSITOM, V2, P3, DOI 10.1385/JCD:2:1:3; SHEARMAN MS, 1995, J NEUROCHEM, V65, P218, DOI 10.1046/j.1471-4159.1995.65010218.x; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Springer JE, 1997, J NEUROCHEM, V68, P2469; SUN FY, 1994, BRAIN RES, V666, P88, DOI 10.1016/0006-8993(94)90285-2; TAOKA Y, 1995, PARAPLEGIA, V33, P450, DOI 10.1038/sc.1995.98; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; URCA G, 1990, BRAIN RES, V529, P7, DOI 10.1016/0006-8993(90)90805-L; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; VOLTERRA A, 1994, ANN NY ACAD SCI, V738, P153; VONEULER M, 1994, EXP NEUROL, V129, P163, DOI 10.1006/exnr.1994.1157; Wada S, 1999, J NEUROSURG, V91, P98, DOI 10.3171/spi.1999.91.1.0098; Watanabe M, 1998, J NEUROTRAUM, V15, P285, DOI 10.1089/neu.1998.15.285; WRATHALL JR, 1992, BRAIN RES, V586, P140, DOI 10.1016/0006-8993(92)91384-Q; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; Wrathall JR, 1997, EXP NEUROL, V145, P565, DOI 10.1006/exnr.1997.6506; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; WRATHALL JR, 1992, EUR J PHARMACOL, V218, P273, DOI 10.1016/0014-2999(92)90179-8; YEZIERSKI RP, 1993, NEUROSCI LETT, V157, P115, DOI 10.1016/0304-3940(93)90656-6; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	92	23	24	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2002	19	8					917	927		10.1089/089771502320317078			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	585JC	WOS:000177520800002	12225652				2022-02-06	
J	Morgan, A; Ward, E; Murdoch, B; Bilbie, K				Morgan, A; Ward, E; Murdoch, B; Bilbie, K			Acute characteristics of pediatric dysphagia subsequent to traumatic brain injury: Videofluoroscopic assessment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute; dysphagia; swallowing impairment; traumatic brain injury; videofluoroscopy	SWALLOWING DISORDERS; HEAD TRAUMA; CHILDREN; PHYSIOLOGY; OUTCOMES; ADULTS	Objective: To document the acute characteristics of swallowing impairment in a group of children post moderate/severe traumatic brain injury (TBI) by means of videofluoroscopy. Participants: Eighteen children with moderate/severe TBI. Main Outcome Measure: Videofluoroscopy at an average of 27.7 days post-injury. Results: Subjects demonstrated a range of dysphagia severity levels: mild-moderate (n = 8), moderate (n = 6), moderate-severe (n = 3), and severe (n = 1) and had a combination of oral and pharyngeal phase characteristics. More specifically; observable features or physiological impairments that were identified included reduced lingual control, hesitancy of tongue movement, repetitive tongue pumping, the presence of aspiration (including silent aspiration), delayed swallow reflex trigger, reduced laryngeal elevation and closure, and reduced peristalsis. Conclusions: These data highlight the diversity of swallowing deficits and dysphagia severity levels in children following TBI and suggest that the former are consistent with a pattern of oropharyngeal impairments.	Univ Queensland, Dept Speech Pathol & Audiol, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Mater Childrens Hosp, Speech Pathol Dept, Brisbane, Qld 4101, Australia		Morgan, A (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.		Bolton, Kate/AAH-2756-2020; Murdoch, Bruce E/C-1397-2012; Ward, Elizabeth/F-9652-2010; Morgan, Angela/J-5235-2017	Ward, Elizabeth/0000-0002-2680-8978; Morgan, Angela/0000-0003-1147-7405			ARVEDSON J, 1994, INT J PEDIATR OTORHI, V28, P173, DOI 10.1016/0165-5876(94)90009-4; BECK T J, 1990, Dysphagia, V5, P118, DOI 10.1007/BF02412634; CASAS MJ, 1995, DYSPHAGIA, V10, P155, DOI 10.1007/BF00260969; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; Cook I J, 1989, Dysphagia, V4, P8, DOI 10.1007/BF02407397; Darrow DH, 1998, OTOLARYNG CLIN N AM, V31, P405, DOI 10.1016/S0030-6665(05)70061-X; Derkay CS, 1998, OTOLARYNG CLIN N AM, V31, P397, DOI 10.1016/S0030-6665(05)70060-8; Dodds W J, 1989, Dysphagia, V3, P171, DOI 10.1007/BF02407219; DODDS WJ, 1990, AM J ROENTGENOL, V154, P953, DOI 10.2214/ajr.154.5.2108569; EKBERG O, 1982, BRIT J RADIOL, V55, P258, DOI 10.1259/0007-1285-55-652-258; EKBERG O, 1982, ACTA OTO-LARYNGOL, V93, P123, DOI 10.3109/00016488209130862; EVANSMORRIS S, 1981, NORMAL ACQUISITION F; Friedman B, 2000, DYSPHAGIA, V15, P153, DOI 10.1007/s004550010018; GELFAND MD, 1981, GASTROENTEROLOGY, V80, P1154; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lazarus CL, 1989, J HEAD TRAUMA REHAB, V4, P34; Lefton-Greif MA, 1998, PEDIAT VIDEOFLUOROSC; LOGEMANN JA, 1989, ARCH PHYS MED REHAB, V70, P767; LOGEMANN JA, 1990, NEUROLOGY, V40, P1136, DOI 10.1212/WNL.40.7.1136; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; Logemann JA., 1993, MANUAL VIDEOFLUOROGR, V2nd ed.; Loughlin G M, 1989, Dysphagia, V3, P126; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; MANDELSTAM P, 1970, GASTROENTEROLOGY, V58, P32; MORGAN A, 2001, ASIA PACIFIC J SPEEC, V1, P9; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; NEWMAN LA, 1991, INVEST RADIOL, V26, P870, DOI 10.1097/00004424-199110000-00005; O'Donoghue S, 1999, FOLIA PHONIATR LOGO, V51, P158, DOI 10.1159/000021494; O'Neil KH, 1999, DYSPHAGIA, V14, P139, DOI 10.1007/PL00009595; Ott DJ, 1998, DYSPHAGIA, V13, P148; Palmer Jeffrey B., 1993, Dysphagia, V8, P209, DOI 10.1007/BF01354540; Perlman A L, 1994, Dysphagia, V9, P90; PUTNAM PE, 1992, PEDIATRICS, V89, P871; ROBBINS J, 1992, GASTROENTEROLOGY, V103, P823, DOI 10.1016/0016-5085(92)90013-O; Rowe LA, 1999, J HEAD TRAUMA REHAB, V14, P497, DOI 10.1097/00001199-199910000-00010; Schurr MJ, 1999, J TRAUMA, V46, P817, DOI 10.1097/00005373-199905000-00009; Tracy J F, 1989, Dysphagia, V4, P90, DOI 10.1007/BF02407151; YLVISAKER M, 1989, J HEAD TRAUMA REHAB, V4, P51	41	23	25	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2002	17	3					220	241		10.1097/00001199-200206000-00004			22	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	552WE	WOS:000175642400004	12086576				2022-02-06	
J	Preston, E; Webster, J				Preston, E; Webster, J			Differential passage of [C-14]sucrose and [H-3]inulin across rat blood-brain barrier after cerebral ischemia	ACTA NEUROPATHOLOGICA			English	Article						cerebral ischemia; blood-brain barrier; cerebrovascular injury; stroke	FOREBRAIN ISCHEMIA; PERMEABILITY; EDEMA; PERMEATION; TRANSPORT; SUCROSE; INULIN	The biophysical nature of blood-brain barrier (BBB) opening after ischemic or hemorrhagic stroke or traumatic brain injury is unresolved. Ultrastructural (electron micrograph) investigations of experimental BBB injury commonly indicate the abnormal presence of vesicles or tubular structures in cerebrovascular endothelial cells, suggesting the likelihood of convective, fluid-phase transport of blood substances into brain. We measured transfer constants (K(i)s) for the simultaneous passage of two intravenously delivered tracers ([C-14]sucrose, Mol wt=342. [H-3]inulin approximate to5,000) across the intact BBB in the rat, and 24 h after global cerebral ischemia (16-20 min duration) or 24, 48 or 72 h after focal ischemia (2 h duration). In both ischemia models, the upward increment in K-i (DeltaK(i)) for sucrose, indicating the extra injury-related tracer flux into brain, significantly exceeded that for inulin, as might be expected with faster diffusion of the smaller molecule through injury pores or channels. This inequality of DeltaK(i)s did not suggest a major role for convective, fluid-phase transport by endothelial vesicular or tubular structures and a predominance of diffusional transport was indicated.	Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada		Preston, E (corresponding author), Natl Res Council Canada, Inst Biol Sci, M54 Montreal Rd, Ottawa, ON K1A 0R6, Canada.	ed.preston@nrc.ca					AMTORP O, 1980, ACTA PHYSIOL SCAND, V110, P337, DOI 10.1111/j.1748-1716.1980.tb06678.x; BROADWELL RD, 1989, ACTA NEUROPATHOL, V79, P117, DOI 10.1007/BF00294368; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; COLE DJ, 1991, ACTA NEUROPATHOL, V82, P266, DOI 10.1007/BF00308811; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1988, J NEUROPATH EXP NEUR, V47, P443, DOI 10.1097/00005072-198807000-00005; HSU CY, 1989, ANN NY ACAD SCI, V559, P282; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; JOHSHITA H, 1990, STROKE, V21, P1051, DOI 10.1161/01.STR.21.7.1051; KLATZO I, 1994, ACTA NEUROCHIR, P3; LOSSINSKY AS, 1983, ACTA NEUROPATHOL, V61, P239, DOI 10.1007/BF00691992; LUCCHESI KJ, 1990, AM J PHYSIOL, V258, pH695, DOI 10.1152/ajpheart.1990.258.3.H695; MAYHAN WG, 1985, AM J PHYSIOL, V248, pH712, DOI 10.1152/ajpheart.1985.248.5.H712; Michel C, 1984, HDB PHYSL CARDIO 2 1, P309; OHNO K, 1978, AM J PHYSIOL, V235, pH299, DOI 10.1152/ajpheart.1978.235.3.H299; PARDRIDGE WM, 1991, PEPTIDE DRUG DELIVER, P149; PRESTON E, 1990, ACT NEUR S, V51, P174; PRESTON E, 1983, J NEUROSCI METH, V9, P45, DOI 10.1016/0165-0270(83)90108-5; Preston E, 1998, BRAIN RES BULL, V45, P111, DOI 10.1016/S0361-9230(97)00278-5; Preston E, 2001, J NEUROTRAUM, V18, P83, DOI 10.1089/089771501750055794; PRESTON E, 1993, NEUROSCI LETT, V149, P75, DOI 10.1016/0304-3940(93)90351-K; Preston E, 1997, BRAIN RES, V761, P4, DOI 10.1016/S0006-8993(97)00323-5; SAMPAOLO S, 1991, ACTA NEUROPATHOL, V82, P107, DOI 10.1007/BF00293952; SMITH KA, 1984, ANNU REV IMMUNOL, V2, P319, DOI 10.1146/annurev.immunol.2.1.319; Stewart PA, 2000, CELL MOL NEUROBIOL, V20, P149, DOI 10.1023/A:1007026504843; Vaz R, 1998, ACTA NEUROCHIR, V140, P76, DOI 10.1007/s007010050061; Xue D., 1998, Society for Neuroscience Abstracts, V24, P1955; ZIYLAN YZ, 1983, EXP NEUROL, V79, P845, DOI 10.1016/0014-4886(83)90047-X	28	23	24	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	MAR	2002	103	3					237	242		10.1007/s004010100458			6	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	528KV	WOS:000174243700006	11907803				2022-02-06	
J	Finnie, JW; Manavis, J; Blumbergs, PC; Summersides, GE				Finnie, JW; Manavis, J; Blumbergs, PC; Summersides, GE			Brain damage in sheep from penetrating captive bolt stunning	AUSTRALIAN VETERINARY JOURNAL			English	Article							AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; MESSENGER-RNA; UP-REGULATION; HEAD-INJURY; MODEL; EUTHANASIA; LAMBS	Objective To determine the severity and distribution of structural changes in the brains of adult sheep stunned by penetrating captive bolt. Procedure The unconstrained heads of ten, anaesthetised, unhorned, 2-year-old Merino sheep were impacted at the summit of the head with a penetrating captive bolt pistol. Six sheep were ventilated and four received no respiratory support. Two hours after impact, brains from the six ventilated sheep were perfusion-fixed with 4% paraformaldehyde. Sixteen whole, serial coronal sections from each brain were stained with haematoxylin and eosin and immunohistochemically for amyloid precursor protein, a sensitive marker of axonal and neuronal reaction in the brain after trauma. Pathological changes in these brains were then quantified by morphometric analysis. Results Structural change in all impacted brains was a mixture of focal injury around the wound track and more widely distributed damage in the cerebral hemispheres, cerebellum and brainstem, but varied considerably in severity between individual sheep. All nonventilated sheep died rapidly following respiratory arrest. Conclusions After penetrating captive bolt stunning, damage to the central reticular formation, axonal connections, and the cortical mantle is the likely reason for failure of respiratory control and traumatic loss of consciousness.	Inst Med & Vet Sci, Vet Serv Div, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia		Finnie, JW (corresponding author), Inst Med & Vet Sci, Vet Serv Div, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.						ANDREWS EJ, 1993, J AM VET MED ASSOC, V202, P230; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; *CAL DEP FOOD AGR, 1999, EM EUTH SHEEP GOATS; CAREY ME, 1995, NEUROSURG CLIN N AM, V6, P629; DALY CC, 1989, RES VET SCI, V46, P406, DOI 10.1016/S0034-5288(18)31189-5; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Finnie JW, 2000, AUST VET J, V78, P775, DOI 10.1111/j.1751-0813.2000.tb10451.x; Finnie JW, 1997, AUST VET J, V75, P204, DOI 10.1111/j.1751-0813.1997.tb10067.x; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LONGAIR J, 1991, CAN VET J, V32, P724; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van den Heuvel C, 2000, J CLIN NEUROSCI, V7, P140; [No title captured]	16	23	24	0	12	AUSTRALIAN VETERINARY ASSN	MELBOURNE	272 BRUNSWICK RD BRUNSWICK, MELBOURNE, VIC 3056, AUSTRALIA	0005-0423			AUST VET J	Aust. Vet. J.	JAN-FEB	2002	80	1-2					67	69		10.1111/j.1751-0813.2002.tb12053.x			3	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	524CR	WOS:000173994900039	12180883				2022-02-06	
J	Zhao, H; Huang, HW; Wu, GC; Cao, XD				Zhao, H; Huang, HW; Wu, GC; Cao, XD			Effect of orphanin FQ on interleukin-1 beta mRNA transcripts in the rat CNS	NEUROSCIENCE			English	Article						orphanin FQ; interleukin-1 beta; neurommurne; neuron; astrocyte; microglia	CENTRAL-NERVOUS-SYSTEM; OPIOID RECEPTOR; NOCICEPTIN/ORPHANIN FQ; MICROGLIA; INJURY; CELLS; BRAIN	To elucidate the mechanism of orphanin FQ on neuroimmune modulation, the relationship between orphanin FQ and interleukin-1beta in the rat CNS in vivo and in vitro was investigated. In our experiments, it was found that orphanin FQ and interleukin-1beta mRNA transcripts showed a similar distribution in cerebral cortex, hippocampus and hypothalamus. By using the in situ hybridization technique, down-regulation of interleukin-1beta mRNA transcripts by central administration of orphanin FQ was further identified in the traumatic animal model. Similar inhibitory effects were also observed on the number of microglia in the CNS. The effects produced by orphanin FQ were abolished by combination with its receptor (OP4)-specific antagonist [Phe(1)Psi(CH2-NH)Gly(2)]nociceptin-(1-13)-NH2, which suggested that the function of orphanin FQ might be attributable to the OP4 pathway. However, the effect on the number of astrocytes in the CNS remained unchanged, despite evidence that OP4 is expressed on astrocytes as well as on neurons and microglia. When analyzed by reverse transcription-polymerase chain reaction, interleukin-1beta gene expression was observed to be enhanced and inhibited in primary neuron and microglial cell cultures exposed to orphanin FQ respectively. Interleukin-1beta gene expression in astrocyte cultures was not affected by treatment with orphanin FQ. Our findings suggest that the neuroimmune function of orphanin FQ might be dependent on interleukin-1beta derived from microglia, and the interaction between microglia and neurons. (C) 2002 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Fudan Univ, Shanghai Med Coll, Dept Neurobiol, Natl Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai 200032, Peoples R China		Cao, XD (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Neurobiol, Natl Key Lab Med Neurobiol, Shanghai 200032, Peoples R China.						Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Anton B, 1996, J COMP NEUROL, V368, P229; BAN EM, 1993, NEUROSCIENCE, V52, P725, DOI 10.1016/0306-4522(93)90421-B; Buzas B, 1998, J NEUROCHEM, V71, P556; Calo G, 2000, BRIT J PHARMACOL, V129, P1261, DOI 10.1038/sj.bjp.0703219; DINARELLO CA, 1991, BLOOD, V77, P1627; Du LN, 1998, ACUPUNCTURE ELECTRO, V23, P1; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; HALFORD WP, 1995, J NEUROIMMUNOL, V59, P91, DOI 10.1016/0165-5728(95)00030-6; Henderson G, 1997, TRENDS PHARMACOL SCI, V18, P293, DOI 10.1016/S0165-6147(97)90645-3; Ikeda K, 1998, J COMP NEUROL, V399, P139, DOI 10.1002/(SICI)1096-9861(19980914)399:1<139::AID-CNE11>3.0.CO;2-C; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; LU LM, 1997, ACTA PHYSL SIN, V49, P235; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Meunier JC, 1997, EUR J PHARMACOL, V340, P1, DOI 10.1016/S0014-2999(97)01411-8; Mogil JS, 1996, NEUROSCIENCE, V75, P333, DOI 10.1016/0306-4522(96)00338-7; Mrak RE, 2000, J NEUROPATH EXP NEUR, V59, P471, DOI 10.1093/jnen/59.6.471; Peluso J, 1998, J NEUROIMMUNOL, V81, P184, DOI 10.1016/S0165-5728(97)00178-1; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229, DOI 10.1007/s004010050792; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Wang AJ, 1996, ACTA PHYSL SIN, V48, P348; WANG J, 2001, CHIN J NEUROSCI, V17, P368; ZHAO H, 2001, ACTA PHYSL SIN, V53, P209	25	23	24	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2002	114	4					1019	1031	PII S0306-4522(02)00233-6	10.1016/S0306-4522(02)00233-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	613LZ	WOS:000179134900019	12379256				2022-02-06	
J	Yorkston, KM; Spencer, K; Duffy, J; Beukelman, D; Golper, LA; Miller, R; Strand, E; Sullivan, M				Yorkston, KM; Spencer, K; Duffy, J; Beukelman, D; Golper, LA; Miller, R; Strand, E; Sullivan, M			Evidence-based medicine and practice guidelines: Application to the field of speech-language pathology	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							CLINICAL-PRACTICE GUIDELINES; TRAUMATIC BRAIN INJURY; TREATMENT EFFICACY; COGNITIVE REHABILITATION; CRITICAL-APPRAISAL; RESEARCH DESIGNS; QUALITY; CARE; DISORDERS; OUTCOMES	Medical speech-language pathology is turning to the tools of evidence-based medicine and practice guidelines as a mean of assisting in decision making and improving the quality of services to individuals with neurologic communication disorders. Evidence-based practice is an approach to decision making in which the clinician uses the best evidence available to decide upon the option that best suits their patients. Practice guidelines are explicit statements that assist practitioners and patients to make decisions about appropriate health care for specific clinical conditions. Trends leading to a proliferation of guidelines along with a critical review of their development and application to the field of speech-language pathology are provided. Development of evidence-based practice guidelines for the management of dysarthria is reviewed including descriptions of the writing committee and the panel of experts, development of the questions to be addressed, types of evidence included, and methods for rating the evidence.	Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; Mayo Clin, Dept Neurol, Div Speech Pathol, Rochester, MN USA; Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA; Vanderbilt Bill Wilkerson Ctr, Dept Speech & Hearing Sci, Nashville, TN USA; Vet Adm Puget Sound Hlth Syst, Dept Rehabil Med, Seattle, WA USA; Univ Nebraska, Munroe Meyer Inst Genet & Rehabil, Omaha, NE 68182 USA		Yorkston, KM (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.						AESCHLEMAN SR, 1991, REHABIL PSYCHOL, V36, P43, DOI 10.1037/0090-5550.36.1.43; *AM SPEECH LANG HE, 1998, PREF PRACT PATT PROF; BAUM HM, 1998, J MED SPEECH-LANG PA, V6, P55; BYNG S, 1998, MEASURING OUTCOMES S, P558; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chambless DL, 1998, J CONSULT CLIN PSYCH, V66, P7, DOI 10.1037/0022-006X.66.1.7; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; COOKE JP, 1996, CONT ENDOCRINOL, V1, P3; CROSBIE J, 1993, J CONSULT CLIN PSYCH, V61, P966, DOI 10.1037/0022-006X.61.6.966; *DHHS, 1994, FED REGISTER, V59, P19723; FIELD MJ, 1992, GUIDELINES CLIN PRAC, P426; Forbes SA, 1997, ARCH PHYS MED REHAB, V78, P1112, DOI 10.1016/S0003-9993(97)90137-4; Gallagher TM, 1998, FOLIA PHONIATR LOGO, V50, P165, DOI 10.1159/000021459; Garrard J, 1999, HLTH SCI LIT REV MAD; Glass, 1976, ED RES, V5, P3, DOI [10.2307/1174772ISSN0536-1036, 10.3102/0013189x005010003, DOI 10.3102/0013189X005010003]; Gray JAM, 1997, EVIDENCE BASED HEALT; GREENER J, 2000, COCHRANE LIB; GRESHAM GE, 1995, AHCRP PUBLICATION; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Hadorn DC, 1996, J CLIN EPIDEMIOL, V49, P749, DOI 10.1016/0895-4356(96)00019-4; Hayes O W, 1994, J Am Osteopath Assoc, V94, P732; Holland AL, 1996, J SPEECH HEAR RES, V39, pS27, DOI 10.1044/jshr.3905.s27; Johnston M. V., 1998, REHABILITATION MED P, P287; KEARNS K P, 1990, Seminars in Speech and Language, V11, P273, DOI 10.1055/s-2008-1064258; Lohr K N, 1994, Int J Qual Health Care, V6, P17; Lohr KN, 1998, HEALTH POLICY, V46, P1, DOI 10.1016/S0168-8510(98)00044-X; LOHR KN, 1995, J LAW MED ETHICS, V23, P49, DOI 10.1111/j.1748-720X.1995.tb01330.x; Miller RG, 1999, NEUROLOGY, V52, P1311, DOI 10.1212/WNL.52.7.1311; Olswang L. B., 1998, MEASURING OUTCOMES S, P134; Olswang L. B., 1990, TREATMENT EFFICACY R, P99; OLSWANG LB, 1993, J FLUENCY DISORD, V18, P125, DOI 10.1016/0094-730X(93)90002-L; Owens D K, 1993, Jt Comm J Qual Improv, V19, P248; Ringel SP, 1996, ARCH NEUROL-CHICAGO, V53, P867, DOI 10.1001/archneur.1996.00550090065012; ROBEY RR, 1999, CLIN APH C KEY W FLO; Sackett D., 1997, EVIDENCE BASED MED; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Solodky C, 1998, MED CARE, V36, pAS13, DOI 10.1097/00005650-199808001-00003; Stason WB, 1997, MED CARE, V35, pJS68, DOI 10.1097/00005650-199706001-00013; STASON WB, 1997, MED CARE S, V35, pJS78; Strand E. A., 1994, MOTOR SPEECH DISORDE, P37; Streiner DL, 1998, CAN J PSYCHIAT, V43, P737, DOI 10.1177/070674379804300709; TROMBLY C, 1995, AM J OCCUP THER, V49, P711, DOI 10.5014/ajot.49.7.711; West RR, 2000, POSTGRAD MED J, V76, P383, DOI 10.1136/pmj.76.897.383; WHURR R, 1992, EUR J DISORDER COMM, V27, P1; Woolf SH, 2000, J FAM PRACTICE, V49, P1081; Yorkston KM, 1996, J SPEECH HEAR RES, V39, pS46, DOI 10.1044/jshr.3905.s46; [No title captured]	48	23	23	0	9	SINGULAR PUBLISHING GROUP INC	CLIFTON PARK	5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	DEC	2001	9	4					243	256					14	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	502YW	WOS:000172771200006					2022-02-06	
J	Zhu, XL; Poon, WS; Chan, CH; Chan, SH				Zhu, XL; Poon, WS; Chan, CH; Chan, SH			Does intensive rehabilitation improve the functional outcome of patients with traumatic brain injury? Interim result of a randomized controlled trial	BRITISH JOURNAL OF NEUROSURGERY			English	Article						functional independent measurement; Glasgow Outcome Scale; intensive rehabilitation; traumatic brain injury	SEVERE HEAD-INJURY; STROKE; EXERCISE	To evaluate the effects of intensive rehabilitation on the functional outcome in patients with traumatic brain injury (TBI), we carried out a randomized controlled assessor-blind trial, comparing two groups of patients receiving different intensities of rehabilitation treatment (2 versus 4 h per day). Patients with moderate and severe TBI, aged from 12 to 65 years, were included. Glasgow Outcome Scale (GOS) and Functional Independent Measurement (FIM) were assessed monthly. The interim results of 36 cases showed that there was a trend of more patients in the study group achieving full FIM scores, and good GOS at 2 and 3 months, but the control group appeared to be catching up towards 6 months. Intensive rehabilitation may improve the early functional outcome of TBI patients. The interim results indicate that the study should be continued.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Neurosurg Unit, Hong Kong, Hong Kong, Peoples R China; Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; Shatin Cheshire Home, Hong Kong, Hong Kong, Peoples R China		Poon, WS (corresponding author), Prince Wales Hosp, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China.		Poon, Wai Sang/F-1558-2011	Chan, Chetwyn C. H./0000-0003-0307-6337			BARNES M, REHABILITATION TRAUM; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; EVANS CD, 1994, NEUROLOGICAL REHABIL, P141; FONG NK, 1997, HONG KONG J OCCUPATI, V8, P39; GARRAWAY WM, 1980, BRIT MED J, V280, P1040, DOI 10.1136/bmj.280.6220.1040; GARRAWAY WM, 1980, BRIT MED J, V281, P828; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HETHERINGTON H, 1994, INJURY, V25, P527, DOI 10.1016/0020-1383(94)90095-7; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHNSTON MV, 1994, ARCH PHYSICAL MED RE, V75, P2; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; LAU AEC, 1998, HONG KONG J OCCUPATI, V9, P52; LEE CMS, 1998, HONG KONG J OCCUPATI, V9, P52; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Marshall LF, 1991, J NEUROSURG S, V75, P14; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; MCLELLAN D, 1988, MANAGEMENT TRAUMATIC; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; PRIGATANO GP, 1988, BNI Q, V4, P30; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rice-Oxley M, 1999, CLIN REHABIL, V13, P7, DOI 10.1191/026921599668051623; SHIEL A, 1999, CLIN REHABIL, V13, P90; SLADE A, 1999, CLIN REHABIL, V13, P94; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Turner-Stokes L, 1999, CLIN REHABIL, V13, P3, DOI 10.1191/026921599673346206; YU J, 1976, ARCH PHYS MED REHAB, V57, P38	38	23	25	0	5	CARFAX PUBLISHING	BASINGSTOKE	RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2001	15	6					464	473		10.1080/02688690120097688			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	513NZ	WOS:000173385800003	11813997				2022-02-06	
J	Cheliout-Heraut, F; Rubinsztajn, R; Ioos, C; Estournet, B				Cheliout-Heraut, F; Rubinsztajn, R; Ioos, C; Estournet, B			Prognostic value of evoked potentials and sleep recordings in the prolonged comatose state of children. Preliminary data	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			English	Article						anoxic coma; children; evoked potentials; sleep recordings; traumatic coma; wake-sleep cycle	SEVERE HEAD-INJURY; BRAIN-STEM; PREDICTION; PATIENT; ELECTROENCEPHALOGRAM; ABNORMALITIES; PATTERNS; ARREST; COMAS; EEG	Objectives - Sleep recordings and evoked potentials (EPs) were, used in five comatose children to evaluate their predictive value for outcome following a severe comatose state. Methods and subjects - The protocol included EEG, Brainstem Evoked Responses (BERs), Somatosensory Evoked Potentials (SEPs) and polysomnography. From 10 to 15 days post-coma (D10 to D15), EEG and clinical examinations were carried out every second day, then one day in four from 15 to 30 days post-coma (D15 to D30), and one day in seven from D30 to six months (M6). Evoked potentials and Polysomnography were recorded on D10-D15 or D30 in the second month (M2) and in M6. Of the five children, three were in anoxic coma and two in traumatic coma. All had extensive lesions and a Glasgow Coma Scale (GCS) score of less than five. The results of the EEG, polysomnographic and EP recordings were compared to the clinical outcome. Results and conclusion - In the three anoxic comas we observed BER abnormalities and the absence of SEP N20 associated with wide cortical lesions with brainstem extension. Sleep recordings showed major alterations of the wake-sleep cycle without any improvement in M6, Abnormalities included loss of the normal REM-sleep pattern associated with alteration of NREM sleep and periods of increase in motor activity without EEG arousal. This sleep pattern appeared to be associated with involvement of the brainstem. in the two traumatic comas, alterations of the early cortical SEP responses were less severe and the BERs were normal. Some sleep spindles were observed as well as the persistence of sleep cycles in the first weeks post-coma. The combined use of EEG, EPs and polysomnography improved the outcome prediction in comparison with the use of just one modality. EPs and sleep recordings were far superior to clinical evaluation and to GCS in the appreciation of the functional status of comatose children. The reappearence of sleep patterns is considered to be of favorable prognosis for outcome of the coma state, as is the presence of sleep spindles in post-trauma coma. This study showed that EPs and sleep recordings help to further distinguish between patients with good or bad outcomes. (C) 2001 Editions scientifiques et medicales Elsevier SAS.	Hop Raymond Poincare, Serv Explorat Fonctionnelles, F-92380 Garches, France; Hop Raymond Poincare, Serv Pediat, F-92380 Garches, France		Cheliout-Heraut, F (corresponding author), Hop Raymond Poincare, Serv Explorat Fonctionnelles, 104 Blvd R Poincare, F-92380 Garches, France.						BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; BERGAMASCO B, 1968, ELECTROEN CLIN NEURO, V24, P374, DOI 10.1016/0013-4694(68)90198-3; BRICOLO A, 1976, CLIN ELECTROENCEPHAL, V7, P184, DOI 10.1177/155005947600700402; BRITT CW, 1981, NEUROLOGY, V31, P393; BRUNKO E, 1987, ELECTROEN CLIN NEURO, V66, P15, DOI 10.1016/0013-4694(87)90133-7; BRUNKO E, 1985, ELECTROEN CLIN NEURO, V62, P338, DOI 10.1016/0168-5597(85)90042-5; CHATRIAN GE, 1963, ELECTROENCEPHALOGR C, V13, P272; Cheliou-Heraut F., 1992, Neurophysiologie Clinique, V22, P269, DOI 10.1016/S0987-7053(05)80259-X; Courjon J, 1971, Rev Electroencephalogr Neurophysiol Clin, V1, P133, DOI 10.1016/S0370-4475(71)80054-0; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Facco E, 1998, ELECTROEN CLIN NEURO, V107, P332, DOI 10.1016/S0013-4694(98)00080-7; FELDMAN MH, 1971, NEUROLOGY, V21, P459, DOI 10.1212/WNL.21.5.459; FREEMON FR, 1974, ELECTROEN CLIN NEURO, V36, P657, DOI 10.1016/0013-4694(74)90232-6; GEORGE B, 1986, NEUROCHIRURGIA, V29, P45; GIUBILEI F, 1995, J NEUROL NEUROSUR PS, V58, P484, DOI 10.1136/jnnp.58.4.484; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit JM, 1999, NEUROPHYSIOL CLIN, V29, P301, DOI 10.1016/S0987-7053(99)90044-8; GUILLEMINAULT C, 1973, ELECTROEN CLIN NEURO, V34, P177, DOI 10.1016/0013-4694(73)90045-X; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; HANSOTIA P, 1981, NEUROLOGY, V31, P83, DOI 10.1212/WNL.31.1.83; HULIHAN JF, 1994, NEUROLOGY, V44, P758, DOI 10.1212/WNL.44.4.758; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; JANKEL WR, 1985, J CLIN NEUROPHYSIOL, V2, P1, DOI 10.1097/00004691-198501000-00001; JENNETT B, 1975, LANCET, V1, P480; JOUET M, 1961, REV NEUROL, V105, P181; MARKAND ON, 1976, NEUROLOGY, V26, P769, DOI 10.1212/WNL.26.8.769; MUNARI C, 1981, ELECTROEN CLIN NEURO, V51, P170, DOI 10.1016/0013-4694(81)90006-7; NAQUET R, 1967, REV NEUROL-FRANCE, V117, P512; PAMPIGLIONE G, 1968, Lancet, P1261; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; Rechtschaffen A., 1968, MANUAL STANDARDIZED; ROSENBERG C, 1984, ARCH NEUROL-CHICAGO, V41, P835, DOI 10.1001/archneur.1984.04050190041012; RUMPL E, 1980, EEG-EMG-Z ELEK ELEKT, V11, P43; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; TURAZZI S, 1977, LANCET, V2, P62; WALSER H, 1985, ARCH NEUROL-CHICAGO, V42, P32, DOI 10.1001/archneur.1985.04060010038013; WALSER H, 1981, EEG-EMG-Z ELEK ELEKT, V12, P198; WILKUS RJ, 1971, ARCH NEUROL-CHICAGO, V24, P538, DOI 10.1001/archneur.1971.00480360072009; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	41	23	24	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0987-7053	1769-7131		NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.	OCT	2001	31	5					283	292		10.1016/S0987-7053(01)00270-2			10	Clinical Neurology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	492GW	WOS:000172160900001	11817270				2022-02-06	
J	Kushner, DS				Kushner, DS			Concussion in sports: Minimizing the risk for complications	AMERICAN FAMILY PHYSICIAN			English	Article							HEAD-INJURY; CONTACT-SPORTS; MILD; GUIDELINES; MANAGEMENT; TRAUMA	Mild traumatic brain injury, or concussion, is a common consequence of collisions, falls and other forms of contact in sports. Concussion may be defined as an acute trauma-induced alteration of mental function lasting fewer than 24 hours, with or without preceding loss of consciousness. The physician's responsibilities in assessing an athlete with concussion include determining the need for emergency intervention and offering guidance about the athlete's ability to return to play. Concussion may be complicated by cerebral edema related to the second impact syndrome, cumulative neuropsychologic deficits, intracranial bleeding or the postconcussion syndrome. The risk of complications is increased in athletes who prematurely return to play and in those with prolonged loss of consciousness or post-traumatic amnesia. An athlete with prolonged loss of consciousness or signs and symptoms that worsen or persist after a concussion should be evaluated in the emergency department. An athlete should not be allowed to resume sports participation until all symptoms of a concussion have resolved.	Univ Miami, Sch Med, Dept Neurol, Miami, FL 33101 USA		Kushner, DS (corresponding author), Univ Miami, Sch Med, Dept Neurol, POB 016960, Miami, FL 33101 USA.		Kushner, David S./AAW-4951-2020	Kushner, David S./0000-0001-6090-6304			Bergman DA, 1999, PEDIATRICS, V104, P1407; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; *COL MED SOC, 1991, GUID MAN CONC SPORTS; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DACEY RG, 1993, HEAD INJURY, P159; GRONWALL D, 1975, LANCET, V2, P995; HAAS DC, 1986, BRAIN, V109, P251, DOI 10.1093/brain/109.2.251; HARRISON D W, 1990, Journal of Emergency Medicine, V8, P21, DOI 10.1016/0736-4679(90)90381-5; JENNETT B, 1973, SCOT MED J, V18, P8, DOI 10.1177/003693307301800103; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lawler KA, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199612000-00005; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LIAU LM, 1996, NEUROLOGICAL SURG, P1549; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; RUBIN W, 1990, NEUROL CLIN, V8, P225, DOI 10.1016/S0733-8619(18)30352-9; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YAMAMOTO LG, 1988, CLIN PEDIATR, V27, P479, DOI 10.1177/000992288802701003	25	23	23	0	3	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	SEP 15	2001	64	6					1007	1014					8	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UU	WOS:000171188200012	11578022				2022-02-06	
J	Baker, F				Baker, F			The effects of live, taped, and no music on people experiencing posttraumatic amnesia	JOURNAL OF MUSIC THERAPY			English	Article							CLOSED-HEAD-INJURY; TRAUMATIC BRAIN INJURY; AGITATION; THERAPY; SCALE; REHABILITATION; ORIENTATION; DEMENTIA; INTERVENTION; BEHAVIOR	This study compared the effects of live, taped, and no music, on agitation and orientation levels of people experiencing posttraumatic amnesia (PTA). Participants (N = 22) were exposed to all 3 conditions, twice over 6 consecutive days. Songs used in the live and taped music conditions were identical and were selected based on participants' own preferred music. Pre and posttesting was conducted for each condition using the Agitated Behavior Scale (Corrigan, 1989) and the Westmead PTA Scale (Shores, Marosszeky, Sandanam, Batchelor, 1986). Participants' memory for the music used was also tested and compared with their memory for pictorial material presented in the Westmead PTA Scale. Results indicate that music significantly reduced agitation (p <. 0001) and enhanced orientation (p < .001) however, the difference between live and taped music was not significant (p =.7). The mean number of pictures in the Westmead PTA scale recalled was 0.84 and the mean number of music selections recalled was 1.22 but this difference was not significant (p =. 7). However, the trend suggests that music selections are more easily encoded in memory and then retrieved on request, than that of pictures. Analysis of responses in a follow-up assessment questionnaire showed that 77% of participants recalled the music program while in PTA, indicating that it reached the memory threshold. Sixty-four percent recalled the live music and 55% recalled the taped music condition however this difference was not significant (p = .7). Results suggest that music therapy programs have an important role to play in the management of people in PTA.	Sogn & Fjordane Coll, Sandane, Norway		Baker, F (corresponding author), Sogn & Fjordane Coll, Sandane, Norway.						ALDRIDGE D, 1990, J ROY SOC MED, V83, P345, DOI 10.1177/014107689008300602; ALDRIDGE D, 1991, ART PSYCHOTHER, V18, P359, DOI 10.1016/0197-4556(91)90077-N; ALDRIDGE D, 1991, ART PSYCHOTHER, V18, P59, DOI 10.1016/0197-4556(91)90008-X; Aldridge D, 1996, MUSIC THERAPY RES PR; ANSDELL G, 1995, MUSIC LIFE CREATIVE; AZOUVI P, 1996, P 5 C INT ASS STUD T, P124; Bailey LM, 1983, MUSIC THERAPY, V3, P17; BRIGHT R, 1999, MUSICMEDICINE, V3, P255; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Brotons M, 1996, J MUSIC THER, V33, P2, DOI 10.1093/jmt/33.1.2; CASBY JA, 1994, AM J OCCUP THER, V48, P883, DOI 10.5014/ajot.48.10.883; Clair A. A., 1994, Activities, Adaptation & Aging, V19, P61, DOI 10.1300/J016v19n01_05; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; FITZGERALDCLOUT.ML, 1993, MUSIC THERAPY PERSPE, V11, P32, DOI DOI 10.1093/MTP/11.1.32; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Gerdner L A, 1993, Arch Psychiatr Nurs, V7, P284, DOI 10.1016/0883-9417(93)90006-I; Goddaer J, 1994, Arch Psychiatr Nurs, V8, P150, DOI 10.1016/0883-9417(94)90048-5; GROENE RW, 1993, J MUSIC THER, V30, P138, DOI 10.1093/jmt/30.3.138; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Hanser S. B., 1995, ART SCI MUSIC THERAP, P342; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; HOWARD ME, 1988, J HEAD TRAUMA REHAB, V3, P14; Kennelly J, 1997, AUSTR J MUSIC THERAP, V8, P18; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MALKMUS D, 1980, REHABILITATION HEAD; MINTZBITMAN S, 1987, COGNITIVE REHABILITA, V5, P22; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; Plylar P A, 1989, J Neurosci Nurs, V21, P353; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rosenfeld JV, 1999, MUSICMEDICINE 3 EXPA, V3, P35; SANDEL ME, 1995, NEUROREHABILITATION, V5, P299, DOI 10.3233/NRE-1995-5404; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Sholberg M. M., 1989, INTRO COGNITIVE REHA; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Thomas DW, 1997, J MUSIC THER, V34, P246, DOI 10.1093/jmt/34.4.246; Whitcomb J. B., 1993, Activities, Adaptation & Aging, V18, P57, DOI 10.1300/J016v18n02_05; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Yuen HK, 1996, BRAIN INJURY, V10, P229, DOI 10.1080/026990596124548; Zafonte RD, 1997, J HEAD TRAUMA REHAB, V12, P78, DOI 10.1097/00001199-199704000-00008; Zencius AH, 1998, BRAIN INJURY, V12, P53, DOI 10.1080/026990598122854	48	23	23	0	13	NATL ASSOC MUSIC THERAPY INC	SILVER SPRING	8455 COLESVILLE RD, STE 1000, SILVER SPRING, MD 20910 USA	0022-2917			J MUSIC THER	J. Music Ther.	FAL	2001	38	3					170	192		10.1093/jmt/38.3.170			23	Music; Rehabilitation	Social Science Citation Index (SSCI)	Music; Rehabilitation	473PL	WOS:000171054500001	11570931	Green Submitted			2022-02-06	
J	Regner, A; Alves, LB; Chemale, I; Costa, MS; Friedman, G; Achaval, M; Leal, L; Emanuelli, T				Regner, A; Alves, LB; Chemale, I; Costa, MS; Friedman, G; Achaval, M; Leal, L; Emanuelli, T			Neurochemical characterization of traumatic brain injury in humans	JOURNAL OF NEUROTRAUMA			English	Article						GFAP; human; glutamate; traumatic brain injury	D-ASPARTATE RECEPTOR; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; BINDING-SITES; L-<H-3>GLUTAMATE BINDING; GLUTAMATE NEUROTOXICITY; EXTRACELLULAR GLUTAMATE; <H-3>MK-801 BINDING; HUMAN CEREBELLUM	Trauma is the leading cause of death in individuals between the ages of 1 and 44 years. And, in the case of severe head injury mortality can reach as high as 35-70%. Despite this fact, there has been little progress in the development of effective pharmacological agents to protect brain injured patients. To date, there is little data on the mechanisms involved in neuronal cellular insult after severe head injury, especially in humans. Glutamate acts both as a primary excitatory neurotransmitter and a potential neurotoxin within the mammalian brain. Evidence indicates that hyperactivity of the glutamate system contributes to neuronal death in brain trauma. Also, in animal models of neurotrauma, this neural injury is followed by gliosis which has been linked to the severity of brain injury. To investigate the glutamate system in brain trauma, we carried out [H-3]glutamate and [H-3]MK801 (a noncompetitive NMDA-receptor antagonist) binding and [H-3]glutamate uptake assays in human cerebral cortex preparations obtained from severely brain injured and control victims. Additionally, to investigate gliosis following brain injury, we performed GFAP immunohistochemistry. There were no significant differences in [H-3]glutamate binding (affinity or density of sites) between the control and head injured groups. In contrast, cerebral cortical [H-3]MK801 binding revealed both a significant increase in the density of sites (B-max) and a decrease in the dissociation constant (Kd) in the head injured group when compared to controls. There were no significant differences in [H-3]glutamate uptake between groups. The injured brains presented an increased number of GFAP-positive astrocytes and more intense GFAP reaction in comparison to control brains. In the context of traumatic brain injury, our results encourage further investigation into compounds capable of selective modulation of NMDA receptor subtype in humans while also therapeutically manipulating glial cell responses following brain trauma.	Univ Fed Rio Grande Sul, Dept Biochem, Porto Alegre, RS, Brazil; Univ Fed Rio Grande Sul, Dept Morphol Sci, Porto Alegre, RS, Brazil; Hosp Pronto Socorro Porto Alegre, Emergency Room, Porto Alegre, RS, Brazil; Hosp Pronto Socorro Porto Alegre, Neurosurg Unit, Porto Alegre, RS, Brazil; Univ Fed Rio Grande Sul, Hosp Clin Porto Alegre, Emergency Care Unit, Porto Alegre, RS, Brazil; Univ Fed Rio Grande Sul, Hosp Clin Porto Alegre, Intens Care Unit, Porto Alegre, RS, Brazil; Univ Fed Santa Maria, Dept Food Technol & Sci, BR-97119900 Santa Maria, RS, Brazil		Regner, A (corresponding author), Univ Fed Rio Grande Sul, Dept Biochem, Porto Alegre, RS, Brazil.		Emanuelli, Tatiana/AAX-9075-2020; Regner, Andrea/M-2596-2014; Friedman, Gilberto/F-7212-2015; Friedman, Gilberto/F-7208-2015	Emanuelli, Tatiana/0000-0003-0168-3416; Regner, Andrea/0000-0002-6657-7991; Friedman, Gilberto/0000-0001-9369-2488			Alessandri B, 1999, ACT NEUR S, V75, P21; Baldwin SA, 1996, GLIA, V16, P266; Bridges RJ, 1999, CURR PHARM DESIGN, V5, P363; BROCKER B, 1991, CURR CONCEPTS IMAGIN, V1, P387; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chan H, 1999, NEUROCHEM RES, V24, P1397, DOI 10.1023/A:1022532623281; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; COWBURN RF, 1988, J NEUROCHEM, V50, P1872, DOI 10.1111/j.1471-4159.1988.tb02491.x; COX JA, 1989, BRAIN RES, V499, P267, DOI 10.1016/0006-8993(89)90774-9; CROSS A, 1986, J NEUROCHEM, V47, P1463, DOI 10.1111/j.1471-4159.1986.tb00779.x; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; Duhaime AC, 1996, NEUROTRAUMA, P365; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; Emanuelli T, 1998, BIOCHEM MOL BIOL INT, V44, P1265; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N; HUBBARD CM, 1989, BRAIN RES, V486, P170, DOI 10.1016/0006-8993(89)91290-0; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Knipper M, 1997, NEUROCHEM INT, V31, P659, DOI 10.1016/S0197-0186(97)00009-0; Kraus J, 1996, NEUROTRAUMA, P13; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Marion D W, 1999, Clin Neurosurg, V45, P184; Merchant RE, 1999, ANN NY ACAD SCI, V890, P42, DOI 10.1111/j.1749-6632.1999.tb07979.x; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Peng TI, 1998, MOL PHARMACOL, V53, P974; PIGGOTT MA, 1992, J NEUROCHEM, V58, P1001, DOI 10.1111/j.1471-4159.1992.tb09354.x; PIGGOTT MA, 1992, BRAIN RES, V588, P277, DOI 10.1016/0006-8993(92)91586-4; Porco JA, 2000, COMB CHEM HIGH T SCR, V3, P93, DOI 10.2174/1386207003331715; PROCTER AW, 1991, J NEUROCHEM, V56, P299, DOI 10.1111/j.1471-4159.1991.tb02596.x; PROCTER AW, 1989, J NEUROCHEM, V53, P698, DOI 10.1111/j.1471-4159.1989.tb11760.x; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Rocha E, 1998, NEUROREPORT, V9, P3971, DOI 10.1097/00001756-199812010-00037; STEELE JE, 1991, J NEUROCHEM, V56, P1248, DOI 10.1111/j.1471-4159.1991.tb11418.x; SUN FY, 1994, BRAIN RES, V661, P63, DOI 10.1016/0006-8993(94)91181-9; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; TSIOTOS P, 1989, BRAIN RES, V481, P87, DOI 10.1016/0006-8993(89)90487-3; TSUNG IP, 1998, MOL PHARMACOL, V53, P974; Valadka A, 2000, TRAUMA, P377; VALADKA AB, 1996, TRAUMA, P267; Vandenberg RJ, 1998, CLIN EXP PHARMACOL P, V25, P393, DOI 10.1111/j.1440-1681.1998.tb02221.x; VARGAS F, 1993, GEN PHARMACOL, V24, P1257, DOI 10.1016/0306-3623(93)90378-B; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; VIJAYAN VK, 1990, MOL CHEM NEUROPATHOL, V13, P107, DOI 10.1007/BF03159912; Wood AM, 1998, J NEUROCHEM, V70, P677	59	23	26	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2001	18	8					783	792		10.1089/089771501316919148			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	464AG	WOS:000170509600004	11526984				2022-02-06	
J	Golding, EM; You, JP; Robertson, CS; Bryan, RM				Golding, EM; You, JP; Robertson, CS; Bryan, RM			Potentiated endothelium-derived hyperpolarizing factor-mediated dilations in cerebral arteries following mild head injury	JOURNAL OF NEUROTRAUMA			English	Article						endothelium-derived hyperpolarizing factor; middle cerebral artery; nitric oxide; purinoceptors; traumatic brain injury; vascular smooth muscle	CORTICAL IMPACT INJURY; TRAUMATIC BRAIN INJURY; NITRIC-OXIDE; BLOOD-FLOW; RAT; ACETYLCHOLINE; RESPONSES; CHANNELS; TONE; EDHF	Evidence in the literature suggests that endothelium-derived hyperpolarizing factor (EDHF) may act in a compensatory manner such that during conditions of compromised nitric oxide (NO), EDHF serves as a back-up mechanism. Given that constitutive NO synthase is chronically downregulated after head trauma, we tested the hypothesis that EDHF is potentiated following injury. Male adult rats were subjected to either sham injury (n = 27) or mild controlled cortical impact (CCI) injury (n = 26). Branches of the middle cerebral artery (MCA) directly within the contusion site were harvested either 1 or 24 h later, pressurized to 60 mm Hg in a vessel chamber and allowed to develop spontaneous tone. Relaxation to luminal application of adenosine triphosphate (ATP) was similar in all groups. Relaxation to ATP in the presence of L-NAME (N(G)-nitro-L-arginine methyl ester) and indomethacin was similar in all groups except for vessels isolated at 24 h following mild CCI injury. In this case, L-NAME and indomethacin had no effect on the ATP-mediated dilation. The ATP-mediated dilation in L-NAME and indomethacin-treated MCA branches was inhibited by charybdotoxin, an inhibitor of large conductance Ca2+-sensitive K+ channels. These findings suggest that there is a significant potentiation of the EDHF-mediated dilation to ATP in cerebral arteries isolated at 24 h following mild CCI injury.	Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA		Golding, EM (corresponding author), Baylor Coll Med, Dept Anesthesiol, 1 Baylor Plaza,Suite 434D, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037250, P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 37250, P01-NS 27616] Funding Source: Medline		ASANO M, 1993, BRIT J PHARMACOL, V108, P214, DOI 10.1111/j.1476-5381.1993.tb13465.x; BRAYDEN JE, 1990, AM J PHYSIOL, V259, pH668, DOI 10.1152/ajpheart.1990.259.3.H668; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; CHEN G, 1988, BRIT J PHARMACOL, V95, P1165, DOI 10.1111/j.1476-5381.1988.tb11752.x; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; GARLAND CJ, 1995, TRENDS PHARMACOL SCI, V16, P23, DOI 10.1016/S0165-6147(00)88969-5; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GOLDING EM, 1999, AM J PHYSIOL, V277, P1457; Hecker M, 2000, NEWS PHYSIOL SCI, V15, P1; Huang A, 2000, AM J PHYSIOL-HEART C, V278, pH762, DOI 10.1152/ajpheart.2000.278.3.H762; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; Malmsjo M, 1999, CARDIOVASC RES, V43, P200, DOI 10.1016/S0008-6363(99)00062-0; Marrelli SP, 1999, AM J PHYSIOL-HEART C, V276, pH33, DOI 10.1152/ajpheart.1999.276.1.H33; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; MONCADA S, 1991, PHARMACOL REV, V43, P109; NAJIBI S, 1994, AM J PHYSIOL, V266, pH2061, DOI 10.1152/ajpheart.1994.266.5.H2061; TAYLOR SG, 1988, BRIT J PHARMACOL, V94, P853, DOI 10.1111/j.1476-5381.1988.tb11597.x; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Waldron GJ, 1999, BRIT J PHARMACOL, V128, P653, DOI 10.1038/sj.bjp.0702858; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; You JP, 1997, AM J PHYSIOL-HEART C, V273, pH1472, DOI 10.1152/ajpheart.1997.273.3.H1472; You JP, 1999, AM J PHYSIOL-HEART C, V277, pH893, DOI 10.1152/ajpheart.1999.277.3.H893; You JP, 1999, STROKE, V30, P1125, DOI 10.1161/01.STR.30.5.1125	28	23	24	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2001	18	7					691	697		10.1089/089771501750357636			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	457CK	WOS:000170119400005	11497095				2022-02-06	
J	Demakis, GJ; Sweet, JJ; Sawyer, TP; Moulthrop, M; Nies, K; Clingerman, S				Demakis, GJ; Sweet, JJ; Sawyer, TP; Moulthrop, M; Nies, K; Clingerman, S			Discrepancy between predicted and obtained WAIS-R IQ scores discriminates between traumatic brain injury and insufficient effort	PSYCHOLOGICAL ASSESSMENT			English	Article; Proceedings Paper	Annual Meeting of the American-Psychological-Association	AUG 18-24, 1999	BOSTON, MA	Amer Psychol Assoc			ESTIMATING PREMORBID INTELLIGENCE; INCOMPLETE EFFORT; CROSS-VALIDATION; SIMULATION INDEX; MEMORY; PERFORMANCE; LITIGATION	This study examines how well the discrepancy between predicted and obtained Wechsler Adult Intelligence Scale- Revised (WAIS-R) scores discriminate between insufficient effort (IE) and traumatic brain injury (TBI). The 27 IE patients performed significantly more poorly on the WAIS-R than the 48 moderate-severe TBI patients. Premorbid IQs were calculated with formulae that use demographics (Barona Index) or demographics and WAIS-R performance (Best-3 and the Oklahoma Premorbid Intelligence Estimation). Predictions were similar on the Barona, but IE patients' predicted IQs were lower than TBIs for measures with a performance component, IE patients demonstrated a greater discrepancy score (i.e., predicted IQ - obtained IQ) than TBIs; variable levels of sensitivity and specificity were obtained when discriminate functions were developed on these scores. The potential advantage of using discrepancy scores Versus performance-based measures to detect insufficient effort is discussed.	Elmhurst Coll, Dept Psychol, Elmhurst, IL 60126 USA; Northwestern Univ, Evanston Hosp, Dept Psychiat & Behav Sci, Evanston, IL 60201 USA; Northwestern Univ, Sch Med, Evanston, IL USA; Cook Cty Hosp, Dept Psychiat, Chicago, IL 60612 USA		Demakis, GJ (corresponding author), Elmhurst Coll, Dept Psychol, 190 Prospect Ave, Elmhurst, IL 60126 USA.	georged@elmhurst.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; Axelrod BN, 1999, J CLIN EXP NEUROPSYC, V21, P368, DOI 10.1076/jcen.21.3.368.916; Axelrod BN, 1999, ARCH CLIN NEUROPSYCH, V14, P341, DOI 10.1016/S0887-6177(98)00028-6; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; EPPINGER MG, 1987, J CONSULT CLIN PSYCH, V55, P86, DOI 10.1037/0022-006X.55.1.86; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; GOUVIER WD, 1983, INT J CLIN NEUROPSYC, V5, P119; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Milanovich JR, 1996, ARCH CLIN NEUROPSYCH, V11, P53, DOI 10.1016/0887-6177(95)00016-X; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PAOLO AM, 1992, ARCH CLIN NEUROPSYCH, V7, P135; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Putnam SH, 1999, STUD NEUROPSYCHOL DE, P39; Rawling P, 1990, NEUROPSYCHOLOGY, V4, P223, DOI 10.1037/0894-4105.4.4.223; Reitan RM, 1997, CLIN NEUROPSYCHOL, V11, P69, DOI 10.1080/13854049708407031; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; ROGERS R, 1990, PROF PSYCHOL-RES PR, V21, P182; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; SmithSeemiller L, 1997, ARCH CLIN NEUROPSYCH, V12, P739, DOI 10.1016/S0887-6177(97)00047-4; SQUIRE LR, 1989, J NEUROSCI, V9, P828; Stevens K B, 1999, Appl Neuropsychol, V6, P68, DOI 10.1207/s15324826an0602_2; Strauss E, 2000, PSYCHOL ASSESSMENT, V12, P237, DOI 10.1037/1040-3590.12.3.237; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tulsky DS, 2000, PSYCHOL ASSESSMENT, V12, P253, DOI [10.1037/1040-3590.12.3.253, 10.1037//1040-3590.12.3.253]; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Wechsler D., 1981, WAIS R MANUAL WECHSL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	44	23	24	1	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2001	13	2					240	248		10.1037//1040-3590.13.2.240			9	Psychology, Clinical	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	470VV	WOS:000170892600007	11433798				2022-02-06	
J	Stover, JF; Schoning, B; Sakowitz, OW; Woiciechowsky, C; Unterberg, AW				Stover, JF; Schoning, B; Sakowitz, OW; Woiciechowsky, C; Unterberg, AW			Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis factor-alpha following controlled cortical impact injury in rats	JOURNAL OF NEUROSURGERY			English	Article						calcineurin; cytokine; brain edema; excitotoxicity; immunosuppression; neuroprotection; rat	TRAUMATIC BRAIN INJURY; NITRIC-OXIDE SYNTHASE; CLOSED-HEAD INJURY; MITOCHONDRIAL DYSFUNCTION; CYCLOSPORINE-A; CALCINEURIN INHIBITORS; CEREBRAL-ISCHEMIA; ARTERY-OCCLUSION; TNF-ALPHA; FK506	Object. Disturbance of calcium homeostasis contributes to evolving tissue damage and energetic impairment following traumatic brain injury (TBI). Calcium-mediated activation of calcineurin results in production of tissue-damaging nitric oxide and free oxygen radicals. Inhibition of calcineurin induced by the immunosuppressant tacrolimus (FK506) has been shown to reduce structural and functional damage after ischemia. The aims of the present study were to investigate time- and dose-dependent short-term antiedematous effects of tacrolimus following TBI. Methods. A left temporoparietal confusion (controlled cortical impact injury [CCII]) was induced in 51 male Sprague-Dawley rats. Tacrolimus (1 or 3 mg/kg body weight) was administered by a single intraperitoneal injection at 5 minutes, 30 minutes, or 4 hours after CCII occurred. Control rats received physiological saline. Water contents of traumatized and nontraumatized hemispheres, as well as cerebrospinal fluid (CSF) levels of mediators reflecting tissue damage (the proinflammatory cytokines interleukin [IL]-6 and tumor necrosis factor [TNF]-alpha, the excitotoxin glutamate, and the adenosine triphosphate-degradation product hypoxanthine), were determined 24 hours after trauma. Although CSF levels of IL-6 and TNF-alpha were completely suppressed by tacrolimus at all time points and at both concentrations. CSF levels of glutamate and hypoxanthine, as well as edema formation, were only marginally influenced. Significant reduction of cerebral water content was confined to nontraumatized hemispheres. In addition, the higher dose of tacrolimus failed to exert significant antiedematous effects on traumatized hemispheres. Conclusions. Under the present study design, the potency of tacrolimus in reducing edema formation following CCII seems limited. However, its immunosuppressive effects could be of value in influencing the posttraumatic inflammatory response known to aggravate tissue damage.	Charite Virchow Med Ctr, Dept Neurosurg, D-13353 Berlin, Germany		Stover, JF (corresponding author), Charite Virchow Med Ctr, Dept Neurosurg, Augustenburger Pl 01, D-13353 Berlin, Germany.	john.stover@charite.de		Sakowitz, Oliver/0000-0003-3248-6335			Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Butcher SP, 1997, J NEUROSCI, V17, P6939; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9808, DOI 10.1073/pnas.90.21.9808; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; GarciaCriado FJ, 1997, TRANSPLANTATION, V64, P594, DOI 10.1097/00007890-199708270-00008; GOLD BG, 1995, J NEUROSCI, V15, P7509; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Ide T, 1996, NEUROSCI LETT, V204, P157, DOI 10.1016/0304-3940(96)12352-1; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; McIntosh TK, 1996, LAB INVEST, V74, P315; MOIA LJMP, 1994, BRAIN RES, V648, P337, DOI 10.1016/0006-8993(94)91138-X; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schinder AF, 1996, J NEUROSCI, V16, P6125; Sharkey J, 1996, STROKE, V27, P2282, DOI 10.1161/01.STR.27.12.2282; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Squadrito F, 1999, BRIT J PHARMACOL, V127, P498, DOI 10.1038/sj.bjp.0702528; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; TAMURA F, J GASTROENTEROL HEPA, V13, P703; Tokime T, 1996, NEUROSCI LETT, V206, P81, DOI 10.1016/S0304-3940(96)12438-1; Toulmond S, 1996, TRENDS NEUROSCI, V19, P409; Tsujikawa A, 1998, STROKE, V29, P1431, DOI 10.1161/01.STR.29.7.1431; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; Wakita H, 1998, BRAIN RES, V792, P105, DOI 10.1016/S0006-8993(98)00126-7; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; ZHANG J, 1995, NEUROL RES, V17, P285, DOI 10.1080/01616412.1995.11740328	44	23	27	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2001	94	5					782	787		10.3171/jns.2001.94.5.0782			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	429NV	WOS:000168524600013	11354410				2022-02-06	
J	Chedid, MK; Vender, JR; Harrison, SJ; McDonnell, DE				Chedid, MK; Vender, JR; Harrison, SJ; McDonnell, DE			Delayed appearance of a traumatic intracranial aneurysm - Case report and review of the literature	JOURNAL OF NEUROSURGERY			English	Article						cerebral angiography; delayed traumatic aneurysm; contrast-enhanced computerized tomography scanning; penetrating head injury	WOUNDS; BRAIN; MANAGEMENT; ARTERY	Giant traumatic intracranial aneurysms are rare, and thus their incidence and clinical behavior are poorly understood. In most cases, traumatic aneurysms develop and become symptomatic within months following injury. The authors present the case of a 46-year-old war veteran, in whom a giant internal carotid artery aneurysm developed as a result of a penetrating cranial shrapnel injury sustained 25 years earlier during the Vietnam war. The aneurysm had not been evident on previous imaging studies. At surgery, a piece of shrapnel was found embedded in the dome of the aneurysm. The presentation, diagnosis, management, and treatment options related to this lesion are discussed.	Med Coll Georgia, Neurosurg Sect, Augusta, GA 30912 USA; Genesys Reg Med Ctr, Neurosurg Sect, Grand Blanc, MI USA		Vender, JR (corresponding author), Med Coll Georgia, Neurosurg Sect, 1120 15th St,Room BI-3088, Augusta, GA 30912 USA.						ACHRAM M, 1980, BRIT J RADIOL, V53, P1144, DOI 10.1259/0007-1285-53-636-1144; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; ARABI B, 1988, NEUROSURGERY, V22, P1056; COSGROVE GR, 1983, J NEUROSURG, V58, P291; Dolenc VV, 1999, BRIT J NEUROSURG, V13, P185, DOI 10.1080/02688699943961; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; FOX JL, 1983, INTRACRANIAL ANEURYS, V3, P1453; FOX JL, 1983, INTRACRANIAL ANEURYS, V1, P423; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; Jackson F E, 1970, J Trauma, V10, P1158, DOI 10.1097/00005373-197012000-00008; KAUFMAN HH, 1980, NEUROSURGERY, V6, P181, DOI 10.1227/00006123-198002000-00011; MCDONALD EJ, 1976, AM J ROENTGENOL, V126, P792, DOI 10.2214/ajr.126.4.792; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PETTY J M, 1969, Journal of Neurosurgery, V30, P741, DOI 10.3171/jns.1969.30.6.0741; Phatouros CC, 2000, NEUROSURGERY, V47, P107, DOI 10.1097/00006123-200007000-00023; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; RAIMONDI AJ, 1968, NEUROCHIRURGIA, V11, P219; SALAR G, 1978, J NEUROSURG, V49, P100, DOI 10.3171/jns.1978.49.1.0100; SPETZLER RF, 1979, NEUROSURGERY, V4, P334, DOI 10.1227/00006123-197904000-00011; Voelker J L, 1997, W V Med J, V93, P317; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294	25	23	24	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	APR	2001	94	4					637	641		10.3171/jns.2001.94.4.0637			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	417YD	WOS:000167862300017	11302667				2022-02-06	
J	Harvey, AG; Bryant, RA				Harvey, AG; Bryant, RA			Reconstructing trauma memories: A prospective study of "amnesic" trauma survivors	JOURNAL OF TRAUMATIC STRESS			English	Article						acute stress disorder; posttraumatic stress disorder; memory; amnesia	POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD-INJURY; BRAIN INJURY; INTERVIEW	The purpose of this study was to investigate memory for trauma in patients who were initially amnesic of the trauma as a result of mild traumatic brain injury (MTBI), Motor vehicle accident survivors M ho sustained a MTBI were assessed for their memory within 1-month posttrauma (n = 79) and again at 2-years posttrauma (n = 50), Consistent with their brain injury: all patients reported significant amnesia of their accident at initial assessment, At 2-years posttrauma, 40% were able to remember their accident. Reporting memory for the trauma M,as associated with shorter duration of posttraumatic amnesia. These findings suggest that people reconstruct memories of trauma in the absence of complete encoding of the experience. Possible mechanisms for memory reconstruction are considered.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ New S Wales, Sch Psychol, Sydney, NSW, Australia		Harvey, AG (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England.		Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; BRYANT RA, 1995, PSYCHOL MED, V25, P869, DOI 10.1017/S0033291700035121; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; CHRISTIANSON S, 1997, RECOVERED MEMORIES F; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hyman IE, 1998, CLIN PSYCHOL REV, V18, P933, DOI 10.1016/S0272-7358(98)00041-5; Peters L, 1996, INT J METHOD PSYCH, V6, P167, DOI 10.1002/(SICI)1234-988X(199610)6:3<167::AID-MPR159>3.3.CO;2-Z; ROEDIGER HL, 1997, RECOVERED MEMORIES F; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3	17	23	23	0	2	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0894-9867			J TRAUMA STRESS	J. Trauma Stress	APR	2001	14	2					277	282		10.1023/A:1011108816888			6	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	451AM	WOS:000169779000002	11469156				2022-02-06	
J	Dijkstra, S; Geisert, EE; Dijkstra, CD; Bar, PR; Joosten, EAJ				Dijkstra, S; Geisert, EE; Dijkstra, CD; Bar, PR; Joosten, EAJ			CD81 and microglial activation in vitro: proliferation, phagocytosis and nitric oxide production	JOURNAL OF NEUROIMMUNOLOGY			English	Article						microglia; tetraspanins; CD81; trauma, nervous system; spinal cord injuries	NECROSIS-FACTOR-ALPHA; ANTIPROLIFERATIVE ANTIBODY; ALPHA-3-BETA-1 INTEGRIN; CELL-ADHESION; TARGET; MYELIN; BRAIN; MACROPHAGE; ASTROCYTES; EXPRESSION	CD81 (TAPA), a member of the tetraspanin family of proteins, is upregulated by astrocytes and microglia after traumatic injury to the rat central nervous system (CNS). To further understand the role of CD81 in the microglial response to injury, we analysed the functional effects of a CD81 antibody, AMP1, on cultured rat microglia. We found that AMP1 suppressed microglial proliferation in a dose-dependent manner. Furthermore, AMP1 stimulated myelin phagocytosis, probably by opsonizing the myelin. The phagocytosis of latex beads, as well as the production of nitric oxide, were not significantly influenced by AMP1. These data indicate that CD81 is involved in an important subset of microglial effector functions after CNS injury. (C) 2001 Elsevier Science B.V. All rights reserved.	UMC Utrecht, Dept Expt Neurol, NL-3508 GA Utrecht, Netherlands; Univ Tennessee, Memphis Coll Med, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Free Univ Amsterdam, Fac Med, Dept Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands		Dijkstra, S (corresponding author), UMC Utrecht, Dept Expt Neurol, POB 85500, NL-3508 GA Utrecht, Netherlands.	s.dijkstra@neuro.azu.nl	bar, peter/A-2897-2009	Dijkstra, Sipke/0000-0003-2535-297X			Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Altomonte M, 1996, SCAND J IMMUNOL, V43, P367; ANTON ES, 1995, J NEUROSCI, V15, P584; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Clarke K, 1998, Mol Vis, V4, P3; Dijkstra S, 2000, J COMP NEUROL, V428, P266, DOI 10.1002/1096-9861(20001211)428:2<266::AID-CNE6>3.0.CO;2-0; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; GEISERT EE, 1991, NEUROSCI LETT, V133, P262, DOI 10.1016/0304-3940(91)90584-G; Geisert EE, 1996, J NEUROSCI, V16, P5478; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GRAEBER MB, 1988, NEUROSCI LETT, V85, P317, DOI 10.1016/0304-3940(88)90585-X; Hellendall RP, 1997, J NEUROIMMUNOL, V74, P19, DOI 10.1016/S0165-5728(96)00202-0; HOL EM, 1994, BRAIN RES, V662, P109, DOI 10.1016/0006-8993(94)90802-8; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; MERRILL JE, 1993, J IMMUNOL, V151, P2132; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Peduzzi JD, 1999, EXP NEUROL, V160, P460, DOI 10.1006/exnr.1999.7234; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; RAIVICH G, 1994, EUR J NEUROSCI, V6, P1615, DOI 10.1111/j.1460-9568.1994.tb00552.x; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; RIESKE E, 1989, BRAIN RES, V492, P1, DOI 10.1016/0006-8993(89)90883-4; SAKAI N, 1995, J NEUROCHEM, V65, P895; SCHICK MR, 1993, J IMMUNOL, V151, P1918; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Smith ME, 1999, NEUROCHEM RES, V24, P261, DOI 10.1023/A:1022566121967; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; SMITH ME, 1993, J NEUROSCI RES, V35, P480, DOI 10.1002/jnr.490350504; Stangel M, 2000, J NEUROIMMUNOL, V106, P137, DOI 10.1016/S0165-5728(00)00210-1; Stipp CS, 2000, J CELL SCI, V113, P1871; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sullivan CD, 1998, J COMP NEUROL, V396, P366; Todd SC, 1996, J EXP MED, V184, P2055, DOI 10.1084/jem.184.5.2055; Van der Goes A, 1999, J NEUROIMMUNOL, V101, P61, DOI 10.1016/S0165-5728(99)00133-2; van der Goes A, 1998, J NEUROIMMUNOL, V92, P67, DOI 10.1016/S0165-5728(98)00175-1; vanderLaan LJW, 1996, J NEUROIMMUNOL, V70, P145, DOI 10.1016/S0165-5728(96)00110-5; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; ZIELASEK J, 1992, CELL IMMUNOL, V141, P111, DOI 10.1016/0008-8749(92)90131-8	48	23	25	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	MAR 1	2001	114	1-2					151	159		10.1016/S0165-5728(01)00240-5			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	413WN	WOS:000167634700018	11240026				2022-02-06	
J	Taly, AB; Nair, KPS; Jayakumar, PN; Ravishankar, D; Kalaivani, PL; Indiradevi, B; Murali, T				Taly, AB; Nair, KPS; Jayakumar, PN; Ravishankar, D; Kalaivani, PL; Indiradevi, B; Murali, T			Neurogenic heterotopic ossification: A diagnostic and therapeutic challenge in neurorehabilitation	NEUROLOGY INDIA			English	Article						rehabilitation; medical complications; heterotopic ossification	SPINAL-CORD INJURY; ASSOCIATION	Heterotopic ossification (HO) is an important cause of restriction in range of movements and secondary motor disability following neurotrauma, orthopaedic interventions and burns, It has not received focussed attention in non-traumatic neurological disorders. In a prospective study of 377 patients, on medical problems in neurological rehabilitation setting, 15 subjects (3.97%) had neurogenic heterotopic ossification. Their clinical diagnosis; was: transverse myelitis (7), neurotuberculosis (4) traumatic myelopathy (2) and stroke (2), Hip (10), knee (4) and elbow joints (I) were involved, The risk factors included urinary tract infection (15), spasticity (6), pressure sores (13) and deep venous thrombosis (DVT) (6), The initial diagnosis was often other than HO and included DVT (3), haematoma (2) and arthritis (2). ESR and serum alkaline phosphatase levels were elevated in all but one subject. The diagnosis of HO was established using S-rags, CT Scan and three-phase bone scan. Following treatment with non-steroidal anti-inflammatory drugs, the range of motion improved in only four patients. HO resulted in significant loss of therapy time during rehabilitation. High index of suspicion about this complication is necessary for early diagnosis and prompt intervention.	Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Psychiat Rehabil, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Neurol Rehabil, Bangalore 560029, Karnataka, India				Nair, Krishnan/AAE-3474-2020; Taly, Arun/AAV-3517-2021	Nair, Krishnan/0000-0002-4004-2315; 			BIERINGSORENSEN F, 1993, PARAPLEGIA, V31, P513, DOI 10.1038/sc.1993.83; BODLEY R, 1993, PARAPLEGIA, V31, P500, DOI 10.1038/sc.1993.81; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; CASSARPULLICINO VN, 1993, PARAPLEGIA, V31, P40, DOI 10.1038/sc.1993.7; COLACHIS SC, 1993, PARAPLEGIA, V31, P507, DOI 10.1038/sc.1993.82; COLACHIS SC, 1993, PARAPLEGIA, V31, P51, DOI 10.1038/sc.1993.8; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; SHARMA R, 1996, IND J PHYS MED REHAB, V7, P10; SNOECX M, 1995, PARAPLEGIA, V33, P464, DOI 10.1038/sc.1995.101; Taly AB, 1999, SPINAL CORD, V37, P47, DOI 10.1038/sj.sc.3100751; TALY AB, 1996, 24 ANN NAT C IND ASS	14	23	24	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAR	2001	49	1					37	40					4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	425HW	WOS:000168286000008	11303239				2022-02-06	
J	Yakovlev, AG; Di, X; Movsesyan, V; Mullins, PGM; Wang, GP; Boulares, H; Zhang, JH; Xu, M; Faden, AI				Yakovlev, AG; Di, X; Movsesyan, V; Mullins, PGM; Wang, GP; Boulares, H; Zhang, JH; Xu, M; Faden, AI			Presence of DNA fragmentation and lack of neuroprotective effect in DFP45 knockout mice subjected to traumatic brain injury	MOLECULAR MEDICINE			English	Article							CASPASE-ACTIVATED DNASE; FOCAL CEREBRAL-ISCHEMIA; CORTICAL IMPACT INJURY; CLOSED-HEAD INJURY; CA2+/MG2+-DEPENDENT ENDONUCLEASE; CELL-DEATH; DEPENDENT ENDONUCLEASE; CHROMATIN CONDENSATION; NEURONAL APOPTOSIS; INHIBITION	Background: Apoptosis plays an important pathophysiologic role in neuronal cell loss and associated neurologic deficits following traumatic brain injury (TBI). DNA fragmentation represents one of the characteristic biochemical features of neuronal apoptosis and is observed after experimental TBI. DFF45 and DFF40 are essential for DNA fragmentation in various models of apoptosis. Materials and Methods: We used mice deficient in DFF45 and wild-type controls. Oligonucleosomal DNA fragmentation induced by TBI was analyzed using in vivo and in vitro assays. Expression and integrity of DFF45 and DFF40 proteins was assessed by Western analysis. Other outcome measurements included neurologic scoring, learning/memory tests, lesion volume measurements (MRI), and assessment of cell viability in vitro among others. Results: We compared the effects of controlled cortical impact (CCI) trauma in DFF45 knockout mice and wild-type controls. Analysis of TBI-induced DNA fragmentation in brain cortex from wild-type and DFF45 knockout mice indicates that, although somewhat delayed, oligonucleosomal cleavage of DNA occurs after TBI in DFF45 knockout mice. DFF45 knockouts showed no significant differences in behavioral outcomes or lesion volumes after TBI as compared to wild-type controls. Using an in vitro reconstitution system, we also demonstrated that cleavage of DFF45 by caspase-3 is not sufficient for DNA fragmentation induced by protein extracts from rat brain cortex. We found that endonuclease activity induced in rat brain cortex following TBI depends on the presence of Mg2+ and Ca2+, but is not inhibited by Zn2+. Primary neuronal cultures from DFF45 knockouts failed to show DNA laddering in response to staurosporine, but did show prominent, albeit delayed, DNA fragmentation following treatment with etoposide. In contrast, primary neurons from wildtype animals demonstrated marked DNA fragmentation following treatment with staurosporine or etoposide. Conclusions: The results of this study suggest that, in addition to DFF45/40, other endonucleases may be essential for chromatin degradation during neuronal apoptosis in adult brain after TBI.	Georgetown Univ, Dept Neurosci, Washington, DC 20007 USA; Georgetown Univ, Dept Biochem & Mol Biol, Washington, DC 20007 USA; Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45221 USA		Faden, AI (corresponding author), Georgetown Univ, Dept Neurosci, Res Bldg,Room Ep12,3970 Reservoir Rd NW, Washington, DC 20007 USA.	fadena@giccs.georgetown.edu	zhang, jianhua/D-3404-2009	Zhang, Jianhua/0000-0002-2128-9574; Mullins, Paul/0000-0002-1339-6361	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38941, NS 36537] Funding Source: Medline		Adjei PN, 1996, J CLIN INVEST, V98, P2588, DOI 10.1172/JCI119078; Adjei PN, 1997, J CLIN INVEST, V100, P951; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Andrew DJ, 1999, IMMUNOPHARMACOLOGY, V41, P1, DOI 10.1016/S0162-3109(98)00049-6; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; Bhattacharya R, 1997, TOXICOLOGY, V123, P207, DOI 10.1016/S0300-483X(97)00130-3; Buki A, 2000, J NEUROSCI, V20, P2825; Cigola E, 1997, EXP CELL RES, V231, P363, DOI 10.1006/excr.1997.3477; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; COHEN JJ, 1984, J IMMUNOL, V132, P38; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; CSERNANSKY CA, 1994, J NEUROSCI RES, V38, P101, DOI 10.1002/jnr.490380113; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Eldadah BA, 1997, J NEUROSCI, V17, P6105; Eldadah BA, 1996, NUCLEIC ACIDS RES, V24, P4092, DOI 10.1093/nar/24.20.4092; Elger B, 1997, EUR J PHARMACOL, V336, P7, DOI 10.1016/S0014-2999(97)01217-X; Enari M, 1998, NATURE, V393, P396, DOI 10.1038/30782; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; ENARI M, 1995, EMBO J, V14, P5201, DOI 10.1002/j.1460-2075.1995.tb00204.x; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fraser MJ, 1996, J CELL SCI, V109, P2343; GIANNAKIS C, 1991, BIOCHEM BIOPH RES CO, V181, P915, DOI 10.1016/0006-291X(91)91278-K; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Heiduschka P, 2000, NEUROPHARMACOLOGY, V39, P889, DOI 10.1016/S0028-3908(99)00245-2; HOCKINGS PD, 1995, JMRI-J MAGN RESON IM, V5, P437, DOI 10.1002/jmri.1880050412; ISHIDA R, 1974, BIOCHEM BIOPH RES CO, V56, P703, DOI 10.1016/0006-291X(74)90662-7; Khodarev NN, 1996, J IMMUNOL, V156, P922; Kimura C, 1998, EXP CELL RES, V239, P411, DOI 10.1006/excr.1997.3912; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Los M, 2000, BIOCHEMISTRY-US, V39, P7365, DOI 10.1021/bi000158w; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Matsushita K, 1996, BRAIN RES, V743, P362, DOI 10.1016/S0006-8993(96)01112-2; McCarty JS, 1999, BIOCHEM BIOPH RES CO, V264, P176, DOI 10.1006/bbrc.1999.1497; McConkey David J., 1996, Scanning Microscopy, V10, P777; MCCONKEY DJ, 1989, FASEB J, V3, P1843, DOI 10.1096/fasebj.3.7.2497041; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Mitamura S, 1998, BIOCHEM BIOPH RES CO, V243, P480, DOI 10.1006/bbrc.1998.8122; MOGIL RJ, 1994, J IMMUNOL, V152, P1674; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; NEWMEYER DD, 1991, METHOD CELL BIOL, V36, P607; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; NIKONOVA L V, 1989, Biokhimiya, V54, P1709; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; RIBEIRO JM, 1993, BIOCHEMISTRY-US, V32, P9129, DOI 10.1021/bi00086a018; RINK A, 1995, AM J PATHOL, V147, P1575; Robertson JD, 2000, J STRUCT BIOL, V129, P346, DOI 10.1006/jsbi.2000.4254; Sakahira H, 2000, J BIOL CHEM, V275, P8091, DOI 10.1074/jbc.275.11.8091; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SHIOKAWA D, 1994, EUR J BIOCHEM, V226, P23, DOI 10.1111/j.1432-1033.1994.tb20022.x; Shiokawa D, 1998, BIOCHEM J, V332, P713, DOI 10.1042/bj3320713; Slane JM, 2000, BRAIN RES, V867, P70, DOI 10.1016/S0006-8993(00)02258-7; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Urbano A, 1998, J BIOL CHEM, V273, P34820, DOI 10.1074/jbc.273.52.34820; VERHAEGEN S, 1995, BIOCHEM PHARMACOL, V50, P1021, DOI 10.1016/0006-2952(95)00233-P; Wohrl W, 1999, BIOCHEM BIOPH RES CO, V254, P552, DOI 10.1006/bbrc.1998.9982; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wright SC, 1997, J EXP MED, V186, P1107, DOI 10.1084/jem.186.7.1107; Wright SC, 1997, FASEB J, V11, P843, DOI 10.1096/fasebj.11.11.9285482; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Wyllie A H, 1992, Semin Immunol, V4, P389; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yakovlev AG, 2000, J BIOL CHEM, V275, P21302, DOI 10.1074/jbc.M001087200; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x; Zhang JH, 1999, J BIOL CHEM, V274, P37450, DOI 10.1074/jbc.274.52.37450; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480; ZHIVOTOVSKY B, 1994, INT ARCH ALLERGY IMM, V105, P333, DOI 10.1159/000236778; ZHIVOTOVSKY B, 1993, EXP CELL RES, V207, P163, DOI 10.1006/excr.1993.1176	77	23	24	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1076-1551	1528-3658		MOL MED	Mol. Med.	MAR	2001	7	3					205	216		10.1007/BF03401955			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	418QU	WOS:000167903500008	11471558	gold, Green Published			2022-02-06	
J	Zafonte, RD; Wood, DL; Harrison-Felix, CL; Millis, SR; Valena, NV				Zafonte, RD; Wood, DL; Harrison-Felix, CL; Millis, SR; Valena, NV			Severe penetrating head injury: A study of outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Glasgow Coma Scale; head injuries; penetrating; wounds; gunshot; rehabilitation	TRAUMATIC BRAIN INJURY; CIVILIAN GUNSHOT WOUNDS; CRANIOCEREBRAL INJURIES; MODEL SYSTEMS; COMA; MANAGEMENT; VIOLENCE; SCALE	Objective: To determine and describe the demographics and functional outcomes of persons who require inpatient rehabilitation for severe penetrating head injury resulting from a gunshot wound to the head. Design: Data were collected prospectively from the time of admission to acute care through discharge from inpatient rehabilitation. Setting: Two sites: an urban, level I, acute care, trauma center and an inpatient rehabilitation hospital with a specialized brain injury unit. Participants: Twenty-seven persons with severe penetrating head injury. Main Outcome Measures: The FIM(TM) instrument, the Disability Rating Scale (DRS), and the length of stay (LOS). Results: Demographic data showed our population to be similar to other groups of persons at high risk for violent injury. Eighty-five percent of the subjects were men with a mean age of 34 years. The majority were African American (93%), reflective of our general patient population. Average acute care LOS was 31 days and average rehabilitation LOS was 44 days. Average FIM gain was 40.2 and, on average, DRS scores improved 7.6 points from rehabilitation admission to discharge. All study participants made enough progress to be discharged to private residences. Conclusion: Although the mortality rate is high among patients with penetrating head injury, those who survive to receive inpatient rehabilitation can achieve functional improvement.	Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15215 USA; Wayne State Univ, Rehabil Inst Michigan, Detroit, MI USA; Craig Hosp, Englewood, CO USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; HealthSouth, Houston, TX USA		Zafonte, RD (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Ste 901, Pittsburgh, PA 15215 USA.	zafonteRD@msx.upmc.edu					AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Ansari SA, 1998, BRIT J NEUROSURG, V12, P340; Carey ME, 1990, J NEUROTRAUM, V7, P13, DOI 10.1089/neu.1990.7.13; *CDCP, 1997, 1997 US INJ MORT STA; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; MILLIS SR, 1995, BRAIN INJURY, V9, P509, DOI 10.3109/02699059509008210; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; RAIMONDI AJ, 1970, J NEUROSURG, V32, P647, DOI 10.3171/jns.1970.32.6.0647; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; *STAT U NY BUFF UB, 1993, GUID UN DAT SET MED; STONE JL, 1995, J TRAUMA, V38, P851, DOI 10.1097/00005373-199506000-00002; VALENA N, 1997, AM J PHYS MED REHABI, V76, P163; Zafonte RD, 1997, BRAIN INJURY, V11, P403	27	23	24	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2001	82	3					306	310		10.1053/apmr.2001.18226			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	407RG	WOS:000167284100003	11245750				2022-02-06	
J	Zafonte, RD; Wood, DL; Harrison-Felix, CL; Valena, NV; Black, K				Zafonte, RD; Wood, DL; Harrison-Felix, CL; Valena, NV; Black, K			Penetrating head injury: A prospective study of outcomes	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; gunshot wounds; outcomes; penetrating head injuries	CIVILIAN GUNSHOT WOUNDS; TRAUMATIC BRAIN INJURY; GLASGOW COMA SCALE; PREDICTION; MANAGEMENT; PROGNOSIS; VIOLENCE	The purpose of our study was to describe the outcomes of persons with penetrating brain injury resulting from a gunshot wound to the head. It is a prospective study of 442 patients admitted with gunshot wounds to the head over a 7 year period to our University Trauma Center Emergency Department, an urban trauma center and an inpatient rehabilitation hospital with a specialized brain injury unit Measures and factor; described include initial Glasgow Coma Scale score, Revised Trauma Score, the Disability Rating Scale, Functional Independence Measure, levels of cognitive functioning, patient demographics, length of stay, hospital charges, and discharge disposition. Initially 36% of patients expired in or were dead upon arrival to the Emergency Department; 64% of patients survived to be admitted for inpatient care. Of those admitted, 41% expired within the first 48 h of admission. Fifty-two percent of those admitted had severe injuries, 7% moderate injuries, and 42% had mild head injuries. Sixty-two percent of the survivors were discharged from acute care to private residences. The remaining 38% were discharged to programs providing varying levels of care depending upon their level of functioning and care needs. Patients sustaining severe injuries following gunshot wound(s) to the head have high early mortality. Survivors able to participate in an inpatient rehabilitation program have good potential for functional improvement.	Univ Pittsburgh, Pittsburgh, PA 15215 USA; Wayne State Univ, Rehabil Inst Michigan, Detroit, MI USA; Craig Hosp, Denver, CO USA		Zafonte, RD (corresponding author), Univ Pittsburgh, 3471 5th Ave,Suite 901, Pittsburgh, PA 15215 USA.						ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; Bell C C, 1990, J Neuropsychiatry Clin Neurosci, V2, P145; *CDC NAT CTR INJ P, 1997, US INJ MORT STAT; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; DITUNNO JF, 1992, J NEUROTRAUM, V9, pS301; FONTANAROSA PB, 1995, JAMA-J AM MED ASSOC, V273, P1792, DOI 10.1001/jama.273.22.1792; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; JENNETT B, 1976, ARCH NEUROL-CHICAGO, V33, P595, DOI 10.1001/archneur.1976.00500090001001; JOHNSTON MV, 1996, MED REHABILITATION T, P197; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; Kellermann AL, 1996, NEW ENGL J MED, V335, P1438, DOI 10.1056/NEJM199611073351906; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; LEVY ML, 1993, NEUROSURGERY, V33, P1018; MAX W, 1993, HEALTH AFFAIR, V12, P171, DOI 10.1377/hlthaff.12.4.171; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; RIVARA FP, 1989, J TRAUMA, V29, P462, DOI 10.1097/00005373-198904000-00008; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; STONE JL, 1995, J TRAUMA, V38, P851, DOI 10.1097/00005373-199506000-00002; Trask T, 1996, NEUROTRAUMA, P869; *UB FDN ACT INC, 1993, GUID UN DAT SET MED; WINTEMUTE GJ, 1991, J HEAD TRAUMA REHAB, V6, P38; [No title captured]	32	23	24	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					219	226		10.1179/016164101101198370			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200016	11320603				2022-02-06	
J	Hentschel, S; Hader, W; Boyd, M				Hentschel, S; Hader, W; Boyd, M			Head injuries in skiers and snowboarders in British Columbia	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							ALPINE SKIING INJURIES; SPINE	Background: At the Vancouver General Hospital Neurosurgical Service there have been a significant number of seriously brain injured snowboarders, seemingly out of proportion to the number of skiers. The purpose of this study was to determine whether snowboarders suffered more serious head injuries than skiers in the Vancouver catchment area. Methods: The British Columbia Trauma Registry was searched for patients incurring head injuries while skiing or snowboarding on British Columbia mountains during the period from January 1992 to December 1997. Patients were included if they were admitted to hospital and underwent neurosurgical consultation. Results: A total of 40 skiers and 14 snowboarders met the above criteria. Of the skiers, 15% sustained a severe head injury by Glasgow Coma Score, another 30% sustaining moderate head injuries, while 29% of snowboarders had a severe injury and 36% a moderate injury. A concussion was present in 60% of the skiers and 21% of the snowboarders. Snowboarders suffered an intracranial hemorrhage in 71% of the cases compared to 28% of the skiers. A craniotomy was performed acutely in 10% of skiers and in 29% of snowboarders, Three deaths occurred as a direct result of head injury, one while snowboarding. All but one of the surviving skiers were able to return home, whereas four of 13 surviving snowboarders required additional inpatient rehabilitation or transfer to another acute hospital for ongoing care. Conclusions: Snowboarders suffer more significant head injuries compared to skiers in this series and are much more likely than skiers to require an intracranial procedure. In our opinion, this indicates that additional safety measures, in particular the use of mandatory helmets, should be considered by ski areas and their patrons.	Univ British Columbia, Vancouver Hosp, Dept Surg, Div Neurosurg, Vancouver, BC V5Z 1M9, Canada; Hlth Sci Ctr, Vancouver, BC V5Z 1M9, Canada		Hentschel, S (corresponding author), Div Neurosurg, Dept Surg, 3rd Floor,910 W 10th Ave, Vancouver, BC V5Z 4E3, Canada.						ABULABAN RB, 1991, CAN MED ASSOC J, V145, P1097; BLADIN C, 1995, SPORTS MED, V19, P358, DOI 10.2165/00007256-199519050-00005; Chow TK, 1996, J TRAUMA, V41, P321, DOI 10.1097/00005373-199608000-00021; Davidson TM, 1996, WESTERN J MED, V164, P231; Davidson TM, 1996, WESTERN J MED, V164, P310; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; KIP P, 1995, ORTHOPEDICS, V18, P737; MYLES ST, 1992, CAN J SURG, V35, P643; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; PRALL JA, 1995, INJURY, V26, P539, DOI 10.1016/0020-1383(95)00085-N; Prall JA, 1995, J TRAUMA, V39, P1115, DOI 10.1097/00005373-199512000-00018; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Sutherland AG, 1996, INJURY, V27, P423, DOI 10.1016/0020-1383(96)00026-5	13	23	23	0	6	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	FEB	2001	28	1					42	46					5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	403AM	WOS:000167020400007	11252293				2022-02-06	
J	Green, P; Iverson, GL				Green, P; Iverson, GL			Validation of the computerized assessment of response bias in litigating patients with head injuries	CLINICAL NEUROPSYCHOLOGIST			English	Article							MEMORY TEST; DEFICIT; BRAIN	The detection of malingering in neuropsychological assessment requires valid measures of incomplete effort. The Computerized Assessment of Response Bias (CARB) is a digit-recognition procedure desiged to detect poor effort during a neuropsychological evaluation. We examined the CARB performance of a consecutive series of litigating patients (N = 119) with a full range of head-injury severity, from trivial to severe. Patients with trivial or mild head injuries performed more poorly than did patients with frank brain injuries. Specifically, patients with moderate to severe traumatic brain injuries obtained higher total scores and demonstrated briefer response latencies than did patients with trivial or mild head injuries.	Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; Riverview Hosp, Port Coquitlam, BC, Canada		Green, P (corresponding author), Neurobehav Assoc, 17107-107 Ave, Edmonton, AB, Canada.			Iverson, Grant/0000-0001-7348-9570			Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BRADY JP, 1961, ARCH GEN PSYCHIAT, V4, P331; CONDER R, 1992, COMPUTERIZED ASSESSM; GROSZ HJ, 1965, ARCH GEN PSYCHIAT, V13, P255; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; MILLER H, 1972, LANCET, V1, P580; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; PANKRATZ L, 1987, ARCH NEUROL-CHICAGO, V44, P798, DOI 10.1001/archneur.1987.00520200006007; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; TEASDALE G, 1974, LANCET, V2, P81; THEODOR LH, 1973, J ABNORM PSYCHOL, V82, P552, DOI 10.1037/h0035362; Wechsler, 1997, WECHSLER ADULT INTEL; Western SL, 1996, ARCH CLIN NEUROPSYCH, V11, P557, DOI 10.1016/0887-6177(95)00043-7	19	23	23	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2001	15	4					492	497		10.1076/clin.15.4.492.1887			6	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	535QR	WOS:000174656100007	11935450				2022-02-06	
J	Grenander, A; Bredbacka, S; Rydvall, A; Aroch, R; Edner, G; Koskinen, LOD; Olivecrona, M				Grenander, A; Bredbacka, S; Rydvall, A; Aroch, R; Edner, G; Koskinen, LOD; Olivecrona, M			Antithrombin treatment in patients with traumatic brain injury - A pilot study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						antithrombin; coagulopathy; D-dimer; fibrin, soluble; injury, brain; thrombin-antithrombin complex	DISSEMINATED INTRAVASCULAR COAGULATION; SEVERE HEAD-INJURY; SOLUBLE FIBRIN; THROMBIN; ASSAY; ABNORMALITIES; COAGULOPATHY; PROCOAGULANT; HEMORRHAGE; PLASMA	This study will determine if early administration of antithrombin concentrate to patients with traumatic brain injury (TBI) can inhibit or significantly shorten the time of coagulopathy. The progress of brain injury monitored by computed tomographic scan (CT) was also assessed, as was the time needed for intensive care and outcome related to Glasgow outcome scale (GOS). Twenty-eight patients with isolated brain trauma verified with CT were included in either of two parallel groups. The Glasgow coma score (GCS) was mean 7.5, and median 7.0; signifying a moderate to severe traumatic brain injury but with a mortality of only 3.5 %. The patients randomized to antithrombin treatment received a total of 100 U/kg BW during 24 hours. To measure hypercoagulability, soluble fibrin (SF), D-dimer (D-d), and thrombin-antithrombin complex (TAT) were assessed together with antithrombin (AT) and routine coagulation tests. Before treatment, SF, D-d, and TAT were markedly increased in both groups. Soluble fibrin and D-dimer (measured after treatment began) appeared to decrease faster in the AT group, and there was a statistically significant difference between the groups at 36 hours for SF and at 36 hours, 48 hours, and at Day 3 for D-d. Thrombin-antithrombin complex levels were very high in both groups but, surprisingly, showed no significant difference between the groups. The authors conclude that antithrombin concentrate administered to patients with severe TBI resulted in a marginal reduction of hypercoagulation. We could not detect any obvious influence by antithrombin on brain injury progress, on CT, or on outcome or time needed for intensive care.	Karolinska Hosp, Dept Anesthesia & Intens Care, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Neurol Surg, S-17176 Stockholm, Sweden; Univ Umea Hosp, Dept Anesthesiol & Intens Care, S-90185 Umea, Sweden; Univ Umea Hosp, Dept Neurol Surg, S-90185 Umea, Sweden		Grenander, A (corresponding author), Karolinska Hosp, Dept Anesthesia & Intens Care, S-17176 Stockholm, Sweden.		Koskinen, Lars-Owe/AAQ-8957-2020	Olivecrona, Magnus/0000-0001-8457-4711; Koskinen, Lars-Owe/0000-0003-3528-8502			ABILDGAARD U, 1977, THROMB RES, V11, P549, DOI 10.1016/0049-3848(77)90208-0; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bick RL, 1998, SEMIN THROMB HEMOST, V24, P3, DOI 10.1055/s-2007-994971; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; CUNNINGHAM DD, 1993, THROMB HAEMOSTASIS, V70, P168; ELMS MJ, 1983, THROMB HAEMOSTASIS, V50, P591; Frebelius S, 1996, ARTERIOSCL THROM VAS, V16, P1292, DOI 10.1161/01.ATV.16.10.1292; Hoots WK, 1997, SEMIN THROMB HEMOST, V23, P3; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; KAUFMAN HH, 1985, CENTRAL NERVOUS SYST, P187; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Lee KR, 1996, ACTA NEUROCHIR, V138, P396, DOI 10.1007/BF01420301; Marshall LF, 1991, J NEUROSURG S, V75, P14; MILLER RS, 1994, J TRAUMA, V37, P442, DOI 10.1097/00005373-199409000-00019; MULLERBERGHAUS G, 1989, SEMIN THROMB HEMOST, V15, P58, DOI 10.1055/s-2007-1002690; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PELZER H, 1988, THROMB HAEMOSTASIS, V59, P101; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; WIMAN B, 1986, THROMB HAEMOSTASIS, V55, P189	26	23	25	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2001	13	1					49	56		10.1097/00008506-200101000-00010			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	384GZ	WOS:000165935600009	11145479				2022-02-06	
J	Panizza, M; Castagna, I; di Summa, A; Saibene, L; Grioni, G; Nilsson, J				Panizza, M; Castagna, I; di Summa, A; Saibene, L; Grioni, G; Nilsson, J			Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX)	FUNCTIONAL NEUROLOGY			English	Article						ashworth; botulinum toxin; spasticity; task score; upper limb	TRAUMATIC BRAIN INJURY; UPPER EXTREMITY SPASTICITY; RECIPROCAL INHIBITION; FOREARM MUSCLES; STROKE PATIENTS; DOUBLE-BLIND; DYSTONIA; TRIAL	Spasticity is a motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks. In order to study the usefulness of botulinum toxin type A (BTX) as a therapy for spasticity, we studied 15 patients affected by spasticity secondary to stroke. Tests included: clinical evaluation of tone (Ashworth scale); active angles of extension and flexion at elbow and wrist; Hmax/Mmax ratio from flexor carpi radialis (FCR); H-reflex presynaptic inhibition from FCR during vibration; Task score: and video recording. Patients were injected with BTX into one or more muscles with total doses not exceeding 200 International Units (IU). The rests were performed immediately prior to injection and repeated 2 weeks afterwards. Furthermore, in eight patients, testing was also performed one month after BTX injection. Between two weeks and one month after BTX there were no statistically significant differences. A statistically significant difference in the Task and Ashworth scores before and after treatment emerged (p<0.0014), but only 6 patients showed a clear improvement in motor performance. Overall, we observed an improvement in the angle of active extension and flexion at the wrist and elbow. There were no significant changes in the Hmax/Mmax ratio and the H-reflex presynaptic inhibition during vibration. All the patients reported a subjective improvement. The results suggest that subjective benefits can be gained from the use of BTX in patients affected by spasticity, and that the degree of motor improvement seems to depend on the motor recovery obtained before treatment.	IRCCS, Rehabil Inst Castel Goffredo, Salvatore Maugeri Fdn, Lab Clin Neurophysiol, I-46042 Castel Goffredo, MN, Italy				CASTAGNA, MARISA/AAA-6279-2021; Grioni, Giuseppe/AAC-1927-2020	CASTAGNA, MARISA/0000-0002-0888-9612; Grioni, Giuseppe/0000-0002-0281-891X			Bhakta BB, 1996, J NEUROL NEUROSUR PS, V61, P30, DOI 10.1136/jnnp.61.1.30; BURGEN ASV, 1949, J PHYSIOL-LONDON, V109, P10, DOI 10.1113/jphysiol.1949.sp004364; DUNNE JW, 1995, J NEUROL NEUROSUR PS, V58, P232, DOI 10.1136/jnnp.58.2.232; DUTTON JJ, 1988, OPHTHALMOLOGY, V95, P1529; Girlanda P, 1997, NEUROREPORT, V8, P3039, DOI 10.1097/00001756-199709290-00008; GRACIES JM, 1997, MUSCLE NERVE       S, V6, pS61; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; JANKOVIC J, 1990, NEUROLOGY, V40, P277, DOI 10.1212/WNL.40.2.277; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; KATZ RT, 1988, AM J PHYS MED REHAB, V67, P108, DOI 10.1097/00002060-198806000-00004; Lance JW, 1980, SPASTICITY DISORDERE; Palmer DT, 1998, AM J PHYS MED REHAB, V77, P348, DOI 10.1097/00002060-199807000-00020; Pavesi G, 1998, J NEUROL NEUROSUR PS, V64, P419, DOI 10.1136/jnnp.64.3.419; PIERROTDESEILLI.E, 1999, SPASTICITY MECH TREA, V1, P1; PRIORI A, 1995, BRAIN, V118, P801, DOI 10.1093/brain/118.3.801; Reiter F, 1998, ARCH PHYS MED REHAB, V79, P532, DOI 10.1016/S0003-9993(98)90068-5; Sampaio C, 1997, CLIN REHABIL, V11, P3, DOI 10.1177/026921559701100102; SCOTT AB, 1973, INVEST OPHTH VISUAL, V12, P924; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; VANERMENGEM E, 1979, REV INFECT DIS, V1, P701; Watanabe Y, 1998, DISABIL REHABIL, V20, P62, DOI 10.3109/09638289809166055; Wilson DJ, 1997, BRAIN INJURY, V11, P157, DOI 10.1080/026990597123610; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939	25	23	27	0	2	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	JUL-SEP	2000	15	3					147	155					9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	365CB	WOS:000089929900002	11062843				2022-02-06	
J	Wright, RA; Ahlskog, JE				Wright, RA; Ahlskog, JE			Focal shoulder-elevation dystonia	MOVEMENT DISORDERS			English	Article; Proceedings Paper	5th International Congress of Parkinsons Disease and Movement Disorders	OCT   11, 1998	NEW YORK, NEW YORK			dystonia; post-traumatic movement disorder; botulinum toxin; shoulder	POSTTRAUMATIC CERVICAL DYSTONIA; PERIPHERAL TRAUMA; MUSCLE	We describe 13 cases of isolated focal dystonia of the shoulder with dystonic elevation but without clinically obvious cervical dystonia. All had significant trapezius muscle hypertrophy and limitation of shoulder movement causing substantial morbidity. In nine, this developed in the immediate aftermath of shoulder region trauma, most often a motor vehicle accident; clinically significant head trauma was not a factor. In two other cases this developed in the context of chronic heavy labor (suggesting possible overuse) and in one other it developed concurrent with the symptoms of discogenic cervical (C6-7) radiculopathy. In the one remaining case, no precipitating factors were identified. Preexisting risk factors for dystonia, such as dopamine antagonist drug use, family history of dystonia, or prior brain injury, were not identified in these patients. Administration of medications used to treat dystonia was unsuccessful but botulinum toxin therapy was beneficial in all six treated cases.	Mayo Clin, Dept Neurol, Rochester, MN 55905 USA		Ahlskog, JE (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.						BRIN MF, 1986, NEUROLOGY, V36, P119; DEWEY RB, 1994, MAYO CLIN PROC, V69, P187, DOI 10.1016/S0025-6196(12)61047-7; GOLDMAN S, 1993, MAYO CLIN PROC, V68, P443, DOI 10.1016/S0025-6196(12)60192-X; GUTMAN L, 1986, MUSCLE NERVE, V19, P811; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; MATTLE HP, 1991, J NEUROL NEUROSUR PS, V54, P325, DOI 10.1136/jnnp.54.4.325; SCHOTT GD, 1985, J NEUROL NEUROSUR PS, V48, P698, DOI 10.1136/jnnp.48.7.698; Tarsy D, 1998, MOVEMENT DISORD, V13, P481, DOI 10.1002/mds.870130318; Thyagarajan D, 1998, NEUROLOGY, V51, P1205, DOI 10.1212/WNL.51.4.1205; TRUONG DD, 1991, ARCH NEUROL-CHICAGO, V48, P221, DOI 10.1001/archneur.1991.00530140117025	11	23	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3185			MOVEMENT DISORD	Mov. Disord.	JUL	2000	15	4					709	713		10.1002/1531-8257(200007)15:4<709::AID-MDS1017>3.0.CO;2-4			5	Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	333MA	WOS:000088132800017	10928583				2022-02-06	
J	Wagner, AK; Hammond, FM; Grigsby, JH; Norton, HJ				Wagner, AK; Hammond, FM; Grigsby, JH; Norton, HJ			The value of trauma scores - Predicting discharge after traumatic brain injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						traumatic brain injury; outcome; revised trauma score; trauma score injury severity score; injury severity score	GUNSHOT WOUNDS; PROGNOSIS; CARE	Objective: To determine the association of acute variables with disposition after acute hospitalization. Design: Revised Trauma Score (RTS), Injury Severity Score (ISS), and the Combined Trauma Score Injury Severity Score (TRISSRTS) were compared with discharge disposition after acute hospitalization of 378 consecutive patients who sustained a traumatic brain injury (TBI) and were treated at a level 1 trauma center between September 1997 and May 1998. Results: Logistic regression modeling found TRISSRTS to predict discharge to home with or without home health assistance or inpatient rehabilitation vs. nursing home placement or death. Subsequent modeling, excluding patients who died or went to nursing homes, identified RTS and ISS as predictors of discharge to home with or without home health vs. inpatient rehabilitation. A sensitivity of 97.78% and 93.91% were achieved with these two models when tested on a population of 4,625 patients with TBI treated during the last 10 yr at the same facility. Conclusions: The results suggest that RTS, ISS, and TRISSRTS are predictors of discharge disposition after acute hospitalization with TBI and may be useful measures of rehabilitation services resource planning early in the course of TBI management.	Charlotte Inst Rehabil, Dept PM&R, Charlotte, NC 28203 USA; Carolinas Healthcare Syst, Charlotte, NC USA		Wagner, AK (corresponding author), Charlotte Inst Rehabil, Dept PM&R, 1100 Blythe Blvd, Charlotte, NC 28203 USA.						Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHEADLE WG, 1989, ANN SURG, V209, P541, DOI 10.1097/00000658-198905000-00005; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Hall KM, 1998, NEUROREHABILITATION, V10, P3, DOI 10.3233/NRE-1998-10102; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Zafonte RD, 1997, BRAIN INJURY, V11, P403	13	23	23	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	2000	79	3					235	242		10.1097/00002060-200005000-00004			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	313FK	WOS:000086989500004	10821308				2022-02-06	
J	Bublak, P; Schubert, T; Matthes-von Cramon, G; von Cramon, DY				Bublak, P; Schubert, T; Matthes-von Cramon, G; von Cramon, DY			Differential demands on working memory for guiding a simple action sequence: Evidence from closed-head-injured subjects	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							DUAL-TASK-PERFORMANCE; CENTRAL EXECUTIVE DEFICIT; TRAUMATIC BRAIN INJURY; FRONTAL-LOBE; INDIVIDUAL-DIFFERENCES; PARKINSONS-DISEASE; DIVIDED ATTENTION; INFORMATION; PERCEPTION; BEHAVIOR	In the present study, a working memory paradigm was used to assess coordinative abilities required for the flexible control of a sequence of actions. Subjects had to maintain and recall a list of digits that functioned as an ensemble of activity cues used for guiding a sequence of forced-choice responses. In three task conditions, the demand on the selection of the activity cues was varied parametrically to manipulate the requirement of coordinating maintenance and processing operations of working memory for guiding the response sequences. A comparison between subjects suffering from severe closed head injury (CHI) and matched controls in a blocked presentation of task conditions revealed that patients, in contrast to controls, did not preplan the sequence by rearranging the ensemble of activity cues prior to execution of the action sequence. Patients' performance was more comparable to controls tested in a random presentation in which preplanning was not possible. Our results further suggest that patients are less efficient in selecting activity cues from working memory, especially in more demanding situations when activity cues have to be completely reordered for guiding a sequence of actions. These results point to an executive dysfunction in CHI subjects that may contribute to the deficits known as inflexible and rigid behavior.	Max Planck Inst Cognit Neurosci, Dept Neurol, Leipzig, Germany; Univ Leipzig, Daycare Clin Cognit Neurol, D-7010 Leipzig, Germany		Bublak, P (corresponding author), Univ Munich, Inst Psychol & Neuropsychol, Leopoldstr 13, D-80802 Munich, Germany.			Schubert, Torsten/0000-0002-6514-6145			Alderman N, 1996, NEUROPSYCHOL REHABIL, V6, P161, DOI 10.1080/713755505; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A.D., 1986, WORKING MEMORY; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; BROWN RG, 1991, BRAIN, V114, P215; CARLSON RA, 1993, J EXP PSYCHOL HUMAN, V19, P531; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Cowan N., 1997, DEV MEMORY CHILDHOOD, P163; Cowey CM, 1996, MEMORY, V4, P19, DOI 10.1080/741940668; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; DALRYMPLEALFORD JC, 1994, J NEUROL NEUROSUR PS, V57, P360, DOI 10.1136/jnnp.57.3.360; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DARK VJ, 1990, MEM COGNITION, V18, P119, DOI 10.3758/BF03197088; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; Garavan H, 1998, MEM COGNITION, V26, P263, DOI 10.3758/BF03201138; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; MAPOU RL, 1992, HDB HEAD TRAUMA ACUT, P75; MAYR U, 1993, J EXP PSYCHOL LEARN, V19, P1297, DOI 10.1037/0278-7393.19.6.1297; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mecklinger A, 1999, J CLIN EXP NEUROPSYC, V21, P606, DOI 10.1076/jcen.21.5.606.873; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; VONCRAMON DY, 1992, NEUROPSYCHOLOGICAL R; WENGER JL, 1995, J EXP PSYCHOL HUMAN, V21, P170; WIEGERSMA S, 1990, NEUROPSYCHOLOGIA, V28, P95, DOI 10.1016/0028-3932(90)90089-7; YEE PL, 1991, COGNITIVE PSYCHOL, V23, P615, DOI 10.1016/0010-0285(91)90007-B; [No title captured]	42	23	23	0	4	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2000	22	2					176	190		10.1076/1380-3395(200004)22:2;1-1;FT176			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	310QF	WOS:000086838300002	10779832				2022-02-06	
J	Cheney, JA; Brown, AL; Bareyre, FM; Russ, AB; Weisser, JD; Ensinger, HA; Leusch, A; Raghupathi, R; Saatman, KE				Cheney, JA; Brown, AL; Bareyre, FM; Russ, AB; Weisser, JD; Ensinger, HA; Leusch, A; Raghupathi, R; Saatman, KE			The novel compound LOE 908 attenuates acute neuromotor dysfunction but not cognitive impairment or cortical tissue loss following traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						behavior; brain injury; cation channels; cognition; motor function	CHANNEL BLOCKER; CEREBRAL EDEMA; HEAD-INJURY; CALCIUM; DEFICITS; MOTOR; NEUROTOXICITY; CONSEQUENCES; INHIBITION; RECOVERY	Experimental traumatic brain injury (TBI) initiates massive disturbances in Ca2+ concentrations in the brain that may contribute to neuronal damage. Intracellular Ca2+ may be elevated via influx through voltage-operated cation channels, ligand-gated ionotropic channels, and store-operated cation channels (SOCs). In the present study, we evaluated the neurobehavioral and histological effects of acute posttraumatic administration of (R,S)-(3,4-dihydro-6,7-dimethoxy-isoquinoline-1-yl)-2-phenyl-N,N-di[2-(2,3,4-trimethoxyphenyl)ethyl]-acetamide (LOE 908), a broad spectrum inhibitor of voltage-operated cation channels and SOCs. Male Sprague-Dawley rats (n = 53) were trained in the Morris water maze, anesthetized (60 mg/kg pentobarbital, i.p.), and subjected to lateral fluid percussion brain injury (2.5-2.7 atm; n = 38) or surgery without injury (n = 15). At 15 min postinjury, animals were randomized to receive intravenous administration of either a high dose of LOE 908 (4 mg/kg bolus followed by 160 mg/kg over 24 h; n = 13), a low dose of LOE 908 (2 mg/kg bolus followed by 80 mg/kg over 24 h; n = 12), or vehicle (n = 13). Uninjured controls received the high dose of LOE 908 (n = 8) or vehicle (n = 7). Treatment with either dose of LOE 908 significantly improved neuromotor function at 48 h postinjury when compared to vehicle treatment. Although a significant deficit in visuospatial memory was observed in brain-injured animals at this timepoint when compared to uninjured animals, neither dose of LOE 908 attenuated injury-induced cognitive dysfunction. Histological evaluation revealed that neither dose of LOE 908 affected cortical lesion size at 48 h postinjury. These data suggest that broad spectrum cation channel blockers may be beneficial in the treatment of neurological motor dysfunction when administered in the acute posttraumatic period.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Boehringer Ingelheim Pharma KG, D-6507 Ingelheim, Germany		Saatman, KE (corresponding author), Univ Penn, Dept Neurosurg, 105C Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.		Raghupathi, Ramesh/AAX-5538-2021		NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS26818, P50-NS08803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, R01NS026818] Funding Source: NIH RePORTER		Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1987, J NEUROSCI, V7, P369; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Di X, 1996, J NEUROTRAUM, V13, P497, DOI 10.1089/neu.1996.13.497; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Encabo A, 1996, BRIT J PHARMACOL, V119, P702, DOI 10.1111/j.1476-5381.1996.tb15729.x; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENTILE N, 1993, J NEUROTRAUM, V10, pS193; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HoehnBerlage M, 1997, J CEREBR BLOOD F MET, V17, P534, DOI 10.1097/00004647-199705000-00007; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KRAUS JF, 1993, HEAD INJURY; KRAUTWURST D, 1993, MOL PHARMACOL, V43, P655; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; PAXINOS G, 1990, STEREOTAXIC ATLAS RA; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RINK A, 1995, AM J PATHOL, V147, P1575; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SHAPIRA Y, 1989, Neurological Research, V11, P169; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; YOUNG W, 1992, J NEUROTRAUMA S1, V9, P9; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	52	23	23	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2000	17	1					83	91		10.1089/neu.2000.17.83			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	278WR	WOS:000085012400007	10674760				2022-02-06	
J	Cheng, C; Reynolds, IJ				Cheng, C; Reynolds, IJ			Subcellular localization of glutamate-stimulated intracellular magnesium concentration changes in cultured rat forebrain neurons using confocal microscopy	NEUROSCIENCE			English	Article						intracellular magnesium; Mg2+; NMDA receptor; magindo-1; confocal microscopy	RECEPTOR-MEDIATED NEUROTOXICITY; TRAUMATIC BRAIN INJURY; CORTICAL-NEURONS; NERVOUS-SYSTEM; FREE MG-2+; IN-VITRO; CALCIUM; MG2+; CHANNELS; ISCHEMIA	Glutamate can stimulate increases in intracellular magnesium concentration ([Mg2+](i)) and induce neurotoxicity, both independent of Ca2+ changes. Although Mg2+ is essential within the cell, very little is known about how it is regulated, especially in neurons. Therefore we used the Auorescenr indicator, magindo(-1) and confocal microscopy to examine possible intracellular pools of Mg2+ in cultured neurons that can be dynamically regulated by glutamate. The magindo-1 fluorescence signal was present throughout the cell body and extends into the neuronal processes. The magindo-1 405 nm/490 nm ratio signal was similar in the cytoplasm and nucleus, suggesting that resting [Mg2+](i) is uniform across the neuron. The addition of 100 mu M glutamate/10 mu M glycine in an extracellular Ca2+- and Na+-free buffer stimulated an increase in [Mg2+](i) in both the nuclear and cytoplasmic regions of similar magnitude and duration. This glutamate exposure also stimulated a [Mg2+](i) increase in neuronal processes which was inhibited by the N-methyl-D-aspartate receptor antagonist, MK-801 (10 mu M) The glutamate-stimulated [Mg2+](i) increase in both the cell body and neuronal processes was dependent on the extracellular Mg2+ concentration. These findings suggest glutamate-stimulated [Mg2+](i) changes may not only impact cytoplasmic processes, but also directly trigger nuclear events involved, for example, in neuronal injury. (C) 1999 IBRO. Published by Elsevier Science Ltd.	Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA		Reynolds, IJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA.		Reynolds, Ian/C-4358-2008; Reynolds, Ian Jeffery/ABH-3197-2020	Reynolds, Ian/0000-0003-3028-5070	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034138] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM 08424] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34138] Funding Source: Medline		AGUS ZS, 1991, ANNU REV PHYSIOL, V53, P299, DOI 10.1146/annurev.physiol.53.1.299; Bara M, 1984, Magnesium, V3, P215; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J PHARMACOL EXP THER, V242, P713; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; GARFINKEL L, 1985, Magnesium, V4, P60; GUNTHER T, 1986, MAGNESIUM, V5, P53; Hartnett KA, 1997, J NEUROCHEM, V68, P1836; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; HYRE K, 1997, J NEUROSCI, V17, P6669; KELEPOURIS E, 1993, MINER ELECTROL METAB, V19, P277; LATTANZIO FA, 1991, BIOCHEM BIOPH RES CO, V177, P184, DOI 10.1016/0006-291X(91)91966-G; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MICHAELS RL, 1990, J NEUROSCI, V10, P283; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MORELLE B, 1994, ANAL BIOCHEM, V218, P170, DOI 10.1006/abio.1994.1156; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Pivovarova NB, 1999, J NEUROSCI, V19, P6372; POPOV EG, 1988, ARCH BIOCHEM BIOPHYS, V261, P91, DOI 10.1016/0003-9861(88)90107-5; RAJDEV S, 1994, NEUROSCIENCE, V62, P667, DOI 10.1016/0306-4522(94)90468-5; REYNOLDS IJ, 1996, SOC NEUR ABSTR, V22, P68; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; Sebille S, 1996, BIOCHEM BIOPH RES CO, V227, P743, DOI 10.1006/bbrc.1996.1579; SILVERMAN HS, 1994, AM J PHYSIOL, V266, pC222, DOI 10.1152/ajpcell.1994.266.1.C222; Stout AK, 1996, J PHYSIOL-LONDON, V492, P641, DOI 10.1113/jphysiol.1996.sp021334; Stout AK, 1999, NEUROSCIENCE, V89, P91, DOI 10.1016/S0306-4522(98)00441-2; Taylor CP, 1999, J NEUROSCI, V19, P619; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1990, J NEUROSCI, V10, P3524; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1991, MG2PLUS EXCITABLE ME, P125; WHITE RJ, 1995, J NEUROSCI, V15, P1318	44	23	24	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2000	95	4					973	979					7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	277EL	WOS:000084919700005	10682704				2022-02-06	
J	Nomura, S; Ishido, T; Teranishi, J; Makiyama, K				Nomura, S; Ishido, T; Teranishi, J; Makiyama, K			Long-term analysis of suprapubic cystostomy drainage in patients with neurogenic bladder	UROLOGIA INTERNATIONALIS			English	Article						suprapubic cystostomy; neurogenic bladder; bladder calculi	CATHETERIZATION	Objective: We assessed the roles of suprapubic cystostomy in patients with neurogenic bladder and analyzed the complications and their courses. Patients and Methods: We reviewed 118 patients with neurogenic bladder managed with suprapubic cystostomy. The original diseases were spinal cord injury in 90, degenerative disease of the central nervous system in 15, spina bifida in 6, cerebral palsy in 3, pontine bleeding in 1, Parkinson's disease in 1, brain tumor in 1, and dysgenesis of the external sphincter in 1. Fifty-six (62.2%) of spinal cord-injured patients demonstrated cervical damage. Renal function, urinary pH and white blood cell values were measured and evaluated after insertion. The stone-free rate after insertion was estimated by the Kaplan-Meier method. Results: Indications for cystostomy were failure of clean intermittent catheterization in 62 (52.5%) and Crede's maneuver in 2, severe urethral damage in 30 (25.4%), replacement of urethral catheter in 3, worsening of the original disease in 15 (12.7%), deterioration of the general condition in 2, mental retardation in 2, and traumatic vesical rupture in 1. Frequent complications were formation of the bladder calculi in 30 (25%) and urinary leakage through the urethra in 11 (10%). No fatal complications occurred. The stone-free rates 5 and 10 years after insertion were 77 and 64%, respectively. The urinary pH of the stone-forming group was significantly higher than that of the stone-free group. The high urinary pit group (>7.24) had a higher risk of stone formation. Conclusions: Although continuous cystostomy drainage is not considered to be ideal management for bladder emptying, some patients with neurogenic bladder may benefit from this procedure. Copyright (C) 2000 S. Karger AG, Basel.	Kanagawa Rehabil Hosp, Dept Urol, Atsugi, Kanagawa 2430121, Japan		Ishido, T (corresponding author), Kanagawa Rehabil Hosp, Dept Urol, 516 Nanasawa, Atsugi, Kanagawa 2430121, Japan.						BARNES DG, 1993, BRIT J UROL, V72, P169, DOI 10.1111/j.1464-410X.1993.tb00681.x; BRINDLEY GS, 1994, PARAPLEGIA, V32, P795, DOI 10.1038/sc.1994.126; HACKLER RH, 1982, BRIT J UROL, V54, P120, DOI 10.1111/j.1464-410X.1982.tb13533.x; HEDELIN H, 1991, BRIT J UROL, V67, P527, DOI 10.1111/j.1464-410X.1991.tb15200.x; HOLMGREN K, 1989, SCAND J UROL NEPHROL, V23, P131, DOI 10.3109/00365598909180827; LAPIDES J, 1972, Journal of Urology, V107, P458; LOCKE JR, 1985, J UROLOGY, V133, P1034, DOI 10.1016/S0022-5347(17)49366-9; PEATFIELD RC, 1983, PARAPLEGIA, V21, P220, DOI 10.1038/sc.1983.35; Perkash I, 1976, Paraplegia, V13, P247; Schurch B, 1996, J UROLOGY, V155, P1023, DOI 10.1016/S0022-5347(01)66376-6; Sheriff MKM, 1998, SPINAL CORD, V36, P171, DOI 10.1038/sj.sc.3100536; STEGMAYR B, 1990, SCAND J UROL NEPHROL, V24, P215, DOI 10.3109/00365599009180861	12	23	24	1	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0042-1138			UROL INT	Urol.Int.		2000	65	4					185	189		10.1159/000064873			5	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	374ZP	WOS:000165375100002	11112866				2022-02-06	
J	Paniak, C; Toller-Lobe, G; Melnyk, A; Nagy, J				Paniak, C; Toller-Lobe, G; Melnyk, A; Nagy, J			Prediction of vocational status three to four months after treated mild traumatic brain injury	JOURNAL OF MUSCULOSKELETAL PAIN			English	Article						brain injury; financial compensation; work	HEAD-INJURY; PAIN	Objectives: To identify variables correlated with vocational functioning 3-4 months after treated mild traumatic brain injury [MTBI]. Methods: One hundred eighteen adults who had received specialized treatment soon after MTBI were interviewed 3-4 months later, to evaluate if they had returned to full time pre-injury vocational activity. Variables previously shown to be related to functioning after MTBI were used in a stepwise discriminant function analysis, in an attempt to predict vocational outcome. Results: Seeking or receiving financial compensation at follow-up, and older age, were the only two variables retained in the discriminant function analysis, as useful in predicting which persons had returned to work and which had not. Conclusions: The strong correlation between financial compensation issues and vocational status in this treated MTBI sample replicates a relationship previously reported numerous times in untreated MTBI samples. The reasons for this strong correlation have not been extensively investigated and remain controversial; further research to help explain this robust and reliable correlation is clearly warranted.	Glenrose Rehabil Hosp, Edmonton, AB T5G 0B7, Canada; Univ Alberta, Edmonton, AB, Canada		Paniak, C (corresponding author), Glenrose Rehabil Hosp, 10230-111 Ave, Edmonton, AB T5G 0B7, Canada.	cpaniak@grhosp.ab.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EVANS RW, 1994, J FORENSIC PSYCHOL, V12, P19; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; KRAUS JF, 1989, MILD HEAD INJURY, P8; *MILD TRAUM BRAIN, 1993, J HEAD TRAUMA REHAB, V8, P87; Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61	13	23	23	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1058-2452	1540-7012		J MUSCULOSKELET PAIN	J. Musculoskelet. Pain		2000	8	1-2					193	200		10.1300/J094v08n01_16			8	Rehabilitation; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Rheumatology	330GV	WOS:000087955200018					2022-02-06	
J	Gong, QZ; Phillips, LL; Lyeth, BG				Gong, QZ; Phillips, LL; Lyeth, BG			Metabotropic glutamate receptor protein alterations after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion; TBI; metabotropic; glutamate; immunohistochemistry; Western blot	FLUID-PERCUSSION MODEL; PHENYLGLYCINE DERIVATIVES; NEURONAL INJURY; NMDA-RECEPTORS; AMINO-ACIDS; AGONIST; BINDING; DEATH; MGLUR; ANTAGONISTS	Glutamate toxicity, mediated via ion channel-linked receptors, plays a key role in traumatic brain injury (TBI) pathophysiology. Excessive glutamate release after TBI also activates protein G-linked metabotropic glutamate receptors (mGluRs), We performed Western blot and immunohistochemical analysis with antibodies for group 1 and 2 mGluRs in hippocampal and cortex tissue at 7 and 15 days after lateral fluid-percussion TBI in rats, Protein homogenates of brain tissue were separated on 7.5% sodium dodecyl sulfate (SDS)-polyacrylamide gels, transferred to nitrocellulose, and incubated with either antibodies recognizing both mGluR2 and mGluR3 or antibodies against mGluR5, Equivalent protein loading of lanes was confirmed by using beta-actin antibody. Immunoreactive proteins were revealed with enhanced chemiluminescence and relative optical density of Western blots quantified by computerized image analysis. At 7 days after TBI, mGluR3 immunobinding ipsilateral to the fluid-percussion injury was reduced by 28% in hippocampus and 25% in cortex in comparison with the contralateral hemisphere (p <.05), mGluR5 immunobinding ipsilateral to the fluid-percussion injury was reduced by 20% in hippocampus and 27% in cortex (p <.05). At 15 days after TBI, the decreases in immunobinding were no longer significant, Immunohistochemical staining with the same antibodies revealed density changes congruent with the Western blot results. These data suggest that TBI produces an alteration in receptor protein expression that spontaneously recovers by 15 days after injury.	Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Court,1 Shields Ave, Davis, CA 95616 USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 29995] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995] Funding Source: NIH RePORTER		Akbar MT, 1996, MOL BRAIN RES, V43, P105, DOI 10.1016/S0169-328X(96)00162-3; Attwell PJE, 1998, BRAIN RES, V787, P286, DOI 10.1016/S0006-8993(97)01500-X; Bond A, 1998, NEUROREPORT, V9, P1191, DOI 10.1097/00001756-199804200-00042; BRUNO V, 1994, EUR J PHARMACOL, V256, P109, DOI 10.1016/0014-2999(94)90624-6; BUISSON A, 1995, NEUROPHARMACOLOGY, V34, P1081, DOI 10.1016/0028-3908(95)00073-F; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 1997, J NEUROTRAUM, V14, P885, DOI 10.1089/neu.1997.14.885; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; HAYASHI Y, 1994, J NEUROSCI, V14, P3370; HAYES RL, 1988, J NEUROTRAUM, V5, P287; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Mukhin A, 1996, J NEUROSCI, V16, P6012; Mukhin AG, 1997, NEUROREPORT, V8, P2561, DOI 10.1097/00001756-199707280-00028; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; ROBERTS PJ, 1995, NEUROPHARMACOLOGY, V34, P813, DOI 10.1016/0028-3908(95)00094-M; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; ROSDAHL D, 1994, NEUROREPORT, V5, P593, DOI 10.1097/00001756-199401000-00015; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; WATKINS J, 1994, TRENDS PHARMACOL SCI, V15, P333, DOI 10.1016/0165-6147(94)90028-0	34	23	23	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1999	16	10					893	902		10.1089/neu.1999.16.893			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	246JD	WOS:000083159900004	10547098				2022-02-06	
J	Halper, AS; Cherney, LR; Cichowski, K; Zhang, M				Halper, AS; Cherney, LR; Cichowski, K; Zhang, M			Dysphagia after head trauma: The effect of cognitive-communicative impairments on functional outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; communication; dysphagia; outcomes; swallowing; traumatic brain injury	BRAIN INJURY; NEUROGENIC DYSPHAGIA; ADULTS	This article discusses the impact of cognitive-communicative and behavior problems on oral intake. Data on the swallowing outcomes of a group of patients in an acute rehabilitation facility are presented. These data illustrate the relationships among severity of dysphagia, admission and discharge Functional Independence Measure (FIM(TM)) scores, admission and discharge cognitive FIM(TM) scores and length of stay. Two case studies that describe the effect of cognitive-communicative disorders on dysphagia are provided.	Rehabil Inst Chicago, Educ & Training Ctr, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Chicago, IL USA; Northwestern Univ, Evanston, IL USA		Halper, AS (corresponding author), Rehabil Inst Chicago, Educ & Training Ctr, 345 E Super, Chicago, IL 60611 USA.						American Speech-Language-Hearing Association, 1987, ASHA, V29, P53; AVERYSMITH W, 1994, AM J OCCUP THER, V48, P235, DOI 10.5014/ajot.48.3.235; BROWN G E, 1992, Dysphagia, V7, P138, DOI 10.1007/BF02493445; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; Cherney LR, 1989, J HEAD TRAUMA REHAB, V4, P42; Cherney LR, 1994, CLIN MANAGEMENT DYSP; FIELD LH, 1989, BRAIN INJURY, V3, P9; Hagen C, 1981, TOP LANG DIS, V1, P73; Halper AS, 1991, CLIN MANAGEMENT COMM; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lazarus CL, 1989, J HEAD TRAUMA REHAB, V4, P34; LOGEMANN J A, 1990, Dysphagia, V4, P202, DOI 10.1007/BF02407266; LOGEMANN JA, 1995, J SPEECH HEAR RES, V38, P556, DOI 10.1044/jshr.3803.556; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; *REH I CHIC, 1996, REH I CHIC FUNCT ASS; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; *STAT U NEW YORK B, 1996, GUID UN DAT SET MED; TEASDALE G, 1974, LANCET, V2, P81; Tippett DC, 1987, DYSPHAGIA, V1, P221; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992; YUEN HK, 1992, AM J OCCUP THER, V46, P943, DOI 10.5014/ajot.46.10.943	21	23	26	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1999	14	5					486	496		10.1097/00001199-199910000-00009			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	245MW	WOS:000083113600009	10653944				2022-02-06	
J	Goozee, JV; Murdoch, BE; Theodoros, DG				Goozee, JV; Murdoch, BE; Theodoros, DG			Electropalatographic assessment of articulatory timing characteristics in dysarthria following traumatic brain injury	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							CLOSED-HEAD INJURY; EPG DATA REDUCTION; SPEECH DISORDERS; VOWEL DISTORTION; SPEAKERS; CONTACT	Electropalatography (EPG) is an instrumental technique that records the location and timing of tongue-to-palate contacts during speech (Hardcastle, 1984; Hardcastle, Gibbon, & Jones, 1991a; Hardcastle, Jones, Knight, Trudgeon, & Calder, 1989). Such a technique would be valuable in objectively assessing the articulatory disturbances exhibited by individuals with dysarthria following traumatic brain injury (TBI). To date, however, only a limited number of studies have reported using EPG for this purpose. The aims of the present study were to use EPG to assess the articulatory timing characteristics exhibited by three male subjects (aged 23, 27, and 29 years) with dysarthria following severe TBI and to examine the EPG results in relation to perceptual and physiological (nonspeech) findings. A word list, consisting of the lingual consonants, / t, d, s, z, k, g /, in the word-initial position of single-syllable real words of CV and CVC construction (where V = / a /), was read aloud three times by each subject while wearing an EPG palate. The results obtained by the TBI subjects were compared with a non-neurologically impaired control and are discussed in a series of three case discussions. Both longer and shorter consonant phase durations were exhibited, as were the features of undershooting and overshooting. The findings demonstrated that electropalatography provides greater insight into the nature of the underlying articulatory disturbances exhibited by individuals with dysarthria following TBI.	Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, St Lucia, Qld 4067, Australia		Murdoch, BE (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, St Lucia, Qld 4067, Australia.		Murdoch, Bruce E/C-1397-2012; Theodoros, Deborah/F-1362-2010				BARLOW SM, 1988, ASS RES OT ABSTR, V11, P218; BARRY RM, 1993, CLIN LINGUIST PHONET, V7, P275, DOI 10.1080/02699209308985567; BARRY RM, 1995, CLIN LINGUIST PHONET, V9, P311, DOI 10.3109/02699209508985339; BARRY RM, 1995, CASE STUDIES CLIN LI, P181; Brown J.R., 1975, MOTOR SPEECH DISORDE; Byrd D, 1996, J PHONETICS, V24, P209, DOI 10.1006/jpho.1996.0012; BYRD D, 1995, J SPEECH HEAR RES, V38, P821, DOI 10.1044/jshr.3804.821; DAGENAIS PA, 1994, J PHONETICS, V22, P225, DOI 10.1016/S0095-4470(19)30202-5; DAGENAIS PA, 1995, J COMMUN DISORD, V28, P303, DOI 10.1016/0021-9924(95)00059-1; DOCHERTY G, 1993, SPEECH RES LAB WORK, V7, P8; Duffy JR., 2020, MOTOR SPEECH DISORDE; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; FLETCHER SG, 1989, J SPEECH HEAR RES, V32, P736, DOI 10.1044/jshr.3204.736; FLETCHER SG, 1991, J ACOUST SOC AM, V89, P850, DOI 10.1121/1.1894646; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; HARDCASTLE W, 1989, CLIN LINGUIST PHONET, V3, P1, DOI 10.3109/02699208908985268; Hardcastle W.J., 1976, PHYSL SPEECH PRODUCT; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; HARDCASTLE WJ, 1984, PHONETICS LABORATORY, V4, P1; HARDCASTLE WJ, 1997, INSTRUMENTAL CLIN PH, P149; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; Linebaugh C. E., 1984, DYSARTHRIAS PHYSL AC, P197; Marquardt TP, 1990, TRAUMATIC BRAIN INJU, P181; MCCLEAN MD, 1987, J SPEECH HEAR RES, V30, P276, DOI 10.1044/jshr.3002.276; NETSELL R, 1975, J SPEECH HEAR DISORD, V40, P170, DOI 10.1044/jshd.4002.170; NGUYEN N, 1996, QMC WORKING PAPERS S, V1, P5; Peterson H. A., 1994, APPRAISAL DIAGNOSIS; ROBIN DA, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P173; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; THOMPSON BE, 1984, EXP FLUIDS, V2, P47; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1983, PHONETICA, V40, P63; ZIEGLER W, 1983, PHONETICA, V40, P312, DOI 10.1159/000261698; [No title captured]	40	23	23	0	2	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	1999	7	3					209	222					14	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	235JJ	WOS:000082538300004					2022-02-06	
J	Newburn, G; Edwards, R; Thomas, H; Collier, J; Fox, K; Collins, C				Newburn, G; Edwards, R; Thomas, H; Collier, J; Fox, K; Collins, C			Moclobemide in the treatment of major depressive disorder (DSM-3) following traumatic brain injury	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; SOCIAL-ADJUSTMENT; CHRONIC PAIN; MOOD; REHABILITATION; AMITRIPTYLINE; COMPLAINTS; FLUOXETINE; RELATIVES; SEQUELAE	Major depression (MDD) following traumatic brain injury (TBI) is a common phenomenon. There are no adequate studies in the literature defining optimum treatments for this condition following TBI. The opportunity arose to analyse a group of patients who were included in a larger study of an antidepressant (moclobemide). As the treatment, but not the delivery, was known, this has the status of an open study. Twenty-six patients with major depression of late onset (mean 4.67 years post-TBI) were identified (18 male, 8 female), with a mean age at injury 28.49 years. The group was moderately depressed with Hamilton Depression score (HAM-D) of 23.385 and moderately anxious with Hamilton Anxiety score (HAM-A) of 21.231. Mean HAM-D reduction was 81% and HAM-A reduction 81%. Of the 26 subjects 23 were defined as responders. Onset of action was rapid, with 17 responding by day 3. Irritability scores showed a mean reduction of 57% and pain scores a reduction of 39%. It is concluded that moclobemide may be an effective treatment for MDD following TBI, but properly controlled studies must be carried out to confirm this.	Rotorua Rehabil Ctr, Rotorua, New Zealand; Mem Hosp, Dept Psychiat, Hastings, New Zealand; Anglesea Clin, Hamilton, New Zealand; Sunnyside Hosp, Christchurch, New Zealand		Newburn, G (corresponding author), Rotorua Rehabil Ctr, POB 614, Rotorua, New Zealand.						Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; Da Prada M, 1988, J Neural Transm Suppl, V26, P31; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; FAVA M, 1991, PSYCHOPHARMACOL BULL, V27, P275; FEDEROFF JP, 1992, AM J PSYCHIAT, V149, P918; Gualtari CT, 1991, BRAIN INJURY, V5, P219; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KRAGHSORENSEN P, 1995, J CLIN PSYCHOPHAR S2, V15, P24; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NEWBURN GM, 1990, AUST NZ J PSYCHIAT, V24, P475, DOI 10.3109/00048679009062902; NEWBURN GM, 1995, J CLIN PSYCHOPHAR S2, V15, P10; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PRIGITANO GP, 1986, NEUROPSYCHOLOGICAL R; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Robinson Robert G., 1994, P219; ROSE ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; RUTHERFORD WH, 1977, LANCET, V1, P1; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SILVER JM, 1992, AM PSYCHIAT PRESS TX, P363; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; VERSIANI M, 1989, BRIT J PSYCHIAT, V155, P72, DOI 10.1192/S0007125000297523; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WILLIAMS R, 1993, INT CLIN PSYCHOPHARM, V7, P155, DOI 10.1097/00004850-199300730-00006	40	23	23	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	1999	13	8					637	642					6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	239YW	WOS:000082799200007	10901691				2022-02-06	
J	Ishikawa, K; Tanaka, H; Takaoka, M; Ogura, H; Shiozaki, T; Hosotsubo, H; Shimazu, T; Yoshioka, T; Sugimoto, H				Ishikawa, K; Tanaka, H; Takaoka, M; Ogura, H; Shiozaki, T; Hosotsubo, H; Shimazu, T; Yoshioka, T; Sugimoto, H			Granulocyte colony-stimulating factor ameliorates life-threatening infections after combined therapy with barbiturates and mild hypothermia in patients with severe head injuries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	58th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma/Trauma-Association-of-Canada	SEP 24-27, 1998	BALTIMORE, MD	Amer Assoc Surg Trauma, Trauma Assoc Canada		granulocyte colony-stimulating factor (G-CSF); head injury; infection; leukopenia; hypothermia	TRAUMATIC BRAIN INJURY; NEUTROPHIL MIGRATION; MODERATE HYPOTHERMIA; CHEMI-LUMINESCENCE; SEPSIS; ACCUMULATION; SUPPRESSION; VOLUNTEERS; FILGRASTIM; MODULATION	Objective: The objective of this study was to clarify the effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) administration on infections in patients with severe head injuries after combined therapy with high-dose barbiturates and mild hypothermia. Patients and Methods: Since 1996, we have administered rhG-CSF to eight patients with severe head injuries for 5 days (group G), Their treatment results were compared with those of 22 patients cared for earlier without rhG-CSF treatment (group N), All patients in both groups met the criteria of total leukocyte count (TLC) less than 5,000/mm(3), C-reactive protein (CRP) over 10 mg/dL, and the presence of an infectious complication. Changes in the TLC, CRP, respiratory index, intracranial pressure, and infectious condition were evaluated in both groups. In addition, the nucleated cell count a:nd differentiation from bone marrow aspiration, neutrophil functions, serum concentrations of interleukin-6, and plasma concentration of leukocyte elastase were evaluated in group G, Results: In group G, TLC, nucleated cell count, and neutrophil functions significantly increased, whereas CRP, respiratory index, and interleukin-6 decreased reciprocally. There was no deterioration of intracranial pressure and leukocyte elastase, Consequently, seven of the eight patients in group G recovered from life-threatening infections, and none of the eight patients died. However, in group N, CRP and respiratory index remained high and TLC did not increase as much as it did in group G, Infections continued after 5 days in 17 of the 22 patients, 7 of whom died from severe infections during hospitalization, Conclusion: Administration of rhG-CSF ameliorated life-threatening infections without causing lung injury or increasing brain swelling in patients with severe head injuries who were treated with combined therapy involving high-dose barbiturates and mild hypothermia.	Osaka Univ, Sch Med, Dept Traumatol, Suita, Osaka 5650871, Japan; Osaka Prefectural Nakakawachi Med Ctr Acute Med, Osaka, Japan; Osaka Prefectural Gen Hosp, Dept Emergency Med, Osaka, Japan		Ishikawa, K (corresponding author), Osaka Univ, Sch Med, Dept Traumatol, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.						BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; BIGGAR WD, 1986, J APPL PHYSIOL, V60, P1186, DOI 10.1152/jappl.1986.60.4.1186; BIGGAR WD, 1984, INFECT IMMUN, V46, P857, DOI 10.1128/IAI.46.3.857-859.1984; BIGGAR WD, 1983, INFECT IMMUN, V40, P708, DOI 10.1128/IAI.40.2.708-712.1983; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; CANCIO LC, 1994, RESUSCITATION, V28, P9, DOI 10.1016/0300-9572(94)90049-3; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; DALE DC, 1995, J INFECT DIS, V172, P1061, DOI 10.1093/infdis/172.4.1061; DEHAAS M, 1994, BLOOD, V84, P3885, DOI 10.1182/blood.V84.11.3885.bloodjournal84113885; Esposito C, 1998, CRIT CARE MED, V26, P636, DOI 10.1097/00003246-199804000-00005; FREWEN TC, 1982, J PEDIATR-US, V100, P663, DOI 10.1016/S0022-3476(82)80782-8; GABRILOVE JL, 1988, J CLIN INVEST, V82, P1454, DOI 10.1172/JCI113751; GILMORE GL, 1995, EXP HEMATOL, V23, P1319; GOLDFARB MA, 1975, AM J SURG, V129, P255, DOI 10.1016/0002-9610(75)90234-2; GORGEN I, 1992, J IMMUNOL, V149, P918; HARTUNG T, 1995, BLOOD, V85, P2482, DOI 10.1182/blood.V85.9.2482.bloodjournal8592482; HARTUNG T, 1997, SHOCK S1, V7, P81; Heard SO, 1998, CRIT CARE MED, V26, P748, DOI 10.1097/00003246-199804000-00027; Ishikawa K, 1998, J TRAUMA, V44, P1047, DOI 10.1097/00005373-199806000-00018; ISHIKAWA K, 1997, 4 INT C IMM CONS TRA, P661; KAWAKAMI M, 1990, BLOOD, V76, P1962; KRESS HG, 1989, ACTA ANAESTH SCAND, V33, P122, DOI 10.1111/j.1399-6576.1989.tb02873.x; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; LIESCHKE GJ, 1992, NEW ENGL J MED, V327, P99; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; MOONEY DP, 1988, ARCH SURG-CHICAGO, V123, P1353; MOORE MAS, 1991, ANNU REV IMMUNOL, V9, P159; NEUWELT EA, 1982, J NEUROSURG, V56, P254, DOI 10.3171/jns.1982.56.2.0254; Niitsu N, 1997, BRIT J CANCER, V76, P1661, DOI 10.1038/bjc.1997.614; OREILLY M, 1992, J TRAUMA, V33, P679, DOI 10.1097/00005373-199211000-00014; Pajkrt D, 1997, BLOOD, V90, P1415, DOI 10.1182/blood.V90.4.1415.1415_1415_1424; Patton JH, 1998, J TRAUMA, V44, P750, DOI 10.1097/00005373-199805000-00002; ROILIDES E, 1991, J INFECT DIS, V163, P579, DOI 10.1093/infdis/163.3.579; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Schops P, 1997, PHYS MED REHAB KUROR, V7, P80, DOI 10.1055/s-2008-1061865; SHENAQ SA, 1986, ANN CLIN LAB SCI, V16, P130; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Tanaka H, 1996, J TRAUMA, V40, P718, DOI 10.1097/00005373-199605000-00006; TEASDALE G, 1974, LANCET, V2, P81; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; VALERIUS T, 1993, BLOOD, V82, P931; vanEeden SF, 1997, AM J PHYSIOL-HEART C, V272, pH1717; WEISBART RH, 1988, NATURE, V332, P647, DOI 10.1038/332647a0; Weiss M, 1996, CYTOKINE, V8, P260, DOI 10.1006/cyto.1996.0035; WHITE IWC, 1983, CAN ANAESTH SOC J, V30, P506, DOI 10.1007/BF03007085	50	23	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	1999	46	6					999	1007		10.1097/00005373-199906000-00004			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	205BR	WOS:000080801900005	10372615				2022-02-06	
J	May, AK; Patterson, MA; Rue, LW; Schiller, HJ; Rotondo, MF; Schwab, CW				May, AK; Patterson, MA; Rue, LW; Schiller, HJ; Rotondo, MF; Schwab, CW			Combined blunt cardiac and pericardial rupture: Review of the literature and report of a new diagnostic algorithm	AMERICAN SURGEON			English	Article; Proceedings Paper	67th Annual Scientific Meeting and Postgraduate Course Program, Southeastern Surgical Congress	FEB 13-17, 1999	TAMPA, FLORIDA				TRAUMATIC RUPTURE; EXPERIENCE; HEART	The spectrum of blunt cardiac injury varies from the asymptomatic cardiac concussion to the immediately fatal cardiac rupture. Although the majority of victims sustaining blunt cardiac rupture die before receiving medical attention, some survive to evaluation. The diagnosis of cardiac rupture, if established, typically results from the signs and symptoms of pericardial tamponade. However, some patients may have remarkably few signs and symptoms suggestive of cardiac injury and represent a significant diagnostic challenge. We provide two cases of cardiac rupture in which the diagnosis was delayed by the presence of an associated pericardial tear with decompression into the mediastinum and pleural space. In neither of the cases did existing institutional algorithms for blunt cardiac injury assist in establishing the diagnosis before the acute demise of the patient. The presence of a coexisting pericardial injury in these patients with blunt cardiac rupture obscured the diagnosis, leading to the deaths of these patients. A discussion of these two cases and review of the literature is provided with recommendations for diagnostic algorithms in patients sustaining blunt thoracic trauma with possible cardiac and pericardial injury.	Univ Alabama, Dept Surg, Sect Trauma Burns & Surg Crit Care, UAB Stn, Birmingham, AL 35294 USA; SUNY Syracuse, Hlth Sci Ctr, Dept Surg, Syracuse, NY 13210 USA; Univ Penn, Med Ctr, Dept Surg, Div Traumatol & Surg Crit Care, Philadelphia, PA 19104 USA		May, AK (corresponding author), Univ Alabama, Dept Surg, Sect Trauma Burns & Surg Crit Care, UAB Stn, Birmingham, AL 35294 USA.						BRATHWAITE CEM, 1990, ANN SURG, V212, P701, DOI 10.1097/00000658-199012000-00008; CLARK DE, 1983, SURGERY, V93, P493; DESFORGES G, 1955, NEW ENGL J MED, V252, P567, DOI 10.1056/NEJM195504072521403; FULDA G, 1991, J TRAUMA, V31, P167, DOI 10.1097/00005373-199131020-00003; FULDA G, 1990, J CARDIOVASC SURG, V31, P523; GETZ BS, 1986, JAMA-J AM MED ASSOC, V255, P761, DOI 10.1001/jama.255.6.761; KATO K, 1994, J TRAUMA, V36, P859, DOI 10.1097/00005373-199406000-00017; Nagy KK, 1996, ACAD EMERG MED, V3, P1024, DOI 10.1111/j.1553-2712.1996.tb03347.x; PERCHINSKY MJ, 1995, ARCH SURG-CHICAGO, V30, P852; Pretre R, 1997, NEW ENGL J MED, V336, P626, DOI 10.1056/NEJM199702273360906; REDDY PS, 1978, CIRCULATION, V58, P265, DOI 10.1161/01.CIR.58.2.265; Tocino Irena, 1993, P51	12	23	25	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	JUN	1999	65	6					568	574					7	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	200RC	WOS:000080553000021	10366211				2022-02-06	
J	Carson, JD; Roberts, MA; White, AL				Carson, JD; Roberts, MA; White, AL			The epidemiology of women's rugby injuries	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						epidemiology; rugby; women, wounds and injuries	SOCCER; BASKETBALL; PLAYERS	Objective: The purpose of this study was to identify all injuries to members of an elite women's rugby team and to compare these injuries with published data on injuries in other women's contact and collision sports. Design: This was a prospective cohort observational study conducted using a monthly log completed by the team's certified athletic therapist to closely monitor attendance at practices and games along with the type and severity of injuries. Setting: Rugby games and practices held in Ontario, Quebec, and the Netherlands. Participants: Forty members of the Ontario Women's Senior Provincial Rugby Team over the 1997 season and the 1998 World Championships. Main Outcome Measures: An injury was defined as a rugby-related event that kept a player out of practice or competition for >24 hours or required the attention of a physician (e.g., suturing lacerations) and in addition included all dental, eye, and nerve injuries and concussions. Results: There were a total of 35 injuries in 4,958 player-hours and 2,926 athletic exposures. This resulted in a rugby injury rate of 7.1 +/- 0.4 per 1,000 player-hours and 12.0 +/- 2 per 1,000 athletic exposures. Conclusion: The incidence of injuries in women's rugby is comparable with that in other women's contact and collision sports, indicating that the sport may be safer than stated in the literature and media.	Univ Toronto, Womens Coll Hosp, Sport Ctr Adv Res & Educ, Toronto, ON M5S 1B2, Canada; York Univ, Sports Med Clin, Toronto, ON M3J 2R7, Canada; Univ Waterloo, Fac Appl Hlth Sci, Waterloo, ON N2L 3G1, Canada		Carson, JD (corresponding author), Univ Toronto, Womens Coll Hosp, Sport Ctr Adv Res & Educ, 76 Grenville St, Toronto, ON M5S 1B2, Canada.						ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; ARENDT EA, 1994, CLIN SPORT MED, V13, P483; CAMPBELL H, 1995, LANCET, V346, P188; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; COAKLEY JJ, 1990, SPORT SOC; ENGSTROM B, 1991, AM J SPORT MED, V19, P372, DOI 10.1177/036354659101900408; GARRAWAY M, 1995, LANCET, V345, P1485; GIBBS N, 1994, SPORTS MED, V18, P438, DOI 10.2165/00007256-199418060-00007; HAGERTY E, 1994, RUGBY, P20; Jakoet I, 1998, S AFR MED J, V88, P45; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; Levy AS, 1997, AM J SPORT MED, V25, P360, DOI 10.1177/036354659702500315; MEEWISSE WH, 1994, CLIN J SPORT MED, V4, P166; MICHELI LJ, 1989, SPROTS CARE FITNESS, P11; *NAT COLL ATHL ASS, 1994, NCAA REP 1993 94 MEN; *NAT COLL ATHL ASS, 1993, NCAA REP 1992 93 SOF; *NAT COLL ATHL ASS, 1996, NCAA REP 1995 96 SOC; Pieter W., 1994, Journal of Sports Traumatology and Related Research, V16, P49; Silver J R, 1992, Br J Sports Med, V26, P253; STEINBERG P, 1998, RUGBY, P24; WEIR MA, 1996, MED SCI SPORTS EXERC, V28, P1171; Young K., 1995, Journal of Sport and Social Issues, V19, P45, DOI 10.1177/019372395019001004; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175; ZELISKO JA, 1982, AM J SPORT MED, V10, P297, DOI 10.1177/036354658201000507; 1994, RUGBY, V20, P4; 1998, RUGBY, V24, P4	26	23	24	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	APR	1999	9	2					75	78		10.1097/00042752-199904000-00006			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	216PV	WOS:000081451800006	10442621				2022-02-06	
J	Beardmore, S; Tate, R; Liddle, B				Beardmore, S; Tate, R; Liddle, B			Does information and feedback improve children's knowledge and awareness of deficits after traumatic brain injury?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							HEAD-INJURY; DYSFUNCTION; SEQUELAE; SCALE	A frequent observation in adults suffering severe traumatic brain injury (TBI) is that many minimise or appear unaware of their deficits. Few data exist for children, but an initial study by Jacobs (1993) found that knowledge in children after TBI was poor, and this raised issues relating to awareness of deficit. The present study had two aims: (1) to investigate the extent of deficient knowledge and awareness in children and adolescents after severe TBI; (2) to develop an intervention designed to improve knowledge of TBI and awareness of deficit and evaluate its efficacy. Initial evaluation with 21 participants, aged between 9 and 16 years, found a very poor understanding of TBI and some were unaware of their deficits. Subjects were randomly assigned to either an injury-information or attention-placebo session. The results of two-way repeated-measures analyses of variance indicated that the intervention session was not successful in increasing the children's knowledge or awareness of deficit. These findings are discussed in the context of possible causes of poor knowledge and unawareness and implications for rehabilitation practice.	Univ Sydney, Dept Psychol, Sydney, NSW 2006, Australia; Royal N Shore Hosp, Sydney, NSW, Australia								Abidin R., 1990, PARENTING STRESS IND; Achenbach TM, 1991, MANUAL CHILD BEHAV C; *AUSTR COMM REH SE, 1993, ACQ BRAIN IMP INF PA; BEAUMONT M, EPILEPSY ED MANUAL T; BERNARD ME, 1987, YOU CAN DO WHAT EVER; BOGAN J, 1991, STUDENT BRAIN INJURY; BURBACH DJ, 1986, HEALTH PSYCHOL, V5, P307, DOI 10.1037/0278-6133.5.3.307; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Chittum WR, 1996, BRAIN INJURY, V10, P763; CRAFT AW, 1975, HDB CLIN NEUROLOGY, V23, P445; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fleming JM, 1996, BRAIN INJURY, V10, P1; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; *HEAD INJ COUNC AU, 1994, BRAIN INJ INF KIT; *HEADW QUEENSL INC, CHILDR HEAD INJ SER; *HUNT BRAIN INJ RE, 1996, WHY DID HAV HAPP OUR; JACOBS MP, 1993, NEUROPSYCHOL REHABIL, V3, P341, DOI 10.1080/09602019308401446; JOHNSON CN, 1982, CHILD DEV, V53, P222, DOI 10.2307/1129656; JOHNSON DA, 1992, BRIT J EDUC PSYCHOL, V62, P404, DOI 10.1111/j.2044-8279.1992.tb01033.x; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; LEHMKUHL G, 1990, BRAIN BEHAV CHILD PS, P267; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; NEUHAUSER C, 1978, AM J ORTHOPSYCHIAT, V48, P335, DOI 10.1111/j.1939-0025.1978.tb01321.x; NOCKLEBY DM, 1987, INT J CLIN NEUROPSYC, V9, P145; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SPIRITO A, 1988, J PEDIATR PSYCHOL, V13, P555, DOI 10.1093/jpepsy/13.4.555; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; [No title captured]	38	23	23	0	4	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN	1999	9	1					45	62		10.1080/713755588			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	159ZG	WOS:000078205400003					2022-02-06	
S	Filbert, MG; Forster, JS; Smith, CD; Ballough, GPH		Trembly, B; Slikker, W		Filbert, MG; Forster, JS; Smith, CD; Ballough, GPH			Neuroprotective effects of HU-211 on brain damage resulting from soman-induced seizures	NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	4th International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	NOV 15-19, 1998	ANNAPOLIS, MARYLAND	US FDA, Natl Ctr Toxicol Res, Dept Vet Affairs Med Ctr			CLOSED-HEAD INJURY; MICROTUBULE-ASSOCIATED PROTEIN-2; NMDA ANTAGONIST; RAT-BRAIN; IMMUNOREACTIVITY; PROTECTS; LIGHT	Neuroprotective effects of HU-211 (dexanabinol), a synthetic nonpsychotropic analog of tetrahydrocannabinol, on brain damage resulting from soman-induced seizures were examined in male Sprague-Dawleg rats challenged with 1.6 LD50 soman, At 5 or 40 min after onset of seizures, the rats were given an intraperitoneal injection of 25 mg/kg HU-211, All, rats that received soman showed electrocorticographic (ECoG) evidence of sustained: seizures and status epilepticus for 4-6 hr, HU-211 had no effect: on either the strength or duration of seizure activity, Administration of HU-211 at 5 min after seizure onset reduced median lesion volume 86% (as assessed by microtubule-associated protein 2 (MAP2)-negative staining), and when administered 40 min post-onset, the reduction in necrosis was 81.5% despite the presence of continuous seizures for 4-5 hr, These observations were corroborated by hemotoxylin and eosin (H&E) histopathological assessment that showed a significant reduction in piriform cortical neuronal damage in HU-211-treated animals, It is concluded that HU-211 provides considerable neuroprotection against brain damage produced by soman-induced seizures.	USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA		Filbert, MG (corresponding author), USA, Med Res Inst Chem Def, 3100 Ricketts Point Rd, Aberdeen Proving Ground, MD 21010 USA.						BALLOUGH GPH, 1995, J NEUROSCI METH, V61, P23, DOI 10.1016/0165-0270(95)00019-Q; Ballough GPH, 1998, MOL CHEM NEUROPATHOL, V34, P1, DOI 10.1007/BF02815133; BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BIEGON A, 1995, NEUROL RES, V17, P275, DOI 10.1080/01616412.1995.11740326; BRAITMAN DJ, 1989, BRAIN RES BULL, V23, P145, DOI 10.1016/0361-9230(89)90173-1; CLIFFORD D, 1989, EXP NEUROL, V10, P272; CLIFFORD DB, 1990, EPILEPSIA, V31, P382, DOI 10.1111/j.1528-1157.1990.tb05492.x; ESHHAR N, 1995, EUR J PHARMACOL, V283, P19, DOI 10.1016/0014-2999(95)00271-L; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; LABRUYERE J, 1986, Society for Neuroscience Abstracts, V12, P344; Matus Andrew, 1994, V13, P155; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; OLNEY JW, 1983, NATURE, V301, P520, DOI 10.1038/301520a0; Shih TM, 1997, J APPL TOXICOL, V17, P255, DOI 10.1002/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.0.CO;2-D; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SMITH G G, 1987, Society for Neuroscience Abstracts, V13, P1031; SPARENBORG S, 1992, NEUROPHARMACOLOGY, V31, P357, DOI 10.1016/0028-3908(92)90068-Z; Striem S., 1996, Society for Neuroscience Abstracts, V22, P196; TAYLOR P, 1996, PHARMACOL BASIS THER, P161; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8	25	23	23	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-222-3	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1999	890						505	514		10.1111/j.1749-6632.1999.tb08032.x			10	Biochemistry & Molecular Biology; Multidisciplinary Sciences; Clinical Neurology; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BP50F	WOS:000085330700048	10668456				2022-02-06	
S	Sala, F; Menna, G; Bricolo, A; Young, W		Trembly, B; Slikker, W		Sala, F; Menna, G; Bricolo, A; Young, W			Role of glycemia in acute spinal cord injury - Data from a rat experimental model and clinical experience	NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	4th International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	NOV 15-19, 1998	ANNAPOLIS, MARYLAND	US FDA, Natl Ctr Toxicol Res, Dept Vet Affairs Med Ctr			CEREBRAL BLOOD-FLOW; INSULIN ADMINISTRATION PROTECTS; ISCHEMIC BRAIN-DAMAGE; HEAD-INJURY; INTRACELLULAR PH; LACTIC-ACIDOSIS; CIRCULATING CATECHOLAMINES; ADMISSION HYPERGLYCEMIA; GLUCOSE CONCENTRATION; HEMORRHAGIC NECROSIS	While experimental and clinical evidence indicates that in brain injury blood glucose increases with injury severity and hyperglycemia worsens neurological outcome, the role of blood glucose in secondary mechanisms of neuronal damage after acute spinal cord injury has not yet been investigated. Data from spinal cord ischemia models suggests a deleterious effect of hyperglycemia,likely due to enhanced lactic acidosis, which is primarily dependent on the amount of glucose available to be metabolized. The purpose of this study is to summarize preliminary experimental and clinical observations on the role of blood glucose in acute spinal cord injury. Between 1995 and 1996 we used the New York University (NYU) rat spinal cord injury model to test the following hypotheses: 1) Blood glucose levels increase with injury severity. 2) Fasting protects from hyperglycemia and prevents secondary damage to the spinal cord. 3) Postinjury-induced hyperglycemia (dextrose 5% 2 gm/Kg) enhances spinal lesion volume. From a clinical perspective, we reviewed blood glucose records of 47 patients admitted to the Department of Neurosrgery in Verona, between 1991 and 1995, within 24 hours of acute spinal cord injury in order to determine: a) the incidence of hyperglycemia (>140 mg/dl); b) the correlation between blood glucose and injury severity; and c) the role of methylprednisolone in affecting blood glucose. Results indicate that in a graded spinal cord injury model: 1) Early after injury, more severe contusions support significantly higher blood glucose levels. 2) Fasting overnight does not directly affect spinal cord lesion volume but influences blood gases, and we observed that a slightly systemic acidosis plays a minor neuroprotective role. Fasting also ensures more consistent normoglycemic baseline blood glucose values. 3) Postinjury-induced moderate hyperglycemia (160-190 mg/dl) does not significantly affect spinal cord injury. In the clinical study, we observed that during the first 24 hours after spinal cord injury: a) Glycemia ranges between 90 and 243 mg/dl (mean value 143 mg/ dl), and close to 50% of the patients present blood glucose values higher than normal. b) Methylprednisolone administration is not associated to significantly higher blood glucose levels. c) There Is a trend for larger glucose rises with more Severe injury.	Univ Verona, Neurosurg Sect, Dept Neurol & Visual Sci, I-37100 Verona, Italy; Rutgers State Univ, Spinal Cord Injury Project, Ctr Neurosci, Brunswick, NJ USA		Sala, F (corresponding author), Osped Civile Maggiore, Neurosurg Sect, Dept Neurol & Visual Sci, Piazzale Stefani 1, I-37100 Verona, Italy.			SALA, Francesco/0000-0003-1263-9859			BECKMAN DL, 1979, P SOC EXP BIOL MED, V160, P200; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BROWNING RG, 1990, ANN EMERG MED, V19, P683, DOI 10.1016/S0196-0644(05)82479-5; Chen YH, 1998, J NEUROSCI, V18, P2982; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; CHERIAN L, 1994, CRIT CARE MED, V22, P1841; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; COMBS DJ, 1990, STROKE, V21, P936, DOI 10.1161/01.STR.21.6.936; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DIETRICH WD, 1993, STROKE, V24, P111, DOI 10.1161/01.STR.24.1.111; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; DUCKROW RB, 1987, STROKE, V18, P52, DOI 10.1161/01.STR.18.1.52; Farooque M, 1996, J NEUROCHEM, V66, P1125; Farooque M, 1997, J NEUROTRAUM, V14, P469, DOI 10.1089/neu.1997.14.469; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; FRAYN KN, 1985, CIRC SHOCK, V16, P229; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GOLDMAN SA, 1989, J CEREBR BLOOD F MET, V9, P471, DOI 10.1038/jcbfm.1989.70; GOTTFRIED JA, 1994, J PHYSIOL-LONDON, V478, P373, DOI 10.1113/jphysiol.1994.sp020258; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HEMMILA MR, 1993, J VASC SURG, V17, P661, DOI 10.1016/0741-5214(93)90108-X; HUANG PP, 1994, J NEUROTRAUM, V11, P547, DOI 10.1089/neu.1994.11.547; Imaizumi T, 1997, J NEUROTRAUM, V14, P299, DOI 10.1089/neu.1997.14.299; Kawai N, 1997, ACT NEUR S, V70, P34; KING LR, 1971, ANN SURG, V173, P337, DOI 10.1097/00000658-197103000-00003; KRAIG RP, 1990, J CEREBR BLOOD F MET, V10, P104, DOI 10.1038/jcbfm.1990.13; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Kristian T, 1996, LIFE SCI, V59, P357, DOI 10.1016/0024-3205(96)00314-1; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; LEMAY DR, 1988, J SURG RES, V44, P352, DOI 10.1016/0022-4804(88)90177-1; LEMAY DR, 1987, J VASC SURG, V6, P383, DOI 10.1067/mva.1987.avs0060383; LEMAY DR, 1989, J NEUROSURG, V71, P594, DOI 10.3171/jns.1989.71.4.0594; LEMAY DR, 1990, J NEUROSURG, V73, P118, DOI 10.3171/jns.1990.73.1.0118; Li PA, 1997, ACTA PHYSIOL SCAND, V161, P567, DOI 10.1046/j.1365-201X.1997.00264.x; LUNDY EF, 1987, SURGERY, V102, P737; MARGULIES DR, 1994, AM SURGEON, V60, P387; MARIE C, 1991, CEREBROVAS BRAIN MET, V3, P29; MARSH WR, 1986, J NEUROSURG, V65, P693, DOI 10.3171/jns.1986.65.5.0693; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MUELHEIM.GH, 1969, P SOC EXP BIOL MED, V130, P574; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; MYERS RE, 1976, J NEUROPATH EXP NEUR, V35, P301, DOI 10.1097/00005072-197605000-00011; MYERS RE, 1976, NEUROLOGY, V26, P345; NAFTCHI NE, 1974, J NEUROSURG, V40, P52, DOI 10.3171/jns.1974.40.1.0052; NAGAI Y, 1993, NMR BIOMED, V6, P1, DOI 10.1002/nbm.1940060102; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; OSTERHOLM JL, 1972, J NEUROSURG, V36, P395, DOI 10.3171/jns.1972.36.4.0395; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; RAWE SE, 1979, J NEUROSURG, V50, P58, DOI 10.3171/jns.1979.50.1.0058; REHNCRONA S, 1989, J CEREBR BLOOD F MET, V9, P65, DOI 10.1038/jcbfm.1989.9; REHNCRONA S, 1980, ACTA PHYSIOL SCAND, V110, P435, DOI 10.1111/j.1748-1716.1980.tb06692.x; RIZZA R, 1979, AM J PHYSIOL, V237, P356; RIZZA RA, 1980, J CLIN INVEST, V65, P682, DOI 10.1172/JCI109714; Robertson CS, 1990, J NEUROTRAUM, V7, P1, DOI 10.1089/neu.1990.7.1; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; ROBERTSON CS, 1987, J NEUROSURG, V67, P739, DOI 10.3171/jns.1987.67.5.0739; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SappeyMarinier D, 1995, NMR BIOMED, V8, P171, DOI 10.1002/nbm.1940080406; Saybasili H, 1998, BRAIN RES, V786, P128, DOI 10.1016/S0006-8993(97)01461-3; SCHOULTZ TW, 1974, LIFE SCI, V15, P1485, DOI 10.1016/0024-3205(74)90123-4; SCHOULTZ TW, 1976, BRAIN RES, V109, P367, DOI 10.1016/0006-8993(76)90536-9; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SIEMKOWICZ E, 1985, ACTA NEUROL SCAND, V71, P417; SIESJO BK, 1993, PROG BRAIN RES, V96, P23; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; STAUB F, 1993, J NEUROL SCI, V119, P79, DOI 10.1016/0022-510X(93)90194-4; TIBBS PA, 1979, J NEUROSURG, V50, P629, DOI 10.3171/jns.1979.50.5.0629; TIBBS PA, 1978, J NEUROSURG, V49, P558, DOI 10.3171/jns.1978.49.4.0558; TOMLINSON FH, 1993, EPILEPSY RES, V14, P123, DOI 10.1016/0920-1211(93)90017-2; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; Wachtler J, 1996, BRAIN RES, V725, P30; Wass CT, 1996, MAYO CLIN PROC, V71, P801; WELSH FA, 1980, STROKE, V11, P355, DOI 10.1161/01.STR.11.4.355; WIDMER H, 1992, J CEREBR BLOOD F MET, V12, P456, DOI 10.1038/jcbfm.1992.63; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	85	23	23	0	4	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-222-3	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1999	890						133	154		10.1111/j.1749-6632.1999.tb07989.x			22	Biochemistry & Molecular Biology; Multidisciplinary Sciences; Clinical Neurology; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BP50F	WOS:000085330700013	10668421				2022-02-06	
J	Leahy, BJ; Lam, CS				Leahy, BJ; Lam, CS			Neuropsychological testing and functional outcome for individuals with traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURIES; REHABILITATION; VARIABLES	The relationship between performance on neuropsychological measures and the vocational and independent living functioning of individuals with traumatic brain injury was examined. The Wechsler Adult intelligence Scale-Revised (WAIS-R) IQ and Stroop Color and Word Test scores differentiated individuals who required no assistance with activities of daily living from those requiring some level of assistance. Only the Stroop Color and Word Test scores differentiated individuals who were competitively employed or engaged in degree-oriented education from those who were unemployed or in sheltered or supported employment. Wechsler Memory Scale-Revised (WMS-R) scores did not differentiate these groups.	IIT, Inst Psychol, Chicago, IL 60616 USA		Lam, CS (corresponding author), IIT, Inst Psychol, 3101 S Dearborn, Chicago, IL 60616 USA.						Acker MB, 1989, NEUROPSYCHOLOGY, V3, P123, DOI 10.1037//0894-4105.3.3.123; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; CALLAHAN D, 1991, PSYCHOL SOCIAL IMPAC, P295; CHELUNG GJ, 1989, ADV PSYCHOL ASSESS, P65; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EISENBERG HM, 1985, CENTRAL NERVOUS SYST, P271; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; Golden CJ, 1978, STROOP COLOR WORD TE; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; JONES M, 1990, DEFINING VALUE CASE; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; Naugle RI, 1990, TRAUMATIC BRAIN INJU, P69; PAPASTRAT LA, 1992, J HEAD TRAUMA REHAB, V7, P11; PUTNAM SH, 1992, CLIN NEUROPSYCHOL, V6, P383; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1981, WAIS R MANUAL; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; ZEIGLER EA, 1987, J REHABIL, V53, P50; [No title captured], DOI DOI 10.1080/13854048808520093	34	23	23	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	1998	12	12					1025	1035		10.1080/026990598121936			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	150BW	WOS:000077643400003	9876862				2022-02-06	
J	Golding, EM; Contant, CF; Robertson, CS; Bryan, RM				Golding, EM; Contant, CF; Robertson, CS; Bryan, RM			Temporal effect of severe controlled cortical impact injury in the rat on the myogenic response of the middle cerebral artery	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; middle cerebral artery; myogenic response; myogenic tone; traumatic brain injury	TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; BLOOD-FLOW; AUTO-REGULATION; AUTOREGULATION; MODEL	The present study examined the effect of severe traumatic brain injury (TBI) on the myogenic response in the rat middle cerebral artery (MCA). Rats were subjected to severe controlled cortical impact (CCI; 5 m/sec, 130-msec duration, 3-mm deformation) injury over the right parietal cortex. At 2, 24, and 120 h postinjury, ipsilateral and contralateral segments of MCAs were isolated, mounted in a vessel chamber, and pressurized. After equilibration, the myogenic tone, the difference in vessel diameter in the presence and absence of calcium for a given pressure, and the myogenic response (the active contractile response elicited by a vessel to increasing pressure), were measured. At 24 h postsurgery, there was a significant interaction between myogenic tone and pressure in the ipsilateral and contralateral MCAs when TBI was compared to shams. However, this was not apparent, at the 2- and 120-h time points. At 2- and 24-h postsurgery, there was a significant interaction between myogenic response and pressure in the ipsilateral MCAs when TBI was compared to shams. While the response of the vascular smooth muscle was altered following injury, it was still functioning, suggesting that these vessels compensate, perhaps through alternate mechanisms or by relying on those remaining intact mechanisms.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA		Golding, EM (corresponding author), Baylor Coll Med, Dept Neurosurg, 6560 Fannin St,Ste 944, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; BRYAN RM, 1995, AM J PHYSIOL-HEART C, V269, pH1171; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; DAVIS MJ, 1993, AM J PHYSIOL, V264, pH2168, DOI 10.1152/ajpheart.1993.264.6.H2168; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Golding EM, 1998, BRAIN RES, V785, P293, DOI 10.1016/S0006-8993(97)01419-4; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KUSCHINSKY W, 1972, CIRC RES, V31, P240, DOI 10.1161/01.RES.31.2.240; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; McCarron JG, 1997, J PHYSIOL-LONDON, V498, P371, DOI 10.1113/jphysiol.1997.sp021864; MEININGER GA, 1992, AM J PHYSIOL, V263, pH647, DOI 10.1152/ajpheart.1992.263.3.H647; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1989, TXB HEAD INJURY, P221; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; NEWLON PG, 1994, J NEUROTRAUM, V11, P121; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; PROCTOR HJ, 1988, J TRAUMA, V28, P347, DOI 10.1097/00005373-198803000-00010; SPARKS HV, 1964, CIRC RES, V15, P254; VANBAVEL E, 1991, J PHYSIOL-LONDON, V436, P371, DOI 10.1113/jphysiol.1991.sp018555; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	30	23	23	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	1998	15	11					973	984		10.1089/neu.1998.15.973			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	139RN	WOS:000077043400006	9840770				2022-02-06	
J	Obrenovitch, TP				Obrenovitch, TP			Neuroprotective strategies: Voltage-gated Na+-channel down-modulation versus presynaptic glutamate release inhibition	REVIEWS IN THE NEUROSCIENCES			English	Article						neuroprotection; neuronal death; glutamate; excitotoxicity; voltage-gated Na+-channels; Na+-channel blockers; riluzole	TRAUMATIC BRAIN INJURY; FOCAL CEREBRAL-ISCHEMIA; HIGH EXTRACELLULAR GLUTAMATE; CAT CAUDATE-NUCLEUS; MODERATE HYPOTHERMIA; RAT STRIATUM; AMINO-ACIDS; TIME-COURSE; AREA CA1; RILUZOLE	Insufficient ATP production relative to cellular requirements is the key factor detrimental to neurons in neurological disorders associated with deficient oxygen/glucose supply or mitochondrial dysfunction, As a large part of the energy consumed by brain cells is used to maintain the Na+ gradient across the cellular membrane, reduction of energy demand by down-modulation of voltage-gated Na+-channels is a rational strategy for neuroprotection against these conditions, Preservation of the inward Na+ gradient is likely to be also beneficial as it is an essential driving force for vital ion exchanges and transport mechanisms (e.g. Ca2+-homeostasis and cell volume regulation). From these elements, I propose that use-dependent Na+-channel blockers increase the resilience of nerve cells to the primary insult and/or subsequent deleterious events, and that reduced efflux of glutamate and other compounds is only a consequence of cellular stress attenuation, The widespread hypothesis that down-modulation of Na+-channels is neuroprotective primarily through reduction of presynaptic glutamate release conflicts with strong experimental evidence.	Univ Bradford, Sch Pharm, Postgrad Studies Pharmacol, Bradford BD7 1DP, W Yorkshire, England								AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Asai S, 1996, NEUROREPORT, V7, P1092, DOI 10.1097/00001756-199604100-00028; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Balkan S, 1997, ACTA NEUROL SCAND, V95, P140, DOI 10.1111/j.1600-0404.1997.tb00085.x; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; BECQUET D, 1990, BRAIN RES, V519, P82, DOI 10.1016/0006-8993(90)90063-H; BENAVIDES J, 1985, NEUROPHARMACOLOGY, V24, P1085, DOI 10.1016/0028-3908(85)90196-0; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CHERAMY A, 1986, NEUROSCIENCE, V19, P1081, DOI 10.1016/0306-4522(86)90124-7; Claus JJ, 1998, NEUROBIOL AGING, V19, P57, DOI 10.1016/S0197-4580(98)00004-9; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Crumrine RC, 1997, STROKE, V28, P2230, DOI 10.1161/01.STR.28.11.2230; Culmsee C, 1998, EUR J PHARMACOL, V342, P193, DOI 10.1016/S0014-2999(97)01499-4; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Gill R, 1997, INT REV NEUROBIOL, V40, P197; GOZLAN H, 1994, J NEUROPHYSIOL, V72, P3017, DOI 10.1152/jn.1994.72.6.3017; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; Hille B., 1991, IONIC CHANNELS EXCIT, V2nd; Hsu KS, 1997, BRIT J PHARMACOL, V122, P671, DOI 10.1038/sj.bjp.0701409; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Iijima T, 1998, J NEUROTRAUM, V15, P277, DOI 10.1089/neu.1998.15.277; Izumi Y, 1998, J CEREBR BLOOD F MET, V18, P97, DOI 10.1097/00004647-199801000-00010; Kawaguchi K, 1997, BRAIN RES, V749, P131, DOI 10.1016/S0006-8993(96)01311-X; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LEKIEFFRE D, 1993, NEUROSCIENCE, V56, P93, DOI 10.1016/0306-4522(93)90565-W; Lesch KP, 1997, J NEURAL TRANSM-SUPP, P155; MacIver MB, 1996, ANESTHESIOLOGY, V85, P626, DOI 10.1097/00000542-199609000-00023; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160; Miele M, 1996, J PHYSIOL-LONDON, V497, P745, DOI 10.1113/jphysiol.1996.sp021805; MoralesVillagran A, 1996, NEUROCHEM INT, V28, P35, DOI 10.1016/0197-0186(95)00064-F; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Obrenovitch TP, 1998, N-S ARCH PHARMACOL, V357, P225, DOI 10.1007/PL00005161; OBRENOVITCH TP, 1990, J NEUROPHYSIOL, V64, P1125, DOI 10.1152/jn.1990.64.4.1125; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Obrenovitch TP, 1996, ACT NEUR S, V66, P50; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; OBRENOVITCH TP, 1993, J NEUROCHEM, V61, P178, DOI 10.1111/j.1471-4159.1993.tb03553.x; OBRENOVITCH TP, 1997, REV CONTEMP PHARMACO, V8, P227; OGATA T, 1992, J NEUROCHEM, V58, P1957, DOI 10.1111/j.1471-4159.1992.tb10075.x; ORREGO F, 1993, NEUROSCIENCE, V56, P539, DOI 10.1016/0306-4522(93)90355-J; Peluffo H, 1997, NEUROSCI LETT, V228, P207, DOI 10.1016/S0304-3940(97)00384-4; REDDY NL, 1995, BIOORG MED CHEM LETT, V5, P2259; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rutledge EM, 1996, J NEUROSCI, V16, P7803; SANCHEZARMASS S, 1994, J NEUROPHYSIOL, V71, P2236, DOI 10.1152/jn.1994.71.6.2236; Schulz JB, 1996, NEUROSCIENCE, V71, P1043, DOI 10.1016/0306-4522(95)00527-7; Segovia G, 1997, NEUROCHEM RES, V22, P1491, DOI 10.1023/A:1021958613125; Shaw PJ, 1997, J NEUROL, V244, pS3, DOI 10.1007/BF03160574; Small DL, 1997, INT REV NEUROBIOL, V40, P137; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; Takahashi M, 1997, J EXP BIOL, V200, P401; Thoresen M, 1997, ACTA PAEDIATR, V86, P1029, DOI 10.1111/j.1651-2227.1997.tb14799.x; Tibbs GR, 1996, J NEUROCHEM, V67, P389; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; Tsuchida E, 1996, J NEUROSURG, V85, P104, DOI 10.3171/jns.1996.85.1.0104; UEDA Y, 1992, STROKE, V23, P253, DOI 10.1161/01.STR.23.2.253; Umemiya M, 1995, BRIT J PHARMACOL, V116, P3227, DOI 10.1111/j.1476-5381.1995.tb15128.x; Urenjak J, 1996, PHARMACOL REV, V48, P21; URENJAK J, 1991, PHARMACOLOGY, V43, P26, DOI 10.1159/000138824; URENJAK J, 1997, REV CONTEMP PHARMACO, V8, P237; Wada E, 1998, J COMP NEUROL, V393, P493; WAHL F, 1994, J NEUROCHEM, V63, P1003; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; WALDMEIER PC, 1995, NEUROLOGY, V45, P1907, DOI 10.1212/WNL.45.10.1907; Warner DS, 1996, ANESTHESIOLOGY, V84, P1475, DOI 10.1097/00000542-199606000-00024; XIE YX, 1994, BRAIN RES, V652, P216, DOI 10.1016/0006-8993(94)90230-5; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	74	23	23	0	3	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	JUL-DEC	1998	9	3					203	211					9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	130CD	WOS:000076500800003	9833651				2022-02-06	
J	Andersson, S; Finset, A				Andersson, S; Finset, A			Heart rate and skin conductance reactivity to brief psychological stress in brain-injured patients	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						brain injury; laterality; stressor reactivity	MENTAL STRESS; PHYSIOLOGICAL-RESPONSE; IMMUNE-RESPONSES; ASYMMETRY; NEUROENDOCRINE; DEPRESSION; ENDOCRINE; MORTALITY; PATTERNS; STROKE	Autonomic reactivity in response to two mentally challenging tasks was studied in 74 patients with traumatic brain injury (TBI; n=33), cerebrovascular insults (CVA; n=27), and hypoxic brain damage (n=14). Heart rate, skin conductance level, and number of spontaneous skin conductance responses were recorded during baseline and two problem-solving stress conditions consisting of Raven progressive matrices and mental arithmetic. CVA and TBI patients with focal right hemisphere injury showed significantly reduced stress reactivity compared to patients with focal left hemisphere injury. This right-left hemisphere difference was maintained when controlled for diagnosis, gender, sex, age, and stressor task performance and involvement. The results indicate that lateralization of lesion rather than diagnosis or etiology is the critical factor in autonomic stress hyporeactivity in brain-injured patients. The results are discussed in relation to brain lateralization of autonomic reactivity and possible clinical consequences of autonomic hyporeactivity for rehabilitation of patients with acquired brain injury. (C) 1998 Elsevier Science Inc.	Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway; Univ Oslo, Inst Behav Sci Med, Oslo, Norway		Andersson, S (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.						ARCHIBALD YM, 1967, J NERV MENT DIS, V145, P25, DOI 10.1097/00005053-196707000-00004; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BOUCSEIN W, 1992, ELECTRODERML ACTIVIT; BURKE HR, 1969, J PSYCHOL, V72, P247, DOI 10.1080/00223980.1969.10543505; CACIOPPO JT, 1994, PSYCHOPHYSIOLOGY, V31, P113, DOI 10.1111/j.1469-8986.1994.tb01032.x; COSTA LD, 1962, J NERV MENT DIS, V134, P162, DOI 10.1097/00005053-196202000-00007; Earle JBB, 1996, INT J PSYCHOPHYSIOL, V21, P1, DOI 10.1016/0167-8760(95)00039-9; Edelberg R., 1972, HDB PSYCHOPHYSIOLOGY, V12, P1011; FINSET A, 1988, CEREBRAL HEMISPHERE, P49; FREYSCHUSS U, 1988, AM J PHYSIOL, V255, pH1443, DOI 10.1152/ajpheart.1988.255.6.H1443; GERENDAI I, 1984, CEREBRAL DOMINANCE B, P167; HACHINSKI VC, 1992, ARCH NEUROL-CHICAGO, V49, P697, DOI 10.1001/archneur.1992.00530310039010; HEILMAN KM, 1978, NEUROLOGY, V28, P229, DOI 10.1212/WNL.28.3.229; HUGDAHL K, 1983, PAVLOVIAN J BIOL SCI, V18, P180; INOUYE T, 1993, ELECTROEN CLIN NEURO, V86, P224, DOI 10.1016/0013-4694(93)90102-2; KANG DH, 1991, BEHAV NEUROSCI, V105, P860, DOI 10.1037/0735-7044.105.6.860; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; Levine M J, 1987, Brain Inj, V1, P171, DOI 10.3109/02699058709034455; LEZAC MD, 1995, NEUROPSYCHOLOGICAL A; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P443, DOI 10.3109/00048679309075801; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; OBRIST PA, 1976, PSYCHOPHYSIOLOGY, V13, P95, DOI 10.1111/j.1469-8986.1976.tb00081.x; PRUNETI CA, 1995, FUNCT NEUROL, V10, P195; Raven J.C., 1976, MANUAL RAVENS PROGR; RENOUX G, 1986, INTEGRATIVE PSYCHIAT, V4, P32; ROINE RO, 1993, STROKE, V24, P1005, DOI 10.1161/01.STR.24.7.1005; ROUSSELLE JG, 1995, INT J PSYCHOPHYSIOL, V20, P49, DOI 10.1016/0167-8760(95)00026-O; Rupright J, 1996, ARCH PHYS MED REHAB, V77, P1205, DOI 10.1016/S0003-9993(96)90150-1; SCHNECK SA, 1971, CLIN NEUROLOGY, V2, P1; SGOUTASEMCH SA, 1994, PSYCHOPHYSIOLOGY, V31, P264, DOI 10.1111/j.1469-8986.1994.tb02215.x; Sloan RP, 1996, PSYCHOSOM MED, V58, P25, DOI 10.1097/00006842-199601000-00005; SOSNOWSKI T, 1991, PSYCHOPHYSIOLOGY, V28, P665, DOI 10.1111/j.1469-8986.1991.tb01011.x; SPYER KM, 1989, TRENDS NEUROSCI, V12, P506, DOI 10.1016/0166-2236(89)90111-2; STEPTOE A, 1987, PSYCHOPHYSIOLOGY, V24, P571; TOMAKA J, 1994, INT J PSYCHOPHYSIOL, V18, P23, DOI 10.1016/0167-8760(84)90012-6; UCHINO BN, 1995, J PERS SOC PSYCHOL, V69, P736, DOI 10.1037/0022-3514.69.4.736; VILLARDITA C, 1985, CORTEX, V21, P627, DOI 10.1016/S0010-9452(58)80010-6; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29; WITTLING W, 1990, NEUROPSYCHOLOGIA, V28, P457, DOI 10.1016/0028-3932(90)90072-V; WITTLING W, 1993, NEUROPSYCHOLOGIA, V31, P591, DOI 10.1016/0028-3932(93)90054-4; Wittling Werner, 1995, P305; ZAMBRINI EY, 1990, NEUROLOGY, V40, P1408; ZOCCOLOTTI P, 1982, Journal of Clinical Neuropsychology, V4, P143, DOI 10.1080/01688638208401124; ZOCCOLOTTI P, 1993, NATO ADV SCI INST SE, V249, P311	46	23	24	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999			J PSYCHOSOM RES	J. Psychosomat. Res.	JUN	1998	44	6					645	656		10.1016/S0022-3999(97)00305-X			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	ZQ034	WOS:000073814800012	9678746				2022-02-06	
J	Matthews, MA; Carey, ME; Soblosky, JS; Davidson, JF; Tabor, SL				Matthews, MA; Carey, ME; Soblosky, JS; Davidson, JF; Tabor, SL			Focal brain injury and its effects on cerebral mantle, neurons, and fiber tracks	BRAIN RESEARCH			English	Article						brain injury; neural degeneration; fiber track degeneration; neurobehavior	DIFFUSE AXONAL INJURY; NEOCORTICAL DAMAGE; MOTOR CORTEX; HEAD-INJURY; RAT; ORGANIZATION; DEGENERATION; DENDRITES; STRIATUM; MODEL	Following a mild cortical impact injury delivered by a piston to the right sensorimotor cortex of the anesthetized rat, we evaluated mantle loss, neuronal changes, and fiber track degeneration by deOlmos silver stains up to 8 weeks after injury. Darkened neurons indicating damage (chromatolysis) occurred widely throughout both hemispheres and were seen from 1 h to 8 weeks after injury. This effect might have occurred from pressure wave damage from piston impact, brain displacement or deafferentation. Cerebral mantle loss was variable but fiber track degeneration related to projection and corticofugal descending tracks associated with the right sensorimotor system was rather constant. Unexpectedly, considerable fiber track degeneration occurred within the cerebellum, especially the inferior vermis. Cells directly under the piston face were surprisingly well-preserved but axon degeneration studies showed that these apparently intact neuronal cell bodies were surrounded by a dense network of degenerating fiber tracks. The intact cells, therefore, may have been functionally cut off from the rest of the brain owing to interruption of their efferents and afferents. The increased susceptibility of axons compared to cell bodies seen with this focal injury is similar to that observed with diffuse brain injury. The early appearing, severe and widespread axon damage we observed suggests that amelioration of focal traumatic brain injury will have to be directed promptly to the preservation of axons as well as cell bodies. (C) 1998 Elsevier Science B.V. All rights reserved.	Louisiana State Univ, Med Ctr, Dept Neurosurg, Brain Protect Res Lab, New Orleans, LA 70112 USA; Louisiana State Univ, Med Ctr, Dept Anat, New Orleans, LA 70112 USA		Carey, ME (corresponding author), Louisiana State Univ, Med Ctr, Dept Neurosurg, Brain Protect Res Lab, 1542 Tulane Ave, New Orleans, LA 70112 USA.						BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRIEDE RL, 1960, J NEUROPATH EXP NEUR, V19, P266, DOI 10.1097/00005072-196004000-00007; FRIEDE RL, 1961, ARCH NEUROL-CHICAGO, V4, P109; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Homayoun P, 1997, J NEUROCHEM, V69, P199; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; MAXWELL WL, 1988, ACTA NEUROPATHOL, V76, P395, DOI 10.1007/BF00686977; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Paxinos G, 1986, RAT BRAIN STEREOTAXI; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; POVLISHOCK JT, 1986, ACTA NEUROPATHOL, V70, P53, DOI 10.1007/BF00689514; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P41; ROULLIER EM, 1991, NEUROSCI LETT, V125, P93; SCHLAEPFER WW, 1974, BRAIN RES, V69, P203, DOI 10.1016/0006-8993(74)90002-X; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; STRICH SJ, 1961, LANCET, V2, P443; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; [No title captured]	44	23	27	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 25	1998	794	1					1	18		10.1016/S0006-8993(98)00107-3			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZX048	WOS:000074475000001	9630470				2022-02-06	
J	Pentland, L; Todd, JA; Anderson, V				Pentland, L; Todd, JA; Anderson, V			The impact of head injury severity on planning ability in adolescence: A functional analysis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; NEUROPSYCHOLOGICAL SEQUELAE; ATTENTIONAL DEFICITS; CHILDREN; CHILDHOOD; SKILLS; PERFORMANCE; STRATEGIES; ADULTS; MILD	This study aimed to investigate the impact of head injury (HT) on executive skills in adolescents. The sample included a mild to moderate HI group (n = 17), a severe HI group (n = 16), and a matched control group (n = 17). Subjects were administered an IQ test and a complex planning task, requiring adolescents to plan an unexpected party. Qualitative features of planning strategies and error patterns were recorded. Significant group differences were noted, with the severe group making more errors and using less efficient strategies on the planning task. No differences were detected between the mild to moderate group and controls, although performances were not indicative of mature planning. Thus, while a history of severe HI is associated with deficits in planning skills, this is not so for milder HI. Further, care needs to be taken not to over-interpret poor planning in this clinical population without considering the normal developmental course of these skills.	Univ Melbourne, Sch Behav Sci, Parkville, Vic 3052, Australia; Grace McKellar Ctr, Geelong, Vic, Australia			v.anderson@psych.unimelb.edu.au					ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P110; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CHALMERS D, 1993, INT J BEHAV DEV, V16, P191, DOI 10.1177/016502549301600206; Condor A, 1995, DEV NEUROPSYCHOL, V11, P485, DOI 10.1080/87565649509540633; Daniel A., 1983, POWER PRIVILEGE PRES; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; GOLDSTEIN FC, 1992, COGNITIVE DISORDERS, P61; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HARTLEY L, 1991, BRAIN INJURY, V6, P271; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1207/s15516709cog0304_1; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; JOHNSON DA, 1989, CHILDRENS HEAD INJUR; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kirk U., 1983, NEUROPSYCHOLOGY LANG, P3; KREITLER S, 1987, BLUEPRINTS THINKING, P205; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVINE B, 1996, J INT NEUROPSYCH SOC, V2, P69; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P69; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PRIGATANO GP, 1993, NEUROPSYCHOL REHABIL, V3, P411, DOI 10.1080/09602019308401449; RADZISZEWSKA B, 1991, DEV PSYCHOL, V27, P381, DOI 10.1037/0012-1649.27.3.381; RUBENSTEIN CL, 1990, J DEV BEHAV PEDIATR, V11, P301; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; STUSS DT, 1987, FRONTAL LOBES REVIS; Tabachnick B. G., 1989, USING MULTIVARIATE S; TEASDALE G, 1974, LANCET, V2, P81; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; WANSART WL, 1990, J LEARN DISABIL, V23, P164, DOI 10.1177/002221949002300306; Wechsler D., 1974, MANUAL WECHSLER INTE; WECHSLER D, MANUAL WECHSLER INTE, P91; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; [No title captured]; [No title captured], DOI DOI 10.1080/13854048708520056	48	23	23	0	3	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY	1998	8	3					301	317		10.1080/713755572			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	ZN339	WOS:000073636000008					2022-02-06	
J	McKeating, EG; Andrews, PJD; Mascia, L				McKeating, EG; Andrews, PJD; Mascia, L			The relationship of soluble adhesion molecule concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							CEREBRAL-ARTERY OCCLUSION; CLOSED-HEAD INJURY; L-SELECTIN; TNF-ALPHA; RAT-BRAIN; ISCHEMIA; ICAM-1; INTERLEUKIN-6; EXPRESSION; ANTIBODIES	Adhesion molecules control the migration of leukocytes into tissue after injury. This may result in further cellular damage. We hypothesized that altered serum concentrations of soluble intercellular adhesion molecule (sICAM)-1 and soluble L-selectin (sL-selectin) after traumatic brain injury would correlate with injury severity and neurological outcome. We investigated serum concentrations of sICAM-1 and sl-selectin in 22 patients with traumatic brain injury admitted to the intensive care unit. The Glasgow Coma Scale (GCS) score and Injury Severity Score were recorded. Paired arterial and jugular venous blood samples were taken on admission and 24, 48, and 96 h after injury. Mean systemic and jugular venous concentrations of sICAM-1 were normal on admission but became significantly increased by 96 h (P = 0.018). sl-selectin concentrations of injured patients were markedly below those of controls at all time points (P < 0.001). There were no significant differences between jugular venous and arterial concentrations of either sICAM-1 or sl-selectin. Serum sICAM-1 was significantly related to neurological outcome (P < 0.001) and to the GCS score (P < 0.001). These changes in adhesion molecule expression after acute brain injury may be important in the pathophysiology of secondary injury. The highly significant relationship between serum sICAM-1 and neurological outcome suggests that the inflammatory response to injury may be detrimental. Drugs that antagonize the actions of the adhesion molecules may have a role in therapy after traumatic brain injury. Implications: This observational study shows that there is a strong association between soluble intercellular adhesion molecule-1 in serum and poor neurological outcome after traumatic brain injury. This suggests that inflammation after brain injury may worsen the prognosis and that therapies directed against this inflammation may prove useful.	Univ Edinburgh, Western Gen Hosp, Dept Anaesthet, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Bari, Dept Intens Care, Bari, Italy		McKeating, EG (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Anaesthet, Edinburgh EH4 2XU, Midlothian, Scotland.		mascia, Luciana/L-3039-2018		Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; CALDENHOVEN E, 1994, J BIOL CHEM, V269, P21146; CHEN H, 1994, ANN NEUROL, V35, P458, DOI 10.1002/ana.410350414; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DONNELLY SC, 1994, LANCET, V344, P215, DOI 10.1016/S0140-6736(94)92995-5; FASSBENDER K, 1995, STROKE, V26, P1361, DOI 10.1161/01.STR.26.8.1361; JANDER S, 1993, NEUROLOGY, V43, P1809, DOI 10.1212/WNL.43.9.1809; JENNETT B, 1975, LANCET, V1, P480; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; SATOH JI, 1991, J NEUROPATH EXP NEUR, V50, P215, DOI 10.1097/00005072-199105000-00004; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; SEBIRE G, 1993, RES VIROLOGY, V144, P47, DOI 10.1016/S0923-2516(06)80011-7; SESSLER CN, 1995, AM J RESP CRIT CARE, V151, P1420, DOI 10.1164/ajrccm.151.5.7735595; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SPERTINI O, 1991, J IMMUNOL, V147, P2565; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; YOUKER K, 1992, J CLIN INVEST, V89, P602, DOI 10.1172/JCI115626; ZHANG ZG, 1995, BRAIN RES, V698, P79, DOI 10.1016/0006-8993(95)00830-J	25	23	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	APR	1998	86	4					759	765		10.1097/00000539-199804000-00016			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	ZE795	WOS:000072831700016	9539598				2022-02-06	
J	Chen, Y; Shohami, E; Bass, R; Weinstock, M				Chen, Y; Shohami, E; Bass, R; Weinstock, M			Cerebro-protective effects of ENA713, a novel acetylcholinesterase inhibitor, in closed head injury in the rat	BRAIN RESEARCH			English	Article						closed-head injury; brain edema; blood-brain barrier; neurological deficit; acetylcholinesterase inhibitor; rat	CONCUSSIVE BRAIN INJURY; TRANSIENT ISCHEMIA; GERBIL BRAIN; PERMEABILITY; HYPOTHERMIA; HU-211	Focal ischemic brain damage and diffuse brain swelling occur in severe cases of traumatic head injury. Ischemia decreases brain acetylcholine (ACh) levels and head trauma upregulates acetylcholinesterase (AChE) in experimental animal models. The present study determined whether a brain-selective AChE inhibitor, ENA713, given once, up to 2 h after closed head injury (CHI) could reduce the vasogenic edema and accelerate recovery from neurological deficits induced by the injury in rats. ENA713 1-5 mg/kg produced a dose-related inhibition of AChE ranging from 40-85% in the cortex and hippocampus. Doses of 1, 2 and 5 mg/kg, significantly reduced the motor and neurological deficits and speeded recovery, as indicated by measurements made 7 and 14 days after injury. The two larger doses were still effective when injected 1 or 2 h after CHI. The acceleration by ENA713 of recovery of motor function was independent of its reduction in body temperature and was prevented by the simultaneous injection of mecamylamine (2.5 mg/kg), but not by scopolamine (0.2 or 1 mg/kg). Edema in the contused hemisphere (24 h after injury) and disruption of the blood brain barrier (4 h after injury) were significantly reduced (about 50%) by doses of 2 and 5 mg/kg, but not by 1 mg/kg. The data support the hypothesis that ENA713 exerts a neuroprotective effect in brain injury by preventing the decrease in cholinergic activity in cerebral vessels and in neurones. (C) 1998 Elsevier Science B.V.	Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel		Weinstock, M (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; BAGHDOYAN HA, 1984, BRAIN RES, V306, P39, DOI 10.1016/0006-8993(84)90354-8; BeitYannai E, 1996, BRAIN RES, V717, P22, DOI 10.1016/0006-8993(95)01492-6; BULLOCK R, 1991, VINKEN BRUYNS HDB CL, V24, P249; CANCIO LC, 1994, RESUSCITATION, V28, P9, DOI 10.1016/0300-9572(94)90049-3; CLEMENT JG, 1993, PHARMACOL BIOCHEM BE, V44, P689, DOI 10.1016/0091-3057(93)90187-X; DAUPHIN F, 1995, PHARMACOL THERAPEUT, V67, P385, DOI 10.1016/0163-7258(95)00022-4; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; GRIEG ME, 1949, SCIENCE, V110, P237; HARDEBO JE, 1984, ACTA NEUROL SCAND, V70, P438; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; SADOSHIMA S, 1995, J CEREBR BLOOD F MET, V15, P845, DOI 10.1038/jcbfm.1995.105; SAIJA A, 1988, Journal of Neurotrauma, V5, P161, DOI 10.1089/neu.1988.5.161; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shohami E, 1996, ISR J MED SCI S, V32, pS9; TANAKA K, 1994, NEUROCHEM RES, V19, P117, DOI 10.1007/BF00966804; TANAKA K, 1995, NEUROCHEM RES, V20, P663, DOI 10.1007/BF01705533; TRANCARD J, 1989, BRAIN RES, V476, P213, DOI 10.1016/0006-8993(89)91241-9; TSUJIMOTO S, 1993, ACTA NEUROCHIR, V124, P127, DOI 10.1007/BF01401134; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WEINSTOCK M, 1994, J NEURAL TRANSM-SUPP, P219; Weinstock M., 1986, ALZHEIMERS PARKINSON, P539; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	31	23	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	FEB 16	1998	784	1-2					18	24		10.1016/S0006-8993(97)00982-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZC505	WOS:000072586800003	9518537				2022-02-06	
J	Friedland, D; Miller, N				Friedland, D; Miller, N			Conversation analysis of communication breakdown after closed head injury	BRAIN INJURY			English	Article							LANGUAGE	This single case study investigated the use of Conversation Analysis (CA) in assessing pragmatic language difficulties after closed head injury (CHI). The aim ws to see if CA captures the types of communication breakdown observed after CHI and whether results from CA can be directly related to scores on formal tests more typically applied after CHI. The results suggested that CA was a sensitive tool for identifying and investigating pragmatic deficits in this case. It facilitated an exploration of whether language impairments identified on formal tests manifest themselves in functional communication; it revealed how different interlocutors adapt to these language difficulties in conversation and also explained why some conversational partners were more successful than others. Considered together, formal test results and CA insights facilitated an in-depth analysis into the precise nature of the communicative impairments of the speaker in this exploratory study, suggesting that CA is a promising approach to the assessment of pragmatic impairments in the CHI population.	Univ Newcastle Upon Tyne, Dept Speech, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England		Miller, N (corresponding author), Univ Newcastle Upon Tyne, Dept Speech, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.						Baddeley, 1990, HUMAN MEMORY THEORY; Bull, 1989, CONVERSATION INTERDI, P21; Bull Peter., 1989, CONVERSATION INTERDI, pp. 238; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; HOLLAND AL, 1984, CLIN APHASIOLOGY C P, P21; Hopper R., 1989, CONVERSATION INTERDI, P48; HOUGH MS, 1994, LANGUAGE INTERVENTIO; Howard D, 1992, PYRAMIDS PALM TREES; Kaplan E, 1983, BOSTON NAMING TEST; Kay J., 1992, PSYCHOLINGUISTIC ASS; Lesser R., 1993, LINGUISTICS APHASIA; LEVISON SC, 1983, PRAGMATICS, P246; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MOSS MB, 1986, ARCH NEUROL-CHICAGO, V43, P239, DOI 10.1001/archneur.1986.00520030031008; MURPHY GL, 1990, DISCOURSE ABILITY BR, P28; Penn C, 1985, S Afr J Commun Disord, V32, P18; PERKINS L, 1995, EUR J DISORDER COMM, V30, P372; Perkins L., 1993, THESIS U NEWCASTLE U; PERKINS M, 1994, CLIN LINGUIST PHONET, V8, P321, DOI 10.3109/02699209408985315; Perkins M. R., 1995, CASE STUDIES CLIN LI, P293; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Wechsler D., 1986, WECHSLER ADULT INTEL; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; [No title captured]; [No title captured]	26	23	24	0	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1998	12	1					1	14		10.1080/026990598122818			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YT347	WOS:000071592500001	9483333				2022-02-06	
J	Georgoulis, AD; Papageorgiou, CD; Makris, CA; Moebius, UG; Soucacos, PN				Georgoulis, AD; Papageorgiou, CD; Makris, CA; Moebius, UG; Soucacos, PN			Anterior cruciate ligament reconstruction with the press-fit technique - 2-5 years followed-up of 42 patients	ACTA ORTHOPAEDICA SCANDINAVICA			English	Article								42 patients underwent anterior cruciate ligament (ACL) reconstruction with the press-fit technique. The ACL was reconstructed with a bone-tendon-bone graft from the medial third of the patellar tendon.The graft was stabilized without screws in the femur and tibia by press-fit. To imitate the anatomical functioning of the ACL, the femoral bone block was placed with the tendon close to the over-the-top position. The tibial block was then placed in a trough on the tibia, so that the ligament fibres were parallel and tight during extension and slightly inverted during flexion. At evaluation mean 41 (25-61) months postoperatively, the mean Lysholm score was 93 (80-100) points, the mean activity level was 6 (3-10) points, and the mean translation of the tibia head, measured by the KT-1000 arthrometer (side-to-side difference), was 2 (0-7) mm. Only 3 of the patients suffered loss of extension (5 degrees). Patients who underwent reconstruction at least 4 months after the injury had better results than those who were operated earlier. The press-fit method allowed for anatomic substitution of the ACL with a stable graft without the disadvantages associated with screws. This method gave early postoperative functioning of the knee and good mid-term results.			Georgoulis, AD (corresponding author), UNIV IOANNINA,SCH MED,DEPT ORTHOPAED SURG,GR-45110 IOANNINA,GREECE.		Makris, Christos/AAN-2146-2021; Papageorgiou, Christos/AAI-5325-2021	Makris, Christos/0000-0003-2571-7449; 			Bernard M, 1996, UNFALLCHIRURG, V99, P332; BERNARD M, 1992, 1 WORLD C SPORTS TRA; BRADLEY J, 1988, J BONE JOINT SURG BR, V70, P94, DOI 10.1302/0301-620X.70B1.3339068; CERULLO G, 1993, ARTHROSCOPY, V9, P712, DOI 10.1016/S0749-8063(05)80515-8; DANIEL DM, 1994, CRUCIAL LIGAMENTS, P387; DIJAN P, 1994, KNEE SURG SPORTS TRA, V2, P207; FAHEY M, 1994, AM J SPORT MED, V22, P410, DOI 10.1177/036354659402200318; Feagin J A Jr, 1976, Am J Sports Med, V4, P95, DOI 10.1177/036354657600400301; FEAGIN JA, 1994, CRUCIAL LIGAMENTS, P269; FEAGIN JA, 1995, SPORTS EXERCISE INJU, V1, P176; FRIEDMANN RL, 1994, CLIN ORTHOPAEDICS, V306, P163; GEORGOULIS AD, 1996, HEID KREUZB S 28 30; GIRGIS FG, 1975, CLIN ORTHOPAEDICS, V106, P216; HERTEL P, 1994, ARTHROSKOPISCHE VERS; HOWELL SM, 1993, J BONE JOINT SURG AM, V75A, P1044, DOI 10.2106/00004623-199307000-00011; JOHNSON LL, 1994, CRUCIAL LIGAMENTS DI, P555; KUROSAKA M, 1987, AM J SPORT MED, V15, P225, DOI 10.1177/036354658701500306; LAIS E, 1991, THESIS FREIE U BERLI; LINSALATA JC, 1996, 2 WORLD C SPORTS TRA; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; NOULIS G, 1875, THESIS FM PARIS, P1; PAESSLER HH, 1992, AM J SPORT MED, V20, P95, DOI 10.1177/036354659202000122; SACHS RA, 1989, AM J SPORT MED, V17, P760, DOI 10.1177/036354658901700606; Schulte K, 1995, ARTHROSCOPY, V11, P372; SHAFFER B, 1993, ARTHROSCOPY, V9, P633, DOI 10.1016/S0749-8063(05)80499-2; Taylor DC, 2009, CLIN ORTHOP RELAT R, V37, P1946; Torg J S, 1976, Am J Sports Med, V4, P84, DOI 10.1177/036354657600400206; Xerogeanes J W, 1995, Knee Surg Sports Traumatol Arthrosc, V3, P9, DOI 10.1007/BF01553518	28	23	23	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0001-6470			ACTA ORTHOP SCAND	Acta Orthop. Scand.	OCT	1997	68			275			42	45		10.1080/17453674.1997.11744742			4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	YF063	WOS:A1997YF06300011	9385264	Bronze			2022-02-06	
J	Persel, CS; Persel, CH; Ashley, MJ; Krych, DK				Persel, CS; Persel, CH; Ashley, MJ; Krych, DK			The use of noncontingent reinforcement and contingent restraint to reduce physical aggression and self-injurious behaviour in a traumatically brain injured adult	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; DIFFERENTIAL REINFORCEMENT; MANAGEMENT; DISORDERS; AGITATION	Many different intervention programmes for reducing undesirable behaviour with people with traumatic brain injury (TBI) have been investigated in recent years. The purpose of this study was to examine the potential of using noncontingent reinforcement (NCR) in combination with contingent restraint to reduce severe behaviour. The subject (E.L.) was a 40-year-old male with TBI admitted to a rehabilitation long-term care programme. E.L. had a history of physical aggression (PA) and self-injurious behaviour (SIB). Assessment conditions included a descriptive analysis, response scatterplot and Self-Injury Trauma (SIT) Scale. Attention was identified as the maintaining positive reinforcement for PA and SIE. Treatment conditions were compared using a reversal (ABAB) design. Attention (NCR) was delivered on a fixed-time schedule that was not dependent on the subject's behaviour. Contingent restraint was applied when E.L. exhibited PA or SIE that was dangerous to himself or others. During treatment, PA occurred over 4 times less often and SIE over 2.5 times less often. Results demonstrated that PA and SIE were sensitive to NCR. NCR can be an effective procedure for reducing severe behaviour maintained by socially-mediated positive reinforcement.	CTR NEURO SKILLS,IRVING,TX		Persel, CS (corresponding author), CTR NEURO SKILLS,DEPT RES & DEV,2658 MT VERNON AVE,BAKERSFIELD,CA 93306, USA.						ALBERTO PA, 1990, APPL BEHAV ANAL TEAC; BAER DM, 1968, J APPL BEHAV ANAL, V1, P91, DOI 10.1901/jaba.1968.1-91; BLACKERBY WF, 1988, J HEAD TRAUMA REHAB, V3, P33; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DAVIS JR, 1994, BRAIN INJURY, V8, P589, DOI 10.3109/02699059409151011; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; GERVASIO AH, 1995, NEUROREHABILITATION, V5, P309, DOI 10.3233/NRE-1995-5405; GIBBS JW, 1985, BEHAV MODIF, V9, P3, DOI 10.1177/01454455850091001; IWATA BA, 1990, J APPL BEHAV ANAL, V23, P99, DOI 10.1901/jaba.1990.23-99; IWATA BA, 1982, ANAL INTERVENTION DE, V2, P1; JACOBS HE, 1993, BEHAV ANAL GUID BRAI; Konarski E. A., 1989, BEHAV RESIDENTIAL TR, V4, P45; LAVIGNA GW, 1986, ALTENATIVE PUNISHMEN; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Marcus BA, 1996, J APPL BEHAV ANAL, V29, P43, DOI 10.1901/jaba.1996.29-43; NEVIN JA, 1990, J EXP ANAL BEHAV, V53, P359, DOI 10.1901/jeab.1990.53-359; REPP AC, 1976, J APPL BEHAV ANAL, V9, P501, DOI 10.1901/jaba.1976.9-501; ROMANCZYK RG, 1986, ADV LEARNING BEHAV D, P29; SMITH P, 1983, PROF ASS RESP TRAIN; Spreat S., 1986, BEHAVIORAL RESIDENTI, V1, P57; TOUCHETTE PE, 1985, J APPL BEHAV ANAL, V18, P343, DOI 10.1901/jaba.1985.18-343; Treadwell K, 1996, J HEAD TRAUMA REHAB, V11, P62, DOI 10.1097/00001199-199602000-00008; UOMOTO JM, 1992, ARCH PHYS MED REHAB, V73, P674; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VOLLMER TR, 1993, J APPL BEHAV ANAL, V26, P9, DOI 10.1901/jaba.1993.26-9; YUEN HK, 1996, BRAIN INJURY, V3, P229; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553	28	23	23	0	10	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1997	11	10					751	760					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XY415	WOS:A1997XY41500006	9354251				2022-02-06	
J	Karger, B; DuChesne, A; Ortmann, C; Brinkmann, B				Karger, B; DuChesne, A; Ortmann, C; Brinkmann, B			Unusual self-inflicted injuries simulating a criminal offence	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						self-inflicted injuries; atypical injuries; wound morphology		A total of 14 cases with self-inflicted injuries intended to simulate a criminal offence are reported. Typical characteristics of self-infliction such as superficiality, localisation at the anterior aspect, parallel course or avoidance of areas with high sensitivity to pain are substantiated by most of the cases analysed. However, the majority of cases also comprised atypical features including large hematomas of the extremities, a gaping cut wound, lip laceration, hematoma of the eyelids, concussion of the brain, large burn injuries and signs of bonding. Therefore, atypical injuries, which are either found in isolation or in combination with typical injury patterns, cannot exclude self-infliction. Initially, most ''victims'' did not intend to report the matter to the police but the persons whose affection was to be obtained made the report. Psychopathological motivations are predominant but rational motives such as attempted insurance fraud also occur.			Karger, B (corresponding author), UNIV MUNSTER,INST LEGAL MED,VON ESMARCH STR 86,D-48149 MUNSTER,GERMANY.						HOLITZNER WV, 1993, Z PSYCHOSOM MED PSYC, V39, P319; HOLZER FJ, 1969, ARCH KRIMINOL, V143, P1; HOLZER FJ, 1969, ARCH KRIMINOL, V143, P96; KNIGHT BH, 1968, MED SCI LAW, V8, P264, DOI 10.1177/002580246800800409; Konig H G, 1987, Arch Kriminol, V180, P13; LOCHTE T, 1913, VIERTELJAHRESSCHR S, V45, P261; MAYER J, 1937, HDB ARTEFAKTE; MCKERRACHER DW, 1968, BRIT J PSYCHIAT, V114, P829, DOI 10.1192/bjp.114.512.829; METTER D, 1989, MED SACH, V1, P14; POLLAK S, 1987, Archiv fuer Kriminologie, V179, P81; PUSCHEL K, 1994, HAUTNAH PADIATR, V6, P170; SCHULZ F, 1981, Aktuelle Dermatologie, V7, P10; SMITH S, 1949, FORENSIC MED, P168; SNEDDON I, 1975, BRIT MED J, V3, P527, DOI 10.1136/bmj.3.5982.527; STRASSMANN F, 1910, VJSCHR GERICHTL ME S, V39, P3; [No title captured]	16	23	23	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0937-9827			INT J LEGAL MED	Int. J. Legal Med.	SEP	1997	110	5					267	272		10.1007/s004140050083			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	XT496	WOS:A1997XT49600007	9297583				2022-02-06	
J	Butler, K; Rourke, BP; Fuerst, DR; Fisk, JL				Butler, K; Rourke, BP; Fuerst, DR; Fisk, JL			A typology of psychosocial functioning in pediatric closed-head injury	CHILD NEUROPSYCHOLOGY			English	Article; Proceedings Paper	24th Annual Meeting of the International-Neuropsychological-Society	FEB 15-17, 1996	CHICAGO, IL	Int Neuropsychol Soc, US PHS, Natl Inst Aging, Alzheimers Dis Cooperat Study			LEARNING-DISABLED CHILDREN; PERSONALITY SUBTYPES; ADJUSTMENT; SEQUELAE; CRITERIA	A typology of psychosocial functioning following pediatric closed-head injury (CHI) was derived by subjecting Personality Inventory for Children Revised (PIC-R) profiles to cluster analyses. Participants (N = 128) aged 6 to 16 years were classified into mild, moderate, and severe injury groups based on loss of consciousness (LOG), Glasgow Coma Scale (GCS), and so forth. On average, subjects were injured at 8.78 years of age and were assessed 2.12 years following their injury. Using four hierarchical-agglomerative clustering techniques, a seven-subtype typology was derived that overlapped, in part, with typologies previously reported for children with learning disabilities (LD). Based on clinical scale elevations of the mean PIC-R profiles, the subtypes were labeled Normal, Cognitive Deficit, Somatic Concern, Mild Anxiety, Internalized Psychopathology, Antisocial, and Social Isolation. Statistically significant relationships were found between psychosocial subtype membership and (a) injury severity, and (b) age at injury. Children assigned to the Social Isolation subtype were more likely to have severe CHI, and to have been injured at younger ages. Children tested after longer intervals since sustaining their CHI also tended to be assigned to the Social Isolation subtype. This subtype had elevations on the PIC-R cognitive triad and Psychosis scales, and may represent a persistent pattern of psychosocial disturbance following childhood CHI.	UNIV WINDSOR,WINDSOR,ON N9B 3P4,CANADA; YALE UNIV,NEW HAVEN,CT 06520; WAYNE STATE UNIV,SCH MED,DETROIT,MI 48202; HENRY FORD HOSP,DETROIT,MI								ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ACHENBACH TM, 1986, TEACHERS REPORT FORM; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Blashfield R.K., 1984, CLUSTER ANAL; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BUTLER K, 1997, UNPUB NEUROPSYCHOLOG; CASEY R, 1986, PEDIATRICS, V78, P497; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Ciccetti D., 1984, VINELAND ADAPTIVE BE; DIKMEN SS, 1989, MILD HEAD INJURY, P229; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1985, NEUROPSYCHOLOGY LEAR, P00187; FUERST DR, 1989, J CONSULT CLIN PSYCH, V57, P275, DOI 10.1037/0022-006X.57.2.275; FUERST DR, 1990, J CONSULT CLIN PSYCH, V58, P657, DOI 10.1037/0022-006X.58.5.657; FUERST DR, 1993, J ABNORM CHILD PSYCH, V21, P597, DOI 10.1007/BF00916445; Fuerst DR, 1995, CHILD NEUROPSYCHOL, V1, P38, DOI 10.1080/09297049508401341; FUERST DR, 1991, THESIS U WINDSOR ONT; GDOWSKI CL, 1985, J ABNORM PSYCHOL, V94, P346, DOI 10.1037/0021-843X.94.3.346; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KNIGHTS RM, 1981, NEUROPSYCHOLOGICAL A, P335; Lachar D, 1982, PERSONALITY INVENTOR; LACOMBE JA, 1991, PSYCHOL ASSESSMENT J, V3, P678; LEVIN HS, 1989, MILD HEAD INJURY, P189; Lorr M., 1983, CLUSTER ANAL SOCIAL; MILLIGAN GW, 1986, MULTIVAR BEHAV RES, V21, P441, DOI 10.1207/s15327906mbr2104_5; MOREY LC, 1984, EDUC PSYCHOL MEAS, V44, P33, DOI 10.1177/0013164484441003; PORTER JE, 1985, NEUROPSYCHOLOGY LEAR, P257; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rourke B. P., 1991, LEARNING DISABILITIE; ROURKE BP, 1986, NEUROPSYCHOLOGICAL A; Rourke BP., 1989, NONVERBAL LEARNING D; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SARLE WS, 1985, SAS USERS GUIDE STAT, P255; SHAFFER D, 1975, CIBA FDN S, P191; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sorensen T.A., 1948, KONGELIGE DANSKE VIE, V5, P1; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; WIRT RD, 1977, MULTIDIMENSIONAL DES; WIRT RD, 1984, MULTIDIMENSIONAL DES; [No title captured]	45	23	23	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	AUG	1997	3	2					98	133		10.1080/09297049708401371			36	Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XR523	WOS:A1997XR52300002					2022-02-06	
J	Prat, R; Markiv, V; Dujovny, M; Misra, M				Prat, R; Markiv, V; Dujovny, M; Misra, M			Evaluation of cerebral autoregulation following diffuse brain injury in rats	NEUROLOGICAL RESEARCH			English	Article						autoregulation; diffuse brain injury; laser-Doppler flowmetry; arterial pressure; cerebral perfusion pressure	LASER-DOPPLER FLOWMETRY; BLOOD-FLOW VELOCITY; HEAD-INJURY; PERFUSION-PRESSURE; MAGNETIC-RESONANCE; MODEL; PH	The normal cerebral circulation has the ability to maintain a stable cerebral blood flow over a wide range of cerebral perfusion pressures and this is known as cerebral autoregulation. This autoregulation may be impaired in the injured brain. Closed head injury was induced in 28 Sprague-Dawley rats weighing 400-450 g. Four groups were studied: control group, head injured rat from meter height using 350 g, 400 g and 450 g respectively. CBF, volume velocity was monitored using laser-Doppler flowmetry together with monitoring of ICP and arterial blood pressure. Correlation to assess the relationship between CBF and CPP was done in each animal every hour. if correlation coefficient was > 0.85 and CPP was within normal range, loss of autoregulation was hypothesized. Chi square test, ANOVA test and unpaired Student's t-test were done and significant level of p<0.05 was established. Mean CBF in injured rats was significantly lower than controls (p=0.028) at the fifth hour. CBV was lower in the group of 450 g 1 m impact than in controls at 3 h (p=0.04). Velocity in the group of all injured rats, was significantly lower than in controls at 3 h (p=0.032) and at 4 h (p=0.027). Loss of autoregulation was seen during first four hours after trauma in all groups of rats who sustained injury. Statistical significant difference (p=0.041) in loss of autoregulation between injured and control animals was seen. No loss of autoregulation was observed in the control group. In conclusion CBF and CPP provide information about loss of autoregulation in diffuse brain injury. Decrease in CBF and increase of ICP is observed as a result of loss of cerebral autoregulation. Knowledge of loss of autoregulation could give important information and help in the management of head injured patients.	UNIV ILLINOIS, DEPT NEUROSURG, CHICAGO, IL 60612 USA								AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Arbit E, 1996, NEUROSURG CLIN N AM, V7, P741; CZOSNYKA M, 1994, ACTA NEUROCHIR, P468; DICKMAN CA, 1991, NEUROSURGERY, V28, P467, DOI 10.1227/00006123-199103000-00026; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUJOVNY M, 1994, NEUROSURGERY, V34, P935; Fabricius M, 1996, J CEREBR BLOOD F MET, V16, P156, DOI 10.1097/00004647-199601000-00018; FLORENCE G, 1992, J CEREBR BLOOD F MET, V12, P674, DOI 10.1038/jcbfm.1992.92; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gennarelli TA, 1993, HEAD INJURY, P137; Giulioni M, 1996, NEUROSURGERY, V39, P1005, DOI 10.1097/00006123-199611000-00024; HABERL RL, 1993, ACTA NEUROCHIR, P64; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; HABERL RL, 1989, AM J PHYSIOL, V256, pH1255, DOI 10.1152/ajpheart.1989.256.4.H1255; HERNANDEZAVILA G, 1995, AM J NEURORADIOL, V16, P1618; ITO J, 1996, NEUROSURGERY, V84, P97; KEMPSKI O, 1995, INT J MICROCIRC, V15, P37, DOI 10.1159/000178947; KIRKPATRICK PJ, 1994, J NEUROL NEUROSUR PS, V57, P1382, DOI 10.1136/jnnp.57.11.1382; LAM AM, 1992, BRIT J ANAESTH, V68, P424, DOI 10.1093/bja/68.4.424; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang E W, 1994, Neurosurg Clin N Am, V5, P573; Lang E W, 1995, New Horiz, V3, P400; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MEYERSON BA, 1991, NEUROSURGERY, V29, P750, DOI 10.1227/00006123-199111000-00018; MISRA M, IN PRESS POSTURAL CH; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SKARPHEDINSSON JO, 1988, ACTA PHYSIOL SCAND, V134, P133, DOI 10.1111/j.1748-1716.1988.tb08469.x; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P7, DOI 10.2176/nmc.33.7; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613; Yamaki T, 1996, J TRAUMA, V40, P50, DOI 10.1097/00005373-199601000-00010	38	23	23	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	AUG	1997	19	4					393	402		10.1080/01616412.1997.11740832			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XQ220	WOS:A1997XQ22000009	9263220				2022-02-06	
J	Tang, YP; Noda, Y; Nabeshima, T				Tang, YP; Noda, Y; Nabeshima, T			Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						D1 receptor; D2 receptor; dopamine; talent learning; traumatic brain injury	RAT-BRAIN; HEAD-INJURY; CORTEX ABLATION; RECEPTORS; RECOVERY; AMPHETAMINE; MICE; HALOPERIDOL; IMPAIRMENT; D1	Much evidence has indicated that a disturbance in dopamine neurotransmission following mild to moderate traumatic brain injury is involved in the development of post traumatic memory deficits. In the present study we examined the effects of a dopamine receptor agonist and some antagonists on latent learning and memory deficits associated with a concussive traumatic brain injury in mice. Anaesthetized animals were subjected to mild traumatic brain injury by dropping a weight onto the head, and a single-dose injection of apomorphine (0.3-3.0 mg/kg) or haloperidol (0.3-3.0 mg/kg) was made i.p. 15 min after the trauma. One week later, a water-finding task consisting of an acquisition trial, a retention test and a retest was employed to assess learning and memory functions. Mice that had received a traumatic brain injury were impaired in task performance, with prolonged latencies for finding and drinking in the retention test and retest. Administration of haloperidol but not of apomorphine significantly shortened the prolonged latency in both of the tests, indicating that antagonism of dopamine receptors is beneficial for the recovery of post traumatic memory deficits. In order to evaluate which receptor subtype plays the major role in this model, we examined the effects of SCH-23390 (0.03-0.3 mg/kg), a D1 receptor antagonist, and sulpiride (3.0-30 mg/kg), a D2 receptor antagonist, in the same experimental paradigm. The results showed that administration of sulpiride but not of SCH-23390 significantly improved the deficits in task performance, indicating that D2 receptors are the major site of action. However, combined treatment with SCH-23390 (0.03-0.3 mg/kg) and sulpiride (3.0 mg/kg) at doses that had no effect when the antagonists were given alone exerted a significant additive effect in improving these deficits, indicating that interaction between D1 and D2 receptors is involved in these processes. The present results suggest that a dopaminergic mechanism contributes to the memory dysfunction associated with traumatic brain injury.	NAGOYA UNIV,SCH MED,DEPT NEUROPSYCHOPHARMACOL,NAGOYA,AICHI 466,JAPAN; NAGOYA UNIV,SCH MED,HOSP PHARM,NAGOYA,AICHI 466,JAPAN				Tang, Ya-Ping/A-1035-2011				ASANUMA M, 1995, ARCH INT PHARMACOD T, V329, P221; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BJORKLUND A, 1984, HDB CHEM NEUROANATOM, P00055; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BOYESON SJ, 1986, J NEUROSCI, V6, P3177; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; BUSHNELL PJ, 1993, PHARMACOL BIOCHEM BE, V45, P765, DOI 10.1016/0091-3057(93)90119-E; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; CARLSSON A, 1975, CHEMICAL TOOLS CATEC, V2, P219; Dixon C. E., 1992, Society for Neuroscience Abstracts, V18, P171; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; ESCHUN G, 1992, SURG NEUROL, V37, P101, DOI 10.1016/0090-3019(92)90184-O; ETTENBERG A, 1986, PHARMACOL BIOCHEM BE, V25, P1231, DOI 10.1016/0091-3057(86)90117-6; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1988, PHARM APPROACHES TRE, P79; FILLOUX FM, 1987, BRAIN RES, V408, P205, DOI 10.1016/0006-8993(87)90373-8; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HAYES RL, 1989, MILD HEAD INJURY, P54; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HOVDA DA, 1989, BEHAV NEUROSCI, V103, P574, DOI 10.1037/0735-7044.103.3.574; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; HURWITZ BE, 1991, STROKE, V22, P648, DOI 10.1161/01.STR.22.5.648; ICHIHARA K, 1992, EUR J PHARMACOL, V213, P243, DOI 10.1016/0014-2999(92)90688-Z; ICHIHARA K, 1988, EUR J PHARMACOL, V151, P435, DOI 10.1016/0014-2999(88)90540-7; ICHIHARA K, 1993, J PHARMACOL EXP THER, V264, P122; IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462; JANSSEN PAJ, 1966, ARZNEI-FORSCHUNG, V16, P339; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; NABESHIMA T, 1994, EUR J PHARMACOL, V255, P57, DOI 10.1016/0014-2999(94)90082-5; NABESHIMA T, 1993, METHODS NEUROSCIENCE, V14, P217; OBOYLE KM, 1987, J NEUROCHEM, V48, P1039, DOI 10.1111/j.1471-4159.1987.tb05623.x; OGAWA N, 1994, BRAIN RES, V657, P207, DOI 10.1016/0006-8993(94)90969-5; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; RAO N, 1985, ARCH PHYS MED REHAB, V66, P20; SALLER CF, 1986, J PHARMACOL EXP THER, V236, P714; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SEEMAN P, 1980, PHARMACOL REV, V32, P229; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SUTTON RL, 1989, BEHAV NEUROSCI, V103, P837, DOI 10.1037/0735-7044.103.4.837; TANG YP, 1997, IN PRESS J NEUROTRAU; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; WHITE FJ, 1984, J PHARMACOL EXP THER, V231, P275; WOLTERINK G, 1993, PSYCHOPHARMACOLOGY, V110, P355, DOI 10.1007/BF02251293	49	23	24	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	AUG	1997	9	8					1720	1727		10.1111/j.1460-9568.1997.tb01529.x			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU211	WOS:A1997XU21100018	9283826				2022-02-06	
J	Ying, WH				Ying, WH			Deleterious network: A testable pathogenetic concept of Alzheimer's disease	GERONTOLOGY			English	Article						Alzheimer's disease; pathogenesis; amyloid precursor protein metabolism; oxidative damage; energy metabolism; calcium homeostasis	AMYLOID-BETA-PEPTIDE; AMYOTROPHIC-LATERAL-SCLEROSIS; FREE-RADICAL THEORY; CALCIUM CHANNELS; HEAD-INJURY; CELL-DEATH; NEUROFIBRILLARY TANGLES; PARKINSONISM-DEMENTIA; HIPPOCAMPAL-NEURONS; GLUCOSE-METABOLISM	Cumulative evidence has indicated that a deleterious network is formed on the basis of close interactions among abnormal amyloid precursor protein (APP) metabolism, oxidative damage, compromised energy metabolism and impaired calcium homeostasis. A unifying hypothesis - the deleterious network hypothesis of Alzheimer's disease (AD)- proposes that the deleterious network, not any single factor, is the common pathway of AD. Aging and multiple genetic or environmental factors could trigger the network by promoting the occurrence of one or more of the key detrimental factors, leading to a number of pathological changes of the disorder. This new hypothesis appears to unify some major theories of AD, providing a sound basis for consistent explanations to a large variety of the observations about the disorder. In this article up-to-date delineation of the novel theory is given. Three types of studies are also proposed for further determining the validity of the new hypothesis. Based on this theory, it is suggested that combinative applications of the approaches which can reduce the incidence of the four key pathological factors could become a new therapeutic strategy of AD.			Ying, WH (corresponding author), UNIV NEW MEXICO,SCH MED,DEPT PHYSIOL,BASIC MED SCI BLDG 234,ALBUQUERQUE,NM 87131, USA.						ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BENSHACHAR D, 1991, J NEUROCHEM, V57, P2133, DOI 10.1111/j.1471-4159.1991.tb06432.x; BLANCO P, 1994, NEUROSCI LETT, V165, P5, DOI 10.1016/0304-3940(94)90696-3; BRAAK H, 1996, ACTA NEUROL SCAND, V165, P3; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; CHENG B, 1992, EXP NEUROL, V117, P114, DOI 10.1016/0014-4886(92)90120-F; CORTOPASSI G, 1995, BBA-MOL BASIS DIS, V1271, P171, DOI 10.1016/0925-4439(95)00025-Y; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Davis Robert E., 1996, Neurology, V46, pA276; DYRKS T, 1992, J BIOL CHEM, V267, P18210; EISEN A, 1992, CAN J NEUROL SCI, V19, P117, DOI 10.1017/S0317167100041482; ELLIS WG, 1974, NEUROLOGY, V24, P101, DOI 10.1212/WNL.24.2.101; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; FRATIGLIONI L, 1996, ACTA NEUROL SCAND  S, V165, P33; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; GIBBSON GE, 1984, J NEUROCHEM, V37, P978; GITTER BD, 1995, P NATL ACAD SCI USA, V92, P10738, DOI 10.1073/pnas.92.23.10738; Goodman YD, 1996, J NEUROCHEM, V66, P1836; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARMAN D, 1993, AGE, V16, P23, DOI 10.1007/BF02436127; HASHAM MI, 1994, CAN J PHYSIOL PHARM, V72, P728, DOI 10.1139/y94-104; HEBBEL RP, 1986, BIOCHIM BIOPHYS ACTA, V862, P8, DOI 10.1016/0005-2736(86)90463-3; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; HOYER S, 1995, DRUG AGING, V6, P210, DOI 10.2165/00002512-199506030-00004; HOYER S, 1991, ANN NY ACAD SCI, V640, P65; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; KANEKO I, 1995, J NEUROCHEM, V65, P2585; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KOROTZER AR, 1995, EUR J PHARM-MOLEC PH, V288, P125, DOI 10.1016/0922-4106(95)90006-3; KOWALTOWSKI AJ, 1995, AM J PHYSIOL-CELL PH, V269, pC141, DOI 10.1152/ajpcell.1995.269.1.C141; Lippa CF, 1996, NEUROLOGY, V46, P406, DOI 10.1212/WNL.46.2.406; Lizasoain I, 1996, BIOCHEM J, V314, P877, DOI 10.1042/bj3140877; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P11743, DOI 10.1073/pnas.90.24.11743; MARK RJ, 1995, J NEUROSCI, V15, P6239; Masliah E, 1996, J NEUROSCI, V16, P5795; MATTSON MP, 1993, BRAIN RES, V602, P21, DOI 10.1016/0006-8993(93)90236-G; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MATTSON MP, 1990, NEURON, V4, P105, DOI 10.1016/0896-6273(90)90447-N; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MCCORMACK JG, 1985, BIOCHEM J, V231, P581, DOI 10.1042/bj2310581; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Mecocci P, 1996, NEUROSCI LETT, V207, P129, DOI 10.1016/0304-3940(96)12509-X; MeierRuge W, 1996, REV NEUROSCIENCE, V7, P1; MEIERRUGE W, 1994, GERONTOLOGY, V40, P246; Montine TJ, 1996, J NEUROPATH EXP NEUR, V55, P202, DOI 10.1097/00005072-199602000-00009; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; OHKURA T, 1994, ENDOCR J, V41, P361, DOI 10.1507/endocrj.41.361; PACIFICI RE, 1991, GERONTOLOGY, V37, P166; PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090; PIKE CJ, 1992, NEUROREPORT, V3, P769, DOI 10.1097/00001756-199209000-00012; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; RODER HM, 1991, J NEUROSCI, V11, P3325; RODER HM, 1993, BIOCHEM BIOPH RES CO, V193, P639, DOI 10.1006/bbrc.1993.1672; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHWAB C, 1995, ACTA NEUROPATHOL, V90, P287; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SHIMOHAMA S, 1993, NEUROLOGY, V43, P1407, DOI 10.1212/WNL.43.7.1407; SLANSKY I, 1995, NEURORADIOLOGY, V37, P270; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255; SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; TODOKI K, 1992, AM J PHYSIOL, V262, pH806, DOI 10.1152/ajpheart.1992.262.3.H806; TRONCOSO JC, 1993, BRAIN RES, V613, P313, DOI 10.1016/0006-8993(93)90918-D; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; VANRENSBURG SJ, 1995, MED HYPOTHESES, V44, P268, DOI 10.1016/0306-9877(95)90178-7; VANRENSBURG SJ, 1993, NEUROREPORT, V4, P1269, DOI 10.1097/00001756-199309000-00015; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Ying W, 1996, MED HYPOTHESES, V47, P307, DOI 10.1016/S0306-9877(96)90071-7; Ying W, 1996, MED HYPOTHESES, V46, P421, DOI 10.1016/S0306-9877(96)90021-3; YING W, IN PRESS MED HYPOTHE; ZOCCARATO F, 1993, BIOCHIM BIOPHYS ACTA, V1176, P208, DOI 10.1016/0167-4889(93)90046-R	99	23	31	1	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0304-324X			GERONTOLOGY	Gerontology	JUL-AUG	1997	43	4					242	253					12	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	XG398	WOS:A1997XG39800007	9222753				2022-02-06	
J	Nabors, NA; Millis, SR; Rosenthal, M				Nabors, NA; Millis, SR; Rosenthal, M			Use of the neurobehavioral cognitive status examination (Cognistat) in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							STROKE PATIENTS; REHABILITATION	Objective: To examine the relationship between the Neurobehavioral Cognitive Status Examination (Cognistat) and established neuropsychological measures of related constructs in a traumatic brain injury (TBI) sample. Design: A retrospective study of 45 patients who were administered Cognistat as part of a neuropsychological evaluation. Setting: A tertiary care rehabilitation center. Patients: Forty-five TBI patients admitted to an inpatient rehabilitation unit from January 1994 through December 1995 and referred for a neuropsychological evaluation. Main Outcome Measure: Cognistat, a neuropsychological screening measure, that assesses orientation, attention, language, memory, calculation, construction, and reasoning. Pearson zero-order correlations were calculated between Cognistat subtests and selected standard neuropsychological measures. It was hypothesized that Cognistat would be associated with the standard neuropsychological measures. Results: The following Cognistat subtests were significantly associated with standard neuropsychological measures: Cognistat Memory with the California Verbal Learning Test and Logical Memory, Cognistat Comprehension with the Token Test, Cognistat Construction with Block Design, and Cognistat Attention with Trails A. No significant relationship was found between Cognistat reasoning subtests and the Wisconsin Card Sorting Test. Conclusion: Consistent with the hypotheses, Cognistat subtests were significantly associated with standard neuropsychological measures of related cognitive constructs. These findings suggest that general statements regarding specific domains of cognitive functioning can be made using Cognistat subtest scores.	WAYNE STATE UNIV,SCH MED,DEPT PHYS MED & REHABIL,DETROIT,MI		Nabors, NA (corresponding author), REHABIL INST MICHIGAN,261 MACK BLVD,DETROIT,MI 48201, USA.						Cammermeyer M, 1988, J Neurosci Nurs, V20, P314; DELIS D, 1987, CALIFORNIA VERBAL LE; Fields S D, 1992, Int Psychogeriatr, V4, P93, DOI 10.1017/S1041610292000929; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FULLERTON KJ, 1986, LANCET, V327, P430; Gresham G.E., 1995, AHCPR PUBLICATION; Hamster K., 1983, MULTILINGUAL APHASIA; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heaton RK, 1991, COMPREHENSIVE NORMS; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; LAMARRE CJ, 1994, J PSYCHIATR NEUROSCI, V19, P103; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LOGUE PE, 1994, J NERV MENT DIS, V181, P341; LUXENBERG JS, 1986, ARCH PHYS MED REHAB, V67, P796; MITRUSHINA M, 1994, HOSP COMMUNITY PSYCH, V45, P252; MYSIW WJ, 1989, AM J PHYS MED REHAB, V68, P168, DOI 10.1097/00002060-198908000-00003; *NO CAL NEUR GROUP, 1988, MAN NEUR COGN STAT E; Oehlert ME, 1996, REHABIL PSYCHOL, V41, P162; OSMON DC, 1992, ARCH PHYS MED REHAB, V73, P414; Reitan R.M., 1993, HALSTEADREITAN NEURO; Roper BL, 1996, NEUROPSY NEUROPSY BE, V9, P54; ROTHLIND JC, 1995, 1995 ANN M AM PSYCH; TEADALE G, 1974, LANCET, V2, P81; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wiederman Michael W., 1995, Clinical Gerontologist, V15, P35, DOI 10.1300/J018v15n04_04	26	23	26	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1997	12	3					79	84		10.1097/00001199-199706000-00008			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XC699	WOS:A1997XC69900008					2022-02-06	
J	Worzniak, M; Fetters, MD; Comfort, M				Worzniak, M; Fetters, MD; Comfort, M			Methylphenidate in the treatment of coma	JOURNAL OF FAMILY PRACTICE			English	Article						methylphenidate; coma; brain injuries; Glascow Coma Scale		While there is significant morbidity and mortality involving patients in semicomatose and comatose states, the care of such patients has traditionally been limited to supportive measures. We report two cases of patients treated with methylphenidate hydrochloride: the first, a patient in a semicomatose state resulting from traumatic brain injury, and the second, a patient in a comatose state secondary to a subdural hematoma that occurred after a fall. Treatment with methylphenidate may provide neurostimulations by augmenting the activity of injured neuronal tissue within the reticular activating system, and by amplifying the net effect of the reduced number of viable neurons. Methylphenidate is a low-cost, potentially efficacious intervention for reducing the duration of comas, for preventing life-threatening and costly complications of prolonged unconsciousness, and for promoting early ambulation and recovery. Further research using more rigorous research designs to ascertain the effectiveness of methylphenidate in the treatment of patients in semicomatose and comatose states is needed.	UNIV MICHIGAN,MED CTR,DEPT FAMILY PRACTICE,ANN ARBOR,MI		Worzniak, M (corresponding author), OAKWOOD HOSP & MED CTR,FAMILY PRACTICE RESIDENCY PROGRAM,FAMILY PRACTICE RESIDENCY,DEARBORN,MI 48123, USA.						BOET J, 1971, ARCH HOSP VARGAS, V13, P103; DING YS, 1994, SYNAPSE, V18, P152, DOI 10.1002/syn.890180207; DUCOURS JL, 1990, NUCL MED COMMUN, V11, P361, DOI 10.1097/00006231-199005000-00003; GUYTON AC, 1991, TXB MED PHYSIOL, P648; HOAGLAND RJ, 1965, AM J MED SCI, V249, P623; JENETT B, 1976, J NEUROL NEUROSUR PS, V39, P647; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KAPLAN HI, 1993, POCKET HDB PSYCHIAT, P168; KRAUS MF, 1995, INT J PSYCHIAT MED, V25, P39, DOI 10.2190/BXRM-3M58-WBC5-A7EL; LICHTIGFELD FJ, 1990, CLIN NEUROPHARMACOL, V13, P459, DOI 10.1097/00002826-199010000-00007; SATEL SL, 1989, J CLIN PSYCHIAT, V50, P241; SCHLEISSNER LA, 1966, CALIF MED, V105, P41	12	23	23	0	2	APPLETON & LANGE	E NORWALK	25 VAN ZANT ST, E NORWALK, CT 06855	0094-3509			J FAM PRACTICE	J. Fam. Pract.	MAY	1997	44	5					495	498					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WY588	WOS:A1997WY58800016	9152268				2022-02-06	
J	Weise, K; Schwab, E; Scheufele, TM				Weise, K; Schwab, E; Scheufele, TM			Elbow injuries in childhood	UNFALLCHIRURG			English	Article						elbow joint injuries; child; adolescence	ACCIDENTS	Fractures and dislocations of the elbow are some of the most common injuries in childhood and adolescence. The majority occur in sport and play activities, e.g., a fall from gymnastics apparatus or a bike, or from popular sports items, such as skateboards or in-line skates. The injuries can be divided into pure dislocations of the joint and fractures of the distal humerus, proximal radius and ulna, or combinations of both. In addition, extra- and intraarticular fracture types are defined, with the latter as partial or complete joint lesions. Dislocations of the elbow joint or the radial head can occur as single injuries or in combination with a fracture. Supracondylar fractures and avulsion fractures of the medial epicondyle are the most frequent extraarticular lesions of the distal humerus. Fractures of the lateral condyle prevail is incomplete intraarticular lesions. In the forearm, radial head and neck fractures are predominant while typical and atypical Monteggia injuries have a special status. The complex joint construction and the age-dependent appearance of the epiphyseal ossification centers sometimes make a correct radiological diagnosis difficult. The trauma history and an exact, clinical examination help to verify the injury, as do comparative X-ray studies of the uninjured side when necessary (but not routinely). Unlike other anatomical areas, most el bow injuries-even in the growing skeleton are treated operatively. Hereby, the growth plates have to be respected using minimal amounts of small implants. Additional immobilization in a cast for 2-4 weeks is necessary in most cases but does not lead to a functional deficit - in contrast to adults. The implants should be removed as early as possible, Despite all therapeutic efforts, a significant number of late sequelae, such as malunions and functional impairment, can be seen. The rate of long-term complications increases in cases of untreated displacement of fragments or joint instability. Corrective measures are performed only in selected cases and after the growth plates are closed, Our own treatment regime is demonstrated using exemplary clinical cases of the different injuries and the results of a long-term follow-up study on sports injuries of the elbow in children. Errors in diagnosis and therapy, as well as possible com plications, are pointed out.			Weise, K (corresponding author), BERUFSGENOSSENSCHAFTLICHE UNFALLKLIN TUBINGEN,SCHNARRENBERGSTR 95,D-72076 TUBINGEN,GERMANY.						HEFTI F, 1981, ORTHOPADE, P274; JONASCH E, 1981, VERLETZUNGEN KINDERN; MEULI HC, 1981, ORTHOPADE, V10, P256; MORGER R, 1972, Z KINDERCHIR, V11, P717; PAAR Q, 1989, MUNCHEN MED WOCHEN, V131, P550; PFISTER A, 1985, TRAINING SPORT PRAVE, pS206; RODEGERDTS U, 1978, ORTHOP PRAX, V14, P98; SCHEUFELE TM, 1990, THESIS EBERHARD KARL; SCHMIDT B, 1989, Z KINDERCHIR, V44, P357; SCHULITZ KP, 1975, ARCH ORTHOP TRAUM SU, V81, P225, DOI 10.1007/BF00416948; SCHUMACHER G, 1978, ORTHOP PRAX, V14, P82; STEINBRUCK K, 1983, ORTHOP PRAX, V19, P927; VINZ H, 1989, Beitraege zur Orthopaedie und Traumatologie, V36, P169; VINZ H, 1989, Beitraege zur Orthopaedie und Traumatologie, V36, P153; von Laer L, 1989, OPER ORTHOP TRAUMATO, V1, P163; VONLAER L, 1981, ORTHOPADE, V10, P264; VONLAER L, 1991, FRAKTUREN LUXATIONEN; VONLAER L, 1993, CHIR PRAX, V47, P117; VONLAER LR, 1990, KORREKTUREINGRIFFE W, P174; WEISE K, 1995, CHIRURG OPERATIONSLE, V9; WIESENBERG S, 1983, CHIR PRAX, V31, P555; WIRTH CH, 1978, ORTHOP PRAX, V14, P103; [No title captured]	23	23	23	0	7	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	APR	1997	100	4					255	269		10.1007/s001130050117			19	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	WX385	WOS:A1997WX38500002	9229775				2022-02-06	
J	Reeves, TM; Zhu, J; Povlishock, JT; Phillips, LL				Reeves, TM; Zhu, J; Povlishock, JT; Phillips, LL			The effect of combined fluid percussion and entorhinal cortical lesions on long-term potentiation	NEUROSCIENCE			English	Article						traumatic brain injury; deafferentation; combined injuries; long-term potentiation; hippocampus; receptor plasticity	TRAUMATIC BRAIN INJURY; EXCITATORY AMINO-ACIDS; NUCLEUS-REUNIENS-THALAMI; DENTATE GYRUS; RAT; REINNERVATION; HIPPOCAMPUS; RECOVERY; DEFICITS; PATHWAY	Among the pathological processes initiated by traumatic brain injury are excessive neuroexcitation and target cell deafferentation. The current study examines the contribution of these injury components, separately as well as their combined effect, on postinjury alterations in the capacity for long-term potentiation and the immunolocalization of N-methyl-D-aspartate receptors and GABA. Adult rats underwent central fluid percussion traumatic brain injury, electrolytic bilateral entorhinal cortex lesions, or a combined injury of both procedures separated by 24 h. At two or 15 days postinjury, the capacity for long-term potentiation of the Schaffer collateral-commissural input to CA1 was measured in acute electrophysiological recordings. Entorhinal cortical lesions resulted in time-dependent increases in the effectiveness of tetanic stimulation to elevate population postsynaptic potentials and population spike amplitudes. These lesions also resulted in a marked intensification in the density of iv-methyl-D-aspartate receptors in the CA1 stratum lacunosum-moleculare. All injury conditions that included fluid percussion as a component (alone or in combined injuries) produced a persistent impairment in long-term potentiation of the evoked population postsynaptic potentials. Thus, in combined injuries, the presence of concussion-induced neuroexcitation attenuated deafferentation-induced response increases. Both N-methyl-D-aspartate receptor and GABA immunobinding following combined injuries were also reduced relative to those observed following entorhinal lesions alone. The present results suggest that a process of receptor plasticity, possibly involving reactive synaptogenesis, may contribute to postdeafferentation enhancements of long-term potentiation, and that a traumatic brain insult will attenuate these enhancements. This interaction of different injury components suggests that recovery of function following brain injury may be enhanced by pharmacological reduction of neuroexcitation during postinjury intervals of reactive receptor plasticity. (C) 1997 IBRO.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROSURG,RICHMOND,VA 23298		Reeves, TM (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,RICHMOND,VA 23298, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS20193, NS12587, NS01750] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, K17NS001750, P50NS012587, R01NS020193] Funding Source: NIH RePORTER		Adams JH, 1992, GREENFIELDS NEUROPAT, P106; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Cotman C.W., 1978, NEURONAL PLASTICITY, P227; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ERB DE, 1991, EXP BRAIN RES, V83, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1988, J NEUROTRAUM, V5, P287; HERKENHAM M, 1978, J COMP NEUROL, V177, P589, DOI 10.1002/cne.901770405; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1995, AXON, P505; REEVES TM, 1995, EXP BRAIN RES, V106, P248; REEVES TM, 1986, EXP BRAIN RES, V65, P167; REEVES TM, 1988, EXP NEUROL, V102, P37, DOI 10.1016/0014-4886(88)90076-3; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; WILSON RC, 1979, BRAIN RES, V176, P65, DOI 10.1016/0006-8993(79)90870-9; WILSON RC, 1981, J NEUROPHYSIOL, V46, P324, DOI 10.1152/jn.1981.46.2.324; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	32	23	23	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0306-4522			NEUROSCIENCE	Neuroscience	MAR	1997	77	2					431	444		10.1016/S0306-4522(96)00486-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WK428	WOS:A1997WK42800013	9472402				2022-02-06	
S	Doppenberg, EMR; Choi, SC; Bullock, R		Slikker, W		Doppenberg, EMR; Choi, SC; Bullock, R			Clinical trials in traumatic brain injury - What can we learn from previous studies?	NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	3rd International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	SEP 09-12, 1996	VARENNA, ITALY	New York Acad Sci, FDA, Natl Ctr Toxicol Res, Arkansas, Dept Vet Affairs Med Ctr, Togus, Maine			SEVERE HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; CONJUGATED SUPEROXIDE-DISMUTASE; KALLIKREIN-KININ SYSTEM; FLUID-PERCUSSION MODEL; CEREBRAL BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; SUBARACHNOID HEMORRHAGE; AXONAL CHANGE; ISCHEMIA		VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT BIOSTAT, RICHMOND, VA 23298 USA		Doppenberg, EMR (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, POB 980631, RICHMOND, VA 23298 USA.						ADAMS JH, 1983, ACTA NEUROCHIR, V32, pS15; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRANSTON NM, 1974, EXP NEUROL, V45, P195, DOI 10.1016/0014-4886(74)90112-5; BROADDUS WC, 1996, 46 ANN M C NEUR SURG; Bullock R., 1995, NEUROCHEMICAL MONITO, P64; CHOI SC, 1996, DISCOVERIES HEAD TRA, P67; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Di X, 1996, RESTOR NEUROL NEUROS, V9, P231, DOI 10.3233/RNN-1996-9406; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Drummond M., 1987, METHODS EC EVALUATIO, V4th; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GRAHAM DI, 1985, BRIT J ANAESTH, V57, P3, DOI 10.1093/bja/57.1.3; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; LANDOLT H, 1994, ACTA NEUROCHIR, P475; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MAIERHAUFF K, 1984, J NEUROSURG, V61, P97, DOI 10.3171/jns.1984.61.1.0097; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Marion DW, 1996, CRIT CARE MED, V24, pS81; MARMAROU A, 1996, ACTA NEUROCHIR S, V66, P188; MARMAROU A, 1993, J NEUROTRAUM, V10, pS61; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; MCCLELLAN DR, 1986, COMA TRAUMATIQUE; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; MUIZELAAR JP, 1994, ADV EXP MED BIOL, V366, P389; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; STEIN SC, 1996, NEUROTRAUMA, P755; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Tsuchida E, 1996, J NEUROSURG, V85, P104, DOI 10.3171/jns.1996.85.1.0104; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UNTERBERG A, 1984, J NEUROSURG, V61, P87, DOI 10.3171/jns.1984.61.1.0087; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WEI EP, 1993, AM J PHYSIOL, V265, pH1439; Whitehead J., 1983, DESIGN ANAL SEQUENTI; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	50	23	23	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-093-X; 1-57331-092-1	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1997	825						305	322		10.1111/j.1749-6632.1997.tb48441.x			18	Multidisciplinary Sciences; Neurosciences; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BJ99G	WOS:A1997BJ99G00027	9369996				2022-02-06	
J	Vink, R; Golding, EM; Williams, JP; McIntosh, TK				Vink, R; Golding, EM; Williams, JP; McIntosh, TK			Blood glucose concentration does not affect outcome in brain trauma: A P-31 MRS study	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						magnesium; nuclear magnetic resonance; magnetic resonance spectroscopy; brain injury; lactic acidosis	NUCLEAR-MAGNETIC-RESONANCE; FREE MAGNESIUM; INJURY; PH; SPECTROSCOPY; DAMAGE; RATS; MECHANISM; ISCHEMIA; ACIDOSIS	Effects of blood glucose concentration on biochemical and neurologic outcome following lateral fluid percussion-induced traumatic injury of moderate severity (2.8 atm) in rats were studied using radioactive phosphorus (P-31) magnetic resonance spectroscopy (MRS) and a battery of tests designed to evaluate posttraumatic neurologic motor function. Prior to injury, male Sprague-Dawley rats (n = 18) were randomly assigned to receive either dextrose, 2 ml 50% (wt/vol), zinc insulin (10 IU/kg) or no treatment, thus dividing the animals into hyperglycemic, hypoglycemic, and normoglycemic groups, respectively. Animals were then injured, monitored for 4 h by P-31 MRS before being allowed to recover, and assessed for posttraumatic motor function. Following brain injury, there was no difference in brain intracellular pH between groups over the 4-h posttraumatic MRS monitoring period. Similarly, intracellular free magnesium, cytosolic phosphorylation potential, and neurologic outcome posttrauma were not significantly different between groups. We conclude that, unlike models of ischemia, blood glucose concentration may not be a significant factor affecting outcome in traumatic brain injury.	UNIV PENN, SCH MED, DIV NEUROSURG, PHILADELPHIA, PA 19104 USA		Vink, R (corresponding author), JAMES COOK UNIV N QUEENSLAND, DIV BIOCHEM & HUMAN PHYSIOL, TOWNSVILLE, QLD 4811, AUSTRALIA.		Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS26818] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818] Funding Source: NIH RePORTER		ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; DIEMER NH, 1981, NEUROPATH APPL NEURO, V7, P217, DOI 10.1111/j.1365-2990.1981.tb00091.x; DUCKROW RB, 1981, J NEUROSURG, V54, P607, DOI 10.3171/jns.1981.54.5.0607; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; GUPTA RK, 1978, J BIOL CHEM, V253, P6172; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HENQUIN JC, 1983, NATURE, V301, P73, DOI 10.1038/301073a0; HOVDA DA, 1992, CENTRAL NERVOUS SYST, P47; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; MALLOY CR, 1986, BIOCHIM BIOPHYS ACTA, V885, P1, DOI 10.1016/0167-4889(86)90032-7; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MYERS RE, 1973, J NEUROPATHOL EXP NE, V35, P301; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; PLUM F, 1983, NEUROLOGY, V33, P222, DOI 10.1212/WNL.33.2.222; REHNCRONA S, 1980, ACTA PHYSIOL SCAND, V110, P435, DOI 10.1111/j.1748-1716.1980.tb06692.x; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WARNER DS, 1987, STROKE, V18, P464, DOI 10.1161/01.STR.18.2.464; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	26	23	23	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	1997	17	1					50	53		10.1097/00004647-199701000-00007			4	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	VZ028	WOS:A1997VZ02800007	8978386	Bronze			2022-02-06	
J	Thurman, DJ; Jeppson, L; Burnett, CL; Beaudoin, DE; Rheinberger, MM; Sniezek, JE				Thurman, DJ; Jeppson, L; Burnett, CL; Beaudoin, DE; Rheinberger, MM; Sniezek, JE			Surveillance of traumatic brain injuries in Utah	WESTERN JOURNAL OF MEDICINE			English	Article							HEAD-INJURY; POPULATION; COUNTY; COMA	From 1990 through 1992 we conducted surveillance of cases requiring hospital admission and of fatal cases of traumatic brain injury among residents of Utah and found an annual incidence rate of 108.8 per 100,000 population. The greatest number of injuries occurred among men and persons aged 15 to 24 years. Motor vehicles were the leading cause of injury, followed by falls and assaults, The incidence rate we found is substantially lower than previously published rates of traumatic brain injury, This may be the result of a decrease in the incidence of these injuries in the decade since earlier studies were done, as well as changing hospital admission criteria that serve to exclude less severe cases of injury, Despite the apparent decline in rates, our findings indicate the continued importance of traumatic brain injury as a public health problem and the need to develop more effective prevention strategies that will address the major causes of these injuries.	UTAH DEPT HLTH,DIV COMMUNITY & FAMILY HLTH SERV,SALT LAKE CITY,UT 84116		Thurman, DJ (corresponding author), CTR DIS CONTROL & PREVENT,NATL CTR INJURY PREVENT & CONTROL,MAILSTOP F41,4770 BUFORD HWY NE,ATLANTA,GA 30341, USA.			Thurman, David/0000-0002-0533-7062			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; *CDC, 1995, INJ MORT NAT SUMM IN; Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; Fleiss J, 1981, STAT METHODS RATES P, V2nd; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; *HLTH CAR FIN ADM, 1989, INT CLASS DIS; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; KALSBEEK WD, 1980, J NEUROSURG S, pS19; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus JF, 1993, HEAD INJURY, P1; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MacKenzie E J, 1989, Md Med J, V38, P725; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V278, P1778; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ., 1995, GUIDELINES SURVEILLA; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	23	23	23	0	1	CALIFORNIA PHYSICIAN MAGAZINE	SAN FRANCISCO	C/O DONNA TAYLOR, EDITOR, PO BOX 7690, SAN FRANCISCO, CA 94102-7690	0093-0415			WESTERN J MED	West. J. Med.	OCT	1996	165	4					192	196					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VU111	WOS:A1996VU11100001	8987423				2022-02-06	
J	Russell, MB; Olesen, J				Russell, MB; Olesen, J			Migraine associated with head trauma	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						migraine associated with head trauma; aetiology; genetics	INJURY; RISK; SEX	Migraine associated with head trauma i.e. onset of migraine in close temporal relation to a head trauma was analyzed in a large population based survey of 4000 forty-year-old males and females. Of the 29 people with migraine associated with head trauma, 20 had migraine without aura associated with head trauma, six had migrainous disorder without aura associated with head trauma and three had migraine with aura associated with head trauma. Eleven had a significant head trauma (loss of consciousness or posttraumatic amnesia lasting more than 10 minutes) and 18 had a minor head trauma. The overall lifetime prevalence of migraine associated with head trauma was 1.4% with a male-female ratio of 1:2.4. The symptomatology of migraine associated and unassociated with head trauma was not different. The first degree relatives of probands with migraine associated with head trauma were blindly interviewed by a physician. The first degree relatives of probands with migraine without aura associated with head trauma had a significantly lower risk of migraine without aura than first degree relatives of probands with migraine without aura unassociated with head trauma. We conclude that migraine without aura associated and unassociated with head trauma have a different aetiology. Thus, it is very likely that a head trauma may cause migraine without aura. The mechanisms involved in trauma induced migraine without aura are unknown.	UNIV COPENHAGEN,GLOSTRUP HOSP,DEPT INTERNAL MED C,GLOSTRUP POPULAT STUDIES,DK-2600 GLOSTRUP,DENMARK		Russell, MB (corresponding author), UNIV COPENHAGEN,GLOSTRUP HOSP,DEPT NEUROL,DK-2600 GLOSTRUP,DENMARK.						BEHRMAN S, 1977, INJURY, V9, P74, DOI 10.1016/0020-1383(77)90059-6; Cartlidge N E, 1981, HEAD INJURY; Guthkelch A N, 1977, Neurosurgery, V1, P101; HAAS DC, 1969, J NEUROL NEUROSUR PS, V32, P548, DOI 10.1136/jnnp.32.6.548; Headache Classification Committee of the International Headache Society, 1988, CEPHALALGIA S7, V8, P1; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; LEONE M, 1994, CEPHALALGIA, V14, P280, DOI 10.1046/j.1468-2982.1994.1404280.x; MATTHEWS WB, 1972, BRIT MED J, V2, P326, DOI 10.1136/bmj.2.5809.326; RASMUSSEN BK, 1992, NEUROLOGY, V42, P1225, DOI 10.1212/WNL.42.6.1225; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; RUSSELL MB, 1995, BRIT MED J, V311, P541, DOI 10.1136/bmj.311.7004.541; Russell MB, 1996, CEPHALALGIA, V16, P156, DOI 10.1046/j.1468-2982.1996.1603156.x; RUSSELL MB, 1995, HUM GENET, V96, P726, DOI 10.1007/BF00210307; RUSSELL MB, 1966, CEPHALALGIA, V16, P239; SELBY G, 1960, J NEUROL NEUROSUR PS, V23, P23, DOI 10.1136/jnnp.23.1.23; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; VOHANKA S, 1990, ACTIV NERV SUPER, V32, P179; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X	20	23	23	2	2	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	1351-5101			EUR J NEUROL	Eur. J. Neurol.	SEP	1996	3	5					424	428		10.1111/j.1468-1331.1996.tb00243.x			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VP378	WOS:A1996VP37800002					2022-02-06	
J	Johnson, SC; Pinkston, JB; Bigler, ED; Blatter, DD				Johnson, SC; Pinkston, JB; Bigler, ED; Blatter, DD			Corpus callosum morphology in normal controls and traumatic brain injury: Sex differences, mechanisms of injury, and neuropsychological correlates	NEUROPSYCHOLOGY			English	Article							HEMISPHERIC DISCONNECTION SYNDROME; DIFFUSE AXONAL INJURY; CLOSED HEAD-INJURY; MORPHOMETRIC ANALYSIS; MR; GENDER; SIZE; LATERALIZATION; SCHIZOPHRENIA; PERFORMANCE	This study examined the relative cross-sectional area of the corpus callosum (CC) from MRI scans of 166 normal controls and 97 patients who have suffered traumatic brain injury (TBI). The issue of sex differences in the normal CC is addressed with regard to methodological limitations of many previous conflicting reports. Women had larger CC relative to cranial Volume than did men, and this appears to be more than simply an artifact of larger heads in men. The TBI sample showed selective atrophy most notable in the genu and isthmus of the CC, which may reflect cortical degeneration ir om common sites of injury or Wallerian degeneration secondary to diffuse axonal injury al sites other than the CC itself. The splenium of the CC was significantly related to functioning on the Digit Symbol task for the female TBI patients. The observed differences between gender on CC morphology and function may reflect global differences in brain organization.	BRIGHAM YOUNG UNIV,DEPT PSYCHOL,PROVO,UT 84602; LDS HOSP,SALT LAKE CITY,UT					Johnson, Sterling/0000-0002-8501-545X			ABOITIZ F, 1992, BRAIN, V115, P1521, DOI 10.1093/brain/115.5.1521; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BIGLER ED, 1996, INT NEUR SOC 24 ANN; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; *BIOM IM RES, 1994, ANALYZE VERS 7 0 COM; BLATTER DD, IN PRESS AM J NEUROR; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bogen J.E., 1993, INT J CLIN NEUROPSYC, Vthird, P337; BOLDRINI P, 1992, CORTEX, V28, P135, DOI 10.1016/S0010-9452(13)80172-4; Braun CMJ, 1989, NEUROPSYCHOLOGY, V3, P91; Burke HL., 1994, NEUROPSYCHOLOGY, V8, P563, DOI [10.1037/0894-4105.8.4.563, DOI 10.1037/0894-4105.8.4.563]; Buxbaum LJ, 1995, NEUROCASE, V1, P3, DOI 10.1093/neucas/1.1.3; BYNE W, 1988, BEHAV NEUROSCI, V102, P222, DOI 10.1037/0735-7044.102.2.222; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; DELACOSTEUTAMSING C, 1982, SCIENCE, V216, P1431, DOI 10.1126/science.7089533; DEMETER S, 1988, HUM NEUROBIOL, V6, P219; DENENBERG VH, 1991, BRAIN RES, V548, P126, DOI 10.1016/0006-8993(91)91113-F; DRIESEN NR, 1995, PSYCHOBIOLOGY, V23, P240; FISHMAN PS, 1993, J NEUROTRAUM, V10, P457, DOI 10.1089/neu.1993.10.457; GALABURDA AM, 1990, NEUROPSYCHOLOGIA, V28, P529, DOI 10.1016/0028-3932(90)90032-J; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; HABIB M, 1991, BRAIN COGNITION, V16, P41, DOI 10.1016/0278-2626(91)90084-L; HAUSER P, 1989, BIOL PSYCHIAT, V26, P659, DOI 10.1016/0006-3223(89)90100-5; Heaton RK, 1991, COMPREHENSIVE NORMS; HINES M, 1992, BEHAV NEUROSCI, V106, P3, DOI 10.1037/0735-7044.106.1.3; HYND GW, 1995, ARCH NEUROL-CHICAGO, V52, P32, DOI 10.1001/archneur.1995.00540250036010; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; INOUE Y, 1990, AM J NEURORADIOL, V11, P897; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P27, DOI 10.1001/archneur.1990.00530010035015; JOHNSON SC, 1994, BRAIN RES BULL, V35, P373, DOI 10.1016/0361-9230(94)90116-3; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KERTESZ A, 1987, NEUROLOGY, V37, P1385, DOI 10.1212/WNL.37.8.1385; KIMURA D, 1992, SCI AM, V267, P119; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; LAISSY JP, 1993, AM J NEURORADIOL, V14, P145; LASSONDE M, 1990, BRAIN LANG, V38, P195, DOI 10.1016/0093-934X(90)90110-3; LAW DJ, 1993, PSYCHOL SCI, V4, P35, DOI 10.1111/j.1467-9280.1993.tb00553.x; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; OKUSKY J, 1988, ANN NEUROL, V24, P379, DOI 10.1002/ana.410240305; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OPPENHEIM JS, 1987, ANN NEUROL, V21, P604, DOI 10.1002/ana.410210615; Pandya DN., 1986, 2 HEMISPHERES ONE BR, P47; PETERS M, 1988, CAN J PSYCHOL, V42, P313, DOI 10.1037/h0084195; Pozzilli C, 1994, J Neuroimaging, V4, P218; RAMAEKERS G, 1991, CHILDS CORPUS CALLOS, P40; RASBAND W, 1994, IMAGE VERS 1 55 COMP; REINARZ SJ, 1988, AM J ROENTGENOL, V151, P791, DOI 10.2214/ajr.151.4.791; ROSENTHAL M, 1993, TRAUMATIC BRAIN INJU; ROSSI A, 1989, AM J PSYCHIAT, V146, P99; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; SEYMOUR SE, 1994, BRAIN, V117, P105, DOI 10.1093/brain/117.1.105; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Smith A., 1982, SYMBOL DIGIT MODALIT; SPERRY R, 1982, SCIENCE, V217, P1223, DOI 10.1126/science.7112125; STRAUSS E, 1994, J CLIN EXP NEUROPSYC, V16, P79, DOI 10.1080/01688639408402618; STRICH SJ, 1961, LANCET, V2, P443; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WEIS S, 1993, AM J NEURORADIOL, V14, P637; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; WITELSON SF, 1991, BRAIN RES, V545, P175, DOI 10.1016/0006-8993(91)91284-8; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	68	23	23	0	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JUL	1996	10	3					408	415		10.1037/0894-4105.10.3.408			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	UY062	WOS:A1996UY06200012					2022-02-06	
J	Fujii, DEM; Ahmed, I				Fujii, DEM; Ahmed, I			Psychosis secondary to traumatic brain injury	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						traumatic brain injury; psychosis; seizure; temporal lobe abnormality	PSYCHIATRIC SEQUELAE; HEAD TRAUMA	The records of 15 inpatients with a history of delusions or hallucinations after sustaining traumatic brain injury were procured from the archives of a state hospital. Studies of brain function and structure such as electroencephalogram (EEG), computerized EEG, single photon emission computerized tomography (SPECT), CT, and MRI were examined to investigate the relationship between lesion site and the presence of secondary psychosis. Although the majority of subjects had bilateral abnormalities on imaging studies, the modal lesion area was the right temporal area, followed closely by the left temporal and frontal areas. The majority of the patients also had a history of seizures and/or temporal lobe abnormalities on EEG studies. The results of our studies are generally consistent with those described in the literature.	UNIV HAWAII,DEPT PSYCHIAT,KANEOHE,HI		Fujii, DEM (corresponding author), HAWAII STATE HOSP,DEPT NEUROPSYCHOL,45-710 KEAAHALA RD,KANEOHE,HI 96744, USA.						ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; [Anonymous], 1987, DIAGNOSTIC STAT MANU, V3rd; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CUMMINGS JL, 1988, PSYCHOSOMATICS, V29, P16, DOI 10.1016/S0033-3182(88)72418-4; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; GUR RC, 1992, ARCH GEN PSYCHIAT, V49, P409; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; KOUFEN DI, 1987, EUR ARCH PSY NEUR SC, V237, P2; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; RIMMEL J, 1990, REHABILITATION ADULT; Smeltzer D., 1994, NEUROPSYCHIATRY TRAU; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8	13	23	23	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	APR	1996	9	2					133	138					6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	UB299	WOS:A1996UB29900008					2022-02-06	
J	Charnley, G; Judet, T; deLoubresse, CG; Mollaret, O				Charnley, G; Judet, T; deLoubresse, CG; Mollaret, O			Excision of heterotopic ossification around the knee following brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article								We present the results of five patients who underwent resection of heterotopic ossification around the knee following traumatic brain injury. All the patients had improved function and no pain at a minimum of 1 year follow up, irrespective of their preoperative neurological status. Oar philosophy for such surgery is outlined and, although the surgical goals may seem small, the outcome for any individual patient may be considerable.	HOP TENON,F-75020 PARIS,FRANCE								AYERS D, 1991, CLIN ORTHOPAEDICS, V265, P87; BOSSE MJ, 1988, J BONE JOINT SURG AM, V70A, P1231, DOI 10.2106/00004623-198870080-00016; DEJERINE MME, 1918, ANN MED, V5, P497; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1991, CLIN ORTHOPAEDICS, V263, P13; MOLLARET O, 1991, THESIS U PARIS; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018	10	23	25	0	0	BUTTERWORTH-HEINEMANN LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB	0020-1383			INJURY	Injury-Int. J. Care Inj.	MAR	1996	27	2					125	128		10.1016/0020-1383(95)00180-8			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	TY672	WOS:A1996TY67200011	8730387				2022-02-06	
J	Wekesa, M; Asembo, JM; Njororai, WWS				Wekesa, M; Asembo, JM; Njororai, WWS			Injury surveillance in a rugby tournament	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						injuries; rugby football		Objective-To investigate injuries in international rugby football. Methods-All injuries that led to temporary stoppage of the game or to the substitution of a player during the Rugby World Cup prequalifying tournament were recorded. Six matches were played, involving the Arabian Gulf, Kenya, Namibia, and Zimbabwe. Results-47 injuries were recorded, giving an injury rate of eight per match. The number of injuries decreased from 38.3% in the first matches to 23.4% in the final ones. The most serious injury was a concussion and the majority of the injuries affected soft tissues. Anatomically, the lower limbs suffered most injuries (46.8%), followed by the head (21.3%), trunk (17.0%), and upper limbs (12.8%). Slightly more injuries occurred in the defensive half of the field of play (53.2%) than in the offensive half (46.8%). More injuries occurred in the second half (61.7%) than in the first half (38.3%). Conclusions-Protective equipment should be introduced to minimise the number and seriousness of injuries in rugby.	EXERCISE & SPORTS CONSULTANCY,NAIROBI,KENYA; KENYA POLYTECH,SPORTS & GAMES DEPT,NAIROBI,KENYA; KENYATTA UNIV,DEPT PHYS EDUC,NAIROBI,KENYA				Simiyu, Wycliffe W. Njororai/AAD-7565-2019	Simiyu, Wycliffe W. Njororai/0000-0002-3164-4269			Blonstein J L, 1974, Trans Med Soc Lond, V90, P20; CLARK DR, 1991, 2 WORLD C SCI FOOTB; DAVIES JE, 1978, BRIT MED J, V2, P1759, DOI 10.1136/bmj.2.6154.1759; DORAN GA, 1984, J SPORT MED PHYS FIT, V24, P90; DURKIN TE, 1977, BRIT J SPORT MED, V11, P72; HAMMACHER ER, 1991, 2 WORLD C SCI FOOTB; HARDIKER RJ, 1981, SPORT FITNESS SPORTS, P118; HOLLMANN W, 1990, SPORTSMEDIZIN ARBEIT; Micheli L J, 1974, J Sports Med, V2, P93; NIELSEN AB, 1989, AM J SPORT MED, V17, P803, DOI 10.1177/036354658901700614; NIELSEN AB, 1988, INT J SPORTS MED, V9, P341, DOI 10.1055/s-2007-1025037; NOAKES TD, 1991, 2 WORLD C SCI FOOTB; REILLY T, 1981, J SPORT MED PHYS FIT, V21, P186; ROY SP, 1974, S AFR MED J, V48, P234; VANDERNEUT HW, 1991, 2 WORLD C SCI FOOTB; VANHEERDEN JJ, 1976, S AFR MED J, V50, P1374; WEKESA M, 1993, E AFR MED J, V70, P671; WEKESA M, 1993, MEDICUS, V12, P8	18	23	23	0	3	BUTTERWORTH-HEINEMANN LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	MAR	1996	30	1					61	63		10.1136/bjsm.30.1.61			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UB727	WOS:A1996UB72700016	8665122	Bronze, Green Published			2022-02-06	
J	Feehan, M; Waller, AE				Feehan, M; Waller, AE			Precompetition injury and subsequent tournament performance in full-contact taekwondo	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						taekwondo; injury; performance; regulation	MARTIAL ARTS	Objective - To determine the pattern of injuries sustained by taekwondo competitors, and how previous injury affects performance in sporting competition. Methods - Competitors at a major New Zealand full-contact taekwondo tournament were given a comprehensive questionnaire immediately before competition. Self reports of injuries sustained through taekwondo in the previous 12 months were determined. Results - No significant sex differences were found. The injury prevalence was high, but comparatively less than reported for other contact sports such as rugby football. However, one in 20 injuries was a closed head injury. No significant associations between prior injury and tournament outcome were found. Conclusions - Taekwondo can be a source of disabling injury, However, the fact that prior injury did not appear to be associated with impaired competition performance may militate against acceptance of control and regulation by competitors and coaches.	UNIV N CAROLINA,SCH MED,DEPT EMERGENCY MED,CHAPEL HILL,NC		Feehan, M (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,FAC SOCIAL & BEHAV SCI,DEPT HLTH POLICY & MANAGEMENT,BALTIMORE,MD 21205, USA.						Birrer R, 1981, Phys Sportsmed, V9, P97, DOI 10.1080/00913847.1981.11711013; Birrer R B, 1983, Br J Sports Med, V17, P131; BIRRER RB, 1988, AM J SPORT MED, V16, P408, DOI 10.1177/036354658801600418; Cho S. H., 1968, KOREAN KARATE FREE F; CHUN R, 1982, ADVANCING TAE KWON D; FISHER RA, 1941, STATISTICAL METHODS; GERRARD DF, 1994, BRIT J SPORT MED, V28, P229, DOI 10.1136/bjsm.28.4.229; Johannsen H V, 1988, Br J Sports Med, V22, P113; LUCAS J, 1992, J PHYS ED RECREA APR; McLatchie G, 1981, Br J Sports Med, V15, P84; OLER M, 1991, J TRAUMA, V31, P251, DOI 10.1097/00005373-199131020-00017; Park Y. H., 1989, TAE KWON DO ULTIMATE; SERINA ER, 1991, J BIOMECH, V10, P951; Siana J E, 1986, Br J Sports Med, V20, P165; Snedecor G.W., 1980, STAT METHODS; WALLER AE, 1994, BRIT J SPORT MED, V28, P223, DOI 10.1136/bjsm.28.4.223; Zemper E D, 1989, Br J Sports Med, V23, P161	17	23	24	0	4	BUTTERWORTH-HEINEMANN LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	DEC	1995	29	4					258	262		10.1136/bjsm.29.4.258			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TQ222	WOS:A1995TQ22200011	8808541	Bronze, Green Published			2022-02-06	
J	Ildan, F; Polat, S; Oner, A; Isbir, T; Cetinalp, E; Kaya, M; Karadayi, A				Ildan, F; Polat, S; Oner, A; Isbir, T; Cetinalp, E; Kaya, M; Karadayi, A			The effect of the treatment of high-dose methylprednisolone on Na+-K+/Mg+2 ATPase activity and lipid peroxidation and ultrastructural findings following cerebral contusion in rat	SURGICAL NEUROLOGY			English	Article						brain; injury; methylprednisolone; Na+-K+/Mg+2 ATPase; lipid peroxidation; ultrastructural study	SPINAL-CORD TRAUMA; (NA+ + K+)-ATPASE; STEROID-THERAPY; INJURY; CAT; SYSTEM; OXYGEN; CORTEX; EDEMA	BACKGROUND Although use of corticosteroid in the management of head trauma has caused a great deal of controversy, corticosteroids have long been an adjunct in the management of severe closed head injury. The glucocorticoid steroid methylprednisolone (MP) has been proven to have significant antioxidant effect when administered in an antioxidant-high dose after central nervous system injury. METHODS The sodium-potassium activated and magnesium dependent adenosine-5'-triphosphatase (Na+-K+/Mg+2 ATPase EC.3.6.1.3.) activity, lipid peroxidation, and early ultrastructural findings were determined during the immediate posttraumatic period in rats. Mechanical brain injury was produced when a calibrated weight-drop device is allowed to fall on to the skull's convexity over the right hemisphere, 1 to 2 mm lateral from the midline. In group I, rats were used to determine Na+-K+/Mg+2 ATPase activity, the extent of lipid peroxidation, by measuring the level of malondialdehyde content and normal ultrastructural findings in two different brain areas (cerebral cortex and brain stem), In group II, physiologic saline was administered right after trauma in the same amount as methylprednisolone. In group III rats, methylprednisolone (30 mg/kg) was administered intravenously right after trauma. RESULTS Na+-K+/Mg+2 ATPase activity significantly decreased in the cerebral cortex and in brain stem within 2 hours after trauma (p < 0.05), There was significant difference in malondialdehyde content between groups II and III (p < 0.05). Methylprednisolone treatment reduced malondialdehyde content and induced the recovery of Na+-K+/Mg+2 activity. CONCLUSIONS These data suggest that inactivation of Na+-K+/Mg+2 ATPase is closely correlated to changes of lipid peroxidation and the alteration of the ultrastructural findings in the early phases after head trauma, The glucocorticoid steroid methylprednisolone has been proven to have significant effect in inactivation of Na+-K+/Mg+2 ATPase with significant reduction of malondialdehyde content.	CUKUROVA UNIV, SCH MED, DEPT HISTOL, Balcali, TURKEY; CUKUROVA UNIV, SCH MED, DEPT BIOCHEM, Balcali, TURKEY		Ildan, F (corresponding author), CUKUROVA UNIV, SCH MED, DEPT NEUROSURG 01330, Balcali, TURKEY.		POLAT, Sait/J-3812-2018	POLAT, Sait/0000-0003-1646-8831			ANDERSON DK, 1982, J NEUROSURG, V56, P106, DOI 10.3171/jns.1982.56.1.0106; BOURKE RS, 1979, NEURAL TRAUMA, P95; BRAUGHLER JM, 1985, J NEUROCHEM, V44, P1282, DOI 10.1111/j.1471-4159.1985.tb08755.x; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; CAMPBELL JB, 1974, J NEUROSURG, V40, P726, DOI 10.3171/jns.1974.40.6.0726; CLASEN RA, 1979, STROKE, V10, P670, DOI 10.1161/01.STR.10.6.670; CLENDENON NR, 1978, NEUROLOGY, V28, P78, DOI 10.1212/WNL.28.1.78; CLENDENON NR, 1978, J NEUROSURG, V49, P563, DOI 10.3171/jns.1978.49.4.0563; Clendenon NR, 1979, NEURAL TRAUMA, P115; DELATORRE JC, 1975, NEUROLOGY, V25, P508, DOI 10.1212/WNL.25.6.508; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; EMERSON TE, 1979, SURG GYNECOL OBSTET, V148, P361; EMERSON TE, 1977, P SOC EXP BIOL MED, V156, P378; GAUDET RJ, 1979, BIOCHEM BIOPH RES CO, V86, P893, DOI 10.1016/0006-291X(79)91796-0; GREEN BA, 1980, SURG NEUROL, V13, P91; HALL ED, 1982, SURG NEUROL, V18, P320, DOI 10.1016/0090-3019(82)90140-9; HALL ED, 1981, EXP NEUROL, V73, P321, DOI 10.1016/0014-4886(81)90067-4; HALL ED, 1982, J NEUROSURG, V57, P247, DOI 10.3171/jns.1982.57.2.0247; HALL ED, 1992, J NEUROTRAUM, V9, P33; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KOVACHICH GB, 1981, BRAIN RES, V206, P229, DOI 10.1016/0006-8993(81)90122-0; KOVACHICH GB, 1980, J NEUROCHEM, V35, P1449, DOI 10.1111/j.1471-4159.1980.tb09022.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLONIG G, 1961, J APPL PHYS, V0032, P01637; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; ORTEGA BD, 1972, STEROIDS BRAIN EDEMA, P167; PRYOR WA, 1976, LIPIDS, V11, P370, DOI 10.1007/BF02532843; READING HW, 1980, Q J EXP PHYSIOL CMS, V65, P105, DOI 10.1113/expphysiol.1980.sp002495; READING HW, 1979, BIOCHEM PHARMACOL, V28, P3471, DOI 10.1016/0006-2952(79)90089-3; SELIGMAN ML, 1979, PHOTOCHEM PHOTOBIOL, V29, P549, DOI 10.1111/j.1751-1097.1979.tb07089.x; SELIGMAN ML, 1977, LIPIDS, V12, P945, DOI 10.1007/BF02533316; SUN AY, 1972, BIOCHIM BIOPHYS ACTA, V266, P350, DOI 10.1016/0005-2736(72)90093-4; TORNHEIM PA, 1978, J NEUROSURG, V48, P220, DOI 10.3171/jns.1978.48.2.0220; WHEELER KP, 1975, BIOCHEM J, V146, P713, DOI 10.1042/bj1460713; YOUNG W, 1982, J NEUROSURG, V57, P667, DOI 10.3171/jns.1982.57.5.0667	38	23	28	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	DEC	1995	44	6					573	580					8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TX871	WOS:A1995TX87100028	8669035				2022-02-06	
J	KERR, C				KERR, C			DYSNOMIA FOLLOWING TRAUMATIC BRAIN INJURY - AN INFORMATION-PROCESSING APPROACH TO ASSESSMENT	BRAIN INJURY			English	Article							WORD MATCHING TASKS; CLOSED HEAD-INJURY; ALZHEIMERS-DISEASE; SEMANTIC ERRORS; RETRIEVAL; APHASIA; DEFICITS; COMPREHENSION; IMPAIRMENT; DISORDERS	Current cognitive neuropsychological models of language have contributed to a greater understanding of the language processing components involved in the simple task of picture naming. The naming abilities of a group of 20 patients who had sustained a traumatic brain injury (TBI) were assessed with the purpose of more accurately describing the precise processing mechanisms underlying the dysnomia. Performance of the TBI group on the Boston Naming Test was analysed for error pattern and compared to a group of controls (n = 20) matched for age, sex and years of education. TBI subjects performed significantly poorer than controls, despite an unexpectedly high rate of naming 'error' in controls. TBI and control subjects showed marked similarity in overall error pattern. The results of a more comprehensive language-processing assessment is reported for a subgroup of six clearly dysnomic TBI subjects. Conclusions are drawn regarding the possible functional locus of the naming impairment in each case, and the contribution of current cognitive neuropsychological studies in anemia rehabilitation is discussed.			KERR, C (corresponding author), ROYAL REHABIL CTR, DEPT SPEECH PATHOL, SYDNEY, NSW 2112, AUSTRALIA.						BUTTERWORTH B, 1984, NEUROPSYCHOLOGIA, V22, P409, DOI 10.1016/0028-3932(84)90036-8; Caramazza A., 1989, COGNITIVE APPROACHES, P383; COLTHEART M, COGNITIVE NEUROPSYCH, P1; COOK K, 1991, P NEWCASTLE TYNE S T, P1; Ellis A., 1988, HUMAN COGNITIVE NEUR; GAINOTTI G, 1976, BRIT J DISORD COMMUN, V11, P57; GAINOTTI G, 1986, BRAIN LANG, V3, P359; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HADAR U, 1987, CORTEX, V23, P505, DOI 10.1016/S0010-9452(87)80011-4; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Hillis AE., 1991, CLIN APHASIOLOGY, P255; HONEY K, 1994, IN PRESS MINISTERIAL; HOWARD D, 1984, COGN NEUROPSYCHOL, V1, P163, DOI 10.1080/02643298408252021; HOWARD D, 1985, BRAIN, V108, P817; HOWARD D, 1989, COGNITIVE APPROACHES, P383; HUFF FJ, 1986, BRAIN LANG, V28, P235, DOI 10.1016/0093-934X(86)90103-3; JORDAN F M, 1990, Brain Injury, V4, P27; Kaplan E, 1983, BOSTON NAMING TEST; KAY J, 1987, BRAIN, V110, P613, DOI 10.1093/brain/110.3.613; KAY J, 1989, PSYCHOLINGUISTIC ASS; KREMIN H, 1993, FOUNDATIONS OF APHASIA REHABILITATION, P261; LESSER R, 1993, FOUNDATIONS OF APHASIA REHABILITATION, P249; LESSER R, 1989, COGNITIVE APPROACHES, P65; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LI EC, 1991, NEUROPSYCHOLOGIA, V29, P1083; LYLE DM, 1990, COMMUNITY HEALTH ST, V14, P118; MARSHALL J, 1990, APHASIOLOGY, V4, P167, DOI 10.1080/02687039008249068; MARTIN A, 1983, BRAIN LANG, V19, P124, DOI 10.1016/0093-934X(83)90059-7; MITCHUM CC, 1990, APHASIOLOGY, V4, P261, DOI 10.1080/02687039008249079; MURDOCH BE, 1987, BRAIN LANG, V31, P122, DOI 10.1016/0093-934X(87)90064-2; Nettleton J., 1991, J NEUROLINGUIST, V6, P139, DOI [10.1016/0911-6044(91)90004-3, DOI 10.1016/0911-6044(91)90004-3]; NICHOLAS LE, 1989, APHASIOLOGY, V3, P569, DOI 10.1080/02687038908249023; NORUSIS MJ, 1993, SPSS WINDOWS BASE SY; PRING T, 1990, APHASIOLOGY, V4, P479, DOI 10.1080/02687039008248788; RAYMER AM, 1993, APHASIOLOGY, V7, P27, DOI 10.1080/02687039308249498; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SHALLICE T, 1986, COGNITIVE NEUROPSYCH, P111; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Siegel S., 1956, NONPARAMETRIC STAT B; SILVERI MC, 1989, APHASIOLOGY, V3, P423, DOI 10.1080/02687038908249004; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713	43	23	23	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV-DEC	1995	9	8					777	796		10.3109/02699059509008234			20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TH499	WOS:A1995TH49900003	8605511				2022-02-06	
J	MARSHALL, LF; MARSHALL, SB				MARSHALL, LF; MARSHALL, SB			PITFALLS AND ADVANCES FROM THE INTERNATIONAL TIRILAZAD TRIAL IN MODERATE AND SEVERE HEAD-INJURY	JOURNAL OF NEUROTRAUMA			English	Article						TRAUMATIC BRAIN INJURY; INTERNATIONAL TIRILAZAD TRIAL; TRIAL DESIGN; FEASIBILITY	LIPID-PEROXIDATION; U74006F	This manuscript reviews current experience with a large-scale clinical trial of the nonglucocorticoid 21-aminosteroid compound, tirilazad mesylate (U-74,006F). The trial itself now encompasses 15 countries with all central coordination conducted in the Data Coordinating Center at the University of California, San Diego. To date, the conduct of this trial has shown that diverse groups of clinicians in multiple countries have been able to work together to adhere to a tightly defined research protocol. Despite the success in initiating and conducting this trial, however, there have been several unanticipated problems that have complicated its progress. In this regard, difficulties have been associated with the use of mean Glasgow coma scores for data analysis. Similarly, a prospective identification of the risk variables was found necessary to preclude the potential for serious errors in data analysis. Lastly, a differential effect of the drug was noted in women compared to men in the European subarachnoid hemorrhage trial where a significant improvement in outcome was observed in males. This differential response appears to be linked to drug metabolism, but the problem may be further compounded by improper dosing because of failure to weigh many patients. Women appear to be routinely underdosed because their weights are routinely underestimated. Overall, this paper shows the feasibility of conducting such a large scale international trial, while also highlighting some of the potential pitfalls and problems that should be avoided in future trials of this nature.	UNIV CALIF SAN DIEGO,SAN DIEGO MED CTR,DIV NEUROSURG,SAN DIEGO,CA 92103		MARSHALL, LF (corresponding author), UNIV CALIF SAN DIEGO,SAN DIEGO MED CTR,NEUROL SERV,200 W ARBOR DR,SAN DIEGO,CA 92103, USA.						BRAUGHLER JM, 1987, J BIOL CHEM, V262, P10438; GAUTILLE T, UNPUB; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1988, STROKE, V19, P997, DOI 10.1161/01.STR.19.8.997; HALL ED, 1988, STROKE, P340; KASSELL ND, 1993, OCT P WORLD C NEUR A; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14	7	23	23	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1995	12	5					929	932		10.1089/neu.1995.12.929			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TE646	WOS:A1995TE64600019	8594222				2022-02-06	
J	ALTURA, BM; MEMON, ZS; ALTURA, BT; CRACCO, RQ				ALTURA, BM; MEMON, ZS; ALTURA, BT; CRACCO, RQ			ALCOHOL-ASSOCIATED ACUTE HEAD TRAUMA IN HUMAN-SUBJECTS IS ASSOCIATED WITH EARLY DEFICITS IN SERUM IONIZED MG AND CA	ALCOHOL			English	Article						BRAIN TRAUMA; ALCOHOL ABUSE; DIVALENT CATIONS; ION-SELECTIVE ELECTRODES; MOTOR VEHICLE ACCIDENTS	FATAL INJURIES; BRAIN INJURY; EMERGENCY; CONSUMPTION; GLUTAMATE; ACCIDENT; BLOOD	Acute head trauma (AHT) (caused by motor vehicle accidents that did not produce loss of consciousness or observed brain lesions on CT scan, or falls) was found to result in early (1-8 h after injury) serum deficits in ionized magnesium (IMg2+) and ionized calcium (ICa2+) assessed with ion-selective electrodes (ISEs). Total Mg (TMg) and other electrolytes as well as serum biochemical analytes were an within the normal reference ranges. AHT patients with acute alcohol intoxication (BAG greater than or equal to 150 mg/dl) or alcohol abuse (BAG > 200 mg/dl) demonstrated deficits (15-35% less than normal) in IMg2+, but serum TMg levels were normal as were electrolytes and serum biochemical analytes. AHT patients with alcohol intoxication or alcohol abuse required hospitalization for 1-3 days prior to release, whereas AHT patients without alcohol intoxication were released in less than 24 h. The ICa2+/IMg2+ ratio, a sign of increased vascular tone and vascular reactivity, was significantly elevated in AHT patients with alcohol intoxication but not in AHT patients without alcohol intoxication or abuse. These serum divalent cation changes early after traumatic brain injury could be of considerable practicable diagnostic value in the assessment of alcohol-associated head injury. Use of ion-selective electrodes to accurately measure IMg2+ could serve as a logical basis for monitoring the response of the body to AHT.	SUNY HLTH SCI CTR, DEPT MED, BROOKLYN, NY 11203 USA; SUNY HLTH SCI CTR, DEPT NEUROL, BROOKLYN, NY 11203 USA		ALTURA, BM (corresponding author), SUNY HLTH SCI CTR, DEPT PHYSIOL, BOX 31, 450 CLARKSON AVE, BROOKLYN, NY 11203 USA.				NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA-08674] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA008674] Funding Source: NIH RePORTER		Altura B M, 1984, Alcohol, V1, P325, DOI 10.1016/0741-8329(84)90056-9; Altura B. M., 1992, Magnesium and Trace Elements, V10, P122; Altura B T, 1984, Magnesium, V3, P195; Altura B T, 1991, Magnes Trace Elem, V10, P90; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; ALTURA BM, 1981, FED PROC, V40, P2672; ALTURA BM, 1993, ALCOHOL, V10, P563, DOI 10.1016/0741-8329(93)90084-2; ALTURA BM, 1991, CLIN RES, V39, pA394; ALTURA BM, ALCOHOL, V12, P131; ALTURA BT, 1992, METHOD FIND EXP CLIN, V14, P297; ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P21, DOI 10.3109/00365519409095208; ALTURA BT, 1980, NEUROSCI LETT, V20, P323, DOI 10.1016/0304-3940(80)90168-8; ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P53, DOI 10.3109/00365519409095211; ALTURA BT, 1982, MAGNESIUM EXP CLIN R, V1, P277; BABU AR, IN PRESS BRAIN RES B; BECKER DP, 1985, CENTRAL NERVOUS SYST; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHERPITEL CJS, 1989, DRUG ALCOHOL DEPEN, V24, P195; CHERPITEL CJS, 1989, J STUD ALCOHOL, V50, P155, DOI 10.15288/jsa.1989.50.155; ECKARDT MJ, 1981, JAMA-J AM MED ASSOC, V246, P648, DOI 10.1001/jama.246.6.648; FLINK EB, 1954, J LAB CLIN MED, V43, P169; GOODMAN RA, 1991, J STUD ALCOHOL, V52, P156, DOI 10.15288/jsa.1991.52.156; HUANG QF, 1994, AM J PHYSIOL, V266, pR158, DOI 10.1152/ajpregu.1994.266.1.R158; HURST PM, 1973, J SAFETY RES, V5, P130; IKEDA Y, 1990, NEUROSURGERY, V27, P1; JENNETT B, 1976, LANCET, V1, P1031; JENNETT B, 1975, LANCET, V1, P280; JONES GA, 1989, ALCOHOL HEALTH RES W, V13, P105; MARSHALL LF, 1990, CURR OPIN NEUROL NEU, V3, P4; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERRINE MW, 1989, SURGEON GENERALS WORKSHOP ON DRUNK DRIVING, P35; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SMITH SM, 1989, AM J PREV MED, V5, P296, DOI 10.1016/S0749-3797(18)31070-5; YATES DW, 1987, J ROY SOC MED, V80, P486, DOI 10.1177/014107688708000810; YATES DW, 1987, BRIT J ADDICT, V82, P163; ZHANG A, 1993, EUR J PHARM-ENVIRON, V248, P229, DOI 10.1016/0926-6917(93)90049-V; ZHANG A, 1992, BIOCHIM BIOPHYS ACTA, V1134, P25, DOI 10.1016/0167-4889(92)90024-6	37	23	23	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0741-8329	1873-6823		ALCOHOL	Alcohol	SEP-OCT	1995	12	5					433	437		10.1016/0741-8329(95)00026-N			5	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse; Pharmacology & Pharmacy; Toxicology	RV112	WOS:A1995RV11200006	8519438				2022-02-06	
J	HAMM, RJ; PIKE, BR; ODELL, DM; LYETH, BG				HAMM, RJ; PIKE, BR; ODELL, DM; LYETH, BG			TRAUMATIC BRAIN INJURY ENHANCES THE AMNESIC EFFECT OF AN NMDA ANTAGONIST IN RATS	JOURNAL OF NEUROSURGERY			English	Article						BRAIN INJURY; FLUID-PERCUSSION INJURY; AMNESIA; MEMORY; GLUTAMATE; RAT	ASPARTATE RECEPTOR ANTAGONIST; LONG-TERM POTENTIATION; SELECTIVE IMPAIRMENT; HEAD-INJURY; AVOIDANCE; MOTOR; RETENTION; BEHAVIOR; RECOVERY; BLOCKADE	The authors have examined the effect of experimental traumatic brain injury on the amnesia produced by the N-methyl-D-aspartate (NMDA) antagonist MK-801. Rats were either subjected to a moderate level of fluid-percussion injury or prepared for injury but not injured (''sham injury''). Nine days following injury or sham injury, the rats were injected either with saline (sham/saline group, nine rats; injured/saline group, nine rats) or with 0.1 mg/kg of MK-801 (sham/MK-801 group, nine rats; injured/MK-801 group, eight rats) 30 minutes before being trained on a passive-avoidance task. Twenty-four hours later, the rats were tested for retention of the passive-avoidance task. Results revealed that the low dose of MK-801 did not significantly affect retention of the passive-avoidance task in the sham-injured group. In injured animals, administration of MK-801 produced a profound amnesia in contrast to the sham-injured animals treated with MK-801 and the injured animals treated with saline. To further investigate this enhanced sensitivity to the amnesic effects of MK-801 exhibited by the injured animals, nine injured and eight sham-injured rats were injected with 0.3 mg/kg of MK-801 15 minutes before injury. Results indicated that the animals treated with MK-801 before injury did not significantly differ from the sham-injured animals in retention of the passive-avoidance task. In addition, test results in the animals treated with MK-801 before injury and reinjected with MK-801 before passive-avoidance testing did not differ from those in untreated injured animals reinjected with saline before passive-avoidance testing. These findings indicate that MK-801 treatment before injury prevented the enhanced sensitivity to MK-801-induced amnesia that follows traumatic brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROSURG,RICHMOND,VA 23298		HAMM, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,VCU BOX 842018,RICHMOND,VA 23284, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BUTELMAN ER, 1990, PHARMACOL BIOCHEM BE, V35, P533, DOI 10.1016/0091-3057(90)90285-P; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAUGIERGRIMAUD S, 1978, NEUROPSYCHOLOGIA, V16, P151, DOI 10.1016/0028-3932(78)90103-3; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1983, PSYCHOPHARMACOLOGY, V79, P67, DOI 10.1007/BF00433018; FEENEY DM, 1988, PHARM APPROACHES TRE, P121; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GANDOLFI O, 1990, NEUROSCI LETT, V113, P304, DOI 10.1016/0304-3940(90)90602-6; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYS RL, 1992, J NEUROTRAUMA S1, V9, pS173; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIM M, 1992, BRAIN RES, V585, P35, DOI 10.1016/0006-8993(92)91188-K; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MONDADORI C, 1989, EXP BRAIN RES, V75, P449; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PAOLI F, 1990, PSYCHOPHARMACOLOGY, V100, P130, DOI 10.1007/BF02245803; POVLISHOCK J T, 1989, Society for Neuroscience Abstracts, V15, P1113; RAY M H, 1991, Society for Neuroscience Abstracts, V17, P167; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Von Monakow C, 1969, BRAIN BEHAVIOR, P27; WHISHAW IQ, 1989, PSYCHOPHARMACOLOGY, V98, P500, DOI 10.1007/BF00441949	32	23	23	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	AUG	1994	81	2					267	271		10.3171/jns.1994.81.2.0267			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NY086	WOS:A1994NY08600018	8027812				2022-02-06	
J	TWUM, M; PARENTE, R				TWUM, M; PARENTE, R			ROLE OF IMAGERY AND VERBAL LABELING IN THE PERFORMANCE OF PAIRED ASSOCIATES TASKS BY PERSONS WITH CLOSED-HEAD INJURY	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MNEMONIC AID; MEMORY; AMNESIA; RECALL	The facilitating effects of visual imagery and verbal labeling strategies on learning and retention were examined with 60 survivors of closed-head injury. Because individuals without known neurological deficits use cognitive strategies when learning new materials, we expected that head-injured subjects could also be taught to use these strategies. Subjects were asked to memorize the verbal and visual paired associates stimulus items from the revised Wechsler Memory Scale-Revised (WMS-R). One group of subjects received mental imagery instructions to help them learn the verbal paired associates. Another group received verbal labeling training to help them learn the visual paired associates. Subjects who received imagery but not verbal labeling instructions were able to recall more paired associations than those who did not receive imagery. Those subjects who received verbal labeling but not imagery instructions recalled more visual paired associations than those who did not. Subjects who received learning instructions also showed better retention of the learned information.	TOWSON STATE UNIV,DEPT PSYCHOL,TOWSON,MD 21204				Parente, Frederick/W-2570-2019	Parente, Frederick/0000-0002-2784-3433			BADDELEY AD, 1973, NEUROPSYCHOLOGIA, V11, P159, DOI 10.1016/0028-3932(73)90003-1; BOWER GH, 1970, J VERB LEARN VERB BE, V9, P529, DOI 10.1016/S0022-5371(70)80096-2; BOWER GH, 1970, AM SCI, V58, P496; BROOKS DN, 1983, REHABILITATION HEAD, P185; BROWN RW, 1954, J ABNORM SOC PSYCH, V49, P454, DOI 10.1037/h0057814; CERMAK L S, 1975, Cortex, V11, P163; CERMAK LS, 1976, NEUROPSYCHOLOGIA, V14, P311, DOI 10.1016/0028-3932(76)90025-7; CROVITZ HF, 1979, CORTEX, V15, P131, DOI 10.1016/S0010-9452(79)80013-1; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; CULLUM CM, 1990, TRAUMATIC BRAIN INJU, P129; CUTTING J, 1978, CORTEX, V14, P485, DOI 10.1016/S0010-9452(78)80024-0; DOPKINS S, 1990, CORTEX, V26, P189, DOI 10.1016/S0010-9452(13)80350-4; ELLIS HC, 1968, J EXP PSYCHOL, V78, P401, DOI 10.1037/h0026453; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; GRIMM BH, 1986, HDB CLIN NEUROPSYCHO, V2, P495; GROSSMAN A, 1979, INT NEUROPSYCHOLOGY; HARRELL M, 1992, COGNITIVE REHABILITA; HITCH GJ, 1991, J EXP CHILD PSYCHOL, V51, P220, DOI 10.1016/0022-0965(91)90033-O; HOWES JL, 1983, NEUROPSYCHOLOGIA, V21, P341, DOI 10.1016/0028-3932(83)90020-9; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; Kolb B., 1990, FUNDAMENTALS HUMAN N; KOVNER R, 1983, J CLIN NEUROPSYCHOL, V5, P65, DOI 10.1080/01688638308401151; KREUTZER J, 1992, ANN REV HEAD INJURY; LENG NRC, 1988, CORTEX, V24, P33, DOI 10.1016/S0010-9452(88)80015-7; LEWINSOHN PM, 1977, J CONSULT CLIN PSYCH, V45, P717, DOI 10.1037/0022-006X.45.5.717; Moffat N., 1984, CLIN MANAGEMENT MEMO, P63; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; PARENTE R, 1993, APPL COGNITIVE PSYCH, V7, P585, DOI 10.1002/acp.2350070704; PARENTE R, 1991, RETRAINING MEMORY TE; PARENTE R, 1991, COGNITIVE REHABILITA, P147; PATTEN BM, 1972, ARCH NEUROL-CHICAGO, V26, P25, DOI 10.1001/archneur.1972.00490070043006; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schacter DL, 1986, CLIN NEUROPSYCHOLOGY, P257; SHEWAN CM, 1974, PERCEPT MOTOR SKILL, V38, P255, DOI 10.2466/pms.1974.38.1.255; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WOOD RL, 1984, CLIN MANAGEMENT MEMO, P148	37	23	23	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1994	16	4					630	639		10.1080/01688639408402674			10	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	NW682	WOS:A1994NW68200015	7962364				2022-02-06	
J	MUNTE, TF; HEINZE, HJ				MUNTE, TF; HEINZE, HJ			BRAIN POTENTIALS REVEAL DEFICITS OF LANGUAGE PROCESSING AFTER CLOSED-HEAD INJURY	ARCHIVES OF NEUROLOGY			English	Article							EVENT-RELATED POTENTIALS; RECOGNITION MEMORY; LEXICAL DECISION; WORD REPETITION; FREQUENCY WORDS; DISSOCIATION; TASK	Objective: To delineate deficits in language processing after closed head injury with use of behavioral measures and event-related brain potentials. Design: Case-control design. All subjects participated in three verbal event-related brain potential experiments, and the resulting measures were compared both within and between groups. Patients/Controls: Eleven patients at least 2 years after severe closed head injury (Glasgow Coma Scale score < 8 at admission and duration of posttraumatic amnesia > 48 hours) were compared with a control group matched for age and educational level. Interventions: None. Main Outcome Measures: Reaction times and percentage correct as behavioral measures in the three experiments (sentence verification, semantic and repetition priming with lexical decision task, and continuous word recognition). Event-related brain potentials were quantified by area measures in successive time windows for the different experimental conditions and for different experiments. Results: The reaction times of the patient group were significantly longer than those of the controls (P < .005). Similarly, the patients' accuracy was significantly worse in all experiments (P < .03). The event-related brain potentials of the controls showed a clear and significant reduction of a negative component (N400) to terminal words of true sentences (sentence verification experiment), semantically primed words and repeated words (lexical decision experiment), and recognized words (continuous word recognition). For the patients, a clear N400 effect was seen only in the sentence verification task (delayed by about 100 milliseconds), while only later event-related brain potential modulations were seen in the other tasks. Conclusion: Language functions are disturbed after closed head injury. The electrophysiologic data suggest difficulties in the integration of incoming linguistic stimuli with the previous context as a possible underlying cause.			MUNTE, TF (corresponding author), HANNOVER MED SCH,DEPT NEUROL,D-30623 HANNOVER,GERMANY.		Munte, Thomas/C-2077-2014				BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; BFOE GA, 1982, BRAIN IMPAIRMENT, P187; BLUMSTEIN SE, 1982, BRAIN LANG, V17, P301, DOI 10.1016/0093-934X(82)90023-2; CAMPBELL K, 1986, CEREBRAL PSYCHOPHYSI, P197; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; Donchin E., 1986, PSYCHOPHYSIOL SYST P, P244; FISCHLER I, 1990, EVENT RELATED BRAIN, P245; FRIEDMAN D, 1990, BIOL PSYCHOL, V30, P61, DOI 10.1016/0301-0511(90)90091-A; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P186; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; HALGREN E, 1987, HUM NEUROBIOL, V6, P129; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; KUTAS M, 1988, ADV PSYCHOPHYSIOLOGY, V3, P230; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P69; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCCALLUM WC, 1973, ELECTROEN CLIN NEURO, V35, P449, DOI 10.1016/0013-4694(73)90020-5; MUNTE TF, 1990, EEG-EMG-Z ELEK ELEKT, V21, P75; MUNTE TF, 1989, BRAIN DYNAMICS, V11, P436; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; RUFF RM, 1986, SAN DIEGO NEUROPSYCH; RUGG MD, 1992, J COGNITIVE NEUROSCI, V4, P69, DOI 10.1162/jocn.1992.4.1.69; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1990, MEM COGNITION, V18, P367, DOI 10.3758/BF03197126; RUGG MD, 1987, Q J EXP PSYCHOL-A, V39, P123, DOI 10.1080/02724988743000060; RUGG MD, 1989, ELECTROEN CLIN NEURO, V72, P395, DOI 10.1016/0013-4694(89)90045-X; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; RUGG MD, IN PRESS COGNITIVE E; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SCHOLZ MB, 1989, Z EEG EMG, V20, P189; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SMITH ME, 1989, J EXP PSYCHOL LEARN, V15, P50, DOI 10.1037/0278-7393.15.1.50; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398	45	23	23	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	MAY	1994	51	5					482	493		10.1001/archneur.1994.00540170058017			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NM110	WOS:A1994NM11000012	8179498				2022-02-06	
J	JOHNSON, DA; ROETHIGJOHNSTON, K; RICHARDS, D				JOHNSON, DA; ROETHIGJOHNSTON, K; RICHARDS, D			BIOCHEMICAL AND PHYSIOLOGICAL-PARAMETERS OF RECOVERY IN ACUTE SEVERE HEAD-INJURY - RESPONSES TO MULTISENSORY STIMULATION	BRAIN INJURY			English	Article							CHILDREN	We investigated the efficacy of applying a programme of multisensory stimulation to patients with severe diffuse traumatic brain injury, during their admission to a tertiary neurosurgical intensive care unit. We attempted to determine the nature and extent of any physiological or biochemical changes occurring as a result of the multisensory stimulation in the initial period of their comatose state. The findings were inconclusive with no significant treatment effect demonstrated.	ATKINSON MORLEYS HOSP, DEPT PSYCHOL, LONDON SW20, ENGLAND; ROYAL SUSSEX CTY HOSP, DEPT CLIN BIOCHEM, BRIGHTON BN2 5BE, E SUSSEX, ENGLAND								Barrie-Shevlin P, 1987, Nursing (Lond), V3, P597; BUCHWALD JS, 1975, UCLA FORUM MED SCI, V18, P315; CAMPBELL AGM, 1984, BMJ-BRIT MED J, V289, P1022, DOI 10.1136/bmj.289.6451.1022; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Evans B M, 1979, Acta Neurochir Suppl (Wien), V28, P52; EVANS BM, 1976, J NEUROL NEUROSUR PS, V39, P392, DOI 10.1136/jnnp.39.4.392; FERRY PC, 1986, ARCH NEUROL-CHICAGO, V43, P281, DOI 10.1001/archneur.1986.00520030067017; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; Freeman E A, 1992, Brain Inj, V6, P95, DOI 10.3109/02699059209008130; FREEMAN EA, 1987, CATASTROPHE COMA; Johnson D. W., 1989, COOPERATION COMPETIT, P23; JOHNSON DA, IN PRESS BRIT J NEUR; JOHNSON LC, 1967, ELECTROEN CLIN NEURO, V22, P11, DOI 10.1016/0013-4694(67)90004-1; KOLB B, 1992, MECHANISMS RECOVERY, P169; KRAEMER GW, 1985, TRENDS NEUROSCI, V8, P339, DOI 10.1016/0166-2236(85)90118-3; LEFEVER FF, 1986, J CLIN EXPT NEUROPSY, V8, P4; LEVINE M, 1976, NEUROPSYCHOLOGY LEAR, P3; LEWINN EB, 1978, LANCET, V2, P156; LEWINN EB, 1980, ROY SOC HEALTH J, V100, P19, DOI 10.1177/146642408010000107; MILLER C, 1985, MED WORLD NEWS, V25, P69; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; OKEN BS, 1985, CENTRAL NERVOUS SYST, P177; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; Quine S, 1988, Brain Inj, V2, P139, DOI 10.3109/02699058809150938; Reivich M, 1983, Hum Neurobiol, V2, P25; RISBERG J, 1986, EXPT TECHNIQUES HUMA, P514; ROSE F D, 1988, Medical Science Research, V16, P257; ROSE FD, 1992, RESTOR NEUROL NEUROS, V4, P241, DOI 10.3233/RNN-1992-4401; ROSE FD, 1992, MECHANISMS RECOVERY, P187; Rosenzwelg M., 1980, RECOVERY FUNCTION TH, P127; Roy C S, 1890, J Physiol, V11, P85; SHARAV T, 1986, MENT RETARD, V24, P81; STEIN DG, 1981, FUNCTIONAL RECOVERY, P424; SUEDFELD P, 1979, RES PSYCHOL MED, P89; TEASDALE G, 1974, LANCET, V2, P81; Teuber H L, 1975, Ciba Found Symp, P159; VANWOERKOM TCAM, 1982, EUR NEUROL, V21, P227, DOI 10.1159/000115485; WALKER JB, 1975, DEV NEUROPSYCHOL, P160; WILL B, 1992, MECHANISMS RECOVERY, P79; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; WILLIAMS PD, 1986, INT J NURS STUD, V23, P21, DOI 10.1016/0020-7489(86)90035-0; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113; YANKO J, 1985, HEAD INJURY REHABILI, P141	45	23	23	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV-DEC	1993	7	6					491	499		10.3109/02699059309008176			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	MA173	WOS:A1993MA17300003	7903180				2022-02-06	
J	RUIJS, MBM; GABREELS, FJM; KEYSER, A				RUIJS, MBM; GABREELS, FJM; KEYSER, A			THE RELATION BETWEEN NEUROLOGICAL TRAUMA PARAMETERS AND LONG-TERM OUTCOME IN CHILDREN WITH CLOSED-HEAD INJURY	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						CLOSED HEAD INJURY; COMA; POSTTRAUMATIC AMNESIA; RESIDUAL SEQUELAE	YOUNG-CHILDREN; COMA SCALE; SEQUELAE; ADOLESCENTS; CONCUSSION; PROGNOSIS; SYMPTOMS	In a study of 54 children with closed head injury, the relation between neurological severity indicators and the occurrence of long-term sequelae was investigated. Patient data were recorded during the clinical phase and during a 2 year follow up period. A correlation analysis identified early predictors for the occurrence of long-term sequelae. In particular, the duration of coma and of post-traumatic amnesia correlated strongly with the occurrence of neurological, behavioural and intellectual residual sequelae but not with the more subjective complaints.	ST RADBOUD HOSP,DEPT CHILD NEUROL,NIJMEGEN,NETHERLANDS		RUIJS, MBM (corresponding author), ST RADBOUD HOSP,INST NEUROL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.						ARTIOLA I, 1980, J NEUROL NEUROSUR PS, V43, P377; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLACK P, 1981, BRAIN DYSFUNCTION CH; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Denker P., 1944, NY STATE J MED, V44, P379; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; FISHER CM, 1982, NEUROLOGY, V32, P667, DOI 10.1212/WNL.32.6.667; GRONWALL D, 1974, LANCET, V2, P605; HEISKANEN O, 1970, ACTA NEUROL SCAND, V46, P343, DOI 10.1111/j.1600-0404.1970.tb05798.x; HJERN B, 1962, ARCH DIS CHILD, V37, P113, DOI 10.1136/adc.37.192.113; JENNETT B, 1976, NEW ZEAL MED J, V84, P144; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; REILLY PL, 1988, CHILD NERV SYST, V4, P30; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SIMPSON D, 1982, LANCET, V2, P450; TEASDALE G, 1974, LANCET, V2, P81; [No title captured]	30	23	24	0	4	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0340-6199			EUR J PEDIATR	Eur. J. Pediatr.	OCT	1993	152	10					844	847		10.1007/BF02073384			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	LY422	WOS:A1993LY42200015	8223789				2022-02-06	
J	HARRINGTON, DE; MALEC, J; CICERONE, K; KATZ, HT				HARRINGTON, DE; MALEC, J; CICERONE, K; KATZ, HT			CURRENT PERCEPTIONS OF REHABILITATION PROFESSIONALS TOWARDS MILD TRAUMATIC BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						MINOR HEAD INJURY; POSTCONCUSSION SYNDROME; POSTTRAUMATIC HEAD SYNDROME; TRAUMATIC HEAD INJURY			COASTLINE COMMUNITY COLL,NEWPORT BEACH,CA; JOHNSON REHABIL INST,EDISON,NJ; MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905; REHABIL INST NEW ORLEANS,NEW ORLEANS,LA								Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; AUERBACK AH, 1967, DIS NERV SYST, V29, P110; BENTON AL, 1989, MILD HEAD INJURY; BINDER LM, 1986, J CLIN EXPER NEUROPS, V8, P321; ERICKSEN JE, 1882, CONCUSSION SPINE NER; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; PAGE H, 1885, INJURIES SPINE SPINA; RUTHERFORD WH, 1989, MILD HEAD INJURY; TRIMBLE MR, 1981, POST TRAUMATIC NEURO; Walton G. L., 1881, BOSTON MED SURG J, V109, P337, DOI 10.1056/NEJM188310111091501	13	23	23	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	1993	74	6					579	586		10.1016/0003-9993(93)90155-4			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LG423	WOS:A1993LG42300004	8503747				2022-02-06	
J	WHITE, BC; KRAUSE, GS				WHITE, BC; KRAUSE, GS			BRAIN INJURY AND REPAIR MECHANISMS - THE POTENTIAL FOR PHARMACOLOGICAL THERAPY IN CLOSED-HEAD TRAUMA	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	SYMP ON NEUROTRAUMA : CONCEPTS, CURRENT PRACTICE AND EMERGING THERAPIES	JUN 11-12, 1992	DEARBORN, MI	WAYNE STATE UNIV SCH MED, DEPT EMERGENCY MED		BRAIN INJURY; TRAUMA, CLOSED-HEAD		Rotational acceleration from closed-head trauma produces shear-strain brain injury at the interface of gray and white matter. The initial injury is followed by progressive damage involving three key phenomena: progression of subtle focal axonal damage to axonal transection between six and 12 hours after injury, progressive development of tissue microhemorrhages between 12 and 96 hours after injury, and development of tissue and cerebral spinal fluid lactic acidosis that does not appear to be explained by tissue ischemia. All of these phenomena could be explained by trauma-induced tissue depolarization, activation of phospholipases and the release of free arachidonic acid, radical generation by metabolism of arachidonate, and lipid peroxidation with consequent membrane degradation and partial mitochondrial uncoupling. Because of terminal differentiation, neurons may have a limited membrane repair capability that might be stimulated by growth factors. Other potential therapeutic interventions include calmodulin inhibitors, iron chelators, and free radical scavengers.			WHITE, BC (corresponding author), DETROIT RECEIVING HOSP & UNIV HLTH CTR,DEPT EMERGENCY MED,4201 ST ANTOINE,DETROIT,MI 48201, USA.							0	23	23	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	1993	22	6					970	979		10.1016/S0196-0644(05)82737-4			10	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LE338	WOS:A1993LE33800003	8503535				2022-02-06	
J	BROWN, DSO; NELL, V				BROWN, DSO; NELL, V			RECOVERY FROM DIFFUSE TRAUMATIC BRAIN INJURY IN JOHANNESBURG - A CONCURRENT PROSPECTIVE-STUDY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						HEAD INJURY; OUTCOME; PSYCHOSOCIAL PROBLEMS; RECOVERY; TRAUMATIC BRAIN INJURY	SEVERE HEAD-INJURY; GLASGOW OUTCOME SCALE; SOCIAL RECOVERY; CONSECUTIVE SERIES; RELATIVES VIEW; RATING-SCALE; FOLLOW-UP; SEQUELAE; PREDICTION; IMPAIRMENT	Three hundred and twenty-six persons with light, moderate, or severe diffuse traumatic brain injury (TBI) were assessed during initial hospitalization in Johannesburg. One hundred and forty-four were followed up at approximately six months, 83 at 12 months, and 71 at 24 months posttrauma. The sample attrition rate was high. When patients could not be found, data were obtained from their caregivers. Recovery was measured in five different areas of functioning: family relationships, psychologic problems, activities of daily living (ADL), employment status, and physical status. Psychologic problems and family relationships worsened with time, but proficiency in ADL improved; physical and employment status remained relatively stable during the survey period. Severity of injury was significantly correlated with outcome in each functional area at some point in the follow-up period. Discrepancies between patients' and care-givers' perceptions of outcome were noted, particularly in the area of psychologic functioning. Caregivers tended to rate the recovery made by the patient as better than the outcome patients perceived themselves to have made. These differences in perception diminished with time. The multifactorial nature of recovery after TBI is indicated by the improvements seen in some functional areas and the worsening of outcome in other areas. These findings suggest that rehabilitation programs for persons with TBI should (1) include caregivers, (2) focus on the adjustment of both parties to their new circumstances, and (3) facilitate a convergence in their perceptions. Adequately defining recovery is a first step to estimating the prevalence of TBI, but necessitates further work. Epidemiology awaits a better understanding of the recovery process after TBI.	UNIV S AFRICA, DEPT PSYCHOL, HLTH PSYCHOL UNIT, POB 4788, JOHANNESBURG 2000, SOUTH AFRICA								ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Baddeley A, 1980, Int Rehabil Med, V2, P138; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWN DSO, 1991, SOC SCI MED, V33, P283, DOI 10.1016/0277-9536(91)90362-G; Campbell A., 1976, QUALITY AM LIFE; Conkey RC, 1938, ARCH PSYCHOL, P5; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN SS, 1989, MILD HEAD INJURY, P229; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; FAHY TJ, 1967, LANCET, V2, P475; FLETCHER RH, 1982, CLIN EPIDEMIOLOGY ES; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; FREUND RJ, 1981, SAS LINEAR MODELS; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; GODFREY HPD, 1987, NEW ZEAL J PSYCHOL, V16, P49; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HART K, 1988, J CLIN PSYCHOL, V44, P780, DOI 10.1002/1097-4679(198809)44:5<780::AID-JCLP2270440519>3.0.CO;2-1; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JANSEN CP, 1987, THESIS U S AFRICA; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Livingston M G, 1985, Int Rehabil Med, V7, P145; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LUNDHOLM J, 1975, SCAND J REHABIL MED, V7, P97; MCCLELLAND RJ, 1988, BRIT J PSYCHIAT, V153, P141, DOI 10.1192/bjp.153.2.141; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MOSELENYANE N, 1989, THESIS U S AFRICA; NAJENSON T, 1975, SCAND J REHABIL MED, V7, P101; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; NELL V, 1990, South African Journal of Psychology, V20, P243; NELL V, 1990, South African Journal of Psychology, V20, P235; NELL V, 1986, BRAIN DAMAGE DIAGNOS; NELL V, 1990, 901 JOH HLTH PSYCH U; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; TEASDALE G, 1974, LANCET, V2, P81; TELLIER A, 1989, J CLIN EXP NEUROPSYC, V11, P361; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WALKER DE, 1987, J CLIN PSYCHOL, V43, P699, DOI 10.1002/1097-4679(198711)43:6<699::AID-JCLP2270430610>3.0.CO;2-9; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; 1977, MANUAL INT STATISTIC, V1	70	23	23	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1992	73	8					758	770					13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	JG938	WOS:A1992JG93800014	1642528				2022-02-06	
J	LEE, JP; LUI, TN; CHANG, CN				LEE, JP; LUI, TN; CHANG, CN			ACUTE POSTTRAUMATIC INTRAVENTRICULAR HEMORRHAGE ANALYSIS OF 25 PATIENTS WITH EMPHASIS ON FINAL OUTCOME	ACTA NEUROLOGICA SCANDINAVICA			English	Article						COMPUTED TOMOGRAPHY; HEAD INJURY; INTRAVENTRICULAR HEMORRHAGE; SHEARING INJURY		A series of 25 patients suffering acute post-traumatic intraventricular hemorrhage (IVH) after closed head injury is reviewed. Post-traumatic IVH was associated with other brain lesion in most cases; intracerebral lesions with contusion, subdural hematoma, and epidural hematoma coexisted with post-traumatic IVH in ten, three, and one instance, respectively. In six cases, no CT abnormality other than IVH was noted. The final outcome in this series is poor, only 10 (40%) patients made a functional survival. Four different groups of IVH were proposed according to the CT scan findings: deep nuclei hemorrhage, brain stem injury, white matter hemorrhage and isolated IVH. The group of isolated IVH usually got a good outcome. The abnormal motor response, abnormal pupil reaction and impaired oculocephalic response were reliable parameters for poor prognosis.	CHANG GUNG MED COLL, DIV NEUROSURG, TAIPEI, TAIWAN		LEE, JP (corresponding author), CHANG GUNG MEM HOSP, DEPT SURG, DIV NEUROSURG, 199 TUNG HWA N RD, TAIPEI 10591, TAIWAN.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; DANZIGER A, 1979, J TRAUMA, V19, P1, DOI 10.1097/00005373-197901000-00001; DAVIS KR, 1977, SEMIN ROENTGENOL, V12, P53, DOI 10.1016/0037-198X(77)90056-6; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DOLINSKAS CA, 1977, AM J ROENTGENOL, V129, P681, DOI 10.2214/ajr.129.4.681; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; FRENCH BN, 1977, SURG NEUROL, V7, P171; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; Kerr P, 1985, Clin Exp Neurol, V21, P123; KIM CH, 1981, SURG NEUROL, V16, P415, DOI 10.1016/0090-3019(81)90233-0; KOBAYASHI S, 1985, CHILD NERV SYST, V1, P18, DOI 10.1007/BF00706725; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; OLIFF M, 1978, J COMPUT ASSIST TOMO, V2, P625, DOI 10.1097/00004728-197811000-00020; PIEK J, 1986, ACTA NEUROCHIR, V83, P105, DOI 10.1007/BF01402386; Stewart W A, 1973, Surg Neurol, V1, P303; TEASDALE G, 1974, LANCET, V2, P81; TSAI FY, 1978, J COMPUT ASSIST TOMO, V2, P323, DOI 10.1097/00004728-197807000-00018; VAPALAHTI M, 1971, BMJ-BRIT MED J, V3, P404, DOI 10.1136/bmj.3.5771.404; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; ZUCCARELLO M, 1981, ACTA NEUROCHIR, V55, P283, DOI 10.1007/BF01808444; [No title captured]	29	23	24	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	AUG	1991	84	2					85	90		10.1111/j.1600-0404.1991.tb04913.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE152	WOS:A1991GE15200002	1950456				2022-02-06	
J	HOEKSTRA, SM; BENDER, JS; LEVISON, MA				HOEKSTRA, SM; BENDER, JS; LEVISON, MA			THE MANAGEMENT OF LARGE SOFT-TISSUE DEFECTS FOLLOWING CLOSE-RANGE SHOTGUN INJURY	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	20TH ANNUAL MEETING OF THE WESTERN TRAUMA ASSOC	FEB 26-MAR 02, 1990	CRESTED BUTTE, CO	W TRAUMA ASSOC			WOUNDS; SCORE	Large soft-tissue defects following close-range shotgun blasts remain a major technical challenge to trauma surgeons. During the period 1980 through 1988, 43 patients who survived greater than 48 hours following this injury were managed in our center. The locations of their soft-tissue defects were: extremity, 22; abdomen/chest, 18; and head/neck, three. All patients underwent immediate surgical exploration and wide debridement of all devitalized tissue along with repair of associated injuries. Management included mandatory frequent dressing changes, debridement, irrigation in the operating room, and the perioperative administration of broad-spectrum antibiotics. Four patients whose abdominal wall defects could not be initially closed had temporary placement of rayon cloth to prevent evisceration. Overall, four patients underwent delayed primary closure, eight were covered with split-thickness skin grafts, nine had closure with myocutaneous flaps, and 19 closed by secondary intent. Two patients, who were transferred to us following initial management, developed wound sepsis due to inadequate debridement and both eventually required amputation as did one patient who developed early myonecrosis following lengthy arterial repair. Frequent operative dressing changes, adequate debridement, and irrigation minimize sepsis following close-range shotgun blasts and should be the treatment of choice for this devastating injury. Techniques of wound closure need to be individualized to the particular situation.	DETROIT RECEIVING HOSP & UNIV HLTH CTR,DEPT SURG,DETROIT,MI; WAYNE STATE UNIV,DETROIT,MI 48202								BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bell M J, 1971, J Trauma, V11, P522, DOI 10.1097/00005373-197106000-00010; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; DEMUTH WE, 1971, J TRAUM, V11, P219, DOI 10.1097/00005373-197103000-00003; LEDGERWOOD A, 1973, AM J SURG, V125, P690, DOI 10.1016/0002-9610(73)90166-9; LEDGERWOOD AM, 1977, SURG CLIN N AM, V57, P111; PARADIES LH, 1966, J BONE JOINT SURG AM, VA 48, P425, DOI 10.2106/00004623-196648030-00002; ROBERTS RM, 1984, SURGERY, V96, P902; RODGERS CM, 1988, SURG CLIN N AM, V68, P823; SCHMITT HJ, 1970, SURG GYNECOL OBSTETR, V130, P682; SHEPARD GH, 1980, J TRAUMA, V20, P1065, DOI 10.1097/00005373-198012000-00011; SHERMAN R T, 1963, J Trauma, V3, P76, DOI 10.1097/00005373-196301000-00007	12	23	24	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	1990	30	12					1489	1493		10.1097/00005373-199012000-00008			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EP971	WOS:A1990EP97100008	2258959				2022-02-06	
J	DELBIGIO, MR; JOHNSON, GE				DELBIGIO, MR; JOHNSON, GE			CLINICAL PRESENTATION OF SPINAL-CORD CONCUSSION	SPINE			English	Article											DELBIGIO, MR (corresponding author), UNIV MANITOBA,FAC MED,NEUROSURG SECT,730 WILLIAM AVE,WINNIPEG R3E 0W8,MANITOBA,CANADA.			Del Bigio, Marc/0000-0001-8366-0394				0	23	23	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0362-2436			SPINE	SPINE	JAN	1989	14	1					37	40		10.1097/00007632-198901000-00007			4	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	R8671	WOS:A1989R867100007	2913666				2022-02-06	
J	FREEDMAN, PE; BLEIBERG, J; FREEDLAND, K				FREEDMAN, PE; BLEIBERG, J; FREEDLAND, K			ANTICIPATORY BEHAVIOR DEFICITS IN CLOSED HEAD-INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60611		FREEDMAN, PE (corresponding author), UNIV ILLINOIS,DEPT PSYCHOL,BOX 4348,CHICAGO,IL 60680, USA.						BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; BUTTER C M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P525; Fuster JM., 1980, PREFRONTAL CORTEX; GRANT DA, 1964, CATEGORIES HUMAN LEA; Luria AR, 1969, HDB CLINICAL NEUROLO, P725; LURIA AR, 1964, FRONTAL GRANULAR COR; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; OPPENHEIMER H, 1971, CLIN PSYCHIATRY ISSU; TANAKA D, 1973, BRAIN RES, V53, P161, DOI 10.1016/0006-8993(73)90775-0; TANAKA D, 1974, BRAIN RES, V54, P195; WATERHOUSE IK, 1957, J COMP PHYSIOL PSYCH, V50, P81, DOI 10.1037/h0047546; [No title captured]	12	23	23	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	1987	50	4					398	401		10.1136/jnnp.50.4.398			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	G8132	WOS:A1987G813200005	3585349	Green Published, Bronze			2022-02-06	
J	DEUTSCHMAN, CS; KONSTANTINIDES, FN; RAUP, S; CERRA, FB				DEUTSCHMAN, CS; KONSTANTINIDES, FN; RAUP, S; CERRA, FB			PHYSIOLOGICAL AND METABOLIC RESPONSE TO ISOLATED CLOSED-HEAD INJURY .2. EFFECTS OF STEROIDS ON METABOLISM - POTENTIATION OF PROTEIN WASTING AND ABNORMALITIES OF SUBSTRATE UTILIZATION	JOURNAL OF NEUROSURGERY			English	Article									JOHNS HOPKINS MED INST,DEPT ANESTHESIOL & CRIT CARE MED,BALTIMORE,MD 21205; UNIV MINNESOTA,SCH MED,DEPT SURG,MINNEAPOLIS,MN 55455; ST PAUL RAMSEY MED CTR,SURG METAB RES FACIL,ST PAUL,MN 55101				Deutschman, Clifford/AAN-2742-2021				Alexander E Jr, 1972, Clin Neurosurg, V19, P240; ASKANAZI J, 1980, ANN SURG, V191, P40, DOI 10.1097/00000658-198001000-00008; BIRGE SJ, 1984, ADV EXP MED BIOL, V171, P53; CERRA FB, 1987, IN PRESS J CLIN NUTR; CLIFTON GL, 1983, SURG FORUM, V34, P538; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; Faupel G, 1976, DYNAMICS BRAIN EDEMA, P337; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; GALICICH JH, 1961, AM PRACT DIG TREAT, V12, P169; GOBIET W, 1976, DYNAMICS BRAIN EDEMA, P351; HOOSHMAND H, 1969, ARCH NEUROL-CHICAGO, V21, P499, DOI 10.1001/archneur.1969.00480170071007; HOYT HJ, 1972, CLIN PHARMACOL THER, V13, P141; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kobrine A I, 1973, Surg Neurol, V1, P38; KOIDE T, 1986, J CEREBR BLOOD F MET, V6, P395, DOI 10.1038/jcbfm.1986.72; MOLOFSKY WJ, 1984, NEUROSURGERY, V15, P424, DOI 10.1227/00006123-198409000-00022; OWEN OE, 1973, J CLIN INVEST, V52, P2596, DOI 10.1172/JCI107452; PAPPIUS HM, 1969, ARCH NEUROL-CHICAGO, V20, P207, DOI 10.1001/archneur.1969.00480080107013; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; SMITH OK, 1967, ENDOCRINOLOGY, V80, P561, DOI 10.1210/endo-80-4-561; TOMAS FM, 1979, BIOCHEM J, V178, P139, DOI 10.1042/bj1780139; WAGLE SR, 1966, P SOC EXP BIOL MED, V121, P1297, DOI 10.3181/00379727-121-31033; WILMORE DW, 1983, SURGICAL NUTRITION, P65; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	30	23	24	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	1987	66	3					388	395		10.3171/jns.1987.66.3.0388			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	G2347	WOS:A1987G234700010	3819833				2022-02-06	
J	GREEN, ED; SIMSON, LR; KELLERMAN, HH; HOROWITZ, RN; STURNER, WQ				GREEN, ED; SIMSON, LR; KELLERMAN, HH; HOROWITZ, RN; STURNER, WQ			CARDIAC CONCUSSION FOLLOWING SOFTBALL BLOW TO THE CHEST	ANNALS OF EMERGENCY MEDICINE			English	Article											GREEN, ED (corresponding author), EDWARD W SPARROW HOSP,DEPT EMERGENCY MED,LANSING,MI 48909, USA.							0	23	24	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.		1980	9	3					155	157		10.1016/S0196-0644(80)80272-1			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JG879	WOS:A1980JG87900009	7362107				2022-02-06	
J	STREIFLER, M; HOFMAN, S				STREIFLER, M; HOFMAN, S			SINISTRAD MIRROR WRITING AND READING AFTER BRAIN CONCUSSION IN A BI-SYSTEMIC (ORIENTO-OCCIDENTAL) POLYGLOT	CORTEX			English	Article									ICHILOV HOSP, MUNICIPAL GOVT MED CTR, DEPT NEUROL, TEL AVIV, ISRAEL; TEL AVIV UNIV, SCH MED, TEL AVIV, ISRAEL								BEELEY AL, 1918, EXPT STUDY LEFT HAND; BENTON AL, 1965, CAN PSYCHOLOGIST, V6, P332, DOI 10.1037/h0083084; Carmichael L, 1932, J GEN PSYCHOL, V6, P296, DOI 10.1080/00221309.1932.9711876; CRITCHLEY M, 1927, MIRROR WRITING; Critchley M., 1970, APHASIOLOGY OTHER AS; CRITCHLEY M, 1964, DEVELOPMENTAL DYSLEX; DENNYBROWN D, 1952, BRAIN, V75, P433; Faust C, 1947, NERVENARZT, V18, P103; Fildes LG, 1923, B J PSYCHOL-GEN SECT, V14, P57, DOI 10.1111/j.2044-8295.1923.tb00112.x; Fox JC, 1926, BRAIN, V49, P333, DOI 10.1093/brain/49.3.333; Fraenkel M, 1908, ARCH PSYCHIAT NERVEN, V43, P1275, DOI 10.1007/BF01812132; Gordon H, 1920, BRAIN, V43, P313; HALPERN L, 1944, HAREFUAH, V26, P105; Head H., 1926, APHASIA KINDRED DISO, V1; HERRMANN G, 1926, AGRPHIE IHRE LOKALDI; Kleist K., 1934, GEHIRNPATHOLOGIE; NEBLETT HC, 1941, SO MED SURG, P103; NEWNHAM R, 1971, ABOUT CHINESE; Oblu N, 1967, Stud Cercet Neurol, V12, P187; Orton S.T., 1937, READING WRITING SPEE; Orton ST, 1943, ARCH OPHTHALMOL-CHIC, V30, P707; Orton ST, 1928, J AMER MED ASSOC, V90, P1095, DOI 10.1001/jama.1928.02690410007003; PARK GE, 1953, J PEDIATR-US, V42, P120, DOI 10.1016/S0022-3476(53)80117-4; POETZL O, 1928, APHASIELEHRE STANDPU, V1; STRAUSS H, 1942, CITED INDIRECTLY; TOWE, 1967, CITED INDIRECTLY; TRUEMAN RH, 1965, POSTGRAD MED, V38, P469, DOI 10.1080/00325481.1965.11695681; WALSH FB, 1957, CLINICAL NEUROOPHTHA	28	23	23	1	3	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex		1976	12	4					356	364		10.1016/S0010-9452(76)80039-1			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CW512	WOS:A1976CW51200006	1009772	Bronze			2022-02-06	
J	RINDER, L; OLSSON, Y				RINDER, L; OLSSON, Y			STUDIES ON VASULAR PERMEABILITY CHANGES IN EXPERIMENTAL BRAIN CONCUSSION .2. DURATION OF ALTERED PERMEABILITY	ACTA NEUROPATHOLOGICA			English	Article																	AIRD RB, 1952, J NEUROSURG, V9, P331, DOI 10.3171/jns.1952.9.4.0331; ALLEN TH, 1948, AM J PHYSIOL, V154, P27, DOI 10.1152/ajplegacy.1948.154.1.27; BAKAY L, 1964, J NEUROPATH EXP NEUR, V23, P393, DOI 10.1097/00005072-196407000-00001; Broman T, 1955, ACTA PSYCH NEUROL, V30, P115, DOI 10.1111/j.1600-0447.1955.tb06051.x; Broman T., 1949, PERMEABILITY CEREBRO; BROMAN T, 1961, ACTA PSYCHIAT SCAND, V36, P69; BROWN GW, 1954, AMA ARCH NEUROL PSY, V71, P707, DOI 10.1001/archneurpsyc.1954.02320420035004; CASSEN B, 1960, AM J PHYSIOL, V198, P1296, DOI 10.1152/ajplegacy.1960.198.6.1296; CAVENESS WF, 1966, HEAD INJURY C P   ED, P203; CAVENESS WF, 1966, HEAD INJURY       ED, P260; CAVENESS WF, 1966, HEAD INJURY C P   ED, P383; CAVENESS WF, 1966, HEAD INJURY       ED, P172; CHASON JL, 1957, J NEUROPATH EXP NEUR, V16, P102, DOI 10.1097/00005072-195701000-00012; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; DAVID H, 1965, Dtsch Z Gesamte Gerichtl Med, V56, P177, DOI 10.1007/BF00577083; DAVID H, 1967, ACTA NEUROPATH BERL, V9, P212; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DOBBING J, 1961, PHYSIOL REV, V41, P130, DOI 10.1152/physrev.1961.41.1.130; DURET H, THESIS PARIS; EICHELBERGER L, 1949, AM J PHYSIOL, V156, P129, DOI 10.1152/ajplegacy.1949.156.1.129; FAAS FH, 1968, J NEUROSURG, V28, P137, DOI 10.3171/jns.1968.28.2.0137; FRIEDE RL, 1960, J NEUROPATH EXP NEUR, V19, P266, DOI 10.1097/00005072-196004000-00007; FRIEDE RL, 1961, ARCH NEUROL-CHICAGO, V4, P449, DOI 10.1001/archneur.1961.00450100097012; FUJITA I, 1966, WAKYAMA MED REP, V11, P75; GERLACH J, 1953, Z NATURFORSCH B, V8, P578, DOI 10.1515/znb-1953-1006; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; GURDJIAN ES, 1961, J NEUROSURG, V18, P58, DOI 10.3171/jns.1961.18.1.0058; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; GURDJIAN ES, 1965, 7 P STAPP CAR CRASH, P470; GUTTINGER W, 1950, Z NATURFORSCH A, V5, P622; HAMBERGER A, 1966, Z ZELLFORSCH MIK ANA, V70, P386, DOI 10.1007/BF00336504; HAMBERGER A, 1966, J NEUROPATH EXP NEUR, V25, P68, DOI 10.1097/00005072-196601000-00004; HOLLISTER NR, AD203385 ASTIA DOC; HOLLISTER NR, 1958, WADC58193 TECHN REP; ISHII S, 1959, J NEUROSURG, V16, P152, DOI 10.3171/jns.1959.16.2.0152; JAKOB A, 1913, HISTOLOGISCHE HISTOP, V5, P182; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Klatzo I, 1965, Prog Brain Res, V15, P73; KLATZO I, 1964, J NEUROPATH EXP NEUR, V23, P18, DOI 10.1097/00005072-196401000-00002; KLATZO I, 1967, 1965 P S BRAIN ED ED, P554; KLATZO IGOR, 1962, ACTA NEUROPATHOLOGICA, V2, P144; KLATZO IGOR, 1965, ACTA NEUROPATHOL, V5, P161; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; LANGFITT TW, 1966, HEAD INJURY, P172; Lee JC, 1960, NEUROLOGY, V10, P814, DOI 10.1212/WNL.10.9.814; LEE JC, 1966, ARCH NEUROL-CHICAGO, V14, P36, DOI 10.1001/archneur.1966.00470070040005; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LINDGREN S, 1967, J TRAUM, V7, P493, DOI 10.1097/00005373-196707000-00001; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; LOEW F, 1958, Dtsch Z Nervenheilkd, V178, P358, DOI 10.1007/BF02388077; Meessen H., 1949, CYTOARCHITECTONIC AT; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; Miller GG, 1927, ARCH SURG-CHICAGO, V14, P891, DOI 10.1001/archsurg.1927.01130160100005; Ommaya A K, 1966, Ann R Coll Surg Engl, V39, P317; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1966, HEAD INJURY, P260; Pilcher C, 1937, ARCH SURG-CHICAGO, V35, P512, DOI 10.1001/archsurg.1937.01190150095009; PILCHER C, 1941, SURG GYNECOL OBSTET, V72, P755; QUADBECK G, 1955, Z NATURFORSCH PT B, V10, P168, DOI 10.1515/znb-1955-0310; RAIMONDI AJ, 1962, ACTA NEUROPATH BERL, V2, P177; Rawson RA, 1943, AM J PHYSIOL, V138, P0708, DOI 10.1152/ajplegacy.1943.138.5.708; RENGACHERY SS, 1967, J NEUROSURG, V26, P614, DOI 10.3171/jns.1967.26.6.0614; RINDER L, IN PRESS; RINDER L, TO BE PUBLISHED; ROWBATHAM GF, 1964, ACUTE INJURIES HEAD; SCHEINKER IM, 1947, J NEUROSURG, V4, P255, DOI 10.3171/jns.1947.4.3.0255; SCHILLER AA, 1953, J GEN PHYSIOL, V36, P489, DOI 10.1085/jgp.36.4.489; SCHMIDT H., 1964, ACTA NEUROPATHOL, V4, P46; SCHRODER J. M., 1965, ACTA NEURO PATHOL, V5, P82; SELLIER K, 1963, HEFTE UNFALLHEILK; SEVERY DM, 1965, 7 P STAPP CAR CRA ED, P470; SJOVALL H, 1943, ACTA PATH MICROB S48; STEINWALL O, 1966, J NEUROPATH EXP NEUR, V25, P542, DOI 10.1097/00005072-196610000-00004; STEINWALL O, 1965, ACTA NEUROL SCAN S13, V41, P1; STREICHER E, 1964, ARCH NEUROL-CHICAGO, V11, P444, DOI 10.1001/archneur.1964.00460220106014; TANI EHCHI, 1965, ACTA NEUROPATHOL, V4, P507; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; UNTERHARNSCHEIDT.F, 1963, MONOGRAPHIEN GESAMTG, P103; VONGIERKE HE, 1966, HEAD INJURY C P, P383; WARD AA, 1966, HEAD INJURY C P, P203; White JC, 1943, ANN SURG, V119, P619, DOI 10.1097/00000658-194310000-00010; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1946, J NEUROSURG, V3, P157, DOI 10.3171/jns.1946.3.2.0157; [No title captured]; [No title captured]; [No title captured]; [No title captured]	91	23	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.		1968	11	3					201	+					1	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	B9000	WOS:A1968B900000002	5709760				2022-02-06	
J	CHASON, JL; FERNANDO, OU; HODGSON, VR; THOMAS, LM; GURDJIAN, ES				CHASON, JL; FERNANDO, OU; HODGSON, VR; THOMAS, LM; GURDJIAN, ES			EXPERIMENTAL BRAIN CONCUSSION - MORPHOLOGIC FINDINGS AND A NEW CYTOLOGIC HYPOTHESIS	JOURNAL OF TRAUMA			English	Article																	Brunner H, 1925, MSCHR OHRENHEILK, V59, P697; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P763; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P922; CANNON WB, 1902, AM J PHYSIOL, V6, P91; CHASON JL, 1958, J NEUROSURG, V15, P135, DOI 10.3171/jns.1958.15.2.0135; CHASON JL, 1957, J NEUROPATH EXP NEUR, V16, P102, DOI 10.1097/00005072-195701000-00012; COURVILLE CB, 1953, COMMOTIO CEREBRI, P67; DELISI L, 1915, RIV SPER FRENIATR, V41, P249; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; DILUZENBERGER A, 1898, NEUROL ZBL, V17, P363; Dixon KC, 1940, LANCET, V2, P360; FRIEDE RL, 1961, ARCH NEUROL-CHICAGO, V4, P449, DOI 10.1001/archneur.1961.00450100097012; GREENFIELD JG, 1939, P ROY SOC MED, V32, P43; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; GURDJIAN ES, 1965, CLIN NEUROSURG, V12, P390; Handler P, 1942, J BIOL CHEM, V143, P49; JACOBSON KB, 1957, J BIOPHYS BIOCHEM CY, V3, P31, DOI 10.1083/jcb.3.1.31; Jakob A., 1912, HISTOL HISTOPATH ARB, V5, P182; KAUFMAN BT, 1960, BIOCHIM BIOPHYS ACTA, V39, P332, DOI 10.1016/0006-3002(60)90171-2; KORNBERG A, 1948, J BIOL CHEM, V176, P665; Mann PJG, 1941, NATURE, V147, P326, DOI 10.1038/147326a0; Mann PJG, 1941, BIOCHEM J, V35, P502, DOI 10.1042/bj0350502; MCILWAIN H, 1944, BIOCHEM J, V44, P470; MCILWAIN HN, 1962, PRACTICAL NEUROCHEMI, P214; MURTHY MRV, 1963, BIOCHIM BIOPHYS ACTA, V78, P71, DOI 10.1016/0006-3002(63)91610-X; QUASTEL JH, 1953, BIOCHIM BIOPHYS ACTA, V10, P256; ROCKOFF SD, 1964, AMER J ROENTGENOL RA, V91, P1026; ROWBOTHAM G F, 1964, Acta Neurochir (Wien), V12, P339, DOI 10.1007/BF01402102; Scagliosi G., 1898, VIRCHOWS ARCH, V152, P487; SCHMAUS H, 1890, VIRCHOWS ARCH PATH A, V122, P470; SUNG SC, 1952, J BIOL CHEM, V197, P175; Trotter W, 1924, LANCET, V1, P935; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561	35	23	23	0	0							J TRAUM			1966	6	6					767	&		10.1097/00005373-196611000-00008			0	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	86024	WOS:A19668602400010	5925020				2022-02-06	
J	CHASON, JL; HARDY, WG; WEBSTER, JE; GURDJIAN, ES				CHASON, JL; HARDY, WG; WEBSTER, JE; GURDJIAN, ES			ALTERATIONS IN CELL STRUCTURE OF THE BRAIN ASSOCIATED WITH EXPERIMENTAL CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																	Brunner H, 1925, MSCHR OHRENHEILK, V59, P697; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P763; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P922; CHASON JL, 1957, J NEUROPATH EXP NEUR, V16, P102, DOI 10.1097/00005072-195701000-00012; CHASON JL, 1955, EXCERPTA MED, V8, P854; COURVILLE CB, 1953, COMMOTIO CEREBRI CER, V14, P47; DELISI L, 1915, RIV SPER FRENIATR, V41, P249; DELUZENBERGER A, 1898, NEUROL ZBL, V17, P363; Dunlap CB, 1924, AM J PSYCHIAT, V3, P403; GRINKER RR, 1934, NEUROLOGY, V9, P792; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; Gurdjian ES, 1944, J NEUROSURG, V1, P393, DOI 10.3171/jns.1944.1.6.0393; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Jakob A., 1912, HISTOL HISTOPATH ARB, V5, P182; KOENIG RS, 1952, J NEUROPATH EXP NEUR, V11, P69, DOI 10.1097/00005072-195201000-00008; LINDENBERG R, 1956, AM J PATHOL, V32, P1147; MINKOWSKI M, 1930, SCHWEIZER MED WCHNSC, V60, P701; NEUBURGER K, 1929, KRANKHEITSFORSCHUNG, V7, P219; OSNATO M, 1926, ARCH NEUROL PSYCHIAT, V16, P667; Rand CW, 1934, ARCH NEURO PSYCHIATR, V31, P527, DOI 10.1001/archneurpsyc.1934.02250030067004; RAND CW, 1947, J NEUROPATH EXP NEUR, V6, P1; Rand CW, 1931, ARCH SURG-CHICAGO, V23, P357, DOI 10.1001/archsurg.1931.01160090002001; RAND CW, 1946, ARCH NEURO PSYCHIATR, V55, P79, DOI 10.1001/archneurpsyc.1946.02300130003001; Scagliosi G., 1898, VIRCHOWS ARCH, V152, P487; SCHMAUS H, 1890, VIRCHOWS ARCH PATH A, V122, P470; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561	29	23	23	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1958	15	2					135	139		10.3171/jns.1958.15.2.0135			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WG961	WOS:A1958WG96100003	13514511				2022-02-06	
J	WARD, AA				WARD, AA			PHYSIOLOGICAL BASIS OF CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																	BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; FRENCH JD, 1952, AMA ARCH NEUROL PSY, V68, P591, DOI 10.1001/archneurpsyc.1952.02320230017002; FRENCH JD, 1953, AMA ARCH NEUROL PSY, V69, P519, DOI 10.1001/archneurpsyc.1953.02320280107010; FRENCH JD, 1952, AMA ARCH NEUROL PSY, V68, P577, DOI 10.1001/archneurpsyc.1952.02320230003001; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398	10	23	23	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1958	15	2					129	134		10.3171/jns.1958.15.2.0129			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WG961	WOS:A1958WG96100002	13514510				2022-02-06	
J	WINDLE, WF; GROAT, RA				WINDLE, WF; GROAT, RA			DISAPPEARANCE OF NERVE CELLS AFTER CONCUSSION	ANATOMICAL RECORD			English	Article																	DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; GROAT RA, 1945, SURG GYNECOL OBSTET, V81, P63; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; Groat RA, 1944, AM J PHYSIOL, V141, P0117, DOI 10.1152/ajplegacy.1944.141.1.117; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; Windle WF, 1943, STAIN TECHNOL, V18, P77, DOI 10.3109/10520294309105794; WINDLE WF, 1944, 70TH T AM NEUR ASS A, P117	8	23	23	0	2	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012	0003-276X			ANAT REC	Anat. Rec.		1945	93	2					201	209		10.1002/ar.1090930210			9	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	YA563	WOS:A1945YA56300009	21003323				2022-02-06	
J	Van de Voorde, P; Turner, NM; Djakow, J; de Lucas, N; Martinez-Mejias, A; Biarent, D; Bingham, R; Brissaud, O; Hoffmann, F; Johannesdottir, GB; Lauritsen, T; Maconochie, I				Van de Voorde, Patrick; Turner, Nigel M.; Djakow, Jana; de Lucas, Nieves; Martinez-Mejias, Abel; Biarent, Dominique; Bingham, Robert; Brissaud, Olivier; Hoffmann, Florian; Johannesdottir, Groa Bjork; Lauritsen, Torsten; Maconochie, Ian			European Resuscitation Council Guidelines 2021: Paediatric Life Support	RESUSCITATION			English	Article						Resuscitation child; Infant; Paediatric; CPR; Basic life support; Advanced life support; Defibrillation; Pediatric; Respiratory failure; Circulatory failure; Shock; Oxygen; Cardiac arrest; Bag-mask ventilation	HOSPITAL CARDIAC-ARREST; CONVULSIVE STATUS EPILEPTICUS; CRITICALLY-ILL CHILDREN; CARDIOVASCULAR CARE SCIENCE; AMERICAN-HEART-ASSOCIATION; POSITIVE AIRWAY PRESSURE; EXTRACORPOREAL CARDIOPULMONARY-RESUSCITATION; AUTOMATED EXTERNAL DEFIBRILLATORS; CHEST COMPRESSION QUALITY; TRAUMATIC BRAIN-INJURY	These European Resuscitation Council Paediatric Life Support (PLS) guidelines, are based on the 2020 International Consensus on Cardiopulmonary Resuscitation Science with Treatment Recommendations. This section provides guidelines on the management of critically ill infants and children, before, during and after cardiac arrest.	[Van de Voorde, Patrick] Ghent Univ Hosp, Fac Med UG, Dept Emergency Med, Ghent, Belgium; [Van de Voorde, Patrick] Fed Dept Hlth, East & West Flanders, EMS Dispatch Ctr, Brussels, Belgium; [Turner, Nigel M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Paediat Cardiac Anesthesiol, Utrecht, Netherlands; [Djakow, Jana] NH Hosp, Paediat Intens Care Unit, Horovice, Czech Republic; [Djakow, Jana] Masaryk Univ, Med Fac, Univ Hosp Brno, Paediat Anaesthesiol & Intens Care Med, Brno, Czech Republic; [de Lucas, Nieves] SAMUR Protecc Civil, Madrid, Spain; [Martinez-Mejias, Abel] Hosp Terassa, Dept Paediat & Emergency Med, Consorci Sanitari Terrassa, Barcelona, Spain; [Biarent, Dominique] Univ Libre Bruxelles, Hop Univ Enfants, Paediat Intens Care & Emergency Dept, Brussels, Belgium; [Bingham, Robert] Great Ormond St Hosp Sick Children, London, England; [Brissaud, Olivier] Univ Bordeaux, Hop Enfants Bordeaux, CHU Pellegrin, Reanimat & Surveillance Continue Pediat & Neonata, Bordeaux, France; [Hoffmann, Florian] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Paediat Intens Care & Emergency Med, Munich, Germany; [Johannesdottir, Groa Bjork] Akureyri Hosp, Paediat Gastroenterol, Akureyri, Iceland; [Lauritsen, Torsten] Univ Hosp Copenhagen, Juliane Marie Ctr, Paediat Anaesthesia, Copenhagen, Denmark; [Maconochie, Ian] Imperial Coll, Fac Med, Imperial Coll Healthcare Trust NHS, Paediat Emergency Med, London, England		Van de Voorde, P (corresponding author), Ghent Univ Hosp, Fac Med UG, Dept Emergency Med, Ghent, Belgium.; Van de Voorde, P (corresponding author), Fed Dept Hlth, East & West Flanders, EMS Dispatch Ctr, Brussels, Belgium.	patrick.vandevoorde@uzgent.be	MARTINEZ-MEJIAS, ABEL/AAC-6216-2021	MARTINEZ-MEJIAS, ABEL/0000-0003-4437-4963			Abadesso C, 2012, PEDIATRIC REP, V4, P57, DOI [10.4081/pr.2012.e16, 10.4081/pr.2012.el6]; Abdelgadir IS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011413.pub2; Abraham MB, 2018, PEDIATR DIABETES, V19, P178, DOI 10.1111/pedi.12698; Abramo TJ, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.04.007; Abramo TJ, 1996, PEDIATR EMERG CARE, V12, P252, DOI 10.1097/00006565-199608000-00004; Abramo TJ, 1997, CRIT CARE MED, V25, P1242, DOI 10.1097/00003246-199707000-00029; Abramson Tiffany M, 2018, Clin Pract Cases Emerg Med, V2, P323, DOI 10.5811/cpcem.2018.8.38854; Acker SN, 2015, J PEDIATR SURG, V50, P331, DOI 10.1016/j.jpedsurg.2014.08.009; Adato B, 2016, EUR J PEDIATR, V175, P1249, DOI 10.1007/s00431-016-2751-5; Akam-Venkata J, 2019, CARDIOL YOUNG, V29, P263, DOI 10.1017/S1047951118002135; Al-Shibli A, 2020, PEDIATR EMERG CARE, V36, P39, DOI 10.1097/PEC.0000000000002019; Alam NH, 2020, ACTA PAEDIATR, V109, P1473, DOI 10.1111/apa.15134; Alangari AA, 2014, CHEST, V145, P772, DOI 10.1378/chest.13-2298; Alansari K, 2020, PEDIATR NEUROL, V109, P28, DOI 10.1016/j.pediatrneurol.2020.03.011; Albreiki M, 2018, EUR J TRAUMA EMERG S, V44, P191, DOI 10.1007/s00068-017-0862-y; Algie CM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011656.pub2; Allen CJ, 2015, J PEDIATR SURG, V50, P177, DOI 10.1016/j.jpedsurg.2014.10.042; Allen SG, 2017, RESP CARE, V62, P1166, DOI 10.4187/respcare.05368; Alqudah Z, 2020, RESUSCITATION, V149, P65, DOI 10.1016/j.resuscitation.2020.01.037; Alqudah Z, 2019, RESUSCITATION, V140, P127, DOI 10.1016/j.resuscitation.2019.05.020; Alqurashi W, 2017, J ALLER CL IMM-PRACT, V5, P1194, DOI 10.1016/j.jaip.2017.05.022; Alshehri A, 2017, ACAD EMERG MED, V24, P875, DOI 10.1111/acem.13190; AlSohime Fahad, 2018, Int J Pediatr Adolesc Med, V5, P116, DOI 10.1016/j.ijpam.2018.07.001; Amagasa S, 2019, RESUSCITATION, V137, P161, DOI 10.1016/j.resuscitation.2019.02.021; American College of Surgeons Committee on Trauma., 2018, ADV TRAUMA LIFE SUPP, V10th edition; Amirnovin R, 2020, J INTENSIVE CARE MED, V35, P371, DOI 10.1177/0885066617752659; Anagnostou K, 2018, CURR PEDIATR REV, V14, P180, DOI 10.2174/1573396314666180507115115; Andersen L, 2015, JAMA-J AM MED ASSOC, V314, P802, DOI 10.1001/jama.2015.9678; Andrew E, 2018, PREHOSP EMERG CARE, V22, P445, DOI 10.1080/10903127.2017.1402110; [Anonymous], 2014, Emerg Med J, V31, P604, DOI 10.1136/emermed-2014-203947.1; Martin AMA, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012247.pub2; Anton-Martin P, 2020, CARDIOL YOUNG, V30, P607, DOI 10.1017/S1047951120000591; Arnholt AM, 2015, PEDIATR CRIT CARE ME, V16, pE224, DOI 10.1097/PCC.0000000000000497; Arulparithi CS, 2015, INDIAN J PEDIATR, V82, P328, DOI 10.1007/s12098-014-1498-0; Atanaskovic-Markovic M, 2019, PEDIAT ALLERG IMM-UK, V30, P269, DOI 10.1111/pai.13034; Atkinson SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112702; Au CC, 2017, J PEDIAT-BRAZIL, V93, P84, DOI 10.1016/j.jped.2017.08.004; Aubertin G, 2012, ARCH PEDIATRIE, V19, P528, DOI 10.1016/j.arcped.2012.02.016; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Austin AL, 2020, PEDIATR EMERG CARE, V36, pE79, DOI 10.1097/PEC.0000000000001312; Avau B, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013230; Balamuth F, 2019, ACAD EMERG MED, DOI 10.1111/acem.13815; Balamuth F, 2016, PEDIATR CRIT CARE ME, V17, P817, DOI 10.1097/PCC.0000000000000858; Balamuth F, 2015, ACAD EMERG MED, V22, P1298, DOI 10.1111/acem.12814; Balfour-Lynn RE, 2014, PAEDIATR RESPIR REV, V15, P181, DOI 10.1016/j.prrv.2014.02.002; Balhara KS, 2019, PREHOSP EMERG CARE, V23, P389, DOI 10.1080/10903127.2018.1513104; Balk DS, 2018, PEDIATR PULM, V53, P1130, DOI 10.1002/ppul.24020; Ballestero Y, 2018, J PEDIATR-US, V194, P204, DOI 10.1016/j.jpeds.2017.10.075; Bamber AR, 2015, FORENSIC SCI MED PAT, V11, P358, DOI 10.1007/s12024-015-9681-9; Barbaro RP, 2017, ASAIO J, V63, P456, DOI 10.1097/MAT.0000000000000603; Barboza CL, 2020, INDIAN J CRIT CARE M, V24, P128, DOI 10.5005/jp-journals-10071-23336; Barnard EBG, 2019, EMERG MED J, V36, P333, DOI 10.1136/emermed-2018-208165; Baruteau AE, 2016, EUR J PEDIATR, V175, P151, DOI 10.1007/s00431-015-2689-z; Bauman BD, 2021, PEDIATR EMERG CARE, V37, pE653, DOI 10.1097/PEC.0000000000001735; Becker HJ, 2020, PEDIATR EMERG CARE, V36, pE695, DOI 10.1097/PEC.0000000000001314; Bellamy D, 2019, PEDIATR CRIT CARE ME, V20, P262, DOI 10.1097/PCC.0000000000001847; Belsky J, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28144; Bennett M, 2007, PEDIATR EMERG CARE, V23, P267, DOI 10.1097/PEC.0b013e3180403088; Berce V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54499-y; Berg RA, 2018, RESUSCITATION, V133, P173, DOI 10.1016/j.resuscitation.2018.08.013; Berg RA, 2018, CIRCULATION, V137, P1784, DOI 10.1161/CIRCULATIONAHA.117.032270; Best RR, 2020, PEDIATR EMERG CARE, V36, P143, DOI 10.1097/PEC.0000000000001169; Bhalala US, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00107; Bhananker SM, 2007, ANESTH ANALG, V105, P344, DOI 10.1213/01.ane.0000268712.00756.dd; Bielski K, 2017, EUR J PEDIATR, V176, P865, DOI 10.1007/s00431-017-2922-z; Bilharz JR, 2018, RESP CARE, V63, P1079, DOI 10.4187/respcare.06021; Birbeck GL, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1766-2; Birkenes TS, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-40; Blacklock C, 2011, ARCH DIS CHILD, V96, P708, DOI 10.1136/adc.2010.206243; Boeschoten S, 2020, EUR J PEDIATR, V179, P455, DOI 10.1007/s00431-019-03502-9; Booth A, 2018, RESUSCITATION, V129, P70, DOI 10.1016/j.resuscitation.2018.03.029; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Borra V, 2019, CLIN TOXICOL, V57, P603, DOI 10.1080/15563650.2019.1574975; Bortcosh W, 2018, CURR OPIN PEDIATR, V30, P350, DOI 10.1097/MOP.0000000000000621; Bradley SM, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1653; Braga MS, 2009, PEDIATRICS, V124, pE69, DOI 10.1542/peds.2009-0153; Brauer CEL, 2016, J ALLER CL IMM-PRACT, V4, P1220, DOI 10.1016/j.jaip.2016.06.003; Brigo F, 2016, EPILEPSY BEHAV, V64, P29, DOI 10.1016/j.yebeh.2016.09.020; Brinck T, 2016, SCAND J SURG, V105, P109, DOI 10.1177/1457496915586650; Brindis SL, 2011, PEDIATR EMERG CARE, V27, P616, DOI 10.1097/PEC.0b013e31822255c9; Brissaud O, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0111-2; Britton PN, 2015, INTERN MED J, V45, P563, DOI 10.1111/imj.12749; Bronzetti G, 2018, INT J CARDIOL, V252, P106, DOI 10.1016/j.ijcard.2017.10.120; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brugada J, 2020, EUR HEART J, V41, P655, DOI 10.1093/eurheartj/ehz467; Brugada J, 2013, EUROPACE, V15, P1337, DOI 10.1093/europace/eut082; Brugger H, 2013, RESUSCITATION, V84, P539, DOI 10.1016/j.resuscitation.2012.10.020; Burman RJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00506; Caglar A, 2017, TURKISH J PEDIATR, V59, P642, DOI 10.24953/turkjped.2017.06.004; Cameron A, 2018, J TRAUMA ACUTE CARE, V84, P994, DOI 10.1097/TA.0000000000001886; Campbell M, 2017, EMERG MED J, V34, P58, DOI 10.1136/emermed-2016-206487.2; Campbell RL, 2014, ANN ALLERG ASTHMA IM, V113, P599, DOI 10.1016/j.anai.2014.10.007; Capizzani AR, 2010, J PEDIATR SURG, V45, P903, DOI 10.1016/j.jpedsurg.2010.02.014; Carapetis JR, 2014, CLIN INFECT DIS, V59, P358, DOI 10.1093/cid/ciu304; Carreiro S, 2020, CLIN TOXICOL, V58, P183, DOI 10.1080/15563650.2019.1634272; Carrillo E, 2016, PREHOSP EMERG CARE, V20, P239, DOI 10.3109/10903127.2015.1086843; CARRUTHERS DM, 1995, THORAX, V50, P186, DOI 10.1136/thx.50.2.186; Castelao EF, 2013, J CRIT CARE, V28, P504, DOI 10.1016/j.jcrc.2013.01.005; Cates Christopher J, 2013, Cochrane Database Syst Rev, pCD000052, DOI 10.1002/14651858.CD000052.pub3; Chamberlain DB, 2017, ANN EMERG MED, V69, P117, DOI 10.1016/j.annemergmed.2016.08.449; Chamberlain JM, 2020, LANCET, V395, P1217, DOI 10.1016/S0140-6736(20)30611-5; Chang R, 2016, SHOCK, V46, P17, DOI 10.1097/SHK.0000000000000577; Chao JY, 2020, J PEDIATR-US, V223, P14, DOI 10.1016/j.jpeds.2020.05.006; Chavez DE, 2013, RESUSCITATION, V84, P979, DOI 10.1016/j.resuscitation.2012.12.010; Chen DY, 2019, NEUROPSYCH DIS TREAT, V15, P905, DOI 10.2147/NDT.S188111; Cheng A, 2018, RESUSCITATION, V132, P33, DOI 10.1016/j.resuscitation.2018.08.021; Cheng A, 2015, RESUSCITATION, V97, P13, DOI 10.1016/j.resuscitation.2015.08.024; Cheng J, 2019, CLIN OTOLARYNGOL, V44, P235, DOI 10.1111/coa.13261; Cheong SA, 2015, EMERG MED AUSTRALAS, V27, P567, DOI 10.1111/1742-6723.12492; Chiarello D, 2020, SEIZURE-EUR J EPILEP, V78, P127, DOI 10.1016/j.seizure.2020.03.019; Chillag S, 2010, SOUTH MED J, V103, P147, DOI 10.1097/SMJ.0b013e3181c99140; Chime NO, 2015, PEDIATR CRIT CARE ME, V16, P404, DOI 10.1097/PCC.0000000000000384; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Choi YJ, 2019, ALLERGY ASTHMA IMMUN, V11, P529, DOI 10.4168/aair.2019.11.4.529; Chou R, 2017, ANN EMERG MED, V70, P143, DOI 10.1016/j.annemergmed.2016.11.032; Chrysostomou C, 2013, CONGENIT HEART DIS, V8, P48, DOI 10.1111/j.1747-0803.2012.00669.x; Chu PY, 2015, EARLY HUM DEV, V91, P345, DOI 10.1016/j.earlhumdev.2015.04.001; Ciccone O, 2017, AFR J EMERG MED, V7, pS3, DOI 10.1016/j.afjem.2017.09.003; Clausen H, 2012, EMERG MED J, V29, P732, DOI 10.1136/emermed-2011-200242; Cohen N, 2018, ANN ALLERG ASTHMA IM, V121, P348, DOI 10.1016/j.anai.2018.06.033; Combret Y, 2017, MINERVA ANESTESIOL, V83, P624, DOI 10.23736/S0375-9393.17.11708-6; Considine J, 2020, RESUSCITATION, V146, P188, DOI 10.1016/j.resuscitation.2019.08.042; Conti G, 2016, CURR OPIN CRIT CARE, V22, P60, DOI 10.1097/MCC.0000000000000271; Conway JA, 2020, CRIT CARE MED, V48, pE489, DOI 10.1097/CCM.0000000000004314; Coolen E, 2019, EUR J PEDIATR, V178, P837, DOI 10.1007/s00431-019-03358-z; Cooney L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159965; Cooney L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153877; Cristiano LM, 2018, PREHOSP EMERG CARE, V22, P452, DOI 10.1080/10903127.2017.1399184; Crocker ME, 2020, LANCET GLOB HEALTH, V8, pE362, DOI 10.1016/S2214-109X(19)30543-1; Cronin JJ, 2016, ANN EMERG MED, V67, P593, DOI 10.1016/j.annemergmed.2015.08.001; Crulli B, 2016, PEDIATR PULM, V51, P165, DOI 10.1002/ppul.23223; Cundiff KM, 2018, PEDIATR EMERG CARE, V34, P385, DOI 10.1097/PEC.0000000000001163; Cunningham A, 2018, J TRAUMA ACUTE CARE, V85, P665, DOI 10.1097/TA.0000000000001839; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Daigle CH, 2020, CRIT CARE MED, V48, pE744, DOI 10.1097/CCM.0000000000004425; Dalziel SR, 2019, LANCET, V393, P2135, DOI 10.1016/S0140-6736(19)30722-6; Davis AL, 2017, CRIT CARE MED, V45, P1061, DOI 10.1097/CCM.0000000000002425; Daw WJ, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000173; De Buck E, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013283.pub2; de Caen AR, 2015, CIRCULATION, V132, pS177, DOI 10.1161/CIR.0000000000000275; de Groot MG, 2020, J PEDIATR INTENSIVE, V9, P34, DOI 10.1055/s-0039-1697679; de la Grandville B, 2019, BRIT J ANAESTH, V122, P682, DOI 10.1016/j.bja.2019.01.036; De Maio VJ, 2012, PREHOSP EMERG CARE, V16, P230, DOI 10.3109/10903127.2011.640419; De Mul A, 2019, J PEDIATR INTENSIVE, V8, P57, DOI 10.1055/s-0038-1667012; Deakin CD, 2020, RESUSCITATION, V155, P24, DOI 10.1016/j.resuscitation.2020.06.008; Deasy C, 2012, RESUSCITATION, V83, P471, DOI 10.1016/j.resuscitation.2011.11.009; del Castillo J, 2014, RESUSCITATION, V85, P1380, DOI 10.1016/j.resuscitation.2014.06.024; Del Rossi G, 2014, PREHOSP EMERG CARE, V18, P539, DOI 10.3109/10903127.2014.916019; Delaloye NJ, 2020, J PATIENT SAF, V16, P73, DOI 10.1097/PTS.0000000000000359; DeLaroche AM, 2016, PEDIATR NEUROL, V65, P39, DOI 10.1016/j.pediatrneurol.2016.09.005; Depret F, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0509-8; Derkenne C, 2020, RESUSCITATION, V146, P34, DOI 10.1016/j.resuscitation.2019.10.038; Despins LA, 2017, J HEALTHC QUAL, V39, P322, DOI 10.1097/JHQ.0000000000000066; Dezfulian C, 2018, PEDIATR CRIT CARE ME, V19, P495, DOI 10.1097/PCC.0000000000001529; Diaz-Parra S, 2014, PEDIATR EMERG CARE, V30, P388, DOI 10.1097/PEC.0000000000000144; DiBrito SR, 2018, J PEDIATR SURG, V53, P1789, DOI 10.1016/j.jpedsurg.2017.12.027; Dittrich MHM, 2020, BURNS, V46, P1036, DOI 10.1016/j.burns.2020.02.003; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Donoghue A, 2009, PEDIATRICS, V124, P1541, DOI 10.1542/peds.2009-0727; Donoghue AJ, 2020, RESUSCITATION, V153, P37, DOI 10.1016/j.resuscitation.2020.05.026; Donoghue AJ, 2020, PEDIATR EMERG CARE, V36, P267, DOI 10.1097/PEC.0000000000002109; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Douvanas A, 2018, J MATERN-FETAL NEO M, V31, P805, DOI 10.1080/14767058.2017.1295953; Dubus JC, 2019, EUR J PEDIATR, V178, P69, DOI 10.1007/s00431-018-3246-3; Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108; Dunne B, 2014, HEART LUNG CIRC, V23, P1029, DOI 10.1016/j.hlc.2014.06.011; Dunne CL, 2020, RESUSCITATION, V153, P219, DOI 10.1016/j.resuscitation.2020.02.021; Dunning J, 2017, ANN THORAC SURG, V103, P1005, DOI 10.1016/j.athoracsur.2016.10.033; Dunning J, 2009, EUR J CARDIO-THORAC, V36, P3, DOI 10.1016/j.ejcts.2009.01.033; Durand P, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01926-2019; Duron V, 2014, J TRAUMA ACUTE CARE, V77, P422, DOI 10.1097/TA.0000000000000394; Eckert MJ, 2014, J TRAUMA ACUTE CARE, V77, P852, DOI 10.1097/TA.0000000000000443; Edmonds ML, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002308.pub2; Edwards-Jackson N, 2020, PAEDIATR INT CHILD H, V40, P11, DOI 10.1080/20469047.2019.1570443; Eisa L, 2015, ARCH DIS CHILD, V100, P684, DOI 10.1136/archdischild-2014-307868; El-Assaad I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-1903; El-Nawawy A, 2017, PEDIATR INFECT DIS J, V36, P155, DOI 10.1097/INF.0000000000001380; El-Nawawy AA, 2018, J TROP PEDIATRICS, V64, P132, DOI 10.1093/tropej/fmx061; Elkbuli A, 2020, J SURG RES, V247, P350, DOI 10.1016/j.jss.2019.10.009; Else SDN, 2020, ANESTH ANALG, V130, P831, DOI 10.1213/ANE.0000000000004403; Emami P, 2019, EUR J TRAUMA EMERG S, V45, P769, DOI 10.1007/s00068-018-01065-2; Emrath ET, 2017, CRIT CARE MED, V45, P1177, DOI 10.1097/CCM.0000000000002365; Engelhardt T, 2019, PEDIATR ANESTH, V29, P985, DOI 10.1111/pan.13716; Enriquez Diego, 2018, Arch. argent. pediatr., V116, pe730, DOI 10.5546/aap.2018.e730; Esangbedo ID, 2020, PEDIATR CRIT CARE ME, V21, pE934, DOI 10.1097/PCC.0000000000002373; Essouri S, 2014, INTENS CARE MED, V40, P84, DOI 10.1007/s00134-013-3129-z; Evans IVR, 2018, JAMA-J AM MED ASSOC, V320, P358, DOI 10.1001/jama.2018.9071; Eytan D, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00052; Farbman KS, 2016, CURR OPIN PEDIATR, V28, P294, DOI 10.1097/MOP.0000000000000340; Ferguson LP, 2020, CRIT CARE MED, V48, pE542, DOI 10.1097/CCM.0000000000004349; Fernandez A, 2017, J PEDIAT-BRAZIL, V93, P60, DOI 10.1016/j.jped.2017.07.002; Fernandez A, 2017, PEDIATR EMERG CARE, V33, P234, DOI 10.1097/PEC.0000000000000717; Fiadjoe J, 2020, PEDIATR ANESTH, V30, P257, DOI 10.1111/pan.13798; Fiadjoe JE, 2016, LANCET RESP MED, V4, P37, DOI 10.1016/S2213-2600(15)00508-1; Figueiredo S, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0420-8; Figueroa L, 2017, ARCH ARGENT PEDIATR, V115, P277, DOI [10.5546/aap.2017.eng.277, 10.5546/aap.2017.277]; Fleming JT, 2015, J ALLER CL IMM-PRACT, V3, P57, DOI 10.1016/j.jaip.2014.07.004; Fleming S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138155; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Flynn-O'Brien KT, 2016, J PEDIATR SURG, V51, P163, DOI 10.1016/j.jpedsurg.2015.10.034; Fraser J, 2014, LANCET, V384, P894, DOI 10.1016/S0140-6736(13)61089-2; Freire-Tellado M, 2017, RESUSCITATION, V115, P173, DOI 10.1016/j.resuscitation.2017.03.008; Fukuda T, 2020, RESUSCITATION, V150, P145, DOI 10.1016/j.resuscitation.2020.02.005; Fukuda T, 2018, EUR HEART J-CARD PHA, V4, P144, DOI 10.1093/ehjcvp/pvx023; Fukuda T, 2017, RESUSCITATION, V111, P1, DOI 10.1016/j.resuscitation.2016.11.010; Fukuda T, 2016, CIRCULATION, V134, P2060, DOI 10.1161/CIRCULATIONAHA.116.023831; Fukushima H, 2015, EMERG MED J, V32, P314, DOI 10.1136/emermed-2013-203112; Fusco Nicholas M, 2015, J Pediatr Pharmacol Ther, V20, P37, DOI 10.5863/1551-6776-20.1.37; Gabrielli S, 2019, J ALLER CL IMM-PRACT, V7, P2232, DOI 10.1016/j.jaip.2019.04.018; Gaensbauer JT, 2018, PEDIATR INFECT DIS J, V37, P1223, DOI 10.1097/INF.0000000000002002; Gallagher RA, 2014, ACAD EMERG MED, V21, P981, DOI 10.1111/acem.12460; Galvez JA, 2019, ANESTHESIOLOGY, V131, P830, DOI 10.1097/ALN.0000000000002847; Gamper G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003709.pub4; Garcia-Marcinkiewicz AG, 2020, ANESTH ANALG, V131, P469, DOI 10.1213/ANE.0000000000004393; Garcia-Salido A, 2020, PEDIATR CRIT CARE ME, V21, pE576, DOI 10.1097/PCC.0000000000002475; Garner AA, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02865-y; Gausche-Hill M, 2014, PREHOSP EMERG CARE, V18, P520, DOI 10.3109/10903127.2014.912706; Gc VS, 2020, ARCH DIS CHILD, V105, P975, DOI 10.1136/archdischild-2019-318427; Gerein RB, 2006, ACAD EMERG MED, V13, P653, DOI 10.1197/j.aem.2005.12.025; Gilhooley Colin, 2019, J Intensive Care Soc, V20, P27, DOI 10.1177/1751143718764541; Gill Badar Ul Ahad, 2014, J Ayub Med Coll Abbottabad, V26, P29; Gill H, 2014, RESUSCITATION, V85, P1394, DOI 10.1016/j.resuscitation.2014.07.002; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Golden C, 2015, JAMA PEDIATR, V169, P186, DOI 10.1001/jamapediatrics.2014.2767; Gonzalez R, 2017, WORLD J PEDIATR, V13, P544, DOI 10.1007/s12519-017-0061-2; Goto T, 2016, WEST J EMERG MED, V17, P129, DOI 10.5811/westjem.2016.1.28685; Goto Y, 2016, CIRCULATION, V134, P2046, DOI 10.1161/CIRCULATIONAHA.116.023821; Goto Y, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003589; Grabenhenrich LB, 2016, J ALLERGY CLIN IMMUN, V137, P1128, DOI 10.1016/j.jaci.2015.11.015; Graff DM, 2019, PEDIATR PULM, V54, P1941, DOI 10.1002/ppul.24499; Granfeldt A, 2020, RESUSCITATION, V149, P150, DOI 10.1016/j.resuscitation.2020.02.025; Gravel CA, 2020, AM J EMERG MED, V38, P1, DOI 10.1016/j.ajem.2019.01.047; Gregson RK, 2017, ARCH DIS CHILD, V102, P403, DOI 10.1136/archdischild-2016-310691; Greif R, 2020, RESUSCITATION, V156, pA188, DOI 10.1016/j.resuscitation.2020.09.014; Grieco DL, 2019, AM J RESP CRIT CARE, V199, P728, DOI 10.1164/rccm.201806-1111OC; Griffis H, 2020, RESUSCITATION, V146, P126, DOI 10.1016/j.resuscitation.2019.09.038; Griffiths B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000060.pub2; Grimsley EA, 2021, PEDIATR EMERG CARE, V37, pE1122, DOI 10.1097/PEC.0000000000001923; Grunwell JR, 2017, PEDIATR CRIT CARE ME, V18, P741, DOI 10.1097/PCC.0000000000001175; Guedj R, 2015, ACAD EMERG MED, V22, P1290, DOI 10.1111/acem.12798; Gumer LB, 2014, PEDIATR EMERG CARE, V30, P660, DOI 10.1097/PEC.0000000000000218; Gupta A, 2018, PEDIATR ANESTH, V28, P1148, DOI 10.1111/pan.13524; Gupta P, 2014, RESUSCITATION, V85, P1473, DOI 10.1016/j.resuscitation.2014.07.016; Gurcharran K, 2019, SEIZURE-EUR J EPILEP, V68, P3, DOI 10.1016/j.seizure.2018.08.021; Hagedoorn NN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2653-9; Halbrich M, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0086-9; Haltmeier T, 2018, INJURY, V49, P62, DOI 10.1016/j.injury.2017.07.035; Hamed RK, 2013, J CLIN ANESTH, V25, P447, DOI 10.1016/j.jclinane.2013.03.013; Hamid MA, 2016, J PAK MED ASSOC, V66, P1015; Han M, 2017, SHOCK, V48, P29, DOI 10.1097/SHK.0000000000000833; Hansen M, 2018, CIRCULATION, V137, P2032, DOI 10.1161/CIRCULATIONAHA.117.033067; Hansen M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012259; Hansen M, 2015, RESUSCITATION, V90, P104, DOI 10.1016/j.resuscitation.2015.02.018; Hansen M, 2011, PEDIATR EMERG CARE, V27, P928, DOI 10.1097/PEC.0b013e3182307a2f; Hansmann A, 2017, AFR J EMERG MED, V7, pS10, DOI 10.1016/j.afjem.2017.10.001; Haque IU, 2008, RESUSCITATION, V79, P82, DOI 10.1016/j.resuscitation.2008.04.026; Haque IU, 2007, PEDIATR CRIT CARE ME, V8, P138, DOI 10.1097/01.PCC.0000257039.32593.DC; Harcke HT, 2020, PREHOSP EMERG CARE, V24, P665, DOI 10.1080/10903127.2019.1698682; Harel-Sterling M, 2019, J ULTRAS MED, V38, P407, DOI 10.1002/jum.14703; Harshman J, 2019, J BURN CARE RES, V40, P166, DOI 10.1093/jbcr/iry060; Hebert A, 2017, PAED CHILD HEALT-CAN, V22, P13, DOI 10.1093/pch/pxw003; HEIMLICH HJ, 1990, POSTGRAD MED, V87, P38, DOI 10.1080/00325481.1990.11716329; Hernandez MC, 2018, J PEDIATR SURG, V53, P352, DOI 10.1016/j.jpedsurg.2017.10.004; Heschl S, 2018, INJURY, V49, P916, DOI 10.1016/j.injury.2018.02.013; Hilmo J, 2014, RESUSCITATION, V85, P1204, DOI 10.1016/j.resuscitation.2014.04.029; Hoffmann F, 2016, PREHOSP EMERG CARE, V20, P493, DOI 10.3109/10903127.2016.1139216; Holmberg MJ, 2020, RESUSCITATION, V152, P107, DOI 10.1016/j.resuscitation.2020.04.031; Holmberg MJ, 2020, RESUSCITATION, V149, P191, DOI 10.1016/j.resuscitation.2019.12.033; Holmberg MJ, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.005580; Holmes JF, 2007, J PEDIATR SURG, V42, P1588, DOI 10.1016/j.jpedsurg.2007.04.023; Holmes JF, 2017, JAMA-J AM MED ASSOC, V317, P2290, DOI 10.1001/jama.2017.6322; Hon KLE, 2017, RECENT PATENTS INFLA, V11, P12, DOI 10.2174/1872213X11666170130143524; Horeczko T, 2013, J EMERG NURS, V39, P182, DOI 10.1016/j.jen.2011.12.020; Houston KA, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1356-z; Howard-Quijano KJ, 2010, ANESTHESIOLOGY, V112, P993, DOI 10.1097/ALN.0b013e3181d31fbe; Hoyme DB, 2020, RESUSCITATION, V153, P88, DOI 10.1016/j.resuscitation.2020.05.048; Hoyme DB, 2017, RESUSCITATION, V117, P18, DOI 10.1016/j.resuscitation.2017.05.023; Hoyt WJ, 2019, J CARDIOVASC ELECTR, V30, P2599, DOI 10.1111/jce.14125; Huang SC, 2012, RESUSCITATION, V83, P710, DOI 10.1016/j.resuscitation.2012.01.031; Huang Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009803.pub2; Hudgins JD, 2021, PEDIATR EMERG CARE, V37, P507, DOI 10.1097/PEC.0000000000001706; Hughes AL, 2014, JAMA OTOLARYNGOL, V140, P29, DOI 10.1001/jamaoto.2013.5550; Hunt EA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2643; Hurst V, 2007, RESUSCITATION, V73, P123, DOI 10.1016/j.resuscitation.2006.07.027; Hyldmo PK, 2016, ACTA ANAESTH SCAND, V60, P1003, DOI 10.1111/aas.12714; Hyldmo PK, 2017, AM J EMERG MED, V35, P1630, DOI 10.1016/j.ajem.2017.05.002; Hyldmo PK, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0143-x; Hyldmo PK, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0116-0; Incecik F, 2016, ANN INDIAN ACAD NEUR, V19, P79, DOI 10.4103/0972-2327.167702; Inwald DP, 2015, INTENS CARE MED, V41, P1457, DOI 10.1007/s00134-015-3905-z; Inwald DP, 2019, ARCH DIS CHILD, V104, P426, DOI 10.1136/archdischild-2018-314924; Iramain R, 2019, PEDIATR PULM, V54, P372, DOI 10.1002/ppul.24244; Iro MA, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1006-1; Isayama K, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-2; Isguder R, 2016, J CHILD NEUROL, V31, P1120, DOI 10.1177/0883073816641187; Jackson LV, 2007, ARCH DIS CHILD, V92, P298, DOI 10.1136/adc.2005.081216; Jain P, 2016, EPILEPSY RES, V122, P47, DOI 10.1016/j.eplepsyres.2016.02.006; Jang HY, 2018, RESUSCITATION, V122, P36, DOI 10.1016/j.resuscitation.2017.11.044; Jardine DS, 2007, PEDIATR REV, V28, P249, DOI 10.1542/pir.28-7-249; Jat KR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009293.pub2; Jat KR, 2011, INDIAN J PEDIATR, V78, P211, DOI 10.1007/s12098-010-0276-x; Jiang J, 2015, AM J EMERG MED, V33, P531, DOI 10.1016/j.ajem.2015.01.025; Jo CH, 2017, PEDIATR EMERG CARE, V33, P462, DOI 10.1097/PEC.0000000000000833; Joffe AR, 2011, ARCH PEDIAT ADOL MED, V165, P419, DOI 10.1001/archpediatrics.2011.47; Johnson MA, 2014, RESUSCITATION, V85, P920, DOI 10.1016/j.resuscitation.2014.03.044; Johnson M, 2019, RESUSCITATION, V140, P50, DOI 10.1016/j.resuscitation.2019.04.039; Johnson M, 2016, AM SURGEON, V82, P876; Johnson PN, 2017, ANN PHARMACOTHER, V51, P656, DOI 10.1177/1060028017706522; Johnson SL, 2020, J NURS CARE QUAL, V35, P70, DOI 10.1097/NCQ.0000000000000407; Jones BP, 2016, J ASTHMA, V53, P607, DOI 10.3109/02770903.2015.1067323; Jones BP, 2016, CHEST, V150, P131, DOI 10.1016/j.chest.2016.02.643; Jones GAL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019253; Jones P, 2016, ARCH DIS CHILD, V101, P77, DOI 10.1136/archdischild-2014-308137; Jones P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086766; Jones P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057478; Jones SI, 2020, PEDIATR CRIT CARE ME, V21, pE592, DOI 10.1097/PCC.0000000000002345; Jousi M, 2019, EUR J EMERG MED, V26, P77, DOI 10.1097/MEJ.0000000000000569; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Julliand S, 2016, ARCH DIS CHILD, V101, P521, DOI 10.1136/archdischild-2015-308857; Jung JY, 2017, AM J EMERG MED, V35, P1303, DOI 10.1016/j.ajem.2017.04.003; Jung WJ, 2019, EUR J EMERG MED, V26, P261, DOI 10.1097/MEJ.0000000000000539; Kaestner M, 2016, HEART, V102, P57, DOI 10.1136/heartjnl-2015-307774; Kaji AH, 2020, ACAD EMERG MED, V27, P394, DOI 10.1111/acem.13869; Kalechstein S, 2012, J PEDIATR SURG, V47, P974, DOI 10.1016/j.jpedsurg.2012.01.055; Kandasamy J, 2019, ARCH DIS CHILD, V104, P793, DOI 10.1136/archdischild-2018-316576; Kao PC, 2009, PEDIATRICS, V124, P49, DOI 10.1542/peds.2008-2536; Kapur J, 2019, NEW ENGL J MED, V381, P2103, DOI 10.1056/NEJMoa1905795; Kapuscinski Christine A, 2020, J Pediatr Pharmacol Ther, V25, P314, DOI 10.5863/1551-6776-25.4.314; Katsunuma T, 2019, ALLERGOL INT, V68, P335, DOI 10.1016/j.alit.2019.02.001; Kayashima K, 2015, J ANESTH, V29, P944, DOI 10.1007/s00540-015-2045-5; Keeney GE, 2014, PEDIATRICS, V133, P493, DOI 10.1542/peds.2013-2273; KEMPER KJ, 1992, CLIN PEDIATR, V31, P405, DOI 10.1177/000992289203100705; Khajeh A, 2018, IRAN J CHILD NEUROL, V12, P85; Khera R, 2019, CIRCULATION, V140, P370, DOI 10.1161/CIRCULATIONAHA.118.039048; Kherbeche H, 2017, EUR J EMERG MED, V24, P262, DOI 10.1097/MEJ.0000000000000335; Khoury A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/762053; Kido T, 2020, RESUSCITATION, V148, P49, DOI 10.1016/j.resuscitation.2019.12.020; Kill C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127759; Kill C, 2014, CRIT CARE MED, V42, pE89, DOI 10.1097/CCM.0b013e3182a63fa0; Kim GJ, 2018, CHEST, V154, P77, DOI 10.1016/j.chest.2018.04.015; Kim JE, 2018, ACTA ANAESTH SCAND, V62, P312, DOI 10.1111/aas.13043; Kim JH, 2020, AM J EMERG MED, V38, P2291, DOI 10.1016/j.ajem.2019.10.018; Kim L, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-40; Kim MJ, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0118-y; Kim Se Young, 2015, Ann Pediatr Endocrinol Metab, V20, P179, DOI 10.6065/apem.2015.20.4.179; Kim YH, 2018, PEDIATR CRIT CARE ME, V19, pE1, DOI 10.1097/PCC.0000000000001369; Kim YS, 2016, J KOREAN MED SCI, V31, P997, DOI 10.3346/jkms.2016.31.6.997; Kjaergaard B, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0262-z; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Klugman D, 2016, PEDIATR CRIT CARE ME, V17, pS222, DOI 10.1097/PCC.0000000000000815; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Kneyber MCJ, 2017, INTENS CARE MED, V43, P1764, DOI 10.1007/s00134-017-4920-z; Knightly R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003898.pub6; Knudson JD, 2013, PEDIATR CARDIOL, V34, P887, DOI 10.1007/s00246-012-0565-4; Kobayashi H, 2020, J HOSP INFECT, V106, P204, DOI 10.1016/j.jhin.2020.06.010; Kobayashi M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011135; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kojima T, 2018, PEDIATR CRIT CARE ME, V19, P528, DOI 10.1097/PCC.0000000000001531; Kojima T, 2018, PEDIATR CRIT CARE ME, V19, P106, DOI 10.1097/PCC.0000000000001373; Kortz TB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181160; Kotoda M, 2020, J HOSP INFECT, V104, P534, DOI 10.1016/j.jhin.2019.11.010; Krage R, 2017, EMERG MED J, V34, P728, DOI 10.1136/emermed-2016-205754; Krishnan SG, 2020, ARCH DIS CHILD, V105, P533, DOI 10.1136/archdischild-2019-318043; Krmpotic K, 2019, J PEDIATR INTENSIVE, V8, P113, DOI 10.1055/s-0039-1683869; Kroll M, 2019, PREHOSP EMERG CARE, V23, P210, DOI 10.1080/10903127.2018.1489020; Kwon Ji-Won, 2020, Clin Exp Pediatr, V63, P3, DOI 10.3345/kjp.2019.00626; Kyo M, 2019, J CHEMOTHERAPY, V31, P388, DOI 10.1080/1120009X.2019.1623362; Ladner TR, 2015, STROKE, V46, P2328, DOI 10.1161/STROKEAHA.115.009961; Ladny JR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009386; Lammers RL, 2014, SIMUL HEALTHC, V9, P174, DOI 10.1097/SIH.0000000000000013; Lampin ME, 2012, ACTA PAEDIATR, V101, pe426, DOI 10.1111/j.1651-2227.2012.02725.x; Lane Roni D, 2020, Hosp Pediatr, V10, P311, DOI 10.1542/hpeds.2019-0250; Lane RD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4153; Langhan ML, 2018, PEDIATR CRIT CARE ME, V19, P98, DOI 10.1097/PCC.0000000000001372; Langhan ML, 2015, AM J EMERG MED, V33, P25, DOI 10.1016/j.ajem.2014.09.050; Langhan ML, 2011, PEDIATR EMERG CARE, V27, P394, DOI 10.1097/PEC.0b013e318217b538; Langhelle A, 2000, RESUSCITATION, V44, P105, DOI 10.1016/S0300-9572(00)00161-1; Lapid FM, 2020, PEDIATR ANESTH, V30, P462, DOI 10.1111/pan.13820; Larach MG, 1997, CLIN PEDIATR, V36, P9; Lasa JJ, 2019, PEDIATR CRIT CARE ME, V20, P1040, DOI 10.1097/PCC.0000000000002038; Latimer AJ, 2018, PREHOSP EMERG CARE, V22, P319, DOI 10.1080/10903127.2017.1392667; Laverriere EK, 2020, PEDIATR CRIT CARE ME, V21, P143, DOI 10.1097/PCC.0000000000002119; Lawton B, 2018, CURR OPIN PEDIATR, V30, P359, DOI 10.1097/MOP.0000000000000616; Le Conte P, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0584-x; Lee JT, 2019, SURG INFECT, V20, P1, DOI 10.1089/sur.2018.222; Lee J, 2016, PEDIATR NEPHROL, V31, P2113, DOI 10.1007/s00467-016-3414-5; Lee JE, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017853; Lee JH, 2019, PEDIATR ANESTH, V29, P331, DOI 10.1111/pan.13594; Lee J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43020-0; Lee KH, 2013, RESUSCITATION, V84, P766, DOI 10.1016/j.resuscitation.2012.11.005; Lee SH, 2020, ANN EMERG MED, V75, P755, DOI 10.1016/j.annemergmed.2019.09.005; Lee SY, 2018, EUR J EMERG MED, V25, P372, DOI 10.1097/MEJ.0000000000000461; Lee SH, 2011, RESUSCITATION, V82, P1214, DOI 10.1016/j.resuscitation.2011.04.016; Lee SS, 2019, J PAEDIATR CHILD H, V55, P1361, DOI 10.1111/jpc.14422; Lee Yun-Jeong, 2016, Korean J Pediatr, V59, P35, DOI 10.3345/kjp.2016.59.1.35; Leonhard G, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0671-x; Levin M, 2019, LANCET RESP MED, V7, P581, DOI 10.1016/S2213-2600(19)30114-6; Lewis J, 2017, J PEDIATR-US, V181, P177, DOI 10.1016/j.jpeds.2016.10.051; Lewis SR, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub7; Li LJ, 2020, SEIZURE-EUR J EPILEP, V78, P43, DOI 10.1016/j.seizure.2020.03.002; Li QY, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00623-19; Li S, 2018, PEDIATR CRIT CARE ME, V19, pE41, DOI 10.1097/PCC.0000000000001384; Li S, 2016, AM J MED QUAL, V31, P47, DOI 10.1177/1062860614547259; Lieberman P, 2015, ANN ALLERG ASTHMA IM, V115, P341, DOI 10.1016/j.anai.2015.07.019; Liedtke AG, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010071; Lim JS, 2013, EMERG MED J, V30, P139, DOI 10.1136/emermed-2011-200978; Lin CY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57320-y; Lin CH, 2013, RESUSCITATION, V84, P586, DOI 10.1016/j.resuscitation.2012.09.028; Lin CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126514; Lin MJ, 2016, PEDIATR CRIT CARE ME, V17, pE469, DOI 10.1097/PCC.0000000000000907; Lin YR, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00220; Lin YR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2391-z; Lin YR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003195; Lin YQ, 2018, RESUSCITATION, V130, P6, DOI 10.1016/j.resuscitation.2018.06.025; Lingappan K, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009975.pub3; Lipman GS, 2019, WILD ENVIRON MED, V30, pS33, DOI 10.1016/j.wem.2018.10.004; Lissaman C, 2019, ARCH DIS CHILD, V104, P12, DOI 10.1136/archdischild-2017-314496; Litman RS, 2003, ANESTHESIOLOGY, V98, P41, DOI 10.1097/00000542-200301000-00010; Liu XX, 2016, PEDIATR PULM, V51, P1414, DOI 10.1002/ppul.23482; Liyanage CK, 2017, EUR ANN ALLERGY CLIN, V49, P196, DOI 10.23822/EurAnnACI.1764-1489.15; Loaec M, 2020, RESUSCITATION, V152, P123, DOI 10.1016/j.resuscitation.2020.05.003; Long B, 2018, ANN EMERG MED, V71, P529, DOI 10.1016/j.annemergmed.2017.11.025; Long E, 2020, PEDIATR ANESTH, V30, P319, DOI 10.1111/pan.13784; Long E, 2019, J ULTRAS MED, V38, P1537, DOI 10.1002/jum.14842; Long E, 2018, PEDIATR CRIT CARE ME, V19, P513, DOI 10.1097/PCC.0000000000001534; Long E, 2017, SHOCK, V47, P550, DOI 10.1097/SHK.0000000000000801; Lopez-Herce J, 2018, PEDIATR CRIT CARE ME, V19, pE152, DOI 10.1097/PCC.0000000000001427; Lopez-Herce J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0607-9; Lopez-Herce J, 2014, REV ESP CARDIOL, V67, P189, DOI 10.1016/j.rec.2013.07.017; Lott C, 2021, RESUSCITATION, V161, P152, DOI 10.1016/j.resuscitation.2021.02.011; Lovrenski Jovan, 2016, Acta Med Acad, V45, P39, DOI 10.5644/ama2006-124.155; Lu CH, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0679-2; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Luo J, 2019, J PEDIATR-US, V215, P199, DOI 10.1016/j.jpeds.2019.07.059; Lyttle MD, 2019, LANCET, V393, P2125, DOI 10.1016/S0140-6736(19)30724-X; Maa T, 2020, J ALLER CL IMM-PRACT, V8, P1239, DOI 10.1016/j.jaip.2019.11.013; Mackay MT, 2016, J PAEDIATR CHILD H, V52, P158, DOI 10.1111/jpc.13086; Maconochie IK, 2020, RESUSCITATION, V156, pA120, DOI 10.1016/j.resuscitation.2020.09.013; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Maeda T, 2018, PEDIATR CRIT CARE ME, V19, pE637, DOI 10.1097/PCC.0000000000001724; Maeda T, 2016, RESUSCITATION, V107, P80, DOI 10.1016/j.resuscitation.2016.08.010; Magoteaux SR, 2017, J PEDIATR SURG, V52, P979, DOI 10.1016/j.jpedsurg.2017.03.021; Maitland Kathryn, 1800, Wellcome Open Res, V2, P100, DOI 10.12688/wellcomeopenres.12747.1; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Male I, 2000, ARCH DIS CHILD, V83, P325, DOI 10.1136/adc.83.4.325; Mandelzweig K, 2018, J CRIT CARE, V47, P310, DOI 10.1016/j.jcrc.2018.01.007; Manrique G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63921-9; Lopez JAM, 2016, ENCRUCIJADAS, V11; Marin JR, 2016, CRIT ULTRASOUND J, V8, DOI 10.1186/s13089-016-0049-5; Marino BS, 2018, CIRCULATION, V137, pE691, DOI 10.1161/CIR.0000000000000524; Masarwa R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-016-1589-6; Matamoros M, 2015, PEDIATR EMERG CARE, V31, P31, DOI 10.1097/PEC.0000000000000323; Matettore A, 2019, PEDIATR CRIT CARE ME, V20, P518, DOI 10.1097/PCC.0000000000001923; Mathew JL, 2017, INDIAN PEDIATR, V54, P133, DOI 10.1007/s13312-017-1016-3; Matos RI, 2013, CIRCULATION, V127, P442, DOI 10.1161/CIRCULATIONAHA.112.125625; Matson Kelly L, 2017, J Pediatr Pharmacol Ther, V22, P81, DOI 10.5863/1551-6776-22.1.81; Matsui S, 2020, INT HEART J, V61, P254, DOI 10.1536/ihj.19-574; Maxien D, 2019, RESUSCITATION, V145, P1, DOI 10.1016/j.resuscitation.2019.09.028; Mayrand KP, 2015, WEST J EMERG MED, V16, P1135, DOI 10.5811/westjem.2015.9.28167; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; McTague A, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001905.pub3; Medley TL, 2019, INT J STROKE, V14, P94, DOI 10.1177/1747493018799958; Meert K, 2018, RESUSCITATION, V124, P96, DOI 10.1016/j.resuscitation.2018.01.013; Melvan JN, 2020, WORLD J PEDIATR CONG, V11, P265, DOI 10.1177/2150135120902102; Mendelson J, 2018, EMERG MED CLIN N AM, V36, P427, DOI 10.1016/j.emc.2017.12.010; Mendler MR, 2017, NEONATOLOGY, V111, P100, DOI 10.1159/000447663; Mendler MR, 2015, NEONATOLOGY, V108, P73, DOI 10.1159/000381416; Menon K, 2015, SHOCK, V44, P402, DOI 10.1097/SHK.0000000000000355; Menon K, 2013, PEDIATR CRIT CARE ME, V14, P474, DOI 10.1097/PCC.0b013e31828a8125; Mentzelopoulos SD, 2021, RESUSCITATION, V161, P408, DOI 10.1016/j.resuscitation.2021.02.017; Mercier E, 2019, RESUSCITATION, V139, P241, DOI 10.1016/j.resuscitation.2019.04.028; Messer AF, 2019, PEDIATR QUAL SAF, V4, DOI 10.1097/pq9.0000000000000225; Michel J, 2017, PEDIATR DRUGS, V19, P35, DOI 10.1007/s40272-016-0199-8; Michelson KA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2741; Michelson KA, 2015, J PEDIATR-US, V167, P719, DOI 10.1016/j.jpeds.2015.05.033; Miescier MJ, 2019, PEDIATR EMERG CARE, V35, P455, DOI 10.1097/PEC.0000000000000981; Mikalsen IB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0278-4; Miller KA, 2019, EMERG MED CLIN N AM, V37, P473, DOI 10.1016/j.emc.2019.03.006; Millin MG, 2020, RESUSCITATION, V148, P161, DOI 10.1016/j.resuscitation.2019.12.039; Mintegi S, 2019, PEDIATR EMERG CARE, V35, P50, DOI 10.1097/PEC.0000000000001031; Mintegi S, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0006; Misir A, 2018, CURR PEDIATR REV, V14, P9, DOI 10.2174/1573396313666170815101504; Mitani Y, 2013, EUROPACE, V15, P1259, DOI 10.1093/europace/eut053; Moffett BS, 2015, CARDIOL YOUNG, V25, P1080, DOI 10.1017/S1047951114001619; Mok YH, 2016, ANN ACAD MED SINGAP, V45, P534; Mokhateb-Rafii T, 2019, PEDIATR CRIT CARE ME, V20, P19, DOI 10.1097/PCC.0000000000001766; Momen AA, 2015, EUR J PAEDIATR NEURO, V19, P149, DOI 10.1016/j.ejpn.2014.11.007; Medeiros DNM, 2015, PEDIATR EMERG CARE, V31, pe11, DOI 10.1097/PEC.0000000000000601; Moore HB, 2016, J PEDIATR SURG, V51, P315, DOI 10.1016/j.jpedsurg.2015.10.040; Moore L, 2018, WORLD J SURG, V42, P1327, DOI 10.1007/s00268-017-4292-0; Morell E, 2020, PEDIATR CRIT CARE ME, V21, P256, DOI 10.1097/PCC.0000000000002127; Morello ML, 2018, PACE, V41, P472, DOI 10.1111/pace.13315; Morgan JK, 2018, ADDICT BEHAV, V80, P22, DOI 10.1016/j.addbeh.2018.01.002; Morgan RW, 2020, CRIT CARE MED, V48, P881, DOI 10.1097/CCM.0000000000004308; Morgan RW, 2020, PEDIATR CRIT CARE ME, V21, P305, DOI 10.1097/PCC.0000000000002187; Morgan RW, 2019, RESUSCITATION, V139, P1, DOI 10.1016/j.resuscitation.2019.03.032; de la Rosa JSO, 2018, SEIZURE-EUR J EPILEP, V56, P34, DOI 10.1016/j.seizure.2018.01.014; Fernandez IS, 2019, SEIZURE-EUR J EPILEP, V68, P16, DOI 10.1016/j.seizure.2018.08.002; Fernandez IS, 2015, NEUROLOGY, V84, P2304, DOI 10.1212/WNL.0000000000001673; Fernandez IS, 2019, NEUROLOGY, V92, pE2339, DOI 10.1212/WNL.0000000000007503; Morgan RW, 2017, J CRIT CARE, V40, P128, DOI 10.1016/j.jcrc.2017.03.023; Mori T, 2020, J PAEDIATR CHILD H, V56, P1376, DOI 10.1111/jpc.14940; Mori T, 2019, J ULTRAS MED, V38, P2945, DOI 10.1002/jum.15000; Morin L, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0545-4; Mortensen RB, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-16; Mortimer T, 2016, J PEDIATR INTENSIVE, V5, P28, DOI 10.1055/s-0035-1568149; Moses JM, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-20; Moskowitz EE, 2018, PEDIATR SURG INT, V34, P857, DOI 10.1007/s00383-018-4290-9; Muchao FP, 2016, PEDIATR PULM, V51, P1122, DOI 10.1002/ppul.23469; Mumma JM, 2018, HUM FACTORS, V60, P212, DOI 10.1177/0018720817744729; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; Murphy KR, 2020, J ALLER CL IMM-PRACT, V8, P1815, DOI 10.1016/j.jaip.2020.01.042; Na JU, 2015, ACTA PAEDIATR, V104, pE70, DOI 10.1111/apa.12857; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nadler R, 2019, J TRAUMA ACUTE CARE, V87, P1315, DOI 10.1097/TA.0000000000002477; Nagata T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003481; Naim MY, 2017, JAMA PEDIATR, V171, P133, DOI 10.1001/jamapediatrics.2016.3643; Najaf-Zadeh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055270; Nasiri E, 2014, SAUDI J ANAESTH, V8, P30, DOI 10.4103/1658-354X.125923; Natsume J, 2017, BRAIN DEV-JPN, V39, P2, DOI 10.1016/j.braindev.2016.06.003; Navarro-Paton R, 2019, RESUSCITATION, V134, P104, DOI 10.1016/j.resuscitation.2018.10.030; Nehme Z, 2018, RESUSCITATION, V128, P43, DOI 10.1016/j.resuscitation.2018.04.030; Nelson P, 2014, ANESTH ANALG, V118, P369, DOI 10.1213/ANE.0b013e3182a8fad0; Neubrand TL, 2019, PEDIATR QUAL SAF, V4, DOI 10.1097/pq9.0000000000000230; Nichols B, 2017, PEDIATR CRIT CARE ME, V18, pE406, DOI 10.1097/PCC.0000000000001237; Niles DE, 2017, SIMUL HEALTHC, V12, P213, DOI 10.1097/SIH.0000000000000228; Ninchoji T, 2018, PEDIATR EMERG CARE, V34, pE64, DOI 10.1097/PEC.0000000000000691; Nishiyama M, 2018, BRAIN DEV-JPN, V40, P884, DOI 10.1016/j.braindev.2018.08.001; Noje C, 2019, PEDIATR CRIT CARE ME, V20, pE30, DOI 10.1097/PCC.0000000000001768; Nolan JP, 2020, RESUSCITATION, V153, P45, DOI 10.1016/j.resuscitation.2020.06.001; Noureen N, 2019, J CLIN NEUROL, V15, P468, DOI 10.3988/jcn.2019.15.4.468; Nuttall AGL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023216; O'Brien S, 2019, J PAEDIATR CHILD H, V55, P746, DOI 10.1111/jpc.14496; O'Connell KJ, 2019, RESUSCITATION, V145, P158, DOI 10.1016/j.resuscitation.2019.08.015; O'Leary F, 2015, ARCH DIS CHILD, V100, P733, DOI 10.1136/archdischild-2014-307401; O'Neil Erika R, 2020, Crit Care Explor, V2, pe0075, DOI 10.1097/CCE.0000000000000075; Oberender F, 2018, PEDIATR CRIT CARE ME, V19, P965, DOI 10.1097/PCC.0000000000001660; Oh JH, 2015, EMERG MED J, V32, P544, DOI 10.1136/emermed-2014-203932; Oh JH, 2015, EMERG MED AUSTRALAS, V27, P108, DOI 10.1111/1742-6723.12364; Ohchi F, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0982-y; Oksan D, 2013, INDIAN PEDIATR, V50, P689, DOI 10.1007/s13312-013-0192-z; Okubo M, 2020, RESUSCITATION, V153, P227, DOI 10.1016/j.resuscitation.2020.04.023; Okubo M, 2019, RESUSCITATION, V145, P175, DOI 10.1016/j.resuscitation.2019.09.007; Olasveengen TM, 2020, RESUSCITATION, V156, pA35, DOI 10.1016/j.resuscitation.2020.09.010; Opiyo N, 2011, ARCH DIS CHILD, V96, P1052, DOI 10.1136/adc.2010.186049; Oropeza AR, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0402-0; Orso D, 2020, J INTENSIVE CARE MED, V35, P354, DOI 10.1177/0885066617752308; Orso D, 2018, J ULTRASOUND, V21, P183, DOI 10.1007/s40477-018-0306-5; Oulego-Erroz I, 2016, J CRIT CARE, V35, P133, DOI 10.1016/j.jcrc.2016.05.010; Overmann KM, 2019, AM J EMERG MED, V37, P1416, DOI 10.1016/j.ajem.2018.10.030; Owattanapanich N, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0572-4; Ozdemir A, 2017, PEDIATR INT, V59, P209, DOI 10.1111/ped.13081; Ozkaya AK, 2019, AM J EMERG MED, V37, P2102, DOI 10.1016/j.ajem.2019.05.063; Paal P, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0303-7; Palatinus JA, 2015, J EMERG MED, V49, P159, DOI 10.1016/j.jemermed.2015.02.046; Paniagua N, 2017, J PEDIATR-US, V191, P190, DOI 10.1016/j.jpeds.2017.08.030; Park JW, 2019, PREHOSP EMERG CARE, V23, P74, DOI 10.1080/10903127.2018.1471559; Park M, 2018, PEDIATR CRIT CARE ME, V19, pE576, DOI 10.1097/PCC.0000000000001679; Park R, 2017, BRIT J ANAESTH, V119, P984, DOI 10.1093/bja/aex344; Parker Margaret M, 2017, Pediatr Crit Care Med, V18, P310, DOI 10.1097/PCC.0000000000001074; Parker MJ, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1689-2; Pasquier M, 2021, ANN THORAC SURG, V111, P1408, DOI 10.1016/j.athoracsur.2020.06.146; Pasquier M, 2018, RESUSCITATION, V126, P58, DOI 10.1016/j.resuscitation.2018.02.026; Patel B, 2019, PEDIATR PULM, V54, P970, DOI 10.1002/ppul.24329; Patel Jigar, 2017, Asian Cardiovasc Thorac Ann, V25, P118, DOI 10.1177/0218492316688416; Patel JK, 2018, RESUSCITATION, V127, P83, DOI 10.1016/j.resuscitation.2018.04.008; Patregnani JT, 2017, PEDIATR CRIT CARE ME, V18, pE378, DOI 10.1097/PCC.0000000000001230; Paul R, 2018, OBSTET GYNECOL, V131, p143S, DOI 10.1097/01.AOG.0000533065.97588.ff; Paul R, 2018, PEDIATR CLIN N AM, V65, P1107, DOI 10.1016/j.pcl.2018.07.012; Pearsall MF, 2014, ANESTH ANALG, V118, P776, DOI 10.1213/ANE.0000000000000148; Pelland-Marcotte MC, 2019, LANCET HAEMATOL, V6, pE144, DOI 10.1016/S2352-3026(18)30224-2; Pellegrino JL, 2019, ARCH DIS CHILD, V104, P530, DOI 10.1136/archdischild-2018-314893; Pepper DJ, 2018, ANN INTERN MED, V168, P610, DOI 10.7326/L18-0140; Perkins GD, 2021, RESUSCITATION, V161, P1, DOI 10.1016/j.resuscitation.2021.02.003; Perkins GD, 2018, RESUSCITATION, V123, P43, DOI 10.1016/j.resuscitation.2017.12.007; Peters MJ, 2018, INTENS CARE MED, V44, P1240, DOI 10.1007/s00134-018-5232-7; Phillips JS, 2017, RESP CARE, V62, P78, DOI 10.4187/respcare.05111; Phillips RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130327; Phillips R, 2020, J PEDIATR SURG, V55, P331, DOI 10.1016/j.jpedsurg.2019.10.008; Pifko EL, 2018, J PAEDIATR CHILD H, V54, P546, DOI 10.1111/jpc.13773; Polites SF, 2020, J TRAUMA ACUTE CARE, V89, P36, DOI 10.1097/TA.0000000000002702; Polites Stephanie F, 2018, J Trauma Acute Care Surg, V85, P108, DOI 10.1097/TA.0000000000001897; Portela JL, 2015, MED INTENSIVA, V39, P160, DOI 10.1016/j.medin.2014.04.003; Posner LS, 2017, DRUG HEALTHC PATIENT, V9, P9, DOI 10.2147/DHPS.S121733; Potes C, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1874-z; Potter SK, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.07.76; Pourmand A, 2018, AM J EMERG MED, V36, P1480, DOI 10.1016/j.ajem.2018.05.009; Pundi KN, 2015, HEART RHYTHM, V12, P776, DOI 10.1016/j.hrthm.2015.01.002; Puzio T, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000362; Qadori M, 2018, ACTA PAEDIATR, V107, P1455, DOI 10.1111/apa.14318; Quail MA, 2012, ARCH DIS CHILD, V97, P177, DOI 10.1136/archdischild-2011-301079; Quinn N, 2020, EMERG MED AUSTRALAS, V32, P117, DOI 10.1111/1742-6723.13392; Quintard H, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0483-1; Qureshi AU, 2012, JCPSP-J COLL PHYSICI, V22, P648, DOI 10.2012/JCPSP.648651; Ramaswamy KN, 2016, PEDIATR CRIT CARE ME, V17, pE502, DOI 10.1097/PCC.0000000000000954; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Ramgopal S, 2020, PREHOSP EMERG CARE, V24, P683, DOI 10.1080/10903127.2019.1699212; Ramnarayan P, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2080-3; Ranjit S, 2018, INDIAN J CRIT CARE M, V22, P154, DOI 10.4103/ijccm.IJCCM_413_17; Ranjit S, 2016, INDIAN J CRIT CARE M, V20, P561, DOI 10.4103/0972-5229.192036; Rauf A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218155; Raymond TT, 2019, PEDIATR CRIT CARE ME, V20, P405, DOI 10.1097/PCC.0000000000001863; Raymond TT, 2015, RESUSCITATION, V89, P106, DOI 10.1016/j.resuscitation.2015.01.007; REDDING JS, 1979, CRIT CARE MED, V7, P475, DOI 10.1097/00003246-197910000-00008; Rehder KJ, 2017, RESP CARE, V62, P849, DOI 10.4187/respcare.05174; Rehn M, 2016, ACTA ANAESTH SCAND, V60, P852, DOI 10.1111/aas.12746; Remick K, 2017, PREHOSP EMERG CARE, V21, P216, DOI 10.1080/10903127.2016.1218979; Reuter-Rice K, 2015, ADV EMERG NURS J, V37, P301, DOI 10.1097/TME.0000000000000077; Ricci F, 2015, EUR HEART J-ACUTE CA, V4, P103, DOI 10.1177/2048872614553166; Richards M, 2020, J TROP PEDIATRICS, V66, P612, DOI 10.1093/tropej/fmaa024; Richardson C, 2017, PEDIATR DRUGS, V19, P539, DOI 10.1007/s40272-017-0254-0; Riskin A, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2043; Ristagno G, 2012, RESUSCITATION, V83, P755, DOI 10.1016/j.resuscitation.2011.12.010; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Robinson M, 2017, ANN ALLERG ASTHMA IM, V119, P164, DOI 10.1016/j.anai.2017.06.001; Rodriguez JJ, 2020, EMERG MED INT, V2020, DOI 10.1155/2020/7012508; Rodriguez SA, 2014, RESUSCITATION, V85, P119, DOI 10.1016/j.resuscitation.2013.09.003; Rodriguez-Ruiz E, 2019, MED INTENSIVA, V43, P346, DOI 10.1016/j.medin.2018.04.010; Rodriguez-Ruiz E, 2019, EUR J PEDIATR, V178, P1529, DOI 10.1007/s00431-019-03452-2; Roh YI, 2019, RESUSCITATION, V143, P100, DOI 10.1016/j.resuscitation.2019.08.022; Rosenberg H, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0310-1; Rossano JW, 2015, PEDIATR EMERG CARE, V31, P526, DOI 10.1097/PEC.0000000000000490; Rostykus P, 2016, PREHOSP EMERG CARE, V20, P524, DOI 10.3109/10903127.2015.1128031; Rousseaux J, 2013, PEDIATR EMERG CARE, V29, P1055, DOI 10.1097/PEC.0b013e3182a5c99c; Saczkowski RS, 2018, RESUSCITATION, V127, P51, DOI 10.1016/j.resuscitation.2018.03.028; Salas N, 2007, RESUSCITATION, V74, P94, DOI 10.1016/j.resuscitation.2006.01.023; Salyer John W, 2003, Respir Care, V48, P386; Samransamruajkit R, 2018, INDIAN J CRIT CARE M, V22, P846, DOI 10.4103/ijccm.IJCCM_367_18; Santhanam I, 2017, ANN INDIAN ACAD NEUR, V20, P142, DOI 10.4103/aian.AIAN_369_16; Saunders R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013402; Schaller Stefan J, 2019, Ger Med Sci, V17, pDoc06, DOI 10.3205/000272; Schauer SG, 2020, J TRAUMA ACUTE CARE, V89, pS185, DOI 10.1097/TA.0000000000002590; Schauer SG, 2018, INJURY, V49, P911, DOI 10.1016/j.injury.2018.01.034; Schoneberg C, 2014, ZBL CHIR, V139, P584, DOI 10.1055/s-0032-1328645; Schreiber S, 2016, ACTA PAEDIATR, V105, P292, DOI 10.1111/apa.13282; Scott A, 2019, J PEDIATR INTENSIVE, V8, P117, DOI 10.1055/s-0039-1678552; Scott HF, 2017, JAMA PEDIATR, V171, P249, DOI 10.1001/jamapediatrics.2016.3681; Scott HF, 2016, J PEDIATR-US, V170, P149, DOI 10.1016/j.jpeds.2015.11.071; Scott HF, 2015, ACAD EMERG MED, V22, P381, DOI 10.1111/acem.12610; Scott HF, 2012, ACAD EMERG MED, V19, P1276, DOI 10.1111/acem.12014; Sepanski RJ, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00066; Sepehripour AH, 2013, INTERACT CARDIOV TH, V17, P564, DOI 10.1093/icvts/ivt208; Shah S, 2020, TROP DOCT, V50, P186, DOI 10.1177/0049475520914831; Shah SN, 2017, JAMA-J AM MED ASSOC, V318, P462, DOI 10.1001/jama.2017.9039; Shaker MS, 2020, J ALLERGY CLIN IMMUN, V145, P1082, DOI 10.1016/j.jaci.2020.01.017; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Shen J, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.928835; Sherman JM, 2020, PEDIATR EMERG CARE, V36, pE146, DOI 10.1097/PEC.0000000000001275; Sherr JL, 2016, DIABETES CARE, V39, P555, DOI 10.2337/dc15-1606; Shibahashi K, 2020, ANN EMERG MED, V75, P57, DOI 10.1016/j.annemergmed.2019.05.036; Shin Hong Ju, 2016, Korean J Thorac Cardiovasc Surg, V49, P151, DOI 10.5090/kjtcs.2016.49.3.151; Shtull-Leber E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173539; Sicherer SH, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4006; SIDDIQU NUR, 2017, COMMUNICATION, V7; Sidhu N, 2016, PEDIATR EMERG CARE, V32, P508, DOI 10.1097/PEC.0000000000000864; Siegler J, 2017, PREHOSP EMERG CARE, V21, P74, DOI 10.1080/10903127.2016.1227003; Silbergleit R, 2019, LANCET, V393, P2101, DOI 10.1016/S0140-6736(19)30896-7; Silva Paula de Souza, 2015, Rev. bras. ter. intensiva, V27, P390, DOI 10.5935/0103-507X.20150065; Silverman EC, 2017, WEST J EMERG MED, V18, P419, DOI 10.5811/westjem.2016.12.32066; Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1; Simons FER, 2015, J ALLERGY CLIN IMMUN, V135, P1125, DOI 10.1016/j.jaci.2014.09.014; Simons FER, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-9; Simons T, 2017, EUR J TRAUMA EMERG S, V43, P797, DOI 10.1007/s00068-016-0758-2; Singh K, 2018, J PEDIATR NEUROSCI, V13, P158, DOI 10.4103/jpn.JPN_126_17; Singh M, 2019, INDIAN J PEDIATR, V86, P1142, DOI 10.1007/s12098-019-03094-0; Singh Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2787-9; Singletary EM, 2020, RESUSCITATION, V156, pA240, DOI 10.1016/j.resuscitation.2020.09.016; Sinha R, 2019, J ANAESTH CLIN PHARM, V35, P509, DOI 10.4103/joacp.JOACP_106_18; Skellett S, 2020, RESUSCITATION, V155, P165, DOI 10.1016/j.resuscitation.2020.07.026; Skogvoll E, 2020, RESUSCITATION, V152, P116, DOI 10.1016/j.resuscitation.2020.05.013; Smallwood CD, 2019, RESP CARE, V64, P855, DOI 10.4187/respcare.07029; Smereka J, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00159; Smereka J, 2017, AM J EMERG MED, V35, P1420, DOI 10.1016/j.ajem.2017.04.024; Smith DE, 2019, T&T CLARK HANDB, P165; Soar J, 2019, RESUSCITATION, V145, P95, DOI 10.1016/j.resuscitation.2019.10.016; Soar J, 2019, RESUSCITATION, V134, P99, DOI 10.1016/j.resuscitation.2018.11.018; Soar JBB, 2021, RESUSCITATION, V161; Sola C, 2017, ANAESTH CRIT CARE PA, V36, P267, DOI 10.1016/j.accpm.2016.10.005; Sole A, 2018, EUR J PEDIATR, V177, P1191, DOI 10.1007/s00431-018-3174-2; Soreide E, 2013, RESUSCITATION, V84, P1487, DOI 10.1016/j.resuscitation.2013.07.020; Spyres MB, 2019, J MED TOXICOL, V15, P228, DOI 10.1007/s13181-019-00736-9; Steensberg AT, 2017, RESUSCITATION, V115, P52, DOI 10.1016/j.resuscitation.2017.04.002; Stein ML, 2020, PEDIATR ANESTH, V30, P269, DOI 10.1111/pan.13814; Stine CN, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01871; Stinson HR, 2019, PEDIATR QUAL SAF, V4, DOI 10.1097/pq9.0000000000000197; Strapazzon G, 2017, EUR J EMERG MED, V24, P398, DOI 10.1097/MEJ.0000000000000390; Stredny CM, 2018, SEIZURE-EUR J EPILEP, V58, P133, DOI 10.1016/j.seizure.2018.04.011; Strutt J, 2019, PEDIATR EMERG CARE, V35, P132, DOI 10.1097/PEC.0000000000001733; Strzelczyk A, 2017, EPILEPSIA, V58, P933, DOI 10.1111/epi.13716; Stub D, 2012, RESUSCITATION, V83, P793, DOI 10.1016/j.resuscitation.2012.03.034; Sun F, 2017, J THORAC DIS, V9, P4599, DOI 10.21037/jtd.2017.10.79; Sun J, 2015, INT J CLIN EXP MED, V8, P16231; Sun Y, 2014, PEDIATR ANESTH, V24, P1056, DOI 10.1111/pan.12458; Sunde GA, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-52; Sutton RM, 2019, CRIT CARE MED, V47, P1627, DOI 10.1097/CCM.0000000000003898; Sutton RM, 2018, RESUSCITATION, V130, P159, DOI 10.1016/j.resuscitation.2018.07.015; Svendsen OS, 2017, ANN THORAC SURG, V103, P920, DOI 10.1016/j.athoracsur.2016.06.093; Swor R, 2013, RESUSCITATION, V84, P426, DOI 10.1016/j.resuscitation.2012.09.014; Szarpak L, 2020, PEDIATR EMERG CARE, V36, pE568, DOI 10.1097/PEC.0000000000001587; Tan BKK, 2013, MINERVA CHIR, V68, P241; Tan DY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171869; Tanno LK, 2019, CURR OPIN ALLERGY CL, V19, P393, DOI 10.1097/ACI.0000000000000539; Tasker RC, 2016, PEDIATR CRIT CARE ME, V17, P968, DOI 10.1097/PCC.0000000000000900; Tate Ramsey C, 2013, JEMS, V38, P36; Taylor KL, 2014, RESUSCITATION, V85, P1342, DOI 10.1016/j.resuscitation.2014.06.027; Terboven T, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0623-5; Theusinger OM, 2019, J EMERG MED, V57, P345, DOI 10.1016/j.jemermed.2019.05.036; Thomas-Jones E, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1210-z; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Tibballs J, 2011, PEDIATR CRIT CARE ME, V12, P14, DOI 10.1097/PCC.0b013e3181dbb4fc; Tibballs J, 2010, RESUSCITATION, V81, P671, DOI 10.1016/j.resuscitation.2010.01.030; Tiwari A, 2016, ANN THORAC MED, V11, P283, DOI 10.4103/1817-1737.191874; Tobin JM, 2020, PREHOSP DISASTER MED, V35, P141, DOI 10.1017/S1049023X20000060; Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP; Topal E, 2013, ALLERGY ASTHMA PROC, V34, P233, DOI 10.2500/aap.2013.34.3658; Topjian AA, 2019, RESUSCITATION, V141, P88, DOI 10.1016/j.resuscitation.2019.05.033; Topjian AA, 2019, RESUSCITATION, V141, P24, DOI 10.1016/j.resuscitation.2019.05.032; Topjian AA, 2018, JAMA PEDIATR, V172, P143, DOI 10.1001/jamapediatrics.2017.4043; Torres-Andres F, 2018, PEDIATR CRIT CARE ME, V19, P451, DOI 10.1097/PCC.0000000000001524; Tosif S, 2017, J TROP PEDIATRICS, V63, P402, DOI 10.1093/tropej/fmw100; Tran A, 2018, J TRAUMA ACUTE CARE, V84, P802, DOI 10.1097/TA.0000000000001816; Tran P, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa028; Trinka E, 2014, CNS DRUGS, V28, P623, DOI 10.1007/s40263-014-0167-1; Tripathi A, 2015, INDIAN PEDIATR, V52, P965, DOI 10.1007/s13312-015-0754-3; Tsou JY, 2020, EUR J EMERG MED, V27, P132, DOI 10.1097/MEJ.0000000000000631; Tsou PY, 2017, RESUSCITATION, V114, P92, DOI 10.1016/j.resuscitation.2017.02.021; Tsuda T, 2019, EUR J PEDIATR, V178, P1333, DOI 10.1007/s00431-019-03421-9; Tsung JW, 2009, RESUSCITATION, V80, P665, DOI 10.1016/j.resuscitation.2009.03.009; Turner PJ, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100066; Ulusoy E, 2019, SEIZURE-EUR J EPILEP, V71, P50, DOI 10.1016/j.seizure.2019.06.011; Uppal P, 2018, SEIZURE-EUR J EPILEP, V58, P147, DOI 10.1016/j.seizure.2018.04.005; Vadi MG, 2017, PEDIATR EMERG CARE, V33, P467, DOI 10.1097/PEC.0000000000000607; Vahlkvist S, 2020, EUR J PEDIATR, V179, P513, DOI 10.1007/s00431-019-03533-2; van der Valk JPM, 2018, ANN ALLERG ASTHMA IM, V120, P300, DOI 10.1016/j.anai.2017.08.018; van Paridon BM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1010-x; van Sambeeck SJ, 2019, EUR J PEDIATR, V178, P1219, DOI 10.1007/s00431-019-03395-8; van Vonderen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109049; Varallo FR, 2019, PHARM PRACT-GRANADA, V17, DOI [10.18549/PharmPract.2019.1.1361, 10.18549/pharmpract.2019.1.1361]; Vassallo J, 2019, ARCH DIS CHILD, V104, P437, DOI 10.1136/archdischild-2018-314985; Ventura AMC, 2015, CRIT CARE MED, V43, P2292, DOI 10.1097/CCM.0000000000001260; Vezina K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010283.pub2; Vignesh V, 2020, INDIAN PEDIATR, V57, P222, DOI 10.1007/s13312-020-1755-4; Vilke Gary M, 2004, Prehosp Emerg Care, V8, P196; Vitaliti Giovanna, 2017, Respir Care, V62, P1036, DOI 10.4187/respcare.05384; von der Weid L, 2018, PAEDIATR INT CHILD H, V38, P113, DOI 10.1080/20469047.2017.1390828; Vonasek BJ, 2020, PAEDIATR INT CHILD H, V40, P148, DOI 10.1080/20469047.2020.1747003; Vukovic AA, 2019, AM J EMERG MED, V37, P27, DOI 10.1016/j.ajem.2018.04.039; Wall JJ, 2017, PEDIATR EMERG CARE, V33, P427, DOI 10.1097/PEC.0000000000001156; Walsh BM, 2017, J EMERG MED, V53, P467, DOI 10.1016/j.jemermed.2017.04.028; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050; Wang EEL, 1996, PEDIATR PULM, V22, P23, DOI 10.1002/(SICI)1099-0496(199607)22:1<23::AID-PPUL4>3.0.CO;2-L; Wang TQ, 2020, SEIZURE-EUR J EPILEP, V80, P5, DOI 10.1016/j.seizure.2020.04.001; Wang YC, 2019, ALLERGY, V74, P1063, DOI 10.1111/all.13732; Wani G, 2019, J FAM MED PRIM CARE, V8, P3367, DOI 10.4103/jfmpc.jfmpc_750_19; Watts K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006100.pub2; Weber MW, 1997, ARCH DIS CHILD, V76, P310, DOI 10.1136/adc.76.4.310; Weberding NT, 2018, ANN EMERG MED, V71, P220, DOI 10.1016/j.annemergmed.2017.09.002; Wei JN, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00503; Weinstock P, 2008, PEDIATR CLIN N AM, V55, P1011, DOI 10.1016/j.pcl.2008.04.001; Weisfeldt Myron L, 2004, Trans Am Clin Climatol Assoc, V115, P115; Weiss SL, 2020, PEDIATR CRIT CARE ME, V21, pE52, DOI [10.1097/PCC.0000000000002198, 10.1007/s00134-019-05878-6]; Weiss SL, 2017, PEDIATR CRIT CARE ME, V18, P823, DOI 10.1097/PCC.0000000000001222; Weiss SL, 2017, J PEDIATR-US, V182, P304, DOI 10.1016/j.jpeds.2016.11.075; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; Weiss SL, 2014, CRIT CARE MED, V42, P2409, DOI 10.1097/CCM.0000000000000509; Welch RD, 2015, EPILEPSIA, V56, P254, DOI 10.1111/epi.12905; Wells M, 2017, RESUSCITATION, V121, P9, DOI 10.1016/j.resuscitation.2017.09.026; Wells M, 2017, INT J EMERG MED, V10, DOI 10.1186/s12245-017-0156-5; Wen LL, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-019-0768-x; Weston PJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011027.pub2; Wieck MM, 2018, J TRAUMA ACUTE CARE, V85, P659, DOI 10.1097/TA.0000000000001908; Williams AM, 2011, INTENS CARE MED, V37, P1338, DOI 10.1007/s00134-011-2238-9; Williams DC, 2019, EXPERT REV RESP MED, V13, P327, DOI 10.1080/17476348.2019.1586536; Wisecup S, 2015, J ASTHMA, V52, P693, DOI 10.3109/02770903.2014.1002566; Wolfe HA, 2019, RESUSCITATION, V143, P57, DOI 10.1016/j.resuscitation.2019.08.006; Wollenek G, 2002, RESUSCITATION, V52, P255, DOI 10.1016/S0300-9572(01)00474-9; Wong HR, 2018, CRIT CARE MED, V46, pe242, DOI 10.1097/CCM.0000000000002932; Wong HR, 2016, CRIT CARE MED, V44, pE1000, DOI 10.1097/CCM.0000000000001833; Workman JK, 2020, ASAIO J, V66, P1152, DOI 10.1097/MAT.0000000000001147; Workman JK, 2016, PEDIATR CRIT CARE ME, V17, pE451, DOI 10.1097/PCC.0000000000000906; Writer Hilary, 2010, BMJ Clin Evid, V2010; Wu ET, 2009, RESUSCITATION, V80, P443, DOI 10.1016/j.resuscitation.2009.01.006; Wulff A, 2019, METHOD INFORM MED, V58, pe43, DOI 10.1055/s-0039-1695717; Xi B, 2016, CIRCULATION, V133, P398, DOI 10.1161/CIRCULATIONAHA.115.017936; Rojas-Reyes MX, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005975.pub3; Yan Hai-Peng, 2016, Zhongguo Dang Dai Er Ke Za Zhi, V18, P506; Yang D, 2019, PEDIATR CARDIOL, V40, P1217, DOI 10.1007/s00246-019-02135-x; Yang JT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9448; Yannopoulos Demetris, 2005, Respir Care, V50, P628; Yates AR, 2019, PEDIATR CRIT CARE ME, V20, P1126, DOI 10.1097/PCC.0000000000002088; Yock-Corrales A, 2011, ANN EMERG MED, V58, P156, DOI 10.1016/j.annemergmed.2010.10.013; Young KD, 2016, ANN EMERG MED, V68, P441, DOI 10.1016/j.annemergmed.2016.02.043; Youngquist S, 2007, PEDIATR EMERG CARE, V23, P250, DOI 10.1097/PEC.0b013e31803f7552; Yurtseven A, 2019, PEDIATR PULM, V54, P894, DOI 10.1002/ppul.24318; Zhan L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010134.pub2; Zhang Y, 2019, Zhonghua Yi Xue Za Zhi, V99, P3564, DOI 10.3760/cma.j.issn.0376-2491.2019.45.007; Zhao ZY, 2016, J CHILD NEUROL, V31, P1093, DOI 10.1177/0883073816638757; Zimmerman E, 2015, PEDIATRICS, V136, P905, DOI 10.1542/peds.2015-1858; Zwingmann J, 2015, RESUSCITATION, V96, P59, DOI 10.1016/j.resuscitation.2015.07.022; Zwingmann J, 2012, CRIT CARE, V16, DOI 10.1186/cc11410	801	22	22	9	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	APR	2021	161						327	387		10.1016/j.resuscitation.2021.02.015			61	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	RE4TN	WOS:000634148700003	33773830	Bronze	Y	N	2022-02-06	
J	Gayen, M; Bhomia, M; Balakathiresan, N; Knollmann-Ritschel, B				Gayen, Manoshi; Bhomia, Manish; Balakathiresan, Nagaraja; Knollmann-Ritschel, Barbara			Exosomal MicroRNAs Released by Activated Astrocytes as Potential Neuroinflammatory Biomarkers	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						MicroRNA; Astrocytes; neuroinflammation; Biomarkers	EXTRACELLULAR VESICLES; EXPRESSION	Neuroinflammation is a hallmark of several neurodegenerative diseases and disorders, including traumatic brain injury (TBI). Neuroinflammation results in the activation of glial cells which exacerbates the neuroinflammatory process by secretion of pro-inflammatory cytokines and results in disruption of glial transmission networks. The glial cells, including astrocytes, play a critical role in the maintenance of homeostasis in the brain. Activated astrocytes release several factors as part of the inflammatory process including cytokines, proteins, and microRNAs (miRNAs). MiRNAs are noncoding RNA molecules involved in normal physiological processes and disease pathogenesis. MiRNAs have been implicated as important cell signaling molecules, and they are potential diagnostic biomarkers and therapeutic targets for various diseases, including neurological disorders. Exosomal miRNAs released by astrocytic response to neuroinflammation is not yet studied. In this study, primary human astrocytes were activated by IL-1 beta stimulation and we examined astrocytic exosomal miRNA cargo released in a neuroinflammatory stress model. Results indicate that acute neuroinflammation and oxidative stress induced by IL-1 beta generates the release of a specific subset of miRNAs via exosomes, which may have a potential role in regulating the inflammatory response. Additionally, these miRNAs may serve as potential biomarkers of neuroinflammation associated with neurological disorders and injuries.	[Gayen, Manoshi] Univ Connecticut, Dept Neurosci, Hlth Ctr, 263 Farmington Ave, Farmington, CT 06030 USA; [Bhomia, Manish; Balakathiresan, Nagaraja; Knollmann-Ritschel, Barbara] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA		Bhomia, M (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA.	gayen@uchc.edu; manish.bhomia.ctr@usuhs.edu; nagaraja.balakathiresan.ctr@usuhs.edu; barbara.knollmann-Ritschel@usuhs.edu	Balakathiresan, Nagaraja Sethuraman/O-3213-2019; Gayen, Manoshi/ABE-5937-2021; Bhomia, Manish/C-7683-2015	Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070; gayen, manoshi/0000-0003-1997-4211; Bhomia, Manish/0000-0003-2808-9927	defense medical research and development program (DMRDP)	The study is supported by a grant from the defense medical research and development program (DMRDP).	Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Barile L, 2017, PHARMACOL THERAPEUT, V174, P63, DOI 10.1016/j.pharmthera.2017.02.020; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bian EB, 2016, ONCOTARGET, V7, P30610, DOI 10.18632/oncotarget.8895; Blandford SN, 2018, GLIA, V66, P2267, DOI 10.1002/glia.23445; Boese AS, 2016, MOL CELL NEUROSCI, V71, P13, DOI 10.1016/j.mcn.2015.12.001; Borges FT, 2013, BRAZ J MED BIOL RES, V46, P824, DOI 10.1590/1414-431X20132964; Chaudhuri AD, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0369-4; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Garden GA, 2016, GLIA, V64, P1755, DOI 10.1002/glia.22998; Grasedieck S, 2012, LEUKEMIA, V26, P2414, DOI 10.1038/leu.2012.106; Huang Z, 2014, GUT, V63, P1247, DOI 10.1136/gutjnl-2012-304213; Jovicic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171418; Kamphuis W, 2015, GLIA, V63, P1036, DOI 10.1002/glia.22800; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Li X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.430; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Paul P, 2018, J CELL PHYSIOL, V233, P2007, DOI 10.1002/jcp.25854; Rao VTS, 2016, J NEUROPATH EXP NEUR, V75, P156, DOI 10.1093/jnen/nlv016; Schain M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0733-2; Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363; Shen WS, 2017, GENE THER, V24, P353, DOI 10.1038/gt.2017.28; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Soria FN, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00026; Teh DBL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13174-w; Verma R, 2018, STROKE, V49, P1701, DOI 10.1161/STROKEAHA.118.020627	28	22	22	2	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	APR	2020	21	7							2312	10.3390/ijms21072312			12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	LR3DN	WOS:000535574200054	32230793	gold, Green Published			2022-02-06	
J	Hartings, JA; Andaluz, N; Bullock, MR; Hinzman, JM; Mathern, B; Pahl, C; Puccio, A; Shutter, LA; Strong, AJ; Vagal, A; Wilson, JA; Dreier, JP; Ngwenya, LB; Foreman, B; Pahren, L; Lingsma, H; Okonkwo, DO				Hartings, Jed A.; Andaluz, Norberto; Bullock, M. Ross; Hinzman, Jason M.; Mathern, Bruce; Pahl, Clemens; Puccio, Ava; Shutter, Lori A.; Strong, Anthony J.; Vagal, Achala; Wilson, J. Adam; Dreier, Jens P.; Ngwenya, Laura B.; Foreman, Brandon; Pahren, Laura; Lingsma, Hester; Okonkwo, David O.			Prognostic Value of Spreading Depolarizations in Patients With Severe Traumatic Brain Injury	JAMA NEUROLOGY			English	Article							ISCHEMIC NEUROLOGICAL DEFICITS; DEPRESSION; CARE; EXCITOTOXICITY; HEMORRHAGE; MANAGEMENT; MODEL	This multicenter cohort study assesses the association between spreading depolarizations in the brains of individuals who have undergone surgery for traumatic brain injury and neurologic outcomes. Question Does the measurement of spreading depolarizations provide clinically meaningful information that is independent of other assessments? Findings In this cohort study of 138 patients who underwent surgery for traumatic brain injury, the occurrence of repetitive spreading depolarizations (clusters) in 51 patients (37.0%) was associated with poor neurologic recovery during intensive care and was a factor independently associated with worse 6-month functional outcomes. Meaning Spreading depolarizations are a common mechanism of secondary injury that should be considered for monitoring and treatment targeting in traumatic brain injury. Importance Advances in treatment of traumatic brain injury are hindered by the inability to monitor pathological mechanisms in individual patients for targeted neuroprotective treatment. Spreading depolarizations, a mechanism of lesion development in animal models, are a novel candidate for clinical monitoring in patients with brain trauma who need surgery. Objective To test the null hypothesis that spreading depolarizations are not associated with worse neurologic outcomes. Design, Setting, and Participants This prospective, observational, multicenter cohort study was conducted from February 2009 to August 2013 in 5 level 1 trauma centers. Consecutive patients who required neurological surgery for treatment of acute brain trauma and for whom research consent could be obtained were enrolled; participants were excluded because of technical problems in data quality, patient withdrawal, or loss to follow-up. Primary statistical analysis took place from April to December 2018. Evaluators of outcome assessments were blinded to other measures. Interventions A 6-contact electrode strip was placed on the brain surface during surgery for continuous electrocorticography during intensive care. Main Outcomes and Measures Electrocorticography was scored for depolarizations, following international consensus procedures. Six-month outcomes were assessed by the Glasgow Outcome Scale-Extended score. Results A total of 157 patients were initially enrolled; 19 were subsequently excluded. The 138 remaining patients (104 men [75%]; median [interquartile range] age, 45 [29-64] years) underwent a median (interquartile range) of 75.5 (42.2-117.1) hours of electrocorticography. A total of 2837 spreading depolarizations occurred in 83 of 138 patients (60.1% incidence) who, compared with patients who did not have spreading depolarizations, had lower prehospital systolic blood pressure levels (mean [SD], 133 [31] mm Hg vs 146 [33] mm Hg; P = .03), more traumatic subarachnoid hemorrhage (depolarization incidences of 17 of 37 [46%], 18 of 32 [56%], 22 of 33 [67%], and 23 of 30 patients [77%] for Morris-Marshall Grades 0, 1, 2, and 3/4, respectively; P = .047), and worse radiographic pathology (in 38 of 73 patients [52%] and 42 of 60 patients [70%] for Rotterdam Scores 2-4 vs 5-6, respectively; P = .04). Of patients with depolarizations, 32 of 83 (39%) had only sporadic events that induced cortical spreading depression of spontaneous electrical activity, whereas 51 of 83 patients (61%) exhibited temporal clusters of depolarizations (>= 3 in a 2-hour span). Nearly half of those with clusters (23 of 51 [45%]) also had depolarizations in an electrically silent area of the cortex (isoelectric spreading depolarization). Patients with clusters did not improve in motor neurologic examinations from presurgery to postelectrocorticography, while other patients did improve. In multivariate ordinal regression adjusting for baseline prognostic variables, the occurrence of depolarization clusters had an odds ratio of 2.29 (95% CI, 1.13-4.65; P = .02) for worse outcomes. Conclusions and Relevance In this cohort study of patients with acute brain trauma, spreading depolarizations were predominant but heterogeneous and independently associated with poor neurologic recovery. Monitoring the occurrence of spreading depolarizations may identify patients most likely to benefit from targeted management strategies.	[Hartings, Jed A.; Andaluz, Norberto; Hinzman, Jason M.; Shutter, Lori A.; Wilson, J. Adam; Ngwenya, Laura B.; Foreman, Brandon] Univ Cincinnati, Dept Neurosurg, Coll Med, Cincinnati, OH 45267 USA; [Bullock, M. Ross] Univ Miami, Dept Neurol Surg, Miami, FL USA; [Mathern, Bruce] Virginia Commonwealth Univ, Div Neurosurg, Richmond, VA USA; [Pahl, Clemens] Kings Coll London, Dept Crit Care Med, London, England; [Puccio, Ava; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA USA; [Strong, Anthony J.] Kings Coll London, Dept Basic & Clin Neurosci, London, England; [Vagal, Achala] Univ Cincinnati, Dept Radiol, Coll Med, Cincinnati, OH 45267 USA; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurosurg, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Ctr Stroke Res, Berlin, Germany; [Lingsma, Hester] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Andaluz, Norberto] Univ Louisville, Sch Med, Dept Neurosurg, Louisville, KY 40292 USA; [Shutter, Lori A.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Pahren, Laura] Univ Cincinnati, Dept Mech Engn, Cincinnati, OH 45267 USA; [Hartings, Jed A.; Ngwenya, Laura B.; Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, Coll Med, Cincinnati, OH USA		Hartings, JA (corresponding author), Univ Cincinnati, Dept Neurosurg, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	jed.hartings@uc.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628; Ngwenya, Laura/0000-0001-7103-971X	US Army Congressionally Directed Medical Research Program Psychological Health/Traumatic Brain Injury Research Program [W81XWH-08-2-0016]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DR 323/5-1, DR 323/10-1]; 7th Framework Programme for Research and Technological Development [602150]	This study was funded by the US Army Congressionally Directed Medical Research Program Psychological Health/Traumatic Brain Injury Research Program (contract W81XWH-08-2-0016). Dr Dreier acknowledges support from Deutsche Forschungsgemeinschaft (grants DR 323/5-1 and DR 323/10-1). Drs Hartings, Lingsma, and Dreier acknowledge support from the 7th Framework Programme for Research and Technological Development (grant 602150 [Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury]).	Aiba I, 2012, J PHYSIOL-LONDON, V590, P5877, DOI 10.1113/jphysiol.2012.234476; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BRANSTON NM, 1977, J NEUROL SCI, V32, P305, DOI 10.1016/0022-510X(77)90014-4; Carlson AP, 2019, J NEUROSURG, V131, P1773, DOI 10.3171/2018.7.JNS181478; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2018, ANN NEUROL, V83, P295, DOI 10.1002/ana.25147; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Eriksen N, 2019, NEUROCRIT CARE, V30, P557, DOI 10.1007/s12028-019-00692-w; Eriksen N, 2019, NEUROLOGY, V92, pE326, DOI 10.1212/WNL.0000000000006814; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00019; Hartings JA, 2017, BRAIN, V140, P2673, DOI 10.1093/brain/awx214; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1857, DOI 10.1177/0271678X16653135; Hartings JA, 2017, CURR OPIN CRIT CARE, V23, P94, DOI 10.1097/MCC.0000000000000395; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Helbok R, 2020, NEUROCRIT CARE, V32, P306, DOI 10.1007/s12028-019-00777-6; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Krenzlin H, 2019, J NEUROTRAUM, V36, P395, DOI 10.1089/neu.2018.5657; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Morris GF, 1997, ACTA NEUROCHIR S, V71, P382; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Reinhart KM, 2018, EXP NEUROL, V305, P121, DOI 10.1016/j.expneurol.2018.04.007; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	45	22	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	APR	2020	77	4					489	499		10.1001/jamaneurol.2019.4476			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LH2CS	WOS:000528595700013	31886870	Green Published, Bronze			2022-02-06	
J	Goetzl, EJ; Yaffe, K; Peltz, CB; Ledreux, A; Gorgens, K; Davidson, B; Granholm, AC; Mustapic, M; Kapogiannis, D; Tweedie, D; Greig, NH				Goetzl, Edward J.; Yaffe, Kristine; Peltz, Carrie B.; Ledreux, Aurelie; Gorgens, Kim; Davidson, Bradley; Granholm, Ann-Charlotte; Mustapic, Maja; Kapogiannis, Dimitrios; Tweedie, David; Greig, Nigel H.			Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins	FASEB JOURNAL			English	Article						extracellular vesicles; neurodegeneration; neuroinflammation	IDENTIFICATION; ATTACK	Possible involvement of complement (C) systems in the pathogenesis of traumatic brain injury (TBI) was investigated by quantifying Cproteins in plasma astrocyte-derived exosomes (ADEs) of subjects with sports-related TBI (sTBI) and TBI in military veterans (mtTBI) without cognitive impairment. All sTBI subjects (n = 24) had mild injuries, whereas eight of the mtTBI subjects had moderate, and 17 had mild injuries. Plasma levels of ADEs were decreased after acute sTBI and returned to normal within months. Cprotein levels in ADEs were from 12- to 35-fold higher than the corresponding levels in neuron-derived exosomes. CD81 exosome marker-normalized ADE levels of classical pathway C4b, alternative pathway factor D and Bb, lectin pathway mannose-binding lectin (MBL), and shared neurotoxic effectors C3b and C5b-9 terminal C complex were significantly higher and those of C regulatory proteins CR1 and CD59 were lower in the first week of acute sTBI (n = 12) than in controls (n = 12). Most C abnormalities were no longer detected in chronic sTBI at 3-12 months after acute sTBI, except for elevated levels of factor D, Bb, and MBL. In contrast, significant elevations of ADE levels of C4b, factor D, Bb, MBL, C3b and C5b-9 terminal C complex, and depressions of CR1 and CD59 relative to those of controls were observed after 1-4 years in early chronic mtTBI (n = 10) and persisted for decades except for normalization of Bb, MBL, and CD59 in late chronic mtTBI (n = 15). Complement inhibitors may be useful therapeutically in acute TBI and post-concussion syndrome.	[Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Med Ctr, Neurol Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine; Peltz, Carrie B.] San Francisco VA Med Ctr, Dept Psychiat, San Francisco, CA USA; [Peltz, Carrie B.] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Ledreux, Aurelie; Granholm, Ann-Charlotte] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO USA; [Gorgens, Kim] Univ Denver, Grad Sch Profess Psychol, Denver, CO USA; [Davidson, Bradley] Univ Denver, Dept Mech & Mat Engn, Denver, CO USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Lab Clin Invest, Baltimore, MD 21224 USA; [Tweedie, David; Greig, Nigel H.] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA		Goetzl, EJ (corresponding author), UCSF, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Kapogiannis, Dimitrios/AAW-4934-2020; Mustapic, Maja/AAV-3212-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Gorgens, Kim/0000-0003-4413-0600	U.S. Department of Defense (DOD)United States Department of Defense [WB1XWH-14-2-0137]; University of Denver (DU) [999]; HHS \ NIH \ National Institute on Aging (NIA)	U.S. Department of Defense (DOD), Grant/Award Number: WB1XWH-14-2-0137; University of Denver (DU), Grant/Award Number: 999; HHS vertical bar NIH vertical bar National Institute on Aging (NIA)	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Carpanini SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00362; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Choi SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097093; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2020, J NEUROTRAUM, V37, P382, DOI 10.1089/neu.2019.6711; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Goetzl EJ, 2017, FASEB J, V31, P1792, DOI 10.1096/fj.201601221R; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harris ME, 2002, J CLIN EXP NEUROPSYC, V24, P214, DOI 10.1076/jcen.24.2.214.995; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Ivnik RJ, 2000, NEUROPSYCHOLOGY, V14, P163, DOI 10.1037/0894-4105.14.2.163; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Winston CN, 2019, ALZH DEMENT-DADM, V11, P61, DOI 10.1016/j.dadm.2018.11.002; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	33	22	23	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3359	3366		10.1096/fj.201902842R		JAN 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	WOS:000506440100001	31916313	hybrid, Green Accepted			2022-02-06	
J	Yin, ZY; Han, ZL; Hu, TP; Zhang, SS; Ge, XT; Huang, S; Wang, L; Yu, JW; Li, WZ; Wang, Y; Li, D; Zhao, J; Wang, YF; Zuo, Y; Li, Y; Kong, XD; Chen, FL; Lei, P				Yin, Zhenyu; Han, Zhaoli; Hu, Tianpeng; Zhang, Shishuang; Ge, Xintong; Huang, Shan; Wang, Lu; Yu, Jinwen; Li, Wenzhu; Wang, Yan; Li, Dai; Zhao, Jing; Wang, Yifeng; Zuo, Yan; Li, Ying; Kong, Xiaodong; Chen, Fanglian; Lei, Ping			Neuron-derived exosomes with high miR-21-5p expression promoted polarization of M1 microglia in culture	BRAIN BEHAVIOR AND IMMUNITY			English	Article						TBI; Neuroinflammation; Microglia polarization; miR-21-5p; Exosome	TRAUMATIC BRAIN-INJURY; EXTRACELLULAR VESICLES; MICRORNA EXPRESSION; IN-VITRO; INFLAMMATION; NEUROINFLAMMATION; BIOGENESIS; MECHANISM; APOPTOSIS; DYNAMICS	Background: Neuroinflammation is a characteristic pathological change of acute neurological deficit and chronic traumatic encephalopathy (CTE) after traumatic brain injury (TBI). Microglia are the key cell involved in neuroinflammation and neuronal injury. The type of microglia polarization determines the direction of neuroinflammation. MiR-21-5p elevated in neurons and microglia after TBI in our previous research. In this study, we explore the influence of miR-21-5p for neuroinflammation by regulating microglia polarization. Methods: In this study, PC12 and BV2 used to instead of neuron and microglia respectively. The co-cultured transwell system used to simulate interaction of PC12 and BV2 cells in vivo environment. Results: We found that PC12-derived exosomes with containing miR-21-5p were phagocytosed by microglia and induced microglia polarization, meanwhile, the expression of miR-21-5p was increased in M1 microglia cells. Polarization of Ml microglia aggravated the release of neuroinflammation factors, inhibited the neurite outgrowth, increased accumulation of P-tau and promoted the apoptosis of PC12 cells, which formed a model of cyclic cumulative damage. Simultaneously, we also got similar results in vivo experiments. Conclusions: PC12-derived exosomes with containing miR-21-5p is the essential of this cyclic cumulative damage model. Therefore, regulating the expression of miR-21-5p or the secretion of exosomes may be an important novel strategy for the treatment of neuroinflammation after TBI.	[Yin, Zhenyu; Han, Zhaoli; Hu, Tianpeng; Zhang, Shishuang; Huang, Shan; Wang, Lu; Yu, Jinwen; Li, Wenzhu; Wang, Yan; Li, Dai; Zhao, Jing; Zuo, Yan; Kong, Xiaodong; Lei, Ping] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin, Peoples R China; [Yin, Zhenyu; Han, Zhaoli; Hu, Tianpeng; Zhang, Shishuang; Huang, Shan; Wang, Lu; Yu, Jinwen; Li, Wenzhu; Wang, Yan; Li, Dai; Zhao, Jing; Zuo, Yan; Kong, Xiaodong; Lei, Ping] Tianjin Inst Geriatr, Tianjin, Peoples R China; [Ge, Xintong] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Li, Ying; Chen, Fanglian] Tianjin Neurol Inst, Tianjin, Peoples R China; [Wang, Yifeng] Tianjin Med Univ, Gen Hosp, Dept Crit Care Med, Tianjin, Peoples R China		Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Inst Geriatr, Anshan Rd, Tianjin 300052, Peoples R China.	leiping1974@163.com	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772060, 81501055]; Tianjin Municipal Science and Technology Commission Natural Fund Project [18JCQNJC81100, 18ZXDBSY00090, 19JCQNJC10200]	This work was supported by Grants 81772060 and 81501055 from the National Natural Science Foundation of China, and Grant 18JCQNJC81100, 18ZXDBSY00090 and 19JCQNJC10200 from the Tianjin Municipal Science and Technology Commission Natural Fund Project.	Ando Y, 2013, J AUTOIMMUN, V41, P111, DOI 10.1016/j.jaut.2012.12.013; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Cao HM, 2019, ACS NANO, V13, P3522, DOI 10.1021/acsnano.8b09776; Cen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066503; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chopp M, 2015, EXPERT OPIN EMERG DR, V20, P523, DOI 10.1517/14728214.2015.1061993; Feng MG, 2018, BIOMED PHARMACOTHER, V101, P1003, DOI 10.1016/j.biopha.2018.02.043; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guinea-Viniegra J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008089; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li X, 2018, J ALLERGY CLIN IMMUN, V141, P1634, DOI 10.1016/j.jaci.2017.08.017; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas Andrew I.R., 2017, LANCET NEUROL, V16, P1, DOI 10.1016/51474-4422(17)30371-X; Maria S, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12465; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nazem A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0291-y; Parayath NN, 2018, NANO LETT, V18, P3571, DOI 10.1021/acs.nanolett.8b00689; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sheedy FJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00019; Shefler I, 2014, J ALLERGY CLIN IMMUN, V133, P217, DOI 10.1016/j.jaci.2013.04.035; Simeoli R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01841-5; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Vuckovic S, 2017, BRIT J HAEMATOL, V177, P423, DOI 10.1111/bjh.14561; Yan AJ, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00529; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002	51	22	24	4	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JAN	2020	83						270	282		10.1016/j.bbi.2019.11.004			13	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	JY4GG	WOS:000504374700028	31707083				2022-02-06	
J	Guan, FX; Zhou, XK; Li, P; Wang, YP; Liu, M; Li, FF; Cui, YB; Huang, TJ; Yao, MH; Zhang, YT; Ma, JJ; Ma, SS				Guan, Fangxia; Zhou, Xinkui; Li, Peng; Wang, Yaping; Liu, Ming; Li, Fangfang; Cui, Yuanbo; Huang, Tuanjie; Yao, Minghao; Zhang, Yanting; Ma, Jianjie; Ma, Shanshan			MG53 attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation via inhibiting TLR4/NF-kappa B pathway in vitro and in vivo	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Article						MG53 protein; Lipopolysaccharide; Neurotoxicity; Cognitive impairment; TLR4/NF-kappa B pathway	TRAUMATIC BRAIN-INJURY; TOLL-LIKE RECEPTORS; NF-KAPPA-B; MEMBRANE REPAIR; ALZHEIMERS-DISEASE; MICE; (-)-EPICATECHIN; MICROGLIA	Neuroinflammation plays important roles in the pathogenesis and development of neurodegenerative disorders. Lipopolysaccharide (LPS) induces neuroinflammation and causes neurotoxicity, which results in cell damage or memory impairment in different cells and animals. In the present study, we investigated the neuroprotective effects of MG53, a member of the TRIM family proteins, against LPS-induced neuroinflammation and neurotoxicity in vitro and in vivo. MG53 significantly protected HT22 cells against LPS-induced cell apoptosis and cell cycle arrest by inhibiting TNF-alpha, IL-6 and IL-1 beta expression. In addition, MG53 ameliorated LPS-induced memory impairment and neuronal cell death in mice. Interestingly, MG53 significantly promoted newborn cell survival, improved neurogenesis, and mitigated neuroinflammation evidenced by lower production of IL-1 beta and IL-6, less activation of microglia in the hippocampus of LPS treated mice. Further studies demonstrated that MG53 significantly inhibited TLR4 expression and nuclear factor-kappa B (NF-kappa B) phosphorylation in LPS treated HT22 cells and mice. Taken together, our results suggested that MG53 attenuated LPS-induced neurotoxicity and neuroinflammation partly by inhibiting TLR4/NF-kappa B pathway in vitro and in vivo.	[Guan, Fangxia; Zhou, Xinkui; Li, Peng; Wang, Yaping; Liu, Ming; Li, Fangfang; Cui, Yuanbo; Huang, Tuanjie; Yao, Minghao; Zhang, Yanting; Ma, Shanshan] Zhengzhou Univ, Sch Life Sci, 100 Sci Ave, Zhengzhou 450001, Henan, Peoples R China; [Guan, Fangxia] Henan Prov Peoples Hosp, Zhengzhou 450003, Henan, Peoples R China; [Li, Peng] Zhumadian Hosp Tradit Chinese Med, Clin Lab, Zhumadian 463000, Henan, Peoples R China; [Ma, Jianjie] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA		Ma, SS (corresponding author), Zhengzhou Univ, Sch Life Sci, 100 Sci Ave, Zhengzhou 450001, Henan, Peoples R China.; Ma, JJ (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA.	Jianjie.Ma@osumc.edu; mss@zzu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601078]; Science and Technology Research Project form Henan Province [152102310272]; Key Research Project of Higher Education of Henan Province [17A310012]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1-AR061385, RO1-DK106394, RO1-AR070752]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR070752, R01AR061385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK106394] Funding Source: NIH RePORTER	This study was supported by the National Natural Science Foundation of China (81601078), Science and Technology Research Project form Henan Province (152102310272), the Key Research Project of Higher Education of Henan Province (17A310012). US National Institutes of Health (RO1-AR061385, RO1-DK106394 and RO1-AR070752).	Backhed F, 2003, MICROBES INFECT, V5, P1057, DOI 10.1016/S1286-4579(03)00207-7; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Barcia C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.17; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng X, 2018, INT IMMUNOPHARMACOL, V56, P29, DOI 10.1016/j.intimp.2018.01.002; Choi YH, 2019, GEN PHYSIOL BIOPHYS, V38, P111, DOI 10.4149/gpb-2018044; Cui YB, 2017, BEHAV BRAIN RES, V320, P291, DOI 10.1016/j.bbr.2016.12.021; de Miranda AS, 2017, J NEUROL SCI, V372, P482, DOI 10.1016/j.jns.2016.10.052; Prince PD, 2017, REDOX BIOL, V11, P342, DOI 10.1016/j.redox.2016.12.023; Du SH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00409; Duann P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010755; Gao HW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.389; Gao W, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00508; Heredia L, 2014, J PHARMACOL TOX MET, V69, P108, DOI 10.1016/j.vascn.2013.12.005; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jia YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5387; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Khan A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01383; Khan S, 2018, CANCER CHEMOTH PHARM, V82, P31, DOI 10.1007/s00280-018-3605-9; Koh EJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22081363; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Lee DS, 2014, EUR J PHARMACOL, V728, P1, DOI 10.1016/j.ejphar.2013.12.041; Li YT, 2015, BIOCHEM BIOPH RES CO, V458, P763, DOI 10.1016/j.bbrc.2015.01.155; Lim KH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011247; Ma SS, 2014, MOL CELL BIOCHEM, V385, P277, DOI 10.1007/s11010-013-1836-y; McElhanon KE, 2018, LIFE SCI, V192, P166, DOI 10.1016/j.lfs.2017.11.035; Mouton PR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.025; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Musa NH, 2017, J DAIRY RES, V84, P488, DOI [10.1017/S0022029917000620, 10.1017/s0022029917000620]; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Nyati KK, 2017, NUCLEIC ACIDS RES, V45, P2687, DOI 10.1093/nar/gkx064; Ramon-Canellas P, 2019, NEUROSCIENCE, V399, P39, DOI 10.1016/j.neuroscience.2018.12.014; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sawikr Y, 2017, ADV PROTEIN CHEM STR, V108, P33, DOI 10.1016/bs.apcsb.2017.02.001; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shirjang S, 2017, CELL IMMUNOL, V315, P1, DOI 10.1016/j.cellimm.2016.12.005; Sun JH, 2015, MOL PHARMACOL, V88, P437, DOI 10.1124/mol.115.098269; Ha VT, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/354843; Vu A, 2017, EUR J PHARMACOL, V808, P1, DOI 10.1016/j.ejphar.2016.10.018; Wang XX, 2018, BEHAV BRAIN RES, V339, P297, DOI 10.1016/j.bbr.2017.10.032; Wang XX, 2016, MOL CELLS, V39, P418, DOI 10.14348/molcells.2016.2345; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Wu X, 2019, PROG NEURO-PSYCHOPH, V88, P360, DOI 10.1016/j.pnpbp.2018.08.016; Xu L, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00498; Yao YG, 2016, ONCOTARGET, V7, P22474, DOI 10.18632/oncotarget.7965; Yuan X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.334; Zhang Y, 2011, CARDIOVASC RES, V91, P108, DOI 10.1093/cvr/cvr029; Zhao M, 2014, NEUROSCIENCE, V269, P93, DOI 10.1016/j.neuroscience.2014.03.039	52	22	22	3	97	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	DEC 20	2019	95								109684	10.1016/j.pnpbp.2019.109684			11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	IZ6PL	WOS:000487204500014	31260721	Green Accepted			2022-02-06	
J	Das, M; Mayilsamy, K; Mohapatra, SS; Mohapatra, S				Das, Mahasweta; Mayilsamy, Karthick; Mohapatra, Shyam S.; Mohapatra, Subhra			Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects	REVIEWS IN THE NEUROSCIENCES			English	Article						exosomes; mesenchymal stem cell (MSC); regenerative medicine; traumatic brain injury (TBI)	MARROW STROMAL CELLS; T-LYMPHOCYTE PROLIFERATION; MURINE BONE-MARROW; FUNCTIONAL RECOVERY; SPINAL-CORD; NEUROVASCULAR PLASTICITY; EXTRACELLULAR VESICLES; INTERNATIONAL-SOCIETY; INTRANASAL DELIVERY; COMPUTED-TOMOGRAPHY	Traumatic brain injury (TBI) is a major cause of injury-related mortality and morbidity in the USA and around the world. The survivors may suffer from cognitive and memory deficits, vision and hearing loss, movement disorders, and different psychological problems. The primary insult causes neuronal damage and activates astrocytes and microglia which evokes immune responses causing further damage to the brain. Clinical trials of drugs to recover the neuronal loss are not very successful. Regenerative approaches for TBI using mesenchymal stem cells (MSCs) seem promising. Results of preclinical research have shown that transplantation of MSCs reduced secondary neurodegeneration and neuroinflammation, promoted neurogenesis and angiogenesis, and improved functional outcome in the experimental animals. The functional improvement is not necessarily related to cell engraftment; rather, immunomodulation by molecular factors secreted by MSCs is responsible for the beneficial effects of this therapy. However, MSC therapy has a few drawbacks including tumor formation, which can be avoided by the use of MSC-derived exosomes. This review has focused on the research works published in the field of regenerative therapy using MSCs after TBI and its future direction.	[Das, Mahasweta; Mayilsamy, Karthick; Mohapatra, Shyam S.; Mohapatra, Subhra] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Das, Mahasweta; Mayilsamy, Karthick; Mohapatra, Subhra] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Mohapatra, Shyam S.] Univ S Florida, Coll Med, Dept Internal Med, Tampa, FL 33612 USA		Mohapatra, S (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Mohapatra, S (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA.	smohapa2@health.usf.edu		Das, Mahasweta/0000-0003-3809-5861	Veterans Affairs Merit Review grantUS Department of Veterans Affairs [BX002668, IK6BX004212, IK6 BX003778]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs	This work is supported by Veterans Affairs Merit Review grant (BX002668, Funder Id: http://dx.doi.org/10.13039/100006364) to Subhra Mohapatra, and Research Career Scientist Awards to Dr. Subhra Mohapatra (IK6BX004212) and Dr. Shyam Mohapatra (IK6 BX003778). Though this report is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, the contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government.	Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alexanian AR, 2011, NEUROREHAB NEURAL RE, V25, P873, DOI 10.1177/1545968311416823; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x; [Anonymous], 2012, Drug Discov Today Technol, V9, pe71, DOI 10.1016/j.ddtec.2011.12.002; Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Badiavas EV, 2003, ARCH DERMATOL, V139, P510, DOI 10.1001/archderm.139.4.510; Baustian C, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0139-5; Belting M, 2015, J INTERN MED, V278, P251, DOI 10.1111/joim.12393; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Boltze J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00155; Boltze J, 2014, J CEREBR BLOOD F MET, V34, P1420, DOI 10.1038/jcbfm.2014.94; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carbonara M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00885; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chamberlain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025663; Chau MJ, 2014, STEM CELLS, V32, P3075, DOI 10.1002/stem.1802; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Choo KB, 2014, INT J MED SCI, V11, P1201, DOI 10.7150/ijms.8356; Cui LL, 2017, STROKE, V48, P2895, DOI 10.1161/STROKEAHA.117.017809; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Denu RA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2989076; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donega V, 2017, NEUROSCIENTIST, V23, P605, DOI 10.1177/1073858417697036; El Bassit G, 2017, ENDOCRINOLOGY, V158, P183, DOI 10.1210/en.2016-1819; Engela AU, 2013, CELL TRANSPLANT, V22, P41, DOI 10.3727/096368912X636984; Eslaminejad MB, 2006, DEV GROWTH DIFFER, V48, P361, DOI 10.1111/j.1440-169x.2006.00874.x; Eslaminejad MB, 2009, IN VITRO CELL DEV-AN, V45, P451, DOI 10.1007/s11626-009-9198-1; Feng Y, 2017, MOL MED REP, V16, P654, DOI 10.3892/mmr.2017.6619; Galeano C, 2018, CELL TRANSPLANT, V27, P501, DOI 10.1177/0963689718754561; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Geesala R, 2017, CYTOTHERAPY, V19, P756, DOI 10.1016/j.jcyt.2017.03.072; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Han EY, 2013, CURR STEM CELL RES T, V8, P172; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Huat TJ, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-91; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; ITOH K, 1989, EXP HEMATOL, V17, P145; Jang SH, 2015, J NEURO-OPHTHALMOL, V35, P270, DOI 10.1097/WNO.0000000000000249; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kainer MA, 2004, NEW ENGL J MED, V350, P2564, DOI 10.1056/NEJMoa023222; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; King A, 2014, ADV WOUND CARE, V3, P614, DOI 10.1089/wound.2013.0497; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Ko E, 2012, STEM CELLS DEV, V21, P1877, DOI 10.1089/scd.2011.0284; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kwon HM, 2014, VASC PHARMACOL, V63, P19, DOI 10.1016/j.vph.2014.06.004; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Landgraf K, 2011, TRANSPL IMMUNOL, V25, P167, DOI 10.1016/j.trim.2011.06.007; Lee Bruce, 2005, NeuroRx, V2, P372; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Li G, 2018, EXPERT OPIN DRUG DEL, V15, P163, DOI 10.1080/17425247.2018.1378642; Lin CH, 2019, J FORMOS MED ASSOC, V118, P1661, DOI 10.1016/j.jfma.2019.01.008; Lin WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063444; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Maerz JK, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0243-6; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mancini OK, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0127-9; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Mastro-Martinez I, 2015, BRAIN INJURY, V29, P1497, DOI 10.3109/02699052.2015.1053525; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meirelles LD, 2016, FRONT BIOSCI-LANDMRK, V21, P130, DOI 10.2741/4380; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Meirelles LD, 2009, TISSUE ENG PT A, V15, P221, DOI 10.1089/ten.tea.2008.0103; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Moreau F, 2013, CEREBROVASC DIS EXTR, V3, P130, DOI 10.1159/000355024; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Nasef A, 2007, GENE EXPRESSION, V13, P217; Navaratna D, 2009, CELL ADHES MIGR, V3, P216, DOI 10.4161/cam.3.2.8396; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Niwa A, 2009, J CELL PHYSIOL, V221, P367, DOI 10.1002/jcp.21864; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Okouchi M, 2007, ANTIOXID REDOX SIGN, V9, P1059, DOI 10.1089/ars.2007.1511; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Orciani M, 2010, FREE RADICAL BIO MED, V49, P830, DOI 10.1016/j.freeradbiomed.2010.06.007; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Pati S, 2016, CURR STEM CELL RES T, V11, P149, DOI 10.2174/1574888X10666151019120050; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qu J, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5251313; Redondo-Castro E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0531-4; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Ren JQ, 2013, STEM CELL RES, V11, P1060, DOI 10.1016/j.scr.2013.07.005; Rizzo R, 2008, CYTOTHERAPY, V10, P364, DOI 10.1080/14653240802105299; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rojewski MT, 2008, TRANSFUS MED HEMOTH, V35, P168, DOI 10.1159/000129013; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Schizas N, 2018, CELL TISSUE RES, V372, P493, DOI 10.1007/s00441-018-2808-z; Schmidt A, 2006, EUR J CELL BIOL, V85, P1179, DOI 10.1016/j.ejcb.2006.05.015; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005; Sheikh AM, 2011, NEUROBIOL DIS, V41, P717, DOI 10.1016/j.nbd.2010.12.009; Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031; Siegel G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-146; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sordi V, 2009, TRANSPLANTATION, V87, pS42, DOI 10.1097/TP.0b013e3181a28533; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Steingen C, 2008, J MOL CELL CARDIOL, V44, P1072, DOI 10.1016/j.yjmcc.2008.03.010; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Sun JM, 2015, EXP NEUROL, V272, P78, DOI 10.1016/j.expneurol.2015.03.011; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Tugwell BD, 2005, ANN INTERN MED, V143, P648, DOI 10.7326/0003-4819-143-9-200511010-00008; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; VANVLASSELAER P, 1994, BLOOD, V84, P753, DOI 10.1182/blood.V84.3.753.bloodjournal843753; Vasandan AB, 2016, SCI REP-UK, V6, DOI 10.1038/srep38308; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Wang ZG, 2017, EXP THER MED, V13, P3613, DOI 10.3892/etm.2017.4423; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wei L, 2017, PROG NEUROBIOL, V157, P49, DOI 10.1016/j.pneurobio.2017.03.003; Williams AM, 2019, J NEUROTRAUM, V36, P54, DOI 10.1089/neu.2018.5711; Wu LW, 2014, TRANSPL IMMUNOL, V30, P122, DOI 10.1016/j.trim.2014.03.001; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zaim M, 2012, ANN HEMATOL, V91, P1175, DOI 10.1007/s00277-012-1438-x; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhao Q., 2016, J CELLULAR IMMUNOTHE, V2, P3, DOI DOI 10.1016/J.JOCIT.2014.12.001; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	189	22	22	5	22	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	DEC	2019	30	8					839	855		10.1515/revneuro-2019-0002			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JQ0ST	WOS:000498665600004	31203262				2022-02-06	
J	Feng, JZ; Wang, Y; Peng, J; Sun, MW; Zeng, J; Jiang, H				Feng, Jin-zhou; Wang, Yu; Peng, Jin; Sun, Ming-wei; Zeng, Jun; Jiang, Hua			Comparison between logistic regression and machine learning algorithms on survival prediction of traumatic brain injuries	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Machine learning; Logistic regression; Survival prediction; Support vector machine; Critical illness	OUTCOME PREDICTION; PERFORMANCE; VALIDATION; MODELS	Purpose: To compare twenty-two machine learning (ML) models against logistic regression on survival prediction in severe traumatic brain injury (STBI) patients in a single center study. Materials and methods: Data was collected from STBI patients admitted to the Sichuan Provincial People's Hospital between December 2009 and November 2011. Twenty-two machine learning (ML) models were tested, and their predictive performance compared with logistic regression (LR) model. Receiver operating characteristics (ROC), area under curve (AUC), accuracy, F-score, precision, recall and Decision Curve Analysis (DCA) were used as performance metrics. Results: A total of 117 patients were enrolled. AUC of all ML models ranged from 86.3% to 94%. AUC of LR was 83%, and accuracy was 88%. The AUC of Cubic SVM, Quadratic SVM and Linear SVM were higher than that of LR. The precision ratio of LR was 95% and recall ratio was 91%, both were lower than most ML models. The F-Score of LR was 0.93, which was only slightly better than that of Linear Discriminant and Quadratic Discriminant. Conclusions: The twenty-two ML models selected have capabilities comparable to classical LR model for outcome prediction in STBI patients. Of these, Cubic SVM, Quadratic SVM, Linear SVM performed significantly better than LR. (C) 2019 Elsevier Inc. All rights reserved.	[Feng, Jin-zhou; Wang, Yu; Peng, Jin; Sun, Ming-wei; Zeng, Jun; Jiang, Hua] Univ Elect Sci & Technol China, Inst Emergency & Disaster Med, Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp,Sch Med, 32 Yi Huan Lu Xi Er Duan, Chengdu, Sichuan, Peoples R China; [Feng, Jin-zhou; Wang, Yu; Peng, Jin; Zeng, Jun; Jiang, Hua] Sino Finnish Med AI Res Ctr, 32 Yi Huan Lu Xi Er Duan, Chengdu, Sichuan, Peoples R China; [Peng, Jin] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Histol Embryol & Neurobiol, 17 Peoples South Rd, Chengdu, Sichuan, Peoples R China		Jiang, H (corresponding author), Univ Elect Sci & Technol China, Inst Emergency & Disaster Med, Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp,Sch Med, 32 Yi Huan Lu Xi Er Duan, Chengdu, Sichuan, Peoples R China.	feng720930@126.com; wangyu@traumabank.org; admin@traumabank.org; 653176424@qq.com; zengjun@medmail.com.cn; hua.jiang@traumabank.org			Key Technology Research and Development Programof the Department of Science and Technology of Sichuan [2014FZ0125, 2018FZ0067]	This work was supported by the Key Technology Research and Development Programof the Department of Science and Technology of Sichuan [grant IDs 2014FZ0125, to HJ and 2018FZ0067, to MWS].	Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Belavagi MC, 2016, PROCEDIA COMPUT SCI, V89, P117, DOI 10.1016/j.procs.2016.06.016; Chen C, 2015, IEEE TRANS COMPUT SO, V2, P65, DOI 10.1109/TCSS.2016.2516039; Decruyenaere A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0206-y; Figaji Anthony A, 2013, Can J Neurol Sci, V40, P433; Griesdale DE, 2013, CANADIAN J NEUROLOGI, V40, P433, DOI [10.1017/S0317167100015286, DOI 10.1017/S0317167100015286]; Han JLXG, 2017, WORLD NEUROSURG, V108, P885, DOI 10.1016/j.wneu.2017.08.147; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jun Zeng, 2017, STUDY SYSTEMS BIOL C; Liu Da-wei, 2010, PRACTICE CRITICAL CA, V156; Liu NT, 2017, SHOCK, V48, P504, DOI 10.1097/SHK.0000000000000898; Majdan M, 2017, J NEUROSCI RURAL PRA, V8, P20, DOI 10.4103/0976-3147.193543; Masashi Sugiyama, 2015, GRAPHIC MACHINE LEAR; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Ravi D, 2017, IEEE J BIOMED HEALTH, V21, P4, DOI 10.1109/JBHI.2016.2636665; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; Sun J, 2016, THESIS; Sun Ming-wei, 2014, CHIN J EMERG MED, V23, P308; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Van Calster B, 2015, MED DECIS MAKING, V35, P162, DOI 10.1177/0272989X14547233; Vellido A, 2020, NEURAL COMPUT APPL, V32, P18069, DOI 10.1007/s00521-019-04051-w; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Zhou H., 2016, MACHINE LEARNING; Zhou Wei-hong, 2013, INJURY MED, V2, P34, DOI [10.3868/j.issn.2095-1566.2013.03.008, DOI 10.3868/J.ISSN.2095-1566.2013.03.008]; 李德培, 2015, [中华神经外科杂志, Chinese Journal of Neurosurgery], V31, P427	29	22	23	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2019	54						110	116		10.1016/j.jcrc.2019.08.010			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT4BE	WOS:000500935700021	31408805				2022-02-06	
J	Poynter, K; Boone, KB; Ermshar, A; Miora, D; Cottingham, M; Victor, TL; Ziegler, E; Zeller, MA; Wright, M				Poynter, Kellie; Boone, Kyle Brauer; Ermshar, Annette; Miora, Deborah; Cottingham, Maria; Victor, Tara L.; Ziegler, Elizabeth; Zeller, Michelle A.; Wright, Matthew			Wait, There's a Baby in this Bath Water! Update on Quantitative and Qualitative Cut-Offs for Rey 15-Item Recall and Recognition	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Rey 15-item plus recognition; Performance validity; Malingering	TRAUMATIC BRAIN-INJURY; CROSS-VALIDATION; MEMORY TEST; B TEST; PERFORMANCE; SPECIFICITY; SENSITIVITY; SCORES; TRIAL; NEUROPSYCHOLOGISTS	Objective: Evaluate the effectiveness of Rey 15-item plus recognition data in a large neuropsychological sample. Method: Rey 15-item plus recognition scores were compared in credible (n = 138) and noncredible (n = 353) neuropsychology referrals. Results: Noncredible patients scored significantly worse than credible patients on all Rey 15-item plus recognition scores. When cut-offs were selected to maintain at least 89.9% specificity, cut-offs could be made more stringent, with the highest sensitivity found for recognition correct (cut-off <= 11; 62.6% sensitivity) and the combination score (recall + recognition - false positives; cut-off <= 22; 60.6% sensitivity), followed by recall correct (cut-off <= 11; 49.3% sensitivity), and recognition false positive errors (>= 3; 17.9% sensitivity). A cut-off of >= 4 applied to a summed qualitative error score for the recall trial resulted in 19.4% sensitivity. Approximately 10% of credible subjects failed either recall correct or recognition correct, whereas two-thirds of noncredible patients (67.7%) showed this pattern. Thirteen percent of credible patients failed either recall correct, recognition correct, or the recall qualitative error score, whereas nearly 70% of noncredible patients failed at least one of the three. Some individual qualitative recognition errors had low false positive rates (<2%) indicating that their presence was virtually pathognomonic for noncredible performance. Older age (>50) and IQ < 80 were associated with increased false positive rates in credible patients. Conclusions: Data on a larger sample than that available in the 2002 validation study show that Rey 15-item plus recognition cut-offs can be made more stringent, and thereby detect up to 70% of noncredible test takers, but the test should be used cautiously in older individuals and in individuals with lowered IQ.	[Poynter, Kellie; Boone, Kyle Brauer; Ermshar, Annette; Miora, Deborah] Alliant Int Univ, Calif Sch Forens Studies, Los Angeles, CA 91803 USA; [Cottingham, Maria] Vet Adm Tennessee Valley Healthcare Syst, Mental Hlth Care Line, Nashville, TN 37212 USA; [Victor, Tara L.] Calif State Univ Dominguez Hills, Carson, CA 90747 USA; [Zeller, Michelle A.] West Los Angeles Vet Adm Med Ctr, Los Angeles, CA 90073 USA; [Wright, Matthew] Harbor UCLA Med Ctr, Torrance, CA 90509 USA		Boone, KB (corresponding author), Alliant Int Univ, Calif Sch Forens Studies, Los Angeles, CA 91803 USA.	kboone@kyleboonephd.com					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bailey KC, 2018, CLIN NEUROPSYCHOL, V32, P119, DOI 10.1080/13854046.2017.1333151; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K. B, 2017, TXB CLIN NEUROPSYCHO; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1224, DOI 10.1080/13854046.2014.987167; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Griffin GAE, 1996, PSYCHOL ASSESSMENT, V8, P383; Keary TA, 2013, J INT NEUROPSYCH SOC, V19, P314, DOI 10.1017/S1355617712001397; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; LaDuke C, 2018, CLIN NEUROPSYCHOL, V32, P145, DOI 10.1080/13854046.2017.1346711; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Love CM, 2014, ASSESSMENT, V21, P618, DOI 10.1177/1073191114528028; Marshall P, 2007, CLIN NEUROPSYCHOL, V21, P826, DOI 10.1080/13854040600801001; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCaul C, 2018, CLIN NEUROPSYCHOL, V32, P1054, DOI 10.1080/13854046.2018.1425481; Morse CL, 2013, CLIN NEUROPSYCHOL, V27, P1395, DOI 10.1080/13854046.2013.832385; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Roberson CJ, 2013, CLIN NEUROPSYCHOL, V27, P495, DOI 10.1080/13854046.2012.737027; Robles L, 2015, J CLIN EXP NEUROPSYC, V37, P614, DOI 10.1080/13803395.2015.1039961; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Solomon RE, 2010, CLIN NEUROPSYCHOL, V24, P1243, DOI 10.1080/13854046.2010.514864; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	34	22	22	2	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2019	34	8					1367	1380		10.1093/arclin/acy087			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	KF8XX	WOS:000509521200007	30395181	Bronze			2022-02-06	
J	Daugherty, J; Waltzman, D; Sarmiento, K; Xu, LK				Daugherty, Jill; Waltzman, Dana; Sarmiento, Kelly; Xu, Likang			Traumatic Brain Injury-Related Deaths by Race/Ethnicity, Sex, Intent, and Mechanism of Injury - United States, 2000-2017	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article							HOSPITALIZATIONS		[Daugherty, Jill; Waltzman, Dana; Sarmiento, Kelly; Xu, Likang] CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA		Daugherty, J (corresponding author), CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	jdaugherty@cdc.gov					Arias Elizabeth, 2016, Vital Health Stat 2, P1; CDC, 2010, EXT CAUS INJ MORT MA; Faul M, 2010, TRAUMATIC BRAIN INJU; Hedegaard H, 2017, MMWR-MORBID MORTAL W, V66, P567; Ivey-Stephenson AZ, 2017, MMWR SURVEILL SUMM, V66, DOI 10.15585/mmwr.ss6618a1; Langlois JA., 2004, TRAUMATIC BRAIN INJU; National Center for Health Statistics, 2019, US CENS POP BRIDG RA; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Stone DM, 2017, PREVENTING SUICIDE T; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1	10	22	24	1	2	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	NOV 22	2019	68	46					1050	1056		10.15585/mmwr.mm6846a2			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	JO7RF	WOS:000497772100002	31751321	gold, Green Published			2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Mapping brain recovery after concussion From acute injury to 1 year after medical clearance	NEUROLOGY			English	Article							CEREBRAL-BLOOD-FLOW; WHITE-MATTER INTEGRITY; RECURRENT CONCUSSION; SPORTS; NETWORK; CONNECTIVITY	Objective To test the hypothesis that concussion-related brain alterations seen at symptomatic injury and medical clearance to return to play (RTP) will have dissipated by 1 year after RTP. Methods For this observational study, 24 athletes with concussion were scanned longitudinally within 1 week after injury, at RTP, and 1 year after RTP. A large control cohort of 122 athletes were also scanned before the season. Each imaging session assessed global functional connectivity (Gconn) and cerebral blood flow (CBF), along with white matter fractional anisotropy (FA) and mean diffusivity (MD). The main effects of concussion on MRI parameters were evaluated at each postinjury time point. In addition, covariation was assessed between MRI parameters and clinical measures of acute symptom severity and time to RTP. Results Different aspects of brain physiology showed different patterns of recovery over time. Both Gconn and FA displayed no significant effects at 1 year after RTP, whereas CBF and MD exhibited persistent long-term effects. The effects of concussion on MRI parameters were also dependent on acute symptom severity and time to RTP for all postinjury time points. Conclusion This study provides the first longitudinal evaluation of concussion focused on time of RTP and 1 year after medical clearance, using multiple different MRI measures to assess brain structure and function. These findings significantly enhance our understanding of the natural course of brain recovery after a concussion.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada		Schweizer, TA (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.; Schweizer, TA (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.; Schweizer, TA (corresponding author), Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada.; Schweizer, TA (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	SchweizerT@smh.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [RN356342-401065, RN294001-367456]; Canadian Institute for Military and Veterans Health Research [W7714-145967]; Siemens Healthineers Canada	This work was supported by the Canadian Institutes of Health Research (grants RN356342-401065, RN294001-367456), the Canadian Institute for Military and Veterans Health Research (grant W7714-145967), and Siemens Healthineers Canada.	Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Murrell CJ, 2013, AGE, V35, P905, DOI 10.1007/s11357-012-9414-x; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Sankar SB, 2019, NEUROBIOL DIS, V124, P544, DOI 10.1016/j.nbd.2018.12.018; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Tan H, 2009, J MAGN RESON IMAGING, V29, P1134, DOI 10.1002/jmri.21721; Tarumi T, 2018, J NEUROCHEM, V144, P595, DOI 10.1111/jnc.14234; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	47	22	22	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 19	2019	93	21					E1980	E1992		10.1212/WNL.0000000000008523			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK3FD	WOS:000512631100007	31619480	Green Published			2022-02-06	
J	Marion, CM; McDaniel, DP; Armstrong, RC				Marion, Christina M.; McDaniel, Dennis. P.; Armstrong, Regina C.			Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						SARM1; Sterile alpha and TIR containing motif 1; Axon; Myelin; TBI; White matter; Corpus callosum; Myelin outfoldings; Demyelination; Traumatic axonal injury	WALLERIAN DEGENERATION; CORPUS-CALLOSUM; MYELIN SHEATHS; MILD; DEATH; PATHOLOGY; REPAIR; MODEL; ACTIVATION; NEUROINFLAMMATION	Traumatic brain injury (TBI) often damages axons in white matter tracts and causes corpus callosum (CC) atrophy in chronic TBI patients. Injured axons encounter irreversible damage if transected, or alternatively may maintain continuity and subsequently either recover or degenerate. Secondary mechanisms can cause further axon damage, myelin pathology, and neuroinflammation. Molecular mechanisms regulating the progression of white matter pathology indicate potential therapeutic targets. SARM1 is essential for execution of the conserved axon death pathway. We examined white matter pathology following mild TBI with CC traumatic axonal injury in mice with Sarml gene deletion (Sarm1 - / -). High resolution ultrastructural analysis at 3 days post-TBI revealed dramatically reduced axon damage in Sarm1 - / - mice, as compared to Sarm1 + / + wild-type controls. Sarml deletion produced larger axons with thinner myelin, and attenuated TBI induced demyelination, i.e. myelin loss along apparently intact axons. At 6 weeks post-TBI, Sarm1 - / - mice had less demyelination and thinner myelin than Sarm1 + / + mice, but axonal protection was no longer observed. We next used Thy1-YFP crosses to assess Sarml involvement in white matter neurodegeneration and neuroinflammation at 8 weeks post-TBI, when significant CC atrophy indicates chronic pathology. Thyl-YFP expression demonstrated continued CC axon damage yet absence of overt cortical pathology. Importantly, significant CC atrophy in Thy1-YFP/Sarm1 + / + mice was associated with reduced neurofilament immunolabeling of axons. Both effects were attenuated in Thy1-YFP/Sarm1 - / - mice. Surprisingly, Thy1-YFP/Sarm1 - / - mice had increased CC astrogliosis. This study demonstrates that Sarmi inactivation reduces demyelination, and white matter atrophy after TBI, while the post-injury stage impacts when axon protection is effective.	[Marion, Christina M.; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [McDaniel, Dennis. P.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Biomed Instrumentat Ctr, Bethesda, MD 20814 USA; [McDaniel, Dennis. P.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Marion, Christina M.; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Program Neurosci, Bethesda, MD 20814 USA		Armstrong, RC (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	regina.armstrong@usuhs.edu	Marion, Christina M/B-8120-2015	Marion, Christina M/0000-0003-0381-4109; Armstrong, Regina/0000-0001-7296-6750	U.S. Department of Defense Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [CNRM703386, CNRM702720]; Defense Health Agency [ST7434918]	The authors thank Tuan Le and Xiaomei Zi for their technical assistance. These studies were funded by the U.S. Department of Defense Center for Neuroscience and Regenerative Medicine (CNRM703386; CNRM702720) and Defense Health Agency (ST7434918).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Blakemore W F, 1981, Prog Clin Biol Res, V59A, P105; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Desbois M, 2018, J BIOL CHEM, V293, P13897, DOI 10.1074/jbc.RA118.002176; DiLeonardi AM, 2012, J NEUROPATH EXP NEUR, V71, P959, DOI 10.1097/NEN.0b013e31826f5876; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Duncan ID, 2017, P NATL ACAD SCI USA, V114, pE9685, DOI 10.1073/pnas.1714183114; Erwig MS, 2019, ELIFE, V8, DOI 10.7554/eLife.43888; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Filous AR, 2016, PROG NEUROBIOL, V144, P173, DOI 10.1016/j.pneurobio.2016.03.009; FRANSON P, 1984, J COMP NEUROL, V223, P138, DOI 10.1002/cne.902230111; Gamage KK, 2017, CURR BIOL, V27, P1250, DOI 10.1016/j.cub.2017.03.058; Geisler S, 2019, J EXP MED, V216, P294, DOI 10.1084/jem.20181040; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gilley J, 2019, HUM MOL GENET, V28, P448, DOI 10.1093/hmg/ddy356; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Goldstein EZ, 2016, EXP NEUROL, V283, P550, DOI 10.1016/j.expneurol.2016.05.001; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loreto A, 2015, CELL REP, V13, P2539, DOI 10.1016/j.celrep.2015.11.032; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Malapati H, 2017, MOL GENET GENOMICS, V292, P909, DOI 10.1007/s00438-017-1320-6; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; Mi S, 2011, NAT MED, V17, P816, DOI 10.1038/nm.2373; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Morrison BM, 2013, TRENDS CELL BIOL, V23, P644, DOI 10.1016/j.tcb.2013.07.007; Murata H, 2018, J BIOL CHEM, V293, P18933, DOI 10.1074/jbc.RA118.004578; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Neukomm LJ, 2017, NEURON, V95, P78, DOI 10.1016/j.neuron.2017.06.031; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Ontaneda D, 2017, MULT SCLER J, V23, P1627, DOI 10.1177/1352458517729465; Ontaneda D, 2017, LANCET, V389, P1357, DOI 10.1016/S0140-6736(16)31320-4; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Pan S, 2017, J CELL BIOL, V216, P3903, DOI 10.1083/jcb.201702150; Patzig J, 2016, ELIFE, V5, DOI 10.7554/eLife.17119; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Pieper AA, 2018, COLD SH Q B, V83, P207, DOI 10.1101/sqb.2018.83.037622; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROSENBLUTH J, 1966, J CELL BIOL, V28, P73, DOI 10.1083/jcb.28.1.73; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Simon DJ, 2018, CURR OPIN NEUROL, V31, P693, DOI 10.1097/WCO.0000000000000621; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; STURROCK RR, 1976, J GERONTOL, V31, P513, DOI 10.1093/geronj/31.5.513; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Summers DW, 2018, P NATL ACAD SCI USA, V115, pE8746, DOI 10.1073/pnas.1806933115; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; VIAL JD, 1958, J BIOPHYS BIOCHEM CY, V4, P551, DOI 10.1083/jcb.4.5.551; WEBSTER HDF, 1962, J CELL BIOL, V12, P361; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhou YX, 2012, NEUROBIOL DIS, V45, P196, DOI 10.1016/j.nbd.2011.08.004; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	91	22	22	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2019	321								113040	10.1016/j.expneurol.2019.113040			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA1KF	WOS:000487575200011	31445042	hybrid			2022-02-06	
J	Yao, MH; Gao, F; Xu, R; Zhang, JN; Chen, YH; Guan, FX				Yao, Minghao; Gao, Feng; Xu, Ru; Zhang, Junni; Chen, Yihao; Guan, Fangxia			A dual-enzymatically cross-linked injectable gelatin hydrogel loaded with BMSC improves neurological function recovery of traumatic brain injury in rats	BIOMATERIALS SCIENCE			English	Article							MESENCHYMAL STEM-CELLS; COLLAGEN SCAFFOLDS; HYALURONIC-ACID; IN-SITU; DIFFERENTIATION; TRANSPLANTATION; PREVENTION	Injectable hydrogels can perfectly fill defective areas and thereby show promise as therapeutic implants or cell/drug delivery vehicles in traumatic brain injury (TBI) or other tissue repair. In this study, an injectable gelatin hydrogel in situ dual-enzymatically cross-linked by glucose oxidase (GOX) and horseradish peroxidase (HRP) was synthesized and optimized, and the therapeutic effect of this hydrogel encapsulated with bone mesenchymal stem cells (BMSC) for TBI rats was investigated. By changing the GOX content, we found that this hydrogel cross-linked by 0.1 U mL(-1) GOX possesses better cytocompatibility than that with a higher GOX content, and minimized immune response in vivo. More importantly, this hydrogel loaded with BMSC could significantly accelerate the healing process of a damaged region, facilitate the survival and proliferation of endogenous nerve cells probably by nutrition supply and apoptosis suppression, and consequently promote the neurological function recovery of the TBI rat model. All these findings highlight that this injectable and BMSC-laden gelatin hydrogel has enormous potential for TBI therapy and other tissue regeneration strategies.	[Yao, Minghao; Gao, Feng; Xu, Ru; Zhang, Junni; Chen, Yihao; Guan, Fangxia] Zhengzhou Univ, Sch Life Sci, 100 Sci Rd, Zhengzhou 450001, Henan, Peoples R China; [Yao, Minghao; Guan, Fangxia] Zhengzhou Univ, Ctr Stem Cell & Regenerat Med, Affiliated Hosp 1, 40 Univ Rd, Zhengzhou 450052, Henan, Peoples R China		Yao, MH; Guan, FX (corresponding author), Zhengzhou Univ, Sch Life Sci, 100 Sci Rd, Zhengzhou 450001, Henan, Peoples R China.; Yao, MH; Guan, FX (corresponding author), Zhengzhou Univ, Ctr Stem Cell & Regenerat Med, Affiliated Hosp 1, 40 Univ Rd, Zhengzhou 450052, Henan, Peoples R China.	yao453343550@126.com; fxguan@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1804198, NSFC 31700820]; National Natural Science Foundation of Henan province [U1804198]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M612420]; Key Scientific Research Projects of Higher Education Institutions in Henan Province [18A180003]	We acknowledge funding from the Joint Fund of the National Natural Science Foundation of China and Henan province (U1804198), the National Natural Science Foundation of China (NSFC 31700820), the China Postdoctoral Science Foundation (2017M612420), and the Key Scientific Research Projects of Higher Education Institutions in Henan Province (18A180003).	Arulmoli J, 2016, ACTA BIOMATER, V43, P122, DOI 10.1016/j.actbio.2016.07.043; Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI [10.1021/cr100123h, 10.1680/jbibn.15.00017]; Bertlein S, 2017, ADV MATER, V29, DOI 10.1002/adma.201703404; Carbonara M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00885; Cosson S, 2015, STEM CELL TRANSL MED, V4, P156, DOI 10.5966/sctm.2014-0203; Dekmak A, 2018, BEHAV BRAIN RES, V340, P49, DOI 10.1016/j.bbr.2016.12.039; Dimatteo R, 2018, ADV DRUG DELIVER REV, V127, P167, DOI 10.1016/j.addr.2018.03.007; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; James S, 2015, STEM CELL REP, V4, P1004, DOI 10.1016/j.stemcr.2015.05.005; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kim BY, 2016, MACROMOL BIOSCI, V16, P1570, DOI 10.1002/mabi.201600312; Kim KS, 2011, ACTA BIOMATER, V7, P666, DOI 10.1016/j.actbio.2010.09.030; Kim SH, 2018, BIOMATERIALS, V178, P401, DOI 10.1016/j.biomaterials.2018.04.057; Lee Y, 2018, ACS APPL MATER INTER, V10, P18372, DOI 10.1021/acsami.8b04522; Li H, 2018, WIRELESS COMMUNICATI, V2018, P1; Lim KS, 2016, ACS BIOMATER SCI ENG, V2, P1752, DOI 10.1021/acsbiomaterials.6b00149; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Morris DC, 2017, NEUROSCI LETT, V659, P7, DOI 10.1016/j.neulet.2017.08.064; Munoz Z, 2014, BIOMATER SCI-UK, V2, P1063, DOI 10.1039/c4bm00070f; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Sakai S, 2015, ACTA BIOMATER, V24, P152, DOI 10.1016/j.actbio.2015.06.023; Santoro M, 2014, J CONTROL RELEASE, V190, P210, DOI 10.1016/j.jconrel.2014.04.014; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Su J, 2019, BIOMATERIALS, V201, P99, DOI 10.1016/j.biomaterials.2019.02.001; Vindigni V, 2009, INT J MOL SCI, V10, P2972, DOI 10.3390/ijms10072972; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xu GH, 2015, ACTA BIOMATER, V15, P55, DOI 10.1016/j.actbio.2014.12.016; Yao MH, 2014, J MATER CHEM B, V2, P3123, DOI 10.1039/c4tb00107a; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g	40	22	22	9	91	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2047-4830	2047-4849		BIOMATER SCI-UK	Biomater. Sci.	OCT 1	2019	7	10					4088	4098		10.1039/c9bm00749k			11	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	JA3UJ	WOS:000487753500009	31355388				2022-02-06	
J	Li, L; Tan, HP; Liu, CY; Yu, LT; Wei, DN; Zhang, ZC; Lu, K; Zhao, KS; Maegele, M; Cai, DZ; Gu, ZT				Li, Li; Tan, Hong-Ping; Liu, Cheng-Yong; Yu, Lin-Tao; Wei, Da-Nian; Zhang, Zi-Chen; Lu, Kui; Zhao, Ke-Sen; Maegele, Marc; Cai, Dao-Zhang; Gu, Zheng-Tao			Polydatin prevents the induction of secondary brain injury after traumatic brain injury by protecting neuronal mitochondria	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; polydatin; mitochondria; endoplasmic reticulum stress; SIRT1; reactive oxygen species; p38; mitochondrial membrane potential; mitochondrial permeability transition pore; lateral fluid percussion; neural regeneration	ENDOPLASMIC-RETICULUM STRESS; SEVERE HEMORRHAGIC-SHOCK; ARTERIAL SMOOTH-MUSCLE; APOPTOSIS; ISCHEMIA; SIRT1; NEUROPROTECTION; HYPOTHERMIA; INHIBITION; DAMAGE	Polydatin is thought to protect mitochondria in different cell types in various diseases. Mitochondrial dysfunction is a major contributing factor in secondary brain injury resulting from traumatic brain injury. To investigate the protective effect of polydatin after traumatic brain injury, a rat brain injury model of lateral fluid percussion was established to mimic traumatic brain injury insults. Rat models were intra-peritoneally injected with polydatin (30 mg/kg) or the SIRT1 activator SRT1720 (20 mg/kg, as a positive control to polydatin). At 6 hours post-traumatic brain injury insults, western blot assay was used to detect the expression of SIRT1, endoplasmic reticulum stress related proteins and p38 phosphorylation in cerebral cortex on the injured side. Flow cytometry was used to analyze neuronal mitochondrial superoxide, mitochondrial membrane potential and mitochondrial permeability transition pore opened. Ultrastructural damage in neuronal mitochondria was measured by transmission electron microscopy. Our results showed that after treatment with polydatin, release of reactive oxygen species in neuronal mitochondria was markedly reduced; swelling of mitochondria was alleviated; mitochondrial membrane potential was maintained; mitochondrial permeability transition pore opened. Also endoplasmic reticulum stress related proteins were inhibited, including the activation of p-PERK, spliced XBP-1 and cleaved ATF6. SIRT1 expression and activity were increased; p38 phosphorylation and cleaved caspase-9/3 activation were inhibited. Neurological scores of treated rats were increased and the mortality was reduced compared with the rats only subjected to traumatic brain injury. These results indicated that polydatin protectrd rats from the consequences of traumatic brain injury and exerted a protective effect on neuronal mitochondria. The mechanisms may be linked to increased SIRT1 expression and activity, which inhibits the p38 phosphorylation-mediated mitochondrial apoptotic pathway.	[Li, Li; Liu, Cheng-Yong; Wei, Da-Nian; Zhang, Zi-Chen; Maegele, Marc; Gu, Zheng-Tao] Southern Med Univ, Affiliated Hosp 3, Acad Orthoped Guangdong Prov, Dept Treatment Ctr Traumat Injuries, Guangzhou, Guangdong, Peoples R China; [Li, Li; Zhao, Ke-Sen; Gu, Zheng-Tao] Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat Res, Guangzhou, Guangdong, Peoples R China; [Tan, Hong-Ping] Guangdong Sanjiu Brain Hosp, Dept Epilepsy Surg, Guangzhou, Guangdong, Peoples R China; [Yu, Lin-Tao; Lu, Kui] Southern Med Univ, Affiliated Hosp 3, Dept Emergency, Acad Orthoped Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Maegele, Marc] UW H, CMMC, Dept Traumatol & Orthoped Surg, Campus Cologne Merheim, Cologne, Germany; [Li, Li; Cai, Dao-Zhang] Southern Med Univ, Acad Orthoped Guangdong Prov, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China		Gu, ZT (corresponding author), Southern Med Univ, Affiliated Hosp 3, Acad Orthoped Guangdong Prov, Dept Treatment Ctr Traumat Injuries, Guangzhou, Guangdong, Peoples R China.; Gu, ZT (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat Res, Guangzhou, Guangdong, Peoples R China.; Cai, DZ (corresponding author), Southern Med Univ, Acad Orthoped Guangdong Prov, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China.	cdz@smu.edu.cn; guzhengtao@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501690]; Scientific Research Staring Foundation for Talent Introduction for Southern Medical University	This study was supported by the National Natural Science Foundation of China, No. 81501690 (to ZTG); the Scientific Research Staring Foundation for Talent Introduction for Southern Medical University (to MM). The funding sources had no role in study conception and design, data analysis or interpretation, paper writing or deciding to submit this paper for publication.	Boeck CR, 2013, MOL CELL BIOCHEM, V384, P129, DOI 10.1007/s11010-013-1790-8; Bown D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211684; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cheng YF, 2006, BRAIN RES, V1110, P193, DOI 10.1016/j.brainres.2006.06.065; Chiu AW, 2017, SEMIN RESP CRIT CARE, V38, P768, DOI 10.1055/s-0037-1607989; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLAMENG W, 1980, J THORAC CARDIOV SUR, V79, P413; Fraunberger EA, 2019, BRAIN INJURY, V19, P1; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; Go BS, 2017, MOL NEUROBIOL, V54, P4041, DOI 10.1007/s12035-016-9969-0; Gulyaeva NV, 2015, J NEUROCHEM, V132, P263, DOI 10.1111/jnc.13016; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Khader A, 2017, J SURG RES, V219, P288, DOI 10.1016/j.jss.2017.06.031; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Lee SW, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1423-6; Li FF, 2020, BRAIN IMAGING BEHAV, V14, P907, DOI 10.1007/s11682-019-00053-3; Li H, 2015, J NEUROL SCI, V357, P270, DOI 10.1016/j.jns.2015.08.004; Li P, 2017, INT J MOL MED, V39, P1127, DOI 10.3892/ijmm.2017.2932; Li PY, 2015, EXPERT OPIN THER TAR, V19, P997, DOI 10.1517/14728222.2015.1054806; Li QZ, 2019, J MOL NEUROSCI, V67, P574, DOI 10.1007/s12031-019-01263-6; Li T, 2014, INT J CLIN EXP PATHO, V7, P8401; Liao P, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1749-y; Ling YN, 2016, CLIN SCI, V130, P1641, DOI 10.1042/CS20160082; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Ruan WC, 2019, CELL MOL NEUROBIOL, V39, P265, DOI 10.1007/s10571-018-00646-4; Song R, 2011, AM J HYPERTENS, V24, P45, DOI 10.1038/ajh.2010.184; Su SY, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-26; Sun DD, 2017, CELL MOL NEUROBIOL, V37, P1349, DOI 10.1007/s10571-017-0484-2; Sun GZ, 2016, NEURAL REGEN RES, V11, P1260, DOI 10.4103/1673-5374.189190; Takeda K, 2002, GENES CELLS, V7, P1099, DOI 10.1046/j.1365-2443.2002.00591.x; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wagner AK, 2019, NEUROPHARMACOLOGY, V145, P133, DOI 10.1016/j.neuropharm.2018.09.011; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Wang XM, 2012, AM J PHYSIOL-REG I, V302, pR805, DOI 10.1152/ajpregu.00350.2011; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zeng Zhenhua, 2016, Oxid Med Cell Longev, V2016, P1737185, DOI 10.1155/2016/1737185; Zeng ZH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/965961; Zeng ZH, 2015, J SURG RES, V198, P192, DOI 10.1016/j.jss.2015.05.041; Zhang XM, 2015, NEUROCHEM INT, V90, P1, DOI 10.1016/j.neuint.2015.06.010; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zheng N, 2017, J CELL PHYSIOL, V232, P2776, DOI 10.1002/jcp.25943	54	22	23	1	12	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	SEP	2019	14	9					1573	1582		10.4103/1673-5374.255972			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HY3XE	WOS:000468060200022	31089056	Green Published, gold			2022-02-06	
J	Liu, SF; Utriainen, D; Chai, C; Chen, YS; Wang, L; Sethi, SK; Xia, S; Haacke, EM				Liu, Saifeng; Utriainen, David; Chai, Chao; Chen, Yongsheng; Wang, Lin; Sethi, Sean K.; Xia, Shuang; Haacke, E. Mark			Cerebral microbleed detection using Susceptibility Weighted Imaging and deep learning	NEUROIMAGE			English	Article						Cerebral microbleeds; Computer aided detection; Deep learning; Convolutional neural networks; Susceptibility weighted imaging; Quantitative susceptibility mapping	TRAUMATIC BRAIN-INJURY; COMPUTER-AIDED DETECTION; IDENTIFICATION; CALCIFICATION	Detecting cerebral microbleeds (CMBs) is important in diagnosing a variety of diseases including dementia, stroke and traumatic brain injury. However, manual detection of CMBs can be time-consuming and prone to errors, whereas the current automatic algorithms for CMB detection are usually limited by large number of false positives. In this study, we present a two-stage CMB detection framework which contains a candidate detection stage based on a 3D fast radial symmetry transform of the composite images from Susceptibility Weighted Imaging (SWI), and a false positive reduction stage based on deep residual neural networks using both the SWI and the high-pass filtered phase images. While the SWI images provide exquisite sensitivity to the presence of blood products, the high-pass filtered phase images enable the differentiation of diamagnetic calcifications from paramagnetic microbleeds. The deep learning model was trained using 154 data sets, and the best models were selected using 25 validation data sets. Finally, the models were tested using 41 cases, including 13 hemodialysis cases, 9 traumatic brain injury cases, 9 stroke cases and 10 healthy controls. Using 3D SWI and high-pass filtered phase images as input, the best model led to a sensitivity of 95.8%, a precision of 70.9%, and 1.6 false positives per case. This model achieved similar performance to the most experienced human rater and outperformed recently reported CMB detection methods. This study demonstrates the potential of applying deep learning techniques to medical imaging for improving efficiency and accuracy in diagnosis.	[Liu, Saifeng; Utriainen, David; Chen, Yongsheng; Wang, Lin; Sethi, Sean K.; Haacke, E. Mark] MRI Inst Biomed Res, Bingham Farms, MI USA; [Utriainen, David; Sethi, Sean K.; Haacke, E. Mark] Magnet Resonance Innovat, Bingham Farms, MI USA; [Chai, Chao; Xia, Shuang] Tianjin First Cent Hosp, Dept Radiol, Tianjin, Peoples R China; [Chen, Yongsheng; Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI USA		Liu, SF (corresponding author), 30200 Telegraph Rd,Ste 104, Bingham Farms, MI 48025 USA.	liusaifeng@gmail.com	Chen, Yongsheng/U-9800-2019	Chen, Yongsheng/0000-0001-7114-5731	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871342]	This work was supported in part by the National Natural Science Foundation of China (grant number 81871342 to Shuang Xia).	Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Barnes SRS, 2011, MAGN RESON IMAGING, V29, P844, DOI 10.1016/j.mri.2011.02.028; Bian W, 2013, NEUROIMAGE-CLIN, V2, P282, DOI 10.1016/j.nicl.2013.01.012; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Chen YC, 2019, J DIGIT IMAGING, V32, P766, DOI 10.1007/s10278-018-0146-z; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dou Q, 2016, IEEE T MED IMAGING, V35, P1182, DOI 10.1109/TMI.2016.2528129; Fan YH, 2003, STROKE, V34, P2459, DOI 10.1161/01.STR.0000090841.90286.81; Fatemi-Ardekani A, 2009, MED PHYS, V36, P5429, DOI 10.1118/1.3250860; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Faziollahi A, 2014, I S BIOMED IMAGING, P113, DOI 10.1109/ISBI.2014.6867822; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Krizhevsky A., 2012, ADV NEURAL INFORM PR, P1097, DOI DOI 10.1145/3065386; Kuijf HJ, 2012, NEUROIMAGE, V59, P2266, DOI 10.1016/j.neuroimage.2011.09.061; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Liu SF, 2017, PROC SPIE, V10134, DOI 10.1117/12.2277121; LIU SF, 2017, NMR BIOMED, V30, DOI DOI 10.1002/NBM.3552; Loshchilov I, 2017, DECOUPLED WEIGHT DEC; Loy G, 2002, LECT NOTES COMPUT SC, V2350, P358; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Pacurar EE, 2016, NEUROIMAGE, V124, P1220, DOI 10.1016/j.neuroimage.2015.04.066; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Yates PA, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00205; ZHAO ZJ, 2019, IEEE T NEUR NET LEAR, DOI DOI 10.1080/24699322.2018.1560097	43	22	22	6	26	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	SEP	2019	198						271	282		10.1016/j.neuroimage.2019.05.046			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	IE6OI	WOS:000472495100023	31121296				2022-02-06	
J	Shahror, RA; Linares, GR; Wang, Y; Hsueh, SC; Wu, CC; Chuang, DM; Chiang, YH; Chen, KY				Shahror, Rami Ahmad; Linares, Gabriel R.; Wang, Yun; Hsueh, Shih-Chang; Wu, Chung-Che; Chuang, De-Maw; Chiang, Yung-Hsiao; Chen, Kai-Yun			Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						fibroblast growth factor 21; mesenchymal stem cells; neurogenesis; spatial learning and memory; traumatic brain injury	MORRIS WATER MAZE; OBJECT RECOGNITION; PPAR-ALPHA; ABERRANT NEUROGENESIS; HIPPOCAMPAL-LESIONS; PERIRHINAL CORTEX; MEMORY DEFICITS; VALPROIC ACID; MILD; MODERATE	Traumatic brain injury (TBI) is a progressive and complex pathological condition that results in multiple adverse consequences, including impaired learning and memory. Transplantation of mesenchymal stem cells (MSCs) has produced limited benefits in experimental TBI models. Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that has neuroprotective effects, promotes remyelination, enhances angiogenesis, and elongates astrocytic processes. In this study, MSCs were genetically engineered to overexpress FGF21 in order to improve their efficacy in TBI. MSCs overexpressing FGF21 (MSC-FGF21) were transplanted to mouse brain by intracerebroventricular injection 24 h after TBI was induced by controlled cortical impact (CCI). Hippocampus-dependent spatial learning and memory, assessed by the Morris water maze test, was markedly decreased 3-4 weeks after TBI, a deficit that was robustly recovered by treatment with MSC-FGF21, but not MSC-mCherry control. Hippocampus-independent learning and memory, assessed by the novel object recognition test, was also impaired; these effects were blocked by treatment with both MSC-FGF21 and MSC-mCherry control. FGF21 protein levels in the ipsilateral hippocampus were drastically reduced 4 weeks post-TBI, a loss that was restored by treatment with MSC-FGF21, but not MSC-mCherry. MSC-FGF21 treatment also partially restored TBI-induced deficits in neurogenesis and maturation of immature hippocampal neurons, whereas MSC-mCherry was less effective. Finally, MSC-FGF21 treatment also normalized TBI-induced impairments in dendritic arborization of hippocampal neurons. Taken together, the results indicate that MSC-FGF21 treatment significantly improved TBI-induced spatial memory deficits, impaired hippocampal neurogenesis, and abnormal dendritic morphology. Future clinical investigations using MSC-FGF21 to improve post-TBI outcomes are warranted.	[Shahror, Rami Ahmad; Hsueh, Shih-Chang; Chuang, De-Maw; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Shahror, Rami Ahmad; Hsueh, Shih-Chang; Chuang, De-Maw; Chiang, Yung-Hsiao; Chen, Kai-Yun] Natl Hlth Res Inst, Taipei, Taiwan; [Shahror, Rami Ahmad; Hsueh, Shih-Chang; Wu, Chung-Che; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, TMU Neurosci Res Ctr, Taipei, Taiwan; [Linares, Gabriel R.; Chuang, De-Maw] NIMH, Intramural Res Program, NIH, MSC-1363, Bethesda, MD 20892 USA; [Linares, Gabriel R.] Univ Southern Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA; [Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan		Chuang, DM (corresponding author), NIMH, Intramural Res Program, NIH, MSC-1363, Bethesda, MD 20892 USA.; Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, 250 Wu Hsing St, Taipei 110, Taiwan.	chuang@mail.nih.gov; kychen08@tmu.edu.tw		Shahror, Rami/0000-0001-6403-9404	Ministry of Science and Technology [MOST 104-2923-B-038-004 -MY2, MOST 107-2314-B-038-063, MOST 107-2314-B-038-042]; Taipei Medical University [TMU 106-5400-004-400, TMU106-5310-001-400]; Intramural Research Program of NIMH, NIH in the USA	This study was supported by Ministry of Science and Technology Grants (MOST 104-2923-B-038-004 -MY2, MOST 107-2314-B-038-063, and MOST 107-2314-B-038-042) and Taipei Medical University (TMU 106-5400-004-400 andTMU106-5310-001-400). We thank the partial support from the Intramural Research Program of NIMH, NIH in the USA and the Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital for generously lending facility support. We also thank Ms. Ioline Henter (NIMH-NIH, USA) for invaluable editorial assistance.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bussey TJ, 1999, J NEUROSCI, V19, P495, DOI 10.1523/JNEUROSCI.19-01-00495.1999; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Child KM, 2018, J NEUROSCI, V38, P6806, DOI 10.1523/JNEUROSCI.3261-17.2018; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Czurko A, 1997, P NATL ACAD SCI USA, V94, P2766, DOI 10.1073/pnas.94.6.2766; Donega V, 2015, PEDIATR RES, V78, P520, DOI 10.1038/pr.2015.145; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Good MA, 2007, BEHAV NEUROSCI, V121, P218, DOI 10.1037/0735-7044.121.1.218; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kuroda M, 2017, J CLIN INVEST, V127, P3502, DOI 10.1172/JCI94337; Lai JH, 2019, J NEUROTRAUM, V36, P1054, DOI 10.1089/neu.2018.5949; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Leng Y, 2015, MOL PSYCHIATR, V20, P215, DOI 10.1038/mp.2013.192; Leng Y, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw035; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Linares GR, 2016, EXP NEUROL, V281, P81, DOI 10.1016/j.expneurol.2016.04.003; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Makela J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-2; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Mishra SK, 2017, STEM CELL TRANSL MED, V6, P316, DOI 10.5966/sctm.2016-0087; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUMBY DG, 1994, BEHAV NEUROSCI, V108, P11, DOI 10.1037/0735-7044.108.1.11; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Norman G, 2004, BEHAV BRAIN RES, V148, P79, DOI 10.1016/S0166-4328(03)00176-1; Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Sakata H, 2012, J NEUROSCI, V32, P3462, DOI 10.1523/JNEUROSCI.5686-11.2012; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sun XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090667; Tsai LK, 2011, STROKE, V42, P2932, DOI 10.1161/STROKEAHA.110.612788; Tsai LK, 2010, NEUROPSYCHOPHARMACOL, V35, P2225, DOI 10.1038/npp.2010.97; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang SY, 2013, INT J DEV NEUROSCI, V31, P30, DOI 10.1016/j.ijdevneu.2012.09.004; Wang ZF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19626; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Xu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082997; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942	67	22	23	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6422		AUG 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IS6VV	WOS:000482290200001	31298621	Green Published, Bronze			2022-02-06	
J	Heyburn, L; Abutarboush, R; Goodrich, S; Urioste, R; Batuure, A; Statz, J; Wilder, D; Ahlers, ST; Long, JB; Sajja, VSSS				Heyburn, Lanier; Abutarboush, Rania; Goodrich, Samantha; Urioste, Rodrigo; Batuure, Andrew; Statz, Jonathan; Wilder, Donna; Ahlers, Stephen T.; Long, Joseph B.; Sajja, Venkata Siva Sai Sujith			Repeated Low-Level Blast Overpressure Leads to Endovascular Disruption and Alterations in TDP-43 and Piezo2 in a Rat Model of Blast TBI	FRONTIERS IN NEUROLOGY			English	Article						blast-induced neurotrauma; blood-brain barrier; Piezo2; TDP-43; low-level blast; training relevant; repeated exposures; cumulative effects	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; EXPOSURE; INFLAMMATION; PERMEABILITY; DEGENERATION; INDUCTION; DAMAGE	Recent evidence linking repeated low-level blast overpressure exposure in operational and training environments with neurocognitive decline, neuroinflammation, and neurodegenerative processes has prompted concern over the cumulative deleterious effects of repeated blast exposure on the brains of service members. Repetitive exposure to low-level primary blast may cause symptoms (subclinical) similar to those seen in mild traumatic brain injury (TBI), with progressive vascular and cellular changes, which could contribute to neurodegeneration. At the cellular level, the mechanical force associated with blast exposure can cause cellular perturbations in the brain, leading to secondary injury. To examine the cumulative effects of repetitive blast on the brain, an advanced blast simulator (ABS) was used to closely mimic "free-field" blast. Rats were exposed to 1-4 daily blasts (one blast per day, separated by 24 h) at 13, 16, or 19 psi peak incident pressures with a positive duration of 4-5 ms, either in a transverse or longitudinal orientation. Blood-brain barrier (BBB) markers (vascular endothelial growth factor (VEGF), occludin, and claudin-5), transactive response DNA binding protein (TDP-43), and the mechanosensitive channel Piezo2 were measured following blast exposure. Changes in expression of VEGF, occludin, and claudin-5 after repeated blast exposure indicate alterations in the BBB, which has been shown to be disrupted following TBI. TDP-43 is very tightly regulated in the brain and altered expression of TDP-43 is found in clinically-diagnosed TBI patients. TDP-43 levels were differentially affected by the number and magnitude of blast exposures, decreasing after 2 exposures, but increasing following a greater number of exposures at various intensities. Lastly, Piezo2 has been shown to be dysregulated following blast exposure and was here observed to increase after multiple blasts of moderate magnitude, indicating that blast may cause a change in sensitivity to mechanical stimuli in the brain and may contribute to cellular injury. These findings reveal that cumulative effects of repeated exposures to blast can lead to pathophysiological changes in the brain, demonstrating a possible link between blast injury and neurodegenerative disease, which is an important first step in understanding how to prevent these diseases in soldiers exposed to blast.	[Heyburn, Lanier; Urioste, Rodrigo; Batuure, Andrew; Wilder, Donna; Long, Joseph B.; Sajja, Venkata Siva Sai Sujith] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA; [Abutarboush, Rania; Goodrich, Samantha; Statz, Jonathan; Ahlers, Stephen T.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD USA; [Abutarboush, Rania; Goodrich, Samantha; Statz, Jonathan] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA		Sajja, VSSS (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	venkatasivasaisujith.sajja.ctr@mail.mil	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501; Heyburn, Lanier/0000-0001-6228-4801	Defense Health Program [602115HP.3720.001]	This work was supported/funded by work unit number 602115HP.3720.001.A1317 as a part of the Exposure Standards for Repeated Blast program is funded by the Defense Health Program managed by Joint Program Committee 5.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Baralle M, 2013, BIOCHEM SOC T, V41, P1536, DOI 10.1042/BST20130186; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; DVBIC. Defense and Veterans Brain Injury Center, 2018, DOD NUMB TRAUM BRAIN; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Geiseler SJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051362; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sajja VS, 2018, NEUROMETHODS, V139, P123, DOI 10.1007/978-1-4939-8564-7_8; Sajja VS, 2017, PULMONARY INJURIES S; Schrenk-Siemens K, 2015, NAT NEUROSCI, V18, P10, DOI 10.1038/nn.3894; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Unnikrishnan G, 2019, EFFECTS ANIMAL ORIEN; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	49	22	22	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 30	2019	10								766	10.3389/fneur.2019.00766			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IM2HU	WOS:000477814400001	31417481	Green Published, gold			2022-02-06	
J	Abeare, C; Messa, I; Whitfield, C; Zuccato, B; Casey, J; Rykulski, N; Erdodi, L				Abeare, Christopher; Messa, Isabelle; Whitfield, Cameron; Zuccato, Brandon; Casey, Joseph; Rykulski, Nicholas; Erdodi, Laszlo			Performance Validity in Collegiate Football Athletes at Baseline Neurocognitive Testing	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						baseline testing; concussion; ImPACT; neurocognitive testing; performance validity; sport neuropsychology	SPORT-RELATED CONCUSSION; RECOGNITION MEMORY TEST; COMPLEX IDEATIONAL MATERIAL; TRAUMATIC BRAIN-INJURY; DIGIT SPAN; CLASSIFICATION ACCURACY; INVALID PERFORMANCE; AMERICAN ACADEMY; RESPONSE BIAS; TEST-SCORES	Objective: To assess the prevalence of invalid performance on baseline neurocognitive testing using embedded measures within computerized tests and individually administered neuropsychological measures, and to examine the influence of incentive status and performance validity on neuropsychological test scores. Setting: Sport-related concussion management program at a regionally accredited university. Participants: A total of 83 collegiate football athletes completing their preseason baseline assessment within the University's concussion management program and a control group of 140 nonathlete students. Design: Cross-sectional design based on differential incentive status: motivated to do poorly to return to play more quickly after sustaining a concussion (athletes) versus motivated to do well due to incentivizing performance (students). Main Measures: Immediate Post-Concussion and Cognitive Testing (ImPACT), performance validity tests, and measures of cognitive ability. Results: Half of the athletes failed at least 1 embedded validity indicator within ImPACT (51.8%), and the traditional neuropsychological tests (49.4%), with large effects for performance validity on cognitive test scores (d: 0.62-1.35), incentive status (athletes vs students; d: 0.36-1.15), and the combination of both factors (d: 1.07-2.20) on measures of attention and processing speed. Conclusion: Invalid performance on baseline assessment is common (50%), consistent across instruments (ImPACT or neuropsychological tests) and settings (one-on-one or group administration), increases as a function of incentive status (risk ratios: 1.3-4.0) and results in gross underestimates of the athletes' true ability level, complicating the clinical interpretation of the postinjury evaluation and potentially leading to premature return to play.	[Abeare, Christopher; Messa, Isabelle; Whitfield, Cameron; Zuccato, Brandon; Casey, Joseph; Erdodi, Laszlo] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; [Rykulski, Nicholas] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA		Abeare, C (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada.	cabeare@uwindsor.ca		Abeare, Christopher/0000-0002-7163-7434	HSSRG Grant from the University of Windsor	This research was supported in part by an HSSRG Grant from the University of Windsor awarded to C. Abeare. We thank the students who were involved in the Sport-Related Concussion Centre and assisted with baseline testing.	Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Abeare CA, 2017, J CLIN EXP NEUROPSYC, V39, P738, DOI 10.1080/13803395.2016.1259396; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barth JT, 1989, MILD HEAD INJURY, P257; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, MEDICAL SYMPTOMS VAL; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; HIGGINS KM, 2017, AOTEAROA NZ SOCIAL C, V16, P1, DOI DOI 10.1080/14649365.2017.1347956; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Hurtubise JL, 2017, PSYCHOL INJ LAW, V10, P121, DOI 10.1007/s12207-017-9287-5; Johnson SC, 2012, CLIN NEUROPSYCHOL, V26, P1230, DOI 10.1080/13854046.2012.709886; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lovell M, 2000, IMPACT IMMEDIATE POS; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rabinowitz AR, 2016, J CLIN EXP NEUROPSYC, V38, P599, DOI 10.1080/13803395.2015.1123224; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Rey A., 1964, CLIN EXAMINATION PSY; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V27, P1262; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Warrington E. K, 1984, MANUAL RECOGNITION M; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wechsler D., 2009, ADV CLIN SOLUTIONS W; Wechsler D., 2008, WECHSLER ADULT INTEL; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4	70	22	22	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2019	34	4					E20	E31		10.1097/HTR.0000000000000451			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IQ4XH	WOS:000480754400003	30499932				2022-02-06	
J	Haag, H; Sokoloff, S; MacGregor, N; Broekstra, S; Cullen, N; Colantonio, A				Haag, Halina (Lin); Sokoloff, Sandra; MacGregor, Nneka; Broekstra, Shirley; Cullen, Nora; Colantonio, Angela			Battered and Brain Injured: Assessing Knowledge of Traumatic Brain Injury Among Intimate Partner Violence Service Providers	JOURNAL OF WOMENS HEALTH			English	Article						traumatic brain injury; intimate partner violence; women; support interventions; domestic violence	OUTCOMES; WOMEN; CONSEQUENCE	Background: Traumatic brain injury (TBI) as a result of intimate partner violence (IPV) is a significant health concern; yet, little is known about the intersection between the two. Existing research is scarce, limiting the ability of health care providers to develop effective supports. This pilot project surveyed the IPV support community in Toronto, Canada to understand the degree of existing TBI-specific knowledge and relevant services available among these service providers and to seek to bridge the divide between research and practice by developing a national knowledge-to-practice network to support brain-injured women survivors of IPV. Materials and Methods: In phase 1, 68 agencies providing IPV support services were invited to complete an anonymous online survey. In phase 2, 22 stakeholders attended a workshop held to disseminate existing knowledge, develop a national knowledge-to-practice network, and determine next steps in research and practice. Results: The results highlighted a general lack of TBI awareness and understanding among IPV service providers. In addition, participants stated that frontline workers and women survivors of IPV alike do not recognize signs or symptoms of TBI. Recommendations addressing research gaps, professional and public education, and service development were identified and are discussed herein. Conclusions: The identified lack of TBI knowledge among IPV service providers highlights the immediate need to increase education among management and frontline workers. Further investigation identifying best practices for knowledge transfer are suggested. The development of a national strategy addressing education, research, and funding is critical for successful uptake and integration of TBI-sensitive services within the IPV sector.	[Haag, Halina (Lin)] Wilfrid Laurier Univ, Lyle S Hallman Fac Social Work, 120 Duke St W, Kitchener, ON N2H 6P6, Canada; [Sokoloff, Sandra; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [MacGregor, Nneka; Broekstra, Shirley] WomenatthecentrE, Toronto, ON, Canada; [Cullen, Nora] West Pk Healthcare Ctr, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela] UHN, Toronto Rehabil Inst, Toronto, ON, Canada		Haag, H (corresponding author), Wilfrid Laurier Univ, Lyle S Hallman Fac Social Work, 120 Duke St W, Kitchener, ON N2H 6P6, Canada.	hhaag@wlu.ca		Colantonio, Angela/0000-0003-2094-4765	Women's College Hospital XChange Grant program; Department of Justice Canada; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC); Ontario Women's Health Scholars Award from the Ontario Ministry of Health; Research Chair in Gender, Work and Health from the Canadian Institutes of Health Research Institute of Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	The authors thank the participants for taking part in the research process and to those with lived experience of IPV/TBI for sharing their stories with us. The study was directly supported by funds from the Women's College Hospital XChange Grant program, the Department of Justice Canada, and the Canadian Institutes of Health Research. Neither organization had any practical role in the study whatsoever. Ms Haag was also supported by a Doctoral Fellowship from the Social Sciences and Humanities Research Council of Canada and the Ontario Women's Health Scholars Award from the Ontario Ministry of Health. Dr. Colantonio was supported by a Research Chair in Gender, Work and Health from the Canadian Institutes of Health Research Institute of Gender and Health (grant no. CGW-126580).	Andelic N, 2013, J REHABIL MED, V45, P708, DOI [10.2340/16501977-1224, 10.2340/16501977-1216]; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Bauman RM, 2018, SEX RES SOC POLICY, DOI 10.1007/s13178-018-0334-0; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Foushee JP, 2017, RADIOL TECHNOL, V89, P83; Garay-Serratos M., 2015, LOS ANGELES TIMES; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Haag HL, TRAUMA VIOLENCE ABUS; Institute of Medicine (US) Committee on Gulf War and Health, 2008, GULF WAR AND HLTH, V7; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jeltsen M., 2015, HUFFINGTON POSTWOMEN; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mishra MN., 2012, INDIAN J FORENSIC ME, V6, P24; Mulholland A., 2015, CTV NEWSGO; Murray CE, 2015, TRAUMA VIOLENCE ABUS, P1; Roberts AR, 2005, J SOC SERV RES, V32, P33, DOI 10.1300/J079v32n01_03; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Synder RL, 2016, NEW YORKER; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; WHO, 2016, VIOL WOM INT PARTN S; World Health Organization, 2016, UND ADDR VIOL WOM IN	31	22	22	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	JUL 1	2019	28	7					990	996		10.1089/jwh.2018.7299		MAY 2019	7	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	IK7CW	WOS:000466750300001	31050575	Green Published, hybrid			2022-02-06	
J	Bliven, E; Rouhier, A; Tsai, S; Willinger, R; Bourdet, N; Deck, C; Madey, SM; Bottlang, M				Bliven, Emily; Rouhier, Alexandra; Tsai, Stanley; Willinger, Remy; Bourdet, Nicolas; Deck, Caroline; Madey, Steven M.; Bottlang, Michael			Evaluation of a novel bicycle helmet concept in oblique impact testing	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Bicycle helmet; Brain injury; Concussion; Impact testing; Impact mitigation; Rotational acceleration	BRAIN-INJURY; HEAD; BIOMECHANICS; ACCELERATION; PERFORMANCE; CONCUSSION; SYSTEM	Background A novel bicycle helmet concept has been developed to mitigate rotational head acceleration, which is a predominant mechanism of traumatic brain injury (TBI). This WAVECEL concept employs a collapsible cellular structure that is recessed within the helmet to provide a rotational suspension. This cellular concept differs from other bicycle helmet technologies for mitigation of rotational head acceleration, such as the commercially available Multi-Directional Impact Protection System (MIPS) technology which employs a slip liner to permit sliding between the helmet and the head during impact. This study quantified the efficacy of both, the WAVECEL cellular concept, and a MIPS helmet, in direct comparison to a traditional bicycle helmet made of rigid expanded polystyrene (EPS). Methods: Three bicycle helmet types were subjected to oblique impacts in guided vertical drop tests onto an angled anvil: traditional EPS helmets (CONTROL group); helmets with a MIPS slip liner (SLIP group); and helmets with a WAVECEL cellular structure (CELL group). Helmet performance was evaluated using 4.8 m/s impacts onto anvils angled at 30 degrees, 45 degrees, and 60 degrees from the horizontal plane. In addition, helmet performance was tested at a faster speed of 6.2 m/s onto the 45 degrees anvil. Five helmets were tested under each of the four impact conditions for each of the three groups, requiring a total of 60 helmets. Headform kinematics were acquired and used to calculate an injury risk criterion for Abbreviated Injury Score (AIS) 2 brain injury. Results: Linear acceleration of the headform remained below 90 g and was not associated with the risk of skull fracture in any impact scenario and helmet type. Headform rotational acceleration in the CONTROL group was highest for 6.2 m/s impacts onto the 45 degrees anvil (7.2 +/- 0.6 krad/s(2)). In this impact scenario, SLIP helmets and CELL helmets reduced rotational acceleration by 22% (p = 0003) and 73% (p < 0.001), respectively, compared to CONTROL helmets. The CONTROL group had the highest AIS 2 brain injury risk of 59 +/- 8% for 6.2 m/s impacts onto the 45 degrees anvil. In this impact scenario, SLIP helmets and CELL helmets reduced the AIS 2 brain injury risk to 34.2% (p = 0.001) and 1.2% (p < 0.001), respectively, compared to CONTROL helmets. Discussion: Results of this study are limited to a narrow range of impact conditions, but demonstrated the potential that rotational acceleration and the associated brain injury risk can be significantly reduced by the cellular WAVECEL concept or a MIPS slip liner. Results obtained under specific impact angles and impact velocities indicated performance differences between these mechanisms. These differences emphasize the need for continued research and development efforts toward helmet technologies that further improve protection from brain injury over a wide range a realistic impact parameters.	[Bliven, Emily; Rouhier, Alexandra; Tsai, Stanley; Madey, Steven M.; Bottlang, Michael] Legacy Res Inst, Biomech Lab, Portland, OR 97232 USA; [Willinger, Remy; Bourdet, Nicolas; Deck, Caroline] Univ Strasbourg, Inst Mecan Fluides & Solides, Strasbourg, France		Bottlang, M (corresponding author), Legacy Biomech Lab, 1225 NE 2nd Ave, Portland, OR 97215 USA.	mbottlan@lhs.org	Bliven, Emily/AAP-8732-2021	Rouhier, Alexandra/0000-0001-7644-516X; Bliven, Emily/0000-0002-7376-5886; Bourdet, Nicolas/0000-0002-1087-6829; DECK, Caroline/0000-0003-2289-1222	National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [SB1NS074734]; Research Foundation of the Legacy Health System; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [SB1NS074734] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under Award Number SB1NS074734. Additional support was provided by the Research Foundation of the Legacy Health System.	AAAM, 2008, ABBR INJ SCAL 2005; Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; [Anonymous], J21101 SAE; [Anonymous], 2016, CONSUMER REPORTS; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Caccese V, 2013, COMPOS STRUCT, V100, P404, DOI 10.1016/j.compstruct.2012.12.034; Caserta GD, 2011, COMPOS STRUCT, V93, P2748, DOI 10.1016/j.compstruct.2011.05.029; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; ECE, 1999, R2205 ECE; Fahlstedt M., 2014, INT CYCL SAF C; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Holbourn A. H, 2019, LANCET, V2, P438; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; Ivarsson J, 2003, J BIOMECH ENG-T ASME, V125, P523, DOI 10.1115/1.1590360; Jadischke R, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034306; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Klug C., 2015, INT RES COUNC BIOM I; McIntosh AS, 2013, J AUSTRALAS COLL ROA, V24, P11; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Otte D, 1989, SAE T, V98, P1606; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Willinger, 2013, INT J CRASHWORTHINES, P1; Willinger R., 2014, P INT CYCL SAF C; YOGANANDAN N, 1989, Journal of Biomechanical Engineering, V111, P250	42	22	23	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	MAR	2019	124						58	65		10.1016/j.aap.2018.12.017			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	HO3OB	WOS:000460831700007	30634159	Green Accepted, hybrid			2022-02-06	
J	Kumar, A; Henry, RJ; Stoica, BA; Loane, DJ; Abulwerdi, G; Bhat, SA; Faden, AI				Kumar, Asit; Henry, Rebecca J.; Stoica, Bogdan A.; Loane, David J.; Abulwerdi, Gelareh; Bhat, Shahnawaz A.; Faden, Alan, I			Neutral Sphingomyelinase Inhibition Alleviates LPS-Induced Microglia Activation and Neuroinflammation after Experimental Traumatic Brain Injury	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							IMPROVES FUNCTIONAL RECOVERY; MAPK SIGNALING PATHWAYS; DENDRITIC CELLS; DOWN-REGULATION; TNF-ALPHA; INFLAMMATION; RELEASE; DISEASE; DEATH; NEURODEGENERATION	Neuroinflammation is one of the key secondary injury mechanisms triggered by traumatic brain injury (TBI). Microglial activation, a hallmark of brain neuroinflammation, plays a critical role in regulating immune responses after TBI and contributes to progressive neurodegeneration and neurologic deficits following brain trauma. Here we evaluated the role of neutral sphingomyelinase (nSMase) in microglial activation by examining the effects of the nSMase inhibitors altenusin and GW4869 in vitro (using BV2 microglia cells and primary microglia), as well as in a controlled cortical injury (CCI) model in adult male C57BL/6 mice. Pretreatment of altenusin or GW4869 prior to lipopolysaccharide (LPS) stimulation for 4 or 24 hours, significantly downregulated gene expression of the pro-inflammatory mediators TNF-alpha, IL-1 beta, IL-6, iNOS, and CCL2 in microglia and reduced the release of nitric oxide and TNF-alpha. These nSMase inhibitors also attenuated the release of microparticles and phosphorylation of p38 MAPK and ERK1/2. In addition, altenusin pretreatment also reduced the gene expression of multiple inflammatory markers associated with microglial activation after experimental TBI, including TNF-alpha, IL-1 beta, IL-6, iNOS, CCL2, CD68, NOX2, and p22(phox). Overall, our data demonstrate that nSMase inhibitors attenuate multiple inflammatory pathways associated with microglial activation in vitro and after experimental TBI. Thus, nSMase inhibitors may represent promising therapeutics agents targeting neuroinflammation.	[Kumar, Asit; Henry, Rebecca J.; Stoica, Bogdan A.; Loane, David J.; Abulwerdi, Gelareh; Bhat, Shahnawaz A.; Faden, Alan, I] Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA; [Kumar, Asit] Johns Hopkins Univ, Dept Neurol, Richard T Johnson Div Neuroimmunol & Neurol Infec, Baltimore, MD 21218 USA		Kumar, A (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol Anat & Neurobiol, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.; Faden, AI (corresponding author), Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA.	asitkumar14@gmail.com; afaden1@som.umaryland.edu	Kumar, Asit/AAG-3916-2021; Loane, David/ABD-5177-2021	Kumar, Asit/0000-0003-1735-7033; Loane, David/0000-0003-0393-3503; Faden, Alan I./0000-0003-0128-2348; Vinueza, Gelareh/0000-0002-1036-6378; Henry, Rebecca/0000-0001-8548-1170	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS037313, R01NS082308, R01NS096002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037313, R01NS096002] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [Grant Number R01NS037313 (A.I.F.), R01NS082308 (D.J.L.), and R01NS096002 (B.A.S.)].	Aly AH, 2008, J NAT PROD, V71, P972, DOI 10.1021/np070447m; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Balusu S, 2016, EMBO MOL MED, V8, P1162, DOI 10.15252/emmm.201606271; Beneventano M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00812; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bilousova T, 2018, BIOCHEM BIOPH RES CO, V499, P751, DOI 10.1016/j.bbrc.2018.03.209; Bohman LE, 2016, J NEUROTRAUM, V33, P168, DOI 10.1089/neu.2015.3885; Brann AB, 2002, J BIOL CHEM, V277, P9812, DOI 10.1074/jbc.M109862200; Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Pena-Philippides JC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0753-x; Chua SW, 2017, ACS CHEM NEUROSCI, V8, P743, DOI 10.1021/acschemneuro.6b00433; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Dinkins MB, 2016, J NEUROSCI, V36, P8653, DOI 10.1523/JNEUROSCI.1429-16.2016; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Figuera-Losada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124481; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Gao HM, 2012, TRENDS PHARMACOL SCI, V33, P295, DOI 10.1016/j.tips.2012.03.008; Gao W, 2016, J CELL MOL MED, V20, P2318, DOI 10.1111/jcmm.12923; Gu LZ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-109; Guedes J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/186872; Guedes JR, 2014, HUM MOL GENET, V23, P6286, DOI 10.1093/hmg/ddu348; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Harrison-Brown M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122030; Hazelton I, 2018, J NEUROTRAUM, V35, P639, DOI 10.1089/neu.2017.5049; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Hung TH, 2017, ONCOTARGET, V8, P103236, DOI 10.18632/oncotarget.21139; Iguchi Y, 2016, BRAIN, V139, P3187, DOI 10.1093/brain/aww237; Jayadev S, 2013, J NEUROCHEM, V127, P592, DOI 10.1111/jnc.12400; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kopitar-Jerata N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00073; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2015, J NEUROCHEM, V135, P1189, DOI 10.1111/jnc.13364; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Li J, 2017, PURINERG SIGNAL, V13, P13, DOI 10.1007/s11302-016-9537-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Martinez TN, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-45; Menck K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1378056; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nigro A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00017; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Olajide OA, 2014, MOL NUTR FOOD RES, V58, P1843, DOI 10.1002/mnfr.201400163; Paolicelli RC, 2018, NEUROSCIENCE, DOI [10.1016/j.neurosci-ence.2018.04.003, DOI 10.1016/J.NEUROSCI-ENCE.2018.04.003]; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pieragostino D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21497-5; Poncelet P, 2015, TRANSFUS APHER SCI, V53, P110, DOI 10.1016/j.transci.2015.10.008; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Sabirzhanov B, 2018, J NEUROTRAUM, V35, P2462, DOI 10.1089/neu.2017.5572; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Shieh CH, 2014, GLIA, V62, P592, DOI 10.1002/glia.22628; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Singh V, 2014, NEUROSCIENCE, V265, P147, DOI 10.1016/j.neuroscience.2014.01.037; Sobue A, 2018, GLIA, V66, P1034, DOI 10.1002/glia.23299; Song L, 2011, J LIPID RES, V52, P1542, DOI 10.1194/jlr.M015412; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Tabatadze N, 2010, J NEUROSCI RES, V88, P2940, DOI 10.1002/jnr.22438; Tan LHR, 2018, MOL NEUROBIOL, V55, P5741, DOI 10.1007/s12035-017-0784-z; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Uchida R, 1999, J ANTIBIOT, V52, P572, DOI 10.7164/antibiotics.52.572; Velagapudi R, 2017, INT IMMUNOPHARMACOL, V48, P17, DOI 10.1016/j.intimp.2017.04.018; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Xiao CC, 2018, CIRC RES, V123, P564, DOI 10.1161/CIRCRESAHA.118.312758; Xiao TT, 2017, TRANSL NEURODEGENER, V6, DOI [10.1186/s40035-017-0072-x, 10.1186/s40035-017-0081-9]; Yang YY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1204-7; Yin HY, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0162-7; Yuan YM, 2015, BRAIN BEHAV IMMUN, V48, P287, DOI 10.1016/j.bbi.2015.04.008; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x; Zhao L, 2017, CARDIOLOGY, V137, P43, DOI 10.1159/000453544; Zheng ZH, 2017, MOL PHARMACOL, V92, P425, DOI 10.1124/mol.117.108829	105	22	22	1	9	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	MAR 1	2019	368	3					338	352		10.1124/jpet.118.253955			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HM1AI	WOS:000459179300002	30563941	Green Published, Bronze			2022-02-06	
J	Li, YJ; Wang, L; Zhang, B; Gao, F; Yang, CM				Li, Ya-jun; Wang, Lin; Zhang, Bei; Gao, Fei; Yang, Chun-Mei			Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						high mobility group box 1; blood brain barrier; status epilepticus; glycyrrhizin; inflammation	MOBILITY GROUP BOX-1; BLOOD-BRAIN-BARRIER; ACUTE LIVER-INJURY; INTRACEREBRAL HEMORRHAGE; CHROMATIN PROTEIN; RECEPTOR 4; IN-VITRO; ACID; EPILEPSY; ANTIBODY	Objectives It has been proven that extracellular HMGB1 is involved in progression of neurologic disorders, such as stroke, traumatic brain injury, meningitis and epilepsy. Glycyrrhizin (GL) is a direct inhibitor of HMGB1, and blocks HMGB1 release into the extracellular. We aim in this study to investigate the neuroprotective effects of GL in a rat model after lithium-pilocarpine-induced status epilepticus (SE). Methods Adult male SD rats were divided into three groups: Sham group, SE-group and (SE + GL)-treated group. The HMGB1 expression in serum and hippocampus, the damage extent of blood brain barrier (BBB) and hippocampal neuronal damage were evaluated by enzyme-linked immunosorbent assay, immunohistochemistry, western blot and nissl's staining. Key findings Glycyrrhizin markedly reduced HMGB1 expression in serum and hippocampus, prevented HMGB1 translocation from nucleus to cytoplasm in hippocampal CA1, CA3 and hilus areas of SE rats. Meanwhile, GL significantly ameliorated neuronal damage in the CA1, CA3 and hilus areas of hippocampus, and protected BBB disruption after SE. The administration of GL significantly decreased the mortality from 25 to 8.9% in rats. Conclusions Glycyrrhizin may exert neuroprotective effects via inhibiting HMGB1 and protect BBB permeability in lithium-pilocarpine-induced rats with SE.	[Li, Ya-jun; Wang, Lin; Zhang, Bei; Gao, Fei; Yang, Chun-Mei] Xian Med Univ, Affiliated Hosp 1, Dept Neurol, 48 West Fenghao Rd, Xian 710077, Shaanxi, Peoples R China		Li, YJ (corresponding author), Xian Med Univ, Affiliated Hosp 1, Dept Neurol, 48 West Fenghao Rd, Xian 710077, Shaanxi, Peoples R China.	liyajun9@hotmail.com		Li, Ya-jun/0000-0002-0716-5823	Shaanxi province science and technology research and development program [2014SF2-17]	This work was supported by grants from Shaanxi province science and technology research and development program (No. 2014SF2-17). We thank Qiang Luo, Bin Sun for their technical assistance and Dr. Austin Cape for careful reading and feedback.	Ashfaq UA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-112; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Choi J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-135; Costa-Ferro ZSM, 2010, SEIZURE-EUR J EPILEP, V19, P84, DOI 10.1016/j.seizure.2009.12.003; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Fink MP, 2014, CRIT CARE, V18, DOI 10.1186/cc13810; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Haleagrahara N, 2011, INT J MOL SCI, V12, P7100, DOI 10.3390/ijms12107100; Hayakawa K, 2012, P NATL ACAD SCI USA, V109, P7505, DOI 10.1073/pnas.1121146109; Isbrucker RA, 2006, REGUL TOXICOL PHARM, V46, P167, DOI 10.1016/j.yrtph.2006.06.002; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kim HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104743; Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lee CH, 2007, BIOL PHARM BULL, V30, P1898, DOI 10.1248/bpb.30.1898; Lei C, 2013, NEUROSCIENCE, V228, P190, DOI 10.1016/j.neuroscience.2012.10.023; Li Z, 2013, NEUROREPORT, V24, P785, DOI 10.1097/WNR.0b013e328363fed3; Liu AH, 2014, EPILEPSY BEHAV, V39, P105, DOI 10.1016/j.yebeh.2014.08.005; Long Q, 2012, NEUROSCIENCE, V212, P214, DOI 10.1016/j.neuroscience.2012.04.002; Luo L, 2014, CELL MOL NEUROBIOL, V34, P987, DOI 10.1007/s10571-014-0075-4; Luo Lidan, 2013, Exp Neurobiol, V22, P107, DOI 10.5607/en.2013.22.2.107; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Marianecci C, 2012, J CONTROL RELEASE, V164, P17, DOI 10.1016/j.jconrel.2012.09.018; Maroso M, 2011, J INTERN MED, V270, P319, DOI 10.1111/j.1365-2796.2011.02431.x; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Ming LJ, 2013, NAT PROD COMMUN, V8, P415; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; MORRISETT RA, 1987, EXP NEUROL, V97, P193, DOI 10.1016/0014-4886(87)90293-7; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Narvaez-Rivera RM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-15; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Ohnishi M, 2011, NEUROPHARMACOLOGY, V61, P975, DOI 10.1016/j.neuropharm.2011.06.026; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Perucca E, 2007, LANCET NEUROL, V6, P793, DOI 10.1016/S1474-4422(07)70215-6; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Saeedi M, 2003, J Dermatolog Treat, V14, P153, DOI 10.1080/09546630310014369; Sansing LH, 2011, ANN NEUROL, V70, P646, DOI 10.1002/ana.22528; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sun Q, 2013, MED HYPOTHESES, V81, P681, DOI 10.1016/j.mehy.2013.07.026; Tang XH, 2013, CHINESE MED J-PEKING, V126, P1900, DOI 10.3760/cma.j.issn.0366-6999.20122710; Tang ZH, 2015, PLANTA MED, V81, P1670, DOI 10.1055/s-0035-1558227; Tsai JJ, 2013, INT J MOL SCI, V14, P12563, DOI 10.3390/ijms140612563; Uzawa A, 2013, CLIN EXP IMMUNOL, V172, P37, DOI 10.1111/cei.12036; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Wang W, 2013, CRIT CARE, V17, DOI 10.1186/cc12558; Zhang JC, 2014, BRAIN RES, V1582, P176, DOI 10.1016/j.brainres.2014.07.002; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334	56	22	22	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	MAR	2019	71	3					390	399		10.1111/jphp.13040			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HK2NQ	WOS:000457750000010	30417405				2022-02-06	
J	Giampa, C; Alvino, A; Magatti, M; Silini, AR; Cardinale, A; Paldino, E; Fusco, FR; Parolini, O				Giampa, Carmela; Alvino, Alessandra; Magatti, Marta; Silini, Antonietta R.; Cardinale, Antonella; Paldino, Emanuela; Fusco, Francesca R.; Parolini, Ornella			Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						human amniotic mesenchymal stem/stromal cells; Huntington's disease; microglia; neuroinflammation; secretome	MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; MUTANT HUNTINGTIN; BRAIN-INJURY; MINOCYCLINE; EXPRESSION; PARKINSONS; GENE; ACTIVATION	Inflammation significantly impacts the progression of Huntington's disease (HD) and the mutant HTT protein determines a pro-inflammatory activation of microglia. Mesenchymal stem/stromal cells (MSC) from the amniotic membrane (hAMSC), and their conditioned medium (CM-hAMSC), have been shown to possess protective effects in vitro and in vivo in animal models of immune-based disorders and of traumatic brain injury, which have been shown to be mediated by their immunomodulatory properties. In this study, in the R6/2 mouse model for HD we demonstrate that mice treated with CM-hAMSC display less severe signs of neurological dysfunction than saline-treated ones. CM-hAMSC treatment significantly delayed the development of the hind paw clasping response during tail suspension, reduced deficits in rotarod performance, and decreased locomotor activity in an open field test. The effects of CM-hAMSC on neurological function were reflected in a significant amelioration in brain pathology, including reduction in striatal atrophy and the formation of striatal neuronal intranuclear inclusions. In addition, while no significant increase was found in the expression of BDNF levels after CM-hAMSC treatment, a significant decrease of microglia activation and inducible nitric oxide synthase levels were observed. These results support the concept that CM-hAMSC could act by modulating inflammatory cells, and more specifically microglia.	[Giampa, Carmela; Alvino, Alessandra; Parolini, Ornella] Univ Cattolica Sacro Cuore, Ist Anat Umana & Biol Cellulare, Rome, Italy; [Giampa, Carmela; Alvino, Alessandra] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy; [Magatti, Marta; Silini, Antonietta R.; Parolini, Ornella] Fdn Poliambulanza, Ctr Ric E Menni, Brescia, Italy; [Cardinale, Antonella; Paldino, Emanuela; Fusco, Francesca R.] Santa Lucia Fdn IRCCS, Lab Neuroanat, Rome, Italy		Parolini, O (corresponding author), Univ Cattolica Sacro Cuore, Ist Anat Umana & Biol Cellulare, Rome, Italy.; Parolini, O (corresponding author), Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy.	ornella.parolini@unicatt.it	Paldino, Emanuela/AAC-2594-2022; PAROLINI, ORNELLA/ABI-7862-2020; Cardinale, Antonella/B-1008-2019; Fusco, Francesca Romana/K-1080-2018	Paldino, Emanuela/0000-0002-8483-543X; PAROLINI, ORNELLA/0000-0002-5211-6430; Cardinale, Antonella/0000-0002-3185-1006; Fusco, Francesca Romana/0000-0003-2226-523X	Contributo MIUR 5 x 1000 [2015]; Universita Cattolica del Sacro Cuore [linea D1-2017, linea D1-2018]	Contributo MIUR 5 x 1000, Grant/Award Number: 2015; Universita Cattolica del Sacro Cuore, Grant/Award Number: "linea D1-2017" and "linea D1-2018"	Adibhatla RM, 2002, BRAIN RES, V938, P81, DOI 10.1016/S0006-8993(02)02447-2; Bouchard J, 2012, J NEUROSCI, V32, P18259, DOI 10.1523/JNEUROSCI.4008-12.2012; Bradford J, 2010, J BIOL CHEM, V285, P10653, DOI 10.1074/jbc.M109.083287; Cha JH, 2004, NEUROLOGY, V63, P547; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Colpo GD, 2017, CNS NEUROL DISORD-DR, V16, P936, DOI 10.2174/1871527316666170613084801; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Deckel AW, 2001, J NEUROSCI RES, V64, P99, DOI 10.1002/jnr.1057; Deng P, 2016, NEURAL REGEN RES, V11, P702, DOI 10.4103/1673-5374.182682; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; Diguet E, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.10818; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Dobson L, 2016, J NEUROCHEM, V137, P782, DOI 10.1111/jnc.13553; Farr OM, 2015, METABOLISM, V64, P114, DOI 10.1016/j.metabol.2014.07.004; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fink KD, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt341; Fujita K, 2011, PLACENTA, V32, P737, DOI 10.1016/j.placenta.2011.07.001; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; HALL JG, 1977, J PHYSIOL-LONDON, V272, pP52; Hanna DMF, 2015, PROG NEURO-PSYCHOPH, V60, P36, DOI 10.1016/j.pnpbp.2015.02.005; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hsiao HY, 2014, HUM MOL GENET, V23, P4328, DOI 10.1093/hmg/ddu151; Hussain G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00144; Im W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059438; Kerkis I, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0248-1; Kondoh T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00018; La Fata G, 2014, NUTRIENTS, V6, P5453, DOI 10.3390/nu6125453; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; Lescaudron L, 2012, CURR MED CHEM, V19, P6018; Lin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025586; Lisi L, 2017, NEUROSCI LETT, V645, P106, DOI 10.1016/j.neulet.2017.02.076; Lo Furno D, 2018, J CELL PHYSIOL, V233, P3982, DOI 10.1002/jcp.26192; Lovaas E, 1997, Adv Pharmacol, V38, P119; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Magatti M., 2016, PLACENTA TREE LIFE, P91, DOI [10.1201/b19620-6, DOI 10.1201/B19620-6]; Magatti M, 2016, METHODS MOL BIOL, V1416, P233, DOI 10.1007/978-1-4939-3584-0_13; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menzie J, 2013, BRAIN SCI, V3, P877, DOI 10.3390/brainsci3020877; Miguez A, 2015, HUM MOL GENET, V24, P4958, DOI 10.1093/hmg/ddv218; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Perez-Severiano F, 2002, BRAIN RES, V951, P36, DOI 10.1016/S0006-8993(02)03102-5; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pollock K, 2016, MOL THER, V24, P965, DOI 10.1038/mt.2016.12; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Schwarz H, 2010, MOVEMENT DISORD, V25, P2219, DOI 10.1002/mds.23236; Silini AR, 2017, CELL TRANSPLANT, V26, P531, DOI 10.3727/096368916X693699; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Smeland OB, 2012, NEUROCHEM INT, V61, P100, DOI 10.1016/j.neuint.2012.04.008; Snyder BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009347; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Stack EC, 2007, EXPERT OPIN INV DRUG, V16, P1933, DOI 10.1517/13543784.16.12.1933; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Thomas M, 2004, MOVEMENT DISORD, V19, P692, DOI 10.1002/mds.20018; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Yang HM, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00193; Yuste JE, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00322; Zeng W, 2015, EXP THER MED, V9, P283, DOI 10.3892/etm.2014.2133; Zhang J, 2001, J NEUROCHEM, V76, P855, DOI 10.1046/j.1471-4159.2001.00080.x; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	64	22	22	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	FEB	2019	23	2					1581	1592		10.1111/jcmm.14113			12	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	HM8KM	WOS:000459729900080	30585395	Green Published, gold			2022-02-06	
J	Albrecht, JS; Barbour, L; Abariga, SA; Rao, V; Perfetto, EM				Albrecht, Jennifer S.; Barbour, Lauren; Abariga, Samuel A.; Rao, Vani; Perfetto, Eleanor M.			Risk of Depression after Traumatic Brain Injury in a Large National Sample	JOURNAL OF NEUROTRAUMA			English	Article						depression; epidemiology; traumatic brain injury	MAJOR DEPRESSION; NEUROPSYCHIATRIC DISTURBANCES; CLAIMS DATA; DISORDER; EPIDEMIOLOGY; AGE; ASSOCIATION; COMORBIDITY; PREDICTORS; DISEASE	Depression is associated with poorer recovery after traumatic brain injury (TBI), yet awareness of depression risk post-TBI among providers and patients is low. The aim of this study was to estimate risk of depression post-TBI among adults 18 years of age and older and to identify risk factors associated with developing depression post-TBI. We conducted a retrospective, matched cohort study using claims data for privately insured and Medicare Advantage enrollees in a large U.S. health plan. Adults 18 years of age diagnosed with TBI (n=207,354) with 12 months continuous insurance coverage pre-TBI and 24 months post-TBI were matched to controls without TBI (n=414,708). We identified the presence of depression on any in- or outpatient claim occurring during the study period (both before and after TBI). Of the initial 622,062 individuals, 62,963 (10%) had depression pre-TBI and were excluded from incidence calculations. Incidence of depression post-TBI was 79.5 (95% confidence interval [CI], 78.5,80.5) per 1,000 person-years compared to 33.5 (95% CI, 33.1,34.0) per 1,000 person-years for those without TBI. The adjusted hazard ratio for depression post-TBI was 1.83 (95% CI, 1.79,1.86). We observed effect modification by sex and age, with males and older adults at increased risk. History of neuropsychiatric disturbances pre-TBI was the strongest predictor of depression post-TBI. Risk of depression increases substantially post-TBI. Groups at increased risk include those with a history of neuropsychiatric disturbances, older adults, and men. This study highlights the importance of long-term monitoring for depression post-TBI.	[Albrecht, Jennifer S.; Barbour, Lauren; Abariga, Samuel A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Albrecht, Jennifer S.] OptumLabs, Cambridge, MA USA; [Rao, Vani] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Perfetto, Eleanor M.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Perfetto, Eleanor M.] Natl Hlth Council, Washington, DC USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 South Pine St,MSTF 334 C, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01 HS024560] Funding Source: Medline		Albrecht JS, 2017, ARCH PHYS MED REHAB, V98, P2548, DOI 10.1016/j.apmr.2017.06.007; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; BLAZER D, 1991, J GERONTOL, V46, pM210, DOI 10.1093/geronj/46.6.M210; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chen S, 2016, BIOMETRICS, V72, P596, DOI 10.1111/biom.12433; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Mannix R., 2013, NEUROSURGERY, V73, P134; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marr A., 2004, CENTRAL NERVOUS SYST; Noyes K, 2011, PSYCHIAT SERV, V62, P1159, DOI 10.1176/ps.62.10.pss6210_1159; OptumLabs, 2017, OPT OPT DAT WAR OLDW; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Solberg LI, 2006, AM J MED QUAL, V21, P238, DOI 10.1177/1062860606288243; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ., 1995, GUIDELINES SURVEILLA; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	42	22	22	2	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					300	307		10.1089/neu.2017.5608			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800013	29808770				2022-02-06	
J	Gorgoraptis, N; Zaw-Linn, J; Feeney, C; Tenorio-Jimenez, C; Niemi, M; Malik, A; Ham, T; Goldstone, AP; Sharp, DJ				Gorgoraptis, Nikos; Zaw-Linn, Joanna; Feeney, Claire; Tenorio-Jimenez, Carmen; Niemi, Mari; Malik, Aysha; Ham, Timothy; Goldstone, Anthony P.; Sharp, David J.			Cognitive impairment and health-related quality of life following traumatic brain injury	NEUROREHABILITATION			English	Article						SF-36; cognition; depression; sleep disturbance; TBI	DEPRESSION FOLLOWING MILD; DAYTIME SLEEPINESS; MAJOR DEPRESSION; HEAD-INJURY; MODERATE; VALIDITY; SF-36; RELIABILITY; REHABILITATION; QUESTIONNAIRE	BACKGROUND: Cognitive impairment is a common and disabling consequence of traumatic brain injury (TBI) but its impact on health-related quality of life is not well understood. OBJECTIVE: To investigate the relationship between cognitive impairment and health-related quality of life (HRQoL) after TBI. METHODS: Retrospective, cross-sectional study of a specialist TBI outpatient clinic patient sample. Outcome measures: Addenbrooke's Cognitive Examination Tool - Revised (ACE-R), and SF-36 quality of life, Beck Depression Inventory II (BDI-II), Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) questionnaires. RESULTS: 240 adults were assessed: n = 172 (71.7%) moderate-severe, 41 (23.8%) mild, 27 (11.3%) symptomatic TBI, 174 (72.5%) male, median age (range): 44 (22-91) years. TBI patients reported poorer scores on all domains of SF-36 compared to age-matched UK normative data. Cognitively impaired patients reported poorer HRQoL on the physical, social role and emotional role functioning, and mental health domains. Cognitive impairment predicted poorer HRQoL on the social and emotional role functioning domains, independently of depressive symptoms, sleep disturbance, daytime sleepiness and TBI severity. Mediation analysis revealed that the effect of depressive symptoms on the emotional role functioning domain of HRQoL was partially mediated by cognitive dysfunction. CONCLUSION: Cognitive impairment is associated with worse health-related quality of life after TBI and partially mediates the effect of depressive symptoms on emotional role functioning.	[Gorgoraptis, Nikos; Ham, Timothy; Goldstone, Anthony P.; Sharp, David J.] Imperial Coll Healthcare NHS Trust, Dept Neurol, London, England; [Gorgoraptis, Nikos; Zaw-Linn, Joanna; Feeney, Claire; Tenorio-Jimenez, Carmen; Niemi, Mari; Malik, Aysha; Ham, Timothy; Goldstone, Anthony P.; Sharp, David J.] Imperial Coll London, Hammersmith Hosp, Div Brain Sci, Dept Med Computat Cognit & Clin Neuroimaging Lab, London, England; [Feeney, Claire; Goldstone, Anthony P.] Imperial Coll Healthcare NHS Trust, Charing Cross & St Marys Hosp, Imperial Ctr Endocrinol, London, England		Gorgoraptis, N (corresponding author), Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor,Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	n.gorgoraptis@imperial.ac.uk	Sharp, David J/A-2119-2013; Tenorio-Jimenez, Carmen/I-1550-2015	Tenorio-Jimenez, Carmen/0000-0002-1773-6036; Goldstone, Anthony/0000-0001-8179-7071	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006, G0701951, MR/L022141/1] Funding Source: UKRI; Department of HealthEuropean Commission [NIHR-RP-011-048] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701951, MR/L022141/1] Funding Source: Medline		Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS30, DOI 10.1053/apmr.2000.20621; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P801, DOI 10.3109/02699052.2012.655368; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beck A. T., 1996, MANUAL BECK DEPRESSI, V1, P82; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Beseoglu K, 2013, BRIT J NEUROSURG, V27, P202, DOI 10.3109/02688697.2012.717984; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowling A, 1999, J PUBLIC HEALTH MED, V21, P255, DOI 10.1093/pubmed/21.3.255; Brazier J, 1999, J Health Serv Res Policy, V4, P174; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carr AJ, 2001, BMJ-BRIT MED J, V322, P1240, DOI 10.1136/bmj.322.7296.1240; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gaber TAZK, 2008, BRAIN INJURY, V22, P589, DOI 10.1080/02699050802132461; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Imai Kosuke, 2010, ADV SOCIAL SCI RES U, P129, DOI DOI 10.1007/978-1-4419-1764-5_8; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Karimi M, 2016, PHARMACOECONOMICS, V34, P645, DOI 10.1007/s40273-016-0389-9; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046; Maruish M.E., 1999, USE PSYCHOL TESTING, P1227; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; MEEBERG GA, 1993, J ADV NURS, V18, P32, DOI 10.1046/j.1365-2648.1993.18010032.x; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Moons P, 2006, INT J NURS STUD, V43, P891, DOI 10.1016/j.ijnurstu.2006.03.015; Ohayon MM, 2002, ARCH INTERN MED, V162, P201, DOI 10.1001/archinte.162.2.201; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; R Core Team, 2014, R LANG ENV STAT COMP; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Riemsma R. P., 2000, HLTH TECHNOLOGY ASSE, V5, P1; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Seymour DG, 2001, J EVAL CLIN PRACT, V7, P411, DOI 10.1046/j.1365-2753.2001.00296.x; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Ware J., 2000, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	63	22	25	2	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2019	44	3					321	331		10.3233/NRE-182618			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IE8IG	WOS:000472616500001	31177238				2022-02-06	
J	Ji, W; Alvarez, Z; Edelbrock, AN; Sato, K; Stupp, SI				Ji, Wei; Alvarez, Zaida; Edelbrock, Alexandra N.; Sato, Kohei; Stupp, Samuel, I			Bioactive Nanofibers Induce Neural Transdifferentiation of Human Bone Marrow Mesenchymal Stem Cells	ACS APPLIED MATERIALS & INTERFACES			English	Article						peptide amphiphile; human mesenchymal stem cell; IKVAV; transdifferentiation; neurons	STROMAL CELLS; EXTRACELLULAR-MATRIX; NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; CLINICAL-TRIALS; BRAIN; BIOMATERIALS; NEUROGENESIS; MIGRATION	The combination of biomaterials with stem cells is a promising therapeutic strategy to repair traumatic injuries in the central nervous system, and human bone marrow mesenchymal stem cells (BMSCs) offer a clinically translatable option among other possible sources of stem cells. We report here on the use of a supramolecular bioactive material based on a peptide amphiphile (PA), displaying a laminin-mimetic IKVAV sequence to drive neural transdifferentiation of human BMSCs. The IKVAV-PA self-assembles into supramolecular nanofibers that induce neuroectodermal lineage commitment after 1 week, as evidenced by the upregulation of the neural progenitor gene nestin (NES) and glial fibrillary acidic protein (GFAP). After 2 weeks, the bioactive IKVAV-PA nanofibers induce significantly higher expression of neuronal markers beta-III tubulin (TUJ-1), microtubule-associated protein-2 (MAP-2), and neuronal nuclei (NEUN), as well as the extracellular matrix laminin (LMN). Furthermore, the human BMSCs exposed to the biomaterial reveal a polarized cytoskeletal architecture and a decrease in cellular size, resembling neuron-like cells. We conclude that the investigated supramolecular biomaterial opens the opportunity to transdifferentiate adult human BMSCs into neuronal lineage.	[Ji, Wei; Alvarez, Zaida; Edelbrock, Alexandra N.; Sato, Kohei; Stupp, Samuel, I] Northwestern Univ, Simpson Querrey Inst, Chicago, IL 60611 USA; [Stupp, Samuel, I] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Ji, Wei] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, B-3000 Leuven, Belgium; [Edelbrock, Alexandra N.; Stupp, Samuel, I] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Sato, Kohei; Stupp, Samuel, I] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stupp, Samuel, I] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Sato, Kohei] Tokyo Inst Technol, Dept Life Sci & Technol, Yokohama, Kanagawa 2268501, Japan		Stupp, SI (corresponding author), Northwestern Univ, Simpson Querrey Inst, Chicago, IL 60611 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	s-stupp@northwestern.edu	Sato, Kohei/V-8820-2018; Ji, Wei/G-8947-2011; Edelbrock, Alexandra N/R-2060-2018; Stupp, Samuel/B-6737-2009; alvarez, zaida/AAA-3132-2020	Sato, Kohei/0000-0002-8948-8537; Ji, Wei/0000-0002-1473-5222; Edelbrock, Alexandra N/0000-0003-3172-977X; Alvarez, Zaida/0000-0001-5104-1388	Center for Regenerative Nanomedicine at the Simpson Querrey Institute at Northwestern University; Research Foundation-Flanders (FWO)FWO [12G2718N]; University of Leuven (KU Leuven)KU Leuven [JUMO-15-0514]; Beatriu de Pinos Fellowship from Agencia de Gestio d'Ajust Universitaris i de Recerca, (AGAUR), Spain [2014 BP -A 00007]; Paralyzed Veterans of America (PVA) Research Foundation [PVA17_RF_0008]; U.S. Army Research Office; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Northwestern University; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource [NSF ECCS-1542205, NSF NNCI-1542205]; Materials Research Science and Engineering Center (MRSEC) program at the Materials Research Center [NSF DMR-1720139]; International Institute for Nanotechnology (IIN); Keck FoundationW.M. Keck Foundation; State of Illinois, through the IIN	This work was primarily supported by the Center for Regenerative Nanomedicine at the Simpson Querrey Institute at Northwestern University. W.J. received postdoctoral support from Research Foundation-Flanders (FWO) Postdoctoral Mandates 12G2718N, and by a Junior Mobility Travel grant from University of Leuven (KU Leuven) (JUMO-15-0514). Z.A. received postdoctoral support from a Beatriu de Pinos Fellowship from Agencia de Gestio d'Ajust Universitaris i de Recerca, (AGAUR), Spain 2014 BP -A 00007, and by grant #PVA17_RF_0008 from the Paralyzed Veterans of America (PVA) Research Foundation. This work was also supported by the following core facilities of Northwestern University: the Peptide Synthesis Core and the Analytical Bionanotechnology Equipment Core both at the Simpson Querrey Institute. The U.S. Army Research Office, the U.S. Army Medical Research and Materiel Command, and Northwestern University provided funding to develop these facilities and ongoing support is being received from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF NNCI-1542205). This work made use of the microscopic facility of the Center for Advanced Microscopy (NCI CCSG P30 CA060553), as well as the EPIC facility of Northwestern University's NUANCE Center, which has received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-1542205); the Materials Research Science and Engineering Center (MRSEC) program (NSF DMR-1720139) at the Materials Research Center; the International Institute for Nanotechnology (IIN); the Keck Foundation; and the State of Illinois, through the IIN. The authors also thank Max Mu Wang's technical assistance and Mark Seniw for the preparation of illustrations for the manuscript.	Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Alvarez Z, 2014, BIOMATERIALS, V35, P4769, DOI 10.1016/j.biomaterials.2014.02.051; Amer MH, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0789-1; Banik BL, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00041; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Berns EJ, 2016, ACTA BIOMATER, V37, P50, DOI 10.1016/j.actbio.2016.04.010; Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Burdick JA, 2016, CELL STEM CELL, V18, P13, DOI 10.1016/j.stem.2015.12.004; Cheng P, 2013, DEVELOPMENT, V140, P2587, DOI 10.1242/dev.089052; Crunkhorn S, 2017, NAT REV DRUG DISCOV, V16, P600, DOI [10.1038/nrd.2017.181, 10.1038/nrd.2017.156]; Curtis E, 2018, CELL STEM CELL, V22, P941, DOI 10.1016/j.stem.2018.05.014; Faissner A, 2015, GLIA, V63, P1330, DOI 10.1002/glia.22839; Farrukh A, 2017, STEM CELL REP, V9, P1432, DOI 10.1016/j.stemcr.2017.09.002; Vallone VBF, 2013, DIFFERENTIATION, V85, P1, DOI 10.1016/j.diff.2012.08.004; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Galipeau J, 2018, CELL STEM CELL, V22, P824, DOI 10.1016/j.stem.2018.05.004; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Goldberger JE, 2011, ANGEW CHEM INT EDIT, V50, P6292, DOI 10.1002/anie.201100202; Goldman SA, 2018, NAT MED, V24, P388, DOI 10.1038/nm.4531; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Guler MO, 2005, NANO LETT, V5, P249, DOI 10.1021/nl048238z; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hussey GS, 2018, NAT REV MATER, V3, P159, DOI 10.1038/s41578-018-0023-x; Jiang HZ, 2007, SOFT MATTER, V3, P454, DOI 10.1039/b614426h; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Khaing ZZ, 2014, MATER TODAY, V17, P332, DOI 10.1016/j.mattod.2014.05.011; Kim BJ, 2002, NEUROREPORT, V13, P1185, DOI 10.1097/00001756-200207020-00023; Kim J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03552; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Kubinova S, 2017, NEURAL REGEN RES, V12, P1430, DOI 10.4103/1673-5374.215249; Lacour SP, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.63; Hong LTA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00583-8; Lee J, 2016, ACTA BIOMATER, V42, P46, DOI 10.1016/j.actbio.2016.06.037; Li A, 2014, BIOMATERIALS, V35, P8780, DOI 10.1016/j.biomaterials.2014.06.049; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Maltman DJ, 2011, NEUROCHEM INT, V59, P347, DOI 10.1016/j.neuint.2011.06.008; Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124; Mruthyunjaya S, 2015, J BIOMED MATER RES A, V103, P746, DOI 10.1002/jbm.a.35221; Mruthyunjaya S, 2011, FEBS LETT, V585, P1915, DOI 10.1016/j.febslet.2011.04.072; Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; NSCIS C., 2014, SPIN CORD INJ FACTS; Okolicsanyi RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137255; Okolicsanyi RK, 2014, DEV BIOL, V388, P1, DOI 10.1016/j.ydbio.2014.01.024; Pan LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104335; Pierret C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-5; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013; Ramos TL, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0124-8; Rice CM, 2013, LANCET, V382, P1204, DOI 10.1016/S0140-6736(13)61810-3; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; Samsonraj RM, 2015, STEM CELLS, V33, P1878, DOI 10.1002/stem.1982; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sato K, 2018, CHEM SOC REV, V47, P7539, DOI 10.1039/c7cs00735c; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093; Theocharidis U, 2014, PROG BRAIN RES, V214, P3, DOI 10.1016/B978-0-444-63486-3.00001-3; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vecino E., 2016, COMPOS FUNCT EXTRACE, DOI DOI 10.5772/62527; White R. E., 2008, J COMP NEUROL, V26, P1370; Willis C.M., 2016, COMPOSITION FUNCTION; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d	84	22	22	3	45	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244	1944-8252		ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	DEC 5	2018	10	48					41046	41055		10.1021/acsami.8b13653			10	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	HD6XR	WOS:000452694100012	30475573				2022-02-06	
J	Jahan-Abad, AJ; Negah, SS; Ravandi, HH; Ghasemi, S; Borhani-Haghighi, M; Stummer, W; Gorji, A; Ghadiri, MK				Jahan-Abad, Ali Jahanbazi; Negah, Sajad Sahab; Ravandi, Hassan Hosseini; Ghasemi, Sedigheh; Borhani-Haghighi, Maryam; Stummer, Walter; Gorji, Ali; Ghadiri, Maryam Khaleghi			Human Neural Stem/Progenitor Cells Derived From Epileptic Human Brain in a Self-Assembling Peptide Nanoscaffold Improve Traumatic Brain Injury in Rats	MOLECULAR NEUROBIOLOGY			English	Article						Tissue engineering; Human neural stem cells; Traumatic brain injury; Epilepsy; Inflammation	ADULT HUMAN BRAIN; MESENCHYMAL STEM-CELLS; TEMPORAL-LOBE EPILEPSY; MARROW STROMAL CELLS; PROGENITOR CELLS; IN-VITRO; NEURONAL DIFFERENTIATION; PRECURSOR CELLS; SUBVENTRICULAR ZONE; TRANSPLANTATION	Traumatic brain injury (TBI) is a disruption in the brain functions following a head trauma. Cell therapy may provide a promising treatment for TBI. Among different cell types, human neural stem cells cultured in self-assembling peptide scaffolds have been suggested as a potential novel method for cell replacement treatment after TBI. In the present study, we accessed the effects of human neural stem/progenitor cells (hNS/PCs) derived from epileptic human brain and human adipose-derived stromal/stem cells (hADSCs) seeded in PuraMatrix hydrogel (PM) on brain function after TBI in an animal model of brain injury. hNS/PCs were isolated from patients with medically intractable epilepsy undergone epilepsy surgery. hNS/PCs and hADSCs have the potential for proliferation and differentiation into both neuronal and glial lineages. Assessment of the growth characteristics of hNS/PCs and hADSCs revealed that the hNS/PCs doubling time was significantly longer and the growth rate was lower than hADSCs. Transplantation of hNS/PCs and hADSCs seeded in PM improved functional recovery, decreased lesion volume, inhibited neuroinflammation, and reduced the reactive gliosis at the injury site. The data suggest the transplantation of hNS/PCs or hADSCs cultured in PM as a promising treatment option for cell replacement therapy in TBI.	[Jahan-Abad, Ali Jahanbazi; Negah, Sajad Sahab; Ravandi, Hassan Hosseini; Ghasemi, Sedigheh; Borhani-Haghighi, Maryam; Gorji, Ali] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Jahan-Abad, Ali Jahanbazi] Shahid Beheshti Univ Med Sci, Dept Clin Biochem, Tehran, Iran; [Negah, Sajad Sahab; Gorji, Ali] Mashhad Univ Med Sci, Dept Neurosci, Fac Med, Mashhad, Iran; [Stummer, Walter; Gorji, Ali; Ghadiri, Maryam Khaleghi] Westfalische Wilhelms Univ Munster, Dept Neurosurg, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Dept Neurol, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Robert Koch Str 45, D-48149 Munster, Germany		Gorji, A (corresponding author), Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran.; Gorji, A (corresponding author), Mashhad Univ Med Sci, Dept Neurosci, Fac Med, Mashhad, Iran.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Dept Neurosurg, Munster, Germany.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Dept Neurol, Munster, Germany.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Robert Koch Str 45, D-48149 Munster, Germany.	gorjial@uni-muenster.de	Jahan-Abad, Ali Jahanbazi/AAW-3641-2021; Negah, Sajad Sahab/AAQ-5852-2020; Stummer, Walter/AAA-3319-2020; Stummer, Walter/AAF-9043-2019	Jahan-Abad, Ali Jahanbazi/0000-0001-8629-7762; naseri, shahrokh/0000-0001-8974-2120; Gorji, Ali/0000-0002-4557-3270	Iran National Science Foundation (INSF)Iran National Science Foundation (INSF); National Institute for Medical Research Development; German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch Dienst (DAAD) [57348208, 57403633]	This study was supported by the Iran National Science Foundation (INSF), the National Institute for Medical Research Development, and the German Academic Exchange Service (DAAD; 57348208 and 57403633) to AG.	Abraham R, 2012, PROG BRAIN RES, V201, P17, DOI 10.1016/B978-0-444-59544-7.00002-0; Aligholi H, 2016, BRAIN RES, V1642, P197, DOI 10.1016/j.brainres.2016.03.043; Aligholi H, 2014, J NEUROSCI METH, V225, P81, DOI 10.1016/j.jneumeth.2013.12.008; Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI 10.1227/01.NEU.0000311081.50648.4C; Azevedo-Pereira RL, 2010, ARQ NEURO-PSIQUIAT, V68, P956, DOI 10.1590/S0004-282X2010000600023; Beretta S, 2017, CELL TRANSPLANT, V26, P1247, DOI 10.1177/0963689717714107; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; Buhnemann C, 2006, BRAIN, V129, P3238, DOI 10.1093/brain/awl261; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Cavalcanti BN, 2013, DENT MATER, V29, P97, DOI 10.1016/j.dental.2012.08.002; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Coulthard LG, 2017, J NEUROSCI, V37, P5395, DOI 10.1523/JNEUROSCI.0525-17.2017; Covacu R, 2017, NEUROSCIENTIST, V23, P27, DOI 10.1177/1073858415616559; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Dobrowolski S., 2013, AM J NEUROSCIENCE, V4, P13, DOI DOI 10.3844/AMJNSP.2013.13.24; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Francis NL, 2016, ACS BIOMATER SCI ENG, V2, P1030, DOI 10.1021/acsbiomaterials.6b00156; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Gupta K, 2013, NEUROSCI LETT, V543, P95, DOI 10.1016/j.neulet.2013.03.010; Hansson A, 2017, TISSUE CELL, V49, P35, DOI 10.1016/j.tice.2016.12.004; Hunt RF, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022376; Jahan-Abad AJ, 2018, MOL NEUROBIOL, V55, P4225, DOI 10.1007/s12035-017-0642-z; Jahanbazi Jahan-Abad A, 2017, AVICENNA J PHYTOMED, P1; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Joo KM, 2013, EXP NEUROL, V240, P168, DOI 10.1016/j.expneurol.2012.11.021; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kizil C, 2015, EMBO REP, V16, P416, DOI 10.15252/embr.201439702; Knight VB, 2017, PEERJ, V5, DOI 10.7717/peerj.2829; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Li X., 2017, J BIOMEDICAL MAT R A, V106, P1082; Liedmann A, 2012, BIORESEARCH OPEN ACC, V1, P16, DOI 10.1089/biores.2012.0209; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120; Nam H, 2015, WORLD J STEM CELLS, V7, P126, DOI 10.4252/wjsc.v7.i1.126; Negah SS, 2018, CELL TISSUE RES, V371, P223, DOI 10.1007/s00441-017-2717-6; Negah SS, 2017, MOL NEUROBIOL, V54, P8050, DOI 10.1007/s12035-016-0295-3; Negah SS, 2016, IRAN J BASIC MED SCI, V19, P1271, DOI 10.22038/ijbms.2016.7907; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Olstorn H, 2007, NEUROSURGERY, V60, P1089, DOI 10.1227/01.NEU.0000255461.91892.0D; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pincus D W, 1997, Clin Neurosurg, V44, P17; Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shetty AK, 2011, NEUROTHERAPEUTICS, V8, P721, DOI 10.1007/s13311-011-0064-y; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Sun D, 2016, NEURAL REGEN RES, V11, P18, DOI 10.4103/1673-5374.169605; Takei J., 2006, AATEX, V11, P170, DOI DOI 10.11232/aatex.11.170; Tang CK, 2009, INT J MOL SCI, V10, P2136, DOI 10.3390/ijms10052136; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Varghese M, 2008, NEUROSURGERY, V63, P1022, DOI 10.1227/01.NEU.0000335792.85142.B0; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Weick JP, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4190438; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu HM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3656193; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yang LQ, 2011, NEUROREPORT, V22, P370, DOI 10.1097/WNR.0b013e3283469615; Zhang L, 2017, NEURAL REGEN RES, V12, P1103, DOI 10.4103/1673-5374.211189; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang S, 2005, TISSUE ENG, P217; Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhao YN, 2009, TISSUE ENG PT A, V15, P13, DOI 10.1089/ten.tea.2008.0039; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958; Zhou FW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120281	78	22	23	5	32	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2018	55	12					9122	9138		10.1007/s12035-018-1050-8			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY3VF	WOS:000448483400026	29651746				2022-02-06	
J	Zeiler, FA; Lee, JK; Smielewski, P; Czosnyka, M; Brady, K				Zeiler, Frederick A.; Lee, Jennifer K.; Smielewski, Peter; Czosnyka, Marek; Brady, Ken			Validation of Intracranial Pressure-Derived Cerebrovascular Reactivity Indices against the Lower Limit of Autoregulation, Part II: Experimental Model of Arterial Hypotension	JOURNAL OF NEUROTRAUMA			English	Article						arterial hypotension; autoregulation; ICP indices; validation	TRAUMATIC BRAIN-INJURY; SWINE MODEL	The aim of this work was to explore the relationship between intracranial pressure (ICP)-derived indices of cerebrovascular reactivity and the lower limit of autoregulation (LLA) during arterial hypotension. We retrospectively reviewed recorded physiological data from piglets that underwent controlled hypotension. Hypotension was induced by inflation of a balloon catheter in the inferior vena cava. ICP, cortical laser Doppler flowmetry (LDF), and arterial blood pressure (ABP) monitoring was conducted. ICP-derived indices were calculated: pressure reactivity index (PRx; correlation between ICP and mean arterial pressure [MAP]); pulse amplitude index (PAx; correlation between pulse amplitude of ICP [AMP] and MAP); and RAC (correlation between AMP and cerebral perfusion pressure [CPP]). LLA was estimated by piece-wise linear regression of CPP versus LDF. We produced error bar plots for PRx, PAx, and RAC against 5-mm Hg bins of CPP, displaying the relationship with the LLA. We compared CPP values at clinically relevant thresholds of PRx, PAx, and RAC to CPP measured at the LLA. Receiver operating curve (ROC) analysis was performed for each index across the LLA using 5-mm Hg bins for CPP. Mean LLA was 36.2 +/- 10.5 mm Hg. Error bar plots demonstrated that PRx, PAx, and RAC increased, with CPP decreasing below the LLA. CPP at clinically relevant thresholds for PRx, PAx, and RAC displayed weak associations with the LLA, indicating that thresholds defined in TBI may not apply to a model of arterial hypotension. ROC analysis indicated that PRx, PAx, and RAC predicted the LLA, with AUCs of: 0.806 (95% confidence interval [CI], 0.750-0.863; p < 0.0001), 0.726 (95% CI, 0.664-0.789; p < 0.0001), and 0.710 (95% CI, 0.646-0.775; p < 0.0001), respectively. Three ICP-derived continuous indices of cerebrovascular reactivity, PRx, PAx, and RAC, were validated against the LLA within this experimental model of arterial hypotension, with PRx being superior.	[Lee, Jennifer K.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Sect Brain Phys, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Brady, Ken] Texas Childrens Hosp, Baylor Coll Med, Pediat Cardiol, Houston, TX 77030 USA		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca		Zeiler, Frederick/0000-0003-1737-0510; czosnyka, marek/0000-0003-2446-8006	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS080984] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS080984] Funding Source: Medline		Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Fraser C.D., 1985, J APPL PHYSIOL, V115, P52; Lee JK, 2012, ANESTH ANALG, V114, P825, DOI 10.1213/ANE.0b013e31824762d5; Lee JK, 2011, CRIT CARE MED, V39, P2337, DOI 10.1097/CCM.0b013e318223b910; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Zeiler FA, 2018, NEUROCRIT CARE, V28, P194, DOI 10.1007/s12028-017-0472-x; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	15	22	22	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2018	35	23					2812	2819		10.1089/neu.2017.5604			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HB1WO	WOS:000450819000007	29808745	Green Published, Green Submitted			2022-02-06	
J	Rodriguez, EG; Cardenas, JC; Cox, CS; Kitagawa, RS; Stensballe, J; Holcomb, JB; Johansson, PI; Wade, CE				Rodriguez, Erika Gonzalez; Cardenas, Jessica C.; Cox, Charles S.; Kitagawa, Ryan S.; Stensballe, Jakob; Holcomb, John B.; Johansson, Paer I.; Wade, Charles E.			Traumatic brain injury is associated with increased syndecan-1 shedding in severely injured patients	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Endothelium; Syndecan-1; Traumatic endotheliopathy; Sympathoadrenal activation	FRESH-FROZEN PLASMA; HEMORRHAGIC-SHOCK; ENDOTHELIAL GLYCOCALYX; SYMPATHOADRENAL ACTIVATION; MORTALITY; RESUSCITATION; COAGULOPATHY; INFLAMMATION; TRANSFUSION; MULTICENTER	Introduction: Head injury and exsanguination are the leading causes of death in trauma patients. Hemorrhagic shock triggers systemic endothelial glycocalyx breakdown, potentially leading to traumatic endotheliopathy (EoT). Levels of syndecan-1, a main glycocalyx component, have been used to assess the integrity of the glycocalyx. In TBI patients, it remains unclear whether syndecan-1 shedding occurs and its correlation with outcomes. We aimed to determine the frequency of EoT+, defined as a syndecan-1 level of 40 ng/ml or higher, after TBI in isolated and polytraumatic injury. We also investigated how the presence of EoT+ affected outcomes in TBI patients. Methods: Severely injured trauma patients were enrolled. From blood samples collected upon patients' arrival to the hospital, we measured syndecan-1 (main biomarker of EoT+), soluble thrombomodulin (sTM, endothelial activation) adrenaline and noradrenaline (sympathoadrenal activation), and assessed TBI patients' coagulation capacity. Results: Of the enrolled patients (n = 331), those with TBI and polytrauma (n = 68) had the highest rate of EoT+ compared to isolated TBI (n = 58) and Non-TBI patients (n = 205) (Polytrauma-TBI 55.9% vs. Isolated-TBI 20.0% vs. non-TBI polytrauma 40.0%; p = 0.001). TBI patients with EoT+ exhibited marked increases in sTM, adrenaline and noradrenaline levels, and physiological and coagulation derangements. In isolated TBI patients, increasing syndecan-1 levels (for every 10 ng/ml increase: 0.14; 95% CI: 0.02, 0.26) and hypocoagulability were negatively associated with survival. Conclusions: This study provides evidence of syndecan-1 shedding after TBI supporting the notion that breakdown of the glycocalyx contributes to the physiological derangements after TBI.	[Rodriguez, Erika Gonzalez; Cardenas, Jessica C.; Holcomb, John B.; Johansson, Paer I.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Surg, Ctr Translat Injury Res CeTIR, 6431 Fannin,MSB 5-204, Houston, TX 77030 USA; [Stensballe, Jakob; Johansson, Paer I.] Copenhagen Univ Hosp, Capital Reg Blood Bank, Sect Transfus Med, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Stensballe, Jakob] Copenhagen Univ Hosp, Ctr Head & Orthoped, Dept Anesthesia, Rigshosp, Copenhagen, Denmark; [Cox, Charles S.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, 6431 Fannin,MSB 5-258, Houston, TX 77030 USA; [Kitagawa, Ryan S.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Mischer Neurosci Inst, Dept Neurosurg, 6400 Fannin,Suite 2800, Houston, TX 77030 USA		Rodriguez, EG (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Surg, Ctr Translat Injury Res CeTIR, 6431 Fannin,MSB 5-204, Houston, TX 77030 USA.	Erika.r.gonzalez@uth.tmc.edu		holcomb, john/0000-0001-8312-9157; Gonzalez Rodriguez, Erika/0000-0003-1401-8925; Johansson, Par Ingemar/0000-0001-9778-5964	The Center for Translational Injury Research of The University of Texas Health Science Center; William Stamp Farish Fund; Howell Family Foundation	This study was supported by The Center for Translational Injury Research of The University of Texas Health Science Center and the William Stamp Farish Fund and the Howell Family Foundation.	Alphonsus CS, 2014, ANAESTHESIA, V69, P777, DOI 10.1111/anae.12661; Ban KC, 2015, SHOCK, V44, P452, DOI 10.1097/SHK.0000000000000452; Brettner F, 2017, CURR OPIN ANESTHESIO, V30, P36, DOI 10.1097/ACO.0000000000000434; Chignalia AZ, 2016, SHOCK, V45, P338, DOI 10.1097/SHK.0000000000000513; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Fox EE, 2017, SHOCK, V47, P567, DOI 10.1097/SHK.0000000000000788; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Gonzalez Rodriguez E, 2018, TRAUMATIC BRAIN INJU; Halaweish I, 2016, J TRAUMA ACUTE CARE, V81, P1080, DOI 10.1097/TA.0000000000001204; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1605-5; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, pS83, DOI 10.1097/TA.0000000000000631; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Ostrowski SR, 2017, J TRAUMA ACUTE CARE, V82, P293, DOI 10.1097/TA.0000000000001304; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Pati S, 2016, J TRAUMA ACUTE CARE, V80, P576, DOI 10.1097/TA.0000000000000961; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Rahbar E, 2014, SHOCK, V41, P181, DOI 10.1097/SHK.0000000000000101; Rodriguez EG, 2018, SHOCK, V50, P31, DOI 10.1097/SHK.0000000000001036; Rodriguez EG, 2017, J AM COLL SURGEONS, V225, P419, DOI 10.1016/j.jamcollsurg.2017.05.012; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Filho IT, 2013, MICROVASC RES, V85, P128, DOI 10.1016/j.mvr.2012.11.005; Torres IP, 2016, AM J PHYSIOL-HEART C, V310, pH1468, DOI 10.1152/ajpheart.00006.2016; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Wu F, 2017, SHOCK, V48, P340, DOI 10.1097/SHK.0000000000000832	36	22	22	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 21	2018	26								102	10.1186/s13049-018-0565-3			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HB3LM	WOS:000450953000001	30463625	Green Published, gold			2022-02-06	
J	Kosari-Nasab, M; Shokouhi, G; Ghorbanihaghjo, A; Abbasi, MM; Salari, AA				Kosari-Nasab, Morteza; Shokouhi, Ghaffar; Ghorbanihaghjo, Amir; Abbasi, Mehran Mesgari; Salari, Ali-Akbar			Hesperidin attenuates depression-related symptoms in mice with mild traumatic brain injury	LIFE SCIENCES			English	Article						Natural flavonoids; Antidepressant drugs; Cytokines; Malondialdehyde; Neurotrophins; Hesperidin	OXIDATIVE STRESS; NEUROTROPHIC FACTOR; MOUSE MODEL; REDUCES NEUROINFLAMMATION; HIPPOCAMPAL NEUROGENESIS; COGNITIVE IMPAIRMENT; IMMUNE ACTIVATION; BDNF LEVELS; INFLAMMATION; BEHAVIORS	Aims: There is increasing evidence showing that mild traumatic brain injury (mTBI) is associated with increased depression-related disorders in humans. Recent studies suggest that dietary intake or supplementation of natural flavonoids like hesperidin can be used for therapy of patients with brain injury and depression. However, the exact mechanisms by which hesperidin indicates its neuroprotective effects are not fully understood. The purpose of this study was to explore the influence of hesperidin on depression-related symptoms in a mouse model of mTBI, and that what mechanisms are primarily involved in the antidepressant effects of this bioflavonoid. Main methods: Ten days after mTBI-induction, mice received oral hesperidin treatment (50 mg/kg/14 days), then animals were subjected to different depression tests including sucrose preference test, forced swim test, novelty-suppressed feeding test, and tail suspension test. We also measured levels of tumor necrosis factor (TNF)-alpha, interleukin-(IL)-1 beta, malondialdehyde (MDA), and brain-derived-neurotrophic-factor (BDNF) in the hippocampus. Key findings: Our results show that mTBI induction induced depressive-like behaviors in mice by increasing inflammatory cytokines (IL-1 beta and TNF-alpha) and oxidative stress marker (MDA), and reducing BDNF levels in the hippocampus. Interestingly, hesperidin treatment was effective to significantly reduce depression-related symptoms in mTBI-induced mice. In addition, hesperidin decreased the levels of IL-1 beta, TNF-alpha and MDA, and increased BDNF levels in the hippocampus. The major strength of our study is that four behavioral tests gave similar results. Significance: This study suggests that the antidepressant-like effect of hesperidin may be mediated, at least in part, by decreased neuroinflammation and oxidative damage, and enhanced BDNF production in the hippocampus.	[Kosari-Nasab, Morteza; Shokouhi, Ghaffar; Ghorbanihaghjo, Amir; Abbasi, Mehran Mesgari; Salari, Ali-Akbar] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Ctr Res Neurosci, Tabriz, Iran; [Ghorbanihaghjo, Amir] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran; [Salari, Ali-Akbar] SICBD, Alborz, Iran		Shokouhi, G; Salari, AA (corresponding author), POB 51656-65811, Tabriz, Iran.	shokouhigh@yahoo.com; aa.salari@yahoo.com	Tabrizi, Ghaffar Shokouhi/L-6326-2017; Salari, Ali-Akbar/I-7843-2013	Tabrizi, Ghaffar Shokouhi/0000-0001-5081-9928; Salari, Ali-Akbar/0000-0002-4970-0337; Kosari-Nasab, Morteza/0000-0001-8454-5873; ghorbanihaghjo, amir/0000-0001-6742-0526	Drug Applied Research Center, Tabriz University of Medical Sciences [94/77]	This study was supported by a grant from the Drug Applied Research Center, Tabriz University of Medical Sciences (grant number 94/77).	Antunes MS, 2016, EUR J PHARMACOL, V789, P411, DOI [10.1016/j.ejphar.2016.07.042, 10.1016/j.ejphar.20]; Antunes MS, 2014, NUTRITION, V30, P1415, DOI 10.1016/j.nut.2014.03.024; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Ayatollahi AM, 2017, NEUROL RES, V39, P1056, DOI 10.1080/01616412.2017.1376789; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Belzung C, 2015, CURR OPIN NEUROBIOL, V30, P24, DOI 10.1016/j.conb.2014.08.013; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Chang CY, 2015, NEUROTOXICOLOGY, V50, P157, DOI 10.1016/j.neuro.2015.08.014; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen MC, 2010, FOOD CHEM TOXICOL, V48, P2980, DOI 10.1016/j.fct.2010.07.037; Ciftci O, 2015, NEUROCHEM RES, V40, P1111, DOI 10.1007/s11064-015-1571-8; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Donato F, 2015, J MED FOOD, V18, P818, DOI 10.1089/jmf.2014.0074; Donato F, 2014, BRAIN RES BULL, V104, P19, DOI 10.1016/j.brainresbull.2014.03.004; Duman RS, 2014, DIALOGUES CLIN NEURO, V16, P11; El-Marasy SA, 2014, CAN J PHYSIOL PHARM, V92, P945, DOI 10.1139/cjpp-2014-0281; Filho CB, 2013, EUR J PHARMACOL, V698, P286, DOI 10.1016/j.ejphar.2012.11.003; Gonul AS, 2005, EUR ARCH PSY CLIN N, V255, P381, DOI 10.1007/s00406-005-0578-6; Haghmorad D, 2017, J NEUROIMMUNOL, V302, P23, DOI 10.1016/j.jneuroim.2016.11.009; Jangra A, 2015, BIOL TRACE ELEM RES, V168, P462, DOI 10.1007/s12011-015-0375-7; Javed H, 2015, J NEUROL SCI, V348, P51, DOI 10.1016/j.jns.2014.10.044; Johnson VJ, 2003, NEUROTOXICOLOGY, V24, P261, DOI 10.1016/S0161-813X(02)00194-8; Kosari-Nasab M, 2018, TOXICOL APPL PHARM, V338, P159, DOI 10.1016/j.taap.2017.11.012; Kumar A, 2013, EUR J PHARMACOL, V720, P16, DOI 10.1016/j.ejphar.2013.10.057; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; Li CY, 2015, BEHAV BRAIN RES, V281, P32, DOI 10.1016/j.bbr.2014.12.012; Li CF, 2016, BRAIN RES BULL, V124, P40, DOI 10.1016/j.brainresbull.2016.03.016; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Loh Kok Poh, 2006, Current Alzheimer Research, V3, P327; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Majidi J, 2016, BRAIN RES BULL, V120, P1, DOI 10.1016/j.brainresbull.2015.10.009; Majidi-Zolbanin J, 2015, NEUROSCIENCE, V294, P69, DOI 10.1016/j.neuroscience.2015.03.016; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mineur YS, 2007, BIOL PSYCHIAT, V61, P250, DOI 10.1016/j.biopsych.2006.04.037; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Pinho-Ribeiro FA, 2015, CHEM-BIOL INTERACT, V228, P88, DOI 10.1016/j.cbi.2015.01.011; Polyakova M, 2015, J AFFECT DISORDERS, V174, P432, DOI 10.1016/j.jad.2014.11.044; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raza SS, 2011, BRAIN RES, V1420, P93, DOI 10.1016/j.brainres.2011.08.047; Rizzetti DA, 2016, NEUROCHEM INT, V101, P30, DOI 10.1016/j.neuint.2016.10.002; Rong Z, 2013, NEUROSCIENCE, V255, P292, DOI 10.1016/j.neuroscience.2013.09.030; Roohbakhsh A, 2015, LIFE SCI, V124, P64, DOI 10.1016/j.lfs.2014.12.030; Roohbakhsh A, 2014, LIFE SCI, V113, P1, DOI 10.1016/j.lfs.2014.07.029; Salari AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29595-0; Salari AA, 2017, INT J DEV NEUROSCI, V57, P62, DOI 10.1016/j.ijdevneu.2017.01.007; Salari AA, 2015, EUR NEUROPSYCHOPHARM, V25, P1260, DOI 10.1016/j.euroneuro.2015.04.022; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Souza LC, 2013, PROG NEURO-PSYCHOPH, V40, P103, DOI 10.1016/j.pnpbp.2012.09.003; Sulakhiya K, 2014, EUR J PHARMACOL, V744, P124, DOI 10.1016/j.ejphar.2014.09.049; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Thenmozhi AJ, 2017, NUTR NEUROSCI, V20, P360, DOI [10.1080/1028415x.2016.1144846, 10.1080/1028415X.2016.1144846]; Wang DM, 2014, CELL MOL NEUROBIOL, V34, P1209, DOI 10.1007/s10571-014-0098-x; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Zhang Y, 2010, BRAIN RES, V1366, P141, DOI 10.1016/j.brainres.2010.09.095	60	22	22	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	NOV 15	2018	213						198	205		10.1016/j.lfs.2018.10.040			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GY2ZM	WOS:000448413900025	30352242				2022-02-06	
J	Dukhinova, M; Kuznetsova, I; Kopeikina, E; Veniaminova, E; Yung, AWY; Veremeyko, T; Levchuk, K; Barteneva, NS; Wing-Ho, KK; Yung, WH; Liu, JYH; Rudd, J; Yau, SSY; Anthony, DC; Strekalova, T; Ponomarev, ED				Dukhinova, Marina; Kuznetsova, Inna; Kopeikina, Ekaterina; Veniaminova, Ekaterina; Yung, Amanda W. Y.; Veremeyko, Tatyana; Levchuk, Kseniia; Barteneva, Natasha S.; Wing-Ho, Kenny Kam; Yung, Wing-Ho; Liu, Julia Y. H.; Rudd, John; Yau, Sonata S. Y.; Anthony, Daniel C.; Strekalova, Tatyana; Ponomarev, Eugene D.			Platelets mediate protective neuroinflammation and promote neuronal plasticity at the site of neuronal injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Neuronal plasticity; Dendritic spines; Serotonin; Neuroinflammation; Glycobiology; Platelets; Platelet-derived microparticles; Traumatic brain injury; CNS repair	TRAUMATIC BRAIN-INJURY; ACTIVATING-FACTOR; CEREBROSPINAL-FLUID; MOUSE MODEL; SEROTONIN; RECEPTOR; PROTEIN; MICE; BLOOD; PHOSPHORYLATION	It is generally accepted that inflammation within the CNS contributes to neurodegeneration after traumatic brain injury (TBI), but it is not clear how inflammation is initiated in the absence of infection and whether this neuroinflammation is predominantly beneficial or detrimental. We have previously found that brain-enriched glycosphingolipids within neuronal lipid rafts (NLR) induced platelet degranulation and secretion of neuro-transmitters and pro-inflammatory factors. In the present study, we compared TBI-induced inflammation and neurodegeneration in wild-type vs. St3gal5 deficient (ST3(-/-)) mice that lack major CNS-specific glycosphingolipids. After TBI, microglial activation and CNS macrophage infiltration were substantially reduced in ST3(-/-) animals. However, ST3(-/-) mice had a larger area of CNS damage with marked neuronal/axonal loss. The interaction of platelets with NLR stimulated neurite growth, increased the number of PSD95-positive dendritic spines, and intensified neuronal activity. Adoptive transfer and blocking experiments provide further that platelet-derived serotonin and platelet activating factor plays a key role in the regulation of sterile neuroinflammation,hemorrhage and neuronal plasticity after TBI.	[Dukhinova, Marina; Kuznetsova, Inna; Kopeikina, Ekaterina; Yung, Amanda W. Y.; Veremeyko, Tatyana; Levchuk, Kseniia; Wing-Ho, Kenny Kam; Yung, Wing-Ho; Liu, Julia Y. H.; Rudd, John; Ponomarev, Eugene D.] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Veniaminova, Ekaterina; Strekalova, Tatyana] Maastricht Univ, Dept Neurosci, Maastricht, Netherlands; [Barteneva, Natasha S.] Harvard Med Sch, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA USA; [Barteneva, Natasha S.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Rudd, John] Chinese Univ Hong Kong, Brain & Mind Inst, Shatin, Hong Kong, Peoples R China; [Yau, Sonata S. Y.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Kowloon, Hong Kong, Peoples R China; [Anthony, Daniel C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Ponomarev, Eugene D.] Kunming Inst Zool & Chinese Univ Hong Kong Joint, Kunmin, Hong Kong, Peoples R China		Ponomarev, ED (corresponding author), Chinese Univ Hong Kong, Shatin, 323A,3-F,Lo Kwee Seong Integrated Biomed Sci Bld, Hong Kong, Peoples R China.	eponomarev@cuhk.edu.hk	Barteneva, Natalie/V-3826-2019; Ponomarev, Eugene D./K-1546-2013; Veniaminova, Ekaterina/Q-1704-2017; Dukhinova, Marina/ABF-9506-2021; Dukhinova, Marina/P-8167-2019; Levchuk, Ksenia/ABD-4642-2020; Yung, Ho/R-6161-2018; Anthony, Daniel C/F-7765-2010; Rudd, John A./R-6603-2018	Barteneva, Natalie/0000-0002-8109-1754; Ponomarev, Eugene D./0000-0002-0871-8522; Veniaminova, Ekaterina/0000-0003-3477-7099; Dukhinova, Marina/0000-0001-8118-9439; Yung, Ho/0000-0002-5542-8173; Anthony, Daniel C/0000-0003-1380-6655; Yung, Amanda WY/0000-0003-4265-9324; Rudd, John A./0000-0002-8316-0792; Yau, Sonata Suk Yu/0000-0002-7425-6741	Lo Kwee-Seong Biomedical Research fund (The Chinese University of Hong Kong), Health and Medical Research Fund Grant [02130636]; Research Grant Council-General Research Fund Grant (Hong Kong Government, Hong Kong) [14113316]	We wish to thank Ekaterina Biryukova and Yana Venerina for technical assistance for analysis of behaviour tests. The work was supported by the Lo Kwee-Seong Biomedical Research fund (The Chinese University of Hong Kong), Health and Medical Research Fund Grant, reference no. 02130636 (Hong Kong Government, Hong Kong), and the Research Grant Council-General Research Fund Grant, reference no 14113316 (Hong Kong Government, Hong Kong).	Barteneva NS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-23; Bazan NG, 1997, NEUROCHEM INT, V30, P225, DOI 10.1016/S0197-0186(96)00020-4; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Cacialli P, 2018, NEURAL REGEN RES, V13, P941, DOI 10.4103/1673-5374.233430; Cane M, 2014, J NEUROSCI, V34, P2075, DOI 10.1523/JNEUROSCI.3353-13.2014; Castejon OJ, 2004, DEV BRAIN RES, V151, P25, DOI 10.1016/j.devbrainres.2004.03.019; Chacon-Fernandez P, 2016, J BIOL CHEM, V291, P9872, DOI 10.1074/jbc.M116.720029; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Collins JM, 2015, EXP NEUROL, V267, P219, DOI 10.1016/j.expneurol.2015.02.034; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Doronin II, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-295; Dukhinova M, 2018, METHODS MOL BIOL, V1745, P167, DOI 10.1007/978-1-4939-7680-5_10; Elhusseiny A, 2001, BRIT J PHARMACOL, V132, P55, DOI 10.1038/sj.bjp.0703763; Fragaki K, 2013, EUR J HUM GENET, V21, P528, DOI 10.1038/ejhg.2012.202; Gill P, 2015, J ALLERGY CLIN IMMUN, V135, P1424, DOI 10.1016/j.jaci.2015.04.019; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Haimovich B, 1999, THROMB HAEMOSTASIS, V81, P618; Han R, 2011, NEUROSCI MED, V2, P370, DOI [10.4236/nm.2011.24049, DOI 10.4236/NM.2011.24049]; Herr N, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00048; Huang M, 2009, SURG NEUROL, V72, P481, DOI 10.1016/j.surneu.2008.12.016; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Iwamoto S, 1996, BIOCHEM BIOPH RES CO, V218, P940, DOI 10.1006/bbrc.1996.0166; Izikki M, 2007, AM J PHYSIOL-LUNG C, V293, pL1045, DOI 10.1152/ajplung.00082.2007; Jones KA, 2009, P NATL ACAD SCI USA, V106, P19575, DOI 10.1073/pnas.0905884106; Kellner Yves, 2014, Front Synaptic Neurosci, V6, P5, DOI 10.3389/fnsyn.2014.00005; Kim BK, 2013, NEUROCHEM INT, V63, P121, DOI 10.1016/j.neuint.2013.05.010; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Lai KC, 2003, J CELL PHYSIOL, V194, P206, DOI 10.1002/jcp.10222; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Law JKY, 2012, ANN BIOMED ENG, V40, P619, DOI 10.1007/s10439-011-0432-0; Lee JS, 2016, AM J MED GENET A, V170, P2200, DOI 10.1002/ajmg.a.37773; Li Q, 2016, MOL NEUROBIOL, V53, P4226, DOI 10.1007/s12035-015-9362-4; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mattugini N, 2018, GLIA, V66, P1644, DOI 10.1002/glia.23329; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Mohammad-Zadeh LF, 2008, J VET PHARMACOL THER, V31, P187, DOI 10.1111/j.1365-2885.2008.00944.x; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Ponomarev ED, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00406; Ponomarev Eugene D, 2011, BMC Res Notes, V4, P517, DOI 10.1186/1756-0500-4-517; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Proia RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/ng1104-1147; Quaegebeur A, 2010, NEURON, V68, P321, DOI 10.1016/j.neuron.2010.10.024; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rivera FJ, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00511; Ryan SD, 2007, J NEUROCHEM, V103, P88, DOI 10.1111/j.1471-4159.2007.04740.x; Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Sotnikov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058979; Starossom SC, 2015, CIRC RES, V117, P779, DOI 10.1161/CIRCRESAHA.115.306847; Starossom SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096256; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Torres-Espin A, 2018, BRAIN, V141, P1946, DOI 10.1093/brain/awy128; Trakhtenberg EF, 2012, INT REV NEUROBIOL, V106, P105, DOI 10.1016/B978-0-12-407178-0.00005-3; Tsuda M, 2007, J NEUROCHEM, V102, P1658, DOI 10.1111/j.1471-4159.2007.04796.x; Veitinger M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-65; Veremeyko T, 2012, JOVE-J VIS EXP, DOI 10.3791/4097; Veremeyko T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00050; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Wang H, 2016, CLIN GENET, V89, P625, DOI 10.1111/cge.12703; Wen FQ, 1999, ARTERIOSCL THROM VAS, V19, P519, DOI 10.1161/01.ATV.19.3.519; Winnubst J, 2015, NEURON, V87, P399, DOI 10.1016/j.neuron.2015.06.029; Wuescher LM, 2015, J THROMB HAEMOST, V13, P303, DOI 10.1111/jth.12795; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yoshikawa M, 2009, P NATL ACAD SCI USA, V106, P9483, DOI 10.1073/pnas.0903279106; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026	80	22	22	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	NOV	2018	74						7	27		10.1016/j.bbi.2018.09.009			21	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	HF4FB	WOS:000454187500003	30217533				2022-02-06	
J	Neri, M; Frati, A; Turillazzi, E; Cantatore, S; Cipolloni, L; Di Paolo, M; Frati, P; La Russa, R; Maiese, A; Scopetti, M; Santurro, A; Sessa, F; Zamparese, R; Fineschi, V				Neri, Margherita; Frati, Alessandro; Turillazzi, Emanuela; Cantatore, Santina; Cipolloni, Luigi; Di Paolo, Marco; Frati, Paola; La Russa, Raffaele; Maiese, Aniello; Scopetti, Matteo; Santurro, Alessandro; Sessa, Francesco; Zamparese, Rosanna; Fineschi, Vittorio			Immunohistochemical Evaluation of Aquaporin-4 and its Correlation with CD68, IBA-1, HIF-1, GFAP, and CD15 Expressions in Fatal Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; aquaporin; genetic analysis; edema; computed tomography (CT) scan; hypoxia; microglia activation	REVEALS COMPLEX; GROWTH-FACTOR; EDEMA; WATER; ASTROCYTES; FLUID; PATHOPHYSIOLOGY; EPIDEMIOLOGY; MECHANISMS; HIF1-ALPHA	Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. Our understanding of its pathobiology has substantially increased. Following TBI, the following occur, edema formation, brain swelling, increased intracranial pressure, changes in cerebral blood flow, hypoxia, neuroinflammation, oxidative stress, excitotoxicity, and apoptosis. Experimental animal models have been developed. However, the difficulty in mimicking human TBI explains why few neuroprotective strategies, drawn up on the basis of experimental studies, have translated into improved therapeutic strategies for TBI patients. In this study, we retrospectively examined brain samples in 145 cases of death after different survival times following TBI, to investigate aquaporin-4 (AQP4) expression and correlation with hypoxia, and neuroinflammation in human TBI. Antibodies anti-glial fibrillary acid protein (GFAP), aquaporin-4 (AQP4), hypoxia induced factor-1 (HIF-1), macrophage/phagocytic activation (CD68), ionized calcium-binding adapter molecule-1 (IBA-1), and neutrophils (CD15) were used. AQP4 showed a significant, progressive increase between the control group and groups 2 (one-day survival) and 3 (three-day survival). There were further increases in AQP4 immunopositivity in groups 4 (seven-day survival), 5 (14-dayssurvival), and 6 (30-day survival), suggesting an upregulation of AQP4 at 7 to 30 days compared to group 1. GFAP showed its highest expression in non-acute cases at the astrocytic level compared with the acute TBI group. Data emerging from the HIF-1 reaction showed a progressive, significant increase. Immunohistochemistry with IBA-1 revealed activated microglia starting three days after trauma and progressively increasing in the next 15 to 20 days after the initial trauma. CD68 expression demonstrated basal macrophage and phagocytic activation mostly around blood vessels. Starting from one to three days of survival after TBI, an increase in the number of CD68 cells was progressively observed; at 15 and 30 days of survival, CD68 showed the most abundant immunopositivity inside or around the areas of necrosis. These findings need to be developed further to gain insight into the mechanisms through which brain AQP4 is upregulated. This could be of the utmost clinicopathological importance.	[Neri, Margherita] Univ Ferrara, Dept Morphol Expt Med & Surg, Via Fossato Mortara 70, I-44121 Ferrara, Italy; [Frati, Alessandro] Sapienza Univ Rome, St Andrea Hosp, Dept Neurosci Mental Hlth & Sensory Organs, Via Grottarossa 1035, I-00189 Rome, Italy; [Frati, Alessandro; Frati, Paola; La Russa, Raffaele; Fineschi, Vittorio] IRCCS Neuromed, Via Atinense 18, I-86077 Pozzilli, Italy; [Turillazzi, Emanuela; Di Paolo, Marco] Univ Pisa, Inst Legal Med, Dept Surg Pathol Med Mol & Crit Area, Osped Santa Chiara, Via Roma 55, I-56126 Pisa, Italy; [Cantatore, Santina; Sessa, Francesco] Univ Foggia, Osped Colonnello DAvanzo, Dept Clin & Expt Med, Sect Legal Med, Via Aviatori 1, I-71100 Foggia, Italy; [Cipolloni, Luigi; Frati, Paola; La Russa, Raffaele; Maiese, Aniello; Scopetti, Matteo; Santurro, Alessandro; Fineschi, Vittorio] Sapienza Univ Rome, Dept Anat Histol Forens & Orthopaed Sci, Viale Regina Elena 336, I-00185 Rome, Italy; [Zamparese, Rosanna] ASUR Area Vasta 5, Unit Legal Med, Viale Marcello Federici, I-63100 Ascoli Piceno, Italy		Fineschi, V (corresponding author), IRCCS Neuromed, Via Atinense 18, I-86077 Pozzilli, Italy.; Fineschi, V (corresponding author), Sapienza Univ Rome, Dept Anat Histol Forens & Orthopaed Sci, Viale Regina Elena 336, I-00185 Rome, Italy.	margherita.neri@unife.it; alessandro.frati@uniroma1.it; emanuela.turillazzi@unipi.it; santina.cantatore@unifg.it; luigi.cipolloni@uniroma1.it; marco.dipaolo@unipi.it; paola.frati@uniroma1.it; raffaele.larussa@uniroma1.it; aniello.maiese@uniroma1.it; matteo.scopetti@uniroma1.it; alessandro.santurro@uniroma1.it; francesco.sessa@unifg.it; rosanna.zamparese@sanita.marche.it; vfinesc@tin.it	Scopetti, Matteo/ABD-6466-2020; Pesce, Alessandro/AAC-2223-2020; Fineschi, Vittorio/AAJ-4808-2020; Cipolloni, Luigi/AAS-2680-2020; Sessa, Francesco/G-1754-2018; Neri, Margherita/AAD-4521-2022; Frati, Alessandro/AAC-2204-2020	Sessa, Francesco/0000-0003-0357-8791; Scopetti, Matteo/0000-0002-7259-3090; FRATI, ALESSANDRO/0000-0001-8062-614X; cipolloni, luigi/0000-0001-6464-3249; Fineschi, Vittorio/0000-0002-1686-3236; NERI, Margherita/0000-0002-6459-1669; Santurro, Alessandro/0000-0001-5491-3719			Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; [Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Barzo P, 1997, ACT NEUR S, V70, P119; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; Castejon OJ, 2013, ULTRASTRUCT PATHOL, V37, P417, DOI 10.3109/01913123.2013.831157; Dai WS, 2018, INT J MOL MED, V42, P1716, DOI 10.3892/ijmm.2018.3749; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Filippidis AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010055; Filippidis AS, 2014, J NEUROTRAUM, V31, P1258, DOI 10.1089/neu.2013.3063; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; FRIGERI A, 1995, J CELL SCI, V108, P2993; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Hoogland ICM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00110; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; ITO U, 1986, ACTA NEUROCHIR, V79, P120, DOI 10.1007/BF01407455; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Li G, 2018, INT J MOL MED, V42, P1935, DOI 10.3892/ijmm.2018.3802; Lo Pizzo M, 2013, NEUROL SCI, V34, P1309, DOI 10.1007/s10072-012-1233-4; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pinchi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20699-1; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sorani MD, 2008, HUM MUTAT, V29, P1108, DOI 10.1002/humu.20762; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Sviri GE, 2015, J NEUROSURG, V123, P1188, DOI 10.3171/2014.11.JNS141152; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang GH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101413; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Wolburg H, 2012, MOL ASPECTS MED, V33, P579, DOI 10.1016/j.mam.2012.02.003; Yang M, 2011, ANAT HISTOL EMBRYOL, V40, P299, DOI 10.1111/j.1439-0264.2011.01070.x; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022	63	22	23	2	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2018	19	11							3544	10.3390/ijms19113544			19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	HC0ZM	WOS:000451528500260	30423808	gold, Green Published, Green Submitted			2022-02-06	
J	Wilde, EA; Ware, AL; Li, XQ; Wu, TC; McCauley, SR; Barnes, A; Newsome, MR; Biekman, BD; Hunter, JV; Chu, ZD; Levin, HS				Wilde, Elisabeth A.; Ware, Ashley L.; Li, Xiaoqi; Wu, Trevor C.; McCauley, Stephen R.; Barnes, Amanda; Newsome, Mary R.; Biekman, Brian D.; Hunter, Jill V.; Chu, Zili D.; Levin, Harvey S.			Orthopedic Injured versus Uninjured Comparison Groups for Neuroimaging Research in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						DTI; MRI; mTBI; OI	UNITED-STATES; RISK-FACTORS; POSTTRAUMATIC-STRESS; UNINTENTIONAL INJURY; HEAD IMPACTS; CHILDREN; DIFFUSION; OUTCOMES; SCALE; HOSPITALIZATION	To address controversy surrounding the most appropriate comparison group for mild traumatic brain injury (mTBI) research, mTBI patients 12-30 years of age were compared with an extracranial orthopedic injury (OI) patient group and an uninjured, typically developing (TD) participant group with comparable demographic backgrounds. Injured participants underwent subacute (within 96h) and late (3 months) diffusion tensor imaging (DTI); TD controls underwent DTI once. Group differences in fractional anisotropy (FA) and mean diffusivity (MD) of commonly studied white matter tracts were assessed. For FA, subacute group differences occurred in the bilateral inferior frontal occipital fasciculus (IFOF) and right inferior longitudinal fasciculus (ILF), and for MD, differences were found in the total corpus callosum, right uncinate fasciculus, IFOF, ILF, and bilateral cingulum bundle (CB). In these analyses, differences (lower FA and higher MD) were generally observed between the mTBI and TD groups but not between the mTBI and OI groups. After a 3 month interval, groups significantly differed in left IFOF FA and in right IFOF and CB MD; the TD group had significantly higher FA and lower MD than both injury groups, which did not differ. There was one exception to this pattern, in which the OI group demonstrated significantly lower FA in the left ILF than the TD group, although neither group differed from the mTBI group. The mTBI and OI groups had generally similar longitudinal results. Findings suggest that different conclusions about group-level DTI analyses could be drawn, depending on the selected comparison group, highlighting the need for additional research in this area. Where possible, mTBI studies may benefit from the inclusion of both OI and TD controls.	[Wilde, Elisabeth A.; Newsome, Mary R.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Wilde, Elisabeth A.] George E Wahlen Dept Vet Affairs, Med Ctr, Salt Lake City, UT USA; [Wilde, Elisabeth A.; Ware, Ashley L.; Li, Xiaoqi; Wu, Trevor C.; McCauley, Stephen R.; Newsome, Mary R.; Biekman, Brian D.; Hunter, Jill V.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.; Chu, Zili D.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Univ Utah, Dept Neurol, 383 Colorow Rd,Suite 302, Salt Lake City, UT 84108 USA; [Ware, Ashley L.; Biekman, Brian D.] Univ Houston, Dept Psychol, Houston, TX USA; [Ware, Ashley L.; Biekman, Brian D.] Univ Houston, TIMES, Houston, TX USA; [Wu, Trevor C.] Mercy Hlth St Marys, Hauenstein Neurosci, Grand Rapids, MI USA; [Barnes, Amanda] Univ Southern Calif, Dept Obstet & Gynecol, Med Ctr, Los Angeles, CA USA; [Hunter, Jill V.; Chu, Zili D.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA		Wilde, EA (corresponding author), Univ Utah, Dept Neurol, 383 Colorow Rd,Suite 302, Salt Lake City, UT 84108 USA.	elisabeth.wilde@hsc.utah.edu			National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS056202]; US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [PT13078]; TBI Endpoints Development grant [W81XWH-14-2-0176]	Support for this research was provided by the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) (P01 NS056202, PI: Douglas Smith, M.D.), US Army Medical Research and Materiel Command (USAMRMC) (PT13078, PI: Geoff Manley, M.D.), and TBI Endpoints Development grant W81XWH-14-2-0176 (PI: Geoff Manley, M.D., Ph.D.). We thank the participants and their family members for their participation in this study. We also thank the anonymous reviewers for their helpful comments and suggestions in revising the manuscript.	Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bigler ED, 2015, BRAIN NEUROTRAUMA MO, P1; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Bruce B, 2007, PAED CHILD HEALT-CAN, V12, P749, DOI 10.1093/pch/12.9.749; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Collins J G, 1990, Vital Health Stat 10, P1; *COMM INJ SCAL, 1998, ABBR INJ SCAL, DOI DOI 10.3171/2012.9.JNS12815; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; Delaney-Black V, 2002, ARCH PEDIAT ADOL MED, V156, P280, DOI 10.1001/archpedi.156.3.280; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LODER RT, 1995, J PEDIATR ORTHOPED, V15, P41, DOI 10.1097/01241398-199501000-00010; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozer K, 2010, J PEDIATR ORTHOPED, V30, P324, DOI 10.1097/BPO.0b013e3181d8fa8c; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schwebel DC, 2007, J DEV BEHAV PEDIATR, V28, P245, DOI 10.1097/01.DBP.0000268561.80204.2a; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	62	22	22	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					239	249		10.1089/neu.2017.5513		OCT 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000447011700001	29786476	Green Published			2022-02-06	
J	Samary, CS; Ramos, AB; Maia, LA; Rocha, NN; Santos, CL; Magalhaes, RF; Clevelario, AL; Pimentel-Coelho, PM; Mendez-Otero, R; Cruz, FF; Capelozzi, VL; Ferreira, TPT; Koch, T; de Abreu, MG; dos Santos, CC; Pelosi, P; Silva, PL; Rocco, PRM				Samary, Cynthia S.; Ramos, Alane B.; Maia, Ligia A.; Rocha, Nazareth N.; Santos, Cintia L.; Magalhaes, Raquel F.; Clevelario, Amanda L.; Pimentel-Coelho, Pedro M.; Mendez-Otero, Rosalia; Cruz, Fernanda F.; Capelozzi, Vera L.; Ferreira, Tatiana P. T.; Koch, Thea; de Abreu, Marcelo Gama; dos Santos, Claudia C.; Pelosi, Paolo; Silva, Pedro L.; Rocco, Patricia R. M.			Focal ischemic stroke leads to lung injury and reduces alveolar macrophage phagocytic capability in rats	CRITICAL CARE			English	Article						Focal ischemic stroke; Lung injury; Brain-lung interaction; Inflammation; Macrophages	TRAUMATIC BRAIN-INJURY; RESPIRATORY MECHANICS; INNATE IMMUNITY; TIDAL-VOLUME; INFLAMMATION; PULMONARY; COMPLICATIONS; POSTSTROKE; INFECTION; PNEUMONIA	Background: Ischemic stroke causes brain inflammation, which we postulate may result in lung damage. Several studies have focused on stroke-induced immunosuppression and lung infection; however, the possibility that strokes may trigger lung inflammation has been overlooked. We hypothesized that even focal ischemic stroke might induce acute systemic and pulmonary inflammation, thus altering respiratory parameters, lung tissue integrity, and alveolar macrophage behavior. Methods: Forty-eight Wistar rats were randomly assigned to ischemic stroke (Stroke) or sham surgery (Sham). Lung function, histology, and inflammation in the lung, brain, bronchoalveolar lavage fluid (BALF), and circulating plasma were evaluated at 24 h. In vitro, alveolar macrophages from naive rats (unstimulated) were exposed to serum or BALF from Sham or Stroke animals to elucidate possible mechanisms underlying alterations in alveolar macrophage phagocytic capability. Alveolar macrophages and epithelial and endothelial cells of Sham and Stroke animals were also isolated for evaluation of mRNA expression of interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha. Results: Twenty-four hours following ischemic stroke, the tidal volume, expiratory time, and mean inspiratory flow were increased. Compared to Sham animals, the respiratory rate and duty cycle during spontaneous breathing were reduced, but this did not affect lung mechanics during mechanical ventilation. Lungs from Stroke animals showed clear evidence of increased diffuse alveolar damage, pulmonary edema, and inflammation markers. This was associated with an increase in ultrastructural damage, as evidenced by injury to type 2 pneumocytes and endothelial cells, cellular infiltration, and enlarged basement membrane thickness. Protein levels of proinflammatory mediators were documented in the lung, brain, and plasma (TNF-alpha and IL-6) and in BALF (TNF-alpha). The phagocytic ability of macrophages was significantly reduced. Unstimulated macrophages isolated from naive rats only upregulated expression of TNF-alpha and IL-6 following exposure to serum from Stroke rats. Exposure to BALF from Stroke or Sham animals did not change alveolar macrophage behavior, or gene expression of TNF-alpha and IL-6. IL-6 expression was increased in macrophages and endothelial cells from Stroke animals. Conclusions: In rats, focal ischemic stroke is associated with brain-lung crosstalk, leading to increased pulmonary damage and inflammation, as well as reduced alveolar macrophage phagocytic capability, which seems to be promoted by systemic inflammation.	[Samary, Cynthia S.; Maia, Ligia A.; Rocha, Nazareth N.; Santos, Cintia L.; Magalhaes, Raquel F.; Clevelario, Amanda L.; Cruz, Fernanda F.; Silva, Pedro L.; Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Carlos Chagas Filho Biophys Inst, Lab Pulm Invest, Ave Carlos Chagas Filho S-N,Bloco G-014, BR-21941902 Rio De Janeiro, RJ, Brazil; [Ramos, Alane B.; Pimentel-Coelho, Pedro M.; Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Lab Cellular & Mol Neurobiol, Rio De Janeiro, RJ, Brazil; [Rocha, Nazareth N.] Fluminense Fed Univ, Dept Physiol & Pharmacol, Niteroi, RJ, Brazil; [Capelozzi, Vera L.] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, SP, Brazil; [Ferreira, Tatiana P. T.] Oswaldo Cruz Fdn FIOCRUZ, Oswaldo Cruz Inst, Lab Inflammat, Rio De Janeiro, SP, Brazil; [Koch, Thea; de Abreu, Marcelo Gama] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Anesthesiol & Intens Care Therapy, Pulm Engn Grp, Dresden, Germany; [dos Santos, Claudia C.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Interdept Div Crit Care, Toronto, ON, Canada; [Pelosi, Paolo] Univ Genoa, Dipartimento Sci Chirurg & Diagnost Integrate DIS, Genoa, Italy; [Pelosi, Paolo] IRCCS Osped Policlin San Martino, Genoa, Italy		Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Carlos Chagas Filho Biophys Inst, Lab Pulm Invest, Ave Carlos Chagas Filho S-N,Bloco G-014, BR-21941902 Rio De Janeiro, RJ, Brazil.	prmrocco@gmail.com	Mendez-Otero, Rosalia/AAL-7551-2020; Pimentel-Coelho, Pedro M/K-1994-2015; Rocco, Patricia/I-7460-2012; Silva, Pedro Leme/AAD-8236-2019; Pimentel-Coelho, Pedro Moreno/AAM-9106-2020; , Capelozzi/N-1737-2019	Mendez-Otero, Rosalia/0000-0002-1798-9930; Pimentel-Coelho, Pedro M/0000-0002-2414-3386; Rocco, Patricia/0000-0003-1412-7136; Silva, Pedro Leme/0000-0001-5838-4949; Pimentel-Coelho, Pedro Moreno/0000-0002-2414-3386; , Capelozzi/0000-0001-9732-5853; Pelosi, Paolo/0000-0001-5055-3023	Brazilian Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Rio de Janeiro State Research Foundation (FAPERJ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ); Coordination for the Improvement of Higher Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Department of Science and Technology-Brazilian Ministry of Health (DECIT/MS); National Institute of Science and Technology for Regenerative Medicine/CNPq; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY026103] Funding Source: NIH RePORTER	This study was supported by the Brazilian Council for Scientific and Technological Development (CNPq), the Rio de Janeiro State Research Foundation (FAPERJ), Coordination for the Improvement of Higher Education Personnel (CAPES), the Department of Science and Technology-Brazilian Ministry of Health (DECIT/MS), and the National Institute of Science and Technology for Regenerative Medicine/CNPq.	Ansell TK, 2016, RESPIROLOGY, V21, P1041, DOI 10.1111/resp.12800; Bai W, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00755; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Ben Assayag E, 2010, MOL MED, V16, P278, DOI 10.2119/molmed.2010.00015; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chang LC, 2013, CNS NEUROSCI THER, V19, P390, DOI 10.1111/cns.12077; Chao MCM, 2010, RESP PHYSIOL NEUROBI, V173, P179, DOI 10.1016/j.resp.2010.08.005; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094; Elmer J, 2013, CRIT CARE MED, V41, P1992, DOI 10.1097/CCM.0b013e31828a3f4d; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; GAUTIER H, 1980, CLIN SCI, V58, P343, DOI 10.1042/cs0580343; Giraidi-Guimaraes A, 2009, BRAIN RES, V1266, P108, DOI 10.1016/j.brainres.2009.01.062; Guldner A, 2015, ANESTHESIOLOGY, V123, P692, DOI 10.1097/ALN.0000000000000754; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hilz MJ, 2008, STROKE, V39, P2421, DOI 10.1161/STROKEAHA.108.518613; Hoymann Heinz Gerd, 2007, Journal of Pharmacological and Toxicological Methods, V55, P16, DOI 10.1016/j.vascn.2006.04.006; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; Kalra L, 2015, LANCET, V386, P1835, DOI 10.1016/S0140-6736(15)00126-9; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Koo BB, 2010, RESP PHYSIOL NEUROBI, V172, P129, DOI 10.1016/j.resp.2010.05.008; Koutsoukou A, 2006, INTENS CARE MED, V32, P1947, DOI 10.1007/s00134-006-0406-0; Lafargue M, 2012, FASEB J, V26, P2919, DOI 10.1096/fj.11-197384; LEE MC, 1976, STROKE, V7, P382, DOI 10.1161/01.STR.7.4.382; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Meisel A, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.220; Morgan EE, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-37; Neumann S, 2015, INT J MOL SCI, V16, P29029, DOI 10.3390/ijms161226141; Olson BJ, 2007, CURR PROTOC PROTEIN, DOI [10.1002/hed.24713, DOI 10.1002/HED.24713]; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Piazza O, 2013, INT J IMMUNOPATH PH, V26, P383, DOI 10.1177/039463201302600211; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qin MZ, 2015, INT J CLIN EXP PATHO, V8, P12943; Renu A, 2015, STROKE, V46, P673, DOI 10.1161/STROKEAHA.114.008147; Riva DR, 2008, CRIT CARE MED, V36, P1900, DOI 10.1097/CCM.0b013e3181760e5d; Rocco PRM, 1997, RESP PHYSIOL, V110, P9, DOI 10.1016/S0034-5687(97)00067-4; Samary CS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1573-1; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shim R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010064; Silveira KSO, 2004, RESP PHYSIOL NEUROBI, V139, P167, DOI 10.1016/j.resp.2003.10.002; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Szigeti K, 2015, J CEREBR BLOOD F MET, V35, P1921, DOI 10.1038/jcbfm.2015.174; Thrift AG, 2017, INT J STROKE, V12, P13, DOI 10.1177/1747493016676285; Toung TJK, 2005, CRIT CARE MED, V33, P203, DOI 10.1097/01.CCM.0000150659.15558.23; TRAUPE H, 1982, STROKE, V13, P615, DOI 10.1161/01.STR.13.5.615; Uhlig C, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-56; Warlow CP, 1998, LANCET, V352, P1, DOI DOI 10.1016/S0140-6736(98)90086-1; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Worthmann H, 2010, ANN NY ACAD SCI, V1207, P116, DOI 10.1111/j.1749-6632.2010.05738.x; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021	60	22	23	4	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	OCT 5	2018	22								249	10.1186/s13054-018-2164-0			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW0XK	WOS:000446593000001	30290827	Green Published, gold			2022-02-06	
J	Abe, N; Choudhury, ME; Watanabe, M; Kawasaki, S; Nishihara, T; Yano, H; Matsumoto, S; Kunieda, T; Kumon, Y; Yorozuya, T; Tanaka, J				Abe, Naoki; Choudhury, Mohammed E.; Watanabe, Minori; Kawasaki, Shun; Nishihara, Tasuku; Yano, Hajime; Matsumoto, Shirabe; Kunieda, Takehiro; Kumon, Yoshiaki; Yorozuya, Toshihiro; Tanaka, Junya			Comparison of the detrimental features of microglia and infiltrated macrophages in traumatic brain injury: A study using a hypnotic bromovalerylurea	GLIA			English	Article						CCL2; FACS; glycolysis; mitochondria; oxidative stress; ROS	NITRIC-OXIDE SYNTHASE; NG2 PROTEOGLYCAN; OXIDATIVE STRESS; NEURONAL DEATH; CELL-DEATH; STROKE; DAMAGE; NEUROPROTECTION; EXPRESSION; CONTRIBUTE	Microglia and blood-borne macrophages in injured or diseased brains are difficult to distinguish because they share many common characteristics. However, the identification of microglia-specific markers and the use of flow cytometry have recently made it easy to discriminate these types of cells. In this study, we analyzed the features of blood-borne macrophages, and activated and resting microglia in a rat traumatic brain injury (TBI) model. Oxidative injury was indicated in macrophages and neurons in TBI lesions by the presence of 8-hydroxy-2'-deoxyguanosine (8-OHdG). Generation of mitochondrial reactive oxygen species (ROS) was markedly observed in granulocytes and macrophages, but not in activated or resting microglia. Dihydroethidium staining supported microglia not being the major source of ROS in TBI lesions. Furthermore, macrophages expressed NADPH oxidase 2, interleukin-1 beta (IL-1 beta), and CD68 at higher levels than microglia. In contrast, microglia expressed transforming growth factor beta 1 (TGF beta 1), interleukin-6 (IL-6), and tumor necrosis factor alpha at higher levels than macrophages. A hypnotic, bromovalerylurea (BU), which has anti-inflammatory effects, reduced both glycolysis and mitochondrial oxygen consumption. BU administration inhibited chemokine CCL2 expression, accumulation of monocytes/macrophages, 8-OHdG generation, mitochondrial ROS generation, and proinflammatory cytokine expression, and markedly ameliorated the outcome of the TBI model. Yet, BU did not inhibit microglial activation or expression of TGF beta 1 and insulin-like growth factor 1 (IGF-1). These results indicate that macrophages are the major aggravating cell type in TBI lesions, in particular during the acute phase. Activated microglia may even play favorable roles. Reduction of cellular energy metabolism in macrophages and suppression of CCL2 expression in injured tissue may lead to amelioration of TBI.	[Abe, Naoki; Choudhury, Mohammed E.; Watanabe, Minori; Kawasaki, Shun; Yano, Hajime; Tanaka, Junya] Ehime Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Toon, Ehime 7910295, Japan; [Abe, Naoki; Nishihara, Tasuku; Yorozuya, Toshihiro] Ehime Univ, Grad Sch Med, Dept Anesthesia & Perioperat Med, Toon, Ehime, Japan; [Kawasaki, Shun] Fujita Hlth Univ, Dept Surg & Palliat Med, Sch Med, Toyoake, Aichi, Japan; [Matsumoto, Shirabe; Kunieda, Takehiro; Kumon, Yoshiaki] Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon, Ehime, Japan		Tanaka, J (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Toon, Ehime 7910295, Japan.	jtanaka@m.ehime-u.ac.jp	Tanaka, Junya/Y-1033-2019; Choudhury, Mohammed/AAB-5611-2022	Tanaka, Junya/0000-0003-1056-5948	Ministry of Education; Ehime University	Ministry of Education; Ehime University; Ehime University	Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Banh RS, 2016, NAT CELL BIOL, V18, P803, DOI 10.1038/ncb3376; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Berman JW, 1996, J IMMUNOL, V156, P3017; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chu HX, 2015, STROKE, V46, P1929, DOI 10.1161/STROKEAHA.115.009426; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hattori T, 2017, GLIA, V65, P974, DOI 10.1002/glia.23139; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Higaki H, 2016, NEUROCHEM INT, V99, P158, DOI 10.1016/j.neuint.2016.06.013; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Islam A, 2018, BBA-MOL BASIS DIS, V1864, P721, DOI 10.1016/j.bbadis.2017.12.022; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kawasaki S, 2017, J PHARMACOL SCI, V134, P116, DOI 10.1016/j.jphs.2017.05.007; Kikuchi S, 2015, BIOCHEM BIOPH RES CO, V459, P319, DOI 10.1016/j.bbrc.2015.02.111; Konishi H, 2017, GLIA, V65, P1927, DOI 10.1002/glia.23204; Lashgari R, 2006, BEHAV BRAIN RES, V171, P324, DOI 10.1016/j.bbr.2006.04.013; Latz E, 2010, BLOOD, V116, P1393, DOI 10.1182/blood-2010-06-287342; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Matsumoto H, 2007, J NEUROSCI RES, V85, P994, DOI 10.1002/jnr.21198; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Miro-Mur F, 2016, BRAIN BEHAV IMMUN, V53, P18, DOI 10.1016/j.bbi.2015.08.010; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nishihara T, 2011, EXP NEUROL, V229, P507, DOI 10.1016/j.expneurol.2011.04.006; Nishioka R, 2016, EXP NEUROL, V277, P150, DOI 10.1016/j.expneurol.2015.12.016; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Rastogi L, 2006, EXP NEUROL, V200, P290, DOI 10.1016/j.expneurol.2006.02.013; Ritzel RM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0329-1; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Serrano-Nascimento C, 2014, ENDOCRINOLOGY, V155, P1145, DOI 10.1210/en.2013-1665; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Song L, 2011, J LIPID RES, V52, P1542, DOI 10.1194/jlr.M015412; Song SJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071418; Stankovic ND, 2016, ACTA NEUROPATHOL, V131, P347, DOI 10.1007/s00401-015-1524-y; Sugimoto K, 2014, GLIA, V62, P185, DOI 10.1002/glia.22598; Tanaka J, 1998, GLIA, V24, P198, DOI 10.1002/(SICI)1098-1136(199810)24:2<198::AID-GLIA5>3.0.CO;2-0; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Tei N, 2013, J NEUROSCI RES, V91, P681, DOI 10.1002/jnr.23202; Toku K, 1998, J NEUROSCI RES, V53, P415, DOI 10.1002/(SICI)1097-4547(19980815)53:4<415::AID-JNR3>3.0.CO;2-9; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Vilalta A, 2018, FEBS J, V285, P3566, DOI 10.1111/febs.14323; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Weaver KD, 2000, J TRAUMA, V48, P1081, DOI 10.1097/00005373-200006000-00014; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yokoyama A, 2006, GLIA, V53, P754, DOI 10.1002/glia.20332; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	70	22	23	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	OCT	2018	66	10					2158	2173		10.1002/glia.23469			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA5LA	WOS:000450312100008	30194744				2022-02-06	
J	Carteron, L; Solari, D; Patet, C; Quintard, H; Miroz, JP; Bloch, J; Daniel, RT; Hirt, L; Eckert, P; Magistretti, PJ; Oddo, M				Carteron, Laurent; Solari, Daria; Patet, Camille; Quintard, Herve; Miroz, John-Paul; Bloch, Jocelyne; Daniel, Roy T.; Hirt, Lorenz; Eckert, Philippe; Magistretti, Pierre J.; Oddo, Mauro			Hypertonic Lactate to Improve Cerebral Perfusion and Glucose Availability After Acute Brain Injury	CRITICAL CARE MEDICINE			English	Article						brain metabolism; cerebral microdialysis; cerebral perfusion; glucose; hypertonic; lactate	INTRACRANIAL HYPERTENSIVE EPISODES; NUCLEAR-MAGNETIC-RESONANCE; IN-VIVO EVIDENCE; BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; ENERGY-METABOLISM; SODIUM LACTATE; MICRODIALYSIS; OXYGEN; ASTROCYTES	Objectives: Lactate promotes cerebral blood flow and is an efficient substrate for the brain, particularly at times of glucose shortage. Hypertonic lactate is neuroprotective after experimental brain injury; however, human data are limited. Design: Prospective study (clinicaltrials.gov NCT01573507). Setting: Academic ICU. Patients: Twenty-three brain-injured subjects (13 traumatic brain injury/10 subarachnoid hemorrhage; median age, 59 yr [41-65 yr]; median Glasgow Coma Scale, 6 [3-7]). Interventions: Three-hour IV infusion of hypertonic lactate (sodium lactate, 1,000 mmol/L; concentration, 30 mu mol/kg/min) administered 39 hours (26-49hr) from injury. Measurements and Main Results: We examined the effect of hypertonic lactate on cerebral perfusion (using transcranial Doppler) and brain energy metabolism (using cerebral microdialysis). The majority of subjects (13/23 = 57%) had reduced brain glucose availability (baseline pretreatment cerebral microdialysis glucose, < 1 mmol/L) despite normal baseline intracranial pressure (10 [7-15] mm Hg). Hypertonic lactate was associated with increased cerebral microdialysis lactate (+55% [31-80%]) that was paralleled by an increase in middle cerebral artery mean cerebral blood flow velocities (+36% [21-66%]) and a decrease in pulsatility index (-21% [13-26%]; all p < 0.001). Cerebral microdialysis glucose increased above normal range during hypertonic lactate (+42% [30-78%]; p < 0.05); reduced brain glucose availability correlated with a greater improvement of cerebral microdialysis glucose (Spearman r = -0.53; p = 0.009). No significant changes in cerebral perfusion pressure, mean arterial pressure, systemic carbon dioxide, and blood glucose were observed during hypertonic lactate (all p > 0.1). Conclusions: This is the first clinical demonstration that hypertonic lactate resuscitation improves both cerebral perfusion and brain glucose availability after brain injury. These cerebral vascular and metabolic effects appeared related to brain lactate supplementation rather than to systemic effects.	[Carteron, Laurent; Solari, Daria; Patet, Camille; Miroz, John-Paul; Eckert, Philippe; Oddo, Mauro] Univ Lausanne, CHUV, Dept Intens Care Med, Lausanne, Switzerland; [Carteron, Laurent; Solari, Daria; Patet, Camille; Miroz, John-Paul; Oddo, Mauro] Univ Lausanne, CHUV, Neurosci Crit Care Res Grp, Lausanne, Switzerland; [Carteron, Laurent] Univ Bourgogne Franche Comte, Univ Hosp Besancon, Dept Anesthesiol & Intens Care Med, Besancon, France; [Quintard, Herve] Nice Univ Hosp, Dept Anesthesia & Intens Care, Nice, France; [Bloch, Jocelyne; Daniel, Roy T.] Univ Lausanne, Dept Clin Neurosci, Serv Neurosurg, CHUV, Lausanne, Switzerland; [Hirt, Lorenz] Univ Lausanne, Dept Clin Neurosci, Serv Neurol, CHUV, Lausanne, Switzerland; [Magistretti, Pierre J.] King Abdullah Univ Sci & Technol KAUST, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Magistretti, Pierre J.] CHU Vaudois, Dept Psychiat, Ctr Neurosci Psychiat, Lausanne, Switzerland; [Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Neuroenerget & Cellular Dynam, Lausanne, Switzerland		Oddo, M (corresponding author), Univ Lausanne, CHUV, Dept Intens Care Med, Lausanne, Switzerland.; Oddo, M (corresponding author), Univ Lausanne, CHUV, Neurosci Crit Care Res Grp, Lausanne, Switzerland.	mauro.oddo@chuv.ch	MIROZ, John-Paul/AAR-7445-2020; Hirt, Lorenz/G-3553-2010; Bloch, Jocelyne/A-9668-2017	Hirt, Lorenz/0000-0002-2921-5000; Bloch, Jocelyne/0000-0002-6405-1590; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [320030_138191, 32003B_155957]; Novartis Foundation for Biomedical Research; Societe Francaise d'Anesthesie et de Reanimation; Fondation des Gueules Cassees; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission	Supported, in part, by grants from the Swiss National Science Foundation (320030_138191 and 32003B_155957 [to Dr. Oddo]), the Novartis Foundation for Biomedical Research (to Dr. Oddo), and the Societe Francaise d'Anesthesie et de Reanimation and the Fondation des Gueules Cassees (both to Dr. Carteron).; Dr. Hirt received other support from Boehringer Ingelheim (speaker fees and travel grants, not related to this work) and research grants not in relation with this work from the Swiss Science Foundation, the Biaggi Foundation, and the Juchum Foundation. Dr. Oddo received support for article research from the Swiss National Science Foundation. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Bergersen LH, 2015, J CEREBR BLOOD F MET, V35, P176, DOI 10.1038/jcbfm.2014.206; Bisri Tatang, 2016, Asian J Neurosurg, V11, P151, DOI 10.4103/1793-5482.145375; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carteron L, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00325; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Gordon GRJ, 2016, ADV EXP MED BIOL, V903, P209, DOI 10.1007/978-1-4899-7678-9_15; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Martin A, 2009, CURR NEUROVASC RES, V6, P82, DOI 10.2174/156720209788185650; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Patet C, 2017, J NEUROL NEUROSUR PS, V88, P332, DOI 10.1136/jnnp-2016-313766; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc12686; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sanchez-Guerrero A, 2017, J CEREBR BLOOD F MET, V37, P2742, DOI 10.1177/0271678X16674222; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Sonneville R, 2015, INTENS CARE MED, V41, P192, DOI 10.1007/s00134-014-3577-0; Steinman MQ, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2010.00010, 10.3389/fnint.2016.00010]; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; Vafaee MS, 2012, J CEREBR BLOOD F MET, V32, P1859, DOI 10.1038/jcbfm.2012.89; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111	47	22	23	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2018	46	10					1649	1655		10.1097/CCM.0000000000003274			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4NA	WOS:000444480100019	29923931				2022-02-06	
J	Jansman, MMT; Hosta-Rigau, L				Jansman, Michelle M. T.; Hosta-Rigau, Leticia			Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers	ADVANCES IN COLLOID AND INTERFACE SCIENCE			English	Article						Encapsulation platforms; Hemoglobin; Hemoglobin-based oxygen carriers; Red blood cells substitutes; Oxygen delivery	LIPOSOME-ENCAPSULATED HEMOGLOBIN; SUPEROXIDE-DISMUTASE-CATALASE; RED-BLOOD-CELLS; HUMAN POLYMERIZED HEMOGLOBIN; BRAIN-BARRIER DISRUPTION; MEMBRANE EMULSIFICATION; SURFACE MODIFICATION; SEMIPERMEABLE MICROCAPSULES; POLY(ETHYLENE GLYCOL); CARBONIC-ANHYDRASE	Blood transfusions, which usually consist in the administration of isolated red blood cells (RBCs), are crucial in traumatic injuries, pre-surgical conditions and anemias. Although RBCs transfusion from donors is a safe procedure, donor RBCs can only be stored for a maximum of 42 days under refrigerated conditions and, therefore, stockpiles of RBCs for use in acute disasters do not exist. With a worldwide shortage of donor blood that is expected to increase over time, the creation of oxygen-carriers with long storage life and compatibility without typing and cross-matching, persists as one of the foremost important challenges in biomedicine. However, research has so far failed to produce FDA approved RBCs substitutes (RBCSs) for human usage. As such, due to unacceptable toxicities, the first generation of oxygen-carriers has been withdrawn from the market. Being hemoglobin (Hb) the main component of RBCs, a lot of effort is being devoted in assembling semi-synthetic RBCS utilizing Hb as the oxygen-carrier component, the so-called Hb-based oxygen carriers (HBOCs). However, a native RBC also contains a multi-enzyme system to prevent the conversion of Hb into non-functional methemoglobin (metHb). Thus, the challenge for the fabrication of next-generation HBOCs relies in creating a system that takes advantage of the excellent oxygen-carrying capabilities of Hb, while preserving the redox environment of native RBCs that prevents or reverts the conversion of Hb into metHb. In this review, we feature the most recent advances in the assembly of the new generation of HBOCs with emphasis in two main approaches: the chemical modification of Hb either by cross-linking strategies or by conjugation to other polymers, and the Hb encapsulation strategies, usually in the form of lipidic or polymeric capsules. The applications of the aforementioned HBOCs as blood substitutes or for oxygen-delivery in tissue engineering are highlighted, followed by a discussion of successes, challenges and future trends in this field. (C) 2018 Elsevier B.V. All rights reserved.	[Jansman, Michelle M. T.; Hosta-Rigau, Leticia] Tech Univ Denmark, Dept Micro & Nanotechnol, Ctr Nanomed & Theranost, DTU Nanotech, Bldg 423, DK-2800 Lyngby, Denmark		Hosta-Rigau, L (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Ctr Nanomed & Theranost, DTU Nanotech, Bldg 423, DK-2800 Lyngby, Denmark.	leri@nanotech.dtu.dk	Hosta-Rigau, Leticia/C-4346-2016	Hosta-Rigau, Leticia/0000-0001-8177-4806; Jansman, Michelle/0000-0002-9269-4825	Danish Council for Independent ResearchDet Frie Forskningsrad (DFF) [6111-00298B]	This work was supported by the Danish Council for Independent Research [Grant No. 6111-00298B].	Agashe H, 2009, ADV PLANAR LIP BILAY, V9, P1, DOI 10.1016/S1554-4516(09)09001-2; Agashe H, 2010, COLLOID SURFACE B, V75, P573, DOI 10.1016/j.colsurfb.2009.09.038; Alayash AI, 2014, TRENDS BIOTECHNOL, V32, P177, DOI 10.1016/j.tibtech.2014.02.006; Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Ariga K, 2007, PHYS CHEM CHEM PHYS, V9, P2319, DOI 10.1039/b700410a; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Ariga K, 2011, ADV DRUG DELIVER REV, V63, P762, DOI 10.1016/j.addr.2011.03.016; Baek JH, 2012, TOXICOL SCI, V127, P567, DOI 10.1093/toxsci/kfs109; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Best JP, 2012, ADV HEALTHC MATER, V1, P35, DOI 10.1002/adhm.201100012; Bian YZ, 2015, ARTIF CELL NANOMED B, V43, P1, DOI 10.3109/21691401.2014.964554; Bian YZ, 2011, ARTIF CELL BLOOD SUB, V39, P127, DOI 10.3109/10731199.2011.581052; Bjorkholm M, 2005, HAEMATOLOGICA, V90, P505; BONNEAUX F, 1995, J PROTEIN CHEM, V14, P1, DOI 10.1007/BF01902838; Bu HX, 2017, RSC ADV, V7, P48166, DOI 10.1039/c7ra09747f; Buehler PW, 2008, BBA-PROTEINS PROTEOM, V1784, P1378, DOI 10.1016/j.bbapap.2007.12.009; Buehler PW, 2010, TRENDS MOL MED, V16, P447, DOI 10.1016/j.molmed.2010.07.006; Butt OI, 2011, AM J PATHOL, V178, P1316, DOI 10.1016/j.ajpath.2010.12.006; Cabrales P, 2013, ANTIOXID REDOX SIGN, V18, P2329, DOI 10.1089/ars.2012.4922; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Chang TMS, 2006, TRENDS BIOTECHNOL, V24, P372, DOI 10.1016/j.tibtech.2006.06.005; Chang TMS, 2010, WIRES NANOMED NANOBI, V2, P418, DOI 10.1002/wnan.95; CHANG TMS, 1968, NATURE, V218, P243, DOI 10.1038/218243a0; CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524; CHANG TMS, 1976, J BIOENG, V1, P25; Chang TMS, 1997, BLOOD SUBSTITUTES PR; Charoenphol P, 2011, ATHEROSCLEROSIS, V217, P364, DOI 10.1016/j.atherosclerosis.2011.04.016; Charoenphol P, 2010, BIOMATERIALS, V31, P1392, DOI 10.1016/j.biomaterials.2009.11.007; Chauvierre C, 2010, BIOMATERIALS, V31, P6069, DOI 10.1016/j.biomaterials.2010.04.039; Chen B, 2013, J PHYS CHEM C, V117, P19751, DOI 10.1021/jp407164q; Chen G, 2016, ARTIF CELL NANOMED B, V44, P56, DOI 10.3109/21691401.2015.1111239; Chen G, 2010, TISSUE ENG PT A, V16, P3231, DOI 10.1089/ten.TEA.2010.0058; Chen JY, 2009, CLINICS, V64, P803, DOI 10.1590/S1807-59322009000800016; Chen PY, 2013, J MACROMOL SCI A, V50, P478, DOI 10.1080/10601325.2013.780947; Cheng DCH, 2004, J THORAC CARDIOV SUR, V127, P79, DOI 10.1016/j.jtcvs.2003.08.024; Cheng Y, 2002, BIOCHEMISTRY-US, V41, P11901, DOI 10.1021/bi0202880; Chu LY, 2003, J COLLOID INTERF SCI, V265, P187, DOI 10.1016/S0021-9797(03)00350-3; Colton CK, 2014, ADV DRUG DELIVER REV, V67-68, P93, DOI 10.1016/j.addr.2014.02.007; Cui JW, 2014, ADV MATER, V26, P7295, DOI 10.1002/adma.201402753; Cummings C, 2014, BIOMACROMOLECULES, V15, P763, DOI 10.1021/bm401575k; D'Agnillo F, 1998, NAT BIOTECHNOL, V16, P667, DOI 10.1038/nbt0798-667; Diamanti S, 2008, POLYMER, V49, P3770, DOI 10.1016/j.polymer.2008.06.020; DJORDJEVICH L, 1980, EXP HEMATOL, V8, P584; Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106; Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b; Duan L, 2015, CHEM-EUR J, V21, P520, DOI 10.1002/chem.201405439; Eaton WA, 1999, NAT STRUCT BIOL, V6, P351, DOI 10.1038/7586; Elmer J, 2012, RESUSCITATION, V83, P285, DOI 10.1016/j.resuscitation.2011.09.020; Farmer M C, 1988, Adv Exp Med Biol, V238, P161; Farris AL, 2016, J MATER CHEM B, V4, P3422, DOI 10.1039/c5tb02635k; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gholipourmalekabadi M, 2016, TRENDS BIOTECHNOL, V34, P1010, DOI 10.1016/j.tibtech.2016.05.012; Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002; GOLDSMIT.HL, 1972, PROC R SOC SER B-BIO, V182, P351, DOI 10.1098/rspb.1972.0084; Gould SA, 1998, J AM COLL SURGEONS, V187, P113, DOI 10.1016/S1072-7515(98)00095-7; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Gu JS, 2009, ARTIF CELL BLOOD SUB, V37, P69, DOI 10.1080/10731190902742240; Guaccio A, 2008, BIOMATERIALS, V29, P1484, DOI 10.1016/j.biomaterials.2007.12.020; Guo C, 2015, ARTIF CELL NANOMED B, V43, P157, DOI 10.3109/21691401.2015.1035479; Gupta AS, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1464; Harrington JP, 2011, J FUNCT BIOMATER, V2, P414, DOI 10.3390/jfb2040414; Haruki R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12778; Hathazi D, 2014, BIOMACROMOLECULES, V15, P1920, DOI 10.1021/bm5004256; He Q, 2009, CHEM SOC REV, V38, P2292, DOI 10.1039/b816475b; Herhenson, 2010, FORMULATION PROCESS, P69, DOI DOI 10.1002/9780470595886.CH3; Hosaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110541; Huang RB, 2010, MOL MEMBR BIOL, V27, P190, DOI 10.3109/09687688.2010.499548; HUNT CA, 1985, SCIENCE, V230, P1165, DOI 10.1126/science.4071041; Jahr JS, 2008, EXPERT OPIN BIOL TH, V8, P1425, DOI [10.1517/14712598.8.9.1425, 10.1517/14712598.8.9.1425 ]; Jenkins JD, 2009, ACTA CRYSTALLOGR D, V65, P41, DOI 10.1107/S0907444908037256; Jia Y, 2016, ADV MATER, V28, P1312, DOI 10.1002/adma.201502581; Jia Y, 2015, CHEM REV, V115, P1597, DOI 10.1021/cr400559g; Jia Y, 2012, ADV FUNCT MATER, V22, P1446, DOI 10.1002/adfm.201102737; Jia YP, 2004, BBA-GEN SUBJECTS, V1672, P164, DOI 10.1016/j.bbagen.2004.03.009; Kameta N, 2011, SOFT MATTER, V7, P4539, DOI 10.1039/c0sm01559h; Kaneda S, 2009, ARTIF ORGANS, V33, P146, DOI 10.1111/j.1525-1594.2008.00699.x; Kim H.W., 2013, HEMOGLOBIN BASED OXY, DOI [10.1007/978-3-642-40717-8, DOI 10.1007/978-3-642-40717-8]; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kimura T, 1998, ARTIF CELL BLOOD SUB, V26, P455, DOI 10.3109/10731199809117466; Knirsch MC, 2015, BIOPROC BIOSYST ENG, V38, P2263, DOI 10.1007/s00449-015-1463-y; Knirsch MC, 2017, BIOPROC BIOSYST ENG, V40, P431, DOI 10.1007/s00449-016-1711-9; Komatsu T, 2011, J AM CHEM SOC, V133, P3246, DOI 10.1021/ja1096122; Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071; Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020; Lai P, 2014, COLLOID SURFACE B, V118, P154, DOI 10.1016/j.colsurfb.2014.03.017; Lai YT, 2015, BIOTECHNOL PROGR, V31, P1676, DOI 10.1002/btpr.2170; Lai YT, 2015, COLLOID SURFACE B, V127, P1, DOI 10.1016/j.colsurfb.2015.01.018; Lam CN, 2013, SOFT MATTER, V9, P2393, DOI 10.1039/c2sm27459k; Li B, 2014, BIOMATER SCI-UK, V2, P1254, DOI 10.1039/c4bm00123k; Li B, 2014, INT J PHARMACEUT, V468, P75, DOI 10.1016/j.ijpharm.2014.04.004; Li DX, 2009, BIOCONJUGATE CHEM, V20, P2062, DOI 10.1021/bc900170e; Li TH, 2011, MACROMOL BIOSCI, V11, P865, DOI 10.1002/mabi.201000469; Liebscher J, 2013, LANGMUIR, V29, P10539, DOI 10.1021/la4020288; Liu GY, 2012, SOFT MATTER, V8, P8811, DOI 10.1039/c2sm25721a; Liu XS, 2013, ACS NANO, V7, P9384, DOI 10.1021/nn404117j; Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a; Lopez-Alonso JP, 2009, BIOCONJUGATE CHEM, V20, P1459, DOI 10.1021/bc9001486; Lu MZ, 2016, COLLOID SURFACE B, V139, P171, DOI 10.1016/j.colsurfb.2015.12.012; Mackenzie CF, 2010, ANESTH ANALG, V110, P685, DOI 10.1213/ANE.0b013e3181cd473b; McCarthy MR, 2001, BIOPHYS CHEM, V92, P103, DOI 10.1016/S0301-4622(01)00194-6; Meng FT, 2003, ARTIF CELL BLOOD SUB, V31, P279, DOI 10.1081/BIO-120023158; Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108; Michel CC, 1996, CARDIOVASC RES, V32, P644, DOI 10.1016/S0008-6363(96)00064-8; Modery-Pawlowski CL, 2013, BIOMACROMOLECULES, V14, P939, DOI 10.1021/bm400074t; Montagne K, 2011, J BIOSCI BIOENG, V112, P485, DOI 10.1016/j.jbiosc.2011.07.004; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Mozzarelli A, 2010, BLOOD TRANSFUS-ITALY, V8, pS59, DOI 10.2450/2010.010S; Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013; Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127; Nag Okhil K, 2013, Pharmaceutics, V5, P542, DOI 10.3390/pharmaceutics5040542; Nag OK, 2013, INT J PHARMACEUT, V446, P119, DOI 10.1016/j.ijpharm.2013.02.026; Nagababu E, 2003, BBA-GEN SUBJECTS, V1620, P211, DOI 10.1016/S0304-4165(02)00537-8; NAGEL RL, 1971, J BIOL CHEM, V246, P69; Nahmias Y, 2006, FASEB J, V20, P2531, DOI 10.1096/fj.06-6192fje; Nakashima T, 2000, ADV DRUG DELIVER REV, V45, P47, DOI 10.1016/S0169-409X(00)00099-5; Napolitano LM, 2009, CRIT CARE CLIN, V25, P279, DOI 10.1016/j.ccc.2009.01.003; Naruto H, 2007, J BIOSCI BIOENG, V104, P343, DOI 10.1263/jbb.104.343; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Neamtu I., 2017, DRUG DELIV, V24, P539, DOI [DOI 10.1080/10717544.2016.1276232, 10.1080/10717544.2016.1276232]; Olofsson C, 2008, TRANSFUSION MED, V18, P28, DOI 10.1111/j.1365-3148.2007.00811.x; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Paciello A, 2016, ADV HEALTHC MATER, V5, P2655, DOI 10.1002/adhm.201600559; Page TC, 2008, Patent No. [U57459535B2, 459535B2]; Powanda DD, 2002, ARTIF CELL BLOOD SUB, V30, P23, DOI 10.1081/BIO-120002725; Rameez S, 2008, BIOCONJUGATE CHEM, V19, P1025, DOI 10.1021/bc700465v; Rameez S, 2012, BIOTECHNOL PROGR, V28, P636, DOI 10.1002/btpr.1532; Richards MP, 2003, J AGR FOOD CHEM, V51, P3886, DOI 10.1021/jf0212082; Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; RUDOLPH AS, 1991, P NATL ACAD SCI USA, V88, P10976, DOI 10.1073/pnas.88.23.10976; RUDT S, 1993, EUR J PHARM SCI, V1, P31, DOI 10.1016/0928-0987(93)90015-3; Sakai H, 1997, BIOCONJUGATE CHEM, V8, P23, DOI 10.1021/bc960069p; Sakai Hiromi, 2012, Curr Drug Discov Technol, V9, P188; Sakai H, 2010, ADV EXP MED BIOL, V662, P433, DOI 10.1007/978-1-4419-1241-1_62; Sakai H, 2009, ARTIF ORGANS, V33, P139, DOI 10.1111/j.1525-1594.2008.00698.x; Sakai Y, 2010, BIOCHEM ENG J, V48, P348, DOI 10.1016/j.bej.2009.10.010; Sen Gupta A, 2016, WIRES NANOMED NANOBI, V8, P255, DOI 10.1002/wnan.1362; SEVERINGHAUS JW, 1966, J APPL PHYSIOL, V21, P1108, DOI 10.1152/jappl.1966.21.3.1108; Sheng Y, 2009, J MATER SCI-MATER M, V20, P1881, DOI 10.1007/s10856-009-3746-9; Silverman TA, 2009, TRANSFUSION, V49, P2495, DOI 10.1111/j.1537-2995.2009.02356.x; Simoni J, 2014, ARTIF ORGANS, V38, P684, DOI 10.1111/aor.12337; Simoni Jan, 2012, Curr Drug Discov Technol, V9, P173; Sims C, 2001, J TRAUMA, V51, P1137, DOI 10.1097/00005373-200112000-00020; Sloan EP, 2010, J TRAUMA, V68, P1158, DOI 10.1097/TA.0b013e3181bbfaac; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; Sou K, 2008, BBA-BIOMEMBRANES, V1778, P1035, DOI 10.1016/j.bbamem.2008.01.006; Squires JE, 2002, SCIENCE, V295, P1002, DOI 10.1126/science.1068443; Stadler AM, 2008, BIOPHYS J, V95, P5449, DOI 10.1529/biophysj.108.138040; Taguchi K., 2012, J DRUG METAB TOXICOL, V3, P128, DOI [10.4172/2157, DOI 10.4172/2157]; Taguchi K, 2017, J FUNCT BIOMATER, V8, DOI 10.3390/jfb8010011; Taguchi K, 2009, DRUG METAB DISPOS, V37, P2197, DOI 10.1124/dmd.109.028852; Tao ZM, 2014, TRENDS BIOTECHNOL, V32, P466, DOI 10.1016/j.tibtech.2014.05.001; Tomaiuolo G, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4895755; Tomita D, 2013, BIOMACROMOLECULES, V14, P1816, DOI 10.1021/bm400204y; Tronstad C, 2010, PHYSIOL MEAS, V31, P1241, DOI 10.1088/0967-3334/31/9/013; Tsuchida E, 2006, ARTIF CELL BLOOD SUB, V34, P581, DOI 10.1080/10731190600973907; Tsuchida E, 2009, BIOCONJUGATE CHEM, V20, P1419, DOI 10.1021/bc800431d; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Vandegriff KD, 2009, ARTIF ORGANS, V33, P133, DOI 10.1111/j.1525-1594.2008.00697.x; Vladisavljevic GT, 2005, ADV COLLOID INTERFAC, V113, P1, DOI 10.1016/j.cis.2004.10.002; Wang QQ, 2014, BBA-PROTEINS PROTEOM, V1844, P1201, DOI 10.1016/j.bbapap.2014.04.005; Wang Q, 2018, ARTIF CELL NANOMED B, V46, P484, DOI 10.1080/21691401.2018.1459636; Wang Q, 2017, BIOMACROMOLECULES, V18, P1333, DOI 10.1021/acs.biomac.7b00077; Wang SS, 2014, RSC ADV, V4, P52940, DOI 10.1039/c4ra06397j; Wang X, 2009, ARTIF CELL BLOOD SUB, V37, P41, DOI 10.1080/10731190802674477; Wang Y, 2017, PROCESS BIOCHEM, V60, P67, DOI 10.1016/j.procbio.2017.05.021; Wei X, 2017, COLLOID SURFACE B, V155, P440, DOI 10.1016/j.colsurfb.2017.04.047; Wijekoon A, 2013, ACTA BIOMATER, V9, P5653, DOI 10.1016/j.actbio.2012.10.034; Winslow RM, 2000, ADV DRUG DELIVER REV, V40, P131, DOI 10.1016/S0169-409X(99)00045-9; Winslow RM, 2004, ARTIF ORGANS, V28, P800, DOI 10.1111/j.1525-1594.2004.07392.x; Xiong Y, 2013, ACS NANO, V7, P7454, DOI 10.1021/nn402073n; Xu F, 2009, INT J PHARMACEUT, V377, P199, DOI 10.1016/j.ijpharm.2009.05.015; YABUKI A, 1990, TRANSFUSION, V30, P516, DOI 10.1046/j.1537-2995.1990.30690333482.x; Yadav VR, 2016, EUR J PHARM SCI, V93, P97, DOI 10.1016/j.ejps.2016.08.010; Yadav VR, 2014, ARTIF ORGANS, V38, P625, DOI 10.1111/aor.12304; Yamada K, 2016, SCI REP-UK, V6, DOI 10.1038/srep36782; Yokomaku K, 2018, J MATER CHEM B, V6, P2417, DOI 10.1039/c8tb00211h; Yu CM, 2018, SENSOR ACTUAT B-CHEM, V256, P217, DOI 10.1016/j.snb.2017.09.166; Yu WP, 1996, ARTIF CELL BLOOD SUB, V24, P169, DOI 10.3109/10731199609117433; Zhang XY, 2017, CURR NANOSCI, V13, P124, DOI 10.2174/1573413712666161018144519; Zhao J, 2007, BIOMATERIALS, V28, P1414, DOI 10.1016/j.biomaterials.2006.10.012; ZUCK TF, 1977, TRANSFUSION, V17, P374, DOI 10.1046/j.1537-2995.1977.17477216866.x	184	22	22	0	47	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0001-8686	1873-3727		ADV COLLOID INTERFAC	Adv. Colloid Interface Sci.	OCT	2018	260						65	84		10.1016/j.cis.2018.08.006			20	Chemistry, Physical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	GX9DX	WOS:000448099800005	30177214	Green Submitted			2022-02-06	
J	Liston, K; McDowell, M; Malcolm, D; Scott-Bell, A; Waddington, I				Liston, Katie; McDowell, Mark; Malcolm, Dominic; Scott-Bell, Andrea; Waddington, Ivan			On being 'head strong': The pain zone and concussion in non-elite rugby union	INTERNATIONAL REVIEW FOR THE SOCIOLOGY OF SPORT			English	Article						amateur; concussion; injury; pain; policy; risk; rugby union	INJURY; CULTURE; PLAYERS; SPORT; UNCERTAINTY; MANAGEMENT; CLINICIAN; BODY; RISK	In recent years there has been growing concern about concussion in sport in general and rugby union in particular. The qualitative study reported here draws on interviews (n=20) with adult players in non-elite club rugby union in Ireland in order to explore the frames of reference within which they perceive, give meaning to and manage concussion. Within a sporting subculture which emphasizes lay sporting values - particularly the value of 'playing hurt' - and which reflects a functional view of injury, non-elite players tend to display an irreverent attitude towards concussion which encourages risky behaviours and underplays, ignores or denies the significance of concussion. We analogously describe these beliefs and actions as being 'head strong'. The paper concludes by identifying the contextual contingencies which make the regulation of injuries in rugby union so difficult and by establishing some core principles of public health education campaigns that might be deployed to militate against the high incidence of concussive injury in future.	[Liston, Katie; McDowell, Mark] Ulster Univ, Jordanstown, Newtownabbey, North Ireland; [Malcolm, Dominic] Loughborough Univ Technol, Loughborough, Leics, England; [Scott-Bell, Andrea] Northumbria Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Waddington, Ivan] Norwegian Sch Sport Sci, Oslo, Norway		Liston, K (corresponding author), Ulster Univ, Sch Sport, Jordanstown BT37 0QB, Newtownabbey, North Ireland.	k.liston@ulster.ac.uk		Scott-Bell, Andrea/0000-0002-1022-9023			Adamson C, 1997, SOCIOL HEALTH ILL, V19, P133, DOI 10.1111/1467-9566.ep10934391; Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Archbold P, 2015, BRIT J SPORTS MED, V51; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bette K.-H., 2004, DOPING PUBLIC POLICY, P101; British Medical Association (BMA), 2002, DRUGS SPORT PRESSURE; Conlon T, 2016, SUNDAY INDEPENDENT; Dunning E., 2008, QUEST EXCITEMENT SPO, V7, P242; Fenton LT, 2010, RES Q EXERCISE SPORT, V81, P212; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Francis N, 2016, SUNDAY INDEPENDENT; Freidson E.., 1970, PROFESSION MED; Heikkinen H, 2010, SOC SCI MED, V71, P877, DOI 10.1016/j.socscimed.2010.05.036; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Howe D. P., 2004, SPORT PROFESSIONALIS; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Joint Committee on Health and Children, 2014, REP CONC SPORT; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Liston K, 2014, NORBERT ELIAS AND EMPIRICAL RESEARCH, P197; Liston K, 2006, SPORT SOC, V9, P388, DOI 10.1080/17430430600673407; Malcolm D, 2002, SOCIOL SPORT J, V19, P149, DOI 10.1123/ssj.19.2.149; Malcolm D, 2006, SOCIOL SPORT J, V23, P376, DOI 10.1123/ssj.23.4.376; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McLoughlin R, 2014, IRFU SUBMISSION OIRE; Murphy P, 2006, SPORT SOC, V9, P542, DOI 10.1080/17430430600768785; Naidoo J, 2000, HLTH PROMOTION FDN P; O'Driscoll B, 2015, THE TEST; O'Reilly P, 2016, SUNDAY TIMES; Piggin J, 2016, BRIT J SPORTS MED, V51; PILL RM, 1990, MAKING CHANGES STUDY; Pollock A, 2014, TACKLING RUGBY WHAT; Raftery M, 2016, BRIT J SPORTS MED, V51; Rebar C.R., 2011, UNDERSTANDING NURSIN, V3rd ed.; Roderick M., 2000, International Review for the Sociology of Sport, V35, P165, DOI 10.1177/101269000035002003; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Safai P., 2012, SOCIAL ORG SPORTS ME, P204; SCIC, 2016, OP LETT PREV INJ CHI; Scott A., 2012, SOCIAL ORG SPORTS ME, P227; Theberge N, 2007, ROUTL CRIT STUD SPOR, P176; Waddington I, 2000, SPORT HLTH DRUGS; Waddington I., 2016, PERMANCE ENHANCEM, V4, P80, DOI [10.1016/j.peh.2016.03.004, DOI 10.1016/J.PEH.2016.03.004]; YOUNG K, 1993, SOCIOL SPORT J, V10, P373, DOI 10.1123/ssj.10.4.373	42	22	22	1	13	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1012-6902	1461-7218		INT REV SOCIOL SPORT	Int. Rev. Sociol. Sport	SEP	2018	53	6					668	684		10.1177/1012690216679966			17	Hospitality, Leisure, Sport & Tourism; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	GR5YV	WOS:000442719900002		Green Submitted, Green Accepted			2022-02-06	
J	Kerr, ZY; Wilkerson, GB; Caswell, SV; Currie, DW; Pierpoint, LA; Wasserman, EB; Knowles, SB; Dompier, TP; Comstock, RD; Marshall, SW				Kerr, Zachary Y.; Wilkerson, Gary B.; Caswell, Shane, V; Currie, Dustin W.; Pierpoint, Lauren A.; Wasserman, Erin B.; Knowles, Sarah B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in United States High School Football (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Football (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; musculoskeletal injuries; lower extremity injuries	ANTERIOR CRUCIATE LIGAMENT; LOWER-EXTREMITY SPRAINS; RISK-FACTORS; CONCUSSION POLICY; RUGBY UNION; NECK-INJURY; PLAYERS; RATES; OSTEOARTHRITIS; PREVENTION	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of football injury data. Objective: To describe the epidemiology of injuries sustained in high school football in the 2005-2006 through 2013-2014 academic years and collegiate football in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from football teams of high school boys (annual average = 100) and collegiate men (annual average = 43). Patients or Other Participants: Football players who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school or the 2004-2005 through 2013-2014 academic years in college. Main Outcome Measure(s): Athletic trainers collected time-loss injury (>= 24 hours) and exposure data. Injury rates per 1000 athlete-exposures (AEs), injury rate ratios (IRRs) with 95% confidence intervals (Cis), and injury proportions by body site and diagnosis were calculated. Results: The High School Reporting Information Online system documented 18 189 time-loss injuries during 4 539 636 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 22 766 time-loss injuries during 3 121 476 AEs. The injury rate was higher among collegiate than high school (7.29 versus 4.01/1000 AEs; IRR = 1.82; 95% CI = 1.79, 1.86) athletes. Most injuries occurred during competitions in high school (53.2%) and practices in college (60.9%). The competition injury rate was higher than the practice injury rate among both high school (IRR = 5.62; 95% CI = 5.46, 5.78) and collegiate (IRR = 6.59; 95% CI = 6.41, 6.76) players. Most injuries at both levels affected the lower extremity and the shoulder/clavicle and were diagnosed as ligament sprains and muscle/tendon strains. However, concussion was a common injury during competitions among most positions. Conclusions: Injury rates were higher in college than in high school and higher for competitions than for practices. Concussion was a frequent injury sustained during competitions, which confirms the need to develop interventions to mitigate its incidence and severity.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Wilkerson, Gary B.] Univ Tennessee, Grad Athlet Training Educ Program, Chattanooga, TN USA; [Caswell, Shane, V] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA USA; [Currie, Dustin W.; Pierpoint, Lauren A.; Comstock, R. Dawn] Univ Colorado, Dept Epidemiol, Aurora, CO USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu	Wilkerson, Gary B./AAG-4103-2021	Wilkerson, Gary B./0000-0001-8433-7329; Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research Resources awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The Injury Surveillance Program was funded by the NCAA. Funding for HS RIO was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	ADKISON JW, 1974, CLIN ORTHOP RELAT R, P131; [Anonymous], FOOTB PRACT GUID 201; [Anonymous], 2013, PAC 12 LIMIT CONTACT; [Anonymous], 2011, IVY LEAGUE LIMITING; [Anonymous], CENS REG US 2009; [Anonymous], PART STAT; [Anonymous], REP 2013 PART SURV; Barenius B, 2014, AM J SPORT MED, V42, P1049, DOI 10.1177/0363546514526139; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Ben Kibler W, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2013-092425; Bizzini M, 2015, BRIT J SPORT MED, V49, P577, DOI 10.1136/bjsports-2015-094765; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Bonza JE, 2009, J ATHL TRAINING, V44, P76, DOI 10.4085/1062-6050-44.1.76; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Buckley WE, 1982, J ATHL TRAINING, V17, P279; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dick R, 2007, J ATHL TRAINING, V42, P221; Dupler TL, 2010, J STRENGTH COND RES, V24, P1975, DOI 10.1519/JSC.0b013e3181e4f9ec; */* E1419, 2015, PEDIATRICS, V136, pE141, DOI DOI 10.1542/PEDS.2015-3282; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Finch CF, 2015, OSTEOARTHR CARTILAGE, V23, P1138, DOI 10.1016/j.joca.2015.02.165; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Green L., 2014, LEGAL PERSPECTIVES R; Gribble PA, 2016, BRIT J SPORT MED, V50, P1493, DOI 10.1136/bjsports-2016-096188; Grimm NL, 2015, AM J SPORT MED, V43, P2049, DOI 10.1177/0363546514556737; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Halpern B, 1988, Am J Sports Med, V16 Suppl 1, pS113; Hamilton GM, 2011, AM J EPIDEMIOL, V173, P941, DOI 10.1093/aje/kwq461; Jones B., 2015, STATES ADOPT PLANS L; Kaminski TW, 2013, J ATHL TRAINING, V48, P528, DOI 10.4085/1062-6050-48.4.02; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Luc B, 2014, J ATHL TRAINING, V49, P806, DOI 10.4085/1062-6050-49.3.35; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchi AG, 1999, ARCH DIS CHILD, V81, P324, DOI 10.1136/adc.81.4.324; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; National Collegiate Athletic Association, 2015, STUD ATHL PART 1981; National Collegiate Athletic Association, 2014 15 SPORTS MED H; Nielsen RO, 2016, J ORTHOP SPORT PHYS, V46, P300, DOI 10.2519/jospt.2016.6510; Petrie TA, 1993, J APPL SPORT PSYCHOL, V5, P1, DOI DOI 10.1080/10413209308411301; Powell J., 1985, ATHLETIC TRAINING, V20, P104; Powell JW, 2004, J ATHL TRAINING, V39, P56; Powell JW, 1999, J ATHL TRAINING, V34, P277; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Simon JE, 2016, J ATHL TRAINING, V51, P205, DOI 10.4085/1062-6050-51.4.05; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290; Wilkerson GB, 2016, J STRENGTH COND RES, V30, P2369, DOI 10.1519/JSC.0000000000001370; Wilkerson GB, 2015, J ATHL TRAINING, V50, P643, DOI 10.4085/1062-6050-50.2.04; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	75	22	22	0	6	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2018	53	8					738	751		10.4085/1062-6050-144-17			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GW7OJ	WOS:000447157700005	30138047	gold, Green Published			2022-02-06	
J	Shah, FA; Park, DJ; Koh, PO				Shah, Fawad-Ali; Park, Dong-Ju; Koh, Phil-Ok			Identification of Proteins Differentially Expressed by Quercetin Treatment in a Middle Cerebral Artery Occlusion Model: A Proteomics Approach	NEUROCHEMICAL RESEARCH			English	Article						Middle cerebral artery occlusion; Proteomics; Quercetin; Stroke	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; TERMINAL HYDROLASE; RAT-BRAIN; ISOCITRATE DEHYDROGENASES; MOLECULAR CHAPERONES; PARKINSONS-DISEASE; SIGNALING PATHWAY; GENE-EXPRESSION	Cerebral ischemia is a major cause of death and neurological disability. It also leads to severe brain tissue damage by excessive generation of oxidative stress. Quercetin is a bioflavonoid substance that acts an antioxidant agent and exerts a neuroprotective effect against cerebral ischemia. The aim of this study was to detect specific proteins that are differentially expressed in response to quercetin treatment in focal cerebral ischemia. Adult male rats were intraperitoneally injected with vehicle or quercetin (10 mg/kg) 30 min prior to right middle cerebral artery occlusion (MCAO). Brain tissues were collected 24 h after MCAO surgery and right cerebral cortices proteins were identified by two-dimensional gel electrophoresis and mass spectrometry. MCAO leads to neurological behavior disorders, infarction, and histopathological change. However, quercetin treatment alleviated MCAO-induced neuronal deficits and damages. We identified specific proteins differentially expressed between vehicle- and quercetin-treated animals. Among these detected proteins, isocitrate dehydrogenase [NAD(+)], adenosylhomocysteinase, pyruvate kinase, and ubiquitin carboxy terminal hydrolase L1 were decreased in vehicle-treated animals, while quercetin administration alleviated the MCAO-induced decreases in these proteins. However, 60 kDa heat shock protein and collapsin response mediator protein 2 were increased in the vehicle-treated animals, and quercetin treatment attenuated increases in these proteins. The expression changes in these proteins were confirmed by Western blot and reverse transcription-PCR analyses. These proteins are associated with cellular differentiation, metabolism, and oxidative stress related proteins. These results suggest that quercetin reduces ischemic injury by modulating the expression of various proteins in focal cerebral ischemia.	[Shah, Fawad-Ali; Park, Dong-Ju; Koh, Phil-Ok] Gyeongsang Natl Univ, Coll Vet Med, Res Inst Life Sci, Dept Anat, 501 Jinjudaero, Jinju 52828, South Korea		Koh, PO (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Res Inst Life Sci, Dept Anat, 501 Jinjudaero, Jinju 52828, South Korea.	pokoh@gnu.ac.kr		Shah, Fawad Ali/0000-0002-5415-2179	National Research Foundation of Korea (NRF) Grant - Korea government (MEST) [NRF-2015R1D1A1A01058270]	This research was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea government (MEST)(NRF-2015R1D1A1A01058270).	Ahmad A, 2011, NEUROCHEM RES, V36, P1360, DOI 10.1007/s11064-011-0458-6; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Andoh T, 2006, BRAIN RES, V1124, P55, DOI 10.1016/j.brainres.2006.09.085; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; BROCH OJ, 1980, J NEUROCHEM, V35, P484, DOI 10.1111/j.1471-4159.1980.tb06291.x; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Cho JY, 2006, NEUROSCI LETT, V404, P330, DOI 10.1016/j.neulet.2006.06.010; DAVIS EJ, 1969, J BIOL CHEM, V244, P161; DECKERT J, 1988, J NEUROSCI, V8, P2338; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Grubbs R, 2010, J INHERIT METAB DIS, V33, P705, DOI 10.1007/s10545-010-9171-x; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Ho L, 2013, FASEB J, V27, P769, DOI 10.1096/fj.12-212118; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Izaki K, 2001, MOL BRAIN RES, V88, P14, DOI 10.1016/S0169-328X(01)00012-2; Jang Ah-Ram, 2016, Lab Anim Res, V32, P194, DOI 10.5625/lar.2016.32.4.194; Jeon Seong-Jun, 2017, Lab Anim Res, V33, P308, DOI 10.5625/lar.2017.33.4.308; Jin ZQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0264-1; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Lindner MD, 2003, J NEUROSCI, V23, P10913; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Magalingam KB, 2015, J MOL NEUROSCI, V55, P609, DOI 10.1007/s12031-014-0400-x; Michalski D, 2009, BRAIN RES, V1303, P161, DOI 10.1016/j.brainres.2009.09.038; Minich T, 2003, J NEUROCHEM, V86, P605, DOI 10.1046/j.1471-4159.2003.01871.x; Morand C, 1998, AM J PHYSIOL-REG I, V275, pR212, DOI 10.1152/ajpregu.1998.275.1.R212; Pandey AK, 2011, BRAIN RES, V1383, P289, DOI 10.1016/j.brainres.2011.01.085; Poon HF, 2006, NEUROBIOL AGING, V27, P1010, DOI 10.1016/j.neurobiolaging.2005.05.006; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.3.CO;2-S; Ryou MG, 2012, STROKE, V43, P1101, DOI 10.1161/STROKEAHA.111.620088; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Shamsaei N, 2017, BASIC CLIN NEUROSCI, V8, P77, DOI 10.15412/J.BCN.03080110; Shen HX, 2010, NEUROBIOL DIS, V37, P711, DOI 10.1016/j.nbd.2009.12.010; Shutenko Z, 1999, BIOCHEM PHARMACOL, V57, P199, DOI 10.1016/S0006-2952(98)00296-2; Siesjo BK, 2008, J NEUROSURG, V108, P616, DOI 10.3171/JNS/2008/108/3/0616; Sun JH, 2008, BIOCHEM BIOPH RES CO, V366, P539, DOI 10.1016/j.bbrc.2007.11.176; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Woodlee MT, 2008, EXP NEUROL, V211, P511, DOI 10.1016/j.expneurol.2008.02.024; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Yang XD, 2003, BIOCHEMISTRY-US, V42, P1900, DOI 10.1021/bi0262350; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5; Zanini C, 2007, J NEUROCHEM, V103, P1344, DOI 10.1111/j.1471-4159.2007.04835.x; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	55	22	25	3	12	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	AUG	2018	43	8					1608	1623		10.1007/s11064-018-2576-x			16	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GM9GO	WOS:000438554800012	29926355				2022-02-06	
J	Wang, F; Han, Y; Wang, BY; Peng, Q; Huang, XQ; Miller, K; Wittek, A				Wang, Fang; Han, Yong; Wang, Bingyu; Peng, Qian; Huang, Xiaoqun; Miller, Karol; Wittek, Adam			Prediction of brain deformations and risk of traumatic brain injury due to closed-head impact: quantitative analysis of the effects of boundary conditions and brain tissue constitutive model	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain-skull interface; Brain injury; Brain tissue constitutive model; Computational biomechanics of the brain	MECHANICAL-PROPERTIES; BIOMECHANICS MODELS; ELEMENT; REGISTRATION; VALIDATION; GENERATION; SIMON	In this study, we investigate the effects of modelling choices for the brain-skull interface (layers of tissues between the brain and skull that determine boundary conditions for the brain) and the constitutive model of brain parenchyma on the brain responses under violent impact as predicted using computational biomechanics model. We used the head/brain model from Total HUman Model for Safety (THUMS)-extensively validated finite element model of the human body that has been applied in numerous injury biomechanics studies. The computations were conducted using a well-established nonlinear explicit dynamics finite element code LS-DYNA. We employed four approaches for modelling the brain-skull interface and four constitutive models for the brain tissue in the numerical simulations of the experiments on post-mortem human subjects exposed to violent impacts reported in the literature. The brain-skull interface models included direct representation of the brain meninges and cerebrospinal fluid, outer brain surface rigidly attached to the skull, frictionless sliding contact between the brain and skull, and a layer of spring-type cohesive elements between the brain and skull. We considered Ogden hyperviscoelastic, Mooney-Rivlin hyperviscoelastic, neo-Hookean hyperviscoelastic and linear viscoelastic constitutive models of the brain tissue. Our study indicates that the predicted deformations within the brain and related brain injury criteria are strongly affected by both the approach of modelling the brain-skull interface and the constitutive model of the brain parenchyma tissues. The results suggest that accurate prediction of deformations within the brain and risk of brain injury due to violent impact using computational biomechanics models may require representation of the meninges and subarachnoidal space with cerebrospinal fluid in the model and application of hyperviscoelastic (preferably Ogden-type) constitutive model for the brain tissue.	[Wang, Fang; Han, Yong; Wang, Bingyu; Peng, Qian; Huang, Xiaoqun] Xiamen Univ Technol, Sch Mech & Automot Engn, Xiamen 361024, Peoples R China; [Wang, Fang; Han, Yong; Wang, Bingyu; Peng, Qian; Huang, Xiaoqun] Fujian Collaborat Innovat Ctr R&D Coach & Special, Xiamen 361024, Peoples R China; [Miller, Karol; Wittek, Adam] Univ Western Australia, Intelligent Syst Med Lab, Perth, WA 6009, Australia; [Miller, Karol] Cardiff Univ, Inst Mech & Adv Mat, Cardiff Sch Engn, Cardiff, S Glam, Wales		Wang, F (corresponding author), Xiamen Univ Technol, Sch Mech & Automot Engn, Xiamen 361024, Peoples R China.; Wang, F (corresponding author), Fujian Collaborat Innovat Ctr R&D Coach & Special, Xiamen 361024, Peoples R China.	wangfang@xmut.edu.cn	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Miller, Karol/0000-0002-6577-2082; WANG, FANG/0000-0002-7409-0841; Wittek, Adam/0000-0001-9780-8361	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51605407, 51505403]; Fujian Provincial Department of Science and Technology [2017J01652]; State Administration of Foreign Experts Affairs P. R. China [GDT20173600566]	The authors would like to gratefully acknowledge the support of National Natural Science Foundation of China (Grant Nos. 51605407, 51505403), Fujian Provincial Department of Science and Technology (Grant No. 2017J01652) and State Administration of Foreign Experts Affairs P. R. China (Grant No. GDT20173600566). All simulations using Total HUman Model for Safety (THUMS) Version 4.0 human body model in this research were conducted at Xiamen University of Technology.	Agrawal S., 2015, COMPUTATIONAL BIOMEC, P83, DOI DOI 10.1007/978-3-319-15503-6_8; Al-Bsharat A. S., 1999, STAPP CAR CRASH J, V43, P321; Antona-Makoshi J, 2013, THESIS; Antona-Makoshi J, 2015, THESIS; Bandak F, 2001, P INT TECHN C ENH SA, P7; Bathe ICJ, 2006, FINITE ELEMENT PROCE; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bilston LE, 2011, BIOL MED PHYS BIOMED, P69, DOI 10.1007/978-1-4419-9997-9_4; Fahlstedt M., 2016, P 2016 IRCOBI C INT, P459; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Garlapati RR, 2014, J NEUROSURG, V120, P1477, DOI 10.3171/2013.12.JNS131165; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hardy W, 2007, THESIS; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hu JW, 2007, J NEUROSURG, V106, P164, DOI 10.3171/jns.2007.106.1.164; Iwamoto M, 2015, TRAFFIC INJ PREV, V16, pS36, DOI 10.1080/15389588.2015.1015000; Jin X., 2009, THESIS; Jin X, 2014, ANN BIOMED ENG, V42, P812, DOI 10.1007/s10439-013-0948-6; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; LSTC, 2007, LS DYNA KEYW US MAN; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Mazumder MMG, 2013, ACTA BIOENG BIOMECH, V15, P3, DOI 10.5277/abb130201; McElhaney JH, 1973, DYNAMIC CHARACTERIST; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Miller K, 2011, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-1-4419-9997-9; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Miller K, 2010, INT J NUMER METH BIO, V26, P117, DOI 10.1002/cnm.1260; Miller R.T., 1998, STAPP CAR CRASH C SA, DOI [10.4271/983154, DOI 10.4271/983154]; NHTSA, 2010, FED MOT VEH SAF STAN; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Shigeta K, 2009, INT TECHN C ENH SAF, P09; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wang FJ, 2017, COMM COM INF SC, V739, P159, DOI 10.1007/978-3-319-63184-4_9; Watanabe R, 2011, P 22 ESV C, P11; Wismans, 1997, P 41 STAPP CAR CRASH, V41, P315, DOI DOI 10.4271/973338; Wittek A, 2008, COMPUT METHOD BIOMEC, V11, P135, DOI [10.1080/10255840701688095, 10.1080/10255840802296665]; Wittek A, 2003, JSME INT J C-MECH SY, V46, P1388, DOI 10.1299/jsmec.46.1388; Wittek A, 2007, J BIOMECH, V40, P919, DOI 10.1016/j.jbiomech.2006.02.021; Wittek A, 2016, ANN BIOMED ENG, V44, P3, DOI 10.1007/s10439-015-1469-2; Wittek A, 2010, PROG BIOPHYS MOL BIO, V103, P292, DOI 10.1016/j.pbiomolbio.2010.09.001; Yang JK, 2011, COMPUTATIONAL BIOMECHANICS FOR MEDICINE: SOFT TISSUES AND THE MUSCULOSKELETAL SYSTEM, P5, DOI 10.1007/978-1-4419-9619-0_2; Yang JK, 2008, CHIN J MECH ENG-EN, V21, P81, DOI 10.3901/CJME.2008.04.081; Yang KH, 2011, BIOL MED PHYS BIOMED, P91, DOI 10.1007/978-1-4419-9997-9_5; Zhang L, 2001, Stapp Car Crash J, V45, P369	58	22	24	2	26	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	AUG	2018	17	4					1165	1185		10.1007/s10237-018-1021-z			21	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	GN3RH	WOS:000438924400018	29754317				2022-02-06	
J	Langdon, C; Lehrer, E; Berenguer, J; Laxe, S; Alobid, I; Quint, L; Mario-Snchez, F; Bernabeu, M; Marin, C; Mullol, J				Langdon, Cristobal; Lehrer, Eduardo; Berenguer, Joan; Laxe, Sara; Alobid, Isam; Quinto, Llorenc; Marino-Sanchez, Franklin; Bernabeu, Montserrat; Marin, Concepcio; Mullol, Joaquim			Olfactory Training in Post-Traumatic Smell Impairment: Mild Improvement in Threshold Performances: Results from a Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						BAST-24; MRI; olfaction; OT; smell loss; TBI	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; TERM-FOLLOW-UP; BULB VOLUME; HEAD-INJURY; DYSFUNCTION; ANOSMIA; DISCRIMINATION; ORGANIZATION; RECOVERY	Traumatic Brain Injury (TBI) can be associated with partial or total smell loss. Recent studies have suggested that olfactory outcome can be positively modulated after olfactory training (OT). This study's aim was to investigate OT's potential role in smell recovery after TBI-induced olfactory loss. A prospective, randomized, and controlled study was developed. Patients with TBI-induced olfactory dysfunction (n = 42) were randomized into an experimental group with OT and a control group without (nOT). OT was performed twice daily with a six odor training set during 12 weeks. Olfactory loss was assessed using subjective olfactometry (Barcelona Smell Test [BAST] 24), a visual analogue scale (VAS), and n-butanol threshold (n-BTt) at baseline at 4, 12, and 24 weeks. Additionally, patients underwent MRI of the olfactory brain and olfactory bulbs (OB). Based on the MRI results, an overall score (0-16) was developed to associate the structural neurological damage with olfactory outcomes. The primary outcome was the change in olfactory measurements (VAS and BAST-24) between baseline and 12 weeks. The secondary outcome was the association of the MRI score with olfactory outcomes at baseline, and the impact on quality of life (QoL). After 12 weeks of training, OT patients showed a significant improvement in n-BTt (0.6 +/- 1.7 OT vs. -0.6 +/- 1.8 nOT, p < 0.05), but not in the smell VAS and BAST-24 scores. Olfactory outcomes (VAS, BAST-24, and n-BTt) were significantly associated with MRI structural findings (p < 0.001), but not with the OB volume or olfactory sulcus length. The present study suggests that 12 weeks of OT mildly improves the olfactory threshold in TBI, whereas the overall MRI score may be used as an imaging marker of olfactory dysfunction and disease severity in TBI patients.	[Langdon, Cristobal; Lehrer, Eduardo; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Lehrer, Eduardo; Alobid, Isam; Mullol, Joaquim] Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain; [Berenguer, Joan] Hosp Clin Barcelona, Dept Radiol, Neuroradiol Unit, Barcelona, Catalonia, Spain; [Berenguer, Joan] Hosp Clin Barcelona, Imaging Diagnost Ctr, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Lehrer, Eduardo; Berenguer, Joan; Alobid, Isam; Marino-Sanchez, Franklin; Marin, Concepcio; Mullol, Joaquim] August Pi i Sunyer Biomed Res Inst IDIBAPS, Clin & Expt Resp Immunoallergy IRCE, Barcelona, Catalonia, Spain; [Laxe, Sara; Bernabeu, Montserrat] Autonomous Univ Barcelona, Guttmann Inst Fdn, Brain Injury Unit, Barcelona, Catalonia, Spain; [Laxe, Sara; Bernabeu, Montserrat] Autonomous Univ Barcelona, Neurorehabil Hosp, Barcelona, Catalonia, Spain; [Laxe, Sara; Bernabeu, Montserrat] Germans Trias & Pujol Sci Hlth Inst Fdn, Barcelona, Catalonia, Spain; [Alobid, Isam; Marino-Sanchez, Franklin] Ctr Biomed Res Network Resp Dis CIBERES, Barcelona, Catalonia, Spain; [Quinto, Llorenc; Mullol, Joaquim] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth, Barcelona, Catalonia, Spain		Mullol, J (corresponding author), Hosp Clin & Univ, Clin & Expt Resp Immunoallergy, ENT Dept, IDIBAPS, C Villarroel 170, Barcelona 08036, Catalonia, Spain.	jmullol@clinic.cat	Lehrer, Eduardo/AAE-9945-2021; Marino Sanchez, Franklin Santiago/L-9210-2018	Lehrer, Eduardo/0000-0002-4591-2607; Langdon, Cristobal/0000-0003-1540-8095; Quinto, Llorenc/0000-0001-9992-6951; Marino Sanchez, Franklin Santiago/0000-0002-4328-0925	Fundacio La Marato de TV3 [201106-10]	This study was sponsored by a research grant (No. 201106-10) from Fundacio La Marato de TV3.	Altundag A, 2015, LARYNGOSCOPE, V125, P1763, DOI 10.1002/lary.25245; Bernert S, 2009, VALUE HEALTH, V12, P750, DOI 10.1111/j.1524-4733.2009.00509.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Cardesin A, 2006, RHINOLOGY, V44, P83; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Damm M, 2014, LARYNGOSCOPE, V124, P826, DOI 10.1002/lary.24340; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Erskine SE, 2017, CLIN OTOLARYNGOL, V42, P81, DOI 10.1111/coa.12667; Escanilla O, 2008, PHYSIOL BEHAV, V94, P621, DOI 10.1016/j.physbeh.2008.03.008; Escanilla O, 2009, BEHAV NEUROSCI, V123, P828, DOI 10.1037/a0015855; Fleiner F, 2012, ENT-EAR NOSE THROAT, V91, P198, DOI 10.1177/014556131209100508; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Formisano R, 2017, NEUROL SCI, V38, P279, DOI 10.1007/s10072-016-2755-y; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Gillett S, 2009, CLIN OTOLARYNGOL, V34, P467, DOI 10.1111/j.1749-4486.2009.01975.x; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green P, 2001, NEUROREHABILITATION, V16, P237; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Herdman M, 2001, Aten Primaria, V28, P425; Hummel T, 2017, RHINOLOGY; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Jaracz K, 2008, NEUROL NEUROCHIR POL, V42, P525; Kalinowski B, 1969, Otolaryngol Pol, V23, P80; Knudsen K, 2015, ACTA NEUROL SCAND, V132, P395, DOI 10.1111/ane.12406; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Konstantinidis I, 2016, RHINOLOGY, V54, P170, DOI [10.4193/Rhin15.264, 10.4193/Rhino15.264]; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; London B, 2008, ANN NEUROL, V63, P159, DOI 10.1002/ana.21293; Marino-Sanchez FS, 2010, RHINOLOGY, V48, P273, DOI [10.4193/Rhin09.206, 10.4193/Rhino09.206]; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Ministerio de Sanidad  Servicios Sociales e Igualdad . Encuesta Nacional de Salud, 2014, SERIE INFORMES MONOG, V3; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Negoias S., 2016, BRAIN IMAGING BEHAV; Pekala K, 2016, INT FORUM ALLERGY RH, V6, P299, DOI 10.1002/alr.21669; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Rombaux P, 2009, B-ENT, P53; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Rombaux P, 2012, OTOLARYNG HEAD NECK, V147, P1136, DOI 10.1177/0194599812459704; Savic I, 2005, CHEM SENSES, V30, pI222, DOI 10.1093/chemse/bjh194; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Seiden AM, 2004, OTOLARYNG CLIN N AM, V37, P1159, DOI 10.1016/j.otc.2004.06.007; Sorokowska A, 2017, RHINOLOGY, V55, P17, DOI 10.4193/Rhin16.195; Toledano A, 2003, Acta Otorrinolaringol Esp, V54, P678; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	60	22	22	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2641	2652		10.1089/neu.2017.5230		JUL 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000439636800001	29790420				2022-02-06	
J	Leeper, CM; Neal, MD; Billiar, TR; Sperry, JL; Gaines, BA				Leeper, Christine M.; Neal, Matthew D.; Billiar, Timothy R.; Sperry, Jason L.; Gaines, Barbara A.			Overresuscitation with plasma is associated with sustained fibrinolysis shutdown and death in pediatric traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	31st Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma(EAST)	JAN 09-13, 2018	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Trauma; pediatric; coagulopathy; traumatic brain injury; fibrinolysis	PRINCIPAL COMPONENT ANALYSIS; ADMISSION RAPID THROMBELASTOGRAPHY; INTERNATIONAL NORMALIZED RATIO; CONVENTIONAL COAGULATION TESTS; HEMORRHAGIC-SHOCK; HEAD TRAUMA; MORTALITY; COAGULOPATHY; CHILDREN; TIME	BACKGROUND Elevated International Normalized Ratio (INR) is a marker of poor outcome but not necessarily bleeding or clinical coagulopathy in injured children. Conversely, children with traumatic brain injury (TBI) tend to be hypercoagulable based on rapid thromboelastography (rTEG) parameters. Many clinicians continue to utilize INR as a treatment target. METHODS Prospective observational study of severely injured children age < 18 with rTEG on arrival and daily thereafter for up to 7 days. Standard rTEG definitions of hyperfibrinolysis (LY30 3), fibrinolysis shutdown (SD) (LY30 0.8), and normal (LY30 = 0.9-2.9) were applied. The first 24-hour blood product transfusion volumes were documented. Abbreviated Injury Scale score 3 defined severe TBI. Sustained SD was defined as two consecutive rTEG with SD and no subsequent normalization. Primary outcomes were death and functional disability, based on functional independence measure score assessed at discharge. RESULTS One hundred one patients were included: median age, 8 years (interquartile range, 4-12 years); Injury Severity Score, 25 (16-30); 72% blunt mechanism; 47% severe TBI; 16% mortality; 45% discharge disability. Neither total volume nor any single product volume transfused (mL/kg; all p > 0.1) differed between TBI and non-TBI groups. On univariate analysis, transfusion of packed red blood cells (p = 0.016), plasma (p < 0.001), and platelets (p = 0.006) were associated with sustained SD; however, in a regression model that included all products (mL/kg) and controlled for severe TBI (head Abbreviated Injury Scale score 3), admission INR, polytrauma, and clinical bleeding, only plasma remained an independent predictor of sustained SD (odds ratio, 1.17; p = 0.031). Patients with both severe TBI and plasma transfusion had 100% sustained SD, 75% mortality, and 100% disability in survivors. Admission INR was elevated in TBI patients, but did not correlate with rTEG activated clotting time (p = NS) and was associated with sustained SD (p = 0.006). CONCLUSION Plasma transfusion is independently associated with sustained fibrinolysis SD. Severe TBI is also associated with sustained SD; the combined effect of plasma transfusion and severe TBI is associated with extremely poor prognosis. Plasma transfusion should not be targeted to INR thresholds but rather to rTEG activated clotting time and clinical bleeding. LEVEL OF EVIDENCE Prognostic and epidemiological study, level III.	[Leeper, Christine M.; Neal, Matthew D.; Billiar, Timothy R.; Sperry, Jason L.] Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Div Pediat Gen & Thorac Surg, Pittsburgh, PA USA; [Leeper, Christine M.; Gaines, Barbara A.] UPMC, Childrens Hosp Pittsburgh, 7th Floor,Fac Pavil One Childrens Hosp Dr, Pittsburgh, PA 15224 USA		Leeper, CM (corresponding author), UPMC, Childrens Hosp Pittsburgh, 7th Floor,Fac Pavil One Childrens Hosp Dr, Pittsburgh, PA 15224 USA.	leepercm@upmc.edu			University of Pittsburgh Clinical and Translational Science InstituteUniversity of Pittsburgh [UL1 TR000005]; Vascular Medicine Institute; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; Janssen PharmaceuticalsJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc	This publication was made possible by grant number UL1 TR000005 (University of Pittsburgh Clinical and Translational Science Institute), the Vascular Medicine Institute, the Hemophilia Center of Western Pennsylvania, and the Institute for Transfusion Medicine. Dr. Neal receives research support from Janssen Pharmaceuticals and is on the consulting and advisory Boards of Janssen Pharmaceuticals, CSL Behring. The remaining authors have no conflicts to declare.	Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Agren A, 2013, SCAND J CLIN LAB INV, V73, P214, DOI 10.3109/00365513.2013.765960; Ali JT, 2017, AM J EMERG MED, V35, P632, DOI 10.1016/j.ajem.2016.12.061; [Anonymous], 2015, CAUS CHILD MORT 2015; Brown JB, 2015, PREHOSP EMERG CARE, V19, P343, DOI 10.3109/10903127.2014.995851; Center for Disease Prevention and Control, 2014, 10 LEAD CAUS DEATH A; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Chin TL, 2014, SURGERY, V156, P570, DOI 10.1016/j.surg.2014.04.030; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Dzik WH, 2009, ROSSIS PRINCIPLES TR, V4; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Hendrickson J E, 2012, J PEDIAT, V160, P204; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Leeper CM, 2017, ANN SURG, V266, P508, DOI 10.1097/SLA.0000000000002355; Leeper CM, 2017, J TRAUMA ACUTE CARE, V82, P27, DOI 10.1097/TA.0000000000001308; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Leeper CM, 2017, SURGERY; Liras IN, 2015, SURGERY, V158, P812, DOI 10.1016/j.surg.2015.05.004; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Moore EE, 2014, SHOCK, V41, P35, DOI 10.1097/SHK.0000000000000110; Moore HB, 2017, J SURG RES, V220, P438, DOI 10.1016/j.jss.2017.04.028; Moore HB, 2015, SURGERY, V158, P386, DOI 10.1016/j.surg.2015.04.008; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Rizoli S, 2013, J TRAUMA ACUTE CARE, V74, P1229; Rowell SE, 2014, J TRAUMA ACUTE CARE, V77, P846, DOI 10.1097/TA.0000000000000459; Seheult JN, 2017, TRANSFUSION MED, V27, P30, DOI 10.1111/tme.12372; Soundar EP, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0064-1; Vogel AM, 2013, J PEDIATR SURG, V48, P1371, DOI 10.1016/j.jpedsurg.2013.03.036; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	37	22	22	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2018	85	1					12	17		10.1097/TA.0000000000001836			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GL8GZ	WOS:000437457000003	29443859				2022-02-06	
J	Porter, KE; Stein, MB; Martis, B; Avallone, KM; McSweeney, LB; Smith, ER; Simon, NM; Gargan, S; Liberzon, I; Hoge, CW; Rauch, SAM				Porter, Katherine E.; Stein, Murray B.; Martis, Brian; Avallone, Kimberly M.; McSweeney, Lauren B.; Smith, Erin R.; Simon, Naomi M.; Gargan, Sean; Liberzon, Israel; Hoge, Charles W.; Rauch, Sheila A. M.			Postconcussive symptoms (PCS) following combat-related traumatic brain injury (TBI) in Veterans with posttraumatic stress disorder (PTSD): Influence of TBI, PTSD, and depression on symptoms measured by the Neurobehavioral Symptom Inventory (NSI)	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article							HEAD-INJURY; AFGHANISTAN; DEPLOYMENT; IRAQ; SOLDIERS; HEALTH; PREDICTORS; MECHANISMS; COMPLAINTS; EXPOSURE	Mild traumatic brain injury (mTBI) is commonly reported in recent combat Veterans. While the majority resolve, some Veterans develop postconcussive symptoms (PCS). Previous research suggests these symptoms are not specific to head injury and are often associated with psychiatric symptoms. The current study examines the relative contributions of posttraumatic stress, depressive symptoms, and TBI on postconcussive symptoms, and explores whether the relationship remains after controlling for symptom overlap. Two hundred eighteen combat Veterans from Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF), and Operation New Dawn (OND) provided the data for this study as part of a baseline evaluation for inclusion into larger treatment study for posttraumatic stress disorder (PTSD). Participants completed the Brief Traumatic Brain Injury Screen (BTBIS), Neurobehavioral Symptom Inventory (NSI), PTSD Checklist-Stressor Version (PCL-S), Beck Depression Inventory-II (BDI-II). Significant differences in NSI total score between individuals with and without history of TBI were not found. A series of regression analyses demonstrated that Depression and PTSD were significant predictors of NSI score even after removal of NSI symptoms that overlap with PTSD or depression. TBI status was also a significant predictor of PCS in most models, but its relative contribution was much smaller than that of depression and PTSD. Within PTSD symptoms, hyperarousal cluster was a significant predictor of NSI scores. Findings demonstrate that depression and PTSD are related to PCS beyond similarities in construct. Further, within a primarily PTSD treatment-seeking population, these psychiatric symptoms appear to be a stronger contributor than TBI.	[Porter, Katherine E.; Martis, Brian; Avallone, Kimberly M.; McSweeney, Lauren B.; Smith, Erin R.; Liberzon, Israel] VA Ann Arbor Healthcare Syst, 2215 Fuller Rd,116C, Ann Arbor, MI 48105 USA; [Porter, Katherine E.; Martis, Brian; Avallone, Kimberly M.; Smith, Erin R.; Gargan, Sean; Liberzon, Israel] Univ Michigan, Ann Arbor, MI 48109 USA; [Stein, Murray B.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [McSweeney, Lauren B.; Rauch, Sheila A. M.] Emory Univ, Sch Med, Atlanta, GA USA; [Simon, Naomi M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Simon, Naomi M.] NYU, Sch Med, New York, NY USA; [Hoge, Charles W.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Rauch, Sheila A. M.] Atlanta VA Med Ctr, Atlanta, GA USA		Porter, KE (corresponding author), VA Ann Arbor Healthcare Syst, 2215 Fuller Rd,116C, Ann Arbor, MI 48105 USA.	katherine.porter2@va.gov	Rauch, Sheila A.M./K-4450-2015	Stein, Murray/0000-0001-9564-2871; Liberzon, Israel/0000-0002-4990-556X	U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command (MRMC; Randomized Controlled Trial of Sertraline, Prolonged Exposure Therapy, and Their Combination in OEF/OIF Combat Veterans with PTSD) [W81XWH-11-1-0073]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]	This work was supported by the U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command (MRMC; Randomized Controlled Trial of Sertraline, Prolonged Exposure Therapy, and Their Combination in OEF/OIF Combat Veterans with PTSD; Grant #W81XWH-11-1-0073); the National Center for Advancing Translational Sciences of the National Institutes of Health (Grant #UL1TR000433). This material is also the result of work supported with resources and the use of facilities at Massachusetts General Hospital, the VA Ann Arbor Healthcare System, Ralph H. Johnson VA Medical Center, and VA San Diego Healthcare System. The views expressed in this article presentation are solely those of the author(s) and do not reflect an endorsement by or the official policy of the Department of Veterans Affairs, Department of Defense, or the U.S. Government, or the official views of the National Institutes of Health.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Department of the Army, 2014, NEUR SYMPT INV REC S; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Grant G., 2016, TRANSLATIONAL RES TR; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kimerling R, 2000, J TRAUMA STRESS, V13, P115, DOI 10.1023/A:1007729116133; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rauch SAM, 2018, CONTEMP CLIN TRIALS, V64, P128, DOI 10.1016/j.cct.2017.10.013; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Silverberg ND, 2017, J TRAUMA STRESS, V30, P318, DOI 10.1002/jts.22184; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Waldron-Perrine B, 2015, BRAIN INJURY, V29, P1051, DOI 10.3109/02699052.2015.1004742; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Weathers F. W., 1993, 9 ANN CONV INT SOC T; Williams JL, 2017, MIL MED, V182, pE1645, DOI 10.7205/MILMED-D-16-00221; Zhang J, 2015, J PSYCHOSOM RES, V79, P100, DOI 10.1016/j.jpsychores.2015.06.001	46	22	22	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JUL	2018	102						8	13		10.1016/j.jpsychires.2018.03.004			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GN0LS	WOS:000438660500002	29554536				2022-02-06	
J	Wahlberg, B; Ghuman, H; Liu, JR; Modo, M				Wahlberg, Brendon; Ghuman, Harmanvir; Liu, Jessie R.; Modo, Michel			Ex vivo biomechanical characterization of syringe-needle ejections for intracerebral cell delivery	SCIENTIFIC REPORTS			English	Article							CONVECTION-ENHANCED DELIVERY; RADIALLY BRANCHED DEPLOYMENT; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; NARROW-BORE NEEDLES; SHEAR-STRESS; BIOMACROMOLECULE ADDITION; ISCHEMIC-STROKE; FLOW BEHAVIOR; INJECTION	Intracerebral implantation of cell suspensions is finding its clinical translation with encouraging results in patients with stroke. However, the survival of cells in the brain remains poor. Although the biological potential of neural stem cells (NSCs) is widely documented, the biomechanical effects of delivering cells through a syringe-needle remain poorly understood. We here detailed the biomechanical forces (pressure, shear stress) that cells are exposed to during ejection through different sized needles (20G, 26G, 32G) and syringes (10, 50, 250 mu L) at relevant flow rates (1, 5, 10 mu L/min). A comparison of 3 vehicles, Phosphate Buffered Saline (PBS), Hypothermosol (HTS), and Pluronic, indicated that less viscous vehicles are favorable for suspension with a high cell volume fraction to minimize sedimentation. Higher suspension viscosity was associated with greater shear stress. Higher flow rates with viscous vehicle, such as HTS reduced viability by similar to 10% and also produced more apoptotic cells (28%). At 5 mu L/min ejection using a 26G needle increased neuronal differentiation for PBS and HTS suspensions. These results reveal the biological impact of biomechanical forces in the cell delivery process. Appropriate engineering strategies can be considered to mitigate these effects to ensure the efficacious translation of this promising therapy.	[Wahlberg, Brendon; Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Ghuman, Harmanvir; Liu, Jessie R.; Modo, Michel] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Ghuman, Harmanvir; Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Modo, Michel] Ctr Neural Basis Cognit, Pittsburgh, PA 15203 USA		Modo, M (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.; Modo, M (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Modo, M (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	mmm154@pitt.edu		Modo, Michel/0000-0003-4436-735X; Ghuman, Harmanvir/0000-0002-9123-7796	National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082226]; National Institute for Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB016629]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB016629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082226] Funding Source: NIH RePORTER	This work was partially supported by the National Institute for Neurological Disorders and Stroke (R01NS082226) and the National Institute for Biomedical Imaging and Bioengineering (R01EB016629).	Agashi K, 2009, REGEN MED, V4, P49, DOI 10.2217/17460751.4.1.49; Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Amer MH, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0028-x; Amer MH, 2015, J PHARM PHARMACOL, V67, P640, DOI 10.1111/jphp.12362; Aurand ER, 2014, STEM CELL RES, V12, P11, DOI 10.1016/j.scr.2013.09.013; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bayoussef Z, 2012, J TISSUE ENG REGEN M, V6, pe61, DOI 10.1002/term.482; Brady ML, 2013, STEREOT FUNCT NEUROS, V91, P69, DOI 10.1159/000342492; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Chu JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31847; Claudio R, 2004, REGION ANESTH PAIN M, V29, P201, DOI 10.1016/j.rapm.2003.12.013; Diaz MF, 2017, STEM CELLS, V35, P1259, DOI 10.1002/stem.2587; Dubois-Dauphin M, 2010, STROKE, V41, P1807, DOI 10.1161/STROKEAHA.110.578427; Heng BC, 2009, CELL TRANSPLANT, V18, P1111, DOI 10.3727/096368909X12483162197006; Jiang W, 2011, CELL TRANSPLANT, V20, P1515, DOI 10.3727/096368910X547435; Kalladka D, 2016, LANCET, V388, P787, DOI 10.1016/S0140-6736(16)30513-X; Keung AJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01817; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka D, 2011, CELL TRANSPLANT, V20, P1901, DOI 10.3727/096368911X566190; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063473; Maisonneuve BGC, 2015, BIOMACROMOLECULES, V16, P275, DOI 10.1021/bm501481y; Maisonneuve BGC, 2013, BIOMACROMOLECULES, V14, P4388, DOI 10.1021/bm401335g; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; McCluskey L, 2008, J NEUROIMMUNOL, V194, P27, DOI 10.1016/j.jneuroim.2007.11.009; Modo MM, 2018, STROKE, V49, P1099, DOI 10.1161/STROKEAHA.117.018293; Morshed KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105357; Nerem RM, 1998, AM J MED SCI, V316, P169, DOI 10.1097/00000441-199809000-00004; Parsha K, 2017, CYTOTHERAPY, V19, P36, DOI 10.1016/j.jcyt.2016.10.006; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Potts Matthew B, 2013, Surg Neurol Int, V4, pS22, DOI 10.4103/2152-7806.109190; Rossetti T, 2016, CELL TRANSPLANT, V25, P645, DOI 10.3727/096368915X690350; Silvestrini MT, 2015, MOL THER, V23, P119, DOI 10.1038/mt.2014.155; Silvestrini MT, 2013, STEREOT FUNCT NEUROS, V91, P92, DOI 10.1159/000343213; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Steinberg GK, 2016, STROKE, V47, P1817, DOI 10.1161/STROKEAHA.116.012995; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stukel JM, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aa9a4b; Stukel JM, 2016, TISSUE ENG PART B-RE, V22, P173, DOI [10.1089/ten.teb.2015.0380, 10.1089/ten.TEB.2015.0380]; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Torquato S, 2000, PHYS REV LETT, V84, P2064, DOI 10.1103/PhysRevLett.84.2064; Vernon AC, 2011, NEUROCHEM INT, V59, P421, DOI 10.1016/j.neuint.2011.04.001; Whitaker MA, 2011, J MATER SCI-MATER M, V22, P1975, DOI 10.1007/s10856-011-4359-7; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Yin DL, 2010, J NEUROSURG, V113, P240, DOI 10.3171/2010.2.JNS091744	47	22	23	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 15	2018	8								9194	10.1038/s41598-018-27568-x			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ4GQ	WOS:000435338900034	29907825	Green Published, gold			2022-02-06	
J	Babl, FE; Oakley, E; Dalziel, SR; Borland, ML; Phillips, N; Kochar, A; Dalton, S; Cheek, JA; Gilhotra, Y; Furyk, J; Neutze, J; Donath, S; Hearps, S; Molesworth, C; Crowe, L; Bressan, S; Lyttle, MD				Babl, Franz E.; Oakley, Ed; Dalziel, Stuart R.; Borland, Meredith L.; Phillips, Natalie; Kochar, Amit; Dalton, Sarah; Cheek, John A.; Gilhotra, Yuri; Furyk, Jeremy; Neutze, Jocelyn; Donath, Susan; Hearps, Stephen; Molesworth, Charlotte; Crowe, Louise; Bressan, Silvia; Lyttle, Mark D.			Accuracy of Clinician Practice Compared With Three Head Injury Decision Rules in Children: A Prospective Cohort Study	ANNALS OF EMERGENCY MEDICINE			English	Article							CRANIAL COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; TRAUMA; PECARN; CHALICE; PREDICTION; CATCH; METHODOLOGY; DERIVATION	Study objective: Three clinical decision rules for head injuries in children (Pediatric Emergency Care Applied Research Network [PECARN], Canadian Assessment of Tomography for Childhood Head Injury [CATCH], and Children's Head Injury Algorithm for the Prediction of Important Clinical Events [CHALICE]) have been shown to have high performance accuracy. The utility of any of these in a particular setting depends on preexisting clinician accuracy. We therefore assess the accuracy of clinician practice in detecting clinically important traumatic brain injury. Methods: This was a planned secondary analysis of a prospective observational study of children younger than 18 years with head injuries at 10 Australian and New Zealand centers. In a cohort of children with mild head injuries (Glasgow Coma Scale score 13 to 15, presenting in <24 hours) we assessed physician accuracy (computed tomography [CT] obtained in emergency departments [EDs]) for the standardized outcome of clinically important traumatic brain injury and compared this with the accuracy of PECARN, CATCH, and CHALICE. Results: Of 20,137 children, 18,913 had a mild head injury. Of these patients, 1,579 (8.3%) received a CT scan during the ED visit, 160 (0.8%) had clinically important traumatic brain injury, and 24 (0.1%) underwent neurosurgery. Clinician identification of clinically important traumatic brain injury based on CT performed had a sensitivity of 158 of 160, or 98.8% (95% confidence interval [CI] 95.6% to 99.8%) and a specificity of 17,332 of 18,753, or 92.4% (95% CI 92.0% to 92.8%). Sensitivity of PECARN for children younger than 2 years was 42 of 42 (100.0%; 95% CI 91.6% to 100.0%), and for those 2 years and older, it was 117 of 118 (99.2%; 95% CI 95.4% to 100.0%); for CATCH (high/medium risk), it was 147 of 160 (91.9%; 95% CI 86.5% to 95.6%); and for CHALICE, 148 of 160 (92.5%; 95% CI 87.3% to 96.1%). Conclusion: In a setting with high clinician accuracy and a low CT rate, PECARN, CATCH, or CHALICE clinical decision rules have limited potential to increase the accuracy of detecting clinically important traumatic brain injury and may increase the CT rate.	[Babl, Franz E.; Oakley, Ed; Cheek, John A.] Royal Childrens Hosp, Emergency Dept, Parkville, Vic, Australia; [Babl, Franz E.; Oakley, Ed; Cheek, John A.; Donath, Susan; Hearps, Stephen; Molesworth, Charlotte; Crowe, Louise; Bressan, Silvia; Lyttle, Mark D.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Babl, Franz E.; Oakley, Ed; Donath, Susan] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Parkville, Vic, Australia; [Dalziel, Stuart R.] Univ Auckland, Emergency Dept Starship Childrens Hlth, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Borland, Meredith L.] Princess Margaret Hosp Children, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Paediat & Child Hlth, Crawley, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Primary Aboriginal & Rural Healthcare, Crawley, Australia; [Phillips, Natalie; Gilhotra, Yuri] Lady Cilento Childrens Hosp, Brisbane, Qld, Australia; [Phillips, Natalie; Gilhotra, Yuri] Univ Queensland, Child Hlth Res Ctr, Sch Med, South Brisbane, Qld, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Cheek, John A.] Monash Med Ctr, Emergency Dept, Clayton, Vic, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Douglas, Qld, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Dept, Auckland, New Zealand; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Lyttle, Mark D.] Univ West England, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England		Babl, FE (corresponding author), Royal Childrens Hosp, Emergency Dept, Parkville, Vic, Australia.; Babl, FE (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Babl, FE (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Parkville, Vic, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Lyttle, Mark/0000-0002-8634-7210; Donath, Susan/0000-0003-2489-3977; Hearps, Stephen/0000-0003-2984-1172; Crowe, Louise/0000-0003-4619-9708	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [GNT1046727, GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation [3112011]; A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation, Melbourne, Australia; Melbourne Children's Clinician Scientist Fellowship, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; and the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia. The study was also supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. Dr. Babl's time was partly funded by a grant from the Royal Children's Hospital Foundation, Melbourne, Australia; a Melbourne Children's Clinician Scientist Fellowship, Melbourne, Australia; and an NHMRC Practitioner Fellowship, Canberra, Australia. Dr. Dalziel's time was partly funded by the Health Research Council of New Zealand (HRC13/556).	Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bossuyt PM, 2003, ACAD RADIOL, V10, P664, DOI 10.1016/S1076-6332(03)80086-7; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Green SM, 2014, ANN EMERG MED, V64, P286, DOI 10.1016/j.annemergmed.2014.01.016; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lockie FD, 2013, EMERG MED AUSTRALAS, V25, P75, DOI 10.1111/1742-6723.12019; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lyttle MD, 2013, EMERG MED J, V30, P790, DOI 10.1136/emermed-2012-201887; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335	29	22	22	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	2018	71	6					703	710		10.1016/j.annemergmed.2018.01.015			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GJ5NX	WOS:000435429300010	29452747				2022-02-06	
J	Beckwith, J; Zhao, W; Ji, SB; Ajamil, A; Bolander, R; Chu, J; McAllister, T; Crisco, J; Duma, S; Rowson, S; Broglio, S; Guskiewicz, K; Mihalik, J; Anderson, S; Schnebel, B; Gunnar Brolinson, P; Collins, M; Greenwald, R				Beckwith, Jonathan G.; Zhao, Wei; Ji, Songbai; Ajamil, Amaris G.; Bolander, Richard P.; Chu, Jeffrey J.; McAllister, Thomas W.; Crisco, Joseph J.; Duma, Stefan M.; Rowson, Steven; Broglio, Steven P.; Guskiewicz, Kevin M.; Mihalik, Jason P.; Anderson, Scott; Schnebel, Brock; Gunnar Brolinson, P.; Collins, Michael W.; Greenwald, Richard M.			Estimated Brain Tissue Response Following Impacts Associated With and Without Diagnosed Concussion	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Finite element model; Sports concussion; Mild traumatic brain injury; Head impact; Brain tissue response; HIT System	COLLEGIATE FOOTBALL PLAYERS; MAXIMUM PRINCIPAL STRAIN; WHITE-MATTER; HEAD ACCELERATION; INJURY; EXPOSURE; PREDICTORS; KINEMATICS; LOCATION; HELMETS	Kinematic measurements of head impacts are sensitive to sports concussion, but not highly specific. One potential reason is these measures reflect input conditions only and may have varying degrees of correlation to regional brain tissue deformation. In this study, previously reported head impact data recorded in the field from high school and collegiate football players were analyzed using two finite element head models (FEHM). Forty-five impacts associated with immediately diagnosed concussion were simulated along with 532 control impacts without identified concussion obtained from the same players. For each simulation, intracranial response measures (max principal strain, strain rate, von Mises stress, and pressure) were obtained for the whole brain and within four regions of interest (ROI; cerebrum, cerebellum, brain stem, corpus callosum). All response measures were sensitive to diagnosed concussion; however, large inter-athlete variability was observed and sensitivity strength depended on measure, ROI, and FEHM. Interestingly, peak linear acceleration was more sensitive to diagnosed concussion than all intracranial response measures except pressure. These findings suggest FEHM may provide unique and potentially important information on brain injury mechanisms, but estimations of concussion risk based on individual intracranial response measures evaluated in this study did not improve upon those derived from input kinematics alone.	[Beckwith, Jonathan G.; Ajamil, Amaris G.; Bolander, Richard P.; Chu, Jeffrey J.; Greenwald, Richard M.] Simbex, 10 Water St Suite 410, Lebanon, NH 03748 USA; [Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Ji, Songbai; Greenwald, Richard M.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [McAllister, Thomas W.] Indiana Sch Med, Dept Psychiat, Indianapolis, IA USA; [Crisco, Joseph J.] Brown Univ, Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA; [Crisco, Joseph J.] Rhode Isl Hosp, Providence, RI USA; [Duma, Stefan M.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Anderson, Scott] Univ Oklahoma, Dept Intercollegiate Athlet, Norman, OK 73019 USA; [Schnebel, Brock] Univ Oklahoma, Dept Orthoped, Norman, OK 73019 USA; [Schnebel, Brock] Univ Oklahoma, Dept Athlet, Norman, OK 73019 USA; [Gunnar Brolinson, P.] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Collins, Michael W.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA USA; [Collins, Michael W.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA		Beckwith, J (corresponding author), Simbex, 10 Water St Suite 410, Lebanon, NH 03748 USA.	jbeckwith@simbex.com	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596; Crisco, Joseph/0000-0002-8786-0905	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048638, R01NS094410, R01NS055020, R01NS092853, R21NS088781]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R01CE001254, 5R49CE000196]; NOCSAE [07-04, 14-19]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44HD40473]; Riddell, Inc. (Chicago, IL); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048638] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000196, R01CE001254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055020, R21NS088781, R01NS092853, R01NS094410] Funding Source: NIH RePORTER	This work was supported in part by awards R01HD048638, R01NS094410, R01NS055020, R01NS092853, and R21NS088781 from the National Institutes of Health, R01CE001254 and 5R49CE000196 from the Centers for Disease Control and Prevention, and NOCSAE (07-04, 14-19). HIT System technology was developed in part under NIH R44HD40473 and research and development support from Riddell, Inc. (Chicago, IL). We thank the researchers and institutions from which the data were collected: Mike Goforth MS, ATC, Virginia Tech Sports Medicine; Dave Dieter MS, ATC, Virginia Tech Sports Medicine; Russell Fiore ATC, Brown University Sports Medicine; Bethany Wilcox PhD, Brown University; Ron Gatlin ATC, Casady HS; Jeff Frechette ATC and Scott Roy ATC, Dartmouth College Sports Medicine; Dean Kleinschmidt ATC and Brian Lund, University of Indiana Sports Medicine; Jesse Townsend ATC, Greensburg Salam HS; Jeff Cienick ATC, Blackhawk HS; John Burnett ATC, Karns City HS; Chris Ashton ATC, University of Minnesota Sports Medicine; Scott Hamilton, Unity HS; Scott Oliaro, Scott Trulock, and Doug Halverson, UNC-Chapel Hill Sports Medicine. Additionally, we would like to especially thank Lindley Brainard and Wendy Chamberlin, Simbex for coordination of data collection from Dartmouth College, Brown University, and Virginia Tech, and Rema Raman PhD and Sonia Jain PhD, University of California San Diego, for review of the statistical analysis.	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Beusenberg MC., 2000, P INT RES C BIOM IMP; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Chu JJ, 2006, J BIOMECH S1, V39, pS534; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gennarelli T. A., 1972, SAE TECHNICAL PAPER, P296; Giordano C, 2014, STAPP CAR CRASH J, V58, P1; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5	38	22	23	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUN	2018	46	6					819	830		10.1007/s10439-018-1999-5			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	GE7LD	WOS:000431413700004	29470745	Green Accepted			2022-02-06	
J	Ko, IG; Kim, SE; Hwang, L; Jin, JJ; Kim, CJ; Kim, BK; Kim, H				Ko, Il-Gyu; Kim, Sung-Eun; Hwang, Lakkyong; Jin, Jun-Jang; Kim, Chang-Ju; Kim, Bo-Kyun; Kim, Hong			Late starting treadmill exercise improves spatial leaning ability through suppressing CREP/BDNF/TrkB signaling pathway following traumatic brain injury in rats	JOURNAL OF EXERCISE REHABILITATION			English	Article						Traumatic brain injury; Treadmill exercise; Spatial learning ability; Brain-derived neurotrophic factor; cAMP-response element binding protein; Apoptosis	VOLUNTARY EXERCISE; GENE-EXPRESSION; UP-REGULATION; APOPTOSIS; RECOVERY; NEUROGENESIS; DYSFUNCTION; MEMORY	Traumatic brain injury (TBI) causes deficit in spatial learning and memory function. Physical activity ameliorates neurological dysfunction after TBI. We investigated the effect of late starting treadmill exercise on spatial learning ability in relation with cAMP-response element binding protein (CREB)/brain-derived neurotrophic factor (BDNF) signaling pathway using TBI rats. For this study, radial 8-arm maze test, TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) staining, caspase-3 immunohistochemistry, and western blot for Bax, Bcl-2, BDNF, tyrosine kinase B (TrkB), CREB, and phosphorylated CREP (p-CREB) were performed. TBI was induced by an electromagnetic-controlled cortical impact. The rats in the exercise groups were scheduled to run on a treadmill for 30 min once a day for 8 weeks starting 3 weeks after TBI. TBI impaired spatial learning ability and increased caspase-3 expression in the hippocampal dentate gyrus. TBI enhanced Bax expression and suppressed Bcl-2 expression in the hippocampus. TBI increased BDNF and TrkB expressions, resulted in the enhancement of p-CREB/CREB ratio in the hippocampus. However, treadmill exercise improved spatial learning ability, decreased caspase-3 expression, suppressed Bax expression, and increased Bcl-2 expression. Treadmill exercise alleviated TBI-induced over-expression of BDNF and TrkB, which suppressed phosphorylation of CREB in the hippocampus. In the present study, late starting treadmill exercise improved spatial learning ability through suppressing TBI-induced activation of CREB/BDNF/TrkB signaling pathway after TBI.	[Ko, Il-Gyu; Kim, Sung-Eun; Hwang, Lakkyong; Jin, Jun-Jang; Kim, Chang-Ju] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Ko, Il-Gyu; Kim, Sung-Eun; Hwang, Lakkyong; Jin, Jun-Jang; Kim, Chang-Ju] Kyung Hee Univ, Kohwang Med Res Inst, Seoul, South Korea; [Kim, Bo-Kyun] Gachon Univ, Coll Hlth Sci, Dept Emergency Technol, Incheon, South Korea; [Kim, Hong] Daegu Haany Univ, Coll Biomed Sci, Dept Oriental Sports Med, 1 Haanydae Ro, Gyongsan 38610, South Korea		Kim, H (corresponding author), Daegu Haany Univ, Coll Biomed Sci, Dept Oriental Sports Med, 1 Haanydae Ro, Gyongsan 38610, South Korea.	joshua@dhu.ac.kr		Hwang, Lakkyong/0000-0001-5173-1258	National Research Foundation of Korea (NRF) - Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of KoreaNational Research Foundation of Korea [NRF-2011-0021908]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0021908).	Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Byun YH, 2005, J SPORT MED PHYS FIT, V45, P222; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Ji ES, 2015, J EXERC REHABIL, V11, P133, DOI 10.12965/jer.150212; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kim YH, 2014, J EXERC REHABIL, V10, P209, DOI 10.12965/jer.140145; Ko IG, 2009, PHARMACOL BIOCHEM BE, V91, P629, DOI 10.1016/j.pbb.2008.10.009; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Park MS, 2014, J EXERC REHABIL, V10, P148, DOI 10.12965/jer.140109; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	26	22	23	0	0	KOREAN SOC EXERCISE REHABILITATION	SEOUL	264 BAEKJEGOBUN-RO, SONGPA-GU, SEOUL, 138-841, SOUTH KOREA	2288-176X	2288-1778		J EXERC REHABIL	J. Exerc. Rehabil.	JUN	2018	14	3					327	334		10.12965/jer.1836248.124			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	GL7FX	WOS:000437363700003	30018914	Green Submitted, Green Published, gold			2022-02-06	
J	Russell, AL; Richardson, MR; Bauman, BM; Hernandez, IM; Saperstein, S; Handa, RJ; Wu, TJ				Russell, Ashley L.; Richardson, M. Riley; Bauman, Bradly M.; Hernandez, Ian M.; Saperstein, Samantha; Handa, Robert J.; Wu, T. John			Differential Responses of the HPA Axis to Mild Blast Traumatic Brain Injury in Male and Female Mice	ENDOCRINOLOGY			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; RECEPTOR-LIKE IMMUNOREACTIVITY; CORTICOTROPIN-RELEASING FACTOR; SEX-DIFFERENCES; GLUCOCORTICOID-RECEPTOR; CYTOARCHITECTONIC SUBDIVISIONS; PITUITARY DYSFUNCTION; GENDER-DIFFERENCES; OXIDATIVE STRESS; MALE-MOUSE	Traumatic brain injury (TBI) affects 10 million people worldwide, annually. TBI is linked to increased risk of psychiatric disorders. TBI, induced by explosive devices, has a unique phenotype. Over one-third of people exposed to blast-induced TBI (bTBI) have prolonged neuroendocrine deficits, shown by anterior pituitary dysfunction. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is linked to increased risk for psychiatric disorders. Not only is there limited information on how the HPA axis responds to mild bTBI (mbTBI), sex differences are understudied. We examined central and peripheral HPA axis reactivity, 7 to 10 days after mbTBI in male and female mice. Males exposed to mbTBI had increased restraint-induced serum corticosterone (CORT), but attenuated restraint-induced corticotropin-releasing factor (CRF)/c-Fos-immunoreactivity (ir) in the paraventricular nucleus of the hypothalamus (PVN). Females displayed an opposite response, with attenuated restraint-induced CORT and enhanced restraint-induced PVN CRF/c-Fos-ir. We examined potential mechanisms underlying this dysregulation and found that mbTBI did not affect pituitary (proopiomelanocortin and CRF receptor subtype 1) or adrenal (11 beta-hydroxylase, 11 beta-dehydrogenase 1, and melanocortin 2 receptor) gene expression. mbTBI did not alter mineralocorticoid or glucocorticoid gene expression in the PVN or relevant limbic structures. In females, but not males, mbTBI decreased c-Fos-ir in non-neuroendocrine (presumably preautonomic) CRF neurons in the PVN. Whereas we demonstrated a sex-dependent link to stress dysregulation of preautonomic neurons in females, we hypothesize that mbTBI may disrupt limbic pathways involved in HPA axis coordination in males. Overall, mbTBI altered the HPA axis in a sex-dependent manner, highlighting the importance of developing therapies to target individual strategies that males and females use to cope with mbTBI.	[Russell, Ashley L.; Wu, T. John] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Russell, Ashley L.; Wu, T. John] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Me, Bethesda, MD 20814 USA; [Richardson, M. Riley; Bauman, Bradly M.; Hernandez, Ian M.; Saperstein, Samantha; Wu, T. John] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20184 USA; [Handa, Robert J.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA		Wu, TJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	twu@usuhs.edu	Wu, John/ABI-3578-2020	Bauman, Bradly/0000-0002-4471-0966; Wu, Tao-Yiao/0000-0002-8274-0226; Russell, Ashley/0000-0003-1137-2769	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	This work was funded by the Department of Defense in the Center for Neuroscience and Regenerative Medicine.	Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; AHIMA RS, 1990, NEUROSCIENCE, V39, P579, DOI 10.1016/0306-4522(90)90244-X; ANTONI FA, 1986, ENDOCR REV, V7, P351, DOI 10.1210/edrv-7-4-351; ARMSTRONG WE, 1980, NEUROSCIENCE, V5, P1931, DOI 10.1016/0306-4522(80)90040-8; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; CECCATELLI S, 1989, EXP BRAIN RES, V78, P33; Chen YC, 2015, ENDOCRINOLOGY, V156, P4769, DOI 10.1210/en.2015-1673; Cho-Clark M, 2014, MOL ENDOCRINOL, V28, P80, DOI 10.1210/me.2013-1203; CRITCHLOW V, 1963, AM J PHYSIOL, V205, P807, DOI 10.1152/ajplegacy.1963.205.5.807; DALLMAN MF, 1973, ENDOCRINOLOGY, V92, P1367, DOI 10.1210/endo-92-5-1367; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; Dedovic K, 2015, NEUROPSYCH DIS TREAT, V11, P1181, DOI 10.2147/NDT.S62289; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Geerling JC, 2010, J COMP NEUROL, V518, P1460, DOI 10.1002/cne.22283; Goel N, 2008, ENDOCRINOLOGY, V149, P6399, DOI 10.1210/en.2008-0433; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Harpaz I, 2013, EUR J IMMUNOL, V43, P758, DOI 10.1002/eji.201242613; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KISS JZ, 1991, J COMP NEUROL, V313, P563, DOI 10.1002/cne.903130403; KOEGLERMULY SM, 1993, J NEUROENDOCRINOL, V5, P95, DOI 10.1111/j.1365-2826.1993.tb00367.x; Licona NE, 2017, ARCH PHYS MED REHAB, V98, P391, DOI 10.1016/j.apmr.2016.09.131; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LUITEN PGM, 1985, BRAIN RES, V329, P374, DOI 10.1016/0006-8993(85)90554-2; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2015, SLEEP MED CLIN, V10, P1, DOI 10.1016/j.jsmc.2014.11.007; McGivern RF, 2009, PHYSIOL BEHAV, V98, P416, DOI 10.1016/j.physbeh.2009.07.004; McKlveen JM, 2013, BIOL PSYCHIAT, V74, P672, DOI 10.1016/j.biopsych.2013.03.024; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; MERCHENTHALER I, 1991, NEUROSCIENCE, V44, P655, DOI 10.1016/0306-4522(91)90085-3; Merswolken M, 2013, INT J BEHAV MED, V20, P461, DOI 10.1007/s12529-012-9233-6; National Center for Biotechnology Information, PRIM BLAST; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nelson NW, 2015, BRAIN NEUROTRAUMA MO; Oyola MG, 2017, J COMP NEUROL, V525, P3666, DOI 10.1002/cne.24295; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Pyner S, 2000, NEUROSCIENCE, V100, P549, DOI 10.1016/S0306-4522(00)00283-9; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; ROLAND BL, 1993, J COMP NEUROL, V332, P123, DOI 10.1002/cne.903320109; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; SAWCHENKO PE, 1987, BRAIN RES, V403, P213, DOI 10.1016/0006-8993(87)90058-8; SAWCHENKO PE, 1987, BRAIN RES, V437, P253, DOI 10.1016/0006-8993(87)91641-6; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Sweis BM, 2016, BEHAV BRAIN RES, V296, P149, DOI 10.1016/j.bbr.2015.09.015; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Thompson CI, 2003, PHYSIOL BEHAV, V80, P103, DOI 10.1016/S0031-9384(03)00224-5; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Varghese Femina P., 2001, Prim Care Companion J Clin Psychiatry, V3, P151; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Viola-Saltzman M, 2016, NEUROPSYCH DIS TREAT, V12, P339, DOI 10.2147/NDT.S69105; Wamsteeker Cusulin JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064943; Weinstock M, 1998, INT J DEV NEUROSCI, V16, P289, DOI 10.1016/S0736-5748(98)00021-5; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; WHITNALL MH, 1993, PROG NEUROBIOL, V40, P573, DOI 10.1016/0301-0082(93)90035-Q; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Woodruff ER, 2016, ENDOCRINOLOGY, V157, P1522, DOI 10.1210/en.2015-1884; WU TJ, 1992, ENDOCRINOLOGY, V131, P2045, DOI 10.1210/en.131.5.2045; Yan L, 2016, J STEROID BIOCHEM, V160, P118, DOI 10.1016/j.jsbmb.2015.10.007	79	22	22	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	JUN	2018	159	6					2363	2375		10.1210/en.2018-00203			13	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GM9XU	WOS:000438610400011	29701827	Bronze			2022-02-06	
J	Evanson, NK; Guilhaume-Correa, F; Herman, JP; Goodman, MD				Evanson, Nathan K.; Guilhaume-Correa, Fernanda; Herman, James P.; Goodman, Michael D.			Optic tract injury after closed head traumatic brain injury in mice: A model of indirect traumatic optic neuropathy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ENGINEERED ROTATIONAL ACCELERATION; AXONAL INJURY; MOUSE MODEL; NEURONAL DEGENERATION; IMPACT MODEL; FLUORO-JADE; NERVE; DEFICITS; MICROGLIA	Adult male C57BL/6J mice have previously been reported to have motor and memory deficits after experimental closed head traumatic brain injury (TBI), without associated gross pathologic damage or neuroimaging changes detectable by magnetic resonance imaging or diffusion tensor imaging protocols. The presence of neurologic deficits, however, suggests neural damage or dysfunction in these animals. Accordingly, we undertook a histologic analysis of mice after TBI. Gross pathology and histologic analysis using Nissl stain and NeuN immunohistochemistry demonstrated no obvious tissue damage or neuron loss. However, Luxol Fast Blue stain revealed myelin injury in the optic tract, while Fluoro Jade B and silver degeneration staining revealed evidence of axonal neurodegeneration in the optic tract as well as the lateral geniculate nucleus of the thalamus and superior colliculus (detectable at 7 days, but not 24 hours, after injury). Fluoro Jade B staining was not detectable in other white matter tracts, brain regions or in cell somata. In addition, there was increased GFAP staining in these optic tract, lateral geniculate, and superior colliculus 7 days post-injury, and morphologic changes in optic tract microglia that were detectable 24 hours after injury but were more prominent 7 days post-injury. Interestingly, there were no findings of degeneration or gliosis in the suprachiasmatic nucleus, which is also heavily innervated by the optic tract. Using micro-computed tomography imaging, we also found that the optic canal appears to decrease in diameter with a dorsal-ventral load on the skull, which suggests that the optic canal may be the site of injury. These results suggest that there is axonal degeneration in the optic tract and a subset of directly innervated areas, with associated neuroinflammation and astrocytosis, which develop within 7 days of injury, and also suggest that this weight drop injury may be a model for studying indirect traumatic optic neuropathy.	[Evanson, Nathan K.; Guilhaume-Correa, Fernanda] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Evanson, Nathan K.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45220 USA; [Herman, James P.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA; [Goodman, Michael D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA		Evanson, NK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA.; Evanson, NK (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45220 USA.	nathan.evason@cchmc.org		Evanson, Nathan/0000-0003-2474-9764; Guilhaume Correa, Fernanda/0000-0002-3878-5283	National Institutes of Health - Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD001097]; Cincinnati Children's Hospital Medical Center Division of Pediatric Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health - Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov), grant HD001097 (NE) and by the Cincinnati Children's Hospital Medical Center Division of Pediatric Rehabilitation Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Cui Q, 2015, NEUROSCIENCE, V284, P845, DOI 10.1016/j.neuroscience.2014.11.002; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dharmarajan S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0855-0; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MU, 2016, J NEUROTRAUM, V33, P990, DOI 10.1089/neu.2015.4023; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Erskine L, 2014, ASN NEURO, V6, DOI 10.1177/1759091414562107; Finkelstein E, 2006, INCIDENCE EC BURDEN, Vxiii; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GROSS CE, 1981, J NEUROSURG, V55, P963, DOI 10.3171/jns.1981.55.6.0963; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAWRENCE PM, 2014, J COMP NEUROL, V522, P3733, DOI DOI 10.1002/CNE.23635; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Martersteck EM, 2017, CELL REP, V18, P2058, DOI 10.1016/j.celrep.2017.01.075; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; Patel VC, 2017, EXP NEUROL, V289, P85, DOI 10.1016/j.expneurol.2016.12.012; Pilati N, 2008, J HISTOCHEM CYTOCHEM, V56, P539, DOI 10.1369/jhc.2008.950246; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rizzo JR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00227; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Steinsapir K D, 1999, Curr Opin Ophthalmol, V10, P340, DOI 10.1097/00055735-199910000-00011; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; You YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052061; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	64	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197346	10.1371/journal.pone.0197346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	WOS:000431851700105	29746557	Green Submitted, Green Published, gold			2022-02-06	
J	Korley, FK; Nikolian, VC; Williams, AM; Dennahy, IS; Weykamp, M; Alam, HB				Korley, Frederick K.; Nikolian, Vahagn C.; Williams, Aaron M.; Dennahy, Isabel S.; Weykamp, Michael; Alam, Hasan B.			Valproic Acid Treatment Decreases Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels in Swine Subjected to Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; biomarkers; glial fibrillary acidic protein; head trauma; neurofilament light chain; traumatic brain injury; valproic acid	HEMORRHAGIC-SHOCK; INTRACRANIAL LESIONS; CEREBROSPINAL-FLUID; BIOMARKERS; MILD; GFAP; RESUSCITATION; INTERVENTION; MARKER; SIZE	The primary aim of this study was to examine the effects of valproic acid (VPA) treatment on serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NF-L) levels. To achieve this aim, we obtained serum samples from: 1) 10 Yorkshire swine subjected to controlled cortical impact traumatic brain injury (CCI TBI) + polytrauma and randomized to receive either normal saline (NS) + VPA (n=5) or NS alone (n=5) and 2) five additional swine subjected to CCI TBI without polytrauma and treated with VPA. GFAP and NF-L levels were measured in samples obtained from baseline until 10 days post-injury using a digital immunoassay from Quanterix Corporation. We found that elevated GFAP and NF-L levels were first detected at 2 h post-injury; and peaked at 24 h and 72 h respectively. GFAP levels returned to baseline levels by Day 10, while NF-L remained elevated at Day 10. In TBI + polytrauma swine, the magnitude and duration of biomarker elevation, quantified by the area under the biomarker-concentration-versus-time curve during the first 10 days (AUC(0-10days)), was higher in the NS group, compared with the VPA group. For GFAP, the AUC(0-10days) was 45,535 (IQR: 35,741-105,711) and 22,837 (IQR: 8,082-46,627) for the NS and NS+VPA groups, respectively. For NF-L, the AUC(0-10days) was 43,073 (IQR: 18,739-120,794) and 4,475 (2,868-11,157) for the NS and NS+VPA groups, respectively. Twenty-four hour GFAP and NF-L levels had the strongest correlation with lesion size and time to normalization of behavior. Accordingly, we conclude that treatment with VPA results in significantly lower serum GFAP and NF-L levels. The time-point at which GFAP and NF-L levels have the strongest correlation with outcome is 24 h post-injury.	[Korley, Frederick K.] Univ Michigan, Sch Med, Dept Emergency Med, 24 Frank Lloyd Wright Dr,Suite H-3100, Ann Arbor, MI 48106 USA; [Nikolian, Vahagn C.; Williams, Aaron M.; Dennahy, Isabel S.; Alam, Hasan B.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA; [Weykamp, Michael] Duke Univ Hosp, Durham, NC USA		Korley, FK (corresponding author), Univ Michigan, Sch Med, Dept Emergency Med, 24 Frank Lloyd Wright Dr,Suite H-3100, Ann Arbor, MI 48106 USA.	korley@med.umich.edu			US Army Medical Research Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0520]; Joyce and Don Massey Family Foundation through the Michigan Center for Integrative Research in Critical Care (MCIRCC) at the University of Michigan	This research was supported by Award Number: W81XWH-09-1-0520 from the US Army Medical Research Materiel Command and by the Joyce and Don Massey Family Foundation, through the Michigan Center for Integrative Research in Critical Care (MCIRCC) at the University of Michigan.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Chia S, 2008, JACC-CARDIOVASC INTE, V1, P415, DOI 10.1016/j.jcin.2008.04.010; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Higgins GA, 2017, PHARM RES-DORDR, V34, P1658, DOI 10.1007/s11095-017-2130-6; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Nikolian VC, 2017, J TRAUMA ACUTE CARE; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Paziana K, 2015, FUTUR NEUROL, V10, P281, DOI 10.2217/FNL.15.13; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Posti J.P., 2017, J NEUROTRAUMA; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; You B, 2010, UROLOGY, V76, P423, DOI 10.1016/j.urology.2010.02.049; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	29	22	23	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1185	1191		10.1089/neu.2017.5581			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000432198500010	29415612				2022-02-06	
J	Polich, G; Iaccarino, MA; Kaptchuk, TJ; Morales-Quezada, L; Zafonte, R				Polich, Ginger; Iaccarino, Mary Alexis; Kaptchuk, Ted J.; Morales-Quezada, Leon; Zafonte, Ross			Placebo Effects in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						dopamine; placebo effects; reward system; TBI; verbal suggestion	RANDOMIZED CONTROLLED-TRIAL; CATECHOL-O-METHYLTRANSFERASE; HEART-RATE-VARIABILITY; EARLY INTERVENTION; NONCONSCIOUS ACTIVATION; CONDITIONED PLACEBO; MAJOR DEPRESSION; SYMPTOMS; COMT; ANALGESIA	In recent years, several randomized controlled trials evaluating pharmaceutical treatments for traumatic brain injury (TBI) have failed to demonstrate efficacy over placebo, with both active and placebo arms improving at comparable rates. These findings could be viewed in opposing ways, suggesting on the one hand failure of the tested outcome, but on the other, representing evidence of robust placebo effects in TBI. In this article, we examine several of the primary psychological processes driving placebo effects (verbal suggestion, cognitive re-framing, interpersonal interactions, conditioning, therapeutic alliance, anxiety reduction) as well as placebo neurobiology (top-down cortical regulation, reward system activation, dopaminergic and serotonergic neurotransmission). We then extrapolate from the literature to explore whether something inherent in TBI makes it particularly responsive to placebos. Viewed as such here, placebos may indeed represent a powerful and effective treatment for a variety of post-TBI complaints.	[Polich, Ginger; Iaccarino, Mary Alexis; Morales-Quezada, Leon; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA; [Iaccarino, Mary Alexis] MassGen Hosp, Children Sport Concuss Program, Boston, MA USA; [Iaccarino, Mary Alexis; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Iaccarino, Mary Alexis; Zafonte, Ross] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Kaptchuk, Ted J.] Harvard Med Sch, Program Placebo Studies & Therapeut Encounter, Beth Israel Deaconess Med Ctr, Boston, MA USA		Polich, G (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA.	gpolich@partners.org			NCCIH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [T32 AT000051, K24 AT004095] Funding Source: Medline; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT000051, K24AT004095] Funding Source: NIH RePORTER		Albring A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049477; Andre-Obadia N, 2011, PAIN, V152, P1233, DOI 10.1016/j.pain.2010.12.027; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Aslaksen PM, 2008, PSYCHOSOM MED, V70, P811, DOI 10.1097/PSY.0b013e31818105ed; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Ballou S, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1964-x; Bbel P, 2017, PLOS ONE, V12, pe0181856; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Benedetti F, 2006, PAIN, V121, P133, DOI 10.1016/j.pain.2005.12.016; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2016, J PHYSIOL-LONDON, V594, P5647, DOI 10.1113/JP271322; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Birkhauer J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170988; Bouchet C, 1996, J CLIN EPIDEMIOL, V49, P15, DOI 10.1016/0895-4356(95)00540-4; BRANTHWAITE A, 1981, BRIT MED J, V282, P1576, DOI 10.1136/bmj.282.6276.1576; BUCKALEW LW, 1972, PSYCHOL REC, V22, P113, DOI 10.1007/BF03394068; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Colagiuri B, 2015, NEUROSCIENCE, V307, P171, DOI 10.1016/j.neuroscience.2015.08.017; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; Crum AJ., 2015, EMERGING TRENDS SOCI; Curie A., 2015, PLOS ONE, P10; Darragh M, 2015, PHYSIOL BEHAV, V145, P45, DOI 10.1016/j.physbeh.2015.03.043; de la Fuente-Fernandez R, 2004, BIOL PSYCHIAT, V56, P67, DOI 10.1016/j.biopsych.2003.11.019; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; de la Fuente-Fernandez R, 2009, PARKINSONISM RELAT D, V15, pS72, DOI 10.1016/S1353-8020(09)70785-0; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Diederich NJ, 2008, NEUROLOGY, V71, P677, DOI 10.1212/01.wnl.0000324635.49971.3d; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dossett ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136855; Espay AJ, 2015, NEUROLOGY, V84, P794, DOI 10.1212/WNL.0000000000001282; Fassler M, 2015, J CLIN EPIDEMIOL, V68, P442, DOI 10.1016/j.jclinepi.2014.11.018; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Freeman EW, 2015, PSYCHOSOM MED, V77, P167, DOI 10.1097/PSY.0000000000000143; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; GRENCAVAGE LM, 1990, PROF PSYCHOL-RES PR, V21, P372, DOI 10.1037/0735-7028.21.5.372; Hall KT, 2015, TRENDS MOL MED, V21, P285, DOI 10.1016/j.molmed.2015.02.009; Hall KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048135; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hrobjartsson A, 2004, J INTERN MED, V256, P91, DOI 10.1111/j.1365-2796.2004.01355.x; Jensen K, 2015, P NATL ACAD SCI USA, V112, P7863, DOI 10.1073/pnas.1504567112; Jensen KB, 2017, NEUROLOGY, V88, P1912, DOI 10.1212/WNL.0000000000003934; Jensen KB, 2015, CEREB CORTEX, V25, P3903, DOI 10.1093/cercor/bhu275; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Kaptchuk TJ, 2011, PHILOS T R SOC B, V366, P1849, DOI 10.1098/rstb.2010.0385; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Leuchter AF, 2009, J CLIN PSYCHOPHARM, V29, P372, DOI 10.1097/JCP.0b013e3181ac4aaf; Lidstone Sarah Christine, 2014, Handb Exp Pharmacol, V225, P139, DOI 10.1007/978-3-662-44519-8_8; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Matuseviciene G, 2016, J REHABIL MED, V48, P19, DOI 10.2340/16501977-2025; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; McAllister T., 2013, WORLD PSYCHIAT, V7, P3; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Meissner Karin, 2014, Handb Exp Pharmacol, V225, P183, DOI 10.1007/978-3-662-44519-8_11; Meissner K, 2013, JAMA INTERN MED, V173, P1941, DOI 10.1001/jamainternmed.2013.10391; Meissner K, 2011, PHILOS T R SOC B, V366, P1808, DOI 10.1098/rstb.2010.0403; Meyer B, 2015, J NEUROSCI, V35, P7365, DOI 10.1523/JNEUROSCI.4793-14.2015; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Miciak M, 2012, SCAND J CARING SCI, V26, P394, DOI 10.1111/j.1471-6712.2011.00923.x; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Oken BS, 2008, BRAIN, V131, P2812, DOI 10.1093/brain/awn116; Papakostas GI, 2015, J CLIN PSYCHIAT, V76, P456, DOI [10.4088/JCP.14r09297, 10.4088/JCP.13086ah1c, 10.4088/JCP.13086tx5c]; Parker S, 2011, MEMORY, V19, P606, DOI 10.1080/09658211.2011.592500; PARSONS HM, 1974, SCIENCE, V183, P922, DOI 10.1126/science.183.4128.922; Pecina M., 2015, MOL PSYCHIATR, V7, P3; Pecina M, 2013, NEUROPSYCHOPHARMACOL, V38, P639, DOI 10.1038/npp.2012.227; Pollo A, 2003, PAIN, V102, P125, DOI 10.1016/S0304-3959(02)00345-7; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; RICKELS K, 1970, PSYCHOPHARMACOLOGIA, V16, P318, DOI 10.1007/BF00404738; Schafer SM, 2015, J PAIN, V16, P412, DOI 10.1016/j.jpain.2014.12.008; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2015, NEUROREHABILITATION, V36, P463, DOI 10.3233/NRE-151234; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sorokin I, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0544-4; Suffoletto B, 2013, J HEAD TRAUMA REHAB, V28, P302, DOI 10.1097/HTR.0b013e3182847468; Takahashi Courtney, 2015, Handb Clin Neurol, V128, P539, DOI 10.1016/B978-0-444-63521-1.00034-0; Thompson JJ, 2009, CULT MED PSYCHIAT, V33, P112, DOI 10.1007/s11013-008-9122-2; Tiwari AK, 2013, INT J NEUROPSYCHOPH, V16, P771, DOI 10.1017/S1461145712000843; Varelmann D, 2010, ANESTH ANALG, V110, P868, DOI 10.1213/ANE.0b013e3181cc5727; Verheul W, 2010, PATIENT EDUC COUNS, V80, P300, DOI 10.1016/j.pec.2010.06.017; Vistisen ST, 2014, BRAIN INJURY, V28, P196, DOI 10.3109/02699052.2013.860477; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; VOUDOURIS NJ, 1989, PAIN, V38, P109, DOI 10.1016/0304-3959(89)90080-8; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wager TD, 2015, NAT REV NEUROSCI, V16, P403, DOI 10.1038/nrn3976; Wang R., 2017, JCI INSIGHT, V2, P1; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Weger UW, 2013, Q J EXP PSYCHOL, V66, P23, DOI 10.1080/17470218.2012.751117; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Winkler E.A., 2017, J CLIN NEUROSCI, P35; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Wise RA, 2009, J ALLERGY CLIN IMMUN, V124, P436, DOI 10.1016/j.jaci.2009.05.041; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; Yu RJ, 2014, HUM BRAIN MAPP, V35, P4583, DOI 10.1002/hbm.22496; Zimmermann-Viehoff F, 2016, J EVID-BASED INTEGR, V21, P3, DOI 10.1177/2156587215588642; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x	118	22	23	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1205	1212		10.1089/neu.2017.5506		APR 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000429343100001	29343158	Green Published			2022-02-06	
J	Griffith, J; Cluff, K; Eckerman, B; Aldrich, J; Becker, R; Moore-Jansen, P; Patterson, J				Griffith, Jacob; Cluff, Kim; Eckerman, Brandon; Aldrich, Jessica; Becker, Ryan; Moore-Jansen, Peer; Patterson, Jeremy			Non-Invasive Electromagnetic Skin Patch Sensor to Measure Intracranial Fluid-Volume Shifts	SENSORS			English	Article						dielectrics; health monitoring systems; intracranial pressure sensors; microwave sensors; point-of-care technologies; volume measurement; wearable sensors	MAGNETIC INDUCTION; SPECTROSCOPY; PRESSURE; BRAIN; CONCUSSION; MODEL; ICP	Elevated intracranial fluid volume can drive intracranial pressure increases, which can potentially result in numerous neurological complications or death. This study's focus was to develop a passive skin patch sensor for the head that would non-invasively measure cranial fluid volume shifts. The sensor consists of a single baseline component configured into a rectangular planar spiral with a self-resonant frequency response when impinged upon by external radio frequency sweeps. Fluid volume changes (10 mL increments) were detected through cranial bone using the sensor on a dry human skull model. Preliminary human tests utilized two sensors to determine feasibility of detecting fluid volume shifts in the complex environment of the human body. The correlation between fluid volume changes and shifts in the first resonance frequency using the dry human skull was classified as a second order polynomial with R-2 = 0.97. During preliminary and secondary human tests, a approximate to 24 MHz and an average of approximate to 45.07 MHz shifts in the principal resonant frequency were measured respectively, corresponding to the induced cephalad bio-fluid shifts. This electromagnetic resonant sensor may provide a non-invasive method to monitor shifts in fluid volume and assist with medical scenarios including stroke, cerebral hemorrhage, concussion, or monitoring intracranial pressure.	[Griffith, Jacob; Cluff, Kim; Eckerman, Brandon; Aldrich, Jessica; Becker, Ryan] Wichita State Univ, Biomed Engn, Wichita, KS 67260 USA; [Moore-Jansen, Peer] Wichita State Univ, Dept Anthropol, Wichita, KS 67260 USA; [Patterson, Jeremy] Wichita State Univ, Human Performance Studies, Wichita, KS 67260 USA; [Patterson, Jeremy] Wichita State Univ, Inst Interdisciplinary Creat, Wichita, KS 67260 USA		Cluff, K (corresponding author), Wichita State Univ, Biomed Engn, Wichita, KS 67260 USA.	jlgriffith2@shockers.wichita.edu; kim.cluff@wichita.edu; bdeckerman@shockers.wichita.edu; jxaldrich@shockers.wichita.edu; linkxor@gmail.com; pmojan@wichita.edu; jeremy.patterson@wichita.edu		Cluff, Kim/0000-0001-5703-0137; Aldrich, Jessica/0000-0001-9291-7876	National Aeronautics and Space Administration (NASA)National Aeronautics & Space Administration (NASA) [NNX16AQ99A]; Kansas NASA EPSCoR Program (KNEP) grant; John A. See innovation	This work was supported in part by a grant from the National Aeronautics and Space Administration (NASA) (Grant number: NNX16AQ99A), a Kansas NASA EPSCoR Program (KNEP) grant, and the John A. See innovation in research award. This material is also the result of work supported in part with the resources and the use of facilities at Wichita State University. The authors would also like to acknowledge George Szatkowski and Kenneth Dudley from NASA, Langley Research Center, for providing expertise in electromagnetics and open circuit resonators.	Abraham M., 2015, J NEUROANAESTHESIOL, V2, P193, DOI DOI 10.4103/2348-0548.165039; Alruwaili FH, 2017, J AM COLL CARDIOL, V69, P1068, DOI 10.1016/S0735-1097(17)34457-1; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Bey T, 2009, WEST J EMERG MED, V10, P6; Bolouri H, 2012, ACTA NEUROL SCAND, V125, P241, DOI 10.1111/j.1600-0404.2011.01614.x; Cluff K, 2018, IEEE T BIO-MED ENG, V65, P847, DOI 10.1109/TBME.2017.2723001; Engelborghs K, 1997, ACT NEUR S, V70, P123; Flores O, 2008, IEEE ENG MED BIO, P678, DOI 10.1109/IEMBS.2008.4649243; Gonzalez C. A., 2006, P 27 ANN INT C IEEE, P3518, DOI DOI 10.1109/IEMBS.2005.1617238; Gonzalez CA, 2007, P ANN INT IEEE EMBS, P2346, DOI 10.1109/IEMBS.2007.4352797; Gonzalez CA, 2007, IEEE T BIO-MED ENG, V54, P953, DOI 10.1109/TBME.2006.889183; Gonzalez CA, 2010, COMPUT SIST, V14, P187; Griffith J., 2017, P AM SOC GRAV SPAC R; Griffith JL, 2016, INT CONF WEARAB IMPL, P211, DOI 10.1109/BSN.2016.7516261; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herczynski A, 2013, AM J PHYS, V81, P202, DOI 10.1119/1.4773441; Kim S, 2012, IEEE T BIO-MED ENG, V59, P619, DOI 10.1109/TBME.2010.2093897; Kumari S., 2015, INT J MICROWAVE OPTI, V10, P190; Mobashsher AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152351; Mobashsher AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20459; Mohammed BJ, 2014, MICROW OPT TECHN LET, V56, P979, DOI 10.1002/mop.28229; Nelson Emily S., 2014, Life-Basel, V4, P621, DOI 10.3390/life4040621; Onorio I., 2016, MEAS SCI TECHNOL, V27; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rogers J, 2016, ARTERIOSCL THROM VAS, V36; Rojas R, 2008, PHYSIOL MEAS, V29, pS255, DOI 10.1088/0967-3334/29/6/S22; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Scharfetter H, 2003, IEEE T BIO-MED ENG, V50, P870, DOI 10.1109/TBME.2003.813533; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Szatkowski G. N., 2014, NASATP2014218554; Wang LJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42063; Watkins W, 2017, J APPL PHYSIOL, V123, P260, DOI 10.1152/japplphysiol.00091.2017; Watson S, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/4/045501; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Woodard S. E., 2011, P IEEE AER C MAR, P1, DOI DOI 10.1109/AER0.2011.5747495; Woodard SE, 2010, IEEE T INSTRUM MEAS, V59, P3206, DOI 10.1109/TIM.2010.2047546; Zhang LF, 2014, AVIAT SPACE ENVIR MD, V85, P78, DOI 10.3357/ASEM.3789.2014; Zhang ZY, 2014, BIO-MED MATER ENG, V24, P3579, DOI 10.3233/BME-141184	38	22	22	1	10	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	APR	2018	18	4							1022	10.3390/s18041022			17	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	GJ7NS	WOS:000435574800094	29596338	gold, Green Published, Green Submitted			2022-02-06	
J	de Campos, JRM; White, TW				Milanez de Campos, Jose Ribas; White, Thomas W.			Chest wall stabilization in trauma patients: why, when, and how?	JOURNAL OF THORACIC DISEASE			English	Article; Proceedings Paper	26th European Conference on General Thoracic Surgery of the European-Society-of-Thoracic-Surgeons (ESTS)	MAY 26-30, 2018	Ljubljana, SLOVENIA	European Soc Thorac Surg		Flail chest; chest wall stabilization (CWS); rib fracture; plating systems	SEVERE RIB FRACTURES; SURGICAL STABILIZATION; FLAIL CHEST; RETAINED HEMOTHORAX; DECREASES INCIDENCE; MANAGEMENT; FIXATION; OUTCOMES; METAANALYSIS; INJURIES	Blunt trauma to the chest wall and rib fractures are remarkably frequent and are the basis of considerable morbidity and possible mortality. Surgical remedies for highly displaced rib fractures, especially in cases of flail chest, have been undertaken intermittently for more than 50 years. Rib-specific plating systems have started to be used in the last 10 years. These have ushered in the modern era of rib repair with chest wall stabilization (CWS) techniques that are safer, easier to perform, and more efficient. Recent consensus statements have sought to define the indications and contraindications, as well as the when, the how, and the technical details of CWS. Repair should be considered for patients who have three or more displaced rib fractures or a flail chest, whether or not mechanical ventilation is required. Additional candidates include patients who fail non-operative management irrespective of fracture pattern and those with rib fractures who need thoracic procedures for other reasons. Traditionally, unstable spine fracture and severe traumatic brain injury are definite contraindications. Pulmonary contusion's role in the decision to perform CWS remains controversial. A range of rib-specific plating systems are now commercially available.	[Milanez de Campos, Jose Ribas] Univ Sao Paulo, Div Thorac Surg, Sao Paulo, Brazil; [White, Thomas W.] Intermt Med Ctr, Trauma & Surg Crit Care, Salt Lake City, UT USA		de Campos, JRM (corresponding author), Univ Sao Paulo, Div Thorac Surg, Sao Paulo, Brazil.	jribas@usp.br					Bemelman Michael, 2017, Korean J Thorac Cardiovasc Surg, V50, P229, DOI 10.5090/kjtcs.2017.50.4.229; Caragounis EC, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0085-2; Chien CY, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0368-y; Coughlin TA, 2016, BONE JOINT J, V98B, P1119, DOI 10.1302/0301-620X.98B8.37282; Dehghan N, 2014, J TRAUMA ACUTE CARE, V76, P462, DOI 10.1097/TA.0000000000000086; Dent DL, 2015, AM J SURG, V210, P1116; Farquhar J, 2017, CAN J SURG, V60, P7; Fitzgerald MT, 2017, J TRAUMA ACUTE CARE, V82, P524, DOI 10.1097/TA.0000000000001330; Kaplan DJ, 2017, J ORTHOP TRAUMA, V31, pS34, DOI 10.1097/BOT.0000000000000910; Kocher GJ, 2017, EUR J CARDIO-THORAC, V51, P696, DOI 10.1093/ejcts/ezw365; Majak P, 2016, CURR OPIN CRIT CARE, V22, P572, DOI 10.1097/MCC.0000000000000364; Majercik S, 2015, AM J SURG, V210, P1112, DOI 10.1016/j.amjsurg.2015.08.008; Majercik S, 2015, J TRAUMA ACUTE CARE, V79, P533, DOI 10.1097/TA.0000000000000820; Marasco S, 2014, J TRAUMA ACUTE CARE, V77, P452, DOI 10.1097/TA.0000000000000375; Nickerson TP, 2016, WORLD J SURG, V40, P236, DOI 10.1007/s00268-015-3169-3; Olsen MF, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0322-4; Pieracci Fredric M, 2015, Trauma Case Rep, V1, P39, DOI 10.1016/j.tcr.2015.10.001; Pieracci FM, 2018, J TRAUMA ACUTE CARE, V84, P1, DOI 10.1097/TA.0000000000001729; Pieracci FM, 2017, INJURY, V48, P307, DOI 10.1016/j.injury.2016.11.026; Pieracci FM, 2016, J TRAUMA ACUTE CARE, V80, P187, DOI 10.1097/TA.0000000000000925; Skedros JG, 2014, INT J SURG CASE REP, V5, P750, DOI 10.1016/j.ijscr.2014.08.023; Swart E, 2017, J ORTHOP TRAUMA, V31, P64, DOI 10.1097/BOT.0000000000000750; Uchida K, 2017, EUR J TRAUMA EMERG S, V43, P541, DOI 10.1007/s00068-016-0687-0	23	22	22	0	3	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2072-1439	2077-6624		J THORAC DIS	J. Thorac. Dis.	APR	2018	10			8	SI		S951	S962		10.21037/jtd.2018.04.69			12	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Respiratory System	GF1HP	WOS:000431685100006	29744222	Green Published, hybrid			2022-02-06	
J	Mei, ZR; Qiu, JH; Alcon, S; Hashim, J; Rotenberg, A; Sun, Y; Meehan, WP; Mannix, R				Mei, Zhengrong; Qiu, Jianhua; Alcon, Sasha; Hashim, Jumana; Rotenberg, Alexander; Sun, Yan; Meehan, William P., III; Mannix, Rebekah			Memantine improves outcomes after repetitive traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Concussion; Repetitive concussion; NMDAR	D-ASPARTATE RECEPTORS; AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; CLOSED-HEAD-INJURY; NMDA-RECEPTOR; AXONAL INJURY; EXTRACELLULAR POTASSIUM; RECURRENT CONCUSSION; FOOTBALL PLAYERS; CELL-DEATH	Repetitive mild traumatic brain injury (rmTBI; e.g., sports concussions) is common and results in significant cognitive impairment. Targeted therapies for rmTBI are lacking, though evidence from other injury models indicates that targeting N-methyl-n-aspartate (NMDA) receptor (NMDAR)-mediated glutamatergic toxicity might mitigate rmTBI-induced neurologic deficits. However, there is a paucity of preclinical or clinical data regarding NMDAR antagonist efficacy in the rmTBI setting. To test whether NMDAR antagonist therapy improves outcomes after rmTBI, mice were subjected to rmTBI injury (4 injuries in 4 days) and randomized to treatment with the NMDA antagonist memantine or with vehicle. Functional outcomes were assessed by motor, anxiety/impulsivity and mnemonic behavioral tests. At the synaptic level, NMDAR-dependent long-term potentiation (LTP) was assessed in isolated neocortical slices. At the molecular level, the magnitude of gliosis and tau hyperphosphorylation was tested by Western blot and immunostaining, and NMDAR subunit expression was evaluated by Western blot and polymerase shain reaction (PCR). Compared to vehicle-treated mice, memantine-treated mice had reduced tau phosphorylation at acute time points after injury, and less glial activation and LTP deficit 1 month after injury. Treatment with memantine also corresponded to normal NMDAR expression after rmTBI. No corresponding protection in behavior outcomes was observed. Here we found NMDAR antagonist therapy may improve histopathological and functional outcomes after rmTBI, though without consistent corresponding improvement in behavioral outcomes. These data raise prospects for therapeutic post-concussive NMDAR antagonism, particularly in athletes and warriors, who suffer functional impairment and neurodegenerative sequelae after multiple concussions.	[Mei, Zhengrong] Guangzhou Med Univ, Affiliated Hosp 3, Dept Pharm, Guangzhou 510150, Guangdong, Peoples R China; [Qiu, Jianhua; Alcon, Sasha; Hashim, Jumana; Meehan, William P., III; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Qiu, Jianhua; Rotenberg, Alexander; Meehan, William P., III; Mannix, Rebekah] Harvard Med Sch, Boston, MA USA; [Rotenberg, Alexander; Sun, Yan] Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA; [Meehan, William P., III] Micheli Ctr Sports Injury Prevent, 9 Hope Ave,Suite 100 Waltham, Suite Waltham, MA 02453 USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Sports Concuss Clin, Boston, MA USA		Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	meizhengrong@126.com; Jianhua.Qiu@childrens.harvard.edu; Sasha.Alcon@childrens.harvard.edu; Jumana.Hashim@childrens.harvard.edu; Alexander.Rotenberg@childrens.harvard.edu; Yan.Sun@childrens.harvard.edu; William.Mehan@childrens.harvard.edu; Rebekah.Mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		CHB IDDRC [1U54HD090255]; Harvard Catalyst (National Football League Players Association); National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; Guangzhou Education Bureau [1201421151];  [T32 HD40128-11A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD043034] Funding Source: NIH RePORTER	CHB IDDRC (1U54HD090255)supported all the behavior studies reported. Rebekah Mannix is supported by T32 HD40128-11A1 and by a grant from Harvard Catalyst (National Football League Players Association) and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. Zhengrong Mei is supported by the grant from Guangzhou Education Bureau 1201421151). Dr. Meehan receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A guide for coaches and parents, and royalties from Wolters Kluwer for working as an author for UpToDate. He is under contract with ABC-Clio publishing for a future book entitled, Concussions, and with Springer International publishing for a future book entitled, Head and Neck Injuries in Young Athletes. His research is funded, in part, by a grant from Harvard Catalyst (National Football League Players Association) and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.	Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bortolotto ZA, 2001, CURR PROTOC NEUROSCI; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; De Montigny A, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/261593; Effgen GB, 2017, J NEUROTRAUM, V34, P934, DOI 10.1089/neu.2016.4528; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Goda M, 2002, J NEUROTRAUM, V19, P1445, DOI 10.1089/089771502320914679; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ishikawa R, 2014, HIPPOCAMPUS, V24, P784, DOI 10.1002/hipo.22270; Kaindl AM, 2012, ANN NEUROL, V72, P536, DOI 10.1002/ana.23626; Kamat PK, 2013, NEUROSCIENCE, V238, P97, DOI 10.1016/j.neuroscience.2013.01.075; Kanaan N.M., 2015, J NEUROPATHOL EXP NE; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lamprecht MR, 2015, J NEUROTRAUM, V32, P1361, DOI 10.1089/neu.2015.3912; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Ma JY, 2015, NEUROBIOL AGING, V36, P2544, DOI 10.1016/j.neurobiolaging.2015.05.017; Mancini M, 2016, NEUROPHARMACOLOGY, V101, P341, DOI 10.1016/j.neuropharm.2015.10.015; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rao VLR, 2001, BRAIN RES, V911, P96; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Wesierska MJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00203; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Zhang JD, 2013, J NEUROSCI RES, V91, P240, DOI 10.1002/jnr.23150; Zhang XQ, 2013, J NEUROSCI, V33, P17737, DOI 10.1523/JNEUROSCI.2049-13.2013	48	22	22	2	47	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		195	204		10.1016/j.bbr.2017.04.017			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400023	28412305	Green Accepted			2022-02-06	
J	Carotenuto, A; Arcara, G; Orefice, G; Cerillo, I; Giannino, V; Rasulo, M; Iodice, R; Bambini, V				Carotenuto, Antonio; Arcara, Giorgio; Orefice, Giuseppe; Cerillo, Ilaria; Giannino, Valentina; Rasulo, Mario; Iodice, Rosa; Bambini, Valentina			Communication in Multiple Sclerosis: Pragmatic Deficit and its Relation with Cognition and Social Cognition	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Language and language disorder; Multiple sclerosis	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; AMYOTROPHIC-LATERAL-SCLEROSIS; LANGUAGE DISORDERS; IMPAIRMENT; DYSFUNCTION; BEHAVIOR; MIND; SCHIZOPHRENIA; MULTICENTER	Objective: Cognitive functions have been largely investigated in multiple sclerosis. Less attention has been paid to social communication abilities, despite their presumptive affect on quality of life. We run the first comprehensive assessment of pragmatic skills in multiple sclerosis, evaluating also the relationship between pragmatics and other cognitive domains. Methods: Forty-two multiple sclerosis patients and 42 controls were tested for pragmatic abilities, neuro-cognition, social cognition, depression, and fatigue. Results: Patients performed poorly in most pragmatic tasks compared to controls. Globally, 55% of patients performed below the 5th percentile in the total pragmatic score. Notably, pragmatic skills did not differ between cognitively impaired and unimpaired patients. However, an association was found between pragmatics and verbal fluency, as measured in the Word List Generation. Finally, we observed an association of pragmatic abilities with social cognition, and a trend with psychosocial functioning. Conclusion: Overall, the study shows a diffuse pragmatic impairment in multiple sclerosis, not associated with the patient's global neuropsychological profile. By contrast, our findings suggest a close relation between pragmatics and specific cognitive aspects such as executive functions, and between pragmatics and social cognition. This study underlines the need of looking beyond classical cognitive performance, to consider underestimated communicative disturbances of high clinical relevance.	[Carotenuto, Antonio; Orefice, Giuseppe; Cerillo, Ilaria; Giannino, Valentina; Rasulo, Mario; Iodice, Rosa] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Via Pansini 5, I-80131 Naples, Italy; [Arcara, Giorgio] San Camillo Hosp IRCCS, Venice, Italy; [Bambini, Valentina] Sch Adv Studies IUSS, Ctr Neurocognit Epistemol & Theoret Syntax NEtS, Pavia, Italy		Carotenuto, A (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Via Pansini 5, I-80131 Naples, Italy.	carotenuto.antonio87@gmail.com	IODICE, Rosa/J-4016-2018; Arcara, Giorgio/K-6351-2016; Carotenuto, Antonio/AAE-1249-2020; Bambini, Valentina/K-6643-2016	IODICE, Rosa/0000-0002-6939-4760; Arcara, Giorgio/0000-0001-6270-6883; Carotenuto, Antonio/0000-0002-1574-9693; Bambini, Valentina/0000-0001-5770-228X			Agrell B., 1995, SCANDINAVIAN J LOGOP, V20, P27, DOI [10.3109/14015439509098727, DOI 10.3109/14015439509098727]; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Arcara G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00070; Arrondo G., 2009, EUROPEAN NEUROLOGICA, V2, P11; Bambini V., 2012, HDB PRAGMATICS, P1, DOI DOI 10.1075/HOP.16.NEU2; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Bambini V, 2016, BRAIN LANG, V153, P1, DOI 10.1016/j.bandl.2015.12.002; Bambini V, 2010, ITAL J LINGUIST, V22, P1; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bisiacchi PS, 2011, ESAME NEUROPSICOLOGI; Blake ML, 2015, NEUROPSYCHOL REHABIL, V25, P15, DOI 10.1080/09602011.2014.932290; Bosco FM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00166; Brownell H, 2013, J HEAD TRAUMA REHAB, V28, P446, DOI 10.1097/HTR.0b013e31825b5e85; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Catani M, 2014, CURR OPIN NEUROBIOL, V28, P165, DOI 10.1016/j.conb.2014.07.018; Catani M, 2013, NEUROSCI BIOBEHAV R, V37, P1724, DOI 10.1016/j.neubiorev.2013.07.001; Chalah MA, 2017, J INT NEUROPSYCH SOC, V23, P266, DOI 10.1017/S1355617716001156; Champagne-Lavau M, 2009, J NEUROLINGUIST, V22, P413, DOI 10.1016/j.jneuroling.2009.02.002; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cummings L, 2014, PRAGMATIC DISORDERS, V3; Cummings L., 2017, RES CLIN PRAGMATICS; Dodich A, 2015, NEUROL SCI, V36, P1907, DOI 10.1007/s10072-015-2281-3; Ferre P, 2011, REHABIL RES PRACT, V2011, DOI 10.1155/2011/131820; Friend KB, 1999, CLIN NEUROPSYCHOL, V13, P78, DOI 10.1076/clin.13.1.78.1979; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Goverover Y, 2018, MULT SCLER J, V24, P1096, DOI 10.1177/1352458517709955; Henry A, 2011, J INT NEUROPSYCH SOC, V17, P1122, DOI 10.1017/S1355617711001147; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1166, DOI 10.1016/j.neuropsychologia.2005.10.006; Hyter YD, 2017, PERSP PRAGMAT PHILO, V11, P493, DOI 10.1007/978-3-319-47489-2_19; Klein OA, 2019, NEUROPSYCHOL REHABIL, V29, P491, DOI 10.1080/09602011.2017.1309323; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lethlean JB, 1997, APHASIOLOGY, V11, P39, DOI 10.1080/02687039708248454; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Luzzatti C., 1991, AACHENER APHASIA TES; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Mattioli F, 2016, MULT SCLER J, V22, P222, DOI 10.1177/1352458515587597; Messer Rachel H., 2015, HLTH AGING CLIN CARE, DOI [10.4137/hacce.s22981, DOI 10.4137/HACCE.S22981, 10.4137/HACCE.S22981]; Montel SR, 2007, MULT SCLER J, V13, P393, DOI 10.1177/1352458506071170; Morere D. A., 2012, ASSESSING LITERACY D, P141, DOI DOI 10.1007/978-1-4614-5269-0_8; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Pottgen J, 2013, J NEUROL NEUROSUR PS, V84, P523, DOI 10.1136/jnnp-2012-304157; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Preziosa P, 2016, HUM BRAIN MAPP, V37, P1627, DOI 10.1002/hbm.23125; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Renauld S, 2016, MULT SCLER RELAT DIS, V10, P103, DOI 10.1016/j.msard.2016.09.005; Rocca MA, 2015, LANCET NEUROL, V14, P302, DOI 10.1016/S1474-4422(14)70250-9; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sacco K, 2008, J COGN SCI, V9, P111; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Spinnler H., 1987, MLA GRUPPO ITALIANO; Stemmer B., 2008, HDB NEUROSCIENCE LAN, P367; Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768; Tillema JM, 2016, MULT SCLER J, V22, P901, DOI 10.1177/1352458515607650; Vrenken Hugo, 2007, Expert Rev Neurother, V7, P271, DOI 10.1586/14737175.7.3.271	60	22	22	2	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2018	33	2					194	205		10.1093/arclin/acx061			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY4QD	WOS:000426808700006	28655166	Bronze			2022-02-06	
J	Gabler, LF; Joodaki, H; Crandall, JR; Panzer, MB				Gabler, Lee F.; Joodaki, Hamed; Crandall, Jeff R.; Panzer, Matthew B.			Development of a Single-Degree-of-Freedom Mechanical Model for Predicting Strain-Based Brain Injury Responses	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						brain injury criteria; rotational head kinematics; finite element modeling; brain deformation; parametric study	HEAD IMPACT; CONCUSSION; TOLERANCE; KINEMATICS; FOOTBALL	Linking head kinematics to injury risk has been the focus of numerous brain injury criteria. Although many early forms were developed using mechanics principles, recent criteria have been developed using empirical methods based on subsets of head impact data. In this study, a single-degree-of-freedom (sDOF) mechanical analog was developed to parametrically investigate the link between rotational head kinematics and brain deformation. Model efficacy was assessed by comparing the maximum magnitude of displacement to strain-based brain injury predictors from finite element (FE) human head models. A series of idealized rotational pulses covering a broad range of acceleration and velocity magnitudes (0.1-15 krad/s(2) and 1-100 rad/s) with durations between 1 and 3000 ms were applied to the mechanical models about each axis of the head. Results show that brain deformation magnitude is governed by three categories of rotational head motion each distinguished by the duration of the pulse relative to the brain's natural period: for short-duration pulses, maximum brain deformation depended primarily on angular velocity magnitude; for long-duration pulses, brain deformation depended primarily on angular acceleration magnitude; and for pulses relatively close to the natural period, brain deformation depended on both velocity and acceleration magnitudes. These results suggest that brain deformation mechanics can be adequately explained by simple mechanical systems, since FE model responses and experimental brain injury tolerances exhibited similar patterns to the sDOF model. Finally, the sDOF model was the best correlate to strain-based responses and highlighted fundamental limitations with existing rotational-based brain injury metrics.	[Gabler, Lee F.; Joodaki, Hamed; Crandall, Jeff R.; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, POB 400237, Charlottesville, VA 22904 USA		Panzer, MB (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, POB 400237, Charlottesville, VA 22904 USA.	lfg4dc@virginia.edu; hj2vq@eservices.virginia.edu; jrc2h@virginia.edu; mbp2q@virginia.edu			Partnership for Dummy Technology and Biomechanics (PDB)	The Partnership for Dummy Technology and Biomechanics (PDB).	Bandak F. A., 2001, 2001060222 SAE; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; CDC, 2016, RAT TBI REL EM DEP V; CDC, 2016, REP C TRAUM BRAIN IN; DVBIC, 2016, DOD WORLDW NUMB TBI; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Fan W. R, 1971, 710870 SAE; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gadd C, 1966, 660793 SAE; GOLDSMITH W, 1972, BIOMECHANICS HEAD IN; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Kimpara, 2011, INT J AUTOMOT ENG, V2, P13, DOI [10.20485/jsaeijae.2.2_13, DOI 10.20485/JSAEIJAE.2.2_13]; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King W., 2013, HUMAN IMPACT RESPONS; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KORNHAUSER M, 1961, PLANET SPACE SCI, V7, P386, DOI 10.1016/0032-0633(61)90316-6; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Newman J A, 2000, Stapp Car Crash J, V44, P215; NOCSAE, 2012, ND00115M17 NOCSAE; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Patrick L. M., 1963, P 7 STAPP CAR CRASH, P483; Payne P. R., 1962, IMP ACC STRESS S SAN, P195; Rao S.S., 1995, MECH VIBRATIONS; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; SAE International, 1995, J2111199503 SAE INT; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Staffeld S. E., 1970, 700902 SAE; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tauffkirchen W, 1970, 700426 SAE; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thibault L. E., 1985, 856022 SAE; Versace J., 1971, 710881 SAE; von Gierke H. E, 1964, BIOASTRONAUTICS, P61; Yanaoka T., 2015, 2015011439 SAE; Zhao W., 2017, BIOMECH MODEL MECHAN, V16, P1; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	48	22	22	0	6	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAR	2018	140	3							031002	10.1115/1.4038357			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FV9OJ	WOS:000424917600003	29114772				2022-02-06	
J	Guertler, CA; Okamoto, RJ; Schmidt, JL; Badachhape, AA; Johnson, CL; Bayly, PV				Guertler, Charlotte A.; Okamoto, Ruth J.; Schmidt, John L.; Badachhape, Andrew A.; Johnson, Curtis L.; Bayly, Philip V.			Mechanical properties of porcine brain tissue in vivo and ex vivo estimated by MR elastography	JOURNAL OF BIOMECHANICS			English	Article						Magnetic resonance elastography; Brain tissue stiffness; Shear modulus; Post-mortem tissue changes; Porcine brain	MAGNETIC-RESONANCE ELASTOGRAPHY; TRANSVERSELY ISOTROPIC MATERIAL; FAST SHEAR-WAVES; VISCOELASTIC PROPERTIES; NONINVASIVE ASSESSMENT; HEAD-INJURY; BEHAVIOR; ELASTICITY; PARAMETERS; IMPACT	The mechanical properties of brain tissue in vivo determine the response of the brain to rapid skull acceleration. These properties are thus of great interest to the developers of mathematical models of traumatic brain injury (TBI) or neurosurgical simulations. Animal models provide valuable insight that can improve TBI modeling. In this study we compare estimates of mechanical properties of the Yucatan mini-pig brain in vivo and ex vivo using magnetic resonance elastography (MRE) at multiple frequencies. MRE allows estimations of properties in soft tissue, either in vivo or ex vivo, by imaging harmonic shear wave propagation. Most direct measurements of brain mechanical properties have been performed using samples of brain tissue ex vivo. It has been observed that direct estimates of brain mechanical properties depend on the frequency and amplitude of loading, as well as the time post-mortem and condition of the sample. Using MRE in the same animals at overlapping frequencies, we observe that porcine brain tissue in vivo appears stiffer than porcine brain tissue samples ex vivo at frequencies of 100 Hz and 125 Hz, but measurements show closer agreement at lower frequencies. (C) 2018 Elsevier Ltd. All rights reserved.	[Guertler, Charlotte A.; Okamoto, Ruth J.; Schmidt, John L.; Bayly, Philip V.] Washington Univ, Mech Engn & Mat Sci, Urbauer 319,Campus Box 1185,1 Brookings Dr, St Louis, MO 63130 USA; [Badachhape, Andrew A.; Bayly, Philip V.] Washington Univ, Biomed Engn, St Louis, MO 63130 USA; [Johnson, Curtis L.] Univ Delaware, Biomed Engn, Newark, DE 19716 USA		Guertler, CA (corresponding author), Washington Univ, Mech Engn & Mat Sci, Urbauer 319,Campus Box 1185,1 Brookings Dr, St Louis, MO 63130 USA.	charlotte.guertler@wustl.edu	Johnson, Curtis/U-8372-2019	Badachhape, Andrew/0000-0002-5857-9495; Okamoto, Ruth/0000-0002-3085-3878; Guertler, Charlotte/0000-0003-0605-0239	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS055951]; NSFNational Science Foundation (NSF) [CMMI-1332433]; ONROffice of Naval Research [N00014-15-C-5160]; Imaging Sciences Pathway Fellowship [NIH 5T32EB01485505]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB014855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	This study was performed with funding from NIH Grant R01 NS055951, NSF Grant CMMI-1332433, ONR Grant N00014-15-C-5160, and Imaging Sciences Pathway Fellowship NIH 5T32EB01485505. Technical assistance from Linda Hood in MR image acquisition is gratefully acknowledged.	Anderson AT, 2016, J MECH BEHAV BIOMED, V59, P538, DOI 10.1016/j.jmbbm.2016.03.005; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; ARBOGAST KB, 1997, P 41 STAPP CAR CRASH, P293; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Badachhape AA, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036146; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Brands D W, 2000, Stapp Car Crash J, V44, P249; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbourn AHS, 1943, LANCET, V2, P438; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Johnson CL, 2016, HUM BRAIN MAPP, V37, P4221, DOI 10.1002/hbm.23314; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Okamoto RJ, 2011, PHYS MED BIOL, V56, P6379, DOI 10.1088/0031-9155/56/19/014; OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Riek K, 2011, J BIOMECH, V44, P1380, DOI 10.1016/j.jbiomech.2010.12.031; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Sack I, 2009, MAGN RESON MED, V61, P668, DOI 10.1002/mrm.21878; Schmidt JL, 2016, J BIOMECH, V49, P1042, DOI 10.1016/j.jbiomech.2016.02.018; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; Sierra H, 2015, J INVEST DERMATOL, V135, P612, DOI 10.1038/jid.2014.371; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tweten DJ, 2015, J BIOMECH, V48, P4002, DOI 10.1016/j.jbiomech.2015.09.009; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7	45	22	22	3	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAR 1	2018	69						10	18		10.1016/j.jbiomech.2018.01.016			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FX6WZ	WOS:000426229300002	29395225	Bronze, Green Accepted			2022-02-06	
J	Zhang, JY; Lee, JH; Gu, XH; Wei, ZZ; Harris, MJ; Yu, SP; Wei, L				Zhang, James Ya; Lee, Jin Hwan; Gu, Xiaohuan; Wei, Zheng Zachory; Harris, Mallory Jessica; Yu, Shan Ping; Wei, Ling			Intranasally Delivered Wnt3a Improves Functional Recovery after Traumatic Brain Injury by Modulating Autophagic, Apoptotic, and Regenerative Pathways in the Mouse Brain	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; autophagy; beta-catenin; functional recovery; regeneration; traumatic brain injury; Wnt	CONTROLLED CORTICAL IMPACT; STEM-CELLS; NEURONAL DIFFERENTIATION; SIGNALING PROMOTES; ISCHEMIC-STROKE; NERVOUS-SYSTEM; BETA-CATENIN; MICE; DEATH; PROLIFERATION	Traumatic brain injury (TBI) is a prevalent disorder, but no effective therapies currently exist. An underlying patho-physiology of TBI includes the pathological elevation of autophagy. beta-Catenin, a downstream mediator of the canonical Wnt pathway, is a repressor of autophagy. The Wnt/beta-catenin pathway plays a crucial role in cell proliferation and neuronal plasticity/repair in the adult brain. We hypothesized that activation of this pathway could promote neuroprotection and neural regeneration following TBI. In the controlled cortical impact (CCI) model of TBI in C57BL/6 mice (total n = 160), we examined intranasal application of recombinant Wnt3a (2 mu g/kg) in a short-term (1 dose/day for 2 days) and long-term (1 dose/day for 7 days) regimen. Immunohistochemistry was performed at 1 to 14 days post-TBI to assess cell death and neurovascular regeneration. Western blotting measured canonical Wnt3a activity, expression of growth factors, and cell death markers. Longitudinal behavior assays evaluated functional recovery. In short-term experiments, Wnt3a treatment with a 60-min delay post-TBI suppressed TBI-induced autophagic activity in neurons (44.3 +/- 6.98 and 4.25 +/- 2.53 LC3+/NeuN+ double positive cells in TBI+Saline and TBI+Wnt3a mice, respectively; p < 0.0001, n = 5/group), reduced autophagic markers light chain 3 (LC3)-II and Beclin-1, as well as injury markers caspase-3 and matrix metalloproteinase 9 (MMP-9). The Wnt3a treatment reduced cell death and contusion volume (0.72 +/- 0.07mm(2) and 0.26 +/- 0.04mm(2) in TBI+Saline and TBI+Wnt3a mice, respectively; p < 0.001, n = 5/group). The 7-day Wnt3a treatment increased levels of beta-catenin and growth factors glial-derived growth factor (GDNF) and vascular endothelial growth factor (VEGF). This chronic Wnt3a therapy augmented neurogenesis (0.52 +/- 0.09 and 1.25 +/- 0.13 BrdU+/NeuN+ co-labeled cells in TBI+Saline mice and TBI+Wnt3a mice, respectively; p < 0.01, n = 6/group) and angiogenesis (0.26 +/- 0.07 and 0.74 +/- 0.13 BrdU+/GLUT1+ co-labeled cells in TBI+Saline and TBI+Wnt3a mice, respectively; p = 0.014, n = 6/group). The treatment improved performance in the rotarod test and adhesive removal test. Targeting the Wnt pathway implements a unique combination of protective and regenerative approaches after TBI.	[Zhang, James Ya; Lee, Jin Hwan; Gu, Xiaohuan; Wei, Zheng Zachory; Harris, Mallory Jessica; Yu, Shan Ping; Wei, Ling] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Wei, Ling] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA		Wei, L (corresponding author), Emory Univ, Sch Med, 101 Woodruff Circle,WMB Suite 617, Atlanta, GA 30322 USA.	lwei7@emory.edu	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091585] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002473] Funding Source: NIH RePORTER; VAUS Department of Veterans Affairs [1I01RX002473-01A1] Funding Source: Federal RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008169] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS091585] Funding Source: Medline; RRD VA [I01 RX002473] Funding Source: Medline		Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Bradbury MW, 1985, EXPT BIOL LYMPHATIC, P355; Chauhan M. B., J NEUROL NEUROSURG, V2; Chen D., ASN NEURO, V7; Chen JL, 2012, SPR SER TRANSL STROK, P231, DOI 10.1007/978-1-4419-9530-8_11; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Clarkson ED, 1997, CELL TISSUE RES, V289, P207, DOI 10.1007/s004410050867; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; Deretic V., 2008, AUTOPHAGOSOME PHAGOS, P9; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Dzietko M, 2013, TRANSL STROKE RES, V4, P189, DOI 10.1007/s12975-012-0221-6; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hamm R. J., J NEUROTRAUMA, V11, P187; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Inoue T, 2006, STEM CELLS, V24, P95, DOI 10.1634/stemcells.2005-0124; Jia ZQ, 2014, CELL SIGNAL, V26, P2299, DOI 10.1016/j.cellsig.2014.07.028; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaur N, 2013, MOL CELL NEUROSCI, V54, P44, DOI 10.1016/j.mcn.2013.01.001; Koch SBJ, 2014, PSYCHONEUROENDOCRINO, V40, P242, DOI 10.1016/j.psyneuen.2013.11.018; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuhn K, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.31; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu S, 2012, CURR PHARM DESIGN, V18, P3653, DOI 10.2174/138161212802002706; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Lucivero V, 2007, NEUROL SCI, V28, P165, DOI 10.1007/s10072-007-0814-0; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Qi LS, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0107-4; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; Thomsen GM, 2014, STEM CELL RES, V13, P48, DOI 10.1016/j.scr.2014.04.013; Thorne RG, 2008, NEUROSCIENCE, V152, P785, DOI 10.1016/j.neuroscience.2008.01.013; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Wang YZ, 2011, J CELL SCI, V124, P1553, DOI 10.1242/jcs.080580; Wei N, 2013, CELL TRANSPLANT, V22, P977, DOI 10.3727/096368912X657251; Wei ZZ, 2015, CELL TRANSPLANT, V24, P391, DOI 10.3727/096368915X686887; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whyte JL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008078; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wood MD, 2012, MUSCLE NERVE, V46, P122, DOI 10.1002/mus.23295; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Yoshinaga Y, 2010, CELL MOL NEUROBIOL, V30, P1049, DOI 10.1007/s10571-010-9536-6; Young JE, 2009, J BIOL CHEM, V284, P2363, DOI 10.1074/jbc.M806088200; Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3	65	22	24	1	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					802	813		10.1089/neu.2016.4871			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000426088600010	29108471	Green Published			2022-02-06	
J	Burton, RL; O'Connell, ME				Burton, Rachel L.; O'Connell, Megan E.			Telehealth Rehabilitation for Cognitive Impairment: Randomized Controlled Feasibility Trial	JMIR RESEARCH PROTOCOLS			English	Article						cognitive rehabilitation; Alzheimer disease; dementia; telehealth	QUALITY-OF-LIFE; EARLY ALZHEIMERS-DISEASE; ZARIT BURDEN INTERVIEW; TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; MULTIPLE-SCLEROSIS; DEMENTIA; PEOPLE; TELEREHABILITATION; INTERVENTION	Background: Nonpharmacological interventions are needed to support the function of older adults struggling with subjective cognitive impairment (SCI), mild cognitive impairment (MCI), and dementia due to Alzheimer disease (AD). Telerehabilitation aims to provide rehabilitation at a distance, but cognitive rehabilitation by videoconferencing has not been explored. Objective: The objective of this study was to compare goal-oriented cognitive rehabilitation delivered in-person with videoconferencing to determine whether telehealth cognitive rehabilitation appears feasible. Methods: Random assignment to in-person or telehealth videoconferencing cognitive rehabilitation with a combined between-subjects, multiple baseline single-case experimental design, cognitive rehabilitation was delivered by a therapist to 6 participants with SCI (n=4), MCI (n=1), or dementia due to AD (n=1). Results: Two of the 6 participants randomly assigned to the telehealth condition withdrew before beginning the intervention. For those who participated in the intervention, 6 out of 6 goals measured with the Canadian Occupational Performance Measure improved for those in the in-person group, and 7 out of 9 goals improved for those in the telehealth group. Conclusions: Delivery of cognitive rehabilitation by telehealth appeared feasible but required modifications such as greater reliance on caregivers and clients for manipulating materials.	[Burton, Rachel L.; O'Connell, Megan E.] Univ Saskatchewan, Dept Psychol, 9 Campus Dr, Saskatoon, SK, Canada		O'Connell, ME (corresponding author), Univ Saskatchewan, Dept Psychol, 9 Campus Dr, Saskatoon, SK, Canada.	megan.oconnell@usask.ca			Alzheimer Society of Canada	RLB was supported by a doctoral award from the Alzheimer Society of Canada.	Bahar-Fuchs A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003260.pub2; Barton C, 2011, TELEMED E-HEALTH, V17, P789, DOI 10.1089/tmj.2011.0083; Beck JS, 2011, COGNITIVE THERAPY BA, VSecond; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Bedard Michel, 2004, Can J Rural Med, V9, P15; Bergquist T, 2008, BRAIN INJURY, V22, P891, DOI 10.1080/02699050802405487; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Brooks JBB, 2011, ARQ NEURO-PSIQUIAT, V69, P887, DOI 10.1590/S0004-282X2011000700007; Bird M, 2001, NEUROPSYCHOL REHABIL, V11, P357, DOI 10.1080/09602010042000042; Bourgeois MS, 2003, J COMMUN DISORD, V36, P361, DOI 10.1016/S0021-9924(03)00051-0; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Burton R, 2016, NEUROREHABILITATION, V39, P329, DOI 10.3233/NRE-161364; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Clare L, 2003, AGING MENT HEALTH, V7, P15, DOI 10.1080/1360786021000045854; Clare L, 2008, NEUROPSYCHOLOG REHAB, P1; Clare L, 2000, J CLIN EXP NEUROPSYC, V22, P132, DOI 10.1076/1380-3395(200002)22:1;1-8;FT132; Clare L, 1999, NEUROCASE, V5, P37, DOI 10.1080/13554799908404063; Clare L, 2011, CLIN GERONTOLOGIST, V34, P220, DOI 10.1080/07317115.2011.555937; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; DALBELLOHAAS VPM, 2014, RURAL REMOTE HLTH, V14; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dobson D., 2009, EVIDENCE BASED PRACT; Finkelstein J, 2008, J REHABIL RES DEV, V45, P1361, DOI 10.1682/JRRD.2008.01.0001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gervasi O, 2010, VIRTUAL REAL-LONDON, V14, P131, DOI 10.1007/s10055-009-0149-7; Greene CJ, 2010, J CONSULT CLIN PSYCH, V78, P746, DOI 10.1037/a0020158; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Kazdin AE., 2011, SINGLE CASE RES DESI; Kurz AF, 2011, INT PSYCHOGERIATR, V23, P1364, DOI 10.1017/S1041610211001001; Logsdon R. G., 1999, J MENTAL HLTH AGING, V5, P21, DOI DOI 10.1037/T00930-000; Lorig K, 2012, J APPL GERONTOL, V31, P423, DOI 10.1177/0733464810389806; Man DWK, 2006, NEUROREHABILITATION, V21, P205; Martin-Khan M, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.03.004; MATYAS TA, 1990, J APPL BEHAV ANAL, V23, P341, DOI 10.1901/jaba.1990.23-341; McMahon C.M., 2003, CLIN PSYCHOL, V7, P50, DOI [https://doi.org/10.1080/13284200410001707483, DOI 10.1080/13284200410001707483]; Morgan DG, 2009, AGING MENT HEALTH, V13, P17, DOI 10.1080/13607860802154432; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; O'Connell ME, 2014, DEMENTIA-LONDON, V13, P382, DOI 10.1177/1471301212474143; O'Rourke N, 2003, GERONTOLOGIST, V43, P121, DOI 10.1093/geront/43.1.121; O'Sullivan M, 2015, AGING NEUROPSYCHOL C, V22, P280, DOI 10.1080/13825585.2014.927818; Pain H, 2016, J TELEMEDICINE TE S1, V13, P46, DOI 10.1258/135763307781645095; Perales J, 2013, INT PSYCHOGERIATR, V25, P691, DOI 10.1017/S1041610212002293; Pollock N., 2005, CANADIAN OCCUPATIONA; Provencher V, 2008, AM J ALZHEIMERS DIS, V23, P47, DOI 10.1177/1533317507307228; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Ridgeway V, 1994, TEST EVERYDAY ATTENT; Rogante M, 2010, NEUROREHABILITATION, V27, P287, DOI 10.3233/NRE-2010-0612; Romanow R.J., 2002, BUILDING VALUES FUTU; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Serafini JD, 2007, SOC WORK HEALTH CARE, V44, P225, DOI 10.1300/J010v44n03_07; Siebern AT, 2010, MED CLIN N AM, V94, P581, DOI 10.1016/j.mcna.2010.02.005; Silberman SA, 2008, INSOMNIA WORKBOOK; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Smith JD, 2012, PSYCHOL METHODS, V17, P510, DOI 10.1037/a0029312; Sohlberg M., 2001, COGNITIVE REHABILITA; Statistics Canada, 2010, SEN; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Thivierge Stephanie, 2008, Neuropsychiatr Dis Treat, V4, P987; Thorgrimsen L, 2003, ALZ DIS ASSOC DIS, V17, P201, DOI 10.1097/00002093-200310000-00002; von Steinbuchel Nicole, 2006, Eur J Ageing, V3, P116, DOI 10.1007/s10433-006-0024-2; Wampold BE, 2015, WORLD PSYCHIATRY, V14, P270, DOI 10.1002/wps.20238; Wilson B, 1984, CLIN MANAGEMENTM MEM, P86; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird; Wilson BA, 2003, STUD NEUROPSYCHOL DE, P1; World Health Organization, 2010, TEL OPP DEV MEMB STA; Wressle E., 1999, SCAND J OCCUP THER, V6, P84, DOI [DOI 10.1080/110381299443771, 10.1080/110381299443771]	69	22	23	3	13	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	FEB	2018	7	2							e43	10.2196/resprot.9420			18	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	GG7ZB	WOS:000432916000028	29422453	Green Submitted, Green Published, gold			2022-02-06	
J	Cassilo, D; Sanderson, J				Cassilo, David; Sanderson, Jimmy			"I Don't Think It's Worth the Risk": Media Framing of the Chris Borland Retirement in Digital and Print Media	COMMUNICATION & SPORT			English	Article						media framing; football; sport and health; Chris Borland; concussions	TELEVISED NEWS; WOMENS SPORTS; COVERAGE; HEALTH; TIME; MASCULINITY; NETWORK; GENDER	Football player safety, specifically concussions, has been a growing area of debate in U.S. mainstream media. Whereas many of these discussions are centered on the health effects experienced by former players, active National Football League (NFL) players often discursively minimize concussions. However, in March 2015, 24-year-old, San Francisco 49ers player Chris Borland voluntarily retired, specifically citing concerns about the health risks associated with concussions sustained while playing football. A textual analysis of 112 digital media and 187 print media articles revealed 10 frames that were used to discuss Borland's decision. Analysis revealed that the most prominent frame used in media outlets was centered on the health risks and consequences of playing football, while other frames discussed parental choice and social mobility associated with football. The results suggest that decisions by NFL players with respect to concussions can be framed in the context of larger social and cultural issues. As this occurs, conversations around safety, masculinity, and football move beyond the microlevel of participation, capturing macrolevel elements, such as parental consent, socioeconomic status, and health prioritization that factor into football participation.	[Cassilo, David] Kent State Univ, Kent, OH 44242 USA; [Sanderson, Jimmy] Clemson Univ, 502 Old Lebanon Rd, Pendleton, SC 29670 USA		Sanderson, J (corresponding author), Clemson Univ, 502 Old Lebanon Rd, Pendleton, SC 29670 USA.	jsande6@clemson.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Angelini JR, 2014, HOWARD J COMMUN, V25, P115, DOI 10.1080/10646175.2014.888380; [Anonymous], 2013, LIMBAUGH USE CONCUSS; Bigman CA, 2014, HEALTH COMMUN, V29, P267, DOI 10.1080/10410236.2012.745043; Billings AC, 2003, J COMMUN, V53, P569, DOI 10.1093/joc/53.4.569; Billings AC, 2014, COMMUN RES REP, V31, P141, DOI 10.1080/08824096.2014.907142; Billings AC, 2015, J MASS COMMUN Q, V92, P142, DOI 10.1177/1077699014560516; Bills LB, 2016, RETIRES 23 CITING CO; Blain G., 2013, I WANT PROTECT CHILD; Boren C., 2016, D TRUMP NFL FOOTBALL; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bronstein C, 2005, J MASS COMMUN Q, V82, P783, DOI 10.1177/107769900508200403; Burch LM, 2015, J BROADCAST ELECTRON, V59, P399, DOI 10.1080/08838151.2015.1054999; Butterworth M.L., 2014, NFL CRITICAL CULTURA, P205; Butterworth ML, 2012, COMMUN CRIT-CULT STU, V9, P241, DOI 10.1080/14791420.2012.675438; Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooky C, 2015, COMMUN SPORT, V3, P261, DOI 10.1177/2167479515588761; Cooky C, 2013, COMMUN SPORT, V1, P203, DOI 10.1177/2167479513476947; Cranmer GA, 2014, HOWARD J COMMUN, V25, P171, DOI 10.1080/10646175.2014.890979; Dias C., 2015, LONG TERM EFFECTS CO; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Entman RM, 2003, POLIT COMMUN, V20, P415, DOI 10.1080/10584600390244176; Fainaru S, 2013, YOUTH FOOTBALL PARTI; Fainaru-Wada M., 2015, SFS BORLAND QUITS SA; Fisher E., 2015, NFL FANTASY FOOTBALL; Florio M., 2015, NFL DOCTOR SAYS CTE; Frederick EL, 2015, COMMUN SPORT, V3, P312, DOI 10.1177/2167479513508393; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Gantt D., 2014, C BORLAND NAMED NFL; Goffman E., 1974, FRAM AN; Herbst D., 2015, EXPERTS ALARMED 13 H; Hull K, 2015, J SPORT SOC ISSUES, V39, P78, DOI 10.1177/0193723514558928; Isidore C., 2015, NFL REVENUE HERE COM; Jhally S., 1989, MEDIA SPORTS SOC, P70; Jhally Sut, 1984, CRIT SOCIOL, V12, P41; Kassing JW, 2009, WESTERN J COMM, V73, P182, DOI 10.1080/10570310902856063; Kian EM, 2009, J BROADCAST ELECTRON, V53, P477, DOI 10.1080/08838150903102519; Kirk M., 2013, LEAGUE DENIAL DOCUME; Koblin J., 2013, ESPN PULLS OUT FRONT; KUYPERS JA, 2005, QUALITATIVE RES REPO, V6, P1, DOI DOI 10.1080/17459430500262083; Lee ST, 2013, HEALTH COMMUN, V28, P119, DOI 10.1080/10410236.2012.658550; Lee S, 2014, J SPORT MANAGE, V28, P176, DOI 10.1123/jsm.2012-0243; Lindlof TR, 2017, QUALITATIVE COMMUNIC; Martin J., 2016, P WARNER ELIMINATES; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; Mcelroy K, 2014, HOWARD J COMMUN, V25, P431, DOI 10.1080/10646175.2014.955928; MESSNER MA, 1993, SOCIOL SPORT J, V10, P119, DOI 10.1123/ssj.10.2.119; Messner MA, 2014, SOCIOL SPORT J, V31, P102, DOI 10.1123/ssj.2013-0111; Miller J. A., 2013, N F L PRESSURE SAID; Nan XL, 2013, J HEALTH COMMUN, V18, P263, DOI 10.1080/10810730.2012.727957; NEUENDORF K.A., 2017, CONTENT ANAL GUIDEBO; Oates TP, 2009, SOCIOL SPORT J, V26, P31, DOI 10.1123/ssj.26.1.31; PAXTON M, 2004, J MEDIA RELIG, V3, P43, DOI DOI 10.1207/s15328415jmr0301_3; Petchesky B., 2016, H ABDULLAH RETIRES A; Petric J., 2013, THESIS; Rodgers K., 2014, NFL CRITICAL CULTURA, P142; Rosenthal G., 2015, 8 BIGGEST SURPRISES; Sabo D., 1994, ANN M NAT ATHL TRAIN; Sanderson, 2011, ITS WHOLE NEW BALLGA; Sanderson J., COMMUNICATI IN PRESS; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Sandomir R., 2011, ESPN EXTENDS DEAL N; Schimmel KS, 2012, INT REV SOCIOL SPORT, V47, P338, DOI 10.1177/1012690211433479; Schimmel KS, 2011, URBAN STUD, V48, P3277, DOI 10.1177/0042098011422396; Schmitt B., 2016, NFL FREE AGENT CRIBB; Schwarz A, 2016, N F L S FLAWED CONCU; Scott R., 2015, CONCUSSION; Seate AA, 2010, COMMUN RES REP, V27, P343, DOI 10.1080/08824096.2010.518917; Seltzer T., 2009, Journal of Sports Media, V4, P1, DOI 10.1353/jsm.0.0040; Sheridan B. (Producer), 2012, HEAD GAMES DOCUMENTA; Spaaij R, 2011, SPORT SOCIAL MOBILIT; Stefanik-Sidener K, 2013, HEALTH COMMUN, V28, P351, DOI 10.1080/10410236.2012.688187; Strachan M., 2015, NFL AFFLIATED DOCTOR; Wenner L.A., 1989, MEDIA SPORTS SOC, P13; Young, 2004, SPORTING BODIES DAMA, P59; Zhang Y, 2015, J MASS COMMUN Q, V92, P99, DOI 10.1177/1077699014558553	77	22	22	1	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	FEB	2018	6	1					86	110		10.1177/2167479516654513			25	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	FR5TC	WOS:000419128100005					2022-02-06	
J	Fievisohn, E; Bailey, Z; Guettler, A; VandeVord, P				Fievisohn, Elizabeth; Bailey, Zachary; Guettler, Allison; VandeVord, Pamela			Primary Blast Brain Injury Mechanisms: Current Knowledge, Limitations, and Future Directions	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							INTRACRANIAL-PRESSURE RESPONSE; POSSIBLE DAMAGE MECHANISM; OPERATION IRAQI FREEDOM; INDUCED OCULAR TRAUMA; IMPACT ACCELERATION; FLUID PRESSURES; SHOCK-WAVE; INDUCED NEUROTRAUMA; OXIDATIVE STRESS; BOMB EXPLOSION	Mild blast traumatic brain injury (bTBI) accounts for the majority of brain injury in United States service members and other military personnel worldwide. The mechanisms of primary blast brain injury continue to be disputed with little evidence to support one or a combination of theories. The main hypotheses addressed in this review are blast wave transmission through the skull orifices, direct cranial transmission, skull flexure dynamics, thoracic surge, acceleration, and cavitation. Each possible mechanism is discussed using available literature with the goal of focusing research efforts to address the limitations and challenges that exist in blast injury research. Multiple mechanisms may contribute to the pathology of bTBI and could be dependent on magnitudes and orientation to blast exposure. Further focused biomechanical investigation with cadaver, in vivo, and finite element models would advance our knowledge of bTBI mechanisms. In addition, this understanding could guide future research and contribute to the greater goal of developing relevant injury criteria and mandates to protect our soldiers on the battlefield.	[Fievisohn, Elizabeth; Bailey, Zachary] Virginia Tech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [Guettler, Allison] Virginia Tech, Dept Mech Engn, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [VandeVord, Pamela] Virginia Tech, Dept Biomed Engn & Mech, 317 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [VandeVord, Pamela] Salem Vet Affairs Med Ctr, Salem, VA 24153 USA		VandeVord, P (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 317 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.; VandeVord, P (corresponding author), Salem Vet Affairs Med Ctr, Salem, VA 24153 USA.	lizf87@vt.edu; zbailey2@vt.edu; aguett@vt.edu; pvord@vt.edu	McNeil, Elizabeth/J-2972-2019	McNeil, Elizabeth/0000-0003-3439-3722			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adams S, 2014, RESP PHYSIOL NEUROBI, V204, P112, DOI 10.1016/j.resp.2014.08.015; Agoston D.V., 2015, BRAIN NEUROTRAUMA MO; Akula P. K., 2013, ASME J MED DEVICE, V7; Akula P, 2015, BIOMED ENG LETT, V5, P281, DOI 10.1007/s13534-015-0204-0; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Aschkenasy-Steuer G, 2005, CRIT CARE, V9, P490, DOI 10.1186/cc3762; Assari S., 2013, IMECE201364992 ASME; Azhari H., 2010, BASICS BIOMEDICAL UL, P313, DOI DOI 10.1002/9780470561478.APP1/SUMMARY; Bailey Z. S., 2016, METHODS MOL BIOL, V1462; Bailey ZS, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00064; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; BILMES L, 2006, 12054 NAT BUR EC RES; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Boone JM., 2011, ESSENTIAL PHYS MED I; BRISMAR B, 1982, J TRAUMA, V22, P216, DOI 10.1097/00005373-198203000-00007; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 1996, J TRAUMA, V40, pS148, DOI 10.1097/00005373-199603001-00032; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00119; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Choi Chul-Hee, 2012, Korean J Audiol, V16, P103, DOI 10.7874/kja.2012.16.3.103; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; CLEMEDSON C. J., 1954, MILITARY SURGEON, V114, P424; CLEMEDSON CJ, 1956, AM J PHYSIOL, V184, P119, DOI 10.1152/ajplegacy.1955.184.1.119; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Cohuet G, 2001, HYPERTENSION, V38, P1167, DOI 10.1161/hy1101.095995; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Cubano M.A., 2013, EM WAR SURG HDB, P257; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Regloix SB, 2017, J ROY ARMY MED CORPS, V163, P333, DOI 10.1136/jramc-2016-000733; DELIUS M, 1990, ULTRASOUND MED BIOL, V16, P467, DOI 10.1016/0301-5629(90)90169-D; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; DVBIC, 2016, DEP DEF NUMB TRAUM B; ELDER FK, 1952, J APPL PHYS, V23, P1065, DOI 10.1063/1.1701987; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; ENGIN AE, 1969, J BIOMECH, V2, P325, DOI 10.1016/0021-9290(69)90089-X; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gibbons AJ, 2011, J MIL VETERANS HEALT, V19, P15; Gilbert F. K., 1985, EXPLOSIVE SHOCKS AIR; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldberg MS, 2010, MIL MED, V175, P220, DOI 10.7205/MILMED-D-09-00130; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; HADDEN WA, 1978, BRIT J SURG, V65, P525, DOI 10.1002/bjs.1800650802; HARVEY EN, 1947, J EXP MED, V85, P321, DOI 10.1084/jem.85.3.321; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Hosseini H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867883; Johnston AM, 2015, AM J RESP CRIT CARE, V191, P1462, DOI 10.1164/rccm.201501-0063IM; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi E., 2012, FRONT NEUROL, V3, P11; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; KWON YW, 1993, COMPUT STRUCT, V48, P637, DOI 10.1016/0045-7949(93)90257-E; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Maxwell AD, 2013, ULTRASOUND MED BIOL, V39, P449, DOI 10.1016/j.ultrasmedbio.2012.09.004; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Morley MG, 2010, DISASTER MED PUBLIC, V4, P154, DOI 10.1001/dmp.v4n2.hra10003; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Needham CE, 2010, SHOCK WAVE HIGH PRES, P9, DOI 10.1007/978-3-642-05288-0_3; Nusholtz G. S., 1984, 841657 SAE; NUSHOLTZ GS, 1987, AVIAT SPACE ENVIR MD, V58, P1157; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Owers C, 2011, BRIT J SURG, V98, P168, DOI 10.1002/bjs.7268; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; PERLMAN HB, 1945, LARYNGOSCOPE, V55, P427; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pinton G, 2012, MED PHYS, V39, P299, DOI 10.1118/1.3668316; Qureshi TA, 2017, J PAK MED ASSOC, V67, P1313; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Romba J., 1961, 1761 AB PROV GROUND; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sankowski R, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00028; Selvan V, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024132; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Shuker ST, 2010, J ORAL MAXIL SURG, V68, P93, DOI 10.1016/j.joms.2009.07.077; SHUPAK A, 1993, ARCH OTOLARYNGOL, V119, P1362; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Smith JE, 2011, PHILOS T R SOC B, V366, P291, DOI 10.1098/rstb.2010.0251; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P38; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P7; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P27; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Takeda S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00171; Tan L. B., 2017, INT J NUMER METH BIO, V33, P1; Toklu HZ, 2015, J CEREBR BLOOD F MET, V35, P1950, DOI 10.1038/jcbfm.2015.151; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2016, METHODS MOL BIOL, V1462, P101, DOI 10.1007/978-1-4939-3816-2_7; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Vrselja Z, 2014, J CEREBR BLOOD F MET, V34, P578, DOI 10.1038/jcbfm.2014.7; WAHL M, 1993, ACTA NEUROCHIR, P3; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Wani Imtiaz, 2009, World J Emerg Surg, V4, P46, DOI 10.1186/1749-7922-4-46; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wardlaw A, 2010, IFMBE PROC, V32, P34, DOI 10.1007/978-3-642-14998-6_9; Ware JB, 2016, RADIOLOGY, V280, P212, DOI 10.1148/radiol.2016151013; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Williams ST, 2017, MIL MED, V182, P226, DOI 10.7205/MILMED-D-16-00042; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wood GW, 2013, INJURY PREV, V19, P19, DOI 10.1136/injuryprev-2011-040277; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	147	22	23	1	17	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	FEB	2018	140	2			SI				020806	10.1115/1.4038710			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	FV9NY	WOS:000424916500008	29222564				2022-02-06	
J	Hui, B; Zhang, LP; Zhou, QH; Hui, L				Hui, Bin; Zhang, Liping; Zhou, Qinhua; Hui, Ling			Pristimerin Inhibits LPS-Triggered Neurotoxicity in BV-2 Microglia Cells Through Modulating IRAK1/TRAF6/TAK1-Mediated NF-kappa B and AP-1 Signaling Pathways In Vitro	NEUROTOXICITY RESEARCH			English	Article						Pristimerin; Neuroinflammation; Neurotoxicity; IRAK1; TRAF6; TAK1	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; PROINFLAMMATORY CYTOKINES; ACTIVATED MICROGLIA; MURINE MACROPHAGES; NEURONAL DEATH; EXPRESSION; RESPONSES; KINASES; SYSTEM	Microglia plays a prominent role in the brain's inflammatory response to injury or infection by migrating to affected locations and secreting inflammatory molecules. However, hyperactivated microglial is neurotoxic and plays critical roles in the pathogenesis of neurodegenerative diseases. Pristimerin, a naturally occurring triterpenoid, possesses antitumor, antioxidant, and anti-inflammatory activities. However, the effect and the molecular mechanism of pristimerin against lipopolysaccharide (LPS)-induced neurotoxicity in microglia remain to be revealed. In the present study, using BV-2 microglial cultures, we investigated whether pristimerin modifies neurotoxicity after LPS stimulation and which intracellular pathways are involved in the effect of pristimerin. Here we show that pristimerin markedly suppressed the release of Regulated on Activation, Normal T Expressed and Secreted (RANTES), transforming growth factor-beta 1 (TGF-beta 1), IL-6, tumor necrosis factor-alpha (TNF-alpha), and nitric oxide (NO). Pristimerin also significantly inhibited migration of BV-2 microglia and alleviated the death of neuron-like PC12 cell induced by the conditioned medium from LPS-activated BV-2 microglial cells. Moreover, pristimerin reduced the expression and interaction of TNF Receptor-Associated Factor 6 (TRAF6) and Interleukin-1 Receptor-Associated Kinases (IRAK1), limiting TGF-beta activating kinase 1 (TAK1) activation, and resulting in an inhibition of IKK alpha/beta/NF-kappa B and MKK7/JNK/AP-1 signaling pathway in LPS-activated BV-2 microglia. Taken together, the anti-neurotoxicity action of pristimerin is mediated through the inhibition of TRAF6/IRAK1/TAK1 interaction as well as the related pathways: IKK alpha/beta/NF-kappa B and MKK7/JNK/AP-1 signaling pathways. These findings may suggest that pristimerin might serve as a new therapeutic agent for treating hyperactivated microglial induced neurodegenerative diseases.	[Hui, Bin; Zhou, Qinhua] Shanghai Univ Med Hlth Sci, Coll Pharm, Shanghai, Peoples R China; [Zhang, Liping] Shanghai Jiao Tong Univ, Dept Emergency Med, Peoples Hosp 6, Shanghai, Peoples R China; [Zhou, Qinhua] Jiaxing Univ, Dept Pharmacol, Coll Med, Jiaxing, Peoples R China; [Hui, Ling] Lanzhou Gen Hosp, Lanzhou Mil Command, Ctr Med Expt, Lanzhou, Gansu, Peoples R China		Zhou, QH (corresponding author), Shanghai Univ Med Hlth Sci, Coll Pharm, Shanghai, Peoples R China.; Zhou, QH (corresponding author), Jiaxing Univ, Dept Pharmacol, Coll Med, Jiaxing, Peoples R China.	zhouqh2016@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372177] Funding Source: Medline; Foundation of Shanghai University of Medicine &amp; Health Sciences [JW-2014ZZBJ-px(YX)-GY01] Funding Source: Medline; Shanghai University of Medicine &amp; Health Sciences [HMSF-16-21-007] Funding Source: Medline		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bellezza I, 2013, MOL IMMUNOL, V54, P347, DOI 10.1016/j.molimm.2013.01.003; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chen CJ, 2004, BIOCHEM PHARMACOL, V67, P957, DOI 10.1016/j.bcp.2003.10.010; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cianciulli A, 2016, INT IMMUNOPHARMACOL, V36, P282, DOI 10.1016/j.intimp.2016.05.007; Cui Y, 2015, KOREAN J PHYSIOL PHA, V19, P219, DOI 10.4196/kjpp.2015.19.3.219; Cui YJ, 2012, EUR J PHARMACOL, V690, P4, DOI 10.1016/j.ejphar.2012.05.041; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Haas AH, 2008, GLIA, V56, P888, DOI 10.1002/glia.20663; Deng QD, 2015, INT IMMUNOPHARMACOL, V29, P302, DOI 10.1016/j.intimp.2015.11.001; Dirsch VM, 1997, EUR J PHARMACOL, V336, P211, DOI 10.1016/S0014-2999(97)01245-4; Drouin-Ouellet J, 2012, TRENDS PHARMACOL SCI, V33, P542, DOI 10.1016/j.tips.2012.07.002; dos Santos VADFM, 2010, MOLECULES, V15, P6956, DOI 10.3390/molecules15106956; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Gatheral T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042386; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; He Q, 2014, NEUROTOX RES, V26, P430, DOI 10.1007/s12640-014-9487-7; He W, 1998, BIOORG MED CHEM LETT, V8, P3659, DOI 10.1016/S0960-894X(98)00671-4; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hui B, 2008, J NEUROSCI RES, V86, P1169, DOI 10.1002/jnr.21566; [惠斌 Hui Bin], 2003, [中国药理学通报, Chinese Pharmacological Bulletin], V19, P656; Hui B, 2014, INT IMMUNOPHARMACOL, V21, P501, DOI 10.1016/j.intimp.2014.06.010; Hurley LL, 2013, NEUROTOX RES, V23, P131, DOI 10.1007/s12640-012-9348-1; Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78; Kang G, 2004, J PHARMACOL SCI, V94, P325, DOI 10.1254/jphs.94.325; Kim EA, 2014, INT IMMUNOPHARMACOL, V22, P73, DOI 10.1016/j.intimp.2014.06.022; Kim HJ, 2013, ARCH PHARM RES, V36, P495, DOI 10.1007/s12272-013-0054-1; Kim JS, 2006, PLANTA MED, V72, P65, DOI 10.1055/s-2005-873145; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Lee KW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-196; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lopez MR, 2011, PLANTA MED, V77, P726, DOI 10.1055/s-0030-1250500; Louboutin JP, 2013, CNS NEUROL DISORD-DR, V12, P815, DOI 10.2174/18715273113126660173; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Luo DQ, 2005, PEST MANAG SCI, V61, P85, DOI 10.1002/ps.953; Ma L, 2017, INT J MOL MED, V40, P31, DOI 10.3892/ijmm.2017.2987; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Morita H, 2008, BIOORG MED CHEM LETT, V18, P1050, DOI 10.1016/j.bmcl.2007.12.016; Nakamichi K, 2010, INT J NEUROSCI, V120, P252, DOI 10.3109/00207451003615763; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; SARGENT JM, 1989, BRIT J CANCER, V60, P206, DOI 10.1038/bjc.1989.252; Suk K, 2003, J PHARMACOL EXP THER, V305, P638, DOI 10.1124/jpet.102.047373; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Von Bernhardi R, 2007, NEUROTOX RES, V12, P215, DOI 10.1007/BF03033906; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Wu CC, 2005, MOL CANCER THER, V4, P1277, DOI 10.1158/1535-7163.MCT-05-0027; Yoshioka Y, 2010, J PHARMACOL SCI, V113, P153, DOI 10.1254/jphs.10060FP; Yousef BA, 2016, ANTICANCER POTENTIAL; Yousef BA, 2016, ONCOL REP, V35, P1091, DOI 10.3892/or.2015.4457; Zeng KW, 2015, J CELL BIOCHEM, V116, P1286, DOI 10.1002/jcb.25084; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	58	22	25	2	41	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	FEB	2018	33	2					268	283		10.1007/s12640-017-9837-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS8DN	WOS:000422640700005	29119451				2022-02-06	
J	Motes, MA; Yezhuvath, US; Aslan, S; Spence, JS; Rypma, B; Chapman, SB				Motes, Michael A.; Yezhuvath, Uma S.; Aslan, Sina; Spence, Jeffrey S.; Rypma, Bart; Chapman, Sandra B.			Higher-order cognitive training effects on processing speed-related neural activity: a randomized trial	NEUROBIOLOGY OF AGING			English	Article						Aging; Cognitive training; Reasoning; Processing speed; Neuroplasticity; fMRI; DSVT; Exercise	TRAUMATIC BRAIN-INJURY; ADULT AGE-DIFFERENCES; PREFRONTAL CORTEX; WORKING-MEMORY; METAANALYSIS; EXERCISE; FITNESS; GAINS; TASK	Higher-order cognitive training has shown to enhance performance in older adults, but the neural mechanisms underlying performance enhancement have yet to be fully disambiguated. This randomized trial examined changes in processing speed and processing speed-related neural activity in older participants (57-71 years of age) who underwent cognitive training (CT, N = 12) compared with wait-listed (WLC, N = 15) or exercise-training active (AC, N = 14) controls. The cognitive training taught cognitive control functions of strategic attention, integrative reasoning, and innovation over 12 weeks. All 3 groups worked through a functional magnetic resonance imaging processing speed task during 3 sessions (baseline, mid-training, and post-training). Although all groups showed faster reaction times (RTs) across sessions, the CT group showed a significant increase, and the WLC and AC groups showed significant decreases across sessions in the association between RT and BOLD signal change within the left prefrontal cortex (PFC). Thus, cognitive training led to a change in processing speed-related neural activity where faster processing speed was associated with reduced PFC activation, fitting previously identified neural efficiency profiles. (C) 2017 The Authors. Published by Elsevier Inc.	[Motes, Michael A.; Aslan, Sina; Spence, Jeffrey S.; Rypma, Bart; Chapman, Sandra B.] Univ Texas Dallas, Ctr BrainHlth, 2200 West Mockingbird Lane, Dallas, TX 75235 USA; [Yezhuvath, Uma S.; Aslan, Sina] Adv MRI LLC, Frisco, TX USA		Chapman, SB (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 West Mockingbird Lane, Dallas, TX 75235 USA.	schapman@utdallas.edu		Motes, Michael/0000-0001-6635-6948	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RC1-AG035954, R01-NS067015, R01-AG033106]; Lyda Hill Foundation; T. Boone Pickens Foundation; Dee Wyly Distinguished University Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033106, RC1AG035954] Funding Source: NIH RePORTER	This work was supported by a grant from the National Institutes of Health (RC1-AG035954, 2009; R01-NS067015, 2010; R01-AG033106; 2009) and by grants from the Lyda Hill Foundation, T. Boone Pickens Foundation, and the Dee Wyly Distinguished University Endowment.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Baniqued PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142169; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Biswal BB, 2010, CEREB CORTEX, V20, P2188, DOI 10.1093/cercor/bhp284; Brehmer Y, 2011, NEUROIMAGE, V58, P1110, DOI 10.1016/j.neuroimage.2011.06.079; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; BUCKHALT JA, 1991, PERS INDIV DIFFER, V12, P683, DOI 10.1016/0191-8869(91)90223-X; Chapman S.B., 2014, MAKE YOUR BRAIN SMAR; Chapman SB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00338; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Chapman SB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00069; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; EARLES JL, 1995, J GERONTOL B-PSYCHOL, V50, pP33, DOI 10.1093/geronb/50B.1.P33; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Ekstrom R.B., 1979, MULTIVARIATE BEHAV R, V79, P8; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Heinzel S, 2016, NEUROIMAGE, V134, P236, DOI 10.1016/j.neuroimage.2016.03.068; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; JENSEN AR, 1992, PERS INDIV DIFFER, V13, P869, DOI 10.1016/0191-8869(92)90004-9; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Kannurpatti SS, 2011, HUM BRAIN MAPP, V32, P1125, DOI 10.1002/hbm.21097; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Mackey AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137627; Motes MA, 2014, BRAIN COGNITION, V84, P44, DOI 10.1016/j.bandc.2013.10.007; Motes MA, 2011, COGN NEUROSCI-UK, V2, P1, DOI 10.1080/17588928.2010.512974; Motes MA, 2010, NEUROIMAGE, V49, P1933, DOI 10.1016/j.neuroimage.2009.08.054; Mudar RA, 2017, INT J GERIATR PSYCH, V32, P548, DOI 10.1002/gps.4492; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Rao NK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00840; Rosano C, 2010, J GERONTOL A-BIOL, V65, P639, DOI 10.1093/gerona/glq038; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Rypma B, 2009, INTELLIGENCE, V37, P207, DOI 10.1016/j.intell.2008.12.004; Salthouse T.A., 1991, THEORETICAL PERSPECT; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SALTHOUSE TA, 1992, J GERONTOL, V47, pP121, DOI 10.1093/geronj/47.3.P121; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Venza EE, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01676; Voelcker-Rehage C, 2013, NEUROSCI BIOBEHAV R, V37, P2268, DOI 10.1016/j.neubiorev.2013.01.028; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Wechsler D., 2008, WECHSLER ADULT INTEL; Yezhuvath US, 2012, NEUROBIOL AGING, V33, P75, DOI 10.1016/j.neurobiolaging.2010.02.005; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005	54	22	23	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	FEB	2018	62						72	81		10.1016/j.neurobiolaging.2017.10.003			10	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	FQ6MM	WOS:000418478600007	29121545	hybrid, Green Accepted			2022-02-06	
J	Uccella, L; Zoia, C; Bongetta, D; Gaetani, P; Martig, F; Candrian, C; Rosso, R				Uccella, Laura; Zoia, Cesare; Bongetta, Daniele; Gaetani, Paolo; Martig, Franz; Candrian, Christian; Rosso, Raffaele			Are Antiplatelet and Anticoagulants Drugs A Risk Factor for Bleeding in Mild Traumatic Brain Injury?	WORLD NEUROSURGERY			English	Article						Blood coagulation; Brain trauma; Clopidogrel; Head CT scan; Rivaroxaban	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; PREINJURY CLOPIDOGREL; WARFARIN; OUTCOMES; THERAPY; MANAGEMENT; SCAN; RULE	OBJECTIVE: Facing mild traumatic brain injury, clinicians must decide whether to perform a computed tomography (CT) scan to detect a potential intracranial hemorrhage. Many useful guidelines have been developed for the general population, but there is no general consensus about the best practice to adopt when dealing with patients on antiplatelet or anticoagulation drugs. The relatively recent introduction of new anticoagulants and second-generation antiplatelet drugs poses new challenges in this field. There are no data in the literature about the relative risk of intracranial bleeding in such categories. METHODS: We enrolled 2773 consecutive patients presenting at our emergency department with mild traumatic brain injury as chief complaint and evaluated the results of their head CT scans, stratifying their anticoagulation and/or antiplatelet drug regime. RESULTS: Of these patients, 1608 matched the criteria for head CT scan and had a Glasgow Coma Scale (GCS) score of 15; 517 were on antiplatelet drugs, whereas 213 were on anticoagulants. The risk of developing intracranial bleeding was significantly higher for patients on antiplatelet drugs, whereas the risk of anticoagulated patients overlapped with that of the general population. The trend for second-generation drugs was of higher risk of bleeding only for antiplatelets. CONCLUSIONS: Patients with a GCS score of 15 on long-term anticoagulation therapy seem to be at no higher risk for intracranial hemorrhage than are nonanticoagulated patients. On the contrary, patients with a GCS score of 15 on antiplatelet therapy seem to be more prone to developing intracranial bleeding than are the general population, with a trend to be more at risk when it comes to second-generation drugs.	[Uccella, Laura; Martig, Franz; Candrian, Christian; Rosso, Raffaele] Civ Hosp, Dept Surg & Orthopaed, Lugano, Switzerland; [Zoia, Cesare; Bongetta, Daniele; Gaetani, Paolo] Fdn IRCCS Policlin S Matteo, Dept Neurosurg, Pavia, Italy; [Bongetta, Daniele] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy		Uccella, L (corresponding author), Civ Hosp, Dept Surg & Orthopaed, Lugano, Switzerland.	laura.uccella@eoc.ch	Zoia, Cesare/B-8463-2015; uccella, laura/ABD-2621-2021; Zoia, Cesare/ABE-5286-2020	Zoia, Cesare/0000-0001-7304-6120; uccella, laura/0000-0002-5401-8703; Zoia, Cesare/0000-0001-7304-6120; Candrian, Christian/0000-0002-3543-981X			Barratt H, 2010, EMERG MED J, V27, P173, DOI 10.1136/emj.2009.075382; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Centers for Disease Control and Prevention, 2014, REP C TRAUM BARIN IN; Cull JD, 2015, AM SURGEON, V81, P128; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Garcia DA, 2011, J FAM PRACTICE, V60, P70; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Michelson AD, 2006, EUR HEART J SUPPL, V8, pG53, DOI 10.1093/eurheartj/sul056; NICEeNational Institute for Health and Care, EXC GUID; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Schoonman GG, 2014, EUR J NEUROL, V21, P1021, DOI 10.1111/ene.12429; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393	24	22	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E339	E345		10.1016/j.wneu.2017.10.173			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900047	29129761				2022-02-06	
J	Bhowmick, S; D'Mello, V; Ponery, N; Abdul-Muneer, PM				Bhowmick, Saurav; D'Mello, Veera; Ponery, Nizmi; Abdul-Muneer, P. M.			Neurodegeneration and Sensorimotor Deficits in the Mouse Model of Traumatic Brain Injury	BRAIN SCIENCES			English	Article						traumatic brain injury; fluid percussion injury; neurodegeneration; apoptosis; sensorimotor deficit	NEUROINFLAMMATION; CLEAVAGE; GROWTH; CONNECTIVITY; EPIDEMIOLOGY; INFLAMMATION; ACTIVATION; INHIBITOR; APOPTOSIS; RECOVERY	Traumatic brain injury (TBI) can result in persistent sensorimotor and cognitive deficits, which occur through a cascade of deleterious pathophysiological events over time. In this study, we investigated the hypothesis that neurodegeneration caused by TBI leads to impairments in sensorimotor function. TBI induces the activation of the caspase-3 enzyme, which triggers cell apoptosis in an in vivo model of fluid percussion injury (FPI). We analyzed caspase-3 mediated apoptosis by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining and poly (ADP-ribose) polymerase (PARP) and annexin V western blotting. We correlated the neurodegeneration with sensorimotor deficits by conducting the animal behavioral tests including grid walk, balance beam, the inverted screen test, and the climb test. Our study demonstrated that the excess cell death or neurodegeneration correlated with the neuronal dysfunction and sensorimotor impairments associated with TBI.	[Bhowmick, Saurav; D'Mello, Veera; Ponery, Nizmi; Abdul-Muneer, P. M.] JFK Med Ctr, Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA		Abdul-Muneer, PM (corresponding author), JFK Med Ctr, Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA.	Sbhowmick@jfkhealth.org; veeradmello@gmail.com; nizmi.ponery@gmail.com; mmuneer@jfkhealth.org	Bhowmick, Saurav/Y-6011-2019	Abdul-Muneer, P. M/0000-0001-8231-4385	Neuroscience Institute at JFK Medical Center, Edison	This work was funded by the Neuroscience Institute at JFK Medical Center, Edison NJ to P.M. Abdul-Muneer.	Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abdul-Muneer P.M., 2017, MOL NEUROBIOL, DOI [10. 1007/s12035-017-0811-0 29128903, DOI 10.1007/S12035-017-0811-029128903]; Abdul-Muneer P.M., 2017, MOL NEUROBIOL, DOI [10. 1007/s12035-017-0812-z 29119534, DOI 10.1007/S12035-017-0812-Z29119534]; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Cardo-Vila M, 2003, MOL CELL, V11, P1151, DOI 10.1016/S1097-2765(03)00138-2; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; DEACON RMJ, 2013, JOVE J VIS EXP JUN, DOI DOI 10.3791/2610; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEVASSEUR JE, 1989, J NEUROSURG, V71, P573, DOI 10.3171/jns.1989.71.4.0573; Luong T.N., 2011, JOVE-J VIS EXP, V10, DOI [10. 3791/2376 21445033, DOI 10.3791/237621445033]; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Muneer PMA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-23; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Ohtake Y, 2014, BIOMATERIALS, V35, P4610, DOI 10.1016/j.biomaterials.2014.02.037; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; POSNER MI, 1984, J NEUROSCI, V4, P1863; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; PROTAIS P, 1976, PSYCHOPHARMACOLOGY, V50, P1, DOI 10.1007/BF00634146; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Shin YS, 2014, NEUROTOXICOLOGY, V40, P111, DOI 10.1016/j.neuro.2013.12.006; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2	51	22	22	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JAN	2018	8	1							11	10.3390/brainsci8010011			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FU8IV	WOS:000424097400011	29316623	gold, Green Submitted, Green Published			2022-02-06	
J	Chesnut, RM; Temkin, N; Dikmen, S; Rondina, C; Videtta, W; Petroni, G; Lujan, S; Alanis, V; Falcao, A; de la Fuenta, G; Gonzalez, L; Jibaja, M; Lavarden, A; Sandi, F; Merida, R; Romero, R; Pridgeon, J; Barber, J; Machamer, J; Chaddock, K				Chesnut, Randall M.; Temkin, Nancy; Dikmen, Sureyya; Rondina, Carlos; Videtta, Walter; Petroni, Gustavo; Lujan, Silvia; Alanis, Victor; Falcao, Antonio; de la Fuenta, Gustavo; Gonzalez, Luis; Jibaja, Manuel; Lavarden, Arturo; Sandi, Freddy; Merida, Roberto; Romero, Ricardo; Pridgeon, Jim; Barber, Jason; Machamer, Joan; Chaddock, Kelley			A Method of Managing Severe Traumatic Brain Injury in the Absence of Intracranial Pressure Monitoring: The Imaging and Clinical Examination Protocol	JOURNAL OF NEUROTRAUMA			English	Article						global health; intracranial hypertension; intracranial pressure monitoring; neurocritical care; severe traumatic brain injury	SEVERE HEAD-INJURY; CARE MANAGEMENT; UNITED-STATES; TRIALS	The imaging and clinical examination (ICE) algorithm used in the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure (BEST TRIP) randomized controlled trial is the only prospectively investigated clinical protocol for traumatic brain injury management without intracranial pressure (ICP) monitoring. As the default literature standard, it warrants careful evaluation. We present the ICE protocol in detail and analyze the demographics, outcome, treatment intensity, frequency of intervention usage, and related adverse events in the ICE-protocol cohort. The 167 ICE protocol patients were young (median 29 years) with a median Glasgow Coma Scale motor score of 4 but with anisocoria or abnormal pupillary reactivity in 40%. This protocol produced outcomes not significantly different from those randomized to the monitor-based protocol (favorable 6-month extended Glasgow Outcome Score in 39%; 41% mortality rate). Agents commonly employed to treat suspected intracranial hypertension included low-/moderate-dose hypertonic saline (72%) and mannitol (57%), mild hyperventilation (adjusted partial pressure of carbon dioxide 30-35mm Hg in 73%), and pressors to maintain cerebral perfusion (62%). High-dose hyperosmotics or barbiturates were uncommonly used. Adverse event incidence was low and comparable to the BEST TRIP monitored group. Although this protocol should produce similar/acceptable results under circumstances comparable to those in the trial, influences such as longer pre-hospital times and non-specialist transport personnel, plus an intensive care unit model of aggressive physician-intensive care by small groups of neurotrauma-focused intensivists, which differs from most high-resource models, support caution in expecting the same results in dissimilar settings. Finally, this protocol's ICP-titration approach to suspected intracranial hypertension (vs. crisis management for monitored ICP) warrants further study.	[Chesnut, Randall M.; Temkin, Nancy; Dikmen, Sureyya; Pridgeon, Jim; Barber, Jason; Machamer, Joan; Chaddock, Kelley] Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA; [Rondina, Carlos; Petroni, Gustavo; Lujan, Silvia] Hosp Emergencia Dr Clemente Alvarez, Rosario, Santa Fe, Argentina; [Videtta, Walter] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Alanis, Victor] Hosp San Juan Dios, Santa Cruz, Bolivia; [Falcao, Antonio] Hosp Clin Unicamp, Campinas, SP, Brazil; [Petroni, Gustavo] Hosp Japones, Santa Cruz, Bolivia; [Gonzalez, Luis] Hosp Luis Vernaza, Guayaquil, Ecuador; [Jibaja, Manuel] Hosp Eugenio Espejo, Quito, Ecuador; [Lavarden, Arturo] Hosp Viedma, Cochabamba, Bolivia; [Sandi, Freddy] Hosp Obrero 1 La Paz, La Paz, Bolivia; [Merida, Roberto] Hosp San Juan Dios, Tarija, Bolivia; [Romero, Ricardo] Fdn Clin Campbell, Barranquilla, Colombia		Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Mailstop 359766,325 Ninth Ave, Seattle, WA 98104 USA.	chesnutr@u.washington.edu		Chesnut, Randall/0000-0001-6377-3666; Falcao, Antonio/0000-0002-1630-7889; ROMERO FIGUEROA, RICARDO LUIS/0000-0002-3124-8717	Integra LifeSciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS080648] Funding Source: NIH RePORTER	Integra LifeSciences donated the ICP monitoring catheters and monitors and provided additional unrestricted support for the parent study. Integra had no role in study design or conduct, data analysis, or the writing of any manuscripts.	Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; TEASDALE G, 1974, LANCET, V2, P81; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Young Jeffrey S, 2003, Neurosurg Focus, V15, pE2	21	22	22	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					54	63		10.1089/neu.2016.4472			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700008	28726590	Green Published, Green Submitted			2022-02-06	
J	De Simoni, S; Jenkins, PO; Bourke, NJ; Fleminger, JJ; Hellyer, PJ; Jolly, AE; Patel, MC; Cole, JH; Leech, R; Sharp, DJ				De Simoni, Sara; Jenkins, Peter O.; Bourke, Niall J.; Fleminger, Jessica J.; Hellyer, Peter J.; Jolly, Amy E.; Patel, Maneesh C.; Cole, James H.; Leech, Robert; Sharp, David J.			Altered caudate connectivity is associated with executive dysfunction after traumatic brain injury	BRAIN			English	Article						traumatic brain injury; functional connectivity; executive dysfunction; corticostriatal; anterior cingulate cortex	DEFAULT MODE NETWORK; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; HUMAN CONNECTOME PROJECT; POSTERIOR CINGULATE CORTEX; RESTING-STATE FMRI; BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; COGNITIVE CONTROL; HUMAN STRIATUM; SUBCORTICAL CONTRIBUTIONS	Traumatic brain injury often produces executive dysfunction. This characteristic cognitive impairment often causes long-term problems with behaviour and personality. Frontal lobe injuries are associated with executive dysfunction, but it is unclear how these injuries relate to corticostriatal interactions that are known to play an important role in behavioural control. We hypothesized that executive dysfunction after traumatic brain injury would be associated with abnormal corticostriatal interactions, a question that has not previously been investigated. We used structural and functional MRI measures of connectivity to investigate this. Corticostriatal functional connectivity in healthy individuals was initially defined using a data-driven approach. A constrained independent component analysis approach was applied in 100 healthy adult dataset from the Human Connectome Project. Diffusion tractography was also performed to generate white matter tracts. The output of this analysis was used to compare corticostriatal functional connectivity and structural integrity between groups of 42 patients with traumatic brain injury and 21 age-matched controls. Subdivisions of the caudate and putamen had distinct patterns of functional connectivity. Traumatic brain injury patients showed disruption to functional connectivity between the caudate and a distributed set of cortical regions, including the anterior cingulate cortex. Cognitive impairments in the patients were mainly seen in processing speed and executive function, as well as increased levels of apathy and fatigue. Abnormalities of caudate functional connectivity correlated with these cognitive impairments, with reductions in right caudate connectivity associated with increased executive dysfunction, information processing speed and memory impairment. Structural connectivity, measured using diffusion tensor imaging between the caudate and anterior cingulate cortex was impaired and this also correlated with measures of executive dysfunction. We show for the first time that altered subcortical connectivity is associated with large-scale network disruption in traumatic brain injury and that this disruption is related to the cognitive impairments seen in these patients.	[De Simoni, Sara; Jenkins, Peter O.; Bourke, Niall J.; Fleminger, Jessica J.; Jolly, Amy E.; Cole, James H.; Leech, Robert; Sharp, David J.] Imperial Coll London, Div Brain Sci, Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, London, England; [Hellyer, Peter J.] Imperial Coll London, Dept Bioengn, London, England; [Patel, Maneesh C.] Charing Cross Hosp, Dept Imaging, London, England		De Simoni, S (corresponding author), Imperial Coll London, Dept Med, Div Brain Sci, C3NL, Du Cane Rd, London W12 0NN, England.	s.de-simoni@imperial.ac.uk	Hellyer, Peter J/F-7112-2013; Sharp, David J/A-2119-2013; Leech, Robert/AAE-8254-2019; Cole, James H/I-5197-2019	Hellyer, Peter J/0000-0002-5139-3401; Leech, Robert/0000-0002-5801-6318; Cole, James H/0000-0003-1908-5588; Jolly, Amy/0000-0002-7413-9772; Fleminger, Jessica/0000-0002-5744-5137	National Institute of Health Research Professorship [NIHR-RP-011-048]; NIHR CRF and BRC at Imperial College Healthcare NHS Trust; Guarantors of Brain Clinical Fellowship; Medical Research Council through a Clinician Scientist FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L022141/1, 1110783] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-011-048] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/L022141/1] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U54MH091657] Funding Source: NIH RePORTER	This paper presents independent research funded by a National Institute of Health Research Professorship (NIHR-RP-011-048) awarded to D.J.S. and supported by the NIHR CRF and BRC at Imperial College Healthcare NHS Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. P.O.J. is funded by Guarantors of Brain Clinical Fellowship. The research was also supported the Medical Research Council through a Clinician Scientist Fellowship awarded to D.J.S.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alsady TM, 2016, HUM BRAIN MAPP, V37, P3544, DOI 10.1002/hbm.23258; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Barnes KA, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00018; Bell PT, 2016, NEUROSCI BIOBEHAV R, V71, P313, DOI 10.1016/j.neubiorev.2016.08.036; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Casey BJ, 2007, AM J PSYCHIAT, V164, P1729, DOI 10.1176/appi.ajp.2007.06101754; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Delis DC., 2001, DELIS KAPLAN EXECUTI; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Geranmayeh F, 2014, J NEUROSCI, V34, P8728, DOI 10.1523/JNEUROSCI.0428-14.2014; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gordon EM, 2015, CEREB CORTEX, V25, P336, DOI 10.1093/cercor/bht229; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Ham TE, 2013, CEREB CORTEX, V23, P703, DOI 10.1093/cercor/bhs056; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KUNISHIO K, 1994, J COMP NEUROL, V350, P337, DOI 10.1002/cne.903500302; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; McColgan P, 2015, BRAIN, V138, DOI 10.1093/brain/awv259; Mennes Maarten, 2011, Front Psychiatry, V2, P83, DOI 10.3389/fpsyt.2011.00083; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Pauli WM, 2016, P NATL ACAD SCI USA, V113, P1907, DOI 10.1073/pnas.1507610113; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Su TW, 2013, SCHIZOPHR RES, V148, P50, DOI 10.1016/j.schres.2013.05.005; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Unschuld PG, 2012, NEUROSCI LETT, V514, P204, DOI 10.1016/j.neulet.2012.02.095; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; YETERIAN EH, 1978, BRAIN RES, V139, P43, DOI 10.1016/0006-8993(78)90059-8	69	22	22	2	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2018	141		1				148	164		10.1093/brain/awx309			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FS2PD	WOS:000419619700023	29186356	hybrid, Green Published			2022-02-06	
J	Folkerson, LE; Sloan, D; Davis, E; Kitagawa, RS; Cotton, BA; Holcomb, JB; Tomasek, JS; Wade, CE				Folkerson, Lindley E.; Sloan, Duncan; Davis, Elizabeth; Kitagawa, Ryan S.; Cotton, Bryan A.; Holcomb, John B.; Tomasek, Jeffrey S.; Wade, Charles E.			Coagulopathy as a predictor of mortality after penetrating traumatic brain injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Coagulopathy; Penetrating brain injury; Rapid thrombelastography; Traumatic brain injury	CIVILIAN GUNSHOT WOUNDS; GLASGOW COMA SCALE; HEAD-INJURIES; PROGNOSTIC-FACTORS; THROMBELASTOGRAPHY; RESUSCITATION; LEVEL; SCORE	Study hypothesis: Traumatic brain injury (TBI) is a leading cause ofmortalitywith penetrating TBI (p-TBI) patients having worse outcomes. These patients are more likely to be coagulopathic than blunt TBI (b-TBI) patients, thus we hypothesize that coagulopathy would be an early predictor of mortality. Methods: We identified highest-level trauma activation patients who underwent an admission head CT and had ICU admission orders from August 2009-May 2013, excluding those with polytrauma and anticoagulant use. Rapid thrombelastography (rTEG) was obtained after emergency department (ED) arrival and coagulopathy was defined as follows: ACT = 128 s, KT = 2.5 s, angle = 56 degrees, MA = 55 mm, LY-30 = 3.0% or platelet count = 150,000/mu L. Regression modeling was used to assess the association of coagulopathy on mortality. Results: 1086 patients with head CT scans performed and ICU admission orders were reviewed. After exclusion criteria were met, 347 patients with isolated TBI were analyzed-99 (29%) with p-TBI and 248 (71%) with bTBI. Patients with p-TBI had a highermortality (41% vs. 10%, p < 0.0001) and a greater incidence of coagulopathy (64% vs. 51%, p < 0.003). After dichotomizing p-TBI patients by mortality, patients who died were younger and were more coagulopathic. When adjusting for factors available on ED arrival, coagulopathy was found to be an early predictor of mortality (OR 3.99, 95% CI 1.37, 11.72, p-value = 0.012). Conclusions: This study demonstrates that p-TBI patients with significant coagulopathy have a poor prognosis. Coagulopathy, in conjunction with other factors, can be used to earlier identify p-TBI patients with worse outcomes and represents a possible area for intervention. (C) 2017 Published by Elsevier Inc.	[Folkerson, Lindley E.; Sloan, Duncan; Davis, Elizabeth; Cotton, Bryan A.; Holcomb, John B.; Tomasek, Jeffrey S.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, 6431 Fannin St,MSB 5-204, Houston, TX 77030 USA; [Folkerson, Lindley E.; Sloan, Duncan; Davis, Elizabeth; Cotton, Bryan A.; Holcomb, John B.; Tomasek, Jeffrey S.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Kitagawa, Ryan S.] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, Houston, TX 77030 USA; [Folkerson, Lindley E.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA		Wade, CE (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, 6431 Fannin St,MSB 5-204, Houston, TX 77030 USA.	Charles.E.Wade@uth.tmc.edu		holcomb, john/0000-0001-8312-9157	State of Texas Emerging Technology Fund; University of Texas Health Science Center's Center for Translational Injury Research	Support for this work was provided by The State of Texas Emerging Technology Fund and The University of Texas Health Science Center's Center for Translational Injury Research.	ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Faul M, 2010, TRAUMATIC BRAIN INJU; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Johansson PI, 2013, TRANSFUSION, V53, P3088, DOI 10.1111/trf.12214; Johansson PI, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-45; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sixta SL, 2012, INT J BURNS TRAUMA, V2, P158; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tapia NM, 2013, J TRAUMA ACUTE CARE, V74, P378, DOI 10.1097/TA.0b013e31827e20e0; The American College of Surgeons Trauma Quality Improvement Program, 2015, ACS TQIP BEST PRACT; Valadka AB, 2000, J TRAUMA, V48, P296, DOI 10.1097/00005373-200002000-00017; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53	31	22	22	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JAN	2018	36	1					38	42		10.1016/j.ajem.2017.06.057			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FP5CZ	WOS:000417638100008	28764996				2022-02-06	
J	Hanley, D; Prichep, LS; Badjatia, N; Bazarian, J; Chiacchierini, R; Curley, KC; Garrett, J; Jones, E; Naunheim, R; O'Neil, B; O'Neill, J; Wright, DW; Huff, JS				Hanley, Daniel; Prichep, Leslie S.; Badjatia, Neeraj; Bazarian, Jeffrey; Chiacchierini, Richard; Curley, Kenneth C.; Garrett, John; Jones, Elizabeth; Naunheim, Rosanne; O'Neil, Brian; O'Neill, John; Wright, David W.; Huff, J. Stephen			A Brain Electrical Activity Electroencephalographic-Based Biomarker of Functional Impairment in Traumatic Brain Injury: A Multi-Site Validation Trial	JOURNAL OF NEUROTRAUMA			English	Article						brain electrical activity; concussion; ED triage; EEG; functional impairment; mTBI; TBI	COLLEGIATE FOOTBALL PLAYERS; CONCUSSION; RECOVERY; CLASSIFICATION; 1ST	The potential clinical utility of a novel quantitative electroencephalographic (EEG)-based Brain Function Index (BFI) as a measure of the presence and severity of functional brain injury was studied as part of an independent prospective validation trial. The BFI was derived using quantitative EEG (QEEG) features associated with functional brain impairment reflecting current consensus on the physiology of concussive injury. Seven hundred and twenty adult patients (18-85 years of age) evaluated within 72h of sustaining a closed head injury were enrolled at 11 U.S. emergency departments (EDs). Glasgow Coma Scale (GCS) score was 15 in 97%. Standard clinical evaluations were conducted and 5 to 10min of EEG acquired from frontal locations. Clinical utility of the BFI was assessed for raw scores and percentile values. A multinomial logistic regression analysis demonstrated that the odds ratios (computed against controls) of the mild and moderate functionally impaired groups were significantly different from the odds ratio of the computed tomography (CT) postive (CT+, structural injury visible on CT) group (p=0.0009 and p=0.0026, respectively). However, no significant differences were observed between the odds ratios of the mild and moderately functionally impaired groups. Analysis of variance (ANOVA) demonstrated significant differences in BFI among normal (16.8%), mild TBI (mTBI)/concussed with mild or moderate functional impairment, (61.3%), and CT+ (21.9%) patients (p<0.0001). Regression slopes of the odds ratios for likelihood of group membership suggest a relationship between the BFI and severity of impairment. Findings support the BFI as a quantitative marker of brain function impairment, which scaled with severity of functional impairment in mTBI patients. When integrated into the clinical assessment, the BFI has the potential to aid in early diagnosis and thereby potential to impact the sequelae of TBI by providing an objective marker that is available at the point of care, hand-held, non-invasive, and rapid to obtain.	[Hanley, Daniel] Johns Hopkins Med Inst, Brain Injury Outcomes, Baltimore, MD 21205 USA; [Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, 1115 Broadway,Room 1082, New York, NY 10010 USA; [Prichep, Leslie S.] BrainScope Co Inc, Bethesda, MD USA; [Badjatia, Neeraj] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Bazarian, Jeffrey] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Chiacchierini, Richard] RP Chiacchierini Consulting LLC, Gaithersburg, MD USA; [Curley, Kenneth C.] Iatrikos Res & Dev Strategies LLC, Tampa, FL USA; [Curley, Kenneth C.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Garrett, John] Baylor Univ, Med Ctr, Dallas, TX USA; [Jones, Elizabeth] Univ Texas Houston, Mem Hermann Hosp, Houston, TX USA; [Naunheim, Rosanne] Washington Univ, Barnes Jewish Med Ctr, St Louis, MO USA; [O'Neil, Brian] Detroit Receiving Hosp & Univ Hlth Ctr, Detroit, MI USA; [O'Neill, John] Allegheny Gen Hosp, Dept Emergency Med, Pittsburgh, PA 15212 USA; [Wright, David W.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Wright, David W.] Grady Mem Hosp, Atlanta, GA USA; [Huff, J. Stephen] Univ Virginia Hlth Syst, Charlottesville, VA USA		Prichep, LS (corresponding author), NYU, Sch Med, Dept Psychiat, 1115 Broadway,Room 1082, New York, NY 10010 USA.	leslie.prichep@nyumc.org	Badjatia, Neeraj/AAS-4855-2021	Hanley, Daniel/0000-0002-9536-4258; Badjatia, Neeraj/0000-0003-1509-9034	U.S ArmyUnited States Department of Defense [W81XWH-14-C-1405]	The authors acknowledge the contributions of all research staff at all the clinical sites and for their efforts toward the conduction of this study, and the patients who volunteer to participate. This study was funded in part by a research contract from the U.S Army, contract #W81XWH-14-C-1405. The views, opinions, and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation. In the conduct of research where humans were the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects).	Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Bigler E., 2014, CONCUSSIONS ATHLETIC, P181; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Creelman, 2005, DETECTION THEORY USE; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; Fakhran S, 2014, FUTUR NEUROL, V9, P517, DOI 10.2217/FNL.14.48; Faul M, 2010, TRAUMATIC BRAIN INJU; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Lemeshow S, 2000, APPL LOGISTIC REGRES; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	34	22	22	0	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					41	47		10.1089/neu.2017.5004			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700006	28599608	Green Submitted			2022-02-06	
J	Johnson, J; Pajarillo, EAB; Taka, E; Reams, R; Son, DS; Aschner, M; Lee, E				Johnson, James, Jr.; Pajarillo, Edward Alain B.; Taka, Equar; Reams, Romonia; Son, Deok-Soo; Aschner, Michael; Lee, Eunsook			Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice	NEUROTOXICOLOGY			English	Article; Proceedings Paper	28th International Neurotoxicology Conference - Manganese Health Effects on Neurodevelopment and Neurodegenerative Diseases (MANGANESE)	SEP 25-28, 2016	Icahn Sch Med Mt Sinai, New York, NY	Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, Int Manganese Inst, Charles River Labs, Int Commiss Occupat Hlth, Soc Toxicol, Elsevier	Icahn Sch Med Mt Sinai	Valproic acid; Sodium butyrate; Glutamate transporters; Manganese; Behavior	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; YIN YANG 1; TRANSCRIPTIONAL REGULATION; NEUROLOGICAL DISORDERS; MOLECULAR PERSPECTIVE; HISTONE DEACETYLASE; ANTIEPILEPTIC DRUGS; HDAC INHIBITORS; MOUSE MODEL	Manganese (Mn) is an essential trace element, but chronic overexposure to this metal, either environmentally or occupationally may cause manganism, a disease analogous to Parkinson's disease. Inhibitors of histone deacetylases, such as valproic acid (VPA) and sodium butyrate (NaB) exert neuroprotective effects in various animal models of neurological disorders. Thus, the present study investigated whether VPA or NaB prevent Mn-induced neurotoxicity by assessing locomotor activities and expression of astrocytic glutamate transporters, glutamate transporter 1 (GLT-1) and glutamate aspartate transporter (GLAST), in C57BL/6 mice. C57BL/6 mice were pretreated with VPA (200 mg/kg, i.p.) or NaB (1200 mg/kg, i.p.) prior to intranasal instillation of Mn (30 mg/kg) continually for 21 days, followed by open-field and rota-rod behavioral tests and analyses of astrocytic glutamate transporters GLT-1 and GLAST protein/mRNA levels. The results showed that Mn significantly decreased locomotor activity as determined by total distance travelled, stereotypic and ambulatory counts. Mn also significantly decreased rota -rod activity reflecting altered motor coordination. Pretreatment with VPA and NaB with Mn reversed the effects of Mn on the locomotor activity and motor coordination. VPA and NaB also attenuated the Mn-induced decrease in GLT-1 and GLAST mRNA and protein levels in the cerebral cortical and cerebellar regions of mice. These results suggest that VPA and NaB exert protective effects against Mn toxicity seem in vitro are also shown in vivo. VPA and NaB pretreatment in mice enhancing astrocytic glutamate transporter GLT-1 expression as well as locomotor activities. Future research endeavors are warranted to determine if the therapeutic potential of VPA and NaB is via common molecular mechanism, namely, inhibition of histone deacetylases. (C) 2017 Published by Elsevier B.V.	[Pajarillo, Edward Alain B.; Taka, Equar; Reams, Romonia; Lee, Eunsook] Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32301 USA; [Johnson, James, Jr.] Meharry Med Coll, Dept Neurosci & Pharmacol, Nashville, TN 37208 USA; [Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA		Lee, E (corresponding author), Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32301 USA.	eunsook.lee@famu.edu	Pajarillo, Edward Alain/ABF-9202-2021	Pajarillo, Edward Alain/0000-0002-5044-7607	 [R01ES024756];  [SC1089630];  [SC1CA200519];  [R01 ES10563];  [1R03ES024849];  [1R21ES025415]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [SC1CA200519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES024756, R21ES025415, R01ES010563, R03ES024849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [SC1GM089630, R25GM059994] Funding Source: NIH RePORTER	The present study has been supported in part by R01ES024756 (EL), SC1089630 (EL), SC1CA200519 (DS), R01 ES10563 (MA), 1R03ES024849 (MA) and 1R21ES025415 (MA).	Aguirre G, 2008, NEUROCHEM INT, V52, P1322, DOI 10.1016/j.neuint.2008.01.015; Belcastro V, 2013, EPILEPSY RES, V107, P1, DOI 10.1016/j.eplepsyres.2013.08.016; BROUILLET EP, 1993, EXP NEUROL, V120, P89, DOI 10.1006/exnr.1993.1042; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Dauncey MJ, 2012, P NUTR SOC, V71, P581, DOI 10.1017/S0029665112000237; Campos MSD, 2016, PHARMACOTHERAPY, V36, P1255, DOI 10.1002/phar.1855; Dhandapani KM, 2007, EXP GERONTOL, V42, P70, DOI 10.1016/j.exger.2006.06.032; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gianutsos G, 1997, FUND APPL TOXICOL, V37, P102, DOI 10.1006/faat.1997.2306; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Henriksson J, 2000, TOXICOL SCI, V55, P392, DOI 10.1093/toxsci/55.2.392; Jayakumar AR, 2016, ADV NEUROBIOL, V13, P327, DOI 10.1007/978-3-319-45096-4_13; Karki P, 2015, J BIOL CHEM, V290, P23725, DOI 10.1074/jbc.M115.649327; Karki P, 2014, MOL CELL BIOL, V34, P1280, DOI 10.1128/MCB.01176-13; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033533; Kimura A, 2015, NEUROSCI LETT, V588, P108, DOI 10.1016/j.neulet.2014.12.054; Kotz C, 2012, ANN NY ACAD SCI, V1264, P72, DOI 10.1111/j.1749-6632.2012.06585.x; Kratsman N, 2016, NEUROPHARMACOLOGY, V102, P136, DOI 10.1016/j.neuropharm.2015.11.003; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Lason W, 2011, PHARMACOL REP, V63, P271, DOI 10.1016/S1734-1140(11)70497-2; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Leke R, 2016, ADV NEUROBIOL, V13, P223, DOI 10.1007/978-3-319-45096-4_8; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6469; LOSCHER W, 1993, EPILEPSY RES, V16, P183, DOI 10.1016/0920-1211(93)90079-M; Ximenes JCM, 2013, N-S ARCH PHARMACOL, V386, P575, DOI 10.1007/s00210-013-0853-4; Malago JJ, 2015, J ZHEJIANG UNIV-SC B, V16, P224, DOI 10.1631/jzus.B1400191; Maski KP, 2011, CURR OPIN PEDIATR, V23, P609, DOI 10.1097/MOP.0b013e32834c9282; Moberly AH, 2012, NEUROTOXICOLOGY, V33, P996, DOI 10.1016/j.neuro.2012.04.014; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Monti B, 2009, MINI-REV MED CHEM, V9, P769, DOI 10.2174/138955709788452621; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Normandin L, 2002, METAB BRAIN DIS, V17, P375, DOI 10.1023/A:1021970120965; Park MJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0765-6; Peres TV, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0099-0; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Qian YR, 2010, KOREAN J PHYSIOL PHA, V14, P435, DOI 10.4196/kjpp.2010.14.6.435; Rayavarapu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012981; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Robison G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048899; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Skidmore FM, 2008, J REHABIL RES DEV, V45, P1343, DOI 10.1682/JRRD.2008.01.0002; Sun J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/395895; Takuma K, 2014, PHARMACOL BIOCHEM BE, V126, P43, DOI 10.1016/j.pbb.2014.08.013; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Ximenes J.C., 2015, J NEURODEGENERATIVE; Yamawaki Y, 2012, WORLD J BIOL PSYCHIA, V13, P458, DOI 10.3109/15622975.2011.585663; Yu QF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059627, 10.1371/journal.pone.0078318]; Zaky A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00337; Zhang LN, 2016, MOL NEUROBIOL, V53, P1124, DOI 10.1007/s12035-014-9071-4; Zhong T, 2014, BRIT J ANAESTH, V113, P634, DOI 10.1093/bja/aeu184	60	22	22	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	JAN	2018	64				SI		230	239		10.1016/j.neuro.2017.06.007			10	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	FV4HM	WOS:000424534200027	28610743	Green Accepted			2022-02-06	
S	Leinonen, V; Vanninen, R; Rauramaa, T		Kovacs, GG; Alafuzoff, I		Leinonen, Ville; Vanninen, Ritva; Rauramaa, Tuomas			Raised intracranial pressure and brain edema	NEUROPATHOLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							APPARENT DIFFUSION-COEFFICIENT; AQUAPORIN-4 EXPRESSION; MOLECULAR-MECHANISMS; CYTOTOXIC EDEMA; CEREBRAL EDEMA; BARRIER; INJURY; PATHOGENESIS; DISRUPTION; HEMORRHAGE	Acutely increased intracranial pressure (ICP) is a life-threatening neurosurgical emergency. Optimal management strategy is selected according to the causative process. Typical causes are intracranial bleeds like traumatic subdural, epidural, or intracerebral hematoma (ICH); spontaneous ICH, intraventricular hemorrhage, subarachnoid hemorrhage, and hydrocephalus. When occurring without significant brain injury and treated effectively before herniation, a full recovery can be expected. In intraparenchymal injuries a full recovery is unlikely since dead cells in the central nervous systemleave an "empty hole," to be replaced by cerebrospinal fluid. The clinical recovery is based on the surviving cells that are able to make new synapses. Surgery may decrease ICP by removing significant mass effect. In all conditions, when notable injury of brain parenchyma occurs, brain edema may gradually increase ICP and further worsen the clinical condition. This is seen typically in large brain infarctions when the formation of brain edema may lead to increased ICP for hours and days. Brain edema is traditionally classified as vasogenic or cytotoxic but according to current knowledge is rather a continuum, starting with cytotoxic cell swelling followed by ionic edema and then vasogenic edema. Here we review the causes of increased ICP, including mechanisms of brain edema, with clinical examples.	[Leinonen, Ville] Univ Eastern Finland, Inst Clin Med, Dept Neurosurg, Kuopio, Finland; [Leinonen, Ville] Kuopio Univ Hosp, NeuroCtr, Dept Neurosurg, Kuopio, Finland; [Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Dept Radiol, Kuopio, Finland; [Vanninen, Ritva] Kuopio Univ Hosp, Dept Radiol, Kuopio, Finland; [Rauramaa, Tuomas] Univ Eastern Finland, Inst Clin Med, Dept Pathol, Kuopio, Finland; [Rauramaa, Tuomas] Kuopio Univ Hosp, Dept Pathol, Kuopio, Finland		Leinonen, V (corresponding author), Kuopio Univ Hosp, NeuroCtr, Dept Neurosurg, POB 100, Kys 70029, Finland.	ville.leinonen@kuh.fi					Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Badaut J, 2007, PEDIATR RES, V62, P248, DOI 10.1203/PDR.0b013e3180db291b; Bartsch P, 2013, NEW ENGL J MED, V368, P2294, DOI 10.1056/NEJMcp1214870; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Cahill J, 2006, STROKE, V37, P1868, DOI 10.1161/01.STR.0000226995.27230.96; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Hofmeijer J, 2004, STROKE, V35, P1476, DOI 10.1161/01.STR.0000128415.31274.3a; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Ishihara H, 2008, J NEUROPATH EXP NEUR, V67, P435, DOI 10.1097/NEN.0b013e31816fd622; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kiviniemi V, 2016, J CEREBR BLOOD F MET, V36, P1033, DOI 10.1177/0271678X15622047; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kuramatsu JB, 2013, J NEURAL TRANSM, V120, pS35, DOI 10.1007/s00702-013-1040-y; Leasure A, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-015-0392-z; Lee DJ, 2012, EPILEPSY RES, V98, P264, DOI 10.1016/j.eplepsyres.2011.09.016; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Liu YW, 2007, RADIOLOGY, V242, P518, DOI 10.1148/radiol.2422051698; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Mendelow AD, 2016, FRONT NEUROL NEUROSC, V37, P148, DOI 10.1159/000437119; Mendelow AD, 2005, LANCET, V365, P387; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Nakano T, 2002, CLIN IMAG, V26, P243, DOI 10.1016/S0899-7071(02)00433-3; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Nico B, 2009, EUR J CANCER, V45, P3315, DOI 10.1016/j.ejca.2009.09.023; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rabinstein AA, 2010, CURR TREAT OPTION NE, V12, P129, DOI 10.1007/s11940-010-0062-0; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Rumpel H, 1998, AM J NEURORADIOL, V19, P1636; Saadoun S, 2003, J CLIN PATHOL, V56, P972, DOI 10.1136/jcp.56.12.972; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Song TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0528-4; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Tait MJ, 2010, NEUROSCIENCE, V167, P60, DOI 10.1016/j.neuroscience.2010.01.053; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Urday S, 2016, CRIT CARE MED, V44, P790, DOI 10.1097/CCM.0000000000001553; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wendon J, 2008, NEUROCRIT CARE, V9, P97, DOI 10.1007/s12028-008-9123-6; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Wolburg H, 2012, MOL ASPECTS MED, V33, P579, DOI 10.1016/j.mam.2012.02.003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675	60	22	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-802615-1; 978-0-12-802395-2	HAND CLINIC			2018	145						25	37		10.1016/B978-0-12-802395-2.00004-3			13	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BM3UR	WOS:000462710900006					2022-02-06	
J	Lichtenstein, JD; Erdodi, LA; Rai, JK; Mazur-Mosiewicz, A; Flaro, L				Lichtenstein, Jonathan D.; Erdodi, Laszlo A.; Rai, Jaspreet K.; Mazur-Mosiewicz, Anya; Flaro, Lloyd			Wisconsin Card Sorting Test embedded validity indicators developed for adults can be extended to children	CHILD NEUROPSYCHOLOGY			English	Article						Performance validity testing; Embedded validity indicators; WCST; Effort testing; Pediatric neuropsychological assessment; Pediatric PVTs	TRAUMATIC BRAIN-INJURY; FALSE-POSITIVE RATES; WORD MEMORY TEST; PERFORMANCE VALIDITY; DIGIT SPAN; NEUROPSYCHOLOGICAL EXAMINATIONS; NEUROLOGICAL DISORDERS; MALINGERING DETECTION; MULTIPLE PERFORMANCE; PATIENT SAMPLES	Past studies have examined the ability of the Wisconsin Card Sorting Test (WCST) to discriminate valid from invalid performance in adults using both individual embedded validity indicators (EVIs) and multivariate approaches. This study is designed to investigate whether the two most stable of these indicatorsfailures to maintain set (FMS) and the logistical regression equation S-B(LRE)can be extended to pediatric populations.The classification accuracy for FMS and S-B-LRE was examined in a mixed clinical sample of 226 children aged 7 to 17 years (64.6% male, MAge=13.6 years) against a combination of established performance validity tests (PVTs).The results show that at adult cutoffs, FMS and S-B-LRE produce an unacceptably high failure rate (33.2% and 45.6%) and low specificity (.55-.72), but an upward adjustment in cutoffs significantly improves classification accuracy. Defining Pass as <2 and Fail as 4 on FMS results in consistently good specificity (.89-.92) but low and variable sensitivity (.00-.33). Similarly, cutting the S-B-LRE distribution at 3.68 produces good specificity (.90-.92) but variable sensitivity (.06-.38). Passing or failing FMS or S-B-LRE is unrelated to age, gender and IQ.The data from this study suggest that in a pediatric sample, adjusted cutoffs on the FMS and S-B-LRE ensure good specificity, but with low or variable sensitivity. Thus, they should not be used in isolation to determine the credibility of a response set. At the same time, they can make valuable contributions to pediatric neuropsychology by providing empirically-supported, expedient and cost-effective indicators to enhance performance validity assessment.	[Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dept Psychiat, Neuropsychol Serv, Lebanon, NH USA; [Erdodi, Laszlo A.; Rai, Jaspreet K.] Univ Windsor, Dept Psychol, Neuropsychol Track, Windsor, ON, Canada; [Mazur-Mosiewicz, Anya] Chicago Sch Profess Psychol, Dept Psychol, Chicago, IL USA; [Mazur-Mosiewicz, Anya] Oklahoma State Univ, Dept Psychiat & Behav Sci, Tulsa, OK USA		Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Psychiat, One Med Ctr Dr, Lebanon, NH 03756 USA.	jonathan.d.lichtenstein@dartmouth.edu					Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brooks B.L., 2015, CHILDREN ADOLESCENT; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Gligorovic M, 2013, J INTELLECT DEV DIS, V38, P134, DOI 10.3109/13668250.2013.772956; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2003, MANUAL WORD MEMORY T; Green P., 2004, MANUAL GREENS MED SY; Green P.J.E., 2008, MANUAL NONVERBAL MED; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Greve KW, 2002, J CLIN EXP NEUROPSYC, V24, P48, DOI 10.1076/jcen.24.1.48.968; Gunn D, 2010, CHILD NEUROPSYCHOL, V16, P105, DOI 10.1080/09297040903352564; Harrison AG, 2015, APPL NEUROPSYCH-CHIL, V4, P197, DOI 10.1080/21622965.2013.850581; Harrison AG, 2014, APPL NEUROPSYCH-CHIL, V3, P152, DOI 10.1080/21622965.2012.753570; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; IVERSON GL, 1998, 21 ITEM TEST RES MAN; Jodzio K, 2010, APPL NEUROPSYCHOL, V17, P267, DOI 10.1080/09084282.2010.525104; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Kirkwood M. W., 2015, VALIDITY TESTING CHI; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee G. J., 2007, FORENSIC NEUROPSYCHO; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P695, DOI 10.1093/arclin/acu049; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Martin R. C., 1995, ARCH CLIN NEUROPSYCH, V10, P364, DOI [10.1093/arclin/10.4.364, DOI 10.1093/ARCLIN/10.4.364]; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Ploetz DM, 2016, CHILD NEUROPSYCHOL, V22, P133, DOI 10.1080/09297049.2014.986446; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; RETZLAFF P, 1992, J CLIN PSYCHOL, V48, P666, DOI 10.1002/1097-4679(199209)48:5<666::AID-JCLP2270480514>3.0.CO;2-J; Romine CB, 2004, ARCH CLIN NEUROPSYCH, V19, P1027, DOI 10.1016/j.acn.2003.12.009; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063	61	22	22	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2018	24	2					247	260		10.1080/09297049.2016.1259402			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FU4JN	WOS:000423819500006	27892806				2022-02-06	
J	Mokhtari, M; Nayeb-Aghaei, H; Kouchek, M; Miri, MM; Goharani, R; Amoozandeh, A; Salamat, SA; Sistanizad, M				Mokhtari, Majid; Nayeb-Aghaei, Hossein; Kouchek, Mehran; Miri, Mir Mohammad; Goharani, Reza; Amoozandeh, Arash; Salamat, Sina Akhavan; Sistanizad, Mohammad			Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						traumatic brain injury; NSE; GCS; memantine	HEAD-INJURY; PROGNOSTIC VALUE; ISCHEMIC-STROKE; CLINICAL-TRIALS; NEUROPROTECTION; STRATEGIES; GLUTAMATE; PRETREATMENT; ANTAGONIST; PREDICTION	Traumatic brain injury (TBI) is a major cause of disability and death globally. Despite significant progress in neuromonitoring and neuroprotection, pharmacological interventions have failed to generate favorable results. We examined the effect of memantine on serum levels of neuron-specific enolase (NSE), a marker of neuronal damage, and the Glasgow Coma Scale (GCS) in patients with moderate TBI. Patients were randomly assigned to the control group (who received standard TBI management) and the treatment group (who, alongside their standard management, received enteral memantine 30 mg twice daily for 7 days). Patients' clinical data, GCS, findings of head computed tomography, and serum NSE levels were collected during the study. Forty-one patients were randomized into the control and treatment groups, 19 and 22 patients respectively. Baseline characteristics and serum NSE levels were not significantly different between the 2 groups. The mean serum NSE levels for the memantine and the control groups on day 3 were 7.95 +/- 2.86 and 12.33 +/- 7.09 ng/mL, respectively (P = .05), and on day 7 were 5.03 +/- 3.25 and 10.04 +/- 5.72 ng/mL, respectively (P = .003). The mean GCS on day 3 was 12.3 +/- 2.0 and 10.9 +/- 1.9 in the memantine and control groups, respectively (P = .03). Serum NSE levels and GCS changes were negatively correlated (r = -0.368, P = .02). Patients with moderate TBI who received memantine had significantly reduced serum NSE levels by day 7 and marked improvement in their GCS scores on day 3 of the study.	[Mokhtari, Majid; Kouchek, Mehran; Miri, Mir Mohammad; Goharani, Reza; Sistanizad, Mohammad] Shahid Beheshti Univ Med Sci, Dept Crit Care & Anesthesiol, Imam Hossein Hosp, Tehran, Iran; [Nayeb-Aghaei, Hossein; Amoozandeh, Arash] Shahid Beheshti Univ Med Sci, Dept Neurosurg, Imam Hossein Hosp, Tehran, Iran; [Salamat, Sina Akhavan; Sistanizad, Mohammad] Shahid Beheshti Univ Med Sci, Dept Clin Pharm, Fac Pharm, Tehran, Iran		Sistanizad, M (corresponding author), Fac Pharm, Dept Clin Pharm, Niayesh Highway,Valiasr Ave,POB 6153-14155, Tehran, Iran.	sistanizadm@sbmu.ac.ir	Sistanizad, Mohammad/H-4734-2018; Mokhtari, Majid/AAD-6749-2020; Sistanizad, Mohammad/Y-6115-2019; Miri, Mir Mohammad/AAX-7212-2021; Kouchek, Mehran/AAX-7128-2021	Sistanizad, Mohammad/0000-0002-7836-6411; Sistanizad, Mohammad/0000-0002-7836-6411; kouchek, mehran/0000-0002-2070-9856; Miri, mir mohammad/0000-0003-3918-6802; Mokhtari, Majid/0000-0001-5980-1003	vice chancellery for research affairs of Shahid Beheshti University of Medical Sciences [SBMU-1391-4586]	This study was funded by a grant from the vice chancellery for research affairs of Shahid Beheshti University of Medical Sciences (grant number SBMU-1391-4586).	Annweiler C, 2014, NEUROBIOL AGING, V35, P331, DOI 10.1016/j.neurobiolaging.2013.07.029; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Bisaga A, 2001, PSYCHOPHARMACOLOGY, V157, P1, DOI 10.1007/s002130100739; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P37, DOI DOI 10.1089/NEU.2007.9990; Collins ED, 2007, EXP CLIN PSYCHOPHARM, V15, P228, DOI 10.1037/1064-1297.15.3.228; Dogan A, 1999, ACTA NEUROCHIR, V141, P1107, DOI 10.1007/s007010050491; El-Maraghi S, 2013, EGYPT J CRIT CARE ME, V1, P25, DOI 10.1016/j.ejccm.2012.12.002; Ergun R, 1998, NEUROL RES, V20, P418; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jain KK, 2011, HANDBOOK OF NEUROPROTECTION, P1, DOI 10.1007/978-1-61779-049-2; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kafi H, 2014, IRAN J PHARM RES, V13, P591; Karolczak D, 2013, POL J PATHOL, V64, P196, DOI 10.5114/PJP.2013.38139; Kilic U, 2013, NEUROSCIENCE, V237, P268, DOI 10.1016/j.neuroscience.2013.01.059; Kim YW, 2010, ANN NUCL MED, V24, P363, DOI 10.1007/s12149-010-0360-3; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Makotrova TA, 2013, ZH NEVROL PSIKHIATR, V113, P82; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Montagne A, 2012, STROKE, V43, P2774, DOI 10.1161/STROKEAHA.112.669374; Mukhin A, 1996, J NEUROSCI, V16, P6012; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Rao VLR, 2001, BRAIN RES, V911, P96; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Stein DM, 2011, NEUROCRIT CARE, V14, P200, DOI 10.1007/s12028-010-9496-1; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yanez M, 2014, NEURODEGENER DIS, V13, P171, DOI 10.1159/000357281; Zaheer S, 2013, ANN INDIAN ACAD NEUR, V16, P504, DOI 10.4103/0972-2327.120442; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	40	22	24	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2700	1552-4604		J CLIN PHARMACOL	J. Clin. Pharmacol.	JAN	2018	58	1					42	47		10.1002/jcph.980			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FQ1FY	WOS:000418102900005	28724200				2022-02-06	
J	Ruet, A; Jourdan, C; Bayen, E; Darnoux, E; Sahridj, D; Ghout, I; Azerad, S; Diehl, PP; Aegerter, P; Charanton, J; Azouvi, CV; Azouvi, P				Ruet, Alexis; Jourdan, Claire; Bayen, Eleonore; Darnoux, Emmanuelle; Sahridj, Dalila; Ghout, Idir; Azerad, Sylvie; Diehl, Pascale Pradat; Aegerter, Philippe; Charanton, James; Azouvi, Claire Vallat; Azouvi, Philippe			Employment outcome four years after a severe traumatic brain injury: results of the Paris severe traumatic brain injury study	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; follow-up study; employment; return to work; disability	FOLLOW-UP; ACUTE PREDICTORS; BOTULINUM TOXIN; JOB STABILITY; RETURN; WORK; MODERATE; PRODUCTIVITY; COHORT	Objective: To describe employment outcome four years after a severe traumatic brain injury by the assessment of individual patients' preinjury sociodemographic data, injury-related and postinjury factors. Design: A prospective, multicenter inception cohort of 133 adult patients in the Paris area (France) who had received a severe traumatic brain injury were followed up postinjury at one and four years. Sociodemographic data, factors related to injury severity and one-year functional and cognitive outcomes were prospectively collected. Methods: The main outcome measure was employment status. Potential predictors of employment status were assessed by univariate and multivariate analysis. Results: At the four-year follow-up, 38% of patients were in paid employment. The following factors were independent predictors of unemployment: being unemployed or studying before traumatic brain injury, traumatic brain injury severity (i.e., a lower Glasgow Coma Scale score upon admission and a longer stay in intensive care) and a lower one-year Glasgow Outcome Scale-Extended score. Conclusion: This study confirmed the low rate of long-term employment amongst patients after a severe traumatic brain injury. The results illustrated the multiple determinants of employment outcome and suggested that students who had received a traumatic brain injury were particularly likely to be unemployed, thus we propose that they may require specific support to help them find work.	[Ruet, Alexis] CHU Caen, Serv Med Phys & Readaptat, Ave Cote Nacre, F-14000 Caen, France; [Ruet, Alexis] INSERM, U1077, Caen, France; [Jourdan, Claire; Sahridj, Dalila; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Jourdan, Claire; Azouvi, Claire Vallat; Azouvi, Philippe] Univ Versailles St Quentin, HANDIReSP, EA 4047, Versailles, France; [Bayen, Eleonore; Diehl, Pascale Pradat] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; [Bayen, Eleonore; Diehl, Pascale Pradat] Univ Paris 06, Paris, France; [Darnoux, Emmanuelle; Ghout, Idir; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, AP HP, Unite Rech Clin, Boulogne, France; [Darnoux, Emmanuelle; Charanton, James] CRFTC, Paris, France; [Azouvi, Claire Vallat] Hop Raymond Poincare, Antenne UEROS SAMSAH UGECAM IDF 92, Garches, France		Ruet, A (corresponding author), CHU Caen, Serv Med Phys & Readaptat, Ave Cote Nacre, F-14000 Caen, France.	ruet-a@chu-caen.fr	AEGERTER, Philippe/AAY-6003-2021; RUET, Alexis/L-8726-2015	AEGERTER, Philippe/0000-0002-9156-5028; RUET, Alexis/0000-0002-5080-5734	French Ministry of Health [AOM04084]; Institut de Recherche en Sante Publique (IRESP); AP-HP (Departement de la Recherche Clinique et du Developpement)	This study was funded by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2004), grant number AOM04084; the Institut de Recherche en Sante Publique (IRESP). It was supported by AP-HP (Departement de la Recherche Clinique et du Developpement).	Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; Baert I, 2012, ARCH PHYS MED REHAB, V93, P669, DOI 10.1016/j.apmr.2011.09.022; Bayen E, 2014, J HEAD TRAUMA REHAB, V31, P59; CLAUS D, 1995, MOVEMENT DISORD, V10, P574, DOI 10.1002/mds.870100508; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Diaz AP, 2014, REV BRAS PSIQUIATR, V36, P213, DOI 10.1590/1516-4446-2013-1303; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; R Core Team, 2018, R LANGUAGE ENV STAT; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sarifakioglu N, 2004, ANN PLAS SURG, V53, P543, DOI 10.1097/01.sap.0000139563.51598.75; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Willmott C, 2015, BRAIN INJURY, V29, P929, DOI 10.3109/02699052.2015.1022882; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	47	22	23	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	18					2200	2207		10.1080/09638288.2017.1327992			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GL6WK	WOS:000437334400012	28521527				2022-02-06	
J	Zeiler, FA; Cardim, D; Donnelly, J; Menon, DK; Czosnyka, M; Smielewski, P				Zeiler, Frederick A.; Cardim, Danilo; Donnelly, Joseph; Menon, David K.; Czosnyka, Marek; Smielewski, Peter			Transcranial Doppler Systolic Flow Index and ICP-Derived Cerebrovascular Reactivity Indices in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebrovascular reactivity; continuous autoregulation indices; co-variance; critical thresholds; TCD	CEREBRAL AUTOREGULATION; PRESSURE	The purpose of our study was to explore relationships between transcranial Doppler (TCD) indices of cerebrovascular reactivity and those derived from intracranial pressure (ICP). Goals included: A) confirming previously described co-variance patterns of TCD/ICP indices, and B) describing thresholds for systolic flow index (Sx; correlation between systolic flow velocity [FVs] and cerebral perfusion pressure [CPP]) associated with outcome. In a retrospective cohort of traumatic brain injury (TBI) patients: with TCD and ICP monitoring, we calculated various continuous indices of cerebrovascular reactivity: A) ICP (pressure reactivity index [PRx]: correlation between ICP and mean arterial pressure [MAP]; PAx: correlation between pulse amplitude of ICP [AMP] and MAP; RAC: correlation between AMP and CPP) and B) TCD (mean flow index [Mx]: correlation between mean flow velocity [FVm] and CPP; Mx_a: correlation between FVm and MAP; Sx: correlation between FVs and CPP; Sx_a: correlation between FVs and MAP; Dx: correlation between diastolic flow velocity [FVd] and CPP; Dx_a: correlation between FVd and MAP). We assessed the relationships via various statistical techniques, including: principal component analysis, agglomerative hierarchal clustering, and k-means cluster analysis (KMCA). We performed sequential chi(2) testing to define thresholds associated with outcome for Sx/Sx_a. Outcome was assessed at 6 months via dichotomized Glasgow Outcome Score (GOS): A) Favorable (GOS 4 or 5) versus Unfavorable (GOS 3 or less), B) Alive versus Dead. We analyzed 410 recordings in 347 patients. All analyses confirmed our previously described co-variance of Sx/Sx_a with ICP-derived indices. Sx displayed thresholds of -0.15 for unfavorable outcome (p < 0.0001) and -0.20 for mortality (p < 0.0001). Sx_a displayed thresholds of +0.05 (p = 0.019) and -0.10 (p = 0.0001) for alive/dead and favorable/unfavorable outcomes. TCD systolic indices are most closely associated with ICP indices. Sx and Sx_a likely provide better approximation of ICP indices, compared with Mx/Mx_a/Dx/Dx_a. Sx provides superior outcome prediction, versus Mx, with defined thresholds.	[Zeiler, Frederick A.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Cardim, Danilo; Donnelly, Joseph; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Sect Brain Phys, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca	Cardim, Danilo Augusto/B-8447-2012; Donnelly, Joseph/E-9235-2018; Donnelly, Joseph/N-6803-2019	Cardim, Danilo Augusto/0000-0002-9261-1321; Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Traveling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba-Faculty of Medicine Dean's Fellowship Fund; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Center, an NIHR Senior Investigator Award; European Union Framework Program 7 grant (CENTER-TBI) [602150]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI17C1790]; Woolf Fisher Scholarship (NZ); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Traveling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba-Faculty of Medicine Dean's Fellowship Fund.; These studies were supported by the National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Center, an NIHR Senior Investigator Award to DKM. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150).; MC is supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number : HI17C1790).; JD is supported by a Woolf Fisher Scholarship (NZ).	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Crawley M.J., 2013, R BOOK, P809; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Pandey M., 2015, BIOSTATISTICS BASIC, P454; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002	13	22	23	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					314	322		10.1089/neu.2017.5364		DEC 2017	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000418126600001	29050524	Green Submitted			2022-02-06	
J	Zeiler, FA; Donnelly, J; Calviello, L; Menon, DK; Smielewski, P; Czosnyka, M				Zeiler, Frederick A.; Donnelly, Joseph; Calviello, Leanne; Menon, David K.; Smielewski, Peter; Czosnyka, Marek			Pressure Autoregulation Measurement Techniques in Adult Traumatic Brain Injury, Part I: A Scoping Review of Intermittent/Semi-Intermittent Methods	JOURNAL OF NEUROTRAUMA			English	Article						adult TBI; autoregulation measurement; intermittent techniques; systematic review	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; DOPPLER ULTRASONOGRAPHY TCD; INTRACRANIAL-PRESSURE; CEREBROVASCULAR AUTOREGULATION; DYNAMIC AUTOREGULATION; STATIC AUTOREGULATION; PERFUSION-PRESSURE; BEDSIDE ASSESSMENT; REACTIVITY	The purpose of this study was to perform a systematic, scoping review of commonly described intermittent/semiintermittent autoregulation measurement techniques in adult traumatic brain injury (TBI). Nine separate systematic reviews were conducted for each intermittent technique: computed tomographic perfusion (CTP)/Xenon-CT (Xe-CT), positron emission tomography (PET), magnetic resonance imaging (MRI), arteriovenous difference in oxygen (AVDO(2)) technique, thigh cuff deflation technique (TCDT), transient hyperemic response test (THRT), orthostatic hypotension test (OHT), mean flow index (Mx), and transfer function autoregulation index (TF-ARI). MEDLINE (R), BIOSIS, EMBASE, Global Health, Scopus, Cochrane Library (inception to December 2016), and reference lists of relevant articles were searched. A two tier filter of references was conducted. The total number of articles utilizing each of the nine searched techniques for intermittent/semi-intermittent autoregulation techniques in adult TBI were: CTP/Xe-CT (10), PET (6), MRI (0), AVDO2 (10), ARI-based TCDT (9), THRT (6), OHT (3), Mx (17), and TF-ARI (6). The premise behind all of the intermittent techniques is manipulation of systemic blood pressure/blood volume via either chemical (such as vasopressors) or mechanical (such as thigh cuffs or carotid compression) means. Exceptionally, Mx and TF-ARI are based on spontaneous fluctuations of cerebral perfusion pressure (CPP) or mean arterial pressure (MAP). The method for assessing the cerebral circulation during these manipulations varies, with both imaging-based techniques and TCD utilized. Despite the limited literature for intermittent/semi-intermittent techniques in adult TBI (minus Mx), it is important to acknowledge the availability of such tests. They have provided fundamental insight into human autoregulatory capacity, leading to the development of continuous and more commonly applied techniques in the intensive care unit (ICU). Numerous methods of intermittent/semi-intermittent pressure autoregulation assessment in adult TBI exist, including: CTP/Xe-CT, PET, AVDO(2) technique, TCDT-based ARI, THRT, OHT, Mx, and TF-ARI. MRI-based techniques in adult TBI are yet to be described, with the main focus of MRI techniques on metabolic-based cerebrovascular reactivity (CVR) and not pressure-based autoregulation.	[Zeiler, Frederick A.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Donnelly, Joseph; Calviello, Leanne; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Sect Brain Phys, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Sect Neurosurg, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Clinician Investigator Program, Winnipeg, MB, Canada		Zeiler, FA (corresponding author), Univ Manitoba, Dept Surg, Rady Fac Hlth Sci, 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada - Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba Faculty of Medicine Dean's Fellowship Fund; Woolf Fisher Scholarship (NZ); National Institute for Healthcare Research (NIHR), UK through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award; European Union Framework Program 7 grant (CENTER-TBI) [602150]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada - Harry S. Morton Travelling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba Faculty of Medicine Dean's Fellowship Fund. J.D. is supported by a Woolf Fisher Scholarship (NZ). These studies were also supported by the National Institute for Healthcare Research (NIHR), UK through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to D.K.M. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150).	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Aaslid R, 2007, STROKE, V38, P1465, DOI 10.1161/STROKEAHA.106.473462; Aslam AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012040.pub2; Berre J. A., 2002, ANESTHESIOLOGY, V2000, pA350; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Carrera E, 2009, J NEUROL SCI, V285, P191, DOI 10.1016/j.jns.2009.06.041; Chieregato A, 2003, ACTA NEUROCHIR SUPPL, V86, P361; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Christ M, 2007, INTENS CARE MED, V33, P246, DOI 10.1007/s00134-006-0451-8; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 2002, ACT NEUR S, V81, P117; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2000, ACT NEUR S, V76, P483; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; Czosnyka M., 2007, J CEREB BLOOD FLOW M, V27; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; DAFFERTSHOFER M, 1995, J CLIN ULTRASOUND, V23, P125, DOI 10.1002/jcu.1870230207; DAFFERTSHOFER M, 1991, J NEUROL SCI, V104, P32, DOI 10.1016/0022-510X(91)90212-P; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Eide PK, 2007, NEUROL RES, V29, P578, DOI 10.1179/016164107X172167; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; Hlatky R, 2006, NEUROCRIT CARE, V4, P127, DOI 10.1385/NCC:4:2:127; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Horsfield MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062588; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lewis PM, 2007, ACTA NEUROCHIR, V149, P549, DOI 10.1007/s00701-007-1160-y; Lewis Philip M, 2012, Acta Neurochir Suppl, V114, P147, DOI 10.1007/978-3-7091-0956-4_27; Liu XY, 2016, ACTA NEUROCHIR SUPPL, V122, P233, DOI 10.1007/978-3-319-22533-3_47; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; McNair N, 2012, BRAIN INJURY, V26, P558; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Ng SCP, 2002, ACT NEUR S, V81, P125; Ng SCP, 2000, ACT NEUR S, V76, P479; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Peterson E, 2009, J TRAUMA, V67, P944, DOI 10.1097/TA.0b013e3181ae6e6d; Peterson EC, 2012, NEUROSURGERY, V71, pE560, DOI 10.1227/01.neu.0000417741.24547.1c; Puppo C, 2007, ACTA NEUROCHIR, V149, P139, DOI 10.1007/s00701-006-1074-0; Puppo C, 2002, ACTA NEUROCHIR SUPPL, V81, P129; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Rangel-Castilla L, 2010, NEUROL RES, V32, P1033, DOI 10.1179/016164110X12767786356598; Riberholt CG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154831; Ingelmo AR, 2016, J INVEST ALLERG CLIN, V26, P144, DOI 10.18176/jiaci.0058; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sahuquillo J, 2000, ACTA NEUROCHIR SUPPL, V76, P485; Sahuquillo J, 1998, ACT NEUR S, V71, P233; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; Schmidt EA, 2003, J NEUROIMAGING, V13, P248, DOI 10.1177/1051228403013003008; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schramm P, 2011, J NEUROSURG ANESTH, V23, P41, DOI 10.1097/ANA.0b013e3181f35854; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steinmeier R, 2002, J NEUROTRAUM, V19, P1127, DOI 10.1089/08977150260337949; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Vajramani GV, 1999, BRIT J NEUROSURG, V13, P468, DOI 10.1080/02688699943277; Varsos GV, 2014, NEUROCRIT CARE, V21, P266, DOI 10.1007/s12028-014-9971-1; Wintermark M, 2006, J NEURORADIOLOGY, V33, P27, DOI 10.1016/S0150-9861(06)77225-X; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Zhang Y, 2016, ACTA NEUROCHIR SUPPL, V122, P205, DOI 10.1007/978-3-319-22533-3_41; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	77	22	22	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3207	3223		10.1089/neu.2017.5085			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000416341700001	28648106	Green Submitted			2022-02-06	
J	Yuan, WH; Wade, SL; Quatman-Yates, C; Hugentobler, JA; Gubanich, PJ; Kurowski, BG				Yuan, Weihong; Wade, Shari L.; Quatman-Yates, Catherine; Hugentobler, Jason A.; Gubanich, Paul J.; Kurowski, Brad G.			Structural Connectivity Related to Persistent Symptoms After Mild TBI in Adolescents and Response to Aerobic Training: Preliminary Investigation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aerobic training; DTI tractography; graph theory; mild traumatic brain injury; persistent symptom; structural connectivity	TRAUMATIC BRAIN-INJURY; HEALTH-CARE UTILIZATION; BEHAVIOR PROBLEMS; UNITED-STATES; INPATIENT REHABILITATION; EDUCATIONAL-SERVICES; EARLY-CHILDHOOD; YOUNG-CHILDREN; SHORT-TERM; PREDICTORS	Objective: To quantify structural connectivity abnormalities in adolescents with mild traumatic brain injury (mTBI) and to investigate connectivity changes following aerobic training using graph theory and diffusion tensor imaging tractography. Setting: Outpatient research setting. Participants: Twenty-two children (age: 15.83 +/- 1.77 years, 10 females) with 4 to 16 weeks of persistent symptoms aftermTBI and a matched healthy comparison group. Design: Randomized clinical trial of aerobic training and stretching comparison combined with case-control comparison. Main Measures: (1) Five global network measures: global efficiency (Eglob), mean local efficiency, modularity, normalized clustering coefficient (gamma), normalized characteristic path length (lambda), and small-worldness (sigma). (2) The self-reported Post-Concussion Symptom Inventory score. Results: At initial enrollment, adolescents with mTBI had significantly lower Eglob and higher gamma, lambda, and sigma (all P <.05) than healthy peers. After the intervention, significantly increased Eglob and decreased lambda (both P <.05) were found in the aerobic training group. Improvement in Post-Concussion Symptom Inventory scores was significantly correlated with the Eglob increase and lambda decrease in the aerobic training and lambda decrease in the stretching comparison group (all P <.05). Conclusion: This pilot study showed initial evidence that structural connectivity analysis was sensitive to brain network abnormalities and may serve as an imaging biomarker in children with persistent symptoms after mTBI.	[Yuan, Weihong] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Ctr, Cincinnati, OH 45229 USA; [Wade, Shari L.; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Quatman-Yates, Catherine; Hugentobler, Jason A.; Gubanich, Paul J.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Yuan, Weihong; Wade, Shari L.; Kurowski, Brad G.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	Brad.Kurowski@cchmc.org	Quatman-Yates, Catherine/U-9580-2019; Quatman-Yates, Catherine/AAK-4507-2021		Cincinnati Children's Research Foundation Trustees Grant program; Ohio Department of Public Safety; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD07468]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T35HD007468] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001426, UL1TR000077] Funding Source: NIH RePORTER	Funding for this study was supported in part by the Cincinnati Children's Research Foundation Trustees Grant program, Ohio Department of Public Safety, National Institute for Child Health and Human Development K23HD07468, and grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other supporting agencies.	Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Ballard DW, 2013, ACAD EMERG MED, V20, P352, DOI 10.1111/acem.12109; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Begali V., 1992, HEAD INJURY CHILDREN; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; BULGREN JA, 2006, TEACHING ADOLESCENTS, P79; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2010, STUD NEUROPSYCHOL NE, P439; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Centers for Disease Control National Center for Injury Prevention and Control Division of Unintentional Injury, 2001, RAT TBI REL HOSP AG; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Connery AK, 2016, CLIN NEUROPSYCHOL, V30, P579, DOI 10.1080/13854046.2016.1177596; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crowe LM, 2005, HDB CLIN NEUROLOGY, V128, P661; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Faul M, 2010, TRAUMATIC BRAIN INJU; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2008, NEUROREHABILTIATION, V23, P13; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haarbauer-Krupa J, 2012, THE ASHA LEADER 0703; Haarbauer-Krupa J, 2009, BRAIN INJURY PROFESS, V6; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Savage RC, 1995, PERSPECT NETW, pV; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schootman M, 2000, BRAIN INJURY, V14, P373; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 2015, J HEAD TRAUMA REHAB, V4, P1; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	82	22	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					378	384		10.1097/HTR.0000000000000318			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100093	28520668	Green Accepted			2022-02-06	
J	Espindola, D; Lee, S; Pinton, G				Espindola, David; Lee, Stephen; Pinton, Gianmarco			Shear Shock Waves Observed in the Brain	PHYSICAL REVIEW APPLIED			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; COLLEGIATE FOOTBALL PLAYERS; TISSUE-EQUIVALENT PHANTOMS; HEAD IMPACT EXPOSURE; TRANSIENT ELASTOGRAPHY; SOFT SOLIDS; INJURY; ULTRASOUND; DEFORMATION; PROPAGATION	The internal deformation of the brain is far more complex than the rigid motion of the skull. An ultrasound imaging technique that we have developed has a combination of penetration, frame-rate, and motion-detection accuracy required to directly observe the formation and evolution of shear shock waves in the brain. Experiments at low impacts on the traumatic-brain-injury scale demonstrate that they are spontaneously generated and propagate within the porcine brain. Compared to the initially smooth impact, the acceleration at the shock front is amplified up to a factor of 8.5. This highly localized increase in acceleration suggests that shear shock waves are a previously unappreciated mechanism that could play a significant role in traumatic brain injury.	[Espindola, David] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, 109 Mason Farm Rd,CB 7575, Chapel Hill, NC 27514 USA; North Carolina State Univ, 4130 Engn Bldg 3,CB 7115, Raleigh, NC 27695 USA		Espindola, D (corresponding author), Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, 109 Mason Farm Rd,CB 7575, Chapel Hill, NC 27514 USA.	david.espindola@unc.edu; gfp@unc.edu	Espindola, DAVID/M-9318-2019	Espindola, DAVID/0000-0001-6675-9560	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS091195]	The authors would like to acknowledge funding from the National Institutes of Health (Grant No. R01-NS091195). They would also like to thank Gregg Trahey and Francisco Melo for their comments on the manuscript.	Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Burgers J.M., 1948, ADV APPL MECH, V1, P171, DOI [DOI 10.1016/S0065-2156(08)70100-5, 10.1016/S0065-2156(08)70100-5]; Catheline S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.164301; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Duck F.A., 1990, PHYS PROPERTIES TISS; Giammarinaro B, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032643; Goriely A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.138001; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hamhaber U, 2010, J MAGN RESON IMAGING, V32, P577, DOI 10.1002/jmri.22294; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Landau L. D., 1959, COURSE THEORETICAL P, V7; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Oppenheim A. V., 1983, SIGNALS SYSTEMS, V2; Park JH, 2015, P NATL ACAD SCI USA, V112, P9236, DOI 10.1073/pnas.1505939112; Pinton G, 2014, IEEE T ULTRASON FERR, V61, P1489, DOI 10.1109/TUFFC.2014.3063; Pinton G, 2012, IEEE INT ULTRA SYM, P142, DOI 10.1109/ULTSYM.2012.0035; Pinton G, 2010, J ACOUST SOC AM, V127, P683, DOI 10.1121/1.3277202; Pinton GF, 2006, IEEE T ULTRASON FERR, V53, P1103, DOI 10.1109/TUFFC.2006.1642509; Pinton GF, 2017, IEEE T ULTRASON FERR, V64, P537, DOI 10.1109/TUFFC.2016.2638801; Pinton GF, 2011, IEEE T ULTRASON FERR, V58, P754, DOI 10.1109/TUFFC.2011.1868; Razani M, 2014, BIOMED OPT EXPRESS, V5, P895, DOI 10.1364/BOE.5.000895; Razani M, 2012, BIOMED OPT EXPRESS, V3, P972, DOI 10.1364/BOE.3.000972; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rusanov V., 1970, J COMPUT PHYS, V5, P507, DOI DOI 10.1016/0021-9991(70)90077-X; Song SZ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.121505; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Tanter M, 2002, IEEE T ULTRASON FERR, V49, P1363, DOI 10.1109/TUFFC.2002.1041078; WHITHAM GB, 1974, PURE APPL MATH; Wochner MS, 2008, J ACOUST SOC AM, V123, P2488, DOI 10.1121/1.2890739; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zabolotskaya EA, 2004, J ACOUST SOC AM, V116, P2807, DOI 10.1121/1.1802533	40	22	22	0	13	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	2331-7019			PHYS REV APPL	Phys. Rev. Appl.	OCT 31	2017	8	4							044024	10.1103/PhysRevApplied.8.044024			9	Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Physics	FL2GY	WOS:000414034600001		Green Submitted, hybrid			2022-02-06	
J	Mukhamedshina, YO; Akhmetzyanova, ER; Martynova, EV; Khaiboullina, SF; Galieva, LR; Rizvanov, AA				Mukhamedshina, Yana O.; Akhmetzyanova, Elvira R.; Martynova, Ekaterina V.; Khaiboullina, Svetlana F.; Galieva, Luisa R.; Rizvanov, Albert A.			Systemic and Local Cytokine Profile following Spinal Cord Injury in Rats: A Multiplex Analysis	FRONTIERS IN NEUROLOGY			English	Article						spinal cord injury; acute and subacute periods; multiplex analysis; cytokine profile; rats	CHEMOATTRACTANT PROTEIN-1 EXPRESSION; INDUCED NEUTROPHIL CHEMOATTRACTANT; TRAUMATIC BRAIN-INJURY; ISCHEMIC BRAIN; CHEMOKINE; INFLAMMATION; RECEPTOR; ASTROCYTES; STROKE; CELLS	Our study of the changes in cytokine profile in blood serum and in the spinal cord after traumatic spinal cord injury (SCI) has shown that an inflammatory reaction and immunological response are not limited to the CNS, but widespread. This fact was confirmed by changes detected in a cytokine profile in blood serum samples [MIP-1 alpha, interleukin 1 (IL-1) alpha, IL-2, IL-5, IL-1 beta, MCP-1, RANTES]. There were also changes in the levels of MIP-1 alpha, IL-1 alpha, IL-2, IL-5, IL-18, GM-colony-stimulating factor, IL-17 alpha, IFN-gamma, IL-10, IL-13, MCP-1, and GRO KC CINC-1 in samples of the rat injured spinal cord. The results underscore the complex cytokine network imbalance exhibited after SCI and show significant changes in the concentrations of 14 cytokines/chemokines with different inflammatory and immunological activities.	[Mukhamedshina, Yana O.; Akhmetzyanova, Elvira R.; Martynova, Ekaterina V.; Khaiboullina, Svetlana F.; Galieva, Luisa R.; Rizvanov, Albert A.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Mukhamedshina, Yana O.] Kazan State Med Univ, Kazan, Russia; [Khaiboullina, Svetlana F.] Univ Nevada, Reno, NV 89557 USA		Mukhamedshina, YO (corresponding author), Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.; Mukhamedshina, YO (corresponding author), Kazan State Med Univ, Kazan, Russia.	yana.k-z-n@mail.ru	Rizvanov, Albert/H-4486-2013; Khaiboullina, Svetlana/M-4793-2016; Akhmetzyanova, Elvira/Q-8062-2017	Rizvanov, Albert/0000-0002-9427-5739; Khaiboullina, Svetlana/0000-0002-5064-570X; Akhmetzyanova, Elvira/0000-0002-5751-6759	Russian FederationRussian Federation [MK-1894.2017.7]; Ministry of Education and Science of Russian FederationMinistry of Education and Science, Russian Federation [20.5175.2017/6.7]	The study was supported by a Presidential Grant for government support of young scientists (PhD, YM) from the Russian Federation (MK-1894.2017.7). AR was supported by state assignment 20.5175.2017/6.7 ("Leading Researcher") of the Ministry of Education and Science of Russian Federation. This work was performed in accordance with the Program of Competitive Growth of the Kazan Federal University and a subsidy allocated to the Kazan Federal University for the state assignment in the sphere of scientific activities.	Alberts B., 2002, HELPER T CELLS LYMPH; Arakelyan A, 2005, MEDIAT INFLAMM, P175, DOI 10.1155/MI.2005.175; BARNA BP, 1994, J NEUROIMMUNOL, V50, P101, DOI 10.1016/0165-5728(94)90220-8; Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; BROWN Z, 1992, KIDNEY INT, V42, P95, DOI 10.1038/ki.1992.266; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; Deo SS, 2010, LUNG INDIA, V27, P66, DOI 10.4103/0970-2113.63609; Dickensheets HL, 1997, J IMMUNOL, V159, P6226; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Imitola J, 2005, PHARMACOL THERAPEUT, V106, P163, DOI 10.1016/j.pharmthera.2004.11.007; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Konyuchenko EA, 2014, FUNDAM RES, V7, P974; Kothur K, 2016, CYTOKINE, V77, P227, DOI 10.1016/j.cyto.2015.10.001; Laliberte AM, 2013, EXP NEUROL, V247, P282, DOI 10.1016/j.expneurol.2013.01.008; Lobo-Silva D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0763-8; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Odinak MM, 2003, B RUSSIAN MIL MED AC, V2, P97; Othieno C, 1999, INFECT IMMUN, V67, P5730, DOI 10.1128/IAI.67.11.5730-5735.1999; Ren M, 2010, EMBO J, V29, P3952, DOI 10.1038/emboj.2010.256; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Romagnani S, 2002, MOL IMMUNOL, V38, P881, DOI 10.1016/S0161-5890(02)00013-5; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schmitz T, 2008, THESCIENTIFICWORLDJO, V8, P1119, DOI 10.1100/tsw.2008.140; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P3387, DOI 10.1167/iovs.08-1691; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; VOJDANI A, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP063; WANG XK, 1995, STROKE, V26, P661, DOI 10.1161/01.STR.26.4.661; WU XB, 1994, J CLIN INVEST, V94, P337, DOI 10.1172/JCI117326; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang ZJ, 2013, PAIN, V154, P2185, DOI 10.1016/j.pain.2013.07.002; Zhou XL, 2015, J NEUROCHEM, V134, P125, DOI 10.1111/jnc.13111; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	43	22	24	0	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 31	2017	8								581	10.3389/fneur.2017.00581			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL1XL	WOS:000414007600001	29163344	Green Published, gold			2022-02-06	
J	Minogue, AM				Minogue, Aedin M.			Role of infiltrating monocytes/macrophages in acute and chronic neuroinflammation: Effects on cognition, learning and affective behaviour	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Article						Macrophage; Cognition; M1/M2 polarisation; Neuroinflammation; Alzheimer's disease; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MARROW-DERIVED MACROPHAGES; CENTRAL-NERVOUS-SYSTEM; BARRIER PERMEABILITY; ALZHEIMERS-DISEASE; INFLAMMATORY STIMULI; A-BETA-PP/PS1 MICE; CELL INFILTRATION; APP/PS1 MICE; ACTIVATION	Peripheral macrophages have limited capacity to gain access to the brain parenchyma under normal physiological conditions. However, accumulating evidence indicates that significant trafficking to the central nervous systems occurs in response to injury or infection and is also apparent under chronic neuroinflammatory conditions. The role of infiltrating macrophages in neuronal function is unclear and confounded by the similarity in morphology and phenotype adopted by both activated macrophages and microglia. Furthermore, the ability of macrophages/microglia to adopt both pro- and anti-inflammatory activation states, along with the fact that these cells display heterogenous expression of molecules associated with both states, has made it difficult to discover their impact upon neuronal injury and cognitive processes. The ability of macrophages to exert a neuroprotective role is influenced by the microenvironment they encounter upon tissue invasion. Upon encountering an inflammatory microenvironment, macrophage polarisation is driven towards a pro-inflammatory (M1) phenotype, a state associated with reduced capacity for restorative processes such as the removal of debris, and enhanced production of pro-inflammatory mediators such as TNF alpha, IL-1 beta and NADPH oxidase. Prolonged production of these inflammatory mediators has been shown to affect neuronal function and health. Thus, macrophage polarisation may be dictated by the inflammatory queues these cells are exposed to upon migration and their subsequent impact on neuronal function may be determined by their ability to resolve the underlying inflammation. (c) 2017 Elsevier Inc. All rights reserved.	[Minogue, Aedin M.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dept Physiol, 152-160 Pearse St, Dublin 2, Ireland; [Minogue, Aedin M.] Trinity Coll Dublin, Trinity Coll, Inst Neurosci, Lloyd Bldg, Dublin 2, Ireland		Minogue, AM (corresponding author), Trinity Coll Dublin, Trinity Coll, Inst Neurosci, Lloyd Bldg, Dublin 2, Ireland.	aminogu@tcd.ie					Barrett JP, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0287-7; Barrett JP, 2015, J ALZHEIMERS DIS, V44, P949, DOI 10.3233/JAD-142076; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Blau CW, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.035; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Chung YC, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.100; Costello DA, 2016, NEUROBIOL AGING, V43, P140, DOI 10.1016/j.neurobiolaging.2016.04.001; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Girard S, 2013, GLIA, V61, P813, DOI 10.1002/glia.22478; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Kapellos TS, 2016, BIOCHEM PHARMACOL, V116, P107, DOI 10.1016/j.bcp.2016.07.011; Kelly RJ, 2013, J ALZHEIMERS DIS, V37, P63, DOI 10.3233/JAD-130539; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lee W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0324-6; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Luth HJ, 2001, BRAIN RES, V913, P57, DOI 10.1016/S0006-8993(01)02758-5; McKim DB, 2016, J NEUROSCI, V36, P2590, DOI 10.1523/JNEUROSCI.2394-15.2016; McManus RM, 2014, NEUROBIOL AGING, V35, P109, DOI 10.1016/j.neurobiolaging.2013.07.025; Minogue AM, 2014, NEUROBIOL AGING, V35, P1442, DOI 10.1016/j.neurobiolaging.2013.12.026; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rawji KS, 2016, BRAIN, V139, P653, DOI 10.1093/brain/awv395; Starr JM, 2009, PSYCHIAT RES-NEUROIM, V171, P232, DOI 10.1016/j.pscychresns.2008.04.003; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Zhu D, 2016, J ALZHEIMERS DIS, V52, P483, DOI 10.3233/JAD-151090	34	22	23	0	68	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	OCT 3	2017	79		A		SI		15	18		10.1016/j.pnpbp.2017.02.008			4	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	EZ9LN	WOS:000405052000003	28189704				2022-02-06	
J	Enam, SF; Krieger, JR; Saxena, T; Watts, BE; Olingy, CE; Botchwey, EA; Bellamkonda, RV				Enam, Syed Faaiz; Krieger, Jack R.; Saxena, Tarun; Watts, Brian E.; Olingy, Claire E.; Botchwey, Edward A.; Bellamkonda, Ravi V.			Enrichment of endogenous fractalkine and anti-inflammatory cells via aptamer-functionalized hydrogels	BIOMATERIALS			English	Article						Fractalkine; Macrophage; Monocyte; Inflammation; Aptamer; Endogenous	TRAUMATIC BRAIN-INJURY; SPINAL-CORD; RECEPTOR CX(3)CR1; NONCLASSICAL MONOCYTES; CHEMOKINE FRACTALKINE; EXOGENOUS FRACTALKINE; ENDOTHELIAL-CELLS; BLOOD MONOCYTES; GROWTH-FACTORS; TISSUE-REPAIR	Early recruitment of non-classical monocytes and their macrophage derivatives is associated with augmented tissue repair and improved integration of biomaterial constructs. A promising therapeutic approach to recruit these subpopulations is by elevating local concentrations of chemoattractants such as fractalkine (FKN, CX3CL1). However, delivering recombinant or purified proteins is not ideal due to their short half-lives, suboptimal efficacy, immunogenic potential, batch variabilities, and cost. Here we report an approach to enrich endogenous FKN, obviating the need for delivery of exogenous proteins. In this study, modified FKN-binding-aptamers are integrated with poly(ethylene glycol) diacrylate to form aptamer-functionalized hydrogels ("aptagels") that localize, dramatically enrich and passively release FKN in vitro for at least one week. Implantation in a mouse model of excisional skin injury demonstrates that aptagels enrich endogenous FKN and stimulate significant local increases in Ly6C(lo)CX3CR1(hi) non-classical monocytes and CD206(+) M2-like macrophages. The results demonstrate that orchestrators of inflammation can be manipulated without delivery of foreign proteins or cells and FKN-aptamer functionalized biomaterials may be a promising approach to recruit anti-inflammatory subpopulations to sites of injury. Aptagels are readily synthesized, highly customizable and could combine different aptamers to treat complex diseases in which regulation or enrichment of multiple proteins may be therapeutic. (C) 2017 Elsevier Ltd. All rights reserved.	[Enam, Syed Faaiz; Saxena, Tarun; Bellamkonda, Ravi V.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Krieger, Jack R.; Olingy, Claire E.; Botchwey, Edward A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Krieger, Jack R.; Olingy, Claire E.; Botchwey, Edward A.] Emory Sch Med, Atlanta, GA 30332 USA; [Watts, Brian E.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27708 USA		Bellamkonda, RV (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	ravi@duke.edu		Enam, Syed Faaiz/0000-0002-5320-6809; Watts, Brian/0000-0003-1731-2441			Acquah C, 2015, ANAL CHIM ACTA, V888, P10, DOI 10.1016/j.aca.2015.05.050; Panek CA, 2015, CELL MOL IMMUNOL, V12, P669, DOI 10.1038/cmi.2014.116; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110; Battig MR, 2014, BIOMATERIALS, V35, P8040, DOI 10.1016/j.biomaterials.2014.06.001; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Blazquez R, 2016, ACTA BIOMATER, V31, P221, DOI 10.1016/j.actbio.2015.11.057; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Brinks V, 2013, PHARM RES-DORDR, V30, P1719, DOI 10.1007/s11095-013-1062-z; Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510; Brown Larry R, 2005, Expert Opin Drug Deliv, V2, P29, DOI 10.1517/17425247.2.1.29; Carlin L.M., 2001, CURR PROTOC IMMUNOL; Cipriani R, 2011, J NEUROSCI, V31, P16327, DOI 10.1523/JNEUROSCI.3611-11.2011; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Das A, 2015, BIOMATERIALS, V64, P98, DOI 10.1016/j.biomaterials.2015.06.019; Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015; Dickey DD, 2016, METHODS, V97, P94, DOI 10.1016/j.ymeth.2015.11.020; Donohue MM, 2012, STROKE, V43, P2300, DOI 10.1161/STROKEAHA.112.657411; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Gaetani P, 2013, J NEUROSURG SCI, V57, P55; Gao SX, 2016, ANAL BIOANAL CHEM, V408, P4567, DOI 10.1007/s00216-016-9556-2; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; He M, 2009, SHOCK, V31, P33, DOI 10.1097/SHK.0b013e31817789da; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hu JP, 2017, J MOL MED, V95, P249, DOI 10.1007/s00109-016-1485-1; Hu PP, 2017, INFLAMMATION, V40, P295, DOI 10.1007/s10753-016-0437-9; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kanwar JR, 2015, CURR MED CHEM, V22, P2539, DOI 10.2174/0929867322666150227144909; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim MS, 2014, J COSMET DERMATOL-US, V13, P44, DOI 10.1111/jocd.12073; Kong HY, 2013, BIOMOL THER, V21, P423, DOI 10.4062/biomolther.2013.085; Krieger JR, 2016, BIOMATERIALS, V77, P280, DOI 10.1016/j.biomaterials.2015.10.045; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lao YH, 2015, ACS NANO, V9, P2235, DOI 10.1021/nn507494p; Lapa SA, 2016, MOL BIOTECHNOL, V58, P79, DOI 10.1007/s12033-015-9907-9; Lee MJ, 2011, CYTOTHERAPY, V13, P165, DOI 10.3109/14653249.2010.512632; Lee SI, 2010, J NEUROSCI RES, V88, P2409, DOI 10.1002/jnr.22411; Li J, 2016, INFLAMMATION, V39, P1704, DOI 10.1007/s10753-016-0405-4; Liu B, 2014, J BIOMED NANOTECHNOL, V10, P3189, DOI 10.1166/jbn.2014.1839; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P402, DOI 10.1038/icb.2013.16; Mokarram N, 2017, P NATL ACAD SCI USA, V114, pE5077, DOI 10.1073/pnas.1705757114; Mokarram N, 2014, ANN BIOMED ENG, V42, P338, DOI 10.1007/s10439-013-0941-0; Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nimjee SM, 2017, ANNU REV PHARMACOL, V57, P61, DOI 10.1146/annurev-pharmtox-010716-104558; Ogle M.E., 2017, ACS BIOMATER SCI ENG; Ogle ME, 2016, EXP BIOL MED, V241, P1084, DOI 10.1177/1535370216650293; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Pabon MM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-9; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pastor F, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040064; Qin WJ, 2014, NEUROSCI LETT, V569, P80, DOI 10.1016/j.neulet.2014.03.052; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Reed JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045877; Ryu JC, 2013, CIRCULATION, V127, P710, DOI 10.1161/CIRCULATIONAHA.112.116103; San Emeterio CL, 2017, BIOMATERIALS, V117, P32, DOI 10.1016/j.biomaterials.2016.11.021; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Shastri A, 2015, NAT CHEM, V7, P447, DOI [10.1038/NCHEM.2203, 10.1038/nchem.2203]; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Slusarczyk J, 2016, BIOCHEM PHARMACOL, V113, P45, DOI 10.1016/j.bcp.2016.05.008; Smith A, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2342187; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Strohl WR, 2015, BIODRUGS, V29, P215, DOI 10.1007/s40259-015-0133-6; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Vasconcelos DP, 2015, BIOMATERIALS, V53, P566, DOI 10.1016/j.biomaterials.2015.02.120; Vorobyeva M, 2016, MOLECULES, V21, DOI 10.3390/molecules21121613; Vugmeyster Yulia, 2012, World J Biol Chem, V3, P73, DOI 10.4331/wjbc.v3.i4.73; Wang RE, 2011, CURR MED CHEM, V18, P4126; Waybrant B, 2014, LANGMUIR, V30, P7465, DOI 10.1021/la500403v; Waybrant B, 2012, CHEM COMMUN, V48, P10043, DOI 10.1039/c2cc34217k; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; White GE, 2014, ARTERIOSCL THROM VAS, V34, P2554, DOI 10.1161/ATVBAHA.114.304717; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; Zhao WM, 2016, FASEB J, V30, P380, DOI 10.1096/fj.14-270090; Zheng FY, 2014, ADV MATER, V26, P7333, DOI 10.1002/adma.201403530; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	87	22	22	6	82	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	OCT	2017	142						52	61		10.1016/j.biomaterials.2017.07.013			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	FE4IW	WOS:000408178600005	28727998				2022-02-06	
J	Scheenen, ME; Visser-Keizer, AC; de Koning, ME; van der Horn, HJ; van de Sande, P; van Kessel, M; van der Naalt, J; Spikman, JM				Scheenen, Myrthe E.; Visser-Keizer, Annemarie C.; de Koning, Myrthe E.; van der Horn, Harm J.; van de Sande, Peter; van Kessel, Marlies; van der Naalt, Joukje; Spikman, Jacoba M.			Cognitive Behavioral Intervention Compared to Telephone Counseling Early after Mild Traumatic Brain Injury: A Randomized Trial	JOURNAL OF NEUROTRAUMA			English	Article						cognitive behavioral therapy; intervention; mild traumatic brain injury; telephone counseling	HEAD-INJURY; POSTCONCUSSION SYNDROME; DEPRESSION SCALE; HOSPITAL ANXIETY; FOLLOW-UP; COMPLAINTS; SYMPTOMS; RISK; PREVENTION; STRESS	Many patients do not return to work (RTW) after mild traumatic brain injury (mTBI) because of persistent complaints that are often resistant to therapy in the chronic phase. Recent studies suggest that psychological interventions should be implemented early post-injury to prevent patients from developing chronic complaints. This study is a randomized, controlled trial that examines the effectiveness of a newly developed cognitive behavioral therapy (CBT) intervention (CBTi) compared to telephonic counseling (TC) in at-risk mTBI patients (patients with high reports of early complaints). Patients underwent either five sessions of CBT treatment or five phone conversations starting 4-6 weeks post-trauma. The main outcome measure was RTW 6 and 12 months post-trauma. Secondary measures comprised functional outcome at 6 and 12 months, and depression, anxiety, and reported post-traumatic complaints at 3, 6, and 12 months post-injury. After excluding dropouts, CBTi consisted of 39 patients and TC of 45 patients. No significant differences were found with regard to RTW, with 65% of CBTi patients and 67% of TC patients reporting a RTW at previous level. However, TC patients reported fewer complaints at 3 (8 vs. 6; p = 0.010) and 12 months post-injury (9 vs. 5; p = 0.006), and more patients in the TC group showed a full recovery 12 months post-injury compared to the CBTi group (62% vs. 39%). The results of this study suggest that early follow-up of at-risk patients can have a positive influence on patients' well-being, and that a low-intensive, low-cost telephonic intervention might be more effective than a CBT intervention at improving outcome in at-risk patients.	[Scheenen, Myrthe E.; Visser-Keizer, Annemarie C.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [van de Sande, Peter] Elisabeth Tweesteden Hosp, Dept Med Psychol, Tilburg, Netherlands; [van Kessel, Marlies] Med Spectrum Twente Enschede, Dept Med Psychol, Enschede, Netherlands		Spikman, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.m.spikman@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dawson DR, 2006, BRAIN COGNITION, V60, P214; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Elfering A, 2006, EUR SPINE J, V15, pS32, DOI 10.1007/s00586-005-1047-7; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; IBM Corporation, 2013, IBM SPSS STAT WINDOW; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Rozental A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157503; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Scheenen M. E., 2017, CLIN REHABIL; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Snell D.L., 2011, BRAIN INJURY, V25; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Zedlitz AMEE, 2012, STROKE, V43, P1046, DOI 10.1161/STROKEAHA.111.632117; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	22	22	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2713	2720		10.1089/neu.2016.4885			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700006	28335664	Green Submitted			2022-02-06	
J	Denninghoff, KR; Nuno, T; Pauls, Q; Yeatts, SD; Silbergleit, R; Palesch, YY; Merck, LH; Manley, GT; Wright, DW				Denninghoff, Kurt R.; Nuno, Tomas; Pauls, Qi; Yeatts, Sharon D.; Silbergleit, Robert; Palesch, Yuko Y.; Merck, Lisa H.; Manley, Geoff T.; Wright, David W.			Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III	PREHOSPITAL EMERGENCY CARE			English	Article						prehospital intubation; traumatic brain injury; TBI; air ambulance; ground transport; outcomes	TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; HYPERVENTILATION; VENTILATION	Objective: Traumatic brain injury (TBI) causes more than 2.5 million emergency department visits, hospitalizations, or deaths annually. Prehospital endotracheal intubation has been associated with poor outcomes in patients with TBI in several retrospective observational studies. We evaluated the relationship between prehospital intubation, functional outcomes, and mortality using high quality data on clinical practice collected prospectively during a randomized multicenter clinical trial. Methods: ProTECT III was a multicenter randomized, double-blind, placebo-controlled trial of early administration of progesterone in 882 patients with acute moderate to severe nonpenetrating TBI. Patients were excluded if they had an index GCS of 3 and nonreactive pupils, those with withdrawal of life support on arrival, and if they had documented prolonged hypotension and/or hypoxia. Prehospital intubation was performed as per local clinical protocol in each participating EMS system. Models for favorable outcome and mortality included prehospital intubation, method of transport, index GCS, age, race, and ethnicity as independent variables. Significance was set at = 0.05. Favorable outcome was defined by a stratified dichotomy of the GOS-E scores in which the definition of favorable outcome depended on the severity of the initial injury. Results: Favorable outcome was more frequent in the 349 subjects with prehospital intubation (57.3%) than in the other 533 patients (46.0%, p = 0.003). Mortality was also lower in the prehospital intubation group (13.8% v. 19.5%, p = 0.03). Logistic regression analysis of prehospital intubation and mortality, adjusted for index GCS, showed that odds of dying for those with prehospital intubation were 47% lower than for those that were not intubated (OR = 0.53, 95% CI = 0.36-0.78). 279 patients with prehospital intubation were transported by air. Modeling transport method and mortality, adjusted for index GCS, showed increased odds of dying in those transported by ground compared to those transported by air (OR = 2.10, 95% CI = 1.40-3.15). Decreased odds of dying trended among those with prehospital intubation adjusted for transport method, index GCS score at randomization, age, and race/ethnicity (OR = 0.70, 95% CI = 0.37-1.31). Conclusions: In this study that excluded moribund patients, prehospital intubation was performed primarily in patients transported by air. Prehospital intubation and air medical transport together were associated with favorable outcomes and lower mortality. Prehospital intubation was not associated with increased morbidity or mortality regardless of transport method or severity of injury.	[Denninghoff, Kurt R.] Univ Arizona, Emergency Med, Tucson, AZ 85721 USA; [Nuno, Tomas] Univ Arizona, Coll Med, Emergency Med, Tucson, AZ USA; [Pauls, Qi; Yeatts, Sharon D.; Palesch, Yuko Y.] Med Univ South Carolina, Charleston, SC USA; [Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Merck, Lisa H.] Brown Univ, Alpert Med Sch, Diagnost Imaging & Emergency Med, Providence, RI 02912 USA; [Manley, Geoff T.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wright, David W.] Emory Univ, Atlanta, GA 30322 USA		Denninghoff, KR (corresponding author), Univ Arizona, Emergency Med, Tucson, AZ 85721 USA.	kdenninghoff@aemrc.arizona.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10 NS059032, U01 NS059041, U10 NS058962, U01 NS056975, U01 NS062778] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS062778, U10NS059032] Funding Source: NIH RePORTER		Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gaither JB, 2012, ANN EMERG MED, V60, P732, DOI 10.1016/j.annemergmed.2012.06.017; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Noth U, 2008, NMR BIOMED, V21, P464, DOI 10.1002/nbm.1210; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	18	22	22	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	SEP-OCT	2017	21	5					539	544		10.1080/10903127.2017.1315201			6	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	FH1YU	WOS:000410936500001	28489506	Green Accepted			2022-02-06	
J	Yue, JK; Robinson, CK; Burke, JF; Winkler, EA; Deng, HS; Cnossen, MC; Lingsma, HF; Ferguson, AR; McAllister, TW; Rosand, J; Burchard, EG; Sorani, MD; Sharma, S; Nielson, JL; Satris, GG; Talbott, JF; Tarapore, PE; Korley, FK; Wang, KKW; Yuh, EL; Mukherjee, P; Diaz-Arrastia, R; Valadka, AB; Okonkwo, DO; Manley, GT				Yue, John K.; Robinson, Caitlin K.; Burke, John F.; Winkler, Ethan A.; Deng, Hansen; Cnossen, Maryse C.; Lingsma, Hester F.; Ferguson, Adam R.; McAllister, Thomas W.; Rosand, Jonathan; Burchard, Esteban G.; Sorani, Marco D.; Sharma, Sourabh; Nielson, Jessica L.; Satris, Gabriela G.; Talbott, Jason F.; Tarapore, Phiroz E.; Korley, Frederick K.; Wang, Kevin K. W.; Yuh, Esther L.; Mukherjee, Pratik; Diaz-Arrastia, Ramon; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.		TRACK-TBI Investigators	Apolipoprotein E epsilon 4 (APOE-epsilon 4) genotype is associated with decreased 6-month verbal memory performance after mild traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						apolipoprotein E; genetic factors; human studies; outcome measures; traumatic brain injury; verbal memory	COMMON DATA ELEMENTS; HEAD-INJURY; LEARNING TEST; E EPSILON-4; E POLYMORPHISM; APOE GENOTYPE; RECOVERY; MODERATE; ALLELE; AGE	Introduction: The apolipoprotein E (APOE) epsilon 4 allele associates with memory impairment in neurodegenerative diseases. Its association with memory after mild traumatic brain injury (mTBI) is unclear. Methods: mTBI patients (Glasgow Coma Scale score 13-15, no neurosurgical intervention, extracranial Abbreviated Injury Scale score <= 1) aged >= 18 years with APOE genotyping results were extracted from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study. Cohorts determined by APOE-epsilon 4(+/-) were assessed for associations with 6-month verbal memory, measured by California Verbal Learning Test, Second Edition (CVLT-II) subscales: Immediate Recall Trials 1-5 (IRT), Short-Delay Free Recall (SDFR), Short-Delay Cued Recall (SDCR), Long-Delay Free Recall (LDFR), and Long-Delay Cued Recall (LDCR). Multivariable regression controlled for demographic factors, seizure history, loss of consciousness, posttraumatic amnesia, and acute intracranial pathology on computed tomography (CT). Results: In 114 mTBI patients (APOE-epsilon 4(-) = 79; APOE-epsilon 4(+)=35), ApoE-epsilon 4(+) was associated with long-delay verbal memory deficits (LDFR: B = -1.17 points, 95% CI [-2.33, -0.01], p = .049; LDCR: B = -1.58 [-2.63, -0.52], p = .004), and a marginal decrease on SDCR (B = -1.02 [-2.05, 0.00], p = .050). CT pathology was the strongest predictor of decreased verbal memory (IRT: B = -8.49, SDFR: B = -2.50, SDCR: B = -1.85, LDFR: B = -2.61, LDCR: B = -2.60; p < .001). Seizure history was associated with decreased short-term memory (SDFR: B = -1.32, p = .037; SDCR: B = -1.44, p = .038). Conclusion: The APOE-epsilon 4 allele may confer an increased risk of impairment of 6-month verbal memory for patients suffering mTBI, with implications for heightened surveillance and targeted therapies. Acute intracranial pathology remains the driver of decreased verbal memory performance at 6 months after mTBI.	[Yue, John K.; Robinson, Caitlin K.; Burke, John F.; Winkler, Ethan A.; Deng, Hansen; Ferguson, Adam R.; Sorani, Marco D.; Sharma, Sourabh; Nielson, Jessica L.; Satris, Gabriela G.; Tarapore, Phiroz E.; Yuh, Esther L.; Mukherjee, Pratik; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Yue, John K.; Robinson, Caitlin K.; Burke, John F.; Winkler, Ethan A.; Deng, Hansen; Ferguson, Adam R.; Sorani, Marco D.; Nielson, Jessica L.; Satris, Gabriela G.; Tarapore, Phiroz E.; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Cnossen, Maryse C.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Rosand, Jonathan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Rosand, Jonathan] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Sharma, Sourabh] Loyola Univ, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA; [Talbott, Jason F.; Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Korley, Frederick K.] Univ Michigan Ann Arbor, Dept Emergency Med, Ann Arbor, MI USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Gainesville, FL USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Gainesville, FL USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	manleyg@neurosurg.ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Burke, John/0000-0002-6190-5116; Nielson, Jessica/0000-0002-3677-3959; Wang, Kevin/0000-0002-9343-6473; Ferguson, Adam/0000-0001-7102-1608	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US DODUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]	This work was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03; US DOD W81XWH-13-1-0441, US DOD W81XWH-14-2-0176 (to G. T. M.)	Albert SM, 1999, AM J PUBLIC HEALTH, V89, P95, DOI 10.2105/AJPH.89.1.95; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Aoki K, 2003, STROKE, V34, P875, DOI 10.1161/01.STR.0000064320.73388.C6; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Berl MM, 2005, NEUROLOGY, V65, P1604, DOI 10.1212/01.wnl.0000184502.06647.28; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Blake RV, 2000, BRAIN, V123, P472, DOI 10.1093/brain/123.3.472; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Davis JJ, 2016, ARCH CLIN NEUROPSYCH, V31, P802, DOI 10.1093/arclin/acw058; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dotson VM, 2009, J INT NEUROPSYCH SOC, V15, P580, DOI 10.1017/S1355617709090821; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Fagan AM, 2000, MICROSC RES TECHNIQ, V50, P297, DOI 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gasquoine PG, 2009, NEUROPSYCHOL REV, V19, P250, DOI 10.1007/s11065-009-9090-5; Gavett BE, 2016, J ALZHEIMERS DIS, V49, P531, DOI 10.3233/JAD-150252; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Grocott HP, 2001, J THORAC CARDIOV SUR, V122, P622, DOI 10.1067/mtc.2001.115152; Gu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123743; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hanks RA, 2016, CLIN NEUROPSYCHOL, V30, P1074, DOI 10.1080/13854046.2016.1194479; Hauser PS, 2013, CURR ALZHEIMER RES, V10, P809; Howell D. C, 2013, STAT METHODS PSYCHOL; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kaup AR, 2015, JAMA NEUROL, V72, P340, DOI 10.1001/jamaneurol.2014.3978; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kern S, 2015, AM J EPIDEMIOL, V181, P214, DOI 10.1093/aje/kwu442; Kerr ME, 1999, ADV EXP MED BIOL, V471, P117; Lange KL, 2002, J INT NEUROPSYCH SOC, V8, P943, DOI 10.1017/S1355617702870096; Lenihan MW, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0541-5; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Orihara Y, 2002, INT J LEGAL MED, V116, P92, DOI 10.1007/s00414-001-0265-8; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Paolo AM, 1997, J CLIN EXP NEUROPSYC, V19, P220, DOI 10.1080/01688639708403853; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Saito H, 2003, J BIOL CHEM, V278, P40723, DOI 10.1074/jbc.M304814200; Schefft BK, 2008, EPILEPSY BEHAV, V13, P162, DOI 10.1016/j.yebeh.2008.01.012; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Strittmatter WJ, 2002, CURR OPIN LIPIDOL, V13, P119, DOI 10.1097/00041433-200204000-00002; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Treble-Barna A, 2016, J INT NEUROPSYCH SOC, V22, P859, DOI 10.1017/S1355617716000631; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; WIENS AN, 1994, CLIN NEUROPSYCHOL, V8, P75, DOI 10.1080/13854049408401545; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zlatar ZZ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00151	92	22	22	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	SEP	2017	7	9							e00791	10.1002/brb3.791			13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FH7KZ	WOS:000411368500022	28948085	Green Published, gold			2022-02-06	
J	Sun, LQ; Zhao, MM; Zhang, JB; Liu, AH; Ji, WJ; Li, YX; Yang, XJ; Wu, ZX				Sun, Liqian; Zhao, Manman; Zhang, Jingbo; Liu, Aihua; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue			MiR-144 promotes beta-amyloid accumulation-induced cognitive impairments by targeting ADAM10 following traumatic brain injury	ONCOTARGET			English	Article						miR-144; ADAM10; TBI; cognitive impairment; beta-amyloid	NEURONIC AUTOPHAGY; MICRORNAS; EXPRESSION; HIPPOCAMPUS; ACTIVATION; DISINTEGRIN; ASTROCYTES; RESPONSES	The dysregulation expression of microRNAs (miRNAs) including miR-144, has been widely documented in TBI. However, little is known about the potential roles of miR-144 in the pathogenesis of TBI. In this study, we investigated the potential effects of miR-144 on cognitive function in vivo and in vitro. The results indicated that inhibition of miR-144 conferred a better neurological outcome after TBI in vivo, as evidenced by reduced lesion volume, alleviated brain edema and increased mNSS, of particular importance, improved cognitive deficits. In vitro, miR-144 knockdown protected neuron against Glu-induced injury, by enhancing cell viability, suppressing LDH release and caspase-3 activity, and reducing cognitive-related proteins levels. However, overexpression of miR-144 in vivo and in vitro showed the opposite effects. To further explore the molecular mechanisms underlying miR-144-induced cognitive dysfunctions, we found a significant inverse correlation between miR-144 and ADAM10 expression. Moreover, the direct interaction between miR-144 and ADAM10 3'-UTR was identified by dual-luciferase reporter assay. Also, we found miR-144 negatively regulated ADAM10 protein expression. Additionally, ADAM10 could modulate beta-amyloid formation involved in cognitive deficits. Notably, ADAM10 knockdown by siRNA apparently abrogated miR-144 inhibitor-mediated neuroprotection. Taken together, these findings demonstrated that elevated miR-144 promoted cognitive impairments induced by beta-amyloid accumulation post-TBI through suppressing of ADAM10 expression.	[Sun, Liqian; Zhang, Jingbo; Liu, Aihua; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China; [Sun, Liqian; Zhang, Jingbo; Liu, Aihua; Ji, Wenjun; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Zhao, Manman] North China Univ Sci & Technol, Sch Basic Med Sci, Dept Histol & Embryol, Tangshan 063000, Peoples R China		Sun, LQ (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China.	slq20000@126.com		Yang, Xinjian/0000-0001-7306-0125	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672481]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M580117]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2015ZZ-49, 2016ZZ-38]	This work was supported by a grant from the National Natural Science Foundation of China (No. 81672481), the China Postdoctoral Science Foundation (No. 2015M580117), and the Project supported by Beijing Postdoctoral Research Foundation (No. 2015ZZ-49 and No. 2016ZZ-38).	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Anuj S, 2014, PLOS ONE, V9; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cai H, 2015, ONCOTARGET, V6, P19759, DOI 10.18632/oncotarget.4331; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; Codocedo JF, 2016, MOL NEUROBIOL, V53, P2320, DOI 10.1007/s12035-015-9201-7; Cohen SM, 2009, NAT METHODS, V6, P873, DOI 10.1038/nmeth1209-873; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feng G, 2015, TUMOR BIOL, P1; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatson J, 2012, CIRCULATION, V2795; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gizem D, 2014, CELL, V158, P959; Goedeke L, 2014, NEUROBIOL DIS, V72, P48, DOI 10.1016/j.nbd.2014.05.034; Hartmann D, 2001, J MOL NEUROSCI, V17, P171, DOI 10.1385/JMN:17:2:171; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Kannangara TS, 2015, CEREB CORTEX, V25, P2102, DOI 10.1093/cercor/bhu017; Kapai NA, 2012, CELL MOL NEUROBIOL, V32, P219, DOI 10.1007/s10571-011-9751-9; Kim KM, 2013, BIOMATERIALS, V34, P2694, DOI 10.1016/j.biomaterials.2013.01.012; Kosik KS, 2010, CELL, V143, P21, DOI 10.1016/j.cell.2010.09.008; Kumar A, 2013, J NEUROSCI, V33, P15710, DOI 10.1523/JNEUROSCI.2176-13.2013; Lan FM, 2015, J NEUROCHEM, V135, P274, DOI 10.1111/jnc.13272; Lee ST, 2011, J MOV DISORD, V4, P55, DOI 10.14802/jmd.11011; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li WG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-55; Liang L, 2014, PLOS ONE, V9; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Nicholls RE, 2016, P NATL ACAD SCI USA, V113, P3347, DOI 10.1073/pnas.1521018113; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Ouyang YB, 2014, NEUROSCI LETT, V565, P53, DOI 10.1016/j.neulet.2013.11.015; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Rahn KA, 2012, CURR MED CHEM, V19, P1335; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sachser RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22771; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sun E, 2015, EXP NEUROL, V268, P46, DOI 10.1016/j.expneurol.2014.08.005; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Tian-Hao B, 2014, J MOL NEUROSCI, V54, P1; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Yu D, 2014, J MOL NEUROSCI, V53, P242, DOI 10.1007/s12031-014-0293-8; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang X., 2013, J NANOMATER, V2013, P1, DOI DOI 10.1155/2013/803150	63	22	22	1	6	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	AUG 29	2017	8	35					59181	59203		10.18632/oncotarget.19469			23	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	FF4RD	WOS:000408941900103	28938628	Green Published, gold			2022-02-06	
J	Schiavone, S; Neri, M; Trabace, L; Turillazzi, E				Schiavone, Stefania; Neri, Margherita; Trabace, Luigia; Turillazzi, Emanuela			The NADPH oxidase NOX2 mediates loss of parvalbumin interneurons in traumatic brain injury: human autoptic immunohistochemical evidence	SCIENTIFIC REPORTS			English	Article							OXIDATIVE STRESS; CEREBROSPINAL-FLUID; PATHOPHYSIOLOGY; BIOMARKER; INVOLVEMENT; DYSFUNCTION; INHIBITION	Pharmacological interventions for traumatic brain injury (TBI) are limited. Together with parvalbumin (PV) loss, increased production of reactive oxygen species (ROS) by the NADPH oxidase NOX enzymes represents a key step in TBI. Here, we investigated the contribution of NOX2-derived oxidative stress to the loss of PV immunoreactivity associated to TBI, performing immunohistochemistry for NOX2, 8-hydroxy-2'-deoxyguanosine (8OHdG) and PV on post mortem brain samples of subjects died following TBI, subjects died from spontaneous intracerebral hemorrhage (SICH) and controls (CTRL). We detected an increased NOX2 expression and 8OHdG immunoreactivity in subjects died from TBI with respect to CTRL and SICH. NOX2 increase was mainly observed in GABAergic PV-positive interneurons, with a minor presence in microglia. No significant differences in other NADPH oxidase isoforms (NOX1 and NOX4) were detected among experimental groups. NOX2-derived oxidative stress elevation appeared a specific TBI-induced phenomenon, as no alterations in the nitrosative pathway were detected. Our results suggest that NOX2-derived oxidative stress might play a crucial role in the TBI-induced loss of PV-positive interneurons.	[Schiavone, Stefania; Neri, Margherita; Trabace, Luigia; Turillazzi, Emanuela] Univ Foggia, Dept Clin & Expt Med, Via Napoli 20, I-71122 Foggia, Italy		Trabace, L (corresponding author), Univ Foggia, Dept Clin & Expt Med, Via Napoli 20, I-71122 Foggia, Italy.	luigia.trabace@unifg.it	Neri, Margherita/AAD-4521-2022	trabace, luigia/0000-0003-3073-8404; NERI, Margherita/0000-0002-6459-1669	Intervento cofinanziato dal Fondo di Sviluppo e Coesione - APQ Ricerca Regione Puglia "Programma regionale a sostegno della specializzazione intelligente e della sostenibilita sociale ed ambientale - FutureIn Research", Italy; Pubblicazione realizzata con un contributo sui fondi del 5 x 1000 dell'IRPEF a favore dell'Universita di Foggia, in memoria di Gianluca Montel	This study was supported by Intervento cofinanziato dal Fondo di Sviluppo e Coesione 2007-2013 - APQ Ricerca Regione Puglia "Programma regionale a sostegno della specializzazione intelligente e della sostenibilita sociale ed ambientale - FutureIn Research", Italy to S.S. The open access cost for this paper was supported by "Pubblicazione realizzata con un contributo sui fondi del 5 x 1000 dell'IRPEF a favore dell'Universita di Foggia, in memoria di Gianluca Montel" to LT.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Butterfield D. A., 2016, PROTEOM CLIN APPL, DOI [10.1002/prca.201600003, DOI 10.1002/PRCA.201600003(2016).]; Cahill-Smith S, 2014, BRIT J CLIN PHARMACO, V78, P441, DOI 10.1111/bcp.12357; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Constantinescu R, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00187; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; Herrera-Melero MC, 2015, BRAIN INJURY, V29, P1439, DOI 10.3109/02699052.2015.1071428; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Marrali G, 2014, J NEUROL, V261, P2178, DOI 10.1007/s00415-014-7470-0; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schiavone S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.76; Schiavone S, 2016, J CLIN PSYCHOPHARM, V36, P513, DOI 10.1097/JCP.0000000000000560; Schiavone S, 2016, PHARMACOL RES, V107, P195, DOI 10.1016/j.phrs.2016.03.019; Schiavone S, 2009, BIOL PSYCHIAT, V66, P384, DOI 10.1016/j.biopsych.2009.04.033; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Sorce S, 2010, J NEUROSCI, V30, P11317, DOI 10.1523/JNEUROSCI.1491-10.2010; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Wang X, 2013, ANTIOXID REDOX SIGN, V18, P1444, DOI 10.1089/ars.2012.4907; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zengi O, 2012, CLIN CHEM LAB MED, V50, P529, DOI 10.1515/CCLM.2011.792; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	39	22	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 18	2017	7								8752	10.1038/s41598-017-09202-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE1LP	WOS:000407980000006	28821783	Green Published, gold			2022-02-06	
J	Doig, RLO; Chiha, W; Giacci, MK; Yates, NJ; Bartlett, CA; Smith, NM; Hodgetts, SI; Harvey, AR; Fitzgerald, M				Doig, Ryan L. O'Hare; Chiha, Wissam; Giacci, Marcus K.; Yates, Nathanael J.; Bartlett, Carole A.; Smith, Nicole M.; Hodgetts, Stuart I.; Harvey, Alan R.; Fitzgerald, Melinda			Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma	BMC NEUROSCIENCE			English	Article						Secondary degeneration; Neurotrauma; Traumatic injury; Ion channel inhibitor; Axonal degeneration; Node of Ranvier; Lipid peroxidation; Oligodendrocyte precursor cells; Oxidative stress	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; ACID RECEPTOR ANTAGONIST; PEROXIDATION BY-PRODUCT; OPTIC-NERVE TRANSECTION; NOGO-A EXPRESSION; OXIDATIVE STRESS; WHITE-MATTER; LIPID-PEROXIDATION; ALZHEIMERS-DISEASE	Background: Following partial injury to the central nervous system, cells beyond the initial injury site undergo secondary degeneration, exacerbating loss of neurons, compact myelin and function. Changes in Ca2+ flux are associated with metabolic and structural changes, but it is not yet clear how flux through specific ion channels contributes to the various pathologies. Here, partial optic nerve transection in adult female rats was used to model secondary degeneration. Treatment with combinations of three ion channel inhibitors was used as a tool to investigate which elements of oxidative and structural damage related to long term functional outcomes. The inhibitors employed were the voltage gated Ca2+ channel inhibitor Lomerizine (Lom), the Ca2+ permeable AMPA receptor inhibitor YM872 and the P2X(7) receptor inhibitor oxATP. Results: Following partial optic nerve transection, hyper-phosphorylation of Tau and acetylated tubulin immunoreactivity were increased, and Nogo-A immunoreactivity was decreased, indicating that axonal changes occurred acutely. All combinations of ion channel inhibitors reduced hyper-phosphorylation of Tau and increased Nogo-A immunoreactivity at day 3 after injury. However, only Lom/oxATP or all three inhibitors in combination significantly reduced acetylated tubulin immunoreactivity. Most combinations of ion channel inhibitors were effective in restoring the lengths of the paranode and the paranodal gap, indicative of the length of the node of Ranvier, following injury. However, only all three inhibitors in combination restored to normal Ankyrin G length at the node of Ranvier. Similarly, HNE immunoreactivity and loss of oligodendrocyte precursor cells were only limited by treatment with all three ion channel inhibitors in combination. Conclusions: Data indicate that inhibiting any of a range of ion channels preserves certain elements of axon and node structure and limits some oxidative damage following injury, whereas ionic flux through all three channels must be inhibited to prevent lipid peroxidation and preserve Ankyrin G distribution and OPCs.	[Doig, Ryan L. O'Hare; Chiha, Wissam; Giacci, Marcus K.; Yates, Nathanael J.; Bartlett, Carole A.; Smith, Nicole M.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Doig, Ryan L. O'Hare; Chiha, Wissam; Hodgetts, Stuart I.; Harvey, Alan R.] Univ Western Australia, Sch Human Sci, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Smith, Nicole M.] Univ Western Australia, Sch Chem & Biochem, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Hodgetts, Stuart I.; Harvey, Alan R.; Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Verdun St, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.; Fitzgerald, M (corresponding author), Perron Inst Neurol & Translat Sci, Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011; Yates, Nathanael J/K-8358-2018; Doig, Ryan O'Hare/AAG-7585-2019; Smith, Nicole/L-2502-2013	Fitzgerald, Melinda/0000-0002-4823-8179; Yates, Nathanael J/0000-0003-2742-6952; Smith, Nicole/0000-0002-5519-8152; Hodgetts, Stuart/0000-0002-3318-0410; Giacci, Marcus/0000-0002-8330-678X; , Alan/0000-0002-2590-831X	National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia [APP1061791]; NHMRC Career Development FellowshipNational Health and Medical Research Council of Australia [APP1087114]	We acknowledge financial support from the National Health and Medical Research Council (NHMRC), Australia (APP1061791). MF is supported by an NHMRC Career Development Fellowship (APP1087114). The funding body had no role in the design of the study, collection, analysis, and interpretation of data or in writing the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Agrawal SK, 1996, J NEUROSCI, V16, P545; Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; Back SA, 1998, J NEUROSCI, V18, P6241; Bartholdi D, 1998, GLIA, V23, P278, DOI 10.1002/(SICI)1098-1136(199807)23:3<278::AID-GLIA10>3.0.CO;2-Q; Blanc EM, 1998, GLIA, V22, P149, DOI 10.1002/(SICI)1098-1136(199802)22:2<149::AID-GLIA6>3.0.CO;2-2; Bodhinathan K, 2010, J NEUROPHYSIOL, V104, P2586, DOI 10.1152/jn.00577.2010; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Butt AM, 2004, EYE, V18, P1110, DOI 10.1038/sj.eye.6701595; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Choudhary S, 2006, BASIC CLIN PHARMACOL, V98, P447, DOI 10.1111/j.1742-7843.2006.pto_270.x; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Doig RLO, 2016, NEUROSCIENCE, V339, P450, DOI 10.1016/j.neuroscience.2016.10.005; Doig RLO, 2015, DISCOV MED, V19, P41; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gard AL, 2001, MICROSC RES TECHNIQ, V52, P709, DOI 10.1002/jemt.1055; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hartigan JA, 1999, J BIOL CHEM, V274, P21395, DOI 10.1074/jbc.274.30.21395; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Huber AB, 2002, J NEUROSCI, V22, P3553; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Klein KU, 2010, BEST PRACT RES-CLIN, V24, P535, DOI 10.1016/j.bpa.2010.10.008; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Limbrick DD, 2003, CELL CALCIUM, V33, P69, DOI 10.1016/S0143-4160(02)00054-4; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Lozic I, 2014, METALLOMICS, V6, P455, DOI 10.1039/c3mt00336a; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Mattson MP, 1997, NEUROREPORT, V8, P2275, DOI 10.1097/00001756-199707070-00036; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McCracken E, 2000, J CEREBR BLOOD F MET, V20, P1529, DOI 10.1097/00004647-200011000-00002; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Merrick SE, 1996, J BIOL CHEM, V271, P5589, DOI 10.1074/jbc.271.10.5589; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Montine TJ, 1996, AM J PATHOL, V148, P89; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neumann B, 2014, CELL REP, V6, P93, DOI 10.1016/j.celrep.2013.12.004; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Pandey K, 2011, J MOL NEUROSCI, V45, P1, DOI 10.1007/s12031-011-9506-6; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Payne SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065710; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Picklo MJ, 1999, J NEUROCHEM, V72, P1617, DOI 10.1046/j.1471-4159.1999.721617.x; Popko B, 2000, GLIA, V29, P149, DOI 10.1002/(SICI)1098-1136(20000115)29:2<149::AID-GLIA8>3.0.CO;2-4; Ritter J, 2013, J NEUROSCI, V33, P8990, DOI 10.1523/JNEUROSCI.5528-12.2013; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Siems WG, 1996, FREE RADICAL BIO MED, V20, P215, DOI 10.1016/0891-5849(95)02041-1; Stirling DP, 2014, ANN NEUROL, V75, P220, DOI 10.1002/ana.24099; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takahashi M, 1998, J PHARMACOL EXP THER, V287, P559; Takahashi M, 2002, CNS DRUG REV, V8, P337; Tamaki Y, 2003, INVEST OPHTH VIS SCI, V44, P4864, DOI 10.1167/iovs.02-1173; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tymianski M, 1996, NEUROSURGERY, V38, P1176; VONBLANKENFELD G, 1993, GLIA, V7, P322, DOI 10.1002/glia.440070407; Wang JW, 2015, NEURAL REGEN RES, V10, P225, DOI 10.4103/1673-5374.152375; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Yu W, 2016, J NEUROSCI, V36, P11084, DOI 10.1523/JNEUROSCI.2273-16.2016; Zhang ZS, 2016, J PHYSIOL-LONDON, V594, P39, DOI 10.1113/JP271207	92	22	23	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	AUG 14	2017	18								62	10.1186/s12868-017-0380-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD5PC	WOS:000407581300001	28806920	Green Published, gold			2022-02-06	
J	Hoffer, ME; Balaban, C; Szczupak, M; Buskirk, J; Snapp, H; Crawford, J; Wise, S; Murphy, S; Marshall, K; Pelusso, C; Knowles, S; Kiderman, A				Hoffer, Michael E.; Balaban, Carey; Szczupak, Mikhaylo; Buskirk, James; Snapp, Hillary; Crawford, James; Wise, Sean; Murphy, Sara; Marshall, Kathryn; Pelusso, Constanza; Knowles, Sean; Kiderman, Alex			The use of oculomotor, vestibular, and reaction time tests to assess mild traumatic brain injury (mTBI) over time	LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY			English	Article						mTBI; Concussion; Vestibular Disorders; Point of Injury Testing	UNITED-STATES; CONCUSSION; VISITS; SPORTS	ObjectivesThe objective of this work is to examine the outcomes of a set of objective measures for evaluating individuals with minor traumatic brain injury (mTBI) over the sub-acute time period. These methods involve tests of oculomotor, vestibular, and reaction time functions. This work expands upon published work examining these test results at the time of presentation. Study DesignThis study is a prospective age- and sex-matched controlled study. Materials and MethodsThe subject group was composed of 106 individuals with mTBI and 300 age- and sex-matched controls without a history of mTBI. All individuals agreeing to participate in the study underwent a battery of oculomotor, vestibular, and reaction time tests (OVRT). Those subjects with mTBI underwent these tests at presentation (within 6 days of injury) and 1 and 2weeks post injury. These outcomes were compared to each other over time as well as to results from the controls that underwent 1 test session. ResultsSix measures from 5 tests can classify the control and mTBI during Session 1 with a true positive rate (sensitivity) of 84.9% and true negative rate (specificity) of 97.0%. Patterns of abnormalities changed over time in the mTBI group and overall normalized in a subset of individuals at the third (final) testing session. ConclusionsWe describe an objective and effective second generation testing algorithm for diagnosing and following the prognosis of mTBI/concussion. This testing paradigm will allow investigators to institute better treatments and provide more accurate return to activity advice. Level of Evidence3	[Hoffer, Michael E.; Szczupak, Mikhaylo; Buskirk, James; Snapp, Hillary; Murphy, Sara; Pelusso, Constanza; Knowles, Sean] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Hoffer, Michael E.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Hoffer, Michael E.; Szczupak, Mikhaylo; Buskirk, James; Pelusso, Constanza] Univ Miami, Sports Performance & Wellness Inst, Miami, FL USA; [Balaban, Carey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Crawford, James; Marshall, Kathryn] Madigan Army Med Ctr, Dept Otolaryngol, Tacoma, WA 98431 USA; [Wise, Sean; Murphy, Sara] Naval Med Ctr, San Diego, CA USA; [Kiderman, Alex] Neurokinetics Inc, Pittsburgh, PA USA		Hoffer, ME (corresponding author), Otolaryngol Dept, 1120 NW 14th St,5th Floor, Miami, FL 33136 USA.	michael.hoffer@miami.edu	Balaban, Carey/I-3467-2017; Buskirk, James/ABF-8288-2020; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Szczupak, Mikhaylo/0000-0002-2569-2184; Hoffer, Michael/0000-0002-5574-4387			Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoffer ME, 2016, PLOS ONE, V11; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hosek B, 2011, DEPLOYMENT IRAQ AFGH; Kerr Zachary Y, 2014, N C Med J, V75, P8; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Olson D, 2013, CURR SPORT MED REP, V12, P381, DOI 10.1249/JSR.0000000000000015; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	17	22	23	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2378-8038			LARYNGOSCOPE INVEST	Laryngoscope Investig. Otol.	AUG	2017	2	4					157	165		10.1002/lio2.74			9	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	FE0WY	WOS:000407941600003	28894835	Green Published, gold			2022-02-06	
J	Leeper, CM; Vissa, M; Cooper, JD; Malec, LM; Gaines, BA				Leeper, Christine M.; Vissa, Madhav; Cooper, James D.; Malec, Lynn M.; Gaines, Barbara A.			Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center	PEDIATRIC BLOOD & CANCER			English	Article						anticoagulants; pediatrics; trauma; venous thrombosis	DEEP-VEIN THROMBOSIS; POSTTHROMBOTIC SYNDROME; RISK-FACTORS; BRAIN-INJURY; PULMONARY-EMBOLISM; EARLY COAGULOPATHY; CHILDREN; MORTALITY; PROPHYLAXIS; ADMISSION	BackgroundPediatric trauma patients are at high risk for development of venous thromboembolism (VTE). Our objective is to describe incidence, risk factors, and timing of development of VTE, anticoagulation complications, and long-term VTE outcomes in a critically injured pediatric population. ProcedureWe did a retrospective review of pediatric (0-17 years) trauma admissions to intensive care unit from 2005 to 2014. Our center employs VTE screening and prevention protocols for high-risk patients based on hypercoagulable history, age, injuries, and medical interventions. We collected demographics, VTE prevention measures, VTE incidence, therapeutic anticoagulant use, and outcomes including postthrombotic syndrome (PTS) and clot resolution. Analysis included Wilcoxon rank-sum, Fisher exact, and logistic regression modeling. ResultsSeven hundred fifty-three subjects were analyzed. No patients on chemical prophylaxis (21/753) developed VTE. Overall incidence of deep vein thrombosis (DVT) was 8.9%; pulmonary embolism (PE) was 0%. Time to diagnosis was median (interquartile range [IQR]) 10.5 (6.5-14.5) days, with 63% of clots being symptomatic. Risk factors for VTE development included severe traumatic brain injury (TBI), acute traumatic coagulopathy (defined by elevated admission international normalized ratio), age less than or equal to 3 or age 13 years or more, injury severity, and child abuse mechanism. At a median (IQR) follow-up of 13 (6-19) months, 52.1% had persistent clot and 15.8% had PTS. Therapeutic anticoagulation was not associated with clot resolution or prevention of PTS. ConclusionTBI therapy is closely linked to the development of DVT. Coagulopathy on admission is associated with hypercoagulability in the postinjury period, suggesting a patient phenotype with systemic coagulation dysregulation. Treatment was not associated with improved VTE outcomes, suggesting that pediatric protocols should emphasize VTE prevention and prophylaxis strategies.	[Leeper, Christine M.] Univ Pittsburgh, Dept Surg, Med Ctr, Div Gen Surg & Trauma, Pittsburgh, PA USA; [Vissa, Madhav; Cooper, James D.; Malec, Lynn M.; Gaines, Barbara A.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA		Leeper, CM (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, UPMC, Sch Med, 7th Floor,Fac Pavil,4401 Penn Ave, Pittsburgh, PA 15224 USA.	leepercm@upmc.edu					Askegard-Giesmann JR, 2012, J PEDIATR SURG, V47, P980, DOI 10.1016/j.jpedsurg.2012.01.060; Avila ML, 2014, BLOOD, V124, P1166, DOI 10.1182/blood-2014-04-570531; Azu MC, 2005, J TRAUMA, V59, P1345, DOI 10.1097/01.ta.0000196008.48461.47; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Candrilli SD, 2009, PEDIATR CRIT CARE ME, V10, P554, DOI 10.1097/PCC.0b013e3181a705d3; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Connelly CR, 2016, JAMA SURG, V151, P50, DOI 10.1001/jamasurg.2015.2670; Cook A, 2005, J TRAUMA, V59, P1114, DOI 10.1097/01.ta.0000196692.40475.61; Creary S, 2012, BLOOD COAGUL FIBRIN, V23, P39, DOI 10.1097/MBC.0b013e32834bdb1c; Cyr C, 2006, ACTA HAEMATOL-BASEL, V115, P198, DOI 10.1159/000090935; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Dietch ZC, 2015, SURGERY, V158, P379, DOI 10.1016/j.surg.2015.03.052; Goldenberg NA, 2010, HAEMATOL-HEMATOL J, V95, P1952, DOI 10.3324/haematol.2010.026989; Hanson SJ, 2016, J TRAUMA ACUTE CARE, V80, P695, DOI 10.1097/TA.0000000000000962; Hanson SJ, 2010, J TRAUMA, V68, P52, DOI 10.1097/TA.0b013e3181a74652; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kreuz W, 2006, ARTERIOSCL THROM VAS, V26, P1901, DOI 10.1161/01.ATV.0000227510.36653.ed; Kuhle S, 2003, THROMB RES, V111, P227, DOI 10.1016/j.thromres.2003.09.008; Kumar R, 2015, THROMB RES, V135, P347, DOI 10.1016/j.thromres.2014.12.005; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Mahajerin A, 2015, HAEMATOLOGICA, V100, P1045, DOI 10.3324/haematol.2015.123455; Manco-Johnson MJ, 2006, ACTA HAEMATOL-BASEL, V115, P207, DOI 10.1159/000090937; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; MCBRIDE WJ, 1994, J TRAUMA, V37, P913, DOI 10.1097/00005373-199412000-00007; O'Brien SH, 2011, PEDIATR CRIT CARE ME, V12, P251, DOI 10.1097/PCC.0b013e3181f36bd9; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Raffini L, 2009, PEDIATRICS, V124, P1001, DOI 10.1542/peds.2009-0768; Schobess R, 2006, HAEMATOLOGICA, V91, P1701; Sharathkumar AA, 2008, J PEDIAT HEMATOL ONC, V30, P261, DOI 10.1097/MPH.0b013e318162bcf5; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Truitt AK, 2005, J PEDIATR SURG, V40, P124, DOI 10.1016/j.jpedsurg.2004.09.017; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Van Arendonk KJ, 2013, JAMA SURG, V148, P1123, DOI 10.1001/jamasurg.2013.3558; Van Ommen CH, 2003, J THROMB HAEMOST, V1, P2516, DOI 10.1046/j.1538-7836.2003.00465.x; Vavilala MS, 2002, J TRAUMA, V52, P922, DOI 10.1097/00005373-200205000-00017; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	44	22	22	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	AUG	2017	64	8							e26415	10.1002/pbc.26415			8	Oncology; Hematology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Hematology; Pediatrics	EX5ZC	WOS:000403320600007	28067012				2022-02-06	
J	Malhotra, RK				Malhotra, Raman K.			Sleep, Recovery, and Performance in Sports	NEUROLOGIC CLINICS			English	Article						Sleep deprivation; Sleep apnea; Insomnia; Jet lag; Circadian rhythm disorder; Recovery; Hypersomnia; Concussion	PROFESSIONAL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; ATHLETIC PERFORMANCE; CONSENSUS STATEMENT; RECOMMENDED AMOUNT; AMERICAN ACADEMY; SERVING ACCURACY; TENNIS PLAYERS; LEAGUE; PREVALENCE	Poor sleep can lead to decreases in performance and recovery for athletes. Sleep disorders and symptoms are commonly seen in athletes, and may be unrecognized. It is important to educate athletes on adequate duration, quality, and timing of sleep. Interventions may include changes to practice times or careful planning for travel to games in different time zones. It is important to screen and treat sleep disorders such as sleep apnea and insomnia that are seen in some athletes. In patients who suffer concussion, it is important to address sleep issues, as poor sleep can prolong or exacerbate other concussion symptoms.	[Malhotra, Raman K.] St Louis Univ, Sch Med, Dept Neurol, Monteleone Hall,1438 South Grand Blvd, St Louis, MO 63104 USA		Malhotra, RK (corresponding author), St Louis Univ, Sch Med, Dept Neurol, Monteleone Hall,1438 South Grand Blvd, St Louis, MO 63104 USA.	Rmalhot1@slu.edu					Albuquerque FN, 2010, J AM COLL CARDIOL, V56, P1432, DOI 10.1016/j.jacc.2010.03.099; Atkinson G, 1998, PERCEPT MOTOR SKILL, V86, P1335, DOI 10.2466/pms.1998.86.3c.1335; Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benton ML, 2013, J CLIN SLEEP MED, V9, P1237, DOI 10.5664/jcsm.3256; Blumert PA, 2007, J STRENGTH COND RES, V21, P1146; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Deschodt VJ, 2004, J STRENGTH COND RES, V18, P149; Dobrosielski DA, 2016, RESP CARE, V61, P1144, DOI 10.4187/respcare.04520; Eagles A, 2004, J SPORTS MED PHYS FI; Edwards BJ, 2005, ERGONOMICS, V48, P1488, DOI 10.1080/00140130500100975; George CFP, 2003, SLEEP MED, V4, P317, DOI 10.1016/S1389-9457(03)00113-8; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Juliff LE, 2015, J SCI MED SPORT, V18, P13, DOI 10.1016/j.jsams.2014.02.007; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kutscher S, 2013, SLEEP, V36, pA408; Lancee J, 2016, SLEEP, V39, P183, DOI 10.5665/sleep.5344; Luke A, 2011, CLIN J SPORT MED, V21, P307, DOI 10.1097/JSM.0b013e3182218f71; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; MOUGIN F, 1990, Science and Sports, V5, P83, DOI 10.1016/S0765-1597(05)80210-2; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; REILLY T, 1994, ERGONOMICS, V37, P107, DOI 10.1080/00140139408963628; Reyner LA, 2013, PHYSIOL BEHAV, V120, P93, DOI 10.1016/j.physbeh.2013.07.002; Rice TB, 2010, SLEEP, V33, P819, DOI 10.1093/sleep/33.6.819; Samuels C, 2008, NEUROL CLIN, V26, P169, DOI 10.1016/j.ncl.2007.11.012; Schwartz J, 2015, PHYSIOL BEHAV, V151, P541, DOI 10.1016/j.physbeh.2015.08.035; Skein M, 2013, INT J SPORT PHYSIOL, V8, P556, DOI 10.1123/ijspp.8.5.556; Smith RS, 2013, SLEEP, V36, P1999, DOI 10.5665/sleep.3248; Swinbourne R, 2016, EUR J SPORT SCI, V16, P850, DOI 10.1080/17461391.2015.1120781; vonsRosen P, 2016, SCAND J MED SCI SPOR, DOI 10.1111/sms.12735<original-structure ref = info:doi/10.1111/sms.12735></original-structure>; Vyazovskiy VV, 2014, NEUROSCIENTIST, V20, P203, DOI 10.1177/1073858413518152; Walker MP, 2005, CLIN SPORT MED, V24, P301, DOI 10.1016/j.csm.2004.11.002; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Wheaton A. G., 2011, Morbidity and Mortality Weekly Report, V60, P239; Winter WC, 2011, SLEEP, V34, pA167	37	22	23	5	94	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					547	+		10.1016/j.ncl.2017.03.002			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OI	WOS:000406819500012	28673415				2022-02-06	
J	Dati, LM; Ulrich, H; Real, CC; Feng, ZP; Sun, HS; Britto, LR				Dati, L. M.; Ulrich, H.; Real, C. C.; Feng, Z. P.; Sun, H. S.; Britto, L. R.			CARVACROL PROMOTES NEUROPROTECTION IN THE MOUSE HEMIPARKINSONIAN MODEL	NEUROSCIENCE			English	Article						carvacrol; dopamine; neuroprotection; TRP channels	PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; TRPM7 CHANNEL; ION CHANNELS; CELL-DEATH; AUTOPHAGY; ISCHEMIA; STRESS; INJURY; BRAIN	Carvacrol is a monoterpene that has been linked to neuroprotection in several animal models of neurodegeneration, including ischemia, epilepsy and traumatic neuronal injury. In this study, we investigated the effects of carvacrol (i.p.) upon the neurodegeneration induced by 6-hydroxydopamine unilateral intrastriatal injections in mice. We have also used the cylinder test to assess the behavioral effects of carvacrol in that model of Parkinson's disease, and immunoblots to evaluate the levels of caspase-3 and TRPM7, one of major targets of carvacrol. Behavioral testing revealed that carvacrol largely reduced the asymmetrical use of the forelimbs induced by unilateral 6-hydroxy-dopamine. Carvacrol dramatically reduced the loss of tyrosine hydroxylase immunostaining both in the substantia nigra and in the striatum that are typical of the model. Immunoblots for tyrosine hydroxylase confirmed this effect. Caspase-3 levels were very high after toxin injections, but carvacrol appeared to reduce them to control levels. Finally, TRPM7, observed by immunoblots, increased after 6-hydroxy-dopamine, suggesting the involvement of this cation channel in the ensuing neurodegenerative process. The present data suggest that carvacrol promotes a marked neuroprotection in the 6hydroxy-dopamine model of Parkinson's disease, possibly by its non-specific blocking effect upon TRPM7 channels. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Dati, L. M.; Real, C. C.; Britto, L. R.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508900 Sao Paulo, SP, Brazil; [Ulrich, H.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Feng, Z. P.; Sun, H. S.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON, Canada; [Sun, H. S.] Univ Toronto, Fac Med, Dept Surg, Toronto, ON, Canada		Britto, LR (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508900 Sao Paulo, SP, Brazil.	lrbritto@usp.br	Real, Caroline C/N-1674-2013; Ulrich, Henning/C-5245-2013	Real, Caroline C/0000-0001-6096-3341; Ulrich, Henning/0000-0002-2114-3815	Sao Paulo Research Foundation (FAPESP, Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/50880-4]; National Council for Scientific and Technological Development (CNPq, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESP fellowshipsFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2014-06471, RGPIN-2016-04574]; University of TorontoUniversity of Toronto; University of Sao Paulo	This study was supported by the Sao Paulo Research Foundation (FAPESP, Project No. 2012/50880-4, Brazil) and the National Council for Scientific and Technological Development (CNPq, Brazil). L.M.D. and C.C.R. are recipients of FAPESP fellowships. This work was also supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants to Z.P.F. (RGPIN-2014-06471) and to H.S.S. (RGPIN-2016-04574), and a University of Toronto and University of Sao Paulo Joint Call Proposal grant to H.S.S., Z.P.F. and L.R.B.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Chen WL, 2015, ONCOTARGET, V6, P16321, DOI 10.18632/oncotarget.3872; Chen WL, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0102-5; Dadon D, 2010, INT J BIOCHEM CELL B, V42, P1430, DOI 10.1016/j.biocel.2010.04.006; Decker AR, 2014, DEV BIOL, V386, P428, DOI 10.1016/j.ydbio.2013.11.015; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Fleig A, 2014, HANDB EXP PHARMACOL, V222, P521, DOI 10.1007/978-3-642-54215-2_21; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Hernandes MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075532; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Khalil A, 2017, EPILEPSIA, V58, P263, DOI 10.1111/epi.13645; Khan S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/379817; Li WT, 2015, NEUROCHEM INT, V90, P107, DOI 10.1016/j.neuint.2015.07.020; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Oh HG, 2015, BIOCHEM BIOPH RES CO, V463, P7, DOI 10.1016/j.bbrc.2015.05.007; Oz M, 2015, PHARMACOL THERAPEUT, V152, P83, DOI 10.1016/j.pharmthera.2015.05.006; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Penner R., 2007, V179, P313; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Smith GA, 2012, BEHAV BRAIN RES, V226, P281, DOI 10.1016/j.bbr.2011.09.025; Sukumaran P, 2016, CELL CALCIUM, V60, P123, DOI 10.1016/j.ceca.2016.02.012; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Sun YY, 2015, CHANNELS, V9, P253, DOI 10.1080/19336950.2015.1075675; Takada Y, 2013, CURR TOP MED CHEM, V13, P322; Turlova E, 2016, MOL NEUROBIOL, V53, P595, DOI 10.1007/s12035-014-9032-y; Verma S, 2012, NEUROSCI LETT, V530, P41, DOI 10.1016/j.neulet.2012.09.044; Vink R, 2009, MAGNESIUM RES, V22, p158S; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]	32	22	22	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 25	2017	356						176	181		10.1016/j.neuroscience.2017.05.013			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EZ9MZ	WOS:000405055800016	28526576				2022-02-06	
J	Georgoff, PE; Nikolian, VC; Halaweish, I; Chtraklin, K; Bruhn, PJ; Eidy, H; Rasmussen, M; Li, YQ; Srinivasan, A; Alam, HB				Georgoff, Patrick E.; Nikolian, Vahagn C.; Halaweish, Ihab; Chtraklin, Kiril; Bruhn, Peter J.; Eidy, Hassan; Rasmussen, Monica; Li, Yongqing; Srinivasan, Ashok; Alam, Hasan B.			Resuscitation with Lyophilized Plasma Is Safe and Improves Neurological Recovery in a Long-Term Survival Model of Swine Subjected to Traumatic Brain Injury, Hemorrhagic Shock, and Polytrauma	JOURNAL OF NEUROTRAUMA			English	Article						fresh frozen plasma; hemorrhagic shock; lyophilized plasma; polytrauma; traumatic brain injury	FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; FREEZE-DRIED PLASMA; DAMAGE CONTROL RESUSCITATION; RED-BLOOD-CELLS; PROVIDES NEUROPROTECTION; VALPROIC ACID; NORMAL SALINE; TRANSFUSION; COAGULOPATHY	We have shown previously that fresh frozen plasma (FFP) and lyophilized plasma (LP) decrease brain lesion size and improve neurological recovery in a swine model of traumatic brain injury (TBI) and hemorrhagic shock (HS). In this study, we examine whether these findings can be validated in a clinically relevant model of severe TBI, HS, and polytrauma. Female Yorkshire swine were subjected to TBI (controlled cortical impact), hemorrhage (40% volume), grade III liver and splenic injuries, rib fracture, and rectus abdominis crush. The animals were maintained in a state of shock (mean arterial pressure 30-35mm Hg) for 2 h, and then randomized to resuscitation with normal saline (NS), FFP, or LP (n = 5 swine/group). Animals were recovered and monitored for 30 d, during which time neurological recovery was assessed. Brain lesion sizes were measured via magnetic resonance imaging (MRI) on post-injury days (PID) three and 10. Animals were euthanized on PID 30. The severity of shock and response to resuscitation was similar in all groups. When compared with NS-treated animals, plasma-treated animals (FFP and LP) had significantly lower neurologic severity scores (PID 1-7) and a faster return to baseline neurological function. There was no significant difference in brain lesion sizes between groups. LP treatment was well tolerated and similar to FFP. In this clinically relevant large animal model of severe TBI, HS, and polytrauma, we have shown that plasma-based resuscitation strategies are safe and result in neurocognitive recovery that is faster than recovery after NS-based resuscitation.	[Georgoff, Patrick E.; Nikolian, Vahagn C.; Halaweish, Ihab; Chtraklin, Kiril; Bruhn, Peter J.; Eidy, Hassan; Rasmussen, Monica; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Neuroradiol Sect, Ann Arbor, MI 48109 USA; [Srinivasan, Ashok] Univ Michigan, Dept Radiol, Neuroradiol Sect, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Gen Surg Sect, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu			US Army Materiel and Research Command [W81XWH-09-1-0520]	This work was supported by the US Army Materiel and Research Command, Contract W81XWH-09-1-0520.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bux J, 2013, TRANSFUSION, V53, P3203, DOI 10.1111/trf.12191; Cancelas J., 2011, TRANSFUSION S, V51, pS85; Cartotto R, 2016, CRIT CARE CLIN, V32, P507, DOI 10.1016/j.ccc.2016.06.002; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; DB K., 1964, BLOOD PROGRAM WORLD; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Glassberg E, 2013, SHOCK, V40, P444, DOI 10.1097/SHK.0000000000000047; Glassberg E, 2013, J TRAUMA ACUTE CARE, V75, pS111, DOI 10.1097/TA.0b013e318299d217; Gokhale SG, 2016, J ROY ARMY MED CORPS, V162, P63, DOI 10.1136/jramc-2014-000361; Halaweish I, 2016, J TRAUMA ACUTE CARE, V81, P1080, DOI 10.1097/TA.0000000000001204; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Imam A, 2015, J NEUROTRAUM, V32, P307, DOI 10.1089/neu.2014.3535; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Keller-Stanislawski B, 2009, TRANSFUSION MED, V19, P340, DOI 10.1111/j.1365-3148.2009.00947.x; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Martinaud C, 2012, ANESTHESIOLOGY, V117, P339, DOI 10.1097/ALN.0b013e3182608cdd; Martinaud C, 2011, J TRAUMA, V71, P1761, DOI 10.1097/TA.0b013e31822f1285; May AK, 1997, AM SURGEON, V63, P233; McCully SP, 2015, J TRAUMA ACUTE CARE, V78, P231, DOI 10.1097/TA.0000000000000524; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Pusateri AE, 2016, TRANSFUSION, V56, pS128, DOI 10.1111/trf.13580; Pusateri AE, 2016, TRANSFUSION, V56, pS16, DOI 10.1111/trf.13331; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sillesen M, 2017, J AM COLL SURGEONS, V224, P49, DOI 10.1016/j.jamcollsurg.2016.09.015; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Spinella PC, 2012, TRANSFUSION, V52, P1146, DOI 10.1111/j.1537-2995.2012.03594.x; Sunde GA, 2015, J TRAUMA ACUTE CARE, V78, pS26, DOI 10.1097/TA.0000000000000633; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van PY, 2011, J TRAUMA, V71, P20, DOI 10.1097/TA.0b013e3182214f44; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	49	22	22	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2017	34	13					2167	2175		10.1089/neu.2016.4859			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ2HM	WOS:000404530400455	28228060				2022-02-06	
J	Treble-Barna, A; Schultz, H; Minich, N; Taylor, HG; Yeates, KO; Stancin, T; Wade, SL				Treble-Barna, Amery; Schultz, Hanna; Minich, Nori; Taylor, H. Gerry; Yeates, Keith Owen; Stancin, Terry; Wade, Shari L.			Long-Term Classroom Functioning and Its Association With Neuropsychological and Academic Performance Following Traumatic Brain Injury During Early Childhood	NEUROPSYCHOLOGY			English	Article						academic achievement; adaptive function; child development; neuropsychological outcomes; traumatic brain injury	RECOVERY 10 YEARS; COGNITIVE PREDICTORS; YOUNG-CHILDREN; OUTCOMES; BEHAVIOR; ACHIEVEMENT; STUDENTS; INTERVENTIONS; ADOLESCENTS; FLUENCY	Objective: The present study utilized ecobehavioral assessment to examine classroom functioning several years following early childhood traumatic brain injury (TBI) or orthopedic injury (OI) and its association with injury factors, neuropsychological abilities, and academic performance. Method: Participants included 39 children with moderate to severe TBI and 51 children with OI sustained between ages 3 and 7 years. At 7.2 (+/- 1.3) years post injury, ecobehavioral assessment was used to examine classroom functioning. Additional outcomes included neuropsychological tests, parent and teacher ratings of dysexecutive behavior, and teacher ratings of academic performance. Groups were compared on measures controlling for demographic characteristics, and associations among outcomes were examined using linear regression. Results: Children with TBI showed lower academic engagement relative to children with OI, as well as more frequent individual teacher attention for children with more severe injuries. For children with TBI, difficulties in classroom functioning were associated with lower cognitive flexibility and higher parent and teacher ratings of dysexecutive behavior. Lower scores on a test of fluid reasoning and a greater frequency of individual teacher attention were also associated with lower academic performance in children with TBI. Conclusions: Difficulties in classroom functioning are evident several years after early childhood TBI and were associated with greater injury severity, neuropsychological weaknesses, and poorer academic performance. Children with impaired cognitive flexibility and fluid reasoning skills were at greatest risk for these difficulties and associated weaknesses in academic performance. Instructional interactions may be a potential target for intervention to promote academic progress in at- risk children.	[Treble-Barna, Amery; Schultz, Hanna] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Minich, Nori; Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat Neuropsychol, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Stancin, Terry] Case Western Reserve Univ, Dept Pediat Psychol, Cleveland, OH 44106 USA; [Wade, Shari L.] Univ Cincinnati, Dept Phys Med & Rehabil, Cincinnati, OH 45221 USA; [Schultz, Hanna] Univ Alberta, Dept Educ Psychol, Edmonton, AB, Canada		Treble-Barna, A (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202,Kaufman Bldg, Pittsburgh, PA 15213 USA.	amery.treble-barna@pitt.edu	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; Trauma Research grants from the State of Ohio Emergency Medical Services; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER	This research was supported by funding through Grant R01 HD42729 from the National Institute of Child Health and Development (NICHD) and by Trauma Research grants from the State of Ohio Emergency Medical Services. Additional support was provided through Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health. We thank Harriet Bannister of the Juniper Gardens Children Project for providing training on the MS-CISSAR.	Abikoff HB, 2002, J ABNORM CHILD PSYCH, V30, P349, DOI 10.1023/A:1015713807297; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Culbertson WC, 1998, ARCH CLIN NEUROPSYCH, V13, P285, DOI 10.1016/S0887-6177(97)00033-4; Delis DC., 2001, DELIS KAPLAN EXECUTI; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gonzalez LM, 2007, EPILEPSIA, V48, P124, DOI 10.1111/j.1528-1167.2006.00907.x; Greenwood C. R., 1997, ECOBEHAVIORAL ASSESS; GREENWOOD CR, 1994, EXCEPT CHILDREN, V61, P197; Greenwood CR, 2003, J SPEC EDUC, V37, P95, DOI 10.1177/00224669030370020401; GREENWOOD CR, 1991, EXCEPT CHILDREN, V57, P521, DOI 10.1177/001440299105700606; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Junod REV, 2006, J SCHOOL PSYCHOL, V44, P87, DOI 10.1016/j.jsp.2005.12.004; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Logan KR, 1997, EXCEPT CHILDREN, V63, P481, DOI 10.1177/001440299706300404; Maggin DM, 2012, J SCHOOL PSYCHOL, V50, P625, DOI 10.1016/j.jsp.2012.06.001; Manly T, 1999, TEA CH TEST EVERYDAY; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Simonsen B., 2008, EDUC TREAT CHILD, V31, P351, DOI [10.1353/etc.0.0007, DOI 10.1353/ETC.0.0007]; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2012, APPL NEUROPSYCH-CHIL, V1, P30, DOI 10.1080/21622965.2012.665776; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Verger K, 2000, BRAIN INJURY, V14, P495; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2004, WECHSLER INTELLIGENC, Vfourth; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wong T, 2014, EARLY HUM DEV, V90, P907, DOI 10.1016/j.earlhumdev.2014.09.011; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	55	22	22	1	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2017	31	5					486	498		10.1037/neu0000325			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EY1GE	WOS:000403713200002	28627915	Green Accepted, Bronze			2022-02-06	
J	Fan, KH; Ma, J; Xiao, WJ; Chen, JM; Wu, J; Ren, JD; Hou, J; Hu, YH; Gu, JW; Yu, BT				Fan, Kaihua; Ma, Jie; Xiao, Wenjing; Chen, Jingmin; Wu, Juan; Ren, Jiandong; Hou, Jun; Hu, Yonghe; Gu, Jianwen; Yu, Botao			Mangiferin attenuates blast-induced traumatic brain injury via inhibiting NLRP3 inflammasome	CHEMICO-BIOLOGICAL INTERACTIONS			English	Article						Mangiferin; Blast-induced traumatic brain injury; NLRP3; Oxidative stress; Inflammation	NF-KAPPA-B; SYSTEMIC INFLAMMATION; NALP3 INFLAMMASOME; OXIDATIVE STRESS; CEREBRAL-CORTEX; ISCHEMIC-STROKE; RAT MODEL; MANAGEMENT; PROTEIN; ACTIVATION	There is growing evidence that Mangiferin possess therapeutic benefit during neuroinflammation on various brain injury models due to its anti-inflammatory properties. It is reported that inflammatory plays a crucial role in the pathogenesis of secondary injury induced by the blast-induced traumatic brain injury (bTBI). However, the role of mangiferin in bTBI is yet to be studied. In our study, the potential effect of mangiferin in the duration of bTBI was examined first. Fortunately, the amelioration of cerebral cortex damage was found in rats suffering bTBI after mangiferin administration. Furthermore, the detail mechanism of mangiferin's beneficial actions in bTBI was also studied. The results revealed that mangiferin might alleviate brain damage in rats with bTBI by inhibiting the NOD-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome activation, which was accompanied by mangiferin's inhibition of oxidative stress and pro-inflammatory cytokines production. Therefore, this research allows us to speculate that, for first time, NLRP3 is involved in the anti-inflammatory effect of mangiferin in the cerebral cortex, and mangiferin could be a potential therapy drug for bTBI. (C) 2017 Elsevier B.V. All rights reserved.	[Fan, Kaihua] Peoples Hosp Leshan, Dept Pharm, Leshan 614000, Sichuan, Peoples R China; [Xiao, Wenjing; Hu, Yonghe] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610013, Sichuan, Peoples R China; [Ma, Jie; Xiao, Wenjing; Wu, Juan; Ren, Jiandong; Hou, Jun; Yu, Botao] Chengdu Mil Gen Hosp, Dept Pharm, 270 Rongdu Ave, Chengdu 610083, Sichuan, Peoples R China; [Chen, Jingmin] Chengdu Mil Gen Hosp, Dept Neurosurgery, 270 Rongdu Ave, Chengdu 610083, Sichuan, Peoples R China; [Hu, Yonghe] Chengdu Mil Gen Hosp, Dept Tradit Chinese Med, 270 Rongdu Ave, Chengdu 610083, Sichuan, Peoples R China; [Gu, Jianwen] 306 Hosp PLA, 9 Anxiang Beili, Beijing 100101, Peoples R China		Hu, YH (corresponding author), Southwest Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610013, Sichuan, Peoples R China.; Yu, BT (corresponding author), Chengdu Mil Gen Hosp, Dept Pharm, 270 Rongdu Ave, Chengdu 610083, Sichuan, Peoples R China.; Gu, JW (corresponding author), 306 Hosp PLA, 9 Anxiang Beili, Beijing 100101, Peoples R China.	huyhzyy@163.com; gujianwen5000@sina.com; baotao_yu@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81402507]; State Administration of Traditional Chinese Medicine of the General Logistics Department [10ZYZ120]; Chengdu Military General Hospital Project [2013YG-B109]	This work was supported by the National Natural Science Foundation of China (Grant No. 81402507); the State Administration of Traditional Chinese Medicine of the General Logistics Department (Grant No. 10ZYZ120); and Chengdu Military General Hospital Project (Grant No. 2013YG-B109).	BHATTACHARYA SK, 1972, J PHARM SCI-US, V61, P1838, DOI 10.1002/jps.2600611136; Biradar SM, 2012, EUR J PHARMACOL, V683, P140, DOI 10.1016/j.ejphar.2012.02.042; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Celtik C, 2004, BRAIN DEV-JPN, V26, P398, DOI 10.1016/j.braindev.2003.12.007; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dou W, 2014, INT IMMUNOPHARMACOL, V23, P170, DOI 10.1016/j.intimp.2014.08.025; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Garrido-Suarez BB, 2014, PHARMACOL BIOCHEM BE, V124, P311, DOI 10.1016/j.pbb.2014.06.019; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hou J, 2016, CAN J PHYSIOL PHARM, V94, P332, DOI 10.1139/cjpp-2015-0073; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li YJ, 2008, CHROMATOGRAPHIA, V67, P957, DOI 10.1365/s10337-008-0612-8; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Marquez L, 2012, EUR J NUTR, V51, P729, DOI 10.1007/s00394-011-0252-x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Ren JD, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/930894; Sanchez GM, 2003, PHYTOTHER RES, V17, P197, DOI 10.1002/ptr.921; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Xiao WJ, 2010, INT J PHARMACEUT, V393, P119, DOI 10.1016/j.ijpharm.2010.04.018; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	36	22	25	4	24	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-2797	1872-7786		CHEM-BIOL INTERACT	Chem.-Biol. Interact.	JUN 1	2017	271						15	23		10.1016/j.cbi.2017.04.021			9	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	EW4AL	WOS:000402444300003	28455230				2022-02-06	
J	Krishnamoorthy, V; Rowhani-Rahbar, A; Chaikittisilpa, N; Gibbons, EF; Rivara, FP; Temkin, NR; Quistberg, A; Vavilala, MS				Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Chaikittisilpa, Nophanan; Gibbons, Edward F.; Rivara, Frederick P.; Temkin, Nancy R.; Quistberg, Alex; Vavilala, Monica S.			Association of Early Hemodynamic Profile and the Development of Systolic Dysfunction Following Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Stress cardiomyopathy; Echocardiography; Trauma; Hemodynamics	SUBARACHNOID HEMORRHAGE; CHAMBER QUANTIFICATION; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; BLOOD-PRESSURE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; CATECHOLAMINES	Background While systolic dysfunction has been observed following traumatic brain injury (TBI), the relationship between early hemodynamics and the development of systolic dysfunction has not been investigated. Our study aimed to determine the early hemodynamic profile that is associated with the development of systolic dysfunction after TBI. Methods We conducted a prospective cohort study among patients under 65 years old without cardiac comorbidities who sustained moderate-severe TBI. Transthoracic echocardiography was performed within the first day after TBI to assess for systolic dysfunction. Hourly systolic blood pressure (SBP), mean arterial pressure (MAP), heart rate, and confounding clinical variables (sedatives, fluid balance, vasopressors, and osmotherapy) were collected during the first 24 h following admission. Multivariable linear mixed models assessed the early hemodynamic profile in patients who developed systolic dysfunction, compared to patients who did not develop systolic dysfunction. Results Thirty-two patients were included, and 7 (22 %) developed systolic dysfunction after TBI. Patients who developed systolic dysfunction experienced early elevation of SBP, MAP, and heart rate, compared to patients who did not develop systolic dysfunction (p < 0.01 for all comparisons). Patients who developed systolic dysfunction experienced a greater rate of decrease in SBP [-10.2 mmHg (95 % CI -16.1, -4.2)] and MAP [-9.1 mmHg (95 % CI -13.9, -4.3)] over the first day of hospitalization, compared to patients who did not develop systolic dysfunction (p < 0.01 for both comparisons). All sensitivity analyses revealed no substantial changes from the primary model. Conclusion Patients who develop systolic dysfunction following TBI have a distinctive hemodynamic profile, with early hypertension and tachycardia, followed by a decrease in blood pressure over the first day after TBI. This profile suggests an early maladaptive catecholamine-excess state as a potential underlying mechanism of TBI-induced systolic dysfunction.	[Krishnamoorthy, Vijay; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,BB-1469, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Gibbons, Edward F.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Chaikittisilpa, Nophanan; Gibbons, Edward F.; Rivara, Frederick P.; Temkin, Nancy R.; Quistberg, Alex; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98105 USA		Krishnamoorthy, V (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,BB-1469, Seattle, WA 98195 USA.; Krishnamoorthy, V (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Krishnamoorthy, V (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98105 USA.	vkrish@u.washington.edu		Rowhani-Rahbar, Ali/0000-0002-2705-4485; Krishnamoorthy, Vijay/0000-0003-4153-2348	NIH-National Research Service AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM086270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086270] Funding Source: NIH RePORTER	NIH-National Research Service Award (T32 GM086270).	Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HUNT D, 1972, AM HEART J, V83, P232, DOI 10.1016/0002-8703(72)90142-1; Knackstedt C, 2015, J AM COLL CARDIOL, V66, P1456, DOI 10.1016/j.jacc.2015.07.052; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Krishnamoorthy V, 2012, ANESTHESIOLOGY, V117, P745, DOI 10.1097/ALN.0b013e31826a7da7; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Moussouttas M, 2015, CEREBROVASC DIS EXTR, V5, P57, DOI 10.1159/000431155; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; TEASDALE G, 1974, LANCET, V2, P81; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38; Zaroff JG, 2006, STROKE, V37, P1680, DOI 10.1161/01.STR.0000226461.52423.dd; Zieleskiewicz L, 2014, ANESTHESIOLOGY, V120, P906, DOI 10.1097/ALN.0000000000000102	27	22	23	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2017	26	3					379	387		10.1007/s12028-016-0335-x			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EV9JA	WOS:000402101100009	28000133	Green Accepted			2022-02-06	
J	Lyons, VH; Moore, M; Guiney, R; Ayyagari, RC; Thompson, L; Rivara, FP; Fleming, R; Crawley, D; Harper, D; Vavilala, MS				Lyons, Vivian H.; Moore, Megan; Guiney, Roxanne; Ayyagari, Rajiv C.; Thompson, Leah; Rivara, Frederick P.; Fleming, Robin; Crawley, Deborah; Harper, Dawn; Vavilala, Monica S.			Strategies to Address Unmet Needs and Facilitate Return to Learn Guideline Adoption Following Concussion	JOURNAL OF SCHOOL HEALTH			English	Article						concussion; academic accommodations; traumatic brain injury (TBI); return to learn (RTL) services	QUALITATIVE CONTENT-ANALYSIS; TRAUMATIC BRAIN-INJURY; EDUCATIONAL-SERVICES; SUPPORT; SCHOOL; TBI; RECOMMENDATIONS; REHABILITATION; FRAMEWORK; SYMPTOMS	BACKGROUND: Many students do not receive return to learn (RTL) services upon return to academics following a concussion. METHODS: Using a mixed-methods approach, we conducted a survey of RTL practices and experiences in Washington State schools between January 2015 and June 2015. We then held a statewide summit of RTL stakeholders and used a modified Delphi process to develop a consensus-based RTL implementation model and process. RESULTS: Survey participants included 83 educators, 57 school nurses, 14 administrators, and 30 parents, representing 144 schools in rural and urban areas. Unmet need domains and recommendations identified were (1) a current lack of school policies; (2) barriers to providing or receiving accommodations; (3) wide variability in communication patterns; and (4) recommendations shared by all stakeholder groups (including desire for readily available best practices, development of a formal school RTL policy for easy adoption and more training). Using stakeholder input from RTL summit participants and survey responses, we developed an RTL implementation model and checklist for RTL guideline adoption. CONCLUSIONS: Washington State children have unmet needs upon returning to public schools after concussion. The student-centered RTL model and checklist for implementing RTL guidelines can help schools provide timely RTL services following concussion.	[Lyons, Vivian H.] Univ Washington, Dept Epidemiol, 1959 NE Pacific St,Hlth Sci Bldg,F-262,Box 357236, Seattle, WA 98195 USA; [Moore, Megan] Univ Washington, Sch Social Work, 4101 15th Ave NE, Seattle, WA 98105 USA; [Guiney, Roxanne] Harborview Med Ctr, Dept Psychiat & Behav Sci, 325 9th Ave,Box 359911, Seattle, WA 98104 USA; [Ayyagari, Rajiv C.] Johns Hopkins Univ, 3400 North Charles St, Baltimore, MD 21218 USA; [Thompson, Leah] Seattle Pediat Concuss Res Collaborat, 4800 Sand Point Way NE, Seattle, WA 98105 USA; [Rivara, Frederick P.] Univ Washington, Pediat, Sch Med, Box 359960,325 9th Ave, Seattle, WA 98104 USA; [Fleming, Robin] Off Superintendent Publ Instruct, Hlth Serv Program, 600 Washington St SE, Olympia, WA 98504 USA; [Crawley, Deborah] Brain Injury Alliance Washington, 316 Broadway Suite 305, Seattle, WA 98122 USA; [Harper, Dawn] Issaquah Valley Elementary Sch, 98927 555 Northwest Holly St, Issaquah, WA 98027 USA; [Vavilala, Monica S.] Harborview Injury Prevent & Res Ctr, Seattle, WA 98122 USA; [Vavilala, Monica S.] Univ Washington, Anesthesiol & Pain Med, Sch Med, 401 Broadway, Seattle, WA 98122 USA		Lyons, VH (corresponding author), Univ Washington, Dept Epidemiol, 1959 NE Pacific St,Hlth Sci Bldg,F-262,Box 357236, Seattle, WA 98195 USA.	vlyons@uw.edu; mm99@uw.edu; rmulvih@uw.edu; rayyaga3@jhu.edu; Leah.Thompson@seattlechildrens.org; fpr@uw.edu; Robin.Fleming@k12.wa.us; deborahc@biawa.org; harperd@issaquah.wednet.edu; vavilala@uw.edu			Washington State Department of Health and Human Services Traumatic Brain Injury Council; Seattle Children's Research Institute (SCRI); National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421] Funding Source: NIH RePORTER	This study was funded by the Washington State Department of Health and Human Services Traumatic Brain Injury Council (Award to Dr. M.S.V.), Seattle Children's Research Institute (SCRI) and the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2TR000421 to Dr. M.M.). The funding sources had no involvement in the study design, data collection, analysis and interpretation of data; in the writing of the report; or in our decision to submit the paper for publication. Special thanks to Molly Fuentes, MD, Christina Schwien, MN, MPH, Sharon Ashman, PhD, Brian Ross, MA, and Mark Gudmastad for their support of this project. We would also like to thank Bud Bannan, MEd, Laura Bienen, David Breiger, PhD, Sara Chrisman, MD, MPH, David Coppel, PhD, Nora Coronado, MSW, MPH, Julie Dawning, MSP, CBIS, Matt Gillingham, Jessica Giordano, MA, AnnGlang, PhD, Kris Harper, BSN, Stanley Herring, MD, Will Hitchcock, Jeanne Hoffman, PhD, Emily Kroshus, ScD, MPH, Cari McCarty, PhD, Anne Messerly, Kristin White, MD, Laura Ploudre, MEd, Benjamin Rogers, Karen Starr, MEd, Elizabeth Stein, BA and Laura Widdice, MN for their engagement in the Return to Learn Summit.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baker JG, 2014, INT J CLIN PRACT, V68, P1286, DOI 10.1111/ijcp.12517; Brown BE., BRAINSTEPS STUDENTS; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carlson, 2015, INJ EPIDEMIOL, V2, P32, DOI DOI 10.1186/s40621-015-0063-2; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dedoose, 2016, WEB APPL MAN AN PRES; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 1996, CHILDREN ACQUIRED BR; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Johnson RB., 2004, EDUC RESEARCHER, V33, P14, DOI [10.3102/0013189X033007014, DOI 10.3102/0013189X033007014]; Kay MC, 2015, J SPORT REHABIL, V24, P210, DOI 10.1123/jsr.2013-0132; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Laxe S, 2015, NEUROCIRUGIA, V26, P84, DOI 10.1016/j.neucir.2014.09.008; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McAvoy K., REAP BENEFITS GOOD C; ORCAS Inc, 2011, ORCAS INC POL RES HD; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sandford BA, 2007, PRACTICAL ASSESSMENT, V12; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Sophie Su Y, 2016, TRANSLATIONAL RES TR; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	34	22	22	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	JUN	2017	87	6					416	426		10.1111/josh.12510			11	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	EW8ME	WOS:000402772000003	28463445	Green Accepted, Green Published			2022-02-06	
J	Meeuwisse, WH; Schneider, KJ; Dvorak, J; Omu, O; Finch, CF; Hayden, KA; McCrory, P				Meeuwisse, Willem H.; Schneider, Kathryn J.; Dvorak, Jiri; Omu, Onutobor (Tobi); Finch, Caroline F.; Hayden, K. Alix; McCrory, Paul			The Berlin 2016 process: a summary of methodology for the 5th International Consensus Conference on Concussion in Sport	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							STATEMENT; ZURICH	The purpose of this paper is to summarise the methodology for the 5th International Consensus Conference on Concussion in Sport. The 18 months of preparation included engagement of a scientific committee, an expert panel of 33 individuals in the field of concussion and a modified Delphi technique to determine the primary questions to be answered. The methodology also involved the writing of 12 systematic reviews to inform the consensus conference and submission and review of scientific abstracts. The meeting itself followed a 2-day open format, a 1-day closed expert panel meeting and two additional half day meetings to develop the Concussion Recognition Tool 5 (Pocket CRT5), Sport Concussion Assessment Tool 5 (SCAT5) and Child SCAT5.	[Meeuwisse, Willem H.; Schneider, Kathryn J.; Omu, Onutobor (Tobi)] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Schneider, Kathryn J.] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB, Canada; [Schneider, Kathryn J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Dvorak, Jiri] Schulthess Clin Zurich, Swiss Concuss Ctr, Zurich, Switzerland; [Finch, Caroline F.] Federat Univ Australia, Australian Collaborat Res Injury Sport & Its Prev, SMB Campus, Ballarat, Vic, Australia; [Hayden, K. Alix] Univ Calgary, Lib & Cultural Resources, Calgary, AB, Canada; [McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia		Schneider, KJ (corresponding author), Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada.	kjschnei@ucalgary.ca	Iriti, Marcello/Q-8580-2017; McCrory, Paul/Q-8688-2019	Iriti, Marcello/0000-0002-5063-1236; McCrory, Paul/0000-0003-4850-0568; Schneider, Kathryn/0000-0002-5951-5899	University of Calgary from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; FIFA; Alberta Children's Hospital Research Institute; Hotchkiss Brain Institute; IOC; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Province of Alberta; Cogstate Inc.; Australian Football League; NFL	WHM is the medical director of the National Hockey League. He has received research grant support through the University of Calgary from the Canadian Institutes of Health Research, Alberta Innovates Health Solutions, the FIFA, Alberta Children's Hospital Research Institute and the Hotchkiss Brain Institute. He is the founding chair of the Sport Injury Prevention Research Centre, which is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the IOC. He has a clinical consulting practice in sport medicine at the University of Calgary Sport Medicine Centre. He is an expert group member of the IOC Medical Commission and has received travel funding in that capacity. KJS is a physiotherapy consultant at Evidence Sport and Spinal Therapy in Calgary, Alberta, Canada. She has received honoraria for speaking at various conferences. She has received research grant support through the University of Calgary from the Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute and the Canada Foundation for Innovation (including matching funds through the Province of Alberta). She is a faculty member at the Sport Injury Prevention Research Centre, within is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the IOC. CFF is a member of World Rugby's Independent Expert Panel on Concussion. She was not involved in any other aspects of the International Consensus Conference on Concussion in Sport except for the planning for the Delphi study and review and editing of the manuscript. PM is a coinvestigator, collaborator, or consultant on grants relating to mild TBI funded by several governmental organisations. He is directly employed by the National Health and Medical Research Council of Australia and is based at the Florey Institute of Neuroscience and Mental Health. He is co-chair of the Australian Centre for Research into Sports Injury and its Prevention (ACRISP), which is one of the International University Research Centres for Prevention of Injury and Protection of Athlete Health supported by the IOC. He is co-chair of the International Concussion in Sport Group. He has a clinical and consulting practise in general and sports neurology. He receives book royalties from McGraw-Hill and was employed in an editorial capacity by the British Medical Journal Publishing Group from 2001 to 2008. He has been reimbursed by the government, professional scientific bodies and sporting bodies for travel costs related to presenting research on mild TBI and sport-related concussion at meetings, scientific conferences and symposiums. He received consultancy fees in 2010 from Axon Sports (US) for the development of educational material (which was not renewed) and has received research funding since 2001 from Cogstate Inc. He has not received any research funding, salary or other monies from the Australian Football League, FIFA or the NFL. The Australian Football League funds research at the Florey Institute under a legal memorandum and PM does not receive any money from this industry-funded research. PM is a cofounder and shareholder in two biomedical companies (involved in eHealth and Compression garment technologies) but does not hold any individual shares in any company related to concussion or brain injury assessment or technology.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGowan J, 2016, TABLE 10 PRESS GUIDE; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; White PE, 2014, BRIT J SPORT MED, V48, P130, DOI 10.1136/bjsports-2013-092720	7	22	22	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2017	51	11					873	876		10.1136/bjsports-2017-097569			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EW3QP	WOS:000402416500007	28446449	Green Submitted, Bronze			2022-02-06	
J	Hartings, JA; Li, CY; Hinzman, JM; Shuttleworth, CW; Ernst, GL; Dreier, JP; Wilson, JA; Andaluz, N; Foreman, B; Carlson, AP				Hartings, Jed A.; Li, Chunyan; Hinzman, Jason M.; Shuttleworth, C. William; Ernst, Griffin L.; Dreier, Jens P.; Wilson, J. Adam; Andaluz, Norberto; Foreman, Brandon; Carlson, Andrew P.			Direct current electrocorticography for clinical neuromonitoring of spreading depolarizations	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Brain ischemia; electrophysiology; brain trauma; subarachnoid hemorrhage; acute stroke; neurocritical care; spreading depression	HUMAN CEREBRAL-CORTEX; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ISCHEMIC NEUROLOGICAL DEFICITS; TRAUMATIC BRAIN-INJURY; DIRECT-CURRENT SHIFTS; FOCAL ISCHEMIA; RAT-BRAIN; POLARIZATION IMPEDANCE; RECEPTOR ACTIVATION; SLOW POTENTIALS	Spreading depolarizations cause cortical electrical potential changes over a wide spectral range that includes slow potentials approaching the direct current (or 0 Hz) level. The negative direct current shift (<0.05 Hz) is an important identifier of cortical depolarization and its duration is a measure of potential tissue injury associated with longer lasting depolarizations. To determine the feasibility of monitoring the full signal bandwidth of spreading depolarizations in patients, we performed subdural electrocorticography using platinum electrode strips and direct current-coupled amplifiers in 27 patients with acute brain injury at two neurosurgical centers. While large baseline direct current offsets developed, loss of data due to amplifier saturation was minimal and rates of baseline drift throughout recordings were generally low. Transient negative direct current shifts of spreading depolarizations were easily recognized and in 306/551 (56%) cases had stereotyped, measurable characteristics. Following a standardized training session, novice scorers achieved a high degree of accuracy and interobserver reliability in identifying depolarizations, suggesting that direct current-coupled recordings can facilitate bedside diagnosis for future trials or clinical decision-making. We conclude that intracranial monitoring of slow potentials can be achieved with platinum electrodes and that unfiltered, direct current-coupled recordings are advantageous for identifying and assessing the impact of spreading depolarizations.	[Hartings, Jed A.; Hinzman, Jason M.; Wilson, J. Adam; Andaluz, Norberto] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH USA; [Hartings, Jed A.; Andaluz, Norberto] UC Neurosci Inst, Neurotrauma Ctr, Cincinnati, OH USA; [Hartings, Jed A.; Andaluz, Norberto] Mayfield Clin, Cincinnati, OH USA; [Li, Chunyan] Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY USA; [Li, Chunyan] Hofstra North Shore LIJ Sch Med, Dept Neurosurg, Hempstead, NY USA; [Shuttleworth, C. William] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Ernst, Griffin L.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Dreier, Jens P.] Charite, Dept Expt Neurol, Berlin, Germany; [Dreier, Jens P.] Charite, Dept Neurol, Berlin, Germany; [Dreier, Jens P.] Charite, Ctr Stroke Res, Berlin, Germany; [Foreman, Brandon] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Carlson, Andrew P.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA		Hartings, JA (corresponding author), Univ Cincinnati, 231 Albert Sabin Way,ML0517, Cincinnati, OH 45267 USA.	jed.hartings@uc.edu	Carlson, Andrew P/B-4369-2012	Carlson, Andrew P/0000-0003-2189-3699; Hartings, Jed/0000-0001-8583-3471; Foreman, Brandon/0000-0002-5418-674X	UNM Department of Neurosurgery; US Army CDMRP PH/TBI Research Program [W81XWH-08-2-0016]; University of New Mexico Department of Neurosurgery; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG DR 323/5-1, DR323/6-1]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)Federal Ministry of Education & Research (BMBF) [01 EO 0801, BCCN 01GQ1001C B2]; Era-Net Neuron [01EW1212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051288] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We further thank Howard Yonas, MD for financial support through the UNM Department of Neurosurgery. Research was funded by the US Army CDMRP PH/TBI Research Program (Contract No. W81XWH-08-2-0016 to JAH) and the University of New Mexico Department of Neurosurgery. JPD acknowledges support by Deutsche Forschungsgemeinschaft (DFG DR 323/5-1 and DR323/6-1), the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801; BCCN 01GQ1001C B2) and Era-Net Neuron 01EW1212.	Aiba I, 2012, J PHYSIOL-LONDON, V590, P5877, DOI 10.1113/jphysiol.2012.234476; CASPERS H, 1987, REV PHYSIOL BIOCH P, V106, P127, DOI 10.1007/BFb0027576; COLLEWIJN H, 1966, EXP NEUROL, V15, P425, DOI 10.1016/0014-4886(66)90140-3; COOPER R, 1980, EEG TECHNOLOGY; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Dreier JP, 2016, J CEREBR BLOOD FLOW; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fernandez IS, 2013, J CLIN NEUROPHYSIOL, V30, P554, DOI 10.1097/01.wnp.0000436898.10125.70; Geddes LA, 2003, ANN BIOMED ENG, V31, P879, DOI 10.1114/1.1581292; Gross DW, 1999, EPILEPSIA, V40, P891, DOI 10.1111/j.1528-1157.1999.tb00795.x; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hartings JA, 2006, J CEREBR BLOOD F MET, V26, P696, DOI 10.1038/sj.jcbfm.9600223; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2013, ACTA NEUROCHIR SUPPL, V115, P131, DOI 10.1007/978-3-7091-1192-5_27; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROPHYSIOL, V102, P2563, DOI 10.1152/jn.00345.2009; Higuchi T, 2002, J CEREBR BLOOD F MET, V22, P71, DOI 10.1097/00004647-200201000-00009; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Ikeda A, 1999, BRAIN, V122, P827, DOI 10.1093/brain/122.5.827; Ikeda A, 1999, BRAIN, V122, P915, DOI 10.1093/brain/122.5.915; Ikeda A, 1998, ELECTROEN CLIN NEURO, V107, P59, DOI 10.1016/S0013-4694(98)00003-0; Ikeda A, 1996, EPILEPSIA, V37, P662, DOI 10.1111/j.1528-1157.1996.tb00631.x; Jeffcote T, 2014, NEUROCRIT CARE, V20, P21, DOI 10.1007/s12028-013-9938-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Li C, 2016, NEURAL ENG, V13; Lindquist BE, 2012, NEUROSCIENCE, V223, P365, DOI 10.1016/j.neuroscience.2012.07.053; Mies G, 1997, NEUROSCI LETT, V221, P165, DOI 10.1016/S0304-3940(96)13317-6; Mirtaheri P, 2005, IEEE T BIO-MED ENG, V52, P2093, DOI 10.1109/TBME.2005.857639; NESHIGE R, 1988, BRAIN, V111, P719; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; RAGHEB T, 1991, ANN BIOMED ENG, V19, P151, DOI 10.1007/BF02368466; Ritaccio A, 2011, EPILEPSY BEHAV, V22, P641, DOI 10.1016/j.yebeh.2011.09.028; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Tallgren P, 2005, CLIN NEUROPHYSIOL, V116, P799, DOI 10.1016/j.clinph.2004.10.001; VANHARREVELD A, 1951, ELECTROEN CLIN NEURO, V3, P323, DOI 10.1016/0013-4694(51)90080-6; Vanhatalo S, 2005, CLIN NEUROPHYSIOL, V116, P1, DOI 10.1016/j.clinph.2004.09.015; Wilson JAS, 2012, ACTA NEUROCHIR S, V115, P67	48	22	22	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1857	1870		10.1177/0271678X16653135			14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200022	27286981	Bronze, Green Published			2022-02-06	
J	Reynolds, BB; Patrie, J; Henry, EJ; Goodkin, HP; Broshek, DK; Wintermark, M; Druzgal, TJ				Reynolds, Bryson B.; Patrie, James; Henry, Erich J.; Goodkin, Howard P.; Broshek, Donna K.; Wintermark, Max; Druzgal, T. Jason			Effects of Sex and Event Type on Head Impact in Collegiate Soccer	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						head injuries/concussion; football (soccer); biomechanics (general); subconcussion; accelerometer	WHITE-MATTER INTEGRITY; HIGH-SCHOOL; FOOTBALL PLAYERS; NECK STRENGTH; CONCUSSION; EXPOSURE; BIOMECHANICS; HISTORY; SPORTS	Background: The effects of head impact in sports are of growing interest for clinicians, scientists, and athletes. Soccer is the most popular sport worldwide, but the burden of head impact in collegiate soccer is still unknown. Purpose: To quantify head impact associated with practicing and playing collegiate soccer using wearable accelerometers. Study Design: Descriptive epidemiological study. Methods: Mastoid patch accelerometers were used to quantify head impact in soccer, examining differences in head impact as a function of sex and event type (practice vs game). Seven female and 14 male collegiate soccer players wore mastoid patch accelerometers that measured head impacts during team events. Data were summarized for each athletic exposure, and statistical analyses evaluated the mean number of impacts, mean peak linear acceleration, mean peak rotational acceleration, and cumulative linear and rotational acceleration, each grouped by sex and event type. Results: There were no differences in the frequency or severity of head impacts between men's and women's soccer practices. For men's soccer, games resulted in 285% more head impacts than practices, but there were no event-type differences in mean impact severity. Men's soccer games resulted in more head impacts than practices across nearly all measured impact severities, which also resulted in men's soccer games producing a greater cumulative impact burden. Conclusion: Similar to other sports, men's soccer games have a greater impact burden when compared with practices, and this effect is driven by the quantity rather than severity of head impacts. In contrast, there were no differences in the quantity or severity of head impacts in men's and women's soccer practices. These data could prompt discussions of practical concern to collegiate soccer, such as understanding sex differences in head impact and whether games disproportionately contribute to an athlete's head impact burden.	Univ Virginia, Charlottesville, VA USA; Univ Virginia Hlth Syst, Charlottesville, VA USA; [Reynolds, Bryson B.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA; [Patrie, James] Univ Virginia, Publ Hlth Sci, Charlottesville, VA USA; [Henry, Erich J.] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Broshek, Donna K.] Univ Virginia, Dept Psychiat & Neurobehavioral Sci, Charlottesville, VA USA; [Wintermark, Max] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA		Druzgal, TJ (corresponding author), Univ Virginia, Dept Radiol, Box 800170, Charlottesville, VA 22908 USA.; Druzgal, TJ (corresponding author), Univ Virginia, Div Neuroradiol, Med Imaging, Box 800170, Charlottesville, VA 22908 USA.		Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815; Goodkin, Howard/0000-0003-0528-4949; Druzgal, Jason/0000-0001-7240-9487; Reynolds, Bryson/0000-0001-9196-1461	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32 EB001628] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB001628] Funding Source: NIH RePORTER		Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Huber P., 1967, P 5 BERK S MATH STAT; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	44	22	22	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	APR 24	2017	5	4							2325967117701708	10.1177/2325967117701708			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	EV4KK	WOS:000401728300001	28491885	Green Published, gold			2022-02-06	
J	Lagerstedt, L; Egea-Guerrero, JJ; Bustamante, A; Montaner, J; Rodriguez-Rodriguez, A; El Rahal, A; Turck, N; Quintana, M; Garcia-Armengol, R; Prica, CM; Andereggen, E; Rinaldi, L; Sarrafzadeh, A; Schaller, K; Sanchez, JC				Lagerstedt, Linnea; Jose Egea-Guerrero, Juan; Bustamante, Alejandro; Montaner, Joan; Rodriguez-Rodriguez, Ana; El Rahal, Amir; Turck, Natacha; Quintana, Manuel; Garcia-Armengol, Roser; Melinda Prica, Carmen; Andereggen, Elisabeth; Rinaldi, Lara; Sarrafzadeh, Asita; Schaller, Karl; Sanchez, Jean-Charles			H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury	PLOS ONE			English	Article							ACID-BINDING PROTEIN; INTRACRANIAL LESIONS; COMPUTED-TOMOGRAPHY; SERUM-LEVELS; AGE; MARKER; S100B; MANAGEMENT; S100-BETA	The majority of patients with mild traumatic brain injury (mTBI) will have normal Glasgow coma scale (GCS) of 15. Furthermore, only 5%-8% of them will be CT-positive for an mTBI. Having a useful biomarker would help clinicians evaluate a patient's risk of developing intracranial lesions. The S100B protein is currently the most studied and promising biomarker for this purpose. Heart fatty-acid binding protein (H-FABP) has been highlighted in brain injury models and investigated as a biomarker for stroke and severe TBI, for example. Here, we evaluate the performances of S100B and H-FABP for differentiating between CT-positive and CT-negative patients. A total of 261 patients with a GCS score of 15 and at least one clinical symptom of mTBI were recruited at three different European sites. Blood samples from 172 of them were collected <= 6 h after trauma. Patients underwent a CT scan and were dichotomised into CT-positive and CT-negative groups for statistical analyses. H-FABP and S100B levels were measured using commercial kits, and their capacities to detect all CT-positive scans were evaluated, with sensitivity set to 100%. For patients recruited <= 6 h after trauma, the CT-positive group demonstrated significantly higher levels of both H-FABP (p = 0.004) and S100B (p = 0.003) than the CT-negative group. At 100% sensitivity, specificity reached 6% (95% CI 2.8-10.7) for S100B and 29% (95% CI 21.4-37.1) for H-FABP. Similar results were obtained when including all the patients recruited, i.e. hospital arrival within 24 h of trauma onset. H-FABP out-performed S100B and thus seems to be an interesting protein for detecting all CT-positive mTBI patients with a GCS score of 15 and at least one clinical symptom.	[Lagerstedt, Linnea; Turck, Natacha; Sanchez, Jean-Charles] Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland; [Jose Egea-Guerrero, Juan; Rodriguez-Rodriguez, Ana] Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, Seville, Spain; [Bustamante, Alejandro; Montaner, Joan] Univ Autonoma Barcelona, VHIR, Neurovasc Res Lab, Barcelona, Spain; [El Rahal, Amir; Schaller, Karl] Geneva Univ Hosp, Div Neurosurg, Dept Clin Neurosci, Geneva Neurosci Ctr, Geneva, Switzerland; [Quintana, Manuel] Univ Autonoma Madrid, Intens Med Unit, Hosp Univ La Paz, IdiPAZ,Dept Med, Madrid, Spain; [Garcia-Armengol, Roser] Hosp Badalona Germans Trias & Pujol, Dept Neurosurg, Neurosci Unit, Badalona, Spain; [Melinda Prica, Carmen] Hosp Tortosa Verge Cinta, Emergency Dept, Tortosa, Spain; [Andereggen, Elisabeth; Rinaldi, Lara] Geneva Univ Hosp, Emergency Ctr, Geneva, Switzerland; [Andereggen, Elisabeth] Geneva Univ Hosp, Dept Surg, Geneva, Switzerland; [Sarrafzadeh, Asita] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany		Sanchez, JC (corresponding author), Univ Geneva, Dept Human Prot Sci, Fac Med, Geneva, Switzerland.	Jean-Charles.Sanchez@unige.ch	Montaner, Joan/D-3063-2015; Egea-Guerrero, Juan Jose JJ/P-5080-2014; IBiS, Neurovascular/P-5842-2016	Montaner, Joan/0000-0003-4845-2279; Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; IBiS, Neurovascular/0000-0001-9511-0672; Lagerstedt, Linnea/0000-0002-3405-9938			Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Erenler AK, 2013, J PAK MED ASSOC, V63, P1176; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Lescuyer Pierre, 2005, Mol Diagn, V9, P1, DOI 10.2165/00066982-200509010-00001; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2016, JAMA NEUROL; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pelsers MMAL, 2005, CLIN CHEM LAB MED, V43, P802, DOI 10.1515/CCLM.2005.135; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Pelsers MMAL, 1999, CLIN CHEM, V45, P441; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Welch RD, 2016, J NEUROTRAUMA; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wolf H, 2015, J NEUROTRAUM, V32, P23, DOI 10.1089/neu.2013.3202; Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	36	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2017	12	4							e0175572	10.1371/journal.pone.0175572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES9KH	WOS:000399875200027	28419114	Green Published, gold, Green Submitted			2022-02-06	
J	Osborn, AJ; Mathias, JL; Fairweather-Schmidt, AK; Anstey, KJ				Osborn, A. J.; Mathias, J. L.; Fairweather-Schmidt, A. K.; Anstey, K. J.			Anxiety and comorbid depression following traumatic brain injury in a community-based sample of young, middle-aged and older adults	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Traumatic brain injury; Anxiety; Depression; Community; Population; Longitudinal; Multivariate	QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; MENTAL-HEALTH; NATIONAL-SURVEY; HEAD-INJURY; POPULATION; IDENTIFICATION; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE	Background: Anxiety is common following a traumatic brain injury (TBI), but who is most at risk, and to what extent, is not well understood. Methods: Longitudinal data from a randomly-selected community sample (Wave 1: 7397, Wave 2: 6621 and Wave 3: 6042) comprising three adult cohorts (young: 20-24 years of age, middle-aged: 40-44, older: 60-64), were analysed. The association between TBI history, anxiety and comorbid depression was assessed, controlling for age, sex, marital/employment status, medical conditions, recent life events, alcohol consumption, social support and physical activity. Results: Thirteen percent of the sample had sustained a TBI by Wave 3, 35% of whom had sustained multiple TBIs. Cross-sectional analyses revealed that clinically-significant anxiety was more common in people who had sustained a TBI. Longitudinal analyses demonstrated an increased risk of anxiety post-TBI, even after controlling for potential demographic, health and psychosocial confounds. Anxiety was more common than depression, although 10% of those with a TBI experienced comorbid anxiety/depression. Limitations: TBIs were not medically confirmed and anxiety and depression were only assessed every four years by self-report, rather than clinical interview. Sample attrition resulted in the retention of healthier individuals at each wave. Conclusions: TBIs are associated with a lifelong increased risk of experiencing clinically-significant anxiety, highlighting the chronic nature of TBI sequelae. Positive lifestyle changes (e.g., increasing physical activity, reducing alcohol consumption) may decrease the risk of anxiety problems in the early years after a TBI. Comorbid anxiety and depression was common, indicating that both should be monitored and treated.	[Osborn, A. J.; Mathias, J. L.; Fairweather-Schmidt, A. K.] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia; [Fairweather-Schmidt, A. K.] Flinders Univ S Australia, Sch Psychol, Bedford Pk, SA, Australia; [Fairweather-Schmidt, A. K.; Anstey, K. J.] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA, Australia.	jane.mathias@adelaide.edu.au	Anstey, Kaarin/A-3852-2008	Anstey, Kaarin/0000-0002-9706-9316			Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anstey KJ, 2012, INT J EPIDEMIOL, V41, P951, DOI 10.1093/ije/dyr025; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Butterworth P, 2004, J CLIN EPIDEMIOL, V57, P742, DOI 10.1016/j.jclinepi.2003.10.015; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Dworkin R. J., 1992, RES PERSONS MENTAL I; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kiely KM, 2015, PSYCHIAT RES, V225, P291, DOI 10.1016/j.psychres.2014.12.023; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Lecrubier Y, 2001, J CLIN PSYCHIAT, V62, P4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McEvoy PM, 2011, AUST NZ J PSYCHIAT, V45, P957, DOI 10.3109/00048674.2011.624083; Merikangas KR, 2010, CURR TOP BEHAV NEURO, V2, P37, DOI 10.1007/7854_2009_32; Ortiz Nadia, 2004, Cogn Behav Neurol, V17, P157, DOI 10.1097/01.wnn.0000140168.25333.2b; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Osborn A.J., J HEAD TRAU IN PRESS; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHUSTER TL, 1990, AM J COMMUN PSYCHOL, V18, P423, DOI 10.1007/BF00938116; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shahin H, 2012, J TRAUMA, V14, P233; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slade T, 2009, AUST NZ J PSYCHIAT, V43, P594, DOI 10.1080/00048670902970882; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Twisk JWR, 2004, EUR J EPIDEMIOL, V19, P769, DOI 10.1023/B:EJEP.0000036572.00663.f2; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	56	22	23	1	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	APR 15	2017	213						214	221		10.1016/j.jad.2016.09.045			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	ER5UH	WOS:000398868300031	27919428				2022-02-06	
J	Chuang, JY; Kao, TJ; Lin, SH; Wu, AC; Lee, PT; Su, TP; Yeh, SH; Lee, YC; Wu, CC; Chang, WC				Chuang, Jian-Ying; Kao, Tzu-Jen; Lin, Shu-Hui; Wu, An-Chih; Lee, Pin-Tse; Su, Tsung-Ping; Yeh, Shiu-Hwa; Lee, Yi-Chao; Wu, Chung-Che; Chang, Wen-Chang			Specificity protein 1-zinc finger protein 179 pathway is involved in the attenuation of oxidative stress following brain injury	REDOX BIOLOGY			English	Article						Zinc finger protein 179; Specificity protein 1; Reactive oxygen species; Traumatic brain injury; Nerve growth factor	GENE-EXPRESSION; SP1; TRANSCRIPTION; ZNF179; DIFFERENTIATION; ISCHEMIA; FAMILY; HDAC1	After sudden traumatic brain injuries, secondary injuries may occur during the following days or weeks, which leads to the accumulation of reactive oxygen species (ROS). Since ROS exacerbate brain damage, it is important to protect neurons against their activity. Zinc finger protein 179 (Znf179) was shown to act as a neuroprotective factor, but the regulation of gene expression under oxidative stress remains unknown. In this study, we demonstrated an increase in Znf179 protein levels in both in vitro model of hydrogen peroxide (H2O2)-induced ROS accumulation and animal models of traumatic brain injury. Additionally, we examined the sub-cellular localization of Znf179, and demonstrated that oxidative stress increases Znf179 nuclear shuttling and its interaction with specificity protein 1 (Sp1). Subsequently, the positive autoregulation of Znf179 expression, which is Sp1-dependent, was further demonstrated using luciferase reporter assay and green fluorescent protein (GFP)-Znf179-expressing cells and transgenic mice. The upregulation of Sp1 transcriptional activity induced by the treatment with nerve growth factor (NGF) led to an increase in Znf179 levels, which further protected cells against H2O2-induced damage. However, Sp1 inhibitor, mithramycin A, was shown to inhibit NGF effects, leading to a decrease in Znf179 expression and lower cellular protection. In conclusion, the results obtained in this study show that Znf179 autoregulation through Sp1-dependent mechanism plays an important role in neuroprotection, and NGF-induced Sp1 signaling may help attenuate more extensive (ROS-induced) damage following brain injury.	[Chuang, Jian-Ying; Kao, Tzu-Jen; Lin, Shu-Hui; Wu, An-Chih; Lee, Yi-Chao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei 110, Taiwan; [Chuang, Jian-Ying; Kao, Tzu-Jen; Lee, Yi-Chao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan; [Lin, Shu-Hui; Wu, An-Chih; Chang, Wen-Chang] Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan; [Lee, Pin-Tse; Su, Tsung-Ping] Natl Inst Drug Abuse, Cellular Pathobiol Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Yeh, Shiu-Hwa] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli 350, Taiwan; [Wu, Chung-Che] Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan		Chang, WC (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan.; Wu, CC (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan.	chuangcy@tmu.edu.tw; geokao@tmu.edu.tw; linivy9@yahoo.com.tw; anchinwu@gmail.com; pin-tse.lee@nih.gov; TSU@intra.nida.nih.gov; bau9763@nhri.org.tw; yc590626@gmail.com; johnwu@tmu.edu.tw; wcchang@tmu.edu.tw		Lee, Yi-Chao/0000-0003-3451-183X	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 103-2320-B-038-046, MOST 105-2320-B-038-063, MOST 105-2911-I-038-503, MOST 104-2923-B-038-002]; Taipei Medical University Hospital [104TMU-TMUH-01]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000206, ZIADA000549] Funding Source: NIH RePORTER	This work was supported by the Ministry of Science and Technology, Taiwan [grant numbers MOST 103-2320-B-038-046, MOST 105-2320-B-038-063, MOST 105-2911-I-038-503, and MOST 104-2923-B-038-002] and Taipei Medical University Hospital [grant numbers 104TMU-TMUH-01].	Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Chan PH, 2005, ANN NY ACAD SCI, V1042, P203, DOI 10.1196/annals.1338.022; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Chuang JY, 2012, ONCOGENE, V31, P4946, DOI 10.1038/onc.2011.649; Chuang JY, 2011, FREE RADICAL BIO MED, V51, P2309, DOI 10.1016/j.freeradbiomed.2011.10.001; Chuang JY, 2011, BIOCHEM BIOPH RES CO, V407, P587, DOI 10.1016/j.bbrc.2011.03.068; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Formisano L, 2015, J NEUROSCI, V35, P7332, DOI 10.1523/JNEUROSCI.2174-14.2015; Kimura T, 1997, AM J MED GENET, V69, P320; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lin DY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-98; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Lomash RM, 2015, CELL REP, V12, P743, DOI 10.1016/j.celrep.2015.06.064; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Rojo AI, 2006, FREE RADICAL BIO MED, V41, P247, DOI 10.1016/j.freeradbiomed.2006.04.002; Ryu H, 2003, J NEUROSCI, V23, P3597; Seki N, 1999, DNA Res, V6, P353, DOI 10.1093/dnares/6.5.353; Seo SJ, 1996, GENE, V178, P177, DOI 10.1016/0378-1119(96)00383-6; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Su TC, 2016, NEUROPHARMACOLOGY, V105, P1, DOI 10.1016/j.neuropharm.2016.01.015; Tsai SYA, 2015, P NATL ACAD SCI USA, V112, pE6562, DOI 10.1073/pnas.1518894112; Tsou J. H., 2016, MOL NEUROBIOL; Ugoya SO, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/141624; Valsecchi V, 2011, STROKE, V42, P754, DOI 10.1161/STROKEAHA.110.597583; Wang SM, 2015, MOL NEUROBIOL, V51, P370, DOI 10.1007/s12035-014-8714-9; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu Y, 2002, BIOCHEM J, V362, P401, DOI 10.1042/0264-6021:3620401; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161; Zhuang YF, 2013, ASIAN PAC J TROP MED, V6, P383, DOI 10.1016/S1995-7645(13)60043-7	36	22	24	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	APR	2017	11						135	143		10.1016/j.redox.2016.11.012			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ6RY	WOS:000398212000015	27918959	Green Published, gold			2022-02-06	
J	Huang, MX; Harrington, DL; Swan, AR; Quinto, AA; Nichols, S; Drake, A; Song, T; Diwakar, M; Huang, CW; Risbrough, VB; Dale, A; Bartsch, H; Matthews, S; Huang, JW; Lee, RR; Baker, DG				Huang, Ming-Xiong; Harrington, Deborah L.; Swan, Ashley Robb; Quinto, Annemarie Angeles; Nichols, Sharon; Drake, Angela; Song, Tao; Diwakar, Mithun; Huang, Charles W.; Risbrough, Victoria B.; Dale, Anders; Bartsch, Hauke; Matthews, Scott; Huang, Jeffrey W.; Lee, Roland R.; Baker, Dewleen G.			Resting-State Magnetoencephalography Reveals Different Patterns of Aberrant Functional Connectivity in Combat-Related Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast brain injury; excitation; inhibition; FC; MEG; TBI	DEFAULT-MODE NETWORK; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SIGNAL SPACE SEPARATION; SOURCE IMAGING APPROACH; MIDLINE THETA-RHYTHM; INDEPENDENT COMPONENT; ALZHEIMERS-DISEASE; COGNITIVE CONTROL; SERVICE MEMBERS; BLAST EXPOSURE	Blast mild traumatic brain injury (mTBI) is a leading cause of sustained impairment in military service members and veterans. However, the mechanism of persistent disability is not fully understood. The present study investigated disturbances in brain functioning in mTBI participants using a source-imaging-based approach to analyze functional connectivity (FC) from resting-state magnetoencephalography (rs-MEG). Study participants included 26 active-duty service members or veterans who had blast mTBI with persistent post-concussive symptoms, and 22 healthy control active-duty service members or veterans. The source time courses from regions of interest (ROIs) were used to compute ROI to whole-brain (ROI-global) FC for different frequency bands using two different measures: 1) time-lagged cross-correlation and 2) phase-lock synchrony. Compared with the controls, blast mTBI participants showed increased ROI-global FC in beta, gamma, and low-frequency bands, but not in the alpha band. Sources of abnormally increased FC included the: 1) prefrontal cortex (right ventromedial prefrontal cortex [vmPFC], right rostral anterior cingulate cortex [rACC]), and left ventrolateral and dorsolateral prefrontal cortex; 2) medial temporal lobe (bilateral parahippocampus, hippocampus, and amygdala); and 3) right putamen and cerebellum. In contrast, the blast mTBI group also showed decreased FC of the right frontal pole. Group differences were highly consistent across the two different FC measures. FC of the left ventrolateral prefrontal cortex correlated with executive functioning and processing speed in mTBI participants. Altogether, our findings of increased and decreased regionalpatterns of FC suggest that disturbances in intrinsic brain connectivity may be the result of multiple mechanisms, and are associated with cognitive sequelae of the injury.	[Huang, Ming-Xiong; Harrington, Deborah L.; Swan, Ashley Robb; Quinto, Annemarie Angeles; Matthews, Scott; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Swan, Ashley Robb; Quinto, Annemarie Angeles; Song, Tao; Diwakar, Mithun; Dale, Anders; Bartsch, Hauke; Matthews, Scott; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Swan, Ashley Robb; Quinto, Annemarie Angeles; Song, Tao; Diwakar, Mithun; Dale, Anders; Bartsch, Hauke; Matthews, Scott; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Swan, Ashley Robb; Quinto, Annemarie Angeles; Song, Tao; Diwakar, Mithun; Dale, Anders; Bartsch, Hauke; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Nichols, Sharon] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Huang, Charles W.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Risbrough, Victoria B.; Matthews, Scott; Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Drake, Angela] Naval Med Ctr, San Diego, CA USA; [Risbrough, Victoria B.; Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Matthews, Scott] VASDHS Residential Rehabil Treatment Program, Aspire Ctr, San Diego, CA USA; [Huang, Jeffrey W.] Westview High Sch, San Diego, CA USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu	Baker, Dewleen/O-4957-2019; Risbrough, Victoria/X-3344-2019	Baker, Dewleen/0000-0002-1736-9838; Bartsch, Hauke/0000-0003-1486-4128	Merit Review Grants from the Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX000499, MHBA-010-14F, NURC-022-10F, NEUC-044-06S, I01-CX000146]; Naval Medical Research Center's Advanced Medical Development program [N62645-11-C-4037]; Veterans AffairsUS Department of Veterans Affairs [I01CX000146, I01BX002558, I01CX000499] Funding Source: NIH RePORTER	This work was supported in part by Merit Review Grants from the Department of Veterans Affairs to M.X. Huang (I01-CX000499, MHBA-010-14F, NURC-022-10F, NEUC-044-06S), R.R. Lee, and D.L. Harrington (I01-CX000146), and Naval Medical Research Center's Advanced Medical Development program (Naval Medical Logistics Command Contract #N62645-11-C-4037, for MRS-II (D.G. Baker, M.X. Huang, V.B. Risbrough). We acknowledge the MRS-II administrative core, Anjana Patel, Andrew De La Rosa, and members of the MRS-II Team, including logistic coordinators, clinician-interviewers, and data collection staff. We thank staff at the VA San Diego Healthcare System and the Veterans Medical Research Foundation (VRMF). We also thank the participating Marines and veteran volunteers for their military service and participation in this study.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Baayen JC, 2003, BRAIN TOPOGR, V16, P85, DOI 10.1023/B:BRAT.0000006332.71345.b7; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chen Y, 2016, CURR ALZHEIMER RES, V13, P234, DOI 10.2174/156720501303160217113858; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Cohen D, 2002, P 13 INT C BIOM, P919; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; de Jongh A, 2003, NEUROIMAGE, V20, P2291, DOI 10.1016/j.neuroimage.2003.07.030; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; DECKER DA, 1972, ELECTROEN CLIN NEURO, V33, P303, DOI 10.1016/0013-4694(72)90157-5; Delis DC., 2001, DELIS KAPLAN EXECUTI; DePalma R. G., 2016, BEHAV BRAIN RES; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Douaud G, 2013, J NEUROSCI, V33, P2147, DOI 10.1523/JNEUROSCI.4437-12.2013; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Forn C, 2013, BRAIN COGNITION, V82, P152, DOI 10.1016/j.bandc.2013.04.003; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Harrington Deborah L, 2014, Timing Time Percept, V2, P145, DOI 10.1163/22134468-00002025; Haufe S, 2011, NEUROIMAGE, V54, P851, DOI 10.1016/j.neuroimage.2010.09.003; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hindriks R, 2013, NEUROIMAGE, V70, P150, DOI 10.1016/j.neuroimage.2012.12.018; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang CW, 2016, CLIN NEUROPHYSIOL, V127, P2308, DOI 10.1016/j.clinph.2016.02.007; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Hyafil A, 2015, TRENDS NEUROSCI, V38, P725, DOI 10.1016/j.tins.2015.09.001; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kandel E.R., 2013, PRINCIPLES NEURAL SC, V5th; Kantarci K, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00316; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; KNAPP CH, 1976, IEEE T ACOUST SPEECH, V24, P320, DOI 10.1109/TASSP.1976.1162830; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kolb B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00377; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Lee KYK, 2011, NEUROIMAGE, V54, pS30, DOI 10.1016/j.neuroimage.2010.05.042; Lewine J D, 1995, Neuroimaging Clin N Am, V5, P575; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; MIZUKI Y, 1980, ELECTROEN CLIN NEURO, V49, P345, DOI 10.1016/0013-4694(80)90229-1; MIZUKI Y, 1992, INT J PSYCHOPHYSIOL, V12, P169, DOI 10.1016/0167-8760(92)90008-Y; MIZUKI Y, 1984, FOLIA PSYCHIAT NEU J, V38, P451; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; NAGATA K, 1985, NEUROSURGERY, V17, P613, DOI 10.1227/00006123-198510000-00014; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Orr JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124797; Ou W, 2008, LECT NOTES COMPUT SC, V5241, P26, DOI 10.1007/978-3-540-85988-8_4; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Scheeringa R, 2012, BRAIN CONNECT, V2, P254, DOI 10.1089/brain.2012.0088; Schilbach L, 2016, NEUROIMAGE-CLIN, V10, P326, DOI 10.1016/j.nicl.2015.11.021; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholvinck ML, 2013, NEUROIMAGE, V80, P297, DOI 10.1016/j.neuroimage.2013.04.010; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song J, 2015, BRAIN CONNECT, V5, P276, DOI 10.1089/brain.2014.0308; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Sours C, 2015, BRAIN CONNECT, V5, P442, DOI 10.1089/brain.2014.0333; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Takahashi N, 1997, CLIN ELECTROENCEPHAL, V28, P49, DOI 10.1177/155005949702800109; Tamnes CK, 2016, J AM ACAD CHILD PSY, V55, P269, DOI 10.1016/j.jaac.2016.01.004; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S, 2004, Neurol Clin Neurophysiol, V2004, P35; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Usui N, 2009, NEUROSCI LETT, V463, P1, DOI 10.1016/j.neulet.2009.07.048; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; Vieth JB, 1996, BRAIN TOPOGR, V8, P215, DOI 10.1007/BF01184772; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xiong KL, 2016, NEURORADIOLOGY, V58, P733, DOI 10.1007/s00234-016-1675-0; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	143	22	22	2	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1412	1426		10.1089/neu.2016.4581			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600011	27762653	Green Submitted			2022-02-06	
J	Betancur, MI; Mason, HD; Alvarado-Velez, M; Holmes, PV; Bellamkonda, RV; Karumbaiah, L				Betancur, Martha I.; Mason, Hannah D.; Alvarado-Velez, Melissa; Holmes, Phillip V.; Bellamkonda, Ravi V.; Karumbaiah, Lohitash			Chondroitin Sulfate Glycosaminoglycan Matrices Promote Neural Stem Cell Maintenance and Neuroprotection Post-Traumatic Brain Injury	ACS BIOMATERIALS SCIENCE & ENGINEERING			English	Article						traumatic brain injury; biomaterials; neuroprotection; chondroitin sulfate glycosaminoglycan; neural stem cells; hydrogels	GROWTH-FACTORS; STEM/PROGENITOR CELLS; GLIAL SCAR; PROTEOGLYCAN; PROLIFERATION; NEUROGENESIS; BINDING; DIFFERENTIATION; REGENERATION; REGIONS	There are currently no effective treatments for moderate-to-severe traumatic brain injuries (TBIs). The paracrine functions of undifferentiated neural stem cells (NSCs) are believed to play a significant role in stimulating the repair and regeneration of injured brain tissue. We therefore hypothesized that fibroblast growth factor (FGF2) enriching chondroitin sulfate glycosaminoglycan (CS-GAG) matrices can maintain the undifferentiated state of neural stem cells (NSCs) and facilitate brain tissue repair subacutely post-TBI. Rats subjected to a controlled cortical impactor (CCI) induced TBI were intraparenchymally injected with CS-GAG matrices alone or with CS-GAG matrices containing PKH26GL labeled allogeneic NSCs. Nissl staining of brain tissue 4 weeks post-TBI demonstrated the significantly enhanced (p < 0.05) tissue protection in CS-GAG treated animals when compared to TBI only control, and NSC only treated animals. CS-GAG-NSC treated animals demonstrated significantly enhanced (p < 0.05) FGF2 retention, and maintenance of PKH26GL labeled NSCs as indicated by enhanced Soxl+ and Ki67+ cell presence over other differentiated cell types. Lastly, all treatment groups and sham controls exhibited a significantly (p < 0.05) attenuated GFAP+ reactive astrocyte presence in the lesion site when compared to TBI only controls.	[Betancur, Martha I.; Mason, Hannah D.; Karumbaiah, Lohitash] Univ Georgia, Regenerat Biosci Ctr, 425 River Rd,ADS Complex, Athens, GA 30602 USA; [Holmes, Phillip V.] Univ Georgia, Dept Psychol, 125 Baldwin St, Athens, GA 30602 USA; [Alvarado-Velez, Melissa; Bellamkonda, Ravi V.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA		Karumbaiah, L (corresponding author), Univ Georgia, Regenerat Biosci Ctr, 425 River Rd,ADS Complex, Athens, GA 30602 USA.	lohitash@uga.edu		Karumbaiah, Lohitash/0000-0001-7969-417X	University of Georgia CAES and OVPR; Georgia Institute of Technology/Emory University Regenerative Engineering and Medicine Center; University of Georgia; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR00454]; National Institutes of Health (NIH/NCRR) - entitled 'Integrated Technology Resource for Biomedical Glycomics' [1P41RR018502-01]	This research was supported by startup funds awarded to L.K. by the University of Georgia CAES and OVPR, and in part by seed grant funding from the Georgia Institute of Technology/Emory University Regenerative Engineering and Medicine Center and The University of Georgia awarded to R.V.B. and L.K. This work is also supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR00454. The National Institutes of Health (NIH/NCRR)-funded grant entitled 'Integrated Technology Resource for Biomedical Glycomics' (Grant 1P41RR018502-01) to the Complex Carbohydrate Research Center, The University of Georgia.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; He Z, 2015, MOL NEUROBIOL, V52, P927, DOI 10.1007/s12035-015-9244-9; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Kan LX, 2007, DEV BIOL, V310, P85, DOI 10.1016/j.ydbio.2007.07.026; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Karumbaiah L, 2015, BIOCONJUGATE CHEM, V26, P2336, DOI 10.1021/acs.bioconjchem.5b00397; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170; Koppe G, 1997, HISTOCHEM J, V29, P11, DOI 10.1023/A:1026408716522; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; Sirko S, 2010, STEM CELLS, V28, P775, DOI 10.1002/stem.309; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; TOOLE BP, 1976, J BIOL CHEM, V251, P895; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998	40	22	23	3	15	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2373-9878			ACS BIOMATER SCI ENG	ACS Biomater. Sci. Eng.	MAR	2017	3	3					420	430		10.1021/acsbiomaterials.6b00805			11	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	EO0JU	WOS:000396384900021	29744379	Green Accepted			2022-02-06	
J	Gardner, AJ; Iverson, GL; Wojtowicz, M; Levi, CR; Kay-Lambkin, F; Schofield, PW; Zafonte, R; Shultz, SR; Lin, AP; Stanwell, P				Gardner, Andrew J.; Iverson, Grant L.; Wojtowicz, Magdalena; Levi, Christopher R.; Kay-Lambkin, Frances; Schofield, Peter W.; Zafonte, Ross; Shultz, Sandy R.; Lin, Alexander P.; Stanwell, Peter			MR Spectroscopy Findings in Retired Professional Rugby League Players	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						concussion; neuroimaging; retired athletes; spectroscopy	MILD COGNITIVE IMPAIRMENT; MAGNETIC-RESONANCE-SPECTROSCOPY; POSTERIOR CINGULATE; USE DISORDERS; CONCUSSION; DISEASE; SYSTEM; INJURY; PET	The aim of this study was to examine brain neurometabolite concentrations in retired rugby league players who had a history of numerous self-reported concussions. Participants were 16 retired professional rugby league players (ages 30-45 years) with an extensive history of concussion and participation in contact sports, and 16 age-and education- matched controls who had no history of neurotrauma or participation in contact sports. All completed a clinical interview, psychological and cognitive testing, and magnetic resonance spectroscopy (MRS) investigation. MRS voxels were placed in posterior cingulate grey matter and parietal white matter. Neurometabolite concentrations were quantified using LCModel. It was hypothesized that retired athletes would differ on N-acetyl aspartate, myo-inositol, choline, glutamate, and glutathione. Retired players had significantly lower concentrations of grey matter glutathione (p = 0.02, d = 0.91). They did not significantly differ in concentrations of other neurometabolites. There were no significant differences between groups on measures of depression, anxiety, or cognitive functioning. The retired athletes reported significantly greater alcohol use (p < 0.01; Cohen's d = 1.49), and they had worse manual dexterity using their non-dominant hand (p = 0.03; d = 1.08). These preliminary findings suggest that MRS might be modestly sensitive to biochemical differences in athletes after their athletic careers have ended in the absence of clinical differences in cognitive performance and self-reported psychological functioning.	[Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Translat Neurosci & Mental Hlth, Level 5, Waratah 2298, Australia; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Levi, Christopher R.] Hunter New England Local Hlth Dist, Sports Concuss Program, New Lambton Hts, Australia; [Kay-Lambkin, Frances] Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Schofield, Peter W.] Hunter New England Local Hlth Dist, Neuropsychiat Serv, New Lambton, Australia; [Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Ctr Clin Spect, Boston, MA USA; [Stanwell, Peter] Univ Newcastle, Sch Hlth Sci, Callaghan, NSW, Australia		Gardner, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Ctr Translat Neurosci & Mental Hlth, Level 5, Waratah 2298, Australia.	andrew.gardner@neurogard.com.au	Stanwell, Peter/F-9136-2012	Stanwell, Peter/0000-0002-4780-0393; Schofield, Peter/0000-0001-8298-8590; Gardner, Andrew/0000-0001-5031-5586; Iverson, Grant/0000-0001-7348-9570; Levi, Christopher/0000-0002-9474-796X	New South Wales Sporting Injuries Committee - Sports Research & Injury Prevention Scheme Grant; Brain Foundation, Australia - Brain Injury Award; Hunter Medical Research Institute; Harvard Integrated Program to Protect and Improve the Health of NFLPA Members; Mooney-Reed Charitable Foundation; Heniz Family Foundation-Brain Injury Research Fund at Spaulding Rehabilitation Hospital; Australian Football League (AFL); ImPACT Applications, Inc.; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc.); Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Alcohol Beverage Medical Research Council; Rehabilitation Research and Development (RR&D) Service of the US Department of Veterans AffairsUS Department of Veterans Affairs; Vancouver Coastal Health Research Institute; Roche Diagnostics Canada; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	Andrew J. Gardner, Peter Stanwell, Frances Kay-Lambkin, and Christopher R. Levi have been funded to conduct research into concussion in rugby league through a New South Wales Sporting Injuries Committee - Sports Research & Injury Prevention Scheme Grant, and a Brain Foundation, Australia - Brain Injury Award. Andrew J. Gardner acknowledges sport concussion research fellowship funding from Jennie Thomas, Life Governor of the Hunter Medical Research Institute, and Anne Greaves of the Hunter Medical Research Institute. Ross Zafonte was supported in part by the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members. Grant Iverson and Ross Zafonte acknowledge support from the Mooney-Reed Charitable Foundation and the Heniz Family Foundation-Brain Injury Research Fund at Spaulding Rehabilitation Hospital. Author Disclosure/Conflict of Interest Statement Andrew Gardner has a clinical practice in neuropsychology involving the assessment and management of individuals who have sustained sport-related concussion (including current and former athletes). He has received travel funding from the Australian Football League (AFL) to present at the Concussion in Football Conference in 2013. He has served as a concussion consultant to the Australian Rugby Union (ARU) from July 2016. Grant Iverson, PhD has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc.). He is a co-investigator, collaborator, or consultant on grants relating to mild TBI funded by several organizations, including, but not limited to, the Canadian Institute of Health Research, Alcohol Beverage Medical Research Council, Rehabilitation Research and Development (RR&D) Service of the US Department of Veterans Affairs, Vancouver Coastal Health Research Institute, and Roche Diagnostics Canada. Frances Kay-Lambkin is supported by a fellowship from the National Health and Medical Research Council of Australia. She is the subject of publishing contracts with multiple companies, including CCBT Ltd in the EU, Magelan, multiple BCBSs and Cobalt Therapeutics LLC in the US, as well as the NHS in the UK. Although she has received no remuneration to date, she may receive royalties in the future. She has not received any equity or payments related to the work discussed in this manuscript.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Benton AL, 1994, MULTILINGUAL APHASIA; Bhidayasiri R, 2012, PARKINSONISM RELAT D, V18, P694, DOI 10.1016/j.parkreldis.2012.01.010; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Crane PK, 2008, J INT NEUROPSYCH SOC, V14, P746, DOI 10.1017/S1355617708081162; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Duffy SL, 2014, ALZHEIMERS DEMENT, V10, P67, DOI 10.1016/j.jalz.2013.01.005; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Glodzik L, 2015, J ALZHEIMERS DIS, V43, P939, DOI 10.3233/JAD-140609; Golden CJ, 1978, STROOP COLOR WORD TE; Guo ZW, 2016, COMPR PSYCHIAT, V69, P179, DOI 10.1016/j.comppsych.2016.06.001; Haga KK, 2009, NEUROBIOL AGING, V30, P353, DOI 10.1016/j.neurobiolaging.2007.07.005; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Hellem T, 2015, J AM PSYCHIAT NURSES, V21, P244, DOI 10.1177/1078390315598606; Hong YJ, 2013, NEUROL SCI, V34, P1215, DOI 10.1007/s10072-012-1225-4; Johnson WM, 2012, NUTRIENTS, V4, P1399, DOI 10.3390/nu4101399; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koerte IK, 2015, J NEUROTRAUMA; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Larroza A, 2014, NEUROLOGIA, V29, P11, DOI 10.1016/j.nrl.2013.02.002; Lin A, 2012, SEMIN NEUROL, V32, P432, DOI 10.1055/s-0032-1331814; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meyers JE., 1995, REY COMPLEX FIGURE T; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Mullins PG, 2008, MAGN RESON MED, V60, P964, DOI 10.1002/mrm.21696; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Psychological Corporation, 2009, ADV CLIN SOL WAIS 4; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Riese F, 2015, NEUROBIOL AGING, V36, P53, DOI 10.1016/j.neurobiolaging.2014.07.030; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seeger U, 2003, MAGNET RESON MED, V49, P19, DOI 10.1002/mrm.10332; Talairach J., 1988, COPLANAR STEREOTACTI; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Weaver KE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/610605; Wechsler D., 2008, WECHSLET ADULT INTEL; Zimny A, 2015, J ALZHEIMERS DIS, V44, P329, DOI 10.3233/JAD-132138	51	22	22	2	14	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	MAR	2017	38	3					241	252		10.1055/s-0042-120843			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	EW5JM	WOS:000402541900009	28192828				2022-02-06	
J	Lai, NS; Zhang, JQ; Qin, FY; Sheng, B; Fang, XG; Li, ZB				Lai, Nian-sheng; Zhang, Jia-qi; Qin, Fei-yun; Sheng, Bin; Fang, Xing-gen; Li, Zhen-bao			Serum microRNAs are non-invasive biomarkers for the presence and progression of subarachnoid haemorrhage	BIOSCIENCE REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; CELL CARCINOMA; CANCER; PROLIFERATION; INVASION; EXPRESSION; PATHWAY; ASSOCIATION; HIPPOCAMPUS; INHIBITION	miRNAs are important regulators of translation and have been associated with the pathogenesis of a number of cardiovascular diseases including stroke and may be possible prognostic biomarkers. The purpose of the present study was to determine the expression levels of miRNAs in the sera of subarachnoid haemorrhage (SAH) patients and to evaluate their relationships with the severity and clinical outcome of SAH. Serum samples on day 3 after the onset of SAH were subjected to microarray analysis with Exqion miRCURY (TM) LNA array and quantitative PCR analysis. Serum samples from SAH patients (n=60) and healthy controls (n=10) were subjected to quantitative PCR analysis. The severities and clinical outcomes of the SAH patients were evaluated with the WFNS grade and the Modified Rankin Scale (mRS). Three miRNAs, miR-502-5p, miR-1297 and miR-4320 were significantly up-regulated in the sera of SAH patients when compared with the healthy controls. The serum miR-502-5p and miR-1297 levels were significantly higher in the patients with severe SAH and a poor outcome than in those with mild SAH and a good outcome (P<0.05). The areas under the receiver operating characteristic (ROC) curves (AUCs) of miR-502-5p, miR-1297 and miR-4320 to distinguish the SAH patients from the healthy controls were 0.958 (P<0.001), 0.950(P<0.001) and 0.843 (P<0.001) respectively. Taken together, these results indicate that miR-502-5p and miR-1297 are potentially valuable indicators of the diagnosis, severity and prognosis of SAH, and miR-4320 was a potentially valuable indicator of the diagnosis of SAH.	[Lai, Nian-sheng; Qin, Fei-yun; Sheng, Bin; Fang, Xing-gen; Li, Zhen-bao] Wannan Med Coll, Affiliated Hosp 1, Dept Neurosurg, Wuhu City 241001, Anhui, Peoples R China; [Zhang, Jia-qi] Xinxiang Cent Hosp, Dept Neurosurg, Xinxiang City 453000, Henan, Peoples R China		Li, ZB (corresponding author), Wannan Med Coll, Affiliated Hosp 1, Dept Neurosurg, Wuhu City 241001, Anhui, Peoples R China.	zhenbaoli123@126.com			Young and Middle-Aged Natural Science Foundation of Wannan Medical College [WK2015F25]; Natural Science Foundation of AnhuiNatural Science Foundation of Anhui Province [1708085QH181]	This work was supported by the Young and Middle-Aged Natural Science Foundation of Wannan Medical College [grant number WK2015F25] and the Natural Science Foundation of Anhui [grant number 1708085QH181].	Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Badjatia N, 2015, NEUROLOGY, V84, P680, DOI 10.1212/WNL.0000000000001259; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Chen LJ, 2015, CIRC RES, V116, P1157, DOI 10.1161/CIRCRESAHA.116.305987; Chen P, 2014, ASIAN PAC J CANCER P, V15, P9185, DOI 10.7314/APJCP.2014.15.21.9185; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dahan D, 2014, AM J PHYSIOL-CELL PH, V307, pC1093, DOI 10.1152/ajpcell.00250.2014; Daniere F, 2015, DIAGN INTERV IMAG, V96, P677, DOI 10.1016/j.diii.2015.05.006; Helbok R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0809-9; Ju HQ, 2016, THERANOSTICS, V6, P1160, DOI 10.7150/thno.14848; Lai NS, 2015, BRIT J CANCER, V112, P1241, DOI 10.1038/bjc.2015.91; Lai PMR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151853; Lei Q, 2015, NEURORADIOLOGY, V57, P63, DOI 10.1007/s00234-014-1435-y; Li YF, 2016, MOL MED REP, V13, P1895, DOI 10.3892/mmr.2015.4692; Liang X, 2016, BIOCHEM BIOPH RES CO, V480, P208, DOI 10.1016/j.bbrc.2016.10.029; Liu Y, 2015, INT J MOL MED, V36, P1345, DOI 10.3892/ijmm.2015.2341; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Muller AH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1341-7; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Powers CJ, 2016, PHYSIOL GENOMICS, V48, P361, DOI 10.1152/physiolgenomics.00052.2015; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Selvamani A, 2014, CLIN SCI, V127, P77, DOI 10.1042/CS20130565; Shao AW, 2014, CNS NEUROSCI THER, V20, P182, DOI 10.1111/cns.12194; Strickland ER, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00117; Stylli S. S., 2016, J NEUROSURG, V29, P1; Su XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144724; Sun LL, 2014, ONCOL REP, V31, P2085, DOI 10.3892/or.2014.3105; Sun M, 2016, CANCER RES, V76, P6299, DOI 10.1158/0008-5472.CAN-16-0356; Triglia T, 2016, EUR J ANAESTH, V33, P662, DOI 10.1097/EJA.0000000000000494; Vijayan M, 2016, BBA-MOL BASIS DIS, V1862, P1984, DOI 10.1016/j.bbadis.2016.08.003; Vivancos J, 2014, NEUROLOGIA, V29, P353, DOI 10.1016/j.nrl.2012.07.009; Wang CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32921; Wang J., 2016, STEM CELLS INT, V2016, P1, DOI DOI 10.1155/2016/9371563; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Yang NQ, 2016, AM J TRANSL RES, V8, P1091; Yang SD, 2014, ASIAN PAC J CANCER P, V15, P6505, DOI 10.7314/APJCP.2014.15.16.6505; Zhang GL, 2016, CELL IMMUNOL, V302, P50, DOI 10.1016/j.cellimm.2016.01.007; Zhao YH, 2015, INT J MOL SCI, V16, P30105, DOI 10.3390/ijms161226223	38	22	22	0	4	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	FEB 28	2017	37		1						BSR20160480	10.1042/BSR20160480			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EM1SA	WOS:000395096100019	28115593	gold, Green Published			2022-02-06	
J	Alosco, ML; Jarnagin, J; Tripodis, Y; Platt, M; Martin, B; Chaisson, CE; Baugh, CM; Fritts, NG; Cantu, RC; Stern, RA				Alosco, Michael L.; Jarnagin, Johnny; Tripodis, Yorghos; Platt, Michael; Martin, Brett; Chaisson, Christine E.; Baugh, Christine M.; Fritts, Nathan G.; Cantu, Robert C.; Stern, Robert A.			Olfactory Function and Associated Clinical Correlates in Former National Football League Players	JOURNAL OF NEUROTRAUMA			English	Article						American football; chronic traumatic encephalopathy; National Football League; olfaction; repetitive head impacts	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; HIGH-SCHOOL FOOTBALL; SMELL IDENTIFICATION TEST; ODOR IDENTIFICATION; ALZHEIMERS-DISEASE; OLDER-ADULTS; NFL PLAYERS; CONCUSSION; DYSFUNCTION	Professional American football players incur thousands of repetitive head impacts (RHIs) throughout their lifetime. The long-term consequences of RHI are not well characterized, but may include olfactory dysfunction. RHI has been associated with changes to brain regions involved in olfaction, and olfactory impairment is common after traumatic brain injury. Olfactory dysfunction is a frequent early sequelae of neurodegenerative diseases (e.g., Alzheimer's disease), and RHI is associated with the neurodegenerative disease, chronic traumatic encephalopathy (CTE). We examined olfaction, and its association with clinical measures, in former National Football League (NFL) players. Ninety-five former NFL players (ages 40-69) and 28 same-age controls completed a neuropsychological and neuropsychiatric evaluation as part of a National Institutes of Health-funded study. The Brief Smell Identification Test (B-SIT) assessed olfaction. Principal component analysis generated a four-factor structure of the clinical measures: behavioral/mood, psychomotor speed/executive function, and verbal and visual memory. Former NFL players had worse B-SIT scores relative to controls (p = 0.0096). A B-SIT cutoff of 11 had the greatest accuracy (c-statistic = 0.61) and specificity (79%) for discriminating former NFL players from controls. In the former NFL players, lower B-SIT scores correlated with greater behavioral/mood impairment (p = 0.0254) and worse psychomotor speed/executive functioning (p = 0.0464) after controlling for age and education. Former NFL players exhibited lower olfactory test scores relative to controls, and poorer olfactory test performance was associated with worse neuropsychological and neuropsychiatric functioning. Future work that uses more-comprehensive tests of olfaction and structural and functioning neuroimaging may improve understanding on the association between RHI and olfaction.	[Alosco, Michael L.; Baugh, Christine M.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Jarnagin, Johnny; Martin, Brett; Chaisson, Christine E.; Fritts, Nathan G.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Platt, Michael] Boston Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Boston, MA 02118 USA; [Martin, Brett] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Chaisson, Christine E.] Boston Univ, Sch Publ Hlth, Dept Biostat, Data Coordinating Ctr, Boston, MA USA; [Baugh, Christine M.] Interfac Initiat Hlth Policy, Cambridge, MA USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol & Neurosurg, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		Stern, RA (corresponding author), Boston Univ, Alzheimers Dis & CTE Ctr, Dept Neurol, 72 East Concord St,Suite B7800, Boston, MA 02118 USA.	bobstern@bu.edu	Baugh, Christine/AAG-2324-2020; , Bob/ABA-8507-2020	Baugh, Christine/0000-0002-9340-6338; Tripodis, Yorghos/0000-0003-2190-7608	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG13846, R01 NS 078337, R01 9500301152, R56 9500304025, U01 NS093334]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1F32NS096803-01]; National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS093334, F32NS096803, R01NS078337, R56NS078337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG019610, P30AG013846] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes of Health (NIH; P30 AG13846, R01 NS 078337, R01 9500301152, R56 9500304025, and U01 NS093334). M.L.A. and research reported in this publication are supported by the NIH under grant number 1F32NS096803-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. C.B. is currently supported by the National Institutes of Mental Health under award number T32MH019733. There were no restrictions on the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication. There is no sponsor.	Albers MW, 2015, ALZHEIMERS DEMENT, V11, P70, DOI 10.1016/j.jalz.2014.04.514; Attems J, 2005, J ALZHEIMERS DIS, V7, P149; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BARRATT ES, 1965, PSYCHOL REP, V16, P547, DOI 10.2466/pr0.1965.16.2.547; Beck A., 1996, MANUAL BDI 2; Beck A.T., 1988, MANUAL BECK HOPELESS; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Charland-Verville V, 2012, AM J RHINOL ALLERGY, V26, P222, DOI 10.2500/ajra.2012.26.3769; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cross DJ, 2013, J NUCL MED, V54, P1278, DOI 10.2967/jnumed.112.116558; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; de Guise E, 2015, BRAIN INJURY, V29, P730, DOI 10.3109/02699052.2015.1004748; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Delank KW, 1996, LARYNGO RHINO OTOL, V75, P154, DOI 10.1055/s-2007-997554; Delis DC., 2001, DELIS KAPLAN EXECUTI; Devanand DP, 2015, NEUROLOGY, V84, P182, DOI 10.1212/WNL.0000000000001132; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; DOTY RL, 1989, PERCEPT PSYCHOPHYS, V45, P381, DOI 10.3758/BF03210709; Doty RL, 1983, SMELL IDENTIFICATION; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Growdon ME, 2015, NEUROLOGY, V84, P2153, DOI 10.1212/WNL.0000000000001614; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Heaton RK, 1993, WISCONSIN CARD SORT; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; HIRSCH AR, 1993, J NEUROL ORTH MED S, V14, P152; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Lezak M. D., 2012, NEUROPSYCHOLOGICAL A, pxxv; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Luzzi S, 2007, NEUROPSYCHOLOGIA, V45, P1823, DOI 10.1016/j.neuropsychologia.2006.12.008; Magerova H, 2014, AM J ALZHEIMERS DIS, V29, P762, DOI 10.1177/1533317514539033; Makizako M, 2014, CHEM SENSES, V39, P39, DOI 10.1093/chemse/bjt052; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miller B.L., 2007, HUMAN FRONTAL LOBES, V2nd; MILLER IW, 1986, J CONSULT CLIN PSYCH, V54, P724, DOI 10.1037/0022-006X.54.5.724; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Patel ZM, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/675635; Pinto JM, 2014, J GERONTOL A-BIOL, V69, P323, DOI 10.1093/gerona/glt063; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitan RM, 1992, TRAIL MAKING TEST MA; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Roberts RO, 2016, JAMA NEUROL, V73, P93, DOI 10.1001/jamaneurol.2015.2952; Roth R.M., 2005, BRIEF BEHAV RATING I; Royet JP, 2001, NEUROIMAGE, V13, P506, DOI 10.1006/nimg.2000.0704; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Sohrabi HR, 2009, J ALZHEIMERS DIS, V17, P135, DOI 10.3233/JAD-2009-1020; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stanciu I, 2014, J INT NEUROPSYCH SOC, V20, P209, DOI 10.1017/S1355617713001409; Stern RA, 1999, BQSS BOSTON QUALITAT; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Swan GE, 2002, NEUROEPIDEMIOLOGY, V21, P58, DOI 10.1159/000048618; Tabert MH, 2005, ANN NEUROL, V58, P155, DOI 10.1002/ana.20533; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vent J, 2010, BRAIN RES, V1320, P1, DOI 10.1016/j.brainres.2010.01.007; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Westervelt HJ, 2008, J CLIN EXP NEUROPSYC, V30, P151, DOI 10.1080/13803390701287408; White T, 2003, NAB NEUROPSYCHOLOGIC; Wilson RS, 2007, J NEUROL NEUROSUR PS, V78, P30, DOI 10.1136/jnnp.2006.099721; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P802, DOI 10.1001/archpsyc.64.7.802; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V26, P61, DOI 10.1159/000090250; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; Yoon JH, 2015, J NEUROL SCI, V355, P174, DOI 10.1016/j.jns.2015.06.013; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	91	22	22	0	26	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					772	780		10.1089/neu.2016.4536			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200003	27430424	Green Published			2022-02-06	
J	van der Horn, HJ; Liemburg, EJ; Scheenen, ME; de Koning, ME; Spikman, JM; van der Naalt, J				van der Horn, Harm J.; Liemburg, Edith J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Spikman, Jacoba M.; van der Naalt, Joukje			Graph Analysis of Functional Brain Networks in Patients with Mild Traumatic Brain Injury	PLOS ONE			English	Article							POSTERIOR CINGULATE CORTEX; STRUCTURAL CONNECTIVITY; POSTTRAUMATIC-STRESS; EMOTION REGULATION; MRI; SYMPTOMS; ABNORMALITIES; DYSFUNCTION; CONCUSSION; COMPLAINTS	Mild traumatic brain injury (mTBI) is one of the most common neurological disorders worldwide. Posttraumatic complaints are frequently reported, interfering with outcome. However, a consistent neural substrate has not yet been found. We used graph analysis to further unravel the complex interactions between functional brain networks, complaints, anxiety and depression in the sub-acute stage after mTBI. This study included 54 patients with uncomplicated mTBI and 20 matched healthy controls. Posttraumatic complaints, anxiety and depression were measured at two weeks post-injury. Patients were selected based on presence (n = 34) or absence (n = 20) of complaints. Resting-state fMRI scans were made approximately four weeks post-injury. High order independent component analysis resulted in 89 neural components that were included in subsequent graph analyses. No differences in graph measures were found between patients with mTBI and healthy controls. Regarding the two patient subgroups, degree, strength, local efficiency and eigenvector centrality of the bilateral posterior cingulate/precuneus and bilateral parahippocampal gyrus were higher, and eigenvector centrality of the frontal pole/bilateral middle & superior frontal gyrus was lower in patients with complaints compared to patients without complaints. In patients with mTBI, higher degree, strength and eigenvector centrality of default mode network components were related to higher depression scores, and higher degree and eigenvector centrality of executive network components were related to lower depression scores. In patients without complaints, one extra module was found compared to patients with complaints and healthy controls, consisting of the cingulate areas. In conclusion, this research extends the knowledge of functional network connectivity after mTBI. Specifically, our results suggest that an imbalance in the function of the default mode-and executive network plays a central role in the interaction between emotion regulation and the persistence of posttraumatic complaints.	[van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands		van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation [Ps2012-06]	This work was supported by Dutch Brain Foundation, grant no. Ps2012-06. J.v.d.N. received the funding. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Elseoud A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00037; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Filippi M, 2013, LANCET NEUROL, V12, P1189, DOI 10.1016/S1474-4422(13)70144-3; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matuseviciene G, 2015, J REHABIL MED; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mulders PC, 2015, NEUROSCI BIOBEHAV R, V56, P330, DOI 10.1016/j.neubiorev.2015.07.014; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Quoidbach J, 2015, PSYCHOL BULL, V141, P655, DOI 10.1037/a0038648; Rigon A, 2015, J NEUROTRAUM, V1, P1; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Servaas MN, 2015, NEUROPSYCHOPHARMACOL, V40, P296, DOI 10.1038/npp.2014.169; Shannon C.E., 1948, Bell System Technical Journal, V27, P379; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheppes G, 2015, ANNU REV CLIN PSYCHO, V11, P379, DOI 10.1146/annurev-clinpsy-032814-112739; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Sun Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/28004; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	80	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2017	12	1							e0171031	10.1371/journal.pone.0171031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7VX	WOS:000396211400011	28129397	Green Submitted, gold, Green Published			2022-02-06	
J	Asken, BM; Snyder, AR; Smith, MS; Zaremski, JL; Bauer, RM				Asken, Breton M.; Snyder, Aliyah R.; Smith, M. Seth; Zaremski, Jason L.; Bauer, Russell M.			Concussion-like symptom reporting in non-concussed adolescent athletes	CLINICAL NEUROPSYCHOLOGIST			English	Article						Brain injury; high school; biopsychosocial; adolescent; sport-related concussion	MILD HEAD-INJURY; POSTCONCUSSION SYNDROME; BASE RATES; SPORT; DISORDER; PARTICIPATION; BENEFITS; CRITERIA; STRESS; REST	Objective: The primary goals of this study were (1) to report rates of concussion-like symptoms in healthy adolescent student athletes assessed using the Sport Concussion Assessment Tool, 3rd edition (SCAT3) at baseline, (2) to examine rates of psychiatric diagnoses in this population, and (3) to evaluate effects of baseline symptoms on SCAT3 cognitive and balance performance. Methods: 349 adolescent student athletes (245 male) were administered the SCAT3 during pre-participation physical examinations. We described the prevalence rate of student athletes meeting criteria for International Classification of Diseases, 10th revision, post-concussional syndrome (ICD-10 PCS) diagnosis at baseline, and evaluated associations between symptom reporting and demographic/medical history factors using chi-square tests. Rates of self-reported psychiatric diagnosis were compared to general population estimates with one-sample binomial tests. We also compared SCAT3 cognitive and balance performance between adolescents with and without baseline ICD-10 PCS symptoms. Results: Overall, 20.3% of participants met ICD-10 PCS criteria at baseline. Rates were similar across sexes and age groups. We found no statistical association with medical history factors. The proportion of student athletes reporting a history of psychiatric diagnosis (5.2%) was significantly lower than general population estimates (14.0%; p<.001), and this effect was consistent across sexes and age groups. SCAT3 cognitive and balance performance did not differ based on baseline symptom reporting. Conclusions: Healthy adolescent student athletes frequently report concussion-like symptoms at baseline. Clinicians should factor pre-injury symptomatology and medical history into concussion management when determining symptom etiology throughout the course of recovery.	[Asken, Breton M.; Snyder, Aliyah R.; Bauer, Russell M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Smith, M. Seth; Zaremski, Jason L.] Univ Florida, Dept Orthopaed & Rehabil, Gainesville, FL USA		Asken, BM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	basken8@phhp.ufl.edu	Snyder, Aliyah/AAT-6250-2020	Asken, Breton/0000-0001-8419-142X; Snyder, Aliyah/0000-0003-1185-7424			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 1992, ICD 10 CLASS MENT BE; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; CHAN CS, 1988, PERCEPT MOTOR SKILL, V66, P875, DOI 10.2466/pms.1988.66.3.875; Daniels E, 2006, SEX ROLES, V55, P875, DOI 10.1007/s11199-006-9138-4; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Fainaru S, 2013, YOUTH FOOTBALL PARTI; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Findlay LC, 2008, CAN J BEHAV SCI, V40, P153, DOI 10.1037/0008-400X.40.3.153; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; IBM Corp, 2016, IBM SPSS STAT WINDOW; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Steptoe A, 1996, LANCET, V347, P1789, DOI 10.1016/S0140-6736(96)91616-5; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	49	22	22	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	1					138	153		10.1080/13854046.2016.1246672			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EK2VR	WOS:000393785300008	27758158				2022-02-06	
J	Chiaretti, A; Conti, G; Falsini, B; Buonsenso, D; Crasti, M; Manni, L; Soligo, M; Fantacci, C; Genovese, O; Calcagni, ML; Di Giuda, D; Mattoli, MV; Cocciolillo, F; Ferrara, P; Ruggiero, A; Staccioli, S; Colafati, GS; Riccardi, R				Chiaretti, Antonio; Conti, Giorgio; Falsini, Benedetto; Buonsenso, Danilo; Crasti, Matteo; Manni, Luigi; Soligo, Marzia; Fantacci, Claudia; Genovese, Orazio; Calcagni, Maria Lucia; Di Giuda, Daniela; Mattoli, Maria Vittoria; Cocciolillo, Fabrizio; Ferrara, Pietro; Ruggiero, Antonio; Staccioli, Susanna; Colafati, Giovanna Stefania; Riccardi, Riccardo			Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report	BRAIN INJURY			English	Article						Nerve Growth Factor; Doublecortin; traumatic brain injury; intranasal administration	DOUBLECORTIN EXPRESSION; ENDOTHELIAL-CELLS; FACTOR INFUSION; CARDIAC-ARREST; NGF; DELIVERY; RATS; RESUSCITATION; DEFICITS; INFANTS	Background: Nerve growth factor (NGF) promotes neural recovery after experimental traumatic brain injury (TBI) supporting neuronal growth, differentiation and survival of brain cells and up-regulating the neurogenesis-associated protein Doublecortin (DCX). Only a few studies reported NGF administration in paediatric patients with severe TBI.Methods: A four-year-old boy in a persistent unresponsive wakefulness syndrome (UWS) was treated with intranasal murine NGF administration 6months after severe TBI. The patient received four cycles of intranasal NGF (0.1mg/kg, twice a day for 10 consecutive days).Results: NGF administration improved functional [Positron Emission Tomography/Computed Tomography (PET/CT); Single photon emission/Computed Tomography (SPECT/CT) and Magnetic Resonance Imaging (MRI)] assessment, electrophysiological [Electroencephalogram (EEG) and Visual Evoked Potential (VEP)] studies and clinical conditions. He showed improvements in voluntary movements, facial mimicry, phonation, attention and verbal comprehension, ability to cry, cough reflex, oral motility, feeding capacity, and bowel and urinary functions. After NGF administration, raised levels of both NGF and DCX were found in the cerebrospinal fluid of the patient. No side effects were reported.Conclusions: Although further studies are needed for better understanding the neuroprotective role of this neurotrophin, intranasal NGF administration appears to be a promising and safe rescuing strategy treatment in children with neurological impairment after TBI.	[Chiaretti, Antonio; Buonsenso, Danilo; Crasti, Matteo; Fantacci, Claudia; Ferrara, Pietro] Univ Cattolica Sacro Cuore, Inst Pediat, Rome, Italy; [Conti, Giorgio; Genovese, Orazio] Univ Cattolica Sacro Cuore, Pediat Intens Care Unit, Rome, Italy; [Falsini, Benedetto; Calcagni, Maria Lucia; Di Giuda, Daniela; Mattoli, Maria Vittoria] Univ Cattolica Sacro Cuore, Inst Ophthalmol, Rome, Italy; [Manni, Luigi; Soligo, Marzia] CNR, Inst Translat Pharmacol, Rome, Italy; [Cocciolillo, Fabrizio] Univ Cattolica Sacro Cuore, Inst Nucl Med, Rome, Italy; [Ruggiero, Antonio; Riccardi, Riccardo] Univ Cattolica Sacro Cuore, Pediat Oncol, Rome, Italy; [Staccioli, Susanna] Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabil, Rome, Italy; [Colafati, Giovanna Stefania] Bambino Gesu Pediat Hosp, Neuroradiol Unit, Dept Imaging, Rome, Italy		Chiaretti, A (corresponding author), Univ Cattolica Sacro Cuore, Inst Pediat, Rome, Italy.	achiaretti@yahoo.it	Buonsenso, Danilo/I-8910-2018; Di Giuda, Daniela/U-1975-2017; Manni, Luigi/J-5637-2018; Colafati, Giovanna Stefania/J-8937-2018; Falsini, Benedetto/V-1070-2019; Soligo, Marzia/AAC-1543-2019; Ruggiero, Antonio/M-7849-2018; Conti, Giorgio/AAB-9546-2022; Cocciolillo, Fabrizio/AAB-9777-2022; Calcagni, Maria Lucia/AAC-7214-2022; Falsini, Benedetto/AAC-5907-2022	Di Giuda, Daniela/0000-0002-5758-3986; Colafati, Giovanna Stefania/0000-0002-1142-4904; Falsini, Benedetto/0000-0002-1694-1062; Ruggiero, Antonio/0000-0002-6052-3511; Conti, Giorgio/0000-0002-8566-9365; Cocciolillo, Fabrizio/0000-0002-5655-1448; FERRARA, Pietro/0000-0001-9449-3464; GENOVESE, Orazio/0000-0002-1989-1363; Falsini, Benedetto/0000-0002-3569-4968; Buonsenso, Danilo/0000-0001-8567-2639			ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; Catz A, 2007, SPINAL CORD, V45, P275, DOI 10.1038/sj.sc.3101960; Centers for Disease Control and Prevention, 2010, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; Chiaretti A, 2005, NEUROL RES, V27, P741, DOI 10.1179/016164105X35611; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Chiaretti A, 2008, NEUROL RES, V30, P223, DOI 10.1179/016164107X247948; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; Cramer Steven C., 2000, Molecular Medicine Today, V6, P301, DOI 10.1016/S1357-4310(00)01744-5; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Dolle JP, 2005, J PHARMACOL EXP THER, V315, P1220, DOI 10.1124/jpet.105.093252; Falsini B, 2008, J NEURO-ONCOL, V88, P87, DOI 10.1007/s11060-008-9537-1; Frey WH, 1997, DRUG DELIV, V4, P87, DOI 10.3109/10717549709051878; FUJIOKA M, 1994, STROKE, V25, P2091, DOI 10.1161/01.STR.25.10.2091; GAROFALO L, 1994, EXP NEUROL, V125, P195, DOI 10.1006/exnr.1994.1024; Geocadin RG, 2008, NEUROL CLIN, V26, P487, DOI 10.1016/j.ncl.2008.03.015; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guidelines E, 2000, CIRCULATION, V102, P1; Hanson LR, 2013, JOVE-J VIS EXP, V8, P212; Holzer M, 2002, NEW ENGL J MED, V346, P549; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Manni L, 2013, GROWTH FACTORS, V31, P115, DOI 10.3109/08977194.2013.804073; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Moser KV, 2004, BRAIN RES, V1017, P53, DOI 10.1016/j.brainres.2004.05.013; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Pan WH, 1998, BRAIN RES, V788, P87, DOI 10.1016/S0006-8993(97)01525-4; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PRADIER P, 1994, J PHYSIOLOGY-PARIS, V88, P273, DOI 10.1016/0928-4257(94)90008-6; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Takase H, 2016, BEHAV BRAIN RES, DOI [10.1016/j.bbr.2016.10.042., DOI 10.1016/J.BBR.2016.10.042.]; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; van Middendorp JJ, 2011, GLOB SPINE J, V1, P1, DOI 10.1055/s-0031-1296049; Wake H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8844; Wijdicks EFM, 2001, AM J NEURORADIOL, V22, P1561; Young J, 2015, BRAIN RES BULL, V115, P17, DOI 10.1016/j.brainresbull.2015.04.003; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	47	22	22	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1538	1547		10.1080/02699052.2017.1376760			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200019	28972396	Green Published			2022-02-06	
J	Degani, AM; Santos, MM; Leonard, CT; Rau, TF; Patel, SA; Mohapatra, S; Danna-dos-Santos, A				Degani, Adriana M.; Santos, Maria M.; Leonard, Charles T.; Rau, Thomas F.; Patel, Sarjubhai A.; Mohapatra, Sambit; Danna-dos-Santos, Alessander			The effects of mild traumatic brain injury on postural control	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; balance; mild brain injury	CEREBRAL CONCUSSION; APPROXIMATE ENTROPY; BALANCE CONTROL; MUSCLE MODES; BODY SWAY; STABILITY; ADULTS; INFORMATION; ADJUSTMENTS; INSTABILITY	Primary objective: The purpose of this study was to investigate the effects of mild traumatic brain injury (mTBI) on multiple postural indices that characterize body sway behaviour. Methods and procedures: The body's centre of pressure (COP) displacement was recorded from 11 individuals with a history of mTBI (29.4 +/- 6.7 years old) and 11 healthy controls (26.8 +/- 3.7 years old) performing bipedal stance on a force platform for 120 seconds. Spatio-temporal (area, amplitude and mean velocity of the COP displacement) and frequency characteristics (frequency containing 80% of the power spectral density) of the body oscillation, as well as its dynamic characteristics (sample entropy estimate of the COP displacement) were extracted from COP signals. Main outcomes and results: All postural indices studied were significantly affected by mTBI (p < 0.010). Participants with a history of mTBI presented a larger, slower, and more random body oscillation compared to controls. Conclusion: The results suggest that (a) balance deficits can be recognized as an effect of mTBI; (b) balance deficits induced by mTBI are multi-dimensional, affecting all three domains included in this study; and (c) the postural indices employed in this study are potential markers to detect changes in postural control following mTBI.	[Degani, Adriana M.; Santos, Maria M.; Leonard, Charles T.; Mohapatra, Sambit; Danna-dos-Santos, Alessander] Univ Montana, Sch Phys Therapy & Rehabil Sci, Motor Control Lab, Missoula, MT 59812 USA; [Leonard, Charles T.; Rau, Thomas F.; Patel, Sarjubhai A.; Mohapatra, Sambit; Danna-dos-Santos, Alessander] Univ Montana, Neural Injury Ctr, Missoula, MT 59812 USA; [Rau, Thomas F.; Patel, Sarjubhai A.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA		Degani, AM (corresponding author), Univ Montana Missoula, Sch Phys Therapy & Rehabil Sci, 32 Campus Dr, Missoula, MT 59812 USA.	adriana.degani@umontana.edu	Mohapatra, Sambit/AAJ-6657-2021	Mohapatra, Sambit/0000-0001-7714-5281			[Anonymous], 2015, C TRAUM BRAIN INJ US; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Bizid R, 2009, J SCI MED SPORT, V12, P60, DOI 10.1016/j.jsams.2007.10.006; Bolbecker AR, 2010, PLOS ONE, V6, P1; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Danna-dos-Santos A, 2008, EXP BRAIN RES, V189, P171, DOI 10.1007/s00221-008-1413-x; Danna-dos-Santos A, 2007, EXP BRAIN RES, V179, P533, DOI 10.1007/s00221-006-0812-0; Danna-Dos-Santos A, 2015, EXP BRAIN RES, V233, P657, DOI 10.1007/s00221-014-4145-0; Degani AM, 2007, J APPL BIOMECH, V23, P261, DOI 10.1123/jab.23.4.261; Degani AM, 2016, THESIS; Dehail P, 2007, J REHABIL MED, V39, P531, DOI 10.2340/16501977-0096; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Flanders M, 2011, BIOL CYBERN, V104, P1, DOI 10.1007/s00422-011-0419-9; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haas CT., 2012, J BIOMED SCI ENG, V5, P9, DOI [10.4236/jbise.2012.59062, DOI 10.4236/JBISE.2012.59062, 10.4236/jbise.2012.59063]; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; INGLIN B, 1988, J GERONTOL, V43, pM105, DOI 10.1093/geronj/43.4.M105; Johansson B, 2014, INT J PHYS MED REHAB, V2, P2; Kandel ER, 2000, PRINCIPLES NEURAL SC, P1414; Kanekar N, 2015, J ELECTROMYOGR KINES, V25, P400, DOI 10.1016/j.jelekin.2014.11.002; Kanekar N, 2014, J NEUROSCI METH, V222, P91, DOI 10.1016/j.jneumeth.2013.10.020; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Latash M. L., 2008, SYNERGY, P432; Lee D.N., 1975, J HUM MOVEMENT STUD, V1, P87; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Shumway-Cook A, 2011, MOTOR CONTROL TRANSL, P656; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov SM, 1997, J MOTOR BEHAV, V29, P263, DOI 10.1080/00222899709600841; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Torres EB, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00039; VANEMMERIK REA, 1993, MOVEMENT DISORD, V8, P305, DOI 10.1002/mds.870080309; WOOLLACOTT M, 1988, ANN NY ACAD SCI, V515, P42, DOI 10.1111/j.1749-6632.1988.tb32964.x; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	54	22	22	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					49	56		10.1080/02699052.2016.1225982			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600007	27936960				2022-02-06	
J	Fernandez-Ortega, JF; Baguley, IJ; Gates, TA; Garcia-Caballero, M; Quesada-Garcia, JG; Prieto-Palomino, MA				Fernandez-Ortega, Juan F.; Baguley, Ian J.; Gates, Thomas A.; Garcia-Caballero, Manuel; Quesada-Garcia, Juan G.; Prieto-Palomino, Miguel A.			Catecholamines and Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						catecholamines; cortisol; hormonal influences; paroxysmal sympathetic hyperactivity; traumatic brain injury	SUBARACHNOID HEMORRHAGE; HEAD-INJURY; NOREPINEPHRINE LEVELS; AFFERENT STIMULI; ACUTE-PHASE; DYSAUTONOMIA; PLASMA; OVERRESPONSIVENESS; ACTIVATION; SYSTEM	Paroxysmal sympathetic hyperactivity (PSH) affects a significant minority of people in the intensive care unit after severe traumatic brain injury. Systematic research has yet to elucidate or quantify the extent of the role of the catecholamines or adrenocortical and thyroid axis hormonal influences in the condition. Data were prospectively collected on 80 consecutive patients, 18 of whom developed clinical signs of PSH (22.5%). Catecholamine and hormonal data were collected sequentially at 4-h intervals or during and between episodes of PSH. Evaluated variables showed 200-300% increases in catecholamines and, to a lesser extent, adrenocortical hormones during paroxysms. The majority of PSH episodes (72%) were noted to be in response to an observable triggering event. These changes were not observed in subjects without PSH. These data go some way to explain why PSH produces adverse consequences in survivors of TBI with the condition.	[Fernandez-Ortega, Juan F.; Quesada-Garcia, Juan G.; Prieto-Palomino, Miguel A.] Univ Hosp Carlos Haya, ICU Serv, C Mirador del Candado 1, Malaga 29018, Spain; [Baguley, Ian J.; Gates, Thomas A.] Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia; [Garcia-Caballero, Manuel] Univ Malaga, Sch Med, Malaga, Spain		Fernandez-Ortega, JF (corresponding author), Univ Hosp Carlos Haya, ICU Serv, C Mirador del Candado 1, Malaga 29018, Spain.	jfezortega@gmail.com	Baguley, Ian/AAM-5828-2021; Gates, Thomas/AAB-5623-2022	Gates, Thomas/0000-0003-0113-8282			Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Baguley I. J., 2006, NEUROREHAB NEURAL RE, V20, P98; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; BENEDICT CR, 1978, J NEUROL NEUROSUR PS, V41, P113, DOI 10.1136/jnnp.41.2.113; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; CHIOLERO RL, 1989, CRIT CARE MED, V17, P328, DOI 10.1097/00003246-198904000-00006; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Goldstein DS, 2010, CLIN AUTON RES, V20, P331, DOI 10.1007/s10286-010-0065-7; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; HAHN PY, 1995, SHOCK, V4, P269, DOI 10.1097/00024382-199510000-00007; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Inamasu J, 2012, ACTA NEUROCHIR, V154, P2179, DOI 10.1007/s00701-012-1515-x; Johansson PI, 2011, J TRAUMA, V72, P428; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Lindgren C, 2013, ACTA ANAESTH SCAND, V57, P452, DOI 10.1111/aas.12014; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Naredi S, 2006, INTENS CARE MED, V32, P1955, DOI 10.1007/s00134-006-0408-y; Ostrowski SR, 2015, J CRIT CARE, V30, P90, DOI 10.1016/j.jcrc.2014.10.006; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rey M, 2005, J CARDIOTHOR VASC AN, V19, P654, DOI 10.1053/j.jvca.2005.07.008; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Sugimoto K, 2013, NEUROSURG REV, V36, P259, DOI 10.1007/s10143-012-0424-z; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875	43	22	27	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					109	114		10.1089/neu.2015.4364			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100013	27251119				2022-02-06	
J	Gallun, FJ; Papesh, MA; Lewis, MS				Gallun, Frederick J.; Papesh, Melissa A.; Lewis, M. Samantha			Hearing complaints among veterans following traumatic brain injury	BRAIN INJURY			English	Article						Hearing; TBI; auditory; Veteran; auditory processing	HIGH-INTENSITY BLASTS; CLOSED-HEAD INJURY; AUDITORY DYSFUNCTION; EXPOSURE; PERFORMANCE; SEQUELAE; SYSTEM; TESTS; TBI	It has been shown that there is an increased risk for impaired auditory function following traumatic brain injury (TBI) in Veterans. Evidence is strongest in the area of self-report, but behavioural and electrophysiological data have been obtained that, are consistent,with these complaints. Peripheral and central dysfunction have both been observed. Historically, studies have focused on penetrating head injuries where central injury is more easily documented than in mild closed head injuries, but several recent reports have expanded the literature to include closed head injuries as well. The lack of imaging technology that can identify which closed head injuries are likely to impact auditory function is a significant barrier to accurate diagnosis and rehabilitation. Current behavioural and electrophysiological measures are effective in substantiating the auditory complaints of these patients but leave many questions unanswered. One significant limitation of current approaches is the lack of clear data regarding the potential influence of those mental health comorbidities that are very likely to be present in the Veteran population. In the area of rehabilitation, there are indications that hearing aids and other assistive listening devices may provide benefit, as can auditory training programmes, yet more research needs to be done.	[Gallun, Frederick J.; Papesh, Melissa A.; Lewis, M. Samantha] VA Portland Hlth Care Syst, VA RR&D Natl Ctr Rehabil Auditory Res, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Gallun, Frederick J.; Lewis, M. Samantha] Oregon Hlth & Sci Univ, Dept Otolaryngol H&NS, Portland, OR 97201 USA; [Gallun, Frederick J.] Oregon Hlth & Sci Univ, Neurosci Grad Program, Portland, OR 97201 USA		Gallun, FJ (corresponding author), VA Portland Hlth Care Syst, VA RR&D Natl Ctr Rehabil Auditory Res, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	Frederick.Gallun@va.gov	Gallun, Frederick J./G-3792-2012	Gallun, Frederick J./0000-0002-4145-2199	VAUS Department of Veterans Affairs [5I01RX000536-02] Funding Source: Federal RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000536] Funding Source: NIH RePORTER; RRD VA [I01 RX000536] Funding Source: Medline		Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bressler S, 2016, HEAR RES; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Gallun FJ, 2016, J REHABIL RES DEV, V53, P705, DOI 10.1682/JRRD.2014.12.0313; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Hoover EC, 2015, SIG 6 PERSPECT HEAR, V19, P12; Hoover EC, J AM ACAD AU I PRESS; JABBARI B, 1987, Seminars in Hearing, V8, P261, DOI 10.1055/s-0028-1091376; Jabbari B, SEMIN HEAR, V8, P240; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kokx-Ryan M, 2016, INT HEAR AID RES C; Krause MO, 2014, BRAIN INJURY, V28, P1473, DOI 10.3109/02699052.2014.920520; MUELLER H G, 1987, Seminars in Hearing, V8, P279; Mueller HG, SEMIN HEAR, V8, P223; Mueller HG, SEMIN HEAR, V8, P267; Mueller HG, SEMIN HEAR, V8, P253; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; MUSIEK FE, 1983, EAR HEARING, V4, P79, DOI 10.1097/00003446-198303000-00002; MUSIEK FE, 1987, AUDIOLOGY, V26, P79; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Saunders Gabrielle H., 2014, Seminars in Hearing, V35, P227, DOI 10.1055/s-0034-1383507; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Vance SC, SEMIN HEAR, V8, P215; Weihing Jeffrey, 2015, Seminars in Hearing, V36, P199, DOI 10.1055/s-0035-1564458	32	22	22	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	9			SI		1183	1187		10.1080/02699052.2016.1274781			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK0NN	WOS:000413176600004	28981349	Green Accepted, hybrid			2022-02-06	
J	Haller, CS; Delhumeau, C; De Pretto, M; Schumacher, R; Pielmaier, L; Rebetez, MML; Haller, G; Walder, B				Haller, Chiara S.; Delhumeau, Cecile; De Pretto, Michael; Schumacher, Rahel; Pielmaier, Laura; Rebetez, Marie My Lien; Haller, Guy; Walder, Bernhard			Trajectory of disability and quality-of-life in non-geriatric and geriatric survivors after severe traumatic brain injury	BRAIN INJURY			English	Article						Head injury; elderly; functional outcome; health-related quality-of-life; recovery	GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; OLDER-ADULTS; INPATIENT REHABILITATION; NATIONAL INSTITUTE; MODEL SYSTEMS; HEALTH SURVEY; COHORT; MULTICENTER; PREDICTORS	Objective: The objective was to investigate disability and health-related quality-of-life (HRQoL) 3, 6 and 12 months after traumatic brain injury (TBI) in non-geriatric (<= 65 years) and geriatric patients (> 65 years). Methods: Patients >= 16 years who sustained a severe TBI (Abbreviated Injury Scale of the head region > 3) were included in this prospective, multi-centre study. Outcome measures were Glasgow Outcome Scale Extended (GOSE; disability), SF-12 (HRQoL). Mixed linear model analyses were performed. Results: Three hundred and fifty-one patients (median age = 50 years; interquartile range (IQR) = 27-67) were included; 73.2% were male and 27.6% were geriatric patients. Median GOSE at 3, 6 and 12 months was 5 (IQR = 3-7), 6 (IQR = 4-8) and 7 (IQR = 5-8); this increase (slope(time) = 0.22, p < 0.0001) was age dependent (slope(age*time) = -0.06, p = 0.003). Median SF-12 physical component scale score at 3, 6 and 12 months was 42.1 (IQR = 33.6-50.7), 46.6 (IQR = 37.4-53.9) and 50.4 (IQR = 392-55.1); this increase (slopetime = 1.52, p < 0.0001) was not age dependent (slope(age*time) = -0.30, p = 0.083). SF-12 mental component scale scores were unchanged. Conclusions: Disability decreased and HRQoL improved after TBI between 3-12 months. In geriatric patients this improvement was relevant for HRQoL only.	[Haller, Chiara S.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Haller, Chiara S.] Massachusetts Mental Hlth Ctr, Div Publ Psychiat, Boston, MA 02115 USA; [Delhumeau, Cecile; De Pretto, Michael; Haller, Guy; Walder, Bernhard] Univ Hosp Geneva HUG, Div Anaesthesiol, Geneva, Switzerland; [Schumacher, Rahel] Univ Hosp Bern, Inselspital, Dept Neurol, Div Cognit & Restorat Neurol, Bern, Switzerland; [Schumacher, Rahel] Univ Bern, Bern, Switzerland; [Pielmaier, Laura] Psychiat Serv Aargau, Windisch, Switzerland; [Rebetez, Marie My Lien] Univ Geneva, Dept Clin Psychol, Geneva, Switzerland; [Haller, Guy] Univ Hosp Geneva HUG, Div Clin Epidemiol, Geneva, Switzerland		Walder, B (corresponding author), Univ Hosp Geneva, Dept APSI, Div Anaesthesiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	bernhard.walder@hcuge.ch		haller, guy/0000-0001-7367-7029; Schumacher, Rahel/0000-0001-7500-7491; De Pretto, Michael/0000-0003-4176-4798	Bangerter-Rhyner-Foundation; Swiss Accident Insurance Foundation	The authors report no conflicts of interest. This study was funded by the Bangerter-Rhyner-Foundation and the Swiss Accident Insurance Foundation. The funding sources had no role in the study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all data. He was also responsible for the final decision-making which eventually lead to the submission of the present material for publication.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Andruszkow H, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-32; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Eapen Blessen C, 2015, Semin Neurol, V35, pe1, DOI 10.1055/s-0035-1549094; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Heyland DK, 2015, INTENS CARE MED, V41, P1911, DOI 10.1007/s00134-015-4028-2; Hill A, 2007, DATA ANAL USING REGR; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Klein AM, 2013, J NEUROTRAUM, V30, P1476, DOI 10.1089/neu.2012.2735; Krellman JW, 2014, ARCH PHYS MED REHAB, V95, P633, DOI 10.1016/j.apmr.2013.10.016; Ladermann A, 2008, KNEE, V15, P206, DOI 10.1016/j.knee.2008.01.010; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Oppenheim-Gluckman H., 2003, Annales de Readaptation et de Medecine Physique, V46, P41, DOI 10.1016/S0168-6054(02)00352-5; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI, V2; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Svedbom A, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0187-y; Swanenburg J, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13976; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tillou A, 2014, JAMA SURG, V149, P83, DOI 10.1001/jamasurg.2013.4244; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	55	22	22	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					319	328		10.1080/02699052.2016.1255777			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900006	28112980				2022-02-06	
J	Naess-Schmidt, ET; Blicher, JU; Eskildsen, SF; Tietze, A; Hansen, B; Stubbs, PW; Jespersen, S; Ostergaard, L; Nielsen, JF				Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Eskildsen, Simon Fristed; Tietze, Anna; Hansen, Brian; Stubbs, Peter William; Jespersen, Sune; Ostergaard, Leif; Nielsen, Jorgen Feldbaek			Microstructural changes in the thalamus after mild traumatic brain injury: A longitudinal diffusion and mean kurtosis tensor MRI study	BRAIN INJURY			English	Article						mTBI; concussion; mean kurtosis tensor; diffusion MRI	RISK-FACTORS; HEAD-INJURY; CONCUSSION; SYMPTOMS; METAANALYSIS; INTEGRITY; RECOVERY; STROKE; MODEL	Primary objective: The primary aim of this study was to assess microstructural changes in the thalamus, hippocampus and corpus callosum with a fast mean kurtosis tensor (MKT) technique, in the acute and sub-acute phase after mTBI. It was hypothesized that MKT would differ between baseline and follow-up in patients. The secondary aim was to relate diffusion measures to symptoms of mTBI.Research design: A longitudinal case-control study.Methods and procedures: Twenty-seven patients with mTBI and 27 age- and gender-matched healthy controls were enrolled in the study. Patients were scanned within 2 weeks and 3 months after mTBI, while the controls were scanned once.Main outcomes and results: MKT decreased significantly (p = 0.02) from baseline to follow-up in the thalamus in patients. Compared to healthy subjects, thalamic MKT values were significantly larger in patients at baseline (p = 0.048). Secondary analysis revealed a significant decrease (p = 0.01) in fractional anisotropy in the splenium of corpus callosum from baseline to follow-up.Conclusions: The current study indicates microstructural changes in the thalamus and corpus callosum from within 14 days to 3 months after mTBI and suggests MKT as a potential biomarker after mTBI.	[Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Stubbs, Peter William; Nielsen, Jorgen Feldbaek] Hammel Neurorehabil Ctr, Aarhus, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Stubbs, Peter William; Nielsen, Jorgen Feldbaek] Univ Res Clin, Aarhus, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Eskildsen, Simon Fristed; Tietze, Anna; Hansen, Brian; Jespersen, Sune; Ostergaard, Leif] Inst Clin Med, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Tietze, Anna; Ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, Aarhus, Denmark; [Stubbs, Peter William] Neurosci Res Australia, Randwick, NSW, Australia		Naess-Schmidt, ET (corresponding author), Hammel Neurorehabil Ctr, 15 Voldbyvej, DK-8450 Hammel, Denmark.; Naess-Schmidt, ET (corresponding author), Inst Clin Med, Univ Res Clin, 15 Voldbyvej, DK-8450 Hammel, Denmark.	erhanaes@rm.dk	Stubbs, Peter William/AAH-7179-2019; Jespersen, Sune Norhoj/B-1914-2008; Nielsen, Jorgen Feldbak/AAR-6384-2021; Nass-Schmidt, Erhard T/E-8425-2019; Nass-Schmidt, Erhard/AAP-8212-2021; Eskildsen, Simon/K-3934-2019; Ostergaard, Lars/AAA-3020-2020; Stubbs, Peter William/AAH-6598-2019; Ostergaard, Leif/A-9281-2008	Jespersen, Sune Norhoj/0000-0003-3146-4329; Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Nass-Schmidt, Erhard T/0000-0002-2539-0362; Nass-Schmidt, Erhard/0000-0002-2539-0362; Eskildsen, Simon/0000-0003-4242-9158; Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Leif/0000-0003-2930-6997; Blicher, Jakob/0000-0003-3443-4790; /0000-0003-4555-8019; Ostergaard, Lars/0000-0002-7619-605X			Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bhushan C, 2015, NEUROIMAGE, V115, P269, DOI 10.1016/j.neuroimage.2015.03.050; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2014, ARCH PHYS MED REHAB, V95, P265; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Glenn GR, 2015, NMR BIOMED, V28, P448, DOI 10.1002/nbm.3271; Granziera C, 2014, HUM BRAIN MAPP, V35, P1461, DOI 10.1002/hbm.22266; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Herron TJ, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00025; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hovda DA, 2014, PROG NEUROL SURG, V28, P28, DOI 10.1159/000358749; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Munivenkatappa A., 2015, BRAIN INJURY, P1; Naess-Schmidt E, 2016, INT J COMPUT ASS RAD, V11, P1979, DOI 10.1007/s11548-016-1433-0; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Sun PZ, 2014, NMR BIOMED, V27, P1413, DOI 10.1002/nbm.3188; Tietze A, 2015, AM J NEURORADIOL, V36, P1; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vestergaard-Poulsen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020653; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	37	22	23	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					230	236		10.1080/02699052.2016.1229034			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500011	28055267				2022-02-06	
J	Robitaille, N; Jackson, PL; Hebert, LJ; Mercier, C; Bouyer, LJ; Fecteau, S; Richards, CL; McFadyen, BJ				Robitaille, Nicolas; Jackson, Philip L.; Hebert, Luc J.; Mercier, Catherine; Bouyer, Laurent J.; Fecteau, Shirley; Richards, Carol L.; McFadyen, Bradford J.			A Virtual Reality avatar interaction (VRai) platform to assess residual executive dysfunction in active military personnel with previous mild traumatic brain injury: proof of concept	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Rehabilitation; gait; dual task walking; concussion	SERVICE MEMBERS; DUAL-TASK; CONCUSSION; GAIT; REHABILITATION; ENVIRONMENTS; POSTSTROKE; ATTENTION; LOCOMOTOR; WALKING	Purpose: This proof of concept study tested the ability of a dual task walking protocol using a recently developed avatar-based virtual reality (VR) platform to detect differences between military personnel post mild traumatic brain injury (mTBI) and healthy controls. Methods: The VR platform coordinated motion capture, an interaction and rendering system, and a projection system to present first (participant-controlled) and third person avatars within the context of a specific military patrol scene. A divided attention task was also added. A healthy control group was compared to a group with previous mTBI (both groups comprised of six military personnel) and a repeated measures ANOVA tested for differences between conditions and groups based on recognition errors, walking speed and fluidity and obstacle clearance. Results: The VR platform was well tolerated by both groups. Walking fluidity was degraded for the control group within the more complex navigational dual tasking involving avatars, and appeared greatest in the dual tasking with the interacting avatar. This navigational behaviour was not seen in the mTBI group. Conclusions: The present findings show proof of concept for using avatars, particularly more interactive avatars, to expose differences in executive functioning when applying context-specific protocols (here for the military).	[Robitaille, Nicolas; Jackson, Philip L.; Hebert, Luc J.; Mercier, Catherine; Bouyer, Laurent J.; Fecteau, Shirley; Richards, Carol L.; McFadyen, Bradford J.] Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Boul Hamel, Quebec City, PQ G1M 2S8, Canada; [Hebert, Luc J.; Mercier, Catherine; Bouyer, Laurent J.; Fecteau, Shirley; Richards, Carol L.; McFadyen, Bradford J.] Laval Univ, Fac Med, Dept Rehabil, Quebec City, PQ, Canada; [Hebert, Luc J.] Laval Univ, Fac Med, Dept Radiol, Quebec City, PQ, Canada; [Jackson, Philip L.] Laval Univ, Sch Psychol, Quebec City, PQ, Canada; [Fecteau, Shirley] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada		McFadyen, BJ (corresponding author), Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Boul Hamel, Quebec City, PQ G1M 2S8, Canada.	Brad.McFadyen@fmed.ulaval.ca	Bouyer, Laurent J/A-9255-2010; Bouyer, Laurent/L-6471-2019	Bouyer, Laurent J/0000-0003-2034-4516; Bouyer, Laurent/0000-0003-2034-4516; Mercier, Catherine/0000-0002-2037-6916; Hebert, Luc J./0000-0001-8903-5258; Jackson, Philip/0000-0001-8991-3217; Richards, Carol L./0000-0002-1824-0817; McFadyen, Bradford/0000-0003-1992-4927	Canadian Forces Surgeon General's Health Research Program [2011-07-038-004-0002]; Fonds de recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec	This work was funded from the Canadian Forces Surgeon General's Health Research Program (# 2011-07-038-004-0002). PLJ and CM were supported by a Chercheur-Boursier Senior salary award from the Fonds de recherche du Quebec - Sante and SF holds a Canada Research Chair.	Darekar A, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0035-3; Deutsch JE, 2007, TOP STROKE REHABIL, V14, P45, DOI 10.1310/tsr1406-45; Edwards J, 2014, APPL NEUROPSYCH-ADUL, V21, P220, DOI 10.1080/09084282.2013.796554; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Gerin-Lajoie M, 2005, MOTOR CONTROL, V9, P242, DOI 10.1123/mcj.9.3.242; Glegg SMN, 2017, DISABIL REHABIL-ASSI, V12, P217, DOI 10.3109/17483107.2015.1111944; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Jackson PL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00112; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Laver KE, 2015, COCHRANE DB SYST REV, V12; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McFadyen BJ, 2015, NEUROPSYCHOL REHABIL, V21, P1; Moreira MC, 2013, DISABIL REHABIL-ASSI, V8, P357, DOI 10.3109/17483107.2012.749428; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Roosink M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120251; Roosink M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-2; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Usoh M, 2000, PRESENCE-TELEOP VIRT, V9, P497, DOI 10.1162/105474600566989; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	23	22	24	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2017	12	7					758	764		10.1080/17483107.2016.1229048			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FQ6RD	WOS:000418490800013	27677827	Green Accepted			2022-02-06	
J	Bennett, TD; Dixon, RR; Kartchner, C; DeWitt, PE; Sierra, Y; Ladell, D; Kempe, A; Runyan, DK; Dean, JM; Keenan, HT				Bennett, Tellen D.; Dixon, Rebecca R.; Kartchner, Cory; DeWitt, Peter E.; Sierra, Yamila; Ladell, Diane; Kempe, Allison; Runyan, Desmond K.; Dean, J. Michael; Keenan, Heather T.			Functional Status Scale in Children With Traumatic Brain Injury: A Prospective Cohort Study	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injuries; craniocerebral trauma; critical care outcomes; patient outcome assessment; pediatrics	PEDIATRIC INTENSIVE-CARE; PERFORMANCE CATEGORY; RISK STRATIFICATION; OUTCOME SCALE; PREDICTION; MORTALITY; ILLNESS; SCORES; UNIT	Objectives: In children with traumatic brain injury, 1) to describe the hospital discharge functional outcome and change from baseline function using the Functional Status Scale and 2) to determine any associations between discharge Functional Status Scale and age, injury mechanism, neurologic examination, imaging, and other predictors of outcome. Design: Prospective observational cohort study, May 2013 to November 2015. Setting: Two U.S. children's hospitals designated as American College of Surgeons level 1 pediatric trauma centers. Patients: Children less than 18 years old admitted to an ICU with acute traumatic brain injury and either a surgical or critical care intervention within the first 24 hours or in-hospital mortality. Interventions: None. Measurements and Main Results: The primary outcome was hospital discharge Functional Status Scale. Most, 133 of 196 (68%), had severe traumatic brain injury (admission Glasgow Coma Scale, 3-8). Overall hospital mortality was 14%; 20% among those with severe traumatic brain injury. Hospital discharge Functional Status Scale had an inverse relationship with Glasgow Coma Scale: for each increase in admission Glasgow Coma Scale by 1, the discharge Functional Status Scale decreased by 0.5 (95% CI, 0.7-0.3). Baseline Functional Status Scale was collected at one site (n = 75). At that site, nearly all (61/62) of the survivors had normal or near-normal (<= 7) preinjury Functional Status Scale. More than one-third, 23 of 62 (37%), of survivors had new morbidity at hospital discharge (increase in Functional Status Scale, >= 3). Among children with severe traumatic brain injury who had baseline Functional Status Scale collected, 21 of 41 survivors (51%) had new morbidity at hospital discharge. The mean change in Functional Status Scale from baseline to hospital discharge was 3.9 +/- 4.9 overall and 5.2 +/- 5.4 in children with severe traumatic brain injury. Conclusions: More than one-third of survivors, and approximately half of survivors with severe traumatic brain injury, will have new morbidity. Hospital discharge Functional Status Scale, change from baseline Functional Status Scale, and new morbidity acquisition can be used as outcome measures for hospital-based care process improvement initiatives and interventional studies of children with traumatic brain injury.	[Bennett, Tellen D.] Univ Colorado, Sch Med, Dept Pediat, Pediat Crit Care Sect, Aurora, CO 80045 USA; [Bennett, Tellen D.; Sierra, Yamila; Ladell, Diane; Kempe, Allison] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Bennett, Tellen D.; Kempe, Allison] Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA; [Dixon, Rebecca R.; Dean, J. Michael; Keenan, Heather T.] Univ Utah, Sch Med, Dept Pediat, Div Pediat Crit Care, Salt Lake City, UT USA; [Kartchner, Cory] Primary Childrens Med Ctr, Salt Lake City, UT USA; [DeWitt, Peter E.] Univ Colorado Denver, Dept Bioinformat & Biostat, Aurora, CO USA; [Runyan, Desmond K.] Univ Colorado, Sch Med, Kempe Ctr, Dept Pediat, Aurora, CO USA		Bennett, TD (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Pediat Crit Care Sect, Aurora, CO 80045 USA.; Bennett, TD (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.; Bennett, TD (corresponding author), Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA.	tell.bennett@ucdenver.edu	Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029; Bennett, Tellen/0000-0003-1483-4236; DeWitt, Peter/0000-0002-6391-0795	Eunice Kennedy Shriver National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620]; National Center for Research Resources (Colorado Clinical and Translational Sciences Institute grant) [UL1 TR001082]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH funds from the Collaborative Pediatric Clinical Research Network (CPCCRN); federal government for research (NICHD, CDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082] Funding Source: NIH RePORTER	Supported, in part, by the Eunice Kennedy Shriver National Institute for Child Health and Human Development (grant number: K23HD074620 to Dr. Bennett) and the National Center for Research Resources (Colorado Clinical and Translational Sciences Institute grant number: UL1 TR001082).; Dr. Bennet received support for article research from the National Institutes of Health (NIH). His institution received funding from NICHD and from National Center for Research Resources. Dr. Dixon disclosed other support: she works for the University of Utah Division of Pediatric Critical Care Medicine; this Division receives NIH funding to be the Data Coordinating Center for the Collaborative Pediatric Critical Care Research Network [CPCCRN], which developed the Functional Status Scale [FSS]. She has not personally received any payments or support from this relationship with the NIH. Dr. Kartchner disclosed other support: all funding was received through the lead author, Tellen Bennett, MD. He has given full disclosure). Drs. Sierra and Ladel's institution received funding from NIH funds from the Collaborative Pediatric Clinical Research Network (CPCCRN) projects for salary and travel reimbursement. CPCCRN developed the FSS that this paper discusses. Dr. Kempe's institution received funding from the NIH. Dr. Keenan's institution received funding: she receives grant funding from the federal government for research (NICHD, CDC). Her institution received funding from the NICHD as a K23 award (Dr. Bennett) for this work. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bennett TD, 2015, PEDIATR CRIT CARE ME, V16, P377, DOI 10.1097/PCC.0000000000000380; Bone MF, 2014, PEDIATR CRIT CARE ME, V15, P640, DOI 10.1097/PCC.0000000000000199; Choong K, 2015, PEDIATR CRIT CARE ME, V16, P310, DOI 10.1097/PCC.0000000000000362; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Frieden T, 2014, C TRAUM BRAIN INJU U; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Slonim AD, 2010, PEDIATRICS, V125, P1208, DOI 10.1542/peds.2009-1451; Tasker RC, 2014, PEDIATR CRIT CARE ME, V15, P569, DOI 10.1097/PCC.0000000000000164; Tufte E., 2001, VISUAL DISPLAY QUANT	24	22	22	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	DEC	2016	17	12					1147	1156		10.1097/PCC.0000000000000934			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	EF2FA	WOS:000390138900010	27753754	Green Accepted			2022-02-06	
J	Katzenberger, RJ; Ganetzky, B; Wassarman, DA				Katzenberger, Rebeccah J.; Ganetzky, Barry; Wassarman, David A.			Age and Diet Affect Genetically Separable Secondary Injuries that Cause Acute Mortality Following Traumatic Brain Injury in Drosophila	G3-GENES GENOMES GENETICS			English	Article						Drosophila Genetic Reference Panel; gene expression; hyperglycemia innate immune response; repetitive TBI; RNA-seq	IMMUNE-RESPONSE; HOST-DEFENSE; EXPRESSION; OUTCOMES; DISEASE; SYSTEM; IMPACT; GENES; MODEL; MELANOGASTER	Outcomes of traumatic brain injury (TBI) vary because of differences in primary and secondary injuries. Primary injuries occur at the time of a traumatic event, whereas secondary injuries occur later as a result of cellular and molecular events activated in the brain and other tissues by primary injuries. We used a Drosophila melanogaster TBI model to investigate secondary injuries that cause acute mortality. By analyzing mortality percentage within 24 hr of primary injuries, we previously found that age at the time of primary injuries and diet afterward affect the severity of secondary injuries. Here, we show that secondary injuries peaked in activity 1-8 hr after primary injuries. Additionally, we demonstrate that age and diet activated distinct secondary injuries in a genotype-specific manner, and that concurrent activation of age- and diet-regulated secondary injuries synergistically increased mortality. To identify genes involved in secondary injuries that cause mortality, we compared genome-wide mRNA expression profiles of uninjured and injured flies under age and diet conditions that had different mortalities. During the peak period of secondary injuries, innate immune response genes were the predominant class of genes that changed expression. Furthermore, age and diet affected the magnitude of the change in expression of some innate immune response genes, suggesting roles for these genes in inhibiting secondary injuries that cause mortality. Our results indicate that the complexity of TBI outcomes is due in part to distinct, genetically controlled, age- and diet-regulated mechanisms that promote secondary injuries and that involve a subset of innate immune response genes.	[Katzenberger, Rebeccah J.; Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53706 USA; [Ganetzky, Barry] Univ Wisconsin, Coll Agr & Life Sci, Dept Genet, Madison, WI 53706 USA		Ganetzky, B; Wassarman, DA (corresponding author), Univ Wisconsin, Dept Genet, Genet Biotechnol Bldg,425G Henry Mall, Madison, WI 53706 USA.	ganetzky@wisc.edu; dawassarman@wisc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS091893-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091893] Funding Source: NIH RePORTER	We thank Grace Boekhoff-Falk, Stanislava Chtarbanova, Douglas Wassarman, and members of the Boekhoff-Falk, Ganetzky, and Wassarman laboratories for their comments that greatly improved the manuscript. We also thank Derek Pavelek in the University of Wisconsin-Madison Biotechnology Center for assistance analyzing the RNA-sequencing data. This work was supported by a grant from the National Institutes of Health (R21 NS091893-01 to B.G. and D.A.W.).	Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Bier E, 2012, DIS MODEL MECH, V5, P48, DOI 10.1242/dmm.000406; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Chakrabarti S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006089; Chakrabarti S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004659; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Clemmons AW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004876; Cohen L, 2009, J BIOL CHEM, V284, P23558, DOI 10.1074/jbc.M109.023358; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Djordjevic J, 2016, CURR ALZHEIMER RES, V13, P730, DOI 10.2174/1567205013666160222110320; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Heiman A, 2014, BRAIN BEHAV IMMUN, V42, P232, DOI 10.1016/j.bbi.2014.06.203; Hellewell SC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/356494; Hosseini Parsa, 2010, BMC Res Notes, V3, P183, DOI 10.1186/1756-0500-3-183; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Huang XJ, 2014, J NEUROTRAUM, V31, P346, DOI 10.1089/neu.2013.2899; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Lamiable O, 2016, P NATL ACAD SCI USA, V113, P698, DOI 10.1073/pnas.1516122113; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Owusu-Ansah E, 2015, ANNU REV CELL DEV BI, V31, P497, DOI 10.1146/annurev-cellbio-100814-125523; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sperry JL, 2014, ANN SURG, V260, P698, DOI 10.1097/SLA.0000000000000918; Stec W, 2013, MOL BIOL CELL, V24, P3000, DOI 10.1091/mbc.E13-05-0275; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wong YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020216; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	80	22	23	0	11	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	DEC	2016	6	12					4151	4166		10.1534/g3.116.036194			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EF8PN	WOS:000390591400034	27754853	Green Published, gold			2022-02-06	
J	Ledwidge, PS; Molfese, DL				Ledwidge, Patrick S.; Molfese, Dennis L.			Long-Term Effects of Concussion on Electrophysiological Indices of Attention in Varsity College Athletes: An Event-Related Potential and Standardized Low-Resolution Brain Electromagnetic Tomography Approach	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; electrophysiology; cognitive function; neuropsychology; traumatic brain injury	AUDITORY ODDBALL TASK; PROFESSIONAL FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; WORKING-MEMORY TASK; COGNITIVE CONTROL; FUNCTIONAL MRI; RECURRENT CONCUSSION; PERSISTENT INFLUENCE; CORTICAL GENERATORS; P300 COMPONENT	This study investigated the effects of a past concussion on electrophysiological indices of attention in college athletes. Forty-four varsity football athletes (22 with at least one past concussion) participated in three neuropsychological tests and a two-tone auditory oddball task while undergoing high-density event-related potential (ERP) recording. Athletes previously diagnosed with a concussion experienced their most recent injury approximately 4 years before testing. Previously concussed and control athletes performed equivalently on three neuropsychological tests. Behavioral accuracy and reaction times on the oddball task were also equivalent across groups. However, athletes with a concussion history exhibited significantly larger N2 and P3b amplitudes and longer P3b latencies. Source localization using standardized low-resolution brain electromagnetic tomography indicated that athletes with a history of concussion generated larger electrical current density in the left inferior parietal gyrus compared to control athletes. These findings support the hypothesis that individuals with a past concussion recruit compensatory neural resources in order to meet executive functioning demands. High-density ERP measures combined with source localization provide an important method to detect long-term neural consequences of concussion in the absence of impaired neuropsychological performance.	[Ledwidge, Patrick S.; Molfese, Dennis L.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Ledwidge, Patrick S.; Molfese, Dennis L.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA		Ledwidge, PS (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA.	pledwidge@huskers.unl.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01EB007684]	This research was partially supported by funding from The National Institutes of Health (1R01EB007684).	Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; Brazdil M, 2005, NEUROIMAGE, V26, P285, DOI 10.1016/j.neuroimage.2005.01.051; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Curran T, 1999, NEUROPSYCHOLOGIA, V37, P771, DOI 10.1016/S0028-3932(98)00133-X; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dien J, 2005, EVENT RELATED POTENT, P57; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Donchin E., 1986, PSYCHOPHYSIOL SYST P, P244; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finkelstein E., 2006, INCIDENCE EC BURDEN; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Greene SJ, 2010, NEUROBIOL AGING, V31, P1304, DOI 10.1016/j.neurobiolaging.2010.04.026; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P633, DOI 10.1111/j.1469-8986.1989.tb03165.x; Juckel G, 2012, NEUROIMAGE, V60, P2027, DOI 10.1016/j.neuroimage.2012.02.019; Junghofer M, 1997, BRAIN TOPOGR, V9, P203, DOI 10.1007/BF01190389; Key APF, 2005, DEV NEUROPSYCHOL, V27, P183, DOI 10.1207/s15326942dn2702_1; Kota S, 2013, NEUROREPORT, V24, P437, DOI 10.1097/WNR.0b013e3283616512; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Mathalon DH, 2003, BIOL PSYCHOL, V64, P119, DOI 10.1016/S0301-0511(03)00105-4; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Molfese DL, 2015, DEV NEUROPSYCHOL, V40, P1, DOI 10.1080/87565641.2015.1006479; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Mulert C, 2004, EUR ARCH PSY CLIN N, V254, P190, DOI 10.1007/s00406-004-0469-2; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reitan R, 1988, HALSTEAD REITAN NEUR; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Saliasi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063701; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song J, 2014, I S BIOMED IMAGING, P620, DOI 10.1109/ISBI.2014.6867947; Spencer KM, 1999, PSYCHOPHYSIOLOGY, V36, P409, DOI 10.1017/S0048577299981180; Srinivasan R, 1998, BEHAV RES METH INS C, V30, P8, DOI 10.3758/BF03209412; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wechsler D., 2008, WECHSLER ADULT INTEL; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3	81	22	22	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2081	2090		10.1089/neu.2015.4251			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800003	27025905	Green Published			2022-02-06	
J	Shah, S; Kimberly, WT				Shah, Shreyansh; Kimberly, W. Taylor			Today's Approach to Treating Brain Swelling in the Neuro Intensive Care Unit	SEMINARS IN NEUROLOGY			English	Article						brain swelling; cerebral edema; diagnosis; treatment	MIDDLE CEREBRAL-ARTERY; SEVERE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; MALIGNANT EDEMA; INFARCTION; STROKE; MANAGEMENT; OCCLUSION	Brain swelling is an urgent clinical problem that frequently accompanies ischemic stroke, brain hemorrhage; and traumatic brain injury; it increases morbidity and mortality associated with them. It occurs due to failure of membrane transporters and leakage of the blood brain barrier (BBB), resulting in combination of cytotoxic, ionic, and vasogenic edema. Currently, decompressive craniectomy and osmotherapy are the mainstays of management, but these therapies do not halt the underlying molecular cascade leading to brain swelling. Recent advances in the molecular underpinnings of cerebral edema have opened up possibilities of newer targeted therapeutic options. Here the authors outline the current approach for rapid diagnosis and intervention to reduce mortality and morbidity associated with brain swelling.	[Shah, Shreyansh; Kimberly, W. Taylor] Massachusetts Gen Hosp, Dept Neurol, Div Neurocrit Care & Emergency Neurol, Lunder 644,55 Fruit St, Boston, MA 02114 USA		Kimberly, WT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Div Neurocrit Care & Emergency Neurol, Lunder 644,55 Fruit St, Boston, MA 02114 USA.	wtkimberly@mgh.harvard.edu	Shah, Shreyansh/V-8581-2019	Shah, Shreyansh/0000-0001-8441-6326	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23NS076597]; AHAAmerican Heart Association [14GRNT19060044]; Remedy Pharmaceuticals, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099209, K23NS076597] Funding Source: NIH RePORTER	Dr. Kimberly has received research grants from NIH K23NS076597, AHA 14GRNT19060044, and Remedy Pharmaceuticals, Inc.	Asuzu D, 2016, NEUROCRIT CARE, V24, P381, DOI 10.1007/s12028-015-0198-6; Battey TWK, 2014, STROKE, V45, P3643, DOI 10.1161/STROKEAHA.114.006884; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cai XM, 2015, SEMIN NEUROL, V35, P638, DOI 10.1055/s-0035-1564687; Carhuapoma JR, 2003, J NEUROSURG ANESTH, V15, P230, DOI 10.1097/00008506-200307000-00010; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Damian MS, 2007, NEUROCRIT CARE, V6, P165, DOI 10.1007/s12028-007-0010-3; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Dey M, 2014, NEUROSURGERY, V74, pS142, DOI 10.1227/NEU.0000000000000221; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Ditillo M, 2011, J TRAUMA, V71, P373; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Fazzina G, 2010, J NEUROTRAUM, V27, P453, DOI 10.1089/neu.2008.0782; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Geeganage C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000323.pub2; Gonda DD, 2013, PEDIATR CRIT CARE ME, V14, P610, DOI 10.1097/PCC.0b013e318291772b; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hauer EM, 2011, CRIT CARE MED, V39, P1766, DOI 10.1097/CCM.0b013e318218a390; Hom J, 2011, AM J NEURORADIOL, V32, P41, DOI 10.3174/ajnr.A2244; Jayakumar AR, 2011, J HEPATOL, V54, P272, DOI 10.1016/j.jhep.2010.06.041; jtittler E, 2014, NEW ENGL J MED, V370, P1091; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Kelly AG, 2010, NEUROLOGY, V75, P682, DOI 10.1212/WNL.0b013e3181eee273; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Node Y, 1990, Adv Neurol, V52, P359; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Olm-Shipman C, 2015, STROKE, V46; Olson DaiWai M, 2003, Crit Care Nurse, V23, P45; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Sansing LH, 2003, J NEUROSURG, V98, P985, DOI 10.3171/jns.2003.98.5.0985; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sheth KN, 2016, NEUROCRIT CARE, V24, P132, DOI 10.1007/s12028-015-0189-7; Sheth KN, 2014, STROKE, V45, P3748, DOI 10.1161/STROKEAHA.114.005804; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2014, NEUROCRIT CARE, V20, P319, DOI 10.1007/s12028-013-9923-1; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Takeuchi S, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12424; Thomalla G, 2010, ANN NEUROL, V68, P435, DOI 10.1002/ana.22125; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vemmos KN, 2003, J HYPERTENS, V21, P2167, DOI 10.1097/00004872-200311000-00027; Venkatasubramanian C, 2011, STROKE, V42, P73, DOI 10.1161/STROKEAHA.110.590646; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021; ZWECKBERGER K, 2014, REV CEREBROVASC DIS, V38, P313, DOI DOI 10.1159/000365864	66	22	25	0	3	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	DEC	2016	36	6					502	507		10.1055/s-0036-1592109			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE0PT	WOS:000389282100005	27907954	Green Accepted			2022-02-06	
J	Vakorin, VA; Doesburg, SM; da Costa, L; Jetly, R; Pang, EW; Taylor, MJ				Vakorin, Vasily A.; Doesburg, Sam M.; da Costa, Leodante; Jetly, Rakesh; Pang, Elizabeth W.; Taylor, Margot J.			Detecting Mild Traumatic Brain Injury Using Resting State Magnetoencephalographic Connectivity	PLOS COMPUTATIONAL BIOLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PARTIAL LEAST-SQUARES; FUNCTIONAL CONNECTIVITY; IMAGING APPROACH; PHASE SYNCHRONIZATION; CLINICAL MANAGEMENT; SYMPTOM SEVERITY; HEAD TRAUMA; MEG; CONCUSSION	Accurate means to detect mild traumatic brain injury (mTBI) using objective and quantitative measures remain elusive. Conventional imaging typically detects no abnormalities despite post-concussive symptoms. In the present study, we recorded resting state magnetoencephalograms (MEG) from adults with mTBI and controls. Atlas-guided reconstruction of resting state activity was performed for 90 cortical and subcortical regions, and calculation of inter-regional oscillatory phase synchrony at various frequencies was performed. We demonstrate that mTBI is associated with reduced network connectivity in the delta and gamma frequency range (>30 Hz), together with increased connectivity in the slower alpha band (8-12 Hz). A similar temporal pattern was associated with correlations between network connectivity and the length of time between the injury and the MEG scan. Using such resting state MEG network synchrony we were able to detect mTBI with 88% accuracy. Classification confidence was also correlated with clinical symptom severity scores. These results provide the first evidence that imaging of MEG network connectivity, in combination with machine learning, has the potential to accurately detect and determine the severity of mTBI.	[Vakorin, Vasily A.; Doesburg, Sam M.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Vakorin, Vasily A.; Doesburg, Sam M.] Simon Fraser Univ, Behav & Cognit Neurosci Inst, Burnaby, BC, Canada; [Doesburg, Sam M.; Taylor, Margot J.] Hosp Sick Children Res Inst, Dept Diagnost Imaging, Toronto, ON, Canada; [Doesburg, Sam M.; Pang, Elizabeth W.; Taylor, Margot J.] Hosp Sick Children Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada; [da Costa, Leodante] Univ Toronto, Sunnybrook Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [da Costa, Leodante] Sunnybrook Med Ctr, Dept Med Imaging, Toronto, ON, Canada; [Jetly, Rakesh] Directorate Mental Hlth, Canadian Forces Hlth Serv, Ottawa, ON, Canada; [Pang, Elizabeth W.; Taylor, Margot J.] Hosp Sick Children, Dept Neurol, Toronto, ON, Canada; [Taylor, Margot J.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Taylor, Margot J.] Univ Toronto, Dept Psychol, Toronto, ON, Canada		Vakorin, VA (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.; Vakorin, VA (corresponding author), Simon Fraser Univ, Behav & Cognit Neurosci Inst, Burnaby, BC, Canada.	vasily_vakorin@sfu.ca	Vakorin, Vasily/AAY-3249-2021	Vakorin, Vasily/0000-0003-0489-1552	Canadian Forces Health Services; Defence Research and Development Canada (DRDC) [W7719-135182/001/TOR]	This work was supported by the Canadian Forces Health Services and funding from Defence Research and Development Canada (DRDC) (contract # W7719-135182/001/TOR) to MJT and EWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Auger F., 1996, TIME FREQUENCY TOOLB; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Boser BE, 1992, P 5 ANN WORKSH COMP, V152, P144; Bosl W, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-18; Cao C, 2014, IEEE T NEUR SYS REH, V18, P11; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chavez M, 2003, IEEE T BIO-MED ENG, V50, P571, DOI 10.1109/TBME.2003.810696; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dunkley BT, 2014, NEUROIMAGE-CLIN, V5, P377, DOI 10.1016/j.nicl.2014.07.017; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Heisz JJ, 2014, J COGNITIVE NEUROSCI, V26, P41, DOI 10.1162/jocn_a_00466; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hosken JWJ, 1998, 1 BREAK, V6, P24; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; James LM, 2015, PSYCHIAT RES-NEUROIM, V231, P1, DOI 10.1016/j.pscychresns.2014.11.007; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Kecman V., 2001, LEARNING SOFT COMPUT; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lalancette M, 2011, PHYS MED BIOL, V56, P5621, DOI 10.1088/0031-9155/56/17/010; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McIntosh AR, 2013, ANNU REV PSYCHOL, V64, P499, DOI 10.1146/annurev-psych-113011-143804; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Quraan MA, 2011, HUM BRAIN MAPP, V32, P812, DOI 10.1002/hbm.21068; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song G., 2011, ADV NORMALIZATION TO; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Tsirka V, 2011, INT J PSYCHOPHYSIOL, V79, P89, DOI 10.1016/j.ijpsycho.2010.09.006; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2013, JAMA PSYCHIAT, V70, P869, DOI 10.1001/jamapsychiatry.2013.104; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Vakorin VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057217; Vakorin VA, 2011, J NEUROSCI, V31, P6405, DOI 10.1523/JNEUROSCI.3153-10.2011; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	60	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA		1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	DEC	2016	12	12							e1004914	10.1371/journal.pcbi.1004914			24	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	EH9XT	WOS:000392126000002	27906973	Green Submitted, Green Published, gold			2022-02-06	
J	Frohlich, M; Wafaisade, A; Mansuri, A; Koenen, P; Probst, C; Maegele, M; Bouillon, B; Sakka, SG				Froehlich, Matthias; Wafaisade, Arasch; Mansuri, Anastasios; Koenen, Paola; Probst, Christian; Maegele, Marc; Bouillon, Bertil; Sakka, Samir G.			Which score should be used for posttraumatic multiple organ failure? - Comparison of the MODS, Denver- and SOFA- Scores	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; Multiple organ failure; Multiple organ dysfunction; Sofa score; Denver Score	AGITATION-SEDATION SCALE; RISK-FACTORS; INJURY; TRAUMA; DYSFUNCTION; EPIDEMIOLOGY; SEPSIS	Background: Multiple organ dysfunction and multiple organ failure (MOF) is still a major complication and challenge in the treatment of severely injured patients. The incidence varies decisively in current studies, which complicates the comparability regarding risk factors, treatment recommendations and patients' outcome. Therefore, we analysed how the currently used scoring systems, the MODS, Denver- and SOFA Score, influence the definition and compared the scores' predictive ability. Methods: Out of datasets of severely injured patients (ISS >= 16, Age >= 16) staying more tha 48 h on the ICU, the scores were calculated, respectively. The scores' predictive ability on day three after trauma for resource requiring measurements and patient specific outcomes were compared using receiver-operating characteristics. Results: One hundred seventy-six patients with a mean ISS 28 +/- 13 could be included. MODS and SOFA score defined the incidence of MOF consistently (46.5 % vs. 52.3 %), while the Denver score defined MOF in 22.2 %. The MODS outperformed Denver-and SOFA score in predicting mortality (area under the curve/AUC: 0.83 vs. 0.67 vs. 0.72), but was inferior predicting the length of stay (AUC 0.71 vs. 0.80 vs. 0.82) and a prolonged time on mechanical ventilation (AUC 0.75 vs. 0.81 vs. 0.84). MODS and SOFA score were comparably sensitive and the Denver score more specific in all analyses. Conclusions: All three scores have a comparable ability to predict the outcome in trauma patients including patients with severe traumatic brain injury (TBI). Either score could be favored depending weather a higher sensitivity or specificity is targeted. The SOFA score showed the most balanced relation of sensitivity and specificity. The incidence of posttraumatic MOF relies decisively on the score applied. Therefore harmonizing the competing scores and definitions is desirable.	[Froehlich, Matthias; Wafaisade, Arasch; Koenen, Paola; Probst, Christian; Maegele, Marc; Bouillon, Bertil] Univ Witten Herdecke, Dept Trauma & Orthoped Surg, Cologne Merheim Med Ctr, Ostmerheimerstr 200, D-51109 Cologne, Germany; [Froehlich, Matthias] Univ Witten Herdecke, Inst Res Operat Med IFOM, Ostmerheimerstr 200, D-51109 Cologne, Germany; [Mansuri, Anastasios; Sakka, Samir G.] Univ Witten Herdecke, Med Ctr Cologne Merheim, Dept Anaesthesiol & Operat Intens Care Med, Cologne, Germany		Frohlich, M (corresponding author), Univ Witten Herdecke, Dept Trauma & Orthoped Surg, Cologne Merheim Med Ctr, Ostmerheimerstr 200, D-51109 Cologne, Germany.; Frohlich, M (corresponding author), Univ Witten Herdecke, Inst Res Operat Med IFOM, Ostmerheimerstr 200, D-51109 Cologne, Germany.	froehlichm@kliniken-koeln.de					Antonelli M, 1999, INTENS CARE MED, V25, P389, DOI 10.1007/s001340050863; Bingold TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134329; BONE RC, 1991, CRIT CARE MED, V19, P973, DOI 10.1097/00003246-199107000-00024; Ciesla DJ, 2004, ARCH SURG-CHICAGO, V139, P590, DOI 10.1001/archsurg.139.6.590; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Dewar DC, 2014, J TRAUMA ACUTE CARE, V77, P624, DOI 10.1097/TA.0000000000000406; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P921, DOI 10.1097/TA.0000000000000199; Grotz M, 2001, CHIRURG, V72, P723, DOI 10.1007/s001040170130; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; Sauaia A, 1996, WORLD J SURG, V20, P392, DOI 10.1007/s002689900062; Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Vasilevskis EE, 2016, CRIT CARE MED, V44, P138, DOI 10.1097/CCM.0000000000001375; Viglino D, 2016, J THORAC DIS, V8, P311, DOI 10.21037/jtd.2016.02.61; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vogel JA, 2016, J AM COLL SURGEONS, V222, P73, DOI 10.1016/j.jamcollsurg.2015.10.010; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007	25	22	25	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 3	2016	24								130	10.1186/s13049-016-0321-5			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EA8BM	WOS:000386860300002	27809885	Green Published, gold			2022-02-06	
J	Campolettano, ET; Rowson, S; Duma, SM				Campolettano, Eamon T.; Rowson, Steven; Duma, Stefan M.			Drill-specific head impact exposure in youth football practice	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; biomechanics; linear; rotational; acceleration; pediatrics; trauma	HIGH-SCHOOL FOOTBALL; PLAYERS; INJURY; ACCELERATION; CONCUSSIONS; KINEMATICS; MAGNITUDE; LOCATION; GAME	OBJECTIVE Although 70% of football players in the United States are youth players (6-14 years old), most research on head impacts in football has focused on high school, collegiate, or professional populations. The objective of this study was to identify the specific activities associated with high-magnitude (acceleration > 40g) head impacts in youth football practices. METHODS A total of 34 players (mean age 9.9 +/- 0.6 years) on 2 youth teams were equipped with helmet-mounted accelerometer arrays that recorded head accelerations associated with impacts in practices and games. Videos of practices and games were used to verify all head impacts and identify specific drills associated with each head impact. RESULTS A total of 6813 impacts were recorded, of which 408 had accelerations exceeding 40g (6.0%). For each type of practice drill, impact rates were computed that accounted for the length of time that teams spent on each drill. The tackling drill King of the Circle had the highest impact rate (95% CI 25.6-68.3 impacts/hr). Impact rates for tackling drills (those conducted without a blocker [95% CI 14.7-21.9 impacts/hr] and those with a blocker [95% CI 10.5-23.1 impacts/hr]) did not differ from game impact rates (95% CI 14.2-21.6 impacts/hr). Tackling drills were observed to have a greater proportion (between 40% and 50%) of impacts exceeding 60g than games (25%). The teams in this study participated in tackling or blocking drills for only 22% of their overall practice times, but these drills were responsible for 86% of all practice impacts exceeding 40g. CONCLUSIONS In youth football, high-magnitude impacts occur more often in practices than games, and some practice drills are associated with higher impact rates and accelerations than others. To mitigate high-magnitude head impact exposure in youth football, practices should be modified to decrease the time spent in drills with high impact rates, potentially eliminating a drill such as King of the Circle altogether.	[Campolettano, Eamon T.; Rowson, Steven; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA		Rowson, S (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	srowson@vt.edu	Rowson, Steven/B-1270-2012; Duma, Stefan/A-8368-2012	Rowson, Steven/0000-0002-3227-0596; 	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award No. R01NS094410. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We gratefully acknowledge the Blacksburg Juniors football teams for their participation in this study.	Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Breslow N. E., 1987, STAT METHODS CANC RE, VII; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pop Warner National Office, 2012, POP WARNER NEWS 0613; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	27	22	22	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2016	18	5					536	541		10.3171/2016.5.PEDS1696			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DZ8FL	WOS:000386106200003	27550390	Green Accepted, Bronze			2022-02-06	
J	Myrga, JM; Juengst, SB; Failla, MD; Conley, YP; Arenth, PM; Grace, AA; Wagner, AK				Myrga, John M.; Juengst, Shannon B.; Failla, Michelle D.; Conley, Yvette P.; Arenth, Patricia M.; Grace, Anthony A.; Wagner, Amy K.			COMT and ANKK1 Genetics Interact With Depression to Influence Behavior Following Severe TBI: An Initial Assessment	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						DRD2; ANKK1; COMT; TBI; behavior; rehabilomics; frontal lobe	TRAUMATIC BRAIN-INJURY; DOPAMINE D2 RECEPTOR; POSTTRAUMATIC-STRESS-DISORDER; O-METHYLTRANSFERASE COMT; MEDIAL PREFRONTAL CORTEX; SERIOUS LIFE EVENTS; A1 ALLELE; COGNITIVE PERFORMANCE; CHALLENGING BEHAVIOR; IMPULSIVE AGGRESSION	Objective. Genetic variations in the dopamine (DA) system are associated with cortical-striatal behavior in multiple populations. This study assessed associations of functional polymorphisms in the ankyrin repeat and kinase domain (ANKK1; Taq1a) and catechol-O-methyltransferase (COMT; Val158Met) genes with behavioral dysfunction following traumatic brain injury (TBI). Participants. This was a prospective study of 90 survivors of severe TBI recruited from a level 1 trauma center. Main measures. The Frontal Systems Behavior Scale, a self- or family report questionnaire evaluating behavior associated with frontal lobe dysfunction, was completed 6 and 12 months postinjury. Depression was measured concurrently with the Patient Health Questionnaire-9. Study participants were genotyped for Val158Met and Taq1a polymorphisms. Results. No statistically significant behavioral differences were observed by Taq1a or Val158Met genotype alone. At 12 months, among those with depression, Met homozygotes (Val158Met) self-reported worse behavior than Val carriers (P = .015), and A2 homozygotes (Taq1a) self-reported worse behavior than A1 carriers (P = .028) in bivariable analysis. Multivariable models suggest an interaction between depression and genetic variation with behavior at 12 months post-TBI, and descriptive analysis suggests that carriage of both risk alleles may contribute to worse behavioral performance than carriage of either risk allele alone. Conclusion. In the context of depression, Val158Met and Taq1a polymorphisms are individually associated with behavioral dysfunction 12 months following severe TBI, with preliminary evidence suggesting cumulative, or perhaps epistatic, effects of COMT and ANKK1 on behavioral dysfunction.	[Myrga, John M.; Juengst, Shannon B.; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Failla, Michelle D.] Vanderbilt Univ, Dept Psychiat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Grace, Anthony A.; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Grace, Anthony A.; Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, Kaufmann Bldg,Suite 202,3471 Fifth Ave, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021; Juengst, Shannon B/AAC-5891-2019	Failla, Michelle/0000-0001-9734-3373; Juengst, Shannon B/0000-0003-4709-545X; Conley, Yvette/0000-0002-1784-6067	National Institute For Disability, Independent Living, and Rehabilitation Research (NIDILRR) [90DP0041]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD048162]; Department of Defense (DoD)United States Department of Defense [W81XWH-071-0701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH101180] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: National Institute For Disability, Independent Living, and Rehabilitation Research (NIDILRR): 90DP0041, National Institutes of Health (NIH): R01 HD048162; Department of Defense (DoD): W81XWH-071-0701.	Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baune BT, 2008, NEUROPSYCHOPHARMACOL, V33, P924, DOI 10.1038/sj.npp.1301462; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Benedetti F, 2010, EUR PSYCHIAT, V25, P476, DOI 10.1016/j.eurpsy.2009.12.007; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; BLUM K, 1995, PHARMACOGENETICS, V5, P121, DOI 10.1097/00008571-199506000-00001; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bosia M, 2007, NEUROSCI LETT, V417, P271, DOI 10.1016/j.neulet.2007.02.076; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chang CH, 2014, BIOL PSYCHIAT, V76, P223, DOI 10.1016/j.biopsych.2013.09.020; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Economidou D, 2012, NEUROPSYCHOPHARMACOL, V37, P2057, DOI 10.1038/npp.2012.53; Eisenberg DTA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-2; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Ferrari PF, 2003, EUR J NEUROSCI, V17, P371, DOI 10.1046/j.1460-9568.2003.02447.x; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Guedes VA, 2016, EXPERT REV NEUROTHER, V16, P61, DOI 10.1586/14737175.2016.1126180; HALL H, 1994, NEUROPSYCHOPHARMACOL, V11, P245, DOI 10.1038/sj.npp.1380111; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002; Hygen BW, 2015, DEV PSYCHOL, V51, P1098, DOI 10.1037/dev0000020; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Juengst S, 2014, ARCH PHYS MED REHAB, V95, pE71, DOI [10.1016/j.apmr.2014.07.227, DOI 10.1016/J.APMR.2014.07.227]; Juengst SB, 2015, ARCH PHYS MED REHAB, V96, pe7; Kandel ER, 1998, AM J PSYCHIAT, V155, P457, DOI 10.1176/ajp.155.4.457; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Lawford BR, 2006, EUR PSYCHIAT, V21, P180, DOI 10.1016/j.eurpsy.2005.01.006; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liu Y, 2011, J NEUROTRAUM, V28, pA105; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Mannisto PT, 1999, PHARMACOL REV, V51, P593; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; Miczek KA, 2002, PSYCHOPHARMACOLOGY, V163, P434, DOI 10.1007/s00213-002-1139-6; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Myrga JM, J HEAD TRAUMA REHABI; Pardini M, 2014, CNS SPECTRUMS, V19, P382, DOI 10.1017/S1092852914000108; Patton MH, 2013, J NEUROSCI, V 33, P16865, DOI 10.1523/JNEUROSCI.2449-13.2013; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Robbins TW, 2005, NAT NEUROSCI, V8, P261, DOI 10.1038/nn0305-261; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Savitz J, 2013, INT J NEUROPSYCHOPH, V16, P2095, DOI 10.1017/S146114571300045X; Seo DJ, 2008, AGGRESS VIOLENT BEH, V13, P383, DOI 10.1016/j.avb.2008.06.003; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Simpson EH, 2014, LEARN MEMORY, V21, P205, DOI 10.1101/lm.032094.113; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Strous RD, 2003, AM J MED GENET B, V120B, P29, DOI 10.1002/ajmg.b.20021; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wagner S, 2010, ACTA PSYCHIAT SCAND, V122, P110, DOI 10.1111/j.1600-0447.2009.01501.x; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Young RM, 2002, ALCOHOL ALCOHOLISM, V37, P451, DOI 10.1093/alcalc/37.5.451; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Zai CC, 2012, WORLD J BIOL PSYCHIA, V13, P65, DOI 10.3109/15622975.2010.543431	83	22	23	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	NOV-DEC	2016	30	10					920	930		10.1177/1545968316648409			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DZ0HD	WOS:000385517400002	27154305	Green Accepted, Bronze			2022-02-06	
J	Stojanovic, MP; Fonda, J; Fortier, CB; Higgins, DM; Rudolph, JL; Milberg, WP; McGlinchey, RE				Stojanovic, Milan P.; Fonda, Jennifer; Fortier, Catherine Brawn; Higgins, Diana M.; Rudolph, James L.; Milberg, William P.; McGlinchey, Regina E.			Influence of Mild Traumatic Brain Injury (TBI) and Posttraumatic Stress Disorder (PTSD) on Pain Intensity Levels in OEF/OIF/OND Veterans	PAIN MEDICINE			English	Article						Traumatic Brain Injury; Post-Traumatic Stress Disorder; Chronic Pain	SLEEP QUALITY INDEX; HEAD-INJURY; VALIDITY; RELIABILITY; EXPERIENCES; PREVALENCE; DISABILITY; INSOMNIA; IRAQ	Objective. Mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are common among US veterans of Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND). We postulated that these injuries may modulate pain processing in these individuals and affect their subjective pain levels. Design. Cross-sectional. Subjects. 310 deployed service members of OEF/OIF/OND without a lifetime history of moderate or severe TBI were included in this study. Methods. All participants completed a comprehensive evaluation for Blast Exposure, mTBI, PTSD, and Pain Levels. The Boston Assessment of TBI-Lifetime Version (BAT-L) was used to assess blast exposure and potential brain injury during military service. The Clinician-Administered PTSD Scale (CAPS) characterized presence and severity of PTSD. The Visual Analog Scale (VAS) was used to assess pain intensity over the previous month before the interview, with higher scores indicative of worse pain. Statistical analysis was performed by ANOVA and results were adjusted for co-morbidities, clinical characteristics and demographic data. Results. In comparison to control participants (veterans without mTBI or current PTSD), veterans with both current PTSD and mTBI reported the highest pain intensity levels, followed by veterans with PTSD only (P<0.0001 and P=0.0005, respectively). Pain levels in veterans with mTBI only were comparable to control participants. Conclusions. Comorbid PTSD and mTBI is associated with increased self-reported pain intensity.mTBI alone was not associated with increased pain.	[Stojanovic, Milan P.; Higgins, Diana M.] VA Boston Healthcare Syst, Anesthesiol Crit Care & Pain Med Serv, Boston, MA USA; [Fonda, Jennifer; Fortier, Catherine Brawn; Rudolph, James L.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Fonda, Jennifer; Fortier, Catherine Brawn; Rudolph, James L.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA USA; [Fonda, Jennifer] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA; [Fortier, Catherine Brawn; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Higgins, Diana M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Rudolph, James L.] Brigham & Womens Hosp, Div Aging, 75 Francis St, Boston, MA 02115 USA		Stojanovic, MP (corresponding author), VA Boston Healthcare Syst, Pain Med Anesthesiol Crit Care & Pain Med Serv, 150 South Huntington Ave, Boston, MA 02130 USA.	mpstojanovic@gmail.com	Fortier, Catherine/AAS-2163-2021; Fonda, Jennifer R./ABG-2890-2021	Fortier, Catherine/0000-0002-8953-9904; Fonda, Jennifer R./0000-0001-9482-2918	Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development (RR&D) Traumatic Brain Injury Center of Excellence [B9254-C]	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development (RR&D) Traumatic Brain Injury Center of Excellence (B9254-C).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 2011, AN VA HEALTHC UT OP; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Department of Defense (DoD), 2012, DEM PROF MIL COMM; Department of Veterans Affairs, 2012, AN VA HLTH CAR UT OP; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; First M.B., 1996, STRUCTURED CLIN INTE; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Games P. A., 1976, J EDUC STAT, V1, P113, DOI DOI 10.2307/1164979; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Janke EA, 2007, J REHABIL RES DEV, V44, P245, DOI 10.1682/JRRD.2006.06.0060; Jaramillo CA, HEADACHE IN PRESS; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Mersky H, 1994, INT ASS STUDY PAIN T, P226; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Von Korff M, 2005, PSYCHOSOM MED, V67, P233, DOI 10.1097/01.psy.0000155662.82621.50; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454	39	22	22	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	NOV	2016	17	11					2017	2025		10.1093/pm/pnw042			9	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	ER4DA	WOS:000398748100007	27040665	hybrid			2022-02-06	
J	Catenaccio, E; Caccese, J; Wakschlag, N; Fleysher, R; Kim, N; Kim, M; Buckley, TA; Stewart, WF; Lipton, RB; Kaminski, T; Lipton, ML				Catenaccio, E.; Caccese, J.; Wakschlag, N.; Fleysher, R.; Kim, N.; Kim, M.; Buckley, T. A.; Stewart, W. F.; Lipton, R. B.; Kaminski, T.; Lipton, M. L.			Validation and calibration of HeadCount, a self-report measure for quantifying heading exposure in soccer players	RESEARCH IN SPORTS MEDICINE			English	Article						Soccer; head injuries; sex differences; self-report	PHYSICAL-ACTIVITY QUESTIONNAIRE; NEUROCOGNITIVE PERFORMANCE; SCHOOL SOCCER; FOOTBALLERS; FREQUENCY; RELIABILITY; CONCUSSIONS; VALIDITY; IMPACTS; SEASON	The long-term effects of repetitive head impacts due to heading are an area of increasing concern, and exposure must be accurately measured; however, the validity of self-report of cumulative soccer heading is not known. In order to validate HeadCount, a 2-week recall questionnaire, the number of player-reported headers was compared to the number of headers observed by trained raters for a men's and a women's collegiate soccer teams during an entire season of competitive play using Spearman's correlations and intraclass correlation coefficients (ICCs), and calibrated using a generalized estimating equation. The average Spearman's rho was 0.85 for men and 0.79 for women. The average ICC was 0.75 in men and 0.38 in women. The calibration analysis demonstrated that men tend to report heading accurately while women tend to overestimate. HeadCount is a valid instrument for tracking heading behaviour, but may have to be calibrated in women.	[Catenaccio, E.; Wakschlag, N.; Fleysher, R.; Kim, N.; Lipton, R. B.; Lipton, M. L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, New York, NY USA; [Caccese, J.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE USA; [Fleysher, R.; Kim, N.; Lipton, M. L.] Albert Einstein Coll Med, Dept Radiol, New York, NY USA; [Kim, M.; Lipton, R. B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Buckley, T. A.; Kaminski, T.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Stewart, W. F.] Sutter Hlth, Sacramento, CA USA; [Lipton, R. B.] Montefiore Med Ctr, Dept Neurol, New York, NY USA; [Lipton, R. B.; Lipton, M. L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY USA; [Lipton, M. L.] Montefiore Med Ctr, Dept Radiol, New York, NY USA; [Lipton, M. L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, MRRC, Jack & Pearl Resnick Campus,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.lipton@einstein.yu.edu	Lipton, Richard B/B-5060-2011; Lipton, Richard Bruce/AAY-2818-2021; Buckley, Thomas A/B-7525-2016; Catenaccio, Eva/M-7250-2019; Caccese, Jaclyn B./AAH-4571-2020	Buckley, Thomas A/0000-0002-0515-0150; Catenaccio, Eva/0000-0003-0550-207X; Caccese, Jaclyn B./0000-0003-2329-3603	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program; Albert Einstein College of Medicine Research Fellowship Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [grant number R01 NS082432], the Dana Foundation David Mahoney Neuroimaging Program, and the Albert Einstein College of Medicine Research Fellowship Program.	Atienza AA, 2005, RES Q EXERCISE SPORT, V76, P358; Babwah T, 2014, RES SPORTS MED, V22, P334, DOI 10.1080/15438627.2014.945644; Ciuti G, 2015, SENSORS-BASEL, V15, P6441, DOI 10.3390/s150306441; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; Friedenreich CM, 2006, AM J EPIDEMIOL, V163, P959, DOI 10.1093/aje/kwj112; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Johnson-Kozlow M, 2007, AM J HEALTH BEHAV, V31, P193, DOI 10.5993/AJHB.31.2.8; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Montenigro P. H., 2016, J NEUROTRAUMA, V33, P1; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rutherford A, 2005, APPL COGNITIVE PSYCH, V19, P477, DOI 10.1002/acp.1091; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	36	22	22	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	OCT-DEC	2016	24	4			SI		416	425		10.1080/15438627.2016.1234472			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	EB8NX	WOS:000387648900012	27788599	Green Accepted			2022-02-06	
J	McCulloch, KL; de Joya, AL; Hays, K; Donnelly, E; Johnson, TK; Nirider, CD; Roth, H; Saliga, S; Ward, I				McCulloch, Karen L.; de Joya, Anna Lisa; Hays, Kaitlin; Donnelly, Erin; Johnson, Tammie Keller; Nirider, Coby D.; Roth, Heidi; Saliga, Sue; Ward, Irene			Outcome Measures for Persons With Moderate to Severe Traumatic Brain Injury: Recommendations From the American Physical Therapy Association Academy of Neurologic Physical Therapy TBI EDGE Task Force	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						measurement; human movement system; standardization	QUALITY-OF-LIFE; DISABILITY RATING-SCALE; COMMON DATA ELEMENTS; PSYCHOMETRIC PROPERTIES; PARTICIPATION ASSESSMENT; INTERRATER RELIABILITY; PREDICTIVE-VALIDITY; RETEST RELIABILITY; INITIAL VALIDATION; SERIAL MEASUREMENT	Background and Purpose: The use of standardized outcome measures (OMs) is essential in assessing the effectiveness of physical therapy (PT) interventions. The purposes of this article are (1) to describe the process used by the TBI EDGE task force to assess the psychometrics and clinical utility of OMs used with individuals with moderate to severe traumatic brain injury (TBI); (2) to describe the consensus recommendations for OM use in clinical practice, research, and professional (entry-level) PT education; and (3) to make recommendations for future work. Methods: An 8-member task force used a modified Delphi process to develop recommendations on the selection of OMs for individuals with TBI. A 4-point rating scale was used to make recommendations based on practice setting and level of ambulation. Recommendations for appropriateness for research use and inclusion in entry-level education were also provided. Results: The TBIEDGEtask force reviewed 88 OMs across the International Classification of Functioning, Disability, and Health (ICF) domains: 15 measured body functions/structure only, 21 measured activity only, 23 measured participation only, and 29 OMs covered more than 1 ICF domain. Discussion and Conclusions: Recommendations made by the TBI EDGE task force provide clinicians, researchers, and educators with guidance for the selection of OMs. The use of these recommendations may facilitate identification of appropriate OMs in the population with moderate to severe TBI. TBI EDGE task force recommendations can be used by clinicians, researchers, and educators when selecting OMs for their respective needs. Future efforts to update the recommendations are warranted in order to ensure that recommendations remain current and applicable. Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, http://links.lww.com/JNPT/A140).	[McCulloch, Karen L.] Univ N Carolina, Div Phys Therapy, Dept Allied Hlth Sci, Sch Med, 321 S Columbia St Bondurant Hall Suite 3024, Chapel Hill, NC 27599 USA; [McCulloch, Karen L.] Univ N Carolina, Div Phys Therapy, Chapel Hill, NC USA; [de Joya, Anna Lisa] TIRR Mem Hermann, Houston, TX USA; [Hays, Kaitlin] Craig Hosp, Denver, CO USA; [Donnelly, Erin] Kessler Inst Rehabil, Saddle Brook, NJ USA; [Johnson, Tammie Keller] Casa Colina Ctr Rehabil, Pomona, CA USA; [Nirider, Coby D.] Touchstone Neurorecovery Ctr, Conroe, TX USA; [Roth, Heidi] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Saliga, Sue] Oakland Univ, Rochester, MI 48063 USA; [Ward, Irene] Kessler Inst Rehabil, W Orange, NJ USA		McCulloch, KL (corresponding author), Univ N Carolina, Div Phys Therapy, Dept Allied Hlth Sci, Sch Med, 321 S Columbia St Bondurant Hall Suite 3024, Chapel Hill, NC 27599 USA.	kmac@med.unc.edu					Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; *AM PHYS THER ASS, 2002, INT GUID PHYS THER P; American Physical TherapyAssociation, 2011, NEUR ENTR LEV CURR C; [Anonymous], 2007, PRACT ASSESS RES EVA, DOI DOI 10.1576/T0AG.7.2.120.27071; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bellon K, 2012, J HEAD TRAUMA REHAB, V27, P314, DOI 10.1097/HTR.0b013e3182562f04; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bodiam C., 1999, BRIT J OCCUP THER, V62, P123, DOI [10.1177/030802269906200310, DOI 10.1177/030802269906200310]; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2015, J HEAD TRAUMA REHAB, V30, P337; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Boonstra AM, 2012, INT J REHABIL RES, V35, P153, DOI 10.1097/MRR.0b013e328352ab28; Boulgarides LK, 2003, PHYS THER, V83, P328, DOI 10.1093/ptj/83.4.328; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cardol M, 2001, ARCH PHYS MED REHAB, V82, P210, DOI 10.1053/apmr.2001.18218; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Commission on Accreditation in Physical Therapy Education, EV CRIT PT PROGR VER; de Hoon EW, 2003, ARCH PHYS MED REHAB, V84, P838, DOI 10.1016/S0003-9993(02)04951-1; Demers L, 1996, Assist Technol, V8, P3; DIFABIO RP, 1990, PHYS THER, V70, P542, DOI 10.1093/ptj/70.9.542; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Donnelly E, 2014, ARCH PHYS MED REHAB, V95, P1417; Duarte E, 2002, J REHABIL MED, V34, P267, DOI 10.1080/165019702760390356; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Franchignoni F, 2003, CLIN REHABIL, V17, P273, DOI 10.1191/0269215503cr608oa; Fujiwara T, 2004, AM J PHYS MED REHAB, V83, P681, DOI 10.1097/01.PHM.0000137308.10562.20; Gandek B, 2007, AM J PHYS MED REHAB, V86, P57, DOI 10.1097/01.PHM.0000233200.43822.21; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Gorman SL, 2010, J NEUROL PHYS THER, V34, P150, DOI 10.1097/NPT.0b013e3181f0065f; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Gray DB, 2006, ARCH PHYS MED REHAB, V87, P189, DOI 10.1016/j.apmr.2005.09.014; Griffen JA, 2010, REHABIL PSYCHOL, V55, P292, DOI 10.1037/a0020503; Haley SM, 2004, MED CARE, V42, P49, DOI 10.1097/01.mlr.0000103520.43902.6c; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Harker WF, 2002, INT J REHABIL RES, V25, P93, DOI 10.1097/00004356-200206000-00003; Hobart JC, 2001, J NEUROL NEUROSUR PS, V71, P225, DOI 10.1136/jnnp.71.2.225; Hofheinz M, 2010, CLIN REHABIL, V24, P831, DOI 10.1177/0269215510367993; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Huijbregts M, 2002, PHYSIOTHER CAN, V54, P25; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jette DU, 2009, PHYS THER, V89, P125, DOI 10.2522/ptj.20080234; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Jonsdottir J, 2007, ARCH PHYS MED REHAB, V88, P1410, DOI 10.1016/j.apmr.2007.08.109; Keysor JJ, 2005, J REHABIL MED, V37, P37, DOI 10.1080/16501970410014830; Kirby RL, 2002, ARCH PHYS MED REHAB, V83, P10, DOI 10.1053/apmr.2002.26823; Klein PJ, 2011, PHYSIOTHER CAN, V63, P115, DOI 10.3138/ptc.2009-51; Lancu Iulian, 2006, Harefuah, V145, P687; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; May LA, 2003, ARCH PHYS MED REHAB, V84, P578, DOI 10.1053/apmr.2003.50021; McCulloch KL, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932010-00002; McDonnell M, 2008, AUST J PHYSIOTHER, V54, P220, DOI 10.1016/S0004-9514(08)70034-5; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Mehrholz J, 2007, ARCH PHYS MED REHAB, V88, P1314, DOI 10.1016/j.apmr.2007.06.764; Mellick D., 2012, CRAIG HANDICAP ASSES; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Newman AC, 2000, BRAIN INJURY, V14, P333; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Noreau L, 2004, DISABIL REHABIL, V26, P346, DOI 10.1080/09638280410001658649; Ontario Neurotrauma Foundation, EV BAS REV MOD SEV A; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Potter K, 2014, PHYS THER, V94, P593, DOI 10.2522/ptj.20130149; Potter K, 2011, J NEUROL PHYS THER, V35, P57, DOI 10.1097/NPT.0b013e318219a51a; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; RADER MA, 1994, BRAIN INJURY, V8, P309, DOI 10.3109/02699059409150982; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Rossier P, 2001, ARCH PHYS MED REHAB, V82, P9, DOI 10.1053/apmr.2001.9396; Roth, 2014, MILD TRAUMATIC BRAIN, P321; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Sullivan JE, 2013, PHYS THER, V93, P1383, DOI 10.2522/ptj.20120492; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Temkin NR, 1998, MED CARE S, V27, pS44; Toyinbo PA, 2016, J HEAD TRAUMA REHAB, V31, P52, DOI 10.1097/HTR.0000000000000089; Tulsky D, 2010, ARCH PHYS MED REHAB, V92, pS1; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tyson SF, 2007, NEUROREHAB NEURAL RE, V21, P341, DOI 10.1177/1545968306296966; VANAGT HME, 1994, SOC SCI MED, V39, P1537, DOI 10.1016/0277-9536(94)90005-1; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Ward Irene, 2014, Arch Phys Med Rehabil, V95, P2229; Wedge Frances M., 2012, Physiotherapy Theory and Practice, V28, P119, DOI 10.3109/09593985.2011.578706; Whitall J, 2006, ARCH PHYS MED REHAB, V87, P656, DOI 10.1016/j.apmr.2006.02.004; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P966, DOI 10.1016/j.apmr.2007.12.031; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; World Health Organization, COMM LANG FUNCT DIS; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	120	22	22	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	OCT	2016	40	4					269	280		10.1097/NPT.0000000000000145			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EC8BG	WOS:000388364300008	27576089	Green Submitted			2022-02-06	
J	Hunt, AW; Paniccia, M; Reed, N; Keightley, M				Williams Hunt, Anne; Paniccia, Melissa; Reed, Nick; Keightley, Michelle			Concussion-Like Symptoms in Child and Youth Athletes at Baseline: What Is "Typical''?	JOURNAL OF ATHLETIC TRAINING			English	Article						brain injuries; pediatrics; symptoms; baseline testing	SPORTS-RELATED CONCUSSION; PHYSICAL-ACTIVITY; NORMATIVE DATA; ICE HOCKEY; ADOLESCENTS; METAANALYSIS; COGNITION; HEADACHE; INJURY; SAMPLE	Context: After a concussion, guidelines emphasize that an athlete should be asymptomatic before starting a return-to-play protocol. However, many concussion symptoms are nonspecific and may be present in individuals without concussion. Limited evidence exists regarding the presence of "typical'' or preinjury (baseline) symptoms in child and youth athletes. Objective: To describe the frequency of symptoms reported at baseline by child and youth athletes and identify how age, sex, history of concussion, and learning factors influence the presence of baseline symptoms. Design: Cross-sectional cohort study. Setting: Baseline testing was conducted at a hospital research laboratory or in a sport or school setting (eg, gym or arena). Patients or Other Participants: A total of 888 child (9 = 12 years old, n = 333) and youth (13 = 17 years old, n = 555) athletes participated (46.4% boys and 53.6% girls, average age = 13.09 6 1.83 years). Main Outcome Measure(s): Demographic and symptom data were collected as part of a baseline protocol. Ageappropriate versions of the Post-Concussion Symptom Inventory (a self-report concussion-symptoms measure with strong psychometric properties for pediatric populations) were administered. Demographic data (age, sex, concussion history, learning factors) were also collected. Results: Common baseline symptoms for children were feeling sleepier than usual (30% boys, 24% girls) and feeling nervous or worried (17% boys, 25% girls). Fatigue was reported by more than half of the youth group (50% boys, 67% girls). Nervousness was reported by 32% of youth girls. Headaches, drowsiness, and difficulty concentrating were each reported by 25% of youth boys and girls. For youths, a higher total symptom score was associated with increasing age and number of previous concussions, although these effects were small (age r(s) = 0.143, number of concussions r(s) = .084). No significant relationships were found in the child group. Conclusions: Children and youths commonly experienced symptoms at baseline, including fatigue and nervousness. Whether clinicians should expect complete symptom resolution after concussion is not clear.	[Williams Hunt, Anne; Reed, Nick; Keightley, Michelle] Holland Bloorview Kids Rehab Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Paniccia, Melissa] Univ Toronto, Toronto, ON, Canada		Hunt, AW (corresponding author), Holland Bloorview Kids Rehab Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	ahunt@hollandbloorview.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TM1-127048]; Holland Chair in Acquired Brain Injury; Canadian Institutes of Health Research NeuroCare Team	This study was supported by a grant from the Canadian Institutes of Health Research #TM1-127048 and the Holland Chair in Acquired Brain Injury. Our sincere thanks to Ms Tali Dick, MScOT OT Reg (Ontario, Canada), for her assistance in the preparation of this manuscript; the Holland Bloorview Concussion Centre's baseline testing team for data collection; and the Canadian Institutes of Health Research NeuroCare Team for grant development and study design.	Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Fricton J, 2009, CURR PAIN HEADACHE R, V13, P413, DOI 10.1007/s11916-009-0081-2; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Hillman CH, 2011, PREV MED, V52, pS21, DOI 10.1016/j.ypmed.2011.01.024; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Khan NA, 2014, PEDIATR EXERC SCI, V26, P138, DOI 10.1123/pes.2013-0125; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckay CD, 2014, ARCH CLIN NEUROPSYCH, V29, P141, DOI 10.1093/arclin/act116; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Tomporowski PD, 2011, PREV MED, V52, pS3, DOI 10.1016/j.ypmed.2011.01.028; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zemek R, GUIDELINES DIAGNOSIS	28	22	22	1	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2016	51	10					749	757		10.4085/1062-6050-51.11.12			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	EI9WR	WOS:000392860600001	27834505	Green Published, Bronze			2022-02-06	
J	Honeybul, S; Ho, KM				Honeybul, Stephen; Ho, Kwok M.			Predicting long-term neurological outcomes after severe traumatic brain injury requiring decompressive craniectomy: A comparison of the CRASH and IMPACT prognostic models	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Decompressive craniectomy; CRASH prediction model; IMPACT prediction model	MIDDLE CEREBRAL-ARTERY; EXTERNAL VALIDATION; HEAD-INJURY; INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; BIFRONTAL CRANIECTOMY; MALIGNANT INFARCTION; HEMICRANIECTOMY; MULTICENTER; MODERATE	Background: Predicting long-term neurological outcomes after severe traumatic brain (TBI) is important, but which prognostic model in the context of decompressive craniectomy has the best performance remains uncertain. Methods: This prospective observational cohort study included all patients who had severe TBI requiring decompressive craniectomy between 2004 and 2014, in the two neurosurgical centres in Perth, Western Australia. Severe disability, vegetative state, or death were defined as unfavourable neurological outcomes. Area under the receiver-operating-characteristic curve (AUROC) and slope and intercept of the calibration curve were used to assess discrimination and calibration of the CRASH (Corticosteroid-Randomisation-After-Significant-Head injury) and IMPACT (International-Mission-For-Prognosis-And-Clinical-Trial) models, respectively. Results: Of the 319 patients included in the study, 119 (37%) had unfavourable neurological outcomes at 18-month after decompressive craniectomy for severe TBI. Both CRASH (AUROC 0.86, 95% confidence interval 0.81-0.90) and IMPACT full-model (AUROC 0.85, 95% CI 0.80-0.89) were similar in discriminating between favourable and unfavourable neurological outcome at 18-month after surgery (p = 0.690 for the difference in AUROC derived from the two models). Although both models tended to over-predict the risks of long-term unfavourable outcome, the IMPACT model had a slightly better calibration than the CRASH model (intercept of the calibration curve = -4.1 vs. -5.7, and log likelihoods -159 vs. -360, respectively), especially when the predicted risks of unfavourable outcome were <80%. Conclusions: Both CRASH and IMPACT prognostic models were good in discriminating between favourable and unfavourable long-term neurological outcome for patients with severe TBI requiring decompressive craniectomy, but the calibration of the IMPACT full-model was better than the CRASH model. Crown Copyright (C) 2016 Published by Elsevier Ltd. All rights reserved.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Perth, WA 6009, Australia; [Honeybul, Stephen] Royal Perth Hosp, Dept Neurosurg, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Dept Intens Care Med, Nedlands, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Perth, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Ahmed AI, 2010, NEUROCRIT CARE, V13, P393, DOI 10.1007/s12028-010-9420-8; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bayram N, 2008, EUR J PEDIATR, V167, P821, DOI 10.1007/s00431-007-0566-0; Bratton S.L., 2007, J NEUROTRAUMA S1, V24; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Dombrowski KE, 2011, BRIT J NEUROSURG, V25, P249, DOI 10.3109/02688697.2010.544784; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Ho KM, 2007, J CLIN EPIDEMIOL, V60, P746, DOI 10.1016/j.jclinepi.2006.10.017; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2016, J NEUROSURG IN PRESS; Honeybul S, 2015, STROKE, V46, P2695, DOI 10.1161/STROKEAHA.115.010078; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Honeybul S, 2012, J MED ETHICS, V38, P657, DOI 10.1136/medethics-2012-100672; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hoppe DJ, 2009, J BONE JOINT SURG AM, V91A, P2, DOI 10.2106/JBJS.H.01571; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Keller E, 2005, ACTA NEUROCHIR SUPPL, V94, P177; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Nguyen Ha Son, 2011, Childs Nerv Syst, V27, P657, DOI 10.1007/s00381-010-1285-9; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Scozzafava J, 2007, NEUROCRIT CARE, V6, P49, DOI 10.1385/NCC:6:1:49; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Weber J, 2004, ZBL NEUROCHIR, V65, P135, DOI 10.1055/s-2004-816239; Wendell LC, 2010, NEUROCRIT CARE, V13, P113, DOI 10.1007/s12028-010-9361-2; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd	49	22	22	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2016	47	9					1886	1892		10.1016/j.injury.2016.04.017			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DU5QG	WOS:000382265800004	27157985				2022-02-06	
J	Paterno, R; Metheny, H; Xiong, GX; Elkind, J; Cohen, AS				Paterno, Rosalia; Metheny, Hannah; Xiong, Guoxiang; Elkind, Jaclynn; Cohen, Akiva S.			Mild Traumatic Brain Injury Decreases Broadband Power in Area CA1	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; in vivo recording; theta rhythm; traumatic brain injury	FLUID PERCUSSION INJURY; GAMMA-OSCILLATIONS; FIRING RATE; HIPPOCAMPUS; INHIBITION; MEMORY; RAT; DYSFUNCTION; POTENTIALS; FREQUENCY	Cognitive impairment caused by traumatic brain injury (TBI) can lead to devastating consequences for both patients and their families. The underlying neurological basis for TBI-induced cognitive dysfunction remains unknown. However, many lines of research have implicated the hippocampus in the pathophysiology of TBI. In particular, past research has found that theta oscillations, long thought to be the electrophysiological basis of learning and memory, are decreased in the hippocampus post-TBI. Here, we recorded in vivo electrophysiological activity in the hippocampi of 16 mice, 8 of which had previously undergone a TBI. Consistent with previous data, we found that theta power in the hippocampus was decreased in TBI animals compared to sham controls; however, this effect was driven by changes in broadband power and not theta oscillations. This result suggests that broadband fluctuations in the hippocampal local field potential can be used as an electrophysiological surrogate of abnormal neurological activity post-TBI.	[Paterno, Rosalia] Hosp Univ Penn, Ctr Sleep & Circadian Neurobiol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Metheny, Hannah; Xiong, Guoxiang; Elkind, Jaclynn; Cohen, Akiva S.] Childrens Hosp Philadelphia, Dept Anesthesiol, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Perelman Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA		Cohen, AS (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Abramson Res Ctr, Dept Anesthesiol & Crit Care Med,Perelman Sch Med, Room 816-h,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	cohena@email.chop.edu			NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL007713] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37 HD059288] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS069629] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER		Addison PS., 2002, ILLUSTRATED WAVELET; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BRAGIN A, 1995, J NEUROSCI, V15, P47; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Ekstrom A, 2007, HIPPOCAMPUS, V17, P606, DOI 10.1002/hipo.20300; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Hinman JR, 2011, J NEUROPHYSIOL, V105, P2675, DOI 10.1152/jn.00837.2010; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Ray S, 2015, TRENDS COGN SCI, V19, P78, DOI 10.1016/j.tics.2014.12.002; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052	29	22	22	5	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1645	1649		10.1089/neu.2015.4107			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300010	26529412	Green Published			2022-02-06	
J	Vink, R				Vink, Robert			Magnesium in the CNS: recent advances and developments	MAGNESIUM RESEARCH			English	Article; Proceedings Paper	14th International Magnesium Symposium - Magnesium and Health	JUN 23-24, 2016	Rome, ITALY			magnesium; treatment; blood brain barrier; alcohol; amyloid; inflammation	TRAUMATIC BRAIN-INJURY; STEM-CELL PROLIFERATION; SPINAL-CORD-INJURY; SUBSTANCE-P; NEUROGENIC INFLAMMATION; POLYETHYLENE-GLYCOL; SULFATE; DEFICIENCY; THERAPY; NEUROPROTECTION	A potential neuroprotective role for magnesium in neurological disease has been appreciated for almost three decades, yet translation to the clinical arena has proven elusive. Accumulating experimental evidence continues to suggest that magnesium plays a critical role in a number of neurological conditions including headache, stress, alcohol/drug intoxication, acute brain injury, seizures, Parkinson's disease and Alzheimer's disease. Simple administration of a magnesium salt in these conditions has not always been therapeutically successful, with a number of studies showing poor penetration of serum magnesium across the blood brain barrier. Several studies have since demonstrated that using a carrier such as polyethylene glycol can address this, simultaneously reducing the dose of magnesium required to achieve the desired central effects while at the same time attenuating deleterious peripheral effects. Alternatively, administering a more permeable magnesium salt, such as magnesium threonate, is seen as the preferred option in more chronic neurological conditions, with positive results having been achieved in experimental models of Alzheimer's disease. Irrespective of the approach, improved central penetration of a magnesium compound that avoids peripheral side effects of high magnesium dosages is clearly a desirable outcome, and should now be investigated in animal models that accurately mimic the complex human condition.	[Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia		Vink, R (corresponding author), Univ South Australia, Off Pro Vice Chancellor Hlth, Adelaide, SA 5000, Australia.	Robert.Vink@unisa.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			Aslanyan S, 2007, STROKE, V38, P1269, DOI 10.1161/01.STR.0000259628.94421.09; Brewer RP, 2001, CLIN NEUROPHARMACOL, V24, P341, DOI 10.1097/00002826-200111000-00005; Busingye DS, 2016, CNS NEUROSCI THER, V22, P854, DOI 10.1111/cns.12591; Chui D, 2011, MAGNESIUM CENTRAL NE, V18, P239; Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Dhandapani SS, 2008, INDIAN J NEUROTRAUM, V5, P27, DOI 10.1016/S0973-0508(08)80025-1; Dibaba DT, 2014, EUR J CLIN NUTR, V68, P510, DOI 10.1038/ejcn.2014.7; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Ema M, 1998, ALCOHOL, V15, P95, DOI 10.1016/S0741-8329(97)00102-X; FLINK EB, 1986, ALCOHOL CLIN EXP RES, V10, P590, DOI 10.1111/j.1530-0277.1986.tb05150.x; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Jia SS, 2016, J CELL PHYSIOL, V231, P1903, DOI 10.1002/jcp.25306; Jia SS, 2016, CELL BIOL INT, V40, P465, DOI 10.1002/cbin.10569; Kodikara S, 2007, Forensic Sci Med Pathol, V3, P283, DOI 10.1007/s12024-007-0041-2; Kramer JH, 1997, J MOL CELL CARDIOL, V29, P97, DOI 10.1006/jmcc.1996.0255; Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI [10.1089/neu.2009.0884, 10.1089/neu.2009-0884]; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Li W, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0065-y; Marinov MB, 1996, J NEUROSURG, V85, P117, DOI 10.3171/jns.1996.85.1.0117; Mazur A, 2007, ARCH BIOCHEM BIOPHYS, V458, P48, DOI 10.1016/j.abb.2006.03.031; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MULLINS PGM, 1995, NEUROREPORT, V6, P1633, DOI 10.1097/00001756-199508000-00011; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Nimmo Alan J, 2009, Recent Pat CNS Drug Discov, V4, P86; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Saver JL, 2015, NEW ENGL J MED, V372, P528, DOI 10.1056/NEJMoa1408827; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Stippler M, 2007, J NEUROTRAUM, V24, P1347, DOI 10.1089/neu.2007.0277; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Van den Heuvel C, 2000, J NEUROTRAUM, V17, P1041, DOI 10.1089/neu.2000.17.1041; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1988, J BIOL CHEM, V263, P757; Vink R, 2012, MAGNESIUM CENTRAL NE; Vink R, 2012, J FORENSIC SCI, V57, P979, DOI 10.1111/j.1556-4029.2012.02108.x; WEGLICKI WB, 1992, AM J PHYSIOL, V263, pR734; Westermaier T, 2003, ACTA NEUROCHIR, V145, P393, DOI 10.1007/s00701-003-0013-6	42	22	25	0	23	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	0953-1424	1952-4021		MAGNESIUM RES	Magnes. Res.	SEP	2016	29	3					95	101		10.1684/mrh.2016.0408			7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	EG7NV	WOS:000391235500003	27829572				2022-02-06	
J	Krewer, C; Schneider, M; Schneider, HJ; Kreitschmann-Andermahr, I; Buchfelder, M; Faust, M; Berg, C; Wallaschofski, H; Renner, C; Uhl, E; Koenig, E; Jordan, M; Stalla, GK; Kopczak, A				Krewer, Carmen; Schneider, Manfred; Schneider, Harald Joern; Kreitschmann-Andermahr, Ilonka; Buchfelder, Michael; Faust, Michael; Berg, Christian; Wallaschofski, Henri; Renner, Caroline; Uhl, Eberhard; Koenig, Eberhard; Jordan, Martina; Stalla, Guenter Karl; Kopczak, Anna			Neuroendocrine Disturbances One to Five or More Years after Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage: Data from the German Database on Hypopituitarism	JOURNAL OF NEUROTRAUMA			English	Article						hypopituitarism; neuroendocrinology; SAH; TBI	ANTERIOR-PITUITARY FUNCTION; GROWTH-HORMONE DEFICIENCY; LONG-TERM; PRACTICAL SCALE; FOLLOW-UP; PREVALENCE; DYSFUNCTION; SURVIVORS; STRESS; ADULTS	Neuroendocrine disturbances are common after traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH), but only a few data exist on long-term anterior pituitary deficiencies after brain injury. We present data from the Structured Data Assessment of Hypopituitarism after TBI and SAH, a multi-center study including 1242 patients. We studied a subgroup of 351 patients, who had sustained a TBI (245) or SAH (106) at least 1 year before endocrine assessment (range 1-55 years) in a separate analysis. The highest prevalence of neuroendocrine disorders was observed 1-2 years post-injury, and it decreased over time only to show another maximum in the long-term phase in patients with brain injury occurring >= 5 years prior to assessment. Gonadotropic and somatotropic insufficiencies were most common. In the subgroup from 1 to 2 years after brain injury (n = 126), gonadotropic insufficiency was the most common hormonal disturbance (19%, 12/63 men) followed by somatotropic insufficiency (11.5%, 7/61), corticotropic insufficiency (9.2%, 11/119), and thyrotropic insufficiency (3.3%, 4/122). In patients observed >= 5 years after brain injury, the prevalence of somatotropic insufficiency increased over time to 24.1%, whereas corticotropic and thyrotrophic insufficiency became less frequent (2.5% and 0%, respectively). The prevalence differed regarding the diagnostic criteria (laboratory values vs. physician's diagnosis vs. stimulation tests). Our data showed that neuroendocrine disturbances are frequent even years after TBI or SAH, in a cohort of patients who are still on medical treatment.	[Krewer, Carmen; Schneider, Manfred; Koenig, Eberhard] Schon Klin Bad Aibling, Bad Aibling, Germany; [Schneider, Harald Joern] Univ Munich, Univ Hosp Innenstadt, Munich, Germany; [Kreitschmann-Andermahr, Ilonka] Univ Duisburg Essen, Dept Neurosurg, Essen, Germany; [Buchfelder, Michael] Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany; [Faust, Michael] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med, Cologne, Germany; [Berg, Christian] Evangel Hosp Mettmann, Dept Internal Med, Mettmann, Germany; [Wallaschofski, Henri] Specialized Med Practice Diabet & Hormonal Disord, Erfurt, Germany; [Renner, Caroline] Univ Leipzig, NRZ Neurol Rehabil Ctr, Leipzig, Germany; [Uhl, Eberhard] Univ Hosp Giessen, Dept Neurosurg, Giessen, Germany; [Jordan, Martina] ClinSupport GmbH, Erlangen, Germany; [Stalla, Guenter Karl; Kopczak, Anna] Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, D-80804 Munich, Germany		Kopczak, A (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	anna_kopczak@psych.mpg.de	Krewer, Carmen/H-2845-2019	Krewer, Carmen/0000-0002-4153-0791; Kopczak, Anna/0000-0002-5037-2342			Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Bondanelli M, 2008, J Endocrinol Invest, V31, P16; Boonen E, 2014, CURR OPIN ENDOCRINOL, V21, P185, DOI 10.1097/MED.0000000000000066; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; HOFFMAN DM, 1994, LANCET, V344, P482, DOI 10.1016/S0140-6736(94)91821-X; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENNETT B, 1975, LANCET, V1, P480; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nemes O, 2015, HORM-INT J ENDOCRINO, V14, P383, DOI 10.14310/horm.2002.1564; Poll EM, 2013, STRESS, V16, P153, DOI 10.3109/10253890.2012.697946; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TEASDALE G, 1974, LANCET, V2, P81; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; van der Eerden AW, 2010, EUR J ENDOCRINOL, V162, P19, DOI 10.1530/EJE-09-0436	48	22	25	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1544	1553		10.1089/neu.2015.4109			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900008	26914840				2022-02-06	
J	Albadawi, H; Oklu, R; Malley, RER; O'Keefe, RM; Uong, TP; Cormier, NR; Watkins, MT				Albadawi, Hassan; Oklu, Rahmi; Malley, Rita Elise Raacke; O'Keefe, Ryan M.; Uong, Thuy P.; Cormier, Nicholas R.; Watkins, Michael T.			Effect of DNase I treatment and neutrophil depletion on acute limb ischemia-reperfusion injury in mice	JOURNAL OF VASCULAR SURGERY			English	Article							DEEP-VEIN THROMBOSIS; EXTRACELLULAR TRAPS; SKELETAL-MUSCLE; DEOXYRIBONUCLEASE-I; ISCHEMIA/REPERFUSION INJURY; ACTIN; HISTONES; INFLAMMATION; CHROMATIN; CELLS	Objective: Extracellular traps (ETs) consisting of DNA-protein complexes formed after tissue injury contribute to the inflammatory and thrombosis cascades, thereby exacerbating injury. Exogenous DNase I has been suggested as a therapeutic strategy to limit injury in the brain and myocardium. These studies were designed to evaluate the effects of exogenous DNase I treatment on skeletal muscle injury after acute hindlimb ischemia-reperfusion (IR) injury in mice and to determine whether neutrophils are a major source of ETs in postischemic muscle tissue. Methods: C57BL6 mice were subjected to 1.5 hours of tourniquet ischemia and 24 hours of reperfusion with and without human recombinant DNase I treatment. A separate set of mice was subjected to neutrophil depletion (ND), followed by the same intervals of IR. Laser Doppler imaging and tissue harvesting were done at 24 hours for assessment of limb perfusion, muscle fiber injury, adenosine triphosphate (ATP) level, markers of inflammation, thrombosis, and formation of ETs. Results: DNase I treatment significantly reduced detection of ETs in postischemic muscle but did not alter skeletal muscle fiber injury, levels of proinflammatory molecules, or ATP level. DNase I treatment did enhance postischemic hindlimb perfusion, decreased infiltrating inflammatory cells, and reduced the expression of thrombin-antithrombin III. ND resulted in a significant yet small reduction in ETs in the postischemic muscle. ND did not alter skeletal muscle fiber injury, hindlimb perfusion, or ATP levels. Conclusions: These data suggest that neither DNase I treatment nor ND was protective against IR injury, even though both decreased detection of ETs in skeletal muscle after IR. Neutrophils are not the only source of ETs after IR. Clinical Relevance: Acute muscle ischemia-reperfusion injury that follows a traumatic event or thrombotic occlusion of a major artery due to vascular disease in the lower extremities can lead to extensive tissue inflammation and necrosis. DNase I was recently proposed as a treatment strategy to degrade neutrophil extracellular traps, which consist of protein-DNA complexes accumulating after tissue injury or thrombosis. Investigators believe that these complexes can enhance the prothrombogenic and proinflammatory milieu in the tissue, thereby exacerbating injury. In this study, we investigate the benefit of DNase I treatment as a tool to degrade these complexes, aiming to ameliorate muscle ischemia-reperfusion injury.	[Albadawi, Hassan; Malley, Rita Elise Raacke; O'Keefe, Ryan M.; Uong, Thuy P.; Cormier, Nicholas R.; Watkins, Michael T.] Massachusetts Gen Hosp, Dept Surg, Div Vasc & Endovasc Surg, Boston, MA 02114 USA; [Oklu, Rahmi] Massachusetts Gen Hosp, Dept Radiol, Div Vasc Imaging & Intervent, Boston, MA 02114 USA; [Albadawi, Hassan; Oklu, Rahmi; Watkins, Michael T.] Harvard Med Sch, Boston, MA USA		Albadawi, H (corresponding author), Massachusetts Gen Hosp, Vasc Res Lab, Dept Surg, Div Vasc & Endovasc Surg, 70 Blossom St Edwards 301, Boston, MA 02114 USA.	halbadawi@partners.org	oklu, rahmi/AAY-4676-2021	Albadawi, Hassan/0000-0001-5913-8571	NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01 AR055843] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR055843] Funding Source: NIH RePORTER		Albadawi H, 2014, J SURG RES, V190, P683, DOI 10.1016/j.jss.2014.01.020; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Allam R, 2013, EUR J IMMUNOL, V43, P3336, DOI 10.1002/eji.201243224; Allen C, 2012, J IMMUNOL, V189, P381, DOI 10.4049/jimmunol.1200409; Bareyre FM, 2001, J NEUROCHEM, V77, P173, DOI 10.1046/j.1471-4159.2001.t01-1-00215.x; Basnakian AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341000; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Borissoff JI, 2013, ARTERIOSCL THROM VAS, V33, P2032, DOI 10.1161/ATVBAHA.113.301627; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Buzder T, 2009, DNA CELL BIOL, V28, P435, DOI 10.1089/dna.2008.0850; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Eulitz D, 2007, APOPTOSIS, V12, P1511, DOI 10.1007/s10495-007-0078-4; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; HAGBERG H, 1985, PFLUG ARCH EUR J PHY, V404, P342, DOI 10.1007/BF00585346; Lam FW, 2013, THROMB RES, V132, P69, DOI 10.1016/j.thromres.2013.04.018; Liu FC, 2014, SHOCK, V41, P491, DOI 10.1097/SHK.0000000000000146; Macanovic M, 1997, CLIN EXP IMMUNOL, V108, P220, DOI 10.1046/j.1365-2249.1997.3571249.x; MALICKABLASZKIEWICZ M, 1990, Z NATURFORSCH C, V45, P1165; MANNHERZ HG, 1980, EUR J BIOCHEM, V104, P367, DOI 10.1111/j.1432-1033.1980.tb04437.x; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; McCormack MC, 2008, SURGERY, V143, P126, DOI 10.1016/j.surg.2007.06.005; Oklu R, 2014, J VASC INTERV RADIOL, V25, P631, DOI 10.1016/j.jvir.2013.12.567; Oklu R, 2013, J VASC SURG, V58, P1627, DOI 10.1016/j.jvs.2013.02.241; Oklu R, 2012, J VASC INTERV RADIOL, V23, P712, DOI 10.1016/j.jvir.2012.01.072; Pisetsky DS, 2013, EUR J IMMUNOL, V43, P3163, DOI 10.1002/eji.201344175; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Savchenko AS, 2014, J THROMB HAEMOST, V12, P860, DOI 10.1111/jth.12571; Savchenko AS, 2014, BLOOD, V123, P141, DOI 10.1182/blood-2013-07-514992; SNABES MC, 1981, J BIOL CHEM, V256, P6291; Suri R, 2005, BIODRUGS, V19, P135, DOI 10.2165/00063030-200519030-00001; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Yao M, 1996, J MOL CELL CARDIOL, V28, P95, DOI 10.1006/jmcc.1996.0009; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	38	22	22	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	AUG	2016	64	2					484	493		10.1016/j.jvs.2015.01.031			10	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	DS4LT	WOS:000380753300033	26704988	Bronze, Green Accepted			2022-02-06	
J	Gooijers, J; Chalavi, S; Beeckmans, K; Michiels, K; Lafosse, C; Sunaert, S; Swinnen, SP				Gooijers, Jolien; Chalavi, Sima; Beeckmans, Kurt; Michiels, Karla; Lafosse, Christophe; Sunaert, Stefan; Swinnen, Stephan P.			Subcortical Volume Loss in the Thalamus, Putamen, and Pallidum, Induced by Traumatic Brain Injury, Is Associated With Motor Performance Deficits	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; gray matter; cortical and subcortical volume; global volume; bimanual motor performance	WHITE-MATTER INTEGRITY; BIMANUAL COORDINATION; LONGITUDINAL CHANGES; BEHAVIOR RELATIONSHIPS; CORTICAL THICKNESS; DIFFUSION-TENSOR; POSTURAL CONTROL; QUANTIFIED MRI; ATROPHY; NETWORK	Background. Traumatic brain injury (TBI) has been associated with altered microstructural organization of white matter (WM) and reduced gray matter (GM). Although disrupted WM organization has been linked to poorer motor performance, the predictive value of GM atrophy for motor impairments in TBI remains unclear. Objective. Here, we investigated TBI-induced GM volumetric abnormalities and uniquely examined their relationship with bimanual motor impairments. Methods. 22 moderate to severe TBI patients (mean age = 25.9 years, standard deviation [SD] = 4.9 years; time since injury = 4.7 years, SD = 3.7 years) and 27 age- and gender-matched controls (mean age = 23.4 years; SD = 3.8 years) completed bimanual tasks and a structural magnetic resonance imaging scan. Cortical and subcortical GM volumes were extracted and compared between groups using FreeSurfer. The association between bimanual performance and GM volumetric measures was investigated using partial correlations. Results. Relative to controls, patients performed significantly poorer on the bimanual tasks and demonstrated significantly smaller total GM as well as overall and regional subcortical GM. However, the groups did not show significant differences in regional cortical GM volume. The majority of the results remained significant even after excluding TBI patients with focal lesions, suggesting that TBI-induced volume reductions were predominantly caused by diffuse injury. Importantly, atrophy of the thalamus, putamen, and pallidum correlated significantly with poorer bimanual performance within the TBI group. Conclusions. Our results reveal that GM atrophy is associated with motor impairments in TBI, providing new insights into the etiology of motor control impairments following brain trauma.	[Gooijers, Jolien; Chalavi, Sima; Swinnen, Stephan P.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Biomed Sci Grp, Tervuursevest 101, B-3001 Leuven, Belgium; [Beeckmans, Kurt] Ctr Epilepsy & Acquired Brain Injury CEPOS, Duffel, Belgium; [Michiels, Karla] Katholieke Univ Leuven Hosp, Dept Phys Med & Rehabil, Campus Pellenberg, Leuven, Belgium; [Lafosse, Christophe] Rehabil Hosp RevArte, Edegem, Belgium; [Sunaert, Stefan] Katholieke Univ Leuven, Grp Biomed Sci, Med Imaging Ctr, Leuven, Belgium; [Swinnen, Stephan P.] Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium		Gooijers, J (corresponding author), Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Biomed Sci Grp, Tervuursevest 101, B-3001 Leuven, Belgium.	Jolien.gooijers@faber.kuleuven.be	Gooijers, Jolien/AAH-9202-2020	Gooijers, Jolien/0000-0002-7569-7223; Chalavi, Sima/0000-0002-2339-8168	Interuniversity Attraction Poles program of the Belgian federal governmentBelgian Federal Science Policy Office [P7/11]; Research Fund KU LeuvenKU Leuven [OT/11/071]; FWO VlaanderenFWO [G.0721.12, G.A114.11]; KU Leuven Research FundKU Leuven [PDMK/14/165]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Interuniversity Attraction Poles program of the Belgian federal government (P7/11). Additional support was provided by the Research Fund KU Leuven (OT/11/071) and FWO Vlaanderen (G.0721.12, G.A114.11). JG is funded by the KU Leuven Research Fund (PDMK/14/165).	Aramaki Y, 2006, CEREB CORTEX, V16, P1338, DOI 10.1093/cercor/bhj075; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; DESROSIERS J, 1995, DISABIL REHABIL, V17, P217, DOI 10.3109/09638289509166638; Desrosiers J, 1993, CAN J OCCUP THER, V60, P9, DOI DOI 10.1177/000841749306000104; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gooijers J, 2014, NEUROSCI BIOBEHAV R, V43, P1, DOI 10.1016/j.neubiorev.2014.03.008; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Nedelec B, 2011, J HAND THER, V24, P31, DOI 10.1016/j.jht.2010.09.001; NEWTON RA, 1995, BRAIN INJURY, V9, P445, DOI 10.3109/02699059509008204; Ng THB, 2013, BEHAV BRAIN RES, V247, P182, DOI 10.1016/j.bbr.2013.03.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Penta M, 1998, ARCH PHYS MED REHAB, V79, P1038, DOI 10.1016/S0003-9993(98)90167-8; Rating the severity of tissue damage. I, 1971, JAMA-J AM MED ASSOC, V215, P277; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Serbruyns L, 2015, CORTEX, V65, P128, DOI 10.1016/j.cortex.2015.01.003; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Wannier T, 2002, NEUROREPORT, V13, P143, DOI 10.1097/00001756-200201210-00033; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wenderoth N, 2006, NEUROIMAGE, V31, P264, DOI 10.1016/j.neuroimage.2005.11.033; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	51	22	22	1	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	AUG	2016	30	7					603	614		10.1177/1545968315613448			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DS7BN	WOS:000380937600001	26498433	Bronze			2022-02-06	
J	Kipp, M; Hochstrasser, T; Schmitz, C; Beyer, C				Kipp, Markus; Hochstrasser, Tanja; Schmitz, Christoph; Beyer, Cordian			Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article; Proceedings Paper	8th International Meeting on Steroids and Nervous System	2015	Torino, ITALY			Multiple sclerosis; Astroglia; Microglia; Inflammation; Invasion; Immune cells; Estrogen; Progesterone; Neuroinflammation; Neuroprotection	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; CUPRIZONE-INDUCED DEMYELINATION; TRAUMATIC BRAIN-INJURY; ESTROGEN-RECEPTOR-BETA; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ANTIGEN-PRESENTING CELLS; MYELIN BASIC-PROTEIN; TOLL-LIKE RECEPTORS; IN-VITRO	Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease that shows a female-to male gender prevalence and alleviation of disease activity during late stage pregnancy. In MS-related animal models, sex steroids ameliorate symptoms and protect from demyelination and neuronal damage. Underlying mechanisms of these protective avenues are continuously discovered, in part by using novel transgenic animal models. In this review article, we highlight the regulation of glia cell function by female sex steroids. We specifically focus on the relevance of glia cells for immune cell recruitment into the central nervous system and show how estrogen and progesterone can modulate these cell-cell communication pathways. Since MS is considered to have a strong neurodegenerative component, principal neuroprotective mechanisms, exerted by sex-steroids will be discussed as well. Activation of steroid receptors might not just act as immunosuppressant but at the same time harmonize brain-intrinsic networks to dampen neurodegeneration and, thus, disease progression in MS. (C) 2015 Elsevier Ltd. All rights reserved.	[Kipp, Markus; Hochstrasser, Tanja; Schmitz, Christoph] Univ Munich, Dept Neuroanat, Munich, Germany; [Beyer, Cordian] Rhein Westfal TH Aachen, Fac Med, Inst Neuroanat, D-52074 Aachen, Germany		Kipp, M (corresponding author), Univ Munich, Dept Neuroanat, Munich, Germany.	markus.kipp@med.uni-muenchen.de					Acaz-Fonseca E., 2015, GLIA; Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Ambrosini E, 2004, NEUROCHEM RES, V29, P1017, DOI 10.1023/B:NERE.0000021246.96864.89; Amor S, 2014, IMMUNOLOGY, V141, P287, DOI 10.1111/imm.12134; Annunziato L, 2013, J CEREBR BLOOD F MET, V33, P969, DOI 10.1038/jcbfm.2013.44; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bajramovic JJ, 2011, CNS NEUROL DISORD-DR, V10, P4; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Bali N, 2013, ENDOCRINOLOGY, V154, P2468, DOI 10.1210/en.2012-2109; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Becher B, 2000, GLIA, V29, P293; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bechmann I, 1999, GLIA, V27, P62, DOI 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Bedoya SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/986789; Belarbi K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00145; Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P413, DOI 10.1007/BF01102943; Blasko E, 2009, J NEUROIMMUNOL, V214, P67, DOI 10.1016/j.jneuroim.2009.06.023; Bo L, 2006, ACTA NEUROL SCAND, V113, P48, DOI 10.1111/j.1600-0404.2006.00615.x; Bondesson M, 2015, BBA-GENE REGUL MECH, V1849, P142, DOI 10.1016/j.bbagrm.2014.06.005; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Bsibsi M, 2014, ACTA NEUROPATHOL, V128, P215, DOI 10.1007/s00401-014-1317-8; Buschmann JP, 2012, J MOL NEUROSCI, V48, P66, DOI 10.1007/s12031-012-9773-x; CARLTON WW, 1966, TOXICOL APPL PHARM, V8, P512, DOI 10.1016/0041-008X(66)90062-7; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Cekanaviciute E, 2014, GLIA, V62, P1227, DOI 10.1002/glia.22675; Chen JJ, 2014, REV NEUROSCIENCE, V25, P269, DOI 10.1515/revneuro-2013-0046; Chen Z., 2015, J NEUROCHEM; Chesik D, 2010, NEUROSCI LETT, V468, P178, DOI 10.1016/j.neulet.2009.10.051; Clarner T, 2015, J IMMUNOL, V194, P3400, DOI 10.4049/jimmunol.1401459; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crawford DK, 2010, BRAIN, V133, P2999, DOI 10.1093/brain/awq237; Cross AK, 1999, GLIA, V28, P183, DOI 10.1002/(SICI)1098-1136(199912)28:3<183::AID-GLIA2>3.0.CO;2-3; D'Agostino PM, 2012, ACTA NEUROPATHOL, V124, P599, DOI 10.1007/s00401-012-1018-0; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Groot CJA, 2001, BRAIN, V124, P1635, DOI 10.1093/brain/124.8.1635; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Dimayuga FO, 2005, J NEUROIMMUNOL, V161, P123, DOI 10.1016/j.jneuroim.2004.12.016; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; El-Etr M, 2011, MATURITAS, V68, P47, DOI 10.1016/j.maturitas.2010.09.014; Ellwardt E, 2014, EXP NEUROL, V262, P8, DOI 10.1016/j.expneurol.2014.02.006; Eng LF, 1996, NEUROCHEM RES, V21, P511, DOI 10.1007/BF02527717; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; Ferrini F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/429815; Finkelsztejn A, 2011, BJOG-INT J OBSTET GY, V118, P790, DOI 10.1111/j.1471-0528.2011.02931.x; Frankenberger M, 2005, INT IMMUNOPHARMACOL, V5, P289, DOI 10.1016/j.intimp.2004.09.033; Freitas-Andrade M., 2015, NEUROSCIENCE; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Gago N, 2001, GLIA, V36, P295, DOI 10.1002/glia.1117; Galbiati M, 2003, ANN NY ACAD SCI, V1007, P162, DOI 10.1196/annals.1286.016; Galea E, 2003, CELL MOL NEUROBIOL, V23, P625, DOI 10.1023/A:1025084415833; Garcia JA, 2013, J IMMUNOL, V191, P1063, DOI 10.4049/jimmunol.1300040; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Giatti S, 2010, NEUROCHEM INT, V56, P118, DOI 10.1016/j.neuint.2009.09.009; Giraud SN, 2010, P NATL ACAD SCI USA, V107, P8416, DOI 10.1073/pnas.0910627107; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gold SM, 2009, PROG BRAIN RES, V175, P239, DOI 10.1016/S0079-6123(09)17516-7; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Gravel M, 2009, J NEUROSCI RES, V87, P1069, DOI 10.1002/jnr.21939; Habib P, 2015, J STEROID BIOCHEM, V146, P3, DOI 10.1016/j.jsbmb.2014.02.018; Habib P, 2014, NEUROENDOCRINOLOGY, V99, P156, DOI 10.1159/000362279; Habib P, 2014, J MOL NEUROSCI, V52, P277, DOI 10.1007/s12031-013-0137-y; Habib P, 2013, J STEROID BIOCHEM, V138, P195, DOI 10.1016/j.jsbmb.2013.06.003; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Heiman A, 2014, BRAIN BEHAV IMMUN, V42, P232, DOI 10.1016/j.bbi.2014.06.203; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herder V, 2011, NEUROPATH APPL NEURO, V37, P676, DOI 10.1111/j.1365-2990.2011.01168.x; Hewett JA, 2009, J NEUROCHEM, V110, P1717, DOI 10.1111/j.1471-4159.2009.06288.x; Hirahara Y, 2013, GLIA, V61, P420, DOI 10.1002/glia.22445; Horvat S, 2006, J NEUROCHEM, V99, P937, DOI 10.1111/j.1471-4159.2006.04134.x; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Janssen K, 2015, MOL NEUROBIOL; Jarvela JT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-29; Jebelli J., 2015, ANN N Y ACAD SCI; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karve LP., 2015, BR J PHARM; Kerschensteiner M, 2003, ANN NEUROL, V53, P292, DOI 10.1002/ana.10446; Khalaj AJ, 2013, P NATL ACAD SCI USA, V110, P19125, DOI [10.1073/pnas.311763110, 10.1073/pnas.1311763110]; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kim H, 2008, BIOCHEM BIOPH RES CO, V372, P243, DOI 10.1016/j.bbrc.2008.05.025; Kim RY, 2014, J NEUROIMMUNOL, V274, P53, DOI 10.1016/j.jneuroim.2014.06.009; Kipp M, 2012, J NEUROENDOCRINOL, V24, P62, DOI 10.1111/j.1365-2826.2011.02163.x; Kipp M, 2008, J MOL NEUROSCI, V35, P235, DOI 10.1007/s12031-008-9057-7; Kipp M, 2006, FRONT NEUROENDOCRIN, V27, P376, DOI 10.1016/j.yfrne.2006.07.001; Kipp M, 2012, MULT SCLER RELAT DIS, V1, P15, DOI 10.1016/j.msard.2011.09.002; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; Kipp M, 2012, FRONT NEUROENDOCRIN, V33, P1, DOI 10.1016/j.yfrne.2012.01.001; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kohno H, 2014, J IMMUNOL, V192, P3816, DOI 10.4049/jimmunol.1301738; Krauspe BM, 2015, J MOL NEUROSCI, V55, P733, DOI 10.1007/s12031-014-0412-6; Kroenke MA, 2007, J NEUROSCI RES, V85, P1685, DOI 10.1002/jnr.21291; Kumar S, 2013, NEUROBIOL DIS, V56, P131, DOI 10.1016/j.nbd.2013.04.005; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Lacroix-Fralish ML, 2006, NEURON GLIA BIOL, V2, P227, DOI 10.1017/S1740925X07000385; Lang BT, 2014, EXP NEUROL, V258, P17, DOI 10.1016/j.expneurol.2014.04.031; Lassmann H, 2014, EXP NEUROL, V262, P2, DOI 10.1016/j.expneurol.2013.12.003; Lecca D, 2012, PURINERG SIGNAL, V8, P539, DOI 10.1007/s11302-012-9310-y; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Leussink VI, 2001, ARCH NEUROL-CHICAGO, V58, P91, DOI 10.1001/archneur.58.1.91; Levin ER, 2015, ANNU REV MED, V66, P271, DOI 10.1146/annurev-med-050913-021703; Levine JB, 1999, GLIA, V28, P215; LIBERSKI PP, 1995, FOLIA NEUROPATHOL, V33, P85; Lim DG, 2007, TRANSPL IMMUNOL, V18, P94, DOI 10.1016/j.trim.2007.05.005; Liu W, 2011, LIFE SCI, V89, P141, DOI 10.1016/j.lfs.2011.05.011; Liu X, 2005, J NEUROSCI RES, V81, P653, DOI 10.1002/jnr.20583; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2004, ANN NEUROL, V56, P308, DOI 10.1002/ana.20182; Luessi F, 2012, EXPERT REV NEUROTHER, V12, P1061, DOI [10.1586/ERN.12.59, 10.1586/ern.12.59]; Maggi P, 2014, ANN NEUROL, V76, P594, DOI 10.1002/ana.24242; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Matyszak MK, 1999, EUR J IMMUNOL, V29, P3063, DOI 10.1002/(SICI)1521-4141(199910)29:10<3063::AID-IMMU3063>3.0.CO;2-G; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Mena MA, 2008, NEUROSCIENTIST, V14, P544, DOI 10.1177/1073858408322839; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Micevych P, 2008, MOL CELL ENDOCRINOL, V290, P44, DOI 10.1016/j.mce.2008.04.016; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Mifsud G, 2014, CNS NEUROSCI THER, V20, P603, DOI 10.1111/cns.12263; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s88, 10.1002/0471142735.im1501s77]; Miyamoto N, 2014, CELL MOL LIFE SCI, V71, P1055, DOI 10.1007/s00018-013-1488-9; Moehle MS, 2014, NEUROSCIENCE; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; Nalbandian G, 2005, IMMUNOL RES, V31, P91, DOI 10.1385/IR:31:2:091; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Niranjan R, 2013, MOL NEUROBIOL, V48, P412, DOI 10.1007/s12035-013-8428-4; Nurulain SM, 2014, CNS NEUROL DISORD-DR, V13, P1397, DOI 10.2174/1871527313666141023142539; Olah M, 2011, CNS NEUROL DISORD-DR, V10, P108, DOI 10.2174/187152711794488575; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Orihuela R, 2015, BR J PHARM, DOI 10.1111/bph.13139; Park J, 2008, J NEUROSCI, V28, P12815, DOI 10.1523/JNEUROSCI.2665-08.2008; Parpura V., 2015, NEUROBIOL DIS; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; Pawlak J, 2005, GLIA, V50, P270, DOI 10.1002/glia.20162; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; PENDER MP, 1991, J NEUROL SCI, V104, P81, DOI 10.1016/0022-510X(91)90219-W; PETTINELLI CB, 1981, J IMMUNOL, V127, P1420; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; Platania P, 2005, NEUROBIOL DIS, V20, P461, DOI 10.1016/j.nbd.2005.03.025; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Rao KVR, 2005, NEUROCHEM RES, V30, P1311, DOI 10.1007/s11064-005-8803-2; Rasband MN, 2005, GLIA, V50, P86, DOI 10.1002/glia.20165; Rasmussen S, 2007, BRAIN, V130, P2816, DOI 10.1093/brain/awm219; Reed JL, 2004, NEUROSCI LETT, V367, P60, DOI 10.1016/j.neulet.2004.05.077; Rice GPA, 2000, NEUROLOGY, V54, P1145, DOI 10.1212/WNL.54.5.1145; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rossi D., 2015, PROG NEUROBIOL; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Salmina AB, 2009, J ALZHEIMERS DIS, V16, P485, DOI 10.3233/JAD-2009-0988; Sarvari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088540; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; SHIVERS RR, 1988, J SUBMICR CYTOL PATH, V20, P1; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Skuljec J, 2011, CELL IMMUNOL, V270, P164, DOI 10.1016/j.cellimm.2011.05.001; Slowik A., 2015, J STEROID BIOCH MOL; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sohrabji F, 2015, FRONT NEUROENDOCRIN, V36, P1, DOI 10.1016/j.yfrne.2014.05.003; Soos JM, 1999, INT IMMUNOL, V11, P1169, DOI 10.1093/intimm/11.7.1169; Sosa RA, 2013, J IMMUNOL, V191, P5848, DOI 10.4049/jimmunol.1300771; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Spence RD, 2012, FRONT NEUROENDOCRIN, V33, P105, DOI 10.1016/j.yfrne.2011.12.001; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Sun PL, 2014, J MOL NEUROSCI, V52, P225, DOI 10.1007/s12031-013-0126-1; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Tan IJ, 2015, AUTOIMMUN REV, V14, P536, DOI 10.1016/j.autrev.2015.02.004; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Theien BE, 2003, BLOOD, V102, P4464, DOI 10.1182/blood-2003-03-0974; Trager U, 2013, J MOL MED, V91, P673, DOI 10.1007/s00109-013-1026-0; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570, DOI 10.2174/187152712801661284; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Velasco I, 2011, CURR TOP MED CHEM, V11, P1684, DOI 10.2174/156802611796117586; Vella J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00108; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu WF, 2013, P NATL ACAD SCI USA, V110, P3543, DOI 10.1073/pnas.1300313110; Xiao L, 2012, GLIA, V60, P1037, DOI 10.1002/glia.22333; Ye JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054590; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yu ZW, 2015, J NEUROSCI, V35, P6350, DOI 10.1523/JNEUROSCI.2468-14.2015; Zendedel A, 2015, J NEUROIMMUNOL, V278, P200, DOI 10.1016/j.jneuroim.2014.11.007; Zendedel A, 2013, J MOL NEUROSCI, V51, P567, DOI 10.1007/s12031-013-0026-4; Zhao YX, 2010, NEUROTHERAPEUTICS, V7, P439, DOI 10.1016/j.nurt.2010.07.004; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	223	22	23	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	AUG	2016	67						125	136		10.1016/j.neubiorev.2015.11.016			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Behavioral Sciences; Neurosciences & Neurology	DS2QD	WOS:000380627700011	26698019				2022-02-06	
J	Majd, S; Power, JHT; Koblar, SA; Grantham, HJM				Majd, Shohreh; Power, John H. T.; Koblar, Simon A.; Grantham, Hugh J. M.			Early glycogen synthase kinase-3 and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						adenosine monophosphate kinase protein; glycogen synthase kinase-3; microtubule-associated protein; neuronal energy stress; phosphorylation; protein phosphatase 2A	ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; TRANSGENIC MICE; NEUROFIBRILLARY DEGENERATION; HYPERPHOSPHORYLATED TAU; PHOSPHORYLATION; RAT; STROKE; PP2A; NEURODEGENERATION	Abnormal tau phosphorylation (p-tau) has been shown after hypoxic damage to the brain associated with traumatic brain injury and stroke. As the level of p-tau is controlled by Glycogen Synthase Kinase (GSK)-3, Protein Phosphatase 2A (PP2A) and Adenosine Monophosphate Kinase (AMPK), different activity levels of these enzymes could be involved in tau phosphorylation following ischaemia. This study assessed the effects of global brain ischaemia/reperfusion on the immediate status of p-tau in a rat model of cardiac arrest (CA) followed by cardiopulmonary resuscitation (CPR). We reported an early dephosphorylation of tau at its AMPK sensitive residues, Ser(396) and Ser(262)after 2min of ischaemia, which did not recover during the first two hours of reperfusion, while the tau phosphorylation at GSK-3 sensitive but AMPK insensitive residues, Ser(202)/Thr(205) (AT8), as well as the total amount of tau remained unchanged. Our data showed no alteration in the activities of GSK-3 and PP2A during similar episodes of ischaemia of up to 8min and reperfusion of up to 2h, and 4weeks recovery. Dephosphorylation of AMPK followed the same pattern as tau dephosphorylation during ischaemia/reperfusion. Catalase, another AMPK downstream substrate also showed a similar pattern of decline to p-AMPK, in ischaemic/reperfusion groups. This suggests the involvement of AMPK in changing the p-tau levels, indicating that tau dephosphorylation following ischaemia is not dependent on GSK-3 or PP2A activity, but is associated with AMPK dephosphorylation. We propose that a reduction in AMPK activity is a possible early mechanism responsible for tau dephosphorylation.	[Majd, Shohreh; Grantham, Hugh J. M.] Flinders Univ South Australia, Sch Med, Ctr Neurosci, Neuronal Injury & Repair Lab, Adelaide, SA 5042, Australia; [Power, John H. T.] Flinders Univ South Australia, Sch Med, Dept Human Physiol, Adelaide, SA, Australia; [Koblar, Simon A.] Univ Adelaide, Sch Med, Queen Elizabeth Hosp TQEH Campus, Adelaide, SA, Australia		Majd, S (corresponding author), Flinders Univ South Australia, Sch Med, Ctr Neurosci, Neuronal Injury & Repair Lab, Adelaide, SA 5042, Australia.	shohreh.majd@flinders.edu.au		Koblar, Simon/0000-0002-8667-203X; Grantham, Hugh/0000-0003-1700-190X	Australian Resuscitation Council; Flinders University Establishment grant	This study was supported by the Australian Resuscitation Council and Flinders University Establishment grant. The authors thank the Biomedical Engineering Department of Flinders University specially Mark McEwen and Noel Kitto for their technical support, the Proteomics Facility of Flinders University specially Dr. Tim Chataway, the Animal Facility of Flinders University, Professor Neil Sims from Medical Biochemistry Department and from the Alzheimer's and Parkinson diseases' lab especially Fariba Chegini for their enthusiastic discussions and support. All authors involved in the study design and development of the model. SM and HG were responsible for completing the experiments. The initial draft was written by SM and reviewed by HG and JP.	Awad H, 2014, PEDIATR PULM, V49, P885, DOI 10.1002/ppul.22919; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen MH, 2007, AM J EMERG MED, V25, P623, DOI 10.1016/j.ajem.2006.11.033; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; DEWAR D, 1995, BRAIN RES, V684, P70, DOI 10.1016/0006-8993(95)00417-O; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P583, DOI 10.1007/s00401-002-002-0587-8; Castro-Alvarez JF, 2011, BEHAV NEUROSCI, V125, P465, DOI 10.1037/a0023167; GEDDES JW, 1994, J CEREBR BLOOD F MET, V14, P554, DOI 10.1038/jcbfm.1994.69; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Guerra-Araiza C, 2007, DEV NEUROBIOL, V67, P510, DOI 10.1002/dneu.20383; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger Diane P, 1800, Int J Alzheimers Dis, V2011, P352805, DOI 10.4061/2011/352805; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Iijima-Ando K, 2010, HUM MOL GENET, V19, P1930, DOI 10.1093/hmg/ddq068; Iqbal K, 1998, J NEURAL TRANSM-SUPP, P169; Kins S, 2001, J BIOL CHEM, V276, P38193; Koh Phil-Ok, 2011, Lab Anim Res, V27, P73, DOI 10.5625/lar.2011.27.1.73; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Lovell MA, 2004, J ALZHEIMERS DIS, V6, P659; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; Mailliot C, 2000, J CEREBR BLOOD F MET, V20, P543, DOI 10.1097/00004647-200003000-00013; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; Mateen FJ, 2011, NEUROLOGY, V77, P1438, DOI 10.1212/WNL.0b013e318232ab33; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Noble W, 2011, EXPERT OPIN DRUG DIS, V6, P797, DOI 10.1517/17460441.2011.586690; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pei JJ, 2006, FEBS LETT, V580, P107, DOI 10.1016/j.febslet.2005.11.059; Pohjasvaara T, 1998, STROKE, V29, P75, DOI 10.1161/01.STR.29.1.75; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; Rudrabhatla P, 2011, CURR ALZHEIMER RES, V8, P623, DOI 10.2174/156720511796717168; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Shackelford DA, 1998, MOL CHEM NEUROPATHOL, V34, P103, DOI 10.1007/BF02815073; Song B, 2013, NEURAL REGEN RES, V8, P3173, DOI 10.3969/j.issn.1673-5374.2013.34.001; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; TATEMICHI TK, 1992, NEUROLOGY, V42, P1185, DOI 10.1212/WNL.42.6.1185; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; van der Harg JM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.354; Virdee K, 2007, FEBS LETT, V581, P2657, DOI 10.1016/j.febslet.2007.05.009; Yoshida H, 2012, J NEUROCHEM, V120, P165, DOI 10.1111/j.1471-4159.2011.07523.x	56	22	24	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2016	44	3					1987	1997		10.1111/ejn.13277			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS9HG	WOS:000381093000008	27177932	Green Published, hybrid			2022-02-06	
J	Sprigg, N; Robson, K; Bath, P; Dineen, R; Roberts, I; Robinson, T; Roffe, C; Werring, D; Salman, RA; Pocock, S; Duley, L; England, T; Whynes, D; Ciccone, A; Laska, AC; Christensen, H; Ozturk, S; Collins, R; Bereczki, D; Egea-Guerrero, JJ; Law, ZK; Czlonkowska, A; Seiffge, D; Beredzie, M				Sprigg, Nikola; Robson, Katie; Bath, Philip; Dineen, Robert; Roberts, Ian; Robinson, Tom; Roffe, Christine; Werring, David; Salman, Rustam Al-Shahi; Pocock, Stuart; Duley, Lelia; England, Tim; Whynes, David; Ciccone, Alfonso; Laska, Ann Charlotte; Christensen, Hanne; Ozturk, Serefnur; Collins, Ronan; Bereczki, Daniel; Egea-Guerrero, Juan Jose; Law, Zhe Kang; Czlonkowska, Anna; Seiffge, David; Beredzie, Maia		Tich-2 Investigators	Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial	INTERNATIONAL JOURNAL OF STROKE			English	Article						Hyperacute intracerebral hemorrhage; tranexamic acid; randomized trial; placebo controlled	TRAUMATIC BRAIN-INJURY; SPOT SIGN SCORE; HEMATOMA EXPANSION; IDENTIFIES PATIENTS; STROKE TRIALS; HIGHEST RISK; CRASH-2	Rationale Outcome after intracerebral hemorrhage remains poor. Tranexamic acid is easy to administer, readily available, inexpensive, and effective in other hemorrhagic conditions. Aim This randomized trial aims to test the hypothesis that intravenous tranexamic acid given within 8h of spontaneous intracerebral hemorrhage reduces death or dependency. Design Phase III prospective double-blind randomized placebo-controlled trial. Participants within 8h of spontaneous intracerebral hemorrhage are randomized to receive either intravenous tranexamic acid 1g 10min bolus followed by 1g 8h infusion, or placebo. Sample size estimates A trial of 2000 participants (300 from start-up phase and 1700 from main phase) will have 90% power to detect an ordinal shift of the modified Rankin Scale with odds ratio 0.79. Study outcomes The primary outcome is death or dependency measured by ordinal shift analysis of the 7 level mRS at day 90. Secondary outcomes are neurological impairment at day 7 and disability, quality of life, cognition, and mood at day 90. Safety outcomes are death, serious adverse events, thromboembolic events, and seizures. Cost outcomes are length of stay in hospital, readmission, and institutionalization. Discussion This pragmatic trial is assessing efficacy of tranexamic acid after spontaneous intracerebral hemorrhage. Recruitment started in 2013; as of 15th January 2016 1355 participants have been enrolled, from 95 centers in seven countries. Recruitment is due to end in 2017. TICH-2 Trial is registered as ISRCTN93732214.	[Sprigg, Nikola; Robson, Katie; Bath, Philip; Dineen, Robert; Roberts, Ian; Robinson, Tom; Roffe, Christine; Werring, David; Salman, Rustam Al-Shahi; Pocock, Stuart; Duley, Lelia; England, Tim; Whynes, David; Ciccone, Alfonso; Laska, Ann Charlotte; Christensen, Hanne; Ozturk, Serefnur; Collins, Ronan; Bereczki, Daniel; Egea-Guerrero, Juan Jose; Law, Zhe Kang; Czlonkowska, Anna; Seiffge, David; Beredzie, Maia; Tich-2 Investigators] Stroke, Div Clin Neurosci, Clin Sci Bldg,Hucknall Rd, Nottingham NG5 1PB, England		Sprigg, N (corresponding author), Stroke, Div Clin Neurosci, Clin Sci Bldg,Hucknall Rd, Nottingham NG5 1PB, England.	Nikola.sprigg@nottingham.ac.uk	Ciccone, Alfonso/AAB-6942-2022; Werring, David/Q-8435-2019; OZTURK, SEREFNUR/AAG-4973-2019; Bereczki, Daniel/AAL-9886-2020; Roffe, Christine/AAT-5611-2020; Egea-Guerrero, Juan Jose JJ/P-5080-2014; England, Timothy J/AAD-3100-2021; Dineen, Robert/S-7192-2019; Law, Zhe Kang/ABC-6224-2020; Seiffge, David/W-8289-2019	Werring, David/0000-0003-2074-1861; Roffe, Christine/0000-0002-5259-6649; Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; England, Timothy J/0000-0001-5330-8584; Law, Zhe Kang/0000-0002-7900-9037; Seiffge, David/0000-0003-3890-3849; Dineen, Robert/0000-0002-9523-2546; Czlonkowska, Anna/0000-0002-1956-1866; Robinson, Thompson/0000-0003-2144-2468; collins, Ronan/0000-0003-0404-8266; Ciccone, Alfonso/0000-0002-4590-3575; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Christensen, Hanne/0000-0002-7472-3194	National Institute of Health Research Health Technology Assessment (NIHR HTA), UK [11_129_109]; Swiss Heart foundation in Switzerland; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002605] Funding Source: UKRI; British Heart FoundationBritish Heart Foundation [SP/12/2/29422] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002605] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [11/129/109] Funding Source: researchfish	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors received financial support for the research from National Institute of Health Research Health Technology Assessment (NIHR HTA project code 11_129_109), UK and Swiss Heart foundation in Switzerland.	Almandoz JED, 2010, STROKE, V41, P54, DOI 10.1161/STROKEAHA.109.565382; Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; [Anonymous], 2011, LANCET, V377, DOI DOI 10.1016/S0140-6736(11)60278-X; Bath P, 2009, STROKE, V40, P888, DOI 10.1161/STROKEAHA.108.519207; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Ederies A, 2009, STROKE, V40, P1672, DOI 10.1161/STROKEAHA.108.541201; Fonville AF, 2013, STROKE, V44, P2729, DOI 10.1161/STROKEAHA.113.001493; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; HORROW JC, 1995, ANESTHESIOLOGY, V82, P383, DOI 10.1097/00000542-199502000-00009; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; MAHONEY F I, 1965, Md State Med J, V14, P61; Meretoja A, 2014, INT J STROKE, V9, P519, DOI 10.1111/ijs.12132; OJACASTRO MF, 2008, INT J STROKE S1, V3, P197; Roos Y, 2003, STROKE, V34, P2308, DOI 10.1161/01.STR.0000089030.04120.0E; Roos YBWEM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3958; Saghaei Mahmoud, 2011, J Med Signals Sens, V1, P55; Salman RA, 2014, STROKE, V45, P3149, DOI 10.1161/STROKEAHA.114.005786; Salman RAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005951.pub3; Sorimachi T, 2005, NEUROSURGERY, V57, P837, DOI 10.1227/01.NEU.0000180815.38967.57; Sprigg N, 2014, J STROKE CEREBROVASC, V23, P1312, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.007; Steiner T, 2010, STROKE, V41, P402, DOI 10.1161/STROKEAHA.109.552919; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; 2010, LANCET, V376, P23, DOI DOI 10.1016/S0140-6736(10)60835-5	30	22	22	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	AUG	2016	11	6					717	723		10.1177/1747493016641960			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	DS7VJ	WOS:000380990700014	27048694	Green Submitted, Green Accepted, Green Published			2022-02-06	
J	Mutch, WAC; Ellis, MJ; Ryner, LN; Morissette, MP; Pries, PJ; Dufault, B; Essig, M; Mikulis, DJ; Duffin, J; Fisher, JA				Mutch, W. Alan C.; Ellis, Michael J.; Ryner, Lawrence N.; Morissette, Marc P.; Pries, Philip J.; Dufault, Brenden; Essig, Marco; Mikulis, David J.; Duffin, James; Fisher, Joseph A.			Longitudinal Brain Magnetic Resonance Imaging CO2 Stress Testing in Individual Adolescent Sports-Related Concussion Patients: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						sports-related concussion; adolescent; post-concussion syndrome; magnetic resonance imaging; blood oxygen level-dependent imaging; cerebrovascular reactivity; longitudinal	CEREBROVASCULAR REACTIVITY IMPAIRMENT; POSTCONCUSSION SYNDROME; CHILDREN; SYMPTOMS; INJURY; RECOVERY	Background: Advanced neuroimaging studies in concussion have been limited to detecting group differences between concussion patients and healthy controls. In this small pilot study, we used brain magnetic resonance imaging (MRI) CO2 stress testing to longitudinally assess cerebrovascular responsiveness (CVR) in individual sports-related concussion (SRC) patients. Methods: Six SRC patients (three males and three females; mean age = 15.7, range = 15-17 years) underwent longitudinal brain MRI CO2 stress testing using blood oxygen level-dependent (BOLD) MRI and model-based prospective end-tidal CO2 targeting under isoxic conditions. First-level and second-level comparisons were undertaken using statistical parametric mapping (SPM) to score the scans and compare them to an atlas of 24 healthy control subjects. Results: All tests were well tolerated and without any serious adverse events. Anatomical MRI was normal in all study participants. The CO2 stimulus was consistent between the SRC patients and control subjects and within SRC patients across the longitudinal study. Individual SRC patients demonstrated both quantitative and qualitative patient-specific alterations in CVR (p < 0.005) that correlated strongly with clinical findings, and that persisted beyond clinical recovery. Conclusion: Standardized brain MRI CO2 stress testing is capable of providing a longitudinal assessment of CVR in individual SRC patients. Consequently, larger prospective studies are needed to examine the utility of brain MRI CO2 stress testing as a clinical tool to help guide the evaluation, classification, and longitudinal management of SRC patients.	[Mutch, W. Alan C.] Univ Manitoba, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada; [Mutch, W. Alan C.; Ellis, Michael J.; Ryner, Lawrence N.; Pries, Philip J.; Dufault, Brenden; Essig, Marco] Univ Manitoba, Winnipeg, MB, Canada; [Mutch, W. Alan C.; Ryner, Lawrence N.; Essig, Marco] Hlth Sci Ctr, Winnipeg, MB, Canada; [Mutch, W. Alan C.; Ellis, Michael J.; Ryner, Lawrence N.; Essig, Marco] Canada North Concuss Network, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Neurosurg Sect, Winnipeg, MB, Canada; [Ellis, Michael J.; Morissette, Marc P.; Essig, Marco] Pan Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.; Morissette, Marc P.] Pan Clin Fdn, Winnipeg, MB, Canada; [Ryner, Lawrence N.; Essig, Marco] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada; [Pries, Philip J.] Univ Manitoba, Coll Med, Winnipeg, MB, Canada; [Dufault, Brenden] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Mikulis, David J.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Mikulis, David J.; Duffin, James; Fisher, Joseph A.] Univ Hlth Network, Cerebrovasc React Res Grp, Toronto, ON, Canada; [Duffin, James; Fisher, Joseph A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Duffin, James; Fisher, Joseph A.] Univ Toronto, Toronto, ON, Canada; [Fisher, Joseph A.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada		Mutch, WAC (corresponding author), Univ Manitoba, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada.; Mutch, WAC (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.; Mutch, WAC (corresponding author), Hlth Sci Ctr, Winnipeg, MB, Canada.; Mutch, WAC (corresponding author), Canada North Concuss Network, Winnipeg, MB, Canada.	wacmutch@shaw.ca	Mikulis, David J/H-5167-2019	Morissette, Marc/0000-0002-5342-8938; essig, marco/0000-0002-7964-2297; Mikulis, David/0000-0003-3956-0892; Duffin, James/0000-0003-2270-7392	Health Sciences Center Foundation; Manitoba Health Research Council; Academic Oversight Committee, Winnipeg, MB, Canada	All phases of this study were supported by grants from the Health Sciences Center Foundation, the Manitoba Health Research Council and the Academic Oversight Committee, Winnipeg, MB, Canada.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bhogal AA, 2015, NEUROIMAGE, V114, P239, DOI 10.1016/j.neuroimage.2015.04.014; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chan ST, 2015, BRAIN INJURY, V29, P403, DOI 10.3109/02699052.2014.974209; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Leung J, 2016, J PHYSIOL-LONDON, V594, P2681, DOI 10.1113/JP271056; Leung J, 2016, J MAGN RESON IMAGING, V43, P1191, DOI 10.1002/jmri.25063; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sobczyk O, 2016, AM J NEURORADIOL, V37, P818, DOI 10.3174/ajnr.A4679; Thomas BP, 2013, NEUROIMAGE, V83, P505, DOI 10.1016/j.neuroimage.2013.07.005; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491	41	22	22	0	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 8	2016	7								107	10.3389/fneur.2016.00107			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ5AW	WOS:000379217800001	27458426	Green Published, gold			2022-02-06	
J	Lee, JH; Wei, L; Gu, XH; Won, SM; Wei, ZZ; Dix, TA; Yu, SP				Lee, Jin Hwan; Wei, Ling; Gu, Xiaohuan; Won, Soonmi; Wei, Zheng Zachory; Dix, Thomas A.; Yu, Shan Ping			Improved Therapeutic Benefits by Combining Physical Cooling With Pharmacological Hypothermia After Severe Stroke in Rats	STROKE			English	Article						cell death; hypothermia; middle cerebral artery; neurotensin receptor 1; shivering; stroke	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; EMERGING ROLE; TEMPERATURE; INDUCTION; HEMORRHAGE; MANAGEMENT; REVERSAL; ANALOGS; SAFETY	Background and Purpose-Therapeutic hypothermia is a promising strategy for treatment of acute stroke. Clinical translation of therapeutic hypothermia, however, has been hindered because of the lack of efficiency and adverse effects. We sought to enhance the clinical potential of therapeutic hypothermia by combining physical cooling (PC) with pharmacologically induced hypothermia after ischemic stroke. Methods-Wistar rats were subjected to 90-minute middle cerebral artery occlusion by insertion of an intraluminal filament. Mild-to-moderate hypothermia was induced 120 minutes after the onset of stroke by PC alone, a neurotensin receptor 1 (NTR1) agonist HPI-201 (formally ABS-201) alone or the combination of both. The outcomes of stroke were evaluated at 3 and 21 days after stroke. Results-PC or HPI-201 each showed hypothermic effect and neuroprotection in stroke rats. The combination of PC and HPI-201 exhibited synergistic effects in cooling process, reduced infarct formation, cell death, and blood-brain barrier damages and improved functional recovery after stroke. Importantly, coapplied HPI-201 completely inhibited PC-associated shivering and tachycardia. Conclusions-The centrally acting hypothermic drug HPI-201 greatly enhanced the efficiency and efficacy of conventional PC; this combined cooling therapy may facilitate clinical translation of hypothermic treatment for stroke.	[Lee, Jin Hwan; Wei, Ling; Gu, Xiaohuan; Won, Soonmi; Wei, Zheng Zachory; Yu, Shan Ping] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Wei, Ling] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Lee, Jin Hwan; Wei, Ling; Gu, Xiaohuan; Wei, Zheng Zachory; Yu, Shan Ping] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA USA; [Dix, Thomas A.] JT Pharmaceut, Mt Pleasant, SC USA; [Dix, Thomas A.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA		Yu, SP (corresponding author), Emory Univ, Sch Med, 101 Woodruff Circle,Woodruff Mem Res Bldg, Atlanta, GA 30322 USA.	spyu@emory.edu	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286	American Heart Association (AHA)American Heart Association [12GRNT12060222, 14POST20130024, 15POST25680013, 15POST25710112]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS090529, NS062097, NS075338, NS085568]; Veteran Affair (VA) National Merit Grant [RX000666]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057255, R01NS085568] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000666] Funding Source: NIH RePORTER	This investigation was supported by American Heart Association (AHA) Grants 12GRNT12060222 (Dr Yu), 14POST20130024 (Dr Won), 15POST25680013 (Dr Lee), 15POST25710112 (Dr Wei), National Institutes of Health (NIH) grants NS090529 (Dr Dix/Dr Yu), NS062097 (Dr Wei), NS075338 (Dr Wei), NS085568 (Dr Wei/ Dr Yu), and a Veteran Affair (VA) National Merit Grant RX000666 (Dr Yu).	Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Dae MW, 2003, STROKE, V34, P734, DOI 10.1161/01.STR.0000057461.56040.FE; Daniele Ornella, 2002, J Stroke Cerebrovasc Dis, V11, P28, DOI 10.1053/jscd.2002.123972; Feigin V, 2003, LANCET NEUROL, V2, P529, DOI 10.1016/S1474-4422(03)00500-3; Feigin VL, 2002, J CLIN NEUROSCI, V9, P502, DOI 10.1054/jocn.2001.1072; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hadden MK, 2005, NEUROPHARMACOLOGY, V49, P1149, DOI 10.1016/j.neuropharm.2005.06.010; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Hemmen TM, 2007, STROKE, V38, P794, DOI 10.1161/01.STR.0000247920.15708.fa; Inderbitzen B, 2002, NEUROSURGERY, V50, P364, DOI 10.1097/00006123-200202000-00023; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Kim JY, 2011, TRANSL STROKE RES, V2, P195, DOI 10.1007/s12975-011-0082-4; Lee JH, 2015, AM J PHYSIOL-CELL PH, V308, pC570, DOI 10.1152/ajpcell.00353.2014; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Leker RR, 2003, STROKE, V34, P2000, DOI 10.1161/01.STR.0000079817.68944.1E; Lenhardt R, 2009, ANESTHESIOLOGY, V111, P110, DOI 10.1097/ALN.0b013e3181a979a3; MARTIN GE, 1980, PEPTIDES, V1, P333, DOI 10.1016/0196-9781(80)90011-X; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Nichols C, 2010, J NEUROINTERV SURG, V2, P67, DOI 10.1136/jnis.2009.001768; Orwig KS, 2009, J MED CHEM, V52, P1803, DOI 10.1021/jm801072v; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Presciutti M, 2012, CRIT CARE NURSE, V32, P33, DOI 10.4037/ccn2012189; Schwab S, 1998, ACT NEUR S, V71, P131; Sessler DI, 2009, CRIT CARE MED, V37, pS203, DOI 10.1097/CCM.0b013e3181aa5568; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Torok E, 2009, NEUROSURGERY, V65, P352, DOI 10.1227/01.NEU.0000345632.09882.FF; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhang MJ, 2013, J CEREBR BLOOD F MET, V33, P157, DOI 10.1038/jcbfm.2012.146	36	22	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUL	2016	47	7					1907	1913		10.1161/STROKEAHA.116.013061			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	DR4AX	WOS:000379844900048	27301934	hybrid, Green Accepted, Green Published			2022-02-06	
J	Moghieb, A; Bramlett, HM; Das, JH; Yang, ZH; Selig, T; Yost, RA; Wang, MS; Dietrich, WD; Wang, KKW				Moghieb, Ahmed; Bramlett, Helen M.; Das, Jyotirmoy H.; Yang, Zhihui; Selig, Tyler; Yost, Richard A.; Wang, Michael S.; Dietrich, W. Dalton; Wang, Kevin K. W.			Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury	MOLECULAR & CELLULAR PROTEOMICS			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; INFLAMMATORY CYTOKINES; REVERSED-PHASE; BIOMARKERS; PROTEIN; PROTEOMICS; CALPAIN; SEPARATION	Acute spinal cord injury (SCI) is a devastating condition with many consequences and no known effective treatment. Although it is quite easy to diagnose traumatic SCI, the assessment of injury severity and projection of disease progression or recovery are often challenging, as no consensus biomarkers have been clearly identified. Here rats were subjected to experimental moderate or severe thoracic SCI. At 24h and 7d postinjury, spinal cord segment caudal to injury center versus sham samples was harvested and subjected to differential proteomic analysis. Cationic/anionic-exchange chromatography, followed by 1D polyacrylamide gel electrophoresis, was used to reduce protein complexity. A reverse phase liquid chromatography-tandem mass spectrometry proteomic platform was then utilized to identify proteome changes associated with SCI. Twenty-two and 22 proteins were up-regulated at 24 h and 7 day after SCI, respectively; whereas 19 and 16 proteins are down-regulated at 24 h and 7 day after SCI, respectively, when compared with sham control. A subset of 12 proteins were identified as candidate SCI biomarkers -TF (Transferrin), FASN (Fatty acid synthase), NME1 (Nucleoside diphosphate kinase 1), STMN1 (Stathmin 1), EEF2 (Eukaryotic translation elongation factor 2), CTSD (Cathepsin D), ANXA1 (Annexin A1), ANXA2 (Annexin A2), PGM1 (Phosphoglucomutase 1), PEA15 (Phosphoprotein enriched in astrocytes 15), GOT2 (Glutamic-oxaloacetic transaminase 2), and TPI-1 (Triosephosphate isomerase 1), data are available via ProteomeXchange with identifier PXD003473. In addition, Transferrin, Cathepsin D, and TPI-1 and PEA15 were further verified in rat spinal cord tissue and/or CSF samples after SCI and in human CSF samples from moderate/severe SCI patients. Lastly, a systems biology approach was utilized to determine the critical biochemical pathways and interactome in the pathogenesis of SCI. Thus, SCI candidate biomarkers identified can be used to correlate with disease progression or to identify potential SCI therapeutic targets.	[Moghieb, Ahmed; Das, Jyotirmoy H.; Yang, Zhihui; Selig, Tyler] Univ Florida, Program Neurotrauma Neuroprote & Biomarkres Res, Gainesville, FL 32611 USA; [Moghieb, Ahmed; Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, 1149 Newell Dr, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA; [Moghieb, Ahmed; Yost, Richard A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Bramlett, Helen M.; Wang, Michael S.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace LPLC 3-18, Miami, FL 33136 USA; [Bramlett, Helen M.; Wang, Michael S.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, 1095 NW 14th Terrace LPLC 3-18, Miami, FL 33136 USA; [Das, Jyotirmoy H.] Washington Univ, Sch Med, St Louis, MO 63110 USA		Wang, KKW (corresponding author), Univ Florida, Dept Psychiat, 1149 Newell Dr, Gainesville, FL 32611 USA.	kwang@ufl.edu		Wang, Kevin/0000-0002-9343-6473	DODUnited States Department of Defense [W81XWH-12-1-0276]; United States ArmyUnited States Department of Defense [W81XWH-12-1-0277]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U24DK097209] Funding Source: NIH RePORTER	This study is supported in part by the DOD grant W81XWH-12-1-0276 (WDD, MSW) and W81XWH-12-1-0277 (KKW) from the United States Army.	Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Allard L, 2005, CLIN CHEM, V51, P2043, DOI 10.1373/clinchem.2005.053942; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Boja ES, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-22; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Cortez R., 2008, CURR TREAT OPTION NE, V9, P115; Davidsson P, 2005, DIS MARKERS, V21, P81, DOI 10.1155/2005/848676; Ding QX, 2006, PROTEOMICS, V6, P505, DOI 10.1002/pmic.200500296; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Fekete T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085190; Gil-Dones F, 2009, BIOMARK INSIGHTS, V4, P135; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Holly LT, 2009, J NEUROSURG-SPINE, V10, P194, DOI 10.3171/2008.12.SPINE08367; Issaq HJ, 2005, J CHROMATOGR B, V817, P35, DOI 10.1016/j.jchromb.2004.07.042; Johann DJ, 2004, ANN NY ACAD SCI, V1022, P295, DOI 10.1196/annals.1318.045; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kobeissy FH, 2008, EXPERT REV PROTEOMIC, V5, P293, DOI 10.1586/14789450.5.2.293; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Kotelnikova E, 2015, MULT SCLER J, V21, P138, DOI 10.1177/1352458514543339; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Ma JJ, 2001, SCAND J PLAST RECONS, V35, P355; Okon EB, 2013, J NEUROTRAUM, V30, P1564, DOI 10.1089/neu.2013.2956; Paul D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/783131; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Reis FM, 2011, SPINAL CORD, V49, P361, DOI 10.1038/sc.2010.121; Sajja BR, 2009, NEUROIMAG CLIN N AM, V19, P45, DOI 10.1016/j.nic.2008.08.002; Sharif A, 2004, NEUROSCIENCE, V126, P263, DOI 10.1016/j.neuroscience.2004.02.039; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Sheng S, 2006, MOL CELL PROTEOMICS, V5, P26, DOI 10.1074/mcp.T500019-MCP200; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; The Christopher & Dana Reeve Foundation, 2008, PARALYSIS, V2008, P1; Tissot Lion J. D. N., 2008, PROTEOMICS, V8, P1945; Tsai MC, 2008, MOL CELL PROTEOMICS, V7, P1668, DOI 10.1074/mcp.M800076-MCP200; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang E, 2013, CANCER LETT, V340, P261, DOI 10.1016/j.canlet.2012.11.050; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yu CG, 2007, NEUROCHEM RES, V32, P2046, DOI 10.1007/s11064-007-9347-4; Yu WJ, 2006, ELECTROPHORESIS, V27, P2100, DOI 10.1002/elps.200500820; Zhang B, 2011, J TRAUMA, V71, P1680, DOI 10.1097/TA.0b013e318231bce7; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16	57	22	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	JUL	2016	15	7					2379	2395		10.1074/mcp.M116.058115			17	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DQ9SS	WOS:000379550200014	27150525	hybrid, Green Published			2022-02-06	
J	Nordstrom, CH; Nielsen, TH; Schalen, W; Reinstrup, P; Ungerstedt, U				Nordstrom, Carl-Henrik; Nielsen, Troels Halfeld; Schalen, Wilhelm; Reinstrup, Peter; Ungerstedt, Urban			Biochemical indications of cerebral ischaemia and mitochondrial dysfunction in severe brain trauma analysed with regard to type of lesion	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Microdialysis; Ischaemia; Mitochondrial dysfunction; Lactate; Pyruvate; Cytoplasmatic redox	ENERGY-METABOLISM; PERFUSION-PRESSURE; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; GLYCOLYTIC METABOLITES; INTRACRANIAL-PRESSURE; BEDSIDE DIAGNOSIS; CYCLOSPORINE-A; AMINO-ACIDS; INJURY	The study focuses on three questions related to the clinical usefulness of microdialysis in severe brain trauma: (1) How frequently is disturbed cerebral energy metabolism observed in various types of lesions? (2) How often does the biochemical pattern indicate cerebral ischaemia and mitochondrial dysfunction? (3) How do these patterns relate to mortality? The study includes 213 consecutive patients with severe brain trauma (342 intracerebral microdialysis catheters). The patients were classified into four groups according to the type of lesion: extradural haematoma (EDH), acute subdural haematoma (SDH), cerebral haemorrhagic contusion (CHC) and no mass lesion (NML). Altogether about 150,000 biochemical analyses were performed during the initial 96 h after trauma. Compromised aerobic metabolism occurred during 38 % of the study period. The biochemical pattern indicating mitochondrial dysfunction was more common than that of ischaemia. In EDH and NML aerobic metabolism was generally close to normal. In SDH or CHC it was often severely compromised. Mortality was increased in SDH with impaired aerobic metabolism, while CHC did not exhibit a similar relation. Compromised energy metabolism is most frequent in patients with SDH and CHC (32 % and 49 % of the study period, respectively). The biochemical pattern of mitochondrial dysfunction is more common than that of ischaemia (32 % and 6 % of the study period, respectively). A correlation between mortality and biochemical data is obtained provided the microdialysis catheter is placed in an area where energy metabolism reflects tissue outcome in a large part of the brain.	[Nordstrom, Carl-Henrik; Nielsen, Troels Halfeld] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark; [Schalen, Wilhelm; Reinstrup, Peter; Ungerstedt, Urban] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden		Nordstrom, CH (corresponding author), Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark.	carl-henrik.nordstrom@med.lu.se	Nielsen, Troels Halfeld/G-3456-2015	Nielsen, Troels Halfeld/0000-0002-3943-8128			Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Jacobsen R, 2016, INTENSIVE CARE MED E, V4, P3; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MACMILLAN VH, 1989, J CEREBR BLOOD F MET, V9, P156, DOI 10.1038/jcbfm.1989.23; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; NORDSTROM CH, 1978, J NEUROCHEM, V30, P479, DOI 10.1111/j.1471-4159.1978.tb06553.x; NORDSTROM CH, 1978, STROKE, V9, P335, DOI 10.1161/01.STR.9.4.335; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Reinstrup P, 2011, NEUROCRIT CARE, V14, P441, DOI 10.1007/s12028-010-9486-3; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; SIESJO BK, 1978, BRAIN ENERGY METABOL, P192; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; TEASDALE G, 1974, LANCET, V2, P81; Thelin EP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00159; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; UNGERSTEDT U, 1974, B SCHWEIZ AKAD MED, V30, P44; Ungerstedt U, 1997, PHYSIOLOGY, STRESS, AND MALNUTRITION, P361; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	36	22	23	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2016	158	7					1231	1240		10.1007/s00701-016-2835-z			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DO3YX	WOS:000377719800001	27188288	Green Submitted			2022-02-06	
J	Wang, JF; Zarbin, M; Sugino, I; Whitehead, I; Townes-Anderson, E				Wang, Jianfeng; Zarbin, Marco; Sugino, Ilene; Whitehead, Ian; Townes-Anderson, Ellen			RhoA Signaling and Synaptic Damage Occur Within Hours in a Live Pig Model of CNS Injury, Retinal Detachment	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						photoreceptor; retinal detachment; RhoA; ROCK; synaptic plasticity	SCLERAL BUCKLING SURGERY; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; VISUAL RECOVERY; LYSOPHOSPHATIDIC ACID; LESIONAL EXPRESSION; AXON RETRACTION; PROTEIN-KINASE; SMOOTH-MUSCLE; IN-VITRO	PURPOSE. The RhoA pathway is activated after retinal injury. However, the time of onset and consequences of activation are unknown in vivo. Based on in vitro studies we focused on a period 2 hours after retinal detachment, in pig, an animal whose retina is holangiotic and contains cones. METHODS. Under anesthesia, retinal detachments were created by subretinal injection of a balanced salt solution. Two hours later, animals were sacrificed and enucleated for GTPase activity assays and quantitative Western blot and confocal microscopy analyses. RESULTS. RhoA activity with detachment was increased 1.5-fold compared to that in normal eyes or in eyes that had undergone vitrectomy only. Increased phosphorylation of myosin light chain, a RhoA effector, also occurred. By 2 hours, rod cells had retracted their terminals toward their cell bodies, disrupting the photoreceptor-to-bipolar synapse and producing significant numbers of spherules with SV2 immunolabel in the outer nuclear layer of the retina. In eyes with detachment, distant retina that remained attached also showed significant increases in RhoA activity and synaptic disjunction. Increases in RAC1 activity and glial fibrillary acidic protein (GFAP) were not specific for detachment, and sprouting of bipolar dendrites, reported for longer detachments, was not seen. The RhoA kinase inhibitor Y27632 significantly reduced axonal retraction by rod cells. CONCLUSIONS. Activation of the RhoA pathway occurs quickly after injury and promotes synaptic damage that can be controlled by RhoA kinase inhibition. We suggest that retinal detachment joins the list of central nervous system injuries, such as stroke and spinal cord injury, that should be considered for rapid therapeutic intervention.	[Wang, Jianfeng; Townes-Anderson, Ellen] Rutgers State Univ, Rutgers Biomed Hlth Sci, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave, Newark, NJ 07103 USA; [Zarbin, Marco; Sugino, Ilene] Rutgers State Univ, Rutgers Biomed Hlth Sci, New Jersey Med Sch, Inst Ophthalmol & Visual Sci, Newark, NJ USA; [Whitehead, Ian] Rutgers State Univ, Rutgers Biomed Hlth Sci, New Jersey Med Sch, Dept Microbiol Biochem & Med Genet, Newark, NJ USA		Townes-Anderson, E (corresponding author), Rutgers State Univ, Rutgers Biomed Hlth Sci, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave, Newark, NJ 07103 USA.	andersel@njms.rutgers.edu		Zarbin, Marco/0000-0002-7811-7132	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY021542] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY021542] Funding Source: Medline		Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Brabeck C, 2003, ARCH NEUROL-CHICAGO, V60, P1245, DOI 10.1001/archneur.60.9.1245; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; Chan D, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.234005; CHISHOLM IA, 1975, T OPHTHAL SOC UK, V95, P167; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Dergham P, 2002, J NEUROSCI, V22, P6570; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; Faure J, 2001, BIOCHIMIE, V83, P409, DOI 10.1016/S0300-9084(01)01263-9; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Fontainhas AM, 2008, INVEST OPHTH VIS SCI, V49, P4177, DOI 10.1167/iovs.07-1580; Fontainhas AM, 2011, INVEST OPHTH VIS SCI, V52, P579, DOI 10.1167/iovs.10-5744; Francke M, 2001, INVEST OPHTH VIS SCI, V42, P1072; Gallo G, 2004, EXP NEUROL, V189, P112, DOI 10.1016/j.expneurol.2004.05.019; Garnock-Jones K, 2014, DRUGS, V74, P2211, DOI 10.1007/s40265-014-0333-2; Gerke C. G. Jr., 1995, Hong Kong Medical Journal, V1, P302; GIRARD P, 1995, OPHTHALMOLOGICA, V209, P323, DOI 10.1159/000310651; Glaven JA, 1999, J BIOL CHEM, V274, P2279, DOI 10.1074/jbc.274.4.2279; GUERIN CJ, 1993, INVEST OPHTH VIS SCI, V34, P175; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Henrich PB, 2009, KLIN MONATSBL AUGENH, V226, P289, DOI 10.1055/s-0028-1109330; Hou Y, 2012, NEUROSCIENCE, V200, P120, DOI 10.1016/j.neuroscience.2011.10.030; Iandiev I, 2006, INVEST OPHTH VIS SCI, V47, P2161, DOI 10.1167/iovs.05-0595; Joo EE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4510; Khodair MA, 2003, INVEST OPHTH VIS SCI, V44, P4976, DOI 10.1167/iovs.03-0036; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; Lewis GP, 1998, INVEST OPHTH VIS SCI, V39, P424; Lewis GP, 2003, MOL NEUROBIOL, V28, P159, DOI 10.1385/MN:28:2:159; Lewis GP, 2002, EYE, V16, P375, DOI 10.1038/sj.eye.6700202; Lin-Jones J, 2009, J COMP NEUROL, V513, P209, DOI 10.1002/cne.21958; Linberg KA, 2009, MOL VIS, V15, P10; Liu F, 2006, OPHTHALMOLOGICA, V220, P174, DOI 10.1159/000091761; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mervin K, 1999, AM J OPHTHALMOL, V128, P155, DOI 10.1016/S0002-9394(99)00104-X; Mowatt L, 2005, EUR J OPHTHALMOL, V15, P109, DOI 10.1177/112067210501500117; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; NachmanClewner M, 1996, J NEUROCYTOL, V25, P597, DOI 10.1007/BF02284827; Ozgur S, 2007, RETINA-J RET VIT DIS, V27, P358; Petratos S, 2008, BRAIN, V131, P90, DOI 10.1093/brain/awm260; PRINCE JH, 1960, AM J OPHTHALMOL, V49, P1202; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; Ross W, 2005, OPHTHALMOLOGY, V112, P1213, DOI 10.1016/j.ophtha.2005.01.040; Ross W H, 2000, Curr Opin Ophthalmol, V11, P191, DOI 10.1097/00055735-200006000-00007; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3; Ryan SJ, 2006, RETINA; Salicone A, 2006, OPHTHALMOLOGY, V113, P1734, DOI 10.1016/j.ophtha.2006.03.064; Santos-Bredariol AS, 2002, J NEUROCYTOL, V31, P149, DOI 10.1023/A:1023997506760; Sasoh M, 1997, DOC OPHTHALMOL, V94, P239, DOI 10.1007/BF02582982; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Sherry DM, 2000, INVEST OPHTH VIS SCI, V41, P2779; SIMOENS P, 1992, EXP EYE RES, V54, P965, DOI 10.1016/0014-4835(92)90161-K; Song Y, 2013, CNS NEUROSCI THER, V19, P603, DOI 10.1111/cns.12116; STEINBERG RH, 1986, EXP EYE RES, V43, P695, DOI 10.1016/S0014-4835(86)80001-X; Sung JK, 2003, BRAIN RES, V959, P29, DOI 10.1016/S0006-8993(02)03717-4; TANI P, 1981, AM J OPHTHALMOL, V92, P611, DOI 10.1016/S0002-9394(14)74651-3; Tonges L, 2012, BRAIN, V135, P3355, DOI 10.1093/brain/aws254; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van Bussel EM, 2014, RETINA-J RET VIT DIS, V34, P1917, DOI 10.1097/IAE.0000000000000296; Wang Jianfeng, 2011, J Vis Exp, DOI 10.3791/2655; Wang WW, 2015, INVEST OPHTH VIS SCI, V56, P7847, DOI 10.1167/iovs.15-17278; Yamashita K, 2007, BRAIN RES, V1154, P215, DOI 10.1016/j.brainres.2007.04.013; Zhang JY, 2014, REPRODUCTION, V148, P99, DOI 10.1530/REP-13-0556	78	22	22	0	2	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	JUL	2016	57	8					3892	3906		10.1167/iovs.16-19447			15	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	DT8GW	WOS:000381729000044	27472075	Green Published, gold, Green Submitted			2022-02-06	
J	Yasui, H; Donahue, DL; Walsh, M; Castellino, FJ; Ploplis, VA				Yasui, Hideki; Donahue, Deborah L.; Walsh, Mark; Castellino, Francis J.; Ploplis, Victoria A.			Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury	AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY			English	Article						acute lung injury; traumatic brain injury; tissue factor; coagulopathy; coagulation pathway	RESPIRATORY-DISTRESS-SYNDROME; NEUROGENIC PULMONARY-EDEMA; EARLY PLATELET DYSFUNCTION; TISSUE FACTOR; VASCULAR-PERMEABILITY; IN-VIVO; COAGULOPATHY; INFLAMMATION; ACTIVATION; HEMORRHAGE	Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury. Am J Physiol Lung Cell Mol Physiol 311:L74-L86, 2016. First published May 17, 2016; doi:10.1152/ajplung.00429.2015.-Acute lung injury (ALI) and systemic coagulopathy are serious complications of traumatic brain injury (TBI) that frequently lead to poor clinical outcomes. Although the release of tissue factor (TF), a potent initiator of the extrinsic pathway of coagulation, from the injured brain is thought to play a key role in coagulopathy after TBI, its function in ALI following TBI remains unclear. In this study, we investigated whether the systemic appearance of TF correlated with the ensuing coagulopathy that follows TBI in ALI using an anesthetized rat blunt trauma TBI model. Blood and lung samples were obtained after TBI. Compared with controls, pulmonary edema and increased pulmonary permeability were observed as early as 5 min after TBI without evidence of norepinephrine involvement. Systemic TF increased at 5 min and then diminished 60 min after TBI. Lung injury and alveolar hemorrhaging were also observed as early as 5 min after TBI. A biphasic elevation of TF was observed in the lungs after TBI, and TF-positive microparticles (MPs) were detected in the alveolar spaces. Fibrin(ogen) deposition was also observed in the lungs within 60 min after TBI. Additionally, preadministration of a direct thrombin inhibitor, Refludan, attenuated lung injuries, thus implicating thrombin as a direct participant in ALI after TBI. The results from this study demonstrated that enhanced systemic TF may be an initiator of coagulation activation that contributes to ALI after TBI.	[Yasui, Hideki; Donahue, Deborah L.; Walsh, Mark; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, WM Keck Ctr Transgene Res, 230 Raclin Carmichael Hall, Notre Dame, IN 46556 USA; [Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Walsh, Mark] Mem Hosp South Bend, South Bend, IN USA		Ploplis, VA (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, 230 Raclin Carmichael Hall, Notre Dame, IN 46556 USA.	vploplis@nd.edu		Walsh, Mark/0000-0002-5795-1144	Indiana State Department of Health; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-019982]	This study was supported by an Indiana Spinal Cord and Brain Injury Grant from the Indiana State Department of Health (to V. A. Ploplis) and, in part, National Heart, Lung, and Blood Institute Grant HL-019982 (to F. J. C).	CARLSON RW, 1979, CHEST, V75, P731, DOI 10.1378/chest.75.6.731; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; CHAPMAN HA, 1985, J CLIN INVEST, V75, P2030, DOI 10.1172/JCI111922; CHEN HI, 1973, AM J PHYSIOL, V224, P223, DOI 10.1152/ajplegacy.1973.224.2.223; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; COLICE GL, 1985, CLIN CHEST MED, V6, P473; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; DELZOPPO GJ, 1992, THROMB HAEMOSTASIS, V68, P642; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; FuchsBuder T, 1996, AM J RESP CRIT CARE, V153, P163, DOI 10.1164/ajrccm.153.1.8542111; Furie B, 2007, J THROMB HAEMOST, V5, P12, DOI 10.1111/j.1538-7836.2007.02482.x; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Heuer JF, 2012, J NEUROL SURG PART A, V73, P289, DOI 10.1055/s-0032-1304813; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Liu ZY, 2014, INT J MOL SCI, V15, P12861, DOI 10.3390/ijms150712861; LUKACS NW, 1995, J IMMUNOL, V154, P5411; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MALIK AB, 1987, AM REV RESPIR DIS, V136, P467, DOI 10.1164/ajrccm/136.2.467; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; MCCLELLAN MD, 1989, J APPL PHYSIOL, V67, P1185, DOI 10.1152/jappl.1989.67.3.1185; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Miller DL, 2002, AM J RESP CELL MOL, V26, P650, DOI 10.1165/ajrcmb.26.6.4688; MING WJ, 1987, J IMMUNOL, V138, P1469; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Rassler B, 2003, MOL CELL BIOCHEM, V250, P55, DOI 10.1023/A:1024942132705; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Schrieber M, 2007, J TRAUMA, V63, P1261; Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; VANDERZEE H, 1980, J APPL PHYSIOL, V48, P273, DOI 10.1152/jappl.1980.48.2.273; Veress LA, 2010, AM J RESP CRIT CARE, V182, P1352, DOI 10.1164/rccm.200910-1618OC; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	57	22	21	0	9	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1040-0605	1522-1504		AM J PHYSIOL-LUNG C	Am. J. Physiol.-Lung Cell. Mol. Physiol.	JUL 1	2016	311	1					L74	L86		10.1152/ajplung.00429.2015			13	Physiology; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Respiratory System	DS4RE	WOS:000380767700008	27190065	Green Published, Bronze			2022-02-06	
J	Sherman, M; Liu, MM; Birnbaum, S; Wolf, SE; Minei, JP; Gatson, JW				Sherman, Matthew; Liu, Ming-Mei; Birnbaum, Shari; Wolf, Steven E.; Minei, Joseph P.; Gatson, Joshua W.			Adult obese mice suffer from chronic secondary brain injury after mild TBI	JOURNAL OF NEUROINFLAMMATION			English	Article						TBI; Inflammation; Obesity	ADIPOSE-TISSUE; INFLAMMATION; SEX; COMORBIDITIES; ACCUMULATION; RESISTANCE; CORTISOL; OUTCOMES	Background: A traumatic brain injury (TBI) event is a devastating injury to the brain that may result in heightened inflammation, neurodegeneration, and subsequent cognitive and mood deficits. TBI victims with co-morbidities such as heart disease, diabetes, or obesity may be more vulnerable to the secondary brain injury that follows the initial insult. Compared to lean individuals, obese subjects tend to have worse clinical outcomes and higher mortality rates after trauma. Methods: To elucidate whether obesity predisposes individuals to worse outcomes after TBI, we subjected adult lean and obese male/female mice to a mild TBI. The injury was administered using a controlled skull impact (CSI) device. Lean or obese 6-month-old C57 BL/6 mice were subjected once to a mild TBI. Additionally, at day 30 after injury, both the lean and obese mice were tested for increased anxiety using the open field test. Results: At day 30 after TBI, compared to the lean mice, we found heightened microglial (MG) activation in the cerebral cortex, corpus callosum, and hypothalamus. Another compelling finding was that, compared to the non-injured obese male control mice, the obese TBI mice had a decrease in the rate of weight gain and serum corticosterone levels at day 30 after injury. Additionally, the injured obese mice displayed higher levels of anxiety as determined by a significant decrease in time spent in the non-peripheral zones in the open field test. In contrast to the obese males, the obese female mice did not exhibit increases in the number of active MG in the brain, changes in weight gain/corticosterone levels, or increased anxiety at day 30 after TBI. Conclusions: The data presented here suggests that obese mice have worse outcomes compared to lean mice after mild TBI. Also, the obese males have worse outcomes than the injured female mice. This data may explain the sequela of chronic secondary brain injury in obese adults after a single mild TBI. Also, this report may help shape how the overweight/obese populations are monitored over the days and months following a TBI.	[Sherman, Matthew; Liu, Ming-Mei; Wolf, Steven E.; Minei, Joseph P.; Gatson, Joshua W.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Gatson, Joshua W.] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Birnbaum, Shari] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX USA		Gatson, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.; Gatson, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Joshua.gatson@utsouthwestern.edu		Wolf, Steven/0000-0003-2972-3440	Department of Surgery at the University of Texas Southwestern Medical Center	Funds were provided by the Department of Surgery at the University of Texas Southwestern Medical Center to complete the research studies.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Aguilar-Valles A, 2015, NEUROPHARMACOLOGY, V96, P124, DOI 10.1016/j.neuropharm.2014.12.023; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bell K R, 2001, Phys Med Rehabil Clin N Am, V12, P169; BERNARDIS LL, 1993, NEUROSCI BIOBEHAV R, V17, P141, DOI 10.1016/S0149-7634(05)80149-6; Bousquet M, 2012, NEUROBIOL DIS, V45, P529, DOI 10.1016/j.nbd.2011.09.009; Brown LM, 2010, BRAIN RES, V1350, P77, DOI 10.1016/j.brainres.2010.04.056; Bruce-Keller AJ, 2009, BBA-MOL BASIS DIS, V1792, P395, DOI 10.1016/j.bbadis.2008.10.004; Buga AM, 2013, BIOGERONTOLOGY, V14, P651, DOI 10.1007/s10522-013-9465-0; Castanon N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00074; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Choi JY, 2005, FREE RADICAL BIO MED, V38, P806, DOI 10.1016/j.freeradbiomed.2004.12.008; Di Napoli M, 2012, NEUROLOGY, V79, P690, DOI 10.1212/WNL.0b013e318264e3be; Ditillo M, 2014, J TRAUMA ACUTE CARE, V76, P176, DOI 10.1097/TA.0b013e3182ab0d7c; Faul M, 2010, TRAUMATIC BRAIN INJU; Fedor A, 2013, OBESITY FACTS, V6, P185, DOI 10.1159/000351138; GOLD RM, 1973, SCIENCE, V182, P488, DOI 10.1126/science.182.4111.488; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Kalmijn S, 2000, J Nutr Health Aging, V4, P202; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; MOLITCH ME, 1983, CLIN ENDOCRINOL META, V12, P825, DOI 10.1016/S0300-595X(83)80066-8; Morris JK, 2010, AM J PHYSIOL-REG I, V299, pR1082, DOI 10.1152/ajpregu.00449.2010; Nguyen JCD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00375; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Pasquali R, 2002, J CLIN ENDOCR METAB, V87, P166, DOI 10.1210/jc.87.1.166; Pasquali R, 2006, ANN NY ACAD SCI, V1083, P111, DOI 10.1196/annals.1367.009; Popa-Wagner A, 2014, BIOGERONTOLOGY, V15, P439, DOI 10.1007/s10522-014-9516-1; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Puig KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030378; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Rodriguez ACI, 2015, PSYCHONEUROENDOCRINO, V62, P301, DOI 10.1016/j.psyneuen.2015.08.014; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sandu RE, 2015, NEURAL REGEN RES, V10, P1349, DOI 10.4103/1673-5374.165208; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Singhal G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00097; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67; Woods SC, 2003, EXP BIOL MED, V228, P1175; Yehuda S, 2005, NUTR NEUROSCI, V8, P309, DOI 10.1080/00268970500509972	50	22	24	1	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUN 30	2016	13								171	10.1186/s12974-016-0641-4			10	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DQ0CE	WOS:000378864800001	27357503	Green Published, gold			2022-02-06	
J	Song, J; Li, N; Xia, Y; Gao, Z; Zou, SF; Kong, L; Yao, YJ; Jiao, YN; Yan, YH; Li, SH; Tao, ZY; Lian, G; Yang, JX; Kang, TG				Song, Jie; Li, Na; Xia, Yang; Gao, Zhong; Zou, Sa-feng; Kong, Liang; Yao, Ying-Jia; Jiao, Ya-Nan; Yan, Yu-Hui; Li, Shao-Heng; Tao, Zhen-Yu; Lian, Guan; Yang, Jing-Xian; Kang, Ting-Guo			Arctigenin Treatment Protects against Brain Damage through an Anti-Inflammatory and Anti-Apoptotic Mechanism after Needle Insertion	FRONTIERS IN PHARMACOLOGY			English	Article						arctigenin; stab wound injury; inflammation; apoptosis; convection enhanced delivery; traumatic brain injury	TUMOR-NECROSIS-FACTOR; STEM-CELL TRANSPLANTATION; SECONDARY DAMAGE; FACTOR-ALPHA; RAT MODEL; IN-VITRO; KAPPA-B; INJURY; INFLAMMATION; DEATH	Convection enhanced delivery (CED) infuses drugs directly into brain tissue. Needle insertion is required and results in a stab wound injury (SWI). Subsequent secondary injury involves the release of inflammatory and apoptotic cytokines, which have dramatic consequences on the integrity of damaged tissue, leading to the evolution of a pericontusional-damaged area minutes to days after in the initial injury. The present study investigated the capacity for arctigenin (ARC) to prevent secondary brain injury and the determination of the underlying mechanism of action in a mouse model of SWI that mimics the process of CED. After CED, mice received a gavage of ARC from 30 min to 14 days. Neurological severity scores (NSS) and wound closure degree were assessed after the injury. Histological analysis and immunocytochemistry were used to evaluated the extent of brain damage and neuroinflammation. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was used to detect universal apoptosis. Enzyme-linked immunosorbent assays (ELISA) was used to test the inflammatory cytokines (tumor necrosis factor (TNF)-alpha, interleukin (IL)-6 and IL-10) and lactate dehydrogenase (LDH) content. Gene levels of inflammation (TNF-alpha, IL-6, and IL-10) and apoptosis (Caspase-3, Bax and Bcl-2) were detected by reverse transcription-polymerase chain reaction (RT-PCR). Using these, we analyzed ARC's efficacy and mechanism of action. Results: ARC treatment improved neurological function by reducing brain water content and hematoma and accelerating wound closure relative to untreated mice. ARC treatment reduced the levels of TNF-alpha and IL-6 and the number of allograft inflammatory factor (IBA)- and myeloperoxidase (MPO)-positive cells and increased the levels of IL-10. ARC-treated mice had fewer TUNEL+ apoptotic neurons and activated caspase-3-positive neurons surrounding the lesion than controls, indicating increased neuronal survival. Conclusions: ARC treatment confers neuroprotection of brain tissue through anti-inflammatory and anti-apoptotic effects in a mouse model of SWI. These results suggest a new strategy for promoting neuronal survival and function after CED to improve long-term patient outcome.	[Song, Jie; Li, Na; Kong, Liang; Yao, Ying-Jia; Jiao, Ya-Nan; Yan, Yu-Hui; Li, Shao-Heng; Tao, Zhen-Yu; Lian, Guan; Yang, Jing-Xian; Kang, Ting-Guo] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian, Peoples R China; [Xia, Yang] Univ Oxford, Dept Engn, St Cross Coll, Oxford, England; [Gao, Zhong; Zou, Sa-feng] Dalian Municipal Cent Hosp, Dept Intervent Therapy, Dept Rehabil, Dalian, Peoples R China		Yang, JX; Kang, TG (corresponding author), Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian, Peoples R China.	421151563@qq.com; ting_guo_kang@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30572336, 81173580]	This work was supported by the National Natural Science Foundation of China (grant No. 30572336 and 81173580).	Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Casanova F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094919; Casanova F, 2014, J NEUROSCI METH, V237, P79, DOI 10.1016/j.jneumeth.2014.08.012; Chen JW, 2006, FREE RADICAL BIO MED, V40, P817, DOI 10.1016/j.freeradbiomed.2005.10.037; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Fan J, 2010, NEUROSCI LETT, V473, P196, DOI 10.1016/j.neulet.2010.02.045; Fan T, 2012, BIOL PHARM BULL, V35, P2004, DOI 10.1248/bpb.b12-00463; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao Z, 2014, J PHARMACOL SCI, V124, P54, DOI 10.1254/jphs.13144FP; Genovese T, 2008, SHOCK, V30, P231, DOI 10.1097/shk.0b013e318162d290; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Green DR., 2011, MEANS END APOPTOSIS; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gu Y, 2012, BIOCHEM PHARMACOL, V84, P468, DOI 10.1016/j.bcp.2012.06.002; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; HOZUMI I, 1990, BRAIN RES, V524, P64, DOI 10.1016/0006-8993(90)90492-T; Hu Y, 2013, BIOL PHARM BULL, V36, P1950, DOI 10.1248/bpb.b13-00561; Hyam SR, 2013, EUR J PHARMACOL, V708, P21, DOI 10.1016/j.ejphar.2013.01.014; Kang HS, 2008, J ETHNOPHARMACOL, V116, P305, DOI 10.1016/j.jep.2007.11.030; Kastrup A, 2008, STROKE, V39, P2385, DOI 10.1161/STROKEAHA.107.505420; Kong L, 2015, BIOL PHARM BULL, V38, P1290, DOI 10.1248/bpb.b15-00142; Kotipatruni RR, 2011, NEUROCHEM RES, V36, P2063, DOI 10.1007/s11064-011-0530-2; Kou XJ, 2011, INT IMMUNOPHARMACOL, V11, P1095, DOI 10.1016/j.intimp.2011.03.005; Kuhnel W., 2003, COLOR ATLAS CYTOLOGY, V4th; Kurapati KRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112818; Kurapati KRV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077624; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lee JY, 2010, BIOL PHARM BULL, V33, P1847, DOI 10.1248/bpb.33.1847; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Loftspring MC, 2011, J CEREBR BLOOD F MET, V31, P1133, DOI 10.1038/jcbfm.2010.203; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luo ZF, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-2; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Nicholson C, 2001, REP PROG PHYS, V64, P815, DOI 10.1088/0034-4885/64/7/202; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; SAAL JS, 1995, SPINE, V20, P1821, DOI 10.1097/00007632-199508150-00013; Salvesen GS, 2002, CELL DEATH DIFFER, V9, P3, DOI 10.1038/sj.cdd.4400963; Schmit A, 2002, EUR CYTOKINE NETW, V13, P298; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Swarup V, 2008, J ANTIMICROB CHEMOTH, V61, P679, DOI 10.1093/jac/dkm503; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Thompson R F., 2000, BRAIN NEUROSCIENCE P; Tsai WJ, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-12; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; Wood P., 2003, NEUROINFLAMMATION ME; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Xia Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0373-x; Yan J, 2013, CELL, V152, P304, DOI 10.1016/j.cell.2012.12.021; Yang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002864; Yao WJ, 2015, AM J CHINESE MED, V43, P183, DOI 10.1142/S0192415X15500123; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai PP, 2015, NEUROPHARMACOLOGY, V95, P1, DOI 10.1016/j.neuropharm.2015.02.026; Zhang N, 2013, INT J MOL SCI, V14, P18657, DOI 10.3390/ijms140918657; Zhang N, 2012, EUR J PHARMACOL, V697, P32, DOI 10.1016/j.ejphar.2012.10.008; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang WZ, 2015, INFLAMMATION, V38, P1406, DOI 10.1007/s10753-015-0115-3; Zhao F, 2009, J ETHNOPHARMACOL, V122, P457, DOI 10.1016/j.jep.2009.01.038; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	85	22	24	2	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JUN 22	2016	7								182	10.3389/fphar.2016.00182			16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DP1WV	WOS:000378281000001	27445818	gold, Green Published			2022-02-06	
J	Lilley, EJ; Williams, KJ; Schneider, EB; Hammouda, K; Salim, A; Haider, AH; Cooper, Z				Lilley, Elizabeth J.; Williams, Katherine J.; Schneider, Eric B.; Hammouda, Khaled; Salim, Ali; Haider, Adil H.; Cooper, Zara			Intensity of treatment, end-of-life care, and mortality for older patients with severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Geriatric surgery; traumatic brain injury; palliative care	LONG-TERM SURVIVAL; MEDICARE BENEFICIARIES; GERIATRIC TRAUMA; DECISION-MAKING; ASSOCIATION; OUTCOMES; AGE; PROGNOSIS; ADULTS; COST	BACKGROUND The Eastern Association for the Surgery of Trauma (EAST) recommends that clinicians consider limiting further aggressive treatment in geriatric patients with severe traumatic brain injury (TBI) who do not improve in 72 hours (nonresponders) owing to their poor prognosis. However, little is known about how these guidelines are followed in practice. This study compared mortality and patient care among geriatric patients with severe TBI classified as responders and nonresponders 72 hours after injury. METHODS Retrospective review of patients 65 years or older at a Level I trauma center with severe TBI (GCS < 8) from 2011 to 2014. We compared in-hospital mortality, end-of-life (EOL) decision making, discharge functional status, and 12-month survival in responders (GCS > 8 at 72 hours) and nonresponders (GCS 8 at 72 hours). RESULTS Of 90 patients, 29 (32%) died within 3 days of injury, 29 (32%) were nonresponders, and 32 (34%) were responders. An additional 19 patients (21%) died before hospital discharge, of whom 17 (89%) were nonresponders. Nonresponders had higher odds of in-hospital death (odds ratio, 31.8; 95% confidence interval [CI], 3.71-272.9; p = 0.002). Family meetings to discuss goals of care were more common in the nonresponder group (p < 0.001) and fewer nonresponders were full code at discharge or death (p < 0.001). There were no significant differences in functional status at discharge. Among patients discharged alive, there were no differences in 12-month survival. CONCLUSION The responder/nonresponder dichotomy identifies patients with higher in-hospital mortality outcomes and is associated with differences in EOL decision making. However, functional impairment and poor survival were prevalent, irrespective of neurologic status at 72 hours. LEVEL OF EVIDENCE Prognostic/epidemiologic study, level III; therapeutic study, level IV.	[Lilley, Elizabeth J.; Schneider, Eric B.; Salim, Ali; Haider, Adil H.; Cooper, Zara] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, 75 Francis St, Boston, MA 02115 USA; [Lilley, Elizabeth J.] Rutgers Robert Wood Johnson Med, Dept Surg, New Brunswick, NJ USA; [Williams, Katherine J.] Med Coll Wisconsin, Populat Hlth Management, Dept Clin Affairs, Milwaukee, WI 53226 USA; [Schneider, Eric B.; Hammouda, Khaled; Salim, Ali; Haider, Adil H.; Cooper, Zara] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Hammouda, Khaled] Brigham & Womens Hosp, Surg ICU Translat Res STAR Ctr, 75 Francis St, Boston, MA 02115 USA		Cooper, Z (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	zcooper@partners.org			Patient-Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [AD-1306-03980]; Dept. of Defense through the Henry M Jackson Foundation	Dr. Haider is the primary investigator of a contract (AD-1306-03980) with The Patient-Centered Outcomes Research Institute (PCORI) entitled "Patient-Centered Approaches to Collect Sexual Orientation/Gender Identity Information in the ED" and the PI on a Health Services Grant from the Dept. of Defense through the Henry M Jackson Foundation entitled "Epidemiology and Provider Induced Collaboration". Dr. Haider is also a co-founder and equity holder of a Johns Hopkins University supported start up known as Patient Doctor Technologies which owns and operates the website www.doctella.com. Dr. Schneider is a member of Bergeim, LLC and has patents pending in the area of CNS injury.	Ahluwalia SC, 2011, J ONCOL PRACT, V7, P361, DOI 10.1200/JOP.2011.000364; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark DE, 2004, J AM GERIATR SOC, V52, P2023, DOI 10.1111/j.1532-5415.2004.52560.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Gill TM, 1998, ANN INTERN MED, V128, P96, DOI 10.7326/0003-4819-128-2-199801150-00004; Hernandez RA, 2015, AM J SURG, V210, P52, DOI 10.1016/j.amjsurg.2014.08.025; Institute of Medicine Committee on Approaching Death, 2014, DYIN AM ADDR KEY END; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; National Quality Forum, 2012, END SUMM PALL CAR EN; Obermeyer Z, 2014, JAMA, V312, P1888; Obermeyer Z, 2015, HEALTH AFFAIR, V34, P993, DOI 10.1377/hlthaff.2014.1055; Ortman JMVV, 2014, AGING NATION OLDER P; Powers BW, 2015, J PALLIAT MED, V18, P400, DOI 10.1089/jpm.2015.0014; Ross A M, 1992, J Neurosci Nurs, V24, P88; Schwarze ML, 2014, JAMA SURG, V149, P631, DOI 10.1001/jamasurg.2013.5143; Shinall MC, 2015, J RELIG HEALTH, V54, P977, DOI 10.1007/s10943-014-9869-4; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786	35	22	22	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2016	80	6					998	1004		10.1097/TA.0000000000001028			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	DO5MX	WOS:000377828300029	26953761				2022-02-06	
J	Zhang, S; Kojic, L; Tsang, M; Grewal, P; Liu, J; Namjoshi, D; Wellington, CL; Tetzlaff, W; Cynader, MS; Jia, W				Zhang, Si; Kojic, Luba; Tsang, Michelle; Grewal, Parampal; Liu, Jie; Namjoshi, Dhananjay; Wellington, Cheryl L.; Tetzlaff, Wolfram; Cynader, Max S.; Jia, William			Distinct roles for metalloproteinases during traumatic brain injury	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Closed and open head injury; Mice model; Metalloproteinases; Gelatinase activity; Immunohistochemistry	CONTROLLED CORTICAL IMPACT; ALPHA-CONVERTING-ENZYME; FOCAL CEREBRAL-ISCHEMIA; MATRIX METALLOPROTEINASES; CELL-DEATH; INTRACEREBRAL HEMORRHAGE; MULTIPLE ROLES; HEAD-INJURY; MODEL; BLOOD	Background: Significant protease activations have been reported after traumatic brain injury (TBI). These proteases are responsible for cleavage of transmembrane proteins in neurons, glial, and endothelial cells and this results in the release of their extracellular domains (ectodomains). Methods: Two TBI models were employed here, representing both closed head injury (CHI) and open head injury (OHI). In situ zymography, immunohistochemistry, bright field and confocal microscopy, quantification of immunopositive cells and statistical analysis were applied. Results: We found, using in situ zymography, that gelatinase activity of matrix metalloproteinases (MMP)-2 and MMP-9 was upregulated in cortex of both injury models. Using immunohistochemistry for several MPPs (Matrix metalloproteinases) and ADAMs (disintegrin and metalloproteinases), including MMP-2, -9, ADAM-10, -17, distinct patterns of induction were observed in the two TBI models. In closed head injury, an early increase in protein expression of MMP-2, -9 and ADAM -17 was found as early as 10 min post injury in cortex and peaked at 1 h for all 4 proteases examined. In contrast, after OHI the maximal expression was observed locally neighboring the impact site, at a later time-point, as long as 24 h after the injury for MMP-2 and MMP-9. Confocal microscopy revealed colocalization of the 4 proteases with the neuronal marker NeuN in CHI, but only MMP2 colocalized with NeuN in OHI. Conclusions: The findings may lead to a trauma-induced therapeutic strategy triggered soon after a primary insult to improve survival and to reduce brain damage following TBI. (C) 2016 Published by Elsevier Ltd.	[Zhang, Si; Kojic, Luba; Tsang, Michelle; Grewal, Parampal; Cynader, Max S.; Jia, William] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Liu, Jie; Tetzlaff, Wolfram] Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada; [Namjoshi, Dhananjay; Wellington, Cheryl L.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada		Jia, W (corresponding author), Univ British Columbia, Dept Surg, Fac Med, Div Neurosurg, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	zhang.si@hotmail.com; lkojic@mail.ubc.ca; myt1@sfu.ca; parampal.grewal@gmail.com; jliu@icord.org; dnamjoshi@cmmt.ubc.ca; cheryl@cmmt.ubc.ca; tetzlaff@icord.org; cynader@brain.ubc.ca; w.jia@ubc.ca	JIA, WILLIAM/AAE-4322-2020; Tetzlaff, Wolfram/AAY-4430-2020				Alexander JS, 2002, J ANAT, V200, P561, DOI 10.1046/j.1469-7580.2002.00057.x; Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; [Anonymous], 2015, J CEREB BLOOD FLOW M; [Anonymous], 2015, MOL NEUROBIOL; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Barzo P, 1997, ACT NEUR S, V70, P119; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Goddard DR, 2001, GLIA, V34, P267, DOI 10.1002/glia.1060; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Grossetete M, 2008, J CEREBR BLOOD F MET, V28, P752, DOI 10.1038/sj.jcbfm.9600572; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Haddad M, 2008, EUR J PHARMACOL, V588, P52, DOI 10.1016/j.ejphar.2008.04.013; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Katakowski M, 2007, J CEREBR BLOOD F MET, V27, P669, DOI 10.1038/sj.jcbfm.9600390; Kolar M, 2008, ACTA NEUROCHIR SUPPL, V102, P373, DOI 10.1007/978-3-211-85578-2_71; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee P, 2012, EXP NEUROL, V234, P50, DOI 10.1016/j.expneurol.2011.12.016; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siao CJ, 2002, CELL MOL BIOL, V48, P151; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Skovronsky DM, 2001, J NEUROBIOL, V49, P40, DOI 10.1002/neu.1064; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vilalta A, 2008, ACTA NEUROCHIR SUPPL, V102, P415, DOI 10.1007/978-3-211-85578-2_81; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Walker EJ, 2009, EXP NEUROL, V216, P122, DOI 10.1016/j.expneurol.2008.11.022; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xue MZ, 2009, BRAIN, V132, P26, DOI 10.1093/brain/awn215; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x; Yong VW, 2007, J NEUROL SCI, V259, P79, DOI 10.1016/j.jns.2006.11.021; Yong VW, 2007, NEUROTHERAPEUTICS, V4, P580, DOI 10.1016/j.nurt.2007.07.005; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zhang S., 2012, DISTINCT PATTERNS PR; Zhang S., 2013, TREATMENT ISCHEMIC S	59	22	23	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2016	96						46	55		10.1016/j.neuint.2016.02.013			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DN1DO	WOS:000376806700005	26939762				2022-02-06	
J	Chung, S; Rho, S; Kim, G; Kim, SR; Baek, KH; Kang, M; Lew, H				Chung, Sokjoong; Rho, Seungsoo; Kim, Gijin; Kim, So-Ra; Baek, Kwang-Hyun; Kang, Myungseo; Lew, Helen			Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						optic nerve; placenta; stem cells; traumatic optic neuropathy; umbilical cord blood mononuclear cells	BONE-MARROW; HUMAN-PLACENTA; BRAIN-INJURY; PARACRINE MECHANISMS; NEUROTROPHIC FACTORS; PROGENITOR CELLS; CEREBRAL-PALSY; ISCHEMIC-HEART; IN-VITRO; REGENERATION	The use of mesenchymal stem cells (MSCs) in cell therapy in regenerative medicine has great potential, particularly in the treatment of nerve injury. Umbilical cord blood (UCB) reportedly contains stem cells, which have been widely used as a hematopoietic source and may have therapeutic potential for neurological impairment. Although ongoing research is dedicated to the management of traumatic optic nerve injury using various measures, novel therapeutic strategies based on the complex underlying mechanisms responsible for optic nerve injury, such as inflammation and/or ischemia, are required. In the present study, a rat model of optic nerve crush (ONC) injury was established in order to examine the effects of transplanting human chorionic plate-derived MSCs (CP-MSCs) isolated from the placenta, as well as human UCB mononuclear cells (CB-MNCs) on compressed rat optic nerves. Expression markers for inflammation, apoptosis, and optic nerve regeneration were analyzed, as well as the axon survival rate by direct counting. Increased axon survival rates were observed following the injection of CB-MNCs at at 1 week post-transplantation compared with the controls. The levels of growth-associated protein-43 (GAP-43) were increased after the injection of CB-MNCs or CP-MSCs compared with the controls, and the expression levels of hypoxia-inducible factor-1 (HIF-1) were also significantly increased following the injection of CB-MNCs or CP-MSCs. ERM-like protein (ERMN) and SLIT-ROBO Rho GTPase activating protein 2 (SRGAP2) were found to be expressed in the optic nerves of the CP-MSC-injected rats with ONC injury. The findings of our study suggest that the administration of CB-MNCs or CP-MSCs may promote axon survival through systemic concomitant mechanisms involving GAP-43 and HIF-1. Taken together, these findings provide further understanding of the mechanisms repsonsible for optic nerve injury and may aid in the development of novel cell-based therapeutic strategies with future applications in regenerative medicine, particularly in the management of optic nerve disorders.	[Chung, Sokjoong; Rho, Seungsoo; Lew, Helen] CHA Univ, Dept Ophthalmol, CHA Bundang Med Ctr, 59 Yatap Ro, Songnam 463712, Gyeonggi Do, South Korea; [Kim, Gijin; Kim, So-Ra; Baek, Kwang-Hyun] CHA Univ, Dept Biomed Sci, CHA Bundang Med Ctr, Songnam 463712, Gyeonggi Do, South Korea; [Kang, Myungseo] CHA Univ, Dept Lab Med, CHA Bundang Med Ctr, Songnam 463712, Gyeonggi Do, South Korea; [Kang, Myungseo] CHA Med Ctr Cord Blood Bank, Songnam, Gyeonggi Do, South Korea		Lew, H (corresponding author), CHA Univ, Dept Ophthalmol, CHA Bundang Med Ctr, 59 Yatap Ro, Songnam 463712, Gyeonggi Do, South Korea.	eye@cha.ac.kr		Baek, Kwang-Hyun/0000-0001-7662-7190	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2014R1A2A2A01002617]	The present study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (no. NRF-2014R1A2A2A01002617).	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Aoki H, 2008, GRAEF ARCH CLIN EXP, V246, P255, DOI 10.1007/s00417-007-0710-6; Benowitz LI, 2010, ARCH OPHTHALMOL-CHIC, V128, P1059, DOI 10.1001/archophthalmol.2010.152; Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Bull ND, 2008, INVEST OPHTH VIS SCI, V49, P3449, DOI 10.1167/iovs.08-1770; Bull ND, 2009, INVEST OPHTH VIS SCI, V50, P4244, DOI 10.1167/iovs.08-3239; Canque B, 2000, BLOOD, V96, P3748, DOI 10.1182/blood.V96.12.3748.h8003748_3748_3756; Charalambous P, 2008, INVEST OPHTH VIS SCI, V49, P3513, DOI 10.1167/iovs.07-1473; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Ebneter A, 2012, CLIN EXP OPHTHALMOL, V40, P626, DOI 10.1111/j.1442-9071.2011.02741.x; Gijtenbeek JMM, 1999, J NEUROL, V246, P339, DOI 10.1007/s004150050360; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gornicka-Pawlak E, 2011, ACTA NEUROBIOL EXP, V71, P46; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hellwig-Burgel T, 2005, J INTERF CYTOK RES, V25, P297, DOI 10.1089/jir.2005.25.297; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Jung J, 2013, STEM CELLS, V31, P1584, DOI 10.1002/stem.1396; Kaneda M, 2010, ADV EXP MED BIOL, V664, P97, DOI 10.1007/978-1-4419-1399-9_12; Kao CH, 2008, SHOCK, V29, P49, DOI 10.1097/shk.0b013c31805cddce; Kato S, 1999, NEUROSCIENCE, V93, P907, DOI 10.1016/S0306-4522(99)00202-X; Kim CY, 2016, VET OPHTHALMOL, V19, P29, DOI 10.1111/vop.12247; Kim MJ, 2011, CELL TISSUE RES, V346, P53, DOI 10.1007/s00441-011-1249-8; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Koriyama Y, 2007, NEUROCHEM INT, V50, P749, DOI 10.1016/j.neuint.2007.01.012; Lee JM, 2012, INT IMMUNOPHARMACOL, V13, P219, DOI 10.1016/j.intimp.2012.03.024; Lee MJ, 2010, J CELL BIOCHEM, V111, P1453, DOI 10.1002/jcb.22873; Lee MW, 2010, INT J HEMATOL, V92, P45, DOI 10.1007/s12185-010-0619-4; Lee Y, 2013, J CELL BIOCHEM, V114, P79, DOI 10.1002/jcb.24303; Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310; Li CD, 2007, CELL TISSUE RES, V330, P437, DOI 10.1007/s00441-007-0504-5; Li JY, 2015, J CRANIOFAC SURG, V26, P548, DOI 10.1097/SCS.0000000000001348; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; Min K, 2013, STEM CELLS, V31, P581, DOI 10.1002/stem.1304; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Newcomb JD, 2007, CELL TRANSPLANT, V16, P151; Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; Papadopoulos KI, 2011, RESTOR NEUROL NEUROS, V29, P17, DOI 10.3233/RNN-2011-0572; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Rho S, 2014, CURR EYE RES, V39, P917, DOI 10.3109/02713683.2014.884597; Sanchez CG, 2011, CARCINOGENESIS, V32, P964, DOI 10.1093/carcin/bgr029; Sun J, 2010, TRANSFUSION, V50, P1980, DOI 10.1111/j.1537-2995.2010.02720.x; Tajima T, 2009, BIOCHEM BIOPH RES CO, V387, P789, DOI 10.1016/j.bbrc.2009.07.115; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vollmer S, 2009, HEPATOLOGY, V50, P253, DOI 10.1002/hep.22928; Zhao TT, 2011, GRAEF ARCH CLIN EXP, V249, P1021, DOI 10.1007/s00417-011-1635-7	51	22	24	0	14	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2016	37	5					1170	1180		10.3892/ijmm.2016.2532			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DK7FR	WOS:000375091000003	26986762	Green Submitted, Green Published, hybrid			2022-02-06	
J	Ferguson, NM; Shein, SL; Kochanek, PM; Luther, J; Wisniewski, SR; Clark, RSB; Tyler-Kabara, EC; Adelson, PD; Bell, MJ				Ferguson, Nikki Miller; Shein, Steven L.; Kochanek, Patrick M.; Luther, Jim; Wisniewski, Stephen R.; Clark, Robert S. B.; Tyler-Kabara, Elizabeth C.; Adelson, P. David; Bell, Michael J.			Intracranial Hypertension and Cerebral Hypoperfusion in Children With Severe Traumatic Brain Injury: Thresholds and Burden in Accidental and Abusive Insults	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; cerebral perfusion pressure; intracranial hypertension; intracranial pressure; pediatric neurocritical care; traumatic brain injury	PERFUSION-PRESSURE; UNITED-STATES; AUTOREGULATION; SURVIVAL; TRIAL	Objectives: The evidence to guide therapy in pediatric traumatic brain injury is lacking, including insight into the intracranial pressure/cerebral perfusion pressure thresholds in abusive head trauma. We examined intracranial pressure/cerebral perfusion pressure thresholds and indices of intracranial pressure and cerebral perfusion pressure burden in relationship with outcome in severe traumatic brain injury and in accidental and abusive head trauma cohorts. Design: A prospective observational study. Setting: PICU in a tertiary children's hospital. Patients: Children less than 18 years old admitted to a PICU with severe traumatic brain injury and who had intracranial pressure monitoring. Interventions: None. Measurements and Main Results: A pediatric traumatic brain injury database was interrogated with 85 patients (18 abusive head trauma) enrolled. Hourly intracranial pressure and cerebral perfusion pressure (in mm Hg) were collated and compared with various thresholds. C-statistics for intracranial pressure and cerebral perfusion pressure data in the entire population were determined. Intracranial hypertension and cerebral hypoperfusion indices were formulated based on the number of hours with intracranial pressure more than 20 mm Hg and cerebral perfusion pressure less than 50 mm Hg, respectively. A secondary analysis was performed on accidental and abusive head trauma cohorts. All of these were compared with dichotomized 6-month Glasgow Outcome Scale scores. The models with the number of hours with intracranial pressure more than 20 mm Hg (C = 0.641; 95% CI, 0.523-0.762) and cerebral perfusion pressure less than 45 mm Hg (C = 0.702; 95% CI, 0.586-0.805) had the best fits to discriminate outcome. Two factors were independently associated with a poor outcome, the number of hours with intracranial pressure more than 20 mm Hg and abusive head trauma (odds ratio = 5.101; 95% CI, 1.571-16.563). As the number of hours with intracranial pressure more than 20 mm Hg increases by 1, the odds of a poor outcome increased by 4.6% (odds ratio = 1.046; 95% CI, 1.012-1.082). Thresholds did not differ between accidental versus abusive head trauma. The intracranial hypertension and cerebral hypoperfusion indices were both associated with outcomes. Conclusions: The duration of hours of intracranial pressure more than 20 mm Hg and cerebral perfusion pressure less than 45 mm Hg best discriminated poor outcome. As the number of hours with intracranial pressure more than 20 mm Hg increases by 1, the odds of a poor outcome increased by 4.6%. Although abusive head trauma was strongly associated with unfavorable outcome, intracranial pressure/cerebral perfusion pressure thresholds did not differ between accidental and abusive head trauma.	[Ferguson, Nikki Miller; Shein, Steven L.; Kochanek, Patrick M.; Clark, Robert S. B.; Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Ferguson, Nikki Miller; Shein, Steven L.; Kochanek, Patrick M.; Clark, Robert S. B.; Bell, Michael J.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Luther, Jim; Wisniewski, Stephen R.] Univ Pittsburgh, Sch Med, Dept Epidemiol & Biostat, Pittsburgh, PA USA; [Tyler-Kabara, Elizabeth C.; Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurol Surg, Phoenix, AZ USA		Bell, MJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Bell, MJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Adelson, David/W-2083-2019; Shein, Steven/I-7763-2019; Tyler-Kabara, Elizabeth/H-4930-2013; Ferguson, Nikki Miller/AAA-4548-2020	Shein, Steven/0000-0003-3382-5159; Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Wisniewski, Stephen/0000-0002-3877-9860	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD040686, NS052478, NS069247, NS081041, HD0499893, NS072308]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32]; Society of Critical Care Medicine; Elsevier book royalties; Consulting through TKGroup, LLC; University of TorontoUniversity of Toronto; DARPA NIH; Codman Neuro;  [NIH/NICHD-5T32HD040686]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069247, U01NS081041, U01NS052478, R01NS072308] Funding Source: NIH RePORTER	The authors of this work received National Institutes of Health grants (Drs. Ferguson and Shein: T32 HD040686; Dr. Wisniewski: NS052478 and NS069247; Dr. Clark: NS069247; Dr. Adelson: NS081041 and NS052478, Dr. Bell: NS081041, HD0499893, NS072308, and NS052478).; Dr. Bell received support for article research from the National Institutes of Health (NIH). Dr. Ferguson received support for article research from the NIH. Her institution received funding from the NIH/NICHD-5T32HD040686. Dr. Shein received support for article research from the NIH. His institution received funding from NIH (T32). Dr. Kochanek is also the editor and/or contributor to multiple textbooks in the field. He received support for article research from the NIH, received funding from the Society of Critical Care Medicine, he serves as a guest professor and lectures frequently at Medical Centers and other Institutions of Higher Education, and he has served as an expert witness in legal cases. His institution received funding from the NIH. Dr. Wisniewski received support for article research from the NIH. His institution received funding from the NIH. Dr. Clark received funding from Elsevier book royalties. His institution received funding from NIH grants unrelated to present work. Dr. Tyler-Kabara received funding from Consulting through TKGroup, LLC (No monies personally received) and from University of Toronto. Her institution received funding from DARPA NIH. Dr. Adelson consulted for Adelson Medical Consulting, LLC; is employed by Phoenix Children's Hospital; provided expert testimony for various medical legal case; and received royalties from Thieme Publishing. His institution received grant support from Codman Neuro and the NIH. Dr. Luther disclosed that he does not have any potential conflicts of interest.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Au AK, 2011, PEDIATR CRIT CARE ME, V12, P566, DOI 10.1097/PCC.0b013e3181fe3420; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Mathews TJ, 2011, PEDIATRICS, V127, P146, DOI 10.1542/peds.2010-3175; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala MS, 2003, J NEUROSURG ANESTH, V15, P307, DOI 10.1097/00008506-200310000-00003; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165	24	22	23	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2016	17	5					444	450		10.1097/PCC.0000000000000709			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Pediatrics	DR0KH	WOS:000379595900016	27028792	Green Accepted			2022-02-06	
J	Gilmore, CS; Camchong, J; Davenport, ND; Nelson, NW; Kardon, RH; Lim, KO; Sponheim, SR				Gilmore, Casey S.; Camchong, Jazmin; Davenport, Nicholas D.; Nelson, Nathaniel W.; Kardon, Randy H.; Lim, Kelvin O.; Sponheim, Scott R.			Deficits in Visual System Functional Connectivity after Blast-Related Mild TBI are Associated with Injury Severity and Executive Dysfunction	BRAIN AND BEHAVIOR			English	Article						blast TBI; executive function; functional connectivity; rest fMRI; TBI severity; traumatic brain injury; Visual	TRAUMATIC BRAIN-INJURY; LATERAL GENICULATE-NUCLEUS; DEPLOYED MILITARY PERSONNEL; RESTING-STATE NETWORKS; WHITE-MATTER; COGNITIVE RESERVE; OCCIPITAL CORTEX; NATIONAL-GUARD; WORKING-MEMORY; FMRI	Introduction: Approximately, 275,000 American service members deployed to Iraq or Afghanistan have sustained a mild traumatic brain injury (mTBI), with 75% of these incidents involving an explosive blast. Visual processing problems and cognitive dysfunction are common complaints following blast-related mTBI. Methods: In 127 veterans, we examined resting fMRI functional connectivity (FC) of four key nodes within the visual system: lateral geniculate nucleus (LGN), primary visual cortex (V1), lateral occipital gyrus (LO), and fusiform gyrus (FG). Regression analyses were performed (i) to obtain correlations between time-series from each seed and all voxels in the brain, and (ii) to identify brain regions in which FC variability was related to blast mTBI severity. Blast-related mTBI severity was quantified as the sum of the severity scores assigned to each of the three most significant blast-related injuries self-reported by subjects. Correlations between FC and performance on executive functioning tasks were performed across participants with available behavioral data (n = 94). Results: Greater blast mTBI severity scores were associated with lower FC between: (A) LGN seed and (i) medial frontal gyrus, (ii) lingual gyrus, and (iii) right ventral anterior nucleus of thalamus; (B) V1 seed and precuneus; (C) LO seed and middle and superior frontal gyri; (D) FG seed and (i) superior and medial frontal gyrus, and (ii) left middle frontal gyrus. Finally, lower FC between visual network regions and frontal cortical regions predicted worse performance on the WAIS digit-symbol coding task. Conclusion: These are the first published results that directly illustrate the relationship between blast-related mTBI severity, visual pathway neural networks, and executive dysfunction -results that highlight the detrimental relationship between blast-related brain injury and the integration of visual sensory input and executive processes.	[Gilmore, Casey S.; Lim, Kelvin O.] Def & Vet Brain Injury Ctr, Minneapolis, MN USA; [Gilmore, Casey S.; Davenport, Nicholas D.; Nelson, Nathaniel W.; Lim, Kelvin O.; Sponheim, Scott R.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Camchong, Jazmin; Davenport, Nicholas D.; Lim, Kelvin O.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN USA; [Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, Minneapolis, MN USA; [Kardon, Randy H.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Kardon, Randy H.] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA		Gilmore, CS (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, Def & Vet Brain Injury Ctr, 1 Vet Way, Minneapolis, MN 55417 USA.	casey.gilmore2@va.gov	Davenport, Nicholas/AAY-8057-2020; Lim, Kelvin/AAF-6833-2020; Sponheim, Scott/J-3857-2017	Davenport, Nicholas/0000-0002-3441-7256; Sponheim, Scott/0000-0002-2782-0856; Lim, Kelvin/0000-0002-2390-7268; Kardon, Randy/0000-0002-3173-7123	Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0038]; Minnesota Veterans Research Institute (MVRI); Rehabilitation Research and Development Service of the VA Office of Research and Development [1I01RX000622]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000113, UL1TR000114] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000622] Funding Source: NIH RePORTER	This work was supported by grants to Scott R. Sponheim from the Congressionally Directed Medical Research Program (W81XWH-08-2-0038), the Minnesota Veterans Research Institute (MVRI), and the Rehabilitation Research and Development Service of the VA Office of Research and Development (Award Number 1I01RX000622).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Camchong J, 2014, DRUG ALCOHOL DEPEN, V139, P145, DOI 10.1016/j.drugalcdep.2014.03.024; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Caverzasi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100274; Chafetz MD, 2004, ARCH CLIN NEUROPSYCH, V19, P555, DOI 10.1016/j.acn.2003.08.004; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Crowe SF, 1999, AUST PSYCHOL, V34, P204, DOI 10.1080/00050069908257455; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; De Moraes Carlos Gustavo, 2013, J Glaucoma, V22 Suppl 5, pS2, DOI 10.1097/IJG.0b013e3182934978; Debbane M, 2012, SCHIZOPHR RES, V139, P33, DOI 10.1016/j.schres.2012.05.021; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; DENNYBROWN D, 1945, J NEUROPATH EXP NEUR, V4, P305, DOI 10.1097/00005072-194504040-00001; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Forkel SJ, 2014, CORTEX, V56, P73, DOI 10.1016/j.cortex.2012.09.005; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fujita N, 2001, AM J NEURORADIOL, V22, P1719; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Golden C.J., 1978, STROOP WORD COLOR TE; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gour N, 2011, NEUROIMAGE, V58, P687, DOI 10.1016/j.neuroimage.2011.05.090; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Han ZZ, 2013, BRAIN, V136, P2952, DOI 10.1093/brain/awt205; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holdnack JA., 2001, WTAR WECHSLER TEST A; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; HOLM S, 1979, SCAND J STAT, V6, P65; Horowitz-Kraus T, 2015, NEUROIMAGE-CLIN, V8, P619, DOI 10.1016/j.nicl.2015.06.010; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2009, ANN NY ACAD SCI, V1164, P229, DOI 10.1111/j.1749-6632.2009.03770.x; Kardon R. H., 2013, ARVO 2013 ANN M; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kim MJ, 2003, NEUROSCIENCE, V120, P283, DOI 10.1016/S0306-4522(03)00021-6; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kubler A, 2006, J COGNITIVE NEUROSCI, V18, P1331, DOI 10.1162/jocn.2006.18.8.1331; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Lauritzen TZ, 2009, J VISION, V9, DOI 10.1167/9.13.18; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magone M. T., 2013, US NEUROL, V9, P61; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Markett S, 2014, HUM BRAIN MAPP, V35, P1700, DOI 10.1002/hbm.22285; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Moussa MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044428; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Patriat R, 2013, NEUROIMAGE, V78, P463, DOI 10.1016/j.neuroimage.2013.04.013; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Reineberg AE, 2015, NEUROIMAGE, V104, P69, DOI 10.1016/j.neuroimage.2014.09.045; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; RUSSELL EW, 1972, J CONSULT CLIN PSYCH, V39, P133, DOI 10.1037/h0033212; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; SALTHOUSE TA, 1992, J GERONTOL, V47, pP121, DOI 10.1093/geronj/47.3.P121; Sarubbo S, 2015, HUM BRAIN MAPP, V36, P3117, DOI 10.1002/hbm.22832; Sarubbo S, 2015, J ANAT, V226, P47, DOI 10.1111/joa.12254; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schneider KA, 2004, J NEUROSCI, V24, P8975, DOI 10.1523/JNEUROSCI.2413-04.2004; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; SPRANDEL HZ, 1995, PSYCHOEDUCATIONAL US; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wardlaw A, 2010, IFMBE PROC, V32, P34, DOI 10.1007/978-3-642-14998-6_9; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WOOSAM J, 1971, PERCEPT MOTOR SKILL, V32, P407, DOI 10.2466/pms.1971.32.2.407; Xu JH, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00200; Zelinsky DG, 2010, PM&R, V2, P852, DOI 10.1016/j.pmrj.2010.06.012; Zhang JX, 2003, NEUROIMAGE, V20, P1531, DOI 10.1016/j.neuroimage.2003.07.016; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhu Q, 2011, J NEUROSCI, V31, P10323, DOI 10.1523/JNEUROSCI.0873-11.2011	124	22	22	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	MAY	2016	6	5							e00454	10.1002/brb3.454			19	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	DQ2FY	WOS:000379019000005	27257516	gold, Green Published			2022-02-06	
J	Jungner, M; Siemund, R; Venturoli, D; Reinstrup, P; Schalen, W; Bentzer, P				Jungner, Marten; Siemund, Roger; Venturoli, Daniele; Reinstrup, Peter; Schalen, Wilhelm; Bentzer, Peter			Blood-brain barrier permeability following traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Blood-brain barrier; Brain injuries; Permeability; Linear models	PERFUSION CT ASSESSMENT; HEAD-INJURY; MICROVASCULAR PERMEABILITY; INTRACRANIAL HYPERTENSION; COMPUTED-TOMOGRAPHY; FLUID RESUSCITATION; CORTICAL CONTUSION; CEREBRAL CONTUSION; EDEMA FORMATION; DIFFUSION MRI	BACKGROUND: Brain edema and intracranial hypertension is deleterious after traumatic brain injury (TBI), but the underlying pathophysiology is complex and poorly understood. One major subject of controversy is the time course and extent of blood-brain barrier (BBB) dysfunction following trauma, and previous studies in humans have only provided semi-quantitative data. The objective of the present study was therefore to quantify changes in BBB-permeability in the early course of TBI, when brain edema is still evolving. METHODS: Sixteen non-consecutive brain trauma patients and two controls were included. Following i.v. injection of iohexol and CT perfusion scans, patients were scanned eight times from 4 to 25 minutes. Blood to brain transfer constant (K-i) for iohexol (molecular weight 821 D), reflecting permeability and available area for diffusion, was calculated offline by Patlak plot analysis of the enhancement curves of intracerebral large venous vessels and pericontusional brain parenchyma. RESULTS: In non-ischemic tissue surrounding contusions and hematomas K-i was increased 2- to 10-fold compared to normal tissue, reaching maximal values of 0.5 mL/min/ 100 g. In non-injured areas and in controls K-i was about 0.06 mL/min/ 100 g. The increase was more pronounced in the most severely injured patients, and was detectable within 24 hours after trauma and up to five days after. CONCLUSIONS: Our results suggest that traumatic brain injury is associated with early focal increases in small molecular BBB-permeability. The results indicate that in the injured brain, capillary hydrostatic and oncotic pressures may influence edema formation.	[Jungner, Marten; Venturoli, Daniele; Reinstrup, Peter; Bentzer, Peter] Lund Univ, Dept Anesthesiol & Intens Care, S-22185 Lund, Sweden; [Jungner, Marten; Siemund, Roger; Venturoli, Daniele; Reinstrup, Peter; Schalen, Wilhelm; Bentzer, Peter] Skane Univ Hosp, Lund, Sweden; [Siemund, Roger] Lund Univ, Dept Radiol, Lund, Sweden; [Schalen, Wilhelm] Lund Univ, Dept Neurosurg, Lund, Sweden		Bentzer, P (corresponding author), Lund Univ, Dept Anesthesiol & Intens Care, S-22185 Lund, Sweden.; Bentzer, P (corresponding author), Skane Univ Hosp, Lund, Sweden.	peter.bentzer@hotmail.com		Siemund, Roger/0000-0002-8333-9442			Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BARTOLINI A, 1994, COMPUT MED IMAG GRAP, V18, P145, DOI 10.1016/0895-6111(94)90023-X; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, ACT NEUR S, V70, P243; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; BULLOCK R, 1990, ACT NEUR S, V51, P286; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Dankbaar JW, 2008, AM J NEURORADIOL, V29, P1671, DOI 10.3174/ajnr.A1203; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; FENSTERMACHER JD, 1981, PHARMACOL THERAPEUT, V14, P217, DOI 10.1016/0163-7258(81)90062-0; Fenstermacher JD, 1984, EDEMA; Fieselmann A, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/467563; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; GROOTHUIS DR, 1991, ANN NEUROL, V30, P581, DOI 10.1002/ana.410300411; GROOTHUIS DR, 1991, J CEREBR BLOOD F MET, V11, P939, DOI 10.1038/jcbfm.1991.159; Hom J, 2009, AM J NEURORADIOL, V30, P1366, DOI 10.3174/ajnr.A1592; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; KUSHI H, 1994, ACTA NEUROCHIR, P472; LANG DA, 1991, ACTA NEUROCHIR, V109, P5, DOI 10.1007/BF01405689; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Lin K, 2007, AM J NEURORADIOL, V28, P1292, DOI 10.3174/ajnr.A0539; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Maeda T, 1997, ACT NEUR S, V70, P102; Maeda T, 2003, ACT NEUR S, V86, P329; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; TOMITA H, 1994, ACTA NEUROCHIR, P547; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Wintermark M, 2001, EUR RADIOL, V11, P1220, DOI 10.1007/s003300000707	41	22	22	0	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	MAY	2016	82	5					525	533					9	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	EA6TG	WOS:000386761300008	26613239				2022-02-06	
J	Pardo, L; Schluter, A; Valor, LM; Barco, A; Giralt, M; Golbano, A; Hidalgo, J; Jia, PL; Zhao, ZM; Jove, M; Portero-Otin, M; Ruiz, M; Gimenez-Llort, L; Masgrau, R; Pujol, A; Galea, E				Pardo, Luis; Schlueter, Agatha; Valor, Luis M.; Barco, Angel; Giralt, Mercedes; Golbano, Arantxa; Hidalgo, Juan; Jia, Peilin; Zhao, Zhongming; Jove, Mariona; Portero-Otin, Manuel; Ruiz, Montserrat; Gimenez-Llort, Lydia; Masgrau, Roser; Pujol, Aurora; Galea, Elena			Targeted activation of CREB in reactive astrocytes is neuroprotective in focal acute cortical injury	GLIA			English	Article						astrocytes; CREB; mitochondria; neuroinflammation; traumatic brain injury	ELEMENT-BINDING PROTEIN; INTERFERON-GAMMA; GENE-EXPRESSION; BRAIN; MICE; CNS; STROKE; CCL2; INTERLEUKIN-6; INFILTRATION	The clinical challenge in acute injury as in traumatic brain injury (TBI) is to halt the delayed neuronal loss that occurs hours and days after the insult. Here we report that the activation of CREB-dependent transcription in reactive astrocytes prevents secondary injury in cerebral cortex after experimental TBI. The study was performed in a novel bitransgenic mouse in which a constitutively active CREB, VP16-CREB, was targeted to astrocytes with the Tet-Off system. Using histochemistry, qPCR, and gene profiling we found less neuronal death and damage, reduced macrophage infiltration, preserved mitochondria, and rescued expression of genes related to mitochondrial metabolism in bitransgenic mice as compared to wild type littermates. Finally, with meta-analyses using publicly available databases we identified a core set of VP16-CREB candidate target genes that may account for the neuroprotective effect. Enhancing CREB activity in astrocytes thus emerges as a novel avenue in acute brain post-injury therapeutics. GLIA 2016;64:853-874	[Pardo, Luis; Golbano, Arantxa; Masgrau, Roser; Galea, Elena] Univ Autonoma Barcelona, Inst Neurociencies, Fac Med, E-08193 Barcelona, Spain; [Pardo, Luis; Golbano, Arantxa; Masgrau, Roser; Galea, Elena] Univ Autonoma Barcelona, Unitat Bioquim, Fac Med, E-08193 Barcelona, Spain; [Schlueter, Agatha; Ruiz, Montserrat; Pujol, Aurora] ISCIII, Ctr Biomed Res Rare Dis CIBERER, Bellvitge Biomed Res Inst IDIBELL, Neurometabol Dis Lab, Barcelona 08907, Spain; [Valor, Luis M.; Barco, Angel] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante 03550, Spain; [Giralt, Mercedes; Hidalgo, Juan] Univ Autonoma Barcelona, Fac Biosci, Inst Neurociencies, E-08193 Barcelona, Spain; [Giralt, Mercedes; Hidalgo, Juan] Univ Autonoma Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, E-08193 Barcelona, Spain; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Jove, Mariona; Portero-Otin, Manuel] Univ Lleida, Dept Expt Med, Biomed Res Inst Lleida, Lleida 25198, Spain; [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Sch Med, Inst Neurociences, Bellaterra 08193, Spain; [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Sch Med, Dept Psychiat & Forens Med, Bellaterra 08193, Spain; [Pujol, Aurora; Galea, Elena] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain		Galea, E (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain.	galea.inc@gmail.com	Galea, Elena/E-1362-2011; Pujol, Aurora/N-4990-2014; Llort, Lydia Gimenez/AAS-7415-2020; Barco, Angel/ABF-1864-2021; Ruiz, Montse/N-4085-2014; Schluter, Agatha/N-4097-2014; Valor, Luis/ABG-1754-2020; Gimenez-Llort, Lydia/I-3347-2015; Pardo-Fernandez, Luis/AAB-3332-2020; Barco, Angel/C-3062-2008; Portero-Otin, Manuel/B-7122-2009; Hidalgo, Juan/C-9082-2011; Masgrau, Roser/D-3047-2011; Jove, Mariona/M-9104-2016; Gimenez-Llort, Lydia/AAI-5182-2021; Schluter, Agatha/AAA-9665-2021	Galea, Elena/0000-0003-4537-9897; Pujol, Aurora/0000-0002-9606-0600; Barco, Angel/0000-0002-0653-3751; Ruiz, Montse/0000-0003-0466-2653; Schluter, Agatha/0000-0001-6732-1528; Pardo-Fernandez, Luis/0000-0002-4355-1369; Barco, Angel/0000-0002-0653-3751; Portero-Otin, Manuel/0000-0002-1823-0299; Hidalgo, Juan/0000-0003-0921-1122; Masgrau, Roser/0000-0002-6722-5939; Jove, Mariona/0000-0001-5577-6162; Gimenez-Llort, Lydia/0000-0002-4091-489X; Valor, Luis M./0000-0002-1229-0565	Ministerio de Economia y Competitividad, Spain - European Regional Development's Fund, FEDER [BFU2010-21921, BFU2012-38844, SAF2011-23272, SAF2011-22506, SAF2011-22855]; Instituto Carlos III, SpainInstituto de Salud Carlos III [ISC3 PI10/00283, PI11/01532]; Autonomous Government of Catalonia AGAUR [2014SGR1430, 2014SGR984]; Generalitat ValencianaGeneralitat ValencianaEuropean CommissionGeneral Electric [Prometeo/2012/005]; Brain & Behavior Research Foundation (NARSAD Independent Investigator Grant); Instituto de Neurociencias de Alicante is a "Centre of Excellence Severo Ochoa"; CIBER on Rare Diseases (CIBERER); ICREAICREA Funding Source: Custom	Grant sponsor: Ministerio de Economia y Competitividad, Spain; Grant numbers: BFU2010-21921, BFU2012-38844 (Co-funded with European Regional Development's Fund, FEDER), SAF2011-23272, SAF2011-22506, SAF2011-22855; Grant sponsor: Instituto Carlos III, Spain; Grant number: ISC3 PI10/00283, PI11/01532; Grant sponsor: Autonomous Government of Catalonia AGAUR; Grant number: 2014SGR1430, 2014SGR984; Grant sponsor: Generalitat Valenciana; Grant number: Prometeo/2012/005; Grant sponsors: Brain & Behavior Research Foundation (NARSAD Independent Investigator Grant, The Instituto de Neurociencias de Alicante is a "Centre of Excellence Severo Ochoa", CIBER on Rare Diseases (CIBERER).	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Almolda B, 2014, GLIA, V62, P1142, DOI 10.1002/glia.22668; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burnside ER, 2014, NEUROPATH APPL NEURO, V40, P26, DOI 10.1111/nan.12114; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CANCILLA PA, 1992, J NEUROPATH EXP NEUR, V51, P560, DOI 10.1097/00005072-199209000-00011; Carriba P, 2012, GLIA, V60, P1330, DOI 10.1002/glia.22352; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; Cowley MJ, 2012, NUCL ACIDS RES, V40; Dong Y, 2014, TRENDS PHARMACOL SCI, V35, P374, DOI 10.1016/j.tips.2014.05.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Franceschini A, 2013, NUCL ACIDS RES, V41; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Heiman M, 2009, NIH PUBLIC ACCESS, V135, P738; Kaur H, 2013, PHARMACOLOGY, V92, P324, DOI 10.1159/000356320; Kim RY, 2014, J NEUROIMMUNOL, V274, P53, DOI 10.1016/j.jneuroim.2014.06.009; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lichtenstein MP, 2012, NEUROSIGNALS, V20, P86, DOI 10.1159/000330805; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Liu YY, 2014, J NEUROSCI, V34, P2813, DOI 10.1523/JNEUROSCI.3541-13.2014; Ma TC, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582460; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Moreno M, 2014, J NEUROSCI, V34, P8175, DOI 10.1523/JNEUROSCI.1137-14.2014; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park SA, 2003, EXP MOL MED, V35, P365, DOI 10.1038/emm.2003.48; Parra-Damas A, 2014, J NEUROSCI, V34, P5776, DOI 10.1523/JNEUROSCI.5288-13.2014; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Prado J, 2013, NEUROCHEM INT, V62, P70, DOI 10.1016/j.neuint.2012.11.008; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; Valor LM, 2010, CELL DEATH DIFFER, V17, P1636, DOI 10.1038/cdd.2010.40; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LJ, 2011, NEUROSCI LETT, V488, P279, DOI 10.1016/j.neulet.2010.11.047; Xu LJ, 2010, GLIA, V58, P1042, DOI 10.1002/glia.20985; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zheng SY, 2012, GENOMICS, V99, P183, DOI 10.1016/j.ygeno.2011.12.005	63	22	22	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAY	2016	64	5					853	874		10.1002/glia.22969			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI0OR	WOS:000373197000013	26880229				2022-02-06	
J	Wang, L; Fu, XW; Peng, X; Xiao, Z; Li, ZG; Chen, GJ; Wang, XF				Wang, Liang; Fu, Xinwei; Peng, Xi; Xiao, Zheng; Li, Zhonggui; Chen, Guojun; Wang, Xuefeng			DNA Methylation Profiling Reveals Correlation of Differential Methylation Patterns with Gene Expression in Human Epilepsy	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Human; Epilepsy; DNA methylation; Microarray; Gene expression	TRAUMATIC BRAIN-INJURY; INTRACTABLE EPILEPSY; PROMOTER METHYLATION; STATUS EPILEPTICUS; EPILEPTOGENESIS; EPIGENETICS; ACTIVATION; HYPOTHESIS; CARNOSINE; SEIZURES	DNA methylation plays important roles in regulating gene expression and has been reported to be related with epilepsy. This study aimed to define differential DNA methylation patterns in drug-refractory epilepsy patients and to investigate the role of DNA methylation in human epilepsy. We performed DNA methylation profiling in brain tissues from epileptic and control patients via methylated-cytosine DNA immunoprecipitation microarray chip. Differentially methylated loci were validated by bisulfite sequencing PCR, and the messenger RNA (mRNA) levels of candidate genes were evaluated by reverse transcriptase PCR. We found 224 genes that showed differential DNA methylation between epileptic patients and controls. Among the seven candidate genes, three genes (TUBB2B, ATPGD1, and HTR6) showed relative transcriptional regulation by DNA methylation. TUBB2B and ATPGD1 exhibited hypermethylation and decreased mRNA levels, whereas HTR6 displayed hypomethylation and increased mRNA levels in the epileptic samples. Our findings suggest that certain genes become differentially regulated by DNA methylation in human epilepsy.	[Wang, Liang; Fu, Xinwei; Xiao, Zheng; Li, Zhonggui; Chen, Guojun; Wang, Xuefeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, Chongqing 400016, Peoples R China; [Peng, Xi] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing 400010, Peoples R China		Wang, XF (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, Chongqing 400016, Peoples R China.	xfyp@163.com		Chen, Guo-Jun/0000-0001-8148-9810	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201003, 81271445]	This work was supported by the National Natural Science Foundation of China (grant numbers 81201003, 81271445). We thank the patients and their families for their participation in this study. We also thank the KangChen Bio-tech for the technical assistance with the MeDIP-chip.	Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Belhedi N, 2014, EPILEPSY RES, V108, P144, DOI 10.1016/j.eplepsyres.2013.10.007; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Freitas RL, 2009, EXP NEUROL, V217, P16, DOI 10.1016/j.expneurol.2009.01.003; Gardiner J, 2010, NEUROSCIENTIST, V16, P28, DOI 10.1177/1073858409334422; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kobow K, 2013, ACTA NEUROPATHOL, V126, P741, DOI 10.1007/s00401-013-1168-8; Kobow K, 2013, EPILEPSIA, V54, P41, DOI 10.1111/epi.12183; Kobow K, 2011, EPILEPSIA, V52, P15, DOI 10.1111/j.1528-1167.2011.03145.x; Kobow K, 2009, J NEUROPATH EXP NEUR, V68, P356, DOI 10.1097/NEN.0b013e31819ba737; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Luo J, 2012, NEUROCHEM RES, V37, P1381, DOI 10.1007/s11064-012-0712-6; Machnes ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076299; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Miyaji T, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-15; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Ortiz RM, 2005, MOL BRAIN RES, V137, P272, DOI 10.1016/j.molbrainres.2005.03.008; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Schumacher Axel, 2008, V439, P109, DOI 10.1007/978-1-59745-188-8_8; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Uribe V, 2010, Clin Genet, V77, P34; Xi ZQ, 2007, EUR J NEUROL, V14, P865, DOI 10.1111/j.1468-1331.2007.01777.x; Xi ZQ, 2009, SYNAPSE, V63, P1017, DOI 10.1002/syn.20681; Yuan J, 2010, J MOL NEUROSCI, V42, P53, DOI 10.1007/s12031-010-9330-4; Zhu Q, 2012, J MOL NEUROSCI, V46, P420, DOI 10.1007/s12031-011-9602-7; Zhu YY, 2007, NEUROSCI LETT, V416, P211, DOI 10.1016/j.neulet.2007.01.075	42	22	23	3	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2016	59	1					68	77		10.1007/s12031-016-0735-6			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DL0JK	WOS:000375318500008	27067309				2022-02-06	
J	DeMar, J; Sharrow, K; Hill, M; Berman, J; Oliver, T; Long, J				DeMar, James; Sharrow, Keith; Hill, Miya; Berman, Jonathan; Oliver, Thomas; Long, Joseph			Effects of Primary Blast Overpressure on Retina and Optic Tract in Rats	FRONTIERS IN NEUROLOGY			English	Article						blast; neurotrauma; retina; optic tract; rat	TRAUMATIC BRAIN-INJURY; INDUCED OCULAR TRAUMA; MOUSE MODEL; AFGHANISTAN WARS; DEGENERATION; TBI; DAMAGE; EYE; PATHOPHYSIOLOGY; MECHANISMS	Blast has been the leading cause of injury, particularly traumatic brain injury and visual system injury, in combat operations in Iraq and Afghanistan. We determined the effect of shock tube-generated primary blast on retinal electrophysiology and on retinal and brain optic tract histopathology in a rat model. The amplitude of a- and b-waves on the electroretinogram (ERG) for both right and left eyes were measured prior to a battlefield simulation Friedlander-type blast wave and on 1, 7, and 14 days thereafter. Histopathologic findings of the right and left retina and the right and left optic tracts (2.8 mm postoptic chiasm) were evaluated 14 days after the blast. For two experiments in which the right eye was oriented to the blast, the amplitude of ERG a- and b-waves at 7 days post blast on the right side but not on the left side was diminished compared to that of sham animals (P = 0.005-0.01) Histopathologic injury scores at 14 days post blast for the right retina but not the left retina were higher than for sham animals (P = 0.01), and histopathologic injury scores at 14 days for both optic tracts were markedly higher than for shams (P < 0.0001). Exposure of one eye to a blast wave, comparable to that causing human injury, produced injury to the retina as determined by ERG and histopathology, and to both postchiasmatic optic tracts as determined by histopathology. This model may be useful for analyzing the effect of therapeutic interventions on retinal damage due to primary blast waves.	[DeMar, James; Hill, Miya; Long, Joseph] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Sharrow, Keith] Med Countermeasures Syst, Frederick, MD USA; [Berman, Jonathan] Walter Reed Army Inst Res, Dept Clin Pharmacol, Silver Spring, MD USA; [Oliver, Thomas] Uniformed Serv Univ Hlth Sci, Clin Res Unit, Bethesda, MD 20814 USA		DeMar, J (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA.	james.c.demar.ctr@mail.mil			USAMRMC/TATRC Vision Research Program [W81XWH-12-2-0082]	This work was supported in part by a USAMRMC/TATRC Vision Research Program grant award, #: W81XWH-12-2-0082.	Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; Banihani SM, 2010, MED HYPOTHESES, V74, P741, DOI 10.1016/j.mehy.2009.10.037; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Hendrickson A, 2015, BRAIN STRUCT FUNCT, V220, P351, DOI 10.1007/s00429-013-0659-7; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Jiang YD, 2014, CYTOKINE, V70, P115, DOI 10.1016/j.cyto.2014.07.004; Jiang YD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-96; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Morley MG, 2010, DISASTER MED PUBLIC, V4, P154, DOI 10.1001/dmp.v4n2.hra10003; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rossi T, 2012, INVEST OPHTH VIS SCI, V53, P8057, DOI 10.1167/iovs.12-10591; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; THANOS S, 1991, J CELL SCI, P125; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; You YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052061; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	32	22	22	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 25	2016	7								59	10.3389/fneur.2016.00059			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK0WV	WOS:000374633800001	27199884	Green Published, gold			2022-02-06	
J	Xu, J; Sisniega, A; Zbijewski, W; Dang, H; Stayman, JW; Wang, X; Foos, DH; Aygun, N; Koliatsos, VE; Siewerdsen, JH				Xu, J.; Sisniega, A.; Zbijewski, W.; Dang, H.; Stayman, J. W.; Wang, X.; Foos, D. H.; Aygun, N.; Koliatsos, V. E.; Siewerdsen, J. H.			Modeling and design of a cone-beam CT head scanner using task-based imaging performance optimization	PHYSICS IN MEDICINE AND BIOLOGY			English	Article						cone-beam computed tomography; cascaded systems analysis; image quality; imaging task; detectability index; traumatic brain injury; intracranial hemorrhage	CASCADED SYSTEMS-ANALYSIS; NOISE-POWER SPECTRUM; FLAT-PANEL DETECTOR; DEDICATED BREAST CT; X-RAY-DETECTOR; COMPUTED-TOMOGRAPHY; ARTIFACT-CORRECTION; QUALITY; MOBILE; RECONSTRUCTION	Detection of acute intracranial hemorrhage (ICH) is important for diagnosis and treatment of traumatic brain injury, stroke, postoperative bleeding, and other head and neck injuries. This paper details the design and development of a cone-beam CT (CBCT) system developed specifically for the detection of low-contrast ICH in a form suitable for application at the point of care. Recognizing such a low-contrast imaging task to be a major challenge in CBCT, the system design began with a rigorous analysis of task-based detectability including critical aspects of system geometry, hardware configuration, and artifact correction. The imaging performance model described the three-dimensional (3D) noiseequivalent quanta using a cascaded systems model that included the effects of scatter, scatter correction, hardware considerations of complementary metaloxide semiconductor (CMOS) and flat-panel detectors (FPDs), and digitization bit depth. The performance was analyzed with respect to a low-contrast (40-80 HU), medium-frequency task representing acute ICH detection. The task-based detectability index was computed using a non-prewhitening observer model. The optimization was performed with respect to four major design considerations: (1) system geometry (including source-to-detector distance (SDD) and sourceto-axis distance (SAD)); (2) factors related to the x-ray source (including focal spot size, kVp, dose, and tube power); (3) scatter correction and selection of an antiscatter grid; and (4) x-ray detector configuration (including pixel size, additive electronics noise, field of view (FOV), and frame rate, including both CMOS and a-Si: H FPDs). Optimal design choices were also considered with respect to practical constraints and available hardware components. The model was verified in comparison to measurements on a CBCT imaging bench as a function of the numerous design parameters mentioned above. An extended geometry (SAD = 750 mm, SDD = 1100 mm) was found to be advantageous in terms of patient dose (20 mGy) and scatter reduction, while a more isocentric configuration (SAD = 550 mm, SDD = 1000 mm) was found to give a more compact and mechanically favorable configuration with minor tradeoff in detectability. An x-ray source with a 0.6 mm focal spot size provided the best compromise between spatial resolution requirements and x-ray tube power. Use of a modest anti-scatter grid (8: 1 GR) at a 20 mGy dose provided slight improvement (similar to 5-10%) in the detectability index, but the benefit was lost at reduced dose. The potential advantages of CMOS detectors over FPDs were quantified, showing that both detectors provided sufficient spatial resolution for ICH detection, while the former provided a potentially superior low-dose performance, and the latter provided the requisite FOV for volumetric imaging in a centered-detector geometry. Task-based imaging performance modeling provides an important starting point for CBCT system design, especially for the challenging task of ICH detection, which is somewhat beyond the capabilities of existing CBCT platforms. The model identifies important tradeoffs in system geometry and hardware configuration, and it supports the development of a dedicated CBCT system for point-of-care application. A prototype suitable for clinical studies is in development based on this analysis.	[Xu, J.; Sisniega, A.; Zbijewski, W.; Dang, H.; Stayman, J. W.; Siewerdsen, J. H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Wang, X.; Foos, D. H.] Carestream Hlth, Rochester, NY 14608 USA; [Aygun, N.; Siewerdsen, J. H.] Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA; [Koliatsos, V. E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA		Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu	Dang, Hao/U-4865-2018	Dang, Hao/0000-0001-5861-6535; Stayman, Joseph/0000-0003-4358-378X; Sisniega, Alejandro/0000-0003-2030-2711	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-CA-112163]; Carestream Health (Rochester NY)	This work was supported by the National Institutes of Health (R01-CA-112163) and academic-industry partnership with Carestream Health (Rochester NY).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Albert M, 2000, MED PHYS, V27, P2417, DOI 10.1118/1.1286592; ANTONUK LE, 1995, P SOC PHOTO-OPT INS, V2432, P216, DOI 10.1117/12.208340; Badal A, 2009, IEEE T MED IMAGING, V28, P1894, DOI 10.1109/TMI.2009.2021615; Badano A, 2011, MED PHYS, V38, P2095, DOI 10.1118/1.3567497; BARRETT HH, 1993, P NATL ACAD SCI USA, V90, P9758, DOI 10.1073/pnas.90.21.9758; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; Boone JM, 1997, MED PHYS, V24, P1661, DOI 10.1118/1.597953; Carlson AP, 2012, J NEUROIMAGING, V22, P408, DOI 10.1111/j.1552-6569.2011.00621.x; Carrino JA, 2014, RADIOLOGY, V270, P816, DOI 10.1148/radiol.13130225; CHO PS, 1995, PHYS MED BIOL, V40, P1863, DOI 10.1088/0031-9155/40/11/007; Cho YB, 2005, MED PHYS, V32, P968, DOI 10.1118/1.1869652; Cunningham IA, 1998, P SOC PHOTO-OPT INS, V3336, P220, DOI 10.1117/12.317021; Dang H, 2015, PHYS MED BIOL, V60, P6153, DOI 10.1088/0031-9155/60/16/6153; DAY GJ, 1983, PHYS MED BIOL, V28, P1429, DOI 10.1088/0031-9155/28/12/008; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; Fredenberg E, 2012, MED PHYS, V39, P5317, DOI 10.1118/1.4739195; Frey EC, 2002, IEEE T MED IMAGING, V21, P1040, DOI 10.1109/TMI.2002.804437; Gang GJ, 2014, MED PHYS, V41, P260, DOI 10.1118/1.4883816; Gang GJ, 2011, MED PHYS, V38, P1754, DOI 10.1118/1.3560428; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Gerlach R, 2008, NEUROSURGERY, V63, P272, DOI 10.1227/01.NEU.0000312362.63693.78; Granfors PR, 2003, MED PHYS, V30, P2715, DOI 10.1118/1.1609151; Hajdok G, 2006, MED PHYS, V33, P3601, DOI 10.1118/1.2336507; Huda W, 2001, MED PHYS, V28, P393, DOI 10.1118/1.1350435; Islam MK, 2006, MED PHYS, V33, P1573, DOI 10.1118/1.2198169; Kidwell CS, 2008, LANCET NEUROL, V7, P256, DOI 10.1016/S1474-4422(08)70041-3; Konstantinidis AC, 2012, NUCL INSTRUM METH A, V689, P12, DOI 10.1016/j.nima.2012.06.024; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Leung R, 2011, AM J RHINOL ALLERGY, V25, P299, DOI 10.2500/ajra.2011.25.3641; Levivier M, 2003, NEUROSURGERY, V53, P1001, DOI 10.1227/01.NEU.0000084167.18475.BA; Li K, 2013, MED PHYS, V40, DOI 10.1118/1.4788647; Linfante I, 1999, STROKE, V30, P2263, DOI 10.1161/01.STR.30.11.2263; Mieville FA, 2013, PHYS MEDICA, V29, P99, DOI 10.1016/j.ejmp.2011.12.004; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; NEITZEL U, 1992, MED PHYS, V19, P475, DOI 10.1118/1.596836; Nilsson HE, 2004, IEEE T NUCL SCI, V51, P1636, DOI 10.1109/TNS.2004.832577; Pineda AR, 2012, MED PHYS, V39, P3240, DOI 10.1118/1.4705354; Powers WJ, 1998, NEUROLOGY, V50, P842, DOI 10.1212/WNL.50.4.842; Prakash P, 2011, MED PHYS, V38, P5612, DOI 10.1118/1.3633937; Prell D, 2009, PHYS MED BIOL, V54, P6575, DOI 10.1088/0031-9155/54/21/009; Proakis J G, 1988, INTRO DIGITAL SIGNAL; Reiser I, 2010, MED PHYS, V37, P1591, DOI 10.1118/1.3357288; Richard S, 2008, MED PHYS, V35, P586, DOI 10.1118/1.2826556; Samei E, 1998, MED PHYS, V25, P102, DOI 10.1118/1.598165; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; Schellinger PD, 2000, AM J NEURORADIOL, V21, P1184; Sechopoulos I, 2009, MED PHYS, V36, P1199, DOI 10.1118/1.3090889; Seltzer S., 1987, NIST STANDARD REFERE, V8, DOI [10.18434/T48G6X, DOI 10.18434/T48G6X]; Siewerdsen J H, 2014, HDB MED IMAGE PERCEP, P335; Siewerdsen JH, 2011, NUCL INSTRUM METH A, V648, pS241, DOI 10.1016/j.nima.2010.11.088; Siewerdsen JH, 1998, MED PHYS, V25, P614, DOI 10.1118/1.598243; Siewerdsen JH, 2005, MED PHYS, V32, P241, DOI 10.1118/1.1836331; Siewerdsen JH, 2004, MED PHYS, V31, P3057, DOI 10.1118/1.1758350; Siewerdsen JH, 2002, MED PHYS, V29, P2655, DOI 10.1118/1.1513158; Siewerdsen JH, 1997, MED PHYS, V24, P71, DOI 10.1118/1.597919; Siewerdsen JH, 1996, P SOC PHOTO-OPT INS, V2708, P484, DOI 10.1117/12.237810; Siewerdsen JH, 2000, MED PHYS, V27, P1903, DOI 10.1118/1.1286590; Sisniega A, 2015, PHYS MED BIOL, V60, P1415, DOI 10.1088/0031-9155/60/4/1415; Sisniega A, 2013, MED PHYS, V40, DOI 10.1118/1.4801895; Suryanarayanan S, 2006, PHYS MED BIOL, V51, P3041, DOI 10.1088/0031-9155/51/12/003; Tanguay J, 2013, MED PHYS, V40, DOI 10.1118/1.4794499; Tward DJ, 2009, MED PHYS, V36, P3830, DOI 10.1118/1.3166933; Tward DJ, 2008, MED PHYS, V35, P5510, DOI 10.1118/1.3002414; Vedantham S, 2013, PHYS MED BIOL, V58, P4099, DOI 10.1088/0031-9155/58/12/4099; Vedula AA, 2003, P SOC PHOTO-OPT INS, V5030, P349, DOI 10.1117/12.480015; Walden RH, 1999, IEEE J SEL AREA COMM, V17, P539, DOI 10.1109/49.761034; Wang AS, 2011, MED PHYS, V38, P4265, DOI 10.1118/1.3592932; Wunderlich A, 2009, IEEE T MED IMAGING, V28, P1198, DOI 10.1109/TMI.2009.2012705; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xu J, 2014, MED PHYS, V41, DOI 10.1118/1.4894733; Xu J, 2012, MED PHYS, V39, P4932, DOI 10.1118/1.4736805; Yan H, 2014, MED PHYS, V41, DOI 10.1118/1.4898324; Yu LF, 2013, MED PHYS, V40, DOI 10.1118/1.4794498; Yu LF, 2010, AM J ROENTGENOL, V194, pW193, DOI 10.2214/AJR.09.2951; Zbijewski W, 2007, IEEE NUCL SCI CONF R, P2985, DOI 10.1109/NSSMIC.2007.4436761; Zhao B, 2008, MED PHYS, V35, P5219, DOI 10.1118/1.2996014; Zhao W, 2003, MED PHYS, V30, P254, DOI 10.1118/1.1538233; Zhao Z, 2014, MED PHYS, V41, DOI 10.1118/1.4875688	80	22	22	0	15	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-9155	1361-6560		PHYS MED BIOL	Phys. Med. Biol.	APR 21	2016	61	8					3180	3207		10.1088/0031-9155/61/8/3180			28	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	DJ2EU	WOS:000374017300014	27025783				2022-02-06	
J	Liu, H; Rose, ME; Culver, S; Ma, XC; Dixon, CE; Graham, SH				Liu, Hao; Rose, Marie E.; Culver, Sherman; Ma, Xiecheng; Dixon, C. Edward; Graham, Steven H.			Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury; PPAR gamma; Inflammation; Rosiglitazone; Behavioral; Cell survival	SPINAL-CORD-INJURY; PPAR-GAMMA; STROKE; AGONIST; DYSFUNCTION; MECHANISMS; THERAPIES; DEFICITS; TARGET; DAMAGE	Rosiglitazone, a potent peroxisome proliferator-activated receptor (PPAR)-gamma agonist, has been shown to confer neuroprotective effects in stroke and spinal cord injury, but its role in the traumatic brain injury (TBI) is still controversial. Using a controlled cortical impact model in rats, the current study was designed to determine the effects of rosiglitazone treatment (6 mg/kg at 5 min, 6 h and 24 h post injury) upon inflammation and histological outcome at 21 d after TBI. In addition, the effects of rosiglitazone upon inflammatory cytokine transcription, vestibulomotor behavior and spatial memory function were determined at earlier time points (24 h, 1-5 d, 14-20 d post injury, respectively). Compared with the vehicle-treated group, rosiglitazone treatment suppressed production of TNF alpha at 24 h after TBI, attenuated activation of microglia/macrophages and increased survival of CA3 neurons but had no effect on lesion volume at 21 d after TBI. Rosiglitazone-treated animals had improved performance on beam balance testing, but there was no difference in spatial memory function as determined by Morris water maze. In summary, this study indicates that rosiglitazone treatment in the first 24 h after TBI has limited anti-inflammatory and neuroprotective effects in rat traumatic injury. Further study using an alternative dosage paradigm and more sensitive behavioral testing may be warranted. Published by Elsevier Inc.	[Liu, Hao; Rose, Marie E.; Culver, Sherman; Ma, Xiecheng; Dixon, C. Edward; Graham, Steven H.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Liu, Hao; Rose, Marie E.; Graham, Steven H.] Univ Pittsburgh, Dept Neurol, Sch Med, Pittsburgh, PA 15260 USA; [Culver, Sherman; Ma, Xiecheng; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15216 USA; [Culver, Sherman; Ma, Xiecheng; Dixon, C. Edward] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15216 USA		Graham, SH (corresponding author), VA Pittsburgh Healthcare Ctr Res, Geriatr Res Educ & Clin Ctr, Off Bldg 30,Mail Code 151, Pittsburgh, PA 15240 USA.	Steven.Graham@va.gov			Veteran's Affairs Rehabilitation Research and Development Merit Review Program Award [I01RX000310]; Veterans AffairsUS Department of Veterans Affairs [I01RX000310] Funding Source: NIH RePORTER	This work was supported by the Veteran's Affairs Rehabilitation Research and Development Merit Review Program Award I01RX000310 (S.H.G.).	Allahtavakoli M, 2009, BRAIN RES, V1271, P121, DOI 10.1016/j.brainres.2009.03.040; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; Carta AR, 2013, CURR DRUG TARGETS, V14, P743, DOI 10.2174/1389450111314070004; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Esposito E, 2011, EXPERT OPIN THER TAR, V15, P943, DOI 10.1517/14728222.2011.581231; Gu C, 2015, BRAIN RES, V1624, P199, DOI 10.1016/j.brainres.2015.07.025; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Liu H, 2013, BRAIN RES, V1519, P71, DOI 10.1016/j.brainres.2013.04.029; Mandrekar-Colucci S, 2013, ASN NEURO, V5, DOI 10.1042/AN20130030; Meng QQ, 2011, NEUROSCI LETT, V503, P191, DOI 10.1016/j.neulet.2011.08.033; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Pearse D, 2010, CURR OPIN INVEST DR, V11, P1207; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Semple BD, 2011, EXP NEUROL, V229, P195, DOI 10.1016/j.expneurol.2011.02.002; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Sobrado M, 2009, J NEUROSCI, V29, P3875, DOI 10.1523/JNEUROSCI.5529-08.2009; Stahel PF, 2008, PPAR RES, V2008, DOI 10.1155/2008/538141; Tehranian R, 2006, BRAIN RES, V1101, P126, DOI 10.1016/j.brainres.2006.05.049; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Ya JC, 2015, MOL MED REP, V12, P6591, DOI 10.3892/mmr.2015.4292; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074	26	22	24	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 15	2016	472	4					648	655		10.1016/j.bbrc.2016.03.003			8	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	DI8LX	WOS:000373753600013	26947332				2022-02-06	
J	Tkachenko, N; Singh, K; Hasanaj, L; Serrano, L; Kothare, SV				Tkachenko, Nataliya; Singh, Kanwaljit; Hasanaj, Lisena; Serrano, Liliana; Kothare, Sanjeev V.			Sleep Disorders Associated With Mild Traumatic Brain Injury Using Sport Concussion Assessment Tool 3	PEDIATRIC NEUROLOGY			English	Article						TBI; sleep disorders; SCAT3; comorbidity	INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; MANAGEMENT; DISTURBANCES; INSOMNIA	BACKGROUND: Sleep problems affect 30% to 80% of patients with mild traumatic brain injury. We assessed the prevalence of sleep disorders after mild traumatic brain injury and its correlation with other symptoms. METHODS AND MATERIALS: Individuals with mild traumatic brain injury were assessed at the New York University Concussion Center during 2013-2014 with the Sports Concussion Assessment Tool, third edition, data following mild traumatic brain injury. The relationship between sleep problems (drowsiness, difficulty falling asleep, fatigue or low energy), psychiatric symptoms (sadness, nervousness or anxiousness), headache, and dizziness were analyzed by Spearman correlation and logistic regression using moderate to severe versus none to mild categorization. RESULTS: Ninety-three patients were retrospectively considered. The most common injury causes were falls (34.4%) and motor vehicle accidents (21.5%). There was a positive correlation between dizziness, headache, psychiatric problems (sadness, anxiety, irritability), and sleep problems (fatigue, drowsiness, and difficulty falling asleep) (P < 0.001). Logistic regression showed a significant association between moderate to severe psychiatric symptoms and moderate to severe sleep symptoms (P < 0.05). Sleep symptoms became more severe with increased time interval from mild traumatic brain injury to Sport Concussion Assessment Tool 3 administration (odds ratio = 1.005, 1.006, and 1.008, P < 0.05). There was significant correlation between motor vehicle accident and drowsiness and difficulty falling asleep (P < 0.05). Medications given in the emergency department had a positive correlation with drowsiness (P < 0.05). CONCLUSIONS: Individuals who report moderate to severe headache, dizziness, and psychiatric symptoms have a higher likelihood of reporting moderate to severe sleep disorders following mild traumatic brain injury and should be counseled and initiated with early interventions. (C) 2016 Elsevier Inc. All rights reserved.	[Tkachenko, Nataliya; Kothare, Sanjeev V.] NYU, Dept Neurol, Langone Med Ctr, Sleep Ctr, New York, NY 10016 USA; [Tkachenko, Nataliya] Dnepropetrovsk State Med Acad, Dept Pediat, Dnepropetrovsk, Ukraine; [Singh, Kanwaljit] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Hasanaj, Lisena; Serrano, Liliana] NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA		Kothare, SV (corresponding author), NYU, Langone Med Ctr, Sch Med, Pediat Sleep Program, 223 East 34th St, New York, NY 10016 USA.	Sanjeev.Kothare@nyumc.org		Kothare, Sanjeev/0000-0001-7849-6649			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT, 2001, J ATHL TRAINING, V36, P253; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Guskiewicz KM, 2004, AM J MED SPORTS, V6, P13; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; Krumholtz I, 2000, Optometry, V71, P426; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Saether R, 2011, RES DEV DISABIL, V32, P727, DOI 10.1016/j.ridd.2010.11.007; Weber M, 2013, J SLEEP DISORDERS TH, V2, P2; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	27	22	22	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	APR	2016	57						46	50		10.1016/j.pediatrneurol.2015.12.019			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	DI5EX	WOS:000373522800010	26795630				2022-02-06	
J	Stemper, BD; Shah, AS; Budde, MD; Olsen, CM; Glavaski-Joksimovic, A; Kurpad, SN; McCrea, M; Pintar, FA				Stemper, Brian D.; Shah, Alok S.; Budde, Matthew D.; Olsen, Christopher M.; Glavaski-Joksimovic, Aleksandra; Kurpad, Shekar N.; McCrea, Michael; Pintar, Frank A.			Behavioral Outcomes Differ between Rotational Acceleration and Blast Mechanisms of Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						concussion; rotational acceleration; blast injuries; mechanism of injury; biomechanics	PROFESSIONAL FOOTBALL PLAYERS; HIPPOCAMPAL SLICE CULTURES; CONTROLLED CORTICAL IMPACT; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; INDUCED NEUROTRAUMA; SHOCK-WAVE; RAT MODEL; EXPOSURE; OVERPRESSURE	Mild traumatic brain injury (mTBI) can result from a number of mechanisms, including blunt impact, head rotational acceleration, exposure to blast, and penetration of projectiles. Mechanism is likely to influence the type, severity, and chronicity of outcomes. The objective of this study was to determine differences in the severity and time course of behavioral outcomes following blast and rotational mTBI. The Medical College of Wisconsin (MCW) Rotational Injury model and a shock tube model of primary blast injury were used to induce mTBI in rats and behavioral assessments were conducted within the first week, as well as 30 and 60 days following injury. Acute recovery time demonstrated similar increases over protocol-matched shams, indicating acute injury severity equivalence between the two mechanisms. Post-injury behavior in the elevated plus maze demonstrated differing trends, with rotationally injured rats acutely demonstrating greater activity, whereas blast-injured rats had decreased activity that developed at chronic time points. Similarly, blast-injured rats demonstrated trends associated with cognitive deficits that were not apparent following rotational injuries. These findings demonstrate that rotational and blast injury result in behavioral changes with different qualitative and temporal manifestations. Whereas rotational injury was characterized by a rapidly emerging phenotype consistent with behavioral disinhibition, blast injury was associated with emotional and cognitive differences that were not evident acutely, but developed later, with an anxiety-like phenotype still present in injured animals at our most chronic measurements.	[Stemper, Brian D.; Shah, Alok S.; Budde, Matthew D.; Glavaski-Joksimovic, Aleksandra; Kurpad, Shekar N.; McCrea, Michael; Pintar, Frank A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Budde, Matthew D.; Pintar, Frank A.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Stemper, Brian D.; Budde, Matthew D.; Olsen, Christopher M.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Olsen, Christopher M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA		Stemper, BD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.; Stemper, BD (corresponding author), Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA.; Stemper, BD (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA.	bstemper@mcw.edu	Olsen, Christopher/G-9595-2013; Kurpad, Shekar/V-2188-2019; Stemper, Brian/AAX-7611-2020	Olsen, Christopher/0000-0003-2700-0310; 	Merit Review Award from the United States (U.S.) Department of Veterans Affairs Rehabilitation Research and Development Service Program (PI: PAP) [RH RX000380]; Department of Neurosurgery, Medical College of Wisconsin; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA039276] Funding Source: NIH RePORTER	This work was supported in part by Merit Review Award number RH RX000380 from the United States (U.S.) Department of Veterans Affairs Rehabilitation Research and Development Service Program (PI: PAP) and the Department of Neurosurgery, Medical College of Wisconsin.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Fijalkowski RJ, 2006, BIOMED SCI INSTRUM, V42, P108; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Shah AS, 2011, ASME INT MECH ENG C; Shah Ms Alok S, 2012, Biomed Sci Instrum, V48, P393; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242	62	22	22	2	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 14	2016	7								31	10.3389/fneur.2016.00031			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DG5HM	WOS:000372108000001	27014184	Green Published, gold			2022-02-06	
J	Konda, S; Tiesman, HM; Reichard, AA				Konda, Srinivas; Tiesman, Hope M.; Reichard, Audrey A.			Fatal Traumatic Brain Injuries in the Construction Industry, 2003-2010	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						brain injuries; TBI; falls; roofers; occupational; older workers	WORK; FALLS; US; EPIDEMIOLOGY; SYSTEM; IMPACT	Background Research on fatal work-related traumatic brain injuries (TBIs) is limited. This study describes fatal TBIs in the US construction industry. Methods Fatal TBIs were extracted from the Bureau of Labor Statistics Census of Fatal Occupational Injuries. Results From 2003 to 2010, 2,210 fatal TBIs occurred in construction at a rate of 2.6 per 100,000 full-time equivalent (FTE) workers. Workers aged 65 years and older had the highest fatal TBI rates among all workers (7.9 per 100,000 FTE workers). Falls were the most frequent injury event (n = 1,269, 57%). Structural iron and steel workers and roofers had the highest fatal TBI rate per 100,000 FTE workers (13.7 and 11.2, respectively). Fall-related TBIs were the leading cause of death in these occupations. Conclusions A large percentage of TBIs in the construction industry were due to falls. Emphasis on safety interventions is needed to reduce these fall-related TBIs, especially among vulnerable workers. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.	[Konda, Srinivas; Tiesman, Hope M.; Reichard, Audrey A.] NIOSH, Div Safety Res, Ctr Dis Control & Prevent, 1095 Willowdale Rd,MS 1811, Morgantown, WV 26506 USA		Konda, S (corresponding author), NIOSH, Div Safety Res, 1095 Willowdale Rd,MS 1811, Morgantown, WV 26506 USA.	skonda@cdc.gov	Konda, Srinivas/G-2747-2015	Konda, Srinivas/0000-0002-8934-4111			American Federation of Labor-Congress of Industrial Organizations (AFL-CIO), 2005, IMM WORK RISK URG NE; BLS, 2013, CURR POP SURV MICR F; BLS, 2003, FAT OCC INJ EMPL RAT; BLS, 2012, BLS SPOTL STAT REC 2; BLS, 2012, CURR POP SURV BAS MO; BLS, 2014, CENS FAT OCC INJ CHA; BLS, 2011, FAT OCC INJ TOT HOUR; *BLS, 1992, OCC INJ ILLN CLASS M; BLS (US Bureau of Labor Statistics), 2003, CENS FAT OCC INJ CFO; Byler C.G., 2013, MONTHLY LABOR REV; CDC, 2012, NIOSH OSHA CPWR CTR; CDC, 2011, CONSTR SAF HLTH; Center for Disease Control, 2013, PREV FALLS OLD AD; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CPWR, 2013, CONSTR CHART BOOK UK; Dembe AE, 2005, OCCUP ENVIRON MED, V62, P588, DOI 10.1136/oem.2004.016667; Dong XWS, 2011, AM J IND MED, V54, P339, DOI 10.1002/ajim.20928; Dong XWS, 2013, J SAFETY RES, V44, P17, DOI 10.1016/j.jsr.2012.08.024; Dong XWS, 2012, HUM FACTORS, V54, P303, DOI 10.1177/0018720811410057; Dong XWS, 2009, ACCIDENT ANAL PREV, V41, P1047, DOI 10.1016/j.aap.2009.06.012; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kica J, 2014, J SAFETY RES, V51, P49, DOI 10.1016/j.jsr.2014.09.003; Konda S, 2014, INJURY PREV, V21, P115; Liu M, 2011, WORK, V39, P283, DOI 10.3233/WOR-2011-1176; Long J, 2015, COMPUT METHOD BIOMEC, V18, P24, DOI 10.1080/10255842.2013.774382; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; NCIPC, 2014, RAT TBI REL EM DEP V; NCOSH, 2000, IMM WORK RISK QUAL S; NIOSH, 2014, MMWR-MORBID MORTAL W, V62, P1037; *OMB, 2000, STAND OCC CLASS MAN; *OMB, 2002, N AM IND CLASS SYST; Orrenius PM, 2009, DEMOGRAPHY, V46, P535, DOI 10.1353/dem.0.0064; OSHA, 2015, SMALL BUSINESS; OSHA, 2005, CONSTR WORK SAF SER; Schwatka NV, 2012, EPIDEMIOL REV, V34, P156, DOI 10.1093/epirev/mxr020; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; U.S. Census Bureau, 2002, IND OCC METH; U. S. Census Bureau, 2010, CONSTR SPEND; Us Census Bureau, 2012, COUNT BUS PATT; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	47	22	24	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	MAR	2016	59	3					212	220		10.1002/ajim.22557			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DG7UW	WOS:000372290200006	26765167				2022-02-06	
J	Walls, MK; Race, N; Zheng, LX; Vega-Alvarez, SM; Acosta, G; Park, J; Shi, RY				Walls, Michael K.; Race, Nicholas; Zheng, Lingxing; Vega-Alvarez, Sasha M.; Acosta, Glen; Park, Jonghyuck; Shi, Riyi			Structural and biochemical abnormalities in the absence of acute deficits in mild primary blast-induced head trauma	JOURNAL OF NEUROSURGERY			English	Article						blast-induced neurotrauma; BBB disruption; oxidative stress; acrolein; 3-HPMA; traumatic brain injury; trauma	BLOOD-BRAIN-BARRIER; SPINAL-CORD-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MEDIAL FOREBRAIN-BUNDLE; OXIDATIVE STRESS; ALPHA,BETA-UNSATURATED ALDEHYDES; ENDOTHELIAL DYSFUNCTION; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; VENTRAL PALLIDUM	OBJECTIVE Blast-induced neurotrauma (BINT), if not fatal, is nonetheless potentially crippling. It can produce a wide array of acute symptoms in moderate-to-severe exposures, but mild BINT (mBINT) is characterized by the distinct absence of acute clinical abnormalities. The lack of observable indications for mBINT is particularly alarming, as these injuries have been linked to severe long-term psychiatric and degenerative neurological dysfunction. Although the long-term sequelae of BINT are extensively documented, the underlying mechanisms of injury remain poorly understood, impeding the development of diagnostic and treatment strategies. The primary goal of this research was to recapitulate primary mBINT in rodents in order to facilitate well-controlled, long-term investigations of blast-induced pathological neurological sequelae and identify potential mechanisms by which ongoing damage may occur postinjury. METHODS A validated, open-ended shock tube model was used to deliver blast overpressure (150 kPa) to anesthetized rats with body shielding and head fixation, simulating the protective effects of military-grade body armor and isolating a shock wave injury from confounding systemic injury responses, head acceleration, and other elements of explosive events. Evans Blue labeled albumin was used to visualize blood-brain barrier (BBB) compromise at 4 hours postinjury. Iba1 staining was used to visualize activated microglia and infiltrating macrophages in areas of peak BBB compromise. Acrolein, a potent posttraumatic neurotoxin, was quantified in brain tissue by immunoblotting and in urine through liquid chromatography with tandem mass spectrometry at 1, 2, 3, and 5 days postinjury. Locomotor behavior, motor performance, and short-term memory were assessed with open field, rotarod, and novel object recognition (NOR) paradigms at 24 and 48 hours after the blast. RESULTS Average speed, maximum speed, and distance traveled in an open-field exploration paradigm did not show significant differences in performance between sham-injured and mBINT rats. Likewise, rats with mBINT did not exhibit deficits in maximum revolutions per minute or total run time in a rotarod paradigm. Short-term memory was also unaffected by mBINT in an NOR paradigm. Despite lacking observable motor or cognitive deficits in the acute term, blast injured rats displayed brain acrolein levels that were significantly elevated for at least 5 days, and acrolein's glutathione-reduced metabolite, 3-HPMA, was present in urine for 2 days after injury. Additionally, mBINT brain tissue demonstrated BBB damage 4 hours postinjury and colocalized neuroinflammatory changes 24 hours postinjury. CONCLUSIONS This model highlights mBINT's potential for underlying detrimental physical and biochemical alterations despite the lack of apparent acute symptoms and, by recapitulating the human condition, represents an avenue for further examining the pathophysiology of mBINT. The sustained upregulation of acrolein for days after injury suggests that acrolein may be an upstream player potentiating ongoing postinjury damage and neuroinflammation. Ultimately, continued research with this model may lead to diagnostic and treatment mechanisms capable of preventing or reducing the severity of long-term neurological dysfunction following mBINT.	[Walls, Michael K.; Zheng, Lingxing; Vega-Alvarez, Sasha M.; Acosta, Glen; Park, Jonghyuck; Shi, Riyi] Purdue Univ, Dept Basic Med Sci, Coll Vet Med, W Lafayette, IN 47907 USA; [Race, Nicholas; Zheng, Lingxing; Park, Jonghyuck; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA		Shi, RY (corresponding author), Purdue Univ, Dept Basic Med Sci, Weldon Sch Biomed Engn, 404 S Univ St, W Lafayette, IN 47907 USA.	riyi@purdue.edu		Race, Nicholas/0000-0002-2683-1692	Indiana State Department of Health [204200]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS073636]; Indiana CTSI Collaboration in Biomedical Translational Research (CBR/CTR) Pilot Program Grant [RR025761]; NIH NCRR Shared InstrumentationUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1 S10 RR023734-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025761, S10RR023734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073636] Funding Source: NIH RePORTER	This work was supported in part by the Indiana State Department of Health (Grant No. 204200 to R.S.), National Institutes of Health (Grant No. NS073636 to R.S.), and Indiana CTSI Collaboration in Biomedical Translational Research (CBR/CTR) Pilot Program Grant (Grant No. RR025761 to R.S.). Funding for the LSM710 was provided by NIH NCRR Shared Instrumentation (Grant No. 1 S10 RR023734-01A1).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; AUSTIN MC, 1990, J PHARMACOL EXP THER, V252, P1370; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borchers Michael T, 2009, Res Rep Health Eff Inst, P5; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Calingasan NY, 1999, J NEUROCHEM, V72, P751, DOI 10.1046/j.1471-4159.1999.0720751.x; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Centers for Disease Control, ACEP CLIN PRACT MAN; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chang JW, 1999, NEUROSCIENCE, V88, P617, DOI 10.1016/S0306-4522(98)00217-6; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Connell S., 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P969, DOI 10.1109/BMEI.2011.6098441; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Due MR, 2014, J NEUROCHEM, V128, P776, DOI 10.1111/jnc.12500; Eckert E, 2010, J CHROMATOGR B, V878, P2506, DOI 10.1016/j.jchromb.2009.09.003; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Hamann K, 2008, J NEUROCHEM, V107, P712, DOI 10.1111/j.1471-4159.2008.05622.x; Hamann K, 2008, J NEUROCHEM, V104, P708, DOI 10.1111/j.1471-4159.2007.05002.x; Hamann K, 2009, J NEUROCHEM, V111, P1348, DOI 10.1111/j.1471-4159.2009.06395.x; Hawkins BT, 2006, J NEUROSCI METH, V151, P262, DOI 10.1016/j.jneumeth.2005.08.006; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC; Kirkham PA, 2003, FREE RADICAL BIO MED, V35, P697, DOI 10.1016/S0891-5849(03)00390-3; Koob AO, 2006, J NEUROSCI METH, V157, P330, DOI 10.1016/j.jneumeth.2006.04.020; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Luo H, 2004, NEUROCHEM INT, V44, P475, DOI 10.1016/j.neuint.2003.09.006; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002; Luo J, 2005, NEUROCHEM RES, V30, P291, DOI 10.1007/s11064-005-2602-7; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Park J, 2014, J NEUROCHEM, V129, P339, DOI 10.1111/jnc.12628; Park YS, 2008, ANN NY ACAD SCI, V1126, P185, DOI 10.1196/annals.1433.034; Pocernich CB, 2001, NEUROCHEM INT, V39, P141, DOI 10.1016/S0197-0186(01)00012-2; Ravikumar M, 2014, BIOMATERIALS, V35, P8049, DOI 10.1016/j.biomaterials.2014.05.084; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Shi R, 2002, NEUROSCIENCE, V115, P337, DOI 10.1016/S0306-4522(02)00457-8; Shi R., 2006, APPL NEUROL, V2, P22; Shi RY, 2011, MOL NUTR FOOD RES, V55, P1320, DOI 10.1002/mnfr.201100217; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; STEIN L, 1969, J COMP PHYSIOL PSYCH, V67, P189, DOI 10.1037/h0026767; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tully M, 2013, INT J MOL SCI, V14, P20037, DOI 10.3390/ijms141020037; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; VandeVord PS, 2013, MEASURING INTRACRANI; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zheng LX, 2013, J NEUROTRAUM, V30, P1334, DOI 10.1089/neu.2013.2888	80	22	22	1	16	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2016	124	3					675	686		10.3171/2015.1.JNS141571			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DE8VQ	WOS:000370915200012	26295915	Green Accepted			2022-02-06	
J	Kailainathan, S; Piers, TM; Yi, JH; Choi, S; Fahey, MS; Borger, E; Gunn-Moore, FJ; O'Neill, L; Lever, M; Whitcomb, DJ; Cho, K; Allen, SJ				Kailainathan, Sumangali; Piers, Thomas M.; Yi, Jee Hyun; Choi, Seongmin; Fahey, Mark S.; Borger, Eva; Gunn-Moore, Frank J.; O'Neill, Laurie; Lever, Michael; Whitcomb, Daniel J.; Cho, Kwangwook; Allen, Shelley J.			Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF)	PHARMACOLOGICAL RESEARCH			English	Article						Pro-brain-derived neurotrophic factor (proBDNF); Val66Met polymorphism; Long-term depression (LTD); Binding kinetics; Neurotrophin receptors; Chemical compounds studied in this article	ACTIVITY-DEPENDENT SECRETION; BASAL FOREBRAIN NEURONS; LONG-TERM DEPRESSION; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; PRECURSOR BDNF; CELL-SURVIVAL; HUMAN-MEMORY; RECEPTOR; POLYMORPHISM	This study describes a fundamental functional difference between the two main polymorphisms of the pro-form of brain-derived neurotrophic factor (proBDNF), providing an explanation as to why these forms have such different age-related neurological outcomes. Healthy young carriers of the Met66 form (present in similar to 30% Caucasians) have reduced hippocampal volume and impaired hippocampal-dependent memory function, yet the same polymorphic population shows enhanced cognitive recovery after traumatic brain injury, delayed cognitive dysfunction during aging, and lower risk of late-onset Alzheimer's disease (AD) compared to those with the more common Val66 polymorphism. To examine the differences between the protein polymorphisms in structure, kinetics of binding to proBDNF receptors and in vitro function, we generated purified cleavage-resistant human variants. Intriguingly, we found no statistical differences in those characteristics. As anticipated, exogenous application of proBDNF Val66 to rat hippocampal slices dysregulated synaptic plasticity, inhibiting long-term potentiation (LTP) and facilitating long-term depression (LTD). We subsequently observed that this occurred via the glycogen synthase kinase 313 (GSK3 beta) activation pathway. However, surprisingly, we found that Met66 had no such effects on either LTP or LTD. These novel findings suggest that, unlike Val66, the Met66 variant does not facilitate synapse weakening signaling, perhaps accounting for its protective effects with aging. (C) 2015 The Authors. Published by Elsevier Ltd.	[Kailainathan, Sumangali; Piers, Thomas M.; Yi, Jee Hyun; Choi, Seongmin; Fahey, Mark S.; O'Neill, Laurie; Lever, Michael; Whitcomb, Daniel J.; Cho, Kwangwook; Allen, Shelley J.] Univ Bristol, Fac Hlth Sci, Sch Clin Sci, Henry Wellcome Labs Integrat Neurosci & Endocrino, Whitson St, Bristol BS1 3NY, Avon, England; [Piers, Thomas M.; Yi, Jee Hyun; Choi, Seongmin; O'Neill, Laurie; Lever, Michael; Whitcomb, Daniel J.; Cho, Kwangwook] Univ Bristol, Ctr Synapt Plast, Whitson St, Bristol BS1 3NY, Avon, England; [Piers, Thomas M.; Choi, Seongmin; Whitcomb, Daniel J.; Cho, Kwangwook] Chonnam Natl Univ Hosp, Biomed Res Inst, Chonnam Bristol Frontier Lab, Gwangju 501757, South Korea; [Borger, Eva; Gunn-Moore, Frank J.] Univ St Andrews, Med & Biol Sci Bldg, St Andrews KY16 9TF, Fife, Scotland; [Kailainathan, Sumangali; Allen, Shelley J.] Southmead Gen Hosp, Fac Hlth Sci, Sch Clin Sci, Learning & Res, Bristol BS10 5NB, Avon, England		Cho, K; Allen, SJ (corresponding author), Univ Bristol, Fac Hlth Sci, Sch Clin Sci, Henry Wellcome Labs Integrat Neurosci & Endocrino, Whitson St, Bristol BS1 3NY, Avon, England.; Cho, K (corresponding author), Univ Bristol, Ctr Synapt Plast, Whitson St, Bristol BS1 3NY, Avon, England.; Cho, K (corresponding author), Chonnam Natl Univ Hosp, Biomed Res Inst, Chonnam Bristol Frontier Lab, Gwangju 501757, South Korea.; Allen, SJ (corresponding author), Southmead Gen Hosp, Fac Hlth Sci, Sch Clin Sci, Learning & Res, Bristol BS10 5NB, Avon, England.	Kei.Cho@bristol.ac.uk; shelley.allen@bristol.ac.uk	Borger, Eva/H-5999-2013	Borger, Eva/0000-0003-4965-2969; Cho, Kwangwook/0000-0001-6724-7073; Allen, Shelley/0000-0001-7870-740X; Gunn-Moore, Francis James/0000-0003-3422-3387; YI, JEE HYUN/0000-0002-9407-593X; Whitcomb, Daniel/0000-0003-2703-1643	Bristol Research into Alzheimer's and Care of the Elderly (BRACE); Sigmund Gestetner Trust Fund (University of Bristol); Alzheimer's Society; Alumni of the University of Bristol; UK Wellcome Trust-MRC Neurodegenerative Disease Initiative Programme [089703]; Korea-UK Alzheimer's Research Consortium Programme under the Korean Ministry of Health and Welfare; Bristol-Chonnam Frontier Programme under the Chonnam National University Hospital; Wolfson Research Merit AwardRoyal Society of London; Royal Society, LondonRoyal Society of London; MRC projectUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_G1000734]; Alzheimers Research UKAlzheimer&apos;s Research UK (ARUK) [ART-PG2002-3] Funding Source: researchfish; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N001893/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_G1000734] Funding Source: researchfish; Alzheimer&quot;s Society [106] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N001893/1, BB/G003963/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_G1000734] Funding Source: UKRI	This work has been supported by Bristol Research into Alzheimer's and Care of the Elderly (BRACE), the Sigmund Gestetner Trust Fund (University of Bristol), the Alzheimer's Society and the Alumni of the University of Bristol. K.C. and D.J.W. were supported by UK Wellcome Trust-MRC Neurodegenerative Disease Initiative Programme 089703, MRC project code MC_G1000734. J.H.Y. was supported by the Korea-UK Alzheimer's Research Consortium Programme under the Korean Ministry of Health and Welfare. T.M.P. and S.C. were supported by Bristol-Chonnam Frontier Programme under the Chonnam National University Hospital. K.C. was supported by the Wolfson Research Merit Award and Royal Society, London.	Allen SJ, 1999, BIOCHEM BIOPH RES CO, V264, P648, DOI 10.1006/bbrc.1999.1561; Anastasia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3490; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bath KG, 2012, NEUROPSYCHOPHARMACOL, V37, P1297, DOI 10.1038/npp.2011.318; Busceti CL, 2015, PHARMACOL RES, V99, P258, DOI 10.1016/j.phrs.2015.06.017; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Doherty GH, 2013, NEUROBIOL AGING, V34, P226, DOI 10.1016/j.neurobiolaging.2012.08.003; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.011.2008; Fan YJ, 2008, EUR J NEUROSCI, V27, P2380, DOI 10.1111/j.1460-9568.2008.06215.x; Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; Glerup S, 2014, NEURON, V82, P1074, DOI 10.1016/j.neuron.2014.04.022; Golpich M, 2015, PHARMACOL RES, V97, P16, DOI 10.1016/j.phrs.2015.03.010; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kimura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0144; Koshimizu H, 2010, NEUROSCI LETT, V473, P229, DOI 10.1016/j.neulet.2010.02.055; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Naylor RL, 2002, BIOCHEM BIOPH RES CO, V291, P501, DOI 10.1006/bbrc.2002.6468; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Regan P, 2015, J NEUROSCI, V35, P4804, DOI 10.1523/JNEUROSCI.2842-14.2015; Romero Obradovic, 1997, GENOME INFORM SER WO, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Yang J., 2014, CELL REP	52	22	25	0	6	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	FEB	2016	104						97	107		10.1016/j.phrs.2015.12.008			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DG1QE	WOS:000371841800010	26687096	Green Published, hybrid			2022-02-06	
J	Leung, A; Fallah, A; Shukla, S; Lin, L; Tsia, A; Song, D; Polston, G; Lee, R				Leung, Albert; Fallah, Amir; Shukla, Shivshil; Lin, Lisa; Tsia, Alice; Song, David; Polston, Gregory; Lee, Roland			rTMS in Alleviating Mild TBI Related Headaches - A Case Series	PAIN PHYSICIAN			English	Article						Transcranial magnetic stimulation; MTBI; mild traumatic rrain injury; headaches; pain neuromodulation	TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; MOTOR CORTEX; PAIN-CONTROL; DOUBLE-BLIND; PREVALENCE; MIGRAINE; PLACEBO	Background: Headache is one of the most common debilitating chronic pain conditions in patients with mild traumatic brain injury. Conventional pharmacological treatments have not been shown to be effective in alleviating debilitating mild traumatic brain injury related headaches (MTBI-HA). Therefore, the development of an innovative non-invasive therapy in managing MTBI-HA is needed in the field of pain management. Repetitive transcranial magnetic stimulation (rTMS) utilizes a basic electromagnetic coupling principle in which a rapid discharge of electrical current is converted into dynamic magnetic flux, allowing the induction of a localized current in the brain for neuromodulation. The treatment is currently FDA approved for treating depression in the United States. Recent meta-analysis studies have implicated its usage in chronic pain management. Objective: The objective of the prospective case series is to assess the potential application of rTMS in alleviating MTBI-HA. Study Design: A prospective evaluation was conducted in patients with established diagnoses of MTBI-HA and treated with neuronavigational guided rTMS. Setting: The study was conducted at the Veteran Administration San Diego Healthcare System where over 400 patients with MTBI were being evaluated annually by the Rehabilitation Medicine Service. A fraction of this patient population was referred and evaluated in the Anesthesia Pain Clinic for the consideration of rTMS for their headaches. Methods: A prospective case series was conducted with human subject protection committee approval. Patients with established diagnoses of MTBI and constant headaches rated at >= 4 on a 0 - 10 Numerical Rating Pain Scale (NRPS), and on stable headache medication regimens were selected to receive the treatment. Four sessions of rTMS were delivered to specific areas of cortices over a 2-month period. Patients' average intensities of lingering constant headaches (defined as duration of headache lasting more than 48 hours), and the average frequency (number of severe headache episodes per day), intensity (NRPS), and duration (hours) of headache exacerbations were assessed before and after the rTMS treatment protocol. Results: Six men (average age of 50) with MTBI-HA received the rTMS treatment protocol. Average pre and post-rTMS constant headache scores (+/- SD) on the NRPS were 5.50 (+/- 1.38) and 2.67 (+/- 1.75), respectively, with an average post-rTMS headache intensity reduction of 53.05% (+/- 19.90). The average headache exacerbation frequency (episodes per week) was reduced by 78.97% (+/- 19.88) with 2 patients reporting complete cessation of severe headache episodes. For those (N = 4) with persistent headache exacerbations, the average duration and intensity of these exacerbations were reduced by 50.0% and 31.7%, respectively. Limitations: This prospective evaluation provides the initial insight that rTMS may be beneficial in alleviating a debilitating chronic pain condition in patients with MTBI-HA. More controlled randomized studies should be conducted to validate its efficacy. Other co-existing cognitive and mood dysfunction should be assessed as well. Conclusions: rTMS offers a non-invasive treatment option for MTBI-HA. The tested treatment protocol was well tolerated by the patients and can be adopted for future randomized controlled studies in further validating the treatment efficacy.	[Leung, Albert; Fallah, Amir; Shukla, Shivshil; Lin, Lisa; Tsia, Alice; Song, David; Polston, Gregory; Lee, Roland] Univ Calif San Diego, Dept Anesthesiol, Sch Med, Vet Adm San Diego Healthcare Syst, 9300 Campus Point Dr 7651, La Jolla, CA 92073 USA		Leung, A (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Sch Med, Vet Adm San Diego Healthcare Syst, 9300 Campus Point Dr 7651, La Jolla, CA 92073 USA.	ayleung@ucsd.edu					Andre-Obadia N, 2006, CLIN NEUROPHYSIOL, V117, P1536, DOI 10.1016/j.clinph.2006.03.025; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; George MS, 2013, CURR OPIN PSYCHIATR, V26, P13, DOI 10.1097/YCO.0b013e32835ab46d; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Leung A, 2009, J PAIN, V10, P1205, DOI 10.1016/j.jpain.2009.03.010; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lipton RB, 2010, LANCET NEUROL, V9, P373, DOI 10.1016/S1474-4422(10)70054-5; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Misra UK, 2013, J NEUROL, V260, P2793, DOI 10.1007/s00415-013-7072-2; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; PascualLeone A, 1995, AUST NZ J PSYCHIAT, V29, P698; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Pleger B, 2004, NEUROSCI LETT, V356, P87, DOI 10.1016/j.neulet.2003.11.037; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	21	22	22	0	11	AM SOC INTERVENTIONAL PAIN PHYSICIANS	PADUCAH	81 LAKEVIEW DR, PADUCAH, KY 42001 USA	1533-3159			PAIN PHYSICIAN	Pain Physician	FEB	2016	19	2					E347	E353					7	Anesthesiology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	DC1QI	WOS:000368991000010	26815263				2022-02-06	
J	Lucas, S; Smith, BM; Temkin, N; Bell, KR; Dikmen, S; Hoffman, JM				Lucas, Sylvia; Smith, Brendon M.; Temkin, Nancy; Bell, Kathleen R.; Dikmen, Sureyya; Hoffman, Jeanne M.			Comorbidity of Headache and Depression After Mild Traumatic Brain Injury	HEADACHE			English	Article						headache; depression; mild traumatic brain injury; traumatic brain injury; posttraumatic headache	CHRONIC POSTTRAUMATIC HEADACHE; PREVALENCE; DISORDERS; SEVERITY; SYMPTOMS; PAIN; ASSOCIATION; FREQUENCY; VALIDITY; CHILDREN	ObjectiveTo examine headache and depression over time in individuals who sustained mild traumatic brain injury (mTBI). Prevalence of headache and depression early after mTBI and at 1 year postinjury as well as the relationship between the two are evaluated. BackgroundHeadache is the most common physical symptom and depression is among the most common psychiatric diagnosis after traumatic brain injury regardless of severity. Headache and depression have been found to be two independent factors related to poor outcome after mTBI, yet there appears to be a paucity of research exploring the comorbidity of these two conditions after injury. Method/DesignLongitudinal survey design over 1 year of 212 participants with mTBI who were admitted to a Level 1 trauma center for observation or other system injuries. Depression was based on a score 10 on the Patient Health Questionnaire-9. Headache was based on participant report of new or worse-than-preinjury headache since hospitalization (baseline) or within the previous 3 months at 1 year postinjury. ResultsThe prevalence of headache and depression at baseline was 64% (135/212) and 15% (31/212), respectively. The prevalence of headache and depression at 1 year was 68% (127/187) and 27% (50/187), respectively. The co-occurrence of headache and depression increased from 11% (23/212) at baseline to 25% (46/187) at 1 year. At 1 year, the risk ratio of individuals who had headache to be depressed was 5.43 (95% CI 2.05-14.40) compared to those without headache (P<.001). The corresponding risk ratio at baseline was 1.64 (95% CI .77-3.49; P=.23). ConclusionsWhile prevalence of headache is consistently high over the first year after injury, rate of depression increased over the first year for those who were followed. Given the high rate of comorbidity, those with headache may develop depression over time. Evaluation for possible depression in those with headache after mTBI should be conducted to address both conditions over the year following injury.	[Lucas, Sylvia; Temkin, Nancy; Dikmen, Sureyya; Hoffman, Jeanne M.] Univ Washington, 325 9th Ave,Box 359924, Seattle, WA 98195 USA; [Smith, Brendon M.] Albany Med Coll, Albany, NY 12208 USA; [Bell, Kathleen R.] Univ Texas Southwestern, Dallas, TX USA		Lucas, S (corresponding author), Univ Washington, 325 9th Ave,Box 359924, Seattle, WA 98195 USA.	lucass@uw.edu		Bell, Kathleen/0000-0002-0928-2046	Department of Education, National Institute on Disability Rehabilitation Research [H133G0900022]	This study was funded by the Department of Education, National Institute on Disability Rehabilitation Research, grant number H133G0900022.	Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; Breslau N, 2000, NEUROLOGY, V54, P308, DOI 10.1212/WNL.54.2.308; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Gesztelyi G, 2005, CEPHALALGIA, V25, P598, DOI 10.1111/j.1468-2982.2005.00937.x; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lerman B, 2011, J NEUROTRAUM, V28, pA16; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Uebersax J, 2009, MCNEMAR TESTS MARGIN; Vaccarino AL, 2008, J AFFECT DISORDERS, V110, P270, DOI 10.1016/j.jad.2008.01.009; Vaccarino AL, 2009, PSYCHOSOM MED, V71, P159, DOI 10.1097/PSY.0b013e3181906572; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x	35	22	22	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	FEB	2016	56	2					323	330		10.1111/head.12762			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF1CV	WOS:000371076900009	26814846				2022-02-06	
J	Willems, C; Fu, QL; Roose, H; Mertens, F; Cox, B; Chen, JH; Vankelecom, H				Willems, Christophe; Fu, Qiuli; Roose, Heleen; Mertens, Freya; Cox, Benoit; Chen, Jianghai; Vankelecom, Hugo			Regeneration in the Pituitary After Cell-Ablation Injury: Time-Related Aspects and Molecular Analysis	ENDOCRINOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRAUMATIC BRAIN-INJURY; STEM-CELLS; STEM/PROGENITOR CELL; SIDE POPULATION; GLAND; DIFFERENTIATION; HORMONE; HYPOPITUITARISM; EXPRESSION	We recently showed that the mouse pituitary holds regenerative competence. Young-adult GHCre/iDTR mice, expressing diphtheria toxin (DT) receptor in GH-producing cells, regenerate the GH(+) cells, as ablated by 3-day DT treatment (3DT), up to 60% after 5 months. The pituitary's stem cells participate in this restoration process. Here, we characterized this regenerative capacity in relation to age and recovery period and started to search for underlying molecular mechanisms. Extending the recovery period (up to 19 mo) does not result in higher regeneration levels. In addition, the regenerative competence disappears at older age, coinciding with a reduction in pituitary stem cell number and fitness. Surprisingly, prolonging DT treatment of young-adult mice to 10 days (10DT) completely blocks the regeneration, although the stem cell compartment still reacts by promptly expanding, and retains in vitro stem cell functionality. To obtain a first broad view on molecular grounds underlying reparative capacity and/or failure, the stem cell-clustering side population was analyzed by whole-genome expression analysis. A number of stemness factors and components of embryonic, epithelial-mesenchymal transition, growth factor and Hippo pathways are higher expressed in the stem cell-clustering side population of the regenerating pituitary (after 3DT) when compared with the basal gland and to the nonregenerating pituitary (after 10DT). Together, the regenerative capacity of the pituitary is limited both in age-related terms and final efficacy, and appears to relyonstem cell-associated pathway activation. Dissection of the molecular profiles may eventually identify targets to induce or boost regeneration in situations of (injury-related) pituitary deficiency.	[Willems, Christophe; Fu, Qiuli; Roose, Heleen; Mertens, Freya; Cox, Benoit; Chen, Jianghai; Vankelecom, Hugo] Univ Leuven KU Leuven, Dept Dev & Regenerat, Cluster Stem Cell Biol & Embryol, Unit Stem Cell Res, B-3000 Leuven, Belgium; [Fu, Qiuli] Zhejiang Univ, Ctr Eye, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China; Key Lab Ophthalmol Zhejiang Prov, Hangzhou 310009, Zhejiang, Peoples R China; [Chen, Jianghai] Huazhong Univ Sci & Technol, Dept Hand Surg, Tongji Med Coll, Union Hosp, Wuhan 430022, Hubei, Peoples R China		Vankelecom, H (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Cluster Stem Cell Biol & Embryol, Unit Stem Cell Res, Campus Gasthuisberg O&N4,Herestr 49, B-3000 Leuven, Belgium.	hugo.vankelecom@med.kuleuven.be		Cox, Benoit/0000-0002-3139-268X; Roose, Heleen/0000-0001-7860-8559; Vankelecom, Hugo/0000-0002-2251-7284	KU Leuven (Research Fund, BOF)KU Leuven; Fund for Scientific Research (FWO), Flanders (Belgium)FWO; FWOFWO [2012DFG32000]; Ministry of Science and Technology of China (MOST)Ministry of Science and Technology, China [2012DFG32000]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30500248, 81300641]; Agency for Innovation by Science and Technology (IWT-Flanders, Belgium)	This work was supported by research grants from the KU Leuven (Research Fund, BOF) and from the Fund for Scientific Research (FWO), Flanders (Belgium), by a joint research grant between the FWO and the Ministry of Science and Technology of China (MOST) (2012DFG32000), and by collaborative efforts in the context of grants from the National Natural Science Foundation of China (30500248 and 81300641). Q.F. received a Selective Bilateral Agreement Scholarship (KU Leuven), F.M. and H.R. obtained a PhD Fellowship from the Agency for Innovation by Science and Technology (IWT-Flanders, Belgium), and B.C. a PhD Fellowship from the FWO.	Alexander JM, 2010, TRENDS MOL MED, V16, P426, DOI 10.1016/j.molmed.2010.06.003; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; BOTNICK LE, 1979, BLOOD CELLS, V5, P195; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Call MK, 2004, EXP EYE RES, V78, P297, DOI 10.1016/j.exer.2003.10.021; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Chen JH, 2006, MOL ENDOCRINOL, V20, P3293, DOI 10.1210/me.2006-0293; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Chen Xin-Ming, 2009, Front Biosci (Schol Ed), V1, P132, DOI 10.2741/e13; Coutu DL, 2011, AGING-US, V3, P920, DOI 10.18632/aging.100369; Davis SW, 2009, HORM RES, V71, P101, DOI 10.1159/000192447; De Bellis A, 2008, EUR J ENDOCRINOL, V158, P147, DOI 10.1530/EJE-07-0647; Dean CE, 1999, ENDOCRINOLOGY, V140, P1104, DOI 10.1210/en.140.3.1104; Drouin J, 2006, FRONT HORM RES, V35, P74, DOI 10.1159/000094310; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Fu QL, 2012, STEM CELLS DEV, V21, P3245, DOI 10.1089/scd.2012.0290; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Garcia-Lavandeira M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004815; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Geiger H, 2014, CURR OPIN IMMUNOL, V29, P86, DOI 10.1016/j.coi.2014.05.002; Gibson DJ, 2014, INVEST OPHTH VIS SCI, V55, P2062, DOI 10.1167/iovs.13-12735; Gremeaux L, 2012, STEM CELLS DEV, V21, P801, DOI 10.1089/scd.2011.0496; Hariharan N, 2015, J MOL CELL CARDIOL, V83, P32, DOI 10.1016/j.yjmcc.2015.04.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Le Tissier PR, 2012, FRONT NEUROENDOCRIN, V33, P252, DOI 10.1016/j.yfrne.2012.08.002; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Luque RM, 2007, ENDOCRINOLOGY, V148, P1946, DOI 10.1210/en.2006-1542; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Melmed S., 2010, PITUITARY; Mertens F, 2015, ENDOCR-RELAT CANCER, V22, P481, DOI 10.1530/ERC-14-0546; Mogi C, 2005, J ENDOCRINOL, V184, P41, DOI 10.1677/joe.1.05870; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Pals K, 2006, J NEUROENDOCRINOL, V18, P203, DOI 10.1111/j.1365-2826.2005.01404.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Riley KG, 2015, DIABETES, V64, P1284, DOI 10.2337/db14-1195; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Sierra A, 2015, CELL STEM CELL, V16, P488, DOI 10.1016/j.stem.2015.04.003; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Vankelecom H, 2012, CURR STEM CELL RES T, V7, P36, DOI 10.2174/157488812798483467; Vankelecom H, 2010, EUR J NEUROSCI, V32, P2063, DOI 10.1111/j.1460-9568.2010.07523.x; White PM, 2012, DEV BIOL, V363, P191, DOI 10.1016/j.ydbio.2011.12.035; Willems C, 2014, REGEN MED, V9, P513, DOI [10.2217/RME.14.19, 10.2217/rme.14.19]; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	59	22	22	1	6	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	FEB	2016	157	2					705	721		10.1210/en.2015-1741			17	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	DD5LT	WOS:000369965900026	26653762	Bronze			2022-02-06	
J	Bourque, M; Morissette, M; Al Sweidi, S; Caruso, D; Melcangi, RC; Di Paolo, T				Bourque, Melanie; Morissette, Marc; Al Sweidi, Sara; Caruso, Donatella; Melcangi, Roberto C.; Di Paolo, Therese			Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice	NEUROENDOCRINOLOGY			English	Article						Neuroprotection; Progesterone; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Dopamine; Neuroactive steroids	TRAUMATIC BRAIN-INJURY; INDUCED DOPAMINE DEPLETION; NEUROACTIVE STEROID-LEVELS; FEMALE RAT-BRAIN; PARKINSONS-DISEASE; CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; CLINICAL-TRIAL; MOUSE MODEL; ESTROGEN	Background: Numerous studies have reported on the neuroprotective activity of estradiol, whereas the effect of the other ovarian steroid, progesterone, is much less documented. Methods: This study sought to investigate neuroprotection with a low dose of progesterone (1 mu g) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated male mice to model Parkinson's disease and compare it to the effect of this steroid in intact mice (experiment 1). We also investigated if high doses of progesterone could protect dopaminergic neurons already exposed to MPTP (experiment 2). We measured progesterone effects on various dopaminergic markers [dopamine and its metabolites, dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2)] and on neuroactive steroids in both plasma and the brain. Results: For experiment 1, our results showed that progesterone completely prevented the effect of MPTP toxicity on dopamine concentrations, on the increase in the 3-methoxytyramine/dopamine ratio, as well as on VMAT2-specific binding in the striatum and the substantia nigra. Progesterone decreased MPTP effects on 3,4-dihydroxyphenylacetic acid concentrations and DAT-specific binding in the lateral part of the anterior striatum and in the middle striatum (medial and lateral parts). Progesterone treatment of intact mice had no effect on the markers investigated. For experiment 2, measures of dopaminergic markers in the striatum showed that 8 mg/kg of progesterone was the most effective dose to reduce MPTP effects, and more limited effects were observed with 16 mg/kg. We found that progesterone treatment increases the levels of brain progesterone itself as well as of its metabolites. Conclusion: Our result showed that progesterone has neuroprotective effects on dopaminergic neurons in MPTP-treated male mice. (C) 2015 S. Karger AG, Basel	[Bourque, Melanie; Morissette, Marc; Al Sweidi, Sara; Di Paolo, Therese] Ctr Hosp Univ Laval, Ctr Hosp Univ Quebec, Neurosci Res Unit, Quebec City, PQ, Canada; [Bourque, Melanie; Al Sweidi, Sara; Di Paolo, Therese] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Caruso, Donatella; Melcangi, Roberto C.] Univ Milan, Dept Pharmacol & Biomol Sci, Ctr Excellence Neurodegenerat Dis, Milan, Italy		Di Paolo, T (corresponding author), Ctr Hosp Univ Quebec, Neurosci Res Unit, 2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada.	therese.dipaolo@crchul.ulaval.ca	Melcangi, Roberto Cosimo/AAA-6534-2022	MELCANGI, COSIMO ROBERTO/0000-0003-0861-8967	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-82692]	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) MOP-82692 to T.D.P.	Adeosun SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050040; Aggarwal R, 2008, J PHARM PHARMACOL, V60, P731, DOI 10.1211/jpp.60.6.0008; AlDakheel A, 2014, NEUROTHERAPEUTICS, V11, P6, DOI 10.1007/s13311-013-0218-1; Aron L, 2011, TRENDS NEUROSCI, V34, P88, DOI 10.1016/j.tins.2010.11.001; Audet-Walsh E, 2011, J CLIN ENDOCR METAB, V96, pE330, DOI 10.1210/jc.2010-2050; Baraka AM, 2011, LIFE SCI, V88, P879, DOI 10.1016/j.lfs.2011.03.010; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bixo M, 1997, BRAIN RES, V764, P173, DOI 10.1016/S0006-8993(97)00455-1; Bourque M, 2014, NEUROBIOL AGING, V35, P2347, DOI 10.1016/j.neurobiolaging.2014.03.017; Bourque M, 2013, NEUROBIOL AGING, V34, P887, DOI 10.1016/j.neurobiolaging.2012.05.022; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Caruso D, 2010, J NEUROENDOCRINOL, V22, P1137, DOI 10.1111/j.1365-2826.2010.02064.x; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Casas S, 2011, PHARMACOL BIOCHEM BE, V99, P614, DOI 10.1016/j.pbb.2011.06.012; Chao OY, 2011, NEUROSCIENCE, V196, P228, DOI 10.1016/j.neuroscience.2011.08.043; Curran-Rauhut Meredith A., 2002, Gene Expression Patterns, V1, P151, DOI 10.1016/S1567-133X(02)00011-X; D'Astous M, 2003, SYNAPSE, V47, P10, DOI 10.1002/syn.10145; de Michele F, 2003, NEUROL SCI, V24, P172, DOI 10.1007/s10072-003-0115-1; DIPAOLO T, 1986, EUR J PHARMACOL, V125, P11, DOI 10.1016/0014-2999(86)90077-4; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Ekue A, 2002, J NEUROENDOCRINOL, V14, P731, DOI 10.1046/j.1365-2826.2002.00833.x; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Grandbois M, 2000, NEUROREPORT, V11, P343, DOI 10.1097/00001756-200002070-00024; Guerra-Araiza C, 2009, J NEUROSCI RES, V87, P470, DOI 10.1002/jnr.21848; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Ishihara Y, 2013, J STEROID BIOCHEM, V135, P1, DOI 10.1016/j.jsbmb.2012.12.013; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jeyaraj DA, 2001, ENDOCR RES, V27, P223, DOI 10.1081/ERC-100107183; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Kilbourn M, 1996, EUR J PHARMACOL, V307, P227, DOI 10.1016/0014-2999(96)00252-X; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Lonstein JS, 2004, J NEUROENDOCRINOL, V16, P534, DOI 10.1111/j.1365-2826.2004.01198.x; Luchetti S, 2010, BRAIN PATHOL, V20, P945, DOI 10.1111/j.1750-3639.2010.00396.x; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Melcangi RC, 2012, J MOL NEUROSCI, V46, P177, DOI 10.1007/s12031-011-9570-y; Morissette M, 2007, NEUROPHARMACOLOGY, V52, P1509, DOI 10.1016/j.neuropharm.2007.02.004; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; PETITCLERC M, 1995, PROG NEURO-PSYCHOPH, V19, P491, DOI 10.1016/0278-5846(95)00029-U; Radley E, 2012, NEUROSCI LETT, V506, P131, DOI 10.1016/j.neulet.2011.10.065; Ruffoli R, 2008, BRAIN RES, V1229, P218, DOI 10.1016/j.brainres.2008.06.116; Sanchez MG, 2010, CNS NEUROSCI THER, V16, pe43, DOI 10.1111/j.1755-5949.2010.00163.x; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Shulman LM, 2007, GENDER MED, V4, P8, DOI 10.1016/S1550-8579(07)80003-9; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Singh S, 2010, PHARMACOL BIOCHEM BE, V94, P416, DOI 10.1016/j.pbb.2009.10.003; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Spark MJ, 2012, MATURITAS, V72, P192, DOI 10.1016/j.maturitas.2012.03.015; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wong R, 2012, J PHARM PHARMACOL, V64, P1614, DOI 10.1111/j.2042-7158.2012.01537.x; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu HBK, 2006, BRAIN RES, V1126, P188, DOI 10.1016/j.brainres.2006.09.074; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yu L, 2000, J NEURAL TRANSM, V107, P1139, DOI 10.1007/s007020070027; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001; Zuloaga DG, 2012, ENDOCRINOLOGY, V153, P4432, DOI 10.1210/en.2012-1469	67	22	22	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology		2016	103	3-4					300	314		10.1159/000438789			15	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	DL6RO	WOS:000375766500012	26227546	Green Published			2022-02-06	
J	Du, XP; West, MB; Cheng, WH; Ewert, DL; Li, W; Saunders, D; Towner, RA; Floyd, RA; Kopke, RD				Du, Xiaoping; West, Matthew B.; Cheng, Weihua; Ewert, Donald L.; Li, Wei; Saunders, Debra; Towner, Rheal A.; Floyd, Robert A.; Kopke, Richard D.			Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							FOCAL CEREBRAL-ISCHEMIA; RADICAL-TRAPPING AGENT; N-ACETYL-CYSTEINE; ALZHEIMERS-DISEASE; DENTATE GYRUS; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL DYSFUNCTION; MOLECULAR-MECHANISMS; CEREBROSPINAL-FLUID	Traumatic brain injury (TBI) can lead to early onset dementia and other related neurodegenerative diseases. We previously demonstrated that damage to the central auditory pathway resulting from blast-induced TBI (bTBI) could be significantly attenuated by a combinatorial antioxidant treatment regimen. In the current study, we examined the localization patterns of normal Tau and the potential blast-induced accumulation of neurotoxic variants of this microtubule-associated protein that are believed to potentiate the neurodegenerative effects associated with synaptic dysfunction in the hippocampus following three successive blast overpressure exposures in nontransgenic rats. We observed a marked increase in the number of both hyperphosphorylated and oligomeric Tau-positive hilar mossy cells and somatic accumulation of endogenous Tau in oligodendrocytes in the hippocampus. Remarkably, a combinatorial regimen of 2,4-disulfonyl alpha-phenyl tertiary butyl nitrone (HPN-07) and N-acetylcysteine (NAC) resulted in striking reductions in the numbers of both mossy cells and oligodendrocytes positively labeled for these pathological Tau immunoreactivity patterns in response to bTBI. This treatment strategy represents a promising therapeutic approach for simultaneously reducing or eliminating both primary auditory injury and nonauditory changes associated with bTBI-induced hippocampal neurodegeneration.	[Du, Xiaoping; West, Matthew B.; Cheng, Weihua; Ewert, Donald L.; Li, Wei; Kopke, Richard D.] Hough Ear Inst, Oklahoma City, OK 73112 USA; [Saunders, Debra; Towner, Rheal A.; Floyd, Robert A.; Kopke, Richard D.] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Otolaryngol, Oklahoma City, OK 73104 USA		Kopke, RD (corresponding author), Hough Ear Inst, Oklahoma City, OK 73112 USA.; Kopke, RD (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.; Kopke, RD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.; Kopke, RD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Otolaryngol, Oklahoma City, OK 73104 USA.	rkopke@houghear.org		Towner, Rheal/0000-0001-7368-8983	United States Department of Navy, Office of Naval Research [N00014-09-1-0999]	This research was supported by Grant N00014-09-1-0999 from the United States Department of Navy, Office of Naval Research. The authors would like to thank Dr. Rakez Kayed (University of Texas Medical Branch, Galveston, TX) for his kind gift of the oligomeric (T22) Tau antibody.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; DEWAR D, 1995, BRAIN RES, V684, P70, DOI 10.1016/0006-8993(95)00417-O; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Du X., 2013, PLOS ONE, V8; Du XP, 2012, HEARING RES, V283, P1, DOI 10.1016/j.heares.2011.11.013; Duffy AM, 2013, HIPPOCAMPUS, V23, P649, DOI 10.1002/hipo.22138; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Floyd RA, 2006, AGING CELL, V5, P51, DOI 10.1111/j.1474-9726.2006.00189.x; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Floyd RA, 2013, FREE RADICAL BIO MED, V62, P145, DOI 10.1016/j.freeradbiomed.2013.01.033; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; GULYAS AI, 1992, NEUROSCIENCE, V48, P1, DOI 10.1016/0306-4522(92)90334-X; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Han M, 2003, CELL MOL BIOL, V49, P1249; Haroutunian V, 2007, NEUROBIOL AGING, V28, P1, DOI 10.1016/j.neurobiolaging.2005.11.001; Hart AM, 2004, NEUROSCIENCE, V125, P91, DOI 10.1016/j.neuroscience.2003.12.040; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; HSU M, 1993, J NEUROSCI, V13, P3964; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hughes PM, 2003, J NEUROPATH EXP NEUR, V62, P1276, DOI 10.1093/jnen/62.12.1276; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Irving EA, 1996, NEUROSCI LETT, V213, P189; Irving EA, 1997, J CEREBR BLOOD F MET, V17, P612; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kril JJ, 2002, ACTA NEUROPATHOL, V103, P370, DOI 10.1007/s00401-001-0477-5; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lu JZ, 2014, JARO-J ASSOC RES OTO, V15, P353, DOI 10.1007/s10162-014-0441-4; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maphis N., 2015, FRONTIERS NEUROSCIEN, V9, P1; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; McCracken E, 2002, J CEREBR BLOOD F MET, V22, P1090, DOI 10.1097/00004647-200209000-00006; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; MIETTINEN R, 1992, NEUROSCIENCE, V48, P29, DOI 10.1016/0306-4522(92)90335-Y; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Mondragon-Rodriguez S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/940603; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Papa L, 2007, APOPTOSIS, V12, P1389, DOI 10.1007/s10495-007-0069-5; Peeling J, 2001, NEUROPHARMACOLOGY, V40, P433, DOI 10.1016/S0028-3908(00)00170-2; Perez M, 2000, FEBS LETT, V486, P270, DOI 10.1016/S0014-5793(00)02323-1; Prasanthi JRP, 2010, FREE RADICAL BIO MED, V49, P1212, DOI 10.1016/j.freeradbiomed.2010.07.007; Rajasekar N, 2013, EUR J PHARMACOL, V715, P381, DOI 10.1016/j.ejphar.2013.04.033; Rapoport SI, 2003, NEUROTOX RES, V5, P385, DOI 10.1007/BF03033167; Ratzliff ADH, 2004, J NEUROSCI, V24, P2259, DOI 10.1523/JNEUROSCI.5191-03.2004; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; SAEZ G, 1982, BIOCHIM BIOPHYS ACTA, V719, P24, DOI 10.1016/0304-4165(82)90302-6; Sagara JI, 2010, NEUROREPORT, V21, P416, DOI 10.1097/WNR.0b013e328337765c; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Shi TY, 2013, NEUROTHERAPEUTICS, V10, P340, DOI 10.1007/s13311-012-0168-z; SHIN RW, 1991, LAB INVEST, V64, P693; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Stephenson AP, 2013, TOXICOL LETT, V218, P299, DOI 10.1016/j.toxlet.2012.12.024; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Su B, 2010, NEUROSCI LETT, V468, P267, DOI 10.1016/j.neulet.2009.11.010; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Takeda A, 2000, J NEUROCHEM, V75, P1234, DOI 10.1046/j.1471-4159.2000.0751234.x; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Wolfe MS, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/796024; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xiao F, 2008, NEUROCHEM RES, V33, P1735, DOI 10.1007/s11064-008-9617-9; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zhao ZG, 2001, BRAIN RES, V909, P46, DOI 10.1016/S0006-8993(01)02618-X	109	22	22	1	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2016	2016								4159357	10.1155/2016/4159357			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DD1GF	WOS:000369668600001	27034735	Green Submitted, Green Published, gold			2022-02-06	
J	Kilbaugh, TJ; Karlsson, M; Duhaime, AC; Hansson, MJ; Elmer, E; Margulies, SS				Kilbaugh, Todd J.; Karlsson, Michael; Duhaime, Ann-Christine; Hansson, Magnus J.; Elmer, Eskil; Margulies, Susan S.			Mitochondrial response in a toddler-aged swine model following diffuse non-impact traumatic brain injury	MITOCHONDRION			English	Article						Pediatric brain injury; Traumatic brain injury; Mitochondria; In vivo studies; Large animal model of injury	MATURATION-DEPENDENT RESPONSE; IMMATURE BRAIN; HEAD-INJURY; RAT-BRAIN; AXONAL INJURY; DYSFUNCTION; PIGLETS; METABOLISM; SEVERITY; NEUROPROTECTION	Traumatic brain injury (TBI) is an important health problem, and a leading cause of death in children worldwide. Mitochondrial dysfunction is a critical component of the secondary TBI cascades. Mitochondrial response in the pediatric brain has limited investigation, despite evidence that the developing brain's response differs from that of the adult, especially in diffuse non-impact TBI. We performed a detailed evaluation of mitochondrial bioenergetics using high-resolution respirometry in a swine model of diffuse TBI (rapid non-impact rotational injury: RNR), and examined the cortex and hippocampus. A substrate-uncoupler-inhibitor-titration protocol examined the role of the individual complexes as well as the uncoupled maximal respiration. Respiration per mg of tissue was also related to citrate synthase activity (CS) as an attempt to control for variability in mitochondrial content following injury. Diffuse RNR stimulated increased complex II-driven respiration relative to mitochondrial content in the hippocampus compared to shams. LEAK (State 40) respiration increased in both regions, with decreased respiratory ratios of convergent oxidative phosphorylation through complex I and II, compared to sham animals, indicating uncoupling of oxidative phosphorylation at 24 h. The study suggests that proportionately, complex I contribution to convergent mitochondrial respiration was reduced in the hippocampus after RNR, with a simultaneous increase in complex-II driven respiration. Mitochondrial respiration 24 h after diffuse TBI varies by location within the brain. We concluded that significant uncoupling of oxidative phosphorylation and alterations in convergent respiration through complex I- and complex II-driven respiration reveals therapeutic opportunities for the injured at-risk pediatric brain. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.	[Kilbaugh, Todd J.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Karlsson, Michael; Hansson, Magnus J.; Elmer, Eskil] Lund Univ, Dept Clin Sci, Mitochondrial Med, BMC A13, SE-22184 Lund, Sweden; [Duhaime, Ann-Christine] Univ Penn, Dept Bioengn, 210 South 33rd St, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, 15 Parkman St, Boston, MA 02114 USA; [Duhaime, Ann-Christine] 15 Parkman St, Boston, MA 02114 USA; [Margulies, Susan S.] 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA		Kilbaugh, TJ (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	kilbaugh@chop.edu; michael.karlsson@med.lu.se; aduhaime@partners.org; magnus.hansson@med.lu.se; eskil.elmer@med.lu.se; margulie@seas.upenn.edu	Hansson, Magnus/G-4486-2014; Elmer, Eskil/F-9341-2014; Karlsson, Michael/AAL-8743-2020	Hansson, Magnus/0000-0002-0201-0638; Elmer, Eskil/0000-0001-7901-1826; Karlsson, Michael/0000-0002-7247-2133; Kilbaugh, Todd/0000-0002-4959-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UO1 NS069545]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545] Funding Source: NIH RePORTER	The authors would like to thank Melissa Byro, Ashley Bebee, Jill Ralston, Sarah Sullivan, Albana Shahini, and Saori Morota for their invaluable technical support. The Oroboros Oxygraph used in the study was a loan from NeuroVive Pharmaceutical AB, Lund Sweden. Studies were supported by the NIH UO1 NS069545.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; BATES TE, 1994, DEV NEUROSCI-BASEL, V16, P321, DOI 10.1159/000112126; BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Brustovetsky N, 2002, NEUROSCI LETT, V332, P91, DOI 10.1016/S0304-3940(02)00948-5; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DELMAESTRO R, 1987, MECH AGEING DEV, V41, P29, DOI 10.1016/0047-6374(87)90051-0; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Jaber SM, 2015, DEV NEUROPSYCHOL, V40, P34, DOI 10.1080/87565641.2014.969733; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Miller AC, 2012, COMMON DATA ELEMENTS; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; SIMS NR, 1986, J NEUROCHEM, V47, P496; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	47	22	22	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	JAN	2016	26						19	25		10.1016/j.mito.2015.11.001			7	Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity	DE6UC	WOS:000370768100003	26549476	Green Accepted			2022-02-06	
J	Liu, J; Xia, S; Hanks, R; Wiseman, N; Peng, CY; Zhou, SK; Haacke, EM; Kou, ZF				Liu, Jun; Xia, Shuang; Hanks, Robin; Wiseman, Natalie; Peng, Changya; Zhou, Shunke; Haacke, E. Mark; Kou, Zhifeng			Susceptibility Weighted Imaging and Mapping of Micro-Hemorrhages and Major Deep Veins after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral microbleeds (CMBs); quantitative susceptibility mapping (QSM); susceptibility weighted imaging; susceptibility weighted imaging and mapping (SWIM); traumatic brain injury	SMALL-VESSEL DISEASE; CEREBRAL AMYLOID ANGIOPATHY; DIFFUSE AXONAL INJURY; VASCULAR COGNITIVE IMPAIRMENT; WHITE-MATTER HYPERINTENSITIES; ALZHEIMER-DISEASE; PERIVASCULAR SPACES; ACUTE STROKE; RISK-FACTORS; MICROBLEEDS	Micro-hemorrhages are a common result of traumatic brain injury (TBI), which can be quantified with susceptibility weighted imaging and mapping (SWIM), a quantitative susceptibility mapping approach. A total of 23 TBI patients (five women, 18 men; median age, 41.25 years old; range, 21.69-67.75 years) with an average Glasgow Coma Scale score of 7 (range, 3-15) at admission were recruited at mean 149d (range, 57-366) after injury. Susceptibility-weighted imaging data were collected and post-processed to create SWIM images. The susceptibility value of small hemorrhages (diameter 10mm) and major deep veins (right septal, left septal, central septal, right thalamostriate, left thalamostriate, internal cerebral, right basal vein of Rosenthal, left basal vein of Rosenthal, and pial veins) were evaluated. Different susceptibility thresholds were tested to determine SWIM's sensitivity and specificity for differentiating hemorrhages from the veins. A total of 253 deep veins and 173 small hemorrhages were identified and evaluated. The mean susceptibility of hemorrhages was 435 +/- 206 parts per billion (ppb) and the mean susceptibility of deep veins was 108 +/- 56ppb. Hemorrhages showed a significantly higher susceptibility than all deep veins (p<0.001). With different thresholds (250, 227 and 200ppb), the specificity was 97%, 95%, and 92%, and the sensitivity was 84%, 90%, and 92%, respectively. These results show that SWIM could be used to differentiate hemorrhages from veins in TBI patients in a semi-automated manner with reasonable sensitivity and specificity. A larger cohort will be needed to validate these findings.	[Liu, Jun; Zhou, Shunke] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Liu, Jun; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Sch Med, Dept Biomed Engn, Detroit, MI 48201 USA; [Hanks, Robin] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48201 USA; [Wiseman, Natalie] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA; [Peng, Changya] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA; [Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI 48201 USA; [Xia, Shuang] Tianjin First Cent Hosp, Dept Radiol, Tianjin, Peoples R China		Kou, ZF (corresponding author), Wayne State Univ, Sch Med, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA.	Zhifeng_kou@wayne.edu	liu, jun/AAW-9645-2020	liu, jun/0000-0002-0344-4745; Wiseman, Natalie/0000-0003-0884-6425	International Society for Magnetic Resonance in Medicine (ISMRM); Department of DefenseUnited States Department of Defense [W81XWH-11-1-0493]; NIDRR [H133A020515]; China Scholarship CouncilChina Scholarship Council; Second Xiang Ya Hospital of Central South University of China	This study was supported by the International Society for Magnetic Resonance in Medicine (ISMRM) seed grant (PI: Zhifeng Kou), the Department of Defense W81XWH-11-1-0493 grant (PI: E Mark Haacke), and NIDRR H133A020515 grant (PI: Robin Hanks), State Scholarship Fund from China Scholarship Council (Awardee: Jun Liu), and the Second Xiang Ya Hospital of Central South University of China.	Atlas S.W., 2009, MRI BRAIN SPINE; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Bai QK, 2013, NEUROL RES, V35, P586, DOI 10.1179/1743132813Y.0000000179; Baik SK, 2012, CEREBROVASC DIS, V34, P206, DOI 10.1159/000342148; Barnes SRS, 2011, MAGN RESON IMAGING, V29, P844, DOI 10.1016/j.mri.2011.02.028; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Benedictus MR, 2013, NEUROBIOL AGING, V34, P2488, DOI 10.1016/j.neurobiolaging.2013.04.023; Bian W, 2014, NEURORADIOLOGY, V56, P91, DOI 10.1007/s00234-013-1297-8; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Bouvy WH, 2014, INVEST RADIOL, V49, P307, DOI 10.1097/RLI.0000000000000027; Brundel M, 2012, J ALZHEIMERS DIS, V31, P259, DOI 10.3233/JAD-2012-120364; Buch S., 2014, MAGN RESON MED, V32, P663; Cavalieri M, 2012, NEURODEGENER DIS, V10, P253, DOI 10.1159/000333120; Cavalieri M, 2010, J NEUROL SCI, V299, P11, DOI 10.1016/j.jns.2010.08.031; Chabriat H, 2014, GERIATR PSYCHOL NEUR, V12, P183, DOI 10.1684/pnv.2014.0467; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Choi P, 2012, STROKE, V43, P1505, DOI 10.1161/STROKEAHA.111.647271; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Danve A, 2014, SEMIN ARTHRITIS RHEU, V44, P86, DOI 10.1016/j.semarthrit.2014.02.001; De Reuck J, 2012, EUR J NEUROL, V19, P1355, DOI 10.1111/j.1468-1331.2012.03776.x; de Rochefort L, 2008, MAGN RESON MED, V60, P1003, DOI 10.1002/mrm.21710; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Faul M, 2010, TRAUMATIC BRAIN INJU; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; Fukui T, 2013, DEMENT GER COGN D EX, V3, P148, DOI 10.1159/000351423; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Ghelmez D, 2013, J Med Life, V6, P437; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goos JDC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.026; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Grossman RI, 2003, NEURORADIOLOGY; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Ham JH, 2014, J NEUROL, V261, P1628, DOI 10.1007/s00415-014-7403-y; Hanyu H, 2003, J NEUROL, V250, P1496, DOI 10.1007/s00415-003-0245-7; Hanyu H, 2003, NEUROSCI LETT, V340, P213, DOI 10.1016/S0304-3940(03)00121-6; Hartz AMS, 2012, STROKE, V43, P514, DOI 10.1161/STROKEAHA.111.627562; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Heringa SM, 2014, J ALZHEIMERS DIS, V38, P211, DOI 10.3233/JAD-130542; Hermier M, 2004, STROKE, V35, P1989, DOI 10.1161/01.STR.0000133341.74387.96; Hilal S, 2014, NEUROSCI LETT, V577, P95, DOI 10.1016/j.neulet.2014.06.024; Hilal S, 2014, ALZ DIS ASSOC DIS, V28, P106, DOI 10.1097/WAD.0000000000000015; Hommet C, 2011, DEMENT GERIATR COGN, V32, P367, DOI 10.1159/000335568; Hu J, 2008, J MAGN RESON IMAGING, V28, P300, DOI 10.1002/jmri.21435; Huang PY, 2012, J NEUROL, V259, P1426, DOI 10.1007/s00415-011-6369-2; Ihara Masafumi, 2013, Brain Nerve, V65, P801; Imaizumi T, 2011, J NEUROIMAGING, V21, P359, DOI 10.1111/j.1552-6569.2011.00593.x; Kanmanthareddy A, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0519-y; Katchanov J, 2005, NERVENARZT, V76, P1250, DOI 10.1007/s00115-005-1884-y; Kester MI, 2014, JAMA NEUROL, V71, P855, DOI 10.1001/jamaneurol.2014.754; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirsch W, 2009, J ALZHEIMERS DIS, V17, P599, DOI 10.3233/JAD-2009-1073; Kou Z, 2010, CLIN MR NEUROIMAGING; Kou Z., 2011, SUSCEPTIBILITY WEIGH; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kuijf HJ, 2012, NEUROIMAGE, V59, P2266, DOI 10.1016/j.neuroimage.2011.09.061; Lanfranconi S, 2010, STROKE, V41, pE513, DOI 10.1161/STROKEAHA.110.581918; Lawrence AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061014; Lian LF, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-98; Liem MK, 2007, STROKE, V38, P923, DOI 10.1161/01.STR.0000257968.24015.bf; Liu S., 2014, BIOMEDICAL ENG; Liu SF, 2013, MAGN RESON MED, V69, P716, DOI 10.1002/mrm.24305; Liu T, 2013, MAGN RESON MED, V69, P467, DOI 10.1002/mrm.24272; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Lupo JM, 2012, INT J RADIAT ONCOL, V82, pE493, DOI 10.1016/j.ijrobp.2011.05.046; Maia LF, 2006, CEREBROVASC DIS, V22, P155, DOI 10.1159/000093245; Martinez-Ramirez S, 2013, NEUROLOGY, V80, P1266, DOI 10.1212/WNL.0b013e31828b8c16; Miyata K, 2003, NEUROL SURG TOKYO, V31, P1223; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Mori N, 2008, INVEST RADIOL, V43, P574, DOI 10.1097/RLI.0b013e31817fb432; Muller M, 2014, NEUROLOGY, V82, P2187, DOI 10.1212/WNL.0000000000000517; Nagata K, 2012, J NEUROL SCI, V322, P87, DOI 10.1016/j.jns.2012.07.001; Nakata-Kudo Y, 2006, DEMENT GERIATR COGN, V22, P8, DOI 10.1159/000092958; Nardone R, 2011, J NEURAL TRANSM, V118, P1349, DOI 10.1007/s00702-011-0650-5; Niwa T, 2010, PEDIATR RADIOL, V40, P1657, DOI 10.1007/s00247-010-1665-z; O'Rourke MF, 2008, HYPERTENSION, V51, pE20, DOI 10.1161/HYPERTENSIONAHA.107.109199; Oberstein SAJL, 2001, NEUROLOGY, V57, P1066, DOI 10.1212/WNL.57.6.1066; Olazaran J, 2014, AM J ALZHEIMERS DIS, V29, P263, DOI 10.1177/1533317513517043; Park JH, 2013, ANN NEUROL, V73, P584, DOI 10.1002/ana.23845; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Patel B, 2013, STROKE, V44, P356, DOI 10.1161/STROKEAHA.112.670216; Pettersen JA, 2008, ARCH NEUROL-CHICAGO, V65, P790, DOI 10.1001/archneur.65.6.790; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Qin Y, 2015, ACTA RADIOL, V56, P329, DOI 10.1177/0284185114524198; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Riba-Llena I, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-130; Romero JR, 2012, STROKE, V43, P3091, DOI 10.1161/STROKEAHA.112.656744; Ryan NS, 2012, BRAIN, V135, DOI 10.1093/brain/awr126; Santhosh K, 2009, CLIN RADIOL, V64, P74, DOI 10.1016/j.crad.2008.04.022; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Scheltens P, 2012, NAT REV NEUROL, V8, P68, DOI 10.1038/nrneurol.2011.222; Schneider JA, 2007, STROKE, V38, P1730, DOI 10.1161/STROKEAHA.107.487173; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Seo SW, 2007, STROKE, V38, P1949, DOI 10.1161/STROKEAHA.106.477315; Seo SW, 2012, J NEUROL SCI, V322, P200, DOI 10.1016/j.jns.2012.05.032; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Tang WK, 2011, J AFFECT DISORDERS, V129, P354, DOI 10.1016/j.jad.2010.08.007; Tang WK, 2011, INT J STROKE, V6, P498, DOI 10.1111/j.1747-4949.2011.00682.x; Theysohn JM, 2011, J MAGN RESON IMAGING, V33, P782, DOI 10.1002/jmri.22513; Tomimoto Hidekazu, 2013, Rinsho Shinkeigaku, V53, P915; Tomimoto Hidekazu, 2012, Brain and Nerve (Tokyo), V64, P1377; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Uetani H, 2013, AM J NEURORADIOL, V34, P984, DOI 10.3174/ajnr.A3332; van der Flier WM, 2012, J NEUROL SCI, V322, P56, DOI 10.1016/j.jns.2012.07.009; Van der Flier WM, 2012, EXP GERONTOL, V47, P853, DOI 10.1016/j.exger.2012.07.007; van der Vlies AE, 2012, NEUROLOGY, V79, P763, DOI 10.1212/WNL.0b013e3182661f91; van Norden AGW, 2013, NEUROBIOL AGING, V34, P2225, DOI 10.1016/j.neurobiolaging.2013.03.021; van Norden AGW, 2012, J ALZHEIMERS DIS, V32, P667, DOI 10.3233/JAD-2012-120784; van Rooden S, 2014, RADIOLOGY, V270, P205, DOI 10.1148/radiol.13130743; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Werring DJ, 2010, J NEUROL SCI, V299, P131, DOI 10.1016/j.jns.2010.08.034; Wycliffe ND, 2004, J MAGN RESON IMAGING, V20, P372, DOI 10.1002/jmri.20130; Xia S, 2014, MAGN RESON IMAGING, V32, P1272, DOI 10.1016/j.mri.2014.08.012; Xu B, 2014, MAGN RESON MED, V72, P438, DOI 10.1002/mrm.24937; Xu Jiewen, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P1362; Yakushiji Y, 2008, STROKE, V39, P3323, DOI 10.1161/STROKEAHA.108.516112; Yamada S, 2012, J NEUROL, V259, P2707, DOI 10.1007/s00415-012-6574-7; Yamaguchi T, 2013, NEUROL MED-CHIR, V53, P318, DOI 10.2176/nmc.53.318; Yan L, 2014, RADIOL MED, V119, P175, DOI 10.1007/s11547-013-0328-1; Yates PA, 2014, NEUROLOGY, V82, P1266, DOI 10.1212/WNL.0000000000000285; Yin J, 2013, TOHOKU J EXP MED, V230, P133, DOI 10.1620/tjem.230.133; Zheng WL, 2013, NEUROIMAGE, V78, P68, DOI 10.1016/j.neuroimage.2013.04.022; Zonneveld HI, 2014, NEUROLOGY, V82, P698, DOI 10.1212/WNL.0000000000000150	137	22	26	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					10	21		10.1089/neu.2014.3856			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200002	25789581				2022-02-06	
J	Liu, S; Cao, YG; Qu, M; Zhang, Z; Feng, L; Ye, ZS; Xiao, MJ; Hou, ST; Zheng, RY; Han, Z				Liu, Shuang; Cao, Yungang; Qu, Man; Zhang, Zheng; Feng, Liang; Ye, Zusen; Xiao, Meijuan; Hou, Sheng T.; Zheng, Rongyuan; Han, Zhao			Curcumin protects against stroke and increases levels of Notch intracellular domain	NEUROLOGICAL RESEARCH			English	Article						Middle cerebral artery occlusion; Curcumin; Neuroprotection; Neurogenesis; Notch; BrdU	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; CEREBRAL INFARCTION; SUBVENTRICULAR ZONE; RATS; ISCHEMIA; DIFFERENTIATION; ATTENUATION; INVOLVEMENT	Objectives: To investigate whether curcumin regulates Notch signaling to cause neuroprotection and neurogenesis after focal ischemia reperfusion injury. Method: Focal ischemia reperfusion injury was modeled in rats by occluding the middle cerebral artery. These animals were given either curcumin (300 mg/kg) or corn oil (vehicle) by intraperitoneal injection starting 1 h after stroke and continuing for 7 d. In parallel, sham-operated control animals received vehicle. All animals were killed on day 12. The different treatment groups were compared in terms of neurobehavioral deficits, BrdU incorporation, and levels of doublecortin (DCX) and Notch intracellular domain (NICD) using immunohistochemistry, immunofluorescence and Western blotting. Results: Animals treated with curcumin showed significantly smaller neurobehavioral deficits than vehicle-treated animals after 3, 7, and 12 d of reperfusion (all p < 0.05). Tissue sections from curcumin-treated animals contained significantly greater numbers of BrdU-positive cells (p < 0.05) and BrdU/DCX-positive cells (p < 0.01), as well as significantly higher NICD levels (p < 0.01). Conclusion: Curcumin may protect from focal cerebral ischemia reperfusion injury as well as stimulate neurogenesis by activating the Notch signaling pathway.	[Liu, Shuang; Cao, Yungang; Qu, Man; Han, Zhao] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou 325027, Peoples R China; [Zhang, Zheng; Feng, Liang; Ye, Zusen; Xiao, Meijuan; Zheng, Rongyuan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Peoples R China; [Hou, Sheng T.] Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada		Han, Z (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou 325027, Peoples R China.	wzhanzhao@aliyun.com	Hou, Sheng Tao/AAM-7756-2020; Hou, Sheng Tao/O-3202-2018; zhang, zheng/V-9479-2018	Hou, Sheng Tao/0000-0001-9736-342X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571114]; Wenzhou Science Technology Bureau [Y20140686]	This study was supported by the National Natural Science Foundation of China [grant number 81571114 to Zhao Han], and Programs of Wenzhou Science Technology Bureau [grant number Y20140686 to Zhao Han].	Ahsan H, 1999, CHEM-BIOL INTERACT, V121, P161, DOI 10.1016/S0009-2797(99)00096-4; Bagley J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-92; Chen B, 2016, TURK NEUROSURG, V26, P8, DOI 10.5137/1019-5149.JTN.11488-14.3; Chen XM, 2014, EXP NEUROL, V261, P267, DOI 10.1016/j.expneurol.2014.07.007; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Han Z, 2012, BIOCHEM BIOPH RES CO, V424, P544, DOI 10.1016/j.bbrc.2012.06.152; Han Z, 2009, NEUROL RES, V31, P390, DOI 10.1179/174313209X444116; Hoppe JB, 2013, NEUROL RES, V35, P857, DOI 10.1179/1743132813Y.0000000225; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kim H, 2005, NEUROL RES, V27, P287, DOI 10.1179/016164105X25234; Kulkarni SK, 2009, THESCIENTIFICWORLDJO, V9, P1233, DOI 10.1100/tsw.2009.137; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Miljan EA, 2009, CURR OPIN MOL THER, V11, P394; Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang SH, 2010, BEHAV PHARMACOL, V21, P47, DOI 10.1097/FBP.0b013e328334b677; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83; Wang XD, 2016, J MATER PROCESS TECH, V238, P1, DOI 10.1016/j.jmatprotec.2016.06.033; Xiao Mei-Juan, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P192; Xing CH, 2012, NEUROL RES, V34, P325, DOI 10.1179/1743132812Y.0000000019; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu Y, 2007, BRAIN RES, V1162, P9, DOI 10.1016/j.brainres.2007.05.071; Yamamoto S, 2014, METHODS MOL BIOL, V1187, P1, DOI 10.1007/978-1-4939-1139-4_1; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yao J, 2012, PROTEIN CELL, V3, P251, DOI 10.1007/s13238-012-2033-6; Zhang Bo, 2009, Chinese Medical Sciences Journal, V24, P41; Zhang YM, 2015, NEUROSCI LETT, V603, P12, DOI 10.1016/j.neulet.2015.07.009; Zhao J, 2008, BRAIN RES, V1229, P224, DOI 10.1016/j.brainres.2008.06.117	35	22	24	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	6			SI		553	559		10.1080/01616412.2016.1187804			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO9ZH	WOS:000378146300012	27320251				2022-02-06	
J	O'Lynnger, TM; Shannon, CN; Le, TM; Greeno, A; Chung, D; Lamb, FS; Wellons, JC				O'Lynnger, Thomas M.; Shannon, Chevis N.; Le, Truc M.; Greeno, Amber; Chung, Dai; Lamb, Fred S.; Wellons, John C., III			Standardizing ICU management of pediatric traumatic brain injury is associated with improved outcomes at discharge	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						critical care; discharge; trauma; traumatic brain injury; protocol	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; INTENSIVE-CARE; CHILDREN; MORTALITY; RECOMMENDATIONS; SURVIVORS; IMPACT; SCALE	OBJECTIVE The goal of critical care in treating traumatic brain injury (TBI) is to reduce secondary brain injury by limiting cerebral ischemia and optimizing cerebral blood flow. The authors compared short-term outcomes as defined by discharge disposition and Glasgow Outcome Scale scores in children with TBI before and after the implementation of a protocol that standardized decision-making and interventions among neurosurgeons and pediatric intensivists. METHODS The authors performed a retrospective pre- and postprotocol study of 128 pediatric patients with severe TBI, as defined by Glasgow Coma Scale (GCS) scores < 8, admitted to a tertiary care center pediatric critical care unit between April 1, 2008, and May 31, 2014. The preprotocol group included 99 patients, and the postprotocol group included 29 patients. The primary outcome of interest was discharge disposition before and after protocol implementation, which took place on April 1, 2013. Ordered logistic regression was used to assess outcomes while accounting for injury severity and clinical parameters. Favorable discharge disposition included discharge home. Unfavorable discharge disposition included discharge to an inpatient facility or death. RESULTS Demographics were similar between the treatment periods, as was injury severity as assessed by GCS score (mean 5.43 preprotocol, mean 5.28 postprotocol; p = 0.67). The ordered logistic regression model demonstrated an odds ratio of 4.0 of increasingly favorable outcome in the postprotocol cohort (p = 0.007). Prior to protocol implementation, 63 patients (64%) had unfavorable discharge disposition and 36 patients (36%) had favorable discharge disposition. After protocol implementation, 9 patients (31%) had unfavorable disposition, while 20 patients (69%) had favorable disposition (p = 0.002). In the preprotocol group, 31 patients (31%) died while 6 patients (21%) died after protocol implementation (p = 0.04). CONCLUSIONS Discharge disposition and mortality rates in pediatric patients with severe TBI improved after implementation of a standardized protocol among caregivers based on best-practice guidelines.	[O'Lynnger, Thomas M.; Shannon, Chevis N.; Wellons, John C., III] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA; [Le, Truc M.; Lamb, Fred S.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Crit Care Med, Nashville, TN USA; [Greeno, Amber; Chung, Dai] Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN 37232 USA		O'Lynnger, TM (corresponding author), Vanderbilt Univ, Med Ctr, Pediat Neurosurg, 9222 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.	olynnger@vanderbilt.edu		Lamb, Fred/0000-0003-2955-5133	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: Medline		Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Greenwald BD, 2015, J NEUROTRAUMA; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lane PL, 2000, CAN J SURG, V43, P442; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; SAUL TG, 1982, AM SURGEON, V48, P477; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Scaife ER, 2010, CURR OPIN PEDIATR, V22, P339, DOI 10.1097/MOP.0b013e3283395f2b; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Society of Critical Care Medicine, 2003, Crit Care Med, V31, pS407; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Xiang J, 2013, BRAIN INJURY, V27, P1555, DOI 10.3109/02699052.2013.831126	33	22	22	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2016	17	1					19	26		10.3171/2015.5.PEDS1544			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CZ3TW	WOS:000367027900005	26451717				2022-02-06	
J	Patanwala, AE; Erstad, BL; Roe, DJ; Sakles, JC				Patanwala, Asad E.; Erstad, Brian L.; Roe, Denise J.; Sakles, John C.			Succinylcholine Is Associated with Increased Mortality When Used for Rapid Sequence Intubation of Severely Brain Injured Patients in the Emergency Department	PHARMACOTHERAPY			English	Article						brain injuries; succinylcholine; intubation; neuromuscular blocking agents	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; SEVERITY SCORE; HEAD-INJURIES; SUXAMETHONIUM; ROCURONIUM; TRAUMA	ObjectiveTo compare succinylcholine and rocuronium regarding mortality in patients with traumatic brain injury (TBI) who are intubated in the emergency department (ED). MethodsThis was a retrospective cohort study conducted in an academic ED in the United States. Adult patients with TBI who underwent rapid sequence intubation (RSI) in the ED with rocuronium or succinylcholine between October 2010 and October 2014 were included. The main outcome of interest was in-hospital mortality. Subjects were stratified based on severity of injury using head abbreviated injury scores. The high-severity group had a severe or critical head injury (score 4 or higher); the low-severity group had a less than severe head injury (score lower than 4). Main ResultsThe final study cohort included 233 patients who were underwent RSI with succinylcholine (149 patients) or rocuronium (84 patients). In patients who received rocuronium, mortality was 22% (12/54) and 23% (7/30) in the low-severity and high-severity categories, respectively (difference 1%, 95% confidence interval [CI] -18% to 20%). In patients who received succinylcholine, mortality was 14% (14/103) and 44% (20/46) in the low-severity and high-severity categories, respectively (difference 30%, 95% CI 14-46). In the multivariate analysis after adjusting for important confounders, there was no significant association between succinylcholine and mortality in the low-severity category (odds ratio [OR] 0.75, 95% CI 0.29-1.92). However, in patients in the high-severity category, succinylcholine was associated with increased mortality compared with rocuronium (OR 4.10, 95% CI 1.18-14.12). ConclusionsIn severely brain-injured patients undergoing RSI in the ED, succinylcholine was associated with increased mortality compared with rocuronium.	[Patanwala, Asad E.; Erstad, Brian L.] Univ Arizona, Dept Pharm Practice & Sci, Coll Pharm, 1295 N Martin,POB 210202, Tucson, AZ 85721 USA; [Roe, Denise J.] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85721 USA; [Sakles, John C.] Univ Arizona, Dept Emergency Med, Coll Med, Tucson, AZ 85721 USA		Patanwala, AE (corresponding author), Univ Arizona, Dept Pharm Practice & Sci, Coll Pharm, 1295 N Martin,POB 210202, Tucson, AZ 85721 USA.	patanwala@pharmacy.arizona.edu					Amini A, 2013, AM J HEALTH-SYST PH, V70, P1513, DOI 10.2146/ajhp120673; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Brown MM, 1996, EUR J ANAESTH, V13, P474, DOI 10.1046/j.1365-2346.1996.00973.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Healthcare Cost and Utilization Project (HCUP), 2015, HCUP NEDS DESCR DAT; Korinek JD, 2014, EUR J EMERG MED, V21, P206, DOI 10.1097/MEJ.0b013e3283606b89; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; May N, 2012, EMERG MED J, V29, P511, DOI 10.1136/emermed-2012-201374.4; MCLESKEY CH, 1974, ANESTH ANALG, V53, P985, DOI 10.1213/00000539-197453060-00033; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Osler T, 1996, J TRAUMA, V41, P386; Patanwala AE, 2011, ACAD EMERG MED, V18, P11, DOI 10.1111/j.1553-2712.2010.00954.x; Perry JJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub2; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Sandoz Inc, 2011, SUCC CHLOR INJ SOL P; Sandoz Inc, 2015, ROC BROM INJ SOL PAC; Watt JM, 2013, EMERG MED J, V30, P893, DOI 10.1136/emermed-2012-201812	20	22	22	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	JAN	2016	36	1					57	63		10.1002/phar.1683			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DC0XP	WOS:000368941600008	26799349				2022-02-06	
J	Pavliscsak, H; Little, JR; Poropatich, RK; McVeigh, FL; Tong, J; Tillman, JS; Smith, CH; Fonda, SJ				Pavliscsak, Holly; Little, Jeanette R.; Poropatich, Ronald K.; McVeigh, Francis L.; Tong, James; Tillman, Johnie S.; Smith, Challis H.; Fonda, Stephanie Jo			Assessment of patient engagement with a mobile application among service members in transition	JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION			English	Article						case management; traumatic brain injury; post-traumatic stress disorder; mobile health; patient engagement	MANAGEMENT; PROGRAM; INTERVENTIONS; EMPOWERMENT; OUTCOMES; PHONES; MODEL; CARE	Objective: This article examines engagement with a mobile application ("mCare") for wounded Service Members rehabilitating in their communities. Many had behavioral health problems, Traumatic Brain Injury (TBI), and/or post-traumatic stress disorder (PTS). The article also examines associations between Service Members' background characteristics and their engagement with mCare. Materials and Methods: This analysis included participants who received mCare (n = 95) in a randomized controlled trial. mCare participants received status questionnaires daily for up to 36 weeks. Participant engagement encompasses exposure to mCare, percentage of questionnaires responded to, and response time. Participants were grouped by health status-that is, presence/absence of behavioral health problems, PTS, and/or TBI. Histograms and regression analyses examined engagement by participants' health status and background characteristics. Results: Exposure to mCare did not differ by health status. Participants usually responded to >= 60% of the questionnaires weekly, generally in <= 10 h; however, participants with behavioral health problems had several weeks with <50% response and the longest response times. Total questionnaires responded to and response time did not differ statistically by health status. Older age and higher General Well-Being Schedule scores were associated with greater and faster response. Discussion: The sustained response to the questionnaires suggests engagement. Overall level of response surpassed trends reported for American's usage of mobile applications. With a few exceptions, Service Members engaged with mCare irrespective of health status. Conclusion: Mobile health has the potential to increase the quantity and quality of patient-provider communications in a community-based, rehabilitation care setting, above that of standard care.	[Pavliscsak, Holly] USAMRMC, TATRC, Mobile Hlth Care Innovat Ctr MHIC, Geneva Fdn, Ft Gordon, GA 30905 USA; [Little, Jeanette R.] US Army, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Mobile Hlth Innovat Ctr, Ft Gordon, GA 30905 USA; [Poropatich, Ronald K.] Univ Pittsburgh, Ctr Mil Med Res, Pittsburgh, PA USA; [McVeigh, Francis L.] US Army, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Adv Technol & Innovat Lab, Ft Detrick, MD USA; [Tong, James] Govt Solut, IMS Hlth, Washington, DC USA; [Tillman, Johnie S.] Integrated Disabil Evaluat Syst, Ft Gordon, GA USA; [Smith, Challis H.] Virginia Dept Behav Hlth & Dev Serv, Qual Management & Dev, Richmond, VA USA; [Fonda, Stephanie Jo] Walter Reed Natl Mil Med Ctr, Geneva Res Fdn, Dept Endocrinol, Bethesda, MD USA		Pavliscsak, H (corresponding author), USAMRMC, TATRC, Mobile Hlth Care Innovat Ctr MHIC, Geneva Fdn, Ft Gordon, GA 30905 USA.	holly.h.pavliscsak.ctr@mail.mil; jeanette.r.little.civ@mail.mil; rkp19@pitt.edu; francis.l.mcveigh.civ@mail.mil; jtong@us.imshealth.com; johnie.s.tillman.civ@mail.mil; chc.smith@us.army.mil; sfonda@genevausa.org			Office of Force Health Protection	This study was funded by the Office of Force Health Protection, and managed by the Mobile Health Innovation Center, an intramural laboratory of the Telemedicine and Advanced Technology Research Center, United States Army Medical Research and Material Command.	Agboola Stephen, 2013, J Diabetes Sci Technol, V7, P623; Ajay VS, 2012, GLOB HEART, V7, P167, DOI 10.1016/j.gheart.2012.03.004; Bailey JV, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007552; Boland P, 2007, J AMBUL CARE MANAG, V30, P126, DOI 10.1097/01.JAC.0000264602.19629.84; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Fazio A F, 1977, Vital Health Stat 2, P1; Feng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118011; Fox Brent I, 2014, Hosp Pharm, V49, P992, DOI 10.1310/hpj4910-992; Hadgkiss EJ, 2015, NEUROL SCI, V36, P845, DOI 10.1007/s10072-015-2089-1; Holtz B, 2012, TELEMED E-HEALTH, V18, P175, DOI 10.1089/tmj.2011.0119; Irvine AB, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3130; Jones KR, 2014, WORLDV EVID-BASED NU, V11, P81, DOI 10.1111/wvn.12030; Laurance J, 2014, HEALTH AFFAIR, V33, P1627, DOI 10.1377/hlthaff.2014.0375; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Localytics, 2014, TIM APP INCR 21 ALL; Localytics, 2011, NUMB TIM MOB APPS WE; Makovsky Integrated Communications, 2015, 5 ANN PULS ONL HLTH; Mbuagbaw L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0654-6; MCDOWELL I, 1987, MEASURING HLTH GUIDE, P125; Musacchio N, 2011, DIABETIC MED, V28, P724, DOI 10.1111/j.1464-5491.2011.03253.x; National Institute of Mental Health, MAJ DEPR AD; Pena-Purcell NC, 2011, DIABETES EDUCATOR, V37, P770, DOI 10.1177/0145721711423319; Poston WSC, 1998, WOMEN HEALTH, V27, P51, DOI 10.1300/J013v27n03_04; Riley GA, 2015, BRAIN INJURY, P1; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029; Verwey R, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-93; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966; Volpp Kevin G, 2009, LDI Issue Brief, V14, P1	29	22	22	2	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1067-5027	1527-974X		J AM MED INFORM ASSN	J. Am. Med. Inf. Assoc.	JAN	2016	23	1					110	118		10.1093/jamia/ocv121			9	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	DJ4MK	WOS:000374179500015	26363048	Green Published, Bronze			2022-02-06	
J	Phillips, KM; Clark, ME; Gironda, RJ; McGarity, S; Kerns, RW; Elnitsky, CA; Andresen, EM; Collins, RC				Phillips, Kristin M.; Clark, Michael E.; Gironda, Ronald J.; McGarity, Suzanne; Kerns, Robert W.; Elnitsky, Christine A.; Andresen, Elena M.; Collins, Rose C.			Pain and psychiatric comorbidities among two groups of Iraq- and Afghanistan-era Veterans	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Afghanistan; anxiety; blast injuries; chronic pain; combat disorders; comorbidities; depression; Iraq; postconcussive disorder; PTSD; sleep; substance use disorder; TBI; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; OPERATIONS ENDURING FREEDOM; PERSISTENT POSTCONCUSSIVE SYMPTOMS; DYADIC ADJUSTMENT SCALE; DEPRESSIVE SYMPTOMS; BLAST EXPOSURE; CARE; SOLDIERS; OUTCOMES	This study aimed to (1) identify the prevalence and severity of pain and psychiatric comorbidities among personnel who had been deployed during Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF), and Operation New Dawn (OND) and (2) assess whether the Department of Veterans Affairs (VA) Polytrauma System of Care and an OIF/OEF/OND registry reflect real differences among patients. Participants (N = 359) were recruited from two VA hospitals. They completed a clinical interview, structured diagnostic interview, and self-report measures. Results indicated pain was the most common complaint, with 87% experiencing pain during the prior week and 56% reporting moderate or severe pain. Eighty percent of participants met criteria for at least one of seven assessed comorbid problems (moderate or severe pain, postconcussional disorder, posttraumatic stress disorder [PTSD], anxiety disorder, mood disorder, substance use disorder, psychosis), and 59 percent met criteria for two or more problems. PTSD and postconcussional disorder rarely occurred in the absence of pain or other comorbidities (0.3% and 0%, respectively). The Polytrauma group had more comorbid psychiatric conditions (chi(2) = 48.67, p < 0.05) and reported greater severity of symptoms (p < 0.05) than the Registry group. This study confirmed the high prevalence of pain and concurrent mental health problems among personnel returning from military deployment.	[Phillips, Kristin M.; Clark, Michael E.; Gironda, Ronald J.; McGarity, Suzanne] James A Haley Vet Hosp, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Clark, Michael E.; Gironda, Ronald J.] Univ S Florida, Tampa, FL USA; [Kerns, Robert W.] Dept Vet Affairs VA Connecticut Healthcare Syst, Pain Res Informat Multimorbid & Educ Ctr Innovat, West Haven, CT USA; [Kerns, Robert W.] Yale Univ, Sch Med, New Haven, CT USA; [Elnitsky, Christine A.] Univ N Carolina, Sch Nursing, Coll Hlth & Human Serv, Charlotte, NC 28223 USA; [Andresen, Elena M.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Andresen, Elena M.] Portland State Univ, Portland, OR 97207 USA; [Collins, Rose C.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA		Phillips, KM (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Kristin.Phillips3@va.gov			VA Health Services Research DevelopmentUS Department of Veterans Affairs [SDR-07-047]; Health Services Research & Development Center of Innovation [CIN 13-407]	This material was based on work supported in part by VA Health Services Research & Development (award SDR-07-047) to M. E. Clark. R. W. Kerns is supported by the Health Services Research & Development Center of Innovation (CIN 13-407).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Beckham JC, 1997, BEHAV MED, V23, P138, DOI 10.1080/08964289709596370; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bosco MA, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/174728; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Caughey GE, 2010, J EPIDEMIOL COMMUN H, V64, P1036, DOI 10.1136/jech.2009.088260; Clark ME, 2004, PAIN MED, V5, P333, DOI 10.1111/j.1526-4637.2004.04059.x; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Department of Veterans Affairs, 2013, AN VA HLTH CAR OP IR; Department of Veterans Affairs, 2005, POL REH CTR; Egede LE, 2007, J GEN INTERN MED, V22, P701, DOI 10.1007/s11606-007-0170-z; Elnitsky CA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-498; Elnitsky CA, 2013, MIL MED, V178, P775, DOI 10.7205/MILMED-D-13-00012; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gironda RJ, 2007, J REHABIL RES DEV, V44, P223, DOI 10.1682/JRRD.2006.06.0058; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hagen C, 1979, REHABILITATION HEAD; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hunsley J, 2001, AM J FAM THER, V29, P325, DOI 10.1080/01926180126501; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Kalra R, 2008, FED PRACT, V25, P36; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Kehle SM, 2012, PSYCHOL ADDICT BEHAV, V26, P42, DOI 10.1037/a0024663; Koike AK, 2002, AM J PSYCHIAT, V159, P1738, DOI 10.1176/appi.ajp.159.10.1738; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McKellar JD, 2003, BRIT J CLIN PSYCHOL, V42, P27, DOI 10.1348/014466503762841995; Michelson H, 2000, QUAL LIFE RES, V9, P1093, DOI 10.1023/A:1016654621784; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Murphy JL, 2013, CLIN J PAIN, V29, P109, DOI 10.1097/AJP.0b013e3182579935; Office of the Deputy Undersecretary of Defense, 2009, DEM 2009 PROF MIL CO; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Peabody JW, 2004, MED CARE, V42, P1066, DOI 10.1097/00005650-200411000-00005; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; SHARPLEY CF, 1984, EDUC PSYCHOL MEAS, V44, P1045, DOI 10.1177/0013164484444029; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stein KD, 1998, CANCER PRACT, V6, P143, DOI 10.1046/j.1523-5394.1998.006003143.x; Stein KD, 2004, J PAIN SYMPTOM MANAG, V27, P14, DOI 10.1016/j.jpainsymman.2003.06.003; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Townsend CO, 2008, PAIN, V140, P177, DOI 10.1016/j.pain.2008.08.005; Ullrich PM, 2013, ARCH PHYS MED REHAB, V94, P80, DOI 10.1016/j.apmr.2012.07.018; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Veterans Health Administration, 2012, ANAL VA HLTH CAR UT; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	69	22	23	0	2	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	4					413	432		10.1682/JRRD.2014.05.0126			20	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DS7YY	WOS:000381000600002	27532156	Green Submitted, gold			2022-02-06	
J	Regasa, LE; Thomas, DM; Gill, RS; Marion, DW; Ivins, BJ				Regasa, Lemma Ebssa; Thomas, D. Michael; Gill, Ranjodh S.; Marion, Donald W.; Ivins, Brian J.			Military Deployment May Increase the Risk for Traumatic Brain Injury Following Deployment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						deployment; epidemiology; postdeployment; predeployment; TBI; TBI diagnosis; traumatic brain injury; US military	ARMY SOLDIERS; MILD; COMBAT; PROPENSITY; BEHAVIORS; MORTALITY; PERSONNEL; ACCURACY; VETERANS; SEQUELAE	Objective: To compare rates of traumatic brain injury (TBI) diagnosis before and after overseas military deployment. Design: We conducted a retrospective examination of a cohort of 119 353 active duty US military service members (Army, Navy, Air Force, and Marines) whose first lifetime overseas deployment began at any time between January 1, 2011, and December 31, 2011, and lasted at least for 30 days. For this cohort, TBI diagnoses were examined during the 76 weeks prior to deployment, during deployment, and 76 weeks following the end of deployment. Main Measures: 4-week rates of TBI diagnosis. Results: The risk of being diagnosed with TBI within 4 weeks after returning from deployment was 8.4 times higher than the average risk before deployment. The risk gradually decreased thereafter up to 40 weeks postdeployment. However, during the 41 to 76 weeks following deployment, risk stabilized but remained on average 1.7 times higher than before deployment. Conclusion: An increased rate of TBI diagnosis following deployment was identified, which may be partly due to delayed diagnosis of TBIs that occurred while service members were deployed. Also, the increased rate may partly be due to riskier behaviors of service members following deployment that results in an increased occurrence of TBIs.	[Regasa, Lemma Ebssa; Thomas, D. Michael; Gill, Ranjodh S.; Marion, Donald W.; Ivins, Brian J.] Def & Vet Brain Injury Ctr, 1335 East West Hwy,Ste 600, Silver Spring, MD 20910 USA; [Regasa, Lemma Ebssa] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, 30 Coll Ave, New Brunswick, NJ 08903 USA; [Regasa, Lemma Ebssa; Marion, Donald W.; Ivins, Brian J.] Gen Dynam Informat Technol, Fairfax, VA USA; [Thomas, D. Michael] Univ Illinois, Sch Publ Hlth, Chicago, IL 60680 USA; [Thomas, D. Michael] Creat Comp Solut Inc, Rockville, MD USA; [Gill, Ranjodh S.] US PHS, Washington, DC USA		Regasa, LE (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Hwy,Ste 600, Silver Spring, MD 20910 USA.	lemma.e.regasa.ctr@mail.mil	Marion, Donald/AAR-5749-2021		Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs	This material is supported by the Defense and Veterans Brain Injury Center (DVBIC). No outside sources contributed to the funding of this study. The authors thank CPT Armen Thoumiain for his assistance with study execution. The authors also thank MAJ Patricia Rohrbeck for providing aggregate data. Comments by colleagues at DVBIC in improving the earlier version of this article are acknowledged.	Adler AB, 2011, J TRAUMA STRESS, V24, P381, DOI 10.1002/jts.20665; Armed Forces Health Surveillance Center, CAS DEF DAT AN HLTH; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bell N S, 2001, Inj Prev, V7, P4, DOI 10.1136/ip.7.1.4; Booth-Kewley S, 2010, AGGRESSIVE BEHAV, V36, P330, DOI 10.1002/ab.20355; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Knapik JJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-231; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Sahai H., 1996, STAT EPIDEMIOLOGY ME; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Sosin DM, 1996, BRAIN INJURY, V10, P47; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomsen CJ, 2011, J PSYCHIATR RES, V45, P1321, DOI 10.1016/j.jpsychires.2011.04.003; US Department of Defense, 2014, DD FORM 2796; US Department of Defense, 2006, DEP DEF INSTR 6490 0; US Department of Defense, 2014, DD FORM 200; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db	27	22	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E28	E35		10.1097/HTR.0000000000000155			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000004	26098261				2022-02-06	
J	Vikane, E; Hellstrom, T; Roe, C; Bautz-Holter, E; Assmus, J; Skouen, JS				Vikane, Eirik; Hellstrom, Torgeir; Roe, Cecilie; Bautz-Holter, Erik; Assmus, Jorg; Skouen, Jan Sture			Predictors for Return to Work in Subjects with Mild Traumatic Brain Injury	BEHAVIOURAL NEUROLOGY			English	Article							CONCUSSION SYMPTOMS QUESTIONNAIRE; GLASGOW OUTCOME SCALE; HEAD-INJURY; FOLLOW-UP; POSTCONCUSSION SYMPTOMS; DEPRESSION SCALE; HOSPITAL ANXIETY; PAIN; MODERATE; RELIABILITY	Objective. To predict return to work (RTW) at 12 months for patients who either were sick-listed or were at risk to be sick-listed with persistent postconcussion symptoms (PCS) at six to eight weeks after injury. Method. A prospective cohort study of 151 patients with mild traumatic brain injury (MTBI) admitted consecutively to outpatient clinics at two University Hospitals in Norway. The study was conducted as part of a randomised clinical trial. Injury characteristics were obtained from the medical records. Sick leave data from one year before to one year after MTBI were obtained from the Norwegian Labour and Welfare Service. Self-report questionnaires were used to obtain demographic and symptom profiles. Results. We observed a significant negative association between RTW at 12 months and psychological distress, global functioning, and being sick-listed at two months after MTBI, as well as having been sick-listed the last year before injury. Conclusion. Psychological distress, global functioning postinjury, and the sick leave trajectory of the subjects were negative predictors for RTW. These findings should be taken into consideration when evaluating future vocational rehabilitation models.	[Vikane, Eirik; Skouen, Jan Sture] Haukeland Hosp, Dept Phys Med & Rehabil, N-5021 Bergen, Norway; [Vikane, Eirik; Skouen, Jan Sture] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway; [Hellstrom, Torgeir; Roe, Cecilie; Bautz-Holter, Erik] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Roe, Cecilie; Bautz-Holter, Erik] Univ Oslo, Fac Med, N-0316 Oslo, Norway; [Assmus, Jorg] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway		Vikane, E (corresponding author), Haukeland Hosp, Dept Phys Med & Rehabil, N-5021 Bergen, Norway.; Vikane, E (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway.	eirik.vikane@gmail.com	Hellstrom, Torgeir/AAY-6043-2021; Hellstrom, Torgeir/AAW-4301-2021	Hellstrom, Torgeir/0000-0003-0831-3274; 	Norwegian Extra Foundation for Health and Rehabilitation	The first author, Eirik Vikane, was financially supported by EXTRA funds from the Norwegian Extra Foundation for Health and Rehabilitation. The authors declare that they have no potential conflict of interests to disclose.	Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Constantino MJ, 2011, J CLIN PSYCHOL, V67, P184, DOI 10.1002/jclp.20754; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Eid J, 1999, SCAND J PSYCHOL, V40, P101, DOI 10.1111/1467-9450.00105; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Eriksen HR, 1999, SCAND J PUBLIC HEALT, V27, P63, DOI 10.1177/14034948990270010401; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Gjesdal S, 2004, EUR J PUBLIC HEALTH, V14, P398, DOI 10.1093/eurpub/14.4.398; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Holen A, 1983, ALEXANDER L KIELLAND; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; Kvale A, 2001, NORD J PSYCHIAT, V55, P177; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lundeberg T, 2001, J REHABIL MED, V33, P279; McKerral M, 2005, J REHABIL MED, V37, P61, DOI 10.1080/16501970510026647; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Salmi L Rachid, 2014, Arch Phys Med Rehabil, V95, pS95, DOI 10.1016/j.apmr.2013.10.026; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Soberg HL, 2011, J TRAUMA, V71, P425, DOI 10.1097/TA.0b013e3181eff54f; Stalnacke B. M., 2012, REHABIL RES PRACT, V2012; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; TEASDALE G, 1974, LANCET, V2, P81; URSIN H, 1988, EUR J APPL PHYSIOL O, V57, P282, DOI 10.1007/BF00635986; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Noordt M, 2014, OCCUP ENVIRON MED, V71, P730, DOI 10.1136/oemed-2013-101891; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; Vindholmen S, 2014, PSYCHOL RES BEHAV MA, V7, P77, DOI 10.2147/PRBM.S56013; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; WEISAETH L, 1989, ACTA PSYCHIAT SCAND, V80, P63, DOI 10.1111/j.1600-0447.1989.tb05255.x; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	53	22	22	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2016	2016								8026414	10.1155/2016/8026414			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DF8AO	WOS:000371579200001	26980942	Green Published, gold, Green Submitted			2022-02-06	
J	Walsh, M; Fritz, S; Hake, D; Son, M; Greve, S; Jbara, M; Chitta, S; Fritz, B; Miller, A; Bader, MK; McCollester, J; Binz, S; Liew-Spilger, A; Thomas, S; Crepinsek, A; Shariff, F; Ploplis, V; Castellino, FJ				Walsh, Mark; Fritz, Stephanie; Hake, Daniel; Son, Michael; Greve, Sarah; Jbara, Manar; Chitta, Swetha; Fritz, Braxton; Miller, Adam; Bader, Mary K.; McCollester, Jonathon; Binz, Sophia; Liew-Spilger, Alyson; Thomas, Scott; Crepinsek, Anton; Shariff, Faisal; Ploplis, Victoria; Castellino, Francis J.			Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy	CURRENT DRUG TARGETS			English	Article						Thromboelastography; point-of-care; acquired coagulopathy; blood component therapy; systemic hemostatic agents; trauma-induced coagulopathy; hemostatic resuscitation; tranexamic acid; targeted pharmacologic therapy	RECOMBINANT-FACTOR-VIIA; FRESH-FROZEN PLASMA; PROTHROMBIN COMPLEX CONCENTRATE; DAMAGE CONTROL RESUSCITATION; ACTIVATED FACTOR-VII; CONVENTIONAL COAGULATION TESTS; BRAIN-INJURY; TRANEXAMIC ACID; FIBRINOGEN CONCENTRATE; MAJOR TRAUMA	Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen levels. The varying sensitivity and specificity of these CCTs have led trauma coagulation researchers and clinicians to use Viscoelastic Tests (VET) such as Thromboelastography (TEG) to provide Targeted Thromboelastographic Hemostatic and Adjunctive Therapy (TTHAT) in a goal directed fashion to those trauma patients in need of hemostatic resuscitation. This review describes the utility of VETs, in particular, TEG, to provide TTHAT in trauma and acquired non-trauma-induced coagulopathy.	[Walsh, Mark; Fritz, Stephanie; Hake, Daniel; Son, Michael; Greve, Sarah; Chitta, Swetha; McCollester, Jonathon; Binz, Sophia; Liew-Spilger, Alyson; Thomas, Scott; Crepinsek, Anton; Shariff, Faisal] Mem Hosp South Bend, South Bend, IN 46601 USA; [Walsh, Mark; Jbara, Manar; Binz, Sophia; Crepinsek, Anton] Indiana Univ Sch Med SB, South Bend, IN USA; E Tennessee State Univ, Dept Internal Med, Johnson City, TN 37614 USA; [Fritz, Braxton] Montgomery Ctr Family Med, Self Reg Healthcare, Greenwood, SC USA; [Miller, Adam] Mayo Clin, Dept Urol, Rochester, MN USA; [Bader, Mary K.] St Joseph Hosp Miss, Viejo, CA USA; [Ploplis, Victoria; Castellino, Francis J.] WM Keck Ctr Transgene Res, Notre Dame, IN USA		Walsh, M (corresponding author), Mem Hosp South Bend, South Bend, IN 46601 USA.	markwalshmd@gmail.com		Shariff, Faisal/0000-0001-6934-4600; Walsh, Mark/0000-0002-5795-1144	Haemonetics Corporation, Niles, IL	MW, FJC, VP received research grants from Haemonetics Corporation, Niles, IL. MW has received educational honoraria from Boehringer Ingelheim, CSL Behring.	Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; Bartal C, 2009, CURR OPIN ANESTHESIO, V22, P281, DOI 10.1097/ACO.0b013e328325a6be; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Bauer KA, 2015, NEW ENGL J MED, V373, P569, DOI 10.1056/NEJMe1506600; Benes J, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00062; Bochsen L, 2007, THROMB J, V5; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Branco BC, 2014, SHOCK, V41, P200, DOI 10.1097/SHK.0000000000000109; Brenni M, 2010, ACTA ANAESTH SCAND, V54, P111, DOI 10.1111/j.1399-6576.2009.02132.x; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brooks A, 2012, TRANSFUSION, V54, P727; Brown JB, 2015, PREHOSP EMERG CARE, V19, P79, DOI 10.3109/10903127.2014.936635; Cap A, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12914; Carroll RC, 2009, TRANSL RES, V154, P34, DOI 10.1016/j.trsl.2009.04.001; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Chen LQ, 2004, J THORAC CARDIOV SUR, V128, P425, DOI 10.1016/j.jtcvs.2004.02.019; Clark AD, 2004, VOX SANG, V86, P120, DOI 10.1111/j.0042-9007.2004.00393.x; Cole E, 2015, ANN SURG, V261, P390, DOI 10.1097/SLA.0000000000000717; Collyer TC, 2009, BRIT J ANAESTH, V102, P492, DOI 10.1093/bja/aep039; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Connors J, 2015, N ENGL J MED; Cotton BA, 2011, NEW ENGL J MED, V365, P2039, DOI 10.1056/NEJMc1111095; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9; Dager WE, 2013, CRIT CARE MED, V41, pE42, DOI 10.1097/CCM.0b013e31827caaa3; Darlington DN, 2011, J TRAUMA, V71, P1152, DOI 10.1097/TA.0b013e318215178c; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Davis PK, 2012, THROMB HAEMOSTASIS, V108, P586, DOI 10.1160/TH12-04-0222; Day JC, 1996, CURRENT POPULATION R; de Lange NM, 2012, OBSTET GYNECOL SURV, V67, P426, DOI 10.1097/OGX.0b013e3182605861; Dias JD, 2015, ARCH PATHOL LAB MED, V139, P665, DOI 10.5858/arpa.2014-0170-OA; Dobson GP, 2015, J TRAUMA ACUTE CARE, V79, P301, DOI 10.1097/TA.0000000000000729; Duchesne JC, 2011, AM SURGEON, V77, P201; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Dumkow LE, 2012, AM J HEALTH-SYST PH, V69, P1646, DOI 10.2146/ajhp120055; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Dzik W, 2011, CRIT CARE, V15, P1; Dzik Walter H, 2004, Curr Hematol Rep, V3, P324; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Ellis TC, 2007, BLOOD COAGUL FIBRIN, V18, P45, DOI 10.1097/MBC.0b013e3280111a8e; Enriquez L, 2009, BR J ANAESTH S1, V103, pil4; Faul M, 2010, TRAUMATIC BRAIN INJU; Fayed N, 2015, TRANSFUS MED HEMOTH, V42, P99, DOI 10.1159/000381733; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Gando S, 2009, J TRAUMA, V67, P381, DOI 10.1097/TA.0b013e3181a84f63; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; Garcia D, 2005, CHEST, V127, P2049, DOI 10.1378/chest.127.6.2049; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Godier A, 2012, ANESTHESIOLOGY, V116, P94, DOI 10.1097/ALN.0b013e318238c036; Gonzalez E, 2015, ANN SURG, V262; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Grassetto A, 2015, POINT OF CARE TESTS; Grassetto A, 2012, CRIT CARE, V16, DOI 10.1186/cc11322; Grassetto A, 2012, BLOOD COAGUL FIBRIN, V23, P551, DOI 10.1097/MBC.0b013e32835553c0; Grottke O, 2014, CRIT CARE, V18, DOI 10.1186/cc13717; Gruen RL, 2013, MED J AUSTRALIA, V199, P310, DOI 10.5694/mja13.10747; Gunter OL, 2008, J TRAUMA, V65, P527, DOI 10.1097/TA.0b013e3181826ddf; Gurbel PA, 2011, THROMB HAEMOSTASIS, V106, P248, DOI 10.1160/TH11-02-0063; Hardaway R, 1988, CARE WOUNDED VIETNAM, P139; Harr JN, 2013, SHOCK, V39, P45, DOI 10.1097/SHK.0b013e3182787122; HARTERT H, 1948, KLIN WOCHENSCHR, V26, P577, DOI 10.1007/BF01697545; HARTERT H., 1962, BIORHEOLOGY, V1, P31; Harvin JA, 2015, J TRAUMA ACUTE CARE, V78, P905, DOI 10.1097/TA.0000000000000612; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hepner DL, 2002, J CLIN ANESTH, V14, P405, DOI 10.1016/S0952-8180(02)00373-2; Heron M, 2008, NATL VITAL STAT REPO, V56; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hoffman M, 2012, J THROMB HAEMOST, V10, P1478, DOI 10.1111/j.1538-7836.2012.04793.x; Hoffman M, 2007, HEMATOL ONCOL CLIN N, V21, P1, DOI 10.1016/j.hoc.2006.11.004; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Holcomb JB, 2011, J TRAUMA, V71, pS318, DOI 10.1097/TA.0b013e318227edbb; Holness L, 2004, TRANSFUS MED REV, V18, P184, DOI 10.1016/j.tmrv.2004.03.004; Hunt H, 2015, THROMBOELASTOGRAPHY; Inaba K, 2010, J AM COLL SURGEONS, V211, P573, DOI 10.1016/j.jamcollsurg.2010.06.392; Inaba K, 2010, J AM COLL SURGEONS, V210, P957, DOI 10.1016/j.jamcollsurg.2010.01.031; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; James KMH, 2008, ANESTH ANALG, V107, P402, DOI 10.1213/ane.0b013e3181770b87; Jeger V, 2009, J TRAUMA, V66, P1253, DOI 10.1097/TA.0b013e31819d3caf; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Johansson PI, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-45; Johansson Par I, 2012, J Emerg Trauma Shock, V5, P120, DOI 10.4103/0974-2700.96479; Johansson PI, 2014, BLOOD, V124, P3052, DOI 10.1182/blood-2014-05-575340; Johansson PI, 2012, CURR OPIN ANESTHESIO, V25, P235, DOI 10.1097/ACO.0b013e32834fab76; Johnson JL, 2010, ARCH SURG-CHICAGO, V145, P973, DOI 10.1001/archsurg.2010.216; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Kane I, 2015, ORTHOP SURG, V7, P26, DOI 10.1111/os.12158; Kang Y, 1985, ANESTH ANALG, V64; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Kitchens CS, 2005, J THROMB HAEMOST, V3, P2607, DOI 10.1111/j.1538-7836.2005.01552.x; Konkle BA, 2011, HEMATOL-AM SOC HEMAT, P391, DOI 10.1182/asheducation-2011.1.391; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Labrador J, 2014, J HEMATOL THROMB DIS, V2, pe105; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Levi M, 2015, J THROMB HAEMOST, V13, P1960, DOI 10.1111/jth.13126; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; MacDonald SG, 2010, SEMIN THROMB HEMOST, V36, P712, DOI 10.1055/s-0030-1265288; Madsen EH, 2010, CLIN CHEM, V56, P839, DOI 10.1373/clinchem.2009.137471; Maegele M, 2009, VOX SANG, V97, P39, DOI 10.1111/j.1423-0410.2009.01179.x; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mamtani R, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-S1-S7; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; McCurdy MT, 2015, JAMA-J AM MED ASSOC, V313, P2077, DOI 10.1001/jama.2015.4421; Mitra B, 2012, INJURY, V43, P33, DOI 10.1016/j.injury.2011.10.011; Mitra B, 2012, INJURY, V43, P1409, DOI 10.1016/j.injury.2011.01.033; Morrison JJ, 2013, JAMA SURG, V148, P218, DOI 10.1001/jamasurg.2013.764; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2009, NEUROCRIT CARE, V11, P307, DOI 10.1007/s12028-009-9219-7; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Neyens R, 2014, J THROMB THROMBOLYS, V37, P80, DOI 10.1007/s11239-013-0933-9; Nienaber U, 2011, INJURY, V42, P697, DOI 10.1016/j.injury.2010.12.015; Omert L, THROMBOELASTOGRAPH T; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Plotkin AJ, 2008, J TRAUMA, V64, pS64, DOI 10.1097/TA.0b013e318160772d; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Pusateri AE, 2013, SHOCK, V39, P121, DOI 10.1097/SHK.0b013e318280409a; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Riskin DJ, 2009, J AM COLL SURGEONS, V209, P198, DOI 10.1016/j.jamcollsurg.2009.04.016; Rose A, 2011, NEW ENGL J MED, V365, P2333, DOI 10.1056/NEJMc1112233; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Sankarankutty A, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-S1-S3; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Sarma A, 2013, CARDIOL THER, V2, P111, DOI 10.1007/s40119-013-0016-1; Schaden E, 2013, WIEN KLIN WOCHENSCHR, V125, P156, DOI 10.1007/s00508-013-0327-1; Schaden E, 2010, BLOOD COAGUL FIBRIN, V21, P256, DOI 10.1097/MBC.0b013e328337014c; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Schochl H, 2011, CRIT CARE, V15, P34; Schochl H, 2012, HAMOSTASEOLOGIE, V32, P22, DOI 10.5482/ha-1178; Schochl H, 2010, NETH J CRIT CARE, V14, P23; Schochl H, 2010, ANAESTHESIA, V65, P199, DOI 10.1111/j.1365-2044.2009.06188.x; Schochl H, 2014, ANESTH ANALG, V119, P1064, DOI 10.1213/ANE.0b013e318270a6f7; Schochl H, 2013, J TRAUMA ACUTE CARE, V74, P1587, DOI 10.1097/TA.0b013e31828c3171; Schochl H, 2013, CURR OPIN ANESTHESIO, V26, P221, DOI 10.1097/ACO.0b013e32835cca92; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10539; Schochl H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-15; Schochl H, 2010, SCAND J CLIN LAB INV, V70, P453, DOI 10.3109/00365513.2010.500396; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Schulman S, 2013, BRIT J HAEMATOL, V164, P296; Schulman S, 2012, BLOOD, V119, P3016, DOI 10.1182/blood-2011-10-378950; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; Shakur H, 2010, TRIALS, V11; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016; Siguret V, 2013, DRUG AGING, V30, P687, DOI 10.1007/s40266-013-0101-0; Silliman CC, 2005, BLOOD, V105, P2266, DOI 10.1182/blood-2004-07-2929; Simon DI, 2009, J AM COLL CARDIOL, V54, P1447, DOI 10.1016/j.jacc.2009.07.011; SJOGREN H, 1991, ACCIDENT ANAL PREV, V23, P77, DOI 10.1016/0001-4575(91)90037-6; Solbeck S, 2014, INT J CARDIOL, V176, P794, DOI 10.1016/j.ijcard.2014.07.084; Solomon C, 2015, ANESTH ANALG, V121, P868, DOI 10.1213/ANE.0000000000000859; Solomon C, 2015, ANESTH ANALG, V121, P289, DOI 10.1213/ANE.0000000000000738; Solomon C, 2013, BLOOD TRANSFUS-ITALY, V11, P412, DOI 10.2450/2012.0043-12; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Soreide K, 2009, BRIT J SURG, V96, P697, DOI 10.1002/bjs.6643; Southworth MR, 2013, NEW ENGL J MED, V368, P1272, DOI 10.1056/NEJMp1302834; Spahn DR, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0637-3; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Spahn DR, 2012, ANESTHESIOLOGY, V116, P9, DOI 10.1097/ALN.0b013e318238c070; Spiezia L, 2008, THROMB HAEMOSTASIS, V100, P1106, DOI 10.1160/TH08-04-0243; Spinella PC, 2008, J TRAUMA, V64, P286, DOI 10.1097/TA.0b013e318162759f; Stainsby D, 2006, BRIT J HAEMATOL, V135, P634; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Stensballe J, 2014, CURR OPIN ANESTHESIO, V27, P212, DOI 10.1097/ACO.0000000000000051; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tapia NM, 2013, J TRAUMA ACUTE CARE, V74, P378, DOI 10.1097/TA.0b013e31827e20e0; Theusinger OM, 2015, TRANSFUS MED HEMOTH, V42, P115, DOI 10.1159/000381320; Theusinger OM, 2015, ANESTH ANALG, V120, P627, DOI 10.1213/ANE.0000000000000561; Theusinger OM, 2014, CURR OPIN CRIT CARE, V20, P646, DOI 10.1097/MCC.0000000000000152; Theusinger Oliver M, 2013, Anesthesiol Clin, V31, P55, DOI 10.1016/j.anclin.2012.10.006; Theusinger OM, 2012, CURR OPIN ANESTHESIO, V25, P59, DOI 10.1097/ACO.0b013e32834dec98; Theusinger OM, 2011, ANESTH ANALG, V113, P1003, DOI 10.1213/ANE.0b013e31822e183f; Toulon P, 2009, THROMB HAEMOSTASIS, V101, P394, DOI 10.1160/TH08-06-0383; Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51; Truumees E, 2012, SPINE, V37, pE863, DOI 10.1097/BRS.0b013e31824ee320; Valle EJ, 2014, J TRAUMA ACUTE CARE, V76, P1373, DOI 10.1097/TA.0000000000000242; Van PY, 2009, J TRAUMA, V66, P1509, DOI 10.1097/TA.0b013e3181a51e33; Velik-Salchner C, 2007, J THROMB HAEMOST, V5, P1019, DOI 10.1111/j.1538-7836.2007.02481.x; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Walsh M., 2014, BLOOD B; Walsh Mark, 2011, J Extra Corpor Technol, V43, P162; Warkentin TE, 2012, BLOOD, V119, P2172, DOI 10.1182/blood-2011-11-393587; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Wojcik C, 2009, INT J EMERG MED, V2, P217, DOI 10.1007/s12245-009-0125-8; Woolley T, 2013, INJURY, V44, P593, DOI 10.1016/j.injury.2012.03.018; Wychowski Maura K, 2012, Ann Pharmacother, V46, pe10, DOI 10.1345/aph.1Q747; Ziegler B, 2013, CLIN APPL THROMB-HEM, V19, P453, DOI 10.1177/1076029612458149; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014	208	22	23	0	5	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-4501	1873-5592		CURR DRUG TARGETS	Curr. Drug Targets		2016	17	8					954	970		10.2174/1389450117666160310153211			17	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DN5OL	WOS:000377119600009	26960340	Green Submitted, Green Published			2022-02-06	
J	Wells, EM; Goodkin, HP; Griesbach, GS				Wells, Elizabeth M.; Goodkin, Howard P.; Griesbach, Grace S.			Challenges in Determining the Role of Rest and Exercise in the Management of Mild Traumatic Brain Injury	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; rest; subthreshold exercise	VOLUNTARY EXERCISE; NEUROTROPHIC FACTOR; ACUTE CONCUSSION; UP-REGULATION; PATHOPHYSIOLOGY; REHABILITATION; SYMPTOMS; SPORT; TIME; RECOMMENDATIONS	Current consensus guidelines recommending physical and cognitive rest until a patient is asymptomatic after a sports concussion (ie, a mild traumatic brain injury) are being called into question, particularly for patients who are slower to recover and in light of preclinical and clinical research demonstrating that exercise aids neurorehabilitation. The pathophysiological response to mild traumatic brain injury includes a complex neurometabolic cascade of events resulting in a neurologic energy deficit. It has been proposed that this energy deficit leads to a period of vulnerability during which the brain is at risk for additional injury, explains why early postconcussive symptoms are exacerbated by cognitive and physical exertion, and is used to rationalize absolute rest until all symptoms have resolved. However, at some point, rest might no longer be beneficial and exercise might need to be introduced. At both extremes, excessive exertion and prolonged avoidance of exercise (physical and mental) have negative consequences. Individuals who have experienced a concussion need guidance for avoidance of triggers of severe symptoms and a plan for graduated exercise to promote recovery as well as optimal functioning (physical, educational, and social) during the postconcussion period.	[Wells, Elizabeth M.] George Washington Sch Med, Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Goodkin, Howard P.] UVA Healthsyst, Dept Neurol, Charlottesville, VA USA; [Goodkin, Howard P.] UVA Healthsyst, Dept Pediat, Charlottesville, VA USA; [Griesbach, Grace S.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA		Wells, EM (corresponding author), George Washington Sch Med, Childrens Natl Med Ctr, Dept Neurol, 111 Michigan Ave NW, Washington, DC 20010 USA.	EWells@childrensnational.org		Goodkin, Howard/0000-0003-0528-4949			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Acocello S, 2014, J NEUROSCI METH, V221, P85, DOI 10.1016/j.jneumeth.2013.09.003; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; da Silva SG, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-61; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Li HW, 2013, BRAIN RES, V1531, P1, DOI 10.1016/j.brainres.2013.07.041; Lovatel GA, 2013, NEUROBIOL LEARN MEM, V101, P94, DOI 10.1016/j.nlm.2013.01.007; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reddy S, 2014, MED SCI SPORT EXER, V46, P429, DOI 10.1249/MSS.0000000000000140; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rodgers SP, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/698528; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Taylor J, 2011, OTOLARYNG CLIN N AM, V44, P309, DOI 10.1016/j.otc.2011.01.004; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vidal PG, 2012, PEDIATR ANN, V41, pE186, DOI 10.3928/00904481-20120827-10	61	22	22	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		86	92		10.1177/0883073815570152			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400009	25688071				2022-02-06	
J	Sarvghad-Moghaddam, H; Jazi, MS; Rezaei, A; Karami, G; Ziejewski, M				Sarvghad-Moghaddam, Hesam; Jazi, Mehdi Salimi; Rezaei, Asghar; Karami, Ghodrat; Ziejewski, Mariusz			Examination of the protective roles of helmet/faceshield and directionality for human head under blast waves	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						shear stress; intracranial pressure (ICP); fluid-structure interaction (FSI).; blast traumatic brain injury (bTBI); finite elements (FEs)	BRAIN; MITIGATION; HELMET; RESPONSES; POLYUREA	A parametric study was conducted to delineate the efficacy of personal protective equipment (PPE), such as ballistic faceshields and advanced combat helmets, in the case of a blast. The propagations of blast waves and their interactions with an unprotected head, a helmeted one, and a fully protected finite element head model (FEHM) were modeled. The biomechanical parameters of the brain were recorded when the FEHM was exposed to shockwaves from the front, back, top, and bottom. The directional dependent tissue response of the brain and the variable efficiency of PPE with respect to the blast orientation were two major results of this study.	[Sarvghad-Moghaddam, Hesam; Jazi, Mehdi Salimi; Rezaei, Asghar; Karami, Ghodrat; Ziejewski, Mariusz] N Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA		Karami, G (corresponding author), N Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA.	g.karami@ndsu.edu					[Anonymous], 2011, ALT HYP VERS 11 0; Bowen LG, 1968, 2113 DEF AT SUPP AG; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Grujicic A, 2012, J MATER ENG PERFORM, V21, P1562, DOI 10.1007/s11665-011-0065-3; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P297, DOI 10.1108/15736101211269122; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Jazi MS, 2014, COMPUT METHOD BIOMEC, V17, P1368, DOI 10.1080/10255842.2012.748755; LSTC, 2007, LS DYNA KEYW US MAN; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Rezaei A, 2014, INT J NUMER METH BIO, V30, P69, DOI 10.1002/cnm.2590; Salimi Jazi M, 2013, ASME 2013 INT MECH E; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; van Hoof J, 2001, P 19 INT S BALL MAY; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	20	22	22	0	121	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	DEC 10	2015	18	16					1846	1855		10.1080/10255842.2014.977878			10	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	CB2HK	WOS:000349447600013	25413615				2022-02-06	
J	Lucke-Wold, BP; Naser, ZJ; Logsdon, AF; Turner, RC; Smith, KE; Robson, MJ; Bailes, JE; Lee, JM; Rosen, CL; Huber, JD				Lucke-Wold, Brandon P.; Naser, Zachary J.; Logsdon, Aric F.; Turner, Ryan C.; Smith, Kelly E.; Robson, Matthew J.; Bailes, Julian E.; Lee, John M.; Rosen, Charles L.; Huber, Jason D.			Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury	TRANSLATIONAL RESEARCH			English	Article							ALPHA-LIPOIC ACID; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; NADPH OXIDASES; NOX FAMILY; PATHWAY; EXPRESSION; APOPTOSIS; TAU; ENCEPHALOPATHY	A total of 1.7 million traumatic brain injuries (TBIs) occur each year in the United States, but available pharmacologic options for the treatment of acute neurotrauma are limited. Oxidative stress is an important secondary mechanism of injury that can lead to neuronal apoptosis and subsequent behavioral changes. Using a clinically relevant and validated rodent blast model, we investigated how nicotinamide adenine dinucleotide phosphate oxidase (Nox) expression and associated oxidative stress contribute to cellular apoptosis after single and repeat blast injuries. Nox4 forms a complex with p22phox after injury, forming free radicals at neuronal membranes. Using immunohistochemical-staining methods, we found a visible increase in Nox4 after single blast injury in Sprague Dawley rats. Interestingly, Nox4 was also increased in postmortem human samples obtained from athletes diagnosed with chronic traumatic encephalopathy. Nox4 activity correlated with an increase in superoxide formation. Alpha-lipoic acid, an oxidative stress inhibitor, prevented the development of superoxide acutely and increased antiapoptotic markers B-cell lymphoma 2 (t = 3.079, P < 0.05) and heme oxygenase 1 (t = 8.169, P < 0.001) after single blast. Subacutely, alpha-lipoic acid treatment reduced proapoptotic markers Bax (t = 4.483, P < 0.05), caspase 12 (t = 6.157, P < 0.001), and caspase 3 (t = 4.573, P < 0.01) after repetitive blast, and reduced tau hyperphosphorylation indicated by decreased CP-13 and paired helical filament staining. Alpha-lipoic acid ameliorated impulsive-like behavior 7 days after repetitive blast injury (t = 3.573, P < 0.05) compared with blast exposed animals without treatment. TBI can cause debilitating symptoms and psychiatric disorders. Oxidative stress is an ideal target for neuropharmacologic intervention, and alpha-lipoic acid warrants further investigation as a therapeutic for prevention of chronic neurodegeneration.	W Virginia Univ, Sch Pharm, Dept Neurosurg, Morgantown, WV 26506 USA; W Virginia Univ, Sch Med, Ctr Neurosci, Morgantown, WV 26506 USA; W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; Drexel Univ, Coll Med, Dept Med, Profess Studies Hlth Sci, Philadelphia, PA 19104 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; Univ Chicago, Pritzker Sch Med, NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL USA; Univ Chicago, Pritzker Sch Med, NorthShore Univ HealthSyst, Dept Pathol, Evanston, IL USA		Huber, JD (corresponding author), W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Hlth Sci Ctr, One Med Ctr Dr,POB 9530, Morgantown, WV 26506 USA.	jdhuber@hsc.wvu.edu	Lucke-Wold, Brandon/AAW-3525-2021; Robson, Matthew/H-3127-2013; Lucke-Wold, Brandon/AAW-1881-2021	Lucke-Wold, Brandon/0000-0001-6577-4080; Robson, Matthew/0000-0002-3277-3062; Fraser, Kelly/0000-0003-1563-050X; Turner, Ryan/0000-0001-5523-0645	West Virginia University Research and Development Grant; American Medical Association Foundation Seed Grant; American Foundation of Pharmaceutical Education Pre-doctoral Fellowship; Neurosurgery Research and Education Foundation Medical Student Summer Research Fellowship; American Foundation of Pharmaceutical Education Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER	A West Virginia University Research and Development Grant funded the current project. An American Medical Association Foundation Seed Grant, an American Foundation of Pharmaceutical Education Pre-doctoral Fellowship, and a Neurosurgery Research and Education Foundation Medical Student Summer Research Fellowship were awarded to support B. Lucke-Wold. A. Logsdon also received an American Foundation of Pharmaceutical Education Predoctoral Fellowship.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Booth-Kewley S, 2010, J NERV MENT DIS, V198, P91, DOI 10.1097/NMD.0b013e3181cc45e9; Borza Liana Rada, 2014, Rev Med Chir Soc Med Nat Iasi, V118, P19; Bramlett H. M., 2014, J NEUROTRAUMA; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen WJ, 2013, INT J ONCOL, V42, P963, DOI 10.3892/ijo.2013.1774; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Curtis L, 2014, J NEUROSURG SCI, V58, P151; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Freeman LC, 2015, J NEUROCHEM; Gao HM, 2012, TRENDS PHARMACOL SCI, V33, P295, DOI 10.1016/j.tips.2012.03.008; Ghadiri T, 2014, J NEUROSCI METH, V233, P18, DOI 10.1016/j.jneumeth.2014.05.035; Giraldo E, 2014, REDOX BIOL, V2, P873, DOI 10.1016/j.redox.2014.03.002; Gomes MB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-80; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Ho YH, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0157-8; Indharty Rr Suzy, 2013, Asian J Neurosurg, V8, P83, DOI 10.4103/1793-5482.116381; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Kates SA, 2014, BASIC CLIN PHARMACOL, V115, P456, DOI 10.1111/bcpt.12254; Kim P, 2012, BIOMOL THER, V20, P125, DOI 10.4062/biomolther.2012.20.1.125; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; Li HY, 2014, J PINEAL RES, V57, P110, DOI 10.1111/jpi.12148; Li Z, 2015, NEUROL SCI, V36, P61, DOI 10.1007/s10072-014-1909-z; Liu XR, 2014, TRANSL STROKE RES, V5, P692, DOI 10.1007/s12975-014-0359-5; Liu XA, 2010, J ALZHEIMERS DIS, V19, P953, DOI 10.3233/JAD-2010-1294; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Lopez-Castroman J, 2014, PSYCHOL MED, V44, P3059, DOI 10.1017/S0033291714000646; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Uranga RM, 2009, TOXICOL SCI, V111, P331, DOI 10.1093/toxsci/kfp152; Meyerhoff JL, 2004, BRAIN RES, V1016, P139, DOI 10.1016/j.brainres.2004.03.019; O'Callaghan JP, 2004, J NEUROSCI METH, V135, P159, DOI 10.1016/j.jneumeth.2003.12.006; Okubo Shuichi, 2013, Acta Neurochir Suppl, V118, P83, DOI 10.1007/978-3-7091-1434-6_14; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Ozbal S, 2015, BIOTECH HISTOCHEM, V90, P206, DOI 10.3109/10520295.2014.977950; Park S, 2014, CURR MED CHEM, V21, P3636, DOI 10.2174/0929867321666140706141806; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058339; Reljanovic M, 1999, FREE RADICAL RES, V31, P171, DOI 10.1080/10715769900300721; Rocamonde B, 2012, NEUROSCIENCE, V224, P102, DOI 10.1016/j.neuroscience.2012.08.028; Rocamonde B, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/521939; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Steimer T, 2003, STRESS, V6, P87, DOI 10.1080/1025389031000111320; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tajes M, 2014, NEUROSCI LETT, V580, P78, DOI 10.1016/j.neulet.2014.07.047; Teichert J, 2005, J CLIN PHARMACOL, V45, P313, DOI 10.1177/0091270004270792; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; Wagener FADTG, 2013, CURR PHARM DESIGN, V19, P2698; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang ZF, 2010, J ALZHEIMERS DIS, V20, P145, DOI 10.3233/JAD-2010-1351; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xu SL, 2013, AM J PHYSIOL-HEART C, V305, pH1484, DOI 10.1152/ajpheart.00382.2013; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhang R, 2009, HYPERTENSION, V53, P556, DOI 10.1161/HYPERTENSIONAHA.108.124594	68	22	23	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	DEC	2015	166	6					509	528		10.1016/j.trsl.2015.08.005			20	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	CY5JR	WOS:000366444400001	26414010				2022-02-06	
J	Nemer, SN; Caldeira, JB; Santos, RG; Guimaraes, BL; Garcia, JM; Prado, D; Silva, RT; Azeredo, LM; Faria, ER; Souza, PCP				Nemer, Sergio Nogueira; Caldeira, Jefferson B.; Santos, Ricardo G.; Guimaraes, Bruno L.; Garcia, Joao Marcio; Prado, Darwin; Silva, Ricardo T.; Azeredo, Leandro M.; Faria, Eduardo R.; Souza, Paulo Cesar P.			Effects of positive end-expiratory pressure on brain tissue oxygen pressure of severe traumatic brain injury patients with acute respiratory distress syndrome: A pilot study	JOURNAL OF CRITICAL CARE			English	Article						Mechanical ventilation; Acute respiratory distress syndrome; Brain injury	INTRACRANIAL-PRESSURE; CARE	Purpose: To verify whether high positive end-expiratory pressure levels can increase brain tissue oxygen pressure, and also their effects on pulse oxygen saturation, intracranial pressure, and cerebral perfusion pressure. Material and Methods: Twenty traumatic brain injury patients with acute respiratory distress syndrome were submitted to positive end-expiratory pressure levels of 5, 10, and 15 cm H2O progressively. The 3 positive end-expiratory pressure levels were used during 20 minutes for each one, whereas brain tissue oxygen pressure, oxygen saturation, intracranial pressure, and cerebral perfusion pressure were recorded. Results: Brain tissue oxygen pressure and oxygen saturation increased significantly with increasing positive end-expiratory pressure from 5 to 10 and from 10 to 15 cm H2O (P = .0001 and P = .0001 respectively). Intracranial pressure and cerebral perfusion pressure did not differ significantly with increasing positive end-expiratory pressure from 5 to 10 and from 10 to 15 cm H2O (P = .16 and P = .79 respectively). Conclusions: High positive end-expiratory pressure levels increased brain tissue oxygen pressure and oxygen saturation, without increase in intracranial pressure or decrease in cerebral perfusion pressure. High positive end-expiratory pressure levels can be used in severe traumatic brain injury patients with acute respiratory distress syndrome as a safe alternative to improve brain oxygenation. (C) 2015 Elsevier Inc. All rights reserved.	[Nemer, Sergio Nogueira; Caldeira, Jefferson B.; Santos, Ricardo G.; Guimaraes, Bruno L.; Garcia, Joao Marcio; Prado, Darwin; Silva, Ricardo T.; Faria, Eduardo R.; Souza, Paulo Cesar P.] Complexo Hosp Niteroi, BR-24020090 Niteroi, RJ, Brazil; [Nemer, Sergio Nogueira; Azeredo, Leandro M.] Hosp Policia Militar Niteroi, BR-24240705 Niteroi, RJ, Brazil; [Nemer, Sergio Nogueira; Caldeira, Jefferson B.] Univ UNIGRANRIO, BR-25071202 Duque de Caxias, Brazil		Nemer, SN (corresponding author), Complexo Hosp Niteroi, Rua La Salle 12, BR-24020090 Niteroi, RJ, Brazil.	snnemer@gmail.com					Barbas CSV, 2014, CURR OPIN CRIT CARE, V20, P10, DOI 10.1097/MCC.0000000000000058; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; COOPER KR, 1985, J NEUROSURG, V63, P552, DOI 10.3171/jns.1985.63.4.0552; Crotti S, 2001, AM J RESP CRIT CARE, V164, P131, DOI 10.1164/ajrccm.164.1.2007011; Gelabert-Gonzalez M, 2003, REV NEUROLOGIA, V36, P744, DOI 10.33588/rn.3608.2002361; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kalanuria AA, 2013, CURR OPIN CRIT CARE, V19, P113, DOI 10.1097/MCC.0b013e32835eba56; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Nemer SN, 2011, J CRIT CARE, V26, P22, DOI 10.1016/j.jcrc.2010.04.015; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Videtta W, 2002, ACT NEUR S, V81, P93; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wolf S, 2005, ACTA NEUROCHIR SUPPL, V95, P103	22	22	24	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2015	30	6					1263	1266		10.1016/j.jcrc.2015.07.019			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0MX	WOS:000363945900021	26307004				2022-02-06	
J	Roberts, RA; Aschner, M; Calligaro, D; Guilarte, TR; Hanig, JP; Herr, DW; Hudzik, TJ; Jeromin, A; Kallman, MJ; Liachenko, S; Lynch, JJ; Miller, DB; Moser, VC; O'Callaghan, JP; Slikker, W; Paule, MG				Roberts, Ruth A.; Aschner, Michael; Calligaro, David; Guilarte, Tomas R.; Hanig, Joseph P.; Herr, David W.; Hudzik, Thomas J.; Jeromin, Andreas; Kallman, Mary J.; Liachenko, Serguei; Lynch, James J., III; Miller, Diane B.; Moser, Virginia C.; O'Callaghan, James P.; Slikker, William, Jr.; Paule, Merle G.			Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward	TOXICOLOGICAL SCIENCES			English	Article						neurotoxicity; biomarker; imaging; CSF; neurotoxicity	CEREBROSPINAL-FLUID BIOMARKERS; TRAUMATIC BRAIN-INJURY; C-TERMINAL HYDROLASE-L1; 18 KDA TSPO; TRIMETHYLTIN; NEURODEGENERATION; CORRELATE	Neurotoxicity has been linked to a number of common drugs and chemicals, yet efficient and accurate methods to detect it are lacking. There is a need for more sensitive and specific biomarkers of neurotoxicity that can help diagnose and predict neurotoxicity that are relevant across animal models and translational from nonclinical to clinical data. Fluid-based biomarkers such as those found in serum, plasma, urine, and cerebrospinal fluid (CSF) have great potential due to the relative ease of sampling compared with tissues. Increasing evidence supports the potential utility of fluid-based biomarkers of neurotoxicity such as microRNAs, F-2-isoprostanes, translocator protein, glial fibrillary acidic protein, ubiquitin C-terminal hydrolase L1, myelin basic protein, microtubule-associated protein-2, and total tau. However, some of these biomarkers such as those in CSF require invasive sampling or are specific to one disease such as Alzheimer's, while others require further validation. Additionally, neuroimaging methodologies, including magnetic resonance imaging, magnetic resonance spectroscopy, and positron emission tomography, may also serve as potential biomarkers and have several advantages including being minimally invasive. The development of biomarkers of neurotoxicity is a goal shared by scientists across academia, government, and industry and is an ideal topic to be addressed via the Health and Environmental Sciences Institute (HESI) framework which provides a forum to collaborate on key challenging scientific topics. Here we utilize the HESI framework to propose a consensus on the relative potential of currently described biomarkers of neurotoxicity to assess utility of the selected biomarkers using a nonclinical model.	[Roberts, Ruth A.] ApconiX, BioHub Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Calligaro, David] Eli Lilly & Co, Div Eli Lilly & Co, Pharmacol Toxicol Res Lilly Res Labs, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Guilarte, Tomas R.] Columbia Univ, New York, NY 10032 USA; [Hanig, Joseph P.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Herr, David W.; Moser, Virginia C.] US EPA, NHEERL, Toxicol Assessment Div, Res Triangle Pk, NC 27711 USA; [Hudzik, Thomas J.] AbbVie Inc, N Chicago, IL 60064 USA; [Jeromin, Andreas; Lynch, James J., III] Quanterix Inc, Lexington, MA 02421 USA; [Kallman, Mary J.] Covance Inc, Indianapolis, IN 46214 USA; [Liachenko, Serguei; Slikker, William, Jr.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Miller, Diane B.; O'Callaghan, James P.] NIOSH, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [Paule, Merle G.] US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Jefferson, AR 72079 USA		Roberts, RA (corresponding author), ApconiX, BioHub Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	ruth.roberts@apconix.com		Liachenko, Serguei/0000-0002-0683-5442	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES009089] Funding Source: NIH RePORTER; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30 ES009089] Funding Source: Medline		Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; BACHMANN MO, 1993, OCCUP MED-OXFORD, V43, P149, DOI 10.1093/occmed/43.3.149; BALABAN CD, 1988, NEUROSCIENCE, V26, P337, DOI 10.1016/0306-4522(88)90150-9; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Blennow K, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006221; Bolon B, 2013, TOXICOL PATHOL, V41, P1028, DOI 10.1177/0192623312474865; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Donnan G A, 1986, Clin Exp Neurol, V22, P155; Dopp E, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/358484; Ferris MJ, 2008, NEUROSCI BIOBEHAV R, V32, P883, DOI 10.1016/j.neubiorev.2008.01.004; FOWLE JR, 1992, ENVIRON HEALTH PERSP, V98, P235, DOI 10.2307/3431277; Gouzoulis-Mayfrank Euphrosyne, 2009, Dialogues Clin Neurosci, V11, P305; Guo D, 2013, STROKE, V44, P1739, DOI 10.1161/STROKEAHA.111.000835; Hanig J, 2014, REGUL TOXICOL PHARM, V70, P641, DOI 10.1016/j.yrtph.2014.09.010; HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213; Keifer Matthew C, 2007, J Agromedicine, V12, P17, DOI 10.1300/J096v12n01_03; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Kreisl WC, 2013, J CEREBR BLOOD F MET, V33, P53, DOI 10.1038/jcbfm.2012.131; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liachenko S, 2015, TOXICOL SCI, V146, P183, DOI 10.1093/toxsci/kfv083; Liu H, 2014, NEUROTOX RES, V26, P179, DOI 10.1007/s12640-014-9461-4; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; MCMILLAN DE, 1986, NEUROTOXICOL TERATOL, V8, P499; Milne GL, 2006, ANTIOXID REDOX SIGN, V8, P1379, DOI 10.1089/ars.2006.8.1379; Miodovnik A, 2011, MT SINAI J MED, V78, P58, DOI 10.1002/msj.20237; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Moser VC, 1996, J TOXICOL ENV HEALTH, V47, P567, DOI 10.1080/009841096161546; O'CALLAGHAN J P, 1991, Biomedical and Environmental Sciences, V4, P197; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; O'Callaghan JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102003; Ogata K, 2015, TOXICOL PATHOL, V43, P198, DOI 10.1177/0192623314530533; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pogge A, 2004, NEUROTOXICOLOGY, V25, P525, DOI 10.1016/j.neuro.2003.10.007; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Pritt ML, 2014, TOXICOL SCI, V141, P398, DOI 10.1093/toxsci/kfu136; Rosen C, 2013, CURR OPIN PSYCHIATR, V26, P276, DOI 10.1097/YCO.0b013e32835f6747; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sadiq S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/132671; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Spencer P.S., 2000, EXPT CLIN NEUROTOXIC; Stephenson E, 2014, NAT REV NEUROL, V10, P459, DOI 10.1038/nrneurol.2014.118; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Tumani H, 2009, NEUROBIOL DIS, V35, P117, DOI 10.1016/j.nbd.2009.04.010; US Environmental Protection Agency. (EPA), 1998, GUID NEUR RISK ASS, V63; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Wan HI, 2012, BIOMARK MED, V6, P119, DOI [10.2217/bmm.11.98, 10.2217/BMM.11.98]; Zhang X, 2013, J APPL TOXICOL, V33, P861, DOI 10.1002/jat.2857	53	22	23	1	20	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	DEC	2015	148	2					332	340		10.1093/toxsci/kfv188			9	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	CZ6FB	WOS:000367195500001	26609132	Green Published, hybrid, Green Submitted			2022-02-06	
J	Sokol, KK; Black, GE; Azarow, KS; Long, W; Martin, MJ; Eckert, MJ				Sokol, Kyle K.; Black, George E.; Azarow, Kenneth S.; Long, William; Martin, Matthew J.; Eckert, Matthew J.			Prehospital interventions in severely injured pediatric patients: Rethinking the ABCs	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	45th Annual Meeting of the Western-Trauma-Association	MAR 01-06, 2015	Telluride, CO	Western Trauma Assoc		Prehospital; pediatric; trauma; tourniquet; intubation	EMERGENCY MEDICAL-SERVICES; ADVANCED LIFE-SUPPORT; COMBAT CASUALTY CARE; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; HEMOSTATIC DRESSINGS; TOURNIQUET USE; SURVIVAL; NEEDS; FIELD	BACKGROUND The current conflict in Afghanistan has resulted in a high volume of significantly injured pediatric patients. The austere environment has demanded emphasis on prehospital interventions (PHIs) to sustain casualties during transport. METHODS The Department of Defense Trauma Registry was queried for all pediatric patients (18 years) treated at Camp Bastion from 2004 to 2012. PHIs were grouped by Advanced Trauma Life Support categories into (1) airway (A)intubation or surgical airway; 2) breathing (B)chest tube or needle thoracostomy; and 3) circulation (C)tourniquet or hemostatic dressing. Outcomes were assessed based on injury severity, hemodynamics, blood products and fluids, as well as mortality rates. RESULTS There were 766 injured children identified with 20% requiring one or more PHIs, most commonly circulation (C, 51%) followed by airway (A, 40%) and breathing (B, 8.7%). The majority of C interventions were tourniquets (85%) and hemostatic dressings (15%). Only 38% of patients with extremity vascular injury or amputation received a C intervention, with a significant reduction in blood products and intravenous fluids associated with receiving a C PHI (both p < 0.05). A interventions consisted of endotracheal intubation for depressed mental status (Glasgow Coma Scale [GCS] score < 8). Among patients with traumatic brain injury, A interventions were associated with higher unadjusted mortality (56% vs. 20%, p < 0.01) and remained independently associated with increased mortality after multivariate adjustment (odds ratio, 5.9; p = 0.001). B interventions were uncommon and performed in only 2% of patients with no recorded adverse outcomes. CONCLUSION There is a high incidence of PHIs among pediatric patients with severe wartime injuries. The most common and effective were C PHI for hemorrhage control, which should remain a primary focus of equipment and training. A interventions were most commonly performed in the setting of severe traumatic brain injury but were associated with worse outcomes. B interventions seem safe and effective and may be underused. LEVEL OF EVIDENCE Care management/therapeutic study, level IV.	[Sokol, Kyle K.; Black, George E.; Martin, Matthew J.; Eckert, Matthew J.] Madigan Army Med Ctr, Dept Surg, Tacoma, WA 98431 USA; [Azarow, Kenneth S.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Long, William; Martin, Matthew J.] Legacy Emanuel Hosp, Trauma & Acute Care Surg Serv, Portland, OR USA		Eckert, MJ (corresponding author), Madigan Army Med Ctr, Dept Surg, 9040-A Fitzsimmons Ave, Tacoma, WA 98431 USA.	matthew.j.eckert.mil@mail.mil	Martin, Matthew/B-2676-2014	Martin, Matthew/0000-0002-9169-9069; Black, George/0000-0002-4046-100X			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS9; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Ali J, 1997, J TRAUMA, V42, P786, DOI 10.1097/00005373-199705000-00006; APPLEBAUM D, 1985, ANN EMERG MED, V14, P656, DOI 10.1016/S0196-0644(85)80882-9; Aylwin CJ, 2008, ANN ROY COLL SURG, V90, P54, DOI 10.1308/003588408X242286; Bankole S, 2011, PEDIATR CRIT CARE ME, V12, pE166, DOI 10.1097/PCC.0b013e3181f36f6e; Barton Erik D., 1995, Journal of Emergency Medicine, V13, P155, DOI 10.1016/0736-4679(94)00135-9; Bennett BL, 2014, MIL MED, V179, P497, DOI 10.7205/MILMED-D-13-00199; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Borgman M, 2012, J TRAUMA ACUTE CARE, V73, pS509, DOI 10.1097/TA.0b013e318275477c; Butler FK, 2010, J TRAUMA, V69, pS10, DOI 10.1097/TA.0b013e3181e4220c; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Cascio AN, 2004, J TRAUMA, V56, P454, DOI 10.1097/01.TA.0000109686.44485.14; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Floccare DJ, 2003, J TRAUMA, V55, P1184, DOI 10.1097/01.TA.0000097177.08594.4B; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Granville-Chapman J, 2011, INJURY, V42, P447, DOI 10.1016/j.injury.2010.09.037; Johansson J, 2012, RESUSCITATION, V83, P1259, DOI 10.1016/j.resuscitation.2012.02.018; Kheirabadi Bijan, 2011, US Army Med Dep J, P25; Kotwal Russ S, 2011, J Spec Oper Med, V11, P127; Kragh JF, 2015, PREHOSP EMERG CARE, V19, P184, DOI 10.3109/10903127.2014.964892; Kragh JF, 2013, AM J EMERG MED, V31, P873, DOI 10.1016/j.ajem.2012.11.030; Kragh JF, 2012, PEDIATR EMERG CARE, V28, P1361, DOI 10.1097/PEC.0b013e318276c260; LAVERY RF, 1992, PEDIATR EMERG CARE, V8, P9, DOI 10.1097/00006565-199202000-00004; Loiselle J M, 2001, Ann Emerg Med, V38, P352; Long E, 2014, PEDIATR ANESTH, V24, P1204, DOI 10.1111/pan.12490; MacIntyre AD, 2011, AM SURGEON, V77, P162; Martinon C, 2011, PEDIATR CRIT CARE ME, V12, P65, DOI 10.1097/PCC.0b013e3181e2a244; McGuigan R, 2007, J PEDIATR SURG, V42, P207, DOI 10.1016/j.jpedsurg.2006.09.020; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; Ordonez C, 2012, WORLD J SURG, V36, P2761, DOI 10.1007/s00268-012-1745-3; Perron A D, 2001, Prehosp Emerg Care, V5, P6, DOI 10.1080/10903120190940245; RAMENOFSKY ML, 1984, J TRAUMA, V24, P818, DOI 10.1097/00005373-198409000-00007; Schmidt U, 2002, UNFALLCHIRURG, V105, P1000, DOI 10.1007/s00113-002-0520-6; Schmidt U, 1998, J TRAUMA, V44, P98, DOI 10.1097/00005373-199801000-00010; Seamon MJ, 2013, INJURY, V44, P634, DOI 10.1016/j.injury.2012.12.020; Seid Terrence, 2012, Int J Crit Illn Inj Sci, V2, P114, DOI 10.4103/2229-5151.100887; SEIDEL JS, 1986, CIRCULATION, V74, P129; SEIDEL JS, 1986, PEDIATRICS, V78, P808; SEIDEL JS, 1984, PEDIATRICS, V73, P769; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; Suominen P, 1998, J PEDIATR SURG, V33, P1388, DOI 10.1016/S0022-3468(98)90014-8; Svenson JE, 1996, PEDIATR EMERG CARE, V12, P173, DOI 10.1097/00006565-199606000-00007; Tien Homer C, 2009, J Spec Oper Med, V9, P65; van Olden GDJ, 2004, J TRAUMA, V57, P381, DOI 10.1097/01.TA.0000096645.13484.E6; Vavilala MS, 2011, PEDIATR CRIT CARE ME, V12, P477, DOI 10.1097/PCC.0b013e3181e8b729; Wilson KL, 2013, AM SURGEON, V79, P257	50	22	22	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2015	79	6					983	989		10.1097/TA.0000000000000706			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	CX4TD	WOS:000365692300023	26680137				2022-02-06	
J	Quan, W; Zhang, ZF; Tian, QL; Wen, XL; Yu, P; Wang, D; Cui, WY; Zhou, L; Park, E; Baker, AJ; Zhang, JM; Jiang, RC				Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Cui, Weiyun; Zhou, Lei; Park, Eugene; Baker, Andrew J.; Zhang, Jianning; Jiang, Rongcai			A rat model of chronic subdural hematoma: Insight into mechanisms of revascularization and inflammation	BRAIN RESEARCH			English	Article						Angiogenesis; Behavior; Chronic subdural hematoma; Histology; Inflammation; Pathology; Rat model	REGULATORY T-CELLS; ENDOTHELIAL PROGENITOR CELLS; TRAUMATIC BRAIN-INJURY; ATRIAL-FIBRILLATION; SURGICAL-TREATMENT; RISK-FACTORS; RECURRENCE; STROKE; GROWTH; PHYSIOPATHOGENESIS	Chronic subdural hematoma (CSDH) is a common neurological occurrence in the elderly population with significant impact on the quality of life and work. Studies have attempted to determine the risk factors and pathophysiological mechanisms of CSDH using models in numerous mammalian species. To date, these animal models have only been able to reproduce limited durations of hematoma which does not accurately reflect the chronic state of CSDH. To address some of these challenges we modified a rat model of CSDH using two consecutive injections of autologous blood resulting in a hematoma of more than three weeks. We observed inflammatory and angiogenic changes related to the development and recovery of CSDH. In this study the technique for producing a CSDH in a small animal model had a success rate of 78.13%. The hematoma was sustainable up to 24 days. Hematoma resolution was associated with a gradual decrease in local pro-inflammatory factors and gradual increase in anti-inflammatory factors as well as proliferation and subsequent maturation of newly formed vessels. These events were also associated with improved behavioral outcome. Expression of anti-inflammatory cytoldnes also paralleled reabsorption of the hematoma. Reduction in hem. atoma size was also associated with neurological recovery. These data suggest that vessel maturation and anti-inflammatory pathways may contribute to the resolution of CSDH and neurological recovery. The regulation of the two mechanisms is a potential target for the treatment of CSDH. The modified model of rat CSDH demonstrated a high level of reproducibility in our hands and may be useful in future CSDH studies. (C) 2015 Elsevier B.V. All rights reserved.	[Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Cui, Weiyun; Zhou, Lei; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Park, Eugene] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Inst Med Sci, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Inst Med Sci, Dept Surg, Toronto, ON, Canada		Zhang, JM (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhangtj@gmail.com; rongcaijiang@gmail.com		Wang, Dong/0000-0002-5245-3074	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301629, 81271359]; Ontario-China Research and Innovation Fund (OCRIF) [2011DFG33430]	We acknowledge Li Liu, Weiyun Cui, Fanglian Chen and Lei Zhou for their technical assistance of experiments and data interpretation. The work was supported by the National Natural Science Foundation of China (Grant nos. 81301629, and 81271359), the Ontario-China Research and Innovation Fund (OCRIF, 2011DFG33430).	AIKAWA H, 1987, J NEUROSURG, V67, P710, DOI 10.3171/jns.1987.67.5.0710; APFELBAUM RI, 1974, J NEUROSURG, V40, P336, DOI 10.3171/jns.1974.40.3.0336; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Brand C, 2014, BRIT J NEUROSURG, V28, P68, DOI 10.3109/02688697.2013.815314; Brea D, 2014, J CELL MOL MED, V18, P1571, DOI 10.1111/jcmm.12304; Chen JC, 2005, STROKE, V36, P2665, DOI 10.1161/01.STR.0000189992.06654.ab; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; D'Abbondanza JA, 2014, NEUROL RES, V36, P176, DOI 10.1179/1743132813Y.0000000279; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; Eijkenboom M, 2004, NEUROSCIENCE, V124, P523, DOI 10.1016/j.neuroscience.2003.11.019; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; GLOVER D, 1976, J NEUROSURG, V45, P393, DOI 10.3171/jns.1976.45.4.0393; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Hong HJ, 2009, SURG NEUROL, V71, P161, DOI 10.1016/j.surneu.2008.01.023; HUBSCHMANN OR, 1980, NEUROSURGERY, V6, P233; Jussen D, 2008, CRIT CARE MED, V36, P543, DOI 10.1097/01.CCM.0B013E3181620A0F; Kalamatianos T, 2013, J NEUROSURG, V118, P353, DOI 10.3171/2012.10.JNS12327; Karabiyikoglu M, 2005, NEUROSURGERY, V57, P565, DOI 10.1227/01.NEU.0000170435.47739.AE; Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149; LABADIE EL, 1976, J NEUROSURG, V45, P382, DOI 10.3171/jns.1976.45.4.0382; Li T, 2014, J NEUROL SCI, V341, P88, DOI 10.1016/j.jns.2014.04.009; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Mark S. G., 2010, HDB NEUROSURGERY, pP897; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Mori K, 1998, NEUROL MED-CHIR, V38, P697, DOI 10.2176/nmc.38.697; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Na SY, 2015, STROKE, V46, P212, DOI 10.1161/STROKEAHA.114.007756; Nordstrom A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001151; Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z; OHSHIMA T, 1982, Neurologia Medico-Chirurgica, V22, P696, DOI 10.2176/nmc.22.696; Pericolini E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111163; PRASAIN N, 2012, JOVE-J VIS EXP   APR, P26095, DOI DOI 10.3791/3872; Pripp AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090149; Rabe H, 2014, IMMUNOLOGY, V141, P467, DOI 10.1111/imm.12209; RAPAPORT FT, 1972, TRANSPL P, V4, P537; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Sahara M, 2014, CELL RES, V24, P820, DOI 10.1038/cr.2014.59; Schebesch KM, 2008, ZBL NEUROCHIR, V69, P61, DOI 10.1055/s-2007-1004582; Shehadah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086621; Siddiq I, 2012, J NEUROTRAUM, V29, P2647, DOI 10.1089/neu.2012.2444; Stanisic M, 2012, INFLAMM RES, V61, P845, DOI 10.1007/s00011-012-0476-0; Stanisic M, 2012, ACTA NEUROCHIR, V154, P113, DOI 10.1007/s00701-011-1203-2; Suzuki M, 1998, ACTA NEUROCHIR, V140, P51, DOI 10.1007/s007010050057; Tokmak M, 2007, J NEUROSURG, V107, P290, DOI 10.3171/JNS-07/08/0290; Wang D, 2010, J NEUROTRAUM, V27, P1489, DOI 10.1089/neu.2009.1057; WATANABE S, 1972, J NEUROSURG, V37, P552, DOI 10.3171/jns.1972.37.5.0552; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217	55	22	23	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 2	2015	1625						84	96		10.1016/j.brainres.2015.08.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW5QQ	WOS:000365052000009	26315377				2022-02-06	
J	Chan, LG; Feinstein, A				Chan, Lai Gwen; Feinstein, Anthony			Persistent Sleep Disturbances Independently Predict Poorer Functional and Social Outcomes 1 Year After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; mild traumatic brain injury; sleep disorders; traumatic brain injury; treatment outcome	MINOR HEAD-INJURY; SEVERITY SCORE; GENERAL HEALTH; SCALE; QUESTIONNAIRE; IMPACT; ADULTS; TBI; RELIABILITY; COMPLAINTS	Objective: To investigate the effect of sleep disturbances on functional and social outcomes after mild traumatic brain injury. Setting: Outpatient traumatic brain injury clinic in a tertiary trauma center. Participants: A total of 374 mild traumatic brain injury patients were assessed within 3 months of injury and followed up every 3 months for 1 year. Design: Analysis of a historical cohort in a naturalistic clinical setting. Main measures: At each visit, symptoms of concussion and psychological distress and indices of functional and social outcomes were measured with the Rivermead Postconcussion Questionnaire, 28-item General Health Questionnaire, and Rivermead Head Injury Follow-up Questionnaire, respectively. Changes in outcome scores over time were explored using repeated measures analysis of variance and compared between subjects with persistent (SD) and recovered (SR) sleep disturbances. Predictors of functional/social outcome were determined using linear regression. Results: The percentages of subjects reporting sleep disturbances at each time point were 71.9%, 57.2%, 55.1%, and 53.7%, respectively. For functional and social outcomes, significant effects of time (F3,315 = 9.54; P<. 001), group (SD vs SR) F1,317 = 5.32; P =.022, and time X group interaction F3,315 = 4.14; P =.007 were found. Persistent sleep disturbance (P = 0.011) and higher symptom burden at 6 months postinjury (P <.0001) were independent predictors of poorer outcome. Conclusion: Sleep disturbance, independent of psychological distress, is an important prognostic factor of functional and social outcomes after mild traumatic brain injury.	[Chan, Lai Gwen] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada; [Chan, Lai Gwen] Tan Tock Seng Hosp, Dept Psychol Med, Jalan Tan Tock Seng, Singapore 308433, Singapore; [Feinstein, Anthony] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Feinstein, Anthony] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada		Chan, LG (corresponding author), Tan Tock Seng Hosp, Dept Psychol Med, Jalan Tan Tock Seng, Singapore 308433, Singapore.	lai_gwen_chan@ttsh.com.sg					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belozertsev Yu A., 2012, Eksperimental'naya i Klinicheskaya Farmakologiya, V75, P31; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Cassidy JD, 2014, ARCH PHYS MED REHAB, V95, P299; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; DJed Buysse, 2005, REV PSYCHIAT SERIES, V24; Goldberg D., 1978, MANUAL GEN HLTH QUES; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Marshall S, 2012, CAN FAM PHYSICIAN, V58, p[257, e128]; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663	42	22	22	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					E67	E75		10.1097/HTR.0000000000000119			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300008	25931180				2022-02-06	
J	Gerrard, P; Kazis, LE; Ryan, CM; Shie, VL; Holavanahalli, R; Lee, A; Jette, A; Fauerbach, JA; Esselman, P; Herndon, D; Schneider, JC				Gerrard, Paul; Kazis, Lewis E.; Ryan, Colleen M.; Shie, Vivian L.; Holavanahalli, Radha; Lee, Austin; Jette, Alan; Fauerbach, James A.; Esselman, Peter; Herndon, David; Schneider, Jeffrey C.			Validation of the Community Integration Questionnaire in the adult burn injury population	QUALITY OF LIFE RESEARCH			English	Article						Community Integration Questionnaire; Burn outcomes; Rehabilitation; Burn injury; Community integration; Participation	TRAUMATIC BRAIN-INJURY; ITEM RESPONSE THEORY; PSYCHOMETRIC PROPERTIES; INTERNATIONAL CLASSIFICATION; REHABILITATION; DISABILITY; OUTCOMES; VALIDITY; HEALTH	Purpose With improved survival, long-term effects of burn injuries on quality of life, particularly community integration, are important outcomes. This study aims to assess the Community Integration Questionnaire's psychometric properties in the adult burn population. Methods Data were obtained from a multicenter longitudinal data set of burn survivors. The psychometric properties of the Community Integration Questionnaire (n = 492) were examined. The questionnaire items were evaluated for clinical and substantive relevance; validation procedures were conducted on different samples of the population; construct validity was assessed using exploratory factor analysis; internal consistency reliability was examined using Cronbach's alpha statistics; and item response theory was applied to the final models. Results The CIQ-15 was reduced by two questions to form the CIQ-13, with a two-factor structure, interpreted as self/family care and social integration. Item response theory testing suggests that Factor 2 captures a wider range of community integration levels. Cronbach's alpha was 0.80 for Factor 1, 0.77 for Factor 2, and 0.79 for the test as a whole. Conclusions The CIQ-13 demonstrates validity and reliability in the adult burn survivor population addressing issues of self/family care and social integration. This instrument is useful in future research of community reintegration outcomes in the burn population.	[Gerrard, Paul; Shie, Vivian L.; Schneider, Jeffrey C.] Harvard Univ, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Sch Med, Boston, MA 02114 USA; [Kazis, Lewis E.; Jette, Alan] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, CAPP, Boston, MA USA; [Ryan, Colleen M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Sumner Redstone Burn Ctr,Surg Serv, Boston, MA USA; [Holavanahalli, Radha] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Lee, Austin] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Fauerbach, James A.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Esselman, Peter] Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Seattle, WA 98104 USA; [Herndon, David] Univ Texas Med Branch, Dept Surg & Pediat, Galveston, TX 77555 USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Boston, MA USA		Schneider, JC (corresponding author), Harvard Univ, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Sch Med, 300 1st Ave, Boston, MA 02114 USA.	jcschneider@partners.org	Herndon, David/AAC-3354-2020; Schneider, Jeffrey/AAO-2126-2020	Ryan, Colleen/0000-0002-6455-936X			[Anonymous], 2013, R LANG ENV STAT COMP; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Djikers M., 1997, J HEAD TRAUMA REHAB, V12, P74; Esselman PC, 2001, J BURN CARE REHABIL, V22, P221, DOI 10.1097/00004630-200105000-00007; Gomez M, 2008, J BURN CARE RES, V29, P130, DOI [1097/BCR.0b013e31815f6efd, 10.1097/BCR.0b013e31815f6efd]; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Jette AM, 2005, J REHABIL MED, V37, P339, DOI 10.1080/16501970500302793; Kamata A, 2008, STRUCT EQU MODELING, V15, P136, DOI 10.1080/10705510701758406; Klein MB, 2011, J BURN CARE RES, V32, P66, DOI 10.1097/BCR.0b013e318203336a; Kratz A. L., 2014, J SPINAL CORD MED; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; Mair P., 2007, J STAT SOFTW, V20, P1, DOI [https://doi.org/10.18637/jss.v020.i09, DOI 10.18637/JSS.V020.I09, 10.18637/jss.v020.i09]; Revelle W., 2015, PSYCH PROCEDURES PSY, V1; Saeki S, 2006, J REHABIL MED, V38, P333, DOI 10.1080/16501970600780245; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Schneider JC, 2011, J BURN CARE RES, V32, P294, DOI 10.1097/BCR.0b013e31820aaf56; Stucki G, 2007, J REHABIL MED, V39, P286, DOI 10.2340/16501977-0044; TAKANE Y, 1987, PSYCHOMETRIKA, V52, P393, DOI 10.1007/BF02294363; Tan WH, 2012, J BURN CARE RES, V33, P110, DOI 10.1097/BCR.0b013e318234d91a; Wasiak J, 2011, BURNS, V37, P913, DOI 10.1016/j.burns.2011.02.012; World Health Organization, 2002, COMM LANG FUNCT DIS	23	22	23	1	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	NOV	2015	24	11					2651	2655		10.1007/s11136-015-0997-4			5	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS7TO	WOS:000362289300009	25986908				2022-02-06	
J	Mastro-Martinez, I; Perez-Suarez, E; Melen, G; Gonzalez-Murillo, A; Casco, F; Lozano-Carbonero, N; Gutierrez-Fernandez, M; Diez-Tejedor, E; Casado-Flores, J; Ramirez-Orellana, M; Serrano-Gonzalez, A				Mastro-Martinez, Ignacio; Perez-Suarez, Esther; Melen, Gustavo; Gonzalez-Murillo, Africa; Casco, Fernando; Lozano-Carbonero, Nieves; Gutierrez-Fernandez, Maria; Diez-Tejedor, Exuperio; Casado-Flores, Juan; Ramirez-Orellana, Manuel; Serrano-Gonzalez, Ana			Effects of local administration of allogenic adipose tissue-derived mesenchymal stem cells on functional recovery in experimental traumatic brain injury	BRAIN INJURY			English	Article						Animal model; cell therapy; neurogenesis; children; MSCs (mesenchymal stem cells); pediatric intensive care medicine; TBI (traumatic brain injury)	FOCAL CEREBRAL-ISCHEMIA; BONE-MARROW; PROGENITOR CELLS; TRANSPLANTATION; ADULT; THERAPY; OPPORTUNITIES; REPLACEMENT; MECHANISMS; VOLUME	Objective: Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in paediatric patients after the first year of life. The aim of this study was to evaluate effects of locally administered allogeneic mesenchymal stem cells (MSC), in the acute period after a TBI.Methodology: MSC were isolated from peritoneal fat of healthy rats, expanded in vitro and labelled with the green fluorescent protein. Rats were placed in one of three experimental groups: (1) Control: TBI, (2) IP-Control: TBI+local saline and (3) IP-Treat: TBI+2x10(5) MSC 24 hours after receiving a moderate, unilateral, controlled cortical impact. Motor and cognitive behavioural tests were performed to evaluate functional recovery. Histological examination and immunohistochemistry were used to identify cell distribution.Main results: Improved performance was found on motor tests in the MSC-treated group compared to control groups. MSC were found in the perilesional area and their number decreased with time after transplantation. MSC treatment increased the cell density in the hippocampus (CA3 pyramidal cells and granule cells in the dentate gyrus) and enhanced neurogenesis in this area.Conclusion: MSC cell therapy resulted in better recovery of motor function compared with the control group. This cellular therapy might be considered for patients suffering from TBI.	[Mastro-Martinez, Ignacio; Perez-Suarez, Esther; Casado-Flores, Juan; Serrano-Gonzalez, Ana] Hosp Nino Jesus, Pediat Intens Crit Care, Madrid 28009, Spain; [Melen, Gustavo; Gonzalez-Murillo, Africa; Casco, Fernando; Lozano-Carbonero, Nieves; Ramirez-Orellana, Manuel] Hosp Nino Jesus, Inst Invest Sanitaria Princesa, Madrid 28009, Spain; [Gutierrez-Fernandez, Maria; Diez-Tejedor, Exuperio] Univ Autonoma Madrid, Dept Neurol, La Paz Univ Hosp, Neurosci Area IdiPAZ,Hlth Res Inst, Madrid, Spain; [Gutierrez-Fernandez, Maria; Diez-Tejedor, Exuperio] Univ Autonoma Madrid, Stroke Ctr, Neurosci & Cerebrovasc Res Lab, Neurosci Area IdiPAZ,Hlth Res Inst, Madrid, Spain		Mastro-Martinez, I (corresponding author), Hosp Nino Jesus, Pediat Intens Crit Care, Av Menendez Pelayo 65, Madrid 28009, Spain.	ignacio.mastro@salud.madrid.org	Mastro-Martinez, Ignacio/N-3555-2019; Gonzalez, Africa/M-3426-2014; Ramirez, Manuel/H-7710-2015	Mastro-Martinez, Ignacio/0000-0001-6812-1608; Gonzalez, Africa/0000-0001-7747-1204; Ramirez, Manuel/0000-0003-0332-6973	Fundacion Mutua MadrilenaInstituto de Salud Carlos III; Fundacion ACS	This study was supported by grants from Fundacion Mutua Madrilena and Fundacion ACS. The funding played no role in the design of the study, collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication. The authors alone are responsible for the content and writing of the paper.	Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Bochev I, 2008, CELL BIOL INT, V32, P384, DOI 10.1016/j.cellbi.2007.12.007; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Brunt KR, 2012, CAN J PHYSIOL PHARM, V90, P327, DOI [10.1139/y2012-007, 10.1139/Y2012-007]; Cao Qi-lin, 2008, V438, P361, DOI 10.1007/978-1-59745-133-8_28; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; de Girolamo L, 2013, CURR PHARM DESIGN, V19, P2459, DOI 10.2174/1381612811319130015; de Lecinana MA, 2006, J NEUROL SCI, V247, P121, DOI 10.1016/j.jns.2006.03.022; Ertas G, 2012, SCI WORLD J, DOI 10.1100/2012/105698; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gutierrez-Fernandez M, 2011, NEUROSCIENCE, V175, P394, DOI 10.1016/j.neuroscience.2010.11.054; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Gutierrez-Fernandez M, 2013, DISCOV MED, V16, P37; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Jain KK, 2009, MOL BIOTECHNOL, V42, P367, DOI 10.1007/s12033-009-9166-8; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kochanek PM, 2010, DEV NEUROSCI-BASEL, V32, P335, DOI 10.1159/000323016; Komotar RJ, 2007, NAT PROTOC, V2, P2345, DOI 10.1038/nprot.2007.359; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mackay KB, 1996, NEURODEGENERATION, V5, P319, DOI 10.1006/neur.1996.0043; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahmood A, 2007, NEUROSURGERY, V61, P206, DOI 10.1227/01.neu.0000279914.37559.de; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mori K, 2005, J CEREBR BLOOD F MET, V25, P887, DOI 10.1038/sj.jcbfm.9600083; Ozen I, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-30; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Persons DA, 1998, NAT MED, V4, P1201, DOI 10.1038/2704; Ribeiro A, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt336; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Richardson RM, 2006, ACTA NEUROCHIR, V148, P773, DOI 10.1007/s00701-006-0778-5; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Sughrue ME, 2006, J NEUROSCI METH, V151, P83, DOI 10.1016/j.jneumeth.2005.04.023; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Walker PA, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/369578; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035	54	22	26	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1497	1510		10.3109/02699052.2015.1053525			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200015	26287760				2022-02-06	
J	Park, Y; Liu, CL; Luo, TF; Dietrich, WD; Bramlett, H; Hu, BR				Park, Yujung; Liu, Chunli; Luo, Tianfei; Dietrich, W. Dalton; Bramlett, Helen; Hu, Bingren			Chaperone-Mediated Autophagy after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						chaperone-mediated autophagy; HSC70; HSP70; Iba-1; LAMP2; lysosome; ubiquitin; traumatic brain injury	TRANSIENT CEREBRAL-ISCHEMIA; NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; POSTSYNAPTIC DENSITIES; PROTEIN AGGREGATION; THERAPEUTIC TARGET; SELECTIVE UPTAKE; BETA DEPOSITION; RAT	Chaperone-mediated autophagy (CMA) and the ubiquitin-proteasomal system (UPS) are two major protein degradation systems responsible for maintaining cellular homeostasis, but how these two systems are regulated after traumatic brain injury (TBI) remains unknown. TBI produces primary mechanical damage that must be repaired to maintain neuronal homeostasis. The level of lysosomal-associated membrane protein type 2A (LAMP2A) is the hallmark of CMA activity. The level of polyubiquitinated proteins (ubi-proteins) reflects UPS activity. This study utilized a moderate fluid percussion injury model in rats to investigate the changes in CMA and the UPS after TBI. Induction of CMA was manifested by significant upregulation of LAMP2A and secondary lysosomes during the periods of 1-15 days of recovery after TBI. In comparison, the levels of ubi-proteins were increased only moderately after TBI. The increases in the levels of LAMP2A and 70kDa heat-shock protein for CMA after TBI were seen mainly in the secondary lysosome-containing fractions. Confocal and electron microscopy further showed that increased LAMP2A or lysosomes were found mainly in neurons and proliferated microglia. Because CMA and the UPS are two major routes for elimination of different types of cellular aberrant proteins, the consecutive activation of these two pathways may serve as a protective mechanism for maintaining cellular homeostasis after TBI.	[Park, Yujung; Liu, Chunli; Luo, Tianfei; Hu, Bingren] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Neurochem Lab Brain Injury, Baltimore, MD 21201 USA; [Dietrich, W. Dalton; Bramlett, Helen] Univ Miami, Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA		Hu, BR (corresponding author), Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA.	bhu@anes.umm.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS040407, NS030291]; AHA EIAAmerican Heart Association [0940042N]; Veteran Affair Merit Award [I01BX001696-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R29NS036810, R56NS036810, R01NS040407, R01NS036810] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001696] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants NS040407 and NS030291, AHA EIA grant 0940042N and Veteran Affair Merit Award I01BX001696-01.	Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Bao HJ, 2015, NEUROCHEM RES, V40, P89, DOI 10.1007/s11064-014-1469-x; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cordaro M, 2015, J NEUROTRAUMA; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Cuervo AM, 2011, NAT REV MOL CELL BIO, V12, P535, DOI 10.1038/nrm3150; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayashi Takeshi, 2006, Current Alzheimer Research, V3, P351, DOI 10.2174/156720506778249498; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Hu BR, 1998, J NEUROSCI, V18, P625; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Kanai M, 1997, MICROSC RES TECHNIQ, V39, P444, DOI 10.1002/(SICI)1097-0029(19971201)39:5<444::AID-JEMT7>3.0.CO;2-G; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; King JS, 2012, TRENDS MOL MED, V18, P583, DOI 10.1016/j.molmed.2012.08.002; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Luo TF, 2013, TRANSL STROKE RES, V4, P581, DOI 10.1007/s12975-013-0299-5; Malkus KA, 2012, NEUROBIOL DIS, V46, P732, DOI 10.1016/j.nbd.2012.03.017; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Martone ME, 1999, J NEUROSCI, V19, P1988; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Muehlfeld C, 2010, CARDIOVASC PATHOL, V19, P65, DOI 10.1016/j.carpath.2008.10.015; Natarajan R, 2004, MOL BIOL CELL, V15, P4798, DOI 10.1091/mbc.E04-05-0366; PONTEN U, 1973, J NEUROCHEM, V21, P1121, DOI 10.1111/j.1471-4159.1973.tb07566.x; Roscoe W, 2005, J BIOL CHEM, V280, P11458, DOI 10.1074/jbc.M409564200; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sakai K, 2014, AM J FOREN MED PATH, V35, P38, DOI 10.1097/PAF.0000000000000067; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Tsigelny IF, 2004, CELL BIOCHEM BIOPHYS, V40, P263, DOI 10.1385/CBB:40:3:263; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wei JS, 2009, AM J PATHOL, V174, P1891, DOI 10.2353/ajpath.2009.080680; Winchester B G, 2001, Eur J Paediatr Neurol, V5 Suppl A, P11, DOI 10.1053/ejpn.2000.0428; Xilouri M, 2013, AUTOPHAGY, V9, P2166, DOI 10.4161/auto.26451; Yabu T, 2011, FEBS J, V278, P673, DOI 10.1111/j.1742-4658.2010.07989.x; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076	63	22	26	4	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2015	32	19					1449	1457		10.1089/neu.2014.3694			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CR8NC	WOS:000361609500003	25891649	Green Published			2022-02-06	
J	Gunther, M; Davidsson, J; Plantman, S; Norgren, S; Mathiesen, T; Risling, M				Gunther, Mattias; Davidsson, Johan; Plantman, Stefan; Norgren, Svante; Mathiesen, Tiit; Risling, Marten			Neuroprotective effects of N-acetylcysteine amide on experimental focal penetrating brain injury in rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Inflammation; N-acetylcysteine amide; Neuroprotection; Sprague-Dawley; Traumatic brain injury	TRAUMATIC BRAIN; THIOL ANTIOXIDANT; GLUTATHIONE; PROTECTS; SUPEROXIDE; NEURODEGENERATION; BIOENERGETICS; INFLAMMATION; ACTIVATION; EXPRESSION	We examined the effects of N-acetylcysteine amide (NACA) in the secondary inflammatory response following a novel method of focal penetrating traumatic brain injury (TBI) in rats. N-acetylcysteine (NAC) has limited but well-documented neuroprotective effects after experimental central nervous system ischemia and TBI, but its bioavailability is very low. We tested NACA, a modified form of NAC with higher membrane and blood-brain barrier permeability. Focal penetrating TBI was produced in male Sprague-Dawley rats randomly selected for NACA treatment (n = 5) and no treatment (n = 5). In addition, four animals were submitted to sham surgery. After 2 hours or 24 hours the brains were removed, fresh frozen, cut in 14 mu m coronal sections and subjected to immunohistochemistry, immunofluorescence, Fluoro-Jade and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analyses. All treated animals were given 300 mg/kg NACA intraperitoneally (IP) 2 minutes post trauma. The 24 hour survival group was given an additional bolus of 300 mg/kg IF after 4 hours. NACA treatment decreased neuronal degeneration by Fluoro-Jade at 24 hours with a mean change of 35.0% (p < 0.05) and decreased TUNEL staining indicative of apoptosis at 2 hours with a mean change of 38.7% (p < 0.05). Manganese superoxide dismutase (MnSOD) increased in the NACA treatment group at 24 hours with a mean change of 35.9% (p < 0.05). Levels of migrating macrophages and activated microglia (Ox-42/CD11b), nitric oxide-producing inflammatory enzyme iNOS, peroxynitrite marker 3-nitrotyrosine, NF kappa B translocated to the nuclei, cytochrome C and Bcl-2 were not affected. NACA treatment decreased neuronal degeneration and apoptosis and increased levels of antioxidative enzyme MnSOD. The antiapoptotic effect was likely regulated by pathways other than cytochrome C. Therefore, NACA prevents brain tissue damage after focal penetrating TBI, warranting further studies towards a clinical application. (C) 2015 Elsevier Ltd. All rights reserved.	[Gunther, Mattias; Plantman, Stefan; Risling, Marten] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Davidsson, Johan] Chalmers Univ Technol, Div Vehicle Safety, Dept Appl Mech, S-41296 Gothenburg, Sweden; [Norgren, Svante] Karolinska Inst, Dept Womens & Childrens Hlth, SE-17177 Stockholm, Sweden; [Mathiesen, Tiit] Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden		Gunther, M (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8,B1 5, SE-17177 Stockholm, Sweden.	mattias.gunther@ki.se	mathiesen, tiit/ABC-3627-2021; , Mattias/A-4442-2013; Davidsson, Johan/A-3229-2016	, Mattias/0000-0003-2372-6114; Davidsson, Johan/0000-0002-1717-1514; Mathiesen, Tiit/0000-0001-9463-1919	ALF Stockholms Lans Landsting; Swedish Defense	This study was funded by ALF Stockholms Lans Landsting and The Swedish Defense. We thank Dr. Glenn Goldstein of Sentient LifeSciences for gifting N-acetylcysteine amide to us for our experimental purposes.	Aitio ML, 2006, BRIT J CLIN PHARMACO, V61, P5, DOI 10.1111/j.1365-2125.2005.02523.x; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Ates B, 2008, FREE RADICAL RES, V42, P372, DOI 10.1080/10715760801998638; Bahat-Stroomza M, 2005, EUR J NEUROSCI, V21, P637, DOI 10.1111/j.1460-9568.2005.03889.x; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; DEVRIES N, 1993, J CELL BIOCHEM, P270; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Drake J, 2002, J NEUROSCI RES, V68, P776, DOI 10.1002/jnr.10266; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Gong XZ, 2010, AM J NEPHROL, V31, P178, DOI 10.1159/000268161; Grinberg L, 2005, FREE RADICAL BIO MED, V38, P136, DOI 10.1016/j.freeradbiomed.2004.09.025; Gunther M, 2012, ACTA NEUROCHIR, V154, P689, DOI 10.1007/s00701-012-1297-1; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; ISSELS RD, 1988, BIOCHEM PHARMACOL, V37, P881, DOI 10.1016/0006-2952(88)90176-1; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Keller JN, 1998, J NEUROSCI, V18, P687; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; MEYER K, 2008, J TRAUMA NURS, V15, P190; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X; Noack H, 1998, GLIA, V23, P285, DOI 10.1002/(SICI)1098-1136(199808)23:4<285::AID-GLIA1>3.0.CO;2-2; Offen D, 2004, J NEUROCHEM, V89, P1241, DOI 10.1111/j.1471-4159.2004.02428.x; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Penugonda S, 2005, BRAIN RES, V1056, P132, DOI 10.1016/j.brainres.2005.07.032; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sunitha K, 2013, FREE RADICAL RES, V47, P357, DOI 10.3109/10715762.2013.781595; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	43	22	23	0	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2015	22	9					1477	1483		10.1016/j.jocn.2015.03.025			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CO4YU	WOS:000359167600020	26100161				2022-02-06	
J	Smith, TA; Halstead, PD; McCalley, E; Kebschull, SA; Halstead, S; Killeffer, J				Smith, Terry A.; Halstead, P. David; McCalley, Elizabeth; Kebschull, Scott A.; Halstead, Scott; Killeffer, James			Angular head motion with and without head contact: implications for brain injury	SPORTS ENGINEERING			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; INTRACRANIAL-PRESSURE; PROFESSIONAL FOOTBALL; GAME IMPACTS; HIGH-SCHOOL; CONCUSSION; ACCELERATION; BIOMECHANICS; PERFORMANCE; HELMETS	Angular acceleration of the head has long been recognized as a biomechanical mechanism for traumatic brain injury. In sporting events as well as during bicycle and motorcycle accidents, this angular acceleration may occur with or without direct contact against a rigid surface. The objective of this research was to investigate the effect of combined indirect and direct loading on headform kinematic response and resulting brain injury predictors produced by finite element modeling. This was accomplished by conducting a series of guided free-fall tests that were designed to subject the headform to specific loading conditions-indirect loading (IL), direct loading (DL), and combined indirect/direct loading (IDL). Three different helmet types were selected for testing (bicycle, hockey and football). For the helmet types tested, the IDL condition resulted in significantly higher values of angular acceleration (6600-11,100 rad/s(2)), maximum principal strain (17.8-31.2), Von Mises stress (9.5-9.8 kPa), and cumulative strain damage measure at 15 % strain (2.7-7.7 %) than IL or DL alone. This trend was consistent across all helmet types and demonstrates the deleterious effects of combined loading on the brain tissue. These results also provide some insight into how seemingly similar impacts can produce substantial differences in brain injury outcome.	[Smith, Terry A.; Kebschull, Scott A.] Dynam Res Inc, Torrance, CA 90501 USA; [Halstead, P. David; McCalley, Elizabeth; Halstead, Scott] Southern Impact Res Ctr, Knoxville, TN USA; [Killeffer, James] Univ Tennessee, Med Ctr, Knoxville, TN USA		Smith, TA (corresponding author), Dynam Res Inc, Torrance, CA 90501 USA.	tas@dynres.com			National Operating Committee on Standards for Athletic Equipment (NOCSAE); Dynamic Research, Inc.	This work was supported in part by the National Operating Committee on Standards for Athletic Equipment (NOCSAE) and by Dynamic Research, Inc. The authors would like to acknowledge the contribution of Mr. Rob Roy for initial concept testing.	[Anonymous], 2013, VIRGINIA TECH HELMET; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Cantu R., 2000, NEUROLOGIC ATHLETIC; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Culver C, 1985, HYBRID, P147; Eppinger RH, 1995, STAPP CAR CRASH J, V38, P145; Fleisig GS, 1996, SPORTS MED, V21, P421, DOI 10.2165/00007256-199621060-00004; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1985, NEUROSURGERY, V2, P1531; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; HURT HH, 1992, P ANN C ASS, P235; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mertz H., 1985, SAE PUBLICATION, VPT-44, P111; Mueller FO, 1977, ANN SURVEY CATASTROP; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; NOCSAE, 2013, ND00111M13 NOCSAE; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A., 2012, P IRCOBI C 2012 DUBL, P419; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Richards D, 2008, J ASTM INT, V5; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang L., 2003, IRCOBI C LISB PORT S, P27; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	48	22	22	0	15	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	SEP	2015	18	3					165	175		10.1007/s12283-015-0175-5			11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	CY8RR	WOS:000366676500004					2022-02-06	
J	Lin, C; He, HQ; Li, Z; Liu, YL; Chao, HL; Ji, J; Liu, N				Lin, Chao; He, Hongquan; Li, Zheng; Liu, Yinglong; Chao, Honglu; Ji, Jing; Liu, Ning			Efficacy of progesterone for moderate to severe traumatic brain injury: a meta-analysis of randomized clinical trials	SCIENTIFIC REPORTS			English	Article							NEUROPROTECTION; RECOVERY	Progesterone has been shown to have neuroprotective effects in multiple animal models of brain injury, whereas the efficacy and safety in patients with traumatic brain injury (TBI) remains contentious. Here, a total of seven randomized controlled trials (RCTs) with 2492 participants were included to perform this meta-analysis. Compared with placebo, there was no significant decrease to be found in the rate of death or vegetative state for patients with acute TBI (RR = 0.88, 95% CI = 0.70, 1.09, p = 0.24). Furthermore, progesterone was not associated with good recovery in comparison with placebo (RR = 1.00, 95% CI = 0.88, 1.14, p = 0.95). Together, our study suggested that progesterone did not improve outcomes over placebo in the treatment of acute TBI.	[Lin, Chao; Li, Zheng; Liu, Yinglong; Chao, Honglu; Ji, Jing; Liu, Ning] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [He, Hongquan] Gaochun Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Ji, J (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	jijing@njmu.edu.cn; liuning_0853@163.com		Liu, Ning/0000-0001-7895-1285	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471269 (BA14)]	This study was supported by grants from the National Natural Science Foundation of China ( No. 81471269 (BA14)).	Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao Guo-min, 2007, Zhonghua Wai Ke Za Zhi, V45, P106; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	32	22	22	0	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 25	2015	5								13442	10.1038/srep13442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6ZY	WOS:000360038200002	26304556	gold, Green Published			2022-02-06	
J	Da Pozzo, E; Giacomelli, C; Barresi, E; Costa, B; Taliani, S; Passetti, FD; Martini, C				Da Pozzo, Eleonora; Giacomelli, Chiara; Barresi, Elisabetta; Costa, Barbara; Taliani, Sabrina; Passetti, Federico Da Settimo; Martini, Claudia			Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection	BIOCHEMICAL SOCIETY TRANSACTIONS			English	Article						central nervous system diseases; neurodegeneration; neuro-inflammation; neurotrauma; translocator protein; translocator protein (TSPO) ligand	18 KDA TSPO; BENZODIAZEPINE-RECEPTOR-LIGAND; POSITRON-EMISSION-TOMOGRAPHY; MICROGLIAL ACTIVATION; SUBCELLULAR LOCATIONS; THERAPEUTIC TARGET; BINDING-SITES; MOUSE MODEL; BRAIN; NEUROINFLAMMATION	The translocator protein (TSPO, 18 kDa), mainly localized in the outer mitochondrial membrane of steroidogenic tissues, is involved in several cellular functions. TSPO level alterations have been reported in a number of human disorders, particularly in cancer, psychiatric and neurological diseases. In the central nervous system (CNS), TSPO is usually expressed in glial cells, but also in some neuronal cell types. Interestingly, the expression of TSPO on glial cells rises after brain injury and increased TSPO expression is often observed in neurological disorders, gliomas, encephalitis and traumatic injury. Since TSPO is up-regulated in brain diseases, several structurally different classes of ligands targeting TSPO have been described as potential diagnostic or therapeutic agents. Recent researches have reported that TSPO ligands might be valuable in the treatment of brain diseases. This review focuses on currently available TSPO ligands, as useful tools for the treatment of neurodegeneration, neuro-inflammation and neurotrauma.	[Da Pozzo, Eleonora; Giacomelli, Chiara; Barresi, Elisabetta; Costa, Barbara; Taliani, Sabrina; Passetti, Federico Da Settimo; Martini, Claudia] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy		Martini, C (corresponding author), Univ Pisa, Dept Pharm, Via Bonanno 6, I-56126 Pisa, Italy.	claudia.martini@unipi.it	Da Pozzo, Eleonora/M-2215-2015; TALIANI, SABRINA/AAO-7850-2020; Da Pozzo, Eleonora/AAW-8186-2020; Giacomelli, Chiara/K-4954-2016; Martini, Claudia/AAC-4089-2019; DA SETTIMO PASSETTI, FEDERICO/M-1451-2015	Da Pozzo, Eleonora/0000-0003-4762-8949; Da Pozzo, Eleonora/0000-0003-4762-8949; Giacomelli, Chiara/0000-0002-6244-602X; Martini, Claudia/0000-0001-9379-3027; COSTA, BARBARA/0000-0002-7598-1275; DA SETTIMO PASSETTI, FEDERICO/0000-0002-7897-7917; Barresi, Elisabetta/0000-0002-9814-7195; TALIANI, SABRINA/0000-0001-8675-939X	Italian Ministry of University and Scientific ResearchMinistry of Education, Universities and Research (MIUR)	This research was supported by the Italian Ministry of University and Scientific Research (FIRB 2010, PRIN 2010-2011).	Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Banati R. B., 2013, WO, Patent No. [2,014,138,791, 2014138791]; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; BENAVIDES J, 1987, BRAIN RES, V421, P167, DOI 10.1016/0006-8993(87)91287-X; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Choi HB, 2002, J NEUROCHEM, V83, P546, DOI 10.1046/j.1471-4159.2002.01122.x; Choi J, 2011, GLIA, V59, P219, DOI 10.1002/glia.21091; Corbett D, 2008, EXP NEUROL, V214, P309, DOI 10.1016/j.expneurol.2008.08.018; Da Pozzo E, 2012, CURR MOL MED, V12, P426; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Ferzaz B, 2002, J PHARMACOL EXP THER, V301, P1067, DOI 10.1124/jpet.301.3.1067; Girard C, 2012, J NEUROENDOCRINOL, V24, P71, DOI 10.1111/j.1365-2826.2011.02215.x; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Hong SH, 2006, J NEUROSCI RES, V83, P1293, DOI 10.1002/jnr.20829; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Leaver KR, 2012, ACS CHEM NEUROSCI, V3, P114, DOI 10.1021/cn200099e; Lenglet T, 2014, EUR J NEUROL, V21, P529, DOI 10.1111/ene.12344; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Naseem Mehar, 2014, SCI WORLD J; OBEIRNE GB, 1990, EUR J BIOCHEM, V188, P131, DOI 10.1111/j.1432-1033.1990.tb15380.x; OLSON JMM, 1988, EUR J PHARMACOL, V152, P47, DOI 10.1016/0014-2999(88)90834-5; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Ryu JK, 2005, NEUROBIOL DIS, V20, P550, DOI 10.1016/j.nbd.2005.04.010; Sarnowska A, 2009, NEUROCHEM INT, V55, P164, DOI 10.1016/j.neuint.2009.01.024; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; Stocco DM, 2014, ENDOCRINOLOGY, V155, P6, DOI 10.1210/en.2013-2041; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sunyach C, 2012, NEUROPHARMACOLOGY, V62, P2346, DOI 10.1016/j.neuropharm.2012.02.013; Taliani S, 2011, CURR TOP MED CHEM, V11, P860, DOI 10.2174/156802611795165142; Tarnok K, 2008, NEUROCHEM INT, V53, P289, DOI 10.1016/j.neuint.2008.08.003; Trapani A, 2013, BIOCONJUGATE CHEM, V24, P1415, DOI 10.1021/bc300666f; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Veiga S, 2005, J NEUROSCI RES, V80, P129, DOI 10.1002/jnr.20430; Veiga S, 2007, GLIA, V55, P1426, DOI 10.1002/glia.20558; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; Woods MJ, 1996, BIOCHEM PHARMACOL, V51, P1283, DOI 10.1016/0006-2952(96)00034-2; Zhao Yan-Yin, 2011, Neuron Glia Biol, V7, P187, DOI 10.1017/S1740925X12000129; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	50	22	22	0	12	PORTLAND PRESS LTD	LONDON	5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND	0300-5127	1470-8752		BIOCHEM SOC T	Biochem. Soc. Trans.	AUG	2015	43		4				559	565		10.1042/BST20150028			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO2QJ	WOS:000359001400005	26551693				2022-02-06	
J	Ji, SB; Zhao, W				Ji, Songbai; Zhao, Wei			A Pre-computed Brain Response Atlas for Instantaneous Strain Estimation in Contact Sports	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Sports concussion; Rotational acceleration; Pre-computation; Dartmouth Head Injury Model	HEAD IMPACT EXPOSURE; HIGH-SCHOOL; WHITE-MATTER; CONCUSSION DIAGNOSIS; AXONAL DAMAGE; FOOTBALL; ACCELERATION; MODEL; PREDICTORS; GENERATION	Finite element models of the human head play an important role in investigating the mechanisms of traumatic brain injury, including sports concussion. A critical limitation, however, is that they incur a substantial computational cost to simulate even a single impact. Therefore, current simulation schemes significantly hamper brain injury studies based on model-estimated tissue-level responses. In this study, we present a pre-computed brain response atlas (pcBRA) to substantially increase the simulation efficiency in estimating brain strains using isolated rotational acceleration impulses parameterized with four independent variables (peak magnitude and duration, and rotational axis azimuth and elevation angles) with values determined from on-field measurements. Using randomly generated testing datasets, the partially established pcBRA achieved a 100% success rate in interpolation based on element-wise differences in accumulated peak strain () according to a "double-10%" criterion or average regional in generic regions and the corpus callosum. A similar performance was maintained in extrapolation. The pcBRA performance was further successfully validated against directly simulated responses from two independently measured typical real-world rotational profiles. The computational cost to estimate element-wise whole-brain or regional was 6 s and < 0.01 s, respectively, vs. 50 min directly simulating a 40 ms impulse. These findings suggest the pcBRA could substantially increase the throughput in impact simulation without significant loss of accuracy from the estimation itself and, thus, its potential to accelerate the exploration of the mechanisms of sports concussion in general. If successful, the pcBRA may also become a diagnostic adjunct in conjunction with sensors that measure head impact kinematics on the field to objectively monitor and identify tissue-level brain trauma in real-time for "return-to-play" decision-making on the sideline.	[Ji, Songbai; Zhao, Wei] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Ji, Songbai] Geisel Sch Med Dartmouth, Dept Surg & Orthopaed Surg, Hanover, NH 03755 USA		Ji, SB (corresponding author), Dartmouth Coll, Thayer Sch Engn, 14 Engn Dr, Hanover, NH 03755 USA.	Songbai.Ji@Dartmouth.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS078607]; Dartmouth Hitchcock Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088781, R21NS078607] Funding Source: NIH RePORTER	This work was sponsored, in part, by the NIH Grant R21 NS078607 and the Dartmouth Hitchcock Foundation.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dumpuri P, 2007, MED IMAGE ANAL, V11, P128, DOI 10.1016/j.media.2006.11.002; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; HAKOPIAN H, 1982, SIAM J NUMER ANAL, V19, P510, DOI 10.1137/0719033; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Ji SB, 2011, FINITE ELEM ANAL DES, V47, P1178, DOI 10.1016/j.finel.2011.05.007; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I, 2003, IS HEAD INJURY CAUSE; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Loader, 1999, LOCAL REGRESSION LIK; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79; Nahum A, 1977, 770922 SAE; Newman, 1986, GEN ACCELERATION MOD; Newman J A, 2000, Stapp Car Crash J, V44, P215; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Talavage TM, 2013, J NEUROTRAUM, V30, P1; Trosseille X., 1992, DEV FEM HUMAN HEAD A; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang L., 2004, J BIOMECH ENG, V126; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0	59	22	23	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	AUG	2015	43	8					1877	1895		10.1007/s10439-014-1193-3			19	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CN2KM	WOS:000358249800015	25449149	Green Accepted			2022-02-06	
J	Monti, G; Tondelli, M; Giovannini, G; Bedin, R; Nichelli, PF; Trenti, T; Meletti, S; Chiari, A				Monti, Giulia; Tondelli, Manuela; Giovannini, Giada; Bedin, Roberta; Nichelli, Paolo F.; Trenti, Tommaso; Meletti, Stefano; Chiari, Annalisa			Cerebrospinal fluid tau proteins in status epilepticus	EPILEPSY & BEHAVIOR			English	Article						Status epilepticus; Tau; Refractory status epilepticus; Epilepsy; Seizures; Biomarkers	NEURON-SPECIFIC ENOLASE; REFRACTORY STATUS EPILEPTICUS; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; TONIC-CLONIC SEIZURES; TRANSIENT INCREASE; ALZHEIMERS-DISEASE; S-100 PROTEIN; BIOMARKERS; ANESTHESIA	Tau protein is a phosphaylated microtubule-associated protein, principally localized at neuronal level in the central nervous system (CNS). Tau levels in the cerebrospinal fluid (CSF) are considered to index both axonal and neuronal damage. To date, however, no study has specifically evaluated the CSF levels of tau proteins in patients with status epileptic-us (SE). We evaluated these established biomarkers of neuronal damage in patients with SE who received a lumbar puncture during SE between 2007 and 2014. Status epilepticus cases due to acute structural brain damage, including CNS infection, were excluded. Clinical, biological, therapeutic, and follow-up data were collected. Group comparison between patients stratified according to SE response to antiepileptic drugs (AEDs), disability, and epilepsy outcomes were performed. Twenty-eight patients were considered for the analyses (mean age 56 years): 14 patients had abnormally high CSF t-tau level, six patients had abnormally high CSF p-tau level, and only three patients had abnormally low A beta(1-42) level. Cerebrospinal fluid t-tau value was higher in patients who developed a refractory SE compared to patients with seizures controlled by AED. Cerebrospinal fluid t-tau values were positively correlated with SE duration and were higher in patients treated with propofol anesthesia compared to patients that had not received this treatment. Patients with higher CSF t-tau had higher risk of developing disability (OR = 32.5, p = 0.004) and chronic epilepsy (OR 12; p = 0.016) in comparison with patients with lower CSF t-tau level. Our results suggest that CSF t-tau level might be proposed as a biomarker of SE severity and prognosis. Prospective studies are needed to evaluate the effects of propofol on tau pathology in this setting. (C) 2015 Elsevier Inc. All rights reserved.	[Monti, Giulia; Tondelli, Manuela; Giovannini, Giada; Nichelli, Paolo F.; Meletti, Stefano] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, I-41126 Modena, Italy; [Monti, Giulia; Tondelli, Manuela; Giovannini, Giada; Bedin, Roberta; Nichelli, Paolo F.; Meletti, Stefano; Chiari, Annalisa] AUSL Modena, NOCSAE Hosp, Neurol Unit, Modena, Italy; [Trenti, Tommaso] ASL Modena, NOCSAE Hosp, Clin Pathol Toxicol, Modena, Italy		Meletti, S (corresponding author), Univ Modena & Reggio Emilia, NOCSAE Hosp, Dept Biomed Metab & Neural Sci, Via Giardini 1355, I-41126 Modena, Italy.	stefano.meletti@unimore.it	Meletti, Stefano/O-3622-2015; Tondelli, Manuela/AAB-7054-2019; Giovannini, Giada/J-8970-2018; Nichelli, Paolo/F-7336-2015; Trenti, Tommaso/K-8457-2016	Meletti, Stefano/0000-0003-0334-539X; Giovannini, Giada/0000-0002-3585-5872; Nichelli, Paolo/0000-0001-9756-6796; Trenti, Tommaso/0000-0001-8093-4011; Annalisa, Chiari/0000-0003-3052-2865	Emilia Romagna RegionRegione Emilia Romagna	S. Meletti received research grant support from the Emilia Romagna Region, from the nonprofit organization CarisMo Foundation and has received personal compensation as a scientific advisory board member for UCB and EISAI. Other authors report no disclosures.	[Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Buttner T, 1999, J NEUROL, V246, P459, DOI 10.1007/s004150050383; Correale J, 1998, NEUROLOGY, V50, P1388, DOI 10.1212/WNL.50.5.1388; DEGIORGIO CM, 1995, NEUROLOGY, V45, P1134, DOI 10.1212/WNL.45.6.1134; Engel J, 2002, PROG BRAIN RES, V135, P509; Frisoni GB, 2013, LANCET NEUROL, V12, P126, DOI 10.1016/S1474-4422(12)70305-8; Gastaut H, 1973, DICT EPILEPSY 1; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; Hocker SE, 2013, JAMA NEUROL, V70, P72, DOI 10.1001/jamaneurol.2013.578; Kramer U, 2011, EPILEPSIA, V52, P28, DOI 10.1111/j.1528-1167.2011.03230.x; Krut JJ, 2013, J NEUROL, V260, P620, DOI 10.1007/s00415-012-6688-y; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Matsui T, 2007, J AM GERIATR SOC, V55, P2096, DOI 10.1111/j.1532-5415.2007.01440.x; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Minicucci F, 2006, EPILEPSIA, V47, P9, DOI 10.1111/j.1528-1167.2006.00870.x; Neligan A, 2011, EPILEPSY RES, V93, P1, DOI 10.1016/j.eplepsyres.2010.09.003; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Palmio J, 2001, J NEUROL SCI, V183, P27, DOI 10.1016/S0022-510X(00)00478-0; Palmio J, 2009, SEIZURE-EUR J EPILEP, V18, P474, DOI 10.1016/j.seizure.2009.04.006; Pitkanen A, 2002, PROG BRAIN RES, V135, P67; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; Riemenschneider M, 2003, MOL PSYCHIATR, V8, P343, DOI 10.1038/sj.mp.4001220; Rosen C, 2013, CURR OPIN PSYCHIATR, V26, P276, DOI 10.1097/YCO.0b013e32835f6747; Rosenow F, 2012, NERVENARZT, V83, P1551, DOI 10.1007/s00115-012-3529-2; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; Run XQ, 2010, J ALZHEIMERS DIS, V22, pS49, DOI 10.3233/JAD-2010-100813; Shahim P, 2014, EUR J NEUROL, V21, P486, DOI 10.1111/ene.12336; Shorvon S, 2011, BRAIN, V134, P2802, DOI 10.1093/brain/awr215; Sjogren M, 2001, CLIN CHEM, V47, P1776; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; Tang JXX, 2011, ANESTHESIOLOGY, V115, P727, DOI 10.1097/ALN.0b013e31822e9306; Tondelli M, 2015, CLIN CHEM LAB MED, V53, P453, DOI 10.1515/cclm-2014-0414; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Whittington RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01388; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x	39	22	22	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2015	49						150	154		10.1016/j.yebeh.2015.04.030			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CO7CK	WOS:000359314900029	25958230				2022-02-06	
J	Zhai, PP; Xu, LH; Yang, JJ; Jiang, ZL; Zhao, GW; Sun, L; Wang, GH; Li, X				Zhai, Pei-Pei; Xu, Li-Hua; Yang, Juan-Juan; Jiang, Zheng-Lin; Zhao, Guang-Wei; Sun, Li; Wang, Guo-Hua; Li, Xia			Reduction of inflammatory responses by L-serine treatment leads to neuroprotection in mice after traumatic brain injury	NEUROPHARMACOLOGY			English	Article						L-serine; Mouse; Traumatic brain injury; Neuroprotection; Inflammatory response; Glycine receptor	SENSITIVE GLYCINE RECEPTORS; GATED CHLORIDE CURRENT; CLOSED-HEAD INJURY; RAT-BRAIN; HYPOTHALAMIC NEURONS; NUCLEUS-ACCUMBENS; TRANSGENIC MICE; CEREBRAL-CORTEX; CELL-DEATH; EXPRESSION	This study was designed to evaluate the neuroprotective effect of L-serine and the underlying mechanisms in mice after traumatic brain injury (TBI) induced using a weight drop model. The mice were intraperitoneally injected with L-serine 3 h after TBI and then injected twice each day for 7 days or until the end of the experiment. The neurological severity score, brain water content, lesion volume, and neurone loss were determined. The levels of TNF-alpha, IL-1 beta, IL-6, and IL-10 and the number of GFAP- and Iba-1-positive cells and activated caspase-3-positive neurones in the brain tissue ipsilateral to TBI were also measured. Simultaneously, the influences of L-serine on these variables were observed. In addition, the expression of glycine receptors and L-serine-induced currents were measured. We found L-serine treatment: 1) decreased the neurological deficit score, brain water content, lesion volume, and neurone loss; 2) inhibited activated caspase-3; and 3) reduced the levels of TNF-alpha, IL-1 beta and IL-6 and the number of GFAP- and Iba-1-positive cells. The effects of L-serine were antagonised by the administration of strychnine, an antagonist of glycine receptors. In addition, we found that glycine receptors were expressed mainly in the cortical neurones but less in the astrocytes or microglial cells, and L-serine activated these receptors and induced strychnine-sensitive currents in these neurones. In conclusion, L-serine induces the activation of glycine receptors, which alleviates neuronal excitotoxicity, a secondary brain injury process, thereby reduces the activation of astrocytes and microglial cells and secretion of proinflammatory cytokines and inhibits neuronal apoptosis. Thus, L-serine treatment leads to neuroprotection of brain tissue through reducing inflammatory responses and improves recovery of the neurological functions in mice after traumatic brain injury. (C) 2015 Elsevier Ltd. All rights reserved.	[Jiang, Zheng-Lin] Nantong Univ, Inst Naut Med, Dept Neurophysiol & Neuropharmacol, Nantong 226001, Jiangsu, Peoples R China; Nantong Univ, Co Innovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China		Jiang, ZL (corresponding author), Nantong Univ, Inst Naut Med, Dept Neurophysiol & Neuropharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	jiangzl@ntu.edu.cn		Jiang, Zheng-Lin/0000-0002-7134-5511	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000497, 81071614, 81372131]; Administration of Science and Technology of Nantong, Jiangsu, China [BK2012086]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project for Innovation Development of Graduate Student of Nantong University	This work was supported partly by grants from the National Natural Science Foundation of China (81000497, 81071614 and 81372131) and from the Administration of Science and Technology of Nantong, Jiangsu, China (BK2012086), by project funding from the Priority Academic Program Development of Jiangsu Higher Education Institutions, and by the Project for Innovation Development of Graduate Student of Nantong University.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; AKAIKE N, 1989, J NEUROPHYSIOL, V62, P1400, DOI 10.1152/jn.1989.62.6.1400; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; BALDWIN HA, 1994, BRIT J PHARMACOL, V112, P188, DOI 10.1111/j.1476-5381.1994.tb13050.x; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chattipakorn SC, 2002, J NEUROPHYSIOL, V87, P1515, DOI 10.1152/jn.00365.2001; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Freire MAM, 2012, W INDIAN MED J, V61, P751; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Jiang ZL, 2004, J NEUROPHYSIOL, V91, P248, DOI 10.1152/jn.00106.2003; KANTHAN R, 1995, STROKE, V26, P870, DOI 10.1161/01.STR.26.5.870; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kilb W, 2002, NEUROSCIENCE, V112, P299, DOI 10.1016/S0306-4522(02)00071-4; KRISHTAL OA, 1988, NEUROSCI LETT, V84, P271, DOI 10.1016/0304-3940(88)90519-8; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Martin G, 2002, J PHARMACOL EXP THER, V302, P1135, DOI 10.1124/jpet.102.033399; McCool BA, 2000, BRAIN RES, V859, P341, DOI 10.1016/S0006-8993(00)02026-6; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mori M, 2002, J PHYSIOL-LONDON, V539, P191, DOI 10.1113/jphysiol.2001.013147; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; Ren TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067044; Rubio-Perez J. M., 2012, THESCIENTIFICWORLDJO, V2012, P2012, DOI DOI 10.1100/2012/756357; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Sergeeva OA, 1998, NEUROSCI LETT, V243, P9, DOI 10.1016/S0304-3940(98)00072-X; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093405; TOKUTOMI N, 1989, BRIT J PHARMACOL, V97, P353, DOI 10.1111/j.1476-5381.1989.tb11961.x; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2010, J NEUROSCI RES, V88, P2035, DOI 10.1002/jnr.22365; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Ye JH, 1996, BRAIN RES, V735, P20; Ye JH, 1999, J PHARMACOL EXP THER, V290, P104; Ye JH, 1998, BRAIN RES, V796, P53, DOI 10.1016/S0006-8993(98)00317-5; Zhang XJ, 2006, NEUROL INDIA, V54, P402; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	62	22	23	3	22	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	AUG	2015	95						1	11		10.1016/j.neuropharm.2015.02.026			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CM0DR	WOS:000357349100001	25747604				2022-02-06	
J	Lee, JH; Won, S; Stein, DG				Lee, Jeong Hun; Won, Soonmi; Stein, Donald G.			Progesterone attenuates thrombin-induced endothelial barrier disruption in the brain endothelial cell line bEnd.3: The role of tight junction proteins and the endothelial protein C receptor	BRAIN RESEARCH			English	Article						Thrombin; Progesterone; Blood-brain barrier; bEnd.3 endothelial cell; Tight junction protein; Endothelial protein C receptor	FOCAL CEREBRAL-ISCHEMIA; SUBARACHNOID HEMORRHAGE; ACTIVATED RECEPTOR-1; NEURONAL DAMAGE; INJURY; RATS; ASTROCYTES; EXPRESSION; DISEASES; MODEL	This study examines the effects of progesterone on blood-brain barrier (BBB) integrity following thrombin administration. Thrombin is expressed in many diseases which affect neural tissue and is associated with breakdown of the BBB. Progesterone has shown protective effects on the BBB in stroke and traumatic brain injury. Methods: Mouse brain endothelial (bEnd.3) cells were treated with progesterone (20 mu mol/l) for 24 h before thrombin administration (60 U/ml). BBB permeability was measured by transendothelial electrical resistance (TEER), because TEER decrease is associated with BBB compromise. Tight junction (TJ) proteins (occludin, claudin-5, and zonula occludens-1) and endothelial protein C receptor (EPCR) were analyzed. Results: Thrombin decreased TEER and progesterone prevented that decrease. TJ proteins and EPCR were also decreased after thrombin treatment and progesterone treatment blocked that effect. Conclusion: Progesterone can attenuate thrombin-induced BBB disruption by blocking the degradation of TJ proteins and EPCR in bEnd.3 cells. (C) 2015 Elsevier B.V. All rights reserved.	[Lee, Jeong Hun] Donggulz Univ, Sch Med, Dept Emergency Med, Goyang Si, Gyeonggi Do, South Korea; [Won, Soonmi; Stein, Donald G.] Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Brain Res Lab, 1365B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020		Allen and Company gifts; AHAAmerican Heart Association [14POST20130024]; Laney Graduate School of Emory University; Dongguk University	This work was supported by Allen and Company gifts; AHA 14POST20130024 to SW; the Laney Graduate School of Emory University, and Dongguk University.	Alabanza LM, 2012, J NEUROIMMUNOL, V245, P48, DOI 10.1016/j.jneuroim.2012.02.004; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Bae JS, 2008, THROMB HAEMOSTASIS, V100, P101, DOI 10.1160/TH08-02-0127; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Cekic M., 2012, RESTOR NEUROL NEUROS, V28, P1; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; Chen B, 2010, STROKE, V41, P2348, DOI 10.1161/STROKEAHA.110.584920; Chen T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05531; Choi SH, 2003, J NEUROSCI, V23, P5877; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; Donovan FM, 1997, J NEUROSCI, V17, P5316; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fernandes S, 2014, MOL NEUROBIOL; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Grammas P, 2006, J ALZHEIMERS DIS, V9, P51; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hua Y, 2009, STROKE, V40, pS88, DOI 10.1161/STROKEAHA.108.533281; Ishida Y, 2006, J NEUROPATH EXP NEUR, V65, P66, DOI 10.1097/01.jnen.0000195941.48033.eb; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kameda K, 2012, BRIT J PHARMACOL, V165, P106, DOI 10.1111/j.1476-5381.2011.01485.x; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kondo N, 2009, EXP CELL RES, V315, P2879, DOI 10.1016/j.yexcr.2009.07.031; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Park KW, 2009, J IMMUNOL, V183, P4666, DOI 10.4049/jimmunol.0803392; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Shin JA, 2014, NEUROBIOL AGING; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Wan WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113126; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Zhao C, 2011, CHIN J NEUROMED, V10	42	22	22	1	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 10	2015	1613						73	80		10.1016/j.brainres.2015.04.002			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK9IG	WOS:000356553200007	25862570				2022-02-06	
J	Abbaszadeh, HA; Tiraihi, T; Noori-Zadeh, A; Delshad, AR; Sadeghizade, M; Taheri, T				Abbaszadeh, Hojjat-Allah; Tiraihi, Taki; Noori-Zadeh, Ali; Delshad, Ali Reza; Sadeghizade, Majid; Taheri, Taher			Human ciliary neurotrophic factor-overexpressing stable bone marrow stromal cells in the treatment of a rat model of traumatic spinal cord injury	CYTOTHERAPY			English	Article						BMSCs; CNS regeneration; CNS traumatic injury; CNTF	RESTRICTED PRECURSOR CELLS; FUNCTIONAL RECOVERY; AXON REGENERATION; BRAIN-INJURY; CNTF; TRANSECTION	Background aims. Traumatic injury to the central nervous system (CNS) often causes motor dysfunctions. However, because of the CNS complexity and variability in the clinical presentations, efforts to repair damaged CNS tissue and restoring its functions are particularly demanding. On the other hand, recent progress in the regenerative therapy field have led to novel approaches for the treatment of traumatic CNS injury and renewed hopes to overcome the obstacles. It appears that the balance between neurite re-growth inhibiting and neurite re-growth inducing molecules determines the axonal re-growth fate. Neurotrophic factors can tilt this balance and indeed promote cell survival and axonal re-growth over neuro-degeneration. One of the promising neurotrophic factors in this field is ciliary neurotrophic factor (CNTF). Methods. We transfected rat bone marrow stromal cells with a mammalian expression vector inserted human CNTF gene through the use of a non-viral method to prepare human CNTF-overexpressing stem cells under ex vivo conditions. We transplanted these modified cells to the rat model of spinal cord traumatic injury to,explore functional recovery after contusion induction. Results. Our data from immunocytochemistry and behavioral tests showed that such cells can act as a powerful potential approach to treat traumatic CNS injuries because these modified cells improved the behavioral test scores in the rat model of spinal cord injury. Conclusions. CNTF-overexpressing bone marrow stromal cells can ameliorate spinal cord traumatic injury and can be used in the treatment of traumatic CNS injuries in the near future.	[Abbaszadeh, Hojjat-Allah] Shahid Beheshti Univ Med Sci, Sch Med, Dept Biol & Anat Sci, Tehran, Iran; [Tiraihi, Taki] Tarbiat Modares Univ, Fac Med Sci, Dept Anat Sci, Tehran, Iran; [Tiraihi, Taki; Taheri, Taher] Khatam Al Anbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Noori-Zadeh, Ali] Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, Tehran, Iran; [Delshad, Ali Reza] Shahed Univ, Sch Med Sci, Dept Anat Sci, Tehran, Iran; [Sadeghizade, Majid] Tarbiat Modares Univ, Dept Genet, Fac Sci, Tehran, Iran		Taheri, T (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Anat, Intersect Shaheed Chamran & Jalal El Ahmad, POB 14122-3155, Tehran, Iran.	takialtr@modares.ac.ir	Abbaszadeh, Hojjat Allah/R-6726-2019; Noori-Zadeh, Ali/Q-4998-2017	Abbaszadeh, Hojjat Allah/0000-0002-7157-1834; Noori-Zadeh, Ali/0000-0002-4897-7684	Shefa Neurosciences Research Center at Khatam Al-Anbia Hospital, Tehran, Iran [86-N-105]; Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	The project was funded by the Shefa Neurosciences Research Center at Khatam Al-Anbia Hospital, Tehran, Iran (grant No. 86-N-105). We are grateful for the support of the Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewin SL, 1997, LARYNGOSCOPE, V107, P992, DOI 10.1097/00005537-199707000-00029; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Morganti-Kossman C, 2012, SPINAL CORD INJURY P, P242; Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002; Naumann T, 2003, BRAIN PATHOL, V13, P309; Noori-Zadeh A, 2014, J NEUROL SCI, V339, P81, DOI 10.1016/j.jns.2014.01.025; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Ohta S, 2005, SPINE, V30, P1154, DOI 10.1097/01.brs.0000162402.79482.fd; Rothaeusler K, 2007, CURR PROTOC CYTOM, V7, P31; Shichinohe H, 2015, NEUROREHAB NEURAL RE, V29, P80, DOI 10.1177/1545968314525856; Stankoff B, 2002, J NEUROSCI, V22, P9221; Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005	21	22	24	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	JUL	2015	17	7					912	921		10.1016/j.jcyt.2015.03.689			10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CL0KS	WOS:000356632200008	25939801				2022-02-06	
J	Bodanapally, UK; Sours, C; Zhuo, JC; Shanmuganathan, K				Bodanapally, Uttam K.; Sours, Chandler; Zhuo, Jiachen; Shanmuganathan, Kathirkamanathan			Imaging of Traumatic Brain Injury	RADIOLOGIC CLINICS OF NORTH AMERICA			English	Article						Trauma; Brain injury; Computed tomography; MR imaging	CLOSED-HEAD INJURY; DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE SPECTROSCOPY; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; STEM LESIONS; SUBARACHNOID HEMORRHAGE; COGNITIVE IMPAIRMENT; OUTCOME PREDICTION; CLINICAL-EFFICACY	Imaging plays an important role in the management of patients with traumatic brain injury (TBI). Computed tomography (CT) is the first-line imaging technique allowing rapid detection of primary structural brain lesions that require surgical intervention. CT also detects various deleterious secondary insults allowing early medical and surgical management. Serial imaging is critical to identifying secondary injuries. MR imaging is indicated in patients with acute TBI when CT fails to explain neurologic findings. However, MR imaging is superior in patients with mild TBI and also predicts neurocognitive outcome.	[Bodanapally, Uttam K.; Sours, Chandler; Zhuo, Jiachen; Shanmuganathan, Kathirkamanathan] Univ Maryland, Med Ctr, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA		Shanmuganathan, K (corresponding author), Univ Maryland, Med Ctr, Dept Diagnost Radiol & Nucl Med, 22 S Greene St, Baltimore, MD 21201 USA.	ksahnrriuganathan@umm.edu					Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Ahmadi J, 1989, Top Magn Reson Imaging, V2, P17; Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P30; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Biffl WL, 2001, WORLD J SURG, V25, P1036, DOI 10.1007/s00268-001-0056-x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bodanapally UK, 2013, NEURORADIOLOGY, V55, P771, DOI 10.1007/s00234-013-1166-5; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; FELDMANN E, 1988, NEUROLOGY, V38, P697, DOI 10.1212/WNL.38.5.697; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gean AD, 2010, RADIOLOGY, V257, P212, DOI 10.1148/radiol.10092075; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gentry LR, 1991, NEUROIMAG CLIN N AM, V1, P411; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Glauser J, 2004, CLEV CLIN J MED, V71, P353, DOI 10.3949/ccjm.71.4.353; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; HAHN FJ, 1985, AM J NEURORADIOL, V6, P844; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson PL, 2002, NEUROIMAG CLIN N AM, V12, P217, DOI 10.1016/S1052-5149(02)00008-4; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KENT DL, 1994, ANN INTERN MED, V120, P856, DOI 10.7326/0003-4819-120-10-199405150-00007; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lee Bruce, 2005, NeuroRx, V2, P372; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lee Kyeong-Seok, 1997, Journal of Korean Medical Science, V12, P353; Leestma JE, 1988, FORENSIC NEUROPATHOL, P409; Lowenhielm P, 1973, P INT C BIOKINETICS, P423; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MACPHERSON BCM, 1990, CLIN RADIOL, V42, P321, DOI 10.1016/S0009-9260(05)82145-2; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; NOGUCHI K, 1995, RADIOLOGY, V196, P773, DOI 10.1148/radiology.196.3.7644642; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; REED D, 1986, AM J NEURORADIOL, V7, P417; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROTHFUS WE, 1987, AM J NEURORADIOL, V8, P1073; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; SCHNEIDER R, 1961, JAMA-J AM MED ASSOC, V177, P362, DOI 10.1001/jama.1961.03040320006002; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; UK National Institute for Health and Clinical Excellence, 2003, HEAD INJ TRIAG ASS I; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; WERNICK S, 1989, J COMPUT ASSIST TOMO, V13, P323, DOI 10.1097/00004728-198903000-00027; WEST OC, 1993, RADIOLOGY, V188, P329, DOI 10.1148/radiology.188.2.8327674; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	147	22	23	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0033-8389	1557-8275		RADIOL CLIN N AM	Radiol. Clin. N. Am.	JUL	2015	53	4					695	+		10.1016/j.rcl.2015.02.011			22	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CL5GF	WOS:000356987100006	26046506				2022-02-06	
J	Christensen, J				Christensen, Jakob			The Epidemiology of Posttraumatic Epilepsy	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; seizures; epilepsy; posttraumatic; epidemiology	TRAUMATIC BRAIN-INJURY; ACUTE SYMPTOMATIC SEIZURE; RISK-FACTORS; HEAD-INJURY; MULTICENTER; DEFINITION; PREVENTION; ADULTS; TRIAL; ILAE	Traumatic brain injury is an important contributor to morbidity and mortality, and results in reduced quality of life and lifespan: An estimated 1.7 million traumatic brain injuries occur annually in the United States alone. Traumatic brain injury carries an increased risk of epilepsy that correlates with the severity of the brain injury. Posttraumatic epilepsy accounts for less than 10% of epilepsy, but traumatic brain injury is one of only a few potentially preventable causes of epilepsy. Despite several well-controlled human studies, there is no current preventive treatment available for humans. Therefore, primary prevention is the only proven way to prevent posttraumatic epilepsy.	Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark		Christensen, J (corresponding author), Aarhus Univ Hosp, Dept Neurol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	Jakob@farm.au.dk		Christensen, Jakob/0000-0002-9385-6435			Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Centers for Disease Control and Prevention, 2012, TRAUMATIC BRAIN INJU; Chen LLK, 2014, MIL MED, V179, P492, DOI 10.7205/MILMED-D-13-00413; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; McGuire SA, 2012, AVIAT SPACE ENVIR MD, V83, P140, DOI 10.3357/ASEM.3104.2012; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Schmidt D, 2014, NEUROTHERAPEUTICS, V11, P401, DOI 10.1007/s13311-013-0252-z; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	32	22	30	2	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	JUN	2015	35	3					218	222		10.1055/s-0035-1552923			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK1YU	WOS:000356006700006	26060901	Bronze			2022-02-06	
J	Knox, L; Douglas, JM; Bigby, C				Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine			'The biggest thing is trying to live for two people': Spousal experiences of supporting decision-making participation for partners with TBI	BRAIN INJURY			English	Article						Caregivers; couples; marital relationship; qualitative research; relationships after TBI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; MARITAL RELATIONSHIPS; FAMILY CAREGIVERS; HEAD-INJURY; ADJUSTMENT; COUPLES; HEALTH; SATISFACTION; INDIVIDUALS	Primary objective: To understand how the spouses of individuals with severe TBI experience the process of supporting their partners with decision-making. Design: This study adopted a constructivist grounded theory approach, with data consisting of in-depth interviews conducted with spouses over a 12-month period. Data were analysed through an iterative process of open and focused coding, identification of emergent categories and exploration of relationships between categories. Participants: Participants were four spouses of individuals with severe TBI (with moderate-severe disability). Spouses had shared committed relationships (marriage or domestic partnerships) for at least 4 years at initial interview. Three spouses were in relationships that had commenced following injury. Main outcome and results: Two main themes emerged from the data. The first identified the saliency of the relational space in which decision-making took place. The second revealed the complex nature of decision-making within the spousal relationship. Conclusions: Spouses experience decision-making as a complex multi-stage process underpinned by a number of relational factors. Increased understanding of this process can guide health professionals in their provision of support for couples in exploring decision-making participation after injury.	[Knox, Lucy; Douglas, Jacinta M.] La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic 3086, Australia; [Douglas, Jacinta M.] Summer Fdn, Blackburn, Vic, Australia; [Bigby, Christine] La Trobe Univ, Dept Social Work & Social Policy, Bundoora, Vic 3086, Australia		Knox, L (corresponding author), La Trobe Univ, Fac Hlth Sci, Dept Human Commun Sci, Bundoora, Vic 3086, Australia.	l.knox@latrobe.edu.au	Knox, Lucy/E-8642-2013; bigby, Christine/I-8526-2015	Knox, Lucy/0000-0001-8331-6032; bigby, Christine/0000-0001-7001-8976; Douglas, Jacinta/0000-0003-0940-6624			Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Charmaz K., 2007, HDB CONSTRUCTIONIST, P397; Charmaz K, 2003, STRATEGIES QUALITATI, V2nd ed, P249, DOI 10.1111/1467-9566.00338; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; CREWE NM, 1988, ARCH PHYS MED REHAB, V69, P435; Crotty M., 1998, FDN SOCIAL RES MEANI; DeMaris A, 2010, J SOC PERS RELAT, V27, P449, DOI 10.1177/0265407510363428; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Douglas J, 2015, RETHIKING R IN PRESS; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Fellows LK, 2012, J INT NEUROPSYCH SOC, V18, P937, DOI 10.1017/S1355617712001294; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Glaser B., 1967, DISCOVERY GROUNDED T; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gosling J, 1999, BRAIN INJURY, V13, P785; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; HILL W, 1982, J MARRIAGE FAM, V44, P927, DOI 10.2307/351455; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kelley D. L., 2012, MARITAL COMMUNICATIO; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Knox L, 2013, DISABIL REHABIL, V35, P1926, DOI 10.3109/09638288.2013.766270; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KRUEGER DL, 1982, J COMMUN, V32, P121, DOI 10.1111/j.1460-2466.1982.tb02505.x; Kurdek LA, 2006, J MARRIAGE FAM, V68, P509, DOI 10.1111/j.1741-3737.2006.00268.x; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE, V4th, P97; MARKMAN HJ, 1993, J CONSULT CLIN PSYCH, V61, P70, DOI 10.1037/0022-006X.61.1.70; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Mellers BA, 1998, ANNU REV PSYCHOL, V49, P447, DOI 10.1146/annurev.psych.49.1.447; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Poole MS, 1989, DYADIC DECISION MAKI, P216; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; Rogge RD, 1999, J CONSULT CLIN PSYCH, V67, P340, DOI 10.1037/0022-006X.67.3.340; Rosen-Grandon JR, 2004, J COUNS DEV, V82, P58, DOI 10.1002/j.1556-6678.2004.tb00286.x; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Sillars A., 1989, DYADIC DECISION MAKI, P179; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Strauss A., 1990, BASICS QUALITATIVE R; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thomsen IV, 1991, SCANDINAVIAN J REH S, V26, P142; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Waite LJ, 2009, SOC SCI RES, V38, P201, DOI 10.1016/j.ssresearch.2008.07.001; WINTER WD, 1973, FAM PROCESS, V12, P83, DOI 10.1111/j.1545-5300.1973.00083.x; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wuest J, 2011, NURS RES, P225; Yeates G, 2013, NEURO DISABILITY PSY, V1, P108	64	22	22	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					745	757		10.3109/02699052.2015.1004753			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700010	25831457				2022-02-06	
J	Nichol, A; Gantner, D; Presneill, J; Murray, L; Trapani, T; Bernard, S; Cameron, P; Capellier, G; Forbes, A; McArthur, C; Newby, L; Rashford, S; Rosenfeld, JV; Smith, T; Stephenson, M; Varma, D; Walker, T; Webb, S; Cooper, DJ				Nichol, Alistair; Gantner, Dashiell; Presneill, Jeffrey; Murray, Lynnette; Trapani, Tony; Bernard, Stephen; Cameron, Peter; Capellier, Gilles; Forbes, Andrew; McArthur, Colin; Newby, Lynette; Rashford, Stephen; Rosenfeld, Jeffrey V.; Smith, Tony; Stephenson, Michael; Varma, Dinesh; Walker, Tony; Webb, Steve; Cooper, D. James			Protocol for a multicentre randomised controlled trial of early and sustained prophylactic hypothermia in the management of traumatic brain injury	CRITICAL CARE AND RESUSCITATION			English	Article							THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CLINICAL-TRIALS; EPIDEMIOLOGY; INDUCTION; IMPACT; RISKS	Introduction: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Prophylactic hypothermia is effective in laboratory models, but clinical studies to date have been inconclusive, partly because of methodological limitations. Our Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury (POLAR) randomised controlled trial is currently underway comparing early, sustained hypothermia versus standard care in patients with severe TBI. We describe our study protocol and the challenges in conducting prophylactic hypothermia research in TBI. Design: We aim to randomise 500 patients to either prophylactic 33 degrees C hypothermia initiated within 3 hours of injury and continued for at least 72 hours, or standard normothermic management. Patients will be enrolled by paramedic services in the prehospital setting, or by emergency department staff at participating sites in Australia, New Zealand and Europe. The primary outcome will be the eight-level extended Glasgow outcome scale (GOSE), dichotomised to favourable and unfavourable outcomes at 6 months after injury. Secondary outcomes will include mortality at hospital discharge and at 6 months, ordinal analyses of 6-month GOSE outcomes, quality of life with health economic evaluations and the differential proportion of adverse events. We will predefine subgroup and interaction analyses. Discussion: After a run-in phase, recruitment for our main study began in December 2010. When the study is completed, we aim to provide evidence on the efficacy of prophylactic hypothermia in TBI to guide clinicians in their management of this devastating condition.	[Nichol, Alistair; Gantner, Dashiell; Presneill, Jeffrey; Murray, Lynnette; Trapani, Tony; Forbes, Andrew; McArthur, Colin; Stephenson, Michael; Webb, Steve; Cooper, D. James] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Nichol, Alistair; Trapani, Tony; Bernard, Stephen; Cooper, D. James] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] St Vincents Univ Hosp, Dept Anaesthesia & Intens Care Med, Dublin 4, Ireland; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Gantner, Dashiell; Bernard, Stephen; Cameron, Peter] Monash Univ, Alfred Hosp, Ctr Excellence Traumat Brain Injury Res, Melbourne, Vic 3181, Australia; [Gantner, Dashiell] Monash Univ, Dept Anaesthesia & Perioperat Med, Melbourne, Vic 3004, Australia; [Gantner, Dashiell] Western Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Presneill, Jeffrey; Bernard, Stephen; Walker, Tony] Royal Brisbane & Womens Hosp, Dept Intens Care, Brisbane, Qld, Australia; [Cameron, Peter] Hamad Med Corp, Emergency Med, Doha, Qatar; [Capellier, Gilles] Hop Jean Minjoz, Reanimat Med CHRU, F-25030 Besancon, France; [Capellier, Gilles] Univ Franche Comte, F-25030 Besancon, France; [McArthur, Colin; Newby, Lynette; Smith, Tony] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Rashford, Stephen] Queensland Ambulance Serv, Brisbane, Qld, Australia; [Rosenfeld, Jeffrey V.; Varma, Dinesh] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA; [Stephenson, Michael] Ambulance Victoria, Melbourne, Vic, Australia; [Varma, Dinesh] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia; [Webb, Steve] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia		Cooper, DJ (corresponding author), Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia.	Jamie.cooper@monash.edu	Cooper, D. James/G-7961-2013	Cooper, D. James/0000-0002-5872-9051; Nichol, Alistair Dualta/0000-0002-4771-5615; Cameron, Peter/0000-0002-1443-557X; Forbes, Andrew/0000-0003-4269-914X; Nichol, Alistair/0000-0002-4689-1238; Gantner, Dashiell/0000-0001-9465-5910	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Victorian Transport Accident Commission	The POLAR RCT is funded by the Australian National Health and Medical Research Council and the Victorian Transport Accident Commission. The cooling vests and blankets are purchased and maintained using project grant funds. Funding agencies and cooling device suppliers and manufacturers have not had and will not have any role in study design, data collection, data analysis or writing of manuscripts.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cook D, 2008, CAN MED ASSOC J, V178, P1181, DOI 10.1503/cmaj.071366; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Cummings P., 2014, BMJ, V348; EuroQol Group, 2014, EQ 5D INSTR DESCR VA; Faul M, 2010, TRAUMATIC BRAIN INJU; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Grant RL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7450; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang J., RANDOMIZED CONTROLLE; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Karnatovskaia LV, 2014, NEUROHOSPITALIST, V4, P153, DOI 10.1177/1941874413519802; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol AD, 2011, LANCET NEUROL, V10, P405, DOI 10.1016/S1474-4422(11)70085-0; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Polderman KH, 2011, LANCET NEUROL, V10, P404, DOI 10.1016/S1474-4422(11)70084-9; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Shankaran S, 2014, JAMA-J AM MED ASSOC, V312, P2629, DOI 10.1001/jama.2014.16058; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; SYDENHAM E, 2009, COCHRANE DATABASE SY; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	43	22	22	0	8	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	JUN	2015	17	2					92	100					9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0ID	WOS:000355158100008	26017126				2022-02-06	
J	Smith, AL; Garbus, H; Rosenkrantz, TS; Fitch, RH				Smith, Amanda L.; Garbus, Haley; Rosenkrantz, Ted S.; Fitch, Roslyn Holly			Sex Differences in Behavioral Outcomes Following Temperature Modulation During Induced Neonatal Hypoxic Ischemic Injury in Rats	BRAIN SCIENCES			English	Article						Temperature modulation; hypoxia ischemia; rodent model; rapid auditory processing; motor; learning/memory; preterm; neuroprotection; neurobehavioral; hypothermia	LOW-BIRTH-WEIGHT; AUDITORY PROCESSING DEFICITS; DEVELOPMENTAL COORDINATION DISORDER; SPATIAL MEMORY DEFICITS; TRAUMATIC BRAIN-INJURY; PRETERM MALE INFANTS; CEREBRAL-ISCHEMIA; TERM INFANT; POSTISCHEMIC HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA	Neonatal hypoxia ischemia (HI; reduced oxygen and/or blood flow to the brain) can cause various degrees of tissue damage, as well as subsequent cognitive/behavioral deficits such as motor, learning/memory, and auditory impairments. These outcomes frequently result from cardiovascular and/or respiratory events observed in premature infants. Data suggests that there is a sex difference in HI outcome, with males being more adversely affected relative to comparably injured females. Brain/body temperature may play a role in modulating the severity of an HI insult, with hypothermia during an insult yielding more favorable anatomical and behavioral outcomes. The current study utilized a postnatal day (P) 7 rodent model of HI injury to assess the effect of temperature modulation during injury in each sex. We hypothesized that female P7 rats would benefit more from lowered body temperatures as compared to male P7 rats. We assessed all subjects on rota-rod, auditory discrimination, and spatial/non-spatial maze tasks. Our results revealed a significant benefit of temperature reduction in HI females as measured by most of the employed behavioral tasks. However, HI males benefitted from temperature reduction as measured on auditory and non-spatial tasks. Our data suggest that temperature reduction protects both sexes from the deleterious effects of HI injury, but task and sex specific patterns of relative efficacy are seen.	[Smith, Amanda L.; Garbus, Haley; Fitch, Roslyn Holly] Univ Connecticut, Dept Psychol, 406 Babbidge Rd,Unit 1020, Storrs, CT 06269 USA; [Rosenkrantz, Ted S.] Univ Connecticut, Sch Med, Dept Pediat, Farmington, CT 06030 USA		Smith, AL (corresponding author), Univ Connecticut, Dept Psychol, 406 Babbidge Rd,Unit 1020, Storrs, CT 06269 USA.	amanda.l.smith@uconn.edu; haley.garbus@uconn.edu; rosenkrant@uchc.edu; Roslyn.h.fitch@uconn.edu	Fitch, Roslyn Holly/A-2562-2014		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD049792]	The authors would like to thank all undergraduates who assisted with behavioral testing. The research was supported by NIH grant HD049792.	Alexander M, 2014, BEHAV BRAIN RES, V259, P85, DOI 10.1016/j.bbr.2013.10.038; Alexander ML, 2012, DEV NEUROSCI-BASEL, V34, P515, DOI 10.1159/000345645; Alexander M, 2013, BRAIN SCI, V3, P177, DOI 10.3390/brainsci3010177; Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Arteni NS, 2003, BRAIN RES, V973, P171, DOI 10.1016/S0006-8993(03)02436-3; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Barrett Robert D., 2007, Birth Defects Research, V81, P163, DOI 10.1002/bdrc.20095; Benasich AA, 2006, NEUROPSYCHOLOGIA, V44, P396, DOI 10.1016/j.neuropsychologia.2005.06.004; Billiards SS, 2006, CLIN PERINATOL, V33, P915, DOI 10.1016/j.clp.2006.10.003; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Choudhury N, 2007, DEVELOPMENTAL SCI, V10, P213, DOI 10.1111/j.1467-7687.2007.00546.x; Corbett D, 2000, BRAIN PATHOL, V10, P145; Curtis WJ, 2006, DEV NEUROPSYCHOL, V29, P341, DOI 10.1207/s15326942dn2902_4; de Kleine MJK, 2003, ARCH DIS CHILD, V88, P870, DOI 10.1136/adc.88.10.870; de Vries LS, 2009, SEMIN PEDIATR NEUROL, V16, P216, DOI 10.1016/j.spen.2009.09.001; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Downie ALS, 2002, BRAIN LANG, V80, P208, DOI 10.1006/brln.2001.2594; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; Fan XY, 2013, PEDIATR RES, V73, P18, DOI 10.1038/pr.2012.139; Fang AY, 2013, PEDIATR RES, V73, P12, DOI 10.1038/pr.2012.138; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Fitch RH, 2008, BRAIN RES BULL, V76, P1, DOI 10.1016/j.brainresbull.2007.07.013; Fitch RH, 2013, FRONT SYST NEUROSCI, V7, DOI [10.3389/fnsys.2013.00058, 10.3389/fusys.2013.00058]; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; GREEN EJ, 1992, BRAIN RES, V580, P197, DOI 10.1016/0006-8993(92)90945-6; Hack M, 2008, CLIN OBSTET GYNECOL, V51, P763, DOI 10.1097/GRF.0b013e3181870922; Hill CA, 2011, DEV NEUROSCI-BASEL, V33, P494, DOI 10.1159/000331651; Hill CA, 2011, INT J DEV NEUROSCI, V29, P381, DOI 10.1016/j.ijdevneu.2011.03.005; Hindmarsh GJ, 2000, EARLY HUM DEV, V60, P115, DOI 10.1016/S0378-3782(00)00105-5; Howe TH, 2011, AM J PHYS MED REHAB, V90, P667, DOI 10.1097/PHM.0b013e31821a703f; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; KARIBE H, 1994, J NEUROSURG, V80, P112, DOI 10.3171/jns.1994.80.1.0112; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Kerenyi A, 2012, PEDIATR RES, V71, P573, DOI 10.1038/pr.2012.8; Kesler SR, 2008, J PEDIATR-US, V152, P513, DOI 10.1016/j.jpeds.2007.08.009; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Kono Y, 2011, PEDIATR INT, V53, P930, DOI 10.1111/j.1442-200X.2011.03424.x; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Lang JT, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-33; Laptook AR, 2013, ANN NEUROL, V73, P520, DOI 10.1002/ana.23843; LAPTOOK AR, 1995, STROKE, V26, P1240, DOI 10.1161/01.STR.26.7.1240; LAPTOOK AR, 1994, PEDIATR RES, V35, P436, DOI 10.1203/00006450-199404000-00010; Laptook AR, 2001, PEDIATRICS, V108, P1103, DOI 10.1542/peds.108.5.1103; Lauterbach MD, 2001, NEUROPSYCHOLOGY, V15, P411, DOI 10.1037/0894-4105.15.3.411; Lee BS, 2010, PEDIATR RES, V68, P303, DOI 10.1203/00006450-201011001-00592; Liu FD, 2009, STROKE, V40, P1842, DOI 10.1161/STROKEAHA.108.538686; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Luu TM, 2009, PEDIATRICS, V123, P1037, DOI 10.1542/peds.2008-1162; Ma H, 2012, CURR MOL MED, V12, P1282, DOI 10.2174/156652412803833517; Mansson J, 2015, ACTA PAEDIATR, V104, P514, DOI 10.1111/apa.12937; Manwani B, 2011, WOMENS HEALTH, V7, P319, DOI [10.2217/WHE.11.22, 10.2217/whe.11.22]; Massaro AN, 2015, DEV MED CHILD NEUROL, V57, P441, DOI 10.1111/dmcn.12646; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McClure MM, 2007, BRAIN RES, V1132, P203, DOI 10.1016/j.brainres.2006.11.006; McClure MM, 2006, BRAIN RES, V1087, P190, DOI 10.1016/j.brainres.2006.03.016; McClure MM, 2005, INT J DEV NEUROSCI, V23, P351, DOI 10.1016/j.ijdevneu.2004.12.008; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; McGettigan C, 2011, J COGNITIVE NEUROSCI, V23, P961, DOI 10.1162/jocn.2010.21491; MEDEN P, 1994, BRAIN RES, V647, P131, DOI 10.1016/0006-8993(94)91407-9; Moreira RS, 2014, J PEDIAT-BRAZIL, V90, P119, DOI 10.1016/j.jped.2013.05.010; Ohmura A, 2005, BRAIN DEV-JPN, V27, P517, DOI 10.1016/j.braindev.2005.01.004; Ortiz-Mantilia S, 2008, DEV PSYCHOBIOL, V50, P107, DOI 10.1002/dev.20278; Patel SD, 2014, BIOCHEM SOC T, V42, P564, DOI 10.1042/BST20130247; Peacock JL, 2012, PEDIATR RES, V71, P305, DOI 10.1038/pr.2011.50; Peiffer AM, 2004, DEV BRAIN RES, V148, P53, DOI 10.1016/j.devbrainres.2003.09.020; Peiffer AM, 2002, NEUROREPORT, V13, P2277, DOI 10.1097/00001756-200212030-00021; Piek JP, 2008, HUM MOVEMENT SCI, V27, P668, DOI 10.1016/j.humov.2007.11.002; Potharst ES, 2013, DEV MED CHILD NEUROL, V55, P178, DOI 10.1111/dmcn.12018; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Raz S, 2010, J INT NEUROPSYCH SOC, V16, P169, DOI 10.1017/S1355617709991147; Renolleau S, 2007, J NEUROCHEM, V100, P1062, DOI 10.1111/j.1471-4159.2006.04269.x; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Smith AL, 2015, DEV NEUROSCI-BASEL, V37, P440, DOI 10.1159/000375487; Smith AL, 2014, BRAIN SCI, V4, P240, DOI 10.3390/brainsci4020240; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Spittle AJ, 2014, SEMIN FETAL NEONAT M, V19, P84, DOI 10.1016/j.siny.2013.11.005; Tsuji M, 2010, EXP NEUROL, V226, P285, DOI 10.1016/j.expneurol.2010.09.002; Van Hus JW, 2014, DEV MED CHILD NEUROL, V56, P587, DOI 10.1111/dmcn.12295; Van Lierde KM, 2009, FOLIA PHONIATR LOGO, V61, P296, DOI 10.1159/000238401; Vannucci RC, 2000, AM J PERINAT, V17, P113, DOI 10.1055/s-2000-9293; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Wagner BP, 2002, PEDIATR RES, V51, P354, DOI 10.1203/00006450-200203000-00015; Wang RH, 2001, EUR J PHARMACOL, V433, P73, DOI 10.1016/S0014-2999(01)01498-4; Xiong M, 2013, EXP NEUROL, V247, P720, DOI 10.1016/j.expneurol.2013.03.015; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhu CL, 2006, EUR J NEUROSCI, V23, P387, DOI 10.1111/j.1460-9568.2005.04581.x; Zwicker JG, 2013, ARCH DIS CHILD, V98, P118, DOI 10.1136/archdischild-2012-302268	95	22	22	0	3	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-3425	2976-3425		BRAIN SCI	Brain Sci.	JUN	2015	5	2					220	240		10.3390/brainsci5020220			21	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	CT9HB	WOS:000363126600009	26010486	gold, Green Published, Green Submitted			2022-02-06	
J	Vartiainen, MV; Holm, A; Peltonen, K; Luoto, TM; Iverson, GL; Hokkanen, L				Vartiainen, M. V.; Holm, A.; Peltonen, K.; Luoto, T. M.; Iverson, G. L.; Hokkanen, L.			King-Devick test normative reference values for professional male ice hockey players	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						sport; concussion; head injury; measurement; neurology	VISUAL SCREENING TOOL; CONCUSSION; UTILITY	The King-Devick (K-D) test, a measure of processing speed, visual tracking, and saccadic eye movements, has shown promise as a supplemental screening test following concussion. However, limited normative data for this test have been published.The K-D test was administered to 185 professional ice hockey players as a preseason baseline test in seasons 2012-2013 and 2013-2014. Their average age was 23.8 years (median=22.0 years, range=16-40 years). The average K-D score was 40.0s (SD=6.1s, range=24.0-65.7s). K-D test performance showed no association with age, education, or the number of self-reported previous concussions in this sample. The association between trials 1 and 2 of the K-D test was good (ICC=0.92, Pearson=0.93). Normative values of the K-D test for professional male ice hockey players are reported. K-D test performance did not vary by age, education, or concussion history in this study.	[Vartiainen, M. V.; Peltonen, K.; Hokkanen, L.] Univ Helsinki, Inst Behav Sci, Div Cognit Psychol & Neuropsychol, SF-00100 Helsinki, Finland; [Holm, A.] Satakunta Cent Hosp, Dept Clin Neurophysiol, Pori, Finland; [Luoto, T. M.] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland; [Iverson, G. L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, G. L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, G. L.] Red Sox Fdn, Boston, MA USA; [Iverson, G. L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Iverson, G. L.] Massachusetts Gen Hosp, Sport Concuss Clin, Boston, MA 02114 USA		Vartiainen, MV (corresponding author), Univ Helsinki, Inst Behav Sci, Div Cognit Psychol & Neuropsychol, Raisalantie 24, SF-00100 Helsinki, Finland.	m.vartiainen@kolumbus.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Hokkanen, Laura/0000-0001-8342-9248; Iverson, Grant/0000-0001-7348-9570			Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015	11	22	22	0	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	JUN	2015	25	3					e327	e330		10.1111/sms.12307			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CI2ID	WOS:000354568800014	25138698				2022-02-06	
J	Boone, DR; Micci, MA; Taglialatela, IG; Hellmich, JL; Weisz, HA; Bi, M; Prough, DS; DeWitt, DS; Hellmich, HL				Boone, Deborah R.; Micci, Maria-Adelaide; Taglialatela, Isabella G.; Hellmich, Judy L.; Weisz, Harris A.; Bi, Min; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.			Pathway-Focused PCR Array Profiling of Enriched Populations of Laser Capture Microdissected Hippocampal Cells after Traumatic Brain Injury	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; FLUORO-JADE; ACTIVATION; NEUROPROTECTION; PROTEIN; DEATH; REPRODUCIBILITY; MODULATION; MECHANISMS	Cognitive deficits in survivors of traumatic brain injury (TBI) are associated with irreversible neurodegeneration in brain regions such as the hippocampus. Comparative gene expression analysis of dying and surviving neurons could provide insight into potential therapeutic targets. We used two pathway-specific PCR arrays (RT2 Profiler Apoptosis and Neurotrophins & Receptors PCR arrays) to identify and validate TBI-induced gene expression in dying (Fluoro-Jade-positive) or surviving (Fluoro-Jade-negative) pyramidal neurons obtained by laser capture microdissection (LCM). In the Apoptosis PCR array, dying neurons showed significant increases in expression of genes associated with cell death, inflammation, and endoplasmic reticulum (ER) stress compared with adjacent, surviving neurons. Pro-survival genes with pleiotropic functions were also significantly increased in dying neurons compared to surviving neurons, suggesting that even irreversibly injured neurons are able to mount a protective response. In the Neurotrophins & Receptors PCR array, which consists of genes that are normally expected to be expressed in both groups of hippocampal neurons, only a few genes were expressed at significantly different levels between dying and surviving neurons. Immunohistochemical analysis of selected, differentially expressed proteins supported the gene expression data. This is the first demonstration of pathway-focused PCR array profiling of identified populations of dying and surviving neurons in the brain after TBI. Combining precise laser microdissection of identifiable cells with pathway-focused PCR array analysis is a practical, low-cost alternative to microarrays that provided insight into neuroprotective signals that could be therapeutically targeted to ameliorate TBI-induced neurodegeneration.	[Boone, Deborah R.; Micci, Maria-Adelaide; Taglialatela, Isabella G.; Hellmich, Judy L.; Weisz, Harris A.; Bi, Min; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	department of Anesthesiology (UTMB); Moody Foundation;  [RO1 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	This work was supported by RO1 NS052532 (HLH), and in part by the department of Anesthesiology (UTMB) and a Moody Foundation grant to DSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen Kristina E, 2011, BMC Res Notes, V4, P69, DOI 10.1186/1756-0500-4-69; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Asztalos S, 2010, CANCER PREV RES, V3, P301, DOI 10.1158/1940-6207.CAPR-09-0069; Boone DR, 2013, JOVE-J VIS EXP, DOI 10.3791/50308; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Brain Trauma Foundation AAoNSCoNSJSoNaCC, 2003, GUID MAN SEV TRAUM B; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen W, 2007, TOHOKU J EXP MED, V212, P319, DOI 10.1620/tjem.212.319; Choi HJ, 2011, BRIT J PHARMACOL, V162, P175, DOI 10.1111/j.1476-5381.2010.01041.x; Ciotti P, 2009, DIAGN MOL PATHOL, V18, P112, DOI 10.1097/PDM.0b013e3181831320; Clark RE, 2013, P NATL ACAD SCI USA, V110, P10365, DOI 10.1073/pnas.1301225110; d'Hellencourt CL, 2005, J NEUROCHEM, V93, P206, DOI 10.1111/j.1471-4159.2004.03017.x; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Elliott-Hunt CR, 2007, J NEUROCHEM, V100, P780, DOI 10.1111/j.1471-4159.2006.04239.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Haines B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031739; Hansel NN, 2008, ALLERGY, V63, P366, DOI 10.1111/j.1398-9995.2007.01540.x; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hernandez-Baltazar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070951; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hou H, 2008, BIOCHEM BIOPH RES CO, V369, P641, DOI 10.1016/j.bbrc.2008.02.094; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Ikeda T, 2000, ACTA NEUROPATHOL, V100, P161, DOI 10.1007/s004019900162; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mori M, 2004, CELL DEATH DIFFER, V11, P1223, DOI 10.1038/sj.cdd.4401483; Murakami H, 2000, KIDNEY INT, V58, P1346, DOI 10.1046/j.1523-1755.2000.00295.x; Nogueira-Silva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030517; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Pan CQ, 2012, FEBS LETT, V586, P2674, DOI 10.1016/j.febslet.2012.04.023; Petito CK, 2001, J NEUROPATH EXP NEUR, V60, P377, DOI 10.1093/jnen/60.4.377; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Ruan YL, 1997, J NEUROSCI RES, V50, P383, DOI 10.1002/(SICI)1097-4547(19971101)50:3<383::AID-JNR4>3.0.CO;2-E; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slevin M, 2010, J VASC RES, V47, P323, DOI 10.1159/000265566; So T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00139; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SUGIMOTO A, 1995, EMBO J, V14, P4434, DOI 10.1002/j.1460-2075.1995.tb00122.x; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Mena JET, 2014, ANAL BIOCHEM, V447, P126, DOI 10.1016/j.ab.2013.11.015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang GB, 2013, NEUROSCI LETT, V543, P72, DOI 10.1016/j.neulet.2013.02.067; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077; Wu H, 2013, J MOL NEUROSCI, V49, P512, DOI 10.1007/s12031-012-9910-6; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zaheer S, 2013, NEUROCHEM RES, V38, P218, DOI 10.1007/s11064-012-0913-z; Zhang JH, 2004, DEV BRAIN RES, V152, P255, DOI 10.1016/j.devbrainres.2004.07.008	74	22	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127287	10.1371/journal.pone.0127287			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	WOS:000355185600078	26016641	Green Submitted, Green Published, gold			2022-02-06	
J	Baker, FA; Rickard, N; Tamplin, J; Roddy, C				Baker, Felicity Anne; Rickard, Nikki; Tamplin, Jeanette; Roddy, Chantal			Flow and meaningfulness as mechanisms of change in self-concept and well-being following a songwriting intervention for people in the early phase of neurorehabilitation	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						songwriting; self-concept clarity; spinal cord injuries; acquired brain injury; depression and anxiety disorders; well-being; flow theory	PATIENT HEALTH QUESTIONNAIRE-9; GENERALIZED ANXIETY DISORDER; TRAUMATIC BRAIN-INJURY; NEGATIVE AFFECT; SATISFACTION; VALIDITY; MUSIC; LIFE; INDIVIDUALS; VALIDATION	Anecdotal evidence suggests that songwriting assists people with spinal cord injury (SCI) or acquired brain injury (ABI) to explore threats to self-concept, yet studies that explore the mechanisms of change have not been reported. In a pilot study, we explored the correlations between changes in self-concept and well-being, with mechanisms of flow and meaningfulness of songwriting. Five people with ABI (all male) and 5 SCI (4 males, 1 female) (mean age 38.90 years, SD = 13.21), with an average 3 months post-injury, participated in a 12-session songwriting program that targeted examination of self-concept. Measures of self-concept, depression, anxiety, emotion regulation, affect, satisfaction with life, and flourishing were collected pre-, mid-, and post-intervention, and compared with repeated measures of flow and meaningfulness of songwriting. Medium effects were found for changes in self-concept (d = 0.557) and depression (d = 0.682) and approached a medium effect for negative affect (d = 0.491). Improvements in self-concept over time were associated with decreases in depression (r(p) = -0.874, n = 9, p < 0.01), anxiety (r(p) = -0.866, n = 9, p < 0.01), and negative affect (r(p) = -0.694, n = 10, p < 0.05), and an increase in flourishing (r(p) = +0.866, n = 9, p < 0.01) and positive affect (r(p) = +0.731, n = 10, p < 0.05). Strong experiences of flow were not positively correlated with positive changes to self-concept and well-being, whereas deriving high levels of meaning were associated with increased negative affect (r(p) = +0.68 p < 0.05), increased anxiety (r(p) = +0.74, p < 0.05), and reduced emotional suppression (r(p) = -0.58, p < 0.05). These findings show that the targeted songwriting intervention appears to be positively associated with enhanced well-being outcomes. However, the findings also suggest that people who find the songwriting process has strong meaning for them might be more likely to start accepting their emotions and as a result experience an increase in anxiety and depression, although full, mediated regression analyses with larger sample sizes are required to explore this further. Acknowledging their changed circumstances may nonetheless assist people with SCI and ABI to grieve their losses and facilitate the building of a healthy post-injured self-concept. We propose that there may be other mechanisms more critical in facilitating the positive changes in self-concept and well-being than flow and meaning, such as the role of story-telling and the impact of music in facilitating the consolidation of self-concept explorations in memory.	[Baker, Felicity Anne; Tamplin, Jeanette] Univ Melbourne, Melbourne, Vic, Australia; [Rickard, Nikki; Roddy, Chantal] Monash Univ, Melbourne, Vic 3004, Australia		Baker, FA (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.	felicity.baker@unimelb.edu.au	Roddy, Chantal/Q-1558-2017; Tamplin, Jeanette/AAR-2855-2021	Roddy, Chantal/0000-0001-5220-9226; Tamplin, Jeanette/0000-0002-3623-033X			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Baker F, 2005, J MUSIC THER, V42, P111, DOI 10.1093/jmt/42.2.111; Baker F., 2005, SONGWRITING METHODS, P116; Baker F, 2004, BRIT J MUSIC THERAPY, V2, P55; Baker F., 2005, AUSTR J MUSIC THERAP, V16, P25; Baker F., 2005, BRAIN IMPAIR, V6, P205, DOI [https://doi.org/10.1375/brim.2005.6.3.205, DOI 10.1375/BRIM.2005.6.3.205, 10.1375/brim.2005.6.3.205]; Baker FA, 2015, THERAPEUTIC SONGWRITING: DEVELOPMENTS IN THEORY, METHODS, AND PRACTICE, P1, DOI 10.1057/9781137499233; Baker F, 2008, NORD J MUSIC THER, V17, P105, DOI 10.1080/08098130809478203; Baker FA, 2013, MUSIC SCI, V17, P131, DOI 10.1177/1029864913476287; Baker FA, 2014, ARTS HEALTH, V6, P143, DOI 10.1080/17533015.2013.808254; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P1838, DOI 10.1016/j.apmr.2012.04.019; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Csikszentmihalyi M., 2008, FLOW PSYCHOL OPTIMAL; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Feinstein D., 2008, PERSONAL MYTHOLOGY U; Fitts WH., 1996, TENNESSEE SELF CONCE; Fortmann AL, 2013, SPINAL CORD, V51, P482, DOI 10.1038/sc.2012.172; Gana K., 2012, PSYCHOL EMOTIONS ACT; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Habermas T, 2000, PSYCHOL BULL, V126, P748, DOI 10.1037//0033-2909.126.5.748; Hinkebein J. H., 2007, COPING CHRONIC ILLNE, P389, DOI DOI 10.1007/978-0-387-48670-3_18; Janata P, 2009, CEREB CORTEX, V19, P2579, DOI 10.1093/cercor/bhp008; Judde S, 2010, NEUROBIOL LEARN MEM, V94, P13, DOI 10.1016/j.nlm.2010.03.002; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; Kelly A, 2013, NEUROPSYCHOL REHABIL, V23, P563, DOI 10.1080/09602011.2013.795903; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lennon A, 2014, BRAIN INJURY, V28, P27, DOI 10.3109/02699052.2013.848378; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; MacKinnon NJ, 2010, SELF, IDENTITY, AND SOCIAL INSTITUTIONS, P1, DOI 10.1057/9780230108493; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Martin AJ, 2008, MOTIV EMOTION, V32, P141, DOI 10.1007/s11031-008-9094-0; Melka SE, 2011, J CLIN PSYCHOL, V67, P1283, DOI 10.1002/jclp.20836; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Obodaru O, 2012, ACAD MANAGE REV, V37, P34, DOI 10.5465/amr.2009.0358; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Salimpoor VN, 2013, PSYCHOL AESTHET CREA, V7, P62, DOI 10.1037/a0031819; Salter JE, 2013, SPINAL CORD, V51, P252, DOI 10.1038/sc.2012.105; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Seligman M. E. P., 2011, FLOURISHING; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tamplin J., 2006, NORD J MUSIC THER, V15, P177, DOI [10.1080/08098130609478164, DOI 10.1080/08098130609478164]; Tamplin J, 2016, NORD J MUSIC THER, V25, P111, DOI 10.1080/08098131.2015.1011208; Tamplin J, 2013, NEUROREHABILITATION, V32, P929, DOI 10.3233/NRE-130916; Tamplin J, 2013, ARCH PHYS MED REHAB, V94, P426, DOI 10.1016/j.apmr.2012.10.006; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; White D., 2014, THESIS CORNELL U NEW	52	22	22	1	38	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 26	2015	9								299	10.3389/fnhum.2015.00299			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CK2VM	WOS:000356072100001	26082702	Green Published, gold			2022-02-06	
J	Xu, LY; Ryu, J; Hiel, H; Menon, A; Aggarwal, A; Rha, E; Mahairaki, V; Cummings, BJ; Koliatsos, VE				Xu, Leyan; Ryu, Jiwon; Hiel, Hakim; Menon, Adarsh; Aggarwal, Ayushi; Rha, Elizabeth; Mahairaki, Vasiliki; Cummings, Brian J.; Koliatsos, Vassilis E.			Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiation	STEM CELL RESEARCH & THERAPY			English	Article							NEURAL STEM-CELLS; SPINAL-CORD-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; SOD1 TRANSGENIC RATS; BRAIN-INJURY; HEAD-INJURY; MOUSE MODEL; FUNCTIONAL RECOVERY; MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM	Introduction: Diffuse axonal injury is an extremely common type of traumatic brain injury encountered in motor vehicle crashes, sports injuries, and in combat. Although many cases of diffuse axonal injury result in chronic disability, there are no current treatments for this condition. Its basic lesion, traumatic axonal injury, has been aggressively modeled in primate and rodent animal models. The inexorable axonal and perikaryal degeneration and dysmyelination often encountered in traumatic axonal injury calls for regenerative therapies, including therapies based on stem cells and precursors. Here we explore the proof of concept that treatments based on transplants of human oligodendrocyte progenitor cells can replace or remodel myelin and, eventually, contribute to axonal regeneration in traumatic axonal injury. Methods: We derived human oligodendrocyte progenitor cells from the human embryonic stem cell line H9, purified and characterized them. We then transplanted these human oligodendrocyte progenitor cells into the deep sensorimotor cortex next to the corpus callosum of nude rats subjected to traumatic axonal injury based on the impact acceleration model of Marmarou. We explored the time course and spatial distribution of differentiation and structural integration of these cells in rat forebrain. Results: At the time of transplantation, over 90 % of human oligodendrocyte progenitor cells expressed A2B5, PDGFR, NG2, O4, Olig2 and Sox10, a profile consistent with their progenitor or early oligodendrocyte status. After transplantation, these cells survived well and migrated massively via the corpus callosum in both injured and uninjured brains. Human oligodendrocyte progenitor cells displayed a striking preference for white matter tracts and were contained almost exclusively in the corpus callosum and external capsule, the striatopallidal striae, and cortical layer 6. Over 3 months, human oligodendrocyte progenitor cells progressively matured into myelin basic protein(+) and adenomatous polyposis coli protein(+) oligodendrocytes. The injured environment in the corpus callosum of impact acceleration subjects tended to favor maturation of human oligodendrocyte progenitor cells. Electron microscopy revealed that mature transplant-derived oligodendrocytes ensheathed host axons with spiral wraps intimately associated with myelin sheaths. Conclusions: Our findings suggest that, instead of differentiating locally, human oligodendrocyte progenitor cells migrate massively along white matter tracts and differentiate extensively into ensheathing oligodendrocytes. These features make them appealing candidates for cellular therapies of diffuse axonal injury aiming at myelin remodeling and axonal protection or regeneration.	[Xu, Leyan; Ryu, Jiwon; Menon, Adarsh; Aggarwal, Ayushi; Rha, Elizabeth; Mahairaki, Vasiliki; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Hiel, Hakim] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Cummings, Brian J.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Sue & Bill Gross Stem Cell Res Ctr, Dept Phys & Med Rehabil, Irvine, CA 92697 USA; [Cummings, Brian J.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Sue & Bill Gross Stem Cell Res Ctr, Dept Neurol Surg, Irvine, CA 92697 USA; [Cummings, Brian J.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Sue & Bill Gross Stem Cell Res Ctr, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Xu, LY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA.	lxu9@jhmi.edu	Cummings, Brian J/C-9180-2012	Cummings, Brian J/0000-0003-3628-5290; Aggarwal, Ayushi/0000-0003-0458-5619; Ryu, Jiwon/0000-0003-0251-7858	Maryland Technology Development Corporation (TEDCO) [TR2-01767]	This work was supported by a Maryland Technology Development Corporation (TEDCO) grant to VEK funded as companion to CIRM grant TR2-01767 to BJC. We would like to thank Ms Devon Hitt who offered great technical help with immunostaining and collection of some quantitative data.	ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; Alsanie WF, 2013, STEM CELLS DEV, V22, P2459, DOI 10.1089/scd.2012.0520; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Boyd A, 2013, ACTA NEUROPATHOL, V125, P841, DOI 10.1007/s00401-013-1112-y; Brazzini A, 2010, J VASC INTERV RADIOL, V21, P443, DOI 10.1016/j.jvir.2010.01.008; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Erlandsson A, 2004, EXP CELL RES, V301, P201, DOI 10.1016/j.yexcr.2004.08.009; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Givogri MI, 2006, J NEUROSCI, V26, P3109, DOI 10.1523/JNEUROSCI.4366-05.2006; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hatch MN, 2009, J NEUROIMMUNOL, V212, P74, DOI 10.1016/j.jneuroim.2009.05.002; Hatch Maya N., 2009, V549, P59, DOI 10.1007/978-1-60327-931-4_5; Haus DL, 2014, STEM CELL RES, V13, P214, DOI 10.1016/j.scr.2014.06.008; Hess DC, 2014, INT J STROKE, V9, P381, DOI 10.1111/ijs.12065; Hooshmand MJ, 2014, MICROSCOPY ADV SCI R, V6, P59; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Koliatsos VE, 2008, EXPERT OPIN BIOL TH, V8, P137, DOI [10.1517/14712598.8.2.137, 10.1517/14712598.8.2.137 ]; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; KOLIATSOS VE, 1994, J COMP NEUROL, V345, P510, DOI 10.1002/cne.903450404; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Nasonkin I, 2009, STEM CELLS, V27, P2414, DOI 10.1002/stem.177; Nasonkin IO, 2006, EXP NEUROL, V201, P525, DOI 10.1016/j.expneurol.2006.05.002; Neirinckx V, 2014, STEM CELLS, V32, P829, DOI 10.1002/stem.1579; Nguyen HX, 2014, J COMP NEUROL, V522, P2767, DOI 10.1002/cne.23604; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Riley J, 2014, NEUROSURGERY, V74, P77, DOI 10.1227/NEU.0000000000000156; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005; Suchet S., 1995, NEUROGLIA, P23; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057534; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tirotta E, 2010, J NEUROIMMUNOL, V224, P101, DOI 10.1016/j.jneuroim.2010.05.013; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Tripathi RB, 2008, J COMP NEUROL, V510, P129, DOI 10.1002/cne.21787; Vaquero J, 1999, J NEUROSURG, V91, P831, DOI 10.3171/jns.1999.91.5.0831; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Xu LY, 2012, REGEN MED, V7, P785, DOI [10.2217/RME.12.76, 10.2217/rme.12.76]; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Zakaria N, 2012, BRAIN RES, V1467, P81, DOI 10.1016/j.brainres.2012.05.046; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 1998, J NEUROSCI RES, V54, P181, DOI 10.1002/(SICI)1097-4547(19981015)54:2<181::AID-JNR6>3.0.CO;2-A	102	22	24	1	17	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	MAY 14	2015	6								93	10.1186/s13287-015-0087-0			18	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	CJ3VA	WOS:000355411000001	25971252	Green Published, Green Submitted, gold			2022-02-06	
J	Bramley, H; Heverley, S; Lewis, MM; Kong, L; Rivera, R; Silvis, M				Bramley, Harry; Heverley, Steven; Lewis, Mechelle M.; Kong, Lan; Rivera, Rowena; Silvis, Matthew			Demographics and Treatment of Adolescent Posttraumatic Headache in a Regional Concussion Clinic	PEDIATRIC NEUROLOGY			English	Article						mild traumatic brain injury; concussion; headache; treatment; amitriptyline	TRAUMATIC BRAIN-INJURY; 4TH INTERNATIONAL-CONFERENCE; STATES HIGH-SCHOOL; SEX-DIFFERENCES; MINOR HEAD; SYMPTOM EXPECTATION; CONSENSUS STATEMENT; GENDER-DIFFERENCES; FOOTBALL PLAYERS; RISK-FACTOR	OBJECTIVE: Mild traumatic brain injury affects over one million pediatric patients annually. Minimal data and no guidelines exist regarding treatment of posttraumatic headache (PTH). The current study investigated treatment and outcomes in patients with posttraumatic headache. METHODS: Medical records of all patients (age 13-18 years of age) seen at a regional concussion program from 2006 to 2011 were reviewed. Statistical analysis using SAS 9.2 was conducted to determine the effectiveness of treatment as well as the association of gender, concussion history, and football participation on the duration of posttraumatic headache. RESULTS: Four hundred subjects met the inclusion criteria. Females were more likely to report posttraumatic headache than males (90% vs. 79%, P = 0.004), more likely to be prescribed amitriptyline (24% vs. 13%, P = 0.004), and had a significantly longer recovery time (median, 80 days versus 34 days, P < 0.001). Seventeen percent of subjects were prescribed amitriptyline for treatment of posttraumatic headache, of which 82% reported a beneficial effect. There was no difference in the percentage of posttraumatic headache or recovery time in football players versus other male athletes from other sport mechanisms. CONCLUSION: Females are more likely to report posttraumatic headache than males and also take longer to recover. Amitriptyline appears to be well-tolerated and an effective treatment strategy for patients with posttraumatic headache. Among pediatric patients evaluated in a concussion clinic, there is no difference in the proportion of football players reporting headaches compared with male players of other sports.	[Bramley, Harry; Lewis, Mechelle M.; Kong, Lan; Rivera, Rowena; Silvis, Matthew] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Heverley, Steven] Tan & Garcia Pediat, Harrisburg, PA USA		Bramley, H (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Mail Code H085,500 Univ Dr, Hershey, PA 17033 USA.	hbramley@hmc.psu.edu					Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Barlow KM, 2014, J CHILD NEUROL; Bekkelund SI, 2003, HEADACHE, V43, P59, DOI 10.1046/j.1526-4610.2003.03010.x; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bettucci D, 1998, ITAL J NEUROL SCI, V19, P20, DOI 10.1007/BF03028807; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Esposito G, 1996, J NUCL MED, V37, P559; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heyer GL, 2014, PEDIATR NEUROL, V51, P489, DOI 10.1016/j.pediatrneurol.2014.07.001; Kinart CM, 2002, HEADACHE, V42, P620, DOI 10.1046/j.1526-4610.2002.02149.x; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton RB, 2004, JAMA-J AM MED ASSOC, V291, P493, DOI 10.1001/jama.291.4.493; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Montgomery SA, 1997, ANN NY ACAD SCI, V836, P329, DOI 10.1111/j.1749-6632.1997.tb52368.x; Moore RA, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD008242.PUB2; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Scher AI, 2014, CEPHALALGIA, V34, P83, DOI 10.1177/0333102413499644; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2006, TRENDS PHARMACOL SCI, V27, P410, DOI 10.1016/j.tips.2006.06.003; Thanacoody H K Ruben, 2005, Toxicol Rev, V24, P205, DOI 10.2165/00139709-200524030-00013; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x	48	22	23	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAY	2015	52	5					493	498		10.1016/j.pediatrneurol.2015.01.008			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CG9BL	WOS:000353609300003	25728223				2022-02-06	
J	Seiger, A; Goldwater, E; Deibert, E				Seiger, Ashley; Goldwater, Eva; Deibert, Ellen			Does Mechanism of Injury Play a Role in Recovery from Concussion?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; football; high school; motor vehicle	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; ATHLETE; RETURN	Background: High school football and soccer are 2 of the leading causes of concussion injuries. However, concussions also occur from mechanisms of injury such as motor vehicle accidents (MVAs), assault, and work-related accidents. Purpose: Determine if recovery from concussion could be related to the mechanism of injury. Setting: Berkshire Medical Center Concussion Clinic. Participants: Patients aged 13 to 21 years suffering concussion from football (n = 31), soccer (n = 9), or MVAs (n = 20). Outcome Measurements: ImPACT (Immediate Post Concussion Assessment Tool) test scores including symptom inventory; number of days sick; length of time to recovery. Results: Most commonly reported symptom at the time of injury was headache. Patients were seen in clinic an average of 16 (football), 14 (soccer), and 21 (MVA) days postinjury. Groups differed significantly on ImPACT Visual Memory and Visual Motor Speed scores (P < .05). MVA patients had a longer median number of days sick (97 days) than football players (32 days; P < .05). Conclusion: This study suggests that concussion from an MVA may be a more serious injury than a typical concussion sustained during sports. Data suggest that MVA patients take longer to present to clinic, have lower Visual Memory and Visual Motor Speed scores on ImPACT, and take longer to recover. Further studies are needed to better understand how the mechanism of injury of concussion may relate to prognosis.	[Seiger, Ashley] Brigham & Womens Hosp, Boston, MA 02115 USA; [Goldwater, Eva] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Deibert, Ellen] Wellspan Adult Neurol, York, PA USA		Seiger, A (corresponding author), Brigham & Womens Hosp, 221 Longwood Ave,BL230, Boston, MA 02115 USA.	aseiger@partners.org					Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; Lau BC, 2001, AM J SPORTS MED, V39, P2311; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2006, IMPACT BEST APPROACH; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446	21	22	22	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					E52	E56		10.1097/HTR.0000000000000051			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100006	24901324				2022-02-06	
J	Wu, SC; Chen, WTL; Lin, HH; Fu, CY; Wang, YC; Lo, HC; Cheng, HT; Tzeng, CW				Wu, Shih-Chi; Chen, William Tzu-Liang; Lin, Hui-Han; Fu, Chih-Yuan; Wang, Yu-Chun; Lo, Hung-Chieh; Cheng, Han-Tsung; Tzeng, Chia-Wei			Use of extracorporeal membrane oxygenation in severe traumatic lung injury with respiratory failure	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							RENAL REPLACEMENT THERAPY; LIFE-SUPPORT; ARDS; INFLAMMATION; DEFINITION; ECMO; CARE	Objectives: The use of extracorporeal membrane oxygenation (ECMO) in managing acute respiratory distress syndrome had been accepted. Severe lung injury with respiratory failure is often encountered in trauma patients. We report our experience with the use of ECMO in severe traumatic lung injury. Methods: Patients with severe traumatic lung injury that met the following criteria were candidates for ECMO: (1) severe hypoxemia, PaO2/fraction of inspired oxygen (1.0) less than 60, and positive end-expiratory pressure greater than 10 cm H2O in spite of vigorous ventilation strategy; (2) irreversible CO2 retention with unstable hemodynamics; and (3) an initial arterial PaO2/fraction of inspired oxygen (1.0) less than 60, where the pulmonary condition and hemodynamics rapidly deteriorated despite vigorous mechanical ventilation strategy. Results: Over 60 months, a total of 19 patients with severe traumatic lung injury who received ECMO management were retrospectively reviewed. The median age was 38 years (25-58 years), the median injury severity score was 29 (25-34), the median admission Acute Physiology and Chronic Health Evaluation II (APACHE II) score was 25 (21-36), and the median blood transfusion volume was 5500 mL (3500-13 000). There were 9 venovenous and 10 venoarterial types. The survival rate was 68.4% (13/19). The survivors were younger (30 vs 53 years; 21-39 vs 48-63). There were 6 mortalities (3 pneumonia, 2 coagulopathy, and 1 cardiac rupture with cardiac tamponade). There were 5 of 19 patients with pre-ECMO traumatic brain hemorrhage (3 survived and 2 mortalities). A total of 16 patients received heparinization with 5 mortalities. Conclusions: The use of ECMO may offer an additional treatment modality in severe traumatic lung injury with respiratory failure that is unresponsive to optimal conventional ventilator support. Timely ECMO intervention is of value. (C) 2015 Elsevier Inc. All rights reserved.	[Wu, Shih-Chi; Wang, Yu-Chun; Lo, Hung-Chieh; Cheng, Han-Tsung; Tzeng, Chia-Wei] China Med Univ Hosp, Trauma & Emergency Ctr, Taichung 404, Taiwan; [Wu, Shih-Chi; Chen, William Tzu-Liang; Wang, Yu-Chun; Lo, Hung-Chieh] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, William Tzu-Liang] China Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taichung 404, Taiwan; [Lin, Hui-Han] China Med Univ Hosp, Dept Cardiovasc Surg, Taichung 404, Taiwan; [Fu, Chih-Yuan] Chang Gung Mem Hosp, Dept Trauma & Emergency Surg, Linkou, Taiwan		Wu, SC (corresponding author), China Med Univ Hosp, Trauma & Emergency Ctr, 2 Yuh Der Rd, Taichung 404, Taiwan.	rw114@mail.cmuh.org.tw; wtchen@mail.cmuh.org.tw; d10760@mail.cmuh.org.tw; drfu5564@yahoo.com.tw; traumawang@yahoo.com.tw; carfishcat@yahoo.com.tw; howardcheng324@gmail.com; D11814@mail.cmuh.org.tw	Chen, William Tzu-Liang/ABA-5673-2021; Figlerowicz, Marek/B-9550-2015; Urbanowicz, Anna/C-9550-2016	Urbanowicz, Anna/0000-0002-6854-7737; Fu, Chih-Yuan/0000-0003-1536-1549			Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Biderman P, 2013, J TRAUMA ACUTE CARE, V75, P907, DOI 10.1097/TA.0b013e3182a8334f; Bouman C, 2003, AC DIAL QUAL IN 2 IN; Brower RG, 2004, NEW ENGL J MED, V351, P327; Burns KEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014623; Checkley W, 2011, JAMA-J AM MED ASSOC, V306, P1703, DOI 10.1001/jama.2011.1504; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Field D, 1996, LANCET, V348, P75; Huang YK, 2009, RESUSCITATION, V80, P535, DOI 10.1016/j.resuscitation.2009.02.016; Keel M, 2007, CURR OPIN CRIT CARE, V13, P674, DOI 10.1097/MCC.0b013e3282f1fe71; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lewandowski K, 2000, CRIT CARE, V4, P156, DOI 10.1186/cc689; Liao Chien-Hung, 2008, J Trauma, V64, pE15, DOI 10.1097/01.ta.0000196342.61425.7e; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Muellenbach RM, 2011, ANAESTHESIST, V60, P647, DOI 10.1007/s00101-011-1872-5; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Ried M, 2013, CRIT CARE, V17, DOI 10.1186/cc12782; Rossaint R, 2006, SHOCK, V26, P322, DOI 10.1097/01.shk.0000225403.15722.e9; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shen JH, 2013, INFLAMMATION, V36, P1186, DOI 10.1007/s10753-013-9654-7; Shi JL, 2014, ARTIF ORGANS, V38, P215, DOI 10.1111/aor.12154; VASILYEV S, 1995, CHEST, V107, P1083, DOI 10.1378/chest.107.4.1083; Vecsei V., 2005, EUR J TRAUMA, V31, P239; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Wolf MJ, 2013, ANN THORAC SURG, V96, P917, DOI 10.1016/j.athoracsur.2013.05.056; Yuan KC, 2008, J TRAUMA, V65, P1151, DOI 10.1097/01.ta.0000235492.09223.83	33	22	23	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2015	33	5					658	662		10.1016/j.ajem.2015.02.007			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CH8MX	WOS:000354291600011	25722287				2022-02-06	
J	Covassin, T; Beidler, E; Ostrowski, J; Wallace, J				Covassin, Tracey; Beidler, Erica; Ostrowski, Jennifer; Wallace, Jessica			Psychosocial Aspects of Rehabilitation in Sports	CLINICS IN SPORTS MEDICINE			English	Article						Psychosocial skills; Rehabilitation; Injury; Psychological recovery	CRUCIATE LIGAMENT RECONSTRUCTION; EMOTIONAL RESPONSES; SERIOUS INJURY; RETURN; CONCUSSION; FEAR; COMMUNICATION; RECOVERY; OUTCOMES; STRESS	When an athlete is injured, the primary focus of the sports medicine team is to treat the physical effects of the injury. However, many injured athletes experience negative psychological responses that should also be addressed throughout the rehabilitation process. Sports medicine professions should use psychosocial skills to help decrease the negative consequences of the injury, such as fear of reinjury, anxiety, depression, and adherence to rehabilitation. These psychosocial skills include goal setting, imagery, relaxation techniques, motivation, and self-talk. This article addresses the negative consequences of injury, psychosocial skills used to aid in the rehabilitation process, and clinical implications of the psychological aspects of rehabilitation in sport.	[Covassin, Tracey; Beidler, Erica; Wallace, Jessica] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Ostrowski, Jennifer] Weber State Univ, Dept Hlth Promot & Human Performance, Ogden, UT 84408 USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 308 West Circle Dr, E Lansing, MI 48824 USA.	covassin@msu.edu					Ardern CL, 2011, BRIT J SPORT MED, V45, P596, DOI 10.1136/bjsm.2010.076364; Arvinen-Barrow M, 2008, SPORT EXERC MED, V37, P15; Bianco T, 2001, RES Q EXERCISE SPORT, V72, P376, DOI 10.1080/02701367.2001.10608974; Cassidy CM, 2006, ATHLET THER TODAY, V11, P57; Chmielewski TL, 2008, J ORTHOP SPORT PHYS, V38, P746, DOI 10.2519/jospt.2008.2887; Clement D, 2013, J ATHL TRAINING, V48, P512, DOI 10.4085/1062-6050-48.3.21; Danish S, 1986, PSYCHOL ASPECTS CARE; Dawson MA, 2014, J ATHL TRAINING, V49, P331, DOI 10.4085/1062-6050-49.1.09; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Evans L, 2000, SPORT PSYCHOL, V14, P188, DOI 10.1123/tsp.14.2.188; Feltz D, 1986, SPORT INJURIES UNTHW, P336; Fisher A. Craig, 1993, Journal of Athletic Training, V28, P43; Flanigan DC, 2013, ARTHROSCOPY, V29, P1322, DOI 10.1016/j.arthro.2013.05.015; Gould D, 1997, SPORT PSYCHOL, V11, P361, DOI 10.1123/tsp.11.4.361; Granquist M. D, 2014, PSYCHOSOCIAL STRATEG; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hagger MS, 2005, J APPL SOC PSYCHOL, V35, P2345, DOI 10.1111/j.1559-1816.2005.tb02106.x; Hall CR, 1998, INT J SPORT PSYCHOL, V29, P73; Hanrahan SJ, 2010, ROUT INT HANDB, P460; HARDY L, 1996, UNDERSTANDING PSYCHO; HIRD JS, 1991, J SPORT EXERCISE PSY, V13, P281, DOI 10.1123/jsep.13.3.281; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Ievleva L., 1991, SPORT PSYCHOL, V5, P25, DOI [DOI 10.1123/TSP.5.1.25, 10.1123/tsp.5.1.25]; Issac A, 1992, SPORT PSYCHOL, V6, P192; JACOBSON E, 1987, AM J PSYCHOL, V100, P522, DOI 10.2307/1422693; Janelle C., 2001, HDB SPORT PSYCHOL, P497; Johnston LH, 2000, BRIT J SPORT MED, V34, P436, DOI 10.1136/bjsm.34.6.436; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kvist J, 2005, KNEE SURG SPORT TR A, V13, P393, DOI 10.1007/s00167-004-0591-8; Larson G, 1996, SPORT PSYCHOL, V10, P15; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; Mainwaring L, 1999, CAN J REHABIL, V12, P145; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCullough KA, 2012, AM J SPORT MED, V40, P2523, DOI 10.1177/0363546512456836; Mortiz S, 1996, SPORT PSYCHOL, V10, P171; Pargman D, 2007, USE IMAGERY REHABILI; Pavio A, 1985, CAN J APPL SPORT SCI, V10, P22; Podlog L, 2006, J APPL SPORT PSYCHOL, V18, P44, DOI 10.1080/10413200500471319; Podlog L, 2007, PSYCHOL SPORT EXERC, V8, P535, DOI 10.1016/j.psychsport.2006.07.008; Podlog L, 2011, PHYS THER SPORT, V12, P36, DOI 10.1016/j.ptsp.2010.07.005; Potter M, 1999, NZ J PHYSIOTHERAPY, V28, P24; Prentice WE, 2013, ARNHEIMS PRINCIPLES; RODGERS W, 1991, J APPL SPORT PSYCHOL, V3, P109, DOI DOI 10.1080/10413209108406438; Ross MJ, 1996, J CONSULT CLIN PSYCH, V64, P406, DOI 10.1037/0022-006X.64.2.406; Sage G., 1977, INTRO MOTOR BEHAV NE, V2nd; SMITH AM, 1990, MAYO CLIN PROC, V65, P38, DOI 10.1016/S0025-6196(12)62108-9; Sordoni CA, 2002, PHYSIOTHER CAN, V54, P177; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; te Wierike SCM, 2013, SCAND J MED SCI SPOR, V23, P527, DOI 10.1111/sms.12010; Tongue JR, 2005, J BONE JOINT SURG AM, V87A, P652, DOI 10.2106/00004623-200503000-00027; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Tripp DA, 2007, REHABIL PSYCHOL, V52, P74, DOI 10.1037/0090-5550.52.1.74; Troxel R.K., 1986, J NATL ATHLETIC TRAI, V21, P104; Udry E, 1997, J SPORT EXERCISE PSY, V19, P229, DOI 10.1123/jsep.19.3.229; Vealey R, 2006, SEEING IS BELIEVING; Walker N, 2004, COPING AND EMOTION IN SPORT, P91; Walker N, 2007, J R SOC PROMO HEALTH, V127, P174, DOI 10.1177/1466424007079494; Watt A.P., 2004, J MENT IMAG, V28, P149; Weinberg R. S., 2011, FDN SPORT EXERCISE P, V5th; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Williams J, 2006, APPL SPORT PSYCHOL P, P285; Williams JM, 1998, J APPL SPORT PSYCHOL, V10, P5, DOI 10.1080/10413209808406375; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	64	22	25	6	89	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	APR	2015	34	2					199	+		10.1016/j.csm.2014.12.004			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	CG6RM	WOS:000353430100003	25818709				2022-02-06	
J	Li, K; Zhao, H; Liu, WJ; Yin, ZY				Li, Kui; Zhao, Hui; Liu, Wenjun; Yin, Zhiyong			Material Properties and Constitutive Modeling of Infant Porcine Cerebellum Tissue in Tension at High Strain Rate	PLOS ONE			English	Article							BRAIN-TISSUE; MECHANICAL-PROPERTIES; IN-VIVO; DEFORMATION; COMPRESSION; ELASTICITY; WHITE	Background The mechanical characterization of infant porcine cerebellum tissue in tension at high strain rate is crucial for modeling traumatic cerebellum injury, which is in turn helpful for understanding the biomechanics of such injuries suffered in traffic accidents. Material and Method In this study, the infant porcine cerebellum tissue was given three loading velocities, ie, 2s(-1), 20s(-1) and 100s(-1) with up to 30% strain to investigate the tensile properties. At least six tensile tests for each strain rate were validly performed. Fung, Gent, Ogden and exponential models were applied to fit the constitutive equations, so as to obtain material parameters from the experimental data. Results The Lagrange stress of infant porcine cerebellum tissue in tension appeared to be no more than 3000Pa at each loading velocity. More specifically, the Lagrange stress at 30% strain was (393.7 +/- 84.4) Pa, (928.3 +/- 56.3) Pa and (2582.4 +/- 282.2) Pa at strain rates of 2s(-1), 20s(-1) and 100s(-1), respectively. Fung (0.833 <= R-2 <= 0.924), Gent (0.797 <= R-2 <= 0.875), Ogden (0.859 <= R-2 <= 0.944) and exponential (0.930 <= R-2 <= 0.972) models provided excellent fitting to experimental data up to 30% strain. Conclusions The infant cerebellum tissue shows a stiffer response with increase of the loading speed, indicating a strong strain-rate sensitivity. This study will enrich the knowledge on the material properties of infant brain tissue, which may augment the biofidelity of finite element model of human pediatric cerebellum.	[Li, Kui; Zhao, Hui; Liu, Wenjun; Yin, Zhiyong] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Inst Traff Med,Dept 4, Chongqing 400042, Peoples R China		Yin, ZY (corresponding author), Third Mil Med Univ, Inst Surg Res, Daping Hosp, Inst Traff Med,Dept 4, Chongqing 400042, Peoples R China.	yinzhiyong86@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [1271006, 31470913]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education MinistryScientific Research Foundation for the Returned Overseas Chinese Scholars	This paper was supported by grants from National Natural Science Foundation of China (No. 1271006, No. 31470913), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bilston LE, 2011, BIOL MED PHYS BIOMED, P69, DOI 10.1007/978-1-4419-9997-9_4; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; FUNG YC, 1979, AM J PHYSIOL, V237, pH620, DOI 10.1152/ajpheart.1979.237.5.H620; FUNG YCB, 1967, AM J PHYSIOL, V213, P1532, DOI 10.1152/ajplegacy.1967.213.6.1532; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Margulies SS, 2013, PEDIAT INJURY BIOMEC, P157; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2001, J BIOMECH, V34, P651, DOI 10.1016/S0021-9290(00)00236-0; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Ogden R.W., 1997, NONLINEAR ELASTIC DE; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2013, J BIOMECH, V46, P1276, DOI 10.1016/j.jbiomech.2013.02.014; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tamura A, 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	28	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123506	10.1371/journal.pone.0123506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	WOS:000352135600148	25830545	Green Submitted, gold, Green Published			2022-02-06	
J	Wasserman, EB; Shah, MN; Jones, CMC; Cushman, JT; Caterino, JM; Bazarian, JJ; Gillespie, SM; Cheng, JD; Dozier, A				Wasserman, Erin B.; Shah, Manish N.; Jones, Courtney M. C.; Cushman, Jeremy T.; Caterino, Jeffrey M.; Bazarian, Jeffrey J.; Gillespie, Suzanne M.; Cheng, Julius D.; Dozier, Ann			IDENTIFICATION OF A NEUROLOGIC SCALE THAT OPTIMIZES EMS DETECTION OF OLDER ADULT TRAUMATIC BRAIN INJURY PATIENTS WHO REQUIRE TRANSPORT TO A TRAUMA CENTER	PREHOSPITAL EMERGENCY CARE			English	Article						brain injuries; triage; emergency medical services; geriatrics	GLASGOW COMA SCALE; SIMPLIFIED MOTOR SCORE; EMERGENCY-DEPARTMENT; PREDICTING SURVIVAL; UNITED-STATES; OUTCOME SCALE; HEAD-INJURY; NOS-TBI; MORTALITY; DEMENTIA	Objective. We sought to identify a scale or components of a scale that optimize detection of older adult traumatic brain injury (TBI) patients who require transport to a trauma center, regardless of mechanism. Methods. We assembled a consensus panel consisting of nine experts in geriatric emergency medicine, prehospital medicine, trauma surgery, geriatric medicine, and TBI, as well as prehospital providers, to evaluate the existing scales used to identify TBI. We reviewed the relevant literature and solicited group feedback to create a list of candidate scales and criteria for evaluation. Using the nominal group technique, scales were evaluated by the expert panel through an iterative process until consensus was achieved. Results. We identified 15 scales for evaluation. The panel's criteria for rating the scales included ease of administration, prehospital familiarity with scale components, feasibility of use with older adults, time to administer, and strength of evidence for their performance in the prehospital setting. After review and discussion of aggregated ratings, the panel identified the Simplified Motor Scale, GCS-Motor Component, and AVPU (alert, voice, pain, unresponsive) as the strongest scales, but determined that none meet all EMS provider and patient needs due to poor usability and lack of supportive evidence. The panel proposed that a dichotomized decision scheme that includes domains of the top-rated scales - level of alertness (alert vs. not alert) and motor function (obeys commands vs. does not obey) - may be more effective in identifying older adult TBI patients who require transport to a trauma center in the prehospital setting. Conclusions. Existing scales to identify TBI are inadequate to detect older adult TBI patients who require transport to a trauma center. A new algorithm, derived from elements of previously established scales, has the potential to guide prehospital providers in improving the triage of older adult TBI patients, but needs further evaluation prior to use.	[Wasserman, Erin B.; Shah, Manish N.; Jones, Courtney M. C.; Cushman, Jeremy T.; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Wasserman, Erin B.; Shah, Manish N.; Jones, Courtney M. C.; Bazarian, Jeffrey J.; Dozier, Ann] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA; [Shah, Manish N.; Gillespie, Suzanne M.] Univ Rochester, Sch Med & Dent, Div Geriatr Aging, Rochester, NY USA; [Caterino, Jeffrey M.] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; [Caterino, Jeffrey M.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Cheng, Julius D.] Univ Rochester, Sch Med & Dent, Dept Surg, Rochester, NY USA		Shah, MN (corresponding author), 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA.	manish.shah@rochester.edu		Wasserman, Erin/0000-0001-5957-5878; Cushman, Jeremy/0000-0003-4767-3731; Shah, Manish/0000-0001-6331-1074	NCIPC CDC HHS [U01 CE002175] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002175] Funding Source: NIH RePORTER		Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; American College of Surgeons CoT, 1997, ADV TRAUM LIF SUPP M; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Caterino JM, 2012, EMERG MED J, V29, P492, DOI 10.1136/emj.2010.110437; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Clesham K, 2008, EMERG MED J, V25, P691, DOI 10.1136/emj.2007.054924; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Faul M, 2010, TRAUMATIC BRAIN INJU; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoyt DBR., 2008, TRAUMA, V6th ed., P57; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Levine SD, 2006, J EMERG MED, V31, P1, DOI 10.1016/j.jemermed.2005.08.007; Lloyd-Jones G, 1999, MED EDUC, V33, P8; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 1997, STANDARDIZED ASSESSM; McDowell I, 2006, MEASURING HLTH GUIDE; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mulholland SA, 2005, INJURY, V36, P1298, DOI 10.1016/j.injury.2005.07.010; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; NHS National institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Olsson T, 2003, ACAD EMERG MED, V10, P1040, DOI 10.1197/S1069-6563(03)00342-7; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Price Timothy G, 2005, Prehosp Emerg Care, V9, P322, DOI 10.1080/10903120590962012; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; RHEE KJ, 1987, AM J EMERG MED, V5, P278, DOI 10.1016/0735-6757(87)90350-0; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Roush WR, 1994, PRINCIPLES EMS SYSTE; Sasser SM., 2012, GUIDELINES FIELD TRI; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Sporer KA, 2012, EMERG MED J; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; WINKLER J V, 1984, Journal of Emergency Medicine, V2, P1, DOI 10.1016/0736-4679(84)90038-6	64	22	22	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	APR-JUN	2015	19	2					202	212		10.3109/10903127.2014.959225			11	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Public, Environmental & Occupational Health	CE6LS	WOS:000351948500004	25290953	Green Accepted			2022-02-06	
J	Wolfe, KR; Bigler, ED; Dennis, M; Gerhardt, CA; Rubin, K; Taylor, HG; Vannatta, K; Yeates, KO				Wolfe, Kelly R.; Bigler, Erin D.; Dennis, Maureen; Gerhardt, Cynthia A.; Rubin, Kenneth; Taylor, H. Gerry; Vannatta, Kathryn; Yeates, Keith Owen			Self-Awareness of Peer-Rated Social Attributes in Children With Traumatic Brain Injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						neurological disorders; neuropsychology; peers; psychosocial functioning	QUALITY-OF-LIFE; EVERYDAY ATTENTION; TEA-CH; ADOLESCENTS; COMPETENCE; PATTERNS; RATINGS; ADHD	Objective This study investigated self-awareness of peer-rated social attributes and its relations to executive function (EF), theory of mind (TOM), and psychosocial adjustment in children with traumatic brain injury (TBI). Methods Self-and peer perceptions of classroom social behavior were assessed for 87 children 8-13 years of age: 15 with severe TBI, 40 with complicated mild/moderate TBI, and 32 with orthopedic injury. Participants completed measures of EF and TOM, and parents rated children's psychosocial adjustment. Results Self-ratings of classroom social behavior did not differ between injury groups. Self-and peer ratings generally agreed, although children with severe TBI rated themselves as less rejected/victimized than did their peers. Higher EF predicted better self-and peer ratings and smaller self-peer discrepancies, which in turn predicted better adjustment. Conclusions Children with TBI show variable social self-awareness, which relates to EF and adjustment. Future studies should identify additional factors that contribute to limited insight.	[Wolfe, Kelly R.; Yeates, Keith Owen] Nationwide Childrens Hosp, Dept Psychol, Columbus, OH 43205 USA; [Wolfe, Kelly R.; Gerhardt, Cynthia A.; Vannatta, Kathryn; Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Wolfe, Kelly R.; Gerhardt, Cynthia A.; Vannatta, Kathryn; Yeates, Keith Owen] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada; [Gerhardt, Cynthia A.; Vannatta, Kathryn] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH 43205 USA; [Rubin, Kenneth] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH USA		Wolfe, KR (corresponding author), Nationwide Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH 43205 USA.	Kelly.Wolfe@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Rubin, Kenneth H/M-5276-2018	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human Development at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 R01 HD048946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development at the National Institutes of Health (grant number 5 R01 HD048946 to K.O.Y.).	Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BOIVIN M, 1994, DEV PSYCHOPATHOL, V6, P483, DOI 10.1017/S0954579400006064; Bowker JCW, 2006, MERRILL PALMER QUART, V52, P671, DOI 10.1353/mpq.2006.0000; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; de Castro BO, 2007, J ABNORM CHILD PSYCH, V35, P165, DOI 10.1007/s10802-006-9063-6; De Los Reyes A, 2013, ANNU REV CLIN PSYCHO, V9, P123, DOI 10.1146/annurev-clinpsy-050212-185617; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleming J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI [https://doi.org/10.1177/030802269505800204, DOI 10.1177/030802269505800204]; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Gresham FM, 2000, J SCHOOL PSYCHOL, V38, P151, DOI 10.1016/S0022-4405(99)00042-4; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Harrison P.L., 2003, ABAS 2 ADAPTIVE BEHA, V2nd ed.; Hayes, 2018, INTRO MEDIATION MODE; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; Howard I, 2005, ETHNIC DIS, V15, pS51; Krueger CE, 2011, CLIN NEUROPSYCHOL, V25, P741, DOI 10.1080/13854046.2011.569759; Laird RD, 2013, J ABNORM CHILD PSYCH, V41, P1, DOI 10.1007/s10802-012-9659-y; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Mikami AY, 2010, J CLIN CHILD ADOLESC, V39, P373, DOI 10.1080/15374411003691735; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rubin KH, 2006, J ABNORM CHILD PSYCH, V34, P143, DOI 10.1007/s10802-005-9017-4; Salley CG, 2010, SELF IDENTITY, V9, P209, DOI 10.1080/15298860902979224; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Zakriski AL, 1996, CHILD DEV, V67, P1048, DOI 10.2307/1131879	45	22	22	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR	2015	40	3			SI		272	284		10.1093/jpepsy/jsu060			13	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	CF3YT	WOS:000352485700002	25080604	Bronze, Green Published			2022-02-06	
J	Zhang, BF; Wang, J; Liu, ZW; Zhao, YL; Li, DD; Huang, TQ; Gu, H; Song, JN				Zhang, Bin-Fei; Wang, Jiao; Liu, Zun-Wei; Zhao, Yong-Lin; Li, Dan-Dong; Huang, Ting-Qin; Gu, Hua; Song, Jin-Ning			Meta-Analysis of the Efficacy and Safety of Therapeutic Hypothermia in Children with Acute Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Arrhythmia; Children; Hypothermia; Meta-analysis; Mortality; Traumatic brain injury	MODERATE HYPOTHERMIA; HEAD-INJURY; ADULTS; TRIAL	OBJECTIVE: To evaluate the efficacy and safety of therapeutic hypothermia in children with acute traumatic brain injury (TBI). METHODS: A systematic literature review using PubMed, Embase, Cochrane Library, Chinese National Knowledge Infrastructure, Wanfang, VIP, and Chinese Biomedical Database was performed to retrieve studies of randomized controlled trials (RCTs) on therapeutic hypothermia for children with TBI published before March 2014. Data extraction and quality evaluation of RCTs were performed by 2 investigators independently. A meta-analysis was performed by RevMan 5.2.7. RESULTS: There were 7 RCTs comprising 442 children (218 in hypothermia group and 224 in normothermia group). Meta-analysis showed therapeutic hypothermia could increase mortality compared with the normothermia group (relative risk [RR][1.84, 95% confidence interval [CI][1.15-2.93, P = 0.01). On the Glasgow Outcome Scale (GOS), the following scores did not differ between the hypothermia group and normothermia group: 3-month GOS 4-5 (RR = 0.89, 95% CI = 0.68-1.16, P = 0.39), 3-month GOS 1-3 (RR = 1.19, 95% CI = 0.80-1.76, P = 0.39), 6-month GOS 4e5 (RR = 0.91, 95% CI = 0.78-1.07, P = 0.26), and 6-month GOS 1-3 (RR = 1.18, 95% CI = 0.88-1.59, P = 0.27). Hypothermia did not increase the rate of pneumonia (RR = 0.84, 95% CI = 0.63-1.12, P = 0.23) or bleeding (RR = 0.94, 95% CI = 0.39-2.26, P = 0.89), but the incidence of arrhythmias was higher in the hypothermia group (RR = 2.60, 95% CI = 1.06-6.41, P = 0.04). CONCLUSIONS: No benefit of therapeutic hypothermia in children with TBI is shown in this study; therapeutic hypothermia may increase the risk of mortality and arrhythmia. There is no evidence that therapeutic hypothermia improves prognosis of children with TBI; there is also no evidence that therapeutic hypothermia increases the risk of pneumonia and coagulation dysfunction. These results are limited by the quality of the included studies and need to be considered with caution. Further large-scale, well-designed RCTs on this topic are needed.	[Zhang, Bin-Fei; Liu, Zun-Wei; Zhao, Yong-Lin; Li, Dan-Dong; Huang, Ting-Qin; Gu, Hua; Song, Jin-Ning] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Xian, Shaanxi, Peoples R China; [Wang, Jiao] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Pediat, Xian, Shaanxi, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Xian, Shaanxi, Peoples R China.	jinningsong@126.com		Li, Dan-Dong/0000-0003-4973-8818	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870844]; Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" [2008ZDKG-66]; Special Research Fund for the Doctoral Disciplinary Points in Universities of Ministry of Education [20110201110060]	This work was supported by the National Natural Science Foundation of China (Grant No. 30870844), the Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" (Grant No. 2008ZDKG-66), and the Special Research Fund for the Doctoral Disciplinary Points in Universities of Ministry of Education (Grant No. 20110201110060).	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Armitage P., 2008, STAT METHODS MED RES, P83; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Higgins J.P.T., 2011, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI [10.1089/neu.2008.0828, 10.1089/neu.2008-0828]; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Mtaweh H, 2014, PEDIATR CRIT CARE ME, V15, P242, DOI 10.1097/PCC.0000000000000041; Milani WRO, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006638.pub2; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741	21	22	23	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2015	83	4					567	573		10.1016/j.wneu.2014.12.010			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CG1NJ	WOS:000353039500035	25514616				2022-02-06	
J	Zygourakis, CC; Kahn, JG				Zygourakis, Corinna C.; Kahn, James G.			Cost-Effectiveness Research in Neurosurgery	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Cost-effectiveness; Cost-utility; QALY; Neurosurgery; Spine surgery	LUMBAR INTERBODY FUSION; INTERVENTION CLINICAL ARTICLE; ANTERIOR CERVICAL DISKECTOMY; ADJACENT-SEGMENT DISEASE; TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; UTILITY ANALYSIS; STEREOTACTIC RADIOSURGERY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL ANEURYSMS	Cost and value are increasingly important components of health care discussions. Despite a plethora of cost and cost-effectiveness analyses in many areas of medicine, there has been little of this type of research for neurosurgical procedures. This scarcity is vexing because this specialty represents one of the most expensive areas in medicine. This article discusses the general principles of cost-effectiveness analyses and reviews the cost- and cost-effectiveness-related research to date in neurosurgical subspecialties. The need for standardization of cost and cost-effectiveness measurement and reporting within neurosurgery is highlighted and a set of metrics for this purpose is defined.	[Zygourakis, Corinna C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Kahn, James G.] Univ Calif San Francisco, Global Hlth Econ Consortium, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94118 USA		Zygourakis, CC (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,Room 779M, San Francisco, CA 94143 USA.	zygourakisc@neurosurg.ucsf.edu					Adogwa O, 2013, J NEUROSURG-SPINE, V18, P147, DOI 10.3171/2012.11.SPINE12226; Adogwa O, 2012, J NEUROSURG-SPINE, V16, P141, DOI 10.3171/2011.9.SPINE11419; Adogwa O, 2012, J NEUROSURG-SPINE, V16, P135, DOI 10.3171/2011.9.SPINE11308; Adogwa O, 2011, J NEUROSURG-SPINE, V15, P138, DOI 10.3171/2011.3.SPINE10562; Al-Khouja LT, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.4.FOCUS1449; Alali AS, 2014, CRIT CARE MED, V42, P2235, DOI 10.1097/CCM.0000000000000500; Alvin MD, 2014, J SPINAL DISORD TECH; [Anonymous], COST EFFECTIVENESS T; Arts MP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-122; Banerjee R, 2008, J NEUROSURG, V108, P1220, DOI 10.3171/JNS/2008/108/6/1220; Bowen James M, 2012, Ont Health Technol Assess Ser, V12, P1; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brill Steven, 2013, Time, V181, P16; Brown DA, 2014, SPINE, V39, pE902, DOI 10.1097/BRS.0000000000000395; Burnett MG, 2010, J NEUROSURG-SPINE, V13, P39, DOI 10.3171/2010.3.SPINE09552; Cho DY, 2006, NEUROSURGERY, V58, P866, DOI 10.1227/01.NEU.0000209892.42585.9B; Vuong DA, 2013, CLIN NEUROL NEUROSUR, V115, P276, DOI 10.1016/j.clineuro.2012.05.005; Vuong DA, 2012, WORLD NEUROSURG, V77, P321, DOI 10.1016/j.wneu.2011.05.050; Fehlings MG, 2014, SPINE, V39, pS99, DOI [10.1097/BRS.0000000000000525, 10.1097/BRS.0000000000000390]; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; Fransen P, 2012, ACTA NEUROL BELG, V112, P245, DOI 10.1007/s13760-012-0095-0; Furlan JC, 2012, NEURO-ONCOLOGY, V14, P631, DOI 10.1093/neuonc/nos062; Greving JP, 2009, NEUROLOGY, V73, P258, DOI 10.1212/01.wnl.0b013e3181a2a4ea; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Hofmeijer J, 2013, STROKE, V44, P2923, DOI 10.1161/STROKEAHA.113.002445; Hoh BL, 2010, STROKE, V41, P337, DOI 10.1161/STROKEAHA.109.569269; Holmes MW, 2013, ARCH DIS CHILD, V98, P939, DOI 10.1136/archdischild-2012-302820; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Jabbarli R, 2014, NEURORADIOLOGY, V56, P817, DOI 10.1007/s00234-014-1406-3; Jethwa PR, 2013, NEUROSURGERY, V72, P511, DOI 10.1227/NEU.0b013e318282a578; KING JT, 1995, J NEUROSURG, V83, P403, DOI 10.3171/jns.1995.83.3.0403; King JT, 1997, J NEUROSURG, V87, P20, DOI 10.3171/jns.1997.87.1.0020; Koffijberg H, 2011, J NEUROL NEUROSUR PS, V82, P718, DOI 10.1136/jnnp.2009.185660; Lee WY, 2009, J CLIN NEUROSCI, V16, P630, DOI 10.1016/j.jocn.2008.06.021; Lester SC, 2014, CANCER-AM CANCER SOC, V120, P433, DOI 10.1002/cncr.28422; Long DM, 2003, NEUROSURGERY, V52, P1056, DOI 10.1227/01.NEU.0000057745.48813.93; Makary M, 2011, J MAGN RESON IMAGING, V34, P1022, DOI 10.1002/jmri.22739; Malmivaara K, 2012, EUR J NEUROL, V19, P1455, DOI 10.1111/j.1468-1331.2012.03744.x; Malmivaara K, 2011, EUR J NEUROL, V18, P656, DOI 10.1111/j.1468-1331.2010.03294.x; Marko NF, 2012, J NEUROSURG, V117, P522, DOI 10.3171/2012.4.JNS11739; Martino J, 2013, ACTA NEUROCHIR, V155, P41, DOI 10.1007/s00701-012-1541-8; Maud A, 2009, J NEUROSURG, V110, P880, DOI 10.3171/2008.8.JNS0858; McCarthy IM, 2014, SPINE J, V14, P2326, DOI 10.1016/j.spinee.2014.01.032; Mehta M, 1997, INT J RADIAT ONCOL, V39, P445, DOI 10.1016/S0360-3016(97)00071-0; Mendez I, 2001, CAN J NEUROL SCI, V28, P61; Mukherjee D, 2013, J CLIN NEUROSCI, V20, P57, DOI 10.1016/j.jocn.2012.05.014; Ney JP, 2013, J CLIN NEUROPHYSIOL, V30, P280, DOI 10.1097/WNP.0b013e3182933d8f; Nussbaum ES, 1996, NEUROSURGERY, V38, P237, DOI 10.1097/00006123-199602000-00001; Overdevest GM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-57; Papatheofanis FJ, 2009, NEUROSURGERY, V64, pA73, DOI 10.1227/01.NEU.0000341205.37067.DE; Parker SL, 2011, MINIM INVAS NEUROSUR, V54, P33, DOI 10.1055/s-0030-1269904; Parker SL, 2014, WORLD NEUROSURG, V82, P230, DOI 10.1016/j.wneu.2013.01.041; Parker SL, 2013, J SPINAL DISORD TECH, V26, P42, DOI 10.1097/BSD.0b013e318232313d; Parker SL, 2012, NEUROSURGERY, V71, P1149, DOI 10.1227/NEU.0b013e318271ebde; Parker SL, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.09.013; PICKARD JD, 1990, BRIT MED J, V301, P629, DOI 10.1136/bmj.301.6753.629; Pollock BE, 2005, CLIN J PAIN, V21, P317, DOI 10.1097/01.ajp.0000125267.40304.57; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rasanen P, 2006, J NEUROSURG-SPINE, V5, P204, DOI 10.3171/spi.2006.5.3.204; Ray WZ, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.4.FOCUS1289; Sanborn MR, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.2.FOCUS121; Sivakanthan S, 2014, NEUROSURGERY, V75, P220, DOI 10.1227/NEU.0000000000000430; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Sonig A, 2012, NEUROSURG FOCUS, V33, pE3, DOI DOI 10.3171/2012.7.F0CUS12193; Sulaiman WAR, 2014, OCHSNER J, V14, P32; Tan SS, 2011, J NEURO-ONCOL, V101, P237, DOI 10.1007/s11060-010-0243-4; Terran J, 2014, OCHSNER J, V14, P14; Tosteson ANA, 2008, SPINE, V33, P2108, DOI 10.1097/BRS.0b013e318182e390; Tosteson ANA, 2008, ANN INTERN MED, V149, P845, DOI 10.7326/0003-4819-149-12-200812160-00003; Tumeh John W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P153, DOI 10.1586/14737167.5.2.153; Tumialan LM, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09305; Undabeitia J, 2011, NEUROCIRUGIA, V22, P535, DOI 10.4321/S1130-14732011000600006; vanRoijen L, 1997, ACTA NEUROCHIR, V139, P942, DOI 10.1007/BF01411303; Virk SS, 2014, J SPINAL DISORD TECH; Vogel TW, 2014, J NEUROSURG-PEDIATR, V13, P324, DOI 10.3171/2013.12.PEDS13320; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; Wellis G, 2003, ACTA NEUROCHIR, V145, P249, DOI 10.1007/s00701-003-0007-4; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Whitmore RG, 2012, NEUROSURGERY, V70, P860, DOI 10.1227/NEU.0b013e3182367272; Widjaja E, 2011, EPILEPSY RES, V94, P61, DOI 10.1016/j.eplepsyres.2011.01.005; World Health Organization, 2003, INTRODUCTION TO DRUG; Zhen Jing-Ran, 2008, Zhonghua Fu Chan Ke Za Zhi, V43, P257; Zhu XL, 2014, WORLD NEUROSURG; Zygourakis C, SURGERY IS MORE COST; Zygourakis CC, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14435	85	22	22	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2015	26	2					189	+		10.1016/j.nec.2014.11.008			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CF4KU	WOS:000352518800007	25771274				2022-02-06	
J	Dayan, PS; Holmes, JF; Hoyle, J; Atabaki, S; Tunik, MG; Lichenstein, R; Miskin, M; Kuppermann, N				Dayan, Peter S.; Holmes, James F.; Hoyle, John, Jr.; Atabaki, Shireen; Tunik, Michael G.; Lichenstein, Richard; Miskin, Michelle; Kuppermann, Nathan		PECARN	Headache in Traumatic Brain Injuries From Blunt Head Trauma	PEDIATRICS			English	Article							DECISION RULE; INTRACRANIAL INJURY; COMPUTED-TOMOGRAPHY; CHILDREN; PREDICTION; VARIABLES	OBJECTIVE: To determine the risk of traumatic brain injuries (TBIs) in children with headaches after minor blunt head trauma, particularly when the headaches occur without other findings suggestive of TBIs (ie, isolated headaches). METHODS: This was a secondary analysis of a prospective observational study of children 2 to 18 years with minor blunt head trauma (ie, Glasgow Coma Scale scores of 14-15). Clinicians assessed the history and characteristics of headaches at the time of initial evaluation, and documented findings onto case report forms. Our outcome measures were (1) clinically important TBI (ciTBI) and (2) TBI visible on computed tomography (CT). RESULTS: Of 27 495 eligible patients, 12 675 (46.1%) had headaches. Of the 12 567 patients who had complete data, 2462 (19.6%) had isolated headaches. ciTBIs occurred in 0 of 2462 patients (0%; 95% confidence interval [CI]: 0%-0.1%) in the isolated headache group versus 162 of 10 105 patients (1.6%; 95% CI: 1.4%-1.9%) in the nonisolated headache group (risk difference, 1.6%; 95% CI: 1.3%-1.9%). TBIs on CT occurred in 3 of 456 patients (0.7%; 95% CI: 0.1%-1.9%) in the isolated headache group versus 271 of 6089 patients (4.5%; 95% CI: 3.9%-5.0%) in the nonisolated headache group (risk difference, 3.8%; 95% CI: 2.3%-4.5%). We found no significant independent associations between the risk of ciTBI or TBI on CT with either headache severity or location. CONCLUSIONS: ciTBIs are rare and TBIs on CT are very uncommon in children with minor blunt head trauma when headaches are their only sign or symptom.	[Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Div Pediat Emergency Med, Morgan Stanley Childrens Hosp, New York, NY 10032 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Hoyle, John, Jr.] Helen DeVos Childrens Hosp, Div Emergency Med, Grand Rapids, MI USA; [Hoyle, John, Jr.] Michigan State Univ, Dept Emergency Med, E Lansing, MI 48824 USA; [Hoyle, John, Jr.] Western Michigan Univ, Dept Emergency Med, Sch Med, Kalamazoo, MI 49008 USA; [Hoyle, John, Jr.] Western Michigan Univ, Dept Pediat, Sch Med, Kalamazoo, MI 49008 USA; [Atabaki, Shireen] George Washington Univ, Sch Med, Dept Pediat, Childrens Natl Med Ctr, Washington, DC 20052 USA; [Atabaki, Shireen] George Washington Univ, Childrens Natl Med Ctr, Dept Emergency Med, Sch Med, Washington, DC 20052 USA; [Tunik, Michael G.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Tunik, Michael G.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Lichenstein, Richard] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Miskin, Michelle] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA		Dayan, PS (corresponding author), New York Presbyterian Morgan Stanley Childrens Ho, 3959 Broadway,CHN-1-116, New York, NY 10032 USA.	psd6@columbia.edu		Holubkov, Richard/0000-0003-0431-3381; Tsung, James/0000-0002-4718-8325; Tunik, Michael/0000-0002-2368-5933	Health Resources and Services Administration (HRSA)/Maternal and Child Health Bureau (MCHB), Division of Research, Education, and Training; Emergency Medical Services of Children (EMSC) [R40MC02461]; EMSC program of the MCHB/HRSA [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, U03MC22685]	Supported by a grant from the Health Resources and Services Administration (HRSA)/Maternal and Child Health Bureau (MCHB), Division of Research, Education, and Training, and the Emergency Medical Services of Children (EMSC) program (R40MC02461). The Pediatric Emergency Care Applied Research Network is supported by cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, and U03MC22685 from the EMSC program of the MCHB/HRSA.	Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Frush DP, 2008, PEDIATR RADIOL, V38, pS629, DOI 10.1007/s00247-008-1006-7; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; National Center for Injury Prevention and Control, TRAUM BRAIN INJ US; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Raghunathan T.E., 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186; Rubin D.B., 1987, MULTIPLE IMPUTATION; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Sun BCH, 2007, ANN EMERG MED, V49, pe1; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032	24	22	23	0	1	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAR	2015	135	3					504	512		10.1542/peds.2014-2695			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CF0BD	WOS:000352206600050	25647678				2022-02-06	
J	Mata-Mbemba, D; Mugikura, S; Nakagawa, A; Murata, T; Kato, Y; Tatewaki, Y; Li, L; Takase, K; Ishii, K; Kushimoto, S; Tominaga, T; Takahashi, S				Mata-Mbemba, Daddy; Mugikura, Shunji; Nakagawa, Atsuhiro; Murata, Takaki; Kato, Yumiko; Tatewaki, Yasuko; Li, Li; Takase, Kei; Ishii, Kiyoshi; Kushimoto, Shigeki; Tominaga, Teiji; Takahashi, Shoki			Intraventricular Hemorrhage on Initial Computed Tomography as Marker of Diffuse Axonal Injury after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; intraventricular hemorrhage; diffuse axonal injury; computed tomography; corpus callosum	CLOSED-HEAD INJURY; MAGNETIC-RESONANCE; INTRACRANIAL-PRESSURE; CT; MR; PROGNOSIS; CLASSIFICATION; MODERATE; LESIONS	Intraventricular hemorrhage (IVH) on initial computed tomography (CT) was reported to predict lesions of diffuse axonal injury (DAI) in the corpus callosum (CC) on subsequent magnetic resonance imaging (MRI). We aimed to examine the relationship between initial CT findings and DAI lesions detected on MRI as well as the relationship between the severity of IVH (IVH score) and severity of DAI (DAI staging). A consecutive 140 patients with traumatic brain injury (TBI) who underwent MRI within 30 days after onset were revisited. We reviewed their initial CT for the following six findings: Status of basal cistern, status of mid-line shift, epidural hematoma, IVH, subarachnoid hemorrhage, and volume of hemorrhagic mass and IVH score were assigned in each patient. Based on MRI findings, patients were divided into DAI and non-DAI groups and were assigned a DAI staging. Then, to confirm that the IVH on initial CT predicts DAI lesions on MRI, we used multi-variate analysis of the six CT findings, including IVH, and examined the relationship between IVH score and DAI staging. The IVH detected on CT was the only predictor of DAI (p=0.0139). The IVH score and DAI staging showed significant positive correlation (p<0.0003). IVH score in DAI stage 3 (with DAI involving the brain stem; p=0.0025) or stage 2 (with DAI involving CC; p=0.0042) was significantly higher than that of DAI stage 0 (no DAI lesions). In conclusion, IVH on initial CT is the only marker of DAI on subsequent MRI, specifically severe DAI (stage 2 or 3).	[Mata-Mbemba, Daddy; Mugikura, Shunji; Murata, Takaki; Kato, Yumiko; Tatewaki, Yasuko; Li, Li; Takase, Kei; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 9808574, Japan; [Nakagawa, Atsuhiro; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan; [Kushimoto, Shigeki] Tohoku Univ, Grad Sch Med, Div Emergency Med, Sendai, Miyagi 9808574, Japan; [Ishii, Kiyoshi] Sendai City Hosp, Dept Radiol, Sendai, Miyagi, Japan		Mugikura, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mugi@rad.med.tohoku.ac.jp	Mata-Mbemba, Daddy/AAP-3184-2020				ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; JAYAKUMAR PN, 1990, ACTA NEUROCHIR, V106, P48, DOI 10.1007/BF01809332; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; SATO M, 1987, ACTA NEUROCHIR, V88, P95, DOI 10.1007/BF01404144; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	33	22	24	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2015	32	5					359	365		10.1089/neu.2014.3453			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CC0SD	WOS:000350045700008	25026366				2022-02-06	
J	Roiger, T; Weidauer, L; Kern, B				Roiger, Trevor; Weidauer, Lee; Kern, Bryce			A Longitudinal Pilot Study of Depressive Symptoms in Concussed and Injured/Nonconcussed National Collegiate Athletic Association Division I Student-Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						psychology; Center for Epidemiologic Studies Depression Scale; athletic injuries	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PROFESSIONAL FOOTBALL PLAYERS; CLINICAL-OUTCOMES ASSESSMENT; SPORT-RELATED CONCUSSION; SOCIAL SUPPORT; RISK-FACTORS; POSTINJURY DEPRESSION; HEAD-INJURY; FOLLOW-UP	Context: Depression, which affects millions of Americans each year, among them collegiate student-athletes, can be caused by a wide range of circumstances, including sport-related injuries. Objective: To longitudinally examine the extent to which National Collegiate Athletic Association Division I student-athletes demonstrated postinjury depressive symptoms. Design: Descriptive epidemiologic study. Setting: National Collegiate Athletic Association Division I collegiate athletics. Patients or Other Participants: Concussed, injured/nonconcussed, and healthy Division I collegiate student-athletes (aged 18-22 years) competing in men's basketball, football, and wrestling and women's basketball, soccer, and volleyball. Main Outcome Measure(s): Participants completed the Center for Epidemiologic Studies Depression Scale at baseline and at 1 week, 1 month, and 3 months postinjury. We measured differences in depressive scores among concussed, injured/nonconcussed, and healthy participants. Longitudinal changes in postconcussion depressive symptoms were also examined. Results: No differences in baseline depressive symptoms among subgroups were noted. After an increase between baseline and 1 week (4.3, 95% confidence interval [CI] = 0.41, 8.16, P = .02), depressive symptoms in the concussion group decreased between 1 week and 1 month (-2.7, 95% CI = -4.96, -0.47, P = .01) and between 1 week and 3 months (-4.0, 95% CI = -6.50, -1.49, P = .004). The injured/nonconcussed group showed differences between baseline and 1 week (4.6, 95% CI -1.08, 8.17, P = .009) and between baseline and 1 month (3.2, 95% CI = -0.05, 6.30, P = .03). No significant differences were present in depressive symptoms between concussed participants and injured/nonconcussed participants at any of the postinjury time points. Conclusions: Depression may present as a postinjury sequela in Division I collegiate athletes. Athletes who sustain a concussion or other injury resulting in time lost from practice or competition need to be observed carefully for signs and symptoms that may indicate depression. Tools such as the Center for Epidemiologic Studies Depression Scale can be valuable in helping clinicians to recognize and manage depressive symptoms in these individuals.	[Roiger, Trevor; Weidauer, Lee] S Dakota State Univ, Brookings, SD 57007 USA; [Kern, Bryce] Sport & Spine Phys Therapy, Wausau, WI USA		Roiger, T (corresponding author), S Dakota State Univ, Box 2203 SIM 116, Brookings, SD 57007 USA.	trevor.roiger@sdstate.edu					Appaneal RN, 2009, J SPORT EXERCISE PSY, V31, P60, DOI 10.1123/jsep.31.1.60; Armstrong S, 2009, J AM COLL HEALTH, V57, P521, DOI 10.3200/JACH.57.5.521-526; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; CHAN CS, 1988, PERCEPT MOTOR SKILL, V66, P875, DOI 10.2466/pms.1988.66.3.875; Eisenberg D, 2007, AM J ORTHOPSYCHIAT, V77, P534, DOI 10.1037/0002-9432.77.4.534; Giza CC, 2001, J ATHL TRAINING, V36, P228; Green SL, 2001, J APPL SPORT PSYCHOL, V13, P40, DOI 10.1080/10413200109339003; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Kelly W. E., 1999, COLL STUD J, V33, P72, DOI [10.1007/s10964-015-0311-3, DOI 10.1007/S10964-015-0311-3]; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McDonald SA, 1990, SPORT PSYCHOL, V4, P261; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Morgan C, 2003, CYBERPSYCHOL BEHAV, V6, P133, DOI 10.1089/109493103321640329; National Collegiate Athletic Association, 2012, 2012 13 NCAA SPORTS, P121; Parsons JT, 2011, J SPORT REHABIL, V20, P17, DOI 10.1123/jsr.20.1.17; Peden AR, 2001, J AM COLL HEALTH, V49, P299, DOI 10.1080/07448480109596316; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richmond TS, 2009, PSYCHOL MED, V39, P1709, DOI 10.1017/S0033291709005376; Roh YH, 2012, ARCH ORTHOP TRAUM SU, V132, P1251, DOI 10.1007/s00402-012-1545-0; Shean G, 2008, J GENET PSYCHOL, V169, P281, DOI 10.3200/GNTP.169.3.281-292; Smarr K., 2003, ARTHRIT CARE RES, V49, pS134, DOI DOI 10.1002/ART.11410; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; STEIN PJ, 1978, J SOC ISSUES, V34, P136, DOI 10.1111/j.1540-4560.1978.tb02545.x; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Valovich McLeod TC, 2008, J ATHL TRAINING, V43, P437, DOI DOI 10.404/1062-6050-43.4.437; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	40	22	22	1	22	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2015	50	3					256	261		10.4085/1062-6050-49.3.83			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	CQ8AM	WOS:000360828300004	25562455	Bronze, Green Published			2022-02-06	
J	Sinha, S; Raheja, A; Garg, M; Moorthy, S; Agrawal, D; Gupta, DK; Satyarthee, GD; Singh, PK; Borkar, SA; Gurjar, H; Tandon, V; Pandey, RM; Sharma, BS				Sinha, Sumit; Raheja, Amol; Garg, Mayank; Moorthy, Skanda; Agrawal, Deepak; Gupta, Deepak K.; Satyarthee, Guru D.; Singh, Pankaj K.; Borkar, Sachin A.; Gurjar, Hitesh; Tandon, Vivek; Pandey, Ravindra M.; Sharma, Bhawani S.			Decompressive craniectomy in traumatic brain injury: A single-center, multivariate analysis of 1,236 patients at a tertiary care hospital in India	NEUROLOGY INDIA			English	Article						Decompressive craniectomy; outcome; predictors of outcome; traumatic brain injury	SEVERE HEAD-INJURIES; INTRACRANIAL HYPERTENSION; MULTICENTER; MANAGEMENT; SURGERY; AGE	Object: To evaluate the outcome of patients undergoing a decompressive craniectomy (DC) in traumatic brain injury (TBI) and the factors predicting outcome. Materials and Methods: A total of 1,236 patients with TBI operated with a DC from January 2008 to December 2013 at a tertiary care hospital were included in the study. The data from the hospital computerized database was retrospectively analyzed and 324 (45%) patients were followed-up for a mean duration of 25.3 months (range 3-42 months) among the cohort of 720 alive patients. The institute's ethical committee clearance was obtained before the start of the study. Results: There were 81% males with a median age [interquartile range (IQR)] of 32 (23-45) years. The mortality rate and median (IQR) Glasgow outcome score (GOS) at discharge in patients presenting with minor, moderate, and severe head injury were 18%, 5 (4-5); 28%, 4 (1-5); and 47.4%, 2 (1-4), respectively. An overall favorable outcome (GOS 4 and 5) at discharge was observed in 46.5% patients and in 39% patients who presented with severe TBI. Only 7.5% patients were in a persistent vegetative state (PVS), while 78% had an overall favorable outcome at the last follow-up of surviving patients (P < 0.001). On multivariate analysis, the factors predictive of a favorable GOS at discharge were: a younger age (odds ratio (OR) 1.03, confidence interval (CI) = 1.02-1.04; P < 0.001), no pupillary abnormalities at admission (OR 2.28, CI = 1.72-3.02; P < 0.001), absence of preoperative hypotension (OR 1.91, CI = 1.08-3.38; P = 0.02), an isolated TBI (OR 1.42, CI = 1.08-1.86; P=0.01), absence of a preoperative infarct (OR 3.68, CI = 1.74-7.81; P=0.001), presence of a minor head injury (OR 6.33, CI = 4.07-9.86; P <0.001), performing a duraplasty (OR 1.86, CI = 1.20-2.87; P = 0.005) rather than a slit durotomy (OR 3.95, CI = 1.67-9.35; P = 0.002), and, avoidance of a contralateral DC (OR 3.58, CI = 1.90-6.73; P < 0.001) Conclusions: The severity of head injury, performing a duraplasty rather than a slit durotomy, avoidance of a contralateral DC, and the presence of preoperative hypotension, infarct, and/or pupillary asymmetry have the highest odds of predicting the short term GOS at the time of discharge, after a DC in patients with TBI. Although DC carries a high risk of mortality, the probability of the survivors having a favorable outcome is significantly more as compared to those who remain in a PVS.	[Sinha, Sumit; Raheja, Amol; Garg, Mayank; Moorthy, Skanda; Agrawal, Deepak; Gupta, Deepak K.; Satyarthee, Guru D.; Singh, Pankaj K.; Borkar, Sachin A.; Gurjar, Hitesh; Tandon, Vivek; Sharma, Bhawani S.] All India Inst Med Sci, Dept Neurosurg & Gamma Knife, New Delhi 110029, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India		Sinha, S (corresponding author), All India Inst Med Sci, Dept Neurosurg & Gamma Knife, New Delhi 110029, India.	sumitneuro@gmail.com	GARG, RAKESH/H-4591-2011; /AAG-3032-2021	GARG, RAKESH/0000-0001-5842-8024; /0000-0002-5499-0746			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agrawal Deepak, 2012, J Emerg Trauma Shock, V5, P217, DOI 10.4103/0974-2700.99685; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Khan SA, 2014, CHILD NERV SYST, V30, P277, DOI 10.1007/s00381-013-2225-2; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401; Peng R, 1998, AM SURGEON, V64, P950; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	27	22	22	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAR-APR	2015	63	2					175	183		10.4103/0028-3886.156277			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CH9WN	WOS:000354387200010	25947980				2022-02-06	
J	Zemek, R; Eady, K; Moreau, K; Farion, KJ; Solomon, B; Weiser, M; Dematteo, C				Zemek, Roger; Eady, Kaylee; Moreau, Katherine; Farion, Ken J.; Solomon, Beverly; Weiser, Margaret; Dematteo, Carol			Canadian pediatric emergency physician knowledge of concussion diagnosis and initial management	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Concussion; Pediatric; Adolescent; Practice Variation; Guidelines	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; PERSISTENT SYMPTOMS; UNITED-STATES; CHILDREN; GUIDELINES; PLAYERS; IDENTIFICATION	Introduction: The diagnosis of concussion is a critical step in the appropriate management of patients following minor head trauma. The authors hypothesized that wide practice variation exists among pediatric emergency medicine physicians in the application of physical and cognitive rest recommendations following an acute concussion. Methods: The authors developed a 35-item questionnaire incorporating case vignettes to examine pediatric emergency physician knowledge of concussion diagnosis, understanding of initial management using return-to-play/school/work guidelines, use of existing concussion protocols, and perceived barriers to protocol use. Using a modified Dillman technique, the authors distributed an online survey to members of Pediatric Emergency Research Canada, a national association of pediatric emergency physicians. Results: Of 176 potential participants, 115 (65%) responded to the questionnaire, 89% (95% confidence interval [CI]: 0.81, 0.93) of whom reported having diagnosed 20 or more concussions annually. Although 90% (95% CI: 0.83, 0.94) of respondents adequately diagnosed concussion, only 64% (95% CI: 0.54, 0.72) correctly applied graduated return-to-play guidelines. Cognitive rest recommendations were also frequently limited: 40% (95% CI: 0.31, 0.49) did not recommend school absence, 30% (95% CI: 0.22, 0.39) did not recommend schoolwork reduction, and 35% (95% CI: 0.27, 0.45) did not recommend limiting screen time. Eighty percent (95% CI: 0.72, 0.87) of respondents reported having used guidelines frequently or always to guide clinical decisions regarding concussion. Conclusion: Despite a proficiency in the diagnosis of concussion, pediatric emergency physicians exhibit wide variation in recommending the graduated return to play and cognitive rest following concussion.	[Zemek, Roger; Farion, Ken J.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Zemek, Roger; Farion, Ken J.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Emergency Med, Ottawa, ON K1N 6N5, Canada; [Eady, Kaylee; Moreau, Katherine] Univ Ottawa, Childrens Hosp Eastern Ontario, Clin Res Unit, Ottawa, ON K1N 6N5, Canada; [Solomon, Beverly] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Weiser, Margaret] Univ Western Ontario, Parkwood Hosp, Dept Psychol, Acquired Brain Injury Program, London, ON, Canada; [Dematteo, Carol] McMaster Univ, CanChild Ctr Childhood Disabil Res, Sch Rehabil Sci, Hamilton, ON, Canada		Zemek, R (corresponding author), Childrens Hosp Eastern Ontario, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Meijer, Anna/K-5118-2016; Zemek, Roger/H-1039-2018				Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Canadian Medical Association (CMA), 2011, HEAD INJ SPORT; Carroll L J, 2011, CONCUSSION CRISIS AN; Centers for Disease Control (CDC) Atlanta, HEADS TOOLK PHYS; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dillman DA., 2000, MAIL INTERNET SURVEY; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hill CA, 2006, WESTERN J NURS RES, V28, P322, DOI 10.1177/0193945905284723; IBM, 2012, SPSS SOFTW; Inc Ci, 2012, FLUIDSURVEYS; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	49	22	23	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	MAR	2015	17	2					115	122		10.1017/cem.2014.38			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CE8LY	WOS:000352095100003	25927255	Bronze			2022-02-06	
J	Kiernan, PT; Montenigro, PH; Solomon, TM; McKee, AC				Kiernan, Patrick T.; Montenigro, Philip H.; Solomon, Todd M.; McKee, Ann C.			Chronic Traumatic Encephalopathy: A Neurodegenerative Consequence of Repetitive Traumatic Brain Injury	SEMINARS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; traumatic brain injury; tauopathy; TDP-43; Alzheimer disease	CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; AXONAL INJURY; AMYLOID-BETA; MOUSE MODEL; TAU PATHOLOGY; NEUROFIBRILLARY TANGLES; COGNITIVE IMPAIRMENT; DOCOSAHEXAENOIC ACID; MULTIPLE EPISODES	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease that develops as a result of repetitive mild traumatic brain injury. Chronic traumatic encephalopathy is characterized by a unique pattern of accumulation of hyperphosphorylated tau in neurons and astrocytes. The tau abnormalities begin focally and perivascularly at the depths of the cerebral sulci, spread to the superficial layers of the adjacent cortex, and eventually become widespread throughout the medial temporal lobes, diencephalon, and brainstem. Abnormalities in 43 kDa TAR DNA-binding protein are also found in most cases of CTE. To date, CTE can only be diagnosed by postmortem neuropathological examination, although there are many ongoing research studies examining imaging techniques and biomarkers that might prove to have diagnostic utility. Currently, the incidence and prevalence of CTE are unknown, although great strides are being made to better understand the clinical symptoms and signs of CTE. Further research is critically needed to better identify the genetic and environmental risk factors for CTE as well as potential rehabilitation and therapeutic strategies.	[Kiernan, Patrick T.; Montenigro, Philip H.; Solomon, Todd M.; McKee, Ann C.] Boston Univ, Chron Traumat Encephalopathy Ctr, Boston, MA 02215 USA; [Montenigro, Philip H.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Solomon, Todd M.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Solomon, Todd M.; McKee, Ann C.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02215 USA; [McKee, Ann C.] VA Boston Healthcare Syst, Jamaica Plain, MA USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol & Lab Sci, Boston, MA 02118 USA		McKee, AC (corresponding author), VA Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.	amckee@bu.edu		Montenigro, Philip/0000-0003-4442-9207	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01N5086659-01]; Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS); Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; National Institute of Aging Boston University Framingham Heart Study [R01 (AG1649)]; National Operating Committee on Standards for Athletic Equipment (NOCSAE); Sports Legacy Institute; Andlinger Foundation; WWE (World Wrestling Entertainment); National Football League (NFL); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA). We also gratefully acknowledge the help of all members of the Chronic Traumatic Encephalopathy Center at Boston University, the Boston VA, as well as the individuals and families whose participation and contributions made this work possible. This work was supported by the National Institute of Neurological Disorders and Stroke (1U01N5086659-01), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS), Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), the National Institute of Aging Boston University Framingham Heart Study R01 (AG1649), the National Operating Committee on Standards for Athletic Equipment (NOCSAE), and the Sports Legacy Institute. This work was also supported by unrestricted gifts from the Andlinger Foundation, the WWE (World Wrestling Entertainment), and the National Football League (NFL).	Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; [Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; Au R, 2012, CURR ALZHEIMER RES, V9, P673; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Biros MH, 1999, ACAD EMERG MED, V6, P1088, DOI 10.1111/j.1553-2712.1999.tb00109.x; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Constantinidis J, 1967, Schweiz Arch Neurol Neurochir Psychiatr, V100, P117; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GORELL JM, 1994, NEUROLOGY, V44, P1865, DOI 10.1212/WNL.44.10.1865; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Harada R, 2013, EUR J NUCL MED MOL I, V40, P125, DOI 10.1007/s00259-012-2261-2; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jicha GA, 2010, J ALZHEIMERS DIS, V19, P253, DOI 10.3233/JAD-2010-1237; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lado WE, 2003, PERCEPT MOTOR SKILL, V97, P1115, DOI 10.2466/PMS.97.7.1115-1127; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; MCCOWN IA, 1959, JAMA-J AM MED ASSOC, V169, P1409, DOI 10.1001/jama.1959.03000300005002; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakajima Y, 2010, TOHOKU J EXP MED, V221, P229, DOI 10.1620/tjem.221.229; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; OLSSON Y, 1971, ACTA NEUROPATHOL, V19, P225, DOI 10.1007/BF00684599; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Sotiropoulos I, 2008, J NEUROCHEM, V107, P385, DOI 10.1111/j.1471-4159.2008.05613.x; Sotiropoulos I, 2011, J NEUROSCI, V31, P7840, DOI 10.1523/JNEUROSCI.0730-11.2011; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strong MJ, 2011, J MOL NEUROSCI, V45, P648, DOI 10.1007/s12031-011-9609-0; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Waite LM, 1997, MED J AUSTRALIA, V167, P429, DOI 10.5694/j.1326-5377.1997.tb126655.x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	113	22	22	16	38	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					20	28		10.1055/s-0035-1545080			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC4AP	WOS:000350293300005	25714864				2022-02-06	
J	Walsh, KS; Paltin, I; Gioia, GA; Isquith, P; Kadan-Lottick, NS; Neglia, JP; Brouwers, P				Walsh, Karin S.; Paltin, Iris; Gioia, Gerard A.; Isquith, Peter; Kadan-Lottick, Nina S.; Neglia, Joseph P.; Brouwers, Pim			Everyday executive function in standard-risk acute lymphoblastic leukemia survivors	CHILD NEUROPSYCHOLOGY			English	Article						Central nervous system; Neuropsychology; Leukemia; Neurobehavioral manifestations; Survivors	TRAUMATIC BRAIN-INJURY; ACUTE LYMPHOCYTIC-LEUKEMIA; LONG-TERM SURVIVORS; CHILDHOOD LEUKEMIA; COGNITIVE IMPAIRMENT; CRANIAL IRRADIATION; CHILDREN; CHEMOTHERAPY; PERFORMANCE; ATTENTION	We aimed to evaluate parent-rated executive function (EF) in pediatric standard risk acute lymphoblastic leukemia (SR-ALL) survivors compared to a healthy comparison (HC) group. We hypothesized that SR-ALL survivors would have greater reported executive dysfunction compared to HC, and that those younger at the time of treatment would demonstrate greater EF difficulties. A sample of 256 SR-ALL survivors evaluated an average nine years after treatment were compared to HC matched for gender, assessment age, and maternal education. Profile analysis was used to compare the groups across EF scales on the BRIEF. The prevalence of clinical elevations in the groups was compared via chi square, and odds ratios were calculated. Regression models were applied to examine the role of age at diagnosis and age at assessment in reported EF. Results indicated that SR-ALL survivors' mean scores of EF are similar to HC, except for flexibility and initiation. Survivors were rated as having clinical impairments with flexibility, initiation, working memory, and emotional control at rates two to three times that of HC. The risk of working memory and self-monitoring deficits was greater in survivors who were older when assessed. There was no relationship between age at diagnosis or treatment regimen on EF. These findings suggest sparing of extensive and severe EF deficits in SR-ALL survivors overall. However, a subset of survivors displays clinically significant executive dysfunction. There appears to be a heightened susceptibility to disrupted metacognitive functions as survivors age. This has implications for how we monitor neurocognitive development and functioning of SR-ALL survivors, and highlights opportunities for cognitive interventions.	[Walsh, Karin S.; Gioia, Gerard A.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Walsh, Karin S.; Gioia, Gerard A.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Paltin, Iris] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Paltin, Iris] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Isquith, Peter] Geisel Sch Med Dartmouth, Norwich, VT USA; [Kadan-Lottick, Nina S.] Yale Univ, Sch Med, New Haven, CT USA; [Kadan-Lottick, Nina S.] Yale Sect Pediat Hematol Oncol, New Haven, CT USA; [Neglia, Joseph P.] Univ Minnesota, Amplatz Childrens Hosp, Minneapolis, MN USA; [Brouwers, Pim] Baylor Coll Med, Houston, TX 77030 USA; [Brouwers, Pim] NIMH, Div AIDS Res, NIH, Rockville, MD 20857 USA		Walsh, KS (corresponding author), Childrens Natl Med Ctr, 111 Michigan Ave, Washington, DC 20010 USA.	kwalsh@childrensnational.org	Isquith, Peter/AAY-4851-2020	Kadan-Lottick, Nina/0000-0002-6857-396X; Walsh, Karin/0000-0001-9637-2164; Neglia, Joseph/0000-0002-5525-0598	American Cancer SocietyAmerican Cancer Society; St. Baldrick's Foundation	This study was supported by research funding by the American Cancer Society to Joseph Neglia and Nina Kadan-Lottick. Dr. Kadan-Lottick's effort was additionally funded as a St. Baldrick's Foundation Scholar.	Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Andrews K, 2001, J PEDIATR PSYCHOL, V26, P1, DOI 10.1093/jpepsy/26.1.1; Buizer AI, 2006, CANCER, V106, P2067, DOI 10.1002/cncr.21820; Buizer AI, 2009, PEDIATR BLOOD CANCER, V52, P447, DOI 10.1002/pbc.21869; Campbell LK, 2007, PEDIATR BLOOD CANCER, V49, P65, DOI 10.1002/pbc.20860; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; Carey ME, 2008, AM J NEURORADIOL, V29, P792, DOI 10.3174/ajnr.A0904; Caron JE, 2009, PEDIATR BLOOD CANCER, V53, P551, DOI 10.1002/pbc.22128; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; de Vries MAG, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-103; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P255, DOI 10.1080/09297049.2010.535654; Jain N, 2009, CANCER-AM CANCER SOC, V115, P4238, DOI 10.1002/cncr.24464; Kadan-Lottick NS, 2009, J CLIN ONCOL, V27, P5986, DOI 10.1200/JCO.2009.23.5408; Kadan-Lottick NS, 2009, BLOOD, V114, P1746, DOI 10.1182/blood-2008-12-186502; Kingma A, 2002, J PEDIAT HEMATOL ONC, V24, P106, DOI 10.1097/00043426-200202000-00010; Kolb B., 1995, BRAIN PLASTICITY BEH; Krappmann P, 2007, PEDIATR HEMAT ONCOL, V24, P101, DOI 10.1080/08880010601123281; Krull KR, 2008, J PEDIATR-US, V152, P101, DOI 10.1016/j.jpeds.2007.05.047; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Molfese VJ, 2010, CONTEMP EDUC PSYCHOL, V35, P116, DOI 10.1016/j.cedpsych.2010.03.004; MOORE IMK, 1991, CANCER, V68, P1913; Payne JM, 2011, CHILD NEUROPSYCHOL, V17, P313, DOI 10.1080/09297049.2010.542746; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Precourt S, 2002, DEV NEUROPSYCHOL, V21, P173, DOI 10.1207/S15326942DN2102_4; RUBENSTEIN CL, 1990, J DEV BEHAV PEDIATR, V11, P301; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Stork LC, 2010, BLOOD, V115, P2740, DOI 10.1182/blood-2009-07-230656; Tolar J, 2005, PEDIATR BLOOD CANCER, V45, P5, DOI 10.1002/pbc.20239; Voigt RG, 2007, CLIN PEDIATR, V46, P523, DOI 10.1177/0009922806299100; von der Weid N, 2003, EUR J CANCER, V39, P359, DOI 10.1016/S0959-8049(02)00260-5; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Waber DP, 2006, DEV NEUROPSYCHOL, V29, P459, DOI 10.1207/s15326942dn2903_5; Waber DP, 2000, J PEDIAT HEMATOL ONC, V22, P206, DOI 10.1097/00043426-200005000-00004; Willoughby MT, 2012, CHILD NEUROPSYCHOL, V18, P79, DOI 10.1080/09297049.2011.578572; [No title captured]	38	22	23	0	27	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JAN 2	2015	21	1					78	89		10.1080/09297049.2013.876491			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AS6TC	WOS:000344394100005	24428397				2022-02-06	
J	Chan, ST; Evans, KC; Rosen, BR; Song, TY; Kwong, KK				Chan, Suk-tak; Evans, Karleyton C.; Rosen, Bruce R.; Song, Tian-yue; Kwong, Kenneth K.			A case study of magnetic resonance imaging of cerebrovascular reactivity: A powerful imaging marker for mild traumatic brain injury	BRAIN INJURY			English	Article						Cerebrovascular reactivity; functional magnetic resonance imaging; mild brain injury	LEVEL-DEPENDENT MRI; RECURRENT CONCUSSION; FOOTBALL PLAYERS; WHITE-MATTER; IMPAIRMENT; PERFUSION; CO2; SOFTWARE; FMRI	Primary objective: To use breath-hold functional magnetic resonance imaging (fMRI) to localize the brain regions with impaired cerebrovascular reactivity (CVR) in a female patient diagnosed with mild traumatic brain injury (mTBI). The extent of impaired CVR was evaluated 2 months after concussion. Follow-up scan was performed 1 year post-mTBI using the same breath-hold fMRI technique. Research design: Case report. Methods and procedures: fMRI blood oxygenation dependent level (BOLD) signals were measured under breath-hold challenge in a female mTBI patient 2 months after concussion followed by a second fMRI with breath-hold challenge 1 year later. CVR was expressed as the percentage change of BOLD signals per unit time of breath-hold. Main outcomes: In comparison with CVR measurement of normal control subjects, statistical maps of CVR revealed substantial neurovascular deficits and hemispheric asymmetry within grey and white matter in the initial breath-hold fMRI scan. Follow-up breath-hold fMRI performed 1 year post-mTBI demonstrated normalization of CVR accompanied with symptomatic recovery. Conclusions: CVR may serve as an imaging biomarker to detect subtle deficits in both grey and white matter for individual diagnosis of mTBI. The findings encourage further investigation of hypercapnic fMRI as a diagnostic tool for mTBI.	[Chan, Suk-tak; Rosen, Bruce R.; Song, Tian-yue; Kwong, Kenneth K.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02114 USA; [Evans, Karleyton C.; Song, Tian-yue] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA		Chan, ST (corresponding author), Athinoula A Martinos Ctr Biomed Imaging, Bldg 149,Thirteenth St,Mail Code 149-2301, Charlestown, MA 02129 USA.	phoebe@nmr.mgh.harvard.edu	Chan, Suk-tak/G-5846-2015	CHAN, SUK-TAK/0000-0001-6627-3173; Kwong, Kenneth K./0000-0001-5056-2173	National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896];  [NIH-K23MH086619]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH086619] Funding Source: NIH RePORTER	This research was carried out in whole at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41EB015896, a P41 Biotechnology Resource Grant supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health. This work was also supported, in part, by NIH-K23MH086619. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chang TY, 2009, AM J NEURORADIOL, V30, P1330, DOI 10.3174/ajnr.A1589; Conklin J, 2010, STROKE, V41, P1610, DOI 10.1161/STROKEAHA.110.579540; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Gold S, 1998, HUM BRAIN MAPP, V6, P73; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Han JS, 2011, STROKE, V42, P1261, DOI 10.1161/STROKEAHA.110.603225; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Korngold C, 2013, J AM ACAD PSYCHIATRY, V41, P430; Krainik A, 2005, STROKE, V36, P1146, DOI 10.1161/01.STR.0000166178.40973.a7; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Pillai JJ, 2012, TECHNOL CANCER RES T, V11, P361, DOI 10.7785/tcrt.2012.500284; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Talairach J., 1988, COPLANAR STEREOTAXIC; Tancredi FB, 2013, J CEREBR BLOOD F MET, V33, P1066, DOI 10.1038/jcbfm.2013.48; Tancredi FB, 2012, J MAGN RESON IMAGING, V36, P312, DOI 10.1002/jmri.23658; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; Zaca D, 2014, J MAGN RESON IMAGING, V40, P383, DOI 10.1002/jmri.24406; Ziyeh S, 2005, STROKE, V36, P751, DOI 10.1161/01.STR.0000157593.03470.3d	26	22	23	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					403	407		10.3109/02699052.2014.974209			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000015	25384127	Green Accepted			2022-02-06	
J	Costine, BA; Missios, S; Taylor, SR; McGuone, D; Smith, CM; Dodge, CP; Harris, BT; Duhaime, AC				Costine, Beth A.; Missios, Symeon; Taylor, Sabrina R.; McGuone, Declan; Smith, Colin M.; Dodge, Carter P.; Harris, Brent T.; Duhaime, Ann-Christine			The Subventricular Zone in the Immature Piglet Brain: Anatomy and Exodus of Neuroblasts into White Matter after Traumatic Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Subventricular zone; Neurogenesis; Neuroblasts	MATURATION-DEPENDENT RESPONSE; CENTRAL-NERVOUS-SYSTEM; CELL-PROLIFERATION; POSTNATAL NEUROGENESIS; OLFACTORY-BULB; DENTATE GYRUS; IN-VITRO; FOREBRAIN; MIGRATION; MICE	Stimulation of postnatal neurogenesis in the subventricular zone (SVZ) and robust migration of neuroblasts to the lesion site in response to traumatic brain injury (TBI) is well established in rodent species; however, it is not yet known whether postnatal neurogenesis plays a role in repair after TBI in gyrencephalic species. Here we describe the anatomy of the SVZ in the piglet for the first time and initiate an investigation into the effect of TBI on the SVZ architecture and the number of neuroblasts in the white matter. Among all ages of immaturity examined the SVZ contained a dense mesh network of neurogenic precursor cells (doublecortin+) positioned directly adjacent to the ependymal cells (ventricular SVZ, Vsvz) and neuroblasts organized into chains that were distinct from the Vsvz (abventricular SVZ, Asvz). Though the architecture of the SVZ was similar among ages, the areas of Vsvz and Asvz neuroblast chains declined with age. At postnatal day (PND) 14 the white matter tracts have a tremendous number of individual neuroblasts. In our scaled corticalimpact model, lesion size increased with age. Similarly, the response of the SVZ to injury was also age dependent. The younger age groups that sustained the proportionately smallest lesions had the largest SVZ areas, which further increased in response to injury. In piglets that were injured at 4 months of age and had the largest lesions, the SVZ did not increase in response to injury. Similar to humans, swine have abundant gyri and gyral white matter, providing a unique platform to study neuroblasts potentially migrating from the SVZ to the lesioned cortex along these white matter tracts. In piglets injured at PND 7, TBI did not increase the total number of neuroblasts in the white matter compared to uninjured piglets, but redistribution occurred with a greater number of neuroblasts in the white matter of the hemisphere ipsilateral to the injury compared to the contralateral hemisphere. At 7 days after injury, less than 1% of neuroblasts in the white matter were born in the 2 days following injury. These data show that the SVZ in the piglet shares many anatomical similarities with the SVZ in the human infant, and that TBI had only modest effects on the SVZ and the number of neuroblasts in the white matter. Piglets at an equivalent developmental stage to human infants were equipped with the largest SVZ and a tremendous number of neuroblasts in the white matter, which may be sufficient in lesion repair without the dramatic stimulation of neurogenic machinery. It has yet to be determined whether neurogenesis and migrating neuroblasts play a role in repair after TBI and/or whether an alteration of normal migration during active postnatal population of brain regions is beneficial in species with gyrencephalic brains. (C) 2015 S. Karger AG, Basel	[Costine, Beth A.; Smith, Colin M.; Duhaime, Ann-Christine] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, Charlestown, MA 02114 USA; [McGuone, Declan] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02114 USA; [Costine, Beth A.; Duhaime, Ann-Christine] Harvard Univ, Sch Med, Dept Neurosurg, Charlestown, MA 02114 USA; [Missios, Symeon] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Taylor, Sabrina R.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Dodge, Carter P.] Childrens Hosp Dartmouth, Dartmouth Med Sch, Dept Anesthesiol, Lebanon, NH USA; [Harris, Brent T.] Georgetown Med Sch, Dept Neurol, Washington, DC USA; [Harris, Brent T.] Georgetown Med Sch, Dept Pathol, Washington, DC USA		Costine, BA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Bldg 149,13th St,Room 3-405, Charlestown, MA 02114 USA.	bcostine@mgh.harvard.edu		Costine-Bartell, Beth/0000-0001-7559-9378	NIH National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD45364-5]; Pediatric Neuroscience Fund of the Children's Hospital at Dartmouth; Nicholas T. Zervas Chair of Harvard Medical School; Joel Alan Viktor Research Fund at Massachusetts General Hospital; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5P30NS045776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045776] Funding Source: NIH RePORTER	This work was supported by R01 HD45364-5 from the NIH National Institute of Child Health and Human Development, the Pediatric Neuroscience Fund of the Children's Hospital at Dartmouth, the Nicholas T. Zervas Chair of Harvard Medical School, and the Joel Alan Viktor Research Fund at Massachusetts General Hospital. The authors express their gratitude to Leslie Adams, Kate Hillier, Ijeoma Chinwuba, Michael Simoni, and Kristen Saliga for their assistance with animal handling, immunohistochemistry and quantification. The authors also wish to thank Kenneth Orndorff (Dartmouth Optical Cellular Imaging Shared Resource Center) and Igor Bagayev (MGH Neuroscience Center Imaging Core supported by NINDS grant 5P30NS045776) for their assistance with confocal microscopy and Emily Belli for proofreading the manuscript.	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P69, DOI 10.1007/BF01098647; Boer K, 2009, EPILEPSIA, V50, P2629, DOI 10.1111/j.1528-1167.2009.02191.x; Breunig JJ, 2007, CELL STEM CELL, V1, P612, DOI 10.1016/j.stem.2007.11.008; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; De Marchis S, 2004, J COMP NEUROL, V476, P290, DOI 10.1002/cne.20217; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Doetsch F, 1997, J NEUROSCI, V17, P5046; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI, V28, P230; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Francis HW, 2006, J NEUROSCI METH, V150, P150, DOI 10.1016/j.jneumeth.2005.06.020; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gleason D, 2008, NEUROSCIENCE, V156, P81, DOI 10.1016/j.neuroscience.2008.06.065; Gordon RJ, 2007, NEUROSCIENCE, V146, P1704, DOI 10.1016/j.neuroscience.2007.03.011; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Guidi S, 2011, BRAIN RES BULL, V85, P169, DOI 10.1016/j.brainresbull.2011.03.028; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Jankovski A, 1996, J COMP NEUROL, V371, P376; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Koob AO, 2008, INT J DEV NEUROSCI, V26, P641, DOI 10.1016/j.ijdevneu.2008.04.001; Liard O, 2009, J NEUROSCI METH, V182, P172, DOI 10.1016/j.jneumeth.2009.06.008; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Malik SZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036016, 10.1371/journal.pone.0039754]; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Peretto P, 2005, J COMP NEUROL, V487, P407, DOI 10.1002/cne.20576; Ponti G, 2006, J COMP NEUROL, V498, P491, DOI 10.1002/cne.21043; Qiu L, 2007, J CEREBR BLOOD F MET, V27, P785, DOI 10.1038/sj.jcbfm.9600385; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Taylor SR, 2013, J NEUROSURG-PEDIATR, V12, P545, DOI 10.3171/2013.8.PEDS13154; Thomsen GM, 2014, STEM CELL RES, V13, P48, DOI 10.1016/j.scr.2014.04.013; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Walton RM, 2013, HISTOCHEM CELL BIOL, V139, P415, DOI 10.1007/s00418-012-1053-x; Yin F, 2011, CYTOTECHNOLOGY, V63, P363, DOI 10.1007/s10616-011-9353-x; Zhang C, 2005, J NEUROTRAUM, V22, P1456, DOI 10.1089/neu.2005.22.1456	43	22	22	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2015	37	2					115	130		10.1159/000369091			16	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	CG8LB	WOS:000353558000003	25678047	Bronze, Green Accepted			2022-02-06	
J	Geeraedts, LMG; Pothof, LAH; Caldwell, E; de Lange-de Klerk, ESM; D'Amours, SK				Geeraedts, Leo M. G., Jr.; Pothof, Leonie A. H.; Caldwell, Erica; de Lange-de Klerk, Elly S. M.; D'Amours, Scott K.			Prehospital fluid resuscitation in hypotensive trauma patients: Do we need a tailored approach?	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Haemorrhage; Prehospital; Fluid resuscitation; Blood transfusion	SHOCK INDEX; INTRAVENOUS FLUID; GUIDELINES; MANAGEMENT; SURVIVAL; INJURY	Aim: The ideal strategy for prehospital intravenous fluid resuscitation in trauma remains unclear. Fluid resuscitation may reverse shock but aggravate bleeding by raising blood pressure and haemodilution. We examined the effect of prehospital i.v. fluid on the physiologic status and need for blood transfusion in hypotensive trauma patients after their arrival in the emergency department (ED). Methods: Retrospective analysis of trauma patients (n = 941) with field hypotension presenting to a level 1 trauma centre. Regression models were used to investigate associations between prehospital fluid volumes and shock index and blood transfusion respectively in the emergency department and mortality at 24 h. Results: A 1 L increase of prehospital i.v. fluid was associated with a 7% decrease of shock index in the emergency department (p < 0.001). Volumes of 0.5-1 L and 1-2 L were associated with reduced likelihood of shock as compared to volumes of 0-0.5 L: OR 0.61 (p = 0.03) and OR 0.54 (p = 0.02), respectively. Volumes of 1-2 L were also associated with an increased likelihood of receiving blood transfusion in ED: OR 3.27 (p < 0.001). Patients who had received volumes of > 2 L have a much greater likelihood of receiving blood transfusion in ED: OR 9.92 (p < 0.001). Mortality at 24 h was not associated with prehospital i.v. fluids. Conclusion: In hypotensive trauma patients, prehospital i.v. fluids were associated with a reduction of likelihood of shock upon arrival in ED. However, volumes of > 1 L were associated with a markedly increased likelihood of receiving blood transfusion in ED. Therefore, decision making regarding prehospital i.v. fluid resuscitation is critical and may need to be tailored to the individual situation. Further research is needed to clarify whether a causal relationship exists between prehospital i.v. fluid volume and blood transfusion. Also, prospective trials on prehospital i.v. fluid resuscitation strategies in specific patient subgroups (e.g. traumatic brain injury and concomitant haemorrhage) are warranted. (C) 2014 Elsevier Ltd. All rights reserved.	[Geeraedts, Leo M. G., Jr.] Vrije Univ Amsterdam Med Ctr, Dept Surg, NL-1007 MB Amsterdam, Netherlands; [Geeraedts, Leo M. G., Jr.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, NL-1007 MB Amsterdam, Netherlands; [Geeraedts, Leo M. G., Jr.] Vrije Univ Amsterdam Med Ctr, Helicopter Emergency Med Serv, Northwestern Netherlands Trauma Area, NL-1007 MB Amsterdam, Netherlands; [Pothof, Leonie A. H.] Canisius Wilhelmina Hosp, Dept Surg, NL-6500 GS Nijmegen, Netherlands; [Caldwell, Erica; D'Amours, Scott K.] Liverpool Hosp, Dept Trauma Serv, Liverpool Bc, NSW 1871, Australia; [de Lange-de Klerk, Elly S. M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands		Geeraedts, LMG (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Surg ZH 7F,POB 7057, NL-1007 MB Amsterdam, Netherlands.	l.geeraedts@vumc.nl; leoniepothof@hotmail.com; erica.caldwell@sswahs.nsw.gov.au; esm.delange@vumc.nl; scott.damours@sswahs.nsw.gov.au					American College of Surgeons Committe on Trauma, 2008, ADV TRAUM LIF SUPP D; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; Dula David J, 2002, Prehosp Emerg Care, V6, P417, DOI 10.1080/10903120290938058; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Hampton DA, 2013, J TRAUMA ACUTE CARE, V75, pS9, DOI 10.1097/TA.0b013e318290cd52; Haut ER, 2011, ANN SURG, V253, P371, DOI 10.1097/SLA.0b013e318207c24f; Holcomb JB, 2011, J TRAUMA, V71, pS315, DOI 10.1097/TA.0b013e318227ed13; Hubetamann Bjorn, 2011, J Emerg Trauma Shock, V4, P465, DOI 10.4103/0974-2700.86630; Hussmann B, 2013, INJURY, V44, P611, DOI 10.1016/j.injury.2012.02.004; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; McSwain NE, 2011, J TRAUMA, V70, pS2, DOI 10.1097/TA.0b013e31821b201d; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Nolan J, 2001, RESUSCITATION, V48, P57, DOI 10.1016/S0300-9572(00)00318-X; RADY MY, 1992, RESUSCITATION, V23, P227, DOI 10.1016/0300-9572(92)90006-X; Revell M, 2002, EMERG MED J, V19, P494, DOI 10.1136/emj.19.6.494; Sampalis JS, 1997, J TRAUMA, V43, P608, DOI 10.1097/00005373-199710000-00008; SHIRES G T, 1964, Int Anesthesiol Clin, V2, P435, DOI 10.1097/00004311-196402000-00016; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Soreide E, 2005, INJURY, V36, P1001, DOI 10.1016/j.injury.2005.01.002; Sumann G, 2009, HIGH ALT MED BIOL, V10, P71, DOI 10.1089/ham.2008.1067; Talving P, 2005, PREHOSP DISASTER MED, V20, P228, DOI 10.1017/S1049023X00002582; Yaghoubian A, 2007, AM SURGEON, V73, P1027; [No title captured], DOI DOI 10.1002/14651858	28	22	23	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					4	9		10.1016/j.injury.2014.08.001			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600002	25173671				2022-02-06	
J	Hinson, HE; Puybasset, L; Weiss, N; Perlbarg, V; Benali, H; Galanaud, D; Lasarev, M; Stevens, RD				Hinson, Holly E.; Puybasset, Louis; Weiss, Nicolas; Perlbarg, Vincent; Benali, Habib; Galanaud, Damien; Lasarev, Mike; Stevens, Robert D.		Neuro Imaging Coma Emergence Reco	Neuroanatomical basis of paroxysmal sympathetic hyperactivity: A diffusion tensor imaging analysis	BRAIN INJURY			English	Article						Diffusion tensor imaging; paroxysmal sympathetic hyperactivity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SUDDEN-DEATH; INSULAR CORTEX; NERVOUS-SYSTEM; STROKE; RAT; ARRHYTHMIAS; TOMOGRAPHY; STRESS; STATE	Primary objective: Paroxysmal sympathetic hyperactivity (PSH) is observed in a sub-set of patients with moderate-to-severe traumatic brain injury (TBI). The neuroanatomical basis of PSH is poorly understood. It is hypothesized that PSH is linked to changes in connectivity within the central autonomic network. Research design: Retrospective analysis in a sub-set of patients from a multi-centre, prospective cohort study Methods and procedures: Adult patients who were <3 weeks after severe TBI were enrolled and screened for PSH using a standard definition. Patients underwent multimodal MRI, which included quantitative diffusion tensor imaging. Main outcomes and results: Principal component analysis (PCA) was used to resolve the set of tracts into components. Ability to predict PSH was evaluated via area under the receiver operating characteristic (AUROC) and tree-based classification analyses. Among 102 enrolled patients, 16 met criteria for PSH. The first principle component was significantly associated (p = 0.024, AUROC = 0.867) with PSH status even after controlling for age and admission GCS. In a classification tree analysis, age, GCS and decreased FA in the splenium of the corpus callosum and in the right posterior limb of the internal capsule discriminated PSH vs no PSH with an AUROC of 0.933. Conclusions: Disconnection involving the posterior corpus callosum and of the posterior limb of the internal capsule may play a role in the pathogenesis or expression of PSH.	[Hinson, Holly E.] Oregon Hlth & Sci Univ, Dept Neurol & Emergency Med, Portland, OR 97239 USA; [Puybasset, Louis] Hop La Pitie Salpetriere, Dept Anesthesiol & Intens Care, Paris, France; [Puybasset, Louis; Perlbarg, Vincent; Benali, Habib] INSERM UPMC, Lab Imagerie Fonct, UMR S 678, Paris, France; [Weiss, Nicolas] Hop La Pitie Salpetriere, Neurol Intens Care Unit, Paris, France; [Galanaud, Damien] Hop La Pitie Salpetriere, Dept Radiol, Paris, France; [Lasarev, Mike] Oregon Hlth & Sci Univ, Oregon Inst Occupat Heath Sci, Portland, OR 97239 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol, Baltimore, MD USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Crit Care Med, Baltimore, MD USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA		Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Neurol & Neurocrit Care, 3181 SW Sam Jackson Pk Rd,CR 127, Portland, OR 97239 USA.	hinson@ohsu.edu	Hinson, Holly/Q-2268-2019; Weiss, Nicolas/E-7345-2011	Hinson, Holly/0000-0003-1598-9782; Weiss, Nicolas/0000-0001-5155-196X; Lasarev, Michael R/0000-0002-1896-2705	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5K12HL108974-03]; Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER	The project described was supported in part by Award Number 5K12HL108974-03 from the National Heart, Lung, and Blood Institute. This publication was supported by Oregon Clinical and Translational Research Institute (OCTRI), grant number (UL1TR000128) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH).	Ay H, 2006, NEUROLOGY, V66, P1325, DOI 10.1212/01.wnl.0000206077.13705.6d; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Gianaros PJ, 2012, HUM BRAIN MAPP, V33, P1700, DOI 10.1002/hbm.21315; HACHINSKI VC, 1992, ARCH NEUROL-CHICAGO, V49, P697, DOI 10.1001/archneur.1992.00530310039010; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Laowattana S, 2006, NEUROLOGY, V66, P477, DOI 10.1212/01.wnl.0000202684.29640.60; Laxe S, 2013, BRAIN INJURY, V27, P1383, DOI 10.3109/02699052.2013.823648; Luyt CE, 2012, ANESTHESIOLOGY, V117, P1311, DOI 10.1097/ALN.0b013e318275148c; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; PEREZTREPICHIO AD, 1993, STROKE, V24, P691, DOI 10.1161/01.STR.24.5.691; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Seifert F, 2013, HUM BRAIN MAPP, V34, P1768, DOI 10.1002/hbm.22035; Soros P, 2012, LANCET NEUROL, V11, P179, DOI 10.1016/S1474-4422(11)70291-5; Sullivan RM, 1999, J NEUROSCI, V19, P2834; TerHorst GJ, 1996, EUR J NEUROSCI, V8, P2029, DOI 10.1111/j.1460-9568.1996.tb00723.x; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Zhang ZH, 1997, BRAIN RES, V760, P243, DOI 10.1016/S0006-8993(97)00284-9	32	22	25	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	4					455	461		10.3109/02699052.2014.995229			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF8JE	WOS:000352803300006	25565392	Green Accepted			2022-02-06	
J	Stevens, LF; Pickett, TC; Schaaf, KPW; Taylor, BC; Gravely, A; Van Houtven, CH; Friedemann-Sanchez, G; Griffin, JM				Stevens, Lillian Flores; Pickett, Treven C.; Schaaf, Kathryn P. Wilder; Taylor, Brent C.; Gravely, Amy; Van Houtven, Courtney Harold; Friedemann-Sanchez, Greta; Griffin, Joan M.			The Relationship between Training and Mental Health among Caregivers of Individuals with Polytrauma	BEHAVIOURAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ZARIT BURDEN INTERVIEW; FAMILIES; REHABILITATION; WAR; DISTRESS; VETERANS; NEEDS; CARE; INFORMATION	This was a hypothesis-generating exploration of relationships between caregiver training during TBI/polytrauma rehabilitation and caregiver mental health. In this cross-sectional study, 507 informal caregivers to US service members with TBI who received inpatient rehabilitation care in a Veterans Affairs' Polytrauma Rehabilitation Center from 2001 to 2009 completed a retrospective, self-report survey. Embedded in the survey were measures of caregiver mental health, including the National Institutes of Health's Patient Reported Outcome Measurement Information System (PROMIS) Anxiety and Depression Short Forms, the Rosenberg Self-Esteem scale, and the Zarit Burden Short Form. Though no groups endorsed clinical levels, mental health symptoms varied by caregiver training category (Trained, Not Trained, and Did Not Need Training). Caregivers who did not receive training on how to navigate healthcare systems endorsed higher depression and burden and lower self-esteem than those who did. Caregivers who did not receive training in supporting their care recipients' emotions endorsed higher anxiety, depression, and burden and lower self-esteem than those who did. Analyses also suggested a different association between training and mental health based on caregivers' relationship to the care recipient and the intensity of care recipient needs. Potential hypotheses for testing in future studies raised by these findings are discussed.	[Stevens, Lillian Flores; Pickett, Treven C.; Schaaf, Kathryn P. Wilder] Hunter Holmes McGuire VAMC, Psychol Sect 116B, Richmond, VA 23249 USA; [Stevens, Lillian Flores; Pickett, Treven C.; Schaaf, Kathryn P. Wilder] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian Flores; Pickett, Treven C.; Schaaf, Kathryn P. Wilder] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Pickett, Treven C.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23284 USA; [Taylor, Brent C.; Gravely, Amy; Griffin, Joan M.] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; [Van Houtven, Courtney Harold] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Friedemann-Sanchez, Greta] Univ Minnesota, Humphrey Sch Publ Affairs, Humphrey Ctr 267, Minneapolis, MN 55455 USA; [Griffin, Joan M.] Kern Ctr Sci Hlth Care Delivery, Mayo Clin, Div Hlth Care Policy & Res, Dept Hlth Sci Res, Rochester, MN 55905 USA		Stevens, LF (corresponding author), Hunter Holmes McGuire VAMC, Psychol Sect 116B, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	lillian.stevens@va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Friedemann-Sanchez, Greta/0000-0002-0493-7218; Van Houtven, Courtney/0000-0002-0783-1611	Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical CenterUS Department of Veterans Affairs; Hunter Holmes McGuire VA Medical Center; Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs; Health Services Research and Development (HSRD) service [SDR-07-044]	The writing of this paper was supported by the Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; the Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center; and the Hunter Holmes McGuire VA Medical Center (Lillian Flores Stevens). The material is based on work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and a grant from the Health Services Research and Development (HSR&D) service (SDR-07-044; Joan M. Griffin).	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arean P. A., 2013, HIGH QUALITY PSYCHOT; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; Cavallo M.M., 2011, TXB TRAUMATIC BRAIN, P483; Chiu YL, 2004, J CLIN NURS, V13, P655, DOI 10.1111/j.1365-2702.2004.00844.x; Choi SW, 2010, QUAL LIFE RES, V19, P125, DOI 10.1007/s11136-009-9560-5; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Coon DW, 2004, AGING MENT HEALTH, V8, P330, DOI 10.1080/13607860410001709683; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Defense and Veterans Brain Injury Center, DOD TBI WORLD WID NU; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Department of Veterans Affairs, 2013, VHA HDB; Ford JH, 2014, J REHABIL RES DEV, V51, P1311, DOI 10.1682/JRRD.2014.03.0066; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gottlieb BH, 2004, AGING MENT HEALTH, V8, P364, DOI 10.1080/13607860410001709719; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hall C, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1125-3; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Perrin PB, 2010, J REHABIL RES DEV, V47, P605, DOI 10.1682/JRRD.2009.10.0170; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rosenberg M., 1965, SOC ADOLESCENT SELF; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schaaf KPW, 2013, REHABIL PSYCHOL, V58, P106, DOI 10.1037/a0031693; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	42	22	22	0	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								185941	10.1155/2015/185941			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CZ1EY	WOS:000366849900001	26770015	gold, Green Published, Green Submitted			2022-02-06	
J	Yeh, DC; Chan, TM; Harn, HJ; Chiou, TW; Chen, HS; Lin, ZS; Lin, SZ				Yeh, Da-Chum; Chan, Tzu-Min; Harn, Horng-Jyh; Chiou, Tzyy-Wen; Chen, Hsin-Shui; Lin, Zung-Sheng; Lin, Shinn-Zong			Adipose Tissue-Derived Stem Cells in Neural Regenerative Medicine	CELL TRANSPLANTATION			English	Article; Proceedings Paper	7th Pan Pacific Sympsosium on Stem Cells and Cancer Research	APR 12-14, 2014	Taichung, TAIWAN			Adipose tissue-derived stem cells (ADSCs); Stroke; Amyotrophic lateral sclerosis; Parkinson's disease; Alzheimer's disease; Huntington's disease; Cavernous nerve injury	TRAUMATIC BRAIN-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; CAVERNOUS NERVE INJURY; ACUTE ISCHEMIC-STROKE; ALZHEIMERS-DISEASE; RAT MODEL; IN-VITRO; NEUROGENIC DIFFERENTIATION; HUNTINGTONS-DISEASE; FUNCTIONAL RECOVERY	Adipose tissue-derived stem cells (ADSCs) have two essential characteristics with regard to regenerative medicine: the convenient and efficient generation of large numbers of multipotent cells and in vitro proliferation without a loss of sternness. The implementation of clinical trials has prompted widespread concern regarding safety issues and has shifted research toward the therapeutic efficacy of stem cells in dealing with neural degeneration in cases such as stroke, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease, cavernous nerve injury, and traumatic brain injury. Most existing studies have reported that cell therapies may be able to replenish lost cells and promote neuronal regeneration, protect neuronal survival, and play a role in overcoming permanent paralysis and loss of sensation and the recovery of neurological function. The mechanisms involved in determining therapeutic capacity remain largely unknown; however, this concept can still be classified in a methodical manner by citing current evidence. Possible mechanisms include the following: 1) the promotion of angiogenesis, 2) the induction of neuronal differentiation and neurogenesis, 3) reductions in reactive gliosis, 4) the inhibition of apoptosis, 5) the expression of neurotrophic factors, 6) immunomodulatory function, and 7) facilitating neuronal integration. In this study, several human clinical trials using ADSCs for neuronal disorders were investigated. It is suggested that ADSCs are one of the choices among various stem cells for translating into clinical application in the near future.	[Yeh, Da-Chum] China Med Univ, Dept Internal Med, Beigan Hosp, Yunlin, Taiwan; [Chan, Tzu-Min] China Med Univ, Dept Med Educ & Res, Beigan Hosp, Yunlin, Taiwan; [Chan, Tzu-Min] China Med Univ, Dept Med Educ & Res, An Nan Hosp, Tainan, Taiwan; [Harn, Horng-Jyh] China Med Univ, Dept Med, Taichung, Taiwan; [Harn, Horng-Jyh] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan; [Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Grad Inst Biotechnol, Hualien, Taiwan; [Chen, Hsin-Shui] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Shui] China Med Univ, Beigang Hosp, Dept Phys Med & Rehabil, Yunlin, Taiwan; [Lin, Zung-Sheng] China Med Univ, Beigan Hosp, Dept Surg, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigan Hosp, Dept Neurosurg, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, Tainan Municipal An Nan Hosp, Dept Neurosurg, Tainan, Taiwan		Lin, SZ (corresponding author), China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan.	shinnzong@yahoo.com.tw	Lin, Shinn-Zong/AAX-2379-2020	Chan, Tzu-Min/0000-0002-0140-5240	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; CMUBH [R103-012, R103-007]	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), CMUBH R103-012, and CMUBH R103-007. The authors declare no conflicts of interest.	Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Chan TM, 2014, CELL TRANSPLANT, V23, P541, DOI 10.3727/096368914X678409; Chan TM, 2014, CELL TRANSPLANT, V23, P399, DOI 10.3727/096368914X678292; Chen J, 2012, CNS NEUROSCI THER, V18, P847, DOI 10.1111/j.1755-5949.2012.00382.x; Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524; Chun W, 2007, FRONT BIOSCI-LANDMRK, V12, P733, DOI 10.2741/2097; Chung JY, 2012, J NEUROL SCI, V317, P40, DOI 10.1016/j.jns.2012.02.035; DU Hou-wei, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P998; Fang Z, 2010, J HUAZHONG U SCI-MED, V30, P75, DOI 10.1007/s11596-010-0113-5; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Gimble JM, 2013, ORGANOGENESIS, V9, P3, DOI 10.4161/org.24279; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Goldstein DS, 2013, ADV PHARMACOL, V68, P235, DOI 10.1016/B978-0-12-411512-5.00012-9; Gu HY, 2013, NEUROSCI LETT, V544, P15, DOI 10.1016/j.neulet.2013.02.057; Gutierrez-Fernandez M, 2013, DISCOV MED, V16, P37; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Im W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059438; Im Wooseok, 2010, PLoS Curr, V2, DOI 10.1371/currents.RRN1183; Kalantri A, 2010, JAMA-J AM MED ASSOC, V304, P1327, DOI 10.1001/jama.2010.1341; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kato A C, 2006, Rev Med Suisse, V2, P1152; Kato A.C., 2006, REV MED SUISSE, V2, P1156; Kim KS, 2014, CELL TRANSPLANT, V23, P1585, DOI 10.3727/096368913X673450; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045757; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee HJ, 2012, CELL TRANSPLANT, V21, P959, DOI 10.3727/096368911X627516; Lin G., 2011, UROLOGY, V77; Ma T, 2013, CELL TRANSPLANT, V22, pS113, DOI 10.3727/096368913X672181; Marconi S, 2013, NEUROSCIENCE, V248, P333, DOI 10.1016/j.neuroscience.2013.05.034; Maucksch C, 2013, J CELL BIOCHEM, V114, P754, DOI 10.1002/jcb.24432; Moriyama M, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-21; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516; Perez-Gonzalez R, 2011, J ALZHEIMERS DIS, V24, P17, DOI 10.3233/JAD-2011-102070; Ra JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-181; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Raschzok N, 2013, CELL TRANSPLANT, V22, P1959, DOI 10.3727/096368912X661382; Ribo M, 2010, AM J NEURORADIOL, V31, P1899, DOI 10.3174/ajnr.A2221; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Safwani WKZW, 2012, APPL BIOCHEM BIOTECH, V166, P2101, DOI 10.1007/s12010-012-9637-4; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tanzi RE, 2013, J ALZHEIMERS DIS, V33, pS5, DOI 10.3233/JAD-2012-129044; Thomas J, 2008, J NEUROSCI NURS, V40, P69, DOI 10.1097/01376517-200804000-00002; WALSH PC, 1982, J UROLOGY, V128, P492, DOI 10.1016/S0022-5347(17)53012-8; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Xu YD, 2014, J SEX MED, V11, P2439, DOI 10.1111/jsm.12636; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Yang YC, 2011, CURR NEUROVASC RES, V8, P1, DOI 10.2174/156720211794520215; You D, 2013, PROSTATE, V73, P278, DOI 10.1002/pros.22567; Yu JM, 2008, STEM CELLS DEV, V17, P463, DOI 10.1089/scd.2007.0181; Zhang HY, 2011, J SEX MED, V8, P437, DOI 10.1111/j.1743-6109.2010.02128.x; Zhou Y, 2013, CYTOTHERAPY, V15, P467, DOI 10.1016/j.jcyt.2013.01.007; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	62	22	25	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2015	24	3			SI		487	492		10.3727/096368915X686940			6	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cell Biology; Research & Experimental Medicine; Transplantation	CF7RQ	WOS:000352754400015	25647067	Bronze			2022-02-06	
J	Li, SJ; Tian, Y; Huang, XT; Zhang, YQ; Wang, DH; Wei, HJ; Dong, JF; Jiang, RC; Zhang, JN				Li, Shengjie; Tian, Ye; Huang, Xintao; Zhang, Yongqiang; Wang, Dehui; Wei, Huijie; Dong, Jingfei; Jiang, Rongcai; Zhang, Jianning			Intravenous transfusion of endothelial colony-forming cells attenuates vascular degeneration after cerebral aneurysm induction	BRAIN RESEARCH			English	Article						Cerebral aneurysm; Endothelial colony-forming cells; Transfusion; Inflammation; Macrophage; Apoptosis	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; PROGENITOR CELLS; INTRACRANIAL ANEURYSMS; BONE-MARROW; INFLAMMATORY RESPONSE; HEMODYNAMIC-CHANGES; MOUSE MODEL	Cerebral aneurysm (CA) rupture is a major cause of subarachnoid hemorrhage with high morbidity and mortality. Using an animal model, we examined the potential of endothelial colony-forming cells (ECFCs) transfusion on vascular degeneration after CA induction and underlying mechanisms. CA was induced in the right anterior cerebral artery-olfactory artery (ACA/OA) bifurcations in Sprague-Dawley rats with or without ECFCs transfusion. The degeneration of internal elastic lamina (IEL), media thickness and CA size were evaluated. Expression of matrix metalloproteinase-2 and 9 (MMP-2 and 9), tissue inhibitor of metalloproteinase-1 (TIMP-1), macrophage chemoattractant protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), nuclear factor kappa B (NF-kappa B), endothelial nitric oxide synthase (eNOS), B-cell leukemia/lymphoma-2 (Bcl-2), and inducible nitric oxide synthase (iNOS) were analyzed by quantitative real-time polymerase chain reaction. The macrophages infiltration and apoptosis of smooth muscle cells (SMCs) were examined immunohistologically. Rats in CA+ECFCs transfusion group showed a notable reduction in IEL degeneration, media thinning and CA size compared with those in CA+saline group. ECFCs transfusion inhibited the MMP-driven wall destruction by downregulating MMP-2, MMP-9 expression and upregulating TIMP-1. ECFCs transfusion dramatically decreased VCAM-1 and NF-kappa B expression, increased eNOS expression and caused no change in MCP-1 expression, which was accompanied by reduced macrophages infiltration. Moreover, ECFCs transfusion reversed downregulation of Bcl-2 expression and upregulation of iNOS expression, and decreased SMCs apoptosis. Collectively, these findings suggest that ECFCs transfusion confers protection against degeneration of aneurysmal wall by inhibiting inflammatory cascades and SMCs apoptosis. (C) 2014 Elsevier B.V. All rights reserved.	[Li, Shengjie; Tian, Ye; Huang, Xintao; Zhang, Yongqiang; Wang, Dehui; Wei, Huijie; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Li, Shengjie; Tian, Ye; Huang, Xintao; Zhang, Yongqiang; Wang, Dehui; Wei, Huijie; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Li, Shengjie; Tian, Ye; Huang, Xintao; Zhang, Yongqiang; Wang, Dehui; Wei, Huijie; Jiang, Rongcai; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Li, Shengjie; Tian, Ye; Huang, Xintao; Zhang, Yongqiang; Wang, Dehui; Wei, Huijie; Jiang, Rongcai; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Dong, Jingfei] Puget Sound Blood Res Inst, Seattle, WA 98102 USA		Jiang, RC (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.	jianghope@gmail.com; jianningzhang@hotmail.com		Huang, Xintao/0000-0002-9683-9518	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81200907]; Tianjin Research Program of Application Foundation and Advanced Technology [12JCQNJC6800]	This work was financially supported by the National Natural Science Foundation of China (Grants 81200907) and Tianjin Research Program of Application Foundation and Advanced Technology (Grants 12JCQNJC6800).	Aoki T, 2008, STROKE, V39, P1276, DOI 10.1161/STROKEAHA.107.503086; Aoki T, 2008, CURR NEUROVASC RES, V5, P37, DOI 10.2174/156720208783565663; Aoki T, 2007, CIRCULATION, V116, P2830, DOI 10.1161/CIRCULATIONAHA.107.728303; Aoki T, 2007, STROKE, V38, P162, DOI 10.1161/01.STR.0000252129.18605.c8; Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556; Cao JP, 2012, ANESTHESIOLOGY, V116, P1278, DOI 10.1097/ALN.0b013e3182567f84; Chyatte D, 1997, STROKE, V28, P799, DOI 10.1161/01.STR.28.4.799; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Fang XG, 2012, J CLIN NEUROSCI, V19, P1283, DOI 10.1016/j.jocn.2011.09.038; Fukuda S, 2000, CIRCULATION, V101, P2532, DOI 10.1161/01.CIR.101.21.2532; Gao L, 2008, STROKE, V39, P2085, DOI 10.1161/STROKEAHA.107.509422; Gill M, 2001, CIRC RES, V88, P167; Hara A, 1998, NEUROL RES, V20, P127; HASHIMOTO N, 1984, Neurological Research, V6, P33; HASHIMOTO N, 1978, SURG NEUROL, V10, P3; Hashimoto T, 2006, NEUROL RES, V28, P372, DOI 10.1179/016164106X14973; HAZAMA F, 1986, AM J PATHOL, V124, P399; Hermansen SE, 2011, AM J PHYSIOL-CELL PH, V300, pC783, DOI 10.1152/ajpcell.00044.2010; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jamous MA, 2007, J NEUROSURG, V107, P405, DOI 10.3171/JNS-07/08/0405; Jin D, 2007, SURG NEUROL S2, V68, pS16; Jin Dianshi, 2007, Surg Neurol, V68 Suppl 2, pS11, DOI 10.1016/j.surneu.2007.02.060; Kadirvel R, 2010, AM J NEURORADIOL, V31, P165, DOI 10.3174/ajnr.A1781; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Kataoka K, 1999, STROKE, V30, P1396, DOI 10.1161/01.STR.30.7.1396; Khurana VG, 2003, STROKE, V34, P2555, DOI 10.1161/01.STR.0000096994.53810.59; KIM C, 1992, SURG NEUROL, V38, P331, DOI 10.1016/0090-3019(92)90017-H; Kim SC, 1997, NEUROSURGERY, V41, P642, DOI 10.1097/00006123-199709000-00027; Kondo S, 1998, STROKE, V29, P181, DOI 10.1161/01.STR.29.1.181; Lavergne M, 2011, CELL PROLIFERAT, V44, P44, DOI 10.1111/j.1365-2184.2010.00722.x; Leone AM, 2009, EUR HEART J, V30, P890, DOI 10.1093/eurheartj/ehp078; Li ZF, 2013, CNS NEUROSCI THER, V19, P352, DOI 10.1111/cns.12086; LOSCALZO J, 1995, NEW ENGL J MED, V333, P251, DOI 10.1056/NEJM199507273330410; Makino H, 2012, STROKE, V43, P2450, DOI 10.1161/STROKEAHA.112.659821; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Morimoto M, 2002, STROKE, V33, P1911, DOI 10.1161/01.STR.0000021000.19637.3D; Muhs A, 2003, HUM GENE THER, V14, P375, DOI 10.1089/104303403321208970; Nuki Y, 2009, HYPERTENSION, V54, P1337, DOI 10.1161/HYPERTENSIONAHA.109.138297; Nuki Y, 2009, J CEREBR BLOOD F MET, V29, P495, DOI 10.1038/jcbfm.2008.136; OKADA Y, 1993, CELL BIOL INT, V17, P863, DOI 10.1006/cbir.1993.1149; Ota R, 2009, J CEREBR BLOOD F MET, V29, P1547, DOI 10.1038/jcbfm.2009.77; Piatkowski A, 2013, INT REV CEL MOL BIO, V306, P43, DOI 10.1016/B978-0-12-407694-5.00002-X; Qiu J, 2013, INT J MOL MED, V31, P91, DOI 10.3892/ijmm.2012.1180; Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Sadamasa N, 2003, STROKE, V34, P2980, DOI 10.1161/01.STR.0000102556.55600.3B; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Sencer A, 2006, NEUROL RES, V28, P415, DOI 10.1179/016164106X115017; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Southgate KM, 1999, ARTERIOSCL THROM VAS, V19, P1640, DOI 10.1161/01.ATV.19.7.1640; Tamura T, 2009, J HYPERTENS, V27, P1284, DOI 10.1097/HJH.0b013e328329d1a7; Tulamo R, 2010, J NEUROINTERV SURG, V2, P120, DOI 10.1136/jnis.2009.002055; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Wei HJ, 2011, NEUROSCI LETT, V498, P114, DOI 10.1016/j.neulet.2011.04.061; Wei HJ, 2011, J NEUROSCI RES, V89, P1822, DOI 10.1002/jnr.22696; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Xu Y, 2011, NEUROSCIENCE, V181, P292, DOI 10.1016/j.neuroscience.2011.02.051; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zhang YM, 2009, AM J PHYSIOL-HEART C, V296, pH1675, DOI 10.1152/ajpheart.00665.2008; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	62	22	23	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 17	2014	1593						65	75		10.1016/j.brainres.2014.09.077			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX5FJ	WOS:000346951900007	25316629				2022-02-06	
J	Li, W; Long, JA; Watts, LT; Jiang, Z; Shen, Q; Li, YX; Duong, TQ				Li, Wei; Long, Justin Alexander; Watts, Lora Talley; Jiang, Zhao; Shen, Qiang; Li, Yunxia; Duong, Timothy Q.			A Quantitative MRI Method for Imaging Blood-Brain Barrier Leakage in Experimental Traumatic Brain Injury	PLOS ONE			English	Article							REPERFUSION INJURY; MODEL SELECTION; PATLAK PLOTS; RAT MODEL; GD-DTPA; PERMEABILITY; STROKE; PARAMETERS; DIFFUSION; BREAKDOWN	Blood-brain barrier (BBB) disruption is common following traumatic brain injury (TBI). Dynamic contrast enhanced (DCE) MRI can longitudinally measure the transport coefficient K-trans which reflects BBB permeability. K-trans measurements however are not widely used in TBI research because it is generally considered to be noisy and possesses low spatial resolution. We improved spatiotemporal resolution and signal sensitivity of K-trans MRI in rats by using a high-sensitivity surface transceiver coil. To overcome the signal drop off profile of the surface coil, a pre-scan module was used to map the flip angle (B-1 field) and magnetization (M-0) distributions. A series of T-1-weighted gradient echo images were acquired and fitted to the extended Kety model with reversible or irreversible leakage, and the best model was selected using F-statistics. We applied this method to study the rat brain one hour following controlled cortical impact (mild to moderate TBI), and observed clear depiction of the BBB damage around the impact regions, which matched that outlined by Evans Blue extravasation. Unlike the relatively uniform T-2 contrast showing cerebral edema, K-trans shows a pronounced heterogeneous spatial profile in and around the impact regions, displaying a nonlinear relationship with T-2. This improved K-trans MRI method is also compatible with the use of high-sensitivity surface coil and the high-contrast two-coil arterial spin-labeling method for cerebral blood flow measurement, enabling more comprehensive investigation of the pathophysiology in TBI.	[Li, Wei; Long, Justin Alexander; Watts, Lora Talley; Jiang, Zhao; Shen, Qiang; Li, Yunxia; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Li, Wei; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA		Li, W (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.	liw5@uthscsa.edu; duongt@uthscsa.edu	Duong, Tim/AAL-8357-2021; Watts, Lora Talley/A-2724-2012; Shen, Qiang/B-8784-2008	Duong, Tim/0000-0001-6403-2827; Watts, Lora Talley/0000-0002-2337-1504; Shen, Qiang/0000-0002-4287-3403; jiang, zhao/0000-0002-8192-9908	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45879, UL1 TR001119, TL1TR001119, KL2 TR001118]; NIH/NINDS via the Clinical Translational Science Awards (CTSA) [TL1TR001119, UL1TR001119, 8UL1TR000149]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001118, TL1TR001119, UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER	The study was supported in part by grants from NIH/NINDS R01 NS45879 (TQD), UL1 TR001119 (WL), TL1TR001119 (JAL), and KL2 TR001118 (LTW) via the Clinical Translational Science Awards (CTSA, parent grant UL1TR001119, 8UL1TR000149, and TL1TR001119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1998, ACT NEUR S, V71, P104; Aryal MP, 2014, MAGN RESON MED, V71, P2206, DOI 10.1002/mrm.24873; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Ding GL, 2008, STROKE, V39, P1563, DOI 10.1161/STROKEAHA.107.502146; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Durukan A, 2009, BRAIN RES, V1280, P158, DOI 10.1016/j.brainres.2009.05.025; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Jiang Z, 2014, NEUROSCI LETT, V566, P298, DOI 10.1016/j.neulet.2014.02.066; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Nagaraja TN, 2010, MAGN RESON MED, V63, P1502, DOI 10.1002/mrm.22339; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tofts PS, 2010, SIGNAL, V3, P31; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Yankeelov TE, 2007, MAGN RESON MED, V57, P353, DOI 10.1002/mrm.21131	26	22	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114173	10.1371/journal.pone.0114173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	WOS:000346907200050	25478693	Green Submitted, Green Published, gold			2022-02-06	
J	Shogren, KA; Kennedy, W; Dowsett, C; Villarreal, MG; Little, TD				Shogren, Karrie A.; Kennedy, William; Dowsett, Chantelle; Villarreal, Mauricio Garnier; Little, Todd D.			Exploring Essential Characteristics of Self-Determination for Diverse Students Using Data From NLTS2	CAREER DEVELOPMENT AND TRANSITION FOR EXCEPTIONAL INDIVIDUALS			English	Article						self-determination; culture; NLTS2	PERCEPTIONS; INTERVENTIONS; DISABILITIES; INDIVIDUALS	This study explored the impact of race/ethnicity on three of the four essential characteristics of self-determination-autonomy, self-realization, and psychological empowerment-directly assessed in the National Longitudinal Transition Study-2. Specifically, the impact of race/ethnicity was examined with six disability groups established in previous research: high incidence disabilities (learning disabilities, emotional disturbances, speech language impairments, and other health impairments), sensory disabilities (visual and hearing impairments), cognitive disabilities (autism, multiple disabilities, and deaf-blindness); intellectual disability, traumatic brain injury, and orthopedic impairments. Measurement equivalence was established across groups, but significant differences in the latent means, variances, and covariances were found suggesting a complex pattern of differences based on race/ethnicity within disability groups. Implications for future research and practice are discussed.	[Shogren, Karrie A.] Univ Illinois, Champaign, IL 61820 USA; [Kennedy, William; Dowsett, Chantelle; Villarreal, Mauricio Garnier; Little, Todd D.] Univ Kansas, Lawrence, KS 66045 USA		Shogren, KA (corresponding author), Univ Illinois, Dept Special Educ, 1310 S 6th St, Champaign, IL 61820 USA.	kshogren@illinois.edu		Garnier-Villarreal, Mauricio/0000-0002-2951-6647	Institute of Education SciencesUS Department of Education; U.S. Department of Education to the University of Illinois [R324A110040]; NSFNational Science Foundation (NSF) [1053160]; Center for Research Methods and Data Analysis at the University of Kansas	The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: The research reported here was supported by the Institute of Education Sciences, U.S. Department of Education, through Grant R324A110040 to the University of Illinois. The opinions expressed are those of the authors and do not represent views of the Institute or the U.S. Department of Education. Partial support for this project was also provided by grant NSF 1053160 (Wei Wu & Todd D. Little coPIs) and the Center for Research Methods and Data Analysis at the University of Kansas (Todd D. Little, director).	Agran M, 2007, J VISUAL IMPAIR BLIN, V101, P453, DOI 10.1177/0145482X0710100802; Algozzine B, 2001, REV EDUC RES, V71, P219, DOI 10.3102/00346543071002219; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cobb B, 2009, CAREER DEV TRANSIT E, V32, P108, DOI 10.1177/0885728809336654; Frankland HC, 2004, EDUC TRAIN DEV DISAB, V39, P191; Hancock GR, 2000, STRUCT EQU MODELING, V7, P534, DOI 10.1207/S15328007SEM0704_2; Hill, 1996, SCALES INDEPENDENT B; Leake D, 2007, CAREER DEV TRANSIT E, V30, P104, DOI 10.1177/08857288070300020101; Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3; Little TD, LONGITUDINAL STRUCTU; Morrier MJ, 2012, J SPEC EDUC, V46, P49, DOI 10.1177/0022466910372137; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Newman L., 2011, 20113005NCSERNLTS2 N; RINDSKOPF D, 1984, PSYCHOMETRIKA, V49, P37, DOI 10.1007/BF02294204; Shogren K. A., EXCEPTIONAL IN PRESS; Shogren K, 2012, RES PRACT PERS SEV D, V37, P170, DOI 10.2511/027494812804153561; Shogren KA, 2011, CAREER DEV TRANSIT E, V34, P115, DOI 10.1177/0885728811398271; Shogren KA, 2010, RES PRACT PERS SEV D, V35, P80, DOI 10.2511/rpsd.35.3-4.80; Shogren KA, 2008, ASSES EFF INTERV, V33, P94, DOI 10.1177/1534508407311395; Skiba RJ, 2008, EXCEPT CHILDREN, V74, P264, DOI 10.1177/001440290807400301; SRI International, 2000, NATL LONG TRANS STUD; Test DW, 2009, CAREER DEV TRANSIT E, V32, P115, DOI 10.1177/0885728809336859; Trainor A. A., 2002, INT QUALITATIVE STUD, V15, P711, DOI [10.1080/0951839022000014394, DOI 10.1080/0951839022000014394]; Trainor AA, 2005, J LEARN DISABIL-US, V38, P233, DOI 10.1177/00222194050380030501; Trainor AA, 2008, CAREER DEV TRANSIT E, V31, P56, DOI 10.1177/0885728807313777; Wagner, 2004, SPECIAL TOPIC REPORT; Wagner M., 2006, NLTS2 SRI INT; Wehmeyer M. L., 2003, THEORY SELF DETERMIN, P182; WEHMEYER ML, 1994, EDUC TRAIN MENT RET, V29, P9; Wehmeyer ML., 1995, ARCS SELF DETERMINAT; Wood WM, 2005, RES PRACT PERS SEV D, V30, P121, DOI 10.2511/rpsd.30.3.121	31	22	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2165-1434	2165-1442		CAREER DEV TRANSIT E	Career Dev. Transit. Except. Individ.	DEC	2014	37	3					168	176		10.1177/2165143413486927			9	Education, Special; Rehabilitation	Emerging Sources Citation Index (ESCI)	Education & Educational Research; Rehabilitation	V1Z8U	WOS:000217386300005		Green Published			2022-02-06	
J	Hartwig, K; Fackler, V; Jaksch-Bogensperger, H; Winter, S; Furtner, T; Couillard-Despres, S; Meier, D; Moessler, H; Aigner, L				Hartwig, Kerstin; Fackler, Viktoria; Jaksch-Bogensperger, Heidi; Winter, Stefan; Furtner, Tanja; Couillard-Despres, Sebastien; Meier, Dieter; Moessler, Herbert; Aigner, Ludwig			Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3 beta signaling	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Neuroprotection; Neurotrophic factors; Cell death	NERVE GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3-BETA; PRESYNAPTIC ADENOSINE RECEPTORS; BRAIN-TISSUE HYDROLYSATE; FIMBRIA-FORNIX LESION; ALZHEIMERS-DISEASE; DRUG CEREBROLYSIN; INDUCED APOPTOSIS; TRANSGENIC MODEL; RAT HIPPOCAMPUS	Cerebrolysin (EVER Neuro Pharma GmbH, Austria) is a peptidergic drug indicated for clinical use in stroke, traumatic brain injury and dementia. The therapeutic effect of Cerebrolysin is thought to ensure from its neurotrophic activity, which shares some properties with naturally occurring neurotrophic factors. However, the exact mechanism of action of Cerebrolysin is yet to be fully deciphered. This study aimed to investigate the neuroprotective effect of Cerebrolysin in a widely used in vitro model of hypoxia-induced neuronal cytotoxicity, namely cobalt chloride (CoCl2)-treatment of PC12 cells. CoCl2-cytotoxicity was indicated by a reduced cell-diameter, cell shrinkage, increased pro-apoptotic Caspase-activities and a decreased metabolic activity. Cerebrolysin maintained the cell-diameter of CoCl2-treated naive PC12 cells, decreased the activation of Caspase 3/7 in CoCl2-stressed naive PC12 cells and restored the cells' metabolic activity in CoCl2-impaired naive and differentiated PC12 cells. Cerebrolysin treatment also decreased the levels of superoxide observed after exposure to CoCl2. Investigating the mechanism of action, we could demonstrate that Cerebrolysin application to CoCl2-stressed PC12 cells increased the phosphorylation of GSK3 beta, resulting in the inhibition of GSK3 beta. This might become clinically relevant for Alzheimer's disease, since GSK3 beta activity has been linked to the production of amyloid beta. Taken together, Cerebrolysin was found to have neuroprotective effects in CoCl2-induced cytotoxicity in PC12 cells. (C) 2014 ISDN. Published by Elsevier Ltd. All rights reserved.	[Jaksch-Bogensperger, Heidi; Furtner, Tanja; Couillard-Despres, Sebastien; Aigner, Ludwig] Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria; [Couillard-Despres, Sebastien; Aigner, Ludwig] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Couillard-Despres, Sebastien] Paracelsus Med Univ, Inst Expt Neuroregenerat, Salzburg, Austria; [Hartwig, Kerstin; Fackler, Viktoria; Winter, Stefan; Meier, Dieter; Moessler, Herbert] EVER Neuro Pharma GmbH, Unterach, Austria		Aigner, L (corresponding author), Paracelsus Med Univ Salzburg, Inst Mol Regenerat Med, Strubergasse 21, A-5020 Salzburg, Austria.	stefan.winter@everpharma.com; ludwig.aigner@pmu.ac.at		Couillard-Despres, Sebastien/0000-0002-8486-6412; Aigner, Ludwig/0000-0002-1653-8046	EVER Neuro Pharma GmbH; European Union's Seventh Framework Program (FP7) [HEALTH-F2-2011-278850 (INMiND), HEALTH-F2-2011-279288 (IDEA)]; State of Salzburg	The present work was supported by a grant from EVER Neuro Pharma GmbH; by the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreements no. HEALTH-F2-2011-278850 (INMiND) and HEALTH-F2-2011-279288 (IDEA); and by the State of Salzburg (to L.A.).	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Alvarez XA, 2006, EUR J NEUROL, V13, P43, DOI 10.1111/j.1468-1331.2006.01222.x; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; Cole AR, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00004; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; EBEWENeuroPharmaGmbH, 2009, CER SOL INJ SUMM PRO; Ekshyyan O, 2005, CELL DEATH DIFFER, V12, P1066, DOI 10.1038/sj.cdd.4401650; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; FrancisTurner L, 1996, NEUROSCI LETT, V202, P193, DOI 10.1016/0304-3940(95)12240-0; FrancisTurner L, 1996, J NEURAL TRANSM-SUPP, P277; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; Gutmann B, 2002, NEUROTOX RES, V4, P59, DOI 10.1080/10298420290007637; Hartbauer M, 2001, J NEURAL TRANSM, V108, P459, DOI 10.1007/s007020170067; HutterPaier B, 1996, J NEURAL TRANSM-SUPP, P267; Jung JY, 2004, NEUROSCI LETT, V371, P85, DOI 10.1016/j.neulet.2004.06.069; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lan AP, 2013, NEUROCHEM RES, V38, P1454, DOI 10.1007/s11064-013-1044-x; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; Linford NJ, 2002, STEROIDS, V67, P1029, DOI 10.1016/S0039-128X(02)00062-4; Loberg RD, 2002, J BIOL CHEM, V277, P41667, DOI 10.1074/jbc.M206405200; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Mallory M, 1999, ACTA NEUROPATHOL, V97, P437, DOI 10.1007/s004010051012; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Piswanger A., 1990, AMINO ACIDS, P651; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; RUTHER E, 1994, PHARMACOPSYCHIATRY, V27, P32, DOI 10.1055/s-2007-1014271; Ruther E, 2000, J NEURAL TRANSM, V107, P815, DOI 10.1007/s007020070061; Sugita Y, 1993, No To Shinkei, V45, P325; Ubhi K, 2013, J NEUROSCI RES, V91, P167, DOI 10.1002/jnr.23142; Valouskova V, 1996, J NEURAL TRANSM-SUPP, P280; Veinbergs I, 2000, J NEURAL TRANSM-SUPP, P273; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; WINDISCH VM, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1353; Wojtowicz JM, 1996, J NEURAL TRANSM-SUPP, P281; Wyatt AW, 2006, CELL PHYSIOL BIOCHEM, V17, P137, DOI 10.1159/000092075; XIONG H, 1995, CAN J PHYSIOL PHARM, V73, P1194, DOI 10.1139/y95-170; YOUNG AP, 1983, BIRTH DEFECTS-ORIG, V19, P33; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061; Zhong XY, 2014, BIOL PHARM BULL, V37, P1199, DOI 10.1248/bpb.b14-00100; Zou WG, 2002, J NEUROSCI RES, V67, P837, DOI 10.1002/jnr.10168; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118	47	22	24	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	NOV	2014	38						52	58		10.1016/j.ijdevneu.2014.07.005			7	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	AY6FN	WOS:000347662800007	25093704	Green Submitted			2022-02-06	
J	Kane, WG; Wright, DA; Fu, RW; Carlson, KF				Kane, Wendy G.; Wright, Dagan A.; Fu, Rongwei; Carlson, Kathleen F.			Racial/Ethnic and Insurance Status Disparities in Discharge to Posthospitalization Care for Patients With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						discharge disposition; ethnicity; healthcare disparities; insurance; race; traumatic brain injury	UNITED-STATES; LEVEL I; DISPOSITION; OUTCOMES; RACE; MODERATE; LIFE	Objectives: Professional, posthospitalization care (PHC) can improve outcomes among patients with traumatic brain injury. We examined disparities in discharge to PHC by patients' race/ethnicity and insurance type. Participants: A total of 6061 adults hospitalized for unintentional traumatic brain injury in Oregon, 2008 to 2011. Main Outcome Measure: Posthospitalization care was assessed on the basis of discharge disposition. Multivariable logistic regression was used to estimate effects of race/ethnicity and insurance on referral to PHC while controlling for potential confounders. Generalized estimating equations were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs), accounting for clustering of data by hospital. Results: 28% of patients were discharged to PHC. While controlling for potential confounders, Hispanics were less likely to be discharged to PHC (OR, 0.62; CI, 0.40-0.96) than non-Hispanic whites. Compared with patients with private insurance, uninsured patients were less likely to be discharged to PHC (OR, 0.19; CI, 0.11-0.32) whereas patients with public insurance (OR, 1.65; CI, 1.33-2.05) and worker's compensation (OR, 1.66; CI, 1.09-2.52) were more likely to be discharged to PHC. Conclusions: Results suggest that racial/ethnic and insurance disparities exist in discharge to postacute care after hospitalization for traumatic brain injury. Future research should examine factors that might contribute to and reduce these inequities in care.	[Kane, Wendy G.; Wright, Dagan A.; Fu, Rongwei; Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Wright, Dagan A.] Oregon Hlth Author, Injury & Violence Prevent Sect, Ctr Prevent & Hlth Promot, Portland, OR USA; [Carlson, Kathleen F.] Portland VA Med Ctr R&D 66, Portland Ctr Study Chron Comorbid Mental & Phys D, Portland, OR 97239 USA		Carlson, KF (corresponding author), Portland VA Med Ctr R&D 66, Portland Ctr Study Chron Comorbid Mental & Phys D, 3715 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kathleen.carlson@va.gov			Veterans Health Administration Health Services Research and Development ServiceUS Department of Veterans Affairs [CDA 08-025]	Funds were not received for this study. Dr Carlson's effort was supported by a career development grant from the Veterans Health Administration Health Services Research and Development Service (CDA 08-025). The opinions expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government.	*AG HEALTHC RES QU, 2003, NAT HEALTHC DISP REP; Agency for Healthcare Research and Quality (AHRQ), 2012, MULT POST REH MOD SE; Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project, COM SOFTW VERS 3 7; Alkhoury F, 2011, AM SURGEON, V77, P277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bergman Karen, 2010, J Trauma Nurs, V17, P102, DOI 10.1097/JTN.0b013e3181ecc452; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Cifu DX, GERIATRIC REHABILITA; Coronado VG, EPIDEMIOLOGY PREVENT; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Duncan GJ, 2002, AM J PUBLIC HEALTH, V92, P1151, DOI 10.2105/AJPH.92.7.1151; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Emergency Medical Services and Trauma Systems Program, 2012, OR TRAUM REG REP 201; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Finkelstein E., 2006, INCIDENCE EC BURDEN; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Hardin JW, 2008, GEN ESTIMATING EQUAT, P1; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Laurence B, 2013, MADICARE COVERAGE IN; Laurence B., 2013, MEDICARE COVERAGE IN; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Research Council, 2008, GULF WAR HLTH, V7, P65; Newhouse JP, 2013, NEW ENGL J MED, V368, P1465, DOI 10.1056/NEJMp1302981; Oregon Health Authority; Public Health Division, OR TRAUM HOSP DES; Sacks GD, 2011, J TRAUMA, V71, P1011, DOI 10.1097/TA.0b013e3182092c27; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Scheetz LJ, 2005, J NURS SCHOLARSHIP, V37, P361, DOI 10.1111/j.1547-5069.2005.00062.x; Sears JM, 2014, INJURY, V45, P16, DOI 10.1016/j.injury.2012.12.024; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; SMEDLEY BD, 2003, UNEQUAL TREATMENT CO, P80; Young JS, 1998, J TRAUMA, V45, P800, DOI 10.1097/00005373-199810000-00033; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	41	22	22	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2014	29	6					E10	E17		10.1097/HTR.0000000000000028			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT7LI	WOS:000345117800002	24590153				2022-02-06	
J	Miyamoto, K; Tsumuraya, T; Ohtaki, H; Dohi, K; Satoh, K; Xu, ZF; Tanaka, S; Murai, N; Watanabe, J; Sugiyama, K; Aruga, T; Shioda, S				Miyamoto, Kazuyuki; Tsumuraya, Tomomi; Ohtaki, Hirokazu; Dohi, Kenji; Satoh, Kazue; Xu, Zhifang; Tanaka, Sachiko; Murai, Norimitsu; Watanabe, Jun; Sugiyama, Koichi; Aruga, Tohru; Shioda, Seiji			PACAP38 Suppresses Cortical Damage in Mice with Traumatic Brain Injury by Enhancing Antioxidant Activity	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						PACAP38; Traumatic brain injury (TBI); Antioxidant enzyme; Superoxide dismutase-2 (SOD-2, Mn-SOD); Glutathione peroxidase 1 (GPx-1)	CYCLASE-ACTIVATING POLYPEPTIDE; STRESS-INDUCED APOPTOSIS; VASOACTIVE-INTESTINAL-PEPTIDE; NEURONAL CELL-DEATH; ADENYLATE-CYCLASE; IN-VITRO; ISCHEMIA/REPERFUSION INJURY; DEFICIENT MICE; INFARCT SIZE; RAT MODEL	The production of reactive oxygen species (ROS) and the resulting oxidative stress in mice in response to a controlled cortical impact (CCI) are typical exacerbating factors associated with traumatic brain injury (TBI). Pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) is a multifunctional peptide that has been shown to exhibit neuroprotective effects in response to a diverse range of injuries to neuronal cells. We recently reported that PACAP38 might regulate oxidative stress in mice. The aim of the present study was to determine whether PACAP38 exerts neuroprotective effects by regulating oxidative stress in mice with TBI. Reactive oxidative metabolites (ROMs) and biological antioxidant potential (BAP) were measured in male C57Bl/6 mice before and 3, 4, and 24 h after CCI. PACAP38 was administered intravenously immediately following CCI, and immunostaining for the oxidative stress indicator nitrotyrosine (NT), and for neuronal death as an indicator of the area affected by TBI, was measured 24 h later. Western blot experiments to determine antioxidant activity [as indicated by superoxide dismutase-2 (SOD-2) and glutathione peroxidase 1 (GPx-1)] in the neocortical region were also performed 3 h post-CCI. Results showed that plasma BAP and ROM levels were dramatically increased 3 h after CCI. PACAP38 suppressed the extent of TBI and NT-positive regions 24 h after CCI, and increased SOD-2 and GPx-1 levels in both hemispheres. Taken together, these results suggest that increasing antioxidant might be involving in the neuroprotective effect of PACAP38 in mice subjected to a CCI.	[Miyamoto, Kazuyuki; Tsumuraya, Tomomi; Ohtaki, Hirokazu; Dohi, Kenji; Satoh, Kazue; Xu, Zhifang; Murai, Norimitsu; Watanabe, Jun; Sugiyama, Koichi; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Miyamoto, Kazuyuki; Aruga, Tohru] Showa Univ, Dept Emergency & Crit Care Med, Sch Med, Tokyo 1428555, Japan; [Tanaka, Sachiko] Showa Univ, Dept Pharmacol Toxicol & Therapeut, Div Toxicol, Sch Pharm, Tokyo 1428555, Japan		Shioda, S (corresponding author), Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shioda@med.showa-u.ac.jp	Xu, Zhifang/AAF-4798-2019	dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); MEXTMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	The project was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology. This work was also supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012.	Abad C, 2002, NEUROIMMUNOMODULAT, V10, P177, DOI 10.1159/000067180; Arimura A, 2006, BLOOD, V107, P661, DOI 10.1182/blood-2005-03-1186; Crack PJ, 2003, J CEREBR BLOOD F MET, V23, P19, DOI 10.1097/01.WCB.0000035181.38851.71; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Delgado M, 2001, J IMMUNOL, V167, P966, DOI 10.4049/jimmunol.167.2.966; Dohi K, 2002, REGUL PEPTIDES, V109, P83, DOI 10.1016/S0167-0115(02)00190-8; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; Frechilla D, 2001, NEUROREPORT, V12, P919, DOI 10.1097/00001756-200104170-00011; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Gasz B, 2006, PEPTIDES, V27, P87, DOI 10.1016/j.peptides.2005.06.022; Kovesdi E, 2008, NEUROTOX RES, V13, P71, DOI 10.1007/BF03033558; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Manno EM, 2008, CRIT CARE, V12, DOI 10.1186/cc7112; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Martinez C, 2002, P NATL ACAD SCI USA, V99, P1053, DOI 10.1073/pnas.012367999; Miyamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379206; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Mori H, 2010, CIRC J, V74, P1183, DOI 10.1253/circj.CJ-09-1024; Nakamachi T, 2012, J MOL NEUROSCI, V48, P518, DOI 10.1007/s12031-012-9819-0; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Ohtaki H, 2010, J MOL NEUROSCI, V42, P397, DOI 10.1007/s12031-010-9350-0; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Racz B, 2007, GEN COMP ENDOCR, V153, P115, DOI 10.1016/j.ygcen.2006.12.006; Ravni A, 2006, J NEUROCHEM, V98, P1229, DOI 10.1111/j.1471-4159.2006.03962.x; Reglodi D, 2000, STROKE, V31, P1411, DOI 10.1161/01.STR.31.6.1411; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Reglodi D, 2002, PEPTIDES, V23, P2227, DOI 10.1016/S0196-9781(02)00262-0; Reglodi D, 2000, ANN NY ACAD SCI, V921, P119; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Tanaka J, 1997, REGUL PEPTIDES, V72, P1, DOI 10.1016/S0167-0115(97)01038-0; Tsuchikawa D, 2012, J MOL NEUROSCI, V48, P508, DOI 10.1007/s12031-012-9817-2; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Vaudry D, 2002, EUR J NEUROSCI, V15, P1451, DOI 10.1046/j.1460-9568.2002.01981.x; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181	43	22	23	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	NOV	2014	54	3					370	379		10.1007/s12031-014-0309-4			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AT3ZN	WOS:000344875700010	24907941				2022-02-06	
J	Shu, IW; Onton, JA; O'Connell, RM; Simmons, AN; Matthews, SC				Shu, I-Wei; Onton, Julie A.; O'Connell, Ryan M.; Simmons, Alan N.; Matthews, Scott C.			Combat veterans with comorbid PTSD and mild TBI exhibit a greater inhibitory processing ERP from the dorsal anterior cingulate cortex	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						N200; P300; Conflict monitoring; Response inhibition; Biomarker	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; DEFAULT-MODE NETWORK; RESPONSE-INHIBITION; COGNITIVE CONTROL; CONCUSSED INDIVIDUALS; FUNCTIONAL NETWORKS; DEPRESSION; CONFLICT	Posttraumatic stress disorder (PTSD) is common among combat personnel with mild traumatic brain injury (mTBI). While patients with either PTSD or mTBI share abnormal activation of multiple frontal brain areas, anterior cingulate cortex (ACC) activity during inhibitory processing may be particularly affected by PTSD. To further test this hypothesis, we recorded electroencephalography from 32 combat veterans with mTBI-17 of whom were also comorbid for PTSD (mTBI+PTSD) and 15 without PTSD (mTBI-only). Subjects performed the Stop Task, a validated inhibitory control task requiring inhibition of initiated motor responses. We observed a larger inhibitory processing eventrelated potential (ERP) in veterans with mTBI+PTSD, including greater N200 negativity. Furthermore, greater N200 negativity correlated with greater PTSD severity. This correlation was most dependent on contributions from the dorsal ACC. Support vector machine analysis demonstrated that N200 and P300 amplitudes objectively classified veterans into mTBI-only or mTBI+PTSD groups with 79.4% accuracy. Our results support a model where, in combat veterans with mTBI, larger ERPs from cingulate areas are associated with greater PTSD severity and likely related to difficulty controlling ongoing brain processes, including trauma-related thoughts and feelings. Published by Elsevier Ireland Ltd.	[Shu, I-Wei; Matthews, Scott C.] VISN22 Mental Illness, Res Educ & Clin Ctr, San Diego, CA 92161 USA; [Shu, I-Wei; O'Connell, Ryan M.; Simmons, Alan N.; Matthews, Scott C.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [O'Connell, Ryan M.; Matthews, Scott C.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; [Simmons, Alan N.; Matthews, Scott C.] Vet Affairs San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Onton, Julie A.] Naval Hlth Res Ctr, San Diego, CA 92106 USA; [Onton, Julie A.] Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA		Shu, IW (corresponding author), Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr,116A, San Diego, CA 92161 USA.	ishu@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112	BUMED under Work Unit 61032; VA Mental Illness Research, Education and Clinical Center; VA Office of Academic AffiliationsUS Department of Veterans Affairs; VA Advanced Fellowship Program in Mental Illness Research Treatment; VA Center of Excellence for Stress and Mental Health; University of California San Diego Academic Senate; U.S. Department of Veterans AffairsUS Department of Veterans Affairs; Congressionally Directed Medical Research ProgramsUnited States Department of Defense; CDA-2 Award from the VA CSRD; Veterans AffairsUS Department of Veterans Affairs [I01CX000292] Funding Source: NIH RePORTER	This work represents Report No. 13-xx and is supported by BUMED under Work Unit 61032. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government. Approved for public release; distribution is unlimited. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (Protocols NHRC.2010.0022 and NHRC.2010.0023).; The authors are grateful to Elena Kosheleva and Jenny Marks for their contributions to this research, which was supported by the VA Mental Illness Research, Education and Clinical Center, VA Office of Academic Affiliations, VA Advanced Fellowship Program in Mental Illness Research Treatment, VA Center of Excellence for Stress and Mental Health, and by grants from the University of California San Diego Academic Senate, U.S. Department of Veterans Affairs, and the Congressionally Directed Medical Research Programs. Dr. Matthews is supported by a CDA-2 Award from the VA CSR&D.	Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brown MRG, 2008, NEUROIMAGE, V39, P793, DOI 10.1016/j.neuroimage.2007.09.035; Brown MRG, 2007, J NEUROPHYSIOL, V98, P1751, DOI 10.1152/jn.00460.2007; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Carrion VG, 2008, DEPRESS ANXIETY, V25, P514, DOI 10.1002/da.20346; Clawson A, 2013, PSYCHOPHYSIOLOGY, V50, P711, DOI 10.1111/psyp.12066; Covey TJ, 2013, INT J PSYCHOPHYSIOL, V87, P363, DOI 10.1016/j.ijpsycho.2013.03.009; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Holmes AJ, 2008, NEUROPSYCHOLOGIA, V46, P2904, DOI 10.1016/j.neuropsychologia.2008.05.028; Huster RJ, 2011, NEUROIMAGE, V56, P1588, DOI 10.1016/j.neuroimage.2011.03.039; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jovanovic T, 2013, CORTEX, V49, P1884, DOI 10.1016/j.cortex.2012.08.011; Kaiser S, 2003, PSYCHIAT RES-NEUROIM, V122, P169, DOI 10.1016/S0925-4927(03)00004-0; Krompinger JW, 2011, BIOL PSYCHOL, V86, P239, DOI 10.1016/j.biopsycho.2010.12.004; Krompinger JW, 2009, BIOL PSYCHOL, V81, P153, DOI 10.1016/j.biopsycho.2009.03.007; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Matthews SC, 2005, NEUROREPORT, V16, P755, DOI 10.1097/00001756-200505120-00020; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; OGURA C, 1991, JPN J PSYCHIAT NEUR, V45, P641; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Quinn CR, 2012, AUST NZ J PSYCHIAT, V46, P374, DOI 10.1177/0004867411432073; Ramage AE, 2013, HUM BRAIN MAPP, V34, P3392, DOI 10.1002/hbm.22155; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ruchsow M, 2008, INT J PSYCHOPHYSIOL, V68, P209, DOI 10.1016/j.ijpsycho.2008.01.010; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stewart JAL, 1999, BRAIN COGNITION, V41, P411, DOI 10.1006/brcg.1999.1141; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; THOMAES K, 2012, PSYCHOL MED, V22, P1; Vanderhasselt MA, 2009, BIOL PSYCHOL, V81, P169, DOI 10.1016/j.biopsycho.2009.03.009; Vanderhasselt MA, 2012, J PSYCHIATR NEUROSCI, V37, P250, DOI 10.1503/jpn.110089; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wu JH, 2010, NEUROSCI LETT, V486, P117, DOI 10.1016/j.neulet.2010.07.040; Zhang BW, 2007, NEUROSCI LETT, V419, P225, DOI 10.1016/j.neulet.2007.04.013; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197; Zhang YY, 2007, NEUROPSYCHOBIOLOGY, V55, P14, DOI 10.1159/000103571; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	66	22	22	2	39	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	OCT 30	2014	224	1					58	66		10.1016/j.pscychresns.2014.07.010			9	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	AQ0MW	WOS:000342478400009	25150386				2022-02-06	
J	Kim, H; Kim, GD; Yoon, BC; Kim, K; Kim, BJ; Choi, YH; Czosnyka, M; Oh, BM; Kim, DJ				Kim, Hakseung; Kim, Gwang-dong; Yoon, Byung C.; Kim, Keewon; Kim, Byung-Jo; Choi, Young Hun; Czosnyka, Marek; Oh, Byung-Mo; Kim, Dong-Joo			Quantitative analysis of computed tomography images and early detection of cerebral edema for pediatric traumatic brain injury patients: retrospective study	BMC MEDICINE			English	Article						Cerebral edema; Computed tomography; Densitometry; Traumatic brain injury; Pediatrics	HISTOGRAM ANALYSIS; VASOGENIC EDEMA; LUNG DENSITY; HEAD-INJURY; ARTERY OCCLUSION; CT DENSITOMETRY; CHILDREN; CLASSIFICATION; MYELINATION; PREDICTION	Background: The purpose of this study was to identify whether the distribution of Hounsfield Unit (HU) values across the intracranial area in computed tomography (CT) images can be used as an effective diagnostic tool for determining the severity of cerebral edema in pediatric traumatic brain injury (TBI) patients. Methods: CT images, medical records and radiology reports on 70 pediatric patients were collected. Based on radiology reports and the Marshall classification, the patients were grouped as mild edema patients (n = 37) or severe edema patients (n = 33). Automated quantitative analysis using unenhanced CT images was applied to eliminate artifacts and identify the difference in HU value distribution across the intracranial area between these groups. Results: The proportion of pixels with HU = 17 to 24 was highly correlated with the existence of severe cerebral edema (P < 0.01). This proportion was also able to differentiate patients who developed delayed cerebral edema from mild TBI patients. A significant difference between deceased patients and surviving patients in terms of the HU distribution came from the proportion of pixels with HU = 19 to HU = 23 (P < 0.01). Conclusions: The proportion of pixels with an HU value of 17 to 24 in the entire cerebral area of a non-enhanced CT image can be an effective basis for evaluating the severity of cerebral edema. Based on this result, we propose a novel approach for the early detection of severe cerebral edema.	[Kim, Hakseung; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea; [Kim, Gwang-dong; Kim, Keewon; Oh, Byung-Mo] Seoul Natl Univ, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Yoon, Byung C.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA USA; [Kim, Byung-Jo] Korea Univ, Coll Med, Dept Neurol, Seoul 136705, South Korea; [Choi, Young Hun] Seoul Natl Univ, Childrens Hosp, Dept Radiol, Seoul, South Korea; [Czosnyka, Marek; Kim, Dong-Joo] Univ Cambridge, Sch Clin, Acad Neurosurg Unit, Cambridge, England		Kim, DJ (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea.	dongjookim@korea.ac.kr	Kim, Hakseung/AAZ-8626-2021; Kim, Byung-Jo/A-5943-2012; Choi, Young Hun/O-3282-2015	Kim, Hakseung/0000-0001-5407-293X; Kim, Byung-Jo/0000-0002-0445-7185; Choi, Young Hun/0000-0002-1842-9062	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A1004827]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0600986] Funding Source: UKRI	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A1004827).	Abe S, 2012, IFMBE PROC, V37, P555; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Barras CD, 2013, AM J NEURORADIOL, V34, P1139, DOI 10.3174/ajnr.A3375; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bauer R, 1999, EXP TOXICOL PATHOL, V51, P143, DOI 10.1016/S0940-2993(99)80088-8; Bendszus M, 1997, NEURORADIOLOGY, V39, P127, DOI 10.1007/s002340050379; Biernacki W, 1997, EUR RESPIR J, V10, P2455, DOI 10.1183/09031936.97.10112455; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Camilla Lindan EG, 2012, FUNDAMENTALS DIAGNOS, P1420; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; CLASEN RA, 1981, J COMPUT ASSIST TOMO, V5, P313, DOI 10.1097/00004728-198106000-00001; Creasy JL, 2011, DATING NEUROLOGICAL INJURY: A FORENSIC GUIDE FOR RADIOLOGISTS, OTHER EXPERT MEDICAL WITNESSES, AND ATTORNEYS, P119, DOI 10.1007/978-1-60761-250-6_9; Degos V, 2010, YB INTENSIVE CARE EM, V2010, P399, DOI [10.1007/978-3-642-10286-8_38, DOI 10.1007/978-3-642-10286-8_38]; DIETRICH RB, 1988, AM J ROENTGENOL, V150, P889, DOI 10.2214/ajr.150.4.889; Doelken M, 2007, DIAGN INTERV RADIOL, V13, P125; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; Dzialowski I, 2007, RADIOLOGY, V243, P720, DOI 10.1148/radiol.2432060137; GARDEUR D, 1977, J COMPUT ASSIST TOMO, V1, P231, DOI 10.1097/00004728-197704000-00014; Hagen T, 2007, NEURORADIOLOGY, V49, P921, DOI 10.1007/s00234-007-0272-7; HEREMANS A, 1992, CHEST, V102, P805, DOI 10.1378/chest.102.3.805; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; IMANAGA H, 1983, Neurological Surgery, V11, P481; Jaffe TA, 2010, AM J ROENTGENOL, V195, P433, DOI 10.2214/AJR.09.3957; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kalef-Ezra J, 1999, ACTA RADIOL, V40, P333, DOI 10.3109/02841859909175564; Kato S, 1996, CHEST, V109, P1439, DOI 10.1378/chest.109.6.1439; Kawata Y, 2012, MED PHYS, V39, P988, DOI 10.1118/1.3679017; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KONDO T, 1982, ACTA NEUROCHIR, V64, P19, DOI 10.1007/BF01405616; Lee C, 2006, CURR OPIN ANESTHESIO, V19, P262, DOI 10.1097/01.aco.0000192787.93386.9c; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mangel L, 2002, NEOPLASMA, V49, P237; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2000, ACT NEUR S, V76, P349; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Murakami JW, 1999, AM J NEURORADIOL, V20, P1406; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Nomori H, 2003, J THORAC CARDIOV SUR, V126, P1584, DOI 10.1016/S0022-5223(03)00885-7; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; Rosand J, 2001, J INTENSIVE CARE MED, V16, P128, DOI 10.1046/j.1525-1489.2001.00128.x; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schneider W, 2000, PHYS MED BIOL, V45, P459, DOI 10.1088/0031-9155/45/2/314; Serafini G, 2008, CURR OPIN ANESTHESIO, V21, P499, DOI 10.1097/ACO.0b013e328304115b; STAUDT M, 1994, PEDIATR RADIOL, V24, P122, DOI 10.1007/BF02020169; Thalacker U, 1998, STRAHLENTHER ONKOL, V174, P14, DOI 10.1007/BF03038222; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WARD JD, 1994, PEDIATR NEUROSURG, V20, P183, DOI 10.1159/000120784; WARE AJ, 1971, GASTROENTEROLOGY, V61, P877; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamashiro T, 2011, COPD, V8, P13, DOI 10.3109/15412555.2010.541537; Yuan R, 2007, CHEST, V132, P617, DOI 10.1378/chest.06-2325; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zach JA, 2012, INVEST RADIOL, V47, P596, DOI 10.1097/RLI.0b013e318262292e; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; Zimmerman RD, 2004, AM J NEURORADIOL, V25, P1304; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	70	22	22	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1741-7015			BMC MED	BMC Med.	OCT 22	2014	12								186	10.1186/s12916-014-0186-2			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT4ER	WOS:000344893100001	25339549	Green Published, gold			2022-02-06	
J	Dunham, CM; Hoffman, DA; Huang, GS; Omert, LA; Gemmel, DJ; Merrell, R				Dunham, C. Michael; Hoffman, David A.; Huang, Gregory S.; Omert, Laurel A.; Gemmel, David J.; Merrell, Renee			Traumatic Intracranial Hemorrhage Correlates with Preinjury Brain Atrophy, but Not with Antithrombotic Agent Use: A Retrospective Study	PLOS ONE			English	Article							BLUNT HEAD TRAUMA; LOW-DOSE ASPIRIN; WARFARIN USE; ANTIPLATELET AGENTS; PREOPERATIVE ASPIRIN; CORONARY-ANGIOGRAPHY; ATRIAL-FIBRILLATION; CEREBRAL ATROPHY; PATIENTS OLDER; INJURY	Background: The impact of antithrombotic agents (warfarin, clopidogrel, ASA) on traumatic brain injury outcomes is highly controversial. Although cerebral atrophy is speculated as a risk for acute intracranial hemorrhage, there is no objective literature evidence. Materials and Methods: This is a retrospective, consecutive investigation of patients with signs of external head trauma and age >= 60 years. Outcomes were correlated with antithrombotic-agent status, coagulation test results, admission neurologic function, and CT-based cerebral atrophy dimensions. Results: Of 198 consecutive patients, 36% were antithrombotic-negative and 64% antithrombotic-positive. ASA patients had higher arachidonic acid inhibition (p = 0.04) and warfarin patients had higher INR (p < 0.001), compared to antithrombotic-negative patients. Antithrombotic-positive intracranial hemorrhage rate (38.9%) was similar to the antithrombotic-negative rate (31.9%; p = 0.3285). Coagulopathy was not present on the ten standard coagulation, thromboelastography, and platelet mapping tests with intracranial hemorrhage and results were similar to those without hemorrhage (p >= 0.1354). Hemorrhagic-neurologic complication (intracranial hemorrhage progression, need for craniotomy, neurologic deterioration, or death) rates were similar for antithrombotic-negative (6.9%) and antithrombotic-positive (8.7%; p = 0.6574) patients. The hemorrhagic-neurologic complication rate was increased when admission major neurologic dysfunction was present (63.2% versus 2.2%; RR = 28.3; p < 0.001). Age correlated inversely with brain parenchymal width (p < 0.001) and positively with lateral ventricular width (p = 0.047) and cortical atrophy (p < 0.001). Intracranial hemorrhage correlated with cortical atrophy (p < 0.001) and ventricular width (p < 0.001). Conclusions: Intracranial hemorrhage is not associated with antithrombotic agent use. Intracranial hemorrhage patients have no demonstrable coagulopathy. The association of preinjury brain atrophy with acute intracranial hemorrhage is a novel finding. Contrary to antithrombotic agent status, admission neurologic abnormality is a predictor of adverse post-admission outcomes. Study findings indicate that effective hemostasis is maintained with antithrombotic therapy.	[Dunham, C. Michael; Huang, Gregory S.; Merrell, Renee] St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA; [Hoffman, David A.] St Elizabeth Hlth Ctr, Div Cardiol, Youngstown, OH USA; [Omert, Laurel A.] CSL Behring, King Of Prussia, PA USA; [Gemmel, David J.] St Elizabeth Hlth Ctr, Youngstown, OH USA		Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA.	dunham.michael@sbcglobal.net		Huang, Gregory/0000-0001-6355-6012; Dunham, C. Michael/0000-0002-7842-9750			Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Akdogan I, 2010, FOLIA MORPHOL, V69, P193; Alghamdi AA, 2007, J CARDIAC SURG, V22, P247, DOI 10.1111/j.1540-8191.2007.00402.x; Annala AP, 2008, AM J CARDIOL, V102, P386, DOI 10.1016/j.amjcard.2008.04.003; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; DIETRICH W, 1995, J CARDIOTHOR VASC AN, V9, P250, DOI 10.1016/S1053-0770(05)80316-7; DOHERTY DL, 1988, ARCH PHYS MED REHAB, V69, P542; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Downey DM, 2009, AM SURGEON, V75, P1100; El-Jack SS, 2006, AM J CARDIOL, V97, P485, DOI 10.1016/j.amjcard.2005.09.079; ELLIS G L, 1990, Emergency Medicine Clinics of North America, V8, P281; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Furie KL, 2012, STROKE, V43, P3442, DOI 10.1161/STR.0b013e318266722a; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Hanif S, 2009, Ir Med J, V102, P255; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jamula E, 2009, THROMB RES, V124, P292, DOI 10.1016/j.thromres.2009.01.007; Jennett B, 1981, MANAGEMENT HEAD INJU, P184; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Lippe CM, 2014, CATHETER CARDIOVASC; Manchikanti Laxmaiah, 2013, Pain Physician, V16, pSE261; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Nelson RS, 2008, AM J SURG, V196, P994, DOI 10.1016/j.amjsurg.2008.07.036; Nematullah A, 2009, J CAN DENT ASSOC, V75, P41; Onal IK, 2013, CLIN RES HEPATOL GAS, V37, P171, DOI 10.1016/j.clinre.2012.04.010; Ortel TL, 2012, BLOOD, V120, P4699, DOI 10.1182/blood-2012-05-423228; Otley CC, 2003, MAYO CLIN PROC, V78, P1392, DOI 10.4065/78.11.1392; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Resnick SM, 2003, J NEUROSCI, V23, P3295; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wallace DL, 2004, J HAND SURG-BRIT EUR, V29B, P203, DOI 10.1016/j.jhsb.2003.12.008; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Yelon J, 2013, TRAUMA, P874	56	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109473	10.1371/journal.pone.0109473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3DZ	WOS:000342670800085	25279785	Green Submitted, gold, Green Published			2022-02-06	
J	Holmes, M; Garver, M; Albrecht, L; Arbabi, S; Pham, TN				Holmes, Meredith; Garver, Matt; Albrecht, Lily; Arbabi, Saman; Pham, Tam N.			Comparison of Two Comorbidity Scoring Systems for Older Adults with Traumatic Injuries	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							SEVERITY SCORE; CO-MORBIDITY; MORTALITY; EMERGENCY; FRAILTY	BACKGROUND: The purpose of this study was to determine the mortality predictive value of two different comorbidity scores, Comorbidity-Polypharmacy Score (CPS) and Charlson scoring system, in a large sample of older trauma patients. STUDY DESIGN: At an urban tertiary care Level I trauma center, trauma patients aged 55 years and older who were initially admitted to critical care were included. This retrospective chart review was conducted at Harborview Medical Center in Seattle, WA. Older trauma patients admitted from January 1, 2010 through December 31, 2010 were screened for inclusion. One-year mortality data were obtained from the Washington State Department of Health. Covariates included age, presence of hypotension, traumatic brain injury, and Injury Severity Score. RESULTS: Records for 667 older trauma patients were reviewed. In multivariate analyses, CPS was an independent predictor of fatal outcomes. Higher CPS was associated with greater mortality, however, it was not superior to Charlson methodology in predicting 1-year mortality in this patient cohort. CONCLUSIONS: The addition of a comorbidity score improves multivariate models predicting long-term mortality in older trauma patients. There was no advantage to using CPS instead of Charlson score, and each was an independent predictor of fatal outcomes. (C) 2014 by the American College of Surgeons	[Holmes, Meredith; Garver, Matt] Univ Washington, Dept Pharm, Harborview Med Ctr, Seattle, WA 98104 USA; [Arbabi, Saman; Pham, Tam N.] Univ Washington, Dept Surg, Harborview Med Ctr, Div Trauma Burns & Crit Care, Seattle, WA 98104 USA; [Albrecht, Lily] Dartmouth Coll, Hanover, NH 03755 USA		Holmes, M (corresponding author), Univ Washington, Dept Pharm, Harborview Med Ctr, 325 Ninth Ave, Seattle, WA 98104 USA.	holmesme@uw.edu					[Anonymous], J TRAUMA S; [Anonymous], J TRAUMA; [Anonymous], J AM COLL SURG; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Englesbe MJ, 2012, ANN SURG, V256, P255, DOI 10.1097/SLA.0b013e31826028b1; Evans DC, 2012, J AM GERIATR SOC, V60, P1465, DOI 10.1111/j.1532-5415.2012.04075.x; Evans David C, 2011, Int J Crit Illn Inj Sci, V1, P104, DOI 10.4103/2229-5151.84793; Jansen JO, 2013, CRIT CARE, V17, DOI 10.1186/cc12499; Justiniano CF, 2013, J SURG RES, V181, P16, DOI 10.1016/j.jss.2012.05.042; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Robinson TN, 2013, AM J SURG, V206, P544, DOI 10.1016/j.amjsurg.2013.03.012; Robinson TN, 2009, ANN SURG, V250, P449, DOI 10.1097/SLA.0b013e3181b45598; Schluter PJ, 2011, INJURY, V42, P83, DOI 10.1016/j.injury.2010.08.036	19	22	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	OCT	2014	219	4					631	637		10.1016/j.jamcollsurg.2014.05.014			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AP9TJ	WOS:000342422500006	25154672				2022-02-06	
J	Jullienne, A; Roberts, JM; Pop, V; Murphy, MP; Head, E; Bix, GJ; Badaut, J				Jullienne, Amandine; Roberts, Jill M.; Pop, Viorela; Murphy, M. Paul; Head, Elizabeth; Bix, Gregory J.; Badaut, Jerome			Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						amyloid; fibronectin; juvenile; P-glycoprotein; perlecan domain V; traumatic brain injury	PERLECAN DOMAIN V; FOCAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; FIBRIL FORMATION; FIBRONECTIN; BARRIER; EXPRESSION; PEPTIDE; GROWTH; ALPHA-5-BETA-1	In our juvenile traumatic brain injury (jTBI) model, emergence of cognitive dysfunctions was observed up to 6 months after trauma. Here we hypothesize that early brain injury induces changes in the neurovascular unit (NVU) that would be associated with amyloid-beta (A beta) accumulation. We investigated NVU changes for up to 6 months in a rat jTBI model, with a focus on the efflux protein P-glycoprotein (P-gp) and on the basement membrane proteins perlecan and fibronectin, all known to be involved in A beta clearance. Rodent-A beta staining is present and increased after jTBI around cerebral blood microvessels, and the diameter of those is decreased by 25% and 34% at 2 and 6 months, respectively, without significant angiogenesis. P-glycoprotein staining in endothelium is decreased by 22% and parallels an increase of perlecan and fibronectin staining around cerebral blood vessels. Altogether, these results strongly suggest that the emergence of long-term behavioral dysfunctions observed in rodent jTBI may be related to endothelial remodeling at the blood-brain barrier alongside vascular dysfunction and altered A beta trafficking. This study shows that it is important to consider jTBI as a vascular disorder with long-term consequences on cognitive functions.	[Jullienne, Amandine; Pop, Viorela; Badaut, Jerome] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92350 USA; [Roberts, Jill M.; Murphy, M. Paul; Head, Elizabeth; Bix, Gregory J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Badaut, Jerome] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA; [Badaut, Jerome] Bordeaux Univ, CNRS, UMR 5287, Bordeaux, France		Bix, GJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	gregorybix@uky.edu; jerome.badaut@u-bordeaux1.fr	Jullienne, Amandine/H-3081-2019	Jullienne, Amandine/0000-0001-9458-055X	NSFNational Science Foundation (NSF) [MRI-DBI 0923559]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065842] Funding Source: NIH RePORTER	We thank Germaine Paris for the technical help, Jacqueline S Coats for surgeries and Monica Romero for a portion of imaging performed at the Loma Linda University School of Medicine Advanced Imaging and Microscopy Core (LLUSM AIM) Facility supported by NSF grant, MRI-DBI 0923559 (to SM Wilson).	Al-Ahmad AJ, 2011, GLIA, V59, P1822, DOI 10.1002/glia.21227; Alhaddad H, 2012, CRIT CARE MED, V40, P3215, DOI 10.1097/CCM.0b013e318265680a; Alosco ML, 2014, INT J GERIATR PSYCH, V29, P428, DOI 10.1002/gps.4023; Burke MC, 2013, NEUROPATHOL APPL NEU, V40, P284; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Clarke DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045257; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; De-Carvalho MCA, 1999, BRAZ J MED BIOL RES, V32, P583, DOI 10.1590/S0100-879X1999000500012; Deb S, 2003, BRAIN RES, V970, P205, DOI 10.1016/S0006-8993(03)02344-8; Faul M, 2010, TRAUMATIC BRAIN INJU; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Hawkes CA, 2013, AGING CELL, V12, P224, DOI 10.1111/acel.12045; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; HOMANDBERG GA, 1986, BIOCHIM BIOPHYS ACTA, V874, P61, DOI 10.1016/0167-4838(86)90102-0; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; King VR, 2010, NEUROSCIENCE, V168, P523, DOI 10.1016/j.neuroscience.2010.03.040; Kiuchi Y, 2002, LIFE SCI, V70, P2421, DOI 10.1016/S0024-3205(02)01501-1; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; Milner R, 2002, MOL CELL NEUROSCI, V20, P616, DOI 10.1006/mcne.2002.1151; Milner R, 2008, MOL CELL NEUROSCI, V38, P43, DOI 10.1016/j.mcn.2008.01.013; MUIR D, 1992, J CELL BIOL, V116, P177, DOI 10.1083/jcb.116.1.177; Parham C, 2014, J ALZHEIMERS DIS, V38, P415, DOI 10.3233/JAD-130683; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Patel NS, 2010, J NEUROCHEM, V112, P66, DOI 10.1111/j.1471-4159.2009.06426.x; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Popa-Wagner A, 2015, J NEURAL TRANSM, V122, P47, DOI 10.1007/s00702-013-1129-3; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P1034, DOI 10.1097/NEN.0b013e3181f46e25; van Horssen J, 2001, ACTA NEUROPATHOL, V102, P604; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Wright S, 2012, NEUROBIOL AGING, V33, P1379, DOI 10.1016/j.neurobiolaging.2010.10.018; Xiong HQ, 2009, J NEUROSCI, V29, P5463, DOI 10.1523/JNEUROSCI.5103-08.2009; Zhao LR, 2005, BRAIN RES, V1054, P1, DOI 10.1016/j.brainres.2005.04.056	40	22	22	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2014	34	10					1637	1645		10.1038/jcbfm.2014.124			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AQ1IV	WOS:000342536000008	25052558	Bronze, Green Published			2022-02-06	
J	Unsworth, CA; Baker, A				Unsworth, Carolyn A.; Baker, Anne			Driver rehabilitation: A systematic review of the types and effectiveness of interventions used by occupational therapists to improve on-road fitness-to-drive	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Driver intervention; Driver rehabilitation; Fitness-to-drive; On-road; Systematic review	TRAUMATIC BRAIN-INJURY; HEALTH-CARE INTERVENTIONS; PERFORMANCE; FEASIBILITY; SIMULATION; ABILITIES; PROGRAM; CLIENTS; STROKE	Objective: Driver rehabilitation has the potential to improve on-road safety and is commonly recommended to clients. The aim of this systematic review was to identify what intervention approaches are used by occupational therapists as part of driver rehabilitation programmes, and to determine the effectiveness of these interventions. Method: Six electronic databases (MEDLINE, CINAHL, Psycinfo, Embase, The Cochrane Library, and OTD-Base) were searched. Two authors independently reviewed studies reporting all types of research designs and for all patient populations, provided the interventions could be administered by occupational therapists. The methodological quality of studies was assessed using the 'Downs and Black Instrument', and the level of evidence for each intervention approach was established using 'Centre for Evidence Based Medicine' criteria. Results: Sixteen studies were included in the review. The most common type of intervention approach used was computer-based driving simulator training (n=8), followed by off-road skill-specific training (n=4), and off-road education programmes (n=3). Car adaptations/modifications were used in one of the included studies. There was significant variability between studies with regards to frequency, duration, and total number of intervention sessions, and the diagnoses of the participants. Of the four intervention approaches, there is evidence to support the effectiveness of off-road skill-specific training (with older clients), and computer-based driving simulator training (with both older clients and participants with acquired brain injury). Conclusion: Three types of intervention approaches are commonly reported, however, there is limited evidence to determine to effectiveness of these in improving fitness-to-drive. Further research is required, with clients from a range of diagnostic groups to establish evidence-based interventions and determine their effectiveness in improving these clients' on-road fitness-to-drive. Crown Copyright (C) 2014 Published by Elsevier Ltd. All rights reserved.	[Unsworth, Carolyn A.; Baker, Anne] La Trobe Univ, Fac Hlth Sci, Melbourne, Vic 3086, Australia; [Unsworth, Carolyn A.] Jonkoping Univ, Dept Rehabil, Sch Hlth Sci, Jonkoping, Sweden		Unsworth, CA (corresponding author), La Trobe Univ, Kingsbury Dr, Bundoora, Vic 3086, Australia.	c.unsworth@latrobe.edu.au		Unsworth, Carolyn/0000-0001-6430-2823; Baker, Anne/0000-0002-3779-5463			Adler G., 2003, QUALITATIVE SOCIAL W, V2, P309, DOI DOI 10.1177/14733250030023006; Adler G, 2006, J AGING STUD, V20, P227, DOI 10.1016/j.jaging.2005.09.003; Anschutz JR, 2010, TOP STROKE REHABIL, V17, P337, DOI 10.1310/tsr1705-337; Bedard M, 2004, CAN J PUBLIC HEALTH, V95, P295, DOI 10.1007/BF03405135; Centre for Evidence-Based Medicine, 2009, LEV EV; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Eby DW, 2003, J SAFETY RES, V34, P371, DOI 10.1016/j.jsr.2003.09.006; Gamache PL, 2011, BRAIN INJURY, V25, P416, DOI 10.3109/02699052.2011.558039; George S., 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008357, DOI 10.1002/14651858.CD008357]; Hitosugi M, 2011, INT J GEN MED, V4, P191, DOI 10.2147/IJGM.S17475; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Huchler S., 2001, EURA MEDICOPHYS, V37, P283; Hunt LA, 2008, AM J OCCUP THER, V62, P136, DOI 10.5014/ajot.62.2.136; Jacobs K, 1997, Work, V8, P281, DOI 10.3233/WOR-1997-8308; Keskinen E., 1996, REPORTS FEDERAL I RO; KEWMAN DG, 1985, REHABIL PSYCHOL, V30, P11; KLAVORA P, 1995, AM J OCCUP THER, V49, P534, DOI 10.5014/ajot.49.6.534; Klonoff PS, 2010, BRAIN INJURY, V24, P63, DOI 10.3109/02699050903512863; Korner-Bitensky N, 2009, J SAFETY RES, V40, P105, DOI 10.1016/j.jsr.2009.02.002; Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136; Liddle J., 2003, BRIT J OCCUPATIONAL, V66, P125, DOI DOI 10.1177/030802260306600307; MATCH E, 1969, EXCEPT CHILDREN, V35, P563, DOI 10.1177/001440296903500711; Mazer BL, 2003, ARCH PHYS MED REHAB, V84, P541, DOI 10.1053/apmr.2003.50085; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [DOI 10.1007/978-1-4613-2173-6_19, 10.1007/978-1-4613-2173-6_19]; OT Australia-Victoria, 1998, COMP STAND OCC THER; Pellerito J. M., 2006, DRIVER REHABILITATIO; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Redepenning S., 2006, DRIVER REHABILITATIO; Reger S I, 1981, Bull Prosthet Res, V10-36, P35; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Stay W. B., 2006, OCCUPATIONAL THERAPY; Sung WH, 2012, J CHIN MED ASSOC, V75, P600, DOI 10.1016/j.jcma.2012.08.004; Unsworth C., 2001, AUSTR OCCUPATIONAL T, V48, P118, DOI [DOI 10.1046/J.0045-0766.2001.00246.X, 10.1046/j.0045-0766.2001.00246.x]; Unsworth CA, 2011, OT DORA BATTERY OCCU; Unsworth CA, 2007, AUST OCCUP THER J, V54, P153, DOI 10.1111/j.1440-1630.2006.00617.x; World Health Organization, 2007, INT CLASS FUNCT DIS	38	22	24	1	30	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	OCT	2014	71						106	114		10.1016/j.aap.2014.04.017			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AN0WF	WOS:000340304000012	24906164				2022-02-06	
J	Gaither, JB; Spaite, DW; Stolz, U; Ennis, J; Mosier, J; Sakles, JJ				Gaither, Joshua B.; Spaite, Daniel W.; Stolz, Uwe; Ennis, Joshua; Mosier, Jarrod; Sakles, John J.			PREVALENCE OF DIFFICULT AIRWAY PREDICTORS IN CASES OF FAILED PREHOSPITAL ENDOTRACHEAL INTUBATION	JOURNAL OF EMERGENCY MEDICINE			English	Article						prehospital; airway management; endotracheal intubation; complications; difficult; failure; success	TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; EMERGENCY-DEPARTMENT; TRACHEAL INTUBATION; LARYNGOSCOPE; MANAGEMENT; SURVIVAL; MEDICINE; TRIAL	Background: Difficult airway predictors (DAPs) are associated with failed endotracheal intubation (ETI) in the emergency department (ED). However, little is known about the relationship between DAPs and failed prehospital ETI. Objective: Our aim was to determine the prevalence of common DAPs among failed prehospital intubations. Methods: We reviewed a quality-improvement database, including all cases of ETI in a single ED, over 3 years. Failed prehospital (FP) ETI was defined as a case brought to the ED after attempted prehospital ETI, but bag-valve-mask ventilation, need for a rescue airway (supraglottic device, cricothyrotomy, etc.), or esophageal intubation was discovered at the ED. Physicians performing ETI evaluated each case for the presence of DAPs, including blood/emesis, facial/neck trauma, airway edema, spinal immobilization, short neck, and tongue enlargement. Results: There were a total of 1377 ED ETIs and 161 had an FP-ETI (11.8%). Prevalence of DAPs in cases with FP-ETI was obesity 13.0%, large tongue 18.0%, short neck 13%, small mandible 4.3%, cervical immobility 49.7%, blood in airway 57.8%, vomitus in airway 23.0%, airway edema 12.4%, and facial or neck trauma 32.9%. The number of cases with FP-ETI and 0, 1, 2, 3, or 4 or more DAPs per case was 22 (13.6%), 43 (26.7%), 23 (24.3%), 42 (26.1%), and 31 (19.3%), respectively. Conclusions: DAPs are common in cases of FP-ETI. Some of these factors may be associated with FP-ETI. Additional study is needed to determine if DAPs can be used to identify patients that are difficult to intubate in the field. (C) 2014 Elsevier Inc.	[Gaither, Joshua B.; Spaite, Daniel W.; Stolz, Uwe; Ennis, Joshua; Mosier, Jarrod; Sakles, John J.] Univ Arizona, Dept Emergency Med, Coll Med, Arizona Emergency Med Res Ctr, Tucson, AZ 85714 USA		Gaither, JB (corresponding author), Univ Arizona, Dept Emergency Med, 3950 S Country Club Rd,2254, Tucson, AZ 85714 USA.			Spaite, Daniel/0000-0003-2601-6476			Berlac P, 2008, ACTA ANAESTH SCAND, V52, P897, DOI 10.1111/j.1399-6576.2008.01673.x; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Clemency BM, 2014, PREHOSP EMERG CARE, V18, P239, DOI 10.3109/10903127.2013.864352; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Freund Y, 2012, EUR J EMERG MED, V19, P304, DOI 10.1097/MEJ.0b013e32834d3e4f; Gaither JB, 2012, ANN EMERG MED, V60, P732, DOI 10.1016/j.annemergmed.2012.06.017; Garza Alex G, 2005, Prehosp Emerg Care, V9, P163, DOI 10.1080/10903120590924654; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Germann C, 2009, PREHOSP EMERG CARE, V13, P44, DOI 10.1080/10903120802474505; Jabre P, 2007, ANN EMERG MED, V50, P258, DOI 10.1016/j.annemergmed.2007.04.022; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Kim YM, 2011, PREHOSP EMERG CARE, V15, P98, DOI 10.3109/10903127.2010.514087; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Mosier JM, 2012, J EMERG MED, V42, P629, DOI 10.1016/j.jemermed.2011.06.007; O'Shea Jeremiah K, 2005, Prehosp Emerg Care, V9, P167, DOI 10.1080/10903120590924663; Prunty H, 2012, PREHOSP EMERG CARE, V16, P156; Sakles JC, 2012, ANN EMERG MED, V60, P739, DOI 10.1016/j.annemergmed.2012.03.031; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Walls R. M., 2008, MANUAL EMERGENCY AIR, V3rd; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1197/aemj.10.7.717; Wang Henry E, 2005, Prehosp Emerg Care, V9, P145; Wang HE, 2009, RESUSCITATION, V80, P50, DOI 10.1016/j.resuscitation.2008.08.016	25	22	22	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	SEP	2014	47	3					294	300		10.1016/j.jemermed.2014.04.021			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AO6ET	WOS:000341443300015	24906900				2022-02-06	
J	Gao, WM; Lu, CW; Kochanek, PM; Berger, RP				Gao, Weimin; Lu, Chuanwen; Kochanek, Patrick M.; Berger, Rachel P.			Serum amyloid A is increased in children with abusive head trauma: a gel-based proteomic analysis	PEDIATRIC RESEARCH			English	Article							C-REACTIVE PROTEIN; BRAIN-INJURY; BIOMARKER CONCENTRATIONS; PEDIATRIC BRAIN; YOUNG-CHILDREN; A-PROTEIN; COMPONENT; INFANTS; INSIGHT; DISEASE	BACKGROUND: Abusive head trauma (AHT) is the leading cause of death from traumatic brain injury in infants and young children. Identification of mild AHT (Glasgow Coma Scale score: 13-15) is difficult because children can present with nonspecific symptoms and with no history of trauma. METHODS: Two-dimensional difference gel electrophoresis combined with mass spectrometry was used to compare the serum protein profile of children with Mild AHT and age-matched controls. Protein changes were confirmed by western blots. Western blots were performed using serum from children with mild, moderate, and severe AHT to assess the effect of injury severity on protein intensity. The protein identified serum amyloid A (SAA) was then measured by enzyme-linked immunosorbent assay. RESULTS: Using serum from 18 mild AHT cases and 20 controls, there were similar to 1,000 protein spots; 2 were significantly different between groups. Both spots were identified as SAA. There was no relationship between protein levels and injury severity. SAA concentrations measured by enzyme-linked immunosorbent assay were increased in cases vs. controls. CONCLUSION: SAA may be a potential biomarker to identify children with mild AHT who present for medical care without a history of trauma and who might otherwise not be recognized as needing a head computed tomography.	[Gao, Weimin; Lu, Chuanwen] Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kochanek, Patrick M.; Berger, Rachel P.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Berger, Rachel P.] Univ Pittsburgh, Childrens Hosp Pittsburgh, UPMC, Dept Pediat, Pittsburgh, PA 15213 USA		Gao, WM (corresponding author), Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA.	weimin.gao@ttu.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	National Institutes of Health (Bethesda, MD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD055986]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055986] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant 1R01HD055986 (Bethesda, MD).	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Aly H, 2011, J PERINATOL, V31, P263, DOI 10.1038/jp.2010.130; BENSON MD, 1975, ARTHRITIS RHEUM-US, V18, P315, DOI 10.1002/art.1780180404; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, CLIN PEDIATR EMERG M, V7, P186, DOI 10.1016/j.cpem.2006.06.001; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Bruun CF, 1998, ELECTROPHORESIS, V19, P776, DOI 10.1002/elps.1150190529; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Fountas KN, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS08311; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Gao WM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-110; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; HIJMANS W, 1979, CLIN EXP IMMUNOL, V35, P96; HUSBY G, 1974, J CLIN INVEST, V53, P1054, DOI 10.1172/JCI107642; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Jylhava J, 2009, J INTERN MED, V266, P286, DOI 10.1111/j.1365-2796.2009.02120.x; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kemp PJ, 2003, ANAT REC PART A, V270A, P41, DOI 10.1002/ar.a.10008; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Lu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038332; Lu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032895; Murphy S, 2012, NEUROTHERAPEUTICS, V9, P3, DOI 10.1007/s13311-011-0093-6; Rallidis LS, 2006, ATHEROSCLEROSIS, V189, P193, DOI 10.1016/j.atherosclerosis.2005.11.032; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; ROSENTHAL CJ, 1975, J CLIN INVEST, V55, P746, DOI 10.1172/JCI107985; Sieswerda-Hoogendoorn Tessa, 2012, J Pediatr, V160, P880, DOI 10.1016/j.jpeds.2012.01.059; SPAIDE RF, 1990, AM FAM PHYSICIAN, V41, P1145; Takata S, 2011, BIOMARKERS, V16, P530, DOI 10.3109/1354750X.2011.607189; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	44	22	22	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	SEP	2014	76	3					280	286		10.1038/pr.2014.86			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AO3ZB	WOS:000341274900009	24941216	Bronze			2022-02-06	
J	Karamanos, E; Teixeira, PG; Sivrikoz, E; Varga, S; Chouliaras, K; Okoye, O; Hammer, P				Karamanos, Efstathios; Teixeira, Pedro G.; Sivrikoz, Emre; Varga, Stephen; Chouliaras, Konstantinos; Okoye, Obi; Hammer, Peter			Intracranial pressure versus cerebral perfusion pressure as a marker of outcomes in severe head injury: a prospective evaluation	AMERICAN JOURNAL OF SURGERY			English	Article						Intracranial pressure monitoring; Cerebral perfusion pressure; Severe traumatic brain injury; Outcomes; Mortality	TRAUMATIC BRAIN-INJURY; HYPERTENSION; AUTOREGULATION; MANAGEMENT; VARIABLES	BACKGROUND: Intracranial pressure (ICP) monitoring is a standard of care in severe traumatic brain injury when clinical features are unreliable. It remains unclear, however, whether elevated ICP or decreased cerebral perfusion pressure (CPP) predicts outcome. METHODS: This is a prospective observational study of patients sustaining severe blunt head injury, admitted to the surgical intensive care unit at the Los Angeles County and University of Southern California Medical Center between January 2010 and December 2011. The study population was stratified according to the findings of ICP and CPP. Primary outcomes were overall in-hospital mortality and mortality because of cerebral herniation. Secondary outcomes were development of complications during the hospitalization. RESULTS: A total of 216 patients met Brain Trauma Foundation guidelines for ICP monitoring. Of those, 46.8% (n = 101) were subjected to the intervention. Sustained elevated ICP significantly increased all in-hospital mortality (adjusted odds ratio [95% confidence interval]: 3.15 [1.11, 8.91], P = .031) and death because of cerebral herniation (adjusted odds ratio [95% confidence interval]: 9.25 [1.19, 10.48], P = .035). Decreased CPP had no impact on mortality. CONCLUSIONS: A single episode of sustained increased ICP is an accurate predictor of poor outcomes. Decreased CPP did not affect survival. (C) 2014 Elsevier Inc. All rights reserved.	[Karamanos, Efstathios; Teixeira, Pedro G.; Sivrikoz, Emre; Varga, Stephen; Chouliaras, Konstantinos; Okoye, Obi; Hammer, Peter] Univ So Calif, Keck Sch Med, Los Angeles Cty Gen Hosp LAC USC, Div Acute Care Surg Trauma Emergency Surg & Surg, Los Angeles, CA 90033 USA		Karamanos, E (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles Cty Gen Hosp LAC USC, Div Acute Care Surg Trauma Emergency Surg & Surg, 2051 Marengo St,C5L100, Los Angeles, CA 90033 USA.	ef.karamanos@gmail.com	Karamanos, Efstathios/AAU-8082-2020; Teixeira, Pedro/H-2239-2011; Sivrikoz, Emre/F-1844-2016	Karamanos, Efstathios/0000-0002-5118-4642; Teixeira, Pedro/0000-0002-7258-7977; 			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; CHAN KH, 1992, J NEUROSURG ANESTH, V4, P188, DOI 10.1097/00008506-199207000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Sahuquillo J, 2000, ACTA NEUROCHIR SUPPL, V76, P485; Sahuquillo J, 2000, ACT NEUR S, V76, P457; SAUL TG, 1982, AM SURGEON, V48, P477; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569	18	22	22	0	7	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	SEP	2014	208	3					363	371		10.1016/j.amjsurg.2013.10.026			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AO2KG	WOS:000341149900006	24524863				2022-02-06	
J	Schonberger, M; Herrberg, M; Ponsford, J				Schoenberger, Michael; Herrberg, Marlene; Ponsford, Jennie			Fatigue as a Cause, Not a Consequence of Depression and Daytime Sleepiness: A Cross-Lagged Analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cross-lagged analysis; daytime sleepiness; depression; fatigue; head injury; longitudinal study; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SCALE	Objectives: To examine the temporal relation between fatigue, depression, and daytime sleepiness after traumatic brain injury. Fatigue is a frequent and disabling consequence of traumatic brain injury (TBI). However, it is unclear whether fatigue is a primary consequence of the structural brain injury or a secondary consequence of injury-related sequelae such as depression and daytime sleepiness. Participants: Eighty-eight adults with complicated mild-severe TBI (69% male). Main Measures: Fatigue Severity Scale; depression subscale of the Hospital Anxiety and Depression Scale; Epworth Sleepiness scale at baseline and 6-month follow-up. Results: A cross-lagged path analysis computed within a structural equation modeling framework revealed that fatigue was predictive of depression (beta = .20, P < .05) and sleepiness (beta = .25, P < .05). However, depression and sleepiness did not predict fatigue (P > .05). Conclusions: The results support the view of fatigue after TBI as "primary fatigue"-that is, a consequence of the structural brain injury rather than a secondary consequence of depression or daytime sleepiness. A rehabilitation approach that assists individuals with brain injury in learning to cope with their neuropsychological and physical limitations in everyday life might attenuate their experience with fatigue.	[Schoenberger, Michael; Herrberg, Marlene] Univ Freiburg, Dept Rehabil Psychol & Psychotherapy, Inst Psychol, D-79106 Freiburg, Germany; [Schoenberger, Michael; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Schoenberger, Michael; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Schonberger, M (corresponding author), Univ Freiburg, Dept Rehabil Psychol & Psychotherapy, Inst Psychol, Engelberger Str 41, D-79106 Freiburg, Germany.	schoenberger@psychologie.uni-freiburg.de			National Health and Medical Research Council (Australia)National Health and Medical Research Council of Australia [334002]; Monash University, MelbourneMonash University	This study was funded by National Health and Medical Research Council (Australia) grant no. 334002 and Monash University, Melbourne.	Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2012, J HEAD TRAUMA REHAB, V6, P1; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Martin JL, 2013, ENCY SLEEP, P254; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Parkes JD, 1998, J SLEEP RES, V7, P41, DOI 10.1046/j.1365-2869.1998.00093.x; PELZ DC, 1964, AM SOCIOL REV, V29, P836, DOI 10.2307/2090866; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Snaith R., 1994, HOSP ANXIETY DEPRESS; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	34	22	22	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					427	431		10.1097/HTR.0b013e31829ddd08			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700011	23867997				2022-02-06	
J	Willmott, C; Withiel, T; Ponsford, J; Burke, R				Willmott, Catherine; Withiel, Toni; Ponsford, Jennie; Burke, Richard			COMT Val(158)Met and Cognitive and Functional Outcomes after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; COMT Val(158)Met; genetics; outcomes; traumatic brain injury	CATECHOL-O-METHYLTRANSFERASE; RAT FRONTAL-CORTEX; HEAD-INJURY; WORKING-MEMORY; PREFRONTAL CORTEX; GENETIC-VARIATION; VAL158MET GENOTYPE; HOMOVANILLIC-ACID; DOPAMINE; ASSOCIATION	There is significant variability in long-term outcomes after traumatic brain injury (TBI), making accurate prognosis difficult. In seeking to enhance understanding of outcomes, this study aimed to investigate whether COMT Val(158)Met allele status was associated with performance on neuropsychological measures of attention and working memory, executive functioning, learning and memory, and speed of information processing in the early rehabilitation phase. The study also aimed to examine whether the COMT polymorphism was associated with longer-term functional outcomes. A total of 223 participants (71.3% male) with moderate-to-severe TBI were recruited as rehabilitation inpatients to participate in a prospective, longitudinal head injury outcome study. The three COMT genotype groups (Val/Val, Val/Met, and Met/Met) were well matched for estimated full-scale IQ, years of education, age at injury, and injury severity. Results showed no significant difference between genotypes on neuropsychological measures (all p>0.05) or functional outcome, as measured by the Glasgow Outcome Scale-Extended (GOS-E), after controlling for age, education, and severity of injury. The presence of frontal lobe pathology was also not associated with cognitive performance. Those with greater injury severity (i.e., longer duration of post-traumatic amnesia) performed more poorly on measures of processing speed and verbal new learning and recall. It was concluded that there was little support for the influence of COMT Val(158)Met on cognitive function, or functional outcome measures, in the acute rehabilitation phase after TBI.	[Willmott, Catherine; Withiel, Toni; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Willmott, Catherine; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia		Willmott, C (corresponding author), Monash Univ, Sch Psychol Sci, Monash Psychol Ctr, Bldg 1,270 Ferntree Gully Rd, Notting Hill, Vic 3168, Australia.	catherine.willmott@monash.edu	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035; Burke, Richard/0000-0003-0086-0767	Victorian Government Transport Accident Commission; Institute for Safety Compensation and Recovery Research	This project was supported by the Victorian Government Transport Accident Commission and the Institute for Safety Compensation and Recovery Research. The authors thank Drs. Katrina Simpson Gershon Spitz for their advice regarding statistical analysis as well as the participants who gave so generously of their time.	Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Bigler ED, 2005, TXB TRAUMATIC BRAIN; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Glatt SJ, 2003, MOL PSYCHIATR, V8, P911, DOI 10.1038/sj.mp.4001321; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; GROSSMAN MH, 1992, LIFE SCI, V50, P473, DOI 10.1016/0024-3205(92)90386-4; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Kinsella G., 2008, INFORM PROCESSING SP, P173; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAllister, 2004, J NEUROPSYCHIATRY CL, V16, P238; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyers JE., 1995, REY COMPLEX FIGURE T; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Millis S.R., 2001, BRAIN INJURY, V15, P401; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; NAYAK AK, 1980, J NEUROL SCI, V47, P211, DOI 10.1016/0022-510X(80)90005-2; Newman LA, 2008, PSYCHOPHARMACOLOGY, V200, P39, DOI 10.1007/s00213-008-1097-8; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Schmidt M., 1996, REY AUDITORY VERBAL; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sengupta S, 2008, NEUROPSYCHOPHARMACOL, V33, P3069, DOI 10.1038/npp.2008.85; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sloan S., 2012, TRAUMATIC BRAIN INJU; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009	65	22	22	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2014	31	17					1507	1514		10.1089/neu.2013.3308			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AO7GO	WOS:000341520700005	24786534				2022-02-06	
J	Herrell, RK; Edens, EN; Riviere, LA; Thomas, JL; Bliese, PD; Hoge, CW				Herrell, Richard K.; Edens, Edward N.; Riviere, Lyndon A.; Thomas, Jeffrey L.; Bliese, Paul D.; Hoge, Charles W.			Assessing Functional Impairment in a Working Military Population: The Walter Reed Functional Impairment Scale	PSYCHOLOGICAL SERVICES			English	Article						functional impairment; military; scale; validation; Land Combat Study	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; PRIMARY-CARE; PHYSICAL HEALTH; COMBAT; IRAQ; ASSOCIATION; VALIDITY; IMPACT	Measurement of functional impairment is a priority for the military and other professional work groups routinely exposed to stressful traumatic events as part of their occupation. Standard measures of impairment used in general or chronically ill populations contain many items not suitable for these populations, and include mental health symptoms items that are not true measures of functioning. We created a new, 14-item scale-the Walter Reed Functional Impairment Scale-to assess functioning in 4 domains (physical, occupational, social, and personal). We asked 3,380 soldiers how much difficulty they currently have in each of the 4 domains on a 5-point scale. Behaviorally based psychosocial and occupational performance measures and general health questions were used to validate the scale. The utility of the scale was assessed against clinical measures of psychopathology and physical health (depression, posttraumatic stress disorder [PTSD], general health, generalized physical symptoms). We utilized Cronbach's alpha, item response theory, and the score test for trend to establish consistency of items and the validity of the scale. The scale exhibited excellent reliability (Cronbach's alpha = 0.92) and validity. The individual items and quartiles of sum scores were strongly correlated with negative occupational and social performance, and the utility of the scale was demonstrated by strong correlations with depression, PTSD, and high levels of generalized physical symptoms. This scale exhibits excellent psychometric properties in this sample of U. S. soldiers and, pending future research, is likely to have utility for other healthy occupational groups.	[Herrell, Richard K.; Riviere, Lyndon A.; Bliese, Paul D.; Hoge, Charles W.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Edens, Edward N.] US Army Training & Doctrine Command, Ft Eustis, VA USA; [Thomas, Jeffrey L.] US Army Med Res Unit Europe, Walter Reed Army Inst Res, Sembach, Germany		Herrell, RK (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Mil Psychiat Branch, Silver Spring, MD 20910 USA.	richard.k.herrell.ctr@mail.mil		Bliese, paul/0000-0002-5384-8879			Adler AB, 2005, MIL PSYCHOL, V17, P3, DOI 10.1207/s15327876mp1701_2; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; Alonso J, 2011, MOL PSYCHIATR, V16, P1234, DOI 10.1038/mp.2010.101; Amaya-Jackson L, 1999, J TRAUMA STRESS, V12, P709, DOI 10.1023/A:1024781504756; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Epping-Jordan J. E., 2000, WHO MENTAL HLTH B, V6, P5; Felker B, 2008, MIL MED, V173, P155, DOI 10.7205/MILMED.173.2.155; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Grubaugh AL, 2005, J NERV MENT DIS, V193, P658, DOI 10.1097/01.nmd.0000180740.02644.ab; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2011, JAMA-J AM MED ASSOC, V306, P549, DOI 10.1001/jama.2011.1096; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; MAHONEY F I, 1958, South Med J, V51, P605, DOI 10.1097/00007611-195805000-00011; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; MOSKOWITZ E, 1957, J Chronic Dis, V5, P342, DOI 10.1016/0021-9681(57)90092-9; PATRICK DL, 1981, J EPIDEMIOL COMMUN H, V35, P65, DOI 10.1136/jech.35.1.65; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; R Core Team, 2017, R LANG ENV STAT COMP; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; Reise S. P., 2002, MEASURING ANAL BEHAV, P88; Richardson RD, 2002, PSYCHOSOM MED, V64, P676, DOI 10.1097/01.PSY.0000021941.35402.18; Rona RJ, 2009, J PSYCHIATR RES, V43, P649, DOI 10.1016/j.jpsychires.2008.09.006; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Samejima F., 1969, PSYCHOMETRIC MONOGRA; SAS Institute Inc, 2008, SAS VERS 9 2; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; StataCorp, 2007, STAT STAT SOFTW REL; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Taft CT, 1999, J TRAUMA STRESS, V12, P3, DOI 10.1023/A:1024786030358; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Toblin RL, 2012, J AFFECT DISORDERS, V136, P469, DOI 10.1016/j.jad.2011.10.048; United States Department of the Army, 1998, PHYS FITN TRAIN; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Weathers F., 1993, INT SOC TRAUM STRESS; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	43	22	22	0	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	AUG	2014	11	3					254	264		10.1037/a0037347			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	AN0SS	WOS:000340294900002	25068298				2022-02-06	
J	Nalliah, RP; Anderson, IM; Lee, MK; Rampa, S; Allareddy, V; Allareddy, V				Nalliah, Romesh P.; Anderson, Ingrid M.; Lee, Min Kyeong; Rampa, Sankeerth; Allareddy, Veerasathpurush; Allareddy, Veerajalandhar			Epidemiology of Hospital-Based Emergency Department Visits Due to Sports Injuries	PEDIATRIC EMERGENCY CARE			English	Article						sports injury; epidemiology; hospital charge	UNITED-STATES; BRITISH-COLUMBIA; CONCUSSIONS	Background: Sports-related injuries in adolescents incur a significant amount of hospital resources. Sports-related injuries are not an uncommon cause of ED visit; however, national estimates of such injuries in teenagers are unknown. Objectives: The aim of this study was to identify and characterize emergency department (ED) visits that result from sports-related injuries among teenagers across the United States. This study describes the outcomes associated with sports-related injuries necessitating ED visits among teenagers at a national level. Study Design: This is a descriptive epidemiology study. Methods: The 2008 Nationwide Emergency Department Sample data set, the largest all-payer health care database in the United States, was used to identify ED visits with external cause of injury related to sports occurring in patients aged 13 through 19 years. Outcomes examined included discharge status after the ED visit and presence of concomitant injuries. Descriptive statistics was used to summarize the estimates. Nationwide representative estimates were computed using the discharge weight variable. Results: There were 432,609 ED visits by those between the ages of 13 and 19 years who experienced sports-related injuries, with total charges close to $447.4 million, with a mean total per-visit charge of $1205. The male patients accounted for 76.8% of the total ED visits. The most frequently occurring injuries were superficial injury or contusion (n = 118,250 ED visits); sprains and strains (n = 105,476); fracture of the upper limb (n = 63,151); open wounds of the head, the neck, and the trunk (n = 46,176); as well as intracranial injury (n = 30,726). Close to 29% of all ED visits occurred among those residing in geographical areas with median household income levels of greater than $64,000. After the ED visit, 1.6% were admitted to the same hospital, with a mean length of stay of 2.4 days and a mean hospital charge for ED visit and inpatient services of $22,703. The male patients composed 87.5% of the hospitalizations. The total of hospitalization charges across the entire United States was $154.8 million. Conclusions: Sports injuries account for a substantial number of 2008 teenage ED visits in the United States. Patient-and hospital-level characteristics were analyzed and highlighted.	[Nalliah, Romesh P.] Harvard Univ, Sch Dent Med, Off Dent Educ, Boston, MA 02115 USA; [Anderson, Ingrid M.; Allareddy, Veerajalandhar] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Lee, Min Kyeong] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Rampa, Sankeerth] Texas A&M Univ, Coll Publ Hlth, College Stn, TX USA; [Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Dept Orthodont, Iowa City, IA 52242 USA		Allareddy, V (corresponding author), Rainbow Babies & Childrens Hosp, Dept Pediat Crit Care, 11100 Euclid Ave, Cleveland, OH 44107 USA.	Veerajalandhar.Allareddy@UHhospitals.org	Nalliah, Romesh/AAV-2016-2020	Nalliah, Romesh/0000-0002-6287-0656			Chew EM, 2012, J HAND SURG-AM, V37A, P1684, DOI 10.1016/j.jhsa.2012.05.010; Collard DCM, 2011, BRIT J SPORT MED, V45, P1058, DOI 10.1136/bjsm.2010.082545; Gage BE, 2012, ACAD EMERG MED, V19, P378, DOI 10.1111/j.1553-2712.2012.01315.x; Habelt S, 2011, ORTHOP REV PAVIA, V3, pe18, DOI [10.4081/or.2011.e18, DOI 10.4081/OR.2011.E18]; Knowles SB, 2007, INJURY PREV, V13, P416, DOI 10.1136/ip.2006.014720; Leadbeater B, 2010, INT J INJ CONTROL SA, V17, P119, DOI 10.1080/17457300903564561; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Nalliah RP, 2013, DENT TRAUMATOL, V29, P115, DOI 10.1111/j.1600-9657.2012.01137.x; Nationwide Emergency Department Sample, HEALTHC COST UT PROJ; Pakzad-Vaezi K, 2011, PAED CHILD HEALT-CAN, V16, P217, DOI 10.1093/pch/16.4.217; Shah SS, 2012, J TRAUMA ACUTE CARE, V72, P1688, DOI 10.1097/TA.0b013e31824a4c5b; Steptoe A, 1996, LANCET, V347, P1789, DOI 10.1016/S0140-6736(96)91616-5; Veleminsky M, 2012, MED SCI MONITOR, V18, pPH19, DOI 10.12659/MSM.882508; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923	14	22	24	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	AUG	2014	30	8					511	515		10.1097/PEC.0000000000000180			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	AN7LG	WOS:000340781000001	25062295				2022-02-06	
J	Liu, DZ; Sharp, FR; Van, KC; Ander, BP; Ghiasvand, R; Zhan, XH; Stamova, B; Jickling, GC; Lyeth, BG				Liu, Da Zhi; Sharp, Frank R.; Van, Ken C.; Ander, Bradley P.; Ghiasvand, Rahil; Zhan, Xinhua; Stamova, Boryana; Jickling, Glen C.; Lyeth, Bruce G.			Inhibition of Src Family Kinases Protects Hippocampal Neurons and Improves Cognitive Function after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive memory deficits; hemorrhage; Src family kinases (SFKs); thrombin; traumatic brain injury (TBI)	FLUID-PERCUSSION MODEL; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; THROMBIN RECEPTOR REVEALS; CENTRAL-NERVOUS-SYSTEM; TYROSINE KINASE; IN-VIVO; CEREBROSPINAL-FLUID; PROTEOLYTIC MECHANISM; CISTERNA-MAGNA; RAT	Traumatic brain injury (TBI) is often associated with intracerebral and intraventricular hemorrhage. Thrombin is a neurotoxin generated at bleeding sites fater TBI and can lead to cell death and subsequent cognitive dysfunction via activation of Src family kinases (SFKs). We hypothesize that inhibiting SFKs can protect hippocampal neurons and improve cognitive memory function after TBI. To test these hypotheses, we show that moderate lateral fluid percussion (LFP) TBI in adult rats produces bleeding into the cerebrospinal fluid (CSF) in both lateral ventricles, which elevates oxyhemoglobin and thrombin levels in the CSF, activates the SFK family member Fyn, and increases Rho-kinase 1(ROCK1) expression. Systemic administration of the SFK inhibitor, PP2, immediately after moderate TBI blocks ROCK1 expression, protects hippocampal CA2/3 neurons, and improves spatial memory function. These data suggest the possibility that inhibiting SFKs after TBI might improve clinical outcomes.	[Liu, Da Zhi; Sharp, Frank R.; Ander, Bradley P.; Zhan, Xinhua; Stamova, Boryana; Jickling, Glen C.] Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA; [Liu, Da Zhi; Sharp, Frank R.; Ander, Bradley P.; Zhan, Xinhua; Stamova, Boryana; Jickling, Glen C.] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA; [Van, Ken C.; Ghiasvand, Rahil; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA		Liu, DZ (corresponding author), Univ Calif Davis, Med Ctr, Dept Neurol, 2805 50th St, Sacramento, CA 95817 USA.	dzliu@ucdavis.edu	Stamova, Boryana/ABA-2981-2020; Jickling, Glen/J-8790-2019	Jickling, Glen/0000-0003-3543-0820; Lyeth, Bruce/0000-0003-4811-1474	AHAAmerican Heart Association [12BGIA12060381]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS054652]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS089901, R01NS054652] Funding Source: NIH RePORTER	This study was supported by AHA grant 12BGIA12060381 (DZL) and NIH grant NS054652 (FRS).	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Ardizzone TD, 2004, STROKE, V35, P2587, DOI 10.1161/01.STR.0000143451.14228.ff; Ardizzone TD, 2007, STROKE, V38, P1621, DOI 10.1161/STROKEAHA.106.478966; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Badjatia N, 2005, NEUROLOGIST, V11, P311, DOI 10.1097/01.nrl.0000178757.68551.26; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Choi UB, 2011, J BIOL CHEM, V286, P29904, DOI 10.1074/jbc.M111.258897; COOKE M P, 1989, New Biologist, V1, P66; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; COUGHLIN SR, 1992, SEMIN THROMB HEMOST, V18, P161, DOI 10.1055/s-2007-1002422; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Donovan FM, 1997, J NEUROSCI, V17, P5316; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Faul M., 2010, TRAUMATIC BRAIN INJU, P7; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145; Fujimoto S, 2007, NEUROSCIENCE, V144, P694, DOI 10.1016/j.neuroscience.2006.09.049; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; Groveman BR, 2012, FEBS J, V279, P20, DOI 10.1111/j.1742-4658.2011.08413.x; Gurkoff GG, 2013, BRAIN RES, V1515, P98, DOI 10.1016/j.brainres.2013.03.043; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Jeon BT, 2013, NEUROTOX RES, V23, P238, DOI 10.1007/s12640-012-9339-2; Joshi A., 2013, AM J RESP CELL MOL B; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kaimachnikov NP, 2009, FEBS J, V276, P4102, DOI 10.1111/j.1742-4658.2009.07117.x; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kubier A, 2012, TOP COMPANION ANIM M, V27, P81, DOI 10.1053/j.tcam.2012.07.003; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Liu D., 2011, J CYTOL HISTOL, V2, P5; Liu DZ, 2008, NEUROBIOL DIS, V30, P201, DOI 10.1016/j.nbd.2008.01.006; Liu DZ, 2012, SCI WORLD J, DOI 10.1100/2012/491737; Liu DZ, 2011, ACTA NEUROCHIR SUPPL, V111, P77, DOI 10.1007/978-3-7091-0693-8_13; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Misra A, 2003, J PHARM PHARM SCI, V6, P252; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; National Institute of Neurological Disorders and Stroke, 2013, TRAUM BRAIN INJ HOP; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Place AT, 2011, MOL PHARMACOL, V80, P665, DOI 10.1124/mol.111.073957; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sharma AK, 2006, TOXICOL PATHOL, V34, P393, DOI 10.1080/01926230600798609; Shimizu A, 2005, BIOL REPROD, V73, P1219, DOI 10.1095/biolreprod.105.041616; Tang H, 2005, J BIOL CHEM, V280, P23918, DOI 10.1074/jbc.M503498200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Trepanier CH, 2012, FEBS J, V279, P12, DOI 10.1111/j.1742-4658.2011.08391.x; UMEMORI H, 1992, MOL BRAIN RES, V16, P303, DOI 10.1016/0169-328X(92)90239-8; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WALLACE WJ, 1982, J BIOL CHEM, V257, P4966; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang T, 2014, J NEUROTRAUM, V31, P370, DOI 10.1089/neu.2013.2917; Watkin H, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-6; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xue MZ, 2006, J NEUROSCI, V26, P10281, DOI 10.1523/JNEUROSCI.2806-06.2006; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	66	22	23	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2014	31	14					1268	1276		10.1089/neu.2013.3250			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4CA	WOS:000340534000004	24428562	Green Published			2022-02-06	
J	Ewing-Cobbs, L; Bloom, DR; Prasad, MR; Waugh, JK; Cox, CS; Swank, PR				Ewing-Cobbs, Linda; Bloom, Douglas R.; Prasad, Mary R.; Waugh, Jane K.; Cox, Charles S., Jr.; Swank, Paul R.			Assessing Recovery and Disability After Physical Trauma: The Pediatric Injury Functional Outcome Scale	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						disability; functional outcome; orthopedic injury; recovery; traumatic brain injury	QUALITY-OF-LIFE; BRAIN-INJURY; ADOLESCENTS 6; SHORT-TERM; FOLLOW-UP; CHILDREN; PREDICTORS; DEFICITS	Objective To establish reliability and validity of the Pediatric Injury Functional Outcome Scale (PIFOS), a brief injury-specific rating scale covering motor, self-care, communication, social-emotional, cognition, physical, and academic areas. Methods In a prospective longitudinal study, the PIFOS structured interview was administered to parents of children 3-15 years of age at 3 and 12 months after hospitalization for traumatic brain injury (TBI) or orthopedic injury (OI). Results The total score had good internal consistency (alpha = .90-.93) and inter-rater reliability (alpha = .90) and correlated significantly with injury severity and neurodevelopmental outcomes. Generalized linear modeling showed the PIFOS was sensitive to the type and severity of injury, showed specific initial and persisting difficulties following TBI and OI, and was responsive to change during the first year after injury. Both groups had residual difficulties with coordination, emotionality, social participation, and discomfort. Conclusion The PIFOS is useful in examining recovery in natural history and intervention studies.	[Ewing-Cobbs, Linda; Prasad, Mary R.; Waugh, Jane K.; Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Bloom, Douglas R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000371] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029462, R01 NS046308] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308, R01NS029462] Funding Source: NIH RePORTER		Aaronson N, 2002, QUAL LIFE RES, V11, P193; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Brennan R. L., 1983, ELEMENTS GEN THEORY; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Cronbach LJ, 1972, DEPENDABILITY BEHAV; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; De Vellis R. F., 1991, SCALE DEV THEORY APP, V26; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Ding R, 2006, J PEDIATR ORTHOPED, V26, P157, DOI 10.1097/01.bpo.0000218521.98244.7e; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA IP, 2000, BEHAV RATING INVENTO; HALEY SM, 1992, PEDIATRIC EVALUATION; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holbrook TL, 2007, J TRAUMA, V62, P577, DOI 10.1097/TA.0b013e318031aa97; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Janssens L, 2008, QUAL LIFE RES, V17, P701, DOI 10.1007/s11136-008-9339-0; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KlOve H, 1963, MED CLIN N AM; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Sparrow S, 2009, VINELAND ADAPTIVE BE; Spector P.E., 1992, SUMMATED RATING SCAL, V82; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Thorndike R. L., 1986, STANFORD BINET INTEL; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Ware JE., 1999, CHILD HLTH QUESTIONN; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wiederholt J.L., 2001, GRAY ORAL READING TE; Willis CD, 2006, INJURY, V37, P1185, DOI 10.1016/j.injury.2006.07.011; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7; Winthrop AL, 2010, CURR OPIN PEDIATR, V22, P346, DOI 10.1097/MOP.0b013e3283394351; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	60	22	24	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JUL	2014	39	6					653	665		10.1093/jpepsy/jsu018			13	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	AK9QR	WOS:000338762200008	24748647	Green Published, Bronze			2022-02-06	
J	Lee, TH; Hampton, DA; Diggs, BS; McCully, SP; Kutcher, M; Redick, BJ; Podbielski, J; Cotton, BA; Cohen, M; Schreiber, MA				Lee, Tim H.; Hampton, David A.; Diggs, Brian S.; McCully, Sean P.; Kutcher, Matt; Redick, Britt J.; Podbielski, Jeannette; Cotton, Bryan A.; Cohen, Mitchell; Schreiber, Martin A.			Traumatic brain injury is not associated with coagulopathy out of proportion to injury in other body regions	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma; coagulopathy; traumatic brain injury	HEAD-INJURY; MECHANISMS; DEATHS; RISK	BACKGROUND: Coagulopathy following trauma is associated with poor outcomes. Traumatic brain injury has been associated with coagulopathy out of proportion to other body regions. We hypothesized that injury severity and shock determine coagulopathy independent of body region injured. METHODS: We performed a prospective, multicenter observational study at three Level 1 trauma centers. Conventional coagulation tests (CCTs) and rapid thrombelastography (r-TEG) were used. Admission vital signs, base deficit (BD), CCTs, and r-TEG data were collected. The Abbreviated Injury Scale (MS) score and Injury Severity Score (ISS) were obtained. Severe injury was defined as AIS score greater than or equal to 3 for each body region. Patients were grouped according to their dominant AIS region of injury. Dominant region of injury was defined as the single region with the highest AIS score. Patients with two or more regions with the same greatest AIS score and patients without a region with an AIS score greater than or equal to 3 were excluded. Coagulation parameters were compared between the dominant AIS region. Significant hypoperfusion was defined as BD greater than or equal to 6. RESULTS: Of the 795 patients enrolled, 462 met criteria for grouping by dominant AIS region. Patients were predominantly white (59%), were male (75%), experienced blunt trauma (71%), and had a median ISS of 25 (interquartile range, 14-29). Patients with BD greater than or equal to 6 (n = 110) were hypocoagulable by CCT and r-TEG compared with patients with BD less than 6 (n = 223). Patients grouped by dominant MS region showed no significant differences for any r-TEG or CCT parameter. Patients with BD greater than or equal to 6 demonstrated no difference in any r-TEG or CCT parameter between dominant MS regions. CONCLUSION: Coagulopathy results from a combination of tissue injury and shock independent of the dominant region of injury. With the use of MS as a measure of injury severity, traumatic brain injury was not independently associated with more profound coagulopathy. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Lee, Tim H.; Hampton, David A.; Diggs, Brian S.; McCully, Sean P.; Kutcher, Matt; Redick, Britt J.; Podbielski, Jeannette; Cotton, Bryan A.; Cohen, Mitchell; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97239 USA		Schreiber, MA (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Care Surg, 3181 SW Sam Jackson Pk Rd,Mail Code L-611, Portland, OR 97239 USA.	schreibm@ohsu.edu		Hampton, David/0000-0002-9870-0835; Kutcher, Matthew/0000-0003-4566-5359			Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Davenport R, 2011, BRIT J HAEMATOL, V155, P537, DOI 10.1111/j.1365-2141.2011.08885.x; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2012, SHOCK, V38, P450, DOI 10.1097/SHK.0b013e31826dbd23; Mattox K, 2012, TRAUMA; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schreiber MA, 2005, CURR OPIN CRIT CARE, V11, P590, DOI 10.1097/01.ccx.0000186374.49320.ab; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	21	22	25	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2014	77	1					67	72		10.1097/TA.0000000000000255			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AK4IY	WOS:000338389600018	24977757				2022-02-06	
J	Rabin, J; Harris, DG; Crews, GA; Ho, M; Taylor, BS; Sarkar, R; O'Connor, JV; Scalea, TM; Crawford, RS				Rabin, Joseph; Harris, Donald G.; Crews, Gordon A.; Ho, Michelle; Taylor, Bradley S.; Sarkar, Rajabrata; O'Connor, James V.; Scalea, Thomas M.; Crawford, Robert S.			Early Aortic Repair Worsens Concurrent Traumatic Brain Injury	ANNALS OF THORACIC SURGERY			English	Article							EARLY FRACTURE FIXATION; AMERICAN-ASSOCIATION; THORACIC AORTA; NONOPERATIVE MANAGEMENT; NATURAL-HISTORY; DELAYED REPAIR; BLUNT TRAUMA; RUPTURE; SURGERY; PROGRESSION	Background. Blunt thoracic aortic injury (BTAI) and traumatic brain injury (TBI) are the leading causes of death after blunt trauma, and TBI is common among patients with BTAI. Although aspects of aortic management, such as repair timing and procedural anticoagulation therapy, may complicate TBI, the optimal management of these patients is undefined. Methods. Adults with BTAI and moderate to severe TBI admitted to a level I trauma center over 12 years were retrospectively analyzed; patients presenting in extremis were excluded. The primary outcome was neurologic progression within 48 hours of aortic repair. Patients undergoing nonoperative aortic management served as controls for baseline TBI progression. Secondary outcomes were aortic morbidity and mortality and overall inpatient survival. Results. Of 309 patients with BTAI, 138 had concurrent TBI, and 75 were included for analysis. Twenty-two (29%) were treated nonoperatively, 29 (39%) had early aortic repair (17 open, 12 endovascular), and 24 (32%) had delayed repair (3 open, 21 endovascular). The severity of TBI was similar between groups. Early aortic repair within 24 hours of admission was independently associated with worsening TBI, regardless of repair modality or anticoagulation use. In contrast, patients undergoing delayed repair had no perioperative neurologic progression despite procedural anticoagulation therapy. Early aortic repair was also associated with increased aortic morbidity and mortality. Conclusions. For patients with BTAI and TBI, early aortic intervention is associated with progressive TBI regardless of repair modality, as well as increased aortic morbidity and mortality. Patients not requiring emergent intervention can undergo delayed repair with full anticoagulation therapy. (C) 2014 by The Society of Thoracic Surgeons	Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Surg, Div Vasc Surg, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Surg, Div Cardiac Surg, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Aort Dis, Baltimore, MD 21201 USA		Harris, DG (corresponding author), Univ Maryland, Med Ctr, Div Gen Surg, 22 S Greene St, Baltimore, MD 21201 USA.	dharris@smail.umaryland.edu		Harris, Donald/0000-0002-5059-5597			Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Caffarelli AD, 2010, J THORAC CARDIOV SUR, V140, P598, DOI 10.1016/j.jtcvs.2010.02.056; Cardarelli MG, 2002, ANN SURG, V236, P465, DOI 10.1097/00000658-200210000-00009; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; de Mestral C, 2013, J AM COLL SURGEONS, V216, P1110, DOI 10.1016/j.jamcollsurg.2013.01.005; Demetriades D, 2008, J TRAUMA, V64, P561, DOI 10.1097/TA.0b013e3181641bb3; Demetriades D, 2009, J TRAUMA, V66, P967, DOI 10.1097/TA.0b013e31817dc483; Di Eusanio M, 2013, ANN THORAC SURG, V95, P1591, DOI 10.1016/j.athoracsur.2013.02.033; Estrera AL, 2010, ANN THORAC SURG, V90, P64, DOI 10.1016/j.athoracsur.2010.03.053; Fabian TC, 1998, ANN SURG, V227, P666, DOI 10.1097/00000658-199805000-00007; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Hemmila MR, 2004, J TRAUMA, V56, P13, DOI 10.1097/01.TA.0000108634.15989.07; Holmes JH, 2002, ANN THORAC SURG, V73, P1149, DOI 10.1016/S0003-4975(01)03585-8; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; Kepros J, 2002, J TRAUMA, V52, P475, DOI 10.1097/00005373-200203000-00010; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MAGGISANO R, 1995, ANN VASC SURG, V9, P44, DOI 10.1007/BF02015316; Nagy K, 2000, J TRAUMA, V48, P1128, DOI 10.1097/00005373-200006000-00021; Neschis DG, 2008, NEW ENGL J MED, V359, P1708, DOI 10.1056/NEJMra0706159; Neschis DG, 2009, ANN SURG, V250, P377, DOI 10.1097/SLA.0b013e3181b3b5c9; Nguyen D, 2009, AM J ROENTGENOL, V192, P3, DOI 10.2214/AJR.07.3702; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Osgood MJ, 2013, J VASC SURG, V57, p30S, DOI 10.1016/j.jvs.2013.02.141; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; Pate JW, 1999, WORLD J SURG, V23, P59, DOI 10.1007/s002689900565; Paul JS, 2011, J TRAUMA, V71, P1519, DOI 10.1097/TA.0b013e31823b9811; Peterson BG, 2005, J TRAUMA, V59, P1062, DOI 10.1097/01.ta.0000188634.72008.d5; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Rabin J, 2014, J THORAC CARDIOV SUR, V147, P143, DOI 10.1016/j.jtcvs.2013.08.053; Scalea TM, 1999, J TRAUMA, V46, P839, DOI 10.1097/00005373-199905000-00012; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; STROMHOLM T, 1995, EUR J VASC ENDOVASC, V10, P36, DOI 10.1016/S1078-5884(05)80196-0; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	40	22	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JUL	2014	98	1					46	51		10.1016/j.athoracsur.2014.04.025			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	AK4ZF	WOS:000338432600019	24857854				2022-02-06	
J	Watts, R; Thomas, A; Filippi, CG; Nickerson, JP; Freeman, K				Watts, Richard; Thomas, Alex; Filippi, Christopher G.; Nickerson, Joshua P.; Freeman, Kalev			Potholes and Molehills: Bias in the Diagnostic Performance of Diffusion-Tensor Imaging in Concussion	RADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; AXONAL INJURY; ABNORMALITIES; VALIDATION; ANISOTROPY	Purpose: To investigate the extent of bias in a clinical study involving "pothole analysis" of diffusion-tensor imaging (DTI) data used to quantify white matter lesion load in diseases with a heterogeneous spatial distribution of pathologic findings, such as mild traumatic brain injury (TBI), and create a mathematical model of the bias. Materials and Methods: Use of the same reference population to define normal findings and make comparisons with a patient group introduces bias, which potentially inflates reported diagnostic performance. In this institutional review board-approved prospective observational cohort study, DTI data were obtained in 20 patients admitted to the emergency department with mild TBI and in 16 control subjects. Potholes and molehills were defined as clusters of voxels with fractional anisotropy values more than 2 standard deviations below and above the mean of the corresponding voxels in the reference population, respectively. The number and volume of potholes and molehills in the two groups were compared by using a Mann-Whitney U test. Results: Standard analysis showed significantly more potholes in mild TBI than in the control group (102.5 +/- 34.3 vs 50.6 +/- 28.9, P < .001). Repeat analysis by using leave-one-out cross-validation decreased the apparent difference in potholes between groups (mild TBI group, 102.5 +/- 34.3; control group, 93.4 +/- 27.2; P = .369). It was demonstrated that even with 100 subjects, this bias can decrease the voxelwise false-positive rate by more than 30% in the control group. Conclusion: The pothole approach to neuroimaging data may introduce bias, which can be minimized by independent training and test groups or cross-validation methods. This bias is sufficient to call into question the previously reported diagnostic performance of DTI for mild TBI.	[Watts, Richard; Filippi, Christopher G.; Nickerson, Joshua P.] Univ Vermont, Dept Radiol, Burlington, VT 05405 USA; [Thomas, Alex; Freeman, Kalev] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Filippi, Christopher G.] Univ Vermont, Dept Neurol, Burlington, VT 05405 USA		Freeman, K (corresponding author), Univ Vermont, Dept Surg, Given Med Bldg E301,89 Beaumont Ave, Burlington, VT 05405 USA.	kalev.freeman@uvm.edu	Filippi, Christopher/AAA-5493-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1 HL120877] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08 GM098795] Funding Source: Medline		Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	23	22	22	0	1	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUL	2014	272	1					217	223		10.1148/radiol.14131856			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AM7GU	WOS:000340034300023	24635677	Green Published			2022-02-06	
J	Tsai, YT; Wang, CC; Leung, PO; Lin, KC; Chio, CC; Hu, CY; Kuo, JR				Tsai, Yin-Tzu; Wang, Che-Chuan; Leung, Pak-On; Lin, Kao-Chang; Chio, Chung-Ching; Hu, Chiao-Ya; Kuo, Jinn-Rung			Extracellular signal-regulated kinase 1/2 is involved in a tamoxifen neuroprotective effect in a lateral fluid percussion injury rat model	JOURNAL OF SURGICAL RESEARCH			English	Article						Fluid percussion injury; Tamoxifen; Extracellular signal-regulated kinases (ERK1/2); Cell apoptosis; Infarction volume; Maximal angle	TRAUMATIC BRAIN-INJURY; ESTROGEN-RECEPTOR MODULATORS; CEREBRAL-ARTERY OCCLUSION; ERK ACTIVATION; PROTEIN; PROGESTERONE; APOPTOSIS; ISCHEMIA; PATHWAY; DAMAGE	Background: The aim of the present study was to determine whether tamoxifen (TMX) causes attenuation of traumatic brain injury (TBI) induced by fluid percussion injury. Materials and methods: Immediately after the onset of fluid percussion TBI, anesthetized male Sprague-Dawley rats were divided into three major groups and intraperitoneally administered the vehicle solution (1 mL/kg), TMX (1 mg/kg), or TMX (1 mg/kg) plus the extracellular signal-regulated kinase 1/2 antagonist SL327 (30 mg/kg). Another group of rats were used as sham-operated controls. The functional outcomes, such as motor outcomes, were evaluated using an incline plane. The cellular infarction volume was evaluated by triphenyltetrazolium chloride staining. Neuronal loss, apoptosis, and p-ERK1/2 and Bcl2 expression in neuronal cortex cells were evaluated by immunofluorescence methods. All the parameters were assessed on day 4 after injury. Results: Compared with the sham-operated controls, the TBI-induced motor deficits and cerebral infarction after TBI were significantly attenuated by TMX therapy. The TBI-induced neuronal loss and apoptosis were also significantly reduced by TMX therapy. The numbers of Bcl2- and phospho-ERK1/2-positive neuronal cells in the ischemic cortex after TBI were significantly increased by TMX therapy. These TMX effects were significantly blocked by SL327 administration. Conclusions: Our results suggest that intravenous injection of TMX may ameliorate TBI in rats by increasing neuronal p-ERK1/2 expression, which might lead to an increase in neuronal Bcl2 expression and a decrease in neuronal apoptosis and cell infarction volume, and it might represent one mechanism by which functional recovery occurred. TMX may be a promising TBI treatment strategy. (C) 2014 Elsevier Inc. All rights reserved.	[Tsai, Yin-Tzu; Leung, Pak-On] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Wang, Che-Chuan; Chio, Chung-Ching; Kuo, Jinn-Rung] Dept Neurosurg, Tainan, Taiwan; [Wang, Che-Chuan] Natl Chiao Tung Univ, Inst Photon Syst, Tainan, Taiwan; [Lin, Kao-Chang; Hu, Chiao-Ya; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lin, Kao-Chang; Kuo, Jinn-Rung] Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Che-Chuan] Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, 901 Chung Hwa Rd, Tainan, Taiwan.	kuojinnrung@gmail.com			 [CMFHR10110]	The project was supported by CMFHR10110. The authors thank all of the researchers, especially Yung-Te Kuo who participated in this study.	Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Benvenuti S, 2005, J CLIN ENDOCR METAB, V90, P1775, DOI 10.1210/jc.2004-0066; Biegon A, 1996, CANCER RES, V56, P4328; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bourque M, 2007, BIOCHEM PHARMACOL, V74, P1413, DOI 10.1016/j.bcp.2007.07.009; Chesnoy-Marchais D, 2005, ENDOCRINOLOGY, V146, P4302, DOI 10.1210/en.2005-0453; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; DonCarlos Lydia L, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS113, DOI 10.1016/j.psyneuen.2009.04.012; Feng Y, 2010, ONCOL REP, V24, P1561, DOI 10.3892/or_00001018; GRILL HJ, 1991, AM J CLIN ONCOL-CANC, V14, pS21; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; JORDAN VC, 1975, EUR J CANCER, V11, P205, DOI 10.1016/0014-2964(75)90119-X; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Kuo JR, 2012, NEUROCHEM INT, V60, P105, DOI 10.1016/j.neuint.2011.11.014; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; LIEN EA, 1991, BRIT J CANCER, V63, P641, DOI 10.1038/bjc.1991.147; Liu JL, 2010, BRAIN RES, V1316, P101, DOI 10.1016/j.brainres.2009.12.055; Marshall L F, 2000, Clin Neurosurg, V46, P105; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mehta SH, 2003, NEUROENDOCRINOLOGY, V77, P44, DOI 10.1159/000068332; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Obata T, 2006, TOXICOLOGY, V222, P46, DOI 10.1016/j.tox.2006.01.023; Osuka K, 2001, J NEUROCHEM, V76, P1842, DOI 10.1046/j.1471-4159.2001.00198.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rutledge EM, 1998, AM J PHYSIOL-CELL PH, V274, pC1511, DOI 10.1152/ajpcell.1998.274.6.C1511; Scherle PA, 2000, J BIOL CHEM, V275, P37086, DOI 10.1074/jbc.M006168200; Sharma K, 2008, BRAIN RES, V1204; Shen JF, 2010, INVEST OPHTH VIS SCI, V51, P35, DOI 10.1167/iovs.09-3544; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Suuronen T, 2005, INFLAMM RES, V54, P194, DOI 10.1007/s00011-005-1343-z; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Thurman DJ, 2001, HEAD TRAUMA THERAPEU; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Toborek M, 2007, J CELL BIOCHEM, V100, P279, DOI 10.1002/jcb.21013; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; Wakade C, 2008, ENDOCRINOLOGY, V149, P367, DOI 10.1210/en.2007-0899; Wang CC, 2013, J SURG RES, V184, P1045, DOI 10.1016/j.jss.2013.04.059; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang Y, 1997, J NEUROSCI, V17, P4341; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009	53	22	23	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN	2014	189	1					106	116		10.1016/j.jss.2014.02.009			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AF6UU	WOS:000334850900014	24636102				2022-02-06	
J	Honeybul, S; Ho, KM; Lind, CRP; Gillett, GR				Honeybul, Stephen; Ho, Kwok M.; Lind, Christopher R. P.; Gillett, Grant R.			Validation of the CRASH model in the prediction of 18-month mortality and unfavorable outcome in severe traumatic brain injury requiring decompressive craniectomy	JOURNAL OF NEUROSURGERY			English	Article						corticosteroid randomization after significant head injury prediction model; decompressive craniectomy; outcome; traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL MICRODIALYSIS; PATHOPHYSIOLOGY; CORTICOSTEROIDS; CALIBRATION; PLOTS	Object. The goal in this study was to assess the validity of the corticosteroid randomization after significant head injury (CRASH) collaborators prediction model in predicting mortality and unfavorable outcome at 18 months in patients with severe traumatic brain injury (TBI) requiring decompressive craniectomy. In addition, the authors aimed to assess whether this model was well calibrated in predicting outcome across a wide spectrum of severity of TBI requiring decompressive craniectomy. Methods. This prospective observational cohort study included all patients who underwent a decompressive craniectomy following severe TBI at the two major trauma hospitals in Western Australia between 2004 and 2012 and for whom 18-month follow-up data were available. Clinical and radiological data on initial presentation were entered into the Web-based model and the predicted outcome was compared with the observed outcome. In validating the CRASH model, the authors used area under the receiver operating characteristic curve to assess the ability of the CRASH model to differentiate between favorable and unfavorable outcomes. Results. The ability of the CRASH 6-month unfavorable prediction model to differentiate between unfavorable and favorable outcomes at 18 months after decompressive craniectomy was good (area under the receiver operating characteristic curve 0.85, 95% CI 0.80-0.90). However, the model's calibration was not perfect. The slope and the intercept of the calibration curve were 1.66 (SE 0.21) and -1.11 (SE 0.14), respectively, suggesting that the predicted risks of unfavorable outcomes were not sufficiently extreme or different across different risk strata and were systematically too high (or overly pessimistic), respectively. Conclusions. The CRASH collaborators prediction model can be used as a surrogate index of injury severity to stratify patients according to injury severity. However, clinical decisions should not be based solely on the predicted risks derived from the model, because the number of patients in each predicted risk stratum was still relatively small and hence the results were relatively imprecise. Notwithstanding these limitations, the model may add to a clinician's ability to have better-informed conversations with colleagues and patients' relatives about prognosis.	[Honeybul, Stephen; Lind, Christopher R. P.] Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Perth, WA 6009, Australia; [Honeybul, Stephen; Lind, Christopher R. P.] Royal Perth Hosp, Perth, WA 6001, Australia; Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Lind, Christopher R. P.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Perth, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010; Lind, Christopher/K-3629-2012	Ho, Kwok M./0000-0002-6705-6004; Lind, Christopher/0000-0001-9991-1725			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Cooper DJ, 2011, NEW ENGL J MED, V365, P2040; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Diedler J, 2010, NEUROCRIT CARE, V12, P313, DOI 10.1007/s12028-010-9350-5; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ho KM, 2011, BRIT J ANAESTH, V106, P528, DOI 10.1093/bja/aeq417; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Ho KM, 2007, J CLIN EPIDEMIOL, V60, P746, DOI 10.1016/j.jclinepi.2006.10.017; Honeybul S, 2012, J MED ETHICS, V38, P657, DOI 10.1136/medethics-2012-100672; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; JENNETT B, 1975, LANCET, V1, P480; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017	35	22	22	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2014	120	5					1131	1137		10.3171/2014.1.JNS131559			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AF7OD	WOS:000334903500016	24605836				2022-02-06	
J	Luoto, TM; Silverberg, ND; Kataja, A; Brander, A; Tenovuo, O; Ohman, J; Iverson, GL				Luoto, Teemu M.; Silverberg, Noah D.; Kataja, Anneli; Brander, Antti; Tenovuo, Olli; Ohman, Juha; Iverson, Grant L.			Sport Concussion Assessment Tool 2 in a Civilian Trauma Sample with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						Military Acute Concussion Evaluation; traumatic brain injury; concussion; Sport Concussion Assessment Tool	ERROR SCORING SYSTEM; HEAD-INJURY; INTERNATIONAL-CONFERENCE; STANDARDIZED ASSESSMENT; POSTTRAUMATIC AMNESIA; EMERGENCY-DEPARTMENT; CONSENSUS STATEMENT; ANKLE INSTABILITY; FOOTBALL PLAYERS; MANAGEMENT	The aim of the study was to evaluate the validity of the Sport Concussion Assessment Tool-Second Edition (SCAT2) in patients with acute mild traumatic brain injuries (mTBIs) in a civilian trauma setting. In addition, the SCAT2 was compared to the Military Acute Concussion Evaluation (MACE). All the participants of the study were prospectively recruited from the emergency department of Tampere University Hospital (Tampere, Finland). Patients (n=49) between the ages of 18 and 60 years, with no premorbid medical or psychiatric conditions, who met the World Health Organization criteria for mTBI, were enrolled. Trauma controls (n=33) were recruited using similar study criteria. The main measures of the study consisted of SCAT2, MACE, and mTBI severity markers, including neuroimaging (computed tomography and conventional magnetic resonance imaging [MRI]), and 1-month clinical outcomes (postconcussion syndrome diagnosis and return to work status). The scoreable components of the SCAT2 performed variably across five dimensions of validity (diagnostic, criterion, divergent, predictive, and responsiveness). The Standardized Assessment of Concussion component reasonably discriminated mTBI patients from controls, was associated with MRI lesions, improved over time, and predicted return to work. Symptom scores differentiated patients with mTBIs from controls, and elevated initial symptom scores in patients with mTBI were associated with a greater risk of persistent postconcussion symptoms. The SCAT2 was superior to the MACE. The SCAT2 appears useful for detecting acute mTBI-related symptoms and cognitive impairment, refining prognosis, and monitoring recovery.	[Luoto, Teemu M.; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33521 Tampere, Finland; [Silverberg, Noah D.] Univ British Columbia, Dept Med, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC, Canada; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, FI-33521 Tampere, Finland; [Tenovuo, Olli] Univ Turku, Dept Neurol, FIN-20520 Turku, Finland; [Tenovuo, Olli] Turku Univ, Cent Hosp, Turku, Finland; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Home Base Program, Massachusetts Gen Hosp, Boston, MA USA; [Iverson, Grant L.] Def & Vet Brain Injury Ctr, Bethesda, MD USA		Luoto, TM (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, POB 2000, FI-33521 Tampere, Finland.	teemu.luoto@pshp.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367; Iverson, Grant/0000-0001-7348-9570	Medical Research Fund of Tampere University Hospital; Maire Taponen Foundation; Emil Aaltonen Foundation; Vancouver Coastal Health Research Institute	The authors thank research assistants Anne Simi and Marika Suopanki-Ervasti for their contribution in data collection. This study was done as part of the first author's PhD thesis research program. This study was presented at the 4th International Consensus Conference on Concussion in Sport in Zurich, November 2012. This study has been supported by the Medical Research Fund of Tampere University Hospital, the Maire Taponen Foundation, and the Emil Aaltonen Foundation. N.D.S. receives funding from the Vancouver Coastal Health Research Institute. G. L. I. notes that the views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or U.S. government.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Herbert David L, 2007, Curr Sports Med Rep, V6, P20, DOI 10.1007/s11932-007-0007-x; Hertel J, 2008, CLIN SPORT MED, V27, P353, DOI 10.1016/j.csm.2008.03.006; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; MedCalc Software, 2013, MEDCALC STAT SOFTW V; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	41	22	22	0	22	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2014	31	8					728	738		10.1089/neu.2013.3174			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AD7PX	WOS:000333457200004	24502622				2022-02-06	
J	Harris, DA; Lam, S				Harris, Dominic A.; Lam, Sandi			Venous thromboembolism in the setting of pediatric traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; deep vein thrombosis; trauma; venous thromboembolism; pediatric; children	DEEP-VEIN THROMBOSIS; RISK-FACTORS; HOSPITALIZED CHILDREN; COAGULATION SYSTEM; POPULATION; COAGULOPATHY; MORTALITY; PATTERNS; OUTCOMES	Object. The risk of venous thromboembolism (VTE) in children with traumatic brain injury (TBI) has not been well characterized given its rarity in the pediatric population. Investigation of risk factors for VTE in this group requires the use of a large sample size. Using nationally representative hospital discharge data for 2009, the authors of this study characterize the incidence and risk factors for VTE in children hospitalized for TBI. Methods. The authors conducted a cross-sectional study using data from the Healthcare Cost and Utilization Project Kids' Inpatient Database to examine VTE in TBI-associated hospitalizations for patients 20 years of age or younger during the year 2009. Results. There were 58,529 children with TBI-related admissions, including 267 with VTE diagnoses. Venous thromboembolisms occurred in 4.6 per 1000 TBI-associated hospitalizations compared with 1.2 per 1000 pediatric hospitalizations overall. By adjusted logistic regression, patients significantly more likely to be diagnosed with VTE had the following: older age of 15-20 years (adjusted odds ratio [aOR] 3.7, 95% CI 1.8-8.0), venous catheterization (aOR 3.0, 95% CI 2.0-4.6), mechanical ventilation (aOR 1.9, 95% CI 1.2-2.9), tracheostomy (aOR 2,3, 95% CI 1.3-4.0), nonaccidental trauma (aOR 2.8,95% CI 1.1-6.9), increased length of stay (aOR 1.02, 95% CI 1.01-1.03), orthopedic surgery (aOR 2.4,95% CI 1.8-3.4), and cranial surgery (aOR 1.8, 95% CI 1.1-2.8). Conclusions. Using the Kids' Inpatient Database, the authors found that risk factors for VTE in the setting of TBI in the pediatric population include older age, venous catheterization, nonaccidental trauma, increased length of hospital stay, orthopedic surgery, and cranial surgery.	[Harris, Dominic A.; Lam, Sandi] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Lam, S (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Neurosurg, 6701 Fannin St,Ste 1230-01, Houston, TX 77030 USA.	sandilam@gmail.com		Lam, Sandi/0000-0003-3294-6637			ANDREW M, 1994, BLOOD, V83, P1251, DOI 10.1182/blood.V83.5.1251.1251; [Anonymous], 2013, INTR HCUP KIDS INP D; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Grandas OH, 2000, AM SURGEON, V66, P273; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Hanson SJ, 2010, J TRAUMA, V68, P52, DOI 10.1097/TA.0b013e3181a74652; Higgerson RA, 2011, PEDIATR CRIT CARE ME, V12, P628, DOI 10.1097/PCC.0b013e318207124a; Ignjatovic V, 2011, SEMIN THROMB HEMOST, V37, P723, DOI 10.1055/s-0031-1297162; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Lapidus LJ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-177; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Miller BE, 1997, ANESTH ANALG, V84, P745, DOI 10.1097/00000539-199704000-00008; Patel AP, 2013, J NEUROSURG, V118, P505, DOI 10.3171/2012.11.JNS121243; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Sandoval JA, 2008, J VASC SURG, V47, P837, DOI 10.1016/j.jvs.2007.11.054; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Vavilala MS, 2002, J TRAUMA, V52, P922, DOI 10.1097/00005373-200205000-00017; Vu LT, 2008, J PEDIATR SURG, V43, P1095, DOI 10.1016/j.jpedsurg.2008.02.036; Walkey AJ, 2013, CRIT CARE MED, V41, P1450, DOI 10.1097/CCM.0b013e31827caa89	28	22	22	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2014	13	4					448	455		10.3171/2014.1.PEDS13479			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AD7IY	WOS:000333438700015	24559280				2022-02-06	
J	Mathias, JL; Harman-Smith, Y; Bowden, SC; Rosenfeld, JV; Bigler, ED				Mathias, Jane L.; Harman-Smith, Yasmin; Bowden, Stephen C.; Rosenfeld, Jeffrey V.; Bigler, Erin D.			Contribution of Psychological Trauma to Outcomes after Traumatic Brain Injury: Assaults versus Sporting Injuries	JOURNAL OF NEUROTRAUMA			English	Article						assault; psychological trauma; sporting injury; post-traumatic stress; outcome; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYNDROME; HEAD-INJURY; RISK-FACTORS; NEUROPSYCHOLOGICAL ASSESSMENT; COGNITIVE PERFORMANCE; GENDER-DIFFERENCES; PROGNOSTIC VALUE; MODEL SYSTEMS; SYMPTOMS	Clinical research into outcomes after traumatic brain injury (TBI) frequently combines injuries that have been sustained through different causes (e.g., car accidents, assaults, and falls), the effect of which is not well understood. This study examined the contribution of injury-related psychological trauma-which is more commonly associated with specific types of injuries-to outcomes after nonpenetrating TBI in order to determine whether it may be having a differential effect in samples containing mixed injuries. Data from three groups that were prospectively recruited for two larger studies were compared: one that sustained a TBI as a result of physical assaults (i.e., psychologically traumatizing) and another as a result of sporting injuries (i.e., nonpsychologically traumatizing), as well as an orthopedic control group (OC). Psychosocial and emotional (postconcussion symptoms, injury-related stress, and depression), cognitive (memory, abstract reasoning, problem solving, and verbal fluency), and functional (general outcome; resumption of home, social, and work roles) outcomes were all assessed. The TBIassault group reported significantly poorer psychosocial and emotional outcomes and higher rates of litigation (criminal rather than civil) than both the TBIsport and OC groups approximately 6 months postinjury, but there were no differences in the cognitive or functional outcomes of the three groups. The findings suggest that the cause of a TBI may assist in explaining some of the differences in outcomes of people who have seemingly comparable injuries. Involvement in litigation and the cause of an injury may also be confounded, which may lead to the erroneous conclusion that litigants have poorer outcomes.	[Mathias, Jane L.; Harman-Smith, Yasmin] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia; [Bowden, Stephen C.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Div Clin Sci, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3181, Australia; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol & Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, N Terrace, Adelaide, SA 5005, Australia.	jane.mathias@adelaide.edu.au	Rosenfeld, Jeffrey V/B-7249-2011	Mathias, Jane/0000-0001-8957-8594; Harman-Smith, Yasmin/0000-0002-9227-8530	National Health and Medical Research Foundation of AustraliaNational Health and Medical Research Council of Australia [207711, 519220]	This research was funded by project grant nos. 207711 and 519220 from the National Health and Medical Research Foundation of Australia.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Babor T. F., 1989, AUDIT ALCOHOL DISORD; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blanchard E. B., 2003, CRASH PSYCHOL ASSESS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Butler DJ, 1999, AM FAM PHYSICIAN, V60, P524; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen J., 2013, STAT POWER ANAL BEHA; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; de Oliveira Thais M., 2012, J NEUROPSYCHOL  1120, DOI 10.1111/jnp.12000; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eid H. O., 2007, SMJ Singapore Medical Journal, V48, P693; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fullerton CS, 2001, AM J PSYCHIAT, V158, P1486, DOI 10.1176/appi.ajp.158.9.1486; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hours M, 2013, ACCIDENT ANAL PREV, V50, P92, DOI 10.1016/j.aap.2012.03.037; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lee SY, 2012, J CLIN NEUROL, V8, P224, DOI 10.3988/jcn.2012.8.3.224; Leon Carrion J., 2001, REV ESPANOLA NEUROPS, V3, P58; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macdonald S, 1999, DRUG ALCOHOL DEPEN, V55, P53, DOI 10.1016/S0376-8716(98)00184-7; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meyers L. S., 2006, APPL MULTIVARIATE RE; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Reynolds S, 2011, J INTENSIVE CARE SOC, V12, P196; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; ROSENFIELD S, 1980, J HEALTH SOC BEHAV, V21, P33, DOI 10.2307/2136692; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2007, ALC INJ EM DEP SUMM; Willer B., 1994, J HEAD TRAUMA REHAB, V8, P75; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yoganandan N, 2010, ACCIDENT ANAL PREV, V42, P1370, DOI 10.1016/j.aap.2010.02.017	89	22	23	0	22	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2014	31	7					658	669		10.1089/neu.2013.3160			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AD7PB	WOS:000333455000007	24228916	Green Published			2022-02-06	
J	Rowe, RK; Harrison, JL; O'Hara, BF; Lifshitz, J				Rowe, Rachel K.; Harrison, Jordan L.; O'Hara, Bruce F.; Lifshitz, Jonathan			Diffuse brain injury does not affect chronic sleep patterns in the mouse	BRAIN INJURY			English	Article						Chronic; concussion; diffuse; mouse; sleep; TBI	OXIDATIVE STRESS; HEAD-INJURY; DISTURBANCES; RAT; WAKEFULNESS; WAKE; FRAGMENTATION; DEPRIVATION; HIPPOCAMPUS; PERFORMANCE	Primary objective: To test if the current model of diffuse brain injury produces chronic sleep disturbances similar to those reported by TBI patients. Methods and procedures: Adult male C57BL/6 mice were subjected to moderate midline fluid percussion injury (n = 7; 1.4 atm; 6-10 minutes righting reflex time) or sham injury (n = 5). Sleep-wake activity was measured post-injury using a non-invasive, piezoelectric cage system. Chronic sleep patterns were analysed weekly for increases or decreases in percentage sleep (hypersomnia or insomnia) and changes in bout length (fragmentation). Main outcomes and results: During the first week after diffuse TBI, brain-injured mice exhibited increased mean percentage sleep and mean bout length compared to sham-injured mice. Further analysis indicated the increase in mean percentage sleep occurred during the dark cycle. Injury-induced changes in sleep, however, did not extend beyond the first week post-injury and were not present in weeks 2-5 post-injury. Conclusions: Previously, it has been shown that the midline fluid percussion model used in this study immediately increased post-traumatic sleep. The current study extended the timeline of investigation to show that sleep disturbances extended into the first week post-injury, but did not develop into chronic sleep disturbances. However, the clinical prevalence of TBI-related sleep-wake disturbances warrants further experimental investigation.	[Rowe, Rachel K.; Harrison, Jordan L.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Rowe, Rachel K.; Harrison, Jordan L.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Rowe, Rachel K.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA; [Rowe, Rachel K.; O'Hara, Bruce F.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Harrison, Jordan L.; Lifshitz, Jonathan] Arizona State Univ, Interdisciplinary Program Neurosci, Phoenix, AZ USA; [O'Hara, Bruce F.] Univ Kentucky, Coll Arts & Sci, Dept Biol, Lexington, KY USA; [Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ USA		Lifshitz, J (corresponding author), Phoenix Childrens Hosp, Translat Neurotrauma Res Program, Barrow Neurol Inst, Phoenix, AZ 85016 USA.	jlifshitz@email.arizona.edu		Rowe, Rachel/0000-0002-9034-3159	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052, R01NS065052-S, R21NS072611, KSCHIRT 10-5A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072611, R01NS065052] Funding Source: NIH RePORTER	Research reported in this publication was supported, in part, by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS065052, R01NS065052-S, R21NS072611 and KSCHIRT 10-5A. Dr O'Hara is a primary owner of Signal Solutions, LLC (Lexington, KY). All other authors had no conflicts of interest.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Billiard M, 2013, SLEEP MED, V14, P462, DOI 10.1016/j.sleep.2013.01.009; BONNET MH, 1985, SLEEP, V8, P11, DOI 10.1093/sleep/8.1.11; BONNET MH, 1986, PHYSIOL BEHAV, V37, P915, DOI 10.1016/S0031-9384(86)80012-9; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chikahisa S, 2011, FRONTIERS NEUROLOGY, V2, P863; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; FAN L, 1995, MOL BRAIN RES, V30, P125; Frieboes RM, 1999, J NEUROPSYCH CLIN N, V11, P354, DOI 10.1176/jnp.11.3.354; Gopalakrishnan A, 2004, SLEEP, V27, P27, DOI 10.1093/sleep/27.1.27; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Kalinchuk AV, 2003, EUR J NEUROSCI, V17, P863, DOI 10.1046/j.1460-9568.2003.02532.x; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; KRUEGER JM, 1995, INT ARCH ALLERGY IMM, V106, P97, DOI 10.1159/000236827; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McShane BB, 2010, J NEUROSCI METH, V193, P321, DOI 10.1016/j.jneumeth.2010.08.024; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; REIMUND E, 1994, MED HYPOTHESES, V43, P231, DOI 10.1016/0306-9877(94)90071-X; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Rowe RK, 2014, SLEEP IN PRESS; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; STEPANSKI E, 1984, SLEEP, V7, P18, DOI 10.1093/sleep/7.1.18; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404	49	22	23	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					504	510		10.3109/02699052.2014.888768			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900015	24702469	Green Accepted			2022-02-06	
J	Mayr, U; LaRoux, C; Rolheiser, T; Osternig, L; Chou, LS; van Donkelaar, P				Mayr, Ulrich; LaRoux, Charlene; Rolheiser, Tyler; Osternig, Louis; Chou, Li-Shan; van Donkelaar, Paul			Executive Dysfunction Assessed with a Task-Switching Task following Concussion	PLOS ONE			English	Article							INJURY SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; ATTENTION; DEFICITS	Concussion frequently results in executive function deficits that can be specifically probed using task-switching tasks. The current study examined in detail the influence of concussion on task switching performance using both spatial and numerical stimuli. Individuals with concussion (n = 16) were tested within 48 hours of injury and 7, 14, and 28 days later. Healthy sex-, age-, height-, weight- and activity-matched controls (n = 16) were also tested at the same intervals. Switch costs were significantly greater in the participants with concussion than in the controls for both types of stimuli. By contrast, the global costs on non-switching trials were unaffected by concussion. We conclude that concussion has pronounced negative effects on the ability to switch task sets that generalize across task combinations (spatial or numerical) and that persist across at least a month after injury.	[Mayr, Ulrich] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [LaRoux, Charlene; Rolheiser, Tyler; Osternig, Louis; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [van Donkelaar, Paul] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada		van Donkelaar, P (corresponding author), Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.	paul.vandonkelaar@ubc.ca			VAUS Department of Veterans Affairs [A4842C8, A4843C]; University of Oregon; Peace Health Oregon Region; DoD-TATRCUnited States Department of Defense [W81XWH-11-1-0717]	This work was supported by VA (A4842C8, A4843C), University of Oregon, Peace Health Oregon Region, DoD-TATRC (W81XWH-11-1-0717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agel J, 2007, J ATHL TRAINING, V42, P249; Arrington CM, 2005, J EXP PSYCHOL LEARN, V31, P683, DOI 10.1037/0278-7393.31.4.683; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dick R, 2007, J ATHL TRAINING, V42, P221; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Mayr U, 2006, PSYCHOL SCI, V17, P774, DOI 10.1111/j.1467-9280.2006.01781.x; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Schmitter-Edgecombe M, 2006, NEUROPSYCHOLOGY, V20, P675, DOI 10.1037/0894-4105.20.6.675; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363	17	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91379	10.1371/journal.pone.0091379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	WOS:000332842400082	24618717	Green Published, gold, Green Submitted			2022-02-06	
J	Kirkwood, MW; Connery, AK; Kirk, JW; Baker, DA				Kirkwood, Michael W.; Connery, Amy K.; Kirk, John W.; Baker, David A.			Detecting performance invalidity in children: Not quite as easy as A, B, C, 1, 2, 3 but automatized sequences appears promising	CHILD NEUROPSYCHOLOGY			English	Article						Response bias; Mild traumatic brain injury; Performance validity testing; Postconcussion; Automatized sequences	DISABILITY CONSULTATIVE EXAM; SYMPTOM VALIDITY TEST; DIGIT SPAN; PEDIATRIC SAMPLE; BRAIN-INJURY; TOMM; ADOLESCENTS; RECOVERY; CAPACITY; EPILEPSY	In adult populations, embedded performance validity indicators are well established, as they are time efficient, resistant to coaching, and allow for more continuous monitoring of effort than standalone measures. Although several recent studies have demonstrated the appropriateness of using standalone validity tests with school-age children, a paucity of pediatric work has examined embedded indicators. The present study investigated the value of a simple automatized sequences task to detect performance invalidity in 439 clinically referred patients with mild head injury aged 8 through 17 years. Sixteen percent of the participants failed the Medical Symptom Validity Test (MSVT). Thirteen percent failed the MSVT and also performed below established cutoffs on either the Test of Memory Malingering or Wechsler Digit Span subtest. The group classified as providing invalid data performed significantly worse than the group passing the MSVT across all sequencing conditions. Sensitivity and specificity for the total time on the sequencing task compared favorably to data produced for many respected adult-based embedded indicators (i.e., sensitivity around 50% when specificity >= 90%). Classification statistics for any embedded performance validity test can be expected to be worse in more severely affected populations; however, the current sequencing task appears to have value in detecting invalid performance in relatively high-functioning older children and adolescents. The fact that the task takes less than a couple of minutes to administer makes it especially appealing.	Univ Colorado Denver, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA; Childrens Hosp Colorado, Aurora, CO USA		Kirkwood, MW (corresponding author), ABPP CN Childrens Hosp Colorado, Concuss Program, 13123 E 16th Ave, Aurora, CO 80045 USA.	Michael.Kirkwood@childrenscolorado.org					Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone K.B., 2007, ASSESSMENT FEIGNED C; Brooks B. L., 2012, ARCH CLIN NEUROPSYCH; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Cohen J., 2013, STAT POWER ANAL BEHA; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Flaro L., 2009, NEUROPSYCHOLOGY MALI, P369; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, MANUAL MED SYMPTOM V; Henry G. K., 2005, FORENSIC NEUROPSYCHO, P205; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Loughan AR, 2012, ARCH CLIN NEUROPSYCH, V27, P716, DOI 10.1093/arclin/acs072; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; McCaffrey R. J., 2009, NEUROPSYCHOLOGY MALI, P377; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063; Yeates K. O., 2012, MILD TRAUMATIC BRAIN, P124	33	22	22	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAR 4	2014	20	2					245	252		10.1080/09297049.2012.759553			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AB0ZB	WOS:000331519900008	23297668				2022-02-06	
J	Aarabi, B; Mirvis, S; Shanmuganathan, K; Vaccaro, AR; Holmes, CJ; Akhtar-Danesh, N; Fehlings, MG; Dvorak, MF				Aarabi, Bizhan; Mirvis, Stuart; Shanmuganathan, Kathirkamanthan; Vaccaro, Alexander R.; Holmes, Cassandra J.; Akhtar-Danesh, Noori; Fehlings, Michael G.; Dvorak, Marcel F.			Comparative effectiveness of surgical versus nonoperative management of unilateral, nondisplaced, subaxial cervical spine facet fractures without evidence of spinal cord injury	JOURNAL OF NEUROSURGERY-SPINE			English	Article						trauma; spinal cord injury; MRI; ASIA scale; cervical facet fracture; nondisplaced fracture; traumatic brain injury	ANTERIOR FUSION; CLASSIFICATION; DISLOCATIONS; FACETECTOMY; INSTABILITY	Object. Facet joints are major stabilizers of cervical motion allowing for effortless and pain-free multidimensional cervical spine movements without significant linear or rotational translation, thus minimizing any chance for spinal cord or nerve root impingement. Unilateral, nondisplaced subaxial facet fractures do not meet the conventional criteria for spinal instability under physiological loads. Limited evidence indicates that even with no or minimal displacement, 20%-80% of these fractures fail nonoperative management. The risk factors for instability in isolated nondisplaced subaxial facet fractures remain uncertain. In this retrospective study of prospectively collected data, the authors attempted to identify the predictors of failure in the management of isolated, nondisplaced subaxial facet fractures admitted to their Level I trauma center over a 10-year period. Methods. Demographic, clinical, imaging, and follow-up data for 25 patients with unilateral nondisplaced subaxial facet fractures who were managed surgically (n = 10) or nonoperatively (n = 15) were statistically analyzed. Results. The mean age of the patients was 38 years, 19 were male, and 21 of the fractures were the result of either motor vehicle acciderits or falls. The mean motorscore on the American Spinal Injury Association scale was 99.2, and the mean Subaxial Injury Classification (SLIC) severity score was 3 (operated 3.5, nonoperated 2.3). Allen mechanistic classification included 22 compressive-extension Stage 1 and 2 distractive-extension Stage 1 fractures. Subaxial facet fractures involved C-7 in 17 patients (68%), C-6 in 7 (28%), and C-3 in 1 (4%). The anatomical plane of fracture through the lateral mass was sagittal in 12 patients, axial in 8, and coronal in 3 patients. Nondisplaced floating lateral mass injuries were noted in 2 patients. The mean instability score, considering 7 components of the discoligamentous complex on MRI, was 3.2 (operated 3.6, nonoperated 3.0). Ten (40%) of 25 patients in this investigation did not have successful management, 9 in the nonoperated and 1 in the operated group (p = 0.018). Unsuccessful management was significantly greater in younger patients (p = 0.0008), possibly indicating selection bias (p = 0.07, Wilcoxon ranksum test). Fracture plane, instability, and SLIC scores did not play a significant role in treatment failure in this study. Conclusions. In this study, surgery was superior to nonoperative management of isolated, nondisplaced, or minimally displaced subaxial cervical spine facet fractures.	[Aarabi, Bizhan] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Mirvis, Stuart; Shanmuganathan, Kathirkamanthan] Univ Maryland, Sch Med, Dept Radiol, Baltimore, MD 21201 USA; [Vaccaro, Alexander R.] Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA; [Holmes, Cassandra J.] Coll William & Mary, Williamsburg, VA USA; [Akhtar-Danesh, Noori] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Akhtar-Danesh, Noori] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Neurosurg, Toronto, ON M5S 1A1, Canada; [Dvorak, Marcel F.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada		Aarabi, B (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, 22 S Greene St,Ste S-12-D, Baltimore, MD 21201 USA.	baarabi@smail.umaryland.edu		Dvorak, Marcel/0000-0002-9404-8448; Fehlings, Michael/0000-0002-5722-6364	Cerapedics; NuVasive; Stryker Spine	Dr. Vaccaro has direct stock ownership in Advanced Spinal Intellectual Properties, Bonovo Orthopaedics, Computational Biodynamics, Cross Current, Cytonics, Electrocore, Flagship Surgical, FlowPharma, Gamma Spine, Globus, In Vivo, Innovative Surgical Design, K-2 Medical, Location Based Intelligence, NeuCore, Paradigm Spine, Progressive Spinal Technologies, R.S.I., Replication Medica, Rothman Institute and Related Properties, Small Bone Innovations, Spine Medica, Spinicity, Spinology, Stout Medical, and Syndicom; is an employee of the Rothman Institute; serves as a consultant to the Gerson Lehrman Group, Guidepoint Global, Innovative Surgical Design, Medacorp, and Stout Medical; has received royalties from Aesculap, Biomet Spine, DePuy, Globus, Medtronics, NuVasive, and Stryker Spine; serves on Boards and Committees for AO Spine, Association of Collaborative Spine Research, Innovative Surgical Design, and Spinicity; and has received grants from Cerapedics, NuVasive, and Stryker Spine.	ALLEN BL, 1982, SPINE, V7, P1, DOI 10.1097/00007632-198200710-00001; Anderson PA, 2007, J BONE JOINT SURG AM, V89A, P1057, DOI 10.2106/JBJS.F.00684; BEYER CA, 1991, J BONE JOINT SURG BR, V73, P977, DOI 10.1302/0301-620X.73B6.1955448; BUCHOLZ RD, 1989, J NEUROSURG, V70, P884, DOI 10.3171/jns.1989.70.6.0884; CUSICK JF, 1988, SPINE, V13, P808, DOI 10.1097/00007632-198807000-00017; DENIS F, 1983, SPINE, V8, P817, DOI 10.1097/00007632-198311000-00003; Dvorak MF, 2007, SPINE, V32, P3007, DOI 10.1097/BRS.0b013e31815cd439; Halliday AL, 1997, SPINE, V22, P2614, DOI 10.1097/00007632-199711150-00007; HARRIS JH, 1986, ORTHOP CLIN N AM, V17, P15; HOLDSWORTH FW, 1963, J BONE JOINT SURG BR, V45, P6, DOI 10.1302/0301-620X.45B1.6; Kwon BK, 2007, J NEUROSURG-SPINE, V7, P1, DOI 10.3171/SPI-07/07/001; Lee SH, 2009, J TRAUMA, V66, P758, DOI 10.1097/TA.0b013e31818cc32a; Lifeso RM, 2000, SPINE, V25, P2028, DOI 10.1097/00007632-200008150-00005; NICOLL EA, 1949, J BONE JOINT SURG BR, V31, P376, DOI 10.1302/0301-620X.31B3.376; Rabb CH, 2007, J SPINAL DISORD TECH, V20, P416, DOI 10.1097/BSD.0b013e318030d32a; RAYNOR RB, 1985, J NEUROSURG, V63, P278, DOI 10.3171/jns.1985.63.2.0278; SCHAEFER DM, 1992, J NEUROSURG, V76, P218, DOI 10.3171/jns.1992.76.2.0218; SHAPIRO SA, 1993, NEUROSURGERY, V33, P832; Spector LR, 2006, SPINE, V31, P2827, DOI 10.1097/01.brs.0000245864.72372.8f; Vaccaro AR, 2007, SPINE, V32, P2365, DOI 10.1097/BRS.0b013e3181557b92; WHITE A A, 1976, Spine, V1, P15, DOI 10.1097/00007632-197603000-00003; White AA., 1990, CLIN BIOMECHANICS SP, V2nd ed, P1; ZDEBLICK TA, 1993, SPINE, V18, P2005, DOI 10.1097/00007632-199310001-00013	23	22	23	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAR	2014	20	3					270	277		10.3171/2013.11.SPINE13733			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AB8OD	WOS:000332049000004	24405465	Green Submitted			2022-02-06	
J	Lin, KH; Shiao, JSC; Guo, NW; Liao, SC; Kuo, CY; Hu, PY; Hsu, JH; Hwang, YH; Guo, YL				Lin, Kuan-Han; Shiao, Judith Shu-Chu; Guo, Nai-Wen; Liao, Shih-Cheng; Kuo, Chun-Ya; Hu, Pei-Yi; Hsu, Jin-Huei; Hwang, Yaw-Huei; Guo, Yue Leon			Long-Term Psychological Outcome of Workers After Occupational Injury: Prevalence and Risk Factors	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Major depression; Occupational injury; Partial post-traumatic stress disorder (PPTSD); Post-traumatic stress disorder (PTSD); Risk factor	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; 1999 TAIWAN EARTHQUAKE; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; SURVIVORS; COMORBIDITY; MORBIDITY; VICTIMS; COMMUNITY	Introduction This study aimed to examine the prevalence rates of both post-traumatic stress disorder (PTSD) and major depression at 12 months in workers experiencing different types of occupational injury in Taiwan. Demographic and injury-related risk factors for psychological symptoms were also evaluated. Methods Our study candidates were injured workers in Taiwan who were hospitalized for 3 days or longer and received hospitalization benefits from the Labor Insurance program. A two-staged survey study was conducted. A self-reported questionnaire including the Brief Symptom Rating Scale and Post-traumatic Symptom Checklist was sent to workers at 12 months after injury. Those who met the criteria were recruited for the second-stage phone interview with a psychiatrist using the Mini-international Neuropsychiatric Interview (MINI). Results A total of 1,233 workers completed the questionnaire (response rate 28.0 %). Among them, 167 (13.5 %) fulfilled the criteria for the MINI interview and were invited. A total of 106 (63.5 %) completed the phone interview. The estimated rate of either PTSD/PPTSD or major depression was 5.2 %. The risk factors for psychological symptoms were female gender, lower education level, loss of consciousness after occupational injury, injury affecting physical appearance, occupational injury experience before this event, life experience before and after this injury, length of hospital stay, self-rated injury severity, and percentage of income to the family. Conclusions These results showed that occupational injury can cause long-term psychological impact in workers. Key demographic and injury characteristics may enhance the identification of at-risk occupational injured workers who would benefit from targeted screening and early intervention efforts.	[Lin, Kuan-Han; Hwang, Yaw-Huei; Guo, Yue Leon] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Sch Publ Hlth, Taipei 10764, Taiwan; [Shiao, Judith Shu-Chu] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei, Taiwan; [Shiao, Judith Shu-Chu] NTU Hosp, Taipei, Taiwan; [Guo, Yue Leon] Natl Cheng Kung Univ, Inst Behav Med, Tainan 70101, Taiwan; [Liao, Shih-Cheng] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Kuo, Chun-Ya] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Hu, Pei-Yi; Hsu, Jin-Huei] Councils Labor Affairs, Inst Occupat Safety & Hlth, Taipei, Taiwan; [Guo, Yue Leon] Natl Taiwan Univ, Coll Med, Dept Environm & Occupat Med, Taipei 100, Taiwan; [Guo, Yue Leon] Natl Taiwan Univ, NTU Hosp, Taipei 100, Taiwan		Guo, YL (corresponding author), Natl Taiwan Univ, Coll Med, Dept Environm & Occupat Med, Rm 339,17 Xuzhou Rd, Taipei 100, Taiwan.	leonguo@ntu.edu.tw	Lin, Kuan-Han/AAF-7584-2020; Guo, Yue-Liang Leon/ABF-2314-2020; LIAO, SHIH-CHENG/C-5665-2017	HWANG, YAW-HUEI/0000-0003-1817-8969; GUO, Yue Leon/0000-0002-8530-4809; SHIAO, JUDITH SHU-CHU/0000-0002-6725-0034; LIAO, SHIH-CHENG/0000-0003-4129-0879; Lin, Kuan-Han/0000-0003-2047-6025			American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th, P427; Armenian HK, 2002, J URBAN HEALTH, V79, P373, DOI 10.1093/jurban/79.3.373; Asmundson GJG, 1998, J ANXIETY DISORD, V12, P57, DOI 10.1016/S0887-6185(97)00049-2; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Breslau N, 2004, PSYCHOL MED, V34, P889, DOI 10.1017/S0033291703001612; Chang CM, 2005, J NERV MENT DIS, V193, P40, DOI 10.1097/01.nmd.0000149217.67211.ab; Chen CH, 2007, COMPR PSYCHIAT, V48, P269, DOI 10.1016/j.comppsych.2006.12.003; CHEN CN, 1993, ARCH GEN PSYCHIAT, V50, P125; Chien IC, 2004, PSYCHIAT SERV, V55, P691, DOI 10.1176/appi.ps.55.6.691; Chou FHC, 2007, PSYCHIAT CLIN NEUROS, V61, P370, DOI 10.1111/j.1440-1819.2007.01688.x; COMPTON WM, 1991, AM J PSYCHIAT, V148, P1697; Dersh J, 2002, J OCCUP ENVIRON MED, V44, P459, DOI 10.1097/00043764-200205000-00014; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; GARRISON CZ, 1995, J AM ACAD CHILD PSY, V34, P1193, DOI 10.1097/00004583-199509000-00017; GOENJIAN A, 1993, BRIT J PSYCHIAT, V163, P230, DOI 10.1192/bjp.163.2.230; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; GOENJIAN AK, 1994, AM J PSYCHIAT, V151, P895; Guo NW, 2012, J OCCUP HLTH; Guo YJ, 2004, PSYCHIAT RES, V127, P35, DOI 10.1016/j.psychres.2004.03.009; Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022; Jeon HJ, 2007, DEPRESS ANXIETY, V24, P577, DOI 10.1002/da.20270; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kuo HW, 2007, J PSYCHOSOM RES, V62, P495, DOI 10.1016/j.jpsychores.2004.11.012; Lai TJ, 2004, J PSYCHIATR RES, V38, P313, DOI 10.1016/j.jpsychires.2003.08.005; Lee M B, 1990, J Formos Med Assoc, V89, P1081; Lee MB, 1990, CHINESE PSYCHIAT, V4, P10; MacDonald HA, 2003, J OCCUP REHABIL, V13, P63, DOI 10.1023/A:1022563930482; Maes M, 2000, EUR ARCH PSY CLIN N, V250, P156, DOI 10.1007/s004060070034; MAJ M, 1989, ACTA PSYCHIAT SCAND, V79, P544, DOI 10.1111/j.1600-0447.1989.tb10301.x; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Mason S, 2002, J TRAUMA, V53, P98, DOI 10.1097/00005373-200207000-00019; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Pincus HA, 2001, J CLIN PSYCHIAT, V62, P5; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Shih RA, 2010, J TRAUMA, V69, P1560, DOI 10.1097/TA.0b013e3181e59c05; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Wu HC, 2006, AUST NZ J PSYCHIAT, V40, P355, DOI 10.1111/j.1440-1614.2006.01802.x; Yang YK, 2003, GEN HOSP PSYCHIAT, V25, P253, DOI 10.1016/S0163-8343(03)00022-7	44	22	23	1	21	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	MAR	2014	24	1					1	10		10.1007/s10926-013-9431-3			10	Rehabilitation; Social Issues	Social Science Citation Index (SSCI)	Rehabilitation; Social Issues	AB8DJ	WOS:000332020000001	23504486				2022-02-06	
J	Sivak, S; Bittsansky, M; Grossmann, J; Nosal', V; Kantorova, E; Sivakova, J; Demkova, A; Hnilicova, P; Dobrota, D; Kurca, E				Sivak, S.; Bittsansky, M.; Grossmann, J.; Nosal', V.; Kantorova, E.; Sivakova, J.; Demkova, A.; Hnilicova, P.; Dobrota, D.; Kurca, E.			Clinical correlations of proton magnetic resonance spectroscopy findings in acute phase after mild traumatic brain injury	BRAIN INJURY			English	Article						Magnetic resonance spectroscopy; mild traumatic brain injury; neuropsychological testing	SPORT-RELATED CONCUSSION; MR SPECTROSCOPY; ABNORMALITIES; RECOVERY	Introduction: Standard brain magnetic resonance imaging (MRI) is typically normal in most patients after mild traumatic brain injury (MTBI). Proton magnetic resonance spectroscopy (H-1-MRS) is more sensitive to detect subtle post-traumatic changes. The aim of the study was to evaluate the clinical correlations of these changes in the acute phase (within 3 days) after MTBI. Methods: Twenty-one patients with MTBI and 22 controls were studied. Both groups underwent neuropsychological testing and single-voxel H-1-MRS examination of both frontal lobes and upper brainstem. Results: Significant decrease in NAA was found in both frontal lobes and in NAA/Cre ratio in the right frontal lobe (p < 0.05). Correlation analysis showed a correlation of NAA in the left frontal lobe with Backward Digit Span (p = 0.022) and Stroop test A (p = 0.0034) and a weak correlation with TMT B time (p = 0.046). The NAA/Cre in the right frontal lobe correlated with Stroop test A (p = 0.007) and with the total score of Digit Span (p = 0.016). Lower NAA was found in the upper brainstem (p = 0.0157) in the sub-group of patients with post-traumatic unconsciousness. Conclusions: This study found a correlation of H-1-MRS metabolite changes with cognitive decline and presence or absence of loss of consciousness in the acute phase after MTBI.	[Sivak, S.; Grossmann, J.; Nosal', V.; Kantorova, E.; Demkova, A.; Kurca, E.] Comenius Univ, Neurol Clin, Martin 03659, Slovakia; [Bittsansky, M.; Hnilicova, P.; Dobrota, D.] Comenius Univ, Dept Med Biochem, Martin 03659, Slovakia; [Sivakova, J.] Comenius Univ, Jessenius Fac Med, Clin Gynecol & Obstet, Martin 03659, Slovakia		Sivak, S (corresponding author), Comenius Univ, Jessenius Fac Med, Neurol Clin, Kollarova 2, Martin 03659, Slovakia.	sivak@jfmed.uniba.sk	Sivak, Stefan/O-4237-2018; Bittsansky, Michal/N-6680-2018; Nosal, Vladimir/X-7567-2018; Hnilicova, Petra/X-8588-2018	Nosal, Vladimir/0000-0001-6044-8294; Sivak, Stefan/0000-0002-0348-3082; Bittsansky, Michal/0000-0002-6372-7165; Hnilicova, Petra/0000-0003-1529-1675	EU resources and European social fund-ITMS [26110230067, 2012/31-UKMA-8]	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This work was supported by the grants co-financed from EU resources and European social fund-ITMS 26110230067 and 2012/31-UKMA-8.	Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Aubry M, 2001, BRIT J SPORT MED, V36, P6, DOI DOI 10.1136/BJSM.36.1.6; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BROWN WJ, 1972, AM J PATHOL, V67, P41; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kuera M., 1980, TEST KONCENTRACE POZ; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; McCullough BJ, 2011, PHYS MED REH CLIN N, V22, P635, DOI 10.1016/j.pmr.2011.08.005; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wechsler D, 1999, WECHSLER MEMORY SCAL; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578	34	22	23	0	19	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2014	28	3					341	346		10.3109/02699052.2013.865270			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AC0RI	WOS:000332202100012	24377396				2022-02-06	
J	Su, SH; Wang, F; Hai, J; Liu, NT; Yu, F; Wu, YF; Zhu, YH				Su, Shao-Hua; Wang, Fei; Hai, Jian; Liu, Ning-Tao; Yu, Fei; Wu, Yi-Fang; Zhu, You-Hou			The Effects of Intracranial Pressure Monitoring in Patients with Traumatic Brain Injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; INTENSIVE-CARE; EUROPEAN-BRAIN; MANAGEMENT; MORTALITY	Background: Although international guideline recommended routine intracranial pressure (ICP) monitoring for patients with severe traumatic brain injury(TBI), there were conflicting outcomes attributable to ICP monitoring according to the published studies. Hence, we conducted a meta-analysis to evaluate the efficacy and safety of ICP monitoring in patients with TBI. Methods: Based on previous reviews, PubMed and two Chinese databases (Wangfang and VIP) were further searched to identify eligible studies. The primary outcome was mortality. Secondary outcomes included unfavourable outcome, adverse events, length of ICU stay and length of hospital stay. Weighted mean difference (WMD), odds ratio (OR) and 95% confidence intervals (CIs) were calculated and pooled using fixed-effects or random-effects model. Results: two randomized controlled trials (RCTs) and seven cohort studies involving 11,038 patients met the inclusion criteria. ICP monitoring was not associated with a significant reduction in mortality (OR, 1.16; 95% CI, 0.87-1.54), with substantial heterogeneity (I-2 = 80%, P < 0.00001), which was verified by the sensitivity analyses. No significant difference was found in the occurrence of unfavourable outcome (OR, 1.40; 95% CI, 0.99-1.98; I-2 = 4%, P = 0.35) and advese events (OR, 1.04; 95% CI, 0.64-1.70; I-2 = 78%, P = 0.03). However, we should be cautious to the result of adverse events because of the substantial heterogeneity in the comparison. Furthermore, longer ICU and hospital stay were the consistent tendency according to the pooled studies. Conclusions: No benefit was found in patients with TBI who underwent ICP monitoring. Considering substantial clinical heterogeneity, further large sample size RCTs are needed to confirm the current findings.	[Su, Shao-Hua; Wang, Fei; Hai, Jian; Liu, Ning-Tao; Yu, Fei; Wu, Yi-Fang; Zhu, You-Hou] Tongji Univ, Sch Med, Tongji Hosp, Dept Neurosurg, Shanghai 200092, Peoples R China		Wang, F (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Neurosurg, Shanghai 200092, Peoples R China.	wangfeidoc@163.com		Su, Shao-Hua/0000-0001-7911-5406			Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; Forsyth RJ, 2010, COCHRANE DB SYST REV, V17; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lane PL, 2000, CAN J SURG, V43, P442; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Wells GA, 2019, NEWCASTLE OTTAVWA SC	25	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87432	10.1371/journal.pone.0087432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	WOS:000331717900011	24586276	gold, Green Submitted, Green Published			2022-02-06	
J	Limond, J; Adlam, ALR; Cormack, M				Limond, J.; Adlam, A-L. R.; Cormack, M.			A Model for Pediatric Neurocognitive Interventions: Considering the Role of Development and Maturation in Rehabilitation Planning	CLINICAL NEUROPSYCHOLOGIST			English	Article						Children; Brain injury; Cognitive rehabilitation	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; WORKING-MEMORY; COGNITIVE REHABILITATION; UTILIZATION DEFICIENCIES; FAMILY INTERVENTION; FLUID INTELLIGENCE; EXECUTIVE FUNCTION; CLINICAL-PRACTICE; GOAL MANAGEMENT	The need for post-acute neurorehabilitation after childhood acquired brain injury is increasingly recognized but recent reviews highlight the limited evidence-base and lack of a neuropsychological treatment model. Evidence from different fields was reviewed to inform the development of a pediatric neurocognitive interventions (PNI) model. The review included literature from child neuropsychology, adult neuropsychology, cognitive neuroscience, learning disabilities, education, and mental health. The resulting PNI model provides a systematic approach to delivering and evaluating appropriate care while minimizing the obstacles to successful outcomes. The model emphasizes the role of development and cognitive maturation in the planning of rehabilitation. Areas that represent significant gaps in our knowledge are discussed and future research directions are suggested based on predictions generated by the proposed model.	[Limond, J.] CoRaL Psychol Ltd, Glasgow G1 3DX, Lanark, Scotland; [Limond, J.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Adlam, A-L. R.] Univ Exeter, Ctr Clin Neuropsychol Res, Sch Psychol, Exeter EX4 4QJ, Devon, England; [Cormack, M.] NHS Lanarkshire, Motherwell, Lanark, Scotland		Limond, J (corresponding author), CoRaL Psychol Ltd, 38 Queen St, Glasgow G1 3DX, Lanark, Scotland.	jenny@coralpsychology.co.uk		Adlam, Anna/0000-0001-7212-4051			Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; Bernstein J. H., 2010, PRINCIPLES PRACTICE, P17; Bjorklund D., 2012, CHILDRENS THINKING C, V5; Bjorklund DF, 1997, DEV REV, V17, P411, DOI 10.1006/drev.1997.0440; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Byard Katie, 2011, Clin Child Psychol Psychiatry, V16, P165, DOI 10.1177/1359104511403582; Carli P, 2004, LANCET, V363, P584, DOI 10.1016/S0140-6736(04)15626-2; Case R., 1995, MEMORY PERFORMANCE C; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; CRONE EA, 2011, DEV COGN NEUROS-NETH, V1, P101, DOI DOI 10.1016/J.DCN.2010.12.001; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DeMarie D, 2004, J COGN DEV, V5, P461, DOI 10.1207/s15327647jcd0504_4; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feeney TJ, 2010, J HEAD TRAUMA REHAB, V25, P416, DOI 10.1097/HTR.0b013e3181fbc0a2; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Franzen KM, 1996, CHILD NEUROPSYCHOL, V2, P176, DOI 10.1080/09297049608402250; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Goswami U, 2008, COGNITIVE DEV LEARNI; Harris JR, 1996, J COMMUN DISORD, V29, P79, DOI 10.1016/0021-9924(94)00035-2; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Haywood HC, 2007, DYNAMIC ASSESSMENT IN PRACTICE: CLINICAL AND EDUCATIONAL APPLICATIONS, P1; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Johnson MH, 2002, DEV PSYCHOPATHOL, V14, P521, DOI 10.1017/S0954579402003073; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; Krasny-Pacini A., J HEAD TRAU IN PRESS; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Lohaugen GCC, 2011, J PEDIATR-US, V158, P555, DOI 10.1016/j.jpeds.2010.09.060; Mackey AP, 2011, DEVELOPMENTAL SCI, V14, P582, DOI 10.1111/j.1467-7687.2010.01005.x; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; McDougall J, 2011, DEV NEUROREHABIL, V14, P41, DOI 10.3109/17518423.2010.521795; McDougall J, 2010, DEV NEUROREHABIL, V13, P204, DOI 10.3109/17518421003620525; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mechelli A, 2002, NEUROIMAGE, V17, P1459, DOI 10.1006/nimg.2002.1231; Medical Research Council (MRC), 2008, DEV EVALUATING COMPL; Mueller MM, 2007, PSYCHOL SCHOOLS, V44, P691, DOI 10.1002/pits.20258; Oatman-Stanford D., 2013, THESIS U EDINBURGH; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; ONeill ME, 1996, J PEDIATR PSYCHOL, V21, P73, DOI 10.1093/jpepsy/21.1.73; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Rankin Peter M, 2005, Pediatr Rehabil, V8, P283, DOI 10.1080/13638490400022436; Reid R, 2005, EXCEPT CHILDREN, V71, P361; Reis J. K., 2007, PEDIAT NEUROPSYCHOLO; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Rous R., 2012, BRAIN IMPAIR, V13, P147; Scherf KS, 2006, J COGNITIVE NEUROSCI, V18, P1045, DOI 10.1162/jocn.2006.18.7.1045; Schwenck C, 2007, CHILD DEV, V78, P1771, DOI 10.1111/j.1467-8624.2007.01090.x; Shallice T., 2011, ORG MIND; Siegler, 1996, EMERGING MINDS PROCE; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Spevack TV, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P6; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tate RL, 2008, BRAIN IMPAIR, V9, P282, DOI 10.1375/brim.9.3.282; Tomlin AM, 2003, PROF PSYCHOL-RES PR, V34, P617, DOI 10.1037/0735-7028.34.6.617; Trickey D., 2008, CHILDRENS ANXIETY CO; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson BA, 2009, DEV NEUROREHABIL, V12, P421, DOI 10.3109/17518420903200573; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, 2007, INT CLASS FUNCT DIS; Wright Ingram, 2004, Pediatr Rehabil, V7, P85, DOI 10.1080/13638490410001668758; Ylvisaker M., 2003, TECHNICAL REPORT; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891	86	22	22	2	32	TAYLOR & FRANCIS INC	PHILADELPHIA	520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2014	28	2					181	198		10.1080/13854046.2013.873083			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AB7TU	WOS:000331994400002	24498935	Green Accepted			2022-02-06	
J	Dickert, NW; Mah, VA; Biros, MH; Harney, DM; Silbergleit, R; Sugarman, J; Veledar, E; Weinfurt, KP; Wright, DW; Pentz, RD				Dickert, Neal W.; Mah, Victoria A.; Biros, Michelle H.; Harney, Deneil M.; Silbergleit, Robert; Sugarman, Jeremy; Veledar, Emir; Weinfurt, Kevin P.; Wright, David W.; Pentz, Rebecca D.			Consulting Communities When Patients Cannot Consent: A Multicenter Study of Community Consultation for Research in Emergency Settings	CRITICAL CARE MEDICINE			English	Article						bioethics; community consultation; ethics; informed consent; research in emergency settings	INFORMED-CONSENT; RESUSCITATION RESEARCH; GLUCOSE CONTROL; EXCEPTION; TRIALS; CARE; EXPERIENCE; MEDICINE; NETWORK; ILL	Objectives: To assess the range of responses to community consultation efforts conducted within a large network and the impact of different consultation methods on acceptance of exception from informed consent research and understanding of the proposed study. Design: A cognitively pretested survey instrument was administered to 2,612 community consultation participants at 12 U.S. centers participating in a multicenter trial of treatment for acute traumatic brain injury. Setting: Survey nested within community consultation for a phase III randomized controlled trial of treatment for acute traumatic brain injury conducted within a multicenter trial network and using exception from informed consent. Subjects: Adult participants in community consultation events. Interventions: Community consultation efforts at participating sites. Measurements and Main Results: Acceptance of exception from informed consent in general, attitude toward personal exception from informed consent enrollment, and understanding of the study content were assessed. Fifty-four percent of participants agreed exception from informed consent enrollment was acceptable in general in the proposed study; 71% were accepting of personal exception from informed consent enrollment. Participants in interactive versus noninteractive community consultation events were more accepting of exception from informed consent in general (63% vs 49%) and personal exception from informed consent inclusion (77% vs 67%). Interactive community consultation participants had high-level recall of study content significantly more often than noninteractive consultation participants (77% vs 67%). Participants of interactive consultation were more likely to recall possible study benefits (61% vs 45%) but less likely to recall potential risks (56% vs 69%). Conclusions: Interactive community consultation methods were associated with increased acceptance of exception from informed consent and greater overall recall of study information but lower recall of risks. There was also significant variability in exception from informed consent acceptance among different interactive consultation events. These findings have important implications for institutional review board and investigators conducting exception from informed consent research and for community engagement efforts in research more generally.	[Dickert, Neal W.] Emory Univ, Div Cardiol, Rollins Sch Publ Hlth, Sch Med,Dept Epidemiol, Atlanta, GA 30322 USA; [Dickert, Neal W.] Atlanta VA Med Ctr, Atlanta, GA USA; [Mah, Victoria A.] Emory Univ, Div Cardiol, Sch Med, Emory Clin Cardiovasc Res Inst, Atlanta, GA 30322 USA; [Biros, Michelle H.] Univ Minnesota, Sch Med, Dept Emergency Med, Minneapolis, MN 55455 USA; [Harney, Deneil M.; Silbergleit, Robert] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Berman Inst Bioeth, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Veledar, Emir] Emory Univ, Sch Med, Div Cardiol, Emory Clin Cardiovasc Inst, Atlanta, GA 30322 USA; [Veledar, Emir] Baptist Hlth South Florida, Ctr Res Grants, Miami, FL USA; [Weinfurt, Kevin P.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Dept Psychol & Neurosci,Duke Clin Res Inst, Durham, NC USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Pentz, Rebecca D.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA		Dickert, NW (corresponding author), Emory Univ, Div Cardiol, Rollins Sch Publ Hlth, Sch Med,Dept Epidemiol, Atlanta, GA 30322 USA.	njr@emory.edu	Veledar, Emir/K-2808-2012; Veledar, Emir/L-6637-2019; Wright, David/F-1209-2013	Veledar, Emir/0000-0002-3831-5433; Wright, David/0000-0002-7145-9105; Sugarman, Jeremy/0000-0001-7022-8332	ProTECT III [5U01NS062778]; Neurological Emergencies Treatment Trial Network [5U01NS056975-07]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL095358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS058994, U01NS056975, U01NS062778] Funding Source: NIH RePORTER	This project was supported, in part, by the ProTECT III (5U01NS062778) and the Neurological Emergencies Treatment Trial Network (5U01NS056975-07) awards from the National Institute of Neurological Disorders and Stroke.	Baren JM, 2007, ACAD EMERG MED, V14, P346, DOI 10.1197/j.aem.2007.01.002; Biros M, 2007, ACAD EMERG MED, V14, P344, DOI 10.1197/j.aem.2006.12.007; Biros MH, 2009, RESUSCITATION, V80, P1382, DOI 10.1016/j.resuscitation.2009.08.019; Bulger EM, 2009, ANN EMERG MED, V53, P341, DOI 10.1016/j.annemergmed.2008.07.021; Cearnal L, 2006, ANN EMERG MED, V48, P726, DOI 10.1016/j.annemergmed.2006.10.010; Clinical and Translational Science Awards Consortium, 2011, NIH PUBL, VSecond; Contant C, 2006, CRIT CARE MED, V34, P2049, DOI 10.1097/01.CCM.0000227649.72651.F1; DeIorio NM, 2007, J EMPIR RES HUM RES, V2, P23, DOI 10.1525/jer.2007.2.3.23; Dickert N, 2005, AM J PUBLIC HEALTH, V95, P1123, DOI 10.2105/AJPH.2004.058933; Dickert NW, 2013, RESUSCITATION, V84, P1416, DOI 10.1016/j.resuscitation.2013.04.006; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Govindarajan P, 2013, ACAD EMERG MED, V20, P98, DOI 10.1111/acem.12039; Holloway KFC, 2006, AM J BIOETHICS, V6, P7, DOI 10.1080/15265160600685556; Kasner SE, 2011, ANN EMERG MED, V57, P346, DOI 10.1016/j.annemergmed.2010.07.009; Lewis RJ, 2009, ANN EMERG MED, V53, P351, DOI 10.1016/j.annemergmed.2008.09.020; Lo B, 2006, CRIT CARE MED, V34, P2236, DOI 10.1097/01.CCM.0000229632.85246.3A; McClure KB, 2003, ACAD EMERG MED, V10, P352, DOI 10.1111/j.1553-2712.2003.tb01348.x; McCullough LB, 2008, CRIT CARE MED, V36, P993, DOI 10.1097/CCM.0B013E318164E9AC; Merchant RM, 2008, ACAD EMERG MED, V15, P581, DOI 10.1111/j.1553-2712.2008.00134.x; Morrison CA, 2009, J SURG RES, V157, P115, DOI 10.1016/j.jss.2009.03.051; Nelson M, 2008, PREHOSP EMERG CARE, V12, P417, DOI 10.1080/10903120802290885; Nichol G, 2004, RESUSCITATION, V62, P3, DOI 10.1016/j.resuscitation.2004.02.013; Potter JE, 2013, INTENS CARE MED, V39, P472, DOI 10.1007/s00134-012-2732-8; Ragin DF, 2008, SOC SCI MED, V66, P1379, DOI 10.1016/j.socscimed.2007.10.022; Ramsey CA, 2011, ACAD EMERG MED, V18, P733, DOI 10.1111/j.1553-2712.2011.01102.x; Richardson LD, 2005, ACAD EMERG MED, V12, P1064, DOI 10.1197/j.aem.2005.06.018; Schmidt TA, 2003, ANN EMERG MED, V41, P79, DOI 10.1067/mem.2003.17; Silbergleit R, 2012, ACAD EMERG MED, V19, P448, DOI 10.1111/j.1553-2712.2012.01328.x; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494; Sugarman J, 2009, RESUSCITATION, V80, P644, DOI 10.1016/j.resuscitation.2009.03.015; US Department of Health & Human Services, 2011, GUID I REV BOARDS CL; Willis GBJRTP, 1999, COGNITIVE INTERVIEWI; Wright DW, 2008, ANN EMERG MED, V51, P355, DOI 10.1016/j.annemergmed.2007.08.021	33	22	22	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2014	42	2					272	280		10.1097/CCM.0b013e3182a27759			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291WS	WOS:000329863400022	24145834	Green Accepted			2022-02-06	
J	Jeffcote, T; Hinzman, JM; Jewell, SL; Learney, RM; Pahl, C; Tolias, C; Walsh, DC; Hocker, S; Zakrzewska, A; Fabricius, ME; Strong, AJ; Hartings, JA; Boutelle, MG				Jeffcote, Toby; Hinzman, Jason M.; Jewell, Sharon L.; Learney, Robert M.; Pahl, Clemens; Tolias, Christos; Walsh, Daniel C.; Hocker, Sara; Zakrzewska, Agnieszka; Fabricius, Martin E.; Strong, Anthony J.; Hartings, Jed A.; Boutelle, Martyn G.			Detection of Spreading Depolarization with Intraparenchymal Electrodes in the Injured Human Brain	NEUROCRITICAL CARE			English	Article						Cortical spreading depolarization; Traumatic brain injury; Secondary brain injury	UNITED-STATES; ISCHEMIA; DEPRESSION; STROKE; VASOSPASM	Spreading depolarization events following ischemic and traumatic brain injury are associated with poor patient outcome. Currently, monitoring these events is limited to patients in whom subdural electrodes can be placed at open craniotomy. This study examined whether these events can be detected using intra-cortical electrodes, opening the way for electrode insertion via burr hole. Animal work was carried out on adult Sprague-Dawley rats in a laboratory setting to investigate the feasibility of recording depolarization events. Subsequently, 8 human patients requiring craniotomy for traumatic brain injury or aneurysmal subarachnoid hemorrhage were monitored for depolarization events in an intensive care setting with concurrent strip (subdural) and depth (intra-parenchymal) electrode recordings. (1) Depolarization events can be reliably detected from intra-cortically placed electrodes. (2) A reproducible slow potential change (SPC) waveform morphology was identified from intra-cortical electrodes on the depth array. (3) The depression of cortical activity known to follow depolarization events was identified consistently from both intra-cortical and sub-cortical electrodes on the depth array. Intra-parenchymally sited electrodes can be used to consistently identify depolarization events in humans. This technique greatly extends the capability of monitoring for spreading depolarization events in injured patients, as electrodes can be sited without the need for craniotomy. The method provides a new investigative tool for the evaluation of the contribution of these events to secondary brain injury in human patients.	[Jeffcote, Toby; Tolias, Christos; Walsh, Daniel C.; Zakrzewska, Agnieszka] Kings Coll Hosp London, Dept Neurosurg, London, England; [Jeffcote, Toby; Learney, Robert M.; Boutelle, Martyn G.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Hinzman, Jason M.; Hartings, Jed A.] Univ Cincinnati, UC Coll Med, Inst Neurosci, Dept Neurosurg, Cincinnati, OH USA; [Jewell, Sharon L.] Kings Coll Hosp London, Dept Neurophysiol, London, England; [Pahl, Clemens] Kings Coll Hosp London, Dept Intens Care Med, London, England; [Hocker, Sara] Mayo Clin, Div Crit Care Neurol, Rochester, MN USA; [Fabricius, Martin E.] Rigshosp, Dept Clin Neurophysiol, DK-2100 Copenhagen, Denmark; [Strong, Anthony J.] Kings Coll London, Inst Psychiat, Dept Acad Neurosurg, London, England		Boutelle, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	jed.hartings@uc.edu; m.boutelle@imperial.ac.uk	Walsh, Daniel/AAZ-1875-2020; Jeffcote, Toby/AAP-7945-2021	Hartings, Jed/0000-0001-8583-3471; Learney, Robert/0000-0003-2870-6120	Wellcome Trust/Department of Health Healthcare Innovation Challenge Fund [HICF-1010-080]; U.S. Army CDMRP PH/TBI Research Program [W81XWH-08-2-0016]; Mayfield Education and Research Foundation	This work was funded in part by a Wellcome Trust/Department of Health Healthcare Innovation Challenge Fund (Grant HICF-1010-080) and in part by the U.S. Army CDMRP PH/TBI Research Program (contract number W81XWH-08-2-0016) and the Mayfield Education and Research Foundation. We thank Chi Leng Leong for help with the figures. All animal work was carried out at the University of Cincinnati. All human clinical investigations were carried out at Kings College Hospital, London, UK.	Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROPHYSIOL, V102, P2563, DOI 10.1152/jn.00345.2009; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Menon DK, 2003, ANESTHESIOLOGY, V98, P805, DOI 10.1097/00000542-200304000-00002; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2005, CRIT CARE MED, V33, P2147, DOI 10.1097/01.CCM.0000179029.95415.51; Stuart RM, 2010, NEUROCRIT CARE, V13, P355, DOI 10.1007/s12028-010-9414-6; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169	29	22	22	0	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2014	20	1					21	31		10.1007/s12028-013-9938-7			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AB2RI	WOS:000331639400004	24343564				2022-02-06	
J	Mechtler, LL; Shastri, KK; Crutchfield, KE				Mechtler, Laszlo L.; Shastri, Kalyan K.; Crutchfield, Kevin E.			Advanced Neuroimaging of Mild Traumatic Brain Injury	NEUROLOGIC CLINICS			English	Article						Mild traumatic brain injury; Concussion; Diffuse axonal injury; Diffusion tensor imaging; Susceptibility-weighted imaging; Magnetic resonance spectroscopy	DIFFUSE AXONAL INJURY; CT HEAD RULE; MAGNETIC-RESONANCE SPECTROSCOPY; PROTON MR SPECTROSCOPY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; WHITE-MATTER; COGNITIVE IMPAIRMENT; CEREBRAL MICROBLEEDS; FUNCTIONAL NETWORKS	This article focuses on advancements in neuroimaging techniques, compares the advantages of each of the modalities in the evaluation of mild traumatic brain injury, and discusses their contribution to our understanding of the pathophysiology as it relates to prognosis. Advanced neuroimaging techniques discussed include anatomic/structural imaging techniques, such as diffusion tensor imaging and susceptibility-weighted imaging, and functional imaging techniques, such as functional magnetic resonance imaging, perfusion-weighted imaging, magnetic resonance spectroscopy, and positron emission tomography.	[Mechtler, Laszlo L.] SUNY Buffalo, Dept Neurol & Neurooncol, Buffalo, NY 14223 USA; [Mechtler, Laszlo L.; Shastri, Kalyan K.] Dent Neurol Inst, Amherst, NY 14226 USA; [Crutchfield, Kevin E.] Sandra & Malcolm Berman Brain & Spine Inst, Comprehens Sports Concuss Program, Baltimore, MD 21209 USA		Mechtler, LL (corresponding author), Dent Neurol Inst, 3980A Sheridan Dr,Suite 101, Amherst, NY 14226 USA.	lmechtler@dentinstitute.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Almandoz JED, 2010, RADIOLOGY, V254, P236, DOI 10.1148/radiol.09090693; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; American College of Radiology, 1996, ACR APPR CRIT HEAD T; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, HEADS CONC; Chen HF, 2004, BRAIN TOPOGR, V17, P39, DOI 10.1023/B:BRAT.0000047335.00110.6a; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Delfaut EM, 1999, RADIOGRAPHICS, V19, P373, DOI 10.1148/radiographics.19.2.g99mr03373; Depreitere B, 2008, ACTA NEUROCHIR SUPPL, V102, P259, DOI 10.1007/978-3-211-85578-2_49; Duckworth JL, 2010, CURR OPIN CRIT CARE, V16, P92, DOI 10.1097/MCC.0b013e3283374900; Enterline DS, 2006, TECH VASC INTERV RAD, V9, P192, DOI 10.1053/j.tvir.2007.03.003; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; King MA, 2009, PEDIATR RADIOL, V39, P1059, DOI 10.1007/s00247-009-1327-1; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Li X, 2012, NEUROIMAGE, V62, P314, DOI 10.1016/j.neuroimage.2012.04.042; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling Geoffrey S F, 2010, Continuum (Minneap Minn), V16, P27, DOI 10.1212/01.CON.0000391451.30299.bc; Liu CL, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00011; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCullough BJ, 2011, PHYS MED REH CLIN N, V22, P635, DOI 10.1016/j.pmr.2011.08.005; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Institute for Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shah NB, 2008, CURR OPIN PEDIATR, V20, P243, DOI 10.1097/MOP.0b013e3282ffafd2; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stein S. C., 1996, NEUROTRAUMA, P31; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wiest PW, 2002, SEMIN ULTRASOUND CT, V23, P402, DOI 10.1016/S0887-2171(02)90011-9; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; World Health Organization, 2012, INT CLASS DIS REL HL; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	111	22	25	0	29	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	FEB	2014	32	1					31	+		10.1016/j.ncl.2013.08.002			29	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	278VI	WOS:000328917600003	24287384				2022-02-06	
J	Menon, K; Ward, R				Menon, Kusum; Ward, Roxanne		Canadian Critical Care Trials Grp	A study of consent for participation in a non-therapeutic study in the pediatric intensive care population	JOURNAL OF MEDICAL ETHICS			English	Article						Children; Research Ethics; Research on Special Populations; Informed Consent; Minors; Parental Consent	TRAUMATIC BRAIN-INJURY; CLINICAL-RESEARCH; UNIT; TRIALS; CHALLENGES; EMERGENCY; ADMISSION	Objective To document the legal guardian-related barriers to consent procurement, and their stated reasons for non-participation in a paediatric critical care research study. Study design A multicentre, prospective, cohort study. Participants Legal guardians of children who participated in a multicentre study on adrenal insufficiency in paediatric critical illness. Data were collected on all consent encounters in the main study. Methods Screening data, reasons for consent not being obtained, paediatric risk of mortality (illness severity) scores and age were collected on all 1707 patients eligible for participation in the Adrenal Insufficiency Study. Results The main barriers to approaching legal guardians for consent were lack of availability of the legal guardians (321/1707) and language barriers (84/1707). Legal guardians of 917 patients were approached with an overall consent rate of 42% (range 14-56% across the seven sites). 81% of the 528 legal guardians who declined consent provided an unsolicited reason for refusal. The three most commonly stated reasons were: being overwhelmed (117/429), not wanting anything else done to their child (63/429) and not wanting an additional medication (53/429). In addition, 14.2% cited research-related concerns as the reason for their non-participation. Conclusions Barriers to consent procurement in a non-therapeutic paediatric critical care study appear to occur at many levels with lack of availability of legal guardians, and legal guardians feeling overwhelmed, being the most commonly recorded reasons. Further research into the impact of these findings on the validity and generalisability of the results of such studies is necessary prior to the development and study of future consent models.	[Menon, Kusum] Childrens Hosp Eastern Ontario, Dept PICU, Ottawa, ON K1H 8L1, Canada; [Ward, Roxanne] CHEORI, Dept Pediat, Ottawa, ON, Canada		Menon, K (corresponding author), Childrens Hosp Eastern Ontario, Dept PICU, Ottawa, ON K1H 8L1, Canada.	menon@cheo.on.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	This study and the original AIP study were funded by the Canadian Institutes for Health Research which had no role in the design, implementation, analysis or write-up of this manuscript.	Ballard Hubert O, 2004, J Perinatol, V24, P409, DOI 10.1038/sj.jp.7211142; Baren JM, 1999, ACAD EMERG MED, V6, P1210, DOI 10.1111/j.1553-2712.1999.tb00135.x; Board R, 2002, HEART LUNG, V31, P53, DOI 10.1067/mhl.2002.121246; Breslow N. E., 1987, STAT METHODS CANC RE, VII; Burgess E, 2003, ARCH DIS CHILD-FETAL, V88, P280; Campbell H, 1998, ARCH DIS CHILD, V79, P192, DOI 10.1136/adc.79.2.192; Choong K, 2009, AM J RESP CRIT CARE, V180, P632, DOI 10.1164/rccm.200902-0221OC; Glickman SW, 2008, ANN EMERG MED, V51, P775, DOI 10.1016/j.annemergmed.2007.11.002; Huckabay L M, 1999, Dimens Crit Care Nurs, V18, P36, DOI 10.1097/00003465-199903000-00009; Hulst JM, 2005, INTENS CARE MED, V31, P880, DOI 10.1007/s00134-005-2647-8; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Menon K, 2012, INTENS CARE MED, V38, P153, DOI 10.1007/s00134-011-2412-0; Menon K, 2010, AM J RESP CRIT CARE, V182, P246, DOI 10.1164/rccm.200911-1738OC; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Needle JS, 2009, PEDIATR CRIT CARE ME, V10, P668, DOI 10.1097/PCC.0b013e3181a706c9; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Preissig CM, 2010, CRIT CARE, V14, DOI 10.1186/cc8865; Raymond TT, 2010, PEDIATRICS, V125, pE866, DOI 10.1542/peds.2009-2427; Rees G, 2004, INTENS CARE MED, V30, P1607, DOI 10.1007/s00134-004-2310-9; Simon CM, 2004, J CLIN ONCOL, V22, P2708, DOI 10.1200/JCO.2004.10.034; Singhal Nalini, 2002, J Perinatol, V22, P57, DOI 10.1038/sj.jp.7210608; Stenson BJ, 2004, ARCH DIS CHILD-FETAL, V89, pF321, DOI 10.1136/adc.2002.021931; Sturdivant L, 2009, CRIT CARE NURS Q, V32, P149, DOI 10.1097/CNQ.0b013e3181a27f6d	24	22	22	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	FEB	2014	40	2					123	126		10.1136/medethics-2012-101075			4	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	AA5ZA	WOS:000331177200015	23345569				2022-02-06	
J	Ponsford, J; Kelly, A; Couchman, G				Ponsford, Jennie; Kelly, Amber; Couchman, Grace			Self-concept and self-esteem after acquired brain injury: A control group comparison	BRAIN INJURY			English	Article						Traumatic brain injury; self-concept; self-esteem	PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; HEAD-INJURY; BODY-IMAGE; REHABILITATION; STROKE; PSYCHOTHERAPY; FREQUENCY; VALIDITY	Primary objective: This study examined the multidimensional self-concept, global self-esteem and psychological adjustment of individuals with traumatic brain injury (TBI) as compared with healthy controls. Research design: Group comparison on self-report questionnaires. Methods and procedures: Forty-one individuals who had sustained a TBI were compared with an age-and gender-matched sample of 41 trauma-free control participants on the Rosenberg Self Esteem Scale, the Tennessee Self Concept Scale (second edition) and the Hospital Anxiety and Depression Scales (HADS). Main outcomes and results: Participants with TBI rated significantly lower mean levels of global self-esteem and self-concept on the Rosenberg Self Esteem Scale and Tennessee Self Concept Scale than the control group. Survivors of TBI rated themselves more poorly on a range of self-dimensions, including social, family, academic/work and personal self-concept compared to controls. They also reported higher mean levels of depression and anxiety on the Hospital Anxiety and Depression Scale. Overall self-concept was most strongly associated with depressive symptoms and anxiety. Conclusions: Self-concept may be lowered following TBI and is associated with negative emotional consequences. Clinicians may improve the emotional adjustment of survivors of TBI by considering particular dimensions of self-concept for intervention focus.	[Ponsford, Jennie; Kelly, Amber; Couchman, Grace] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Bld 17,Wellington Rd, Clayton, Vic, Australia.	jennie.ponsford@monash.edu					Battle J., 1992, CULTURE FREE SELF ES, V2nd; Ben-Yishay Y, 2008, NEUROPSYCHOL REHABIL, V18, P513, DOI 10.1080/09602010802141525; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bracken B., 1992, MULTIDIMENSIONAL SEL; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Coopersmith, 1967, ANTECEDENTS SELF EST; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Davison KK, 2001, PEDIATRICS, V107, P46, DOI 10.1542/peds.107.1.46; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Draper K, 2007, NEUROPSYCHOL REHABIL, V19, P645; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; Fidell L.S., 2001, USING MULTIVARIATE S; Fitts WH, 1992, TENNESSEE SELFCONCEP; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Howes HFR, 2005, BRAIN INJURY, V19, P403, DOI 10.1080/02699050400025158; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; KRAVETZ S, 1995, BRAIN INJURY, V9, P131, DOI 10.3109/02699059509008186; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LITTLEFIELD CH, 1992, DIABETES CARE, V15, P90, DOI 10.2337/diacare.15.1.90; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; MCGUIRE B, 1981, APPL PSYCH MEAS, V5, P449, DOI 10.1177/014662168100500402; PELHAM BW, 1989, J PERS SOC PSYCHOL, V57, P672, DOI 10.1037/0022-3514.57.4.672; Piers EV, 1991, PIERS HARRIS CHILDRE; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350; ROSENBERG M, 1989, SOC FORCES, V68, P34, DOI 10.2307/2579218; Rosenberg M., 1965, SOC ADOLESCENT SELF; Snaith R., 1994, HOSP ANXIETY DEPRESS; Snaith RP, 1994, HADS HOSP ANXIETY DE; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Vickery CD, 2008, CLIN REHABIL, V22, P179, DOI 10.1177/0269215507080142; Vickery CD, 2008, REHABIL PSYCHOL, V53, P101, DOI 10.1037/0090-5550.53.1.101; Vickery CD, 2006, CLIN REHABIL, V20, P1075, DOI 10.1177/0269215506071269; Walsh JA, 1989, CRIM JUSTICE BEHAV, V13, P50; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x	48	22	22	2	42	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					146	154		10.3109/02699052.2013.859733			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900003	24456054				2022-02-06	
J	Wong, JYH; Choi, AWM; Fong, DYT; Wong, JKS; Lau, CL; Kam, CW				Wong, Janet Yuen-Ha; Choi, Anna Wai-Man; Fong, Daniel Yee-Tak; Wong, John Kit-Shing; Lau, Chu-Leung; Kam, Chak-Wah			Patterns, aetiology and risk factors of intimate partner violence-related injuries to head, neck and face in Chinese women	BMC WOMENS HEALTH			English	Article						Head injuries; Maxillofacial injuries; Intimate partner violence; Abused Chinese women	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; BATTERED WOMEN; EMERGENCY-DEPARTMENT; SEVERITY SCORE; VICTIMS; POPULATION; MARRIAGES; ABUSE; STAY	Background: Intimate partner violence (IPV) related injuries have been recognized among health care professionals. However, few studies have provided detailed information on injuries to the head, neck and face regions in Chinese women. As abused Chinese women are generally unwilling to disclose IPV and there are differences in socio-demographic characteristics, societal norms and behaviours, the women may exhibit different patterns, aetiology and risk factors of IPV-related HNF injuries. This study aims to examine the patterns of head, neck and face injuries presenting to Accident and Emergency departments, including the anatomical regions, types, severity, aetiology and demographic and non-demographic risk factors of injuries inflicted by intimate partners in Chinese context. Methods: Medical charts of 223 women presented to the Accident and Emergency departments of two regional hospitals in Hong Kong between January 2010 and December 2011 were reviewed independently by two reviewers. Results: Head, neck and face injuries remained the most common injuries found in abused Chinese women (77.6%), and punching with a fist was the most common aetiology (60.2%). In particular, punching with a fist was significantly associated on the upper third of the maxillofacial region (p = .01) and the back part of the head (p = .03). Moreover, cohabiting and separated women were more likely to have multiple injuries than those who were married (OR = 3.3, 95% CI = 1.4, 7.8; OR = 2.1, 95% CI = .4, 11.9). Conclusions: The findings enhance the understanding of head, neck and face injuries and inform clinicians about the linkage among injuries and risks in abused Chinese women.	[Wong, Janet Yuen-Ha; Fong, Daniel Yee-Tak] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Pokfulam, Hong Kong, Peoples R China; [Choi, Anna Wai-Man] Univ Hong Kong, Fac Social Sci, Dept Social Work & Social Adm, Pokfulam, Hong Kong, Peoples R China; [Wong, John Kit-Shing; Kam, Chak-Wah] Tuen Mun Hosp, Dept Accid & Emergency Med, Tuen Mun, Hong Kong, Peoples R China; [Lau, Chu-Leung] Pok Oi Hosp, Dept Accid & Emergency Med, Yuen Long, Hong Kong, Peoples R China		Wong, JYH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, 4-F,William MW Mong Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	janetyh@hku.hk	Wong, Janet Yuen Ha/F-4433-2011; Fong, Daniel YT/C-4269-2009; Choi, Wai Man/F-9776-2012	Wong, Janet Yuen Ha/0000-0002-3000-4577; Fong, Daniel YT/0000-0001-7365-9146; Choi, Wai Man/0000-0002-9341-8515			Amon M, 2006, J TRAUMA, V61, P924, DOI 10.1097/01.ta.0000195979.25659.fe; [Anonymous], 2011, STAT NEWL REP CHILD; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BEVERLAND DE, 1983, INJURY, V15, P19, DOI 10.1016/0020-1383(83)90156-0; Bhandari M, 2006, J TRAUMA, V61, P1473, DOI 10.1097/01.ta.0000196419.36019.5a; Brownridge, 2009, OPEN SOCIAL SCI J, V2, P32, DOI DOI 10.2174/1874945300902010032; Campbell JC, 2004, J INTERPERS VIOLENCE, V19, P1464, DOI 10.1177/0886260504269698; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; CDC, 2003, HEADS FACTS PHYS MIL; *CDCP, 2003, HEADS BRAIN INJ YOUR; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Dolezal T., 2009, HIDDEN COSTS HLTH CA; Hedlund GL, 2009, FORENSIC SCI MED PAT, V5, P280, DOI 10.1007/s12024-009-9132-6; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kenney CT, 2006, DEMOGRAPHY, V43, P127, DOI 10.1353/dem.2006.0007; Kim J, 2008, J INTERPERS VIOLENCE, V23, P1465, DOI 10.1177/0886260508314307; Kothari CL, 2006, ANN EMERG MED, V47, P190, DOI 10.1016/j.annemergmed.2005.10.016; Lam CLK, 2002, SOC SCI MED, V55, P1635, DOI 10.1016/S0277-9536(01)00296-9; Lau C. L., 2008, Hong Kong Medical Journal, V14, P451; Le BT, 2001, J ORAL MAXIL SURG, V59, P1277, DOI 10.1053/joms.2001.27490; Lemeshow S, 2000, APPL LOGISTIC REGRES; Logan TK, 2004, J INTERPERS VIOLENCE, V19, P1478, DOI 10.1177/0886260504269699; Meyer S, 2012, AUST NZ J CRIMINOL, V45, P179, DOI 10.1177/0004865812443677; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; Muelleman RL, 1996, ANN EMERG MED, V28, P486, DOI 10.1016/S0196-0644(96)70110-5; Osborne JW, 2004, PRACTICAL ASSESSMENT, V9; Roberts AC, 1998, PREFRONTAL CORTEX EX; Romans S, 2007, J INTERPERS VIOLENCE, V22, P1495, DOI 10.1177/0886260507306566; Saddki N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-268; Saltzman L.E., 2002, INTIMATE PARTNER VIO; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Thompson RS, 2006, AM J PREV MED, V30, P447, DOI 10.1016/j.amepre.2006.01.016; Tiwari A, 2001, Can J Nurs Res, V33, P63; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Ulrich YC, 2003, AM J PREV MED, V24, P9, DOI 10.1016/S0749-3797(02)00577-9; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5; World Health Organization, 2013, RESPONDING INTIMATE; World Health Organization, 2002, WORLD REPORT VIOLENC; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Yuen-Tsang A, 2005, AFFILIA J WOM SOC WO, V20, P284, DOI 10.1177/0886109905277614	44	22	25	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6874			BMC WOMENS HEALTH	BMC Womens Health	JAN 10	2014	14								6	10.1186/1472-6874-14-6			9	Public, Environmental & Occupational Health; Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Obstetrics & Gynecology	AB7NI	WOS:000331976800001	24410868	Green Published, gold			2022-02-06	
J	Cha, Y; Kim, Y; Hwang, S; Chung, Y				Cha, Yuri; Kim, Young; Hwang, Sujin; Chung, Yijung			Intensive gait training with rhythmic auditory stimulation in individuals with chronic hemiparetic stroke: A pilot randomized controlled study	NEUROREHABILITATION			English	Article						Gait; rhythmic auditory stimulation; stroke	TRAUMATIC BRAIN-INJURY; BALANCE SCALE; REHABILITATION; RELIABILITY; PERFORMANCE; MODEL	BACKGROUND: Motor relearning protocols should involve task-oriented movement, focused attention, and repetition of desired movements. OBJECTIVES: To investigate the effect of intensive gait training with rhythmic auditory stimulation on postural control and gait performance in individuals with chronic hemiparetic stroke. METHODS: Twenty patients with chronic hemiparetic stroke participated in this study. Subjects in the Rhythmic auditory stimulation training group (10 subjects) underwent intensive gait training with rhythmic auditory stimulation for a period of 6 weeks (30 min/day, five days/week), while those in the control group (10 subjects) underwent intensive gait training for the same duration. Two clinical measures, Berg balance scale and stroke specific quality of life scale, and a 2-demensional gait analysis system, were used as outcome measure. To provide rhythmic auditory stimulation during gait training, the MIDI Cuebase musical instrument digital interface program and a KM Player version 3.3 was utilized for this study. RESULTS: Intensive gait training with rhythmic auditory stimulation resulted in significant improvement in scores on the Berg balance scale, gait velocity, cadence, stride length and double support period in affected side, and stroke specific quality of life scale compared with the control group after training. CONCLUSIONS: Findings of this study suggest that intensive gait training with rhythmic auditory stimulation improves balance and gait performance as well as quality of life, in individuals with chronic hemiparetic stroke.	[Cha, Yuri; Kim, Young] Sahmyook Univ, Dept Phys Therapy, Grad Sch, Seoul 139800, South Korea; [Hwang, Sujin] Baekseok Univ, Div Hlth Sci, Dept Phys Therapy, Cheonan, South Korea; [Chung, Yijung] Sahmyook Univ, Dept Phys Therapy, Coll Hlth & Welfare, Seoul 139800, South Korea		Chung, Y (corresponding author), Sahmyook Univ, Dept Phys Therapy, Coll Hlth & Welfare, POB Hwarangro 815, Seoul 139800, South Korea.	yijung36@syu.ac.kr		Chung, Yijung/0000-0002-2431-8895			BERG K, 1995, SCAND J REHABIL MED, V27, P27; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Conesa L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-13; Conklyn D, 2010, NEUROREHAB NEURAL RE, V24, P835, DOI 10.1177/1545968310372139; Daly JJ, 2007, THESCIENTIFICWORLDJO, V7, P2031, DOI 10.1100/tsw.2007.299; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; Dobkin BH, 2003, CLIN SCI NEUROLOGIC; Dy SM, 2012, J GEN INTERN MED, V27, P760, DOI 10.1007/s11606-012-2054-0; Fernandez-Concepcion O, 2005, REV NEUROLOGIA, V41, P391, DOI 10.33588/rn.4107.2005156; Fritz S, 2011, J NEUROL PHYS THER, V35, P141, DOI 10.1097/NPT.0b013e31822a2a09; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; Kadivar Z, 2011, NEUROREHAB NEURAL RE, V25, P626, DOI 10.1177/1545968311401627; Kim SJ, 2012, CLIN REHABIL, V26, P904, DOI 10.1177/0269215511434648; Kuys SS, 2011, DISABIL REHABIL, V33, P1848, DOI 10.3109/09638288.2010.549895; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Malcolm MP, 2009, TOP STROKE REHABIL, V16, P69, DOI 10.1310/tsr1601-69; Mergner T, 2003, PROG BRAIN RES, V142, P189; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Schauer M, 2003, CLIN REHABIL, V17, P713, DOI 10.1191/0269215503cr668oa; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Thaut AH, 2007, NEUROREHAB NEURAL RE, V21, P455, DOI 10.1177/1545968307300523; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362	24	22	25	1	22	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	4					681	688		10.3233/NRE-141182			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW4HK	WOS:000346241600006	25318784				2022-02-06	
J	Conley, YP; Okonkwo, DO; Deslouches, S; Alexander, S; Puccio, AM; Beers, SR; Ren, DAX				Conley, Yvette P.; Okonkwo, David O.; Deslouches, Sandra; Alexander, Sheila; Puccio, Ava M.; Beers, Sue R.; Ren, Dianxu			Mitochondrial Polymorphisms Impact Outcomes after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; mitochondria; outcome; polymorphism; TBI	PARKINSONS-DISEASE; INCREASED RISK; STRUCTURED INTERVIEWS; ALLELE 4216C; HEAD-INJURY; RAT-BRAIN; DYSFUNCTION; DNA; CELLS; ASSOCIATION	Patient outcomes are variable following severe traumatic brain injury (TBI); however, the biological underpinnings explaining this variability are unclear. Mitochondrial dysfunction after TBI is well documented, particularly in animal studies. The aim of this study was to investigate the role of mitochondrial polymorphisms on mitochondrial function and patient outcomes out to 1 year after a severe TBI in a human adult population. The Human MitoChip V2.0 was used to evaluate mitochondrial variants in an initial set of n=136 subjects. SNPs found to be significantly associated with patient outcomes [Glasgow Outcome Scale (GOS), Neurobehavioral Rating Scale (NRS), Disability Rating Scale (DRS), in-hospital mortality, and hospital length of stay] or neurochemical level (lactate:pyruvate ratio from cerebrospinal fluid) were further evaluated in an expanded sample of n=336 subjects. A10398G was associated with DRS at 6 and 12 months (p=0.02) and a significant time by SNP interaction for DRS was found (p=0.0013). The A10398 allele was associated with greater disability over time. There was a T195C by sex interaction for GOS (p=0.03) with the T195 allele associated with poorer outcomes in females. This is consistent with our findings that the T195 allele was associated with mitochondrial dysfunction (p=0.01), but only in females. This is the first study associating mitochondrial DNA variation with both mitochondrial function and neurobehavioral outcomes after TBI in humans. Our findings indicate that mitochondrial DNA variation may impact patient outcomes after a TBI potentially by influencing mitochondrial function, and that sex of the patient may be important in evaluating these associations in future studies.	[Conley, Yvette P.; Deslouches, Sandra; Alexander, Sheila; Ren, Dianxu] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Beers, Sue R.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA		Conley, YP (corresponding author), Univ Pittsburgh, Sch Nursing, Grad Sch Publ Hlth, 440 Victoria Bldg,3500 Victoria St, Pittsburgh, PA 15261 USA.	yconley@pitt.edu		Conley, Yvette/0000-0002-1784-6067	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NR008424, P50NS30318, R01NR013342]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424, R01NR013342] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (grant numbers R01NR008424; P50NS30318; and R01NR013342).	Araujo GW, 2008, J NEUROENDOCRINOL, V20, P930, DOI 10.1111/j.1365-2826.2008.01747.x; Arnold S, 2008, J MOL ENDOCRINOL, V41, P289, DOI 10.1677/JME-08-0085; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BETTINI E, 1992, J NEUROCHEM, V58, P1923, DOI 10.1111/j.1471-4159.1992.tb10070.x; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; Chen JQ, 1998, CARCINOGENESIS, V19, P2187, DOI 10.1093/carcin/19.12.2187; Chen JQ, 2003, TOXICOL SCI, V75, P271, DOI 10.1093/toxsci/kfg183; Cook AM, 2009, EXPERT OPIN DRUG SAF, V8, P411, DOI 10.1517/14740330903066742; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DITUNNO JF, 1992, J NEUROTRAUM, V9, pS301; Farace E, 2000, Neurosurg Focus, V8, pe6; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaweda-Walerych K, 2008, J NEURAL TRANSM, V115, P1521, DOI 10.1007/s00702-008-0121-9; Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276; Gomez R, 2009, J TRAUMA, V66, P850, DOI 10.1097/TA.0b013e3181991ac8; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Holt I. J, 1994, MITOCHONDRIA DNA PRO, P27; Hoofien D, 2001, BRAIN INJURY, V15, P189; Huebinger RM, 2010, SHOCK, V33, P19, DOI 10.1097/SHK.0b013e3181a99508; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kirchner SC, 2000, NEUROTOXICOLOGY, V21, P441; Lemasters JJ, 1999, J BIOENERG BIOMEMBR, V31, P305, DOI 10.1023/A:1005419617371; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Mattson MP, 1997, NEUROREPORT, V8, P3817, DOI 10.1097/00001756-199712010-00031; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nilsen J, 2007, J NEUROSCI, V27, P14069, DOI 10.1523/JNEUROSCI.4391-07.2007; Nilsen J, 2004, CNS NEUROL DISORD-DR, V3, P297, DOI 10.2174/1568007043337193; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; VANITALLIE CM, 1988, MOL ENDOCRINOL, V2, P332, DOI 10.1210/mend-2-4-332; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Zheng JB, 1999, J STEROID BIOCHEM, V68, P65, DOI 10.1016/S0960-0760(98)00161-7; Zheng JB, 1999, EUR J PHARMACOL, V368, P95, DOI 10.1016/S0014-2999(99)00012-6	55	22	22	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2014	31	1					34	41		10.1089/neu.2013.2855			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	302WJ	WOS:000330635500004	23883111	Green Published			2022-02-06	
J	Di Pietro, V; Amorini, AM; Tavazzi, B; Vagnozzi, R; Logan, A; Lazzarino, G; Signoretti, S; Lazzarino, G; Belli, A				Di Pietro, Valentina; Amorini, Angela Maria; Tavazzi, Barbara; Vagnozzi, Roberto; Logan, Ann; Lazzarino, Giacomo; Signoretti, Stefano; Lazzarino, Giuseppe; Belli, Antonio			The Molecular Mechanisms Affecting N-Acetylaspartate Homeostasis Following Experimental Graded Traumatic Brain Injury	MOLECULAR MEDICINE			English	Article							ACETYL-L-ASPARTATE; CENTRAL-NERVOUS-SYSTEM; TEMPORAL WINDOW; MITOCHONDRIAL; ASPARTOACYLASE; VULNERABILITY; CONCUSSIONS; DAMAGE; MODEL; NAA	To characterize the molecular mechanisms of N-acetylaspartate (NAA) metabolism following traumatic brain injury (TBI), we measured the NAA, adenosine triphosphate (ATP) and adenosine diphosphate (ADP) concentrations and calculated the ATP/ADP ratio at different times from impact, concomitantly evaluating the gene and protein expressions controlling NAA homeostasis (the NAA synthesizing and degrading enzymes N-acetyltransferase 8-like and aspartoacylase, respectively) in rats receiving either mild or severe TBI. The reversible changes in NAA induced by mild TBI were due to a combination of transient mitochondrial malfunctioning with energy crisis (decrease in ATP and in the ATP/ADP ratio) and modulation in the gene and protein levels of N-acetyltransferase 8-like and increase of aspartoacylase levels. The irreversible decrease in NAA following severe TBI, was instead characterized by profound mitochondrial malfunctioning (constant 65% decrease of the ATP/ADP indicating permanent impairment of the mitochondrial phosphorylating capacity), dramatic repression of the N-acetyltransferase 8-like gene and concomitant remarkable increase in the aspartoacylase gene and protein levels. The mechanisms underlying changes in NAA homeostasis following graded TBI might be of note for possible new therapeutic approaches and will help in understanding the effects of repeat concussions occurring during particular periods of the complex NAA recovery process, coincident with the so called window of brain vulnerability.	[Di Pietro, Valentina; Logan, Ann; Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Neuropharmacol & Neurobiol Sect, Birmingham, W Midlands, England; [Amorini, Angela Maria; Tavazzi, Barbara; Lazzarino, Giacomo] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, I-00168 Rome, Italy; [Vagnozzi, Roberto] Univ Roma Tor Vergata, Dept Biomed & Prevent, Neurosurg Sect, Rome, Italy; [Signoretti, Stefano] San Camillo Hosp, Dept Neurosci Head & Neck Surg, Div Neurosurg, Rome, Italy; [Lazzarino, Giuseppe] Univ Catania, Dept Biol Geol & Environm Sci, Div Biochem & Mol Biol, Catania, Italy		Tavazzi, B (corresponding author), Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Largo F Vito 1, I-00168 Rome, Italy.	btavazzi@rm.unicatt.it	Signoretti, stefano/AAL-5631-2020; TAVAZZI, BARBARA/AAB-9830-2019; Belli, Antonio/I-3799-2015; lazzarino, giuseppe/K-2277-2015	Signoretti, stefano/0000-0002-8086-1622; TAVAZZI, BARBARA/0000-0001-8743-0895; Belli, Antonio/0000-0002-3211-9933; Di Pietro, Valentina/0000-0001-9430-4723; lazzarino, giuseppe/0000-0002-5917-7279; AMORINI, Angela Maria/0000-0003-3525-9955; Logan, Ann/0000-0003-3215-5042; Lazzarino, Giacomo/0000-0003-1639-0966	University of Catania; University of Rome Tor Vergata; Catholic University of Rome	This work was done at The Institute of Biochemistry and Clinical Biochemistry, Catholic University of Rome, Rome, Italy and The Neuropharmacology and Neurobiology Section, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. This work was supported in part by research funds of the University of Catania, University of Rome Tor Vergata and Catholic University of Rome.	Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Amaral Ana I, 2013, Front Endocrinol (Lausanne), V4, P54, DOI 10.3389/fendo.2013.00054; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Arun P, 2009, NEUROCHEM INT, V55, P219, DOI 10.1016/j.neuint.2009.03.003; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Benarroch EE, 2008, NEUROLOGY, V70, P1353, DOI 10.1212/01.wnl.0000311267.63292.6c; Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104; Clark JF, 2006, MED HYPOTHESES, V67, P506, DOI 10.1016/j.mehy.2006.02.047; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Jessen F, 2011, J ALZHEIMERS DIS, V27, P393, DOI 10.3233/JAD-2011-110398; Kamada Kyousuke, 1995, Neurologia Medico-Chirurgica, V35, P1, DOI 10.2176/nmc.35.1; LAZZARINO G, 1989, ANAL BIOCHEM, V181, P239, DOI 10.1016/0003-2697(89)90236-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Maniega SM, 2008, NEUROLOGY, V71, P1993, DOI 10.1212/01.wnl.0000336970.85817.4a; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; Moreno A, 2001, J NEUROCHEM, V77, P347, DOI 10.1046/j.1471-4159.2001.00282.x; Qian JC, 2013, NEUROCHEM RES, V38, P208, DOI 10.1007/s11064-012-0910-2; Rae C, 2012, NEUROCHEM RES, V37, P2541, DOI 10.1007/s11064-012-0847-5; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Rigotti DJ, 2012, NEUROLOGY, V78, P1383, DOI 10.1212/WNL.0b013e318253d609; Rubin Y, 1997, J NEUROTRAUM, V14, P441, DOI 10.1089/neu.1997.14.441; Satrustegui J, 2007, J NEUROSCI RES, V85, P3359, DOI 10.1002/jnr.21299; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Signoretti S, 2002, ACT NEUR S, V81, P373; Tahay G, 2012, BIOCHEM J, V441, P105, DOI 10.1042/BJ20111179; Tallan HH., 1957, J BIOL CHEM, P22441; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2012, BRAIN INJURY PATHOGE, P501; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263	40	22	25	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1076-1551	1528-3658		MOL MED	Mol. Med.	JAN-JUN	2014	20						147	157		10.2119/molmed.2013.00153			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9QL	WOS:000334343100003	24515258	Green Published, Green Submitted, gold			2022-02-06	
J	Ganti, L; Khalid, H; Patel, PS; Daneshvar, Y; Bodhit, AN; Peters, KR				Ganti, Latha; Khalid, Hussain; Patel, Pratik Shashikant; Daneshvar, Yasamin; Bodhit, Aakash N.; Peters, Keith R.			Who gets post-concussion syndrome? An emergency department-based prospective analysis	INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE			English	Article						Post-concussion syndrome; Mild traumatic brain injury; Emergency department	TRAUMATIC BRAIN-INJURY; SYMPTOMS; PREDICTION	Background: The objective of this study was to determine who gets post-concussion syndrome (PCS) after mild traumatic brain injury or head injury. Methods: Patients presented within an hour of mild traumatic brain injury (mTBI). Written informed consent was obtained from all patients, who then provided detailed answers to surveys at the time of injury as well as at 1 week and 1 month follow-up. Statistical analyses were performed using JMP 11.0 for the Macintosh. Results: The most commonly reported symptoms of PCS at first follow-up were headache (27%), trouble falling asleep (18%), fatigue (17%), difficulty remembering (16%), and dizziness (16%). Furthermore, only 61% of the cohort was driving at 1 week follow-up, compared to 100% prior to the injury. Linear regression analysis revealed the consumption of alcohol prior to head injury, the mechanism of head injury being a result of motor vehicle collision (MVC) or fall, and the presence of a post-injury headache to be significantly associated with developing PCS at 1 week follow-up, while the occurrence of a seizure post-injury or having an alteration in consciousness post-injury was significantly associated with developing PCS at 1 month follow-up. On multivariate regression analysis, the presence of a headache post-injury was the most robust predictor, retaining statistical significance even after controlling for age, gender, and presence of loss of consciousness (LOC), alteration of consciousness (AOC), post-traumatic amnesia (PTA), seizure, or vomiting. Conclusions: The results of this prospective study suggest that headache right after the head injury, an alteration of consciousness after the head injury, and alcohol consumption prior to the head injury are significant predictors of developing PCS, which occurs with equal frequency in men and women. Early identification of those who are at risk of developing PCS would diminish the burden of the injury and could potentially reduce the number of missed work and school days.	[Ganti, Latha] North Florida South Georgia Vet Affairs Med Ctr, 1601 Archer Rd, Gainesville, FL 32610 USA; [Khalid, Hussain] Univ Florida, Coll Med, Gainesville, FL 32610 USA; [Patel, Pratik Shashikant; Daneshvar, Yasamin; Bodhit, Aakash N.] UF Hlth, Dept Emergency Med, Gainesville, FL 32610 USA; [Peters, Keith R.] UF Hlth, Dept Radiol, Gainesville, FL 32610 USA; [Peters, Keith R.] UF Hlth, Dept Neurol Surg, Gainesville, FL 32610 USA		Ganti, L (corresponding author), North Florida South Georgia Vet Affairs Med Ctr, 1601 Archer Rd, Gainesville, FL 32610 USA.	lathagantimd@gmail.com	Bodhit, Aakash/AAM-5786-2021; Ganti, Latha/AAF-6268-2020	Bodhit, Aakash/0000-0003-2722-025X; Ganti, Latha/0000-0001-7717-3864	Toral Family Foundation, SW 19th Street, Davie, FL, USA	This work was supported by an endowment from The Toral Family Foundation, 13131 SW 19th Street, Davie, FL 33325, USA (toralfamilyfoundation.org).	Auxemery Y, 2012, ENCEPHALE, V38, P329, DOI 10.1016/j.encep.2011.07.003; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8098; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Zafonte R, 2011, JAMA-J AM MED ASSOC, V306, P79, DOI 10.1001/jama.2011.819	19	22	22	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1865-1372	1865-1380		INT J EMERG MED	Int. J. Emergency Medicine		2014	7								31	10.1186/s12245-014-0031-6			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V22VC	WOS:000215048300031	25635191	Green Published, gold			2022-02-06	
J	Gosseries, O; Charland-Verville, V; Thonnard, M; Bodart, O; Laureys, S; Demertzi, A				Gosseries, Olivia; Charland-Verville, Vanessa; Thonnard, Marie; Bodart, Olivier; Laureys, Steven; Demertzi, Athena			Amantadine, Apomorphine and Zolpidem in the Treatment of Disorders of Consciousness	CURRENT PHARMACEUTICAL DESIGN			English	Article						Amantadine; apomorphine; zolpidem; disorders of consciousness; vegetative state/unresponsive wakefulness syndrom; minimally conscious state; pharmacological treatments; mechanism of action	TRAUMATIC BRAIN-INJURY; PERSISTENT VEGETATIVE STATE; PLACEBO-CONTROLLED TRIAL; SEVERE HEAD-INJURY; CONTINUOUS SUBCUTANEOUS APOMORPHINE; ADVANCED PARKINSON-DISEASE; DIFFUSE AXONAL INJURY; IMPAIRED CONSCIOUSNESS; CLINICAL PHARMACOKINETICS; UNRESPONSIVE WAKEFULNESS	Survivors of severe brain injuries may end up in a state of 'wakeful unresponsiveness' or in a minimally conscious state. Pharmacological treatments of patients with disorders of consciousness aim to improve arousal levels and recovery of consciousness. We here provide a systematic overview of the therapeutic effects of amantadine, apomorphine and zolpidem in patients recovering from coma. Evidence from clinical trials using these commonly prescribed pharmacological agents suggests positive changes of the patients' neurological status, leading sometimes to dramatic improvements. These findings are discussed in the context of current hypotheses of these agents' therapeutic mechanisms on cerebral function. In order to improve our understanding of the underlying pathophysiological mechanisms of these drugs, we suggest combining sensitive and specific behavioral tools with neuroimaging and electrophysiological measures in large randomized, double-blind, placebo-controlled experimental designs. We conclude that the pharmacokinetics and pharmacodynamics of amantadine, apomorphine and zolpidem need further exploration to determine which treatment would provide a better neurological outcome regarding the patient's etiology, diagnosis, time since injury and overall condition.	[Gosseries, Olivia] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium; Univ Liege, Dept Neurol, B-4000 Liege, Belgium; Univ Hosp Liege, Liege, Belgium		Gosseries, O (corresponding author), Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Sart Tilman B30,Allee 6 Aout 8, B-4000 Liege, Belgium.	ogosseries@ulg.ac.be	Gosseries, Olivia/AAB-6469-2020; Demertzi, Athena/I-1251-2019; Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011	Gosseries, Olivia/0000-0001-9011-7496; Demertzi, Athena/0000-0001-8021-3759; Laureys, Steven/0000-0002-3096-3807; 	Belgian National Funds for Scientific Research (FNRS)Fonds de la Recherche Scientifique - FNRS; Fonds Leon Fredericq; James S. McDon-nell Foundation; Mind Science Foundation; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Concerted Research Action; Public Utility Foundation "Universite Europeenne du Travail" and "Fondazione Europea di Ricerca Biomedica"	This study was funded by the Belgian National Funds for Scientific Research (FNRS), Fonds Leon Fredericq, James S. McDon-nell Foundation; Mind Science Foundation; European Commission; Concerted Research Action; Public Utility Foundation "Universite Europeenne du Travail" and "Fondazione Europea di Ricerca Biomedica". VCV and OB are research fellows, OG and AD are postdoctoral researchers and SL is research director at FNRS.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BLEIDNER WE, 1965, J PHARMACOL EXP THER, V150, P484; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Braver T, 2000, PRINCIPLES FRONTAL L, P428; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Cairns H, 1941, BRAIN, V64, P273, DOI 10.1093/brain/64.4.273; Chandler M C, 1988, Brain Inj, V2, P309; Chatelle C, 2013, ZOLPIDEM RECOVERY CO; Chen L, 2004, EXP NEUROL, V186, P212, DOI 10.1016/j.expneurol.2003.11.003; Chen L, 2007, NEUROSCI RES, V58, P77, DOI 10.1016/j.neures.2007.02.002; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Clauss P, 2001, SAMJ S AFR MED J, V91, P788; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss RP, 2000, S AFR MED J, V90, P68; Cohen L, 2004, NEW ENGL J MED, V350, P949, DOI 10.1056/NEJM200402263500922; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; CORSINI GU, 1979, LANCET, V1, P954; Daniele A, 1997, LANCET, V349, P1222, DOI 10.1016/S0140-6736(05)62416-6; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Dewhurst F, 2009, PALLIATIVE MED, V23, P777, DOI 10.1177/0269216309106979; Du B, 2014, AM J MED SCI, V347, P178, DOI 10.1097/MAJ.0b013e318287c79c; ENNA SJ, 1977, ARCH NEUROL-CHICAGO, V34, P683, DOI 10.1001/archneur.1977.00500230053008; FAHN S, 1975, NEUROLOGY, V25, P695, DOI 10.1212/WNL.25.8.695; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Fridman EA, 2009, BRAIN INJURY, V23, P172, DOI 10.1080/02699050802649662; Gee S ..., 1869, CLIN SOC T, V2, P166; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 1997, SEMIN NEUROL, V17, P105, DOI 10.1055/s-2008-1040919; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Gosseries O, 2011, NEUROREHABILITATION, V28, P3, DOI 10.3233/NRE-2011-0625; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Hagen C, 1987, LEVELS COGNITIVE FUN; Hall SD, 2010, CLIN NEUROPHYSIOL, V121, P549, DOI 10.1016/j.clinph.2009.11.084; Himeno E, 2011, ANN NEUROL, V69, P248, DOI 10.1002/ana.22319; HORIGUCHI J, 1990, CLIN NEUROPHARMACOL, V13, P84, DOI 10.1097/00002826-199002000-00009; Hubsher G, 2012, NEUROLOGY, V78, P1096, DOI 10.1212/WNL.0b013e31824e8f0d; Hughes S, 2005, BRAIN INJURY, V19, P1197, DOI 10.1080/02699050500309296; Jackson CW, 1996, J CLIN PSYCHIAT, V57, P372; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; KARKELA JT, 1993, J FORENSIC SCI, V38, P603; Katzenschlager R, 2005, MOVEMENT DISORD, V20, P151, DOI 10.1002/mds.20276; Kolls BJ, 2006, CLIN NEUROPHARMACOL, V29, P292, DOI 10.1097/01.WNF.0000220824.57769.E5; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2005, LANCET NEUROL, V4, P789, DOI 10.1016/S1474-4422(05)70230-1; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2001, YB INTENSIVE CARE EM; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; LeWitt PA, 2009, CLIN NEUROPHARMACOL, V32, P89, DOI 10.1097/WNF.0b013e31816d91f9; Lo YL, 2008, ANN NEUROL, V64, P477, DOI 10.1002/ana.21183; Machado C, 2011, CAN J NEUROL SCI, V38, P341, DOI 10.1017/S0317167100011562; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MILLAC P, 1970, LANCET, V2, P720; Mohee A, 2012, EXPERT OPIN DRUG MET, V8, P1447, DOI 10.1517/17425255.2012.727797; Neef C, 1999, CLIN PHARMACOKINET, V37, P257, DOI 10.2165/00003088-199937030-00004; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; OCEBM Levels of Evidence Working Group, 2011, OXF LEV EV; Oliveira L, 2011, BRAIN INJURY, V25, P315, DOI 10.3109/02699052.2011.556103; Ossig C, 2013, J NEURAL TRANSM, V120, P523, DOI 10.1007/s00702-013-1008-y; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Patrick PD, 2000, BEHAV INTERVENT, V15, P225, DOI 10.1002/1099-078X(200007/09)15:3<225::AID-BIN58>3.0.CO;2-8; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Plum F., 1983, DIAGNOSIS STUPOR COM; Poza J, 2007, P ANN INT IEEE EMBS, P6180; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rappaport M., 2000, COMA NEAR COMA SCALE; Reynolds JC, 2013, RESUSCITATION, V84, P818, DOI 10.1016/j.resuscitation.2012.11.014; Rezak M, 2007, DM-DIS MON, V53, P259, DOI 10.1016/j.disamonth.2007.02.003; Ribaric S, 2012, MOLECULES, V17, P5289, DOI 10.3390/molecules17055289; Riley A, 2010, J SEX MED, V7, P1508, DOI 10.1111/j.1743-6109.2009.01540.x; SALVA P, 1995, CLIN PHARMACOKINET, V29, P142, DOI 10.2165/00003088-199529030-00002; Sanger DJ, 1999, PHARMACOL BIOCHEM BE, V64, P269, DOI 10.1016/S0091-3057(99)00081-7; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Sawada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015298; Sawaguchi T, 2001, NEUROSCI RES, V41, P115, DOI 10.1016/S0168-0102(01)00270-X; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schiff ND, 2007, ANN NEUROL, V62, P5, DOI 10.1002/ana.21158; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schiff ND, 2009, ANN NY ACAD SCI, V1157, P101, DOI 10.1111/j.1749-6632.2008.04123.x; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schneider WN, 1999, BRAIN INJURY, V13, P863; SCHWAB RS, 1969, J AMER MED ASSOC, V208, P1168, DOI 10.1001/jama.208.7.1168; Schwartz JRL, 2008, CURR NEUROPHARMACOL, V6, P367, DOI 10.2174/157015908787386050; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Snyman N, 2010, NEUROPEDIATRICS, V41, P223, DOI 10.1055/s-0030-1269893; Stahl S.M, 2000, ESSENTIAL PSYCHOPHAR; Stern G, 1957, LONDON HOSP GAZATTE, P144; Stern Gerald, 2013, Pract Neurol, V13, P335, DOI 10.1136/practneurol-2012-000432; Struhal W, 2012, WIEN KLIN WOCHENSCHR, V124, P461, DOI 10.1007/s00508-012-0202-5; TEASDALE G, 1974, LANCET, V2, P81; Thonnard M, 2013, FUNCT NEUROL, V28, P259, DOI 10.11138/FNeur/2013.28.4.259; TIMBERLAKE WH, 1978, ANN NEUROL, V3, P119, DOI 10.1002/ana.410030206; U.S. Department Of Health And Human Services, 2010, COMM TERM CRIT ADV E; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; VANWOERKOM TCAM, 1982, EUR NEUROL, V21, P227, DOI 10.1159/000115485; Vargus-Adams JN, 2010, PM&R, V2, P37, DOI 10.1016/j.pmrj.2009.10.010; Weill E, 1884, LYON MED, V48, P411; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wojtecki L, 2012, PARKINSONISM RELAT D, V18, P1002, DOI 10.1016/j.parkreldis.2012.04.012; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zafonte R, 2009, PROG BRAIN RES, V177, P293, DOI 10.1016/S0079-6123(09)17720-8	125	22	24	1	13	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2014	20	26					4167	4184					18	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy	AK6AA	WOS:000338508000005	24025057				2022-02-06	
J	Gubata, ME; Packnett, ER; Blandford, CD; Piccirillo, AL; Niebuhr, DW; Cowan, DN				Gubata, Marlene E.; Packnett, Elizabeth R.; Blandford, Caitlin D.; Piccirillo, Amanda L.; Niebuhr, David W.; Cowan, David N.			Trends in the Epidemiology of Disability Related to Traumatic Brain Injury in the US Army and Marine Corps: 2005 to 2010	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						military personnel; traumatic brain injury; disability evaluation	OPERATION ENDURING FREEDOM; POSTTRAUMATIC-STRESS-DISORDER; LONG-TERM DISABILITY; IRAQI FREEDOM; UNITED-STATES; RISK-FACTORS; U.S. ARMY; MILITARY; AFGHANISTAN; PREVALENCE	Background: Traumatic brain injury (TBI) has been recognized as a major public health issue for several decades. Despite technological advancements in protective equipment and medical care available during recent military conflicts, TBI is the most common neurological condition among Soldiers and Marines evaluated for discharge from service. This study describes the demographic, service-related, and disability characteristics of Soldiers and Marines referred for combat-related TBI disability evaluation. Methods: Cross-sectional analysis of Soldiers and Marines evaluated for combat-related disability between October 1, 2004 and September 30, 2010 was performed. Traumatic brain injury cases were identified using the Veterans Affairs Schedule for Rating Disabilities code for TBI and compared with other combat-related disabilities. Results: Combat-related TBI disability rates have significantly increased in both the Army and the Marine Corps since 2005. Significantly more unfitting conditions are present on average in combat-related TBI cases than in other combat-related disability cases. Combat-related TBI disability cases are more likely to be medically retired than other types of combat-related disability. Conclusions: Because veterans with combat-related TBI disabilities are likely to require chronic care for TBI-associated medical conditions, disability evaluation policy and programs must ensure that combat-related TBI disabilities are accurately identified and compensated, and the potential long-term care needs are addressed.	[Gubata, Marlene E.; Packnett, Elizabeth R.; Blandford, Caitlin D.; Piccirillo, Amanda L.; Niebuhr, David W.; Cowan, David N.] Walter Reed Army Inst Res, Dept Epidemiol, Prevent Med Program, Silver Spring, MD 20910 USA; [Packnett, Elizabeth R.; Blandford, Caitlin D.; Piccirillo, Amanda L.; Cowan, David N.] Allied Technol Grp Inc, Rockville, MD USA		Gubata, ME (corresponding author), Walter Reed Army Inst Res, Dept Epidemiol, Prevent Med Program, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	marlene.gubata@us.army.mil			Defense Health Program	This study was supported by funds provided by the Defense Health Program.	Amoroso P J, 1999, Mil Med, V164, P1; [Anonymous], 2011, ANN BEN REP FISC YEA; [Anonymous], 2006, SECR DEF PERS READ P; Armed Forces Health Surveillance Center, 2008, MED SURV MONTHL REP, V15, P28; Armed Forces Health Surveillance Center, 2009, MSMR MED SURVEILL MO, V16, P24; Bell N, 2008, TALE 2 DISABILITY CO; Bell NS, 2011, J TRAUMA STRESS, V24, P34, DOI 10.1002/jts.20612; Bell NS, 2008, DISABIL HEALTH J, V1, P163, DOI 10.1016/j.dhjo.2008.05.002; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bohnker BK, 2003, MIL MED, V168, P482, DOI 10.1093/milmed/168.6.482; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Brown S, 2011, BRAIN INJURY, V25, P453, DOI 10.3109/02699052.2011.556581; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cross JD, 2011, J AM ACAD ORTHOP SUR, V19, pS1, DOI 10.5435/00124635-201102001-00002; Defense Manpower Data Center, 2011, CONT TRACK SYST DEPL; Eisenburg MF, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS108; Faul M, 2010, TRAUMATIC BRAIN INJU; Feuerstein M, 1997, J OCCUP ENVIRON MED, V39, P68, DOI 10.1097/00043764-199701000-00013; Gubata ME, 2012, TRISERVICE DISABILIT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Hollander IE, 2010, MIL MED, V175, P705, DOI 10.7205/MILMED-D-09-00214; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Masini BD, 2009, J ORTHOP TRAUMA, V23, P261, DOI 10.1097/BOT.0b013e31819dfa04; Niebuhr DW, 2011, MIL MED, V176, P170, DOI 10.7205/MILMED-D-10-00114; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Packnett ER, 2012, J TRAUMA STRESS, V25, P485, DOI 10.1002/jts.21743; Patzkowski JC, 2012, J AM ACAD ORTHOP SUR, V20, pS23, DOI 10.5435/JAAOS-20-08-S23; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS09324; Rivera JC, 2012, J AM ACAD ORTHOP SUR, V20, pS64, DOI 10.5435/JAAOS-20-08-S64; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwartz C, 2007, RISK FACTORS DISCHAR; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sikorski C, 2012, MIL MED, V177, P128, DOI 10.7205/MILMED-D-11-00250; Songer TJ, 2000, AM J PREV MED, V18, P33, DOI 10.1016/S0749-3797(00)00107-0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	46	22	23	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					65	75		10.1097/HTR.0b013e318295f590			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400012	23756433				2022-02-06	
J	Hoyle, JD; Callahan, JM; Badawy, M; Powell, E; Jacobs, E; Gerardi, M; Melville, K; Miskin, M; Atabaki, SM; Dayan, P; Holmes, JF; Kuppermann, N				Hoyle, John D., Jr.; Callahan, James M.; Badawy, Mohamed; Powell, Elizabeth; Jacobs, Elizabeth; Gerardi, Michael; Melville, Kraig; Miskin, Michelle; Atabaki, Shireen M.; Dayan, Peter; Holmes, James F.; Kuppermann, Nathan		Traumatic Brain Injury Study Grp P	Pharmacological Sedation for Cranial Computed Tomography in Children After Minor Blunt Head Trauma	PEDIATRIC EMERGENCY CARE			English	Article						traumatic brain injury; pharmacological sedation; computed tomography	PEDIATRIC EMERGENCY-DEPARTMENT; PROCEDURAL SEDATION; ADVERSE EVENTS; CHLORAL HYDRATE; YOUNG-CHILDREN; HELICAL CT; ANALGESIA; SAFE; DEXMEDETOMIDINE; PHYSICIANS	Objective Children evaluated in emergency departments for blunt head trauma (BHT) frequently undergo computed tomography (CT), with some requiring pharmacological sedation. Cranial CT sedation complications are understudied. The objective of this study was to document the frequency, type, and complications of pharmacological sedation for cranial CT in children. Methods We prospectively enrolled children (younger than 18 years) with minor BHT presenting to 25 emergency departments from 2004 to 2006. Data collected included sedation agent and complications. We excluded patients with Glasgow Coma Scale scores of less than 14. Results Of 57,030 eligible patients, 43,904 (77%) were enrolled in the parent study; 15,176 (35%) had CT scans performed or planned, and 527 (3%) received pharmacological sedation for CT. Sedated patients' characteristics were as follows: median age, 1.7 years (interquartile range, 1.1-2.5 years); male 61%; Glasgow Coma Scale score of 15, 86%; traumatic brain injury on CT, 8%. There were 488 patients (93%) who received 1 sedative. Sedation use (0%-21%) and regimen varied by site. Pentobarbital (n = 164) and chloral hydrate (n = 149) were the most frequently used agents. Sedation complications occurred in 49 patients (9%; 95% confidence interval [CI], 7%-12%): laryngospasm 1 (0.2%; 95% CI, 0%-1.1%), failed sedation 31 (6%; 95% CI, 4%-8%), vomiting 6 (1%; 95% CI, 0.4%-2%), hypotension 13 (4%; 95% CI, 2%-7%), and hypoxia 1 (0.2%; 95% CI, 0%-2%). No cases of apnea, aspiration, or reversal agent use occurred. One patient required intubation. Vomiting and failed sedation were most common with chloral hydrate. Conclusions Pharmacological sedation is infrequently used for children with minor BHT undergoing CT, and complications are uncommon. The variability in sedation medications and frequency suggests a need for evidence-based guidelines.	[Hoyle, John D., Jr.] Western Michigan Univ, Sch Med, Dept Emergency Med, Kalamazoo, MI 49008 USA; [Hoyle, John D., Jr.] Western Michigan Univ, Sch Med, Dept Pediat, Kalamazoo, MI 49008 USA; [Hoyle, John D., Jr.] Michigan State Univ, Dept Emergency Med, E Lansing, MI 48824 USA; [Callahan, James M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13210 USA; [Callahan, James M.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA; [Badawy, Mohamed] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Badawy, Mohamed] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY USA; [Powell, Elizabeth] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Jacobs, Elizabeth] Holy Cross Hosp, Dept Pediat, Silver Spring, MD USA; [Gerardi, Michael] Morristown Mem Hosp, Atlantic Hlth Syst, Dept Emergency Med, Morristown, NJ USA; [Melville, Kraig] Calvert Mem Hosp, Dept Emergency Med, Prince Frederick, MD USA; [Miskin, Michelle] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Atabaki, Shireen M.] George Washington Univ, Dept Pediat, Childrens Natl Med Ctr, Sch Med, Washington, DC 20052 USA; [Atabaki, Shireen M.] George Washington Univ, Dept Emergency Med, Sch Med, Washington, DC 20052 USA; [Dayan, Peter] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Dept Emergency Med, Davis, CA 95616 USA; [Kuppermann, Nathan] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA		Hoyle, JD (corresponding author), Helen DeVos Childrens Hosp, Emergency Dept, MC 49,100 Michigan St NE, Grand Rapids, MI 49503 USA.	jdhoyle@hotmail.com		Holubkov, Richard/0000-0003-0431-3381; Powell, Elizabeth/0000-0003-3147-9889	Health Resources and Services Administration/Maternal and Child Health Bureau, Division of Research, Training, and EducationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); Emergency Medical Services of Children Program [R40MC02461]; Emergency Medical Services of Children Program of the Health Resources and Services Administration/Maternal and Child Health Bureau [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008]	This work was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau, Division of Research, Training, and Education, and the Emergency Medical Services of Children Program (R40MC02461). The Pediatric Emergency Care Applied Research Network (PECARN) is supported by cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, and U03MC00008 from the Emergency Medical Services of Children Program of the Health Resources and Services Administration/Maternal and Child Health Bureau.	Agrawal D, 2003, ANN EMERG MED, V42, P636, DOI 10.1016/S0196-0644(03)00516-X; [Anonymous], 2004, ANN EMERG MED, V44, P342, DOI 10.1016/j.annemergmed.2004.04.012; BARST SM, 1994, PAEDIATR ANAESTH, V4, P243; Baxter AL, 2007, PEDIATR EMERG CARE, V23, P690, DOI 10.1097/PEC.0b013e3181558d5c; Bell A, 2011, EMERG MED AUSTRALAS, V23, P458, DOI 10.1111/j.1742-6723.2011.01418.x; Bender BJ, 2007, PEDIATR EMERG CARE, V23, P624, DOI 10.1097/PEC.0b013e318149f66f; Bhatt M, 2009, ANN EMERG MED, V53, P426, DOI 10.1016/j.annemergmed.2008.09.030; Boswinkel JP, 2005, PEDIATR ANN, V34, P650, DOI 10.3928/0090-4481-20050801-13; Casamassimo P, 2006, PEDIATRICS, V118, P2587, DOI 10.1542/peds.2006-2780; Cengiz M, 2006, PEDIATR ANESTH, V16, P621, DOI 10.1111/j.1460-9592.2005.01820.x; Chung T, 2000, PEDIATR RADIOL, V30, P332, DOI 10.1007/s002470050752; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Cote CJ, 2000, PEDIATRICS, V105, P805, DOI 10.1542/peds.105.4.805; Cote CJ, 2000, PEDIATRICS, V106, P633, DOI 10.1542/peds.106.4.633; Cravero JP, 2006, CURR OPIN ANESTHESIO, V19, P443, DOI 10.1097/01.aco.0000236147.83364.99; Cravero JP, 2006, PEDIATRICS, V118, P1087, DOI 10.1542/peds.2006-0313; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson CC, 2010, CLIN PEDIATR, V49, P350, DOI 10.1177/0009922809339346; Freedman SB, 2011, ACAD EMERG MED, V18, P38, DOI 10.1111/j.1553-2712.2010.00960.x; Godwin SA, 2005, ANN EMERG MED, V45, P177, DOI 10.1016/j.annemergmed.2004.11.002; Hoyle JD, 2011, ACAD EMERG MED, V18, P140, DOI 10.1111/j.1553-2712.2010.00970.x; Isaacman DJ, 2001, PEDIATRICS, V108, P354, DOI 10.1542/peds.108.2.354; Kaste SC, 1997, AM J ROENTGENOL, V168, P1001, DOI 10.2214/ajr.168.4.9124104; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Krauss B, 2006, LANCET, V367, P766, DOI 10.1016/S0140-6736(06)68230-5; Kroft Lucia J M, 2010, Pediatr Radiol, V40, P294, DOI 10.1007/s00247-009-1436-x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois J., 2001, TRAUMATIC BRAIN INJU, P1; Lemos AA, 2006, RADIOL MED, V111, P911, DOI 10.1007/s11547-006-0090-8; Malis DJ, 1997, OTOLARYNG HEAD NECK, V116, P53, DOI 10.1016/S0194-5998(97)70352-8; Malviya S, 1997, ANESTH ANALG, V85, P1207, DOI 10.1097/00000539-199712000-00005; Malviya S, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e42; Mason KP, 2012, BRIT J ANAESTH, V108, P13, DOI 10.1093/bja/aer407; Mason KP, 2008, PEDIATR ANESTH, V18, P393, DOI 10.1111/j.1460-9592.2008.02451.x; Mason KP, 2011, AM J ROENTGENOL, V196, pW194, DOI 10.2214/AJR.10.5045; Mason KP, 2004, RADIOLOGY, V233, P723, DOI 10.1148/radiol.2333031872; Mason KP, 2004, RADIOLOGY, V230, P537, DOI 10.1148/radiol.2302030107; Mensour Mark, 2006, CJEM, V8, P94; Moro-Sutherland DM, 2000, ACAD EMERG MED, V7, P1370, DOI 10.1111/j.1553-2712.2000.tb00494.x; Newman DH, 2003, ANN EMERG MED, V42, P627, DOI 10.1016/S0196-0644(03)00446-3; Pappas JN, 2000, RADIOLOGY, V215, P897, DOI 10.1148/radiology.215.3.r00jn34897; Pena BMG, 1999, ANN EMERG MED, V34, P483, DOI 10.1016/S0196-0644(99)80050-X; Pitetti RD, 2003, ARCH PEDIAT ADOL MED, V157, P1090, DOI 10.1001/archpedi.157.11.1090; Pomeranz ES, 2000, PEDIATRICS, V105, P1110, DOI 10.1542/peds.105.5.1110; Roback MG, 2005, ACAD EMERG MED, V12, P508, DOI 10.1197/j.aem.2004.12.009; Roback MG, 2004, ANN EMERG MED, V44, P454, DOI 10.1016/j.annemergmed.2004.03.015; Sacchetti A, 2005, PEDIATR EMERG CARE, V21, P295, DOI 10.1097/01.pec.0000159072.40067.c8; Sacchetti A, 2007, PEDIATR EMERG CARE, V23, P218, DOI 10.1097/PEC.0b013e31803e176c; Sanborn PA, 2005, RADIOLOGY, V237, P288, DOI 10.1148/radiol.2371041415; Shavit I, 2010, PEDIATR EMERG CARE, V26, P742, DOI 10.1097/PEC.0b013e3181f70e4e; Starkey E, 2011, ARCH DIS CHILDHOOD-E, V96, P101, DOI 10.1136/adc.2008.153072; Treluyer JM, 2004, FUND CLIN PHARMACOL, V18, P347, DOI 10.1111/j.1472-8206.2004.00232.x; WHITE KS, 1995, PEDIATR RADIOL, V25, P344, DOI 10.1007/BF02021698	53	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2014	30	1					1	7		10.1097/PEC.0000000000000059			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	AH6ST	WOS:000336261700001	24365725				2022-02-06	
J	Levack, WMM; Boland, P; Taylor, WJ; Siegert, RJ; Kayes, NM; Fadyl, JK; McPherson, KM				Levack, William M. M.; Boland, Pauline; Taylor, William J.; Siegert, Richard J.; Kayes, Nicola M.; Fadyl, Joanna K.; McPherson, Kathryn M.			Establishing a person-centred framework of self-identity after traumatic brain injury: a grounded theory study to inform measure development	BMJ OPEN			English	Article							POSTTRAUMATIC GROWTH; YOUNG-PEOPLE; HEAD-INJURY; REHABILITATION; ADJUSTMENT; DISABILITY; ADULTS	Objective: To develop a theoretically sound, client-derived framework to underpin development of a measure reflecting the impact of traumatic brain injury (TBI) on a person's self-identity. Design: Grounded theory, based on transcription of audio recordings from focus group meetings with people who have experienced TBI, analysed with constant comparative methods. Setting: 8 different urban and rural communities in New Zealand. Participants: 49 people (34 men, 15 women), 6 months to 36 years after mild-to-severe TBI. Results: The central concept emerging from the data was that of desiring to be or having lost a sense of being an integrated and valued person. The three main subthemes were: (1) having a coherent, satisfying and complete sense of oneself, (2) respect, validation and acceptance by others and (3) having a valued place in the world. Conclusions: This study reinforces the notion that change in self-identity is an important aspect of life after TBI, and provides information on what this concept means to people with TBI. In order to scientifically evaluate relationships between self-identity and other aspects of health (eg, depression, quality of life), and to test the effect of interventions to address problems with self-identity after TBI, a quantitative tool for evaluation of this construct is required. Themes from this research provide a foundation for the development of a measure of self-identity grounded in the language and experience of people with TBI.	[Levack, William M. M.; Boland, Pauline; Taylor, William J.] Univ Otago, Dept Med, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Siegert, Richard J.] AUT Univ, Fac Hlth & Environm Sci, Dept Psychol, Wellington, New Zealand; [Siegert, Richard J.; Kayes, Nicola M.; Fadyl, Joanna K.; McPherson, Kathryn M.] AUT Univ, Div Rehabil & Occupat Studies, Person Ctr Res Ctr, Auckland, New Zealand		Levack, WMM (corresponding author), Univ Otago, Dept Med, Rehabil Teaching & Res Unit, Wellington, New Zealand.	william.levack@otago.ac.nz	Siegert, Richard J./K-2030-2019; Levack, William Mark Magnus/F-9607-2018; Boland, Pauline/K-2878-2019	Levack, William Mark Magnus/0000-0001-6631-908X; Boland, Pauline/0000-0003-0218-327X; Siegert, Richard/0000-0002-3074-0929; Taylor, William/0000-0001-6075-8479; McPherson, Kathryn/0000-0003-1240-8882; McPherson, Kath/0000-0003-0487-8497	University of Otago; Laura Fergusson Trust Auckland	This work was funded by a research grant from the University of Otago. KMMP's position is partly funded by the Laura Fergusson Trust Auckland.	Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Charmaz K., 2014, BROKERAGE CLOSURE IN; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Conneeley AL, 2012, BRAIN IMPAIR, V13, P72, DOI 10.1017/BrImp.2012.3; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P42, DOI 10.1080/09602011.2010.525947; Douglas J., 2012, SOCIAL CURE IDENTITY; Erikson E. H., 1963, CHILDHOOD SOC; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Fotopoulou A, 2008, NEUROPSYCHOL REHABIL, V18, P541, DOI 10.1080/09602010802083545; Glaser B. G., 1992, EMERGENCE VS FORCING; Gracey F., 2012, THE SOCIAL CURE, P273; Hammell K.W., 2006, PERSPECTIVES DISABIL; Heller W, 2006, J REHABIL, V72, P44; Hogan BA, 1999, NEUROREHABILITATION, V13, P21; Hoogerdijk B, 2011, SCAND J OCCUP THER, V18, P122, DOI 10.3109/11038121003645985; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; McGrath JC, 2011, BRAIN IMPAIR, V12, P82, DOI 10.1375/brim.12.2.82; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; MORRIS SD, 2004, J COGN REHABIL, V22, P15; Morse J. M., 2002, README 1 USERS GUIDE; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Ownsworth T, 2011, BRAIN IMPAIR, V12, P79; Patterson FL, 2009, J MENT HLTH COUNS, V31, P149; Rogan C, 2013, NEUROPSYCHOL REHABIL, V23, P639, DOI 10.1080/09602011.2013.799076; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Sullivan M, 2007, BEING SOCIOLOGICAL; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	36	22	22	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2014	4	5							e004630	10.1136/bmjopen-2013-004630			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI6IQ	WOS:000336976900045	24833684	Green Published, gold			2022-02-06	
S	Maruta, J; Ghajar, J		Niranjan, A; Lunsford, LD		Maruta, Jun; Ghajar, Jamshid			Detecting Eye Movement Abnormalities from Concussion	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							SYNCHRONIZATION; INJURY	An attention-based biomarker may be useful for concussion screening. A key role of attention is to generate time-based expectancies of specific sensory information, and it is postulated that postconcussion cognitive impairments and symptoms may stem from a primary deficit in this predictive timing mechanism. There is a close relationship between gaze and attention, but in addressing predictive timing, there is a need for an appropriate testing paradigm and methods to quantify oculomotor anomalies. We have utilized a continuous predictive visual tracking paradigm because human visual tracking requires predicting the temporal course of a stimulus and dynamically synchronizing the required action with the stimulus. We have shown that concussion patients often show disrupted gaze-target synchronization characterized by large gaze position error variability and overall phase advancement. Various attention components interact with visual tracking, and thus there is a possibility that different neurological and physiological conditions produce identifiable visual tracking characteristics. Analyzing neuromotor functions, specifically oculomotor synchronization, can provide a fast, accurate, and reliable assessment of cognitive functions. (C) 2014 S. Karger AG, Basel	[Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY 10007 USA; [Ghajar, Jamshid] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA		Maruta, J (corresponding author), Brain Trauma Fdn, World Trade Ctr 7, 34th Floor,250 Greenwich St, New York, NY 10007 USA.	jmaruta@braintrauma.org		Maruta, Jun/0000-0002-5054-6605			Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; HUGHES A, 1971, DOC OPHTHALMOL, V30, P33, DOI 10.1007/BF00142518; Maruta J, 2012, P SOC PHOTO-OPT INS, V8371; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; UMEDA Y, 1975, ORL J OTO-RHINO-LARY, V37, P290, DOI 10.1159/000275237; VANDERSTEEN J, 1983, VISION RES, V23, P1655, DOI 10.1016/0042-6989(83)90180-3	13	22	22	0	17	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						226	233		10.1159/000358786	10.1159/isbn.978-3-318-02649-8		8	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000020	24923406				2022-02-06	
J	Mondello, S; Cantrell, A; Italiano, D; Fodale, V; Mondello, P; Ang, D				Mondello, Stefania; Cantrell, Amy; Italiano, Domenico; Fodale, Vincenzo; Mondello, Patrizia; Ang, Darwin			Complications of Trauma Patients Admitted to the ICU in Level I Academic Trauma Centers in the United States	BIOMED RESEARCH INTERNATIONAL			English	Article							BLUNT CHEST TRAUMA; BRAIN-INJURY; GENDER; MORTALITY; OUTCOMES; MALES; IMPACT; ADULT; COSTS	Background. The aims of this study were to evaluate the complications that occur after trauma and the characteristics of individuals who develop complications, to identify potential risk factors that increase their incidence, and finally to investigate the relationship between complications and mortality. Methods. We did a population-based retrospective study of trauma patients admitted to ICUs of a level I trauma center. Logistic regression analyses were performed to determine independent predictors for complications. Results. Of the 11,064 patients studied, 3,451 trauma patients developed complications (31.2%). Complications occurred significantly more in younger male patients. Length of stay was correlated with the number of complications (R = 0.435, P < 0.0001). The overall death rate did not differ between patients with or without complications. The adjusted odds ratio (OR) of developing complication for patients over age 75 versus young adults was 0.7 (P < 0.0001). Among males, traumatic central nervous system (CNS) injury was an important predictor for complications (adjusted OR 1.24). Conclusions. Complications after trauma were found to be associated with age, gender, and traumatic CNS injury. Although these are not modifiable factors, they may identify subjects at high risk for the development of complications, allowing for preemptive strategies for prevention.	[Mondello, Stefania; Fodale, Vincenzo] Univ Messina, Dept Neurosci, I-98125 Messina, Italy; [Cantrell, Amy] Univ Florida, Coll Publ Hlth & Hlth Profess, Coll Med, Dept Biostat, Gainesville, FL 32611 USA; [Italiano, Domenico] Univ Messina, Dept Clin & Expt Med & Pharmacol, I-98125 Messina, Italy; [Mondello, Patrizia] Univ Messina, Dept Human Pathol, I-98125 Messina, Italy; [Ang, Darwin] Univ S Florida, Ocala, FL USA; [Ang, Darwin] Ocala Reg Med Ctr, Trauma Serv, Ocala, FL USA		Mondello, S (corresponding author), Univ Messina, Dept Neurosci, Via Consolare Valeria, I-98125 Messina, Italy.	stm_mondello@hotmail.com	Mondello, Patrizia/AAD-2126-2021; Mondello, Stefania/A-1813-2012; Fodale, Vincenzo/G-5554-2010; Mondello, Patrizia/AAD-6271-2020	Mondello, Patrizia/0000-0002-0355-3757; Mondello, Stefania/0000-0002-8587-3614; Fodale, Vincenzo/0000-0001-9540-5665; 			Ang DN, 2009, J AM COLL SURGEONS, V209, P595, DOI 10.1016/j.jamcollsurg.2009.08.003; Angele MK, 1998, J TRAUMA, V44, P78, DOI 10.1097/00005373-199801000-00007; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; CDC, 2004, NAT EST TENLEADING C; de Jongh MAC, 2011, J TRAUMA, V71, pE102, DOI 10.1097/TA.0b013e31820e351f; DePorter J, 1997, Best Pract Benchmarking Healthc, V2, P147; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Feliciano DV, 2008, TRAUMA; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P732, DOI 10.1001/archsurg.2012.1138; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Harrington DT, 2010, ARCH SURG-CHICAGO, V145, P432, DOI 10.1001/archsurg.2010.71; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Irwin ZN, 2004, SPINE, V29, P796, DOI 10.1097/01.BRS.0000119400.92204.B5; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; McDonald K, 2002, TECHNICAL REV; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Pape HC, 2000, J TRAUMA, V49, P496, DOI 10.1097/00005373-200009000-00018; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; Shafi S, 2010, J TRAUMA, V69, P1367, DOI 10.1097/TA.0b013e3181fb785d; Slee V. N., 2005, N CAROLINA MED J, V66, P331; SLEE VN, 1978, ANN INTERN MED, V88, P424, DOI 10.7326/0003-4819-88-3-424; Sperry JL, 2008, J LEUKOCYTE BIOL, V83, P499, DOI 10.1189/jlb.0607360; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; World Health Organization, **NON-TRADITIONAL**	32	22	22	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								473419	10.1155/2014/473419			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AJ1PQ	WOS:000337428500001		Green Published, gold, Green Submitted			2022-02-06	
J	Pekny, T; Faiz, M; Wilhelmsson, U; Curtis, MA; Matej, R; Skalli, O; Pekny, M				Pekny, Tulen; Faiz, Maryam; Wilhelmsson, Ulrika; Curtis, Maurice A.; Matej, Radoslav; Skalli, Omar; Pekny, Milos			Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease	APMIS			English	Article						Astrocytes; GFAP; intermediate filaments; Alexander disease; neurodegenerative diseases	FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENTS; MICE DEFICIENT; VIMENTIN; GFAP; ACTIVATION; REGENERATION; ABSENCE; STRESS; CELLS	Alexander disease (AxD) is a neurodegenerative disorder with prominent white matter degeneration and the presence of Rosenthal fibers containing aggregates of glial fibrillary acidic protein (GFAP), and small stress proteins HSP27 and B-crystallin, and widespread reactive gliosis. AxD is caused by mutations in GFAP, the main astrocyte intermediate filament protein. We previously showed that intermediate filament protein synemin is upregulated in reactive astrocytes after neurotrauma. Here, we examined immunohistochemically the presence of synemin in reactive astrocytes and Rosenthal fibers in two patients with AxD. There was an abundance of GFAP-positive Rosenthal fibers and widespread reactive gliosis in the white matter and subpial regions. Many of the GFAP-positive reactive astrocytes were positive for synemin, and synemin was also present in Rosenthal fibers. We show that synemin is expressed in reactive astrocytes in AxD, and is also present in Rosenthal fibers. The potential role of synemin in AxD pathogenesis remains to be investigated.	[Pekny, Tulen; Faiz, Maryam; Wilhelmsson, Ulrika; Curtis, Maurice A.; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, SE-41390 Gothenburg, Sweden; [Skalli, Omar] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Matej, Radoslav] Thomayers Hosp, Dept Pathol & Mol Med, Prague, Czech Republic		Pekny, M (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, Medicinaregatan 9A, SE-41390 Gothenburg, Sweden.	Milos.Pekny@neuro.gu.se		Curtis, Maurice/0000-0003-4496-0233; Wilhelmsson, Ulrika/0000-0003-3227-2687	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [11548]; AFA Insurance; Swedish Stroke Foundation; Torsten Foundation; Ragnar Soderberg Foundation; Swedish Society for Medicine; Region of Vastra Gotaland; Frimurare Foundation; Amlov's Foundation; Sten A. Olsson Foundation for Research and Culture; Foundation Edit Jacobson's Donation Fund; Trygg-Hansa; Hjarnfonden; ALF Goteborg [11392]; EUEuropean Commission [237956]; TargetBraIn [279017]; NanoNet COST ActionEuropean Cooperation in Science and Technology (COST) [BM1002]	We would like to thank the late Prof. Milan Elleder for his involvement in this project. Rita Grander, Ann-Marie Alborn, and Prof. Klas Blomgren are acknowledged for technical help. This work was supported by grants from the Swedish Medical Research Council (11548), AFA Insurance, Swedish Stroke Foundation, Torsten and Ragnar Soderberg Foundations, the Swedish Society for Medicine, the Region of Vastra Gotaland (RUN), Frimurare Foundation, Amlov's Foundation, Sten A. Olsson Foundation for Research and Culture, Foundation Edit Jacobson's Donation Fund, Trygg-Hansa, Hjarnfonden, ALF Goteborg (11392), the EU FP7 Programs EduGlia (237956) and TargetBraIn (279017), and NanoNet COST Action (BM1002).	Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Matej R, 2008, CLIN NEUROPATHOL, V27, P64; Messing A, 2010, NEUROTHERAPEUTICS, V7, P507, DOI 10.1016/j.nurt.2010.05.013; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2004, TRENDS NEUROSCI, V27, P243, DOI 10.1016/j.tins.2004.01.012; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Tang GM, 2008, AUTOPHAGY, V4, P701, DOI 10.4161/auto.6028; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; TOMOKANE N, 1991, AM J PATHOL, V138, P875; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Yoshida T, 2011, J NEUROL, V258, P1998, DOI 10.1007/s00415-011-6056-3	25	22	22	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0903-4641	1600-0463		APMIS	APMIS	JAN	2014	122	1					76	80		10.1111/apm.12088			5	Immunology; Microbiology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Microbiology; Pathology	278SD	WOS:000328909100010	23594359				2022-02-06	
J	Sun, LQ; Gao, JL; Cui, CM; Cui, Y; Jing, XB; Zhao, MM; Wang, YC; Tian, YX; Wang, KJ; Cui, JZ				Sun, Li-Qian; Gao, Jun-Ling; Cui, Chang-Men; Cui, Ying; Jing, Xiao-Bin; Zhao, Man-Man; Wang, Yong-Chao; Tian, Yan-Xia; Wang, Kai-Jie; Cui, Jian-Zhong			Astrocytic p-connexin 43 regulates neuronal autophagy in the hippocampus following traumatic brain injury in rats	MOLECULAR MEDICINE REPORTS			English	Article						CX43; CBX; autophagy; LC3; TBI	GAP-JUNCTION COMMUNICATION; INDUCED CELL-DEATH; CEREBRAL-ISCHEMIA; COGNITIVE IMPAIRMENT; GLUTAMATE TRANSPORT; MODEL; MICE; GLIA; PROTEIN; PATHOPHYSIOLOGY	Gap junctions are conductive channels formed by membrane proteins termed connexins, which permit the intercellular exchange of metabolites, ions and small molecules. Previous data demonstrated that traumatic brain injury (TBI) activates autophagy and increases microtubule-associated protein 1 light chain 3 (LC3) immunostaining predominantly in neurons. Although previous studies have identified several extracellular factors that modulate LC3 expression, knowledge of the regulatory network controlling LC3 in health and disease remains incomplete. The aim of the present study was to assess whether gap junctions control the in vivo expression of LC3 in TBI. Using a modified weight-drop device, adult male Sprague-Dawley rats (weight, 350-375 g) were subjected to TBI. Phosphorylated gap junction protein levels and LC3-II levels were quantified using western blot analysis. The spatial distribution of immunoreactivity for phosphorylated connexin 43 (p-CX43) and LC3-II was analyzed by immunofluorescence. The results showed that p-CX43 expression in the hippocampus reached a maximum level 6 h following injury. In addition, the immunoreactivity of p-CX43 was localized in the astrocytes surrounding pyramidal neurons. The LC3-II protein content remained at high levels 24 h following injury. Double immunolabeling demonstrated that LC3-II dots colocalized with the hippocampus pyramidal neurons. Furthermore, inhibition of p-CX43 reduced TBI-induced autophagy, according to western blot analysis. As astrocytic gap junction coupling is affected in various forms of brain injury, the results suggest that point gap junctions/connexins are important regulators of autophagy in the hippocampal neurons following TBI.	[Sun, Li-Qian; Cui, Chang-Men; Cui, Jian-Zhong] Hebei Med Univ, Dept Surg, Shijiazhuang 050017, Hebei, Peoples R China; [Gao, Jun-Ling; Zhao, Man-Man; Wang, Yong-Chao; Tian, Yan-Xia] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China; [Cui, Ying; Wang, Kai-Jie; Cui, Jian-Zhong] Tangshan Gongren Hosp, Tangshan 063000, Hebei, Peoples R China; [Jing, Xiao-Bin] Tangshan Ophthalmol Hosp, Tangshan 063000, Hebei, Peoples R China		Cui, JZ (corresponding author), Hebei Med Univ, Dept Surg, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	cjz20000@tom.com			Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2012401071]	The present study was supported by a grant from the Natural Science Foundation of Hebei Province (grant no. H2012401071).	Anderson CM, 2000, GLIA, V32, P1; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cotrina ML, 2009, PURINERG SIGNAL, V5, P223, DOI 10.1007/s11302-009-9138-2; Cottrell GT, 2003, AM J PHYSIOL-CELL PH, V284, pC511, DOI 10.1152/ajpcell.00214.2002; Dermietzel R, 1998, GLIA, V24, P1, DOI 10.1002/(SICI)1098-1136(199809)24:1<1::AID-GLIA1>3.0.CO;2-A; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Giaume C, 1997, GLIA, V21, P114; Hansson E, 2000, NEUROCHEM INT, V37, P317, DOI 10.1016/S0197-0186(00)00033-4; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Khorasani MZ, 2009, PAK J PHARM SCI, V22, P349; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Magistretti PJ, 2000, BRAIN RES, V886, P108, DOI 10.1016/S0006-8993(00)02945-0; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; PAUL DL, 1995, CURR OPIN CELL BIOL, V7, P665, DOI 10.1016/0955-0674(95)80108-1; Pozuelo-Rubio M, 2011, CELL DEATH DIFFER, V18, P479, DOI 10.1038/cdd.2010.118; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Rozental R, 2001, METH MOL B, V154, P447; Song SX, 2012, MOL MED REP, V327, P331; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	40	22	22	0	12	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JAN	2014	9	1					77	82		10.3892/mmr.2013.1787			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	AA0KJ	WOS:000330783700013	24220542	Bronze			2022-02-06	
J	Zamorski, MA; Boulos, D				Zamorski, Mark A.; Boulos, David			The impact of the military mission in Afghanistan on mental health in the Canadian Armed Forces: a summary of research findings	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						Military personnel; Canada; stress disorders; post-traumatic; combat; epidemiology	SUICIDE ATTEMPTS; DISORDERS; COMBAT; PREVALENCE; VALIDATION; DEPLOYMENT; PERSONNEL; SOLDIERS; SUPPORT; UTILITY	Background: As Canada's mission in Afghanistan winds down, the Canadian Forces (CF) are reflecting on the psychological impact of the mission on more than 40,000 deployed personnel. Methods: All major CF studies of mental health outcomes done before and during the Afghanistan era are summarized, with an eye toward getting the most complete picture of the mental health impact of the mission. Studies on traumatic brain injury (TBI), high-risk drinking, and suicidality are included given their conceptual link to mental health. Results: CF studies on the mental health impact of pre-Afghanistan deployments are few, and they have inadequate detail on deployment experiences. Afghanistan era findings confirm service-related mental health problems (MHPs) in an important minority. The findings of the studies cohere, both as a group and in the context of data from our Allies. Combat exposure is the most important driver of deployment-related MHPs, but meaningful rates will be found in those in low-threat areas. Reserve service and cumulative effects of multiple deployments are not major risk factors in the CF. Many deployed personnel will seek care, but further efforts to decrease the delay are needed. Only a fraction of the overall burden of mental illness is likely deployment attributable. Deployment-related mental disorders do not translate into an overall increase in in-service suicidal behavior in the CF, but there is concerning evidence of increased suicide risk after release. TBI occurred in a distinct minority on this deployment, but severe forms were rare. Most TBI cases do not have persistent "post-concussive'' symptoms; such symptoms are closely associated with MHPs. Conclusion: The mental health impact of the mission in Afghanistan is commensurate with its difficult nature. While ongoing and planned studies will provide additional detail on its impacts, greater research attention is needed on preventive and therapeutic interventions.	[Zamorski, Mark A.; Boulos, David] Canadian Forces Hlth Serv Grp, Ottawa, ON, Canada		Zamorski, MA (corresponding author), Canadian Forces Hlth Serv Grp Headquarters, 1745 Alta Vista Dr, Ottawa, ON K1A 0K6, Canada.	mark.zamorski@forces.gc.ca		Boulos, David/0000-0001-7585-0681			American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armed Forces Health Surveillance Center, 2007, MED SURVEILL MON REP, V14, P2; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P7; Belik SL, 2010, AM J EPIDEMIOL, V172, P1250, DOI 10.1093/aje/kwq290; Belik SL, 2009, CAN J PSYCHIAT, V54, P93, DOI 10.1177/070674370905400207; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Boulos D, 2013, CAN MED ASSOC J, V185, pE545, DOI 10.1503/cmaj.122120; Bryant RA, 2011, DEPRESS ANXIETY, V28, P99, DOI 10.1002/da.20786; Canadian Armed Forces, 2013, ROAD MENT READ R2 M; Department of National Defence, 2010, 2008 2009 HLTH LIF I; Department of National Defence, 2005, HLTH LIF INF SURV 20; Fikretoglu D, 2010, MED CARE, V48, P10, DOI 10.1097/MLR.0b013e3181bd4bf9; Garber B., 2008, CANADIAN FORCES HLTH; Garber BG, 2012, CAN J PSYCHIAT, V57, P736, DOI 10.1177/070674371205701205; *GOSS GILR INC, 1998, HLTH STUD CAN FORC P; Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169; Kessler Ronald C., 1998, INT J METH PSYCH RES, V7, P171, DOI [DOI 10.1002/MPR.47, 10.1002/mpr.47]; Lee JEC, 2013, J OCCUP HEALTH PSYCH, V18, P327, DOI 10.1037/a0033059; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Mendes DD, 2008, INT J PSYCHIAT MED, V38, P241, DOI 10.2190/PM.38.3.b; Office of the Surgeon General U.A.M.C., 2006, FIN REP MENT HLTH AD; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Sareen J, 2008, AM J PUBLIC HEALTH, V98, P2191, DOI 10.2105/AJPH.2008.134205; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Sedge P., 2012, PREVALENCE OCCUPATIO; Smith B, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-37; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; *STAT CAN, 2003, DAIL CAN COMM HLTH S; Statistics Canada, 2011, CAN FORC CANC MORT S; Statistics Canada, 2004, CAN COMM HLTH SURV C; Statistics Canada, 2002, CAN COMM HLTH SURV M; Stein DJ, 2009, CNS SPECTRUMS, V14, P25; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Thompson J., 2011, VETERANS AFFAIRS CAN; Warden D. L., 2005, WAR NEUROTRAUMA DEFE; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Weathers F. W., 1993, PTSD CHECKLIST PCL R; Weathers F. W., 1994, PTSD CHECKLIST PCL C; Zamorski M. A., 2011, REPORT FINDINGS ENHA; Zamorski M. A, 2009, PRELIMINARY REPORT S; Zamorski MA, 2006, CAN PSYCH ASS ANN M; Zamorski MA., 2010, REPORT CANADIAN FORC; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319, DOI 10.1177/070674371405900605; Zamorski MA, 2011, INT REV PSYCHIATR, V23, P173, DOI 10.3109/09540261.2011.562186	47	22	22	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8198	2000-8066		EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2014	5								23822	10.3402/ejpt.v5.23822			13	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	AO2HG	WOS:000341138800001	25206951	Green Published, gold			2022-02-06	
J	Wong, GKC; Teoh, J; Yeung, J; Chan, E; Siu, E; Woo, P; Rainer, T; Poon, WS				Wong, George Kwok Chu; Teoh, Jeremy; Yeung, Janice; Chan, Emily; Siu, Eva; Woo, Peter; Rainer, Timothy; Poon, Wai Sang			Outcomes of traumatic brain injury in Hong Kong: Validation with the TRISS, CRASH, and IMPACT models	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Mortality; Outcome; Prediction; Traumatic brain injury	PROGNOSTIC MODELS; EMERGENCY CARE; PREDICTION; SCORE; MORTALITY; MODERATE	We aimed to test prognostic models (the Trauma Injury Severity Score, International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury, and Corticosteroid Randomisation After Significant Head Injury models) for 14-day mortality, 6-month mortality, and 6-month unfavorable outcome in a cohort of trauma patients with traumatic brain injury (TBI) in Hong Kong. We analyzed 661 patients with significant TBI treated in a regional trauma centre in Hong Kong over a 3-year period. The discriminatory power of the models was assessed as the area under the receiver operating characteristic curve. One-sample t-tests were used to compare actual outcomes in the cohort against predicted outcomes. All three prognostic models were shown to have good discriminatory power and no significant systemic over-estimation or under-estimation. In conclusion, all three predictive models are applicable to eligible TBI patients in Hong Kong. These predictive models can be utilized to audit TBI management outcomes for trauma service development in the future. (C) 2013 Elsevier Ltd. All rights reserved.	[Wong, George Kwok Chu; Teoh, Jeremy; Chan, Emily; Siu, Eva; Woo, Peter; Poon, Wai Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Shatin, Hong Kong, Peoples R China; [Yeung, Janice; Rainer, Timothy] Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Acad Unit, Hong Kong, Hong Kong, Peoples R China		Wong, GKC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Shatin, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Rainer, Timothy H/I-2591-2013; Poon, Wai Sang/F-1558-2011; Wong, George Kwok Chu/L-4344-2016; Teoh, Jeremy Yuen Chun/H-5184-2016; Wong, George KC/A-6378-2011	Rainer, Timothy H/0000-0003-3355-3237; Teoh, Jeremy Yuen Chun/0000-0002-9361-2342; Wong, George KC/0000-0002-6078-2548			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Cheng CH, 2008, ANN SURG, V247, P335, DOI 10.1097/SLA.0b013e31815ccc2e; de Jongh MAC, 2010, BRIT J SURG, V97, P1805, DOI 10.1002/bjs.7216; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P326, DOI 10.1097/TA.0b013e31825a7758; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	18	22	23	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2013	20	12					1693	1696		10.1016/j.jocn.2012.12.032			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261UO	WOS:000327690300010	23993210				2022-02-06	
J	Rao, V; Klepstad, P; Losvik, OK; Solheim, O				Rao, Vidar; Klepstad, Pal; Losvik, Ole Kristian; Solheim, Ole			Confusion with cerebral perfusion pressure in a literature review of current guidelines and survey of clinical practise	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							SEVERE HEAD-INJURY; TRAUMATIC BRAIN INJURY; MANAGEMENT; HYPERTENSION; REACTIVITY	Background: Cerebral perfusion pressure (CPP) is defined as the difference between the mean arterial pressure (MAP) and the intracranial pressure (ICP). However, since patients with traumatic brain injury (TBI) are usually treated with head elevation, the recorded CPP values depends on the zero level used for calibration of the arterial blood pressure. Although international guidelines suggest that target values of optimal CPP are within the range of 50 - 70 mmHg in patients with TBI, the calibration of blood pressure, which directly influences CPP, is not described in the guidelines. The aim of this study was to review the literature used to support the CPP recommendations from the Brain Trauma Foundation, and to survey common clinical practice with respect to MAP, CPP targets and head elevation in European centres treating TBI patients. Methods: A review of the literature behind CPP threshold recommendations was performed. Authors were contacted if the publications did not report how MAP or CPP was measured. A short questionnaire related to measurement and treatment targets of MAP and CPP was sent to European neurosurgical centres treating patients with TBI. Results: Assessment methods for CPP measurement were only retrieved from 6 of the 11 studies cited in the TBI guidelines. Routines for assessment of CPP varied between these 6 publications. The 58 neurosurgical centres that answered our survey reported diverging routines on how to measure MAP and target CPP values. Higher CPP threshold were not observed if blood pressure was calibrated at the heart level (p = 0.51). Conclusions: The evidence behind the recommended CPP thresholds shows no consistency on how blood pressure is calibrated and clinical practice for MAP measurements and CPP target values seems to be highly variable. Until a consensus is reached on how to measure CPP, confusion will prevail.	[Rao, Vidar; Solheim, Ole] St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Rao, Vidar; Solheim, Ole] Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, N-7034 Trondheim, Norway; [Klepstad, Pal] St Olavs Hosp, Dept Anaesthesiol & Intens Care Med, Trondheim, Norway; [Klepstad, Pal] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Losvik, Ole Kristian] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway		Rao, V (corresponding author), St Olavs Hosp, Dept Neurosurg, Trondheim, Norway.	vidarrao@gmail.com		Losvik, Ole Kristian/0000-0001-8846-3277; Solheim, Ole/0000-0002-5954-4817			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; McGraw CP, 1989, ICPVII, P839; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Weber C, 2013, ACTA NEUROCHIR, V155, P747, DOI 10.1007/s00701-013-1640-1	13	22	23	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 21	2013	21								78	10.1186/1757-7241-21-78			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	266SB	WOS:000328042900002	24262017	gold, Green Published			2022-02-06	
J	Carlozzi, NE; Grech, J; Tulsky, DS				Carlozzi, Noelle E.; Grech, Julie; Tulsky, David S.			Memory functioning in individuals with traumatic brain injury: An examination of the Wechsler Memory Scale-Fourth Edition (WMS-IV)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; TBI; Wechsler Memory Scale-Fourth Edition; WMS-IV; Memory; Assessment	CONFIRMATORY FACTOR-ANALYSIS; MILD HEAD-INJURY; VERBAL-LEARNING TEST; OF-THE-LITERATURE; COGNITIVE REHABILITATION; NEUROPSYCHOLOGICAL RECOVERY; FOLLOW-UP; WAIS-IV; MODERATE; DEFICITS	This study was designed to examine the construct validity of the Wechsler Memory Scale-Fourth Edition (WMS-IV) in individuals with traumatic brain injury (TBI). One hundred individuals with TBI (n = 35 complicated mild/moderate TBI; n = 65 severe TBI) and 100 matched controls from the WMS-IV normative dataset completed the WMS-IV. Multivariate analyses indicated that severe TBI participants had poorer performance than matched controls on all index scores and subtests. Individuals with complicated mild/moderate TBI performed more poorly than controls on all index scores, as well as on tests of visual memory (Designs I and II; Visual Reproduction I and II) and visual working memory (Spatial Addition; Symbol Span), but not on auditory verbal memory tests (Logical Memory I and II; Verbal Paired Associates I and II). After controlling for time since injury, severe TBI participants had significantly lower scores than the complicated mild/moderate TBI on 4 of the 5 WMS-IV index scores (Auditory Memory, Visual Memory, Immediate Memory, Delayed Memory) and 4 of the 10 WMS-IV subtests (Designs I and II, Verbal Pairs II, Logical Memory II). Effect sizes for index and subtest scores were generally moderate for the complicated mild/moderate group and moderate-to-large for the severe TBI group. Findings provide support for the construct validity of the WMS-IV in individuals with TBI.	[Carlozzi, Noelle E.; Grech, Julie; Tulsky, David S.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd,Bldg NC, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu		Tulsky, David/0000-0002-4335-4509	National Institute on Disability and Rehabilitation Research [H133G070138]	This study was supported in part by the National Institute on Disability and Rehabilitation Research [grant number H133G070138].	ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J, 1977, STAT POWER ANAL BEHA; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Drozdick LW, 2011, ASSESSMENT, V18, P141, DOI 10.1177/1073191110382843; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hoelzle JB, 2011, J CLIN EXP NEUROPSYC, V33, P283, DOI 10.1080/13803395.2010.511603; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Langeluddecke PM, 2005, J CLIN EXP NEUROPSYC, V27, P576, DOI 10.1080/13803390490918372; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pearson, WMS 3 WMS 4 RAT CHAN; Price LR, 2002, J CLIN EXP NEUROPSYC, V24, P574, DOI 10.1076/jcen.24.5.574.1013; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; Tulsky D., 2003, CLIN INTERPRETATION, P147; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vallat-Azouvi C, 2012, NEUROPSYCHOL REHABIL, V22, P634, DOI 10.1080/09602011.2012.681110; Walker AJ, 2009, J INT NEUROPSYCH SOC, V15, P938, DOI 10.1017/S1355617709990610; Wechsler D., 2009, WECHSLER MEMORY SCAL; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	42	22	22	1	43	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 1	2013	35	9					906	914		10.1080/13803395.2013.833178			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	238PF	WOS:000325959200002	24033318				2022-02-06	
J	Hildenbrand, KJ; Vasavada, AN				Hildenbrand, Kasee J.; Vasavada, Anita N.			COLLEGIATE AND HIGH SCHOOL ATHLETE NECK STRENGTH IN NEUTRAL AND ROTATED POSTURES	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						isometric; cervical musculature; MCU; concussion	CERVICAL EXTENSION STRENGTH; ISOMETRIC STRENGTH; MUSCLE STRENGTH; HEALTHY-VOLUNTEERS; HEAD; BIOMECHANICS; MUSCULATURE; RELIABILITY; FOOTBALL; DATABASE	A knowledge of neck strength is important for developing conditioning protocols and for evaluating the relationship between neck strength and head and neck injury, but very few studies have examined neck strength in relationship to athletic participation. The purpose of this study was to quantify isometric neck strength in collegiate and high school athletes. We hypothesized that (a) male athletes would have significantly greater neck strength than females; (b) collegiate athletes would be significantly stronger than high school athletes; and (c) neck strength would vary significantly with head posture. A total of 149 subjects participated (77 men and 72 women; 90 college and 59 high school level). Flexion, extension, and lateral flexion neck strength were measured in neutral and rotated head and neck postures. Neck strength varied significantly according to participants' sex, age, and posture (p < 0.05). Male college students were stronger than those in all other groups (female college students, male high school students, and female high school students). The average female neck strength was 61, 54, and 56% of the average male neck strength for extension, flexion, and lateral flexion, respectively. High school athletes' neck strength was 75, 68, and 65% of collegiate athletes' neck strength for extension, flexion, and lateral flexion, respectively. On average, neck strength was the greatest for extension compared with other force directions. The subjects showed large variation in neck strength with posture, but in general, there were no consistent trends among the subjects. This finding suggests that those whose neck strength was considerably lower in nonneutral postures may consider training to increase strength in rotated postures. These data provide important baseline information for future studies evaluating injury risk or training protocols.	[Hildenbrand, Kasee J.] Washington State Univ, Coll Educ, Athlet Training Educ Program, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA		Hildenbrand, KJ (corresponding author), Washington State Univ, Coll Educ, Athlet Training Educ Program, Pullman, WA 99164 USA.	khildenbrand@wsu.edu					Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; BERG HE, 1994, ARCH PHYS MED REHAB, V75, P661, DOI 10.1016/0003-9993(94)90189-9; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Burnett AF, 2004, AVIAT SPACE ENVIR MD, V75, P611; Burnett Angus F, 2005, Work, V25, P205; Chiu TTW, 2002, CLIN REHABIL, V16, P851, DOI 10.1191/0269215502cr550oa; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Choi H, 1999, J APPL BIOMECH, V15, P120, DOI 10.1123/jab.15.2.120; ELIASZIW M, 1987, STAT MED, V6, P647, DOI 10.1002/sim.4780060602; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; JACOBS K, 1995, CAN J APPL PHYSIOL, V20, P230, DOI 10.1139/h95-017; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; Keating LJ, 2005, J WHIPLASH RELAT DIS, V4, P43; Kreighbaum E, 1996, BIOMECHANICS QUALITA; Kumar S, 2001, CLIN BIOMECH, V16, P380, DOI 10.1016/S0268-0033(01)00023-7; Lavallee AV, 2013, J BIOMECH, V46, P527, DOI 10.1016/j.jbiomech.2012.09.029; Lee SG, 1989, ISSUES CONTROL MODEL, P5; MAYER T, 1994, SPINE, V19, P762, DOI 10.1097/00007632-199404000-00006; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; MORONEY SP, 1988, J ORTHOPAED RES, V6, P713, DOI 10.1002/jor.1100060514; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POLLOCK ML, 1993, ARCH PHYS MED REHAB, V74, P1080, DOI 10.1016/0003-9993(93)90065-I; Salo PK, 2006, J ORTHOP SPORT PHYS, V36, P495, DOI 10.2519/jospt.2006.2122; STURZENEGGER M, 1994, NEUROLOGY, V44, P688, DOI 10.1212/WNL.44.4.688; Suderman BL, 2012, THESIS WASHINGTON ST; Taylor MK, 2006, AVIAT SPACE ENVIR MD, V77, P1131; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Vincent A., 2006, THESIS U WASHINGTON; Ylinen JJ, 2003, J STRENGTH COND RES, V17, P755	32	22	22	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	NOV	2013	27	11					3173	3182		10.1519/JSC.0b013e31828a1fe2			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	245WS	WOS:000326495200031	23439331				2022-02-06	
J	Irimia, A; Goh, SYM; Torgerson, CM; Chambers, MC; Kikinis, R; Van Horn, JD				Irimia, Andrei; Goh, S. Y. Matthew; Torgerson, Carinna M.; Chambers, Micah C.; Kikinis, Ron; Van Horn, John D.			Forward and inverse electroencephalographic modeling in health and in acute traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						Electroencephalography; Traumatic brain injury; finite element method; Magnetic resonance imaging	ELECTRICAL-CONDUCTIVITY; SOURCE LOCALIZATION; POSTTRAUMATIC EPILEPSY; DIELECTRIC-PROPERTIES; EEG; HEAD; ANISOTROPY; MEG; PERTURBATIONS; SEGMENTATION	Objective: EEG source localization is demonstrated in three cases of acute traumatic brain injury (TBI) with progressive lesion loads using anatomically faithful models of the head which account for pathology. Methods: Multimodal magnetic resonance imaging (MRI) volumes were used to generate head models via the finite element method (FEM). A total of 25 tissue types-including 6 types accounting for pathology-were included. To determine the effects of TBI upon source localization accuracy, a minimum-norm operator was used to perform inverse localization and to determine the accuracy of the latter. Results: The importance of using a more comprehensive number of tissue types is confirmed in both health and in TBI. Pathology omission is found to cause substantial inaccuracies in EEG forward matrix calculations, with lead field sensitivity being underestimated by as much as similar to 200% in (peri-) contusional regions when TBI-related changes are ignored. Failing to account for such conductivity changes is found to misestimate substantial localization error by up to 35 mm. Conclusions: Changes in head conductivity profiles should be accounted for when performing EEG modeling in acute TBI. Significance: Given the challenges of inverse localization in TBI, this framework can benefit neurotrauma patients by providing useful insights on pathophysiology. (c) 2013 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Irimia, Andrei; Goh, S. Y. Matthew; Torgerson, Carinna M.; Chambers, Micah C.; Van Horn, John D.] Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA; [Kikinis, Ron] Harvard Univ, Sch Med, Dept Radiol, Surg Planning Lab, Boston, MA 02115 USA		Van Horn, JD (corresponding author), Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA.	jack.vanhorn@loni.ucla.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John/0000-0003-1537-0816	National Alliance for Medical Image Computing (NA-MIC), under NIH Roadmap Initiative Grant [2U54EB005149]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS081792, P01NS058489]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB005149, P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489, R41NS081792] Funding Source: NIH RePORTER	We acknowledge Zeynep Akalin Akar, Eric Halgren, Eran Mukamel, Paul M. Vespa, and the staff in the Laboratory of Neuro Imaging at UCLA for assistance and useful discussions. 3D Slicer is a multi-platform, free and open source software package for visualization and medical image computing available from www.slicer.org. This work was supported by the National Alliance for Medical Image Computing (NA-MIC; www.na-mic.org), under NIH Roadmap Initiative Grant 2U54EB005149 (to R. K., sub-award to J. D. V. H.), and by the NINDS, Grants R41NS081792 (to Stephen R. Aylward and J. D. V. H.) and P01NS058489 (to Paul M. Vespa). The authors report no conflict of interest.	Acar Z., 2004, PHYS MED BIOL, V49, P5011; Acar ZA, 2010, J NEUROSCI METH, V190, P258, DOI 10.1016/j.jneumeth.2010.04.031; Akhtari M, 2002, BRAIN TOPOGR, V14, P151, DOI 10.1023/A:1014590923185; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Awada KA, 1998, IEEE T BIO-MED ENG, V45, P1135, DOI 10.1109/10.709557; Baumann SB, 1997, IEEE T BIO-MED ENG, V44, P220, DOI 10.1109/10.554770; Binette JS, 2004, J BIOMECH ENG-T ASME, V126, P475, DOI 10.1115/1.1785805; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Chauveau N, 2004, HUM BRAIN MAPP, V21, P86, DOI 10.1002/hbm.10152; Chen FM, 2010, MED PHYS, V37, P4475, DOI 10.1118/1.3466831; Cook MJD, 2008, IEEE ENG MED BIO, P4563, DOI 10.1109/IEMBS.2008.4650228; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; EBERSOLE J S, 1990, Brain Topography, V3, P21, DOI 10.1007/BF01128858; Ebersole JS, 1999, EEG CL N SU, V50, P167; EBERSOLE JS, 1991, NEUROLOGY, V41, P1425, DOI 10.1212/WNL.41.9.1425; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gencer NG, 2004, PHYS MED BIOL, V49, P701, DOI 10.1088/0031-9155/49/5/004; Hallez H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-46; Haufe S, 2010, IEEE T BIO-MED ENG, V57, P1954, DOI 10.1109/TBME.2010.2046325; Haynes W.M, 2011, CRC HDB CHEM PHYS; HE B, 1987, IEEE T BIO-MED ENG, V34, P406, DOI 10.1109/TBME.1987.326056; Holmes MJ, 2013, BRAIN CONNECT, V3, P22, DOI 10.1089/brain.2012.0103; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Irimia A, 2012, NEUROIMAGE, V59, P2464, DOI 10.1016/j.neuroimage.2011.08.104; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Irimia A, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051908; Jacquir S, 2007, P ANN INT IEEE EMBS, P1711, DOI 10.1109/IEMBS.2007.4352639; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Lau T. M., 2012, J BEHAV BRAIN SCI, V2, P387, DOI DOI 10.4236/JBBS.2012.23044; Lee HO, 2008, J KOREAN NEUROSURG S, V44, P196, DOI 10.3340/jkns.2008.44.4.196; Lee WH, 2009, CLIN NEUROPHYSIOL, V120, P2071, DOI 10.1016/j.clinph.2009.09.007; Lima EA, 2006, SQUID HDB APPL SQUID; Lindenblatt G, 2001, PHYS MED BIOL, V46, P3051, DOI 10.1088/0031-9155/46/11/319; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Mani J, 2006, POSTTRAUMATIC EPILEP; Marin G, 1998, HUM BRAIN MAPP, V6, P250, DOI 10.1002/(SICI)1097-0193(1998)6:4<250::AID-HBM5>3.0.CO;2-2; Odabaee M, 2013, NEUROIMAGE, V68, P229, DOI 10.1016/j.neuroimage.2012.11.062; Pohlmeier R, 1997, BRAIN TOPOGR, V9, P157, DOI 10.1007/BF01190384; Ramon C, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-55; Reyes-Gasga J, 1999, J MATER SCI, V34, P2183, DOI 10.1023/A:1004540617013; RIJKHOFF NJM, 1994, IEEE T BIO-MED ENG, V41, P413, DOI 10.1109/10.293215; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sazonov AV, 2009, BIOL CYBERN, V100, P129, DOI 10.1007/s00422-008-0283-4; Trakic A, 2010, PHYSIOL MEAS, V31, P13, DOI 10.1088/0967-3334/31/1/002; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; von Ellenrieder N, 2006, IEEE T BIO-MED ENG, V53, P421, DOI 10.1109/TBME.2005.869769; YAN Y, 1991, MED BIOL ENG COMPUT, V29, P475, DOI 10.1007/BF02442317; Yang L, 2010, CLIN NEUROPHYSIOL, V121, P1240, DOI 10.1016/j.clinph.2010.02.153; Yitembe BR, 2013, INT J NUMER METH BIO, V29, P363, DOI 10.1002/cnm.2510; Yitembe BR, 2011, IEEE T BIO-MED ENG, V58, P1430, DOI 10.1109/TBME.2011.2107740; Zhang YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2398883	57	22	22	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	NOV	2013	124	11					2129	2145		10.1016/j.clinph.2013.04.336			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236FE	WOS:000325779800011	23746499	Green Accepted			2022-02-06	
J	Meekes, J; Braams, O; Braun, KPJ; Jennekens-Schinkel, A; van Nieuwenhuizen, O				Meekes, Joost; Braams, Olga; Braun, Kees P. J.; Jennekens-Schinkel, Aag; van Nieuwenhuizen, Onno		Dutch Collaborative Epilepsy Surg	Verbal memory after epilepsy surgery in childhood	EPILEPSY RESEARCH			English	Article						Child; Epilepsy surgery; Temporal/extra-temporal resection; Verbal memory; SRB analysis	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; SEMANTIC MEMORY; EFFECT SIZE; CHILDREN; DECLINE; LOBECTOMY; STATISTICS; SCLEROSIS; RESECTION	Purpose: To investigate verbal memory after epilepsy surgery both group-wise and at the level of individual children, and to assess associations with side of surgery and removal of the temporal lobe. Methods: A prospective controlled study in a consecutive sample of 21 children undergoing epilepsy surgery, with comprehensive assessments of verbal memory before surgery and six, 12 and 24 months after surgery. For each patient, two age- and gender-matched controls were tested at similar intervals. Standardized regression-based (SRB) analysis was applied to compare post-surgical change in individual patients with change in controls. Results: Group-wise, average normed scores on verbal memory tests were higher after epilepsy surgery than before, corroborating earlier reports. By dint of empirically based SRB analysis, however, considerable individual differences in post-surgical change were revealed. Children with resections that included the left temporal lobe functioned significantly poorer than predicted on the basis of their pre-surgical performance. In contrast, verbal memory performance after surgery was consistent with pre-surgical baseline in the majority of children with resections that spared the left temporal lobe. Conclusions: Despite cessation of epileptic seizures, verbal memory remains vulnerable in children who required surgery including the left temporal lobe. In most - but not all - children with other types of surgery, post-surgical verbal memory is consistent with their individual pre-surgical base level. (C) 2013 Elsevier B.V. All rights reserved.	[Meekes, Joost; Braams, Olga; Jennekens-Schinkel, Aag] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Sect Neuropsychol Children & Adolescents, NL-3508 AB Utrecht, Netherlands; [Meekes, Joost; Braams, Olga; Jennekens-Schinkel, Aag; van Nieuwenhuizen, Onno] Bio Res Ctr Children, NL-6816 VS Arnhem, Netherlands; [Braun, Kees P. J.; van Nieuwenhuizen, Onno] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Child Neurol, NL-3508 AB Utrecht, Netherlands		Meekes, J (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Sect Neuropsychol Children & Adolescents, Room KG 01-327-1,POB 85090, NL-3508 AB Utrecht, Netherlands.	meekes.joost@gmail.com; o.b.braams@umcutrecht.nl; k.braun@umcutrecht.nl; a.jennekens@umcutrecht.nl; OnnovanNieuwenhuizen@umcutrecht.nl		Meekes, Joost/0000-0001-6902-8958	Bio Foundation; Epilepsies of Childhood Foundation	This work was supported by grants from Bio Foundation and the Epilepsies of Childhood Foundation. These sponsors had no involvement in the design of the study; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the manuscript.	Alexander AI, 2005, ARCH CLIN NEUROPSYCH, V20, P587, DOI 10.1016/j.acn.2004.12.005; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Baxendale S, 2006, EPILEPSIA, V47, P1887, DOI 10.1111/j.1528-1167.2006.00810.x; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Berg AT, 2012, NEUROLOGY, V79, P1384, DOI 10.1212/WNL.0b013e31826c1b55; Binder JR, 2008, EPILEPSIA, V49, P1377, DOI 10.1111/j.1528-1167.2008.01625.x; Busch RM, 2011, ARCH CLIN NEUROPSYCH, V26, P739, DOI 10.1093/arclin/acr067; CHELUNE GJ, 1995, ARCH CLIN NEUROPSYCH, V10, P413; Dekker, 2004, KAUFMAN INTELLIGENTI; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Dulay MF, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11340; Engel Jerome Jr., 1993, P609; Geerts A, 2010, EPILEPSIA, V51, P1189, DOI 10.1111/j.1528-1167.2010.02546.x; Helmstaedter C, 2011, EPILEPSIA, V52, P1402, DOI 10.1111/j.1528-1167.2011.03157.x; HERMANN BP, 1995, EPILEPSIA, V36, P137, DOI 10.1111/j.1528-1157.1995.tb00972.x; Jambaque I, 2007, NEUROPSYCHOLOGIA, V45, P2850, DOI 10.1016/j.neuropsychologia.2007.05.008; Kaufman A. S., 1993, MANUAL KAUFMAN ADOLE; Kort W., 2005, WISC 3 NL HANDLEIDIN; L?ders H., 1993, CLIN NEUROPSYCHOL, V7, P300, DOI DOI 10.1080/13854049308401901; Lah S, 2004, EPILEPSY BEHAV, V5, P804, DOI 10.1016/j.yebeh.2004.08.005; Langfitt JT, 2007, NEUROLOGY, V68, P1988, DOI 10.1212/01.wnl.0000264000.11511.30; Lawrence MA., 2012, EZ EASY ANAL VISUALI; Lendt M, 1999, EPILEPSIA, V40, P1543, DOI 10.1111/j.1528-1157.1999.tb02038.x; Lendt M, 2002, EPILEPSY BEHAV, V3, P51, DOI 10.1006/ebeh.2001.0296; Loring DW, 2007, NEUROPSYCHOL REV, V17, P413, DOI 10.1007/s11065-007-9043-9; Mabbott DJ, 2003, NEUROPSYCHOLOGIA, V41, P995, DOI 10.1016/S0028-3932(02)00318-4; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Messas CS, 2008, EPILEPSY BEHAV, V12, P311, DOI 10.1016/j.yebeh.2007.10.014; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; R Development Core Team, 2011, R LANG ENV STAT COMP; Race E, 2012, NEUROPSYCHOL REV, V22, P105, DOI 10.1007/s11065-012-9197-y; REYNOLDS C. R., 2007, TEST MEMORY LEARNING; Ripley B.D, 2002, MODERN APPL STAT S, DOI DOI 10.1007/978-0-387-21706-2; Rzezak P, 2011, EPILEPSY BEHAV, V21, P242, DOI 10.1016/j.yebeh.2011.03.032; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; Skirrow C, 2011, NEUROLOGY, V76, P1330, DOI 10.1212/WNL.0b013e31821527f0; Stroup E, 2003, NEUROLOGY, V60, P1266, DOI 10.1212/01.WNL.0000058765.33878.0D; Thaler NS, 2011, APPL NEUROPSYCHOL, V18, P168, DOI 10.1080/09084282.2011.595443; Van Schooneveld MMJ, 2013, BRAIN DEV-JPN, V35, P721, DOI 10.1016/j.braindev.2013.01.011; Wechsler D, 2002, WECHSLER INTELLIGENC; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	41	22	23	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	NOV	2013	107	1-2					146	155		10.1016/j.eplepsyres.2013.08.017			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273HB	WOS:000328524800017	24042124	hybrid			2022-02-06	
J	Yang, M; Kosterin, P; Salzberg, BM; Milovanova, TN; Bhopale, VM; Thom, SR				Yang, Ming; Kosterin, Paul; Salzberg, Brian M.; Milovanova, Tatyana N.; Bhopale, Veena M.; Thom, Stephen R.			Microparticles generated by decompression stress cause central nervous system injury manifested as neurohypophysial terminal action potential broadening	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						decompression sickness; nitric oxide synthase; NADPH oxidase; leukocytes; platelets	TRAUMATIC BRAIN-INJURY; INDUCED NEUTROPHIL ACTIVATION; GAS CAVITATION NUCLEI; ENDOTHELIAL MICROPARTICLES; VASCULAR INJURIES; OXIDASE ACTIVITY; SICKNESS; AIR; DYSFUNCTION; PEROXIDASE	The study goal was to use membrane voltage changes during neurohypophysial action potential (AP) propagation as an index of nerve function to evaluate the role that circulating microparticles (MPs) play in causing central nervous system injury in response to decompression stress in a murine model. Mice studied 1 h following decompression from 790 kPa air pressure for 2 h exhibit a 45% broadening of the neurohypophysial AP. Broadening did not occur if mice were injected with the MP lytic agent polyethylene glycol telomere B immediately after decompression, were rendered thrombocytopenic, or were treated with an inhibitor of nitric oxide synthase-2 (iNOS) prior to decompression, or in knockout (KO) mice lacking myeloperoxidase or iNOS. If MPs were harvested from control (no decompression) mice and injected into naive mice, no AP broadening occurred, but AP broadening was observed with injections of equal numbers of MPs from either wild-type or iNOS KO mice subjected to decompression stress. Although not required for AP broadening, MPs from decompressed mice, but not control mice, exhibit NADPH oxidase activation. We conclude that inherent differences in MPs from decompressed mice, rather than elevated MPs numbers, mediate neurological injury and that a component of the perivascular response to MPs involves iNOS. Additional study is needed to determine the mechanism of AP broadening and also mechanisms for MP generation associated with exposure to elevated gas pressure.	[Yang, Ming; Milovanova, Tatyana N.; Bhopale, Veena M.; Thom, Stephen R.] Univ Penn, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kosterin, Paul; Salzberg, Brian M.] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Salzberg, Brian M.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA		Thom, SR (corresponding author), Univ Maryland, Dept Emergency Med, 110 South Paca St, Baltimore, MD 21201 USA.	sthom@smail.umaryland.edu	Salzberg, BM/A-1040-2007		Office of Naval ResearchOffice of Naval Research; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-40966]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040966, R01NS060703] Funding Source: NIH RePORTER	Funding was provided by grants from the Office of Naval Research and the National Institutes of Health (NS-40966).	Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Altman PL, 1964, BIOLOGY DATA BOOK, P264; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; Brown CM, 2008, EXP NEUROL, V210, P782, DOI 10.1016/j.expneurol.2007.11.021; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; Erdem I, 2009, AVIAT SPACE ENVIR MD, V80, P2, DOI 10.3357/ASEM.2234.2009; FOX FE, 1954, J ACOUST SOC AM, V26, P984, DOI 10.1121/1.1907466; FRANCIS TJR, 1988, J NEUROPATH EXP NEUR, V47, P475, DOI 10.1097/00005072-198807000-00008; Frontczak-Baniewicz M, 2001, NEUROENDOCRINOL LETT, V22, P81; Ganong WF, 2000, CLIN EXP PHARMACOL P, V27, P422, DOI 10.1046/j.1440-1681.2000.03259.x; Gao GK, 2009, UNDERSEA HYPERBAR M, V36, P33; HATTON GI, 1984, PEPTIDES, V5, P121, DOI 10.1016/0196-9781(84)90271-7; Janiszewski M, 2004, CRIT CARE MED, V32, P818, DOI 10.1097/01.CCM.0000114829.17746.19; Jansen F, 2013, CARDIOVASC RES, V98, P94, DOI 10.1093/cvr/cvt013; Jersey SL, 2010, AVIAT SPACE ENVIR MD, V81, P64, DOI 10.3357/ASEM.2303.2010; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Koch AE, 2008, UNDERSEA HYPERBAR M, V35, P197; Kohshi Kiyotaka, 2003, Sangyo Eiseigaku Zasshi, V45, P97; Kosterin P, 2005, J MEMBRANE BIOL, V208, P113, DOI 10.1007/s00232-005-0824-x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Madden LA, 2010, AVIAT SPACE ENVIR MD, V81, P41, DOI 10.3357/ASEM.2610.2010; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Pontier JM, 2012, APPL PHYSIOL NUTR ME, V37, P1; REAVES TA, 1982, NEUROSCIENCE, V7, P1545, DOI 10.1016/0306-4522(82)90263-9; SALZBERG BM, 1983, NATURE, V306, P36, DOI 10.1038/306036a0; Schmiegelow M, 2000, HORM RES, V54, P53, DOI 10.1159/000053232; SENSEMAN DM, 1983, J GEN PHYSIOL, V81, P887, DOI 10.1085/jgp.81.6.887; Tashiro T, 2002, ENDOCR PATHOL, V13, P183, DOI 10.1385/EP:13:3:183; Thom SR, 2013, J APPL PHYSIOL, V114, P1396, DOI 10.1152/japplphysiol.00106.2013; Thom SR, 2013, J APPL PHYSIOL, V114, P550, DOI 10.1152/japplphysiol.01386.2012; Thom SR, 2012, J APPL PHYSIOL, V112, P1268, DOI 10.1152/japplphysiol.01305.2011; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Vince RV, 2009, EUR J APPL PHYSIOL, V105, P507, DOI 10.1007/s00421-008-0927-z; Vorbrodt AW, 1996, J NEUROCYTOL, V25, P645, DOI 10.1007/BF02284831; Yang M, 2012, J APPL PHYSIOL, V112, P204, DOI 10.1152/japplphysiol.00953.2011; YOUNT DE, 1977, AVIAT SPACE ENVIR MD, V48, P185; Yount DE, 1997, J COLLOID INTERF SCI, V193, P50, DOI 10.1006/jcis.1997.5048	40	22	22	0	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	NOV	2013	115	10					1481	1486		10.1152/japplphysiol.00745.2013			6	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	257PW	WOS:000327398600009	24052032	Green Published			2022-02-06	
J	Gupta, RK; Prasad, S				Gupta, R. K.; Prasad, S.			Early down regulation of the glial Kir4.1 and GLT-1 expression in pericontusional cortex of the old male mice subjected to traumatic brain injury	BIOGERONTOLOGY			English	Article						Glia; Aging; Traumatic brain injury (TBI); Glutamate and K+ homeostasis; GLT-1/EAAT2; Kir4.1	GLUTAMATE TRANSPORTER GLT-1; FLUID PERCUSSION; HEAD-INJURY; EXTRACELLULAR POTASSIUM; RAT-BRAIN; PROTEINS; ESTROGEN; ACCUMULATION; MECHANISMS; ASTROCYTES	Astroglia play multiple roles in brain function by providing matrix to neurons, secreting neurotrophic factors, maintaining K+ and glutamate homeostasis and thereby controlling synaptic plasticity which undergoes alterations during aging. K+ and glutamate homeostasis is maintained by astrocytes membrane bound inwardly rectifying K+ channel (Kir4.1) and glutamate transporter-1 (GLT-1 or EAAT-2) proteins, respectively in the synapse and their expression may be altered due to traumatic brain injury (TBI). Also, it is not well understood whether this change is age dependent. To find out this, TBI was experimentally induced in adult and old male AKR strain mice using CHI technique, and expression of the Kir4.1 and GLT-1 in the pericontusional cortex at various time intervals was studied by Western blotting and semi quantitative RT-PCR techniques. Here, we report that expression of both Kir4.1 and GLT-1 genes at transcript and protein levels is significantly down regulated in the pericontusional ipsi-lateral cortex of old TBI mice as compared to that in the adult TBI mice as function of time after injury. Further, expression of both the genes starts decreasing early in old mice i.e., from the first hour after TBI as compared to that starts from fourth hour in adult TBI mice. Thus TBI affects expression of Kir4.1 and GLT-1 genes in age- and time dependent manner and it may lead to accumulations of more K+ and glutamate early in the synapse of old mice as compared to adult. This may be implicated in the TBI induced early and severe neuronal depolarization and excito-neurotoxicity in old age.	[Gupta, R. K.; Prasad, S.] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India		Prasad, S (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	s.sprasadbhu@gmail.com	Gupta, Rajaneesh/AAD-5893-2019	Gupta, Rajaneesh/0000-0003-0212-6478	Council of Scientific and Industrial Research (CSIR), Govt. of India (CSIR) [09/013 (0111) 2007-EMR I]; CSIRCouncil of Scientific & Industrial Research (CSIR) - India [37/1389/09/EMR-II]; BRNS, Govt. of IndiaDepartment of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS) [2009/37/55/3298]	R.K. Gupta acknowledges the Council of Scientific and Industrial Research (CSIR), Govt. of India for a Junior and Senior Research Fellowship (CSIR Award No. File No: 09/013 (0111) 2007-EMR I). S. Prasad acknowledges the research grants support from CSIR (37/1389/09/EMR-II) and BRNS (2009/37/55/3298), Govt. of India.	Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bordey A, 1998, EPILEPSY RES, V32, P286, DOI 10.1016/S0920-1211(98)00059-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buga AM, 2008, ROM J MORPHOL EMBRYO, V49, P279; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Francke M, 1997, GLIA, V20, P210, DOI 10.1002/(SICI)1098-1136(199707)20:3<210::AID-GLIA5>3.0.CO;2-B; Gershkoff A M, 1993, Arch Phys Med Rehabil, V74, pS402; GIFFARD RG, 1990, BRAIN RES, V530, P138, DOI 10.1016/0006-8993(90)90670-7; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Goleburn G, 2001, J CLIN GEROPSYCHOL, V7, P161, DOI DOI 10.1023/A:1011335027445; Gordon MN, 1997, J COMP NEUROL, V388, P106; Gupta RK, 2013, AGE, V35, P59, DOI 10.1007/s11357-011-9330-5; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Homayoun P, 1997, J NEUROCHEM, V69, P199; Itoh T, 2013, BRAIN STRUCT FUNCT, V218, P209, DOI 10.1007/s00429-012-0394-5; Joh HD, 2006, J CEREBR BLOOD F MET, V26, P518, DOI 10.1038/sj.jcbfm.9600211; Kanungo MS, 1994, GENES AGING, P167; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Lyeth BG, 1996, BRAIN RES, V742, P63, DOI 10.1016/S0006-8993(96)01002-5; MacFarlane SN, 1997, J NEUROSCI, V17, P7316; MALENKA RC, 1981, SCIENCE, V214, P339, DOI 10.1126/science.7280695; Marcaggi P, 2004, GLIA, V47, P217, DOI 10.1002/glia.20027; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; Modi PK, 2010, CELL MOL NEUROBIOL, V30, P709, DOI 10.1007/s10571-009-9495-y; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; POLLEN D A, 1970, Science (Washington D C), V167, P1252, DOI 10.1126/science.167.3922.1252; Prasad S, 2011, RECENT TRENDS BIOTEC, V2, P1; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x; Vemuganti LRR, 1998, J NEUROCHEM, V70, P2020; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	56	22	22	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1389-5729	1573-6768		BIOGERONTOLOGY	Biogerontology	OCT	2013	14	5					531	541		10.1007/s10522-013-9459-y			11	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	234CM	WOS:000325617400006	24026668				2022-02-06	
J	Klein, AM; Howell, K; Straube, A; Pfefferkorn, T; Bender, A				Klein, Anke-Maria; Howell, Kaitlen; Straube, Andreas; Pfefferkorn, Thomas; Bender, Andreas			Rehabilitation outcome of patients with severe and prolonged disorders of consciousness after aneurysmal subarachnoid hemorrhage (aSAH)	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Aneurysmal subarachnoid hemorrhage; Outcome; Clinical course; Recovery of consciousness; Predicting outcome; Neurorehabilitation	RUPTURED INTRACRANIAL ANEURYSMS; TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; FOLLOW-UP; STROKE; MANAGEMENT; RECOVERY; IMPACT; LIFE; FIM	Objectives: Our objectives were to evaluate rehabilitation outcome of aSAH survivors with severe disorders of consciousness (DOC) and to examine potential predictors of long-term outcome. Severe DOC includes patients in a vegetative state (VS) and in a minimally conscious state (MCS). Patients and methods: This is a retrospective single-center cohort study of consecutive aSAH patients with severe and prolonged DOC upon admission to neurorehabilitation. Clinical assessments started right after discharge from ICU, a median of 26 days after the aSAH. Two different outcome criteria were used, one addressing the functional aspect (assessed by the Functional Independence Measure [FIM]) the other one addressing the level of consciousness ("behavioral outcome", assessed by the Coma Remission Scale [CRS]). Improved outcome was defined by an increase in FIM scores of at least 22 points (minimal clinically important difference) or by reaching a full score of 24 points on the CRS. Separate least square linear regression models were calculated to examine potential predictors for functional and behavioral outcome. Results: Out of 63 patients, 19.0% and 39.7% of the patients achieved an improved functional and behavioral outcome, respectively. Age and level of consciousness upon admission to neurorehabilitation were independent prognostic factors for both outcome definitions. Both groups reached the better outcome category after a median of 11 and 9 weeks, respectively. In an individual patient, the longest delay to achievement of improved functional outcome was 30 weeks and to favorable behavioral outcome was 22 weeks after rehabilitation admission. Conclusion: About one-third of severely affected aSAH patients with DOC regained at least a favorable behavioral status during early neurorehabilitation. It is interesting to note that in our study population, the beginning of clinical improvement took up to 6 months after aSAH. (C) 2013 Elsevier B.V. All rights reserved.	[Klein, Anke-Maria; Howell, Kaitlen; Straube, Andreas; Pfefferkorn, Thomas; Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany; [Klein, Anke-Maria] Univ Munich, Dept Phys Med & Rehabil, D-81377 Munich, Germany; [Howell, Kaitlen; Bender, Andreas] Therapiezentrum Burgau, Dept Neurol, D-89331 Burgau, Germany		Bender, A (corresponding author), Univ Munich, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.	anke-maria.klein@med.uni-muenchen.de; kshowell@fulbrightmail.org; andreas.straube@med.uni-muenchen.de; thomas.pfefferkorn@med.uni-muenchen.de; anbender@med.uni-muenchen.de		Bender, Andreas/0000-0002-6328-7104			Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Canovas D, 2012, EUR J NEUROL, V19, P457, DOI 10.1111/j.1468-1331.2011.03542.x; Clinchot DM, 1997, ARCH PHYS MED REHAB, V78, P346, DOI 10.1016/S0003-9993(97)90223-9; Dombovy ML, 1998, BRAIN INJURY, V12, P887; Douds GL, 2012, NEUROLOGY RES INT, V2012, P6; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gnanalingham KK, 2006, CLIN NEUROL NEUROSUR, V108, P117, DOI 10.1016/j.clineuro.2005.11.001; Goddard AJP, 2004, J NEUROL NEUROSUR PS, V75, P868, DOI 10.1136/jnnp.2003.033068; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Grill E, 2013, ARCH PHYS MED REHAB, DOI [10.1016/j.apmr.2012.10.040, DOI 10.1016/J.APMR.2012.10.040.[EPUB]; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Helbok R, 2012, J NEUROLOGY NEUROSUR; Hutter BO, 1998, NEUROPSY NEUROPSY BE, V11, P22; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; JENNETT B, 1975, LANCET, V1, P480; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kwakkel G, 1996, AGE AGEING, V25, P479, DOI 10.1093/ageing/25.6.479; Lanzino G, 1996, J NEUROSURG, V85, P410, DOI 10.3171/jns.1996.85.3.0410; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Lule D, 2009, PROG BRAIN RES, V177, P339, DOI 10.1016/S0079-6123(09)17723-3; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Saciri BM, 2002, J NEUROL NEUROSUR PS, V72, P334, DOI 10.1136/jnnp.72.3.334; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Wang YM, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-12	31	22	23	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2013	115	10					2136	2141		10.1016/j.clineuro.2013.08.004			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	236XQ	WOS:000325833200037	23993657				2022-02-06	
J	Lovell, MR; Solomon, GS				Lovell, Mark R.; Solomon, Gary S.			Neurocognitive Test Performance and Symptom Reporting in Cheerleaders with Concussions	JOURNAL OF PEDIATRICS			English	Article							SPORTS-RELATED CONCUSSION; UNITED-STATES; HIGH-SCHOOL; INJURIES; EPIDEMIOLOGY; IMPACT; SPECIFICITY; RELIABILITY; SENSITIVITY	Objective To evaluate neurocognitive test results and symptom reporting after sports-related concussion in a group of female cheerleaders. Study design Junior and senior high school female cheerleaders (n = 138) underwent preparticipation baseline testing and repeated the ImPACT (Immediate Postconcussion Assessment and Cognitive Testing) evaluation within 7 days of concussive injury (range, 0-7 days; mean, 3.9 days). Postinjury neurocognitive and symptom scores were compared with preinjury (baseline) scores. "Abnormal" test performance was determined statistically using Reliable Change Index scores and self-reported symptoms. Main outcome variables included the composite scores indices from the ImPACT test, as well as symptoms reported by participants. Preinjury baseline and postinjury test results were compared using MANOVA. Results As a group, cheerleaders with concussion evaluated within 7 days of injury performed poorly on the ImPACT test battery relative to their own baseline (F = 6.5; P = .00). In addition, 61% of the cheerleaders with concussions reported an increase in symptoms compared with baseline. The groups did not differ significantly by position on the squad (F = 0.37; P = .96). Of the group of cheerleaders who did not report increased symptoms at the time of postinjury evaluation, 37% had at least 1 abnormal ImPACT composite score result, suggesting some residual cognitive decline compared with baseline. Conclusion The diagnosis and management of concussion in cheerleaders should not consist solely of self-reported symptoms. Neurocognitive test results represent an important component of the evaluation process and may identify athletes with residual neurocognitive deficits who report being clinically asymptomatic.	[Lovell, Mark R.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA		Solomon, GS (corresponding author), 1506 Village Vanderbilt,1500 21st Ave South, Nashville, TN 37212 USA.	gary.solomon@vanderbilt.edu	Solomon, Gary/K-9011-2019				[Anonymous], 2012, PEDIATRICS, V130, P966; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mueller FO, 2009, J ATHL TRAINING, V44, P565, DOI 10.4085/1062-6050-44.6.565; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	16	22	22	0	27	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476			J PEDIATR-US	J. Pediatr.	OCT	2013	163	4					1192	+		10.1016/j.jpeds.2013.05.061			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	224HM	WOS:000324873700051	23941669				2022-02-06	
J	Yan, EB; Johnstone, VPA; Alwis, DS; Morganti-Kossmann, MC; Rajan, R				Yan, E. B.; Johnstone, V. P. A.; Alwis, D. S.; Morganti-Kossmann, M. -C.; Rajan, R.			CHARACTERISING EFFECTS OF IMPACT VELOCITY ON BRAIN AND BEHAVIOUR IN A MODEL OF DIFFUSE TRAUMATIC AXONAL INJURY	NEUROSCIENCE			English	Article						traumatic brain injury; impact velocity; diffuse axonal injury; behaviour deficit; electrophysiology; sensory cortex	LATERAL FLUID PERCUSSION; PROFESSIONAL FOOTBALL; MOUSE MODEL; ACCELERATION; MOTOR; BIOMECHANICS; PERFORMANCE; CONCUSSION; SEVERITY; CHILDREN	The velocity of impact between an object and the human head is a critical factor influencing brain injury outcomes but has not been explored in any detail in animal models. Here we provide a comprehensive overview of the interplay between impact velocity and injury severity in a well-established weight-drop impact acceleration (WDIA) model of diffuse brain injury in rodents. We modified the standard WDIA model to produce impact velocities of 5.4, 5.85 and 6.15 m/s while keeping constant the weight and the drop height. Gradations in impact velocity produced progressive degrees of injury severity measured behaviourally, electrophysiologically and anatomically, with the former two methods showing greater sensitivity to changes in impact velocity. There were impact velocity-dependent reductions in sensorimotor performance and in cortical depth-related depression of sensory cortex responses; however axonal injury (demonstrated by immunohistochemistry for beta-amyloid precursor protein and neurofilament heavy-chain) was discernible only at the highest impact velocity. We conclude that the WDIA model is capable of producing graded axonal injury in a repeatable manner, and as such will prove useful in the study of the biomechanics, pathophysiology and potential treatment of diffuse axonal injury. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Yan, E. B.; Johnstone, V. P. A.; Alwis, D. S.; Rajan, R.] Monash Univ, Dept Physiol, Monash, Vic 3800, Australia; [Morganti-Kossmann, M. -C.] Monash Univ, Dept Epidemiol & Prevent Med, Monash, Vic 3800, Australia; [Morganti-Kossmann, M. -C.] Australian New Zealand Ctr Intens Care Res, Carlton, Vic, Australia		Rajan, R (corresponding author), Monash Univ, Dept Physiol, Monash, Vic 3800, Australia.	Ramesh.rajan@monash.edu	Johnstone, Victoria/B-5083-2015; rajan, ramesh/L-4842-2019	Johnstone, Victoria/0000-0001-9885-3607; Rajan, Ramesh/0000-0001-9862-0520; Morganti-Kossmann, Cristina/0000-0002-0807-2063	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1029311]	This study was funded by Grant No. APP1029311 from the National Health and Medical Research Council of Australia.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Brands DWA, 2002, PRED BRAIN MECH CLOS, P155; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Dischinger PC, 1998, ACCIDENT ANAL PREV, V30, P831, DOI 10.1016/S0001-4575(98)00036-0; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Faul M, 2010, TRAUMATIC BRAIN INJU; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; HALL GF, 1995, J COMP NEUROL, V353, P38, DOI 10.1002/cne.903530106; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Han Y, 2012, TRAFFIC INJ PREV, V13, P507, DOI 10.1080/15389588.2012.661111; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helps Y., 2008, HOSP SEPARATIONS DUE; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; MAIC, 2012, STAT INF 1 JAN 30 JU; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nance ML, 2006, ANN SURG, V243, P121, DOI 10.1097/01.sla.0000193838.11102.56; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Tencer AF, 2005, ACCIDENT ANAL PREV, V37, P287, DOI 10.1016/j.aap.2004.09.005; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Wood DP, 2005, P I MECH ENG D-J AUT, V219, P183, DOI 10.1243/095440705X6703; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Ydenius A, 2010, TRAFFIC INJ PREV, V11, P526, DOI 10.1080/15389588.2010.492053; Yuelin Zhang, 2011, Journal of Biomechanical Science and Engineering, V6, P191, DOI 10.1299/jbse.6.191; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao H, 2010, INT J CRASHWORTHINES, V15, P313, DOI 10.1080/13588260903335290	54	22	23	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 17	2013	248						17	29		10.1016/j.neuroscience.2013.05.045			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299UV	WOS:000330422100002	23735754				2022-02-06	
J	Chiu, HY; Chen, PY; Chen, NH; Chuang, LP; Tsai, PS				Chiu, Hsiao-Yean; Chen, Pin-Yuan; Chen, Ning-Hung; Chuang, Li-Pang; Tsai, Pei-Shan			Trajectories of sleep changes during the acute phase of traumatic brain injury: A 7-day actigraphy study	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						hierarchical linear model; sleep; symptom trajectory; traumatic brain injury	GENDER DIFFERENCES; HEAD-INJURY; DISTURBANCES; PREVALENCE; DISORDERS; HYPERSOMNIA; PARAMETERS; INSOMNIA; RHYTHMS; SERIES	Background/Purpose: To examine trajectories of change in sleep during the acute phase of traumatic brain injury (TB, and whether specific demographic and disease characteristics predicted the initial levels of sleep and the trajectories of change in sleep parameters. Methods: This was a prospective observational study. Fifty-two patients with first-ever TBI were enrolled. Sleep parameters were measured using actigraphy for 7 consecutive days after admission. Hierarchical linear modeling was used for data analyses in 52 TBI patients and in a subgroup of mild TBI patients (n = 31). Results: Participants had significant lower sleep efficiency, longer wake time after sleep onset, and longer 24-hour total sleep time (TST) than the normative data (all p < 0.05). Seventy-two percent of participants experienced prolonged 24-hour TST. Both daytime and 24-hour TST showed a significant downward trend across the study period. An initial Glasgow Coma Scale score < 11 significantly predicted the slope of change of daytime TST over time. Without initial loss of consciousness and age < 40 years were independent predictors of the change pattern of 24-hour TST over time. In the mild TBI subgroup, 24-hour TST significantly and gradually declined over time. Gender significantly predicted the trajectory of 24-hour sleep duration. Conclusion: Poor sleep efficiency and longer sleep duration are common symptoms in acute TB! patients. Both head injury severity and age predicted the trajectories of daytime and 24-hour sleep duration during the acute phase of TBI, whereas gender predicted the trajectories of 24-hour sleep duration in the mild TBI subgroup. Copyright (C) 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.	[Chiu, Hsiao-Yean; Tsai, Pei-Shan] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei 110, Taiwan; [Chen, Pin-Yuan] Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan, Taiwan; [Chen, Pin-Yuan; Chuang, Li-Pang] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chen, Ning-Hung; Chuang, Li-Pang] Chang Gung Mem Hosp, Sleep Ctr, Tao Yuan, Taiwan; [Chen, Ning-Hung; Chuang, Li-Pang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Tao Yuan, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei 110, Taiwan		Tsai, PS (corresponding author), Taipei Med Univ, Grad Inst Nursing, 250 Wu Hsing St, Taipei 110, Taiwan.	ptsai@tmu.edu.tw	Chuang, Li-Pang/L-8929-2019	Chuang, Li-Pang/0000-0001-5466-8995			Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ancoli-Israel S, 2009, SLEEP MED, V10, pS7, DOI 10.1016/j.sleep.2009.07.004; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; CAMPBELL SS, 1989, SLEEP, V12, P529; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Hagen C, 1998, LEVELS COGNITIVE FUN; Hagen C, 1979, LEVELS COGNITIVE FUN; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Lindberg E, 1997, SLEEP, V20, P381, DOI 10.1093/sleep/20.6.381; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Morgado Fabiana Lenharo, 2011, Radiol Bras, V44, P35, DOI 10.1590/S0100-39842011000100010; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ohayon MM, 2005, SLEEP, V28, P981; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Raudenbush SW, 2001, ANNU REV PSYCHOL, V52, P501, DOI 10.1146/annurev.psych.52.1.501; Raudenbush SW, 2010, HLM7 HIERARCHICAL LI; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Sowers MF, 2008, SLEEP, V31, P1339; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wolkove N, 2007, CAN MED ASSOC J, V176, P1299, DOI 10.1503/cmaj.060792; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	43	22	22	0	5	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646	1876-0821		J FORMOS MED ASSOC	J. Formos. Med. Assoc.	SEP	2013	112	9					545	553		10.1016/j.jfma.2013.06.007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237XY	WOS:000325906200007	23906685	Bronze			2022-02-06	
J	Farrell-Carnahan, L; Franke, L; Graham, C; McNamee, S				Farrell-Carnahan, Leah; Franke, Laura; Graham, Carolyn; McNamee, Shane			Subjective Sleep Disturbance in Veterans Receiving Care in the Veterans Affairs Polytrauma System Following Blast-Related Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INSOMNIA; PREDICTORS; IMPACT; IRAQ; AFGHANISTAN; MECHANISMS; DEPRESSION; SEVERITY; BEHAVIOR	Objectives: This investigation sought to characterize prevalence and factors associated with subjective sleep disturbance (SSD) in a clinical sample of veterans with blast-related mild traumatic brain injury (mTBI). Methods: Adult veterans with history of blast-related mTBI were enrolled in a cross-sectional study. Data on demographics, injury, and current symptoms, including SSD, were obtained. Descriptive and univariate analyses investigated prevalence of SSD and associated factors. Results: Participants were 114 veterans with blast-related mTBI (96% male; mean age = 31 years, SD = 8; mean number of days since injury = 1,044, SD = 538). 78% screened positive for post-traumatic stress disorder and 77% reported SSD. Loss of consciousness at time of injury, current nightmares, depression, headache, fatigue, and positive screen for post-traumatic stress disorder were significantly associated with SSD (p < 0.05). Conclusions: SSD was pervasive in this clinical sample and was significantly associated with multiple modifiable emotional symptoms as well as headache and fatigue; this is consistent with previous literature including samples with history of nonblast-related mTBI. Future research incorporating objective measurement of SSD and associated symptoms is needed to inform evidence-based screening, assessment, and treatment efforts for veterans with history of mTBI.	[Farrell-Carnahan, Leah; McNamee, Shane] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA; [Franke, Laura] Def & Vet Brain Injury Ctr, Richmond, VA 23249 USA; [Farrell-Carnahan, Leah; Franke, Laura; Graham, Carolyn; McNamee, Shane] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Dept Phys Med & Rehabil, Richmond, VA 23223 USA		Farrell-Carnahan, L (corresponding author), Hunter Holmes McGuire Vet Affairs Med Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.				Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	We thank William C. Walker, MD, principal investigator; Michelle Nichols, MSN, RN, research nurse manager/coinvestigator; and Tiffany Lewis, MA, study coordinator and research assistant. We also thank research assistants: Angela Satariano, COTA; Tiffany Amos, BS; Emily Lynn, BS; April Dean, BS; Jordan Stinson, BS; Nichole Kelly, MS; Jasmine Smith, BS; and William Came, PhD, psychologist/consultant. The parent study, Prospective Traumatic Brain Injury Tracking Protocol, is funded by Defense and Veterans Brain Injury Center.	Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; COUCH JR, 1995, J NEUROL REHABIL, V9, P83; Defense and Veterans Brain Injury Center, 2013, DEF VET BRAIN INJ CT; Department of Veterans Affairs, 2010, DEP VET AFF VA DOD C; Department of Veterans Affairs, 2009, DEP VET AFF MAN MAJ; Department of Veterans Affairs, 2009, DEP VET AFF MAN CONC; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Evans RW., 2006, NEUROLOGY TRAUMA, P95; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; Graham CA, 2003, J SEX RES, V40, P325, DOI 10.1080/00224490209552198; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hatoum HT, 1998, PHARMACOECONOMICS, V14, P629, DOI 10.2165/00019053-199814060-00004; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; JENNETT B, 1975, LANCET, V1, P480; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Leger D, 2006, SLEEP, V29, P171; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; National Centre for PTSD, 2012, US PTSD CHECKL; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI 10.1016/B978-0-12-590241-0.50006-X; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845	42	22	22	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP	2013	178	9					951	956		10.7205/MILMED-D-13-00037			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7UC	WOS:000340805500009	24005542	Bronze			2022-02-06	
J	Godbolt, AK; DeBoussard, CN; Stenberg, M; Lindgren, M; Ulfarsson, T; Borg, J				Godbolt, Alison K.; DeBoussard, Catharine Nygren; Stenberg, Maud; Lindgren, Marie; Ulfarsson, Trandur; Borg, Jorgen			DISORDERS OF CONSCIOUSNESS AFTER SEVERE TRAUMATIC BRAIN INJURY: A SWEDISH ICELANDIC STUDY OF INCIDENCE, OUTCOMES AND IMPLICATIONS FOR OPTIMIZING CARE PATHWAYS	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; prognosis; vegetative state; minimally conscious state; outcome; care pathways	REACTION LEVEL SCALE; GLASGOW COMA SCALE; PROLONGED POSTTRAUMATIC UNAWARENESS; PERSISTENT VEGETATIVE STATE; LATE RECOVERY; HEAD-INJURY; REHABILITATION; STIMULATION; GUIDELINES; RLS85	Background: Very severe traumatic brain injury may cause disorders of consciousness in the form of coma, unresponsive wakefulness syndrome (also known as vegetative state) or minimally conscious state. Previous studies of outcome for these patients largely pre-date the 2002 definition of minimally conscious state. Objectives: To establish the numbers of patients with disorder of consciousness at 3 weeks, 3 months and 1 year after severe traumatic brain injury, and to relate conscious state 3 weeks after injury to outcomes at 1 year. Design: Multi-centre, prospective, observational study of severe traumatic brain injury. Inclusion criteria: lowest (non-sedated) Glasgow Coma Scale 3-8 during the first 24 h; requirement for neurosurgical intensive care; age 18-65 years; alive 3 weeks after injury. Diagnosis of coma, unresponsive wakefulness syndrome, minimally conscious state or emerged from minimally conscious state was based on clinical and Coma Recovery Scale Revised assessments 3 weeks, 3 months and 1 year after injury. One-year outcome was measured with Glasgow Outcome Scale Extended (GOSE). Results: A total of 103 patients was included in the study. Of these, 81% were followed up to 1 year (76% alive, 5% dead). Three weeks after injury 36 were in coma, unresponsive wakefulness syndrome or minimally conscious state and 11 were anaesthetized. Numbers of patients who had emerged from minimally conscious state 1 year after injury, according to status at 3 weeks were: coma (0/6), unresponsive wakefulness syndrome (9/17), minimally conscious state (13/13), anaesthetized (9/11). Outcome at 1 year was good (GOSE>4) for half of patients in minimally conscious state or anaesthetized at 3 weeks, but for none of the patients in coma or unresponsive wakefulness syndrome. These differences in outcome were not revealed by prognostic predictions based on acute data. Conclusion: Patients in minimally conscious state or anaesthetized 3 weeks after injury have a better prognosis than patients in coma or unresponsive wakefulness syndrome, which could not be explained by acute prognostic models.	[Godbolt, Alison K.; DeBoussard, Catharine Nygren; Borg, Jorgen] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Godbolt, Alison K.; DeBoussard, Catharine Nygren; Borg, Jorgen] Danderyd Hosp, Univ Dept Rehabil Med Stockholm, Stockholm, Sweden; [Godbolt, Alison K.] Univ Uppsala Hosp, Dept Rehabil Med, Uppsala, Sweden; [Godbolt, Alison K.] Uppsala Univ, Uppsala, Sweden; [Stenberg, Maud] Norrlands Univ Hosp, Dept Rehabil Med, Umea, Sweden; [Lindgren, Marie] Cty Council Ostergotland, Clin Dept Rehabil Med, Linkoping, Sweden; [Ulfarsson, Trandur] Sahlgrens Univ Hosp, Dept Rehabil Med, S-41345 Gothenburg, Sweden		Godbolt, AK (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden.	alison.godbolt@ki.se	Stenberg, Maud/AAX-4366-2021	Godbolt, Alison/0000-0003-4511-6181; Borg, Jorgen/0000-0002-2372-7478	AFA insurance [060833]; ALF-grants from Uppsala University Hospital; Danderyd Hospital	The authors would like to thank the patients and their relatives, the PROBRAIN collaborators*, the clinical staff of our units, and our neurosurgical colleagues for allowing recruitment of their patients. This study was supported by grant 060833 from AFA insurance. The funders had no access to data and no input to study design or data analysis. AKG has received support from ALF-grants from Uppsala University Hospital and Danderyd Hospital. We also thank Dr Anna Tolli, Danderyd Hospital and Karolinska Institute, Dr Kristina Lindgren, Karlstad Hospital, Dr Bjorn Johansson, University Hospital Uppsala and Dr Christer Tengvar, University Hospital Uppsala, who assisted in assessment of patients. Paramedical staff contributing to the study included Stina Gunnarsson and Marina Bystrom Odhe, (Linkoping), Anna-Lisa Nilsson (Lima), Marie Sandgren (Stockholm), Steffan Stenson (Uppsala), and Siv Svensson (Gothenburg). Seija Lund was nurse coordinator in Stockholm and Ingrid Morberg in Gothenburg. Lisbet Broman gave advice on statistical aspects.	ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 2001, BMC EMERG MED, V1, P1; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Godbolt AK, 2011, AM J PHYS MED REHAB, V90, P482, DOI 10.1097/PHM.0b013e31820f9768; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; INGVAR DH, 1973, ACTA NEUROL SCAND, V49, P233; JENNETT B, 1972, LANCET, V1, P734; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; NHS Scotland, 2009, TRAUM BRAIN INJ TBI; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; TESSERIS J, 1991, ACTA NEUROCHIR, V110, P65, DOI 10.1007/BF01402050; the Multi-Society Task Force on PVS, 1994, N ENGL J MED, V330, P1572; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yamamoto T, 2010, EUR J NEUROSCI, V32, P1145, DOI 10.1111/j.1460-9568.2010.07412.x	29	22	22	1	10	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					741	748		10.2340/16501977-1167			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500008	24002309	Green Published, Green Submitted, gold			2022-02-06	
J	Hui, X; Haider, AH; Hashmi, ZG; Rushing, AP; Dhiman, N; Scott, VK; Selvarajah, S; Haut, ER; Efron, DT; Schneider, EB				Hui, Xuan; Haider, Adil H.; Hashmi, Zain G.; Rushing, Amy P.; Dhiman, Nitasha; Scott, Valerie K.; Selvarajah, Shalini; Haut, Elliott R.; Efron, David T.; Schneider, Eric B.			Increased risk of pneumonia among ventilated patients with traumatic brain injury: every day counts!	JOURNAL OF SURGICAL RESEARCH			English	Article						Pneumonia; Mechanical ventilation; Trauma; Traumatic brain injury	ACUTE LUNG INJURY; ASPIRATION; HEAD; EPIDEMIOLOGY; CARE	Background: Patients with traumatic brain injury (TBI) frequently require mechanical ventilation (MV). The objective of this study was to examine the association between time spent on MV and the development of pneumonia among patients with TBI. Materials and methods: Patients older than 18 y with head abbreviated injury scale (AIS) scores coded 1-6 requiring MV in the National Trauma Data Bank 2007-2010 data set were included. The study was limited to hospitals reporting pneumonia cases. AIS scores were calculated using ICDMAP-90 software. Patients with injuries in any other region with AIS score >3, significant burns, or a hospital length of stay >30 d were excluded. A generalized linear model was used to determine the approximate relative risk of developing all-cause pneumonia (aspiration pneumonia, ventilator-associated pneumonia [VAP], and infectious pneumonia identified by the International Classification of Disease, Ninth Revision, diagnosis code) for each day of MV, controlling for age, gender, Glasgow coma scale motor score, comorbidity (Charlson comorbidity index) score, insurance status, and injury type and severity. Results: Among the 24,525 patients with TBI who required MV included in this study, 1593 (6.5%) developed all-cause pneumonia. After controlling for demographic and injury factors, each additional day on the ventilator was associated with a 7% increase in the risk of pneumonia (risk ratio 1.07, 95% confidence interval 1.07-1.08). Conclusions: Patients who have sustained TBIs and require MV are at higher risk for VAP than individuals extubated earlier; therefore, shortening MV exposure will likely reduce the risk of VAP. As patients with TBI frequently require MV because of neurologic impairment, it is key to develop aggressive strategies to expedite ventilator independence. (C) 2013 Elsevier Inc. All rights reserved.	[Hui, Xuan; Haider, Adil H.; Hashmi, Zain G.; Rushing, Amy P.; Dhiman, Nitasha; Scott, Valerie K.; Selvarajah, Shalini; Haut, Elliott R.; Efron, David T.; Schneider, Eric B.] Johns Hopkins Univ, Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, Baltimore, MD 21287 USA		Haider, AH (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, 1800 New Orleans St,Zayed 6107, Baltimore, MD 21287 USA.	ahaider1@jhmi.edu	Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X	National Institutes of Health/National Institute of General Medical Science (NIGMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112-01]; American College of Surgeons; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112] Funding Source: NIH RePORTER	Financial support for this work was provided by the National Institutes of Health/National Institute of General Medical Science (NIGMS) K23GM093112-01 and American College of Surgeons C. James Carrico Fellowship for the Study of Trauma and Critical Care (Dr. Haider).	Adnet F, 1996, LANCET, V348, P123, DOI 10.1016/S0140-6736(05)64630-2; [Anonymous], 2010, MEDICARE FACT SHEET; Association for Professional in Infection Control and Epidemiology, 2009, GUID EL VENT ASS PNE; Besser RE, 2009, CDCS ROLE PREVENTING, P16; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 2012, NEW ENGL J MED; CIOCON JO, 1988, ARCH INTERN MED, V148, P429, DOI 10.1001/archinte.148.2.429; Clark DE, 2010, ICDPIC STATA MODULE; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; FINEGOLD SM, 1991, REV INFECT DIS, V13, pS737; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; GEORGE DL, 1995, CLIN CHEST MED, V16, P29; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kikawada M, 2005, DRUG AGING, V22, P115, DOI 10.2165/00002512-200522020-00003; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; MacKenzie E, 1997, ICDMAP 90 SOFTWARE U, P1; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Palmer BL, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000308961.99857.33; Semenov YR, 2012, LARYNGOSCOPE, V122, P1994, DOI 10.1002/lary.23446; Spicer Rebecca S, 2011, Ann Adv Automot Med, V55, P365; Straube B, 2009, HEALTH AFFAIR, V28, P1494, DOI 10.1377/hlthaff.28.5.1494; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019; VERGHESE A, 1983, MEDICINE, V62, P271, DOI 10.1097/00005792-198309000-00002	30	22	23	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2013	184	1					438	443		10.1016/j.jss.2013.05.072			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	207NX	WOS:000323609400072	23816243				2022-02-06	
J	Li, M; Hu, YH; Chen, G				Li, M.; Hu, Y. H.; Chen, G.			Hypernatremia severity and the risk of death after traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Hypernatremia; Intensive care unit; Mortality rate	INTENSIVE-CARE-UNIT; CRITICALLY-ILL; ACQUIRED HYPERNATREMIA; MORTALITY; SODIUM; SERUM; TOO	Purpose: To investigate the relationship between severity of hypernatremia and the risk of death for patients with traumatic brain injury (TBI) who have been admitted to the neurosurgical intensive care unit (NICU). Methods: A total of 1044 patients with TBI were admitted to our NICU from January 2005 to January 2010. Of these patients, 881 were included in this study. Based on blood serum sodium level in the NICU the 881 patients were divided into four groups: 614 had normal serum sodium (Na < 150 mmol/L), 34 had mild hypernatremia (Na 150-<155 mmol/L), 66 had moderate hypernatremia (Na 155-160 mmol/L) and 167 had severe hypernatremia (Na >= 160 mmol/L). Results: The mortality rates for the mild, moderate, and severe hypernatremia groups were 20.6%, 42.4%, and 86.8%, respectively; the mortality rate for the normal group was 2.0%. In multivariable analysis, mild, moderate, and severe hypernatremia were independent risk factors for mortality; compared with the normal group the odds ratios of mild, moderate, and severe hypernatremia were 9.50, 4.34, and 29.35, respectively. Conclusions: Severe hypernatremia is an independent risk factor with extremely high odds ratio for death in patients with TBI who are admitted to the NICU. (C) 2012 Elsevier Ltd. All rights reserved.	[Li, M.; Hu, Y. H.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Neurosurg Intens Care Unit, Hangzhou 310009, Zhejiang, Peoples R China; [Chen, G.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China		Chen, G (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, 88 Jie Fang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	Limin258481@163.com					Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Bullock MR, 1996, J NEUROTRAUM, V13, P705; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; GENNARI FJ, 1974, NEW ENGL J MED, V291, P714, DOI 10.1056/NEJM197410032911408; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Hoorn EJ, 2008, NEPHROL DIAL TRANSPL, V23, P1562, DOI 10.1093/ndt/gfm831; Howanitz JH, 2007, AM J CLIN PATHOL, V127, P56, DOI 10.1309/Q3Y27QQLEL19340A; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kumar S, 1998, LANCET, V352, P220, DOI 10.1016/S0140-6736(97)12169-9; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Lindner G, 2010, INTENS CARE MED, V36, P1718, DOI 10.1007/s00134-010-1968-4; Lindner G, 2009, AM J KIDNEY DIS, V54, P674, DOI 10.1053/j.ajkd.2009.04.015; LOEB JN, 1974, NEW ENGL J MED, V290, P1184, DOI 10.1056/NEJM197405232902107; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Mandal AK, 1997, AM J EMERG MED, V15, P130, DOI 10.1016/S0735-6757(97)90082-6; O'Donoghue SD, 2009, ANAESTHESIA, V64, P514, DOI 10.1111/j.1365-2044.2008.05857.x; Palevsky PM, 1996, ANN INTERN MED, V124, P197, DOI 10.7326/0003-4819-124-2-199601150-00002; Polderman KH, 1999, CRIT CARE MED, V27, P1105, DOI 10.1097/00003246-199906000-00029; Shea AM, 2008, J AM SOC NEPHROL, V19, P764, DOI 10.1681/ASN.2007070752; SNYDER NA, 1987, ANN INTERN MED, V107, P309, DOI 10.7326/0003-4819-107-2-309; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340	25	22	24	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1213	1218		10.1016/j.injury.2012.05.021			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600014	22709549				2022-02-06	
J	Roe, C; Skandsen, T; Anke, A; Ader, T; Vik, A; Lund, SB; Manskow, U; Sollid, S; Sundstrom, T; Hestnes, M; Andelic, N				Roe, Cecilie; Skandsen, Toril; Anke, Audny; Ader, Tiina; Vik, Anne; Lund, Stine Borgen; Manskow, Unn; Sollid, Snorre; Sundstrom, Terje; Hestnes, Morten; Andelic, Nada			SEVERE TRAUMATIC BRAIN INJURY IN NORWAY: IMPACT OF AGE ON OUTCOME	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; aged; treatment; outcome; prognosis	HEAD-INJURY; EPIDEMIOLOGY; MORTALITY; SCALE; HEMATOMA; MODERATE	Objective: The aim of this study was to investigate the influence of age on mortality and 3-month outcome in a Norwegian cohort of patients with severe traumatic brain injury. Methods: Norwegian residents >= 16 years of age who were admitted with a severe traumatic brain injury to the country's 4 major trauma centres in 2009 and 2010 were included, as were adults (16-64 years) and elderly patients (>= 65 years). Results: Half of the adult subjects and 84% of the elderly subjects were injured by falls. One-third of the adults and half of the elderly subjects were admitted to a local hospital before being transported to a regional trauma hospital. Subdural haematomas were more frequent in the elderly subjects. One-quarter of adults and two-thirds of the elderly subjects died within 3 months. At 3 months, 41% of the adult survivors were still in-patients, mainly in rehabilitation units (92%). Of the surviving elderly subjects, 14% were in-patients and none were in rehabilitation units. There was no difference in functional level for survivors at the 3-month follow-up. Conclusion: Old age is associated with fall-induced severe traumatic brain injury and high mortality rates. Less intensive treatment strategies were applied to elderly patients in the present study despite high rates of haemorrhage. Few surviving elderly patients received rehabilitation at 3 months post-injury.	[Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neurosci, Trondheim, Norway; [Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Vik, Anne; Lund, Stine Borgen] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Anke, Audny; Manskow, Unn] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Anke, Audny; Manskow, Unn] Univ Tromso, Inst Clin Med, Fac Hlth Sci, Tromso, Norway; [Sollid, Snorre] Univ Hosp North Norway, Dept Neurosurg, Tromso, Norway; [Sundstrom, Terje] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; [Sundstrom, Terje] Univ Bergen, Dept Biomed, Bergen, Norway; [Sundstrom, Terje] Univ Bergen, Dept Surg Sci, Bergen, Norway; [Ader, Tiina] Haukeland Hosp, Dept Phys Med & Rehabil, N-5021 Bergen, Norway; [Hestnes, Morten] Oslo Univ Hosp, Trauma Registry, Oslo, Norway		Roe, C (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	e.c.t.roe@medisin.uio.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338; Anke, Audny/0000-0002-2491-2560; Andelic, Nada/0000-0002-3719-4406; Sundstrom, Terje/0000-0002-6503-7141			Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Czosnyka M, 2005, ACT NEUR S, V95, P341; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Magnussen J, 2007, SOC SCI MED, V64, P2129, DOI 10.1016/j.socscimed.2007.02.018; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Protheroe RT, 2011, ANAESTHESIA, V66, P1035, DOI 10.1111/j.1365-2044.2011.06874.x; Sollid Snorre, 2008, Tidsskr Nor Laegeforen, V128, P1524; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, WHO GLOB REP FALLS P	40	22	22	0	5	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					734	740		10.2340/16501977-1198			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500007	24002308	Green Submitted, Green Published, gold			2022-02-06	
J	Smith, BA; Harmatys, KM; Xiao, SZ; Cole, EL; Plaunt, AJ; Wolter, W; Suckow, MA; Smith, BD				Smith, Bryan A.; Harmatys, Kara M.; Xiao, Shuzhang; Cole, Erin L.; Plaunt, Adam J.; Wolter, William; Suckow, Mark A.; Smith, Bradley D.			Enhanced Cell Death Imaging Using Multivalent Zinc(II)-bis(dipicolylamine) Fluorescent Probes	MOLECULAR PHARMACEUTICS			English	Article						cell death imaging; multivalency; zinc(II)-bis(dipicolylamine); in vivo fluorescence imaging; phosphatidylserine; squaraine rotaxane	COORDINATION-COMPLEXES; INDUCED APOPTOSIS; MOLECULAR PROBES; BRAIN-INJURY; FIND-ME; DEXAMETHASONE; CANCER; MICE; PHOSPHATIDYLSERINE; MECHANISMS	There is a clinical need for imaging technologies that can accurately detect cell death in a multitude of pathological conditions. Zinc(II)-bis(dipicolylamine) (Zn(2)BDPA) Coordination complexes are known to associate with the anionic phosphatidylserine that is exposed on the surface Of dead and dying : cells; and fluorescent Monovalent Zn(2)BDPA probes are :successful cell death imaging agents. This present study compared the membrane targeting ability of two structurally related deep red fluorescent probes, bis-Zn(2)BDPA-SR and tetra-Zn(2)BDPA-SR, with two and four appended Za(2)BDPA units, respectively. Vesicle and cell microscopy studies. indicated that a higher number Zn(2)BDPA targeting units improved probe, selectivity for phosphatidylserine-rich Vesicles, and increased probe localization at the plasma membrane of dead and dying cells. The fluorescent probes were also tested in three separate animal models, (1) necrotic prostate tumor rat model, (2) thymus atrophy mouse model, and (3) traumatic brain injury mouse model. In each case, there was more tetra-Zn(2)BDPA-SR accumulation at the site of cell death than bis-Zn(2)BDPA-SR. The results indicate that multivalent Zn(2)BDPA probes are promising molecules for effective imaging of cell death processes in cell culture and in living subjects.	[Smith, Bryan A.; Harmatys, Kara M.; Xiao, Shuzhang; Cole, Erin L.; Plaunt, Adam J.; Smith, Bradley D.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Wolter, William; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA		Smith, BD (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 236 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	smith.115@nd.edu	Suckow, Mark/C-2696-2014	Suckow, Mark/0000-0001-7317-697X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM059078, T32GM075762]; Notre Dame Integrated Imaging Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM059078, T32GM075762] Funding Source: NIH RePORTER	We are grateful for funding support from NIH grants R01GM059078 (to B.D.S.) and T32GM075762 (to B.A.S.) and the Notre Dame Integrated Imaging Facility. We thank Sarah Chapman in the NDIIF for technical assistance.	AHMED SA, 1994, IMMUNOPHARMACOLOGY, V28, P55; Blankenberg FG, 2012, J NUCL MED, V53, P1659, DOI 10.2967/jnumed.112.108944; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cole EL, 2012, ORG BIOMOL CHEM, V10, P5769, DOI 10.1039/c2ob06783h; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Englund EA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1629; Frey B, 2009, J IMMUNOTOXICOL, V6, P209, DOI 10.3109/15476910903204058; Gassensmith JJ, 2009, CHEM COMMUN, P6329, DOI 10.1039/b911064j; Hanshaw RG, 2005, CHEMBIOCHEM, V6, P2214, DOI 10.1002/cbic.200500149; Ichiyoshi H, 2003, EXP MOL PATHOL, V75, P178, DOI 10.1016/S0014-4800(03)00050-9; Jiang H, 2005, ORG LETT, V7, P3013, DOI 10.1021/ol0510421; Johnson JR, 2007, ANGEW CHEM INT EDIT, V46, P5528, DOI 10.1002/anie.200701491; Kawahara S, 2001, EUR J INORG CHEM, P2437; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Krachler AM, 2011, P NATL ACAD SCI USA, V108, P11614, DOI 10.1073/pnas.1102360108; Lakshmi C, 2004, TETRAHEDRON, V60, P11307, DOI 10.1016/j.tet.2004.08.052; Lambert TN, 2003, COORDIN CHEM REV, V240, P129, DOI 10.1016/S0010-8545(02)00257-6; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Munoz LE, 2007, J LEUKOCYTE BIOL, V81, P6, DOI 10.1189/jlb.0306166; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Smith BA, 2012, BIOCONJUGATE CHEM, V23, P1989, DOI 10.1021/bc3003309; Smith BA, 2012, ACS CHEM NEUROSCI, V3, P530, DOI 10.1021/cn3000197; Smith BA, 2011, APOPTOSIS, V16, P722, DOI 10.1007/s10495-011-0601-5; Smith BA, 2011, MOL PHARMACEUT, V8, P583, DOI 10.1021/mp100395u; Smith BA, 2010, J AM CHEM SOC, V132, P67, DOI 10.1021/ja908467y; Stoffel M, 2004, J NEUROTRAUM, V21, P733, DOI 10.1089/0897715041269678; SUN XM, 1992, BIOCHEM PHARMACOL, V44, P2131; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; White AG, 2012, BIOORG MED CHEM LETT, V22, P2833, DOI 10.1016/j.bmcl.2012.02.078; White AG, 2010, BIOCONJUGATE CHEM, V21, P1297, DOI 10.1021/bc1000998; Xiao SZ, 2013, TETRAHEDRON LETT, V54, P861, DOI 10.1016/j.tetlet.2012.11.103; Xiao SZ, 2010, ORG LETT, V12, P140, DOI 10.1021/ol902546m	37	22	22	2	69	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384	1543-8392		MOL PHARMACEUT	Mol. Pharm.	SEP	2013	10	9					3296	3303		10.1021/mp300720k			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	240WP	WOS:000326128700003	23915311	Green Accepted			2022-02-06	
J	King, EG; Kretzmer, TS; Vanderploeg, RD; Asmussen, SB; Clement, VL; Belanger, HG				King, Emily G.; Kretzmer, Tracy S.; Vanderploeg, Rodney D.; Asmussen, Sarah B.; Clement, Veronica L.; Belanger, Heather G.			Pilot of a Novel Intervention for Postconcussive Symptoms in Active Duty, Veterans, and Civilians	REHABILITATION PSYCHOLOGY			English	Article						mild TBI; postconcussive symptoms; psychoeducational intervention; computer intervention	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MINOR HEAD-INJURY; RANDOMIZED-TRIAL; MILITARY; CONCUSSION; IMPACT; REHABILITATION; PSYCHOTHERAPY; METAANALYSIS	Purpose/Objective: The authors present a study aimed at pilot testing a novel delivery method, namely a computer intervention, for postconcussive symptom reduction in active duty, veteran, and civilian patients with acute and chronic complaints. Following a concussion/mild traumatic brain injury (MTBI), most individuals recover completely, but a significant proportion report postconcussive symptoms months to years following the injury. Psychoeducational intervention has shown to be effective in reducing postconcussive symptoms in studies done with acute civilian samples, but the efficacy of psychoeducational interventions with individuals who served in combat or have chronic complaints remains unclear. Research Method/Design: Twenty-five active duty, veteran, and civilian participants took part in this study. At baseline, each participant completed a self-run psychoeducational computer-based treatment. Participants were reassessed 1-month postintervention via phone to evaluate postconconcussive symptom severity. Results: Participants reported significantly fewer postconcussive symptoms at follow-up than baseline (d = .99). Intervention satisfaction was reported, with feedback related to ease of use and quality. Conclusions/Implications: Extending previous studies, current findings demonstrated that psychoeducational intervention following MTBI was associated with postconcussive symptom complaint reduction in both acute and chronic patients. These data also confirm the feasibility of using computerized psychoeducation and speak to the importance of providing education to both acute and chronic patients across settings. Feedback from participants was generally positive. Further investigation with a control group is warranted.	[King, Emily G.; Kretzmer, Tracy S.; Vanderploeg, Rodney D.; Clement, Veronica L.; Belanger, Heather G.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Kretzmer, Tracy S.; Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Asmussen, Sarah B.; Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Asmussen, Sarah B.] DVBIC Concuss Clin Camp Pendleton & Navy Med Ctr, San Diego, CA USA		King, EG (corresponding author), Bay Pines VA Healthcare Syst, Mental Hlth & Behav Sci, St Petersburg, FL USA.	Emily.King@va.gov					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Barak A, 2008, J TECHNOL HUMAN SERV, V26, P109, DOI 10.1080/15228830802094429; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Department of Veterans Affairs and Department of Defense, CLIN PRACT GUID MAN; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, OXFORD WORKSHOP SERI; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rizzo A, 2011, J CLIN PSYCHOL MED S, V18, P176, DOI 10.1007/s10880-011-9247-2; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Strachan M, 2012, CONTEMP CLIN TRIALS, V33, P402, DOI 10.1016/j.cct.2011.11.007; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weathers FW, 1991, PCL C DSM 4	55	22	22	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2013	58	3					272	279		10.1037/a0033116			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	204ZB	WOS:000323408700006	23815304				2022-02-06	
